Citrus Sinensis ID: 011180

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-
Protein Sequence
MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPKPNGKQ
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccHHHccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccHHHHHHHHcccccccccccccccEEEEEEEccccccccccccccEEEEEEccccccccHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHccHHHHHHcccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHHcccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccEEEEEEEEEccccccccccccEEEEccccccccccccccEEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEEcccccccccccccEEEEEEEEccccccccHHHHHHHHHHHHHcccccEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEcccccccccccccccEEEEEEccccccccHHHHHccccccHcHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mglspesvkvknwevnnsdnnnnsksrkvkkkkdggaeqeeeeEIGCWVRFRFiescmpsrskvdssmsgtstnyadgkssnekrrdrpvvpvsstttsnaesasstpkfSEELKVASQLRKFMFNDLKlatrnfrpesllgeggfgcvfkgwveengtapvkpgtgLTVAVKTLNHDGLQGHKEWLAEVNFlgnllhpnLVKLVGYcieddqrllvyefmprgslenhlfrkgslplpwsIRMKIALGAAKGLAFLheeaekpviyrdfktsnilldadynaklsdfglakdapedgkthvstrvmgtygyaapeyvmtghltsksdVYSFGVVLLEMLTgrrsmdknrpngehnlvewarphlgdkrrfyrlldprleghfsikgsQKATQLAAQClsrdpkarprMSEVVETLKplqnlkdmassSYYFQTmqadntwsirnskngirtqggfmtrngqplrtlshpngphaspyrhpqqspkpngkq
Flexible Loop (DISEMBL)
mglspesvkvknwevnnsdnnnnsksrkvkkkkdggaeqeeeeeigcwvrFRFIESCMPsrskvdssmsgtstnyadgkssnekrrdrpvvpvsstttsnaesasstpkfsEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFglakdapedgkthvstrVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTgrrsmdknrpngehnlvewarphlgdkRRFYRLLDPRLEGHfsikgsqkaTQLAAQCLsrdpkarprMSEVVEtlkplqnlkDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGphaspyrhpqqspkpngkq
Low Complexity Region (SEG)
MGLSPESVKvknwevnnsdnnnnsksrkvkkkkDGGAeqeeeeeIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVsstttsnaesasstPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPKPNGKQ
Disordered region (IsUnstruct)
********************************************IGCWVRFRFIESC*************************************************************QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD*****KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG*************NLVEWARPHLGDKRRFYRLLDPRLEGHFSI********************************************YYFQTMQADNTWSI************************************************
Disordered Region (DISOPRED)
*********************************************GCWVRFR********************************************************************RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL************************************************************************
Disordered Region (DISEMBL)
MGLSPESVKVKNWEVNNSDNNNN********************EIGCWVRFRFIESCM******************************************************ELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIK************************EVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGP******************
Disordered Region (DISPRO)
***SPESVKVKNWEVNNSD********KVKKKKD*GAEQEEEEEIGCWVRFRFIESCM***********************************************************SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL*********************************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPKPNGKQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	491	2.2.26 [Sep-21-2011]
Q9LFP7	493	Probable receptor-like pr	yes	no	0.973	0.969	0.762	0.0
Q9SRH7	490	Receptor-like serine/thre	no	no	0.910	0.912	0.787	0.0
Q8GXZ3	410	Serine/threonine-protein	no	no	0.647	0.775	0.664	1e-124
Q06548	410	Protein kinase APK1A, chl	no	no	0.714	0.856	0.584	1e-124
P46573	412	Protein kinase APK1B, chl	no	no	0.647	0.771	0.644	1e-123
P43293	389	Probable serine/threonine	no	no	0.661	0.835	0.621	1e-123
O49840	426	Protein kinase 2B, chloro	no	no	0.745	0.859	0.592	1e-122
O48814	395	Serine/threonine-protein	no	no	0.712	0.886	0.562	1e-118
O49839	426	Protein kinase 2A, chloro	no	no	0.745	0.859	0.571	1e-117
Q8H186	389	Probable receptor-like pr	no	no	0.627	0.791	0.602	1e-113

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  738 bits (1905), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 382/501 (76%), Positives = 414/501 (82%), Gaps = 23/501 (4%)

Query: 1   MGLSPESVKVK-NW--EVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESC 57
           MGL  ++VK K NW  E      N N K +     K    E+EE E  GCWV+FRF+  C
Sbjct: 1   MGL--DAVKAKGNWKSEKPKETENKNHKKKNGDDNKSRNEEEEEGEASGCWVKFRFMIGC 58

Query: 58  MPSRSKVDSSMSG-----TSTNYADGKSSNEKRRDRPVVPVSSTTT-SNAESASSTPKFS 111
           +PS+S +D+S S       +    + KS+NEK  D+PV  VSSTTT SNAES+SSTP  S
Sbjct: 59  IPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVIS 118

Query: 112 EELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
           EEL ++S LRKF FNDLKL+TRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVA
Sbjct: 119 EELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVA 178

Query: 172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 231
           VKTLN DGLQGHKEWLAE+NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF
Sbjct: 179 VKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 238

Query: 232 RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 291
           R+ SLPLPWSIRMKIALGAAKGL+FLHEEA KPVIYRDFKTSNILLDADYNAKLSDFGLA
Sbjct: 239 RR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLA 297

Query: 292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           KDAP++GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP
Sbjct: 298 KDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 357

Query: 352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
           NGEHNLVEWARPHL DKRRFYRLLDPRLEGHFSIKG+QK TQLAAQCLSRDPK RP+MS+
Sbjct: 358 NGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSD 417

Query: 412 VVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQ---PLRTLS 468
           VVE LKPL +LKDMASSSYYFQTMQA+        KNG     GF +RNGQ     RTLS
Sbjct: 418 VVEALKPLPHLKDMASSSYYFQTMQAERL------KNGSGRSQGFGSRNGQHQPVFRTLS 471

Query: 469 HPNGPHASPYRHPQQSPKPNG 489
            P+G  +SPYRH   SPKP G
Sbjct: 472 SPHG--SSPYRHQIPSPKPKG 490

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  711 bits (1835), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 359/456 (78%), Positives = 394/456 (86%), Gaps = 9/456 (1%)

Query: 37  AEQEEEEEIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSST 96
           +E  EEE  GCWV+FR+I  C  S S V++S++  ST+    +S+  +  D+PV PVSST
Sbjct: 38  SEHYEEEANGCWVKFRYIVCCASSTSDVETSLT-LSTSTVGSQSAIVQSNDQPVGPVSST 96

Query: 97  TT-SNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVE 155
           TT SNAES+ STP  SEEL + S L+KF F DLKLATRNFRPESLLGEGGFGCVFKGWVE
Sbjct: 97  TTTSNAESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVE 156

Query: 156 ENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL 215
           ENGTAPVKPGTGLTVAVKTLN DGLQGHKEWLAE+N+LGNLLHPNLVKLVGYCIEDDQRL
Sbjct: 157 ENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRL 216

Query: 216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 275
           LVYEFMPRGSLENHLFR+ SLPLPWSIRMKIALGAAKGL+FLHEEA KPVIYRDFKTSNI
Sbjct: 217 LVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNI 275

Query: 276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVV 335
           LLD +YNAKLSDFGLAKDAP++GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVV
Sbjct: 276 LLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVV 335

Query: 336 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLA 395
           LLEMLTGRRSMDKNRPNGEHNLVEWARPHL DKRRFYRLLDPRLEGHFS+KG+QK TQLA
Sbjct: 336 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLA 395

Query: 396 AQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGG 455
           AQCLSRD K RP+MSEVVE LKPL +LKDMAS+SYYFQTMQA+       + +G  +  G
Sbjct: 396 AQCLSRDSKIRPKMSEVVEVLKPLPHLKDMASASYYFQTMQAERL----KAGSGSGSGRG 451

Query: 456 FMTRNGQPL-RTLSHPNG-PHASPYRHPQQSPKPNG 489
           F +RNGQP+ RTLS P+G   +SPYRH   SPKP G
Sbjct: 452 FGSRNGQPVFRTLSSPHGQAGSSPYRHQIPSPKPKG 487

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  445 bits (1144), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 216/325 (66%), Positives = 260/325 (80%), Gaps = 7/325 (2%)

Query: 103 SASSTPKFSEELKVA---SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 159
           S  STP+F ++ +     +Q+  F   +L+  T++FRP+ +LGEGGFG V+KG++++N  
Sbjct: 34  SDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLR 93

Query: 160 APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE 219
             +K    L VAVK LN +GLQGH+EWL EVNFLG L HPNLVKL+GYC EDD RLLVYE
Sbjct: 94  VGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYE 150

Query: 220 FMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 279
           FM RGSLENHLFRK + PL WS RM IALGAAKGLAFLH  AE+PVIYRDFKTSNILLD+
Sbjct: 151 FMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDS 209

Query: 280 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 339
           DY AKLSDFGLAK  P+  +THVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLEM
Sbjct: 210 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEM 269

Query: 340 LTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 399
           LTGR+S+DK RP+ E NLV+WARP L DKR+  +++DPRLE  +S++ +QKA  LA  CL
Sbjct: 270 LTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCL 329

Query: 400 SRDPKARPRMSEVVETLKPLQNLKD 424
           S++PKARP MS+VVETL+PLQ   D
Sbjct: 330 SQNPKARPLMSDVVETLEPLQCTGD 354

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  444 bits (1142), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 215/368 (58%), Positives = 274/368 (74%), Gaps = 17/368 (4%)

Query: 57  CMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKV 116
           C+ ++ K +SS + T  +  D  S   K     V P              +P+   E+  
Sbjct: 4   CLSAQVKAESSGASTKYDAKDIGSLGSKASSVSVRP--------------SPRTEGEILQ 49

Query: 117 ASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN 176
           +  L+ F F +LK ATRNFRP+S+LGEGGFGCVFKGW++E      +PGTGL +AVK LN
Sbjct: 50  SPNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLN 109

Query: 177 HDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL 236
            DG QGH+EWLAEVN+LG   H +LVKL+GYC+ED+ RLLVYEFMPRGSLENHLFR+G  
Sbjct: 110 QDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLY 169

Query: 237 --PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
             PL W +R+K+ALGAAKGLAFLH  +E  VIYRDFKTSNILLD++YNAKLSDFGLAKD 
Sbjct: 170 FQPLSWKLRLKVALGAAKGLAFLHS-SETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDG 228

Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 354
           P   K+HVSTRVMGT+GYAAPEY+ TGHLT+KSDVYSFGVVLLE+L+GRR++DKNRP+GE
Sbjct: 229 PIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGE 288

Query: 355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
            NLVEWA+P+L +KR+ +R++D RL+  +S++ + K   L+ +CL+ + K RP MSEVV 
Sbjct: 289 RNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVS 348

Query: 415 TLKPLQNL 422
            L+ +Q+L
Sbjct: 349 HLEHIQSL 356

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  443 bits (1140), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 207/321 (64%), Positives = 257/321 (80%), Gaps = 3/321 (0%)

Query: 106 STPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPG 165
           + P+   E+  +  L+ F F +LK ATRNFRP+S+LGEGGFG VFKGW++E      KPG
Sbjct: 40  TNPRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPG 99

Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           TG+ +AVK LN DG QGH+EWLAEVN+LG   HPNLVKL+GYC+ED+ RLLVYEFMPRGS
Sbjct: 100 TGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGS 159

Query: 226 LENHLFRKGSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 283
           LENHLFR+GS   PL W++R+K+ALGAAKGLAFLH  AE  VIYRDFKTSNILLD++YNA
Sbjct: 160 LENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNA 218

Query: 284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           KLSDFGLAKD P   K+HVSTR+MGTYGYAAPEY+ TGHLT+KSDVYS+GVVLLE+L+GR
Sbjct: 219 KLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGR 278

Query: 344 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP 403
           R++DKNRP GE  LVEWARP L +KR+ +R++D RL+  +S++ + K   LA +CL+ + 
Sbjct: 279 RAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEI 338

Query: 404 KARPRMSEVVETLKPLQNLKD 424
           K RP M+EVV  L+ +Q L +
Sbjct: 339 KLRPNMNEVVSHLEHIQTLNE 359

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  443 bits (1139), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 204/328 (62%), Positives = 263/328 (80%), Gaps = 3/328 (0%)

Query: 99  SNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENG 158
           S+  S S  P+   E+   + L+ F  ++LK ATRNFRP+S++GEGGFGCVFKGW++E+ 
Sbjct: 32  SSTASFSYMPRTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESS 91

Query: 159 TAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY 218
            AP KPGTG+ +AVK LN +G QGH+EWLAE+N+LG L HPNLVKL+GYC+E++ RLLVY
Sbjct: 92  LAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVY 151

Query: 219 EFMPRGSLENHLFRKGSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL 276
           EFM RGSLENHLFR+G+   PL W+ R+++ALGAA+GLAFLH  A+  VIYRDFK SNIL
Sbjct: 152 EFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNIL 210

Query: 277 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 336
           LD++YNAKLSDFGLA+D P    +HVSTRVMGT GYAAPEY+ TGHL+ KSDVYSFGVVL
Sbjct: 211 LDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVL 270

Query: 337 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA 396
           LE+L+GRR++DKN+P GEHNLV+WARP+L +KRR  R++DPRL+G +S+  + K   LA 
Sbjct: 271 LELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLAL 330

Query: 397 QCLSRDPKARPRMSEVVETLKPLQNLKD 424
            C+S D K+RP M+E+V+T++ L   K+
Sbjct: 331 DCISIDAKSRPTMNEIVKTMEELHIQKE 358

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  439 bits (1129), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 218/368 (59%), Positives = 272/368 (73%), Gaps = 2/368 (0%)

Query: 57  CMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESAS-STPKFSEELK 115
           C+ S +KVDSS      N A   S    +  R  VP S +  S +   S  TP+   E+ 
Sbjct: 4   CLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEGEIL 63

Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
            +  L+ F FN+LK ATRNFRP+SLLGEGGFG VFKGW++       KPG+G+ VAVK L
Sbjct: 64  SSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKL 123

Query: 176 NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS 235
             +G QGHKEWL EVN+LG L HPNLVKLVGYC+E + RLLVYEFMP+GSLENHLFR+G+
Sbjct: 124 KTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGA 183

Query: 236 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 295
            PL W+IRMK+A+GAAKGL FLH +A+  VIYRDFK +NILLDA++N+KLSDFGLAK  P
Sbjct: 184 QPLTWAIRMKVAIGAAKGLTFLH-DAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGP 242

Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
              KTHVST+VMGT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GRR++DK++   E 
Sbjct: 243 TGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQ 302

Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 415
           +LV+WA P+LGDKR+ +R++D RL G +  KG+  A  LA QCL+ D K RP+MSEV+  
Sbjct: 303 SLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAK 362

Query: 416 LKPLQNLK 423
           L  L++ K
Sbjct: 363 LDQLESTK 370

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  424 bits (1091), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 207/368 (56%), Positives = 267/368 (72%), Gaps = 18/368 (4%)

Query: 56  SCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELK 115
           SC  SR K D   +G S++      S+ K        V++   +  E  SSTP       
Sbjct: 3   SCFSSRVKADIFHNGKSSDLYGLSLSSRKSS----STVAAAQKTEGEILSSTP------- 51

Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
               ++ F FN+LKLATRNFRP+S++GEGGFGCVFKGW++E+   P KPGTGL +AVK L
Sbjct: 52  ----VKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKL 107

Query: 176 NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS 235
           N +G QGH+EWL E+N+LG L HPNLVKL+GYC+ED+ RLLVYEFM +GSLENHLFR+G+
Sbjct: 108 NQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGA 167

Query: 236 L--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 293
              PLPW +R+ +AL AAKGLAFLH +  K VIYRD K SNILLDADYNAKLSDFGLA+D
Sbjct: 168 YFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLSDFGLARD 226

Query: 294 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 353
            P    ++VSTRVMGTYGYAAPEY+ +GHL ++SDVYSFGV+LLE+L+G+R++D NRP  
Sbjct: 227 GPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAK 286

Query: 354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
           E NLV+WARP+L  KR+   ++D RL+  +  + + +   +A QCLS +PK+RP M +VV
Sbjct: 287 EENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVV 346

Query: 414 ETLKPLQN 421
             L+ LQ+
Sbjct: 347 RALQQLQD 354

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  421 bits (1083), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 212/371 (57%), Positives = 272/371 (73%), Gaps = 5/371 (1%)

Query: 56  SCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVP--VSSTTTSNAESASSTPKFSEE 113
           +C+ S +KVD+S      N A   S    +  R   P  +S+T+ S   S    P    E
Sbjct: 3   NCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLRTE 62

Query: 114 LKVAS--QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
            ++ S   L+ F FN+LK AT+NFR ++LLGEGGFGCVFKGW+++      +PG+G+ VA
Sbjct: 63  GEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVA 122

Query: 172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 231
           VK L  +G QGHKEWL EVN+LG L HPNLV LVGYC E + RLLVYEFMP+GSLENHLF
Sbjct: 123 VKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF 182

Query: 232 RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 291
           R+G+ PL W+IRMK+A+GAAKGL FLH EA+  VIYRDFK +NILLDAD+NAKLSDFGLA
Sbjct: 183 RRGAQPLTWAIRMKVAVGAAKGLTFLH-EAKSQVIYRDFKAANILLDADFNAKLSDFGLA 241

Query: 292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           K  P    THVST+V+GT+GYAAPEYV TG LT+KSDVYSFGVVLLE+++GRR+MD +  
Sbjct: 242 KAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNG 301

Query: 352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
             E++LV+WA P+LGDKR+ +R++D +L G +  KG+  A  LA QCL+ D K RP+MSE
Sbjct: 302 GNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSE 361

Query: 412 VVETLKPLQNL 422
           V+ TL+ L+++
Sbjct: 362 VLVTLEQLESV 372

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  408 bits (1049), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 188/312 (60%), Positives = 242/312 (77%), Gaps = 4/312 (1%)

Query: 113 ELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAV 172
           E+  ++ ++ F FN+LKLATRNFR +S++GEGGFGCVF+GW++E    P K  +GL +AV
Sbjct: 39  EILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIAV 98

Query: 173 KTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
           K LN DG QGH+EWL E+N+LG L HPNLVKL+GYC+ED+QRLLVYEFM +GSLENHLF 
Sbjct: 99  KRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFA 158

Query: 233 KGSL---PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG 289
            G+    PL W +R+K+AL AAKGLAFLH +  K VIYRD K SNILLD+D+NAKLSDFG
Sbjct: 159 NGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDSDFNAKLSDFG 217

Query: 290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 349
           LA+D P   +++VSTRVMGT+GYAAPEYV TGHL ++SDVYSFGVVLLE+L GR+++D N
Sbjct: 218 LARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHN 277

Query: 350 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 409
           RP  E NLV+WARP+L  +R+   ++D RL   +  +G+ +   +A QCLS +PK+RP M
Sbjct: 278 RPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTM 337

Query: 410 SEVVETLKPLQN 421
            +VV  L  LQ+
Sbjct: 338 DQVVRALVQLQD 349

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	491
255552850	479	Protein kinase APK1B, chloroplast precur	0.971	0.995	0.825	0.0
224077698	480	predicted protein [Populus trichocarpa]	0.969	0.991	0.819	0.0
359473277	481	PREDICTED: probable receptor-like protei	0.967	0.987	0.795	0.0
255558222	495	Protein kinase APK1B, chloroplast precur	0.979	0.971	0.784	0.0
359488899	475	PREDICTED: probable receptor-like protei	0.961	0.993	0.793	0.0
147857978	495	hypothetical protein VITISV_008843 [Viti	0.969	0.961	0.777	0.0
356567562	487	PREDICTED: probable receptor-like protei	0.902	0.909	0.843	0.0
356526888	487	PREDICTED: probable receptor-like protei	0.902	0.909	0.839	0.0
351722951	485	serine/threonine protein kinase-like pro	0.910	0.921	0.826	0.0
356498172	491	PREDICTED: probable receptor-like protei	0.900	0.900	0.830	0.0

>gi|255552850|ref|XP_002517468.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223543479|gb|EEF45010.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  821 bits (2120), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 406/492 (82%), Positives = 433/492 (88%), Gaps = 15/492 (3%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGL P+S+KVKN E  +    N               + EEE+EIGCW + R I  CMPS
Sbjct: 1   MGLGPDSLKVKNLEDKSKKKKN--------------KKDEEEKEIGCWPKLRLIGGCMPS 46

Query: 61  RSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPV-SSTTTSNAESASSTPKFSEELKVASQ 119
           RSKVD+S+SGT+  Y + KS+ EK +D+PVVPV SSTTTSN ESASSTPKFSEELK+ASQ
Sbjct: 47  RSKVDNSLSGTTAQYVESKSTEEKSKDQPVVPVISSTTTSNGESASSTPKFSEELKLASQ 106

Query: 120 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 179
           LR F FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVAVKTLNHDG
Sbjct: 107 LRIFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 166

Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
           LQGHKEWLAEV+FLGNLLHPNLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP
Sbjct: 167 LQGHKEWLAEVSFLGNLLHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 226

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
           WSIRMKIALGAAKGLAFLHEEAE+ VIYRDFKTSNILLDADYNAKLSDFGLAKD PE GK
Sbjct: 227 WSIRMKIALGAAKGLAFLHEEAERSVIYRDFKTSNILLDADYNAKLSDFGLAKDGPESGK 286

Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 359
           THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE
Sbjct: 287 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346

Query: 360 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           WARPH GD+RRFYRLLDPRLEGHFSIKG+QKA QLA+QCLSRDPKARPRMSEVVETLKPL
Sbjct: 347 WARPHFGDRRRFYRLLDPRLEGHFSIKGAQKAIQLASQCLSRDPKARPRMSEVVETLKPL 406

Query: 420 QNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYR 479
            NLKDMASSSYYFQTMQAD   S  ++KNGIRTQ GF+TRNGQPLR+LS  +   ASPY 
Sbjct: 407 PNLKDMASSSYYFQTMQADRNKSNMHTKNGIRTQAGFVTRNGQPLRSLSSLSDTRASPYN 466

Query: 480 HPQQSPKPNGKQ 491
            P QSPKPNGK+
Sbjct: 467 QPYQSPKPNGKK 478

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224077698|ref|XP_002305368.1| predicted protein [Populus trichocarpa] gi|222848332|gb|EEE85879.1| predicted protein [Populus trichocarpa]

 Score =  807 bits (2084), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 403/492 (81%), Positives = 431/492 (87%), Gaps = 16/492 (3%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGLSP+SVKVKN            +  K KK K     +++EE+IGCW +FR   SCMPS
Sbjct: 1   MGLSPDSVKVKN----------FKEKSKSKKNKKNQGNEKDEEDIGCWFKFRSTGSCMPS 50

Query: 61  RSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPV--SSTTTSNAESASSTPKFSEELKVAS 118
           RSKVDSS+SG ST+Y   KS NEK +D+P+VP   S+TTTSNAESASS P FSEELK+AS
Sbjct: 51  RSKVDSSLSGISTHYVPSKSKNEKNKDQPIVPAMSSTTTTSNAESASSLPTFSEELKLAS 110

Query: 119 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 178
           QLRKF FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVAVKTLNHD
Sbjct: 111 QLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 170

Query: 179 GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL 238
           GLQGHKEWLAEV+FLGNLLH NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR+ SLPL
Sbjct: 171 GLQGHKEWLAEVSFLGNLLHKNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPL 229

Query: 239 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 298
           PWSIRMKIALGAA+GLAFLHEEA++PVIYRDFKTSNILLDADYNAKLSDFGLAKDAP+ G
Sbjct: 230 PWSIRMKIALGAAQGLAFLHEEADRPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDGG 289

Query: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358
           KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV
Sbjct: 290 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 349

Query: 359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP 418
           EWARPH GDKRRFYRLLDPRLEGHFSIKG+QK  QLAAQCLSRDPKARP+MSEVVE LKP
Sbjct: 350 EWARPHFGDKRRFYRLLDPRLEGHFSIKGAQKGIQLAAQCLSRDPKARPQMSEVVEALKP 409

Query: 419 LQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPY 478
           L NLKDMASSSYYFQ+MQAD   S  N+KNG RTQ GF+TRNGQPLR+LS      ASPY
Sbjct: 410 LPNLKDMASSSYYFQSMQADRNKSNMNAKNGTRTQAGFVTRNGQPLRSLSD---VRASPY 466

Query: 479 RHPQQSPKPNGK 490
             PQQSPKP G+
Sbjct: 467 NQPQQSPKPKGR 478

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359473277|ref|XP_003631281.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] gi|296086431|emb|CBI32020.3| unnamed protein product [Vitis vinifera]

 Score =  796 bits (2055), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 394/495 (79%), Positives = 432/495 (87%), Gaps = 20/495 (4%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGL    VKV++WEV  S         K +KKKDGG    EEE   CWV+ RF+ SC+ S
Sbjct: 1   MGLGGNDVKVESWEVGKS---------KGRKKKDGG----EEETGCCWVKLRFMASCISS 47

Query: 61  RSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPV-SSTTTSNAESASSTPKFSEELKVASQ 119
           RSKVDSS+SGTST+Y + +S+N+  RD+PV PV SSTTTSNAES SST K  EELKVAS+
Sbjct: 48  RSKVDSSISGTSTHY-ENRSTNDTSRDQPVAPVVSSTTTSNAESNSSTSKLEEELKVASR 106

Query: 120 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 179
           LRKF FNDLK+ATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVAVKTLNHDG
Sbjct: 107 LRKFSFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 166

Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
           LQGHKEWLAEVNFLG+L+HPNLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFR+ +LPLP
Sbjct: 167 LQGHKEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-ALPLP 225

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
           W+IRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDA+YNAKLSDFGLAKD PE  K
Sbjct: 226 WAIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDK 285

Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 359
           THVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE
Sbjct: 286 THVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 345

Query: 360 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           WARPHLG++RRFYRL+DPRLEGHFSIKG+QKA QLAA CLSRDPK RP MSEVVE LKPL
Sbjct: 346 WARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPL 405

Query: 420 QNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNG-QPLRTLSHPNGPHASPY 478
            NLKDMASSSYYFQTMQA+   S  N++NG+RTQ G ++RNG Q  R+LS PNG HASPY
Sbjct: 406 PNLKDMASSSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPY 465

Query: 479 ---RHPQQSPKPNGK 490
              ++P QSPKPNGK
Sbjct: 466 HQNQYPYQSPKPNGK 480

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255558222|ref|XP_002520138.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223540630|gb|EEF42193.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  787 bits (2033), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 396/505 (78%), Positives = 428/505 (84%), Gaps = 24/505 (4%)

Query: 1   MGLSPES---VKVKNWEVNNSDNNNNSKSRKVKKKKD-----GGA---EQEEEEEIGCWV 49
           MGL  E     K  +WEV      N       KKK+D     GGA   +  EE E GCW 
Sbjct: 1   MGLGSEDGNRAKASSWEVCKPKGRN-------KKKQDVSNSSGGASPGDVVEEAETGCWF 53

Query: 50  RFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVP-VSSTTTSNAESASSTP 108
           +FRFI SC+ SRSKVDSS+SGTST + + KS+N+  RD+P  P +SSTTTSNAES SST 
Sbjct: 54  KFRFIGSCISSRSKVDSSVSGTST-HCESKSTNDTSRDQPTAPTISSTTTSNAESNSSTS 112

Query: 109 KFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGL 168
           K  EELK+AS+LRKF FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGL
Sbjct: 113 KLEEELKIASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGL 172

Query: 169 TVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN 228
           TVAVKTLNHDGLQGHKEWLAEVN+LG+L+HPNLVKL+GYCIEDDQRLLVYEFMPRGSLEN
Sbjct: 173 TVAVKTLNHDGLQGHKEWLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLEN 232

Query: 229 HLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF 288
           HLFR+ SLPLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDADYNAKLSDF
Sbjct: 233 HLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDF 291

Query: 289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDK 348
           GLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEM+TGRRSMDK
Sbjct: 292 GLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDK 351

Query: 349 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 408
           NRP GEHNLVEWARPHLG++RRFYRL+DPRLEGHFSIKG+QKA QLAA CLSRDPKARP 
Sbjct: 352 NRPIGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPL 411

Query: 409 MSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLS 468
           MSEVVE LKPL NLKDMASSSYYFQ+MQAD   S  N+K+  RTQGG + RNGQ  R+LS
Sbjct: 412 MSEVVEVLKPLPNLKDMASSSYYFQSMQADKIASSPNAKSSNRTQGGLL-RNGQQQRSLS 470

Query: 469 HPNGPHASPYRH--PQQSPKPNGKQ 491
            PNG HASPY H  P QSPKPNGKQ
Sbjct: 471 IPNGSHASPYHHQYPFQSPKPNGKQ 495

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488899|ref|XP_003633841.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera]

 Score =  781 bits (2018), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 389/490 (79%), Positives = 425/490 (86%), Gaps = 18/490 (3%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGL P++++V NWEV NS         K +KKKD     +EEE  GCW++FRF+ SCM +
Sbjct: 1   MGLGPDAIQVGNWEVGNS---------KGRKKKD-----DEEEATGCWIKFRFMGSCMSA 46

Query: 61  RSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPV-SSTTTSNAESASSTPKFSEELKVASQ 119
           RSKV+SS+S +ST YA+ KS+N+  RD+PV PV SS+TTSN ES  STP   EELKVASQ
Sbjct: 47  RSKVESSVSSSSTQYAESKSTNDTSRDQPVAPVVSSSTTSNGESTPSTPNTGEELKVASQ 106

Query: 120 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 179
           LRKF FN+LK ATRNFRPESLLGEGGFGCVFKGW+   GT PVKPGTGLTVAVKTLNHDG
Sbjct: 107 LRKFTFNELKSATRNFRPESLLGEGGFGCVFKGWINGTGTTPVKPGTGLTVAVKTLNHDG 166

Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
           LQGHKEWLAEVNFLG+LLHPNLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFR+ +LPLP
Sbjct: 167 LQGHKEWLAEVNFLGDLLHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-ALPLP 225

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
           WSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLD DYNAKLSDFGLAKD PE  K
Sbjct: 226 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDVDYNAKLSDFGLAKDGPEGDK 285

Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 359
           THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE
Sbjct: 286 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 345

Query: 360 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           WARPHLG++RRFYRLLDPRLEG FSIKG+QKA QLAA CLSRDPKARP MSEVVE LKPL
Sbjct: 346 WARPHLGERRRFYRLLDPRLEGRFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 405

Query: 420 QNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYR 479
            NLKDMASSS +FQTMQA+ T S  NS++GIR Q GF++RNGQP R+LS PNGPHASPY 
Sbjct: 406 PNLKDMASSSSFFQTMQAERTGSTPNSRSGIRAQAGFLSRNGQPNRSLSMPNGPHASPYN 465

Query: 480 H--PQQSPKP 487
           H  P +SPKP
Sbjct: 466 HNNPHRSPKP 475

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147857978|emb|CAN82516.1| hypothetical protein VITISV_008843 [Vitis vinifera]

 Score =  781 bits (2018), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/508 (77%), Positives = 430/508 (84%), Gaps = 32/508 (6%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGL    VKV++WEV  S         K +KKKDGG    EEE   CWV+ RF+ SC+ S
Sbjct: 1   MGLGGNDVKVESWEVGKS---------KGRKKKDGG----EEETGCCWVKLRFMASCISS 47

Query: 61  RSKVDSSMSGTSTNYADGKSSN-EKR------------RDRPVVPV-SSTTTSNAESASS 106
           RSKVDSS+SGTST+Y  G   + E R            RD+PV PV SSTTTSNAES SS
Sbjct: 48  RSKVDSSISGTSTHYDLGVXFDVEPRSLNVFWCDFGLCRDQPVAPVVSSTTTSNAESNSS 107

Query: 107 TPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGT 166
           T K  EELKVAS+LRKF FNDLK+ATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGT
Sbjct: 108 TSKLEEELKVASRLRKFSFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 167

Query: 167 GLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 226
           GLTVAVKTLNHDGLQGHKEWLAEVNFLG+L+HPNLVKL+GYCIEDDQRLLVYEFMPRGSL
Sbjct: 168 GLTVAVKTLNHDGLQGHKEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSL 227

Query: 227 ENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 286
           ENHLFR+ +LPLPW+IRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDA+YNAKLS
Sbjct: 228 ENHLFRR-ALPLPWAIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLS 286

Query: 287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 346
           DFGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSM
Sbjct: 287 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 346

Query: 347 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           DKNRPNGEHNLVEWARPHLG++RRFYRL+DPRLEGHFSIKG+QKA QLAA CLSRDPK R
Sbjct: 347 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVR 406

Query: 407 PRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNG-QPLR 465
           P MSEVVE LKPL NLKDMASSSYYFQTMQA+   S  N++NG+RTQ G ++RNG Q  R
Sbjct: 407 PLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQR 466

Query: 466 TLSHPNGPHASPY---RHPQQSPKPNGK 490
           +LS PNG HASPY   ++P QSPKPNGK
Sbjct: 467 SLSIPNGSHASPYHQNQYPYQSPKPNGK 494

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356567562|ref|XP_003551987.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max]

 Score =  779 bits (2012), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 378/448 (84%), Positives = 406/448 (90%), Gaps = 5/448 (1%)

Query: 46  GCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPV-SSTTTSNAESA 104
           GCW R RFI SC+ SRSKVDSS+SGTSTNYA+ KS+ +  RD+P VPV SSTTTSNAES 
Sbjct: 41  GCWFRLRFIGSCISSRSKVDSSVSGTSTNYAESKSTIDTSRDQPTVPVVSSTTTSNAESN 100

Query: 105 SSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 164
           SST K  EE KV+S+LRKF FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKP
Sbjct: 101 SSTSKLEEEFKVSSRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160

Query: 165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
           GTGLTVAVKTLNHDGLQGHKEWLAEVN+LG+L+HP+LVKL+GYCIEDDQRLLVYEFMPRG
Sbjct: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRG 220

Query: 225 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 284
           SLENHLFR+ SLPLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDA+YNAK
Sbjct: 221 SLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAK 279

Query: 285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
           LSDFGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRR
Sbjct: 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 339

Query: 345 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 404
           SMDKNRPNGEHNLVEWARPHLG++RRFYRL+DPRLEGHFSIKG+QKA  LAA CLSRDPK
Sbjct: 340 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPK 399

Query: 405 ARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPL 464
           ARP MSEVVE LKPL NLKDMASSSYYFQTMQAD   +  N++NG RTQG  +TRNGQ  
Sbjct: 400 ARPLMSEVVEALKPLPNLKDMASSSYYFQTMQADRFSASPNTRNG-RTQGALLTRNGQQQ 458

Query: 465 RTLSHPNGPHASPYRH--PQQSPKPNGK 490
           R+LS P+G HASPY H  PQ SPKPNGK
Sbjct: 459 RSLSIPHGTHASPYHHQFPQPSPKPNGK 486

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356526888|ref|XP_003532048.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max]

 Score =  773 bits (1997), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/448 (83%), Positives = 405/448 (90%), Gaps = 5/448 (1%)

Query: 46  GCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVV-PVSSTTTSNAESA 104
           GCW R RFI SC+ SRSKVDSS+SGTSTNYA+ KS+ +  RD+P +  VSSTTTSNAES 
Sbjct: 41  GCWFRLRFIGSCISSRSKVDSSVSGTSTNYAESKSTIDTSRDQPTLRVVSSTTTSNAESN 100

Query: 105 SSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 164
           SST K  EELKVAS+LRKF FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKP
Sbjct: 101 SSTSKLEEELKVASRLRKFAFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160

Query: 165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
           GTGLTVAVKTLNHDGLQGHKEWLAEVN+LG+L+HP+LVKL+GYCIEDDQRLLVYEFMPRG
Sbjct: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRG 220

Query: 225 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 284
           SLENHLFR+ SLPLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDA+YN+K
Sbjct: 221 SLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNSK 279

Query: 285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
           LSDFGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRR
Sbjct: 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 339

Query: 345 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 404
           SMDKNRPNGEHNLVEWARPHLG++RRFY+L+DPRLEGHFSIKG+QKA  LAA CLSRDPK
Sbjct: 340 SMDKNRPNGEHNLVEWARPHLGERRRFYKLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPK 399

Query: 405 ARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPL 464
           ARP MSEVVE LKPL NLKDMASSSYYFQTMQAD      N++NG RTQG  +TRNGQ  
Sbjct: 400 ARPLMSEVVEALKPLPNLKDMASSSYYFQTMQADRFSVSPNTRNG-RTQGALLTRNGQQQ 458

Query: 465 RTLSHPNGPHASPYRH--PQQSPKPNGK 490
           R+LS P+G HASPY H  PQ SPKPNGK
Sbjct: 459 RSLSIPHGTHASPYHHQFPQPSPKPNGK 486

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351722951|ref|NP_001235470.1| serine/threonine protein kinase-like protein [Glycine max] gi|223452506|gb|ACM89580.1| serine/threonine protein kinase-like protein [Glycine max]

 Score =  769 bits (1985), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/455 (82%), Positives = 408/455 (89%), Gaps = 8/455 (1%)

Query: 42  EEEIGCWVRFRFIESCMPSRSKVDSSMSG--TSTNYADGKSSNEKRRDRPVVP-VSSTTT 98
           E E GCWVR RFI SC+ SRSKVD+S+SG  TST+YA+ KS+N+  RD+P  P VSSTTT
Sbjct: 32  EAEAGCWVRLRFIGSCISSRSKVDTSVSGSGTSTHYAESKSTNDTSRDQPTAPAVSSTTT 91

Query: 99  SNAES-ASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEEN 157
           SNAES +SST K  EELK+AS+LRKF FN+LKLATRNFRPES LGEGGFGCVFKGW+EEN
Sbjct: 92  SNAESNSSSTSKLEEELKIASRLRKFSFNELKLATRNFRPESFLGEGGFGCVFKGWIEEN 151

Query: 158 GTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV 217
           GTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG+L+HPNLVKLVGYCIE+DQRLLV
Sbjct: 152 GTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHPNLVKLVGYCIEEDQRLLV 211

Query: 218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL 277
           YEFMPRGSLENHLFR+ S+PLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILL
Sbjct: 212 YEFMPRGSLENHLFRR-SIPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 270

Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL 337
           DA+YNAKLSDFGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL
Sbjct: 271 DAEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL 330

Query: 338 EMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQ 397
           EMLTGRRSMDK+RPNGEHNLVEWARPHLG++RRFYRL+DPRLEGHFS+KG+QKA  LAA 
Sbjct: 331 EMLTGRRSMDKHRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSVKGAQKAALLAAH 390

Query: 398 CLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFM 457
           CLSRDPKARP MSEVVE LKPL NLKDMASSSYYFQ MQAD   +  N++NG R QG  +
Sbjct: 391 CLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQAMQADRIGASPNTRNG-RMQGALL 449

Query: 458 TRNGQPLRTLSHPNGPHASPYRH--PQQSPKPNGK 490
           TRNGQ  R+LS PNG +ASPY H  PQ SPKPNGK
Sbjct: 450 TRNGQQQRSLSIPNGTYASPYHHQFPQPSPKPNGK 484

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356498172|ref|XP_003517927.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max]

 Score =  766 bits (1977), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 373/449 (83%), Positives = 403/449 (89%), Gaps = 7/449 (1%)

Query: 47  CWVRFRFIESCMPSRSKVDSSMS--GTSTNYADGKSSNEKRRDRPVVP-VSSTTTSNAES 103
           CWVR RFI SC+ SRSKVD+S+S  G ST+YA+ KS+N+  RD+P  P VSSTTTSNAES
Sbjct: 44  CWVRLRFIGSCISSRSKVDTSVSASGISTHYAESKSTNDTSRDQPTAPAVSSTTTSNAES 103

Query: 104 ASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVK 163
            SST K  EELK+AS+LRKF FNDLK ATRNFRPES LGEGGFGCVFKGW+EENGTAPVK
Sbjct: 104 NSSTSKLEEELKIASRLRKFSFNDLKSATRNFRPESFLGEGGFGCVFKGWIEENGTAPVK 163

Query: 164 PGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           PGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG+L+HPNLVKLVGYCIEDDQRLLVYEFMPR
Sbjct: 164 PGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHPNLVKLVGYCIEDDQRLLVYEFMPR 223

Query: 224 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 283
           GSLENHLFR+ S+PLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDADYNA
Sbjct: 224 GSLENHLFRR-SMPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNA 282

Query: 284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           KLSDFGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR
Sbjct: 283 KLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342

Query: 344 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP 403
           RSMDK+RPNGEHNLVEWARPHLG++RRFYRL+DPRLEGHFS+KG+QKA QLAA CLSRDP
Sbjct: 343 RSMDKHRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSVKGAQKAAQLAAHCLSRDP 402

Query: 404 KARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQP 463
           K+RP MSEVVE LKPL +LKDMASSSYYFQ MQAD   +  N++NG R QG  +TRNGQ 
Sbjct: 403 KSRPLMSEVVEALKPLPSLKDMASSSYYFQAMQADRFGASPNTRNG-RMQGALLTRNGQQ 461

Query: 464 LRTLSHPNGPHASPYRH--PQQSPKPNGK 490
            R+LS PNG +ASPY H  PQ SPKPNGK
Sbjct: 462 QRSLSIPNGTYASPYHHQFPQPSPKPNGK 490

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	491
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.885	0.882	0.781	1.7e-185
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.892	0.893	0.771	1.3e-180
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.883	0.958	0.760	1e-178
TAIR|locus:2058847	426	APK2B "protein kinase 2B" [Ara	0.747	0.861	0.579	1.4e-112
TAIR|locus:2053240	423	PK1B "protein kinase 1B" [Arab	0.643	0.747	0.648	2.2e-112
TAIR|locus:2180127	389	NAK [Arabidopsis thaliana (tax	0.672	0.848	0.613	5.9e-112
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.629	0.753	0.670	9.7e-112
TAIR|locus:2012492	426	APK2A "protein kinase 2A" [Ara	0.745	0.859	0.557	3.8e-110
TAIR|locus:2039772	395	BIK1 "botrytis-induced kinase1	0.635	0.789	0.612	1.9e-106
TAIR|locus:2205050	387	AT1G69790 [Arabidopsis thalian	0.749	0.950	0.523	1.6e-104

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 1799 (638.3 bits), Expect = 1.7e-185, P = 1.7e-185
 Identities = 354/453 (78%), Positives = 383/453 (84%)

Query:    46 GCWVRFRFIESCMPSRSKVDSSMS---GTSTNYA--DGKSSNEKRRDRPVVPVXXXXXXX 100
             GCWV+FRF+  C+PS+S +D+S S   G++      + KS+NEK  D+PV  V       
Sbjct:    47 GCWVKFRFMIGCIPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTTS 106

Query:   101 XX-XXXXXPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 159
                     P  SEEL ++S LRKF FNDLKL+TRNFRPESLLGEGGFGCVFKGW+EENGT
Sbjct:   107 NAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGT 166

Query:   160 APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE 219
             APVKPGTGLTVAVKTLN DGLQGHKEWLAE+NFLGNLLHPNLVKLVGYCIEDDQRLLVYE
Sbjct:   167 APVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYE 226

Query:   220 FMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 279
             FMPRGSLENHLFR+ SLPLPWSIRMKIALGAAKGL+FLHEEA KPVIYRDFKTSNILLDA
Sbjct:   227 FMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDA 285

Query:   280 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 339
             DYNAKLSDFGLAKDAP++GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM
Sbjct:   286 DYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 345

Query:   340 LTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 399
             LTGRRSMDKNRPNGEHNLVEWARPHL DKRRFYRLLDPRLEGHFSIKG+QK TQLAAQCL
Sbjct:   346 LTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCL 405

Query:   400 SRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTR 459
             SRDPK RP+MS+VVE LKPL +LKDMASSSYYFQTMQA+        KNG     GF +R
Sbjct:   406 SRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQTMQAERL------KNGSGRSQGFGSR 459

Query:   460 NGQ--PL-RTLSHPNGPHASPYRHPQQSPKPNG 489
             NGQ  P+ RTLS P+G  +SPYRH   SPKP G
Sbjct:   460 NGQHQPVFRTLSSPHG--SSPYRHQIPSPKPKG 490

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1753 (622.1 bits), Expect = 1.3e-180, P = 1.3e-180
 Identities = 345/447 (77%), Positives = 377/447 (84%)

Query:    46 GCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVXXXXXXXXXXXX 105
             GCWV+FR+I  C  S S V++S++  ST+    +S+  +  D+PV PV            
Sbjct:    47 GCWVKFRYIVCCASSTSDVETSLT-LSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAESS 105

Query:   106 -XXPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 164
                P  SEEL + S L+KF F DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP
Sbjct:   106 LSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 165

Query:   165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
             GTGLTVAVKTLN DGLQGHKEWLAE+N+LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG
Sbjct:   166 GTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 225

Query:   225 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 284
             SLENHLFR+ SLPLPWSIRMKIALGAAKGL+FLHEEA KPVIYRDFKTSNILLD +YNAK
Sbjct:   226 SLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAK 284

Query:   285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
             LSDFGLAKDAP++GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR
Sbjct:   285 LSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344

Query:   345 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 404
             SMDKNRPNGEHNLVEWARPHL DKRRFYRLLDPRLEGHFS+KG+QK TQLAAQCLSRD K
Sbjct:   345 SMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSK 404

Query:   405 ARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPL 464
              RP+MSEVVE LKPL +LKDMAS+SYYFQTMQA+   +   S +G R   GF +RNGQP+
Sbjct:   405 IRPKMSEVVEVLKPLPHLKDMASASYYFQTMQAERLKAGSGSGSG-R---GFGSRNGQPV 460

Query:   465 -RTLSHPNGPH-ASPYRHPQQSPKPNG 489
              RTLS P+G   +SPYRH   SPKP G
Sbjct:   461 FRTLSSPHGQAGSSPYRHQIPSPKPKG 487

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 1735 (615.8 bits), Expect = 1.0e-178, P = 1.0e-178
 Identities = 340/447 (76%), Positives = 379/447 (84%)

Query:    46 GCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVXXXXXXXXXXXX 105
             G W RF+FI SC+ SRSKVDSSM+ T+   A+ K   EK    P  P             
Sbjct:    18 GFWFRFKFIFSCISSRSKVDSSMNATAV-IAEPKKVIEKLEGHPA-PTKDTGCAESGSST 75

Query:   106 XXPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPG 165
               P  S ELK +S+LR FMFNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPG
Sbjct:    76 --PLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPG 133

Query:   166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
             TGLTVAVKTLN DGLQGHKEWLAE+NFLGNL+HP+LVKLVGYC+E+DQRLLVYEFMPRGS
Sbjct:   134 TGLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGS 193

Query:   226 LENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 285
             LENHLFR+ +LPLPWS+RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD +YNAKL
Sbjct:   194 LENHLFRR-TLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKL 252

Query:   286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 345
             SDFGLAKDAP++ K+HVSTRVMGTYGYAAPEYVMTGHLT+KSDVYSFGVVLLE+LTGRRS
Sbjct:   253 SDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRS 312

Query:   346 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 405
             +DK+RPNGE NLVEW RPHL DK+RFYRLLDPRLEGH+SIKG+QKATQ+AAQCL+RD KA
Sbjct:   313 VDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKA 372

Query:   406 RPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGG-FMTRNGQPL 464
             RP+MSEVVE LKPL NLKD ASSS  FQTMQ         +KNG+RTQGG F++RNG P+
Sbjct:   373 RPKMSEVVEALKPLPNLKDFASSSSSFQTMQPV-------AKNGVRTQGGGFVSRNGPPM 425

Query:   465 RTLSHPNGPHASPYRHPQQSPKPNGKQ 491
             R+LS  N P ASPYR+ +QSPKP GK+
Sbjct:   426 RSLSSLNLPQASPYRYARQSPKPKGKE 452

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)]

 Score = 1111 (396.2 bits), Expect = 1.4e-112, P = 1.4e-112
 Identities = 214/369 (57%), Positives = 267/369 (72%)

Query:    56 SCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVXXXXXXXXXXXXX-XPKFSEEL 114
             +C+ S +KVDSS      N A   S    +  R  VP                P+   E+
Sbjct:     3 NCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEGEI 62

Query:   115 KVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT 174
               +  L+ F FN+LK ATRNFRP+SLLGEGGFG VFKGW++       KPG+G+ VAVK 
Sbjct:    63 LSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKK 122

Query:   175 LNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 234
             L  +G QGHKEWL EVN+LG L HPNLVKLVGYC+E + RLLVYEFMP+GSLENHLFR+G
Sbjct:   123 LKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRG 182

Query:   235 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
             + PL W+IRMK+A+GAAKGL FLH+ A+  VIYRDFK +NILLDA++N+KLSDFGLAK  
Sbjct:   183 AQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAG 241

Query:   295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 354
             P   KTHVST+VMGT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GRR++DK++   E
Sbjct:   242 PTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGME 301

Query:   355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
              +LV+WA P+LGDKR+ +R++D RL G +  KG+  A  LA QCL+ D K RP+MSEV+ 
Sbjct:   302 QSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLA 361

Query:   415 TLKPLQNLK 423
              L  L++ K
Sbjct:   362 KLDQLESTK 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)]

 Score = 1109 (395.4 bits), Expect = 2.2e-112, P = 2.2e-112
 Identities = 207/319 (64%), Positives = 256/319 (80%)

Query:   108 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 167
             P+   E+  +  L+ F F +LK ATRNFRP+S+LGEGGFG VFKGW++E      KPGTG
Sbjct:    53 PRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTG 112

Query:   168 LTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 227
             + +AVK LN DG QGH+EWLAEVN+LG   HPNLVKL+GYC+ED+ RLLVYEFMPRGSLE
Sbjct:   113 VVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLE 172

Query:   228 NHLFRKGSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 285
             NHLFR+GS   PL W++R+K+ALGAAKGLAFLH  AE  VIYRDFKTSNILLD++YNAKL
Sbjct:   173 NHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKL 231

Query:   286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 345
             SDFGLAKD P   K+HVSTR+MGTYGYAAPEY+ TGHLT+KSDVYS+GVVLLE+L+GRR+
Sbjct:   232 SDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRA 291

Query:   346 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 405
             +DKNRP GE  LVEWARP L +KR+ +R++D RL+  +S++ + K   LA +CL+ + K 
Sbjct:   292 VDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKL 351

Query:   406 RPRMSEVVETLKPLQNLKD 424
             RP M+EVV  L+ +Q L +
Sbjct:   352 RPNMNEVVSHLEHIQTLNE 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)]

 Score = 1105 (394.0 bits), Expect = 5.9e-112, P = 5.9e-112
 Identities = 205/334 (61%), Positives = 264/334 (79%)

Query:   108 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 167
             P+   E+   + L+ F  ++LK ATRNFRP+S++GEGGFGCVFKGW++E+  AP KPGTG
Sbjct:    41 PRTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTG 100

Query:   168 LTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 227
             + +AVK LN +G QGH+EWLAE+N+LG L HPNLVKL+GYC+E++ RLLVYEFM RGSLE
Sbjct:   101 IVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLE 160

Query:   228 NHLFRKGSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 285
             NHLFR+G+   PL W+ R+++ALGAA+GLAFLH  A+  VIYRDFK SNILLD++YNAKL
Sbjct:   161 NHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKL 219

Query:   286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 345
             SDFGLA+D P    +HVSTRVMGT GYAAPEY+ TGHL+ KSDVYSFGVVLLE+L+GRR+
Sbjct:   220 SDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRA 279

Query:   346 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 405
             +DKN+P GEHNLV+WARP+L +KRR  R++DPRL+G +S+  + K   LA  C+S D K+
Sbjct:   280 IDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKS 339

Query:   406 RPRMSEVVETLKPLQNLKDMASSSYYFQTMQADN 439
             RP M+E+V+T++ L   K+ AS       +  DN
Sbjct:   340 RPTMNEIVKTMEELHIQKE-ASKEQQNPQISIDN 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009617 "response to bacterium" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 1103 (393.3 bits), Expect = 9.7e-112, P = 9.7e-112
 Identities = 212/316 (67%), Positives = 256/316 (81%)

Query:   108 PKFSEELKVA---SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 164
             P+F ++ +     +Q+  F   +L+  T++FRP+ +LGEGGFG V+KG++++N    +K 
Sbjct:    39 PRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLK- 97

Query:   165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
                L VAVK LN +GLQGH+EWL EVNFLG L HPNLVKL+GYC EDD RLLVYEFM RG
Sbjct:    98 --SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRG 155

Query:   225 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 284
             SLENHLFRK + PL WS RM IALGAAKGLAFLH  AE+PVIYRDFKTSNILLD+DY AK
Sbjct:   156 SLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAK 214

Query:   285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
             LSDFGLAK  P+  +THVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLEMLTGR+
Sbjct:   215 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRK 274

Query:   345 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 404
             S+DK RP+ E NLV+WARP L DKR+  +++DPRLE  +S++ +QKA  LA  CLS++PK
Sbjct:   275 SVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPK 334

Query:   405 ARPRMSEVVETLKPLQ 420
             ARP MS+VVETL+PLQ
Sbjct:   335 ARPLMSDVVETLEPLQ 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)]

 Score = 1088 (388.1 bits), Expect = 3.8e-110, P = 3.8e-110
 Identities = 207/371 (55%), Positives = 265/371 (71%)

Query:    56 SCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVXXXXXXXXXXXXXXP----KFS 111
             +C+ S +KVD+S      N A   S    +  R   P               P    +  
Sbjct:     3 NCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLRTE 62

Query:   112 EELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
              E+  +  L+ F FN+LK AT+NFR ++LLGEGGFGCVFKGW+++      +PG+G+ VA
Sbjct:    63 GEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVA 122

Query:   172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 231
             VK L  +G QGHKEWL EVN+LG L HPNLV LVGYC E + RLLVYEFMP+GSLENHLF
Sbjct:   123 VKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF 182

Query:   232 RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 291
             R+G+ PL W+IRMK+A+GAAKGL FLHE A+  VIYRDFK +NILLDAD+NAKLSDFGLA
Sbjct:   183 RRGAQPLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLA 241

Query:   292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
             K  P    THVST+V+GT+GYAAPEYV TG LT+KSDVYSFGVVLLE+++GRR+MD +  
Sbjct:   242 KAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNG 301

Query:   352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
               E++LV+WA P+LGDKR+ +R++D +L G +  KG+  A  LA QCL+ D K RP+MSE
Sbjct:   302 GNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSE 361

Query:   412 VVETLKPLQNL 422
             V+ TL+ L+++
Sbjct:   362 VLVTLEQLESV 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1053 (375.7 bits), Expect = 1.9e-106, P = 1.9e-106
 Identities = 193/315 (61%), Positives = 249/315 (79%)

Query:   109 KFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGL 168
             K   E+  ++ ++ F FN+LKLATRNFRP+S++GEGGFGCVFKGW++E+   P KPGTGL
Sbjct:    41 KTEGEILSSTPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGL 100

Query:   169 TVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN 228
              +AVK LN +G QGH+EWL E+N+LG L HPNLVKL+GYC+ED+ RLLVYEFM +GSLEN
Sbjct:   101 VIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLEN 160

Query:   229 HLFRKGSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 286
             HLFR+G+   PLPW +R+ +AL AAKGLAFLH +  K VIYRD K SNILLDADYNAKLS
Sbjct:   161 HLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLS 219

Query:   287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 346
             DFGLA+D P    ++VSTRVMGTYGYAAPEY+ +GHL ++SDVYSFGV+LLE+L+G+R++
Sbjct:   220 DFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRAL 279

Query:   347 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
             D NRP  E NLV+WARP+L  KR+   ++D RL+  +  + + +   +A QCLS +PK+R
Sbjct:   280 DHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSR 339

Query:   407 PRMSEVVETLKPLQN 421
             P M +VV  L+ LQ+
Sbjct:   340 PTMDQVVRALQQLQD 354

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009620 "response to fungus" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0050832 "defense response to fungus" evidence=RCA;IMP

GO:0052033 "pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)]

 Score = 1035 (369.4 bits), Expect = 1.6e-104, P = 1.6e-104
 Identities = 198/378 (52%), Positives = 267/378 (70%)

Query:    56 SCMPSRSKV---DSSMSGTSTNYADGKSSNEKRRDRPVVPVXXXXXXXXXX-XXXXPKFS 111
             +C+ S ++V   +S+  G+S      K +   R     +P                P+  
Sbjct:     3 NCLDSSARVGNRESTFGGSSR--ISRKPNQSSRLSSLTIPSYSNNSFTTSSWSNLTPRSE 60

Query:   112 EELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
              EL  +  L+ F FN+LK ATRNF+P S++GEGGFGCV+KGW+ E   +P KPG+G+ VA
Sbjct:    61 GELLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSGMVVA 120

Query:   172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 231
             VK L  +G QGHKEWL EV++LG L H NLVKL+GYC+E ++RLLVYE+MP+GSLENHLF
Sbjct:   121 VKKLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHLF 180

Query:   232 RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 291
             R+G+ P+PW  RMK+A  AA+GL+FLHE     VIYRDFK SNILLD D+NAKLSDFGLA
Sbjct:   181 RRGAEPIPWKTRMKVAFSAARGLSFLHEAK---VIYRDFKASNILLDVDFNAKLSDFGLA 237

Query:   292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
             K  P   +THV+T+V+GT GYAAPEY+ TG LTSKSDVYSFGVVLLE+L+GR ++DK++ 
Sbjct:   238 KAGPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSKV 297

Query:   352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
               E NLV+WA P+L D+R+ +R++D +L G +  KG+  A  +A +CL+ +PK RP M++
Sbjct:   298 GVERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMAD 357

Query:   412 VVETLKPLQ-NLKDMASS 428
             V+ TL+ L+ + K M S+
Sbjct:   358 VLSTLQQLETSSKKMGST 375

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LFP7	Y5158_ARATH	2, ., 7, ., 1, 1, ., 1	0.7624	0.9735	0.9695	yes	no
Q9SRH7	Y3130_ARATH	2, ., 7, ., 1, 1, ., 1	0.7872	0.9103	0.9122	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00028989001 SubName- Full=Chromosome chr1 scaffold_46, whole genome shotgun sequence; (481 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	491
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-57
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-57
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-57
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-55
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-54
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-53
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-53
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-39
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-36
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-32
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-30
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-29
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-29
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-29
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-28
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-28
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-28
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-26
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-26
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-25
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-24
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-24
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-24
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-24
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-24
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-23
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-23
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-23
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-22
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-21
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-21
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-19
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-19
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-19
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-18
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-18
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-18
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-17
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-16
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-16
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-16
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-15
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-15
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	6e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-15
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-14
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-12
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-10
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	8e-04

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  190 bits (484), Expect = 3e-57
 Identities = 96/280 (34%), Positives = 138/280 (49%), Gaps = 26/280 (9%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 196
              LGEG FG V+KG ++         G  + VAVKTL  D   Q  +E+L E   +  L
Sbjct: 4   GKKLGEGAFGEVYKGTLK-----GKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
            HPN+VKL+G C E++  ++V E+MP G L ++L +     L  S  +  AL  A+G+ +
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           L     K  I+RD    N L+  +   K+SDFGL++D  +D    V         + APE
Sbjct: 119 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPE 174

Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
            +  G  TSKSDV+SFGV+L E+ T         P    +  E    +L   ++ YRL  
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE-VLEYL---KKGYRLPK 225

Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           P            +  +L  QC + DP+ RP  SE+VE L
Sbjct: 226 PP-------NCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  190 bits (484), Expect = 4e-57
 Identities = 95/280 (33%), Positives = 134/280 (47%), Gaps = 27/280 (9%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 196
              LGEG FG V+KG ++            + VAVKTL  D   Q  +E+L E   +  L
Sbjct: 4   GKKLGEGAFGEVYKGKLK-----GKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
            HPN+VKL+G C E++   +V E+M  G L ++L RK    L  S  +  AL  A+G+ +
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEY 117

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           L     K  I+RD    N L+  +   K+SDFGL++D  +D   +          + APE
Sbjct: 118 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPE 173

Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
            +  G  TSKSDV+SFGV+L E+ T         P    +  E    +L   +  YRL  
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLEYL---KNGYRLPQ 224

Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           P            +   L  QC + DP+ RP  SE+VE L
Sbjct: 225 PP-------NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  190 bits (484), Expect = 4e-57
 Identities = 94/285 (32%), Positives = 134/285 (47%), Gaps = 34/285 (11%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 192
           +     LG G FG V+K             GTG  VAVK L       +  +    E+  
Sbjct: 1   YELLRKLGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
           L  L HPN+V+L+    + D   LV E+   G L ++L R G L      + KIAL   +
Sbjct: 52  LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLS-EDEAK-KIALQILR 109

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL +LH      +I+RD K  NILLD +   K++DFGLAK   +   + ++T V GT  Y
Sbjct: 110 GLEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFV-GTPWY 164

Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
            APE ++ G     K DV+S GV+L E+LTG+                     L   +  
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLI 211

Query: 372 YRLLDPRLEGHF--SIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
            R+L P LE        GS++A  L  +CL++DP  RP   E+++
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  184 bits (470), Expect = 1e-55
 Identities = 80/279 (28%), Positives = 119/279 (42%), Gaps = 67/279 (24%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           LGEGGFG V+    ++ G           VA+K +  +      E  L E+  L  L HP
Sbjct: 1   LGEGGFGTVYLARDKKTGK---------KVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VKL G   +++   LV E+   GSL++ L       L     ++I L   +GL +LH 
Sbjct: 52  NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLH- 109

Query: 260 EAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
                +I+RD K  NILLD+D    KL+DFGL+K    D        ++GT  Y APE +
Sbjct: 110 --SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVL 165

Query: 319 M-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP 377
           +  G+ + KSD++S GV+L E+                                      
Sbjct: 166 LGKGYYSEKSDIWSLGVILYEL-------------------------------------- 187

Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
                       +   L  + L +DP+ RP   E++E L
Sbjct: 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  182 bits (464), Expect = 3e-54
 Identities = 96/283 (33%), Positives = 135/283 (47%), Gaps = 38/283 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG V+KG ++         GT   VAVKTL      +  +E+L E + +  L HP
Sbjct: 7   LGEGAFGEVYKGTLK-----GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+V+L+G C + +   +V E+MP G L + L RK    L     +++AL  AKG+ +L  
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE- 119

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST------RVMGTYGYA 313
              K  ++RD    N L+  +   K+SDFGL++D  ED             + M      
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------ 171

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 373
           APE +  G  TSKSDV+SFGV+L E+ T         P    +  E     L D    YR
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLELLEDG---YR 222

Query: 374 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           L  P            +  +L  QC + DP+ RP  SE+VE L
Sbjct: 223 LPRPE-------NCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  180 bits (459), Expect = 2e-53
 Identities = 96/295 (32%), Positives = 132/295 (44%), Gaps = 53/295 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHP 199
           LGEG FG V+KG          K G    VAVKTL  D   +  K++L E   +  L HP
Sbjct: 3   LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-------FRKGSLPLPWSIRMKIALGAAK 252
           N+V+L+G C E++   LV E+M  G L ++L              L     +  A+  AK
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTHVSTRV 306
           G+ +L     K  ++RD    N L+  D   K+SDFGL++D  +D          +  R 
Sbjct: 117 GMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173

Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE---HNL-VEWAR 362
           M      APE +  G  TSKSDV+SFGV+L E+ T           G      L  E   
Sbjct: 174 M------APESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPYPGLSNEEVL 217

Query: 363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
            +L   R+ YRL  P            +  +L   C   DP+ RP  SE+VE L+
Sbjct: 218 EYL---RKGYRLPKPEY-------CPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  180 bits (458), Expect = 2e-53
 Identities = 84/282 (29%), Positives = 124/282 (43%), Gaps = 34/282 (12%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 193
           +     LGEG FG V+               TG  VA+K +    ++  +E  L E+  L
Sbjct: 1   YEILEKLGEGSFGKVYLA---------RDKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             L HPN+V+L     ++D+  LV E+   G L + L ++G L      R          
Sbjct: 52  KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSA 109

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           L +LH    K +++RD K  NILLD D + KL+DFGLA+      K    T V GT  Y 
Sbjct: 110 LEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYM 163

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFY 372
           APE ++        D++S GV+L E+LTG+       P  G+  L+E  +     K  F 
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIGKPKPPFP 217

Query: 373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                          S +A  L  + L +DP+ R    E ++
Sbjct: 218 P---------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  144 bits (365), Expect = 5e-40
 Identities = 76/282 (26%), Positives = 124/282 (43%), Gaps = 49/282 (17%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F     +G+GGFG V+K   +          TG  VA+K +  +  +  ++ + E+  L 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILK 52

Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
              HPN+VK  G  ++ D+  +V EF   GSL++ L +  +  L  S    +     KGL
Sbjct: 53  KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGL 111

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH      +I+RD K +NILL +D   KL DFGL+     D K   +   +GT  + A
Sbjct: 112 EYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTM--VGTPYWMA 165

Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR---------RSMDKNRPNGEHNLVEWARPHL 365
           PE +       K+D++S G+  +E+  G+         +++ K   NG            
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG------------ 213

Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
                   L +P        K S +      +CL ++P+ RP
Sbjct: 214 -----PPGLRNPE-------KWSDEFKDFLKKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (362), Expect = 2e-39
 Identities = 84/272 (30%), Positives = 129/272 (47%), Gaps = 33/272 (12%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGNLL 197
           LLG G FG V+    +          TG  +AVK+  L+ D  +  +    E+  L +L 
Sbjct: 7   LLGRGSFGSVYLALDK---------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57

Query: 198 HPNLVKLVGYCIEDDQR-LLVY-EFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
           HPN+V+  G   ++++  L ++ E++  GSL + L + G LP P  IR K      +GLA
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-VIR-KYTRQILEGLA 115

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 315
           +LH      +++RD K +NIL+D+D   KL+DFG AK   +      +  V GT  + AP
Sbjct: 116 YLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 375
           E +        +D++S G  ++EM TG+       P  E      A   +G         
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGK------PPWSELGNPMAALYKIG-----SSGE 221

Query: 376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            P +  H     S++A     +CL RDPK RP
Sbjct: 222 PPEIPEHL----SEEAKDFLRKCLRRDPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 8e-36
 Identities = 72/208 (34%), Positives = 105/208 (50%), Gaps = 22/208 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGNLL 197
           L+G G FG V+KG   E         TG  VA+K   L     +  K  + E++ L NL 
Sbjct: 7   LIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKGLA 255
           HPN+VK +G  IE    L ++ E+   GSL   + + G  P       +   L   +GLA
Sbjct: 58  HPNIVKYIG-SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL---QGLA 113

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 315
           +LHE+    VI+RD K +NIL   D   KL+DFG+A    +  K      V+GT  + AP
Sbjct: 114 YLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAP 168

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           E +     ++ SD++S G  ++E+LTG 
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  132 bits (333), Expect = 4e-35
 Identities = 72/206 (34%), Positives = 105/206 (50%), Gaps = 15/206 (7%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHP 199
           LGEG FG V     +  G       TG  VAVK+LNH G + H  ++  E+  L  L H 
Sbjct: 12  LGEGHFGKVELCRYDPLGD-----NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66

Query: 200 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           N+VK  G C +   R   L+ E++P GSL ++L ++    +     +  +    KG+ +L
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST--RVMGTYGYAAP 315
                +  I+RD    NIL++++   K+SDFGLAK  PED   +          + Y AP
Sbjct: 126 GS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-AP 181

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLT 341
           E + T   +S SDV+SFGV L E+ T
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  128 bits (321), Expect = 8e-33
 Identities = 98/378 (25%), Positives = 148/378 (39%), Gaps = 45/378 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 190
           ++R    LGEG FG V+     +             VA+K L        KE    L E+
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK------------LVALKVLAKKLESKSKEVERFLREI 48

Query: 191 NFLGNLLHP-NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIAL 248
             L +L HP N+VKL  +  ++    LV E++  GSLE+ L       PL  S  + I  
Sbjct: 49  QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKLSDFGLAKDAPEDGKT----HVS 303
                L +LH    K +I+RD K  NILLD D    KL DFGLAK  P+ G T     + 
Sbjct: 109 QILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165

Query: 304 TRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRR-SMDKNRPNGEHNLVE 359
           +  +GT GY APE ++     + +S SD++S G+ L E+LTG      +   +     ++
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225

Query: 360 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE----- 414
                          L   L        S+ A+ L  + L++DPK R   S  +      
Sbjct: 226 IIL------ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279

Query: 415 ----TLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHP 470
                   L +L     S+    ++       I +  +   +       +         P
Sbjct: 280 HLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDD-SNFSKELAP 338

Query: 471 NGPHASPYRHPQQSPKPN 488
           NG  +SP+          
Sbjct: 339 NGVSSSPHNSSSLLLSTA 356

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  124 bits (314), Expect = 1e-32
 Identities = 70/209 (33%), Positives = 110/209 (52%), Gaps = 27/209 (12%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH 198
           + +G+G FG V  G              G  VAVK L  D       +LAE + +  L H
Sbjct: 12  ATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           PNLV+L+G  ++ +   +V E+M +GSL ++L  +G   +  + ++  AL   +G+ +L 
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTRVMGTYGYAAP 315
              EK  ++RD    N+L+  D  AK+SDFGLAK+A    + GK  V         + AP
Sbjct: 120 ---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAP 168

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLT-GR 343
           E +     ++KSDV+SFG++L E+ + GR
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 7e-32
 Identities = 89/274 (32%), Positives = 126/274 (45%), Gaps = 47/274 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 197
           LG+G FG V    V +  T       G   A+K L    +   KE    L E N L  + 
Sbjct: 1   LGKGSFGKVLL--VRKKDT-------GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM--KIALGAAKGL 254
           HP +VKL  Y  + +++L LV E+ P G L +HL ++G      +     +I L     L
Sbjct: 52  HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----L 106

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH      +IYRD K  NILLDAD + KL+DFGLAK+   +G +  +T   GT  Y A
Sbjct: 107 EYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEYLA 161

Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR--FY 372
           PE ++        D +S GV+L EMLTG+                   P   + R+  + 
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGK------------------PPFYAEDRKEIYE 203

Query: 373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           ++L   L   F    S +A  L +  L +DP  R
Sbjct: 204 KILKDPLR--FPEFLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 5e-31
 Identities = 81/281 (28%), Positives = 130/281 (46%), Gaps = 35/281 (12%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
            +G+G FG V+KG ++              VAVKT         K  +L E   L    H
Sbjct: 2   KIGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH 51

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           PN+VKL+G C++     +V E +P GSL   L RK    L     ++++L AA G+ +L 
Sbjct: 52  PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLE 110

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAPE 316
               K  I+RD    N L+  +   K+SDFG++++  E+G  +  +  +      + APE
Sbjct: 111 ---SKNCIHRDLAARNCLVGENNVLKISDFGMSRE--EEGGIYTVSDGLKQIPIKWTAPE 165

Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
            +  G  TS+SDV+S+G++L E  +   +      N +       R  +      YR+  
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERI---ESGYRMPA 216

Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
           P+L          +  +L  QC + DP+ RP  SE+   L+
Sbjct: 217 PQLCPE-------EIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (295), Expect = 5e-30
 Identities = 71/296 (23%), Positives = 117/296 (39%), Gaps = 61/296 (20%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 191
            +     +G+G FG V+   V            G    +K   L++   +  ++ L EV 
Sbjct: 1   KYEIIKQIGKGSFGKVYL--VRRKSD-------GKLYVLKEIDLSNMSEKEREDALNEVK 51

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHL--FRKGSLPLP----WSIRM 244
            L  L HPN++K      E+  +L  V E+   G L   +   +K   P P        +
Sbjct: 52  ILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
           ++ L     L +LH    + +++RD K  NI L ++   KL DFG++K           T
Sbjct: 111 QLCLA----LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKT 162

Query: 305 RVMGTYGYAAPE------YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358
            V GT  Y +PE      Y        KSD++S G VL E+ T +   +           
Sbjct: 163 VV-GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGENLLE----- 210

Query: 359 EWARPHLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                 L  K  +  Y    P +   +    S +   L +  L +DP+ RP ++++
Sbjct: 211 ------LALKILKGQY----PPIPSQY----SSELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  116 bits (292), Expect = 1e-29
 Identities = 81/282 (28%), Positives = 118/282 (41%), Gaps = 33/282 (11%)

Query: 140 LLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLL 197
            LG+G FG V +G W    G         + VAVK L  D L     ++L E   + +L 
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKV-------IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           H NL++L G  +     ++V E  P GSL + L +        S     A+  A G+ +L
Sbjct: 55  HENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST---RVMGTYGYAA 314
                K  I+RD    NILL +D   K+ DFGL +  P++   +V     +V   + + A
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCA 168

Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 374
           PE + T   +  SDV+ FGV L EM T          +G   L         D +   RL
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQIL------KKID-KEGERL 220

Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
             P           Q    +  QC + +P  RP  + + E L
Sbjct: 221 ERPE-------ACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 1e-29
 Identities = 87/302 (28%), Positives = 128/302 (42%), Gaps = 62/302 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LG+G FG V++G         VK      VA+KT+N +     + E+L E + +      
Sbjct: 14  LGQGSFGMVYEG----LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------FRKGSLPLPWSIRMKIALGAA 251
           ++V+L+G        L+V E M +G L+++L           G  P      +++A   A
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE------DGKTHVSTR 305
            G+A+L   A K  ++RD    N ++  D   K+ DFG+ +D  E       GK  +  R
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
            M      APE +  G  T+KSDV+SFGVVL EM T               L E  +P+ 
Sbjct: 187 WM------APESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAE--QPYQ 223

Query: 366 GDKRRFYRLLDPRLEGHFSIKGS---------QKATQLAAQCLSRDPKARPRMSEVVETL 416
           G        L       F I G           K  +L   C   +PK RP   E+V +L
Sbjct: 224 G--------LSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275

Query: 417 KP 418
           K 
Sbjct: 276 KD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  115 bits (291), Expect = 2e-29
 Identities = 87/285 (30%), Positives = 132/285 (46%), Gaps = 47/285 (16%)

Query: 140 LLGEGGFGCVFKGWVEENGT-APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH 198
           LLG G FG V++G   ++G    VK      V++      G +  K+   E+  L  L H
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVK-----EVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM---KIALGAAKGLA 255
           PN+V+ +G   E+D   +  E +P GSL   L + GS P P  IR+   +I L    GL 
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP-VIRLYTRQILL----GLE 116

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-----GTY 310
           +LH   ++  ++RD K +NIL+D +   KL+DFG+AK         V          G+ 
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSP 165

Query: 311 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 369
            + APE +   G     +D++S G  +LEM TG+       P  +   V  A   +G  +
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK------PPWSQLEGVA-AVFKIGRSK 218

Query: 370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                  P +  H     S +A     +CL RDP  RP  +E++E
Sbjct: 219 EL-----PPIPDHL----SDEAKDFILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  114 bits (288), Expect = 5e-29
 Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 17/208 (8%)

Query: 135 FRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           F  E  LG G FG V++G W              + VA+K L  D L   +++  EV  L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWK-----------NRVRVAIKILKSDDLLKQQDFQKEVQAL 56

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             L H +L+ L   C   +   ++ E M +GSL   L       LP +  + +A   A+G
Sbjct: 57  KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           +A+L    E+  I+RD    NIL+  D   K++DFGLA+   ED       ++   Y + 
Sbjct: 117 MAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWT 171

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           APE    G  ++KSDV+SFG++L EM T
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  113 bits (284), Expect = 1e-28
 Identities = 84/278 (30%), Positives = 131/278 (47%), Gaps = 36/278 (12%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V+ G W+E+             VA+KT+  +G    ++++ E   +  L HP
Sbjct: 12  IGSGQFGLVWLGYWLEKR-----------KVAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            LV+L G C E     LV+EFM  G L ++L  ++G       + M   L   +G+A+L 
Sbjct: 60  KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGM--CLDVCEGMAYLE 117

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
                 VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +++PE  
Sbjct: 118 SSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVF 173

Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 378
                +SKSDV+SFGV++ E+ +  ++  +NR N E  +VE            +RL  PR
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE-------TINAGFRLYKPR 224

Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           L        SQ   +L   C    P+ RP  S ++  L
Sbjct: 225 L-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 2e-28
 Identities = 91/273 (33%), Positives = 127/273 (46%), Gaps = 43/273 (15%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V+ G W   NGT  V        AVKTL   G    + +L E   +  L H 
Sbjct: 14  LGAGQFGEVWMGTW---NGTTKV--------AVKTLK-PGTMSPEAFLQEAQIMKKLRHD 61

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS---LPLPWSIRMKIALGAAKGLAF 256
            LV+L   C E++   +V E+M +GSL + L + G    L LP  + M  A   A+G+A+
Sbjct: 62  KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDM--AAQIAEGMAY 118

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAP 315
           L     +  I+RD    NIL+  +   K++DFGLA+   +D  T     +      + AP
Sbjct: 119 LE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAP 173

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRL 374
           E    G  T KSDV+SFG++L E++T  R      P  G  N     R  L    R YR+
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRV-----PYPGMTN-----REVLEQVERGYRM 223

Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
             PR          ++   L  QC  +DP+ RP
Sbjct: 224 --PRPPNC-----PEELYDLMLQCWDKDPEERP 249

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 4e-28
 Identities = 72/227 (31%), Positives = 117/227 (51%), Gaps = 24/227 (10%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLH 198
           LG G FG V+KG W+ E     VK    + VA+K L  +   + +KE L E   + ++ H
Sbjct: 15  LGSGAFGTVYKGVWIPEG--EKVK----IPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSL----ENHLFRKGSLP-LPWSIRMKIALGAAKG 253
           P++V+L+G C+   Q  L+ + MP G L     NH    GS   L W +++      AKG
Sbjct: 69  PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           +++L E   K +++RD    N+L+    + K++DFGLAK    D K + +        + 
Sbjct: 122 MSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 359
           A E ++    T KSDV+S+GV + E++T G +  +        +L+E
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  112 bits (281), Expect = 5e-28
 Identities = 83/279 (29%), Positives = 124/279 (44%), Gaps = 36/279 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG G  G V K           +P TG  +AVKT+  +      K+ L E++ L     P
Sbjct: 9   LGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            +V   G    +    +  E+M  GSL+  + ++    +P  I  KIA+   KGL +LHE
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-GKTHVSTRVMGTYGYAAPEYV 318
           + +  +I+RD K SNIL+++    KL DFG++        KT V     GT  Y APE +
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERI 171

Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD-- 376
                + KSD++S G+ L+E+ TGR                   P  G       +++  
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPP-----------ENDPPDGIFELLQYIVNEP 220

Query: 377 -PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
            PRL      K S         CL +DP+ RP   E++E
Sbjct: 221 PPRLPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  112 bits (281), Expect = 7e-28
 Identities = 71/215 (33%), Positives = 99/215 (46%), Gaps = 22/215 (10%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTLNHDGL-QGHKEWLAEVNFLGNLLH 198
           LGEG FG VF G         ++P      VAVKTL         K++  E   L N  H
Sbjct: 13  LGEGAFGKVFLGECYH-----LEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG------------SLPLPWSIRMKI 246
            N+VK  G C E D  ++V+E+M  G L   L   G               L  S  ++I
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           A+  A G+ +L   A +  ++RD  T N L+  D   K+ DFG+++D        V    
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184

Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           M    +  PE +M    T++SDV+SFGVVL E+ T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  111 bits (280), Expect = 9e-28
 Identities = 91/294 (30%), Positives = 133/294 (45%), Gaps = 19/294 (6%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVN 191
           R  +   +LGEG FG V     +     P   GTG  VAVKTL  +  Q +   W  E+N
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
            L  L H N+VK  G C E   +   L+ E++P GSL ++L  K  L L  +  +  A  
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNL--AQLLLFAQQ 115

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +G+A+LH    +  I+RD    N+LLD D   K+ DFGLAK  PE G  +   R  G 
Sbjct: 116 ICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGD 171

Query: 310 YG--YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
               + A E +     +  SDV+SFGV L E+LT      ++ P     ++   +  +  
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQM-T 229

Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 421
             R   LL+  +         Q+   L   C   + K RP    ++  LK + +
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  110 bits (277), Expect = 2e-27
 Identities = 95/296 (32%), Positives = 136/296 (45%), Gaps = 49/296 (16%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTG-LTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL 197
            LG G FG V++G      T  + PG+G + VAVKTL      Q  KE+L E + + N  
Sbjct: 2   FLGSGAFGEVYEG----TATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN 57

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPW---SIRMKIALGAAK 252
           HPN+VKL+G C+ ++ + ++ E M  G L ++L   R      P       + I L  AK
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDA------PEDGKTH 301
           G  +L +      I+RD    N L+     DAD   K+ DFGLA+D        ++G+  
Sbjct: 118 GCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 302 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 360
           +  R M      APE ++ G  T++SDV+SFGV++ E+LT G       +P    N  E 
Sbjct: 175 LPVRWM------APESLLDGKFTTQSDVWSFGVLMWEILTLG------QQPYPALNNQEV 222

Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
               L       RL  P            K  QL   C ++DP  RP    + E L
Sbjct: 223 ----LQHVTAGGRLQKPE-------NCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  109 bits (275), Expect = 2e-27
 Identities = 79/287 (27%), Positives = 127/287 (44%), Gaps = 47/287 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           +G+G FG VFK          V+       A+K ++   +     +E + E   L  L  
Sbjct: 8   IGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAKGL 254
             +++     ++  +  +V E+   G L   L  +   PLP    W   ++I LG    L
Sbjct: 59  SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           A LH    K +++RD K+ N+ LDA  N K+ D G+AK       T+ +  ++GT  Y +
Sbjct: 115 AHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLS 169

Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 374
           PE         KSDV++ GVVL E  TG+   D    N +  L+           +  R 
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGALI----------LKIIRG 216

Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 421
           + P +   +    SQ+  QL  QCL++D + RP      +T + L+N
Sbjct: 217 VFPPVSQMY----SQQLAQLIDQCLTKDYRQRP------DTFQLLRN 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 4e-27
 Identities = 83/281 (29%), Positives = 127/281 (45%), Gaps = 34/281 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V KG          K G  + VAVKTL       G KE+L E + +  L HP
Sbjct: 3   LGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            +V+L+G C  +   +LV E  P G L  +L ++  +P+     +  A   A G+A+L  
Sbjct: 57  CIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--AHQVAMGMAYLES 113

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEY 317
              K  ++RD    N+LL   + AK+SDFG+++ A   G  +      G +   + APE 
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPEC 169

Query: 318 VMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
           +  G  +SKSDV+S+GV L E  + G +   + +      ++E             RL  
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG----------ERLPR 219

Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
           P        +  Q+   +   C    P+ RP  SE+  T +
Sbjct: 220 PE-------ECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 5e-27
 Identities = 76/284 (26%), Positives = 127/284 (44%), Gaps = 35/284 (12%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGN 195
           E ++G G FG V +G ++  G   +       VA+KTL   G    +    L E + +G 
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEI------DVAIKTL-KAGSSDKQRLDFLTEASIMGQ 61

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
             HPN+++L G   +    +++ E+M  GSL+  L R+          + +  G A G+ 
Sbjct: 62  FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMK 120

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTRVMGTYGYA 313
           +L   +E   ++RD    NIL++++   K+SDFGL++  +  E   T    ++     + 
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWT 175

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK-RRFY 372
           APE +     TS SDV+SFG+V+ E+++           GE    + +   +       Y
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMS----------YGERPYWDMSNQDVIKAVEDGY 225

Query: 373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           RL  P               QL   C  +D   RP  S++V TL
Sbjct: 226 RLPPPM-------DCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 1e-26
 Identities = 80/278 (28%), Positives = 120/278 (43%), Gaps = 36/278 (12%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V  G W  +           + VA+K +  +G     +++ E   +  L HP
Sbjct: 12  LGSGQFGVVHLGKWRGK-----------IDVAIKMI-REGAMSEDDFIEEAKVMMKLSHP 59

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           NLV+L G C +     +V E+M  G L N+L  RKG L   W + M       + + +L 
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM--CSDVCEAMEYLE 117

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
                  I+RD    N L+  D   K+SDFGLA+   +D  T  S        +A PE  
Sbjct: 118 ---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVF 173

Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 378
                +SKSDV+SFGV++ E+ +  +   +   N E  +VE      G     YRL  P+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE--SVSAG-----YRLYRPK 224

Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           L          +   +   C    P+ RP   +++  L
Sbjct: 225 L-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  113 bits (283), Expect = 2e-26
 Identities = 90/301 (29%), Positives = 141/301 (46%), Gaps = 36/301 (11%)

Query: 121 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDG 179
           +    ND+  + +    E+++  G  G  +KG   +NG   V         VK +N  + 
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFV---------VKEINDVNS 728

Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
           +       +E+  +G L HPN+VKL+G C  +    L++E++   +L   L       L 
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLS 778

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
           W  R KIA+G AK L FLH      V+  +     I++D      L    L      D K
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTK 837

Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLV 358
             +S+       Y APE   T  +T KSD+Y FG++L+E+LTG+   D     G H ++V
Sbjct: 838 CFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE--FGVHGSIV 889

Query: 359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQ--KATQLAAQCLSRDPKARPRMSEVVETL 416
           EWAR    D       +DP + G  S+  ++  +   LA  C + DP ARP  ++V++TL
Sbjct: 890 EWARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Query: 417 K 417
           +
Sbjct: 949 E 949

Length = 968

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  107 bits (269), Expect = 3e-26
 Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 45/278 (16%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLL 197
            +LG+G  G V+K              TG   A+K ++ DG  +  K+ L E+  L +  
Sbjct: 7   KVLGQGSSGVVYKV---------RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
            P +VK  G   ++ +  +V E+M  GSL + L + G +P P  +   IA    KGL +L
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEP--VLAYIARQILKGLDYL 115

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 317
           H   ++ +I+RD K SN+L+++    K++DFG++K   E+     +T V GT  Y +PE 
Sbjct: 116 H--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTFV-GTVTYMSPER 171

Query: 318 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD- 376
           +     +  +D++S G+ LLE   G+                           F+ L+  
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----------------FFELMQA 214

Query: 377 ------PRL-EGHFSIKGSQKATQLAAQCLSRDPKARP 407
                 P L    F    S +     + CL +DPK RP
Sbjct: 215 ICDGPPPSLPAEEF----SPEFRDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  104 bits (262), Expect = 2e-25
 Identities = 85/283 (30%), Positives = 132/283 (46%), Gaps = 36/283 (12%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNLLH 198
           +LG+G +G V+ G   +     VK      V + T N    +   E L  EV+ L +L H
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVK-----QVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            N+V+ +G C++D+   +  EF+P GS+ + L R G LP P  +  K       G+A+LH
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEP--VFCKYTKQILDGVAYLH 119

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG----KTHVSTRVMGTYGYAA 314
                 V++RD K +N++L  +   KL DFG A+     G     +++   + GT  + A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           PE +       KSD++S G  + EM TG+    SMD+            A  ++G     
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----------AMFYIGA---- 222

Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           +R L PRL   F    S  A      CL+RD   RP   +++ 
Sbjct: 223 HRGLMPRLPDSF----SAAAIDFVTSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 72/208 (34%), Positives = 104/208 (50%), Gaps = 24/208 (11%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G W   N T PV        AVKTL    +   K++LAE   +  L HP
Sbjct: 14  LGAGQFGEVWEGLW---NNTTPV--------AVKTLKPGTMDP-KDFLAEAQIMKKLRHP 61

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFL 257
            L++L   C  ++   +V E M  GSL  +L      +L LP  I M  A   A G+A+L
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM--AAQVASGMAYL 119

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPE 316
             +     I+RD    N+L+  +   K++DFGLA+   ED        +      + APE
Sbjct: 120 EAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPE 174

Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLT-GR 343
             +    + KSDV+SFG++L E++T GR
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  104 bits (261), Expect = 2e-25
 Identities = 79/285 (27%), Positives = 133/285 (46%), Gaps = 42/285 (14%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G +G V++G W + +          LTVAVKTL  D ++   E+L E   +  + HP
Sbjct: 14  LGGGQYGEVYEGVWKKYS----------LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHP 62

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           NLV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L  
Sbjct: 63  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE- 121

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYV 318
             +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE +
Sbjct: 122 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESL 177

Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDP 377
                + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+ 
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEK 220

Query: 378 --RLEGHFSIKG-SQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
             R+E     +G   K  +L   C   +P  RP  +E+ +  + +
Sbjct: 221 GYRMERP---EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  104 bits (262), Expect = 2e-25
 Identities = 86/296 (29%), Positives = 125/296 (42%), Gaps = 63/296 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQG-HKEWLAEVNFLGNLLH 198
           +G G FG V+           V   TG  +AVK +   D      KE   E+  L  L H
Sbjct: 8   IGGGTFGKVYTA---------VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH 58

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           PNLVK  G  +  ++  +  E+   G+LE  L   G + L   +     L   +GLA+LH
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAYLH 116

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV---MGTYGYAAP 315
                 +++RD K +NI LD +   KL DFG A    ++  T +   V    GT  Y AP
Sbjct: 117 S---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL-KNNTTTMGEEVQSLAGTPAYMAP 172

Query: 316 EYV----MTGHLTSKSDVYSFGVVLLEMLTGRR---SMDKNRPNGEHNLVEWA------- 361
           E +      GH  + +D++S G V+LEM TG+R    +D           E+        
Sbjct: 173 EVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDN----------EFQIMFHVGA 221

Query: 362 --RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 415
             +P + D       L    EG   +           +CL  DPK RP  SE+++ 
Sbjct: 222 GHKPPIPDS------LQLSPEGKDFLD----------RCLESDPKKRPTASELLQH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (261), Expect = 4e-25
 Identities = 64/238 (26%), Positives = 98/238 (41%), Gaps = 48/238 (20%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---------K 184
           +F+   ++GEG F  V             +  T    A+K L+   L            K
Sbjct: 2   DFKFGKIIGEGSFSTVVLAK---------EKETNKEYAIKILDKRQLIKEKKVKYVKIEK 52

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
           E L  +N      HP ++KL  Y  +D++ L  V E+ P G L  ++ + GSL      R
Sbjct: 53  EVLTRLN-----GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TR 105

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
              A      L +LH    K +I+RD K  NILLD D + K++DFG AK    +     +
Sbjct: 106 FYAAE-ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161

Query: 304 TRVM------------------GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
                                 GT  Y +PE +        SD+++ G ++ +MLTG+
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  102 bits (255), Expect = 2e-24
 Identities = 83/292 (28%), Positives = 121/292 (41%), Gaps = 44/292 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G         V+    L VAVKTL      Q   ++L E   +    H 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVE----LQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL---PWSIRMK----IALGAAK 252
           N+V+L+G   E   R ++ E M  G L++  F + + P    P S+ MK     A   AK
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKS--FLRENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           G  +L E      I+RD    N LL        AK++DFG+A+D           R M  
Sbjct: 128 GCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWAR--PHL 365
             +  PE  + G  TSK+DV+SFGV+L E+ +        R N E    +    R  P  
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPK 244

Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
           G     YR++                      C    P+ RP  + ++E ++
Sbjct: 245 GCPGPVYRIM--------------------TDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  101 bits (254), Expect = 3e-24
 Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 32/219 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLLH 198
           LGEG FG V+KG  E  G       T  +VA+KTL  N +  +  +E+  E   + +L H
Sbjct: 13  LGEGAFGKVYKG--ELTGPNERLSAT--SVAIKTLKENAEP-KVQQEFRQEAELMSDLQH 67

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--------------GSLPLPWSIRM 244
           PN+V L+G C ++    +++E++  G L   L R                   L  S  +
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            IA+  A G+ +L   +    ++RD    N L+      K+SDFGL++    D  +    
Sbjct: 128 HIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR----DIYSADYY 180

Query: 305 RVMGT----YGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 339
           RV         +  PE ++ G  T++SD++SFGVVL E+
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 3e-24
 Identities = 82/295 (27%), Positives = 132/295 (44%), Gaps = 43/295 (14%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLL 197
           +LGEG FG V +G + ++  + +K      VAVKT+  D       +E+L+E   + +  
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59

Query: 198 HPNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHLF--RKGSLP--LPWSIRMKIA 247
           HPN++KL+G C E          +++  FM  G L + L   R G LP  LP    +K  
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           +  A G+ +L   + +  I+RD    N +L  D    ++DFGL+K     G  +   R+ 
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI-YSGDYYRQGRIA 175

Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + A E +     TSKSDV++FGV + E+ T  R          H + ++      
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYL----- 228

Query: 367 DKRRFYRLLDPR--LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
             R   RL  P   L+  + +            C   DPK RP  +++ E L+ +
Sbjct: 229 --RHGNRLKQPEDCLDELYDL---------MYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  102 bits (254), Expect = 4e-24
 Identities = 73/218 (33%), Positives = 103/218 (47%), Gaps = 27/218 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E    +P K    + VAVK L    L   K++  E   L NL H +
Sbjct: 13  LGEGAFGKVF--LAECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-----------------KGSLPLPWSIR 243
           +VK  G C + D  ++V+E+M  G L N   R                 KG L L  S  
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGL--SQM 125

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           + IA   A G+ +L   A +  ++RD  T N L+ A+   K+ DFG+++D        V 
Sbjct: 126 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
              M    +  PE +M    T++SDV+SFGV+L E+ T
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  101 bits (252), Expect = 7e-24
 Identities = 85/300 (28%), Positives = 134/300 (44%), Gaps = 42/300 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAP-------VKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 192
           LGEG FG V    V      P       V+ G  L VAVK L  D  +  + ++L EV  
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL----------------FRKGSL 236
           L  L  PN+++L+G C+++D   ++ E+M  G L   L                     L
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 237 PLP-WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 295
           P   +S  + +AL  A G+ +L   +    ++RD  T N L+  +   K++DFG++++  
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE- 354
                 +  R +    + A E ++ G  T+ SDV++FGV L E+L     + K +P GE 
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL----MLCKEQPYGEL 245

Query: 355 --HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
               ++E A     D+ R   L  P           Q   +L  QC SRD + RP  S++
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPP-------CPQGLYELMLQCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  100 bits (251), Expect = 8e-24
 Identities = 64/235 (27%), Positives = 103/235 (43%), Gaps = 40/235 (17%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 192
           N      +G+G FG VF+      G  P +P T   VAVK L  +       ++  E   
Sbjct: 6   NIEYVRDIGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAAL 61

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK------------------- 233
           +    HPN+VKL+G C       L++E+M  G L   L  +                   
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 234 -GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
              LPL  + ++ IA   A G+A+L   +E+  ++RD  T N L+  +   K++DFGL++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Query: 293 DA------PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +              +  R M       PE +     T++SDV+++GVVL E+ +
Sbjct: 179 NIYSADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  100 bits (251), Expect = 1e-23
 Identities = 83/296 (28%), Positives = 126/296 (42%), Gaps = 42/296 (14%)

Query: 141 LGEGGFGCV-------FKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 192
           LGEG FG V        + + E+           + VAVK L  D      +++L EV  
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK----------GSLPLPWSI 242
           L  L  PN+ +L+G C  D    ++ E+M  G L N   +K           S  L +S 
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSGLACNSKSLSFST 131

Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
            + +A   A G+ +L        ++RD  T N L+  +Y  K++DFG++++        V
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE---HNLV 358
             R      + A E V+ G  T+KSDV++FGV L E+LT  R      +P        ++
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE-----QPYEHLTDQQVI 243

Query: 359 EWA-RPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT-QLAAQCLSRDPKARPRMSEV 412
           E A      D R+ Y L  P            K   +L  +C  RD + RP   E+
Sbjct: 244 ENAGHFFRDDGRQIY-LPRP--------PNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  100 bits (249), Expect = 1e-23
 Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 23/219 (10%)

Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWL 187
           L     R   LLG G FG V KG W+ E  +  +       VA+KT+ +  G Q  +E  
Sbjct: 4   LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIP------VAIKTIQDRSGRQTFQEIT 57

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RKGSLP----LPWSI 242
             +  +G+L H  +V+L+G C       LV +  P GSL +H+   + SL     L W +
Sbjct: 58  DHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116

Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L E     +++R+    NILL +D   +++DFG+A     D K + 
Sbjct: 117 QI------AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167

Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            +       + A E ++ G  T +SDV+S+GV + EM++
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 99.9 bits (250), Expect = 2e-23
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 25/215 (11%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 190
           +     LGEG +G V+K   ++ G           VA+K +      +G+      L E+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGE---------IVALKKIRLDNEEEGIP--STALREI 49

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALG 249
           + L  L HPN+VKL+     + +  LV+E+     L+ +L  R G L     I+  I   
Sbjct: 50  SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL-IK-SIMYQ 106

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GLA+ H      +++RD K  NIL++ D   KL+DFGLA+      +T+ +  V+ T
Sbjct: 107 LLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-T 161

Query: 310 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
             Y APE ++     S + D++S G +  EM+TG+
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 80/280 (28%), Positives = 119/280 (42%), Gaps = 39/280 (13%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVK-PGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 196
           S LGEG  G V K           +   TG+  A+KT+  D      K+ L E+    + 
Sbjct: 7   SRLGEGAGGSVTK----------CRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC 56

Query: 197 LHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHL--FRKGSLPLPWSIRMKIALGAAK 252
             P +VK  G  +++    +    E+   GSL++     +K    +   +  KIA    K
Sbjct: 57  KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTHVSTRVMGTYG 311
           GL++LH    + +I+RD K SNILL      KL DFG++ +       T       GT  
Sbjct: 117 GLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSF 168

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM--DKNRPNGEHNLVEWARPHLGDKR 369
           Y APE +     +  SDV+S G+ LLE+   R     +   P G   L+ +         
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY--------- 219

Query: 370 RFYRLLDPRL--EGHFSIKGSQKATQLAAQCLSRDPKARP 407
               + +P L  E    IK S++      QCL +DP  RP
Sbjct: 220 -IVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN----HDGLQGHKEWLAEVNFLGNL 196
           +GEG  G VFK    E         TG TVA+K +       G+    + L E+  L   
Sbjct: 8   IGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIP--NQALREIKALQAC 56

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
            HP +VKL+         +LV E+MP   L   L R    PLP +          KG+A+
Sbjct: 57  QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVL-RDEERPLPEAQVKSYMRMLLKGVAY 114

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           +H      +++RD K +N+L+ AD   K++DFGLA+   E+     S +V  T  Y APE
Sbjct: 115 MHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE 170

Query: 317 YVMTG--HLTSKSDVYSFGVVLLEMLTGR 343
            ++ G        D+++ G +  E+L G 
Sbjct: 171 -LLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 97.8 bits (243), Expect = 4e-23
 Identities = 87/279 (31%), Positives = 134/279 (48%), Gaps = 34/279 (12%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLH 198
           LLG+G FG VFKG +++             VAVKT   D  Q  K ++L+E   L    H
Sbjct: 2   LLGKGNFGEVFKGTLKDK----------TPVAVKTCKEDLPQELKIKFLSEARILKQYDH 51

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           PN+VKL+G C +     +V E +P G   + L RK    L     +K AL AA G+A+L 
Sbjct: 52  PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLE 110

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYAAPEY 317
               K  I+RD    N L+  +   K+SDFG+++   ED   + S+ +      + APE 
Sbjct: 111 ---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEA 165

Query: 318 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP 377
           +  G  +S+SDV+S+G++L E      S+      G  N  + AR  +    + YR+  P
Sbjct: 166 LNYGRYSSESDVWSYGILLWETF----SLGVCPYPGMTN--QQAREQV---EKGYRMSCP 216

Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           +       K      ++  +C    P+ RP+ SE+ + L
Sbjct: 217 Q-------KCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 98.8 bits (247), Expect = 5e-23
 Identities = 71/221 (32%), Positives = 102/221 (46%), Gaps = 38/221 (17%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAE 189
            +F     LG G FG V    V   G+           A+K L+   +   K+    L E
Sbjct: 1   DDFEFIKTLGTGSFGRVML--VRHKGSGKY-------YALKILSKAKIVKLKQVEHVLNE 51

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM---K 245
              L ++ HP LV L G   +DD  L LV E++P G L +HL + G  P P + R    +
Sbjct: 52  KRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAAQ 109

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
           + L     L +LH      ++YRD K  N+LLD+D   K++DFG AK         V  R
Sbjct: 110 VVLA----LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGR 154

Query: 306 VM---GTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTG 342
                GT  Y APE ++  G+     D ++ G+++ EML G
Sbjct: 155 TYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 98.3 bits (245), Expect = 5e-23
 Identities = 74/214 (34%), Positives = 109/214 (50%), Gaps = 16/214 (7%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  E+  
Sbjct: 4   RHLKFIQQLGKGNFGSV-----ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEI 58

Query: 193 LGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
           L +L H N+VK  G C    +R   LV E++P GSL ++L +K    L     +  A   
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQI 117

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG-- 308
            KG+ +L     K  ++RD  T NIL++++   K+ DFGL K  P+D K +   R  G  
Sbjct: 118 CKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGES 173

Query: 309 -TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
             + Y APE +     +  SDV+SFGVVL E+ T
Sbjct: 174 PIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.0 bits (244), Expect = 6e-23
 Identities = 72/217 (33%), Positives = 109/217 (50%), Gaps = 26/217 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLA--- 188
           N+R   LLG+G FG V+               TG  +AVK +  D       KE  A   
Sbjct: 3   NWRRGKLLGQGAFGRVY---------LCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC 53

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
           E+  L NL H  +V+  G C+ DD+ L ++ E+MP GS+++ L   G   L  ++  K  
Sbjct: 54  EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYT 110

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTR 305
               +G+ +LH      +++RD K +NIL D+  N KL DFG +K         T + + 
Sbjct: 111 RQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS- 166

Query: 306 VMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLT 341
           V GT  + +PE V++G     K+DV+S G  ++EMLT
Sbjct: 167 VTGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 77/289 (26%), Positives = 112/289 (38%), Gaps = 38/289 (13%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNL 196
            ++GEG +G V K   +          TG  VA+K    + D     K  L EV  L  L
Sbjct: 7   GVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
            H N+V L        +  LV+E++ R  LE      G LP P ++R        + +A+
Sbjct: 58  RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLP-PDAVR-SYIWQLLQAIAY 115

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
            H      +I+RD K  NIL+      KL DFG A+       + ++  V  T  Y APE
Sbjct: 116 CHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE 171

Query: 317 YVMTGHLTSKS-DVYSFGVVLLEMLTGR----------------RSMDKNRPNGEHNLVE 359
            ++      K  DV++ G ++ E+L G                 + +    P   H  + 
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP--SHQELF 229

Query: 360 WARPHLGDKRRFYRLLDPR-LEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            + P       F     P  LE  +  K S  A      CL  DPK R 
Sbjct: 230 SSNPRFA-GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 96.6 bits (240), Expect = 1e-22
 Identities = 81/296 (27%), Positives = 131/296 (44%), Gaps = 52/296 (17%)

Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
           L  +  +    +G+G FG V  G              G  VAVK + +D     + +LAE
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAE 49

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
            + +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  +G   L     +K +L
Sbjct: 50  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTR 305
              + + +L        ++RD    N+L+  D  AK+SDFGL K+A    + GK  V   
Sbjct: 110 DVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 164

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
                 + APE +     ++KSDV+SFG++L E+ +  R             V + R  L
Sbjct: 165 ------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPL 205

Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKAT----QLAAQCLSRDPKARPRMSEVVETLK 417
            D       + PR+E  + +            +  QC   D   RP   ++ E L+
Sbjct: 206 KD-------VVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 97.4 bits (242), Expect = 1e-22
 Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 18/212 (8%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E     P +    + VAVKTL        K++  E   L NL H +
Sbjct: 13  LGEGAFGKVF--LAECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL---------FRKGSLP--LPWSIRMKIALG 249
           +VK  G C+E D  ++V+E+M  G L   L           +G+ P  L  S  + IA  
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
            A G+ +L   A +  ++RD  T N L+  +   K+ DFG+++D        V    M  
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
             +  PE +M    T++SDV+S GVVL E+ T
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 65/207 (31%), Positives = 87/207 (42%), Gaps = 20/207 (9%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL 197
           LG+GGFG V          A     TG   A K L+   L   +G +  L E   L  + 
Sbjct: 1   LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
              +V L  Y  E    L LV   M  G L+ H++  G    P +  +  A     GL  
Sbjct: 52  SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           LH+     ++YRD K  N+LLD   N ++SD GLA +     K        GT GY APE
Sbjct: 111 LHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPE 164

Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGR 343
            +         D ++ G  L EM+ GR
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 97.0 bits (241), Expect = 2e-22
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 50/311 (16%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTLNHDGLQGH-KEWLAEVN 191
           N      LGEG FG V K          +K   G T VAVK L  +      ++ L+E N
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFR-----LKGRAGYTTVAVKMLKENASSSELRDLLSEFN 55

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------------------- 230
            L  + HP+++KL G C +D   LL+ E+   GSL + L                     
Sbjct: 56  LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115

Query: 231 -FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG 289
                   L     +  A   ++G+ +L   AE  +++RD    N+L+      K+SDFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172

Query: 290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDK 348
           L++D  E+      ++      + A E +     T++SDV+SFGV+L E++T G      
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Query: 349 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 408
             P    NL++            YR+  P          S++   L   C  ++P  RP 
Sbjct: 233 IAPERLFNLLKTG----------YRMERPE-------NCSEEMYNLMLTCWKQEPDKRPT 275

Query: 409 MSEVVETLKPL 419
            +++ + L+ +
Sbjct: 276 FADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 75/303 (24%), Positives = 129/303 (42%), Gaps = 49/303 (16%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLA 188
             NF+ E  +G+G F  V+K     +G           VA+K +    +   K   + L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDG---------RVVALKKVQIFEMMDAKARQDCLK 51

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLP----WSI 242
           E++ L  L HPN++K +   IE+++  +V E    G L   +  F+K    +P    W  
Sbjct: 52  EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111

Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
            +++       L  +H    K +++RD K +N+ + A    KL D GL +      KT  
Sbjct: 112 FVQL----CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTA 162

Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 362
           +  ++GT  Y +PE +       KSD++S G +L EM                       
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQS 204

Query: 363 PHLGDKRRFYRLLDPRLEGHF----SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP 418
           P  GDK   Y L     +  +    +   S++   L ++C++ DP+ RP +S V++  K 
Sbjct: 205 PFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264

Query: 419 LQN 421
           +  
Sbjct: 265 MHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 74/288 (25%), Positives = 114/288 (39%), Gaps = 39/288 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN---HDGLQGHKEWLAEV 190
           +F    ++G+G FG V    V++  T           A+K +N          +  L E 
Sbjct: 1   HFELLRVIGKGAFGKVCI--VQKRDT-------KKMFAMKYMNKQKCVEKGSVRNVLNER 51

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
             L  L HP LV L  Y  +D++ + LV + +  G L  HL +K        ++  I   
Sbjct: 52  RILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS-EEQVKFWIC-E 108

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
               L +LH    K +I+RD K  NILLD   +  ++DF +A     D  T   T   GT
Sbjct: 109 IVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGT 162

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 369
            GY APE +     +   D +S GV   E L G+R    +       + +  R       
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS----RTIRDQIRAKQETAD 218

Query: 370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
                        +    S +A     + L RDP+   R+ + ++ LK
Sbjct: 219 V-----------LYPATWSTEAIDAINKLLERDPQK--RLGDNLKDLK 253

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 78/288 (27%), Positives = 134/288 (46%), Gaps = 34/288 (11%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 196
           E ++G G FG V +G ++  G   +       VA+KTL      +  +++L+E + +G  
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSEASIMGQF 62

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 255
            HPN++ L G   +    +++ EFM  G+L++ L    G   +   + M    G A G+ 
Sbjct: 63  DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGM--LRGIAAGMK 120

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG---TYGY 312
           +L   +E   ++RD    NIL++++   K+SDFGL++   +D      T  +G      +
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
            APE +     TS SDV+S+G+V+ E+++ G R           N +E          + 
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----------QD 227

Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           YRL  P       +       QL   C  +D  ARP+  ++V TL  +
Sbjct: 228 YRLPPP-------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.4 bits (237), Expect = 3e-22
 Identities = 82/278 (29%), Positives = 126/278 (45%), Gaps = 40/278 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG FG V +G             TG  VAVK +  D     + +L E   +  L H N
Sbjct: 14  IGEGEFGAVLQGEY-----------TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKN 60

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G  I  +   +V E M +G+L N L  +G   +     ++ +L  A+G+ +L   
Sbjct: 61  LVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES- 118

Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             K +++RD    NIL+  D  AK+SDFGLA+          ++++     + APE +  
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGS---MGVDNSKL--PVKWTAPEALKH 171

Query: 321 GHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 379
              +SKSDV+S+GV+L E+ + GR    K         VE          + YR+  P  
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE----------KGYRMEPP-- 219

Query: 380 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
           EG            L   C   +PK RP   ++ E L+
Sbjct: 220 EG-----CPADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.1 bits (240), Expect = 4e-22
 Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 51/277 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVNFLGNLLH 198
           +GEG  G V+K              TG  VA+K +    L+   + L   E+  + +  H
Sbjct: 27  IGEGASGEVYKA---------TDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           PN+V      +  D+  +V E+M  GSL + +  +  + +       +     +GL +LH
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVLQGLEYLH 133

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR--VMGTYGYAAPE 316
               + VI+RD K+ NILL  D + KL+DFG A           S R  V+GT  + APE
Sbjct: 134 S---QNVIHRDIKSDNILLSKDGSVKLADFGFAA----QLTKEKSKRNSVVGTPYWMAPE 186

Query: 317 YVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--RRFYR 373
            V+       K D++S G++ +EM  G        P           P+L +   R  + 
Sbjct: 187 -VIKRKDYGPKVDIWSLGIMCIEMAEG-------EP-----------PYLREPPLRALFL 227

Query: 374 LLD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
           +     P L+     K S +      +CL +DP+ RP
Sbjct: 228 ITTKGIPPLKN--PEKWSPEFKDFLNKCLVKDPEKRP 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 95.6 bits (238), Expect = 4e-22
 Identities = 66/208 (31%), Positives = 109/208 (52%), Gaps = 18/208 (8%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLH 198
           ++G+G FGCV+ G + ++    +        AVK+LN    L+  +++L E   + +  H
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIH------CAVKSLNRITDLEEVEQFLKEGIIMKDFSH 55

Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 56  PNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP---TVKDLIGFGLQVAKGME 112

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 95.2 bits (237), Expect = 5e-22
 Identities = 82/290 (28%), Positives = 136/290 (46%), Gaps = 44/290 (15%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--------NHDGLQGH--KEWLAE 189
           L+G+G +G V+      N T      TG  +AVK +         HD  Q    K   +E
Sbjct: 8   LIGKGTYGRVYLAL---NVT------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--PLPWSIRMKIA 247
           +  L +L H N+V+ +G+   ++   +  E++P GS+ + L   G     L      ++ 
Sbjct: 59  IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL 118

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
               +GLA+LH    K +++RD K  N+L+DAD   K+SDFG++K + +D   +     M
Sbjct: 119 ----EGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS-DDIYDNDQNMSM 170

Query: 308 -GTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
            G+  + APE + +     ++K D++S G V+LEM  GR      RP  +   +  A   
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIA-AMFK 223

Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           LG+KR       P +    S+  S  A      C + +P  RP   E+++
Sbjct: 224 LGNKRS-----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 72/255 (28%), Positives = 111/255 (43%), Gaps = 28/255 (10%)

Query: 169 TVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 227
            VA+K ++ +  Q    E   EV  +    HPN+VK     +  D+  LV  ++  GSL 
Sbjct: 28  KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87

Query: 228 N---HLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 284
           +     + +G L     I   +     KGL +LH   +   I+RD K  NILL  D + K
Sbjct: 88  DIMKSSYPRGGLDEA--IIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVK 142

Query: 285 LSDFGLAKDAPEDGKTHVSTR--VMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEML 340
           ++DFG++    + G      R   +GT  + APE VM        K+D++SFG+  +E+ 
Sbjct: 143 IADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELA 201

Query: 341 TGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKA-TQLAAQCL 399
           TG     K  P     L     P             P LE     K   K+  ++ + CL
Sbjct: 202 TGAAPYSKYPPMKVLMLTLQNDP-------------PSLETGADYKKYSKSFRKMISLCL 248

Query: 400 SRDPKARPRMSEVVE 414
            +DP  RP   E+++
Sbjct: 249 QKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 81/298 (27%), Positives = 124/298 (41%), Gaps = 63/298 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           +GEG +G V+K   +          TG  VA+K +    L+   E      L E+  L  
Sbjct: 7   IGEGTYGVVYKARDKL---------TGEIVAIKKIK---LRFESEGIPKTALREIKLLKE 54

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLEN--HLFRKGSLPLPWSIRMKIALGAAK 252
           L HPN++KL+         L LV+EFM      +   L +     LP S+         +
Sbjct: 55  LNHPNIIKLLD-VFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQ 109

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTH-VSTRVMGT 309
           GLAF H      +++RD K  N+L++ +   KL+DFGLA+   +P    TH V TR    
Sbjct: 110 GLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW--- 163

Query: 310 YGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP--NGEHNLVEWARPH-- 364
             Y APE ++     ++  D++S G +  E+L+ R       P   G+  + +  +    
Sbjct: 164 --YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR-------PLFPGKSEIDQLFKIFRT 214

Query: 365 LGD-----------KRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARP 407
           LG              R Y+   P+  G          S +A  L +Q L  DP  R 
Sbjct: 215 LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI 272

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 83/291 (28%), Positives = 127/291 (43%), Gaps = 57/291 (19%)

Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
             LKL  +       LG G FG V+ G+   +            VA+K+L   G    + 
Sbjct: 6   ETLKLVKK-------LGAGQFGEVWMGYYNGH----------TKVAIKSLK-QGSMSPEA 47

Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
           +LAE N +  L HP LV+L    +  +   ++ E+M  GSL + L     + L  +  + 
Sbjct: 48  FLAEANLMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DAPEDG 298
           +A   A+G+AF+     K  I+RD + +NIL+      K++DFGLA+        A E  
Sbjct: 107 MAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA 163

Query: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HN 356
           K  +         + APE +  G  T KSDV+SFG++L E++T  R       N E   N
Sbjct: 164 KFPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN 215

Query: 357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L            R YR+  PR +        ++  +L   C    P+ RP
Sbjct: 216 L-----------ERGYRM--PRPDN-----CPEELYELMRLCWKEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVK-PGTGLTVAVKTLNHDGLQGH-KEWL-AEVNFLGNLL 197
           +G+G FG V K          V+    G  +  K +++  +    K+ L +EVN L  L 
Sbjct: 8   IGKGSFGTVRK----------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57

Query: 198 HPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHL--FRKGSLPLP----WSIRMKIALG 249
           HPN+V+     I+   + L  V E+   G L   +   +K    +     W I  ++ L 
Sbjct: 58  HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117

Query: 250 AAKGLAFLH--EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED---GKTHVST 304
               L   H   +    V++RD K +NI LDA+ N KL DFGLAK    D    KT+V  
Sbjct: 118 ----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-- 171

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
              GT  Y +PE +       KSD++S G ++ E+    
Sbjct: 172 ---GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 60/287 (20%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F     LGEG +G V+K   +E G           VA+K +  +     +E + E++ L 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQ---------VVAIKVVPVEE--DLQEIIKEISILK 53

Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
               P +VK  G   ++    +V E+   GS+ + + +  +  L       I     KGL
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTRVMGTYG 311
            +LH       I+RD K  NILL+ +  AKL+DFG++    D      T     V+GT  
Sbjct: 113 EYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-----VIGTPF 164

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR---------RSMD--KNRPNGEHNLVEW 360
           + APE +      +K+D++S G+  +EM  G+         R++    N+P         
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP-------- 216

Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
             P L D  ++                S +      +CL +DP+ RP
Sbjct: 217 --PTLSDPEKW----------------SPEFNDFVKKCLVKDPEERP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 93.1 bits (231), Expect = 4e-21
 Identities = 79/286 (27%), Positives = 131/286 (45%), Gaps = 33/286 (11%)

Query: 141 LGEGGFG----CVFKGWVEENG-TAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLG 194
           LGEG FG    C  +G  E  G  AP   G  + VAVK L  D  +    ++L E+  + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL---------ENHLFRKGSLP-LPWSIRM 244
            L +PN+++L+G C+ DD   ++ E+M  G L         E+      ++P +  +  +
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            +A+  A G+ +L   A    ++RD  T N L+   Y  K++DFG++++        +  
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG---EHNLVEWA 361
           R +    + A E ++ G  T+ SDV++FGV L EM T    + K +P     +  ++E  
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQPYSLLSDEQVIENT 245

Query: 362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
                ++ R   L    L             +L  +C SRD K RP
Sbjct: 246 GEFFRNQGRQIYLSQTPL-------CPSPVFKLMMRCWSRDIKDRP 284

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 92.4 bits (229), Expect = 6e-21
 Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 20/214 (9%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E +   P +      VAVK L        +++  E   L  L H +
Sbjct: 13  LGEGAFGKVF--LAECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSL---------ENHLFRKGSL----PLPWSIRMKIA 247
           +V+  G C E    L+V+E+M  G L         +  +   G       L     + IA
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
              A G+ +L   A    ++RD  T N L+      K+ DFG+++D        V  R M
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               +  PE ++    T++SD++SFGVVL E+ T
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 91.8 bits (228), Expect = 8e-21
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 50/290 (17%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----------LAE 189
            LG G FGCV+K   + NG           +A+K +N       K+           ++E
Sbjct: 7   HLGSGAFGCVYKVRKKNNG--------QNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58

Query: 190 VNFLG-NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF----RKGSLPLP--WSI 242
           V  +   L HPN+V+     +E+D+  +V + +    L  H      +K        W+I
Sbjct: 59  VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118

Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
            +++ L     L +LH+E  K +++RD   +NI+L  D    ++DFGLAK    + K   
Sbjct: 119 FVQMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL-- 170

Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 362
            T V+GT  Y+ PE V       K+DV++FG +L +M T         P    N++  A 
Sbjct: 171 -TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLA- 222

Query: 363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                 +    + +P  EG +    S+  T +   CL+ D +ARP + +V
Sbjct: 223 -----TKIVEAVYEPLPEGMY----SEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 91.8 bits (228), Expect = 1e-20
 Identities = 67/203 (33%), Positives = 94/203 (46%), Gaps = 9/203 (4%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 198
           LG G FG V    VE       K    + VAVK L        +E L +E+  + +L  H
Sbjct: 43  LGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            N+V L+G C      L++ E+   G L N L RK    L     +  +   AKG+AFL 
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
             A K  I+RD    N+LL      K+ DFGLA+D   D    V         + APE +
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215

Query: 319 MTGHLTSKSDVYSFGVVLLEMLT 341
                T +SDV+S+G++L E+ +
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 91.3 bits (226), Expect = 2e-20
 Identities = 67/209 (32%), Positives = 110/209 (52%), Gaps = 23/209 (11%)

Query: 140 LLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL 197
           +LG G FG V+KG WV E  T  +       VA+K LN   G + + E++ E   + ++ 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIP------VAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSL----ENHLFRKGS-LPLPWSIRMKIALGAAK 252
           HP+LV+L+G C+    +L V + MP G L      H    GS L L W +++      AK
Sbjct: 68  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AK 120

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+ +L E   + +++RD    N+L+ +  + K++DFGLA+    D K + +        +
Sbjct: 121 GMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            A E +     T +SDV+S+GV + E++T
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 15/203 (7%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
            +GEG FG V++G               + VAVKT  +      +E +L E   +    H
Sbjct: 13  CIGEGQFGDVYQG------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFL 257
           P++VKL+G    ++   +V E  P G L ++L   K SL L  +  +  +   +  LA+L
Sbjct: 67  PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDL--ASLILYSYQLSTALAYL 123

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 317
                K  ++RD    N+L+ +    KL DFGL++   ED   + +++      + APE 
Sbjct: 124 E---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPES 179

Query: 318 VMTGHLTSKSDVYSFGVVLLEML 340
           +     TS SDV+ FGV + E+L
Sbjct: 180 INFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 90.0 bits (223), Expect = 3e-20
 Identities = 76/286 (26%), Positives = 137/286 (47%), Gaps = 32/286 (11%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           + ++G G FG VF+G ++  G   V       VA+KTL     +  + ++L+E + +G  
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEV------AVAIKTLKPGYTEKQRQDFLSEASIMGQF 63

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
            H N+++L G   +    +++ E+M  G+L+ +L         + + + +  G A G+ +
Sbjct: 64  SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKY 122

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGYA 313
           L   ++   ++RD    NIL++++   K+SDFGL++   D PE   T    ++     + 
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWT 177

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 373
           APE +     TS SDV+SFG+V+ E+++        RP  + +  E  +  + D    +R
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSF-----GERPYWDMSNHEVMKA-INDG---FR 228

Query: 374 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           L  P       +       QL  QC  +D   RPR  ++V  L  L
Sbjct: 229 LPAP-------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.0 bits (221), Expect = 6e-20
 Identities = 71/289 (24%), Positives = 122/289 (42%), Gaps = 49/289 (16%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 190
           +F+    LG+G +G V+K  V+               A+K ++  G    KE    + E+
Sbjct: 1   DFKVLKKLGKGSYGSVYK--VKRLSD-------NQFYALKEVDL-GSMSQKEREDAVNEI 50

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--PLPWSIRMKIAL 248
             L ++ HPN++      ++ ++  +V E+ P G L   + ++      +P     +I +
Sbjct: 51  RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
              +GL  LHE+    +++RD K++NILL A+   K+ D G++K      K +++   +G
Sbjct: 111 QLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIG 163

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-----RSMDKNRPNGEHNLVEWARP 363
           T  Y APE       + KSD++S G +L EM T       RSM   R             
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR------------- 210

Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                 +  R   P +   +    SQ         L   PK RP   ++
Sbjct: 211 -----YKVQRGKYPPIPPIY----SQDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 89.5 bits (222), Expect = 6e-20
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 23/216 (10%)

Query: 134 NFRPESL-----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 187
           + R E L     LG G  G V K  V+   T       G  +A K ++        K+ L
Sbjct: 1   DLRNEDLETISDLGAGNGGSVSK--VKHIPT-------GTVMAKKVVHIGAKSSVRKQIL 51

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E+  +     P +V   G  + ++   +  EFM  GSL+  +++KG  P+P  I  KIA
Sbjct: 52  RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGG-PIPVEILGKIA 109

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           +   +GL +L+      +++RD K SNIL+++    KL DFG++ +        ++   +
Sbjct: 110 VAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFV 163

Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           GT  Y +PE +  G  T KSDV+S G+ ++E+  G+
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.8 bits (220), Expect = 7e-20
 Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 42/281 (14%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V  G W  +             VA+K +  +G     E++ E   +  L H 
Sbjct: 12  LGTGQFGVVKYGKWRGQY-----------DVAIKMIK-EGSMSEDEFIEEAKVMMKLSHE 59

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            LV+L G C +     +V E+M  G L N+L   G    P  + +++     +G+A+L  
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLE- 117

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAPE 316
              K  I+RD    N L+D     K+SDFGL++   +D   + S+  +G+     ++ PE
Sbjct: 118 --SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--EYTSS--VGSKFPVRWSPPE 171

Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 375
            ++    +SKSDV++FGV++ E+ + G+   ++   N E   VE     +    R YR  
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSE--TVE----KVSQGLRLYR-- 222

Query: 376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
            P L        S+K   +   C     + RP   +++ ++
Sbjct: 223 -PHL-------ASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.8 bits (220), Expect = 7e-20
 Identities = 75/276 (27%), Positives = 124/276 (44%), Gaps = 32/276 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K    + VA+K +N +G    ++++ E   +  L HP 
Sbjct: 12  LGSGQFGVVHLG----------KWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPK 60

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L G C +     +V EFM  G L N+L R+    L   + + +     +G+ +L   
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLERN 119

Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
           +    I+RD    N L+ +    K+SDFG+ +   +D  T  S+       ++ PE    
Sbjct: 120 S---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNF 175

Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
              +SKSDV+SFGV++ E+ T  +   + + N E  +VE          R +RL  P+L 
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVEMI-------SRGFRLYRPKL- 225

Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
                  S    ++   C    P+ RP  +E++  +
Sbjct: 226 ------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 8e-20
 Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 42/288 (14%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFL 193
           ++   L+G G +G V++G             TG  VA+K +N D       +   EV  L
Sbjct: 3   YQRLELIGRGAYGAVYRG---------KHVPTGRVVALKIINLDTPDDDVSDIQREVALL 53

Query: 194 GNLLH---PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW-SIRMKIAL 248
             L     PN+ K  G       RL ++ E+   GS+   L + G +   + S+ ++  L
Sbjct: 54  SQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVL 111

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
            A   L ++H+     VI+RD K +NIL+    N KL DFG+A  A  +  +   +  +G
Sbjct: 112 VA---LKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFVG 163

Query: 309 TYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           T  + APE +  G    +K+D++S G+ + EM TG              L+  ++P    
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP---- 219

Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 415
                    PRLE +     S+   +  A CL  +PK R    E++++
Sbjct: 220 ---------PRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 73/207 (35%), Positives = 106/207 (51%), Gaps = 17/207 (8%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNLLHP 199
           LGEG FG      VE     P    TG  VAVK+L  +    H   L  E+  L NL H 
Sbjct: 12  LGEGHFG-----KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66

Query: 200 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAF 256
           N+VK  G C ED      L+ EF+P GSL+ +L R K  + L    ++K A+   KG+ +
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDY 124

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR--VMGTYGYAA 314
           L     +  ++RD    N+L+++++  K+ DFGL K A E  K + + +  +     + A
Sbjct: 125 L---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYA 180

Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE ++       SDV+SFGV L E+LT
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 88.8 bits (220), Expect = 1e-19
 Identities = 75/293 (25%), Positives = 134/293 (45%), Gaps = 28/293 (9%)

Query: 141 LGEGGFG----CVFKG---WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 192
           LGEG FG    C  +G   +++++ +  V     + VAVK L  D  +  + ++L E+  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---------KGSLPLPWSIR 243
           +  L  PN+++L+  CI  D   ++ E+M  G L   L R            + + +S  
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           + +A   A G+ +L   +    ++RD  T N L+  +Y  K++DFG++++        + 
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
            R +    + + E ++ G  T+ SDV++FGV L E+LT  +    ++ + E  ++E    
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTGE 248

Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
              D+ R   L  P L             +L   C  R+ K RP   E+  TL
Sbjct: 249 FFRDQGRQVYLPKPAL-------CPDSLYKLMLSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 66/294 (22%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFL 193
           F     +G+G FG V+K          +   T   VA+K ++ +  +   E +  E+ FL
Sbjct: 3   FTLLECIGKGSFGEVYKA---------IDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFL 53

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPW-SIRMKIALGAAK 252
                P + K  G  ++  +  ++ E+   GS    L + G L   + +  ++  L    
Sbjct: 54  SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLDETYIAFILREVL---L 109

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTRVMGT 309
           GL +LHEE     I+RD K +NILL  + + KL+DFG++           T V     GT
Sbjct: 110 GLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GT 161

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG---RRSMD---------KNRPNGEHNL 357
             + APE +       K+D++S G+  +E+  G      +          KN P      
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP------ 215

Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
                              P LEG+   K S+      + CL++DPK RP   E
Sbjct: 216 -------------------PSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKE 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 71/217 (32%), Positives = 101/217 (46%), Gaps = 38/217 (17%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---------GLQGHKEWLAEV 190
           +LG+G FG V          A +K GT    AVK L  D              K  LA  
Sbjct: 2   VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSI--RMKIA 247
                  HP L +L   C +   RL  V E++  G L  H+ R G    P +     +I 
Sbjct: 53  G-----KHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIV 106

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           LG    L FLHE   + +IYRD K  N+LLD++ + K++DFG+ K+    G T  ++   
Sbjct: 107 LG----LQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFC 157

Query: 308 GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
           GT  Y APE +++      + D ++ GV+L EML G+
Sbjct: 158 GTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 68/224 (30%), Positives = 102/224 (45%), Gaps = 38/224 (16%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNH-----DGLQGHKEW 186
            +     LGEG +  V+K   +E G           VA+K   L       DG+  +   
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGR---------IVAIKKIKLGERKEAKDGI--NFTA 49

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL-PWSIR-- 243
           L E+  L  L HPN++ L+          LV+EFM    LE  + +  S+ L P  I+  
Sbjct: 50  LREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIKSY 107

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTH 301
           M + L   +GL +LH      +++RD K +N+L+ +D   KL+DFGLA+   +P    TH
Sbjct: 108 MLMTL---RGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH 161

Query: 302 -VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
            V TR      Y APE +    H     D++S G +  E+L   
Sbjct: 162 QVVTRW-----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 78/305 (25%), Positives = 122/305 (40%), Gaps = 75/305 (24%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +GEG +G V+K     N        TG  VA+K +    ++  KE      + E+  L  
Sbjct: 7   IGEGTYGQVYKA---RNKK------TGELVALKKIR---MENEKEGFPITAIREIKLLQK 54

Query: 196 LLHPNLVKLVGYCIEDDQR--LLVYEFMP---RGSLENHLFRKGSLPLPWSIRMKIALGA 250
           L HPN+V+L        +    +V+E+M     G L++               +K     
Sbjct: 55  LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPE-------------VKFTESQ 101

Query: 251 AK--------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
            K        GL +LH      +++RD K SNIL++ D   KL+DFGLA+   +      
Sbjct: 102 IKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158

Query: 303 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR---------RSMDK---- 348
           + RV+ T  Y  PE ++       + D++S G +L E+  G+           ++K    
Sbjct: 159 TNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL 217

Query: 349 -NRPNGEHNLVEWARPHLGDKRRFYRLLDP------RLEGHFSIKGSQKATQLAAQCLSR 401
              P  E     W  P +  K  ++  L P      RL   F       A  L  + L+ 
Sbjct: 218 CGSPTDE----NW--PGV-SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL 270

Query: 402 DPKAR 406
           DPK R
Sbjct: 271 DPKKR 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 87.2 bits (217), Expect = 4e-19
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 45/219 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           LG+G FG V+    +E G           VA+K +     +    W     L EV  L  
Sbjct: 7   LGDGTFGSVYLARNKETGE---------LVAIKKMK----KKFYSWEECMNLREVKSLRK 53

Query: 196 L-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-----RKGSLPLPWSIRMKIALG 249
           L  HPN+VKL     E+D+   V+E+M     E +L+     RKG  P   S+   I   
Sbjct: 54  LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGK-PFSESVIRSIIYQ 107

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD----APEDGKTHVSTR 305
             +GLA +H+       +RD K  N+L+      K++DFGLA++     P     +VSTR
Sbjct: 108 ILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDYVSTR 162

Query: 306 VMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
                 Y APE ++ +   +S  D+++ G ++ E+ T R
Sbjct: 163 -----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 76/291 (26%), Positives = 119/291 (40%), Gaps = 31/291 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNF 192
           N +  + LG G FG VF    +         G    V VK L          E+  E++ 
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEE----GGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-----RKGSLPLPWSIRMKIA 247
              L H N+V+L+G C E +   ++ E+   G L+  L       +   P P S + K+A
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 248 LGA--AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
           L    A G+  L   +    ++RD    N L+ +    K+S   L+KD        +   
Sbjct: 122 LCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
           ++    + APE V     ++KSDV+SFGV++ E+ T                 E     L
Sbjct: 179 LI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------------QGELPFYGL 222

Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
            D+    RL   +LE         +  +L  +C + +PK RP  SE+V  L
Sbjct: 223 SDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 43/283 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G FG V+K              TGL  A K +  +  +  ++++ E++ L    HPN
Sbjct: 13  LGDGAFGKVYKA---------QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +V L      +++  ++ EF   G+L++ +  +    L       +     + L FLH  
Sbjct: 64  IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHS- 121

Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
               VI+RD K  NILL  D + KL+DFG+ AK+     K       +GT  + APE V 
Sbjct: 122 --HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVA 176

Query: 320 TGHLTS-----KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 374
                      K+D++S G+ L+E+           P+ E N +          R   ++
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQME------PPHHELNPM----------RVLLKI 220

Query: 375 LD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           L    P L+     K S         CL +DP  RP  +E+++
Sbjct: 221 LKSEPPTLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 86.1 bits (214), Expect = 6e-19
 Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 29/211 (13%)

Query: 144 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLLHPN 200
           G +G VF            K  TG   A+K +    +       + L E + L     P 
Sbjct: 4   GAYGRVFLA---------KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54

Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           +VKL  Y  +  + L LV E++P G L + L   GSL      R+ IA      L +LH 
Sbjct: 55  VVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV-ARIYIA-EIVLALEYLHS 111

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DAPEDGKTHVSTRVMGTYGY 312
                +I+RD K  NIL+D++ + KL+DFGL+K           D +     R++GT  Y
Sbjct: 112 NG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTPDY 167

Query: 313 AAPEYVMTGHLTSKS-DVYSFGVVLLEMLTG 342
            APE V+ G   SK+ D +S G +L E L G
Sbjct: 168 IAPE-VILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.8 bits (212), Expect = 7e-19
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   N T          VAVKTL   G    + +L E N +  L H  
Sbjct: 14  LGAGQFGEVWMGYYN-NST---------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHDK 62

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLH 258
           LV+L     +++   ++ E+M +GSL + L     G + LP  I     +  A+G+A++ 
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 120

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  I+RD + +N+L+      K++DFGLA+   ED +            + APE +
Sbjct: 121 R---KNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI 176

Query: 319 MTGHLTSKSDVYSFGVVLLEMLT 341
             G  T KSDV+SFG++L E++T
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.9 bits (212), Expect = 8e-19
 Identities = 85/283 (30%), Positives = 128/283 (45%), Gaps = 40/283 (14%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
           ++   + R +  LG+G FG V+ G W   NGT          VA+KTL   G    + +L
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTW---NGTT--------KVAIKTLK-PGTMMPEAFL 49

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS---LPLPWSIRM 244
            E   +  L H  LV L    + ++   +V EFM +GSL + L ++G    L LP  + M
Sbjct: 50  QEAQIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDM 107

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             A   A G+A++        I+RD + +NIL+  +   K++DFGLA+   ED +     
Sbjct: 108 --AAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQ 161

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE  + G  T KSDV+SFG++L E++T  R       N         R  
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---------REV 212

Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R YR+  P+          +   +L   C  +DP  RP
Sbjct: 213 LEQVERGYRMPCPQ-------GCPESLHELMKLCWKKDPDERP 248

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 85.7 bits (212), Expect = 9e-19
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 29/219 (13%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK-----TLNHDGLQGHKEWLA----E 189
           +L+G G FG V+ G         +   +G  +AVK     +++       +  L     E
Sbjct: 6   ALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE 56

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           +  L  L H N+V+ +G  ++ D   +  E++P GS+   L   G+      +R  +   
Sbjct: 57  IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL-VRNFVR-Q 114

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR---- 305
             KGL +LH    + +I+RD K +NIL+D     K+SDFG++K   E       T     
Sbjct: 115 ILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARP 170

Query: 306 -VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
            + G+  + APE V     T K+D++S G +++EMLTG+
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 75/246 (30%), Positives = 101/246 (41%), Gaps = 58/246 (23%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 190
           +F    ++G G FG V+               TG   A+K L    +    +     AE 
Sbjct: 2   DFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAHVRAER 52

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----M 244
           + L +   P +VKL  Y  +D++ L LV E+MP G L N L RK   P     R     +
Sbjct: 53  DILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAEL 110

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT---- 300
            +AL +   L F+H         RD K  NIL+DAD + KL+DFGL K   +        
Sbjct: 111 VLALDSVHKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161

Query: 301 ------------------HVSTRVM-----GTYGYAAPEYVMTGH-LTSKSDVYSFGVVL 336
                             H   RV      GT  Y APE V+ G     + D +S GV+L
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVIL 220

Query: 337 LEMLTG 342
            EML G
Sbjct: 221 YEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 70/215 (32%), Positives = 93/215 (43%), Gaps = 38/215 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-----GLQGH----KEWLAEVN 191
           LG GGFG V    V+             T A+K +        G Q H    KE L E N
Sbjct: 1   LGVGGFGRVEL--VKVKSK-------NRTFALKCVKKRHIVETGQQEHIFSEKEILEECN 51

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVY---EFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
                 HP +VKL  Y    D++  +Y   E+   G L   L  +G     ++ R  IA 
Sbjct: 52  ------HPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFD-EYTARFYIA- 100

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
                  +LH    + +IYRD K  N+LLD++   KL DFG AK      KT       G
Sbjct: 101 CVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCG 154

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           T  Y APE ++        D +S G++L E+LTGR
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 34/238 (14%)

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           L E+  L  L HPN++    + ++D+  L+  E+   G+L + + R+        + +  
Sbjct: 47  LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                  ++++H+     +++RD KT NI L      KL DFG++K    +  +   T V
Sbjct: 107 LFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAET-V 161

Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV------EW 360
           +GT  Y +PE         KSD+++ G VL E+LT +R+ D   P    NLV       +
Sbjct: 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQGNY 218

Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP 418
                           P +  +     S +   L    L +DP+ RP   EV++    
Sbjct: 219 T---------------PVVSVY-----SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 85/276 (30%), Positives = 117/276 (42%), Gaps = 34/276 (12%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 191
           FR   +LG+GGFG V    V           TG   A K L    ++   G    L E  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQ 52

Query: 192 FLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
            L  + +   V  + Y  E  D   LV   M  G L+ H++  G         +  A   
Sbjct: 53  ILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
             GL  LH+E    ++YRD K  NILLD   + ++SD GLA   PE G+T +  RV GT 
Sbjct: 112 CCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-GTV 165

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 370
           GY APE V     T   D ++ G +L EM+ G+    + +   +   VE           
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----------- 214

Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
             RL+   ++  +S K S  A  L    L +DPK R
Sbjct: 215 --RLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 32/286 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 14  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 251
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 130 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 231

Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
             ++D            ++ T L   C   +PK RP   E+V  LK
Sbjct: 232 KFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 77/289 (26%), Positives = 132/289 (45%), Gaps = 38/289 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 14  LGQGSFGMVYEGIAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 251
           ++V+L+G   +    L++ E M RG L+++L              P      +++A   A
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+  A K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 130 DGMAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGMSNE- 228

Query: 372 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 417
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 229 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 54/189 (28%), Positives = 94/189 (49%), Gaps = 16/189 (8%)

Query: 165 GTGLTVAVKTL----NHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY 218
            TG  +AVK +    N    Q    +    E+  +  L HP++++++G   ED    L  
Sbjct: 23  KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82

Query: 219 EFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD 278
           E+M  GS+ + L + G      ++ +       +GL++LHE     +I+RD K +N+L+D
Sbjct: 83  EWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLID 137

Query: 279 AD-YNAKLSDFGLAKDAPED--GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGV 334
           +     +++DFG A        G      +++GT  + APE V+ G    +S DV+S G 
Sbjct: 138 STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVGC 196

Query: 335 VLLEMLTGR 343
           V++EM T +
Sbjct: 197 VIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 84/271 (30%), Positives = 123/271 (45%), Gaps = 40/271 (14%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V+ G W   NG           VAVKTL   G    + +L E   +  L H 
Sbjct: 14  LGNGQFGEVWMGTW---NGNT--------KVAVKTLK-PGTMSPESFLEEAQIMKKLRHD 61

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAF 256
            LV+L    + ++   +V E+M +GSL + L + G   +L LP  + M  A   A G+A+
Sbjct: 62  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDM--AAQVAAGMAY 117

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           +        I+RD +++NIL+      K++DFGLA+   ED +            + APE
Sbjct: 118 IER---MNYIHRDLRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPE 173

Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
             + G  T KSDV+SFG++L E++T  R       N         R  L    R YR+  
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---------REVLEQVERGYRMPC 224

Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
           P+              +L  QC  +DP+ RP
Sbjct: 225 PQ-------DCPISLHELMLQCWKKDPEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 89/288 (30%), Positives = 134/288 (46%), Gaps = 67/288 (23%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNF 192
            +LG+GG+G VF+  V +   A     TG   A+K L    +        H +  AE N 
Sbjct: 2   KVLGKGGYGKVFQ--VRKVTGA----DTGKIFAMKVLKKATIVRNQKDTAHTK--AERNI 53

Query: 193 LGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK------ 245
           L  + HP +V L+ Y  +   +L L+ E++  G L  HL R+G       I M+      
Sbjct: 54  LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREG-------IFMEDTACFY 105

Query: 246 ---IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTH 301
              I+L     L  LH++    +IYRD K  NILLDA  + KL+DFGL K++  +G  TH
Sbjct: 106 LSEISLA----LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158

Query: 302 VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
                 GT  Y APE +M +GH     D +S G ++ +MLTG                  
Sbjct: 159 T---FCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTG------------------ 196

Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKAR 406
           A P   + R+  + +D  L+G  ++    + +A  L  + L R+P +R
Sbjct: 197 APPFTAENRK--KTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSR 242

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)

Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 54

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 55  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 109

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 110 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 165

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 216

Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 217 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 68/246 (27%), Positives = 106/246 (43%), Gaps = 44/246 (17%)

Query: 196 LLH----PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
           +LH    P +V   G    D +  +  E M  GSL+  L + G +P    I  KI++   
Sbjct: 52  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN--ILGKISIAVL 109

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS--TRVMGT 309
           +GL +L E+ +  +++RD K SNIL+++    KL DFG++      G+   S     +GT
Sbjct: 110 RGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGT 161

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM-------------DKNRPNGEHN 356
             Y +PE +   H T +SD++S G+ L+EM  GR  +                       
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKE 221

Query: 357 LVEWARPHLGDKRR---FYRLLD-------PRLE-GHFSIKGSQKATQLAAQCLSRDPKA 405
                  H  D  R    + LLD       P+L  G F    S +      +CL ++PK 
Sbjct: 222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAF----SDEFQDFVDKCLKKNPKE 277

Query: 406 RPRMSE 411
           R  + E
Sbjct: 278 RADLKE 283

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 83.1 bits (205), Expect = 6e-18
 Identities = 77/300 (25%), Positives = 123/300 (41%), Gaps = 49/300 (16%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 190
           NFR E  +G G F  V++     +G           VA+K +    L   +   + + E+
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGV---------PVALKKVQIFDLMDAKARADCIKEI 53

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIAL 248
           + L  L HPN++K     IED++  +V E    G L   +  F+K    +P     K  +
Sbjct: 54  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
                L  +H    + V++RD K +N+ + A    KL D GL +      KT  +  ++G
Sbjct: 114 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 168

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
           T  Y +PE +       KSD++S G +L EM                       P  GDK
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDK 210

Query: 369 RRFYRLLD--------PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 420
              Y L          P    H+    S++  QL   C++ DP+ RP ++ V +  K + 
Sbjct: 211 MNLYSLCKKIEQCDYPPLPSDHY----SEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.0 bits (205), Expect = 7e-18
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 16/212 (7%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 192
             + E ++G G FG V  G ++  G   +       VA+KTL     +  + ++L+E + 
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREI------PVAIKTLKAGYTEKQRRDFLSEASI 58

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
           +G   HPN++ L G   +    ++V E+M  GSL+  L RK          + +  G A 
Sbjct: 59  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVIQLVGMLRGIAS 117

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGT 309
           G+ +L   ++   ++RD    NIL++++   K+SDFGL++   D PE   T    ++   
Sbjct: 118 GMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--P 172

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
             + APE +     TS SDV+S+G+V+ E+++
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 84.1 bits (208), Expect = 7e-18
 Identities = 57/166 (34%), Positives = 83/166 (50%), Gaps = 19/166 (11%)

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAK 252
           HP LV L   C + + RL  V EF+  G L  H+ R+  LP      +S  + +AL    
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN--- 110

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
              FLHE   + +IYRD K  N+LLDA+ + KL+D+G+ K+    G T  ++   GT  Y
Sbjct: 111 ---FLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNY 162

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHN 356
            APE +         D ++ GV++ EM+ GR   D      N + N
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 85/314 (27%), Positives = 131/314 (41%), Gaps = 57/314 (18%)

Query: 114 LKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 173
           L +  Q      NDL+           +G G  G V+K   ++ G           +AVK
Sbjct: 3   LTIDGQKYPADLNDLEN-------LGEIGSGTCGQVYKMRFKKTGH---------VMAVK 46

Query: 174 TLNHDG-LQGHKEWLAEVNFLGNLLH--PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 230
            +   G  + +K  L +++ +    H  P +VK  GY I D    +  E M   +  + L
Sbjct: 47  QMRRTGNKEENKRILMDLDVV-LKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKL 103

Query: 231 FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 290
            ++   P+P  I  K+ +   K L +L E+    VI+RD K SNILLDA  N KL DFG+
Sbjct: 104 LKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGI 161

Query: 291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK----SDVYSFGVVLLEMLTGRRSM 346
           +     D K    TR  G   Y APE +       K    +DV+S G+ L+E+ TG+   
Sbjct: 162 SGRLV-DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF-- 216

Query: 347 DKNRPNGEHNLVEWARPHLGDKRRF---YRLLD---PRLEGHFSIKGSQKATQLAAQCLS 400
                           P+   K  F    ++L    P L  +     S         CL+
Sbjct: 217 ----------------PYKNCKTEFEVLTKILQEEPPSLPPNEGF--SPDFCSFVDLCLT 258

Query: 401 RDPKARPRMSEVVE 414
           +D + RP+  E+++
Sbjct: 259 KDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 85.7 bits (212), Expect = 1e-17
 Identities = 59/194 (30%), Positives = 92/194 (47%), Gaps = 19/194 (9%)

Query: 166 TGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLV--GYCIEDDQRLLVYEF 220
           TG  VA+K L  D  +   +   +  E      L HPN+V L+  G          V+E+
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60

Query: 221 MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--- 277
           +P  +L   L   G+LP   + R+   L     LA  H +    +++RD K  NI++   
Sbjct: 61  VPGRTLREVLAADGALPAGETGRL--MLQVLDALACAHNQG---IVHRDLKPQNIMVSQT 115

Query: 278 DADYNAKLSDFGLAKDAPEDGKTHV-----STRVMGTYGYAAPEYVMTGHLTSKSDVYSF 332
               +AK+ DFG+    P      V     +T V+GT  Y APE +    +T  SD+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 333 GVVLLEMLTGRRSM 346
           G++ LE LTG+R +
Sbjct: 176 GLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 79/303 (26%), Positives = 126/303 (41%), Gaps = 58/303 (19%)

Query: 128 LKLATRNFRPESLL------GEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 181
           L+L      P S L      GEG  G V                TG  VAVK ++    Q
Sbjct: 8   LQLVVDPGDPRSYLDNFVKIGEGSTGIV---------CIATDKSTGRQVAVKKMDLRKQQ 58

Query: 182 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 241
             +    EV  + +  HPN+V++    +  D+  +V EF+  G+L +         +   
Sbjct: 59  RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD---------IVTH 109

Query: 242 IRMK------IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG----LA 291
            RM       + L   K L+FLH +    VI+RD K+ +ILL +D   KLSDFG    ++
Sbjct: 110 TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166

Query: 292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           K+ P          ++GT  + APE +      ++ D++S G++++EM+ G        P
Sbjct: 167 KEVPR------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220

Query: 352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
                        L   +R    L P+L+     K S +      + L RDP  R   +E
Sbjct: 221 -------------LQAMKRIRDNLPPKLKNL--HKVSPRLRSFLDRMLVRDPAQRATAAE 265

Query: 412 VVE 414
           ++ 
Sbjct: 266 LLN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 42/287 (14%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGN 195
           E +LG G FG + +G ++     P K    L VA+ TL   G    +   +LAE   LG 
Sbjct: 10  ERILGTGRFGELCRGCLK----LPSK--RELPVAIHTL-RAGCSDKQRRGFLAEALTLGQ 62

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
             H N+V+L G     +  ++V E+M  G+L++ L RK    L     M +  G A G+ 
Sbjct: 63  FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGMK 121

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG--YA 313
           +L   +E   +++      +L+++D   K+S F       ED    + T + G     +A
Sbjct: 122 YL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWA 175

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF- 371
           APE +   H +S SDV+SFG+V+ E+++ G R               W        +   
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY-------------WDMSGQDVIKAVE 222

Query: 372 --YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
             +RL  PR              QL   C  ++   RPR S++   L
Sbjct: 223 DGFRLPAPR-------NCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 28/248 (11%)

Query: 170 VAVKTLNHDGLQGHKEWLA--EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 227
           V +K +  + +   +   A  E   L  L HPN+++     +ED   ++V E+ P G+L 
Sbjct: 28  VIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLA 87

Query: 228 NHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKLS 286
            ++ ++ +  L       I     + L  LH    K +++RD KT NILLD      K+ 
Sbjct: 88  EYIQKRCNSLLD---EDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIG 144

Query: 287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 346
           DFG++K      K +    V+GT  Y +PE         KSD+++ G VL E+ + +R+ 
Sbjct: 145 DFGISKILSSKSKAYT---VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF 201

Query: 347 D-KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 405
           +  N P     ++      + D+                   S    QL    L+ DP  
Sbjct: 202 EAANLPALVLKIMSGTFAPISDRY------------------SPDLRQLILSMLNLDPSK 243

Query: 406 RPRMSEVV 413
           RP++S+++
Sbjct: 244 RPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 69/207 (33%), Positives = 93/207 (44%), Gaps = 20/207 (9%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLL 197
           LG+GGFG V    V+          TG   A K L+   L+   G K  L E   L  + 
Sbjct: 1   LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
            P +V L  Y  E    L LV   M  G L+ H++  G   L     +  +     G+  
Sbjct: 52  SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           LH      ++YRD K  N+LLD   N +LSD GLA +   DGKT   T+  GT GY APE
Sbjct: 111 LHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKT--ITQRAGTNGYMAPE 164

Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGR 343
            +     +   D ++ G  + EM+ GR
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 26/205 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 197
           +G G FG V+      N        T   VAVK +++ G Q +++W   + EV FL  L 
Sbjct: 29  IGHGSFGAVY---FATNSH------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           HPN ++  G  +++    LV E+   GS  + L      PL       I  GA +GLA+L
Sbjct: 80  HPNTIEYKGCYLKEHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYL 137

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 317
           H      +I+RD K  NILL      KL+DFG A       K+  +   +GT  + APE 
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEV 188

Query: 318 VMT---GHLTSKSDVYSFGVVLLEM 339
           ++    G    K DV+S G+  +E+
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 23/218 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-L 197
            LGEG FG V K   E  G     P    TVAVK L  D   +   + ++E+  +  +  
Sbjct: 19  PLGEGAFGQVVKA--EAVGL--DNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR------KGSLPLPWSIRMKI----- 246
           H N++ L+G C ++    +V E+   G+L + L          S   P      +     
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 247 ---ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
              A   A+G+ FL   A K  I+RD    N+L+  D+  K++DFGLA+D         +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191

Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           T       + APE +     T +SDV+SFGV+L E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 81.6 bits (201), Expect = 6e-17
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 23/219 (10%)

Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+      P      + VA+K L      + +KE L
Sbjct: 4   LKETEFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEIL 57

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL----ENHLFRKGS-LPLPWSI 242
            E   + ++ +P++ +L+G C+    +L + + MP G L      H    GS   L W +
Sbjct: 58  DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 116

Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L E   + +++RD    N+L+    + K++DFGLAK    D K + 
Sbjct: 117 QI------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167

Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 81.2 bits (200), Expect = 6e-17
 Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 22/219 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 190
           +F    +LG+G FG V          A  K GT    A+K L  D +    +    + E 
Sbjct: 1   DFNFLMVLGKGSFGKVM--------LAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
             L     P  +  +  C +   RL  V E++  G L  H+ + G    P ++    A  
Sbjct: 52  RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAE 109

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-G 308
            + GL FLH    + +IYRD K  N++LD++ + K++DFG+ K+   DG   V+TR   G
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCG 163

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 347
           T  Y APE +         D +++GV+L EML G+   D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 26/231 (11%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKE 185
           +L L+   F  E  LGE  FG ++KG +   G    +      VA+KTL + +  Q   E
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQ-----LVAIKTLKDINNPQQWGE 53

Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK------------ 233
           +  E + +  L HPN+V L+G   ++    +++E++ +G L   L  +            
Sbjct: 54  FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113

Query: 234 -GSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 290
            G++   L     + IA+  A G+ +L   +    +++D    NIL+    + K+SD GL
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGL 170

Query: 291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +++        V  + +    +  PE +M G  +S SD++SFGVVL E+ +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.4 bits (198), Expect = 8e-17
 Identities = 75/295 (25%), Positives = 131/295 (44%), Gaps = 41/295 (13%)

Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWL 187
           L     +   +LG G FG V+KG W       P      + VA+K L  +   + +KE L
Sbjct: 4   LKETELKKVKVLGSGAFGTVYKGIW------IPDGENVKIPVAIKVLRENTSPKANKEIL 57

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF----RKGSLPL-PWSI 242
            E   +  +  P + +L+G C+    +L V + MP G L +++     R GS  L  W +
Sbjct: 58  DEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCV 116

Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+++L E     +++RD    N+L+ +  + K++DFGLA+    D   + 
Sbjct: 117 QI------AKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167

Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 361
           +        + A E ++    T +SDV+S+GV + E++T G +  D        +L+E  
Sbjct: 168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG 227

Query: 362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
                      RL  P +        +     +  +C   D + RPR  E+V+  
Sbjct: 228 E----------RLPQPPI-------CTIDVYMIMVKCWMIDSECRPRFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 24/214 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLH 198
           LGEG FG V +G + ++ +        L VAVKT+          +++L+E   +    H
Sbjct: 7   LGEGEFGSVMEGQLNQDDSI-------LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59

Query: 199 PNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHLF--RKGSLP--LPWSIRMKIAL 248
           PN+++L+G C++  +       +++  FM  G L + L   R G  P  LP  + +K   
Sbjct: 60  PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+ +L   + K  I+RD    N +L+ + N  ++DFGL+K    +G  +   R+  
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAK 175

Query: 309 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               + A E +     T+KSDV+SFGV + E+ T
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 61/236 (25%), Positives = 98/236 (41%), Gaps = 60/236 (25%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 192
           +     +G G +G V            V   TG  VA+K +++  D L   K  L E+  
Sbjct: 2   YELLKPIGSGAYGVVCSA---------VDKRTGRKVAIKKISNVFDDLIDAKRILREIKL 52

Query: 193 LGNLLHPNLVKL--VGYCIEDDQRL------LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
           L +L H N++ L  +   +            +V E M     E  L +         I+ 
Sbjct: 53  LRHLRHENIIGLLDI---LRPPSPEDFNDVYIVTELM-----ETDLHK--------VIKS 96

Query: 245 KIALGAA----------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
              L             +GL +LH      VI+RD K SNIL++++ + K+ DFGLA+  
Sbjct: 97  PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153

Query: 295 PEDGKT------HVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
             D         +V TR      Y APE +++    +K+ D++S G +  E+LT +
Sbjct: 154 DPDEDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 40/303 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 199
           +G+G FG VFKG   +N T  V       VA+K ++ +  +   E +  E+  L     P
Sbjct: 12  IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            + K  G  ++D +  ++ E++  GS  + L   G  PL  +    I     KGL +LH 
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHS 119

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRVMGTYGYAAPEYV 318
           E +   I+RD K +N+LL      KL+DFG+A    +   T +     +GT  + APE +
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVI 173

Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 378
                 SK+D++S G+  +E+  G     +  P     L+    P             P 
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PT 220

Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQAD 438
           LEG++    S+   +    CL+++P  RP   E+++    ++  K    +SY  + +   
Sbjct: 221 LEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK---KTSYLTELIDRY 273

Query: 439 NTW 441
             W
Sbjct: 274 KRW 276

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 83/301 (27%), Positives = 123/301 (40%), Gaps = 68/301 (22%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H 198
           ++GEG +G V+K    +         TG  VA+K ++       +E   E N L     H
Sbjct: 13  VIGEGTYGKVYKA-RHKK--------TGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNH 62

Query: 199 PNLVKLVG------YCIEDDQRLLVYEFMPRGS---LENHLFRKG-SLPLPWSIRMKIAL 248
           PN+    G          DDQ  LV E    GS   L   L +KG  L   W     IA 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAY 117

Query: 249 ---GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKTHVST 304
                 +GLA+LHE     VI+RD K  NILL  +   KL DFG++       G+ +   
Sbjct: 118 ILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174

Query: 305 RVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 359
              GT  + APE +           ++SDV+S G+  +E+  G                 
Sbjct: 175 ---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG----------------- 214

Query: 360 WARPHLGDK---RRFYRLL---DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
             +P L D    R  +++     P L+       S+K     ++CL ++ + RP M E++
Sbjct: 215 --KPPLCDMHPMRALFKIPRNPPPTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELL 270

Query: 414 E 414
           E
Sbjct: 271 E 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 30/215 (13%)

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAK 252
           +P LV L   C +   RL LV E++  G L  H+ R+  LP      ++  + IAL    
Sbjct: 55  NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN--- 110

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
              FLHE   + +IYRD K  N+LLDAD + KL+D+G+ K+    G T  ++   GT  Y
Sbjct: 111 ---FLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNY 162

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR-RF 371
            APE +         D ++ GV++ EM+ GR   D    N + N  ++    + +K  R 
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI 222

Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
            R L            S KA+ +    L++DPK R
Sbjct: 223 PRFL------------SVKASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 16/167 (9%)

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           P + KL       D   LV E++  G   + +   G LP  W  +  IA     G+  LH
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLH 114

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
           +     +I+RD K  N+L+D   + KL+DFGL+++         + + +GT  Y APE +
Sbjct: 115 QRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETI 165

Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-----NGEHNLVEW 360
           +       SD +S G V+ E L G        P     N     + W
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 21/217 (9%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D   +   + ++E+  +  +  H
Sbjct: 20  LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++ E+  +G+L  +L           F    LP   L +   +
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             A   A+G+ +L   A +  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                  + APE +     T +SDV+SFGV+L E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 72/298 (24%), Positives = 121/298 (40%), Gaps = 45/298 (15%)

Query: 134 NFRPESLLGEGGFGCVFKGWVE-ENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           NF+ E  +G G F  V++     +     +K        V+       +  ++ + E++ 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALK-------KVQIFEMMDAKARQDCVKEIDL 55

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIALGA 250
           L  L HPN++K +   IED++  +V E    G L   +  F+K    +P     K  +  
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
              +  +H    + V++RD K +N+ + A    KL D GL +      KT  +  ++GT 
Sbjct: 116 CSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTP 170

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 370
            Y +PE +       KSD++S G +L EM                       P  GDK  
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDKMN 212

Query: 371 FYRLLD-------PRLEG-HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 420
            + L         P L   H+    S+K  +L + C+  DP  RP +  V +  K + 
Sbjct: 213 LFSLCQKIEQCDYPPLPTEHY----SEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 72/208 (34%), Positives = 95/208 (45%), Gaps = 24/208 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGNL 196
           +G+G FG V     +           G   AVK L    +   KE    +AE N  L N+
Sbjct: 3   IGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKI-ALGAAKGL 254
            HP LV L  Y  +   +L  V +++  G L  HL R+ S P P   R +  A   A  L
Sbjct: 54  KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAEIASAL 109

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH      +IYRD K  NILLD+  +  L+DFGL K+  E  KT  ++   GT  Y A
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLA 164

Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           PE +         D +  G VL EML G
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 20/217 (9%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 190
           N+R   LLG+G FG V+  +        V  G  L       + +  +  KE  A   E+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCY-------DVDTGRELAAKQVQFDPESPETSKEVSALECEI 55

Query: 191 NFLGNLLHPNLVKLVGYCIED--DQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
             L NL H  +V+  G C+ D  ++ L ++ E+MP GS+++ L   G+L    S+  K  
Sbjct: 56  QLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALT--ESVTRKYT 112

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR-V 306
               +G+++LH      +++RD K +NIL D+  N KL DFG +K       +    R V
Sbjct: 113 RQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169

Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
            GT  + +PE +       K+DV+S G  ++EMLT +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 69/214 (32%), Positives = 99/214 (46%), Gaps = 22/214 (10%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGN 195
            +LG+G FG V     E  GT  +        A+K L  D +    +    + E   L  
Sbjct: 6   MVLGKGSFGKVMLA--ERKGTDEL-------YAIKILKKDVIIQDDDVECTMVEKRVLAL 56

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
              P  +  +  C +   RL  V E++  G L  H+ + G    P ++    A   A GL
Sbjct: 57  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--AAEIAIGL 114

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYA 313
            FLH    K +IYRD K  N++LDA+ + K++DFG+ K+    GKT   TR   GT  Y 
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYI 168

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 347
           APE +         D ++FGV+L EML G+   D
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 18/213 (8%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-LAEVNF 192
           NF+    LGEG +  V+KG    N T      TG  VA+K ++ D  +G     + E++ 
Sbjct: 1   NFKQLEKLGEGTYATVYKG---RNRT------TGEIVALKEIHLDAEEGTPSTAIREISL 51

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAA 251
           +  L H N+V+L      +++ +LV+E+M    L+ ++   G    L  +          
Sbjct: 52  MKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLL 110

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           KG+AF HE     V++RD K  N+L++     KL+DFGLA+       T  +  V  T  
Sbjct: 111 KGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLW 165

Query: 312 YAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
           Y AP+ ++     S S D++S G ++ EM+TGR
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 73/250 (29%), Positives = 98/250 (39%), Gaps = 45/250 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN-------FL 193
           +G+GG+G VF            K  TG  VA+K +    L      L EV         L
Sbjct: 9   VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55

Query: 194 GNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIAL 248
                  LVKL+ Y  +DD+ L L  E++P G     L   G L       +   M  A+
Sbjct: 56  TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
            A   L ++H         RD K  N L+DA  + KL+DFGL+K       +     V+G
Sbjct: 115 DALHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVG 160

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWA----RP 363
           +  Y APE +         D +S G +L E L G      + PN    NL  W     RP
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRP 220

Query: 364 HLGDKRRFYR 373
              D R    
Sbjct: 221 VYDDPRFNLS 230

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 77.8 bits (191), Expect = 5e-16
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 22/218 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 188
           N+R   LLG+G FG V+  +  +         TG  +AVK +  + +  +  KE  A   
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALEC 53

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L NLLH  +V+  G   +  +R L    E MP GS+++ L   G+L    ++  K 
Sbjct: 54  EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALT--ENVTRKY 111

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR- 305
                +G+++LH      +++RD K +NIL D+  N KL DFG +K       +    + 
Sbjct: 112 TRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS 168

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           V GT  + +PE +       K+D++S G  ++EMLT +
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 30/222 (13%)

Query: 135 FRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNF 192
                LL EG FG +F G  ++E      KPG    V VKT+ +H         L E   
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTLLLQESCL 61

Query: 193 LGNLLHPNLVKLVGYCIED-DQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMK---- 245
           L  L H N++ ++  CIED +   ++Y +M  G+L+  L   R G    P ++  +    
Sbjct: 62  LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PED-----GK 299
           +A+  A G+++LH+   + VI++D    N ++D +   K++D  L++D  P D       
Sbjct: 122 MAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN 178

Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            +   + M      A E ++    +S SDV+SFGV+L E++T
Sbjct: 179 ENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.0 bits (192), Expect = 5e-16
 Identities = 73/284 (25%), Positives = 121/284 (42%), Gaps = 50/284 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LG G  G V+K +            T   +AVK +  D  ++  K+ ++E+  L     P
Sbjct: 9   LGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            ++   G    +++  +  EFM  GSL+  ++RK    +P  +  +IA+   KGL +L  
Sbjct: 60  YIIGFYGAFFVENRISICTEFMDGGSLD--VYRK----IPEHVLGRIAVAVVKGLTYLWS 113

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-GKTHVSTRVMGTYGYAAPEYV 318
                +++RD K SN+L++     KL DFG++        KT+V     GT  Y APE +
Sbjct: 114 ---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERI 165

Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--------HNLVEWARPHLGDKRR 370
                   SDV+S G+  +E+  GR    + + N            +V+   P L     
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV--- 222

Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     G F    S+K      QC+ + PK RP    +++
Sbjct: 223 ----------GQF----SEKFVHFITQCMRKQPKERPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 36/210 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 197
           +G G FG V+                   VA+K +++ G Q +++W   + EV FL  L 
Sbjct: 23  IGHGSFGAVYFARDVRTNE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGS----LENHLFRKGSLPLPWSIRMKIALGAAKG 253
           HPN ++  G  + +    LV E+   GS    LE H  +K   PL       I  GA +G
Sbjct: 74  HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVH--KK---PLQEVEIAAICHGALQG 127

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRVMGTYGY 312
           LA+LH       I+RD K  NILL      KL+DFG A   +P       +   +GT  +
Sbjct: 128 LAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTPYW 177

Query: 313 AAPEYVMT---GHLTSKSDVYSFGVVLLEM 339
            APE ++    G    K DV+S G+  +E+
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 33/222 (14%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL 196
           E ++GEG FG V +  ++       K G  +  A+K L     +  H+++  E+  L  L
Sbjct: 7   EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59

Query: 197 -LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------PLPWS 241
             HPN++ L+G C       +  E+ P G+L + L +   L               L   
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 301
             ++ A   A G+ +L   +EK  I+RD    N+L+  +  +K++DFGL++     G+  
Sbjct: 120 QLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEV 171

Query: 302 VSTRVMGTYG--YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
              + MG     + A E +     T+KSDV+SFGV+L E+++
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 79/280 (28%), Positives = 119/280 (42%), Gaps = 36/280 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           +G G FG VF G +  + T          VAVK+         K ++L E   L    HP
Sbjct: 3   IGRGNFGEVFSGRLRADNTP---------VAVKSCRETLPPDLKAKFLQEARILKQYSHP 53

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+V+L+G C +     +V E +  G     L  +G   L     +++   AA G+ +L  
Sbjct: 54  NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP-RLKVKELIQMVENAAAGMEYLES 112

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAPEY 317
              K  I+RD    N L+      K+SDFG++++  EDG  + ST  M      + APE 
Sbjct: 113 ---KHCIHRDLAARNCLVTEKNVLKISDFGMSREE-EDG-VYASTGGMKQIPVKWTAPEA 167

Query: 318 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLD 376
           +  G  +S+SDV+SFG++L E  +       N  N +    +E          +  RL  
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE----------QGVRLPC 217

Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           P L             +L  +C   DP  RP  S V + L
Sbjct: 218 PEL-------CPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 78.3 bits (193), Expect = 6e-16
 Identities = 76/213 (35%), Positives = 106/213 (49%), Gaps = 31/213 (14%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVN 191
           +LG+G FG VF   V +       P  G   A+K L    L+          ++ LAEVN
Sbjct: 3   VLGQGSFGKVF--LVRK----ITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
                 HP +VKL  Y  + + +L L+ +F+  G L   L  K  +     ++  +A   
Sbjct: 57  ------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-EL 107

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
           A  L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K   S    GT 
Sbjct: 108 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTV 162

Query: 311 GYAAPEYV-MTGHLTSKSDVYSFGVVLLEMLTG 342
            Y APE V   GH T  +D +SFGV++ EMLTG
Sbjct: 163 EYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 80/295 (27%), Positives = 122/295 (41%), Gaps = 43/295 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 26  LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 244
            N++ L+G C +D    ++ E+  +G+L  +L  +    + +                 +
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 250

Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQL---AAQCLSRDPKARPRMSEVVETL 416
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 251 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 77.2 bits (190), Expect = 6e-16
 Identities = 67/220 (30%), Positives = 95/220 (43%), Gaps = 37/220 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G     G +  +      V VK L           +L EV     L HP
Sbjct: 3   IGNGWFGKVLLGEAH-RGMSKAR------VVVKELRASATPDEQLLFLQEVQPYRELNHP 55

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSIRMKIALGAAKGL 254
           N+++ +G CIE    LLV EF P G L+N+L R        +     +  ++A   A GL
Sbjct: 56  NVLQCLGQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQK-DVLQRMACEVASGL 113

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PED-----GKTHVSTRVMG 308
            +LH+      I+ D    N  L AD + K+ D+GLA +  PED         V  R   
Sbjct: 114 LWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR--- 167

Query: 309 TYGYAAPEYV-------MTGHLTSKSDVYSFGVVLLEMLT 341
              + APE V       +    T KS+++S GV + E+ T
Sbjct: 168 ---WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 87/273 (31%), Positives = 117/273 (42%), Gaps = 42/273 (15%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 196
           LLG+G FG V    V+E  T       G   A+K L  + +    E    L E   L N 
Sbjct: 2   LLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA--AKG 253
            HP L  L  Y  +   RL  V E+   G L  HL R+      +S       GA     
Sbjct: 53  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV----FSEDRARFYGAEIVSA 107

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T  +    GT  Y 
Sbjct: 108 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYL 163

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 373
           APE +         D +  GVV+ EM+ GR             L+      L ++ RF R
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEEIRFPR 217

Query: 374 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
            L P            +A  L +  L +DPK R
Sbjct: 218 TLSP------------EAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 89/274 (32%), Positives = 114/274 (41%), Gaps = 45/274 (16%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 196
           LLG+G FG V    V E  T       G   A+K L  + +    E    L E   L N 
Sbjct: 2   LLGKGTFGKVI--LVREKAT-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA--AKG 253
            HP L  L  Y  +   RL  V E+   G L  HL R+         R +   GA     
Sbjct: 53  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARF-YGAEIVSA 107

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           L +LH      V+YRD K  N++LD D + K++DFGL K+   DG T       GT  Y 
Sbjct: 108 LGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 162

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGDKRRFY 372
           APE +         D +  GVV+ EM+ GR        N +H  L E     L ++ RF 
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHEKLFELI---LMEEIRFP 215

Query: 373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           R L            S +A  L A  L +DPK R
Sbjct: 216 RTL------------SPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G FG V+K   +E         TG   A K +     +  ++++ E+  L    HP 
Sbjct: 20  LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFLHE 259
           +VKL+G    D +  ++ EF P G+++  +      L  P  I++ I     + L +LH 
Sbjct: 71  IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQV-ICRQMLEALQYLHS 128

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +I+RD K  N+LL  D + KL+DFG++  A            +GT  + APE VM
Sbjct: 129 ---MKIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVM 183

Query: 320 TGHLTS-----KSDVYSFGVVLLEM 339
              +       K+D++S G+ L+EM
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 71/215 (33%), Positives = 99/215 (46%), Gaps = 39/215 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGNLLH 198
           +GEG +G VFK    E         TG  VA+K    + D     K  L E+  L  L H
Sbjct: 9   IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59

Query: 199 PNLVKLVGYCIE---DDQRL-LVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAK 252
           PNLV L    IE     ++L LV+E+    ++ N L +  +G   +P  +  KI     +
Sbjct: 60  PNLVNL----IEVFRRKRKLHLVFEYCDH-TVLNELEKNPRG---VPEHLIKKIIWQTLQ 111

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKT-HVSTRVMGT 309
            + F H+      I+RD K  NIL+      KL DFG A+    P D  T +V+TR    
Sbjct: 112 AVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---- 164

Query: 310 YGYAAPEYVMTGHLT--SKSDVYSFGVVLLEMLTG 342
             Y APE ++ G        DV++ G V  E+LTG
Sbjct: 165 -WYRAPE-LLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 72/238 (30%), Positives = 104/238 (43%), Gaps = 44/238 (18%)

Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK-TLNHDGLQG-HKEWLA 188
             R++     LGEG FG V+K           +  TG  VA+K  L H+   G     L 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGFPITALR 56

Query: 189 EVNFLGNLLHPNLVKLVGYCIE-----DDQRLLVYEFMP------RGSLENHLFRKGSLP 237
           E+  L  L HPN+V L+   +E       +R  VY   P       G LEN   +   L 
Sbjct: 57  EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LT 113

Query: 238 LPWSIR--MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--- 292
               I+  M   L   +G+ +LHE     +++RD K +NIL+D     K++DFGLA+   
Sbjct: 114 ES-QIKCYMLQLL---EGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYD 166

Query: 293 DAPEDGK------THVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             P + K      T   T ++ T  Y  PE ++     T+  D++  G V  EM T R
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 68/222 (30%), Positives = 111/222 (50%), Gaps = 31/222 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K   +          TG  VA+K +  D    G+      + E
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTA--IRE 49

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIA 247
           ++ L  L HPN+VKL+     +++  LV+EF+ +  L+  +       +PLP        
Sbjct: 50  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQ 108

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTR 305
           L   +GLAF H      V++RD K  N+L++ +   KL+DFGLA+    P    TH    
Sbjct: 109 L--LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---E 160

Query: 306 VMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSM 346
           V+ T  Y APE ++   + ++  D++S G +  EM+T RR++
Sbjct: 161 VV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 84/282 (29%), Positives = 116/282 (41%), Gaps = 46/282 (16%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 191
           FR   +LG+GGFG V    V           TG   A K L    ++   G    L E  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQ 52

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
            L  +    +V L       D   LV   M  G L+ H++  G+   P     +    AA
Sbjct: 53  ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN---PGFEEERALFYAA 109

Query: 252 K---GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
           +   GL  LH E     +YRD K  NILLD   + ++SD GLA   PE     +  RV G
Sbjct: 110 EILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRV-G 163

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
           T GY APE +     T   D +  G ++ EM+ G+                   P  G K
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ------------------SPFRGRK 205

Query: 369 RRFYR-LLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKAR 406
            +  R  +D R+   E  +S K S++A  +    L++DPK R
Sbjct: 206 EKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLG-N 195
           +LG+G FG V    ++E+G            AVK L  D +    +    + E   L   
Sbjct: 2   VLGKGSFGKVMLARLKESGR---------LYAVKVLKKDVILQDDDVECTMTEKRILSLA 52

Query: 196 LLHPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
             HP L +L   C +   RL  V EF+  G L  H+ +        +      + +A  L
Sbjct: 53  RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--L 109

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            FLH+   K +IYRD K  N+LLD + + KL+DFG+ K+   +GKT  ++   GT  Y A
Sbjct: 110 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIA 164

Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           PE +         D ++ GV+L EML G
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 16/204 (7%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHP 199
           LG G FGCV KG  +            + VA+K L ++  +    E + E   +  L +P
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQ-------IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            +V+++G C E +  +LV E    G L   L  K    +  S  +++    + G+ +L  
Sbjct: 56  YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEG 113

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEY 317
              K  ++RD    N+LL   + AK+SDFGL+K    D  ++   R  G +   + APE 
Sbjct: 114 ---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPEC 169

Query: 318 VMTGHLTSKSDVYSFGVVLLEMLT 341
           +     +S+SDV+S+G+ + E  +
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 78/313 (24%), Positives = 136/313 (43%), Gaps = 50/313 (15%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL 196
           + ++GEG FG V K  ++       K G  +  A+K +     +  H+++  E+  L  L
Sbjct: 12  QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64

Query: 197 -LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------PLPWS 241
             HPN++ L+G C       L  E+ P G+L + L +   L               L   
Sbjct: 65  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124

Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 301
             +  A   A+G+ +L   ++K  I+RD    NIL+  +Y AK++DFGL++     G+  
Sbjct: 125 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEV 176

Query: 302 VSTRVMGTYG--YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 359
              + MG     + A E +     T+ SDV+S+GV+L E++    S+      G      
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SLGGTPYCGMTCAEL 232

Query: 360 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL-KP 418
           + +   G     YRL  P       +    +   L  QC    P  RP  ++++ +L + 
Sbjct: 233 YEKLPQG-----YRLEKP-------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280

Query: 419 LQNLKDMASSSYY 431
           L+  K   +++ Y
Sbjct: 281 LEERKTYVNTTLY 293

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 60/186 (32%), Positives = 88/186 (47%), Gaps = 23/186 (12%)

Query: 165 GTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFM 221
           GTG   A+K L    +   K+      E + L  L HP +V ++    ++++   + EF+
Sbjct: 41  GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100

Query: 222 PRGSLENHLFRKGSLPLPWSIRMKIA--LGAAKGLAF--LHEEAEKPVIYRDFKTSNILL 277
             G L  HL + G  P        +A    A   LAF  LH    K +IYRD K  N+LL
Sbjct: 101 VGGELFTHLRKAGRFP------NDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLL 151

Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVL 336
           D   + K++DFG AK  P+   T     + GT  Y APE + + GH     D ++ GV+L
Sbjct: 152 DNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLL 205

Query: 337 LEMLTG 342
            E + G
Sbjct: 206 YEFIAG 211

Length = 329

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 30/216 (13%)

Query: 198 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAK 252
           HP LV L   C + + RL  V E++  G L  H+ R+  LP      +S  + +AL    
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN--- 110

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
              +LHE     +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y
Sbjct: 111 ---YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRR 370
            APE +         D ++ GV++ EM+ GR   D   +  N + N  ++          
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--------- 213

Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           F  +L+ ++    S+  S KA  +    L++DPK R
Sbjct: 214 FQVILEKQIRIPRSL--SVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 26/231 (11%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HK 184
           ++ L+T  F  E  LGE  FG V+KG +   GTAP +      VA+KTL  D  +G   +
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHL--FGTAPGEQTQ--AVAIKTLK-DKAEGPLRE 53

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK------GSLPL 238
           E+  E      L HPN+V L+G   ++    +++ +     L   L  +      GS   
Sbjct: 54  EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 239 PWSIR--------MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 290
             +++        + I    A G+ FL   +   V+++D  T N+L+    N K+SD GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGL 170

Query: 291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            ++        +    +    + +PE +M G  +  SD++S+GVVL E+ +
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 70/289 (24%), Positives = 115/289 (39%), Gaps = 69/289 (23%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G +G V+K      G           VA+K +  +     +    E++ L    HPN
Sbjct: 11  IGSGTYGDVYKARDIATGE---------LVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +V   G  +  D+  +V E+   GSL++ +++    PL       +     KGLA+LHE 
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHE- 119

Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR--VMGTYGYAAPEYV 318
                I+RD K +NILL  D + KL+DFG++    +   T ++ R   +GT  + APE  
Sbjct: 120 --TGKIHRDIKGANILLTEDGDVKLADFGVSA---QLTAT-IAKRKSFIGTPYWMAPEVA 173

Query: 319 ---MTGHLTSKSDVYSFGVVLLEM-----------------LTGRRSMDKNRPNGEHNLV 358
                G    K D+++ G+  +E+                 L  + +             
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP---------- 223

Query: 359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
               P L DK ++                S        +CL++DPK RP
Sbjct: 224 ----PKLKDKEKW----------------SPVFHDFIKKCLTKDPKKRP 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 24/206 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G FG V+K   +E         TG+  A K ++    +  ++++ E++ L +  HPN
Sbjct: 13  LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +VKL+     ++   ++ EF   G+++  +      PL       +     + L +LHE 
Sbjct: 64  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN 122

Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
               +I+RD K  NIL   D + KL+DFG++  A            +GT  + APE VM 
Sbjct: 123 K---IIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMC 177

Query: 321 GHLTS-------KSDVYSFGVVLLEM 339
              TS       K+DV+S G+ L+EM
Sbjct: 178 E--TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 30/208 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG G FG V KG  +   +         TVAVK L +D        E L E N +  L +
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEK-------TVAVKILKNDNNDPALKDELLREANVMQQLDN 55

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLEN------HLFRKGSLPLPWSIRMKIALGAAK 252
           P +V+++G C E +  +LV E    G L        H+  K    L   + M        
Sbjct: 56  PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM-------- 106

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY-- 310
           G+ +L E      ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +  
Sbjct: 107 GMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD-ENYYKAKTHGKWPV 162

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLE 338
            + APE +     +SKSDV+SFGV++ E
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 69/209 (33%), Positives = 104/209 (49%), Gaps = 20/209 (9%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 197
           E  LG G FG V+     ++            VAVKT+   G    + +LAE N +  L 
Sbjct: 11  EKKLGAGQFGEVWMATYNKH----------TKVAVKTMK-PGSMSVEAFLAEANVMKTLQ 59

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLA 255
           H  LVKL    +  +   ++ EFM +GSL + L        PLP  I     +  A+G+A
Sbjct: 60  HDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMA 116

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 315
           F+ +   +  I+RD + +NIL+ A    K++DFGLA+   ED +            + AP
Sbjct: 117 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAP 172

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
           E +  G  T KSDV+SFG++L+E++T  R
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 30/212 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           +GEG +G V+K   +          TG  VA+K +    L+   E      + E++ L  
Sbjct: 7   IGEGTYGVVYKARDKL---------TGEIVALKKIR---LETEDEGVPSTAIREISLLKE 54

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
           L HPN+V+L+   +  + +L LV+EF+    L+ ++       L   +         +G+
Sbjct: 55  LNHPNIVRLLD-VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTRVMGTYGY 312
           A+ H      V++RD K  N+L+D +   KL+DFGLA+    P    TH    V+ T  Y
Sbjct: 113 AYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWY 165

Query: 313 AAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            APE ++     S   D++S G +  EM+  R
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 21/217 (9%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LH 198
           LGEG FG V +   E  G    +P   +TVAVK L  +   +   + ++E+  +  +  H
Sbjct: 20  LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------------FRKGSLPLPWSIRM 244
            N++ L+G C ++    ++ E+  +G+L   L               +     L +   +
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             A   A+G+ +L     +  I+RD    N+L+  D   K++DFGLA+   +      ++
Sbjct: 138 SCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                  + APE +     T +SDV+SFG+++ E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 75.5 bits (185), Expect = 6e-15
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 18/216 (8%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 187
           +L   +F   S LG G  G VFK           KP +GL +A K ++ +       + +
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIRNQII 51

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K++
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVS 109

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           +   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 110 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 163

Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 33/220 (15%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-L 197
           ++GEG FG V K  ++       K G  +  A+K +     +  H+++  E+  L  L  
Sbjct: 2   VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL-PWSIR------------- 243
           HPN++ L+G C       L  E+ P G+L + L +   L   P                 
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           +  A   A+G+ +L   ++K  I+RD    NIL+  +Y AK++DFGL++     G+    
Sbjct: 115 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 166

Query: 304 TRVMGTYG--YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            + MG     + A E +     T+ SDV+S+GV+L E+++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 75.7 bits (187), Expect = 6e-15
 Identities = 71/219 (32%), Positives = 107/219 (48%), Gaps = 39/219 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGN 195
           LG+G +G V+K          +   T   VA+K +  D  +   +  A     E+ FL  
Sbjct: 15  LGKGAYGIVWKA---------IDRRTKEVVALKKI-FDAFRNATD--AQRTFREIMFLQE 62

Query: 196 LL-HPNLVKLVG-YCIEDDQRL-LVYEFMPRGSLENHL---FRKGSLPLPWSIRMK-IAL 248
           L  HPN+VKL+     E+D+ + LV+E+M     E  L    R   L     +  + I  
Sbjct: 63  LGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILE---DVHKRYIMY 114

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTR 305
              K L ++H      VI+RD K SNILL++D   KL+DFGLA+   +  E+ +  V T 
Sbjct: 115 QLLKALKYIHS-GN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171

Query: 306 VMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            + T  Y APE ++     +K  D++S G +L EML G+
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 74.6 bits (183), Expect = 6e-15
 Identities = 84/282 (29%), Positives = 119/282 (42%), Gaps = 46/282 (16%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 191
           FR   +LG+GGFG V    V           TG   A K L    ++   G    L E  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKR 52

Query: 192 FLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
            L  +    +V L  Y  E  D   LV   M  G L+ H++  G+   P     +    A
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGN---PGFDEQRAIFYA 108

Query: 251 AK---GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           A+   GL  L  E    ++YRD K  NILLD   + ++SD GLA   PE G+T V  RV 
Sbjct: 109 AELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE-GET-VRGRV- 162

Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT GY APE +     T   D +  G ++ EM+ G+    K +       V+        
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREE----- 212

Query: 368 KRRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKAR 406
                  +D R+   +  +S K S+ A  +    L+++PK R
Sbjct: 213 -------VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 75.1 bits (184), Expect = 7e-15
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 21/217 (9%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 23  LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM-------------- 244
            N++ L+G C +D    ++ E+  +G+L  +L  +    + +S  +              
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                  + APE +     T +SDV+SFGV++ E+ T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 33/218 (15%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVN 191
           + +     +G+G  G V+        TA +   TG  VA+K +N    Q  KE +  E+ 
Sbjct: 19  KKYTRFEKIGQGASGTVY--------TA-IDVATGQEVAIKQMNLQQ-QPKKELIINEIL 68

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
            +    HPN+V  +   +  D+  +V E++  GSL +         +     M     AA
Sbjct: 69  VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD---------VVTETCMDEGQIAA 119

Query: 252 ------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVST 304
                 + L FLH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    +
Sbjct: 120 VCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RS 173

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            ++GT  + APE V       K D++S G++ +EM+ G
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 74.3 bits (182), Expect = 8e-15
 Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 35/275 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 199
           +G+G FG V+KG   +N T  V       VA+K ++ +  +   E +  E+  L     P
Sbjct: 12  IGKGSFGEVYKGI--DNRTKEV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            + +  G  ++  +  ++ E++  GS  + L + G  PL  +    I     KGL +LH 
Sbjct: 63  YITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPG--PLEETYIATILREILKGLDYLHS 119

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
           E +   I+RD K +N+LL    + KL+DFG+A     D +   +T V GT  + APE + 
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVIK 174

Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 379
                 K+D++S G+  +E+  G        P     L+    P             P L
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTL 221

Query: 380 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           EG +    S+   +    CL++DP+ RP   E+++
Sbjct: 222 EGQY----SKPFKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.7 bits (183), Expect = 9e-15
 Identities = 72/236 (30%), Positives = 108/236 (45%), Gaps = 34/236 (14%)

Query: 118 SQLRKFMFNDLKLATRNFR--PESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLT 169
           S  R     D ++A   F+  PE L      +G G FG V+  +  +  T  V       
Sbjct: 2   STSRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVY--FARDVRTNEV------- 52

Query: 170 VAVKTLNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 226
           VA+K +++ G Q +++W   + EV FL  + HPN ++  G  + +    LV E+   GS 
Sbjct: 53  VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSA 111

Query: 227 ENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 286
            + L      PL       I  GA +GLA+LH      +I+RD K  NILL      KL+
Sbjct: 112 SD-LLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLA 167

Query: 287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEM 339
           DFG A  A        +   +GT  + APE ++    G    K DV+S G+  +E+
Sbjct: 168 DFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 88/276 (31%), Positives = 116/276 (42%), Gaps = 49/276 (17%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 196
           LLG+G FG V    V E  T       G   A+K L  + +    E    + E   L N 
Sbjct: 2   LLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA--AKG 253
            HP L  L  Y  +   RL  V E+   G L  HL R+         R +   GA     
Sbjct: 53  RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARF-YGAEIVSA 107

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  +    GT  Y 
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGDKRR 370
           APE +         D +  GVV+ EM+ GR    + D  R      L E     L ++ R
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELI---LMEEIR 213

Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           F R L P            +A  L A  L +DPK R
Sbjct: 214 FPRTLSP------------EAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 24/217 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 188
           N+R   LLG G FG V+  +  +         TG  +AVK +  + D  +  KE  A   
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALEC 53

Query: 189 EVNFLGNLLHPNLVKLVGYCIED--DQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIRMK 245
           E+  L NL H  +V+  G C+ D  +++L ++ E+MP GS+++ L   G+L    ++  +
Sbjct: 54  EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALT--ENVTRR 110

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
                 +G+++LH      +++RD K +NIL D+  N KL DFG +K       +    +
Sbjct: 111 YTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK 167

Query: 306 -VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            V GT  + +PE +       K+DV+S    ++EMLT
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 21/214 (9%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLL 197
           +LG+G FG V +  ++         G+   VAVK L  D       +E+L E   +    
Sbjct: 6   MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59

Query: 198 HPNLVKLVGYCIED--DQRL----LVYEFMPRGSLENHLF--RKGSLP--LPWSIRMKIA 247
           HPN++KL+G  +      RL    ++  FM  G L   L   R G  P  LP    ++  
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           +  A G+ +L   + K  I+RD    N +L+ +    ++DFGL+K               
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               + A E +     T+ SDV++FGV + E++T
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 80/286 (27%), Positives = 127/286 (44%), Gaps = 43/286 (15%)

Query: 137 PESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-E 189
           PE L      +G+G FG VFKG   +N T  V       VA+K ++ +  +   E +  E
Sbjct: 2   PEELFTKLERIGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQE 52

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIAL 248
           +  L     P + K  G  ++  +  ++ E++  GS  + L R G       +  +K  L
Sbjct: 53  ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEIL 111

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
              KGL +LH E +   I+RD K +N+LL    + KL+DFG+A     D +   +T V G
Sbjct: 112 ---KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV-G 163

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
           T  + APE +      SK+D++S G+  +E+  G        P     L+    P     
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP----- 218

Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                   P L G F    S+   +    CL++DP  RP   E+++
Sbjct: 219 --------PTLTGEF----SKPFKEFIDACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 22/213 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 196
           +LG+G FG V             + GT    A+K L  D +    +    + E   L   
Sbjct: 7   VLGKGSFGKV---------MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
             P  +  +  C +   RL  V E++  G L   + + G    P ++    A   A GL 
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--AAEIAIGLF 115

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAA 314
           FLH    K +IYRD K  N++LD++ + K++DFG+ K+   DG   V+T+   GT  Y A
Sbjct: 116 FLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIA 169

Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 347
           PE +         D ++FGV+L EML G+   +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 84/297 (28%), Positives = 127/297 (42%), Gaps = 44/297 (14%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLL 197
           L+GEG +G V K   +E         TG  VA+K    + D     K  + E+  L  L 
Sbjct: 8   LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIRMKIALGAAKGLAF 256
           H NLV L+       +  LV+EF+    L++   +  G   L  S   K      +G+ F
Sbjct: 59  HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEF 115

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKT-HVSTRVMGTYGYA 313
            H      +I+RD K  NIL+      KL DFG A+   AP +  T +V+TR      Y 
Sbjct: 116 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYR 167

Query: 314 APEYVMTGHLTSKS-DVYSFGVVLLEMLTGR------RSMDK---------NRPNGEHNL 357
           APE ++      ++ D+++ G ++ EMLTG         +D+         N       +
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227

Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
            +      G +    + ++P LE  F  K S     LA QCL  DP  RP  S+++ 
Sbjct: 228 FQKNPLFAGMRLPEVKEIEP-LEKRFP-KLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 85/276 (30%), Positives = 119/276 (43%), Gaps = 34/276 (12%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLA--EVN 191
           FR   +LG+GGFG V    V           TG   A K L    ++  K E +A  E  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52

Query: 192 FLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
            L  +    +V L  Y  E  D   LV   M  G L+ H++  G+        +  A   
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEI 111

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
             GL  LH E    ++YRD K  NILLD   + ++SD GLA + PE G+T +  RV GT 
Sbjct: 112 TCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE-GET-IRGRV-GTV 165

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 370
           GY APE V     T   D +  G ++ EM+ G+    + +   +   VE         RR
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---------RR 216

Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
                    +  +S K S+ A  +  Q L++DP  R
Sbjct: 217 V-----KEDQEEYSEKFSEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 72/214 (33%), Positives = 98/214 (45%), Gaps = 32/214 (14%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLG-N 195
           +LG+G FG VF         A +K GT    A+K L  D +    +    + E   L   
Sbjct: 2   MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52

Query: 196 LLHPNLVKLVGYCI--EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK- 252
             HP L  L  YC     +    V E++  G L  H+       LP     +    AA+ 
Sbjct: 53  WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP-----RATFYAAEI 105

Query: 253 --GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP-EDGKTHVSTRVMGT 309
             GL FLH    K ++YRD K  NILLD D + K++DFG+ K+    D KT       GT
Sbjct: 106 ICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGT 159

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++     +  D +SFGV+L EML G+
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 81/291 (27%), Positives = 119/291 (40%), Gaps = 45/291 (15%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGN 195
              +G G FG V K   + +GT          +AVK      D  +  K  L +++ +  
Sbjct: 9   LGEIGRGAFGTVNKMLHKPSGT---------IMAVKRIRSTVDEKE-QKRLLMDLDVVMR 58

Query: 196 LLH-PNLVKLVGYCIEDDQRLLVYEFMPRGSLEN---HLFRKGSLPLPWSIRMKIALGAA 251
               P +VK  G    +    +  E M   SL+    +++      +P  I  KIA+   
Sbjct: 59  SSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATV 117

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS---TRVMG 308
           K L +L EE +  +I+RD K SNILLD + N KL DFG++      G+   S   TR  G
Sbjct: 118 KALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS------GQLVDSIAKTRDAG 169

Query: 309 TYGYAAPEYVMTGHLTS---KSDVYSFGVVLLEMLTGRRSMDK-NRPNGEHNLVEWARPH 364
              Y APE +          +SDV+S G+ L E+ TG+    K N         +  +  
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQLTQVV 224

Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 415
            GD       L    E  FS             CL +D   RP+  E++E 
Sbjct: 225 KGDPPI----LSNSEEREFSP----SFVNFINLCLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 71/208 (34%), Positives = 97/208 (46%), Gaps = 22/208 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGN 195
           ++G+G FG V     + +G            AVK L    +   KE    +AE N  L N
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKC---------YAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
           + HP LV L  Y  +  ++L  V +F+  G L  HL R+ S P P + R   A   A  L
Sbjct: 53  VKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFYAA-EIASAL 109

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH      ++YRD K  NILLD+  +  L+DFGL K+      T  +T   GT  Y A
Sbjct: 110 GYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLA 164

Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           PE +      +  D +  G VL EML G
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.8 bits (178), Expect = 4e-14
 Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 18/216 (8%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 187
           +L   +F   S LG G  G V K           KP +GL +A K ++ +       + +
Sbjct: 1   ELKDDDFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQII 51

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E+  L     P +V   G    D +  +  E M  GSL+  L  K +  +P  I  K++
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVS 109

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           +   +GLA+L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 110 IAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 163

Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 34/216 (15%)

Query: 137 PESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---L 187
           PE L      +G G FG V+      N            VA+K +++ G Q +++W   +
Sbjct: 13  PEKLFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDII 63

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV FL  L HPN ++  G  + +    LV E+   GS  + L      PL       + 
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVT 121

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRV 306
            GA +GLA+LH      +I+RD K  NILL      KL DFG A   AP       +   
Sbjct: 122 HGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXF 171

Query: 307 MGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEM 339
           +GT  + APE ++    G    K DV+S G+  +E+
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 78/274 (28%), Positives = 116/274 (42%), Gaps = 39/274 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL 197
           LG+GGFG V          A     TG   A K LN   L   +G++  + E   L  + 
Sbjct: 1   LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV- 50

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLF----RKGSLPLPWSIRMKIALGAAK 252
           H   +  + Y  +    L LV   M  G L  H++         P P +      +    
Sbjct: 51  HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQI--IS 108

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL  LH+   + +IYRD K  N+LLD D N ++SD GLA +  +DG++  +    GT G+
Sbjct: 109 GLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVEL-KDGQSK-TKGYAGTPGF 163

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 372
            APE +         D ++ GV L EM+  R      R  GE   VE       +K    
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEK--VE-------NKELKQ 211

Query: 373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           R+L+  +   +  K S  +       L++DP+ R
Sbjct: 212 RILNDSVT--YPDKFSPASKSFCEALLAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 72.0 bits (177), Expect = 8e-14
 Identities = 66/219 (30%), Positives = 88/219 (40%), Gaps = 33/219 (15%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH---------DGLQGHKE 185
           FR  ++LG G FG V     E   T       G   A+K L           + L   K 
Sbjct: 1   FRCLAVLGRGHFGKVL--LAEYKKT-------GELYAIKALKKGDIIARDEVESLMCEKR 51

Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
                N      HP LV L   C + +  +  V E+   G L  H+        P   R 
Sbjct: 52  IFETANSER---HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEP---RA 103

Query: 245 KI-ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
              A     GL +LHE     ++YRD K  N+LLD +   K++DFGL K+    G    S
Sbjct: 104 VFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TS 159

Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           T   GT  + APE +     T   D +  GV++ EML G
Sbjct: 160 T-FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 8e-14
 Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 22/160 (13%)

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E   L  + HP +++L  +  E DQR L  + E++P G L ++L   G     +S    +
Sbjct: 51  EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGL 104

Query: 247 ALGA--AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
              +     L +LH    K ++YRD K  NILLD + + KL+DFG AK      K    T
Sbjct: 105 FYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRT 155

Query: 305 RVM-GTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTG 342
             + GT  Y APE +   GH  +  D ++ G+++ EML G
Sbjct: 156 WTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 58/205 (28%), Positives = 85/205 (41%), Gaps = 55/205 (26%)

Query: 229 HLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF 288
            ++ KG L +P  I  KIA+   K L +LH +    VI+RD K SN+L++ +   KL DF
Sbjct: 92  KVYDKG-LTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDF 148

Query: 289 G--------LAKDAPEDGKTHVSTRVMGTYGYAAPEYV----MTGHLTSKSDVYSFGVVL 336
           G        +AK           T   G   Y APE +           KSDV+S G+ +
Sbjct: 149 GISGYLVDSVAK-----------TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197

Query: 337 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD------PRL-EGHFSIKGSQ 389
           +E+ TGR   D            W  P       F +L        P+L    FS     
Sbjct: 198 IELATGRFPYDS-----------WKTP-------FQQLKQVVEEPSPQLPAEKFSP---- 235

Query: 390 KATQLAAQCLSRDPKARPRMSEVVE 414
           +      +CL ++ K RP   E+++
Sbjct: 236 EFQDFVNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 69/211 (32%), Positives = 94/211 (44%), Gaps = 26/211 (12%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLG-N 195
           +LG+G FG V    ++         G G   AVK L  D +    +    + E   L   
Sbjct: 2   VLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA 52

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK--- 252
             +P L  L       +    V EF+  G L  H+  KG   L      +    AA+   
Sbjct: 53  WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-----YRATFYAAEIVC 107

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL FLH    K +IYRD K  N++LD D + K++DFG+ K+    G    ST   GT  Y
Sbjct: 108 GLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-GDNRAST-FCGTPDY 162

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
            APE +     T   D +SFGV+L EML G+
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 53/151 (35%), Positives = 74/151 (49%), Gaps = 17/151 (11%)

Query: 198 HPNLVKLVGYCI--EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK--- 252
           HP L  L  +C     +    V E++  G L  H+   G          +    AA+   
Sbjct: 55  HPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-----RARFYAAEIIC 107

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL FLH+   K +IYRD K  N+LLD D + K++DFG+ K+   +G+   ST   GT  Y
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN-MNGEGKAST-FCGTPDY 162

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
            APE +         D +SFGV+L EML G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 52/150 (34%), Positives = 78/150 (52%), Gaps = 16/150 (10%)

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           P LV L  Y  + D +L L+ +++  G L  HL+++        +R+ IA      L  L
Sbjct: 65  PFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHL 121

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYAAP 315
           H+     +IYRD K  NILLD++ +  L+DFGL+K+  A E+ + +      GT  Y AP
Sbjct: 122 HQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAP 175

Query: 316 EYVMT---GHLTSKSDVYSFGVVLLEMLTG 342
           E +     GH     D +S GV+  E+LTG
Sbjct: 176 EVIRGGSGGH-DKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 65/256 (25%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGN 195
           L+G+GG G V+  +          P     VA+K +  D L       K +L E     +
Sbjct: 9   LIGKGGMGEVYLAY---------DPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAAD 58

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMP----------------RGSLENHLFRKGSLPLP 239
           L+HP +V +  Y I  D    VY  MP                + SL   L  K S+   
Sbjct: 59  LIHPGIVPV--YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK------- 292
            SI  KI       + ++H    K V++RD K  NILL       + D+G A        
Sbjct: 116 LSIFHKIC----ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168

Query: 293 -----DAPEDGKTH----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-- 341
                D  E    +    +  +++GT  Y APE ++    +  +D+Y+ GV+L +MLT  
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228

Query: 342 -------GRRSMDKNR 350
                  GR+   ++ 
Sbjct: 229 FPYRRKKGRKISYRDV 244

Length = 932

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 35/230 (15%)

Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
             L++   +F    ++G G FG V    V    +  V        A+K L+   +    +
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEV--QLVRHKSSKQV-------YAMKLLSKFEMIKRSD 86

Query: 186 ----WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 240
               W  E + + +     +V+L  Y  +DD+ L +V E+MP G L N L     +P  W
Sbjct: 87  SAFFW-EERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKW 143

Query: 241 SI----RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 296
           +      + +AL A   + F+H         RD K  N+LLD   + KL+DFG       
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDA 194

Query: 297 DGKTHVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 342
           +G     T V GT  Y +PE + +    G+   + D +S GV L EML G
Sbjct: 195 NGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 69/209 (33%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGN 195
           ++G+G FG V     + +G+           AVK L    +   KE    +AE N  L N
Sbjct: 2   VIGKGSFGKVLLAKRKSDGS---------FYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKI-ALGAAKG 253
           L HP LV L  Y  +  ++L  V +++  G L  HL R+     P   R +  A   A  
Sbjct: 53  LKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP---RARFYAAEVASA 108

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           + +LH      +IYRD K  NILLD+  +  L+DFGL K+  E  +T  ++   GT  Y 
Sbjct: 109 IGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYL 163

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           APE +         D +  G VL EML G
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (169), Expect = 7e-13
 Identities = 84/271 (30%), Positives = 117/271 (43%), Gaps = 41/271 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLL 197
           +G+G FG V +  V +  T  +        A+KT+    +    E    LAE   L  + 
Sbjct: 1   IGKGSFGKVMQ--VRKRDTQRI-------YALKTIRKAHIVSRSEVTHTLAERTVLAQVN 51

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
            P +V L  +  +  ++L LV  F+  G L +HL R+G   L      +     A+ L  
Sbjct: 52  CPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDL-----SRARFYTAELLCA 105

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRVMGTYGYAAP 315
           L    +  VIYRD K  NILLD   +  L DFGL K +  +D KT+      GT  Y AP
Sbjct: 106 LENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT---FCGTPEYLAP 162

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 375
           E ++    T   D ++ GV+L EMLTG        P  + N+ E  R  L +  RF    
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTGL------PPFYDENVNEMYRKILQEPLRFPDGF 216

Query: 376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           D            + A  L    LSRDP  R
Sbjct: 217 D------------RDAKDLLIGLLSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 64/231 (27%), Positives = 101/231 (43%), Gaps = 53/231 (22%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAE 189
            F   + +GEG +G V++              +G  VA+K +      DG+      L E
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISS--LRE 56

Query: 190 VNFLGNLLHPNLVKL---------------VGYCIEDDQRLLVYEFMPRGSLENHLFRKG 234
           +  L NL HPN+V+L               + YC +D   LL  + MP            
Sbjct: 57  ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT----------- 103

Query: 235 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
             P   S    + L   +GL +LHE     +I+RD K SN+LL      K++DFGLA+  
Sbjct: 104 --PFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-T 157

Query: 295 PEDGKTHVSTRVMGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEMLTGR 343
                  ++ +V+ T  Y APE +   T + T+  D+++ G +L E+L  +
Sbjct: 158 YGLPAKPMTPKVV-TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 37/90 (41%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           L FLH      VIYRD K  NILLDA+ + KL+DFG+ K+   +G T  +T   GT  Y 
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           APE +         D ++ GV++ EM+ G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 35/215 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGN 195
           +GEG +G V+KG             TG  VA+K +    L+  +E +      E++ L  
Sbjct: 8   IGEGTYGVVYKG---------RNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKE 55

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSI---RMKIAL-GAA 251
           L HPN+V L    +++ +  L++EF+    L+ +L    SLP    +    +K  L    
Sbjct: 56  LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL---DSLPKGQYMDAELVKSYLYQIL 111

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTRVMGT 309
           +G+ F H    + V++RD K  N+L+D     KL+DFGLA+    P      V T  + T
Sbjct: 112 QGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP----VRVYTHEVVT 164

Query: 310 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
             Y APE ++     S   D++S G +  EM T +
Sbjct: 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 64/259 (24%), Positives = 113/259 (43%), Gaps = 43/259 (16%)

Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           TG  VAVK ++    Q  +    EV  + +  H N+V +    +  D+  +V EF+  G+
Sbjct: 46  TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 226 LENHLFRKGSLPLPWSIRMK------IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 279
           L +         +    RM       + L   + L++LH +    VI+RD K+ +ILL +
Sbjct: 106 LTD---------IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTS 153

Query: 280 DYNAKLSDFG----LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVV 335
           D   KLSDFG    ++K+ P+         ++GT  + APE +      ++ D++S G++
Sbjct: 154 DGRIKLSDFGFCAQVSKEVPK------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 207

Query: 336 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLA 395
           ++EM+ G                 +  P L   RR    L PR++    +    +     
Sbjct: 208 VIEMIDGEPPY-------------FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG--FL 252

Query: 396 AQCLSRDPKARPRMSEVVE 414
              L R+P  R    E+++
Sbjct: 253 DLMLVREPSQRATAQELLQ 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 68/263 (25%), Positives = 121/263 (46%), Gaps = 46/263 (17%)

Query: 89  PVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGC 148
           P+ P SS+++S++ S++S    S              ++L+   R       +G G  G 
Sbjct: 46  PLPPPSSSSSSSSSSSASGSAPSAAKS---------LSELERVNR-------IGSGAGGT 89

Query: 149 VFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVG 206
           V+K          +   TG   A+K +  NH+     ++   E+  L ++ HPN+VK   
Sbjct: 90  VYK---------VIHRPTGRLYALKVIYGNHED-TVRRQICREIEILRDVNHPNVVKCHD 139

Query: 207 YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPV 265
               + +  ++ EFM  GSLE  H+  +  L         +A     G+A+LH    + +
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-------DVARQILSGIAYLHR---RHI 189

Query: 266 IYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS 325
           ++RD K SN+L+++  N K++DFG+++   +      S+  +GT  Y +PE + T     
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTDLNHG 247

Query: 326 K-----SDVYSFGVVLLEMLTGR 343
                  D++S GV +LE   GR
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 51/179 (28%), Positives = 79/179 (44%), Gaps = 25/179 (13%)

Query: 189 EVNFLGNLLHPNLVKLV-GYCIEDDQRLLVYEFMP--RGSLENHLFRKGSLPLPWSIRMK 245
           E++ L  + H  ++ L+  Y      +  V   MP  +  L  ++ R G LPL  +I   
Sbjct: 136 EIDILKTISHRAIINLIHAY----RWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAI--T 189

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
           I     + LA+LH    + +I+RD KT NI LD   NA L DFG A       K      
Sbjct: 190 IQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA------CKLDAHPD 240

Query: 306 VMGTYGYA------APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNL 357
               YG++      +PE +      +K+D++S G+VL EM     ++  K   +    L
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299

Length = 392

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 65/242 (26%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 191
            ++P   +G G +G V            +   +G  VA+K + H  D     K  L E+ 
Sbjct: 6   RYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR---------LLVYEFM---------PRGSLENHLFRK 233
            L +  H N++      I D  R          +V + M             L     R 
Sbjct: 57  ILRHFKHDNII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY 111

Query: 234 GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK- 292
               L             +GL ++H      VI+RD K SN+L++ D   ++ DFG+A+ 
Sbjct: 112 FLYQL------------LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156

Query: 293 --DAPEDGKT----HVSTRVMGTYGYAAPE--YVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
              +P + K     +V+TR      Y APE    +  + T+  D++S G +  EML GRR
Sbjct: 157 LSSSPTEHKYFMTEYVATR-----WYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GRR 209

Query: 345 SM 346
            +
Sbjct: 210 QL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 44/280 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V          A VK  +G  VAVK ++    Q  +    EV  + +  H N
Sbjct: 28  IGEGSTGIVC--------IATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 254
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   K L
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLKAL 129

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           + LH +    VI+RD K+ +ILL  D   KLSDFG      ++     S  ++GT  + A
Sbjct: 130 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMA 184

Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 374
           PE +       + D++S G++++EM+ G        P     ++   R +L  K +    
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKNLHK 241

Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           + P L+G               + L RDP  R   +E+++
Sbjct: 242 VSPSLKGFLD------------RLLVRDPAQRATAAELLK 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 25/225 (11%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAE---VNFL 193
           ++G GGFG V+            K  TG   A+K L+   +   QG    L E   ++ +
Sbjct: 1   IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
                P +V +       D+   + + M  G L  HL + G          ++   A + 
Sbjct: 52  STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS-----EKEMRFYATEI 106

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           +  L     + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +GT+GY 
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHAS---VGTHGYM 162

Query: 314 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
           APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 85/302 (28%), Positives = 137/302 (45%), Gaps = 48/302 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGNLLH 198
           LG+G +G V+K           +P TG+T+A+K +  + L   K  + + E++ L   + 
Sbjct: 9   LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVS 58

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP--LPWSIRMKIALGAAKGLAF 256
           P +V   G    +    +  E+M  GSL+  L+  G     +P  +  +I     KGL F
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-GKTHVSTRVMGTYGYAAP 315
           L EE    +I+RD K +N+L++ +   KL DFG++ +      KT++     G   Y AP
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAP 170

Query: 316 EYVMTGHL------TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL-GDK 368
           E + +G        T +SDV+S G+ +LEM  GR       P    N+       + GD 
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIFAQLSAIVDGDP 227

Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNLK-DM 425
                   P L   +    S  A    A+CL++ P  RP  ++++E   L   +N   DM
Sbjct: 228 --------PTLPSGY----SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDM 275

Query: 426 AS 427
           A 
Sbjct: 276 AE 277

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 66.7 bits (162), Expect = 3e-12
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 19/203 (9%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G VF           +   TG  VA+K +N       +  + E+  +  L +PN
Sbjct: 27  IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +V  +   +  D+  +V E++  GSL + +          +   +  L A   L FLH  
Sbjct: 78  IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQA---LEFLHAN 134

Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
               VI+RD K+ N+LL  D + KL+DFG  A+  PE  K    + ++GT  + APE V 
Sbjct: 135 Q---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVT 188

Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
                 K D++S G++ +EM+ G
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 22/207 (10%)

Query: 163 KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP 222
           KPG    V +K     G +G    L E   L N+ HP+++++    +      +V   +P
Sbjct: 87  KPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LP 137

Query: 223 RGSLENHLF-RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 281
             S + + +  K S PLP    + I     +GL +LH +    +I+RD KT NI ++   
Sbjct: 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVD 194

Query: 282 NAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 338
              + D G A+    AP          + GT    APE +      SK+D++S G+VL E
Sbjct: 195 QVCIGDLGAAQFPVVAPAF------LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFE 248

Query: 339 MLTGRRSMDKNRPNGEHNLVEWARPHL 365
           ML    ++ ++ P+     V+    HL
Sbjct: 249 MLAYPSTIFEDPPSTPEEYVKSCHSHL 275

Length = 357

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 5/94 (5%)

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRVMGTY 310
           +GL ++H      V++RD K SN+LL+ + + K+ DFGLA+   PE   T   T  + T 
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 311 GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            Y APE ++     +K+ D++S G +L EML+ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 22/210 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG+G +G V+         A     T + +A+K +     +  +    E+     L H 
Sbjct: 15  VLGKGTYGIVY---------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA--KGLAFL 257
           N+V+ +G   E+    +  E +P GSL   L R    PL  + +  I       +GL +L
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTKQILEGLKYL 124

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 315
           H+     +++RD K  N+L++  Y+   K+SDFG +K     G    +    GT  Y AP
Sbjct: 125 HDNQ---IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLA--GINPCTETFTGTLQYMAP 178

Query: 316 EYVMTGH--LTSKSDVYSFGVVLLEMLTGR 343
           E +  G     + +D++S G  ++EM TG+
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 66.7 bits (162), Expect = 4e-12
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 32/260 (12%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA+K +N       +  + E+  +    +PN
Sbjct: 27  IGQGASGTVYTA---------IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 256
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALDF 130

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 315
           LH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 131 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAP 184

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRS-MDKNRPNGEHNLVEWARPHLGDKRR---- 370
           E V       K D++S G++ +EM+ G    +++N     + +     P L +  R    
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244

Query: 371 FYRLLDPRLEGHFSIKGSQK 390
           F   L+  LE     +GS K
Sbjct: 245 FRDFLNRCLEMDVDRRGSAK 264

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 18/205 (8%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LGEG +  VFKG  +          T   VA+K +  +  +G     + EV+ L NL H 
Sbjct: 13  LGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+V L      +    LV+E++    L+ +L   G+L    ++++       +GL++ H+
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHK 121

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
              + +++RD K  N+L++     KL+DFGLA+      KT+ +  V  T  Y  P+ ++
Sbjct: 122 ---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLL 176

Query: 320 -TGHLTSKSDVYSFGVVLLEMLTGR 343
            +   ++  D++  G +L EM TGR
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 66.3 bits (161), Expect = 5e-12
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 27/207 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 256
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF 131

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 315
           LH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAP 185

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           E V       K D++S G++ +EM+ G
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 65.2 bits (159), Expect = 7e-12
 Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 45/282 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           +GEG FG       +E+G   V         +K +N   +     +E   EV  L N+ H
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYV---------IKEINISKMSPKEREESRKEVAVLSNMKH 58

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP------WSIRMKIALGAAK 252
           PN+V+      E+    +V ++   G L   +  +  +  P      W +++ +AL    
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL---- 114

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
               +H+   + +++RD K+ NI L  D   KL DFG+A+    +    ++   +GT  Y
Sbjct: 115 --KHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYY 167

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 372
            +PE        +KSD+++ G VL EM T + + +        NLV      L   R  Y
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA---GNMKNLV------LKIIRGSY 218

Query: 373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
               P +  H+    S     L +Q   R+P+ RP ++ ++E
Sbjct: 219 ----PPVSSHY----SYDLRNLVSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 65.9 bits (160), Expect = 8e-12
 Identities = 66/208 (31%), Positives = 92/208 (44%), Gaps = 21/208 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 196
           LLG+G FG V    V E  +       G   A+K L  + +    E    L E   L N 
Sbjct: 2   LLGKGTFGKVI--LVREKAS-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
            HP L  L  Y  +   RL  V E++  G L  HL R+       +      + +A  L 
Sbjct: 53  RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LD 109

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 315
           +LH      ++YRD K  N++LD D + K++DFGL K+   D  T  +    GT  Y AP
Sbjct: 110 YLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAP 164

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           E +         D +  GVV+ EM+ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 64.9 bits (158), Expect = 8e-12
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 19/159 (11%)

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAKGL 254
           PN+V L  Y + +D   LV +    G L +H+ +  ++P      W+  M +AL A    
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
             LH E    ++ RD   +NILLD   + +L+ F    +  +         +     Y A
Sbjct: 101 --LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCA 150

Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 353
           PE       T   D +S G +L E+LTG +++ +  P+G
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 48/181 (26%), Positives = 89/181 (49%), Gaps = 16/181 (8%)

Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           +G  VAVK ++    Q  +    EV  + +  H N+V++    +  ++  ++ EF+  G+
Sbjct: 45  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 226 LENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 285
           L + +       L       +     + L +LH +    VI+RD K+ +ILL  D   KL
Sbjct: 105 LTDIV---SQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKL 158

Query: 286 SDFG----LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           SDFG    ++KD P+         ++GT  + APE +      ++ D++S G++++EM+ 
Sbjct: 159 SDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD 212

Query: 342 G 342
           G
Sbjct: 213 G 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 76/302 (25%), Positives = 124/302 (41%), Gaps = 42/302 (13%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 192
           ++ + ++G+G +G V          + +   TG  VA+K +N   + +      L E+  
Sbjct: 2   YKIQEVIGKGSYGVV---------CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKL 52

Query: 193 LGNLLHPNLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
           L  L HP++V++    +   +R      +V+E M     + H   K +  L         
Sbjct: 53  LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFL 109

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRV 306
               + L ++H      V +RD K  NIL +AD   K+ DFGLA+ A  D  T +  T  
Sbjct: 110 YQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166

Query: 307 MGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH------NLV 358
           + T  Y APE   +     T   D++S G +  E+LTG+        N  H      +L+
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--NVVHQLDLITDLL 224

Query: 359 EWARPHLGDK------RRFYRLLDPRLEGHFSIK---GSQKATQLAAQCLSRDPKARPRM 409
               P    +      RR+   +  +    FS K       A +L  + L+ DPK RP  
Sbjct: 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA 284

Query: 410 SE 411
            E
Sbjct: 285 EE 286

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 11/94 (11%)

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           +GL ++H      +I+RD K SNI ++ D   K+ DFGLA+   ++   +V+TR      
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180

Query: 312 YAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGR 343
           Y APE +M    H     D++S G ++ E+LTG+
Sbjct: 181 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 40/218 (18%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT----LNHDGLQGHKEWLAEVNFLG 194
           + +GEG +G V+K              TG  VA+K     L+ +G+      L E+  L 
Sbjct: 5   AEIGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLK 53

Query: 195 NLL---HPNLVKLVGYC--IEDDQRL---LVYEFMPR---GSLENHLFRKGSLPLPWSIR 243
            L    HPN+V+L+  C     D+ L   LV+E + +     L      K  LP P +I+
Sbjct: 54  QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC--PKPGLP-PETIK 110

Query: 244 --MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 301
             M+  L   +G+ FLH      +++RD K  NIL+ +D   K++DFGLA+    +    
Sbjct: 111 DLMRQLL---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL- 163

Query: 302 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 339
             T V+ T  Y APE ++     +  D++S G +  E+
Sbjct: 164 --TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 20/184 (10%)

Query: 170 VAVKTLNHDGLQGHKEWLA----EVNFLGNLLHPNLVKLVGYCIEDDQRL----LVYEFM 221
           V ++T      +GHK  +     E+  L  +   N++K+ G+ I+    L    L+ E+ 
Sbjct: 46  VIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104

Query: 222 PRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 281
            RG L   L ++  L      ++ +A+   KGL  L++   KP  Y++  + + L+  +Y
Sbjct: 105 TRGYLREVLDKEKDLSF--KTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENY 160

Query: 282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEM 339
             K+   GL K        +V+  V     Y + + +       T K D+YS GVVL E+
Sbjct: 161 KLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEI 215

Query: 340 LTGR 343
            TG+
Sbjct: 216 FTGK 219

Length = 283

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 80/311 (25%), Positives = 111/311 (35%), Gaps = 72/311 (23%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAE 189
           ++F+   LLG+G  G VF   V   GT  +        A+K L+   +    +    L E
Sbjct: 1   KHFKKIKLLGKGDVGRVF--LVRLKGTGKL-------FALKVLDKKEMIKRNKVKRVLTE 51

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK---GSLPLPWSIRMKI 246
              L  L HP L  L      +    LV ++ P G L   L ++     L      R   
Sbjct: 52  QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEE-VARFYA 109

Query: 247 A-LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV--- 302
           A +  A  L +LH      ++YRD K  NILL    +  LSDF L+K +  +        
Sbjct: 110 AEVLLA--LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL 164

Query: 303 ---------------------STRVM---GTYGYAAPEYVM-TGHLTSKSDVYSFGVVLL 337
                                S R     GT  Y APE +   GH  S  D ++ G++L 
Sbjct: 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLY 223

Query: 338 EMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR--FYRLLDPRLEGHFSIKGSQKATQLA 395
           EML G                    P  G  R   F  +L   +    S   S  A  L 
Sbjct: 224 EMLYGT------------------TPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLI 265

Query: 396 AQCLSRDPKAR 406
            + L +DP  R
Sbjct: 266 RKLLVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 31/224 (13%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL----- 187
           + +   + +GEG +G VFK    +NG        G  VA+K +    +Q  +E +     
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVR---VQTGEEGMPLSTI 49

Query: 188 ---AEVNFLGNLLHPNLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
              A +  L    HPN+V+L   C       + +  LV+E + +  L  +L +     +P
Sbjct: 50  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 108

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
                 +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+       
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 165

Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
               T V+ T  Y APE ++     +  D++S G +  EM   +
Sbjct: 166 L---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 72/290 (24%), Positives = 105/290 (36%), Gaps = 66/290 (22%)

Query: 166 TGLTVAVKTLNHDGLQGHKEWL---AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP 222
           T   VAVK +N D     ++      E+     L HPN++  V   I D +  +V   M 
Sbjct: 24  TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82

Query: 223 RGS----LENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD 278
            GS    L+ H F +G   LP      I       L ++H    K  I+R  K S+ILL 
Sbjct: 83  YGSCEDLLKTH-FPEG---LPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLS 135

Query: 279 ADYNAKLSDFGLAKDAPEDGKTHV--------STRVMGTYGYAAPEYV---MTGHLTSKS 327
            D    LS    +    + GK           S + +    + +PE +   + G+   KS
Sbjct: 136 GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPEVLQQNLQGY-NEKS 191

Query: 328 DVYSFGVVLLEMLTG--------RRSMDKNRPNGEHNLVEWAR---PHLGDKRRFYRLLD 376
           D+YS G+   E+  G           M          L+E  R   P L DK  +    D
Sbjct: 192 DIYSVGITACELANGHVPFKDMPATQM----------LLEKVRGTVPCLLDKSTYPLYED 241

Query: 377 PRLEGHFSIKGSQKAT---------------QLAAQCLSRDPKARPRMSE 411
              +   S +                     Q    CL RDP++RP  S+
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 32/219 (14%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 190
           + P + +G G +G V+K            P +G  VA+K++    N DGL      + EV
Sbjct: 2   YEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLP--LSTVREV 50

Query: 191 NFLGNLL---HPNLVKLVGYC--IEDDQRL---LVYEFMPRGSLENHLFRKGSLPLPWSI 242
             L  L    HPN+V+L+  C     D+     LV+E + +  L  +L +     LP   
Sbjct: 51  ALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAET 109

Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
              +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+         +
Sbjct: 110 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQM 162

Query: 303 S-TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
           + T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 23/212 (10%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G V  +G  P +      V VK L     +Q   ++L E     +L H 
Sbjct: 3   IGNGWFGKVILGEVN-SGYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSL--PLPWSIRMKIALGAAKGLA 255
           NL++ +G C E    LLV EF P G L+ +L   RK  L  P P +++ ++A   A GL 
Sbjct: 56  NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEIALGLL 114

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 315
            LH+      I+ D    N LL AD   K+ D+GL+ +  ++       ++     + AP
Sbjct: 115 HLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171

Query: 316 EYV--MTGHL-----TSKSDVYSFGVVLLEML 340
           E V  + G+L     T +S+V+S GV + E+ 
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 49/145 (33%), Positives = 70/145 (48%), Gaps = 20/145 (13%)

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW----SIRMKIALGAAKGLAFLHEEA 261
           Y  +DD+ L +V E+MP G L N L     +P  W    +  + +AL A   + F+H   
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH--- 165

Query: 262 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT- 320
                 RD K  N+LLD   + KL+DFG      ++G     T V GT  Y +PE + + 
Sbjct: 166 ------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQ 218

Query: 321 ---GHLTSKSDVYSFGVVLLEMLTG 342
              G+   + D +S GV L EML G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 10/147 (6%)

Query: 212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK 271
           D+   + + M  G L  HL + G          ++   AA+ +  L     + V+YRD K
Sbjct: 70  DKLSFILDLMNGGDLHYHLSQHGVFS-----EAEMRFYAAEIILGLEHMHNRFVVYRDLK 124

Query: 272 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVY 330
            +NILLD   + ++SD GLA D  +  K H S   +GT+GY APE +  G    S +D +
Sbjct: 125 PANILLDEHGHVRISDLGLACDFSKK-KPHAS---VGTHGYMAPEVLQKGVAYDSSADWF 180

Query: 331 SFGVVLLEMLTGRRSMDKNRPNGEHNL 357
           S G +L ++L G     +++   +H +
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 68/210 (32%), Positives = 96/210 (45%), Gaps = 25/210 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLL 197
           +G+G FG V++           K  T    A+K L+   +   KE    + E N L   L
Sbjct: 1   IGKGTFGQVYQ---------VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL 51

Query: 198 HPNLVKLVG--YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
                 +VG  +  + D  L LV ++M  G L  HL ++G        R K  + A   L
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYI-AELVL 107

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           A  H   +  ++YRD K  NILLDA  +  L DFGL+K    D KT  +    GT  Y A
Sbjct: 108 ALEHLH-KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLA 164

Query: 315 PEYVM--TGHLTSKSDVYSFGVVLLEMLTG 342
           PE ++   G+ T   D +S GV++ EM  G
Sbjct: 165 PEVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 52/154 (33%), Positives = 74/154 (48%), Gaps = 23/154 (14%)

Query: 199 PNLVKLVGYC-IEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW----SIRMKIALGAAK 252
           P +V+L  +C  +DD+ L +V E+MP G L N L     +P  W    +  + +AL A  
Sbjct: 103 PWVVQL--FCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIH 159

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
            +  +H         RD K  N+LLD   + KL+DFG      E G     T V GT  Y
Sbjct: 160 SMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDY 209

Query: 313 AAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 342
            +PE + +    G+   + D +S GV L EML G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 23/226 (10%)

Query: 189 EVNFLGNLLHPNLVKLV-GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
           E   L  L HPN+V     +  ED    +V  F   G L + L  +    LP +  ++  
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           +  A  L +LHE   K +++RD KT N+ L      K+ D G+A+    + +  +++ ++
Sbjct: 109 VQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLI 163

Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y +PE         KSDV++ G  + EM T + + +    N   +LV         
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLV--------- 211

Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
               YR+++ +L        S +  +L A  LS+ P+ RP +  ++
Sbjct: 212 ----YRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 37/220 (16%)

Query: 142 GEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLH 198
           G G +G V+K               G   A+K    D  Q     +    E+  L  L H
Sbjct: 9   GRGTYGRVYKAK-------RKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 199 PNLVKLVGYCIEDDQRL--LVYEFMPRGSLE--NHLFRKGSLPLPWSIRMKIALGAAKGL 254
            N+V LV   +E   +   L++++      +      +   + +P S+   +      G+
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DAP------EDGKTHV 302
            +LH      V++RD K +NIL+  +       K+ D GLA+  +AP       D     
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP---- 174

Query: 303 STRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLT 341
              V+ T  Y APE ++   H T   D+++ G +  E+LT
Sbjct: 175 ---VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 51/159 (32%), Positives = 75/159 (47%), Gaps = 17/159 (10%)

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           +H    K +I+RD K++NILL ++   KL DFG +K         V     GT  Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
                  + K+D++S GV+L E+LT +R  D     GE N+ E     L  +   Y  L 
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GE-NMEEVMHKTLAGR---YDPLP 266

Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 415
           P +        S +  ++    LS DPK RP  S+++  
Sbjct: 267 PSI--------SPEMQEIVTALLSSDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 60/177 (33%), Positives = 81/177 (45%), Gaps = 13/177 (7%)

Query: 171 AVKTLNHDGLQGHKE---WLAEVN-FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 226
           AVK L    +   KE    ++E N  L N+ HP LV L       D+   V +++  G L
Sbjct: 24  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83

Query: 227 ENHLFRKGSLPLPWSIRMKI-ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 285
             HL R+     P   R +  A   A  L +LH      ++YRD K  NILLD+  +  L
Sbjct: 84  FYHLQRERCFLEP---RARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVL 137

Query: 286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           +DFGL K+  E   T  ++   GT  Y APE +         D +  G VL EML G
Sbjct: 138 TDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 51/169 (30%), Positives = 72/169 (42%), Gaps = 18/169 (10%)

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
           A+G+ FL   A +  I+RD    NILL  +   K+ DFGLA+D  +D             
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 370
            + APE +     T++SDV+SFGV+L E+ +   S     P  + N     R   G + R
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS---PYPGVQINEEFCQRLKDGTRMR 297

Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                 P +              +   C   DPK RP  S +VE L  L
Sbjct: 298 APENATPEIYR------------IMLACWQGDPKERPTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 22/207 (10%)

Query: 141 LGEGGFGCVFKGW--VEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLL 197
           LGEG +  VFKG   + EN            VA+K +  +  +G     + EV+ L +L 
Sbjct: 14  LGEGTYATVFKGRSKLTEN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           H N+V L      D    LV+E++ +  L+ ++   G++    ++++ +     +GLA+ 
Sbjct: 63  HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYC 120

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 317
           H    + V++RD K  N+L++     KL+DFGLA+      KT+ +  V  T  Y  P+ 
Sbjct: 121 HR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV 175

Query: 318 VM-TGHLTSKSDVYSFGVVLLEMLTGR 343
           ++ +   +++ D++  G +  EM +GR
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 39/217 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGNLLH 198
           +GEG +G VFK    E         T   VA+K   L+ D        L E+  L  L H
Sbjct: 8   IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMP----------RGSLENHLFRKGSLPLPWSIRMKIAL 248
            N+V+L      D +  LV+E+             G ++  + +     L          
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL---------- 108

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
              KGLAF H      V++RD K  N+L++ +   KL+DFGLA+      + + S  V+ 
Sbjct: 109 --LKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV- 161

Query: 309 TYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRR 344
           T  Y  P+ +    L S S D++S G +  E+    R
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 61.7 bits (149), Expect = 1e-10
 Identities = 80/292 (27%), Positives = 119/292 (40%), Gaps = 43/292 (14%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F    L+G G +G V+KG         VK  TG   A+K ++  G +  +E   E+N L 
Sbjct: 8   FELVELVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTGDE-EEEIKQEINMLK 57

Query: 195 NLLH-PNLVKLVGYCIE------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
              H  N+    G  I+      DDQ  LV EF   GS+ + +       L       I 
Sbjct: 58  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
               +GL+ LH+     VI+RD K  N+LL  +   KL DFG++  A  D         +
Sbjct: 118 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI 172

Query: 308 GTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 362
           GT  + APE +            KSD++S G+  +EM  G   +    P     L+    
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--- 229

Query: 363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R   PRL+   S K S+K       CL ++   RP   ++++
Sbjct: 230 ----------RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 37/114 (32%), Positives = 57/114 (50%), Gaps = 3/114 (2%)

Query: 232 RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 291
            + S PL     ++ +   A+G+ FL   A K  I+RD    N+LL     AK+ DFGLA
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259

Query: 292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 345
           +D   D    V         + APE +     T +SDV+S+G++L E+ +  +S
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 66/226 (29%), Positives = 99/226 (43%), Gaps = 44/226 (19%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFL 193
             +GEG +G V+K              TG  VA+K +    L   KE      + E+  L
Sbjct: 13  GQIGEGTYGQVYKA---------RDKDTGELVALKKVR---LDNEKEGFPITAIREIKIL 60

Query: 194 GNLLHPNLVKLVGYCIEDDQRL----------LVYEFMPR---GSLENHL--FRKGSLPL 238
             L H N+V L     +    L          LV+E+M     G LE+ L  F +  +  
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK- 119

Query: 239 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 298
             S  MK  L   +GL + H+   K  ++RD K SNILL+     KL+DFGLA+    + 
Sbjct: 120 --SF-MKQLL---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
               + +V+ T  Y  PE ++       + DV+S G +L E+ T +
Sbjct: 171 SRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 32/243 (13%)

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
           +E++ L    H  +VK       DD+ LL+ E+   G L   + ++    LP+    ++ 
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L   + +  L E   + +++RD K++NI L      KL DFG +K   +     V++   
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232

Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y APE       + K+D++S GV+L E+LT                    RP  G 
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLT------------------LHRPFKGP 274

Query: 368 KRR------FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPL 419
            +R       Y   DP     F    S     L    LS++P  RP   +++ T  LK +
Sbjct: 275 SQREIMQQVLYGKYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329

Query: 420 QNL 422
            NL
Sbjct: 330 ANL 332

Length = 478

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 47/219 (21%)

Query: 143 EGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGNLL 197
           EG +G V++   ++         TG  VA+K L  +     KE      L E+N L  L 
Sbjct: 15  EGTYGVVYRARDKK---------TGEIVALKKLKMEK---EKEGFPITSLREINILLKLQ 62

Query: 198 HPNLVKL----VGYCIEDDQRLLVYEFMP---RGSLENHLFRKGSLPLPWSIR-----MK 245
           HPN+V +    VG  +  D+  +V E++    +  +E           P+        M 
Sbjct: 63  HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM-------KQPFLQSEVKCLML 113

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
             L    G+A LH+     +++RD KTSN+LL+     K+ DFGLA++     K +  T+
Sbjct: 114 QLL---SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQ 165

Query: 306 VMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
           ++ T  Y APE ++     ++  D++S G +  E+LT +
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 5/93 (5%)

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           +GL +LH      +++RD K  N+L++++   K+ DFGLA+    D   H++  V+  Y 
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169

Query: 312 YAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
           Y APE +M + H TS  D++S G +  E+L  R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 61/227 (26%), Positives = 91/227 (40%), Gaps = 23/227 (10%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F     LG G FG V          A  K      VA+K      +   K+   
Sbjct: 26  KMKYEDFNFIRTLGTGSFGRVI--------LATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77

Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
             +E   L  + HP  V L G   ++    LV EF+  G     L R    P        
Sbjct: 78  VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP------ND 131

Query: 246 IALGAAKGLAFLHEEAEK-PVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
           +    A  +  + E  +   ++YRD K  N+LLD D   K++DFG AK    D +T+   
Sbjct: 132 VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYT-- 187

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
            + GT  Y APE ++       +D ++ G+ + E+L G      N P
Sbjct: 188 -LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 51/149 (34%), Positives = 76/149 (51%), Gaps = 14/149 (9%)

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA-AKGLAF 256
           P LV L  Y  + D +L L+ +++  G L  HL ++          ++I  G     L  
Sbjct: 65  PFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEH 120

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           LH+     +IYRD K  NILLD++ +  L+DFGL+K+  ED +   +    GT  Y AP+
Sbjct: 121 LHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-EVERAYSFCGTIEYMAPD 176

Query: 317 YVM---TGHLTSKSDVYSFGVVLLEMLTG 342
            V     GH     D +S GV++ E+LTG
Sbjct: 177 IVRGGDGGH-DKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 18/168 (10%)

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP------LPWSI 242
           EV  L  + HPN+V       E+ +  +V E+   G L   + R+  +       L W +
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108

Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTH 301
             +I+LG    L  +H+   + +++RD K+ NI L  +   AKL DFG+A+    +    
Sbjct: 109 --QISLG----LKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSME 157

Query: 302 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 349
           ++   +GT  Y +PE        +K+D++S G VL E+ T +   + N
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 24/218 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           NF    +LG G +G VF   V +         TG   A+K L    L    + +      
Sbjct: 1   NFELLKVLGTGAYGKVF--LVRKVT----GHDTGKLYAMKVLQKAALVQKAKTVEHTRTE 54

Query: 194 GNLLH-----PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            N+L      P LV L  Y  + + +L L+ +++  G +  HL+++ +        ++  
Sbjct: 55  RNVLEHVRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFY 110

Query: 248 LGAA-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
            G     L  LH+     ++YRD K  NILLD++ +  L+DFGL+K+   + K    +  
Sbjct: 111 SGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-F 166

Query: 307 MGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEMLTG 342
            GT  Y APE +    GH     D +S G+++ E+LTG
Sbjct: 167 CGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 50/169 (29%), Positives = 69/169 (40%), Gaps = 18/169 (10%)

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
           AKG+ FL   A +  I+RD    NILL  +   K+ DFGLA+D  +D             
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 370
            + APE +     T +SDV+SFGV+L E+ +               L     P +     
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------------LGASPYPGVKIDEE 290

Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           F R L            + +  Q    C   +P  RP  SE+VE L  L
Sbjct: 291 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 77/281 (27%), Positives = 123/281 (43%), Gaps = 48/281 (17%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGNL 196
           LG+G F  ++KG    ++    V PG  ++V +K L       H++ LA     + +  L
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLA 255
            H +LVKL G C+  D+ ++V E++  G L+  L R K ++ L W  ++ +A   A  L 
Sbjct: 59  SHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALH 115

Query: 256 FLHEEAEKPVIYRDFKTSNILL-DADYN------AKLSDFGLAKDAPEDGKTHVSTRVMG 308
           +L    +K +++ +    NIL+     N       KLSD G+              RV  
Sbjct: 116 YLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-----TVLSREERVER 167

Query: 309 TYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
              + APE +  G   LT  +D +SFG  LLE+ +          NGE  L   +     
Sbjct: 168 I-PWIAPECIRNGQASLTIAADKWSFGTTLLEICS----------NGEEPLSTLSS---S 213

Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
           +K RFY     + +    +    +   L  QC + DP  RP
Sbjct: 214 EKERFY-----QDQHRLPMPDCAELANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 46/223 (20%)

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS-LPLPWSIRMKIALGAAKGLAF 256
           H ++V L G C+ D + ++V EF+  G L+  + RK   L  PW  + K+A   A  L++
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 257 LHEEAEKPVIYRDFKTSNILL-----DADYNA--KLSDFGLAKDAPEDGKTHVSTR--VM 307
           L    +K +++ +  T NILL     D +     KLSD G+           V +R   +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQECV 169

Query: 308 GTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
               + APE V  + +L+  +D +SFG  L E+            NGE  L +     L 
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY----------NGEIPLKD---KTLA 216

Query: 367 DKRRFYRLLDPRLEGHFSI--KGSQKATQLAAQCLSRDPKARP 407
           +K RFY       EG   +     ++   L   C++ DP  RP
Sbjct: 217 EKERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 18/205 (8%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LGEG +  V+KG    NG           VA+K ++    +G     + E + L  L H 
Sbjct: 13  LGEGSYATVYKGISRINGQ---------LVALKVISMKTEEGVPFTAIREASLLKGLKHA 63

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+V L       +    V+E+M     +  +   G L  P+++R+       +GLA++H 
Sbjct: 64  NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH-PYNVRL-FMFQLLRGLAYIHG 121

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
           +    +++RD K  N+L+      KL+DFGLA+      +T+ S  V  T  Y  P+ ++
Sbjct: 122 QH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176

Query: 320 -TGHLTSKSDVYSFGVVLLEMLTGR 343
                +S  D++  G + +EML G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 59.8 bits (145), Expect = 8e-10
 Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 16/182 (8%)

Query: 166 TGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMP 222
           TG  VA+K +          K    E+  L +L H N++ L    I   + +  V E + 
Sbjct: 34  TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92

Query: 223 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN 282
            G+  + L      PL             +GL ++H      V++RD K SNIL++ + +
Sbjct: 93  -GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCD 146

Query: 283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLT 341
            K+ DFGLA+        +VSTR      Y APE ++T      + D++S G +  EML 
Sbjct: 147 LKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE 201

Query: 342 GR 343
           G+
Sbjct: 202 GK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.4 bits (144), Expect = 9e-10
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           +GEG +G V+K              T  T+A+K +    L+   E      + E++ L  
Sbjct: 10  IGEGTYGVVYKARDRV---------TNETIALKKIR---LEQEDEGVPSTAIREISLLKE 57

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
           + H N+V+L      + +  LV+E++    L+ H+           +         +G+A
Sbjct: 58  MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAK--DAPEDGKTHVSTRVMGTYGY 312
           + H      V++RD K  N+L+D   NA KL+DFGLA+    P    TH       T  Y
Sbjct: 117 YCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWY 169

Query: 313 AAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
            APE ++ + H ++  D++S G +  EM+  +
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 24/170 (14%)

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
           AKG++FL   A K  I+RD    NILL      K+ DFGLA+D   D    V        
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 370
            + APE +     T +SDV+S+G++L E+ +               L     P +    +
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS---------------LGSSPYPGMPVDSK 325

Query: 371 FYRLLDPRLEGH--FSIKGS-QKATQLAAQCLSRDPKARPRMSEVVETLK 417
           FY+++    EG+   S + +  +   +   C   DP  RP   ++V+ ++
Sbjct: 326 FYKMIK---EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 9/93 (9%)

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182

Query: 312 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 55/197 (27%), Positives = 83/197 (42%), Gaps = 38/197 (19%)

Query: 233 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
               PL     +  +   A+G+ FL   A +  I+RD    NILL  +   K+ DFGLA+
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221

Query: 293 DAPED------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 346
           D  +D      G   +  + M      APE +     T++SDV+SFGV+L E+ +     
Sbjct: 222 DIYKDPDYVRKGDARLPLKWM------APESIFDKVYTTQSDVWSFGVLLWEIFS----- 270

Query: 347 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT----QLAAQCLSRD 402
                     L     P +     F R    RL+    ++  + AT     +   C   +
Sbjct: 271 ----------LGASPYPGVQIDEEFCR----RLKEGTRMRAPEYATPEIYSIMLDCWHNN 316

Query: 403 PKARPRMSEVVETLKPL 419
           P+ RP  SE+VE L  L
Sbjct: 317 PEDRPTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 9/93 (9%)

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           KGL ++H      +I+RD K  N+ ++ D   K+ DFGLA+    +   +V TR      
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180

Query: 312 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           Y APE ++   H T   D++S G ++ EMLTG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            GL ++H      +I+RD K  N+ ++ D   K+ DFGLA+ A  +   +V TR      
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179

Query: 312 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           Y APE ++   H     D++S G ++ EMLTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHK-EWLAEVNFLGNLL 197
           LGEG +  V+KG  +  G           VA+K   L H+  +G     + E + L +L 
Sbjct: 13  LGEGSYATVYKGRSKLTGQL---------VALKEIRLEHE--EGAPFTAIREASLLKDLK 61

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           H N+V L           LV+E++    L+ ++   G      ++R+       +GLA+ 
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRL-FLFQLLRGLAYC 119

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 317
           H+   + V++RD K  N+L+      KL+DFGLA+      KT+ +  V  T  Y  P+ 
Sbjct: 120 HQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDV 174

Query: 318 VM--TGHLTSKSDVYSFGVVLLEMLTGR 343
           ++  T + TS  D++  G +  EM TGR
Sbjct: 175 LLGSTEYSTS-LDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LGEG +  V+KG  +          T   VA+K +  +  +G     + EV+ L +L H 
Sbjct: 14  LGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+V L      +    LV+E++ +  L+ +L   G+     ++++ +     +GL + H 
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHR 122

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
              + V++RD K  N+L++     KL+DFGLA+      KT+ +  V  T  Y  P+ ++
Sbjct: 123 ---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILL 177

Query: 320 -TGHLTSKSDVYSFGVVLLEMLTGR 343
            +   +++ D++  G +  EM TGR
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 68/256 (26%), Positives = 103/256 (40%), Gaps = 69/256 (26%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNF 192
           +F    ++G G FG V             K  TG   A+K L   + L+  KE +A V  
Sbjct: 2   DFESIKVIGRGAFGEV---------RLVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRA 50

Query: 193 LGNLL----HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKI- 246
             ++L    +P +VKL  Y  +D+  L L+ E++P G +   L +K +     + R  I 
Sbjct: 51  ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET-RFYIA 108

Query: 247 ----ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL------------ 290
               A+ +   L ++H         RD K  N+LLDA  + KLSDFGL            
Sbjct: 109 ETILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159

Query: 291 ----AKDAPEDGKTHVST---------------RVM-----GTYGYAAPEYVMTGHLTSK 326
               +   P +    +S                R +     GT  Y APE  +      +
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE 219

Query: 327 SDVYSFGVVLLEMLTG 342
            D +S GV++ EML G
Sbjct: 220 CDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 43/222 (19%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           ++    +GEG F  V K    + G            A+K +       H + L +VN L 
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGK---------YYAIKCMKK-----HFKSLEQVNNLR 46

Query: 195 NLL-------HPNLVKLVGYCIEDDQ--RL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
            +        HPN+++L+   + D +  RL LV+E M     E  L +    PLP     
Sbjct: 47  EIQALRRLSPHPNILRLIE-VLFDRKTGRLALVFELMDMNLYE--LIKGRKRPLPEKRVK 103

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK----T 300
                  K L  +H      + +RD K  NIL+  D   KL+DFG  +      K     
Sbjct: 104 SYMYQLLKSLDHMHR---NGIFHRDIKPENILIK-DDILKLADFGSCRGI--YSKPPYTE 157

Query: 301 HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLT 341
           ++STR      Y APE ++T G+   K D+++ G V  E+L+
Sbjct: 158 YISTR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 61/259 (23%), Positives = 106/259 (40%), Gaps = 37/259 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTLNHD-GLQGHKEWLAEVNFLGNLLH 198
           +G G FG V            +   TG+  V VK L  +   +   E+L + +    L H
Sbjct: 3   IGNGWFGKVLLS--------EIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH 54

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGAAK 252
           PN+++ +G C+E    LLV+E+   G L+++L       R   L L      ++A   A 
Sbjct: 55  PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL----LQRMACEIAA 110

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  +H+      ++ D    N  L +D   K+ D+G+     ++              +
Sbjct: 111 GVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167

Query: 313 AAPEYV-------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
            APE V       +T   T  S+V++ GV L E+        +N      +L +    + 
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF-------ENAAQPYSHLSDREVLNH 220

Query: 366 GDKRRFYRLLDPRLEGHFS 384
             K +  +L  P+LE  +S
Sbjct: 221 VIKDQQVKLFKPQLELPYS 239

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 29/208 (13%)

Query: 218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL 277
           Y+      ++N L   GS  L     +      A+G+ FL   A K  ++RD    N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270

Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL 337
                 K+ DFGLA+D   D              + APE +     T+ SDV+S+G++L 
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330

Query: 338 EMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQ---- 393
           E+ +               L     P +     FY     +++  + +     ATQ    
Sbjct: 331 EIFS---------------LGGTPYPGMIVDSTFYN----KIKSGYRMAKPDHATQEVYD 371

Query: 394 LAAQCLSRDPKARPR---MSEVVETLKP 418
           +  +C + +P+ RP    +S++VE+L P
Sbjct: 372 IMVKCWNSEPEKRPSFLHLSDIVESLLP 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 33/224 (14%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
              + P   +G G +G V          +     T   VA+K + +  D     K  L E
Sbjct: 4   DTKYVPIKPIGRGAYGIV---------CSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE 54

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHLFRKGSLPLPWSIR 243
           +  L +L H N++ +    +    R       +VYE M     + H   + S  L     
Sbjct: 55  IKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHC 110

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK---T 300
                   +GL ++H      V++RD K SN+LL+A+ + K+ DFGLA+   E G     
Sbjct: 111 QYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE 167

Query: 301 HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 343
           +V TR      Y APE ++     T+  DV+S G +  E+L  +
Sbjct: 168 YVVTR-----WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 38/235 (16%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           DL     + RP   LG G  G VF         + V       VAVK +     Q  K  
Sbjct: 2   DLGSRYMDLRP---LGCGSNGLVF---------SAVDSDCDKRVAVKKIVLTDPQSVKHA 49

Query: 187 LAEVNFLGNLLHPNLVKL--------------VGYCIEDDQRLLVYEFMPRGSLENHLFR 232
           L E+  +  L H N+VK+              VG   E +   +V E+M    L N +  
Sbjct: 50  LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLAN-VLE 107

Query: 233 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLA 291
           +G L      R+       +GL ++H      V++RD K +N+ ++  D   K+ DFGLA
Sbjct: 108 QGPLSEEH-ARL-FMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLA 162

Query: 292 K--DAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 343
           +  D     K ++S  ++  + Y +P  +++  + T   D+++ G +  EMLTG+
Sbjct: 163 RIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 84/297 (28%), Positives = 127/297 (42%), Gaps = 63/297 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNLL-H 198
           +G+G +G V+K   +++G+           AVK L  D +    E + AE N L +L  H
Sbjct: 30  IGKGTYGKVYKVTNKKDGS---------LAAVKIL--DPISDVDEEIEAEYNILQSLPNH 78

Query: 199 PNLVKLVGYCIEDD-----QRLLVYEFMPRGS---LENHLFRKGSLPLPWSIRMKIALGA 250
           PN+VK  G   + D     Q  LV E    GS   L   L   G   L  ++   I  GA
Sbjct: 79  PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYGA 137

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV---- 306
             GL  LH      +I+RD K +NILL  +   KL DFG++           STR+    
Sbjct: 138 LLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQL-------TSTRLRRNT 187

Query: 307 -MGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
            +GT  + APE +           ++ DV+S G+  +E+  G   +    P     L + 
Sbjct: 188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLFKI 245

Query: 361 AR---PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
            R   P L    ++ R  +     HF            +QCL +D +ARP ++ ++E
Sbjct: 246 PRNPPPTLLHPEKWCRSFN-----HF-----------ISQCLIKDFEARPSVTHLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 77/292 (26%), Positives = 118/292 (40%), Gaps = 43/292 (14%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F    ++G G +G V+KG         VK  TG   A+K ++    +  +E   E+N L 
Sbjct: 18  FELVEVVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTEDE-EEEIKLEINMLK 67

Query: 195 NLLH-PNLVKLVGYCIE------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
              H  N+    G  I+      DDQ  LV EF   GS+ + +       L       I 
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
               +GLA LH      VI+RD K  N+LL  +   KL DFG++  A  D         +
Sbjct: 128 REILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI 182

Query: 308 GTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 362
           GT  + APE +            +SD++S G+  +EM  G   +    P     L+    
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 242

Query: 363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           P             P+L+   S K S+K       CL ++  +RP   ++++
Sbjct: 243 P-------------PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 80/290 (27%), Positives = 124/290 (42%), Gaps = 49/290 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGNLL- 197
           +G+G +G VFK   ++NG+           AVK L+  HD     +E  AE N L  L  
Sbjct: 26  IGKGTYGKVFKVLNKKNGS---------KAAVKILDPIHDI---DEEIEAEYNILKALSD 73

Query: 198 HPNLVKLVG-YCIED----DQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIALGA 250
           HPN+VK  G Y  +D    DQ  LV E    GS+ + +  F K    +   I   I   A
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
             GL  LH       I+RD K +NILL  +   KL DFG++  A            +GT 
Sbjct: 134 LMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTP 188

Query: 311 GYAAPEYV-----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
            + APE +     +     ++ DV+S G+  +E+  G   +    P              
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------------- 234

Query: 366 GDKRRFYRL-LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
              R  +++  +P    H     S +      +CL++D + RP +S++++
Sbjct: 235 --MRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 7/158 (4%)

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           E + L  + HP++++L G    +    L+   +PR   + + +      +     + I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
              + + +LHE     +I+RD K  NI ++   +  L DFG A   P D   +      G
Sbjct: 190 SVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 346
           T    APE +         D++S G+VL EM T   S+
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 34/212 (16%)

Query: 141 LGEGGFGCVF----KGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGN 195
           LG+G FG V+    K  V E     +K      + V  LN ++ +Q ++E       L  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLK-----EIPVGELNPNETVQANQE----AQLLSK 58

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLP------WSIRMKIA 247
           L HP +VK     +E D   ++ E+     L+  L   +     L       W I++ + 
Sbjct: 59  LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL- 117

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
                G+ ++H+   + +++RD K  NI L  +   K+ DFG+++     G   ++T   
Sbjct: 118 -----GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTFT 166

Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 339
           GT  Y +PE +      SKSD++S G +L EM
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 77/302 (25%), Positives = 118/302 (39%), Gaps = 57/302 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           +G+G FG VFK        A  K  T   VA+K +    ++  KE      L E+  L  
Sbjct: 20  IGQGTFGEVFK--------ARHKK-TKQIVALKKVL---MENEKEGFPITALREIKILQL 67

Query: 196 LLHPNLVKLVGYCIEDDQR--------LLVYEFMPR--GSLENHLFRKGSLPLPWSIRMK 245
           L H N+V L+  C               LV+EF       L ++   K +L     + MK
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV-MK 126

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVS 303
           + L    GL ++H      +++RD K +NIL+  D   KL+DFGLA+     ++ K +  
Sbjct: 127 MLL---NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 304 TRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE--- 359
           T  + T  Y  PE ++         D++  G ++ EM T    M  N    +  L+    
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240

Query: 360 -------W---ARPHLGDKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 405
                  W    +  L  K        R +  RL+ +        A  L  + L  DP  
Sbjct: 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVK---DPHALDLIDKLLVLDPAK 297

Query: 406 RP 407
           R 
Sbjct: 298 RI 299

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 17/167 (10%)

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSL-----PLPWSI 242
           E   L  + HPN+V        D    +V E+   G L   +  ++G L      L W +
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107

Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           +M +      G+  +HE   K V++RD K+ NI L  +   KL DFG A+     G  + 
Sbjct: 108 QMCL------GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYA 157

Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 349
            T V GT  Y  PE        +KSD++S G +L E+ T +     N
Sbjct: 158 CTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 9/93 (9%)

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           +GL ++H      +I+RD K SN+ ++ D   ++ DFGLA+ A ++   +V+TR      
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180

Query: 312 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           Y APE ++   H     D++S G ++ E+L G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 35/102 (34%), Positives = 59/102 (57%), Gaps = 9/102 (8%)

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGT 309
           GL ++H      V++RD K  N+L++AD   K+ DFGLA+   + P +    + T  + T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172

Query: 310 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNR 350
             Y APE +++    +K+ DV+S G +L E+L GR+ + K +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 36/219 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK----TLNHDGLQGHKEWLAEVNFLGNL 196
           +GEG +G V+K              TG  VA+K     ++ +G+      L E++ L  L
Sbjct: 9   IGEGTYGKVYKA---------RDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQML 57

Query: 197 LH-PNLVKL--VGYCIEDDQRL---LVYEFMPRGSLENHL---FRKGSLPLPWSIRMKIA 247
                +V+L  V +  E + +    LV+E++    L+  +    R    PLP        
Sbjct: 58  SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFM 116

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAK--DAPEDGKTHVST 304
               KG+A  H+     V++RD K  N+L+D      K++D GL +    P    TH   
Sbjct: 117 YQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH--- 170

Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTG 342
             + T  Y APE ++   H ++  D++S G +  EM   
Sbjct: 171 -EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 54.3 bits (130), Expect = 7e-08
 Identities = 48/174 (27%), Positives = 69/174 (39%), Gaps = 47/174 (27%)

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAKGLAFLHEEA 261
           Y  +D + L L+ EF+P G +   L +K +L       +     +A+ A   L F+H   
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH--- 124

Query: 262 EKPVIYRDFKTSNILLDADYNAKLSDFGL----------------AKDAPED-------- 297
                 RD K  N+LLDA  + KLSDFGL                  + P D        
Sbjct: 125 ------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 298 ---------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
                     +  ++   +GT  Y APE  M        D +S GV++ EML G
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 54.0 bits (130), Expect = 8e-08
 Identities = 58/218 (26%), Positives = 88/218 (40%), Gaps = 53/218 (24%)

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           AE + L    +  +VKL  Y  +D   L  V +++P G + + L R G      + R  I
Sbjct: 50  AERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-RFYI 107

Query: 247 ALGAAKGLAFLHEEAEK-PVIYRDFKTSNILLDADYNAKLSDFGLA-------------- 291
           A      L    E   K   I+RD K  NIL+D D + KL+DFGL               
Sbjct: 108 A-----ELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQK 162

Query: 292 -----KDA--PEDGKTHVSTRVM--------------------GTYGYAAPEYVM-TGHL 323
                +D+  P +  + +    +                    GT  Y APE ++ TG+ 
Sbjct: 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY- 221

Query: 324 TSKSDVYSFGVVLLEMLTGRRSMDKNRPNG-EHNLVEW 360
           T   D +S GV+L EML G+     + P   +  ++ W
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 64/280 (22%), Positives = 113/280 (40%), Gaps = 38/280 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G +G V+K              TG   A+K +  +  +       E+  + +  H N
Sbjct: 17  IGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +V   G  +  D+  +  EF   GSL++     G  PL  S    ++    +GL +LH +
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK 125

Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
            +   ++RD K +NILL  + + KL+DFG++  A            +GT  + APE    
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 321 ---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV---EWARPHLGDKRRFYRL 374
              G      D+++ G+  +E+   +  M    P     L+    +  P L DK      
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK------ 234

Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     +K S          L+++PK RP   ++++
Sbjct: 235 ----------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 74/313 (23%), Positives = 110/313 (35%), Gaps = 53/313 (16%)

Query: 52  RFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAES--ASSTPK 109
           R +E   P+   +    +      A    S  +  D      S      A    A   P 
Sbjct: 81  RALEDAAPAGELLVPRSNADLFASAGDGPSGAEDSD-----ASHLDFDEAPPDAAGPVPL 135

Query: 110 FSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFG----CVFKGWVEE-------NG 158
              +LK   +              +FR    L  G FG    C  +   EE       N 
Sbjct: 136 AQAKLKHDDEF-----------LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNS 184

Query: 159 TAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKL--------VGYCIE 210
           T   KP     +A +           E   E+  LG L H N++K+          Y I 
Sbjct: 185 TNQGKPKCERLIAKRVKAGSRAAIQLE--NEILALGRLNHENILKIEEILRSEANTYMIT 242

Query: 211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--MKIALGAAKGLAFLHEEAEKPVIYR 268
                 +Y FM   + +     K   PL    R  MK  L A   + ++H+   K +I+R
Sbjct: 243 QKYDFDLYSFMYDEAFD----WKDR-PLLKQTRAIMKQLLCA---VEYIHD---KKLIHR 291

Query: 269 DFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSD 328
           D K  NI L+ D    L DFG A    E  +       +GT    +PE +        +D
Sbjct: 292 DIKLENIFLNCDGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITD 350

Query: 329 VYSFGVVLLEMLT 341
           ++S G++LL+ML+
Sbjct: 351 IWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 55/226 (24%), Positives = 112/226 (49%), Gaps = 36/226 (15%)

Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV 190
             ++++  +++G G FG V++          +   T   VA+K +  D    ++E L   
Sbjct: 64  PNKSYKLGNIIGNGSFGVVYEA---------ICIDTSEKVAIKKVLQDPQYKNRELL--- 111

Query: 191 NFLGNLLHPNLVKLVGY----CIEDDQRLL----VYEFMPRGSLENHL--FRKGSLPLPW 240
             + NL H N++ L  Y    C + +++ +    V EF+P+ ++  ++  + + +  LP 
Sbjct: 112 -IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPL 169

Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKD--APED 297
            +    +    + LA++H    K + +RD K  N+L+D + +  KL DFG AK+  A + 
Sbjct: 170 FLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226

Query: 298 GKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTG 342
             +++ +R      Y APE ++   + T+  D++S G ++ EM+ G
Sbjct: 227 SVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 3/91 (3%)

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
           A G+ FL   A K  ++RD    N+L+      K+ DFGLA+D   D             
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            + APE +     T+ SDV+SFG++L E+ T
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 32/187 (17%)

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEML------TGRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 303

Query: 408 RMSEVVE 414
            + E ++
Sbjct: 304 SVDEALQ 310

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 50/204 (24%), Positives = 97/204 (47%), Gaps = 18/204 (8%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LGEG +  V+KG  + NG           VA+K +     +G     + E + L  L H 
Sbjct: 13  LGEGSYATVYKGKSKVNGK---------LVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+V L       +   LV+E++     +      G L  P ++++ +     +GL+++H+
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLH-PENVKLFL-FQLLRGLSYIHQ 121

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
              + +++RD K  N+L+      KL+DFGLA+   +   +H  +  + T  Y  P+ ++
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 320 -TGHLTSKSDVYSFGVVLLEMLTG 342
            +   ++  D++  G + +EM+ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 17/211 (8%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEW-LAEVNF 192
           F    ++GEG +G V K   +E         T   VA+K   + +  +  KE  L E+  
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKM 53

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
           L  L   N+V+L        +  LV+E++ +  LE  L    +   P  +R  I     K
Sbjct: 54  LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYI-YQLIK 111

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
            + + H+     +++RD K  N+L+  +   KL DFG A++  E G     T  + T  Y
Sbjct: 112 AIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWY 167

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
            +PE ++        D++S G +L E+  G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 183

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
            APE ++        D++S G ++ EM+ G 
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 53/177 (29%), Positives = 74/177 (41%), Gaps = 29/177 (16%)

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP------WSIRMKIALGAAKGLAFLHE 259
           Y  +D+  L LV ++   G L   L  K    LP      +   M IA+ +   L ++H 
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH- 125

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                   RD K  NIL+D + + +L+DFG      EDG    S  V GT  Y +PE + 
Sbjct: 126 --------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQ 176

Query: 320 T-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
                 G    + D +S GV + EML G        P    +LVE     +  K RF
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMNHKERF 227

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
            APE ++        D++S G ++ EM+ G 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 42/151 (27%), Positives = 70/151 (46%), Gaps = 20/151 (13%)

Query: 207 YCIEDDQRLL--VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKP 264
           +C  + +R L  V E++  G     L   G+LP+  + RM  A      L +LH      
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA-RMYFA-ETVLALEYLHNYG--- 121

Query: 265 VIYRDFKTSNILLDADYNAKLSDFGLAK-------------DAPEDGKTHVSTRVMGTYG 311
           +++RD K  N+L+ +  + KL+DFGL+K                +D +  +  +V GT  
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           Y APE ++        D ++ G++L E L G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 26/222 (11%)

Query: 141 LGEGGFGCVFKGWVEENGT----APVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGN 195
           LGEG +G V K +    G       VK         K     G+ G H   L E+  +  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK-IALGAAKGL 254
           + H N++ LV   +E D   LV + M    L+  + RK  L      ++K I L    GL
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTES---QVKCILLQILNGL 132

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--------DAPEDGKTHVSTRV 306
             LH+      ++RD   +NI +++    K++DFGLA+        D     +T      
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 307 MG----TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
           M     T  Y APE +M         D++S G +  E+LTG+
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 42/149 (28%), Positives = 65/149 (43%), Gaps = 22/149 (14%)

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFR-----KGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           Y  +D   L LV E+ P G L + L R        +   +   + +A+ +   + ++H  
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH-- 125

Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
                  RD K  N+L+D   + KL+DFG A     +     S   +GT  Y APE + T
Sbjct: 126 -------RDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTT 177

Query: 321 GHLTSKS------DVYSFGVVLLEMLTGR 343
            +   K       D +S GV+  EM+ GR
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 48/174 (27%), Positives = 69/174 (39%), Gaps = 47/174 (27%)

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAKGLAFLHEEA 261
           Y  +D   L L+ EF+P G +   L +K +L       +     +A+ +   L F+H   
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH--- 124

Query: 262 EKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDA-------------PED-------- 297
                 RD K  N+LLD+  + KLSDFGL    K A             P D        
Sbjct: 125 ------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 298 ---------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
                     +  ++   +GT  Y APE  M        D +S GV++ EML G
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A  +    + T  + T  Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYY 188

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++        D++S G ++ E++ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 46/232 (19%)

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAF 256
           H +L  + G C+   + ++V EF+  G L+  L + KG +P+ W  ++ +A   A  L++
Sbjct: 75  HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSY 132

Query: 257 LHEEAEKPVIYRDFKTSNILLD----ADYNA---KLSDFGLAKDAPEDGKTHVSTRVMGT 309
           L    +K +++ +    NILL     A+  +   KLSD G++  A    +     R+   
Sbjct: 133 LE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS--REERVERI--- 184

Query: 310 YGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
             + APE V  G  L++ +D +SFG  LLE+            +GE  L E       +K
Sbjct: 185 -PWIAPECVPGGNSLSTAADKWSFGTTLLEICF----------DGEVPLKERTPS---EK 230

Query: 369 RRFY----RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
            RFY    RL +P           ++   L +QCL+ +P  RP    ++  L
Sbjct: 231 ERFYEKKHRLPEP---------SCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 63/297 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G F  +FKG   E G       T   V +K L+       + +    + +  L H +
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKT--EVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKGLAF-LH 258
           LV   G C+  D+ ++V E++  GSL+ +L +  +L  + W       L  AK LA+ LH
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALH 114

Query: 259 EEAEKPVIYRDFKTSNILLDADYNA--------KLSDFG-----LAKDAPEDGKTHVSTR 305
              +K + + +    N+LL  + +         KLSD G     L K+   +       R
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-------R 167

Query: 306 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
           +     +  PE +    +L+  +D +SFG  L E+ +G      ++P    + ++  +  
Sbjct: 168 I----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKP---LSALDSQK-- 213

Query: 365 LGDKRRFY--RLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 416
              K +FY  R   P          + K T+LA    QC+  +P  RP    ++  L
Sbjct: 214 ---KLQFYEDRHQLP----------APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 65/256 (25%), Positives = 96/256 (37%), Gaps = 72/256 (28%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL---AEVNFLGNLL 197
           LG G FG V             K  T    A+KTL    +    +     AE + L    
Sbjct: 9   LGIGAFGEV---------CLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD 59

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAK 252
           +  +VKL  Y  +D   L  V +++P G + + L R    P      +   + +A+ +  
Sbjct: 60  NEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA-------------------KD 293
            + F+H         RD K  NIL+D D + KL+DFGL                    +D
Sbjct: 119 KMGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169

Query: 294 A--PEDGKTHVST------------------------RVMGTYGYAAPEYVMTGHLTSKS 327
           +  P D    VS                          ++GT  Y APE ++    T   
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229

Query: 328 DVYSFGVVLLEMLTGR 343
           D +S GV+L EML G+
Sbjct: 230 DWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           +H   +   ++RD K  N+LLD + + +L+DFG      +DG    S  V GT  Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPE 173

Query: 317 YVMT-----GHLTSKSDVYSFGVVLLEMLTG 342
            +       G    + D +S GV + EML G
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 52/167 (31%), Positives = 75/167 (44%), Gaps = 29/167 (17%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +F    ++G+G FG V    V+       K  TG   A+KTL    +   K+ LA V   
Sbjct: 2   DFHTVKVIGKGAFGEV--RLVQ-------KKDTGKIYAMKTLLKSEMF-KKDQLAHVKAE 51

Query: 194 GNLL----HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRM 244
            ++L     P +V L  Y  +D Q L L+ EF+P G L   L +  +        +    
Sbjct: 52  RDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAEC 110

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 291
            +A+ A   L F+H         RD K  NIL+D   + KLSDFGL+
Sbjct: 111 VLAIEAVHKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 9e-06
 Identities = 29/82 (35%), Positives = 42/82 (51%), Gaps = 6/82 (7%)

Query: 266 IYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----T 320
           ++RD K  N+LLD + + +L+DFG       DG T  S   +GT  Y +PE +       
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQSNVAVGTPDYISPEILQAMEDGK 182

Query: 321 GHLTSKSDVYSFGVVLLEMLTG 342
           G    + D +S GV + EML G
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 26/223 (11%)

Query: 120 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 179
           LR+   +D +L  R       +G G +G V+K              TG   AVK +  + 
Sbjct: 3   LRRNPQHDYELIQR-------VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEP 46

Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
                    E+  +    H N+V   G  +  ++  +  E+   GSL++     G  PL 
Sbjct: 47  GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLS 104

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
                 +     +GLA+LH + +   ++RD K +NILL  + + KL+DFG+A  A     
Sbjct: 105 ELQIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA--AKITAT 159

Query: 300 THVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEM 339
                  +GT  + APE       G      D+++ G+  +E+
Sbjct: 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 45/187 (24%), Positives = 68/187 (36%), Gaps = 59/187 (31%)

Query: 207 YCIED-DQRLLVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAKGLAFLHEEA 261
           Y  +D D    V +++P G + + L R G  P      +   +  A+ +   + F+H   
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH--- 124

Query: 262 EKPVIYRDFKTSNILLDADYNAKLSDFGL--------------AKDAPEDGKTHVSTR-- 305
                 RD K  NIL+D D + KL+DFGL              + D         S    
Sbjct: 125 ------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 306 -----------------------------VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 336
                                        ++GT  Y APE ++    T   D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 337 LEMLTGR 343
            EML G+
Sbjct: 239 YEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 19/168 (11%)

Query: 189 EVNFLGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGS------LPLPW 240
           E+  L  L HPN++ L  V     D +  L++++          F + S      + LP 
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107

Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NAKLSDFGLAK--DA 294
           S+   +      G+ +LH      V++RD K +NIL+  +       K++D G A+  ++
Sbjct: 108 SMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLT 341
           P      +   V+ T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 165 PLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 34/97 (35%), Positives = 44/97 (45%), Gaps = 10/97 (10%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 196
           LG G FG V    VE       K    +TVAVK L        +E L      +++LGN 
Sbjct: 43  LGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 97

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK 233
            H N+V L+G C      L++ E+   G L N L RK
Sbjct: 98  -HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 3/83 (3%)

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 315
           ++H E    +I+RD KT N+L++   +  L DFG A  A     T     + GT    AP
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331

Query: 316 EYVMTGHLTSKSDVYSFGVVLLE 338
           E +     T   D++S G+V+ E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.0 bits (98), Expect = 5e-04
 Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 19/168 (11%)

Query: 189 EVNFLGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGS------LPLPW 240
           E+  L  L HPN++ L  V     D +  L++++          F + S      + LP 
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107

Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NAKLSDFGLAK--DA 294
            +   +      G+ +LH      V++RD K +NIL+  +       K++D G A+  ++
Sbjct: 108 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLT 341
           P      +   V+ T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 165 PLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 70/335 (20%), Positives = 127/335 (37%), Gaps = 63/335 (18%)

Query: 59  PSRSKVDSSMSGTSTNY--ADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKV 116
            SRS   +  SG+  +   A    S   +           TT+   +    P   ++ KV
Sbjct: 44  TSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPP-PKKKKV 102

Query: 117 ASQLRK----------FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGT 166
              L             +  D+ ++T+ F+  SLLGEG FG V + W  +          
Sbjct: 103 TYALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKE------- 155

Query: 167 GLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN------LVKLVGYCIEDDQRLLVYEF 220
               AVK +  +  +  ++   E+ F+  +   +      L+K+  Y   +   + +   
Sbjct: 156 --YCAVKIV-RNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI--V 210

Query: 221 MPR--GSLENHLFRKGSLPLPWSIR--MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL 276
           MP+    L + + + G    P+S R   +I       L + H E    +++ D K  NIL
Sbjct: 211 MPKYGPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENIL 264

Query: 277 LDADYNA----------------KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
           ++                     ++ D G   D     + H  T ++ T  Y +PE V+ 
Sbjct: 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCD-----ERHSRTAIVSTRHYRSPEVVLG 319

Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                 +D++S G ++ E+ TG+   D +  N EH
Sbjct: 320 LGWMYSTDMWSMGCIIYELYTGKLLYDTH-DNLEH 353

Length = 467

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	491
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
PRK10345	210	hypothetical protein; Provisional	99.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
smart00090	237	RIO RIO-like kinase.	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.55
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.55
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.47
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
KOG1243	690	consensus Protein kinase [General function predict	99.4
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.38
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.37
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.3
KOG3087	229	consensus Serine/threonine protein kinase [General	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.27
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.19
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.08
COG4248	637	Uncharacterized protein with protein kinase and he	99.03
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.98
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.82
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.79
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.71
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.67
PRK09902	216	hypothetical protein; Provisional	98.65
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.57
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.53
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.5
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.43
PF01636	239	APH: Phosphotransferase enzyme family This family	98.41
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.4
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.34
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.23
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.19
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.18
PLN02876	822	acyl-CoA dehydrogenase	98.17
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.1
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.97
PRK10593	297	hypothetical protein; Provisional	97.96
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.91
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.89
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.89
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.82
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.66
PRK05231	319	homoserine kinase; Provisional	97.54
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.51
PLN02236	344	choline kinase	97.3
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.23
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.13
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.12
KOG2270	520	consensus Serine/threonine protein kinase involved	97.07
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.0
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.89
PLN02756	418	S-methyl-5-thioribose kinase	96.68
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.63
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.62
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.55
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.54
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.54
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.53
PRK12396	409	5-methylribose kinase; Reviewed	96.41
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.35
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.03
PRK06148	1013	hypothetical protein; Provisional	95.85
COG2334	331	Putative homoserine kinase type II (protein kinase	95.79
PRK11768	325	serine/threonine protein kinase; Provisional	95.56
PTZ00384	383	choline kinase; Provisional	95.25
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.25
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.23

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-54  Score=432.10  Aligned_cols=291  Identities=57%  Similarity=0.982  Sum_probs=254.9

Q ss_pred             hhchhhhhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCC
Q 011180          119 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH  198 (491)
Q Consensus       119 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H  198 (491)
                      ..+.|.+.++..+|++|....+||+|+||.||+|...+          |..||||.+.....+..++|.+|+.+|.+++|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H  130 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH  130 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence            45679999999999999999999999999999999864          46899998876543315669999999999999


Q ss_pred             CceeeeeeEEeecC-ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 011180          199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       199 pnIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl  277 (491)
                      ||||+|+|||.+.+ +.+||||||++|+|.++|......+++|..+++||.++|+||+|||....++|||||||++||||
T Consensus       131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL  210 (361)
T KOG1187|consen  131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL  210 (361)
T ss_pred             cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence            99999999999998 49999999999999999987644378999999999999999999999887789999999999999


Q ss_pred             CCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011180          278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  357 (491)
Q Consensus       278 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~  357 (491)
                      |+++++||+|||+|+..... .....+...||.+|+|||++..+..+.++|||||||+|+||++|+.+.+...+.....+
T Consensus       211 D~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l  289 (361)
T KOG1187|consen  211 DEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL  289 (361)
T ss_pred             CCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence            99999999999999766541 12222211799999999999999999999999999999999999999988777777779


Q ss_pred             hHhhhcccCCccchhhccCcccc-CCCCh-hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          358 VEWARPHLGDKRRFYRLLDPRLE-GHFSI-KGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ++|..+.+.+. .+.+++|+.+. +.+.. .....+..++.+|++.+|.+||+|.+|++.|+.+..
T Consensus       290 ~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  290 VEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            99988777665 78899999987 66664 577889999999999999999999999999966543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-53  Score=425.10  Aligned_cols=249  Identities=29%  Similarity=0.478  Sum_probs=216.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .+|...++||+|||+.||++++.+         +|..||+|++.+...   ...+.+.+||+|.++|.|||||+++++|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~---------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE   88 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLD---------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE   88 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcC---------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence            469999999999999999999866         788999999987533   33467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+.+|||+|+|..++|..++.+++  ++++.+++.++.||+.||.|||+++   |||||||..||||+++.+|||+|||
T Consensus        89 Ds~nVYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   89 DSNNVYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             cCCceEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccc
Confidence            9999999999999999999987544  8999999999999999999999998   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ||..+..++...  .+.||||.|.|||++.....+..+||||+|||||.||+|++||+.....+....+.....      
T Consensus       164 LAt~le~~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y------  235 (592)
T KOG0575|consen  164 LATQLEYDGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY------  235 (592)
T ss_pred             eeeeecCccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc------
Confidence            999887554433  358999999999999999999999999999999999999999987644433333322211      


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                  .+|...+.++++||.++|+.||.+|||+++||.+
T Consensus       236 ------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  236 ------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ------------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                        1222347899999999999999999999999976

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-52  Score=402.42  Aligned_cols=251  Identities=29%  Similarity=0.437  Sum_probs=211.3

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +.+..+.||+|..|+||+++++.         +++.+|+|++.... ....+++.+|+++++..+|||||.+||+|...+
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~---------t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKP---------TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcC---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            45567889999999999999987         78899999995442 334578999999999999999999999999999


Q ss_pred             c-eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          213 Q-RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       213 ~-~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      . ..|+||||++|+|++++...+  .+++.....|+.+|++||.|||+ .+   ||||||||+||||+..|.|||||||.
T Consensus       151 ~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             ceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccc
Confidence            4 999999999999999997764  68899999999999999999996 55   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCC--CCcchhhHhhhcccCCc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP--NGEHNLVEWARPHLGDK  368 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~  368 (491)
                      +..+.+.    ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+  .....+..+.-.     
T Consensus       226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-----  296 (364)
T KOG0581|consen  226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-----  296 (364)
T ss_pred             cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-----
Confidence            9887553    44568999999999999999999999999999999999999999976421  111222221110     


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                           -..|.+...   .+++++.+||..||++||.+|||+.|+++|
T Consensus       297 -----~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  297 -----EPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             -----CCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 011222221   358899999999999999999999999987

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-51  Score=397.05  Aligned_cols=251  Identities=29%  Similarity=0.474  Sum_probs=206.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .+|.+.+.||.|+||+||+|+++.         ++..||||.+.+..+  ...+.+..|+.+|+.|+|||||.+++++..
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~---------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~   80 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKK---------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED   80 (429)
T ss_pred             ccceehhhccCcceEEEEEeEecc---------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec
Confidence            579999999999999999999987         567999999987743  344567899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC------CCeE
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD------YNAK  284 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~------~~~k  284 (491)
                      ++.+|||||||.||+|.++|..++  .+++..+..++.||+.||++||+++   ||||||||.||||+..      -.+|
T Consensus        81 ~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LK  155 (429)
T KOG0595|consen   81 DDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLK  155 (429)
T ss_pred             CCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEE
Confidence            999999999999999999999886  6899999999999999999999988   9999999999999764      4689


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      |+|||+|+.+...   ....+.||++.|||||+++...|+.|+|+||+|+|||++++|+.||+...+.+....++.....
T Consensus       156 IADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~  232 (429)
T KOG0595|consen  156 IADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI  232 (429)
T ss_pred             ecccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc
Confidence            9999999998753   3345689999999999999999999999999999999999999999876554433222221111


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .               ..++...+..+.+|+...|.+++.+|.++.+.+.+
T Consensus       233 ~---------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  233 V---------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             c---------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence            1               11112224445577777777777777766665543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.5e-52  Score=399.73  Aligned_cols=253  Identities=28%  Similarity=0.400  Sum_probs=208.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc-------HHHHHHHHHHHhcCCCCceeee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~il~~l~HpnIv~l  204 (491)
                      .+.|.+.+.||+|+||.|-+|..+.         +|+.||||++++.....       ...+.+|++||++|+|||||++
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~---------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~  241 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKK---------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRI  241 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcc---------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEE
Confidence            3468889999999999999998876         88999999998764322       1235799999999999999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC---C
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---Y  281 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~---~  281 (491)
                      +++|...+..||||||+.||+|.+.+..++  .+.+..-..++.|++.||.|||+.|   |+||||||+|||+..+   .
T Consensus       242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~  316 (475)
T KOG0615|consen  242 KDFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDC  316 (475)
T ss_pred             eeeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcce
Confidence            999999999999999999999999998876  4666677889999999999999999   9999999999999655   7


Q ss_pred             CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCC-cchh
Q 011180          282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG-EHNL  357 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~pf~~~~~~~-~~~~  357 (491)
                      .+||+|||+|+...+   ...+.+.|||+.|.|||++.+..   +..++|+||+||+||-+|+|.+||....... ....
T Consensus       317 llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ  393 (475)
T KOG0615|consen  317 LLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ  393 (475)
T ss_pred             EEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH
Confidence            899999999998753   34556799999999999998653   3458899999999999999999997654322 1111


Q ss_pred             hHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      +...+...              ......+.++++.+||.+||..||++|||+.|+|++
T Consensus       394 I~~G~y~f--------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  394 ILKGRYAF--------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             HhcCcccc--------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            11111111              111223458999999999999999999999999976

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-50  Score=388.16  Aligned_cols=243  Identities=31%  Similarity=0.454  Sum_probs=206.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|++.++||+|+||+||+++.++         +++.+|+|++++.....   .+...+|..||..++||.||+++..|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~d---------t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF   94 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKD---------TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF   94 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcc---------cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence            3479999999999999999999885         78899999998875443   34578899999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      ++.+.+|||+||+.||.|..+|.+.+  .+++..+..++.+|+.||.|||+.+   ||||||||+|||||.+|+++|+||
T Consensus        95 Qt~~kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDF  169 (357)
T KOG0598|consen   95 QTEEKLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDF  169 (357)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEecc
Confidence            99999999999999999999998876  6888988999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ||++.....+..  ..++|||+.|||||++.+..|+.++|+|||||++|||++|.+||...........+      +...
T Consensus       170 gL~k~~~~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I------~~~k  241 (357)
T KOG0598|consen  170 GLCKEDLKDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI------LKGK  241 (357)
T ss_pred             ccchhcccCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH------hcCc
Confidence            999965443322  34589999999999999999999999999999999999999999765432221111      1111


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP  407 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP  407 (491)
                      .           ..++.-.+.++++|++++|.+||.+|.
T Consensus       242 ~-----------~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 L-----------PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             C-----------CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            0           011112378899999999999999996

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-49  Score=399.30  Aligned_cols=256  Identities=36%  Similarity=0.593  Sum_probs=211.7

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeE-EEEEEecCCCccc--HHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +.+.+.||.|+||+||+|.+.           |.. ||||++.......  .++|.+|+.+|.+|+|||||+++|++.+.
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~  111 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP  111 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            445566999999999999995           445 9999997654332  45899999999999999999999999988


Q ss_pred             C-ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-CeEEeccC
Q 011180          212 D-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG  289 (491)
Q Consensus       212 ~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kL~DFG  289 (491)
                      . .++|||||+++|+|.++|.......+++..++.++.||+.||.|||+++.  ||||||||+||||+.++ ++||+|||
T Consensus       112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFG  189 (362)
T KOG0192|consen  112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFG  189 (362)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCc
Confidence            7 79999999999999999988434489999999999999999999999774  99999999999999998 99999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhh--cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      +++......  ...+...||+.|||||++.  ...|+.|+|||||||+||||+||+.||...........+         
T Consensus       190 lsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v---------  258 (362)
T KOG0192|consen  190 LSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV---------  258 (362)
T ss_pred             cceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH---------
Confidence            998765422  2223367999999999999  569999999999999999999999999766541111111         


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                             ........++..++..+..||.+||..||..||++.+++..|+.+..
T Consensus       259 -------~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  259 -------VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             -------HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence                   01111222233367899999999999999999999999999987655

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=395.13  Aligned_cols=256  Identities=27%  Similarity=0.388  Sum_probs=216.7

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcC-CCCceeee
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNL-LHPNLVKL  204 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l-~HpnIv~l  204 (491)
                      .....||..++.||+|+|++||+|+.+.         +++.||||++.+.-..   ..+.+.+|-.+|.+| .||.|++|
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~---------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL  139 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKA---------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL  139 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecC---------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence            3445689999999999999999999876         7889999999766432   224567899999999 69999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      +..|+|+..+|+|+||+++|+|.++|.+.+  .|++.....++.+|+.||+|||++|   ||||||||+|||||+||++|
T Consensus       140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhik  214 (604)
T KOG0592|consen  140 YFTFQDEESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIK  214 (604)
T ss_pred             EEEeecccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEE
Confidence            999999999999999999999999999887  6888888999999999999999999   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCc---------ee--eeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 011180          285 LSDFGLAKDAPEDGKT---------HV--STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG  353 (491)
Q Consensus       285 L~DFGla~~~~~~~~~---------~~--~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~  353 (491)
                      |+|||.|..+......         ..  ...++||..|++||++.....+..+|+|+||||||+|+.|.+||.+..+.-
T Consensus       215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl  294 (604)
T KOG0592|consen  215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL  294 (604)
T ss_pred             EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH
Confidence            9999999877543221         11  145899999999999999999999999999999999999999997654322


Q ss_pred             cchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      .                |.++++  +...|+...++.+.+||+++|..||.+|+|..+|-+|.
T Consensus       295 i----------------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  295 I----------------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             H----------------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence            1                111211  22344445578999999999999999999999998874

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-49  Score=371.09  Aligned_cols=265  Identities=27%  Similarity=0.375  Sum_probs=212.1

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .|+...++|+|+||+||+|++++         ||+.||||.+....  ....+-.++||++|++|.|+|+|.++++|...
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~---------TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk   73 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKD---------TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK   73 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCC---------cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc
Confidence            57788899999999999999987         89999999986543  22335578999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ..++||+|||+. ++.+.|..... .++...+..++.|++.|+.|+|+++   +|||||||+||||+.+|.+||||||+|
T Consensus        74 rklhLVFE~~dh-TvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFA  148 (396)
T KOG0593|consen   74 RKLHLVFEYCDH-TVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFA  148 (396)
T ss_pred             ceeEEEeeecch-HHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhh
Confidence            999999999966 45555555433 6889999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc------
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH------  364 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~------  364 (491)
                      +.+...+  ...+..+.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+.|.+....+...++......      
T Consensus       149 R~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq  226 (396)
T KOG0593|consen  149 RTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQ  226 (396)
T ss_pred             HhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHH
Confidence            9886432  33466789999999999987 68999999999999999999999999887665554443322111      


Q ss_pred             --cCCccchhhccCcc------ccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 --LGDKRRFYRLLDPR------LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 --~~~~~~~~~~~~~~------l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        +.....|..+.-|.      ++..| +..+.-+.+|++.||+.||.+|++.++++.+
T Consensus       227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  227 SIFSSNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             HHhccCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence              11111121111111      11122 2335688999999999999999999999865

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-50  Score=372.59  Aligned_cols=256  Identities=27%  Similarity=0.410  Sum_probs=207.0

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeee-EEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVG-YCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~-~~~~  210 (491)
                      +|.+++.||+|+||.||++....         +|..||.|.+.-+...  ...++..|+.+|++|+|||||++++ .+.+
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~---------~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~   90 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLL---------DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE   90 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeecc---------CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc
Confidence            68899999999999999999876         6779999999855433  3457899999999999999999998 4555


Q ss_pred             cCc-eEEEEEecCCCChHHHhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEecCCCCCcEEECCCCCeEEe
Q 011180          211 DDQ-RLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEK-PVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       211 ~~~-~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~-~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      +.. ++||||||.+|+|...|..  +....+++..+++++.|++.||..+|..-++ -|+||||||.||+|+.+|.+||+
T Consensus        91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG  170 (375)
T KOG0591|consen   91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG  170 (375)
T ss_pred             cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence            555 8999999999999998853  3455799999999999999999999994311 29999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      ||||++.+...  .......+|||.||+||.+....|+.++||||+||++|||+.-++||.+..      +.+.....-.
T Consensus       171 DfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~~KI~q  242 (375)
T KOG0591|consen  171 DFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLCKKIEQ  242 (375)
T ss_pred             cchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHHHHHHc
Confidence            99999988653  334566899999999999999999999999999999999999999998752      2111111000


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      .  .+     |.+.   ....+..+..||..|+..||..||+...++..+
T Consensus       243 g--d~-----~~~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  243 G--DY-----PPLP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             C--CC-----CCCc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            0  00     0011   123488999999999999999999955555443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-47  Score=384.92  Aligned_cols=258  Identities=32%  Similarity=0.469  Sum_probs=213.4

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .+.+.+++.||+|.||.||+|.+...          ..||+|.++... ...+.|.+|+++|++|+|+|||+++++|..+
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~----------~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~  273 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGS----------TKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ  273 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCC----------CcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence            33456678899999999999999742          369999998764 3457899999999999999999999999998


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +.+|||||||+.|+|.++|.......+.....+.++.|||+|++||++++   +|||||...||||+++..+||+|||||
T Consensus       274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccc
Confidence            89999999999999999998855667889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +...++ .........-...|.|||.+..+.++.|||||||||+||||+| |+.|+......+   +++           
T Consensus       351 r~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~-----------  415 (468)
T KOG0197|consen  351 RLIGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLE-----------  415 (468)
T ss_pred             cccCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHH-----------
Confidence            955443 3333333334678999999999999999999999999999999 666665432221   111           


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                         .++....-.-|..|+..+.+||..||+.+|++|||++.+...|+.+..
T Consensus       416 ---~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  416 ---LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             ---HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence               122222223345679999999999999999999999999999887644

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=373.91  Aligned_cols=257  Identities=31%  Similarity=0.473  Sum_probs=207.9

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC-
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD-  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-  212 (491)
                      +|...+.||+|+||.||++.+.+         +|..+|||.+........+.+.+|+.+|++|+|||||+++|...... 
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~---------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~   88 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKK---------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN   88 (313)
T ss_pred             hhhhhccccCccceEEEEEEecC---------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence            57788999999999999999876         57789999987654333667899999999999999999999755444 


Q ss_pred             -ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCCeEEeccCC
Q 011180          213 -QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGL  290 (491)
Q Consensus       213 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kL~DFGl  290 (491)
                       .++|+|||+++|+|.+++.+.+. .+++..+..+..||++||+|||+++   ||||||||+||||+. ++.+||+|||+
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcc
Confidence             58999999999999999998876 7999999999999999999999988   999999999999999 79999999999


Q ss_pred             cccCCCC-CCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          291 AKDAPED-GKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       291 a~~~~~~-~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      +...... ..........||+.|||||++..+ ....++|||||||++.||+||.+||...  .......-         
T Consensus       165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~---------  233 (313)
T KOG0198|consen  165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALL---------  233 (313)
T ss_pred             ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHH---------
Confidence            9876531 111223347899999999999854 3345999999999999999999999653  11111000         


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                          .+........++...+.++.+|+.+||.+||.+|||+.++|++..-
T Consensus       234 ----~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  234 ----LIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             ----HHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence                0000001113344458899999999999999999999999998653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-48  Score=377.89  Aligned_cols=264  Identities=27%  Similarity=0.386  Sum_probs=214.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHH--HHHHHHHHhcCC-CCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGNLL-HPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~il~~l~-HpnIv~l~~~~~  209 (491)
                      ++|.+++.||.|+||.||+|+.++         +|..||||.+++.-.. .++  -+||+..|++|+ |||||++.+++.
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~---------~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~   79 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKE---------TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIR   79 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecC---------CCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhh
Confidence            479999999999999999999887         6778999999766433 333  368999999999 999999999999


Q ss_pred             ecC-ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          210 EDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       210 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      +.+ .+|+||||| ..+|++++..+ ...|++..++.|+.||++||+|+|.+|   +.||||||+|||+..+..+||+||
T Consensus        80 d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDF  154 (538)
T KOG0661|consen   80 DNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADF  154 (538)
T ss_pred             ccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccc
Confidence            988 999999999 56999999887 568999999999999999999999999   999999999999998899999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhh-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--cc-
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PH-  364 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--~~-  364 (491)
                      |+||......   ..+..+.|..|+|||++. .+.|+.++||||+|||++|+.+-++.|.+....+....+....  +. 
T Consensus       155 GLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~  231 (538)
T KOG0661|consen  155 GLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK  231 (538)
T ss_pred             ccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence            9999875432   235578899999999886 5789999999999999999999999998877665544332211  11 


Q ss_pred             --cCCccchhhccCcc--------ccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 --LGDKRRFYRLLDPR--------LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 --~~~~~~~~~~~~~~--------l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        +.....+...+.-.        +..-++ ..+.++.+||.+||..||.+|||+.+++++
T Consensus       232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             ccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence              11111111112111        111122 268899999999999999999999999987

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-47  Score=355.81  Aligned_cols=238  Identities=29%  Similarity=0.401  Sum_probs=206.4

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHH---HHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ..+|...+.||.|+||.|.+++.+.         +|..+|+|++++...-..+   ....|..+|+.+.||+++++++.|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~---------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~  113 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKH---------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF  113 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEcc---------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee
Confidence            3579999999999999999999987         6779999999887554433   457799999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+.+||||||++||.|..+|.+.+  .+++..++.++.||+.||+|||+.+   |++|||||+|||||.+|.+||+||
T Consensus       114 ~d~~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  114 KDNSNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEec
Confidence            99999999999999999999998776  6889999999999999999999998   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |+|+.....     .-+.||||.|+|||++....|+.++|+|||||++|||+.|.+||....+......+      +...
T Consensus       189 GFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI------~~~~  257 (355)
T KOG0616|consen  189 GFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI------LEGK  257 (355)
T ss_pred             cceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH------HhCc
Confidence            999987543     34589999999999999999999999999999999999999999877663222211      1111


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCC
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR  406 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~R  406 (491)
                      -            .||...+..+++|+.++|+.|-.+|
T Consensus       258 v------------~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 V------------KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             c------------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            1            2333347889999999999999998

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=383.68  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=216.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ..|.....||+|+.|.||.|....         ++..||||.+........+-++.|+.+|+.++|+|||.+++.|...+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~---------~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKIS---------TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD  343 (550)
T ss_pred             hhhcchhhhccccccceeeeeecc---------CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence            468888899999999999998765         67789999998877666677899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      .+|+|||||+||+|.|.+...   .+++.++..|++++++||+|||.++   |||||||.+|||++.+|.+||+|||++.
T Consensus       344 eLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFca  417 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCA  417 (550)
T ss_pred             eeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeee
Confidence            999999999999999998654   5889999999999999999999999   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .+.....  .....+|||+|||||++....|+.++||||||++++||+.|++||-...+.....++..  ..        
T Consensus       418 qi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~--ng--------  485 (550)
T KOG0578|consen  418 QISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NG--------  485 (550)
T ss_pred             ccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh--cC--------
Confidence            8765443  34568999999999999999999999999999999999999999976444332222211  00        


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                           ...-..+...+..+++|+.+||+.|+.+|+++.|+|+|
T Consensus       486 -----~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  486 -----TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             -----CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence                 11112234458999999999999999999999999987

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=380.42  Aligned_cols=251  Identities=29%  Similarity=0.400  Sum_probs=208.5

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC----Cc-ccHHHHHHHHHHHhcCC-CCceeee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GL-QGHKEWLAEVNFLGNLL-HPNLVKL  204 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~il~~l~-HpnIv~l  204 (491)
                      ..+.|.+.+.||+|+||.|++|.+..         ++..||||++.+.    .. ...+.+.+|+.+++.+. ||||+++
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~---------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l   85 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRL---------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRL   85 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeecc---------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEE
Confidence            45689999999999999999999876         6789999988764    11 22355678999999999 9999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-CCe
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNA  283 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~-~~~  283 (491)
                      ++++.....+|+|||||.||+|.+++...+  .+.+..+..++.||+.||+|||+.+   |+||||||+|||++.+ +++
T Consensus        86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~  160 (370)
T KOG0583|consen   86 LEVFATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNL  160 (370)
T ss_pred             EEEEecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCE
Confidence            999999999999999999999999998854  6888999999999999999999998   9999999999999999 999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCC-CC-ccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      ||+|||++....  .......+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+......   +..  
T Consensus       161 Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~~--  233 (370)
T KOG0583|consen  161 KLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LYR--  233 (370)
T ss_pred             EEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HHH--
Confidence            999999999874  1122335689999999999999877 76 78999999999999999999998632111   111  


Q ss_pred             hcccCCccchhhccCccccCCCChhh-HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKG-SQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       ......            -.++... +.++.+|+.+||..||.+|+|+.+|+++
T Consensus       234 -ki~~~~------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  234 -KIRKGE------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             -HHhcCC------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence             111111            1122222 7889999999999999999999999944

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=367.19  Aligned_cols=264  Identities=28%  Similarity=0.390  Sum_probs=217.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccH-HHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ..+|++..+||.|.-++||+|+...         ++..||||++..+..... ..+.+|+..|+.++||||++++..|..
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p---------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv   95 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIP---------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV   95 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecc---------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence            4579999999999999999999976         667999999987765544 788999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      +..+|+||.||.+|++.+++...-...+++..+..|++++++||.|||++|   .||||||+.||||+.+|.|||+|||.
T Consensus        96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgv  172 (516)
T KOG0582|consen   96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGV  172 (516)
T ss_pred             cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCcee
Confidence            999999999999999999998776667999999999999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCCceee--eccccCCCCCCchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          291 AKDAPEDGKTHVS--TRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       291 a~~~~~~~~~~~~--~~~~Gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      +..+...+.....  ..++||++|||||+++.  ..|+.|+||||||++..||.+|..||....+....-+.-...+.. 
T Consensus       173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~-  251 (516)
T KOG0582|consen  173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT-  251 (516)
T ss_pred             eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC-
Confidence            8776554432221  45799999999999654  579999999999999999999999998776544322211111110 


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                             ..-..+..+-....+..+.++|..||++||.+|||+++++++
T Consensus       252 -------~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  252 -------LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             -------cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence                   000011111112235689999999999999999999999975

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.8e-47  Score=377.14  Aligned_cols=257  Identities=26%  Similarity=0.350  Sum_probs=211.0

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCceeeeee
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVG  206 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~  206 (491)
                      ...++|.++..||+|+||.||+|+-+.         ||..+|+|++++.....   .+-++.|-.+|....+|+||+||.
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~---------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY  208 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKD---------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY  208 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEcc---------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence            345799999999999999999999876         88999999998875543   345678999999999999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      .|++.+.+||||||++||++..+|.+.+  .|++..+..++.+++-|+.-||+.|   ||||||||+|+|||..|++||+
T Consensus       209 sFQD~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLS  283 (550)
T KOG0605|consen  209 SFQDKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLS  283 (550)
T ss_pred             EecCCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeec
Confidence            9999999999999999999999998876  7888999999999999999999999   9999999999999999999999


Q ss_pred             ccCCcccCCCC----------------------CCc------e-----------------eeeccccCCCCCCchhhhcC
Q 011180          287 DFGLAKDAPED----------------------GKT------H-----------------VSTRVMGTYGYAAPEYVMTG  321 (491)
Q Consensus       287 DFGla~~~~~~----------------------~~~------~-----------------~~~~~~Gt~~y~aPE~~~~~  321 (491)
                      ||||+.-+...                      ...      .                 .....+|||.|||||++.+.
T Consensus       284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k  363 (550)
T KOG0605|consen  284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK  363 (550)
T ss_pred             cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence            99998532110                      000      0                 01125799999999999999


Q ss_pred             CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhc
Q 011180          322 HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSR  401 (491)
Q Consensus       322 ~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~  401 (491)
                      .|+..+|+|||||||||||.|.+||....+......+..-+..+.-              .-....+.++.|||.+||. 
T Consensus       364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f--------------P~~~~~s~eA~DLI~rll~-  428 (550)
T KOG0605|consen  364 GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF--------------PEEVDLSDEAKDLITRLLC-  428 (550)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC--------------CCcCcccHHHHHHHHHHhc-
Confidence            9999999999999999999999999887776543332221111110              0112236899999999999 


Q ss_pred             CCCCCCC---HHHHHHH
Q 011180          402 DPKARPR---MSEVVET  415 (491)
Q Consensus       402 dP~~RPt---~~evl~~  415 (491)
                      ||.+|.-   +.||-+|
T Consensus       429 d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  429 DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             CHHHhcCcccHHHHhcC
Confidence            9999965   6666554

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-47  Score=374.43  Aligned_cols=269  Identities=26%  Similarity=0.339  Sum_probs=213.2

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ..+.|+.++.||+|.||.||+|++..         +|+.||+|.+..+..  ....-..+||.||++|+||||++|.+..
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~---------tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eiv  185 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLE---------TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIV  185 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecc---------cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence            34568889999999999999999987         788999999987653  3345678999999999999999999998


Q ss_pred             eec--CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          209 IED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       209 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      .+.  ..+|||+|||++ +|.-++... ...|++.++..++.||+.||+|||..+   |+|||||.+|||||.+|.+||+
T Consensus       186 t~~~~~siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKia  260 (560)
T KOG0600|consen  186 TSKLSGSIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIA  260 (560)
T ss_pred             EecCCceEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEec
Confidence            876  689999999965 888877554 457999999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--c
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--P  363 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--~  363 (491)
                      |||||+.+....... .+..+-|..|+|||++.+. .|+.++|+||.||||.||+.|++.|.+....+....+-..-  +
T Consensus       261 DFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP  339 (560)
T KOG0600|consen  261 DFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP  339 (560)
T ss_pred             cccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence            999999776554333 3456679999999999874 89999999999999999999999998876655444332110  0


Q ss_pred             ccCCcc--c--hhhccCcc------ccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKR--R--FYRLLDPR------LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~--~--~~~~~~~~------l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ......  .  .+..+.+.      +.+. -...+..+.+|+..+|..||.+|.|+.++|+.
T Consensus       340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  340 TEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            000000  0  01111111      1111 11226788999999999999999999999864

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-46  Score=381.52  Aligned_cols=248  Identities=29%  Similarity=0.403  Sum_probs=211.1

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      -|++++.||.|+.|.|-+|++..         ||+.+|||++.+.. ..  ....+.+||-||+-|.||||+.+|++|.+
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~---------TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~   83 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAE---------TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN   83 (786)
T ss_pred             ceeccccccCCCCceehhhhccc---------ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc
Confidence            48899999999999999999987         89999999997762 21  23457899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ..++|||.||+++|.|+++|..++  ++++..+.++++||+.|+.|+|..+   |+||||||+|+||+..+++||+|||+
T Consensus        84 ~~~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGM  158 (786)
T KOG0588|consen   84 KQHLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGM  158 (786)
T ss_pred             CceEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccce
Confidence            999999999999999999999987  6888889999999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      |..-..+.   .-.+.||++.|.|||++.+..|+ .++||||.|||||.||+|+.||++.........+.....      
T Consensus       159 AsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f------  229 (786)
T KOG0588|consen  159 ASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF------  229 (786)
T ss_pred             eecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc------
Confidence            98654432   23457999999999999999885 689999999999999999999985432211111111111      


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                                  +.+...+.++++||.+||..||.+|.|+++|++|.
T Consensus       230 ------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  230 ------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                        12233478999999999999999999999999984

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.8e-46  Score=341.54  Aligned_cols=266  Identities=27%  Similarity=0.402  Sum_probs=213.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .+|..+++||+|.||+||+|++..         +|+.||||.++.....+  ....++||+.|+.++|+||+.++++|..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~---------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~   72 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTE---------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH   72 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecC---------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence            368888999999999999999876         78899999998664332  3467899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+.+.||+|||+ .+|+..|..+ ...+....+..++.++++||+|||.+.   |+||||||.|+|++.+|.+||+|||+
T Consensus        73 ~~~l~lVfEfm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGL  147 (318)
T KOG0659|consen   73 KSNLSLVFEFMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGL  147 (318)
T ss_pred             CCceEEEEEecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccc
Confidence            999999999995 5899888766 457889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--------
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--------  361 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~--------  361 (491)
                      |+.+...+...  +..+-|..|+|||.+.|. .|+..+||||.|||+.||+-|.+-|.+....+....+-.+        
T Consensus       148 Ar~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~  225 (318)
T KOG0659|consen  148 ARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQ  225 (318)
T ss_pred             hhccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCccc
Confidence            99887654432  223679999999999864 7999999999999999999999998876554433322111        


Q ss_pred             hcccCC---ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 RPHLGD---KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 ~~~~~~---~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ++.+..   .-.+.....+.+.. +-..++.++.+|+.+||..||.+|+|+.|++++
T Consensus       226 WP~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  226 WPEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            111111   11111111222222 223456777999999999999999999999865

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.1e-46  Score=375.66  Aligned_cols=248  Identities=29%  Similarity=0.416  Sum_probs=214.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||+|+||+||+|+.+.         +.+.||+|.+.+....  ..+.+.+|++|++.|+|||||.++++|+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~---------t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt   72 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKY---------TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET   72 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccc---------ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence            478899999999999999998876         7889999999876543  34668899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ..++|+|.|||.| +|..+|...+  .++++.+..|+.+++.||.|||+++   |+|||+||.|||++.+|++|+||||+
T Consensus        73 ~~~~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~  146 (808)
T KOG0597|consen   73 SAHLWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGL  146 (808)
T ss_pred             cceEEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhh
Confidence            9999999999965 9999998765  6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      |+.+..  .+.+.+.+.|||.|||||.+.+..|+..+|+||+|||+||+++|++||....      +.......+.+.  
T Consensus       147 Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~--  216 (808)
T KOG0597|consen  147 ARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDP--  216 (808)
T ss_pred             hhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCC--
Confidence            998754  4566778899999999999999999999999999999999999999996432      111111111111  


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                ..++...+..+..|+..+|.+||..|.|..+++.|
T Consensus       217 ----------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  217 ----------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ----------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                      12334568899999999999999999999999976

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-45  Score=357.68  Aligned_cols=260  Identities=28%  Similarity=0.343  Sum_probs=213.6

Q ss_pred             HHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccH---HHHHHHHHHHhcCCCCceeee
Q 011180          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       128 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~il~~l~HpnIv~l  204 (491)
                      ..+..++|++++.||.|.-|+||+|....         ++..+|+|++.+......   .+...|-+||..++||.++.|
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTL  142 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTL  142 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchh
Confidence            34455678999999999999999999876         567899999988765544   356679999999999999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      |+.|+.+...|||||||+||+|..+++++....+++..+..++.+|+-||+|||-.|   ||+|||||+||||.++|++.
T Consensus       143 Ya~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIM  219 (459)
T KOG0610|consen  143 YASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIM  219 (459)
T ss_pred             hheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEE
Confidence            999999999999999999999999999988889999999999999999999999999   99999999999999999999


Q ss_pred             EeccCCcccCCC---------------------------------CCCc---------------------eeeeccccCC
Q 011180          285 LSDFGLAKDAPE---------------------------------DGKT---------------------HVSTRVMGTY  310 (491)
Q Consensus       285 L~DFGla~~~~~---------------------------------~~~~---------------------~~~~~~~Gt~  310 (491)
                      |+||.|+.....                                 ....                     .....++||-
T Consensus       220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh  299 (459)
T KOG0610|consen  220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH  299 (459)
T ss_pred             eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence            999999753311                                 0000                     0112368999


Q ss_pred             CCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHH
Q 011180          311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQK  390 (491)
Q Consensus       311 ~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  390 (491)
                      .|+|||++.+...+.++|+|+|||+|||||+|..||.+.......                ..++-..+.-.-....+..
T Consensus       300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl----------------~NIv~~~l~Fp~~~~vs~~  363 (459)
T KOG0610|consen  300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL----------------RNIVGQPLKFPEEPEVSSA  363 (459)
T ss_pred             ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH----------------HHHhcCCCcCCCCCcchhH
Confidence            999999999999999999999999999999999999876543221                1111111111111244788


Q ss_pred             HHHHHHHhhhcCCCCCCC----HHHHHHH
Q 011180          391 ATQLAAQCLSRDPKARPR----MSEVVET  415 (491)
Q Consensus       391 l~~li~~cL~~dP~~RPt----~~evl~~  415 (491)
                      ++|||+++|.+||.+|.-    +.||-+|
T Consensus       364 akDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  364 AKDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HHHHHHHHhccChhhhhccccchHHhhcC
Confidence            999999999999999988    6666554

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=370.73  Aligned_cols=249  Identities=28%  Similarity=0.437  Sum_probs=215.1

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .|+..++||+|+||.||+|.+..         +++.||||++..+... ..+++.+|+.+|.+++++||.++|+.|..+.
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~---------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~   84 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNK---------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT   84 (467)
T ss_pred             ccccchhccccccceeeeeeecc---------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence            57788999999999999999876         7889999999877544 3577889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      .+|++||||.||++.++|....  .+.+..+..++++++.||.|||.++   .+|||||+.||||..+|.+||+|||.+.
T Consensus        85 ~LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~  159 (467)
T KOG0201|consen   85 KLWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAG  159 (467)
T ss_pred             cHHHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceee
Confidence            9999999999999999997654  4477777889999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .+.......  .+++||+.|||||++.+..|+.++||||||++.|||++|.+|+....+.....++             .
T Consensus       160 ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------------p  224 (467)
T KOG0201|consen  160 QLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------------P  224 (467)
T ss_pred             eeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------------c
Confidence            876544332  5689999999999999889999999999999999999999999887764332222             1


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .-..|.+.+.|    +..+++||..||.+||+.||++.++|++
T Consensus       225 k~~PP~L~~~~----S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  225 KSAPPRLDGDF----SPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCCCCcccccc----CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            22334455543    7789999999999999999999999976

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-46  Score=340.65  Aligned_cols=251  Identities=26%  Similarity=0.395  Sum_probs=215.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|.+++.||+|.||.||+|+.+.         ++..||+|++.+...   ....++.+|++|-+.|+||||+++|++|
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekk---------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKK---------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             hhhccccccccCCccccEeEeeecc---------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            3579999999999999999999987         677999999977643   2346789999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .++...||++||.++|+|+..|.......+++.....+..|++.||.|+|..+   ||||||||+|+|++..+.+||+||
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCC
Confidence            99999999999999999999998766667889999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |.+......    .....|||..|.+||.+.+..++..+|+|++|++.||++.|.+||......+...-+..        
T Consensus       169 GwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k--------  236 (281)
T KOG0580|consen  169 GWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK--------  236 (281)
T ss_pred             CceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--------
Confidence            999876422    23458999999999999999999999999999999999999999976542211111110        


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                                +.-.++...+..+.+||.+||.++|.+|.+..+++++-
T Consensus       237 ----------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  237 ----------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             ----------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence                      11122334478999999999999999999999999873

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-46  Score=378.98  Aligned_cols=246  Identities=28%  Similarity=0.427  Sum_probs=208.8

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCC-CCceeee
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLL-HPNLVKL  204 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~-HpnIv~l  204 (491)
                      .+..++|.++++||+|+||+|+++..+.         +++.+|||+++++..-   +.+..+.|.+|+.... ||.++.+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~---------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L  434 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKG---------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL  434 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcC---------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence            4555789999999999999999999986         6779999999988543   4466788999988886 9999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      +..|+..+++|+||||+.||++..++..   ..+++..+..++..|+.||+|||+++   |||||||.+|||||.+|.+|
T Consensus       435 ~~~fQT~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~k  508 (694)
T KOG0694|consen  435 FSCFQTKEHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVK  508 (694)
T ss_pred             ccccccCCeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEE
Confidence            9999999999999999999995544322   26899999999999999999999999   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      |+|||+++.....+.  .+.++||||.|||||++.+..|+.++|+|||||+|||||.|..||.+....+..+.+      
T Consensus       509 iADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI------  580 (694)
T KOG0694|consen  509 IADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI------  580 (694)
T ss_pred             ecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------
Confidence            999999987653332  346799999999999999999999999999999999999999999876543322211      


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM  409 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~  409 (491)
                      +.+            ...|+...+.++.+|++++|.+||.+|.-+
T Consensus       581 ~~d------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  581 VND------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             hcC------------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            111            123555668999999999999999999765

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-46  Score=359.55  Aligned_cols=248  Identities=23%  Similarity=0.393  Sum_probs=212.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHH---HHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .+|.+.+.||+|.||.|-+|+...         .|+.||||.++++...+..+   +.+||+||..|+||||+.+|.+|+
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~---------sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE  123 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHK---------SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE  123 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhcc---------CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence            468899999999999999998765         78899999999887665544   678999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      ..+...|||||..+|.|+||+...+  .+++..+..+++||..|+.|+|.++   ++|||||.+|||||.++++||+|||
T Consensus       124 NkdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFG  198 (668)
T KOG0611|consen  124 NKDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFG  198 (668)
T ss_pred             CCceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccc
Confidence            9999999999999999999998876  6899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |+..+....   ..+++||++.|.+||++.+..|. ..+|.|||||+||.|+.|..||++....   .++......    
T Consensus       199 LSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvrQIs~G----  268 (668)
T KOG0611|consen  199 LSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVRQISRG----  268 (668)
T ss_pred             hhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHHHhhcc----
Confidence            998875532   34568999999999999998885 6899999999999999999999875322   222211110    


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                       .+           +.+..+..+.-||++||..||.+|.|+.+|..|-
T Consensus       269 -aY-----------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  269 -AY-----------REPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -cc-----------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence             00           1112256678899999999999999999998774

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-45  Score=368.97  Aligned_cols=268  Identities=30%  Similarity=0.440  Sum_probs=207.3

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeeeeE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~  207 (491)
                      +..++|++.+.||+|+||.||+|.+....    ...++..||||++..... ...+.+.+|+.+|..+ +||||++++++
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGID----KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGA   79 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccC----CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence            34568999999999999999999864211    112456899999975432 2345688999999999 89999999998


Q ss_pred             Eeec-CceEEEEEecCCCChHHHhhhCC----------------------------------------------------
Q 011180          208 CIED-DQRLLVYEFMPRGSLENHLFRKG----------------------------------------------------  234 (491)
Q Consensus       208 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------  234 (491)
                      +... +.+++||||+++|+|.+++....                                                    
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            8764 45789999999999999986532                                                    


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeecc
Q 011180          235 --------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV  306 (491)
Q Consensus       235 --------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~  306 (491)
                              ...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..............
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  236 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA  236 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence                    124778888999999999999999988   999999999999999999999999999865433222222234


Q ss_pred             ccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCCh
Q 011180          307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSI  385 (491)
Q Consensus       307 ~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  385 (491)
                      .++..|+|||++.+..++.++|||||||+||||++ |..||........  ....    +....      ..    ..+.
T Consensus       237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~~----~~~~~------~~----~~~~  300 (338)
T cd05102         237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQR----LKDGT------RM----RAPE  300 (338)
T ss_pred             CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHH----HhcCC------CC----CCCC
Confidence            56788999999999999999999999999999997 9999975432111  1110    00000      00    1112


Q ss_pred             hhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          386 KGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       386 ~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      ..+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         301 NATPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            33678999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=360.07  Aligned_cols=264  Identities=25%  Similarity=0.338  Sum_probs=207.8

Q ss_pred             HHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--------------cHHHHHHHHHHH
Q 011180          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------GHKEWLAEVNFL  193 (491)
Q Consensus       128 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~E~~il  193 (491)
                      .....++|++++.||+|.||.|-+|++..         +++.||||++.+....              ..+.+.+||.||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~---------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIail  162 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEV---------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAIL  162 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecC---------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHH
Confidence            34555789999999999999999999876         6779999999754221              235788999999


Q ss_pred             hcCCCCceeeeeeEEeec--CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 011180          194 GNLLHPNLVKLVGYCIED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  271 (491)
Q Consensus       194 ~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlK  271 (491)
                      ++|+|||||+|+++..+.  +.+|||+|||..|.+...-...  ..+.+.++++|+++++.||+|||.++   |||||||
T Consensus       163 Kkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~--~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIK  237 (576)
T KOG0585|consen  163 KKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK--PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIK  237 (576)
T ss_pred             HhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCc--ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccc
Confidence            999999999999998764  6899999999998876543222  13889999999999999999999999   9999999


Q ss_pred             CCcEEECCCCCeEEeccCCcccCCCC---CCceeeeccccCCCCCCchhhhcCC----CCccccchhHHHHHHHHHhCCC
Q 011180          272 TSNILLDADYNAKLSDFGLAKDAPED---GKTHVSTRVMGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEMLTGRR  344 (491)
Q Consensus       272 p~NILl~~~~~~kL~DFGla~~~~~~---~~~~~~~~~~Gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~  344 (491)
                      |+|+||+++|++||+|||.+......   +........+|||.|||||.+.++.    .+.+.||||+||+||.|+.|+.
T Consensus       238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~  317 (576)
T KOG0585|consen  238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL  317 (576)
T ss_pred             hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence            99999999999999999998866322   1111223478999999999988742    3568999999999999999999


Q ss_pred             CCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          345 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       345 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ||-..........                +.+..+.-.-.......+++||++||.+||..|.++.+|..|......
T Consensus       318 PF~~~~~~~l~~K----------------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  318 PFFDDFELELFDK----------------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             CcccchHHHHHHH----------------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            9966533222111                111112111112347889999999999999999999999988764444

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=352.11  Aligned_cols=280  Identities=27%  Similarity=0.364  Sum_probs=220.7

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEec--CCCcccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ....|...+.||+|+||.|..|.+..         +|..||||.+.  .+.....++.++|+++|+.++|+||+.+++++
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~---------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~   90 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKR---------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIF   90 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcC---------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeec
Confidence            34567778999999999999999887         77899999997  34455668899999999999999999999998


Q ss_pred             ee-----cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          209 IE-----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       209 ~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ..     -+.+|+|+|+| +.+|...|....  .+....+..++.||+.||+|+|+.+   |+||||||+|+|++.+..+
T Consensus        91 ~p~~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~l  164 (359)
T KOG0660|consen   91 RPPSRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDL  164 (359)
T ss_pred             ccccccccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCE
Confidence            76     35789999999 678998886653  5889999999999999999999999   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||||||+|+...........+..+-|..|.|||++.. ..|+.++||||+||||.||++|++.|.+........++....
T Consensus       165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l  244 (359)
T KOG0660|consen  165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL  244 (359)
T ss_pred             EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence            9999999998864433334466788999999998864 689999999999999999999999998876655444332211


Q ss_pred             cccCC----------ccchhhccCcc----ccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhcCccccccc
Q 011180          363 PHLGD----------KRRFYRLLDPR----LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNLKDMA  426 (491)
Q Consensus       363 ~~~~~----------~~~~~~~~~~~----l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--L~~l~~~~~~~  426 (491)
                      ....+          .+.+..-+...    +...|+ ..++.+.+|+.+||..||.+|+|++|+|+|  |..+....+.+
T Consensus       245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            11100          00111111111    111122 447889999999999999999999999987  56666555544

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.9e-44  Score=353.92  Aligned_cols=252  Identities=29%  Similarity=0.416  Sum_probs=205.6

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      |++.+.||+|+||.||+|.+..         +|..||||.+......   ....+.+|+.+|..++|+||+++++++.+.
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~   72 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK   72 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEec---------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence            7788999999999999999876         6779999998754322   234578899999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        73 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~  149 (285)
T cd05631          73 DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLA  149 (285)
T ss_pred             CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            99999999999999998886655456899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ........   .....||..|+|||++.+..++.++|||||||++|||++|+.||..............   ...     
T Consensus       150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~-----  218 (285)
T cd05631         150 VQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RVK-----  218 (285)
T ss_pred             EEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---Hhh-----
Confidence            87543221   2345799999999999999999999999999999999999999976543221111110   000     


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  415 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~  415 (491)
                          .  ....++...+..+.+|+.+||..||.+||+     +++++++
T Consensus       219 ----~--~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         219 ----E--DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ----c--ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence                0  011122334678999999999999999997     7888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8e-44  Score=353.89  Aligned_cols=272  Identities=28%  Similarity=0.441  Sum_probs=208.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCc-------ccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTA-------PVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l  204 (491)
                      ++|.+.+.||+|+||.||+|.+......       ....+++..||+|++..... ....++.+|+.+|..++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            5799999999999999999987543211       11234566899999976532 234578999999999999999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKG-----------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIY  267 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH  267 (491)
                      ++++.+.+..+|||||+++|+|.+++....                 ...+++..++.++.||+.||.|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999886432                 124677888999999999999999988   999


Q ss_pred             cCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh--CCCC
Q 011180          268 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRRS  345 (491)
Q Consensus       268 rDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~p  345 (491)
                      |||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999987644333333334556889999999998899999999999999999987  4566


Q ss_pred             CCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          346 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       346 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      |......   ..............       .......+..++..+.+|+.+||..||.+|||+.+|.+.|+
T Consensus       242 ~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDE---QVIENAGEFFRDQG-------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHH---HHHHHHHHHhhhcc-------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            6543221   11111111000000       00001112234678999999999999999999999998886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-45  Score=366.57  Aligned_cols=267  Identities=26%  Similarity=0.441  Sum_probs=215.4

Q ss_pred             hhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCcee
Q 011180          125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLV  202 (491)
Q Consensus       125 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv  202 (491)
                      ..++.+..+++.+...||.|.||+||+|.|..            .||||+++.+...  ..+.|..|+.+|++-+|.||+
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIl  451 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENIL  451 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhe
Confidence            35666777788899999999999999999975            5999999877554  346799999999999999999


Q ss_pred             eeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      -++|||..... .||+.+|+|-+|+.+|+-.. ..|.....+.|+.||++|+.|||.++   |||||||..||+|.++++
T Consensus       452 LFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~k  526 (678)
T KOG0193|consen  452 LFMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLK  526 (678)
T ss_pred             eeehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCc
Confidence            99999988776 99999999999999997654 36888889999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  359 (491)
                      |||+||||+..-.............|...|||||+++.   .+|+..+||||||||+|||++|..||........    .
T Consensus       527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI----i  602 (678)
T KOG0193|consen  527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI----I  602 (678)
T ss_pred             EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe----E
Confidence            99999999875433222222233568889999999974   4789999999999999999999999973322211    1


Q ss_pred             hhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          360 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      |.   .+...     +.+.+ .....+++.++++|+..||..++++||.+.+|+..|+.+..
T Consensus       603 fm---VGrG~-----l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  603 FM---VGRGY-----LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             EE---ecccc-----cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            11   11110     00111 01123568899999999999999999999999998887655

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=357.53  Aligned_cols=246  Identities=25%  Similarity=0.343  Sum_probs=203.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||++.....   ...+.+.+|+.+|+.++||||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   71 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRI---------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH   71 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence            368999999999999999999875         577999999965432   23456788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..++||||+++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          72 DQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             cCCeEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecC
Confidence            9999999999999999999997654  6888999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++.......     ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+      .... 
T Consensus       147 ~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i------~~~~-  214 (291)
T cd05612         147 FAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI------LAGK-  214 (291)
T ss_pred             cchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC-
Confidence            998664321     2357999999999999889999999999999999999999999654321111110      0000 


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~  415 (491)
                                 ..++...+..+.+||++||+.||.+||+     +.+++++
T Consensus       215 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 -----------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -----------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                       0112223678899999999999999995     8888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-44  Score=363.34  Aligned_cols=246  Identities=27%  Similarity=0.401  Sum_probs=203.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .+|.+.+.||+|+||.||+|++..         ++..||||++.....   ...+.+.+|+.+|..++||||+++++++.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   88 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKG---------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ   88 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            469999999999999999999876         677999999975422   23456889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +++..|+||||+++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        89 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         89 DENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             cCCEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeecc
Confidence            9999999999999999999997654  5788888999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++.......     ...+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ..+.   ..... 
T Consensus       164 ~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~---i~~~~-  231 (329)
T PTZ00263        164 FAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYEK---ILAGR-  231 (329)
T ss_pred             CceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHHH---HhcCC-
Confidence            998764322     23579999999999999999999999999999999999999996543211   1110   00000 


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~  415 (491)
                                 ..++...+..+.+||.+||+.||.+||+     +.+++.|
T Consensus       232 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        232 -----------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -----------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                       0111223677899999999999999997     6787766

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-44  Score=341.90  Aligned_cols=267  Identities=24%  Similarity=0.329  Sum_probs=211.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.....|++|+||+||+|+++.         ++..||+|.++.+....  .-.-++||.+|.+++|||||.+-.+..-
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~---------t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG  146 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKK---------TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG  146 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCC---------cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence            468888999999999999999876         77899999998664211  1245899999999999999999988764


Q ss_pred             c--CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          211 D--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       211 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .  +.+|||||||+. +|..++...+ .++...++..++.|++.||+|||.+.   |+|||||++|+|++..|.+||+||
T Consensus       147 ~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDF  221 (419)
T KOG0663|consen  147 SNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADF  221 (419)
T ss_pred             cccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEeccc
Confidence            3  579999999954 8999887765 58999999999999999999999999   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh------
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA------  361 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~------  361 (491)
                      |+|+.+...-.  ..+..+-|..|+|||.+.+. .|+.++|+||+|||+.||+++++.|.+....+..+.+-..      
T Consensus       222 GLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte  299 (419)
T KOG0663|consen  222 GLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE  299 (419)
T ss_pred             chhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence            99998866532  24567789999999999874 7999999999999999999999999887765554433211      


Q ss_pred             --hcccCCcc-----chhhccCccccCCCChh-hHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 --RPHLGDKR-----RFYRLLDPRLEGHFSIK-GSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 --~~~~~~~~-----~~~~~~~~~l~~~~~~~-~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        ++.+....     .+....-..+...|... .++...+|+..+|..||.+|.|+.+.|++
T Consensus       300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence              11111100     00000111122223322 36888999999999999999999999865

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.7e-44  Score=360.73  Aligned_cols=243  Identities=32%  Similarity=0.412  Sum_probs=199.6

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  215 (491)
                      ++||+|+||.||+|.+..         +|..||||++.....   .....+.+|+.+|..++||||+++++++...+..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05571           1 KLLGKGTFGKVILVREKA---------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence            469999999999999876         677999999975422   22356788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCC
Q 011180          216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  295 (491)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~  295 (491)
                      |||||+++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        72 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          72 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            9999999999999987654  6889999999999999999999988   9999999999999999999999999987543


Q ss_pred             CCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhcc
Q 011180          296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  375 (491)
Q Consensus       296 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (491)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   .....   ....       
T Consensus       147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~---~~~~-------  211 (323)
T cd05571         147 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI---LMEE-------  211 (323)
T ss_pred             cCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHH---HcCC-------
Confidence            2221  1234679999999999999999999999999999999999999996532211   11110   0000       


Q ss_pred             CccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       376 ~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                           ..++...+..+.+||.+||+.||++||     ++.+++++
T Consensus       212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         212 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence                 012223467899999999999999999     79999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-44  Score=375.77  Aligned_cols=267  Identities=24%  Similarity=0.299  Sum_probs=216.0

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeE-
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGY-  207 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~-  207 (491)
                      +...++++++.|.+|||+.||+|.+..         .|..||+|.+-.......+.+.+||.+|+.|. |+|||.|++. 
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss  104 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSS  104 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence            445578899999999999999999875         34789999987666677788999999999998 9999999993 


Q ss_pred             Eeec------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 011180          208 CIED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       208 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~  281 (491)
                      ....      -+++|+||||.||.|-|++..+....|.+.++++|+.++++|+++||... .+|||||||-|||||+.++
T Consensus       105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g  183 (738)
T KOG1989|consen  105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADG  183 (738)
T ss_pred             cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCC
Confidence            2221      25679999999999999998776667999999999999999999999987 7899999999999999999


Q ss_pred             CeEEeccCCcccCCCCCCcee-------eeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 011180          282 NAKLSDFGLAKDAPEDGKTHV-------STRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  351 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~-------~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~  351 (491)
                      ..||||||.|......-....       .-...-|+.|+|||++.   +..++.|+|||+|||+||-|++...||+....
T Consensus       184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~  263 (738)
T KOG1989|consen  184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK  263 (738)
T ss_pred             CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence            999999999874322111100       00123589999999875   67899999999999999999999999976532


Q ss_pred             CCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccccccc
Q 011180          352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMA  426 (491)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~~~~~  426 (491)
                      ..                    +++..+.-.-....+..+.+||+.||+.||.+||++-+|+..+..+.+.....
T Consensus       264 la--------------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~  318 (738)
T KOG1989|consen  264 LA--------------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI  318 (738)
T ss_pred             ee--------------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence            21                    12222211122355899999999999999999999999999998877655443

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.2e-43  Score=349.43  Aligned_cols=246  Identities=21%  Similarity=0.328  Sum_probs=200.5

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCceeeeeeEEee----c
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIE----D  211 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~----~  211 (491)
                      ..||+|++|.||+|.+           +|..||||.+.......   .+.+.+|+.+|.+++|||||++++++.+    .
T Consensus        26 ~~i~~g~~~~v~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~   94 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-----------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL   94 (283)
T ss_pred             eEEeeCCceEEEEEEE-----------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence            6799999999999987           46789999997654333   3567799999999999999999999877    3


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ...++||||+++|+|.+++....  .+++.....++.|++.||.|||+. +   ++||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~  169 (283)
T PHA02988         95 PRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGL  169 (283)
T ss_pred             CceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccch
Confidence            46789999999999999997654  678889999999999999999984 6   88999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ++......     ....|+..|+|||++.+  ..++.++|||||||++|||++|..||.......   +....   ....
T Consensus       170 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i---~~~~  238 (283)
T PHA02988        170 EKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLI---INKN  238 (283)
T ss_pred             Hhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---HhcC
Confidence            88654321     23468999999999876  689999999999999999999999997543211   11110   0000


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                ....++..++..+.+|+.+||+.||.+|||+.++++.|+.++.
T Consensus       239 ----------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        239 ----------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ----------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                      0111222357889999999999999999999999999987753

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=358.65  Aligned_cols=252  Identities=27%  Similarity=0.340  Sum_probs=216.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc---HHHHHHHHHHHhcCC-CCceeeeeeE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLL-HPNLVKLVGY  207 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~-HpnIv~l~~~  207 (491)
                      ...|.+.+.||.|.||.||+|+.+.         +|..+|+|++.+.....   ...+.+|+.+|++|. |||||.++++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~---------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~  104 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKS---------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA  104 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecC---------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3468999999999999999999876         68899999998776543   357899999999999 9999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC----CCCe
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA----DYNA  283 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~----~~~~  283 (491)
                      |.+...+++|||+|.||.|.+.|...   .+++..+..++.||+.++.|||+.+   |+||||||+|||+..    ++.+
T Consensus       105 ~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~i  178 (382)
T KOG0032|consen  105 FEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRI  178 (382)
T ss_pred             EEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcE
Confidence            99999999999999999999999877   2899999999999999999999988   999999999999943    3579


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      |++|||++.....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+...  
T Consensus       179 k~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--  253 (382)
T KOG0032|consen  179 KLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--  253 (382)
T ss_pred             EEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--
Confidence            9999999998765   22345689999999999999999999999999999999999999999876544333222111  


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                  +..+...+....+..+.++|++||..||.+|+|+.++|+|
T Consensus       254 ------------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 ------------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ------------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                        1122333344558999999999999999999999999997

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-44  Score=359.82  Aligned_cols=254  Identities=26%  Similarity=0.359  Sum_probs=207.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||++.....   .....+..|+.++..++||||+++++++.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~   71 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKD---------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ   71 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            368999999999999999999875         577899999975422   23456788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..||||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          72 DDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             cCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCc
Confidence            9999999999999999999997654  6788999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++.....     .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+......+.   
T Consensus       147 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---  218 (333)
T cd05600         147 LSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ---  218 (333)
T ss_pred             CCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---
Confidence            9986543     22346799999999999999999999999999999999999999976443221111110000000   


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                            .+.. .......+.++.+||.+||..+|.+||++.+++++
T Consensus       219 ------~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 ------RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ------CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                  0000 00001336789999999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-43  Score=349.35  Aligned_cols=268  Identities=23%  Similarity=0.287  Sum_probs=204.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||+|+||.||+|++..         ++..||||++.....  ...+.+.+|+.+++.++||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR   71 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECC---------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence            369999999999999999999875         677899999875432  234567899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..++||||++++.|..+....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~  146 (287)
T cd07848          72 RGKLYLVFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGF  146 (287)
T ss_pred             CCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccC
Confidence            99999999999887666544322  36888999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC----
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----  366 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~----  366 (491)
                      +......... ......||+.|+|||++.+..++.++|||||||++|||++|++||...........+......+.    
T Consensus       147 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd07848         147 ARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM  225 (287)
T ss_pred             cccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence            9876432221 12345789999999999988999999999999999999999999976433221111111000000    


Q ss_pred             ----CccchhhccCccc------cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 ----DKRRFYRLLDPRL------EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ----~~~~~~~~~~~~l------~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          ....+.....+..      ...+....+..+.+||.+||+.||.+|||++++++|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                0000000000000      001111246789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.4e-43  Score=362.86  Aligned_cols=264  Identities=27%  Similarity=0.406  Sum_probs=206.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      .++|++.+.||+|+||.||+|.+...    ....++..||||+++... ....+.+.+|+.+|..+ +||||+++++++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            34799999999999999999975321    112256789999997543 23345688999999999 8999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCC-------------------------------------------------------
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKG-------------------------------------------------------  234 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------------------------  234 (491)
                      +.+..++|||||++|+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            9999999999999999999986432                                                       


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCC
Q 011180          235 ------------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  296 (491)
Q Consensus       235 ------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~  296 (491)
                                        ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                              124778889999999999999999988   99999999999999999999999999987644


Q ss_pred             CCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhcc
Q 011180          297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  375 (491)
Q Consensus       297 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (491)
                      ...........++..|+|||++.+..++.++|||||||++|||++ |..||.......  ..........          
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~----------  334 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEGY----------  334 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhCc----------
Confidence            332222222345678999999999999999999999999999998 888886532211  1111111100          


Q ss_pred             CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       376 ~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                          ....+...+.++.+||.+||+.||.+||++.+|++.|+.
T Consensus       335 ----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         335 ----RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                000111235789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.6e-44  Score=378.33  Aligned_cols=266  Identities=29%  Similarity=0.457  Sum_probs=221.2

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ...+....+.||+|+||+||+|......    .......||||.++..... ..++|.+|+++|..|+|||||+|+|+|.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~----p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLL----PGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCC----CCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            3446677789999999999999875422    1224578999999877655 6789999999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCC--------CCC----CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKG--------SLP----LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~----l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl  277 (491)
                      +++.+|+|+|||..|+|.++|...+        +.+    +...+.+.||.|||.|+.||-++.   +|||||-.+|+||
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLV  636 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLV  636 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhcee
Confidence            9999999999999999999997532        223    888999999999999999999988   9999999999999


Q ss_pred             CCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011180          278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN  356 (491)
Q Consensus       278 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~  356 (491)
                      .++..|||+||||++.....++........-..+|||||.+..+.|+.+||||||||+|||+++ |..|+.+....+   
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---  713 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---  713 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---
Confidence            9999999999999998877666655544555789999999999999999999999999999998 777776543322   


Q ss_pred             hhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      .++..+.             ..+ -.-+..++.++++||..||+.+|.+||+++||-..|+...
T Consensus       714 VIe~i~~-------------g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  714 VIECIRA-------------GQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             HHHHHHc-------------CCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            2222211             111 2334567999999999999999999999999999998653

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-43  Score=363.01  Aligned_cols=265  Identities=27%  Similarity=0.411  Sum_probs=208.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|++...+.    ..++..||||++..... .....+.+|+.+|+.+ .|+|||++++++.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGK----EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCc----ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            3479999999999999999998754221    12456899999975432 2345688999999999 8999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCC-------------------------------------------------------
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKG-------------------------------------------------------  234 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~-------------------------------------------------------  234 (491)
                      ..+..++|||||++|+|.+++....                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            9999999999999999999885421                                                       


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCce
Q 011180          235 -------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH  301 (491)
Q Consensus       235 -------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~  301 (491)
                                   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.........
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                         124678888999999999999999988   9999999999999999999999999998664432222


Q ss_pred             eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhccCcccc
Q 011180          302 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE  380 (491)
Q Consensus       302 ~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  380 (491)
                      ......++..|||||++.+..++.++|||||||++|||++ |..||........  .......              ...
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~~~--------------~~~  333 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMVKR--------------GYQ  333 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHHHc--------------ccC
Confidence            2223345678999999998999999999999999999997 9999965432211  1111000              000


Q ss_pred             CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          381 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       381 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ...+...+.++.+|+.+||+.||.+|||+.+|++.|+++
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111112367899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.1e-43  Score=354.22  Aligned_cols=266  Identities=25%  Similarity=0.381  Sum_probs=207.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|++.+.||+|+||.||++++..         ++..||+|++..... .....+.+|+++|+.++||||+++++++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            4689999999999999999999875         677899999976532 234578899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ++..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~  150 (331)
T cd06649          75 DGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV  150 (331)
T ss_pred             CCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence            999999999999999999987654  5888999999999999999999853  299999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc--
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--  368 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--  368 (491)
                      +.......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||............  ........  
T Consensus       151 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~  224 (331)
T cd06649         151 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF--GRPVVDGEEG  224 (331)
T ss_pred             cccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh--cccccccccC
Confidence            97664321    23357999999999999889999999999999999999999999653321110000  00000000  


Q ss_pred             --------------------------cchhhccCc----cccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          369 --------------------------RRFYRLLDP----RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       369 --------------------------~~~~~~~~~----~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                                                ......++-    ..........+.++.+||.+||+.||++|||+.+|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                      000000000    000000112367899999999999999999999999774

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.3e-43  Score=348.13  Aligned_cols=267  Identities=24%  Similarity=0.354  Sum_probs=204.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|.+.+.||.|+||.||+|.+..         ++..||+|++..... .....+.+|+.+++.++||||+++++++.++
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE   75 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECC---------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            469999999999999999998875         677899999875432 2335678999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||++ ++|.+++...+. .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~  150 (288)
T cd07871          76 RCLTLVFEYLD-SDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLA  150 (288)
T ss_pred             CeEEEEEeCCC-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcce
Confidence            99999999996 589998866543 5788899999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh--------h
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--------R  362 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~--------~  362 (491)
                      +........  .....|++.|+|||++.+ ..++.++|||||||++|+|++|++||...........+...        .
T Consensus       151 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07871         151 RAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW  228 (288)
T ss_pred             eeccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence            765332211  233568999999998865 56899999999999999999999999765433222111100        0


Q ss_pred             cccCCccchhhccCccccC----CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 PHLGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      +.......+...+.+....    ......+.++.+||.+||..||.+|||++|+++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0011111111111111100    0011236788999999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-44  Score=357.29  Aligned_cols=252  Identities=27%  Similarity=0.395  Sum_probs=214.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|..++.+|+|+||.+++++++.+         +..|++|.+.......  ......|+.+++++.|||||.+++.|.+
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~---------~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~   74 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSD---------DKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE   74 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccC---------CceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence            4688999999999999999999874         4489999998665433  3457889999999999999999999999


Q ss_pred             cCc-eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          211 DDQ-RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       211 ~~~-~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      ++. ++|||+||+||+|.+.|.+.....+++..+..++.||+.||.|||++.   |+|||||+.||+++.++.|||+|||
T Consensus        75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfG  151 (426)
T KOG0589|consen   75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFG  151 (426)
T ss_pred             CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchh
Confidence            988 999999999999999998887778999999999999999999999877   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +|+.+....  ......+||+.||.||++.+.+|+.|+|||||||++|||++-+++|.......   ++......     
T Consensus       152 laK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~~~-----  221 (426)
T KOG0589|consen  152 LAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKINRG-----  221 (426)
T ss_pred             hhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHhhc-----
Confidence            999886543  23345789999999999999999999999999999999999999997654322   11111100     


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          .     ....+...+.++..||+.||..+|..||++.++|.+
T Consensus       222 ----~-----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 ----L-----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----c-----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                1     112233347899999999999999999999999976

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.1e-43  Score=355.01  Aligned_cols=243  Identities=29%  Similarity=0.389  Sum_probs=199.4

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  215 (491)
                      +.||+|+||.||+|.+..         ++..||||++.....   .....+.+|+.+|+.++||||+++++++...+..+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   71 (328)
T cd05593           1 KLLGKGTFGKVILVREKA---------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC   71 (328)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence            469999999999999876         677999999975422   23456788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCC
Q 011180          216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  295 (491)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~  295 (491)
                      |||||+++|+|.+++....  .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        72 lv~Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          72 FVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             EEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            9999999999999886654  6889999999999999999999988   9999999999999999999999999987543


Q ss_pred             CCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhcc
Q 011180          296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  375 (491)
Q Consensus       296 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (491)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ...   ......       
T Consensus       147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~---~~~~~~-------  211 (328)
T cd05593         147 TDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE---LILMED-------  211 (328)
T ss_pred             Cccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHH---HhccCC-------
Confidence            2211  1234679999999999998999999999999999999999999996542211   111   010000       


Q ss_pred             CccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       376 ~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                           ..++...+..+.+||.+||..||.+|+     ++.+++++
T Consensus       212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         212 -----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                 012223367899999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.7e-43  Score=355.44  Aligned_cols=248  Identities=25%  Similarity=0.362  Sum_probs=195.4

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +|...+.||+|+||.||+|.+..         ++..||||++..... ...+.+.+|+++|+.++|+||+++++++.+.+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  145 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRP---------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG  145 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECC---------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence            56778899999999999998875         567899999865432 23456889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+..      ...+..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       146 ~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~  216 (353)
T PLN00034        146 EIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSR  216 (353)
T ss_pred             eEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccce
Confidence            999999999999986532      3456777889999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      .......  .....+||..|+|||++..     ...+.++|||||||++|||++|+.||..........+.....  .. 
T Consensus       217 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~-  291 (353)
T PLN00034        217 ILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MS-  291 (353)
T ss_pred             ecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--cc-
Confidence            6643221  1233579999999998743     234568999999999999999999997432221111111000  00 


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                 .........+.++.+||.+||..||++|||+.|++++
T Consensus       292 -----------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 -----------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       0011122346789999999999999999999999975

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-43  Score=357.57  Aligned_cols=247  Identities=26%  Similarity=0.329  Sum_probs=203.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|.+...        .+..||+|++.....   ...+.+.+|+.++..++||||+++++++.
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~  101 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK  101 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            4699999999999999999987642        235899999865321   23456788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..|+||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG  176 (340)
T PTZ00426        102 DESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFG  176 (340)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCC
Confidence            9999999999999999999997654  6888999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++......     ....+||+.|+|||++.+..++.++|||||||++|||++|..||........   ...   ..... 
T Consensus       177 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~---i~~~~-  244 (340)
T PTZ00426        177 FAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---YQK---ILEGI-  244 (340)
T ss_pred             CCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---HHH---HhcCC-
Confidence            99865432     1235799999999999988999999999999999999999999975432111   100   00000 


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                                 ..++...+..+.++|++||+.||.+|+     ++++++++
T Consensus       245 -----------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 -----------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                       011222367789999999999999995     89998876

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.7e-43  Score=343.58  Aligned_cols=263  Identities=28%  Similarity=0.484  Sum_probs=211.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||+|+||.||+|.+.....    ......||+|.+..... ....++.+|+.++..++||||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNE----RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCC----CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            368899999999999999998765321    11446899999875432 2345688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl  277 (491)
                      +..+++|||+++++|.+++.....              ..+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~  157 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV  157 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence            999999999999999999875421              35788889999999999999999988   9999999999999


Q ss_pred             CCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011180          278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN  356 (491)
Q Consensus       278 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~  356 (491)
                      ++++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.......   
T Consensus       158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---  234 (283)
T cd05048         158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---  234 (283)
T ss_pred             cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999986544333223334567889999999988899999999999999999998 999987543221   


Q ss_pred             hhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      .......              ......+..++.++.+|+.+||+.||.+||++.+|+++|+.+
T Consensus       235 ~~~~i~~--------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         235 VIEMIRS--------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHHHc--------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            1111110              001112234578999999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=333.84  Aligned_cols=254  Identities=24%  Similarity=0.348  Sum_probs=208.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++.|.+.+.||+|.|+.||++.+..         +|+.+|+|+++...+  .+.+++.+|++|-+.|+|||||++.+.+.
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~---------tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~   80 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   80 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhcc---------chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence            4568888999999999999998876         888999999875533  35678899999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---CCCeEEe
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLS  286 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~---~~~~kL~  286 (491)
                      +....|||+|+|.|++|..-|..+  .-+++..+-.++.||+++|.|+|.++   |||||+||+|+|+..   .--+||+
T Consensus        81 ~~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~  155 (355)
T KOG0033|consen   81 EESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLA  155 (355)
T ss_pred             ccceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeec
Confidence            999999999999999998766554  35777888889999999999999999   999999999999943   3469999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||+|..+...   ......+|||.|||||++...+|+..+|||+.|||||-|+.|.+||++....   .+.+.....  
T Consensus       156 ~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~~g--  227 (355)
T KOG0033|consen  156 DFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIKAG--  227 (355)
T ss_pred             ccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHhcc--
Confidence            99999988632   2334578999999999999999999999999999999999999999764322   121111110  


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                       .-    .    +.+.+....++++++|+++||..||.+|.|+.|+|+|-
T Consensus       228 -~y----d----~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp  268 (355)
T KOG0033|consen  228 -AY----D----YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP  268 (355)
T ss_pred             -cc----C----CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence             00    1    11222334578999999999999999999999999764

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-43  Score=351.51  Aligned_cols=241  Identities=32%  Similarity=0.375  Sum_probs=196.8

Q ss_pred             cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       141 lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      ||+|+||.||+|.+..         ++..||+|++....   ......+.+|+.+|..++||||+++++++.+.+..++|
T Consensus         1 lg~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   71 (312)
T cd05585           1 IGKGSFGKVMQVRKRD---------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV   71 (312)
T ss_pred             CCcCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence            7999999999999875         57789999987532   22345678899999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      |||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        72 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  146 (312)
T cd05585          72 LAFINGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD  146 (312)
T ss_pred             EcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence            99999999999997654  5888999999999999999999988   999999999999999999999999999864322


Q ss_pred             CCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCc
Q 011180          298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  377 (491)
Q Consensus       298 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (491)
                      .  ......+||+.|+|||++.+..++.++|||||||++|||++|..||......      +.....+...         
T Consensus       147 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~---------  209 (312)
T cd05585         147 D--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEP---------  209 (312)
T ss_pred             C--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCC---------
Confidence            2  1223467999999999999999999999999999999999999999653211      1111111110         


Q ss_pred             cccCCCChhhHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 011180          378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPR---MSEVVET  415 (491)
Q Consensus       378 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt---~~evl~~  415 (491)
                         ..++...+..+.+||.+||..||.+||+   +.+++.+
T Consensus       210 ---~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         210 ---LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             ---CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence               0122234678999999999999999985   5666655

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=358.37  Aligned_cols=243  Identities=30%  Similarity=0.475  Sum_probs=203.4

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCce
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      ...++-||.|+-|.||+|+++           ++.||||.++.       .-..+|+-|++|+||||+.|.|+|....-+
T Consensus       126 IsELeWlGSGaQGAVF~Grl~-----------netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcy  187 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH-----------NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCY  187 (904)
T ss_pred             hhhhhhhccCcccceeeeecc-----------CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCcee
Confidence            444567999999999999985           45899998742       223589999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      |||||||..|-|...|....  .+.......+..+||.|+.|||.+.   |||||||.-||||..+..|||+|||.++..
T Consensus       188 CIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  188 CIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             EEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhh
Confidence            99999999999999997654  6788888999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .+.   ...-.++||..|||||++.....+.|+|||||||||||||||..||..-...    .+.|.     -...    
T Consensus       263 ~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwG-----VGsN----  326 (904)
T KOG4721|consen  263 SDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWG-----VGSN----  326 (904)
T ss_pred             hhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEe-----ccCC----
Confidence            543   1223489999999999999999999999999999999999999999643221    11121     1111    


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                         .|.-..+..|++-++-||++||.-.|..||++.+|+.||+-.
T Consensus       327 ---sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  327 ---SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ---cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence               122234556788999999999999999999999999999743

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.3e-43  Score=354.03  Aligned_cols=243  Identities=31%  Similarity=0.399  Sum_probs=198.7

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  215 (491)
                      +.||+|+||.||++.+..         +|..||+|++.....   .....+.+|+.+++.++||||+++++++...+..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05595           1 KLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence            469999999999999865         677999999975422   22345678999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCC
Q 011180          216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  295 (491)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~  295 (491)
                      |||||+++|+|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        72 lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          72 FVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            9999999999998887654  6889999999999999999999988   9999999999999999999999999987543


Q ss_pred             CCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhcc
Q 011180          296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  375 (491)
Q Consensus       296 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (491)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   ...   .....       
T Consensus       147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~---~~~~~-------  211 (323)
T cd05595         147 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FEL---ILMEE-------  211 (323)
T ss_pred             CCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---HHH---HhcCC-------
Confidence            2211  12346799999999999999999999999999999999999999965432111   110   00000       


Q ss_pred             CccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       376 ~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                           ..++...+..+.+||.+||..||.+|+     ++.+++++
T Consensus       212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         212 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence                 012223367899999999999999998     88998876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.2e-43  Score=340.35  Aligned_cols=260  Identities=25%  Similarity=0.402  Sum_probs=207.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|++.+.||+|+||.||+|.+....      ..+..||+|.++.... .....+.+|+.++..++||||+++++++..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   77 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPS------KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR   77 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCC------CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence            346899999999999999999876432      2567899999976532 233568899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..+|||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||.
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~  153 (266)
T cd05064          78 GNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRR  153 (266)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcc
Confidence            999999999999999999987653 36889999999999999999999988   99999999999999999999999998


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ......    +..
T Consensus       154 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~----~~~  225 (266)
T cd05064         154 LQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAVE----DGF  225 (266)
T ss_pred             cccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHH----CCC
Confidence            7654322111 1112345678999999999999999999999999999775 999996543221   111110    000


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                                ....+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus       226 ----------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 ----------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                      0011223467899999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=349.68  Aligned_cols=249  Identities=25%  Similarity=0.370  Sum_probs=215.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccH--HHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      +-|.+++.||+|.|.+|-+|++..         +|..||||++.+..+...  ..+.+|++.|+.++|||||+||++...
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVF---------TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT   88 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVF---------TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT   88 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhc---------ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence            458999999999999999999876         889999999988766543  468899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-CCCCCeEEeccC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNAKLSDFG  289 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl-~~~~~~kL~DFG  289 (491)
                      ...+|||+|+-++|+|+|+|.++.. .+.+..+.+++.||+.|+.|+|+.+   +|||||||+||.+ .+-|-|||.|||
T Consensus        89 QTKlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   89 QTKLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             cceEEEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecc
Confidence            9999999999999999999988754 6899999999999999999999999   9999999999987 567899999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ++..+......   +..||+..|.|||++.+..|+ +++||||||||||-|++|++||......+..             
T Consensus       165 FSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL-------------  228 (864)
T KOG4717|consen  165 FSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL-------------  228 (864)
T ss_pred             ccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh-------------
Confidence            99888654432   457999999999999999887 5899999999999999999999765433322             


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         ..++|-.  ...+...+.++++||..||.+||.+|.+.++|..+
T Consensus       229 ---TmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  229 ---TMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ---hhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence               2233332  23455568999999999999999999999999864

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.8e-43  Score=359.08  Aligned_cols=254  Identities=26%  Similarity=0.315  Sum_probs=200.5

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .|.+++.||+|+||+||+|.+..         ++..||||++.....   .....+.+|+.+|+.++||||+++++++.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~   72 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVD---------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD   72 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence            58899999999999999998875         677999999975432   223567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..||||||+++|+|.+++....  .+++..+..++.||+.||.|||..+   |+||||||+||||+.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          73 KDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcC
Confidence            999999999999999999987654  5788888999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCC---------------------------------------------ceeeeccccCCCCCCchhhhcCCCCc
Q 011180          291 AKDAPEDGK---------------------------------------------THVSTRVMGTYGYAAPEYVMTGHLTS  325 (491)
Q Consensus       291 a~~~~~~~~---------------------------------------------~~~~~~~~Gt~~y~aPE~~~~~~~~~  325 (491)
                      +........                                             .......+||+.|+|||++.+..++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (381)
T cd05626         148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ  227 (381)
T ss_pred             CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence            764311000                                             00112357999999999999889999


Q ss_pred             cccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhh--hcCC
Q 011180          326 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL--SRDP  403 (491)
Q Consensus       326 ~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL--~~dP  403 (491)
                      ++|||||||++|||++|..||...........+  .  ....          .+........+.++.+||.+|+  ..++
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i--~--~~~~----------~~~~~~~~~~s~~~~dli~~ll~~~~~~  293 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV--I--NWEN----------TLHIPPQVKLSPEAVDLITKLCCSAEER  293 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHH--H--cccc----------ccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence            999999999999999999999764432111100  0  0000          0000011123678899999854  5566


Q ss_pred             CCCCCHHHHHHH
Q 011180          404 KARPRMSEVVET  415 (491)
Q Consensus       404 ~~RPt~~evl~~  415 (491)
                      ..|+++.+++++
T Consensus       294 ~~R~~~~~~l~h  305 (381)
T cd05626         294 LGRNGADDIKAH  305 (381)
T ss_pred             cCCCCHHHHhcC
Confidence            669999999976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=359.42  Aligned_cols=254  Identities=25%  Similarity=0.340  Sum_probs=202.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++.....   .....+.+|+.+|..++||||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~   71 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKD---------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ   71 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            379999999999999999999876         677999999975421   22345778999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..||||||+++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          72 DENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             cCCeEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecc
Confidence            9999999999999999999997654  5889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCce------------------------------------eeeccccCCCCCCchhhhcCCCCccccchhHH
Q 011180          290 LAKDAPEDGKTH------------------------------------VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFG  333 (491)
Q Consensus       290 la~~~~~~~~~~------------------------------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlG  333 (491)
                      ++..+.......                                    .....+||+.|+|||++.+..++.++||||||
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  226 (364)
T cd05599         147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG  226 (364)
T ss_pred             cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence            987543211000                                    01124699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC---HH
Q 011180          334 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR---MS  410 (491)
Q Consensus       334 vil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt---~~  410 (491)
                      |++|||++|..||.........   ..   .......        +........+..+.+||.+||. +|.+|++   +.
T Consensus       227 ~il~el~~G~~Pf~~~~~~~~~---~~---i~~~~~~--------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~  291 (364)
T cd05599         227 VIMYEMLVGYPPFCSDNPQETY---RK---IINWKET--------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN  291 (364)
T ss_pred             hHHHHhhcCCCCCCCCCHHHHH---HH---HHcCCCc--------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence            9999999999999754322111   00   0000000        0000011236788999999996 9999997   88


Q ss_pred             HHHHH
Q 011180          411 EVVET  415 (491)
Q Consensus       411 evl~~  415 (491)
                      +++++
T Consensus       292 ~ll~h  296 (364)
T cd05599         292 EIKSH  296 (364)
T ss_pred             HHhcC
Confidence            88876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9e-43  Score=343.57  Aligned_cols=267  Identities=25%  Similarity=0.346  Sum_probs=199.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcC---CCCceeeeeeE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNL---LHPNLVKLVGY  207 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~HpnIv~l~~~  207 (491)
                      ++|++.+.||+|+||.||+|.+...        .+..||||.+......  ....+.+|+.+++.+   .||||++++++
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~   72 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   72 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCC--------CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence            3699999999999999999987542        4568999998654322  234566777777665   69999999998


Q ss_pred             Eee-----cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          208 CIE-----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       208 ~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      +..     ....++||||+. ++|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~  148 (290)
T cd07862          73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ  148 (290)
T ss_pred             EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCC
Confidence            852     356899999995 69999987665556899999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      +||+|||+++.....   .......||+.|+|||.+.+..++.++|||||||++|||++|.+||......+....+....
T Consensus       149 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~  225 (290)
T cd07862         149 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  225 (290)
T ss_pred             EEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence            999999999765432   12234578999999999998899999999999999999999999997654322111110000


Q ss_pred             cccCCccchh-------hccCccc---cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 PHLGDKRRFY-------RLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~~~~~~~~~~-------~~~~~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       .......+.       ..+.+..   ........+..+.+|+.+||+.||++|||+.+++++
T Consensus       226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         226 -GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             -CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence             000000000       0000000   000111236778999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.8e-43  Score=352.02  Aligned_cols=267  Identities=26%  Similarity=0.383  Sum_probs=199.8

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|++.+.||+|+||.||+|.+..         ++..||||.+...  .......+.+|+.+|+.++||||+++++++...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   71 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTH---------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP   71 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence            48889999999999999999875         6779999998643  223345688999999999999999999988643


Q ss_pred             C-----ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          212 D-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       212 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      .     ..|+||||| +++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~  145 (338)
T cd07859          72 SRREFKDIYVVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKIC  145 (338)
T ss_pred             CCCCCceEEEEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEc
Confidence            2     479999999 578999886654  5889999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCc-eeeeccccCCCCCCchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          287 DFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       287 DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      |||+++........ ......+||+.|+|||++.+  ..++.++|||||||++|||++|++||...........+.....
T Consensus       146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~  225 (338)
T cd07859         146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG  225 (338)
T ss_pred             cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence            99999865332211 12234679999999999875  6789999999999999999999999965432111110000000


Q ss_pred             --------cc--CCccchhhccCccccCCC---ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 --------HL--GDKRRFYRLLDPRLEGHF---SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 --------~~--~~~~~~~~~~~~~l~~~~---~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                              .+  .....+...+.......+   ....+..+.+|+.+||+.||.+|||+++++++
T Consensus       226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                    00  000000000000000000   01235678999999999999999999999976

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.2e-42  Score=337.88  Aligned_cols=256  Identities=27%  Similarity=0.410  Sum_probs=209.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .+|.+.+.||+|+||.||+|.+..         ++..||+|.+..+. ....++.+|+++++.+.|+||+++++++..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   75 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence            468888999999999999999875         56689999987553 34567899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+++.......+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          76 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccc
Confidence            9999999999999999997665556899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ......         
T Consensus       153 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~---------  219 (263)
T cd05052         153 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE---------  219 (263)
T ss_pred             ccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH---------
Confidence            76443221 1112234668999999998999999999999999999998 889986532211   111110         


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                           .......+...+..+.+|+.+||..||++||++.++++.|+.+
T Consensus       220 -----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         220 -----KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -----CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                 0111122233468899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-42  Score=365.52  Aligned_cols=270  Identities=22%  Similarity=0.335  Sum_probs=198.6

Q ss_pred             hhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC------C
Q 011180          125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL------H  198 (491)
Q Consensus       125 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~------H  198 (491)
                      .+++....++|++.++||+|+||+||+|.+..         ++..||||+++... ....++..|+.++..+.      |
T Consensus       121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~  190 (467)
T PTZ00284        121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRK---------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADR  190 (467)
T ss_pred             CCccccCCCcEEEEEEEEeccCEEEEEEEEcC---------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccC
Confidence            34455667899999999999999999999865         57789999996432 22334556777776665      4


Q ss_pred             CceeeeeeEEeec-CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEE
Q 011180          199 PNLVKLVGYCIED-DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       199 pnIv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlKp~NIL  276 (491)
                      .+|++++++|... ..+|||||++ +++|.+++.+.+  .+++..+..|+.||+.||.|||. .+   ||||||||+|||
T Consensus       191 ~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NIL  264 (467)
T PTZ00284        191 FPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENIL  264 (467)
T ss_pred             cceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence            5689999988765 5688999998 789999887654  68899999999999999999997 47   999999999999


Q ss_pred             ECCCC----------------CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHH
Q 011180          277 LDADY----------------NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML  340 (491)
Q Consensus       277 l~~~~----------------~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ell  340 (491)
                      |+.++                .+||+|||++.....     .....+||+.|+|||++.+..|+.++|||||||+||||+
T Consensus       265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell  339 (467)
T PTZ00284        265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY  339 (467)
T ss_pred             EecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence            98665                499999998764322     123468999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCCCcchhhHhhhcccCC----------ccchhhc---cCccccC-----------CCChhhHHHHHHHHH
Q 011180          341 TGRRSMDKNRPNGEHNLVEWARPHLGD----------KRRFYRL---LDPRLEG-----------HFSIKGSQKATQLAA  396 (491)
Q Consensus       341 tG~~pf~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~---~~~~l~~-----------~~~~~~~~~l~~li~  396 (491)
                      +|+.||...........+......+..          ...++..   +.+....           .........+.+||.
T Consensus       340 tG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~  419 (467)
T PTZ00284        340 TGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIY  419 (467)
T ss_pred             hCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHH
Confidence            999999765432222221111000000          0000000   0000000           000112456789999


Q ss_pred             HhhhcCCCCCCCHHHHHHH
Q 011180          397 QCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       397 ~cL~~dP~~RPt~~evl~~  415 (491)
                      +||+.||.+|||++|+|+|
T Consensus       420 ~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        420 GLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             HhCCcChhhCCCHHHHhcC
Confidence            9999999999999999976

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9e-43  Score=367.58  Aligned_cols=254  Identities=24%  Similarity=0.299  Sum_probs=206.2

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCc
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  213 (491)
                      .|.+.+.||+|+||.||+|....+        .+..||+|.+..........+.+|+.+|+.++|||||++++++...+.
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~  139 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK  139 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence            388999999999999999987652        256799998765544444567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          214 RLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      .||||||+++|+|.++|...  ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCc
Confidence            99999999999999987542  2346888999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      +..............+||+.|+|||++.+..++.++|||||||++|||++|+.||......   ....   ..+..    
T Consensus       217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~---~~~~~----  286 (478)
T PTZ00267        217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQ---QVLYG----  286 (478)
T ss_pred             eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHhC----
Confidence            8765433323334567999999999999999999999999999999999999999653221   1111   00000    


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        ..+     .++...+..+.+||.+||..||.+||++.+++.+
T Consensus       287 --~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        287 --KYD-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             --CCC-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence              000     1122336789999999999999999999999764

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1e-42  Score=350.45  Aligned_cols=256  Identities=29%  Similarity=0.387  Sum_probs=203.0

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc----ccHHHHHHHHHHHhcCC-CCceeeeeeEE
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLL-HPNLVKLVGYC  208 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~-HpnIv~l~~~~  208 (491)
                      +|++.+.||+|+||.||+++.....      .++..||+|++.+...    ...+.+..|+.++..+. |+||+++++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGH------DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF   74 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccC------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence            4889999999999999999875322      2678999999965321    22345778999999995 99999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      ...+..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        75 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          75 QTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             ecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeC
Confidence            99999999999999999999987654  5888999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      |+++........ .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...........+.  ....  
T Consensus       150 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~--  224 (332)
T cd05614         150 GLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRIL--  224 (332)
T ss_pred             cCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHh--
Confidence            999865432222 12346799999999998765 47889999999999999999999996543222211110  0000  


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                            ..++    .++...+..+.+|+.+||+.||++||     ++++++++
T Consensus       225 ------~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         225 ------KCDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ------cCCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                  0111    12223367889999999999999999     77788876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.4e-43  Score=352.98  Aligned_cols=244  Identities=30%  Similarity=0.402  Sum_probs=198.4

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  215 (491)
                      +.||+|+||.||+|.+..         +|..||+|++.....   .....+..|++++..++||||+++++++...+..|
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~   71 (325)
T cd05594           1 KLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC   71 (325)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence            469999999999998865         677999999975422   23356778999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      |||||+++|+|.+++....  .+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 lv~E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          72 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            9999999999999886654  68899999999999999999997 57   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+      ....      
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i------~~~~------  212 (325)
T cd05594         147 IKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEE------  212 (325)
T ss_pred             CCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH------hcCC------
Confidence            32221  123357999999999999999999999999999999999999999654321111110      0000      


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  416 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~L  416 (491)
                            ..++...+..+.+|+.+||+.||.+|+     ++.+++++-
T Consensus       213 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  253 (325)
T cd05594         213 ------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK  253 (325)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence                  011222367899999999999999997     899999773

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.2e-43  Score=349.97  Aligned_cols=246  Identities=30%  Similarity=0.442  Sum_probs=198.6

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc----ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      +.||+|+||.||+++.....      .++..||||++.....    .....+..|+.+|+.++||||+++++++..++..
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~   75 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGA------DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL   75 (323)
T ss_pred             ceeeecCCeEEEEEEEcccC------CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence            67999999999999875322      2678999999975422    2234567899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      |+||||+++++|.+++...+  .+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          76 YLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            99999999999999987654  5778888899999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ...   ....        
T Consensus       151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~~~---~~~~--------  214 (323)
T cd05584         151 IHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---TID---KILK--------  214 (323)
T ss_pred             ccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---HHH---HHHc--------
Confidence            32221  1234579999999999998889999999999999999999999996543211   111   0000        


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                        ..  ..++...+..+.+||.+||+.||.+||     ++.+++++
T Consensus       215 --~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         215 --GK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             --CC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence              00  012223367889999999999999999     88888876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-42  Score=350.10  Aligned_cols=266  Identities=26%  Similarity=0.400  Sum_probs=205.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|++.+.||+|+||.||+|.+..         ++..||+|.+..... .....+.+|+++|+.++|+||+++++++.+
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence            4689999999999999999998875         577899999876532 234568899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      .+..+|||||+++++|.+++...+  .+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg  149 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG  149 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCC
Confidence            999999999999999999997654  578889999999999999999974 5   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc----
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL----  365 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~----  365 (491)
                      ++.......    .....||..|+|||++.+..++.++|||||||++|+|++|+.||...................    
T Consensus       150 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (333)
T cd06650         150 VSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES  225 (333)
T ss_pred             cchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence            987653321    223568999999999998899999999999999999999999997543221111000000000    


Q ss_pred             -----------------CCcc---chhhccCcccc---CCCC-hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          366 -----------------GDKR---RFYRLLDPRLE---GHFS-IKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       366 -----------------~~~~---~~~~~~~~~l~---~~~~-~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                       ...+   ......+....   ..++ ...+.++.+||.+||+.||.+|||+.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                             0000   00000000000   0000 1125678999999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9.1e-43  Score=355.30  Aligned_cols=255  Identities=25%  Similarity=0.343  Sum_probs=200.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||+||+|.+..         ++..||||++.....   .....+.+|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~   71 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKD---------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ   71 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            479999999999999999998875         677999999975422   22346778999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +....|||||||++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          72 DKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             cCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeecc
Confidence            9999999999999999999997654  6889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCc---------------------------------eeeeccccCCCCCCchhhhcCCCCccccchhHHHHH
Q 011180          290 LAKDAPEDGKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL  336 (491)
Q Consensus       290 la~~~~~~~~~---------------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil  336 (491)
                      +++........                                 ......+||+.|+|||++.+..++.++|||||||++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil  226 (363)
T cd05628         147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence            98754321100                                 001235799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhh--cCCCCCCCHHHHHH
Q 011180          337 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLS--RDPKARPRMSEVVE  414 (491)
Q Consensus       337 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~--~dP~~RPt~~evl~  414 (491)
                      |||++|..||...........+.   . .....    .+.+    .  ...+..+.+||.+|+.  .++..||++++|++
T Consensus       227 ~ell~G~~Pf~~~~~~~~~~~i~---~-~~~~~----~~p~----~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~  292 (363)
T cd05628         227 YEMLIGYPPFCSETPQETYKKVM---N-WKETL----IFPP----E--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKT  292 (363)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHH---c-CcCcc----cCCC----c--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence            99999999997543321111110   0 00000    0000    0  1136788899988664  23345689999987


Q ss_pred             H
Q 011180          415 T  415 (491)
Q Consensus       415 ~  415 (491)
                      +
T Consensus       293 h  293 (363)
T cd05628         293 N  293 (363)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-42  Score=344.63  Aligned_cols=266  Identities=22%  Similarity=0.328  Sum_probs=200.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++...... ....+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKV---------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT   74 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECC---------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence            3579999999999999999999875         5778999999754322 23467889999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ....++||||+ .++|.+++.... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~  149 (303)
T cd07869          75 KETLTLVFEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGL  149 (303)
T ss_pred             CCeEEEEEECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCc
Confidence            99999999999 468888876543 35788889999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC--
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD--  367 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--  367 (491)
                      +........  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  .........++.  
T Consensus       150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~  225 (303)
T cd07869         150 ARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPN  225 (303)
T ss_pred             ceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCC
Confidence            875432211  1233568999999998875 468899999999999999999999997542211  111110000000  


Q ss_pred             ccch---hh--ccCc---------cccCCCC-hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRF---YR--LLDP---------RLEGHFS-IKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~---~~--~~~~---------~l~~~~~-~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...+   ..  .+.+         .+...++ ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            0000   00  0000         0000000 0124678899999999999999999999965

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-43  Score=356.08  Aligned_cols=254  Identities=30%  Similarity=0.372  Sum_probs=206.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||++.....   .....+..|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKD---------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ   71 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence            369999999999999999999875         577999999975422   23456788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +++..|+||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          72 DEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             cCCeEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCC
Confidence            9999999999999999999997763  6889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCC---------------------------CceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhC
Q 011180          290 LAKDAPEDG---------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG  342 (491)
Q Consensus       290 la~~~~~~~---------------------------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG  342 (491)
                      ++.......                           .........||+.|+|||++.+..++.++|||||||+||||++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence            998664432                           00112335799999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 011180          343 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVET  415 (491)
Q Consensus       343 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-~~evl~~  415 (491)
                      +.||...........+      .....        .+........+..+.+||.+||. ||.+||+ +.+++++
T Consensus       227 ~~Pf~~~~~~~~~~~i------~~~~~--------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         227 FPPFYSDTLQETYNKI------INWKE--------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCCCHHHHHHHH------hccCC--------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            9999765422111100      00000        00000011137889999999997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-42  Score=349.29  Aligned_cols=246  Identities=27%  Similarity=0.425  Sum_probs=196.7

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHH---hcCCCCceeeeeeEE
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFL---GNLLHPNLVKLVGYC  208 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il---~~l~HpnIv~l~~~~  208 (491)
                      |++.+.||+|+||.||+|.+..         ++..||||++.....   ...+.+.+|++++   ..+.||||+++++++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~   71 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKK---------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF   71 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence            6788999999999999998875         677999999975421   2234566666655   567899999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..|+||||+++++|..++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          72 QTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcc
Confidence            9999999999999999999887542   5889999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |++........  .....+||+.|+|||++.+..++.++|||||||++|||++|..||........   ..   ......
T Consensus       146 g~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~~---~i~~~~  217 (324)
T cd05589         146 GLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---FD---SIVNDE  217 (324)
T ss_pred             cCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---HH---HHHhCC
Confidence            99875432221  12346799999999999999999999999999999999999999975432111   11   000000


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                                  ..++...+..+.+||.+||+.||.+||     ++.+++++
T Consensus       218 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         218 ------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                        012223367889999999999999999     56777665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.1e-42  Score=345.79  Aligned_cols=261  Identities=24%  Similarity=0.405  Sum_probs=206.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .+|++.+.||+|+||.||+|.+..++..     .+..||||++..... ...+++.+|+.+++.++||||+++++++...
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCc-----cceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            4699999999999999999998653321     244699999875432 3346788999999999999999999998764


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                       ..++|+||+++|+|.+++..... .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a  156 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLA  156 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccc
Confidence             57899999999999999976543 5788889999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ......    ... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~-  228 (316)
T cd05108         157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KGE-  228 (316)
T ss_pred             ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh----CCC-
Confidence            87654333222222345678999999999999999999999999999997 999986532211   111110    000 


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                               ....+..++..+.+++.+||..||.+||++.+++..|..+.
T Consensus       229 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         229 ---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                     00111223567899999999999999999999999987663

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-43  Score=357.95  Aligned_cols=255  Identities=23%  Similarity=0.318  Sum_probs=200.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||++.....   ...+.+.+|++++..+.||||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~   71 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKD---------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ   71 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            378999999999999999998876         677999999865422   22356788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..||||||+++|+|.+++...+  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          72 DAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             cCCeeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecc
Confidence            9999999999999999999987654  6788899999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCc---------------------------------------------eeeeccccCCCCCCchhhhcCCCC
Q 011180          290 LAKDAPEDGKT---------------------------------------------HVSTRVMGTYGYAAPEYVMTGHLT  324 (491)
Q Consensus       290 la~~~~~~~~~---------------------------------------------~~~~~~~Gt~~y~aPE~~~~~~~~  324 (491)
                      +++........                                             ......+||+.|+|||++.+..++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  226 (377)
T cd05629         147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG  226 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence            98643211000                                             000124799999999999999999


Q ss_pred             ccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCC
Q 011180          325 SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK  404 (491)
Q Consensus       325 ~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~  404 (491)
                      .++|||||||++|||++|..||...........+      ......+ .     +..  ....+.++.+||.+||. +|.
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~~~-~-----~p~--~~~~s~~~~dli~~lL~-~~~  291 (377)
T cd05629         227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKI------INWRETL-Y-----FPD--DIHLSVEAEDLIRRLIT-NAE  291 (377)
T ss_pred             CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHH------HccCCcc-C-----CCC--CCCCCHHHHHHHHHHhc-CHh
Confidence            9999999999999999999999654322111100      0000000 0     000  01236789999999997 666


Q ss_pred             CC---CCHHHHHHHh
Q 011180          405 AR---PRMSEVVETL  416 (491)
Q Consensus       405 ~R---Pt~~evl~~L  416 (491)
                      +|   +++.+++++-
T Consensus       292 ~r~~r~~~~~~l~hp  306 (377)
T cd05629         292 NRLGRGGAHEIKSHP  306 (377)
T ss_pred             hcCCCCCHHHHhcCC
Confidence            65   5999998763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.3e-42  Score=348.64  Aligned_cols=248  Identities=28%  Similarity=0.398  Sum_probs=199.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCC-CceeeeeeEEe
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLH-PNLVKLVGYCI  209 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H-pnIv~l~~~~~  209 (491)
                      +|++.+.||+|+||.||+|.+..         ++..||||++.....   ...+.+..|++++..+.| ++|+.+++++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   71 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence            58899999999999999998875         567899999975421   234567889999999976 56888999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..|+||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          72 TMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecC
Confidence            9999999999999999999987654  5788999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++........  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ......   ..  
T Consensus       147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~---~~--  216 (324)
T cd05587         147 MCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSIM---EH--  216 (324)
T ss_pred             cceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH---cC--
Confidence            9875322211  1234679999999999999999999999999999999999999996543211   111110   00  


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~  415 (491)
                                ...++...+..+.+|+.+||..||.+|++.     .+++++
T Consensus       217 ----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         217 ----------NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                      011222346788999999999999999986     555544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.1e-42  Score=338.89  Aligned_cols=264  Identities=25%  Similarity=0.423  Sum_probs=207.2

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      +.+++|++.+.||+|+||.||+|.+...    .....+..||||.+..... ....++.+|+.+++.++||||+++++++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~   78 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            3566899999999999999999987531    1122467899999865432 2345688999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGS--------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  280 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~  280 (491)
                      .+....++||||+++++|.+++.....        ..+++..+..++.|++.||.|||+.+   ++||||||+|||++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~  155 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED  155 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCC
Confidence            999999999999999999999865321        23577888999999999999999988   9999999999999999


Q ss_pred             CCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 011180          281 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       281 ~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~  359 (491)
                      +.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......   ....
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~  232 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR  232 (277)
T ss_pred             CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH
Confidence            9999999999986544322222222356788999999998899999999999999999999 68888643221   1111


Q ss_pred             hhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          360 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      ....   ..  .         ...+...+..+.+|+.+||+.||.+|||+.++++.|+
T Consensus       233 ~~~~---~~--~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         233 FVME---GG--L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHc---CC--c---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1100   00  0         0111233678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.2e-42  Score=347.79  Aligned_cols=243  Identities=29%  Similarity=0.433  Sum_probs=194.1

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  214 (491)
                      +.||+|+||.||+|.+..         ++..||||+++....   ...+.+..|..++..+ .||||+++++++...+..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~   71 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG---------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            469999999999999875         677899999975421   2234556677777654 799999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      ++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            99999999999999987654  6888999999999999999999988   999999999999999999999999999765


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......   .....   ...       
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~i---~~~-------  211 (316)
T cd05592         147 MNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDSI---LND-------  211 (316)
T ss_pred             CCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHHH---HcC-------
Confidence            3322  12234679999999999998899999999999999999999999997543211   11100   000       


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~-evl~~  415 (491)
                           ...++...+.++.+|+.+||+.||.+||++. +++++
T Consensus       212 -----~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         212 -----RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence                 0112223367889999999999999999875 55443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.6e-43  Score=358.28  Aligned_cols=253  Identities=27%  Similarity=0.325  Sum_probs=199.7

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      +|.+.+.||+|+||.||+|++..         ++..||||++.....   .....+.+|+.+++.++|+||+++++++.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~   72 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVD---------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD   72 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence            58899999999999999999875         677899999975422   223567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..|||||||++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          73 KDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCC
Confidence            999999999999999999987654  5788889999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCC---------------------------------------------CceeeeccccCCCCCCchhhhcCCCCc
Q 011180          291 AKDAPEDG---------------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTS  325 (491)
Q Consensus       291 a~~~~~~~---------------------------------------------~~~~~~~~~Gt~~y~aPE~~~~~~~~~  325 (491)
                      +..+....                                             ........+||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (382)
T cd05625         148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ  227 (382)
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence            75331000                                             000112357999999999999999999


Q ss_pred             cccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCC
Q 011180          326 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA  405 (491)
Q Consensus       326 ~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~  405 (491)
                      ++|||||||+||||++|+.||....+......+.    ....          .+........+.++.+||.+|+ .+|.+
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~----~~~~----------~~~~p~~~~~s~~~~~li~~l~-~~p~~  292 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI----NWQT----------SLHIPPQAKLSPEASDLIIKLC-RGPED  292 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHH----ccCC----------CcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence            9999999999999999999997643321111000    0000          0000001123678899998876 59999


Q ss_pred             CCC---HHHHHHH
Q 011180          406 RPR---MSEVVET  415 (491)
Q Consensus       406 RPt---~~evl~~  415 (491)
                      |++   +.++++|
T Consensus       293 R~~~~~~~ei~~h  305 (382)
T cd05625         293 RLGKNGADEIKAH  305 (382)
T ss_pred             cCCCCCHHHHhcC
Confidence            987   8888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.3e-43  Score=359.34  Aligned_cols=253  Identities=26%  Similarity=0.294  Sum_probs=201.3

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      +|++.+.||+|+||.||+|.+..         ++..||||++.....   .....+.+|+.+|..+.|+||+++++++.+
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~   72 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVD---------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD   72 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence            69999999999999999999875         677999999865322   223557889999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ++.+|||||||++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~  147 (376)
T cd05598          73 KDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL  147 (376)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCC
Confidence            999999999999999999997654  5788888999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCC-----------------------------------------CceeeeccccCCCCCCchhhhcCCCCccccc
Q 011180          291 AKDAPEDG-----------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDV  329 (491)
Q Consensus       291 a~~~~~~~-----------------------------------------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~Dv  329 (491)
                      +..+....                                         ........+||+.|||||++.+..++.++||
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  227 (376)
T cd05598         148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  227 (376)
T ss_pred             CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence            75321000                                         0001123579999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC--
Q 011180          330 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP--  407 (491)
Q Consensus       330 wSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP--  407 (491)
                      |||||++|||++|+.||....+......+..    ..          ..+........+..+.+||.+|+ .+|.+|+  
T Consensus       228 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~----~~----------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~  292 (376)
T cd05598         228 WSVGVILYEMLVGQPPFLADTPAETQLKVIN----WE----------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGK  292 (376)
T ss_pred             eeccceeeehhhCCCCCCCCCHHHHHHHHhc----cC----------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence            9999999999999999976543221111100    00          00000111123678889999976 5999999  


Q ss_pred             -CHHHHHHH
Q 011180          408 -RMSEVVET  415 (491)
Q Consensus       408 -t~~evl~~  415 (491)
                       ++.+++++
T Consensus       293 ~t~~ell~h  301 (376)
T cd05598         293 NGADEIKAH  301 (376)
T ss_pred             CCHHHHhCC
Confidence             89999977

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.1e-44  Score=328.28  Aligned_cols=254  Identities=27%  Similarity=0.389  Sum_probs=208.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc----cc----HHHHHHHHHHHhcCC-CCcee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QG----HKEWLAEVNFLGNLL-HPNLV  202 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~----~~~~~~E~~il~~l~-HpnIv  202 (491)
                      ...|...+.||.|..++|.+|.++.         +|..+|+|++.....    ..    .+.-.+|+.||+++. ||||+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~---------t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II   86 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKE---------TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYII   86 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcc---------cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEE
Confidence            3468888999999999999998876         778899999864321    11    234567999999996 99999


Q ss_pred             eeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      .+.++|+.+..+++|+|.|+.|.|.|+|...-  .+++.....|+.|+.+|+.|||..+   ||||||||+|||++++.+
T Consensus        87 ~l~D~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~  161 (411)
T KOG0599|consen   87 DLQDVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMN  161 (411)
T ss_pred             EeeeeccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccc
Confidence            99999999999999999999999999997654  7899999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  356 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~  356 (491)
                      +||+|||++..+..+...   ...||||+|.|||.+..      ..|+..+|+|++|||||.|+.|.+||+.....-.  
T Consensus       162 i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM--  236 (411)
T KOG0599|consen  162 IKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM--  236 (411)
T ss_pred             eEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH--
Confidence            999999999988765433   45899999999999853      4688899999999999999999999975432211  


Q ss_pred             hhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                          .+..+.....|        ...-..+.+..+++||.+||+.||.+|.|++|+|.|-
T Consensus       237 ----LR~ImeGkyqF--------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  237 ----LRMIMEGKYQF--------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             ----HHHHHhccccc--------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence                11111111111        1111233478899999999999999999999999873

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.7e-42  Score=338.10  Aligned_cols=261  Identities=30%  Similarity=0.454  Sum_probs=209.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|.+.+.||+|+||.||+|.+....    ...++..||||.+...... ..+.+.+|+++|..+.|+||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLE----PENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeecccc----CcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            46888999999999999999875421    1124678999999765433 356789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKG------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  279 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~  279 (491)
                      ...++||||+++++|.+++...+            ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~  157 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGY  157 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcC
Confidence            99999999999999999997543            234788889999999999999999988   999999999999999


Q ss_pred             CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 011180          280 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV  358 (491)
Q Consensus       280 ~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~  358 (491)
                      ++.++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.......   ..
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~  234 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VI  234 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH
Confidence            99999999999976543322222233456788999999999999999999999999999998 999986543221   11


Q ss_pred             HhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      ......              .....+...+..+.+|+.+||..||.+||++.||++.|+
T Consensus       235 ~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ECITQG--------------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHcC--------------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            111100              000111233678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.8e-42  Score=355.21  Aligned_cols=267  Identities=23%  Similarity=0.373  Sum_probs=209.0

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~  208 (491)
                      ..++|.+.++||+|+||.||+|.+....    ....+..||||++..... ...+.+.+|+.+|.++. |||||++++++
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLS----RSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccC----CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            3467999999999999999999874321    112355799999975432 23456889999999996 99999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCC------------------------------------------------------
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKG------------------------------------------------------  234 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~------------------------------------------------------  234 (491)
                      .+.+..|||||||++|+|.++|....                                                      
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            99999999999999999999886421                                                      


Q ss_pred             ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 011180          235 ----------------------------------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  274 (491)
Q Consensus       235 ----------------------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~N  274 (491)
                                                              ...+++..+..++.||+.||.|||+.+   |+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence                                                    124677888899999999999999988   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 011180          275 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  353 (491)
Q Consensus       275 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~  353 (491)
                      ||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            9999999999999999986643322222233457789999999998899999999999999999997 889986532211


Q ss_pred             cchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      .  .......    .          .....+...+..+.+|+.+||+.||++|||+.+|.+.|+.+.
T Consensus       348 ~--~~~~~~~----~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 T--FYNKIKS----G----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             H--HHHHHhc----C----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            1  0000000    0          000112234678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.7e-43  Score=357.34  Aligned_cols=263  Identities=24%  Similarity=0.346  Sum_probs=209.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-C-----CceeeeeeE
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H-----PNLVKLVGY  207 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H-----pnIv~l~~~  207 (491)
                      +|.+.++||+|+||.|.+|++..         +++.||||+++... .-..+...|+.||..|+ |     -|||+++++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~---------T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~  256 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHK---------TGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY  256 (586)
T ss_pred             EEEEEEEecccccceeEEEEecC---------CCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence            78999999999999999999876         78899999997654 33456678999999997 4     589999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC--CCeEE
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD--YNAKL  285 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~--~~~kL  285 (491)
                      |...+++|||+|++ .-+|+++|..+....++...+..|+.||+.||.+||+.+   |||+||||+||||..-  ..|||
T Consensus       257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKV  332 (586)
T KOG0667|consen  257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKV  332 (586)
T ss_pred             cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeE
Confidence            99999999999999 679999999988888999999999999999999999988   9999999999999643  47999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc--
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--  363 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~--  363 (491)
                      +|||.|......-.     ..+-+..|+|||++.+..|+.+.||||||||++||++|.+.|.+....+....+.....  
T Consensus       333 IDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P  407 (586)
T KOG0667|consen  333 IDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP  407 (586)
T ss_pred             EecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence            99999987654322     34568899999999999999999999999999999999999988766543322211000  


Q ss_pred             ------ccCCccchhhc------------------------------cC---c----cccCCCChhhHHHHHHHHHHhhh
Q 011180          364 ------HLGDKRRFYRL------------------------------LD---P----RLEGHFSIKGSQKATQLAAQCLS  400 (491)
Q Consensus       364 ------~~~~~~~~~~~------------------------------~~---~----~l~~~~~~~~~~~l~~li~~cL~  400 (491)
                            .......++..                              .+   |    .+...........+.+|+++||.
T Consensus       408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~  487 (586)
T KOG0667|consen  408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE  487 (586)
T ss_pred             CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence                  00000001000                              00   0    00001112335678999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 011180          401 RDPKARPRMSEVVET  415 (491)
Q Consensus       401 ~dP~~RPt~~evl~~  415 (491)
                      .||.+|+|..++++|
T Consensus       488 ~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  488 WDPAERITPAQALNH  502 (586)
T ss_pred             cCchhcCCHHHHhcC
Confidence            999999999999987

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=358.05  Aligned_cols=272  Identities=29%  Similarity=0.446  Sum_probs=216.7

Q ss_pred             hhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCcee
Q 011180          126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLV  202 (491)
Q Consensus       126 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv  202 (491)
                      ..+.+..++..+.++||+|+||.||+|.++..+..     ....||||..+...   ....+++++|+++|+.++|||||
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-----~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV  224 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-----KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV  224 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCc-----eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence            44555666778889999999999999999763221     11228999998532   34567899999999999999999


Q ss_pred             eeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      ++||++..+..++||||+|.||+|.++|.+.+. .++..+...++.+++.||+|||+++   +|||||-.+|+|++.++.
T Consensus       225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~  300 (474)
T KOG0194|consen  225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGV  300 (474)
T ss_pred             EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCe
Confidence            999999999999999999999999999988765 6899999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  361 (491)
                      +||+|||+++.....  ........-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.........+.  
T Consensus       301 vKISDFGLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~--  376 (474)
T KOG0194|consen  301 VKISDFGLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV--  376 (474)
T ss_pred             EEeCccccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH--
Confidence            999999998865311  111101123578999999999999999999999999999999 788886654332211110  


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccccc
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD  424 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~~~  424 (491)
                          .          ....-..+...+..+..++.+||..||++||+|.++.+.|+.+.....
T Consensus       377 ----~----------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  377 ----K----------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ----h----------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                0          001111223447889999999999999999999999999987755443

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-42  Score=333.71  Aligned_cols=267  Identities=25%  Similarity=0.357  Sum_probs=206.3

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCc-eeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPN-LVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~  210 (491)
                      .|...++||+|+||+||+|+.+.         +|..||+|.+..+...  .-....+|+.+|++|.|+| ||.+++++..
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~---------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~   82 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKR---------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHT   82 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEec---------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence            46667789999999999999987         6789999999765432  2345689999999999999 9999999998


Q ss_pred             cC------ceEEEEEecCCCChHHHhhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          211 DD------QRLLVYEFMPRGSLENHLFRKGS--LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       211 ~~------~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      .+      .++|||||+ .-+|..++.....  ..++...+..++.||+.||+|||+++   |+||||||.||||+++|.
T Consensus        83 ~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~  158 (323)
T KOG0594|consen   83 SNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGV  158 (323)
T ss_pred             cccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCc
Confidence            87      789999999 6699999977653  35777889999999999999999999   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      +||+|||+|+...-....  .+..++|..|+|||++.+. .|+..+||||+|||++||+++++.|.+....+....+-..
T Consensus       159 lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~  236 (323)
T KOG0594|consen  159 LKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL  236 (323)
T ss_pred             EeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence            999999999966533222  3456789999999999986 8999999999999999999999999877653222211100


Q ss_pred             --------hcccC---Ccc-chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 --------RPHLG---DKR-RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 --------~~~~~---~~~-~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                              ++...   +.. .++..-.+......-........+++.+||+.+|.+|.|++.+++|
T Consensus       237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                    11110   000 1111110110000001113578999999999999999999999976

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=339.93  Aligned_cols=253  Identities=31%  Similarity=0.418  Sum_probs=204.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .|++.++||+|+||.||++.+..         ++..||||++......   ....+.+|+.+++.++||||+++++++..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcC---------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence            47888999999999999998865         5678999998654322   23456789999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCC
Confidence            999999999999999999887654456899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +........   ....+|++.|+|||++.+..++.++|||||||++|||++|..||...........+.  .....    
T Consensus       149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~--~~~~~----  219 (285)
T cd05605         149 AVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--RRVKE----  219 (285)
T ss_pred             ceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH--HHhhh----
Confidence            986543221   123578999999999998899999999999999999999999997543221111110  00000    


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                              ....++...+..+.+||.+||..||.+||     ++++++++
T Consensus       220 --------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 --------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             --------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                    00112223467889999999999999999     78888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.3e-42  Score=348.05  Aligned_cols=243  Identities=29%  Similarity=0.427  Sum_probs=196.1

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  214 (491)
                      ++||+|+||.||+|.+..         ++..||||++....   ......+..|+.++..+ +||||+++++++.+.+..
T Consensus         1 ~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   71 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL   71 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence            469999999999999876         57789999997542   12345667888888876 699999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        72 ~iv~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             EEEEcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            99999999999999887654  6888999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ....   .....      
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~---i~~~~------  212 (320)
T cd05590         147 IFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEA---ILNDE------  212 (320)
T ss_pred             CcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHH---HhcCC------
Confidence            32221  2234679999999999998899999999999999999999999997543211   1111   11100      


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~------~evl~~  415 (491)
                            ..++...+..+.+|+.+||+.||.+||++      ++++.+
T Consensus       213 ------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         213 ------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence                  01122236788999999999999999998      555544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.8e-42  Score=347.53  Aligned_cols=242  Identities=27%  Similarity=0.390  Sum_probs=196.9

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      +|.+.+.||+|+||.||+|++..         ++..||||++.+...   .....+..|..++..+ +|++|+++++++.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence            58889999999999999998875         577899999976432   2234567788888877 5899999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..+|||||+++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          72 TMDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             cCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCC
Confidence            9999999999999999999987654  5888999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   +....   ...  
T Consensus       147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i---~~~--  216 (323)
T cd05616         147 MCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSI---MEH--  216 (323)
T ss_pred             CceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHH---HhC--
Confidence            9875432221  1234679999999999999999999999999999999999999997543211   11110   000  


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM  409 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~  409 (491)
                                ...++...+.++.+|+.+||+.||.+|++.
T Consensus       217 ----------~~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         217 ----------NVAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ----------CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                      011222346789999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-42  Score=354.14  Aligned_cols=262  Identities=21%  Similarity=0.250  Sum_probs=199.9

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ..+|.+.+.||+|+||.||+|.+..         +++.||||....      ..+.+|+++|+.|+|||||++++++...
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~---------~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~  155 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNK---------TCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYN  155 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECC---------CCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEEC
Confidence            4579999999999999999999876         677999997532      3467899999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ...++|||++ .++|..++....  .+++..++.++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||++
T Consensus       156 ~~~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a  229 (391)
T PHA03212        156 KFTCLILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA  229 (391)
T ss_pred             CeeEEEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcc
Confidence            9999999999 578988886654  5788999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc----chhhHhhhcccCC
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE----HNLVEWARPHLGD  367 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~----~~~~~~~~~~~~~  367 (491)
                      +....... ......+||+.|+|||++.+..++.++|||||||++|||++|..||........    ...........+.
T Consensus       230 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~  308 (391)
T PHA03212        230 CFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT  308 (391)
T ss_pred             cccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence            75432211 122346799999999999999999999999999999999999988754322110    0000000000000


Q ss_pred             ---------c---cchh-hcc-----CccccCCC--ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 ---------K---RRFY-RLL-----DPRLEGHF--SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ---------~---~~~~-~~~-----~~~l~~~~--~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                               .   ...+ ...     .+.....+  ....+.++.+||.+||+.||.+|||+.|++++
T Consensus       309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                     0   0000 000     00000000  01235688999999999999999999999965

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.4e-42  Score=336.98  Aligned_cols=261  Identities=26%  Similarity=0.452  Sum_probs=207.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .+|++.+.||+|+||.||+|.+...+.     ..+..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGM-----DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCC-----CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            368889999999999999998743221     1567899999975432 2335788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKG---------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NIL  276 (491)
                      +..|+||||+++++|.+++....               ...+++..+..++.|++.||.|||+.+   |+||||||+|||
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEE
Confidence            99999999999999999985332               124788888999999999999999988   999999999999


Q ss_pred             ECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011180          277 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  355 (491)
Q Consensus       277 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~  355 (491)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......   
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---  233 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---  233 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence            99999999999999987644332222333456778999999988889999999999999999998 88888653221   


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                      ...+......              ....+..++..+.+++.+||+.||.+||++.+|+++|..
T Consensus       234 ~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         234 EVIEMVRKRQ--------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHcCC--------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1111111100              001112336789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-42  Score=333.69  Aligned_cols=261  Identities=26%  Similarity=0.455  Sum_probs=209.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|++.+.||+|+||.||+|.+.....      +...||||.+...... ....+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGK------KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK   76 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCC------CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence            3579999999999999999999865321      3457999998755322 34578899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||+
T Consensus        77 ~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~  152 (266)
T cd05033          77 SRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL  152 (266)
T ss_pred             CCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccch
Confidence            9999999999999999999876543 6889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ..........    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~----  225 (266)
T cd05033         153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVEDGY----  225 (266)
T ss_pred             hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHHcCC----
Confidence            987752222222222345678999999998899999999999999999998 99998543211   1111111000    


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                                ....+...+..+.+|+.+||+.+|++||++.+|+++|+.+
T Consensus       226 ----------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 ----------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                      0011123467899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.7e-42  Score=347.38  Aligned_cols=243  Identities=28%  Similarity=0.410  Sum_probs=197.0

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  214 (491)
                      ++||+|+||.||+|.+..         ++..||||++.....   .....+..|++++..+ +||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~   71 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG---------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL   71 (321)
T ss_pred             CccccCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence            469999999999998865         677999999975422   2334567899998866 799999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      ||||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          72 FFVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence            99999999999999887654  6888899999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ....   .....      
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~---i~~~~------  212 (321)
T cd05591         147 ILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFES---ILHDD------  212 (321)
T ss_pred             ccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHH---HHcCC------
Confidence            32221  1234679999999999998899999999999999999999999997543211   1111   11000      


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-------CHHHHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-------RMSEVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-------t~~evl~~  415 (491)
                            ..++...+.++.+|+.+||+.||.+||       ++.+++++
T Consensus       213 ------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 ------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence                  011222367889999999999999999       78888766

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.1e-42  Score=335.40  Aligned_cols=256  Identities=30%  Similarity=0.475  Sum_probs=211.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ..+|.+.+.||.|+||.||+|.+..          +..||+|++..........+.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG   74 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence            4568999999999999999998864          457999999877655567889999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~  151 (261)
T cd05148          75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLA  151 (261)
T ss_pred             CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccch
Confidence            99999999999999999998765557899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      .........  .....++..|+|||.+....++.++||||||+++|+|++ |..||.......   .......       
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~-------  219 (261)
T cd05148         152 RLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITA-------  219 (261)
T ss_pred             hhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHh-------
Confidence            876432211  123346778999999988899999999999999999998 899986543211   1111110       


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                             ......+...+..+.++|.+||..||.+|||+.++++.|+.+
T Consensus       220 -------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 -------GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                   011112234467899999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.1e-42  Score=349.07  Aligned_cols=265  Identities=28%  Similarity=0.414  Sum_probs=206.6

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      .++|++.++||+|+||.||+|......    ...+++.||+|++..... ...+.+.+|+.++.++ +|+||+++++++.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIE----KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccc----cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            357999999999999999999764321    112567899999875432 2345678899999999 7999999999886


Q ss_pred             ec-CceEEEEEecCCCChHHHhhhCCC-----------------------------------------------------
Q 011180          210 ED-DQRLLVYEFMPRGSLENHLFRKGS-----------------------------------------------------  235 (491)
Q Consensus       210 ~~-~~~~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------  235 (491)
                      .. ..+++||||+++++|.++|.....                                                     
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            54 567899999999999998864321                                                     


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccC
Q 011180          236 ------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT  309 (491)
Q Consensus       236 ------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt  309 (491)
                            ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||+++.+.............++
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                  25789999999999999999999988   999999999999999999999999999876443322222334567


Q ss_pred             CCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhH
Q 011180          310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGS  388 (491)
Q Consensus       310 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  388 (491)
                      ..|+|||++.+..++.++|||||||+||||++ |..||........  +.....    ...          ....+...+
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~~----~~~----------~~~~~~~~~  302 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRLK----EGT----------RMRAPEYAT  302 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHHh----ccC----------CCCCCccCC
Confidence            88999999999999999999999999999998 9999865332211  111100    000          000112235


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          389 QKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       389 ~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      .++.+|+.+||+.+|++||++.+|+++|+.+
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            7899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=355.89  Aligned_cols=254  Identities=26%  Similarity=0.429  Sum_probs=211.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +.|.|+..||.|+||.||+|..++         ++...|.|++........++++-||.||..+.||+||+|++.|+.++
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nke---------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en  102 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKE---------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN  102 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhccc---------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence            357888999999999999999876         56678889998776677788999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      .+||+.|||.||-++.++...++ .+.+.++..++.|++.||.|||+++   |||||||..|||++-+|.++|+|||.+.
T Consensus       103 kLwiliEFC~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSA  178 (1187)
T KOG0579|consen  103 KLWILIEFCGGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSA  178 (1187)
T ss_pred             ceEEEEeecCCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccc
Confidence            99999999999999988877755 7999999999999999999999988   9999999999999999999999999986


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      .....  ......+.|||+|||||+++     ..+|+.++||||||++|.||..+.+|.....+.-.  ++..+...-  
T Consensus       179 Kn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--llKiaKSeP--  252 (1187)
T KOG0579|consen  179 KNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSEP--  252 (1187)
T ss_pred             cchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HHHHhhcCC--
Confidence            54321  22234589999999999886     35899999999999999999999999765443221  111111110  


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                          ..++.       +...+..+.+|+++||.+||..||++.++++|-
T Consensus       253 ----PTLlq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp  290 (1187)
T KOG0579|consen  253 ----PTLLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP  290 (1187)
T ss_pred             ----CcccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence                01111       123377899999999999999999999999863

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.1e-42  Score=345.95  Aligned_cols=243  Identities=29%  Similarity=0.432  Sum_probs=195.0

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  214 (491)
                      ++||+|+||.||+|.+..         +|..||+|+++....   .....+..|+.++..+ +||||+++++++.+.+..
T Consensus         1 ~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~   71 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG---------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence            469999999999999875         677999999975421   2334567788888754 899999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      ||||||+.+|+|.+++....  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          72 FFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEECCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            99999999999999987654  5788899999999999999999988   999999999999999999999999998753


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+.+.....          
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~~~----------  211 (316)
T cd05620         147 VFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIRVD----------  211 (316)
T ss_pred             ccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhC----------
Confidence            22111  223467999999999999999999999999999999999999999654321   111111100          


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~-evl~~  415 (491)
                       .+    .++...+.++.+||.+||+.||.+||++. +++++
T Consensus       212 -~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         212 -TP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             -CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence             01    11122367889999999999999999985 55544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.6e-42  Score=346.22  Aligned_cols=250  Identities=26%  Similarity=0.399  Sum_probs=197.6

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  214 (491)
                      ++||+|+||.||+|.+..         ++..||||+++....   .....+.+|+.++..+ +||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~   71 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK---------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence            469999999999999876         577899999976432   2234577899999988 699999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      ||||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          72 FFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            99999999999999886654  6899999999999999999999988   999999999999999999999999998753


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc--chhhHhhhcccCCccchh
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  372 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||........  .....+....+       
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------  217 (329)
T cd05588         147 IRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-------  217 (329)
T ss_pred             ccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-------
Confidence            22211  12346799999999999999999999999999999999999999964322211  01111110000       


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR------MSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt------~~evl~~  415 (491)
                        ....  ..++...+..+.+||.+||+.||.+|++      +.+++++
T Consensus       218 --~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         218 --LEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             --HcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence              0000  0112233678899999999999999997      5677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.1e-43  Score=338.46  Aligned_cols=261  Identities=25%  Similarity=0.339  Sum_probs=199.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC-
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD-  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-  212 (491)
                      .|...+++|.|+||.||+|...+         ++..||||.+..+..    .-.+|+++|+.+.|||||+++.+|.... 
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~   91 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTE   91 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence            47778999999999999999987         567899998865532    3347999999999999999998887542 


Q ss_pred             ----ceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-CCeEE
Q 011180          213 ----QRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKL  285 (491)
Q Consensus       213 ----~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kL  285 (491)
                          ...||||||+. +|.+.+...  ....++...+.-+..||++||.|||+.+   |+||||||.|||+|.+ |.+||
T Consensus        92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKi  167 (364)
T KOG0658|consen   92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKI  167 (364)
T ss_pred             CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEe
Confidence                23589999965 899888631  2346777788889999999999999988   9999999999999866 99999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      ||||.|+.+......   ....-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+....+....+..... 
T Consensus       168 cDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG-  243 (364)
T KOG0658|consen  168 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG-  243 (364)
T ss_pred             ccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC-
Confidence            999999987543322   23456889999999986 4899999999999999999999999988655443322211100 


Q ss_pred             cCCcc------------chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 LGDKR------------RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+...            .+..+.......-+....++++.+|+.++|..+|.+|.++.|++.+
T Consensus       244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            00000            0111111111111334558899999999999999999999999865

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-42  Score=355.46  Aligned_cols=258  Identities=24%  Similarity=0.293  Sum_probs=205.3

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeee
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLV  205 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~  205 (491)
                      ....++|.+.+.||+|+||.||+|++..         ++..||+|++.....   .....+.+|+.+++.++||||++++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~  109 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKS---------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH  109 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence            3455689999999999999999999876         677899999965321   2234577899999999999999999


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      +++.+.+..||||||+++|+|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL  183 (370)
T cd05596         110 YAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL  183 (370)
T ss_pred             EEEecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEE
Confidence            9999999999999999999999988653   4778888899999999999999988   999999999999999999999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhcC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      +|||++......... .....+||+.|+|||++.+.    .++.++|||||||++|||++|..||...........    
T Consensus       184 ~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----  258 (370)
T cd05596         184 ADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK----  258 (370)
T ss_pred             EeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH----
Confidence            999999866432221 12345799999999998653    478999999999999999999999976432211110    


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETL  416 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~L  416 (491)
                        ......        .+.-......+..+.+||.+||..+|.+  |+++.+++++-
T Consensus       259 --i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         259 --IMDHKN--------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             --HHcCCC--------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence              000000        0000001123788999999999999988  99999999873

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8e-43  Score=350.94  Aligned_cols=254  Identities=25%  Similarity=0.281  Sum_probs=204.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||+++....   ...+.+.+|+.+++.+.|+||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~   71 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKA---------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ   71 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence            368999999999999999998876         677999999976432   23456788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..+|||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          72 DKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             cCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCC
Confidence            9999999999999999999997653 36889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhh------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      ++......... ......||+.|+|||++.      ...++.++|||||||++|||++|..||.........      ..
T Consensus       148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~  220 (330)
T cd05601         148 SAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY------NN  220 (330)
T ss_pred             CCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH------HH
Confidence            99876543222 223457999999999986      456789999999999999999999999654321110      00


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+... ..       +........+..+.+|+.+||. +|.+|||+.+++++
T Consensus       221 i~~~~-~~-------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         221 IMNFQ-RF-------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HHcCC-Cc-------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            00000 00       0000011236789999999997 99999999999865

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.9e-42  Score=338.39  Aligned_cols=265  Identities=29%  Similarity=0.455  Sum_probs=211.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||.||++......    ...++..||+|.+........+.+.+|+.++.++.||||+++++++...+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~----~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCC----CCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            47899999999999999999864311    11245679999997665455667899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKG-----------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~  281 (491)
                      ..++||||+++++|.+++...+           ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence            9999999999999999986542           124899999999999999999999988   99999999999999999


Q ss_pred             CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 011180          282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW  360 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~  360 (491)
                      .++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......   ....
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~  234 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC  234 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999986643332222233456788999999998899999999999999999998 898886543211   1111


Q ss_pred             hhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ....  .   .     .    ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       235 i~~~--~---~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         235 ITQG--R---V-----L----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHcC--C---c-----C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            1100  0   0     0    0011235679999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.7e-42  Score=364.68  Aligned_cols=256  Identities=26%  Similarity=0.331  Sum_probs=205.9

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||+|+||+||+|.+..         +|..||||++.....  .....+.+|+.+|..++|+||+++++.+
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~  100 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVS---------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF  100 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence            34689999999999999999998875         577999999976543  2345678899999999999999998877


Q ss_pred             eecC--------ceEEEEEecCCCChHHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC
Q 011180          209 IEDD--------QRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  278 (491)
Q Consensus       209 ~~~~--------~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~  278 (491)
                      ...+        .+++||||+++|+|.++|....  ...+++..+..++.|++.||.|||+.+   |+||||||+||||+
T Consensus       101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~  177 (496)
T PTZ00283        101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLC  177 (496)
T ss_pred             ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEe
Confidence            5432        3679999999999999986532  346889999999999999999999988   99999999999999


Q ss_pred             CCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011180          279 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  358 (491)
Q Consensus       279 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  358 (491)
                      .++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||+||||++|+.||......      
T Consensus       178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------  251 (496)
T PTZ00283        178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------  251 (496)
T ss_pred             CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------
Confidence            99999999999998764332222334568999999999999999999999999999999999999999653211      


Q ss_pred             HhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      +.....+...      .     ..++...+..+.+|+.+||+.||.+||++.+++++
T Consensus       252 ~~~~~~~~~~------~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        252 EVMHKTLAGR------Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHHhcCC------C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111111000      0     01223346789999999999999999999999875

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.3e-42  Score=338.13  Aligned_cols=265  Identities=29%  Similarity=0.447  Sum_probs=213.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||.||+|.+.....    ..++..|++|.+........+.+.+|+.+++.++|+||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSP----TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCC----CCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            468889999999999999998643211    1245679999997766555677899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  278 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~  278 (491)
                      ..++||||+++++|.+++...+              ...+++..++.++.||+.||+|||+.+   |+||||||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence            9999999999999999986542              124789999999999999999999988   99999999999999


Q ss_pred             CCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011180          279 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL  357 (491)
Q Consensus       279 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~  357 (491)
                      .++.++|+|||++................|+..|+|||++.+..++.++|||||||++|||++ |..||.......   .
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~  234 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V  234 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence            999999999999986644333223334567889999999999999999999999999999998 999986543221   1


Q ss_pred             hHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      .+......              ....+...+..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       235 ~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         235 IECITQGR--------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHhCCC--------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            11111000              000111236789999999999999999999999999988744

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-42  Score=331.89  Aligned_cols=257  Identities=27%  Similarity=0.406  Sum_probs=207.5

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ..++|++.+.||+|+||.||+|.+.          .+..||+|.+.... ...+++.+|+.++++++|+||+++++++..
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~----------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN----------NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL   72 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec----------CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence            3457999999999999999999864          24579999997654 345678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..++||||+++++|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||+
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~  149 (261)
T cd05068          73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGL  149 (261)
T ss_pred             CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcce
Confidence            999999999999999999997655456899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......   .......    . 
T Consensus       150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~----~-  220 (261)
T cd05068         150 ARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQVDQ----G-  220 (261)
T ss_pred             EEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc----C-
Confidence            9876532111 1111223457999999988899999999999999999999 999986542211   1111000    0 


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                               .....+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       221 ---------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         221 ---------YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ---------CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                     00011223367899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=331.74  Aligned_cols=259  Identities=28%  Similarity=0.447  Sum_probs=204.4

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      |.+.+.||+|+||.||+|.+..+..      ++..||||.+..+..  .....+.+|+.+++.++||||+++++++....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   74 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDG------SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS   74 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCC------CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence            5678999999999999998865322      457899999875532  23457889999999999999999999887655


Q ss_pred             c------eEEEEEecCCCChHHHhhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          213 Q------RLLVYEFMPRGSLENHLFRK----GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       213 ~------~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      .      .++||||+++++|..++...    ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.
T Consensus        75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~  151 (273)
T cd05035          75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMT  151 (273)
T ss_pred             ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCe
Confidence            4      78999999999999988543    2235888999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  361 (491)
                      +||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......   ...+..
T Consensus       152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~  228 (273)
T cd05035         152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL  228 (273)
T ss_pred             EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence            99999999986644332222222345678999999988899999999999999999999 88888653221   111111


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ...              .....+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       229 ~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 RHG--------------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HcC--------------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            100              00111223467899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.6e-42  Score=352.57  Aligned_cols=259  Identities=24%  Similarity=0.311  Sum_probs=204.1

Q ss_pred             hHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceee
Q 011180          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVK  203 (491)
Q Consensus       127 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~  203 (491)
                      .+....++|++.+.||+|+||.||+|.+..         ++..||+|++.+...   .....+.+|+.+++.++||||++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~  107 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKS---------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ  107 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEee
Confidence            344556789999999999999999999876         677899999864321   22345778999999999999999


Q ss_pred             eeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          204 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      +++++.+++..|+||||+++|+|.+++...   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+
T Consensus       108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~  181 (370)
T cd05621         108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHL  181 (370)
T ss_pred             EEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCE
Confidence            999999999999999999999999998643   4788889999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  359 (491)
                      ||+|||++........ ......+||+.|+|||++.+.    .++.++|||||||+||||++|..||.........    
T Consensus       182 kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~----  256 (370)
T cd05621         182 KLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY----  256 (370)
T ss_pred             EEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH----
Confidence            9999999987643222 122346799999999998754    3788999999999999999999999754321111    


Q ss_pred             hhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 011180          360 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVET  415 (491)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~  415 (491)
                        ........        .+........+..+.+|+.+||..++.+  |+++.+++++
T Consensus       257 --~~i~~~~~--------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         257 --SKIMDHKN--------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --HHHHhCCc--------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              00000000        0000011123678899999999865544  8999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-42  Score=336.67  Aligned_cols=255  Identities=35%  Similarity=0.578  Sum_probs=199.1

Q ss_pred             cCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceE
Q 011180          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (491)
Q Consensus       137 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  215 (491)
                      +.+.||.|.||.||+|.+...     ....+..|+||.++.... ...+.+.+|++++++++||||++++|++...+..+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~-----~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQK-----DNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEEST-----TTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcc-----cCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence            457899999999999999831     122577899999965432 33678999999999999999999999999888899


Q ss_pred             EEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCC
Q 011180          216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  295 (491)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~  295 (491)
                      +||||+++|+|.++|.......+++..++.|+.||+.||.|||+.+   |+|+||+++|||++.++.+||+|||++....
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            9999999999999998875557999999999999999999999988   9999999999999999999999999998774


Q ss_pred             CCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       296 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      ............+...|+|||.+....++.++||||||+++|||++ |+.||....   ...+......    ..     
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~~~----~~-----  222 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKLKQ----GQ-----  222 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHHHT----TE-----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccc----cc-----
Confidence            3333333333456789999999999999999999999999999999 678875431   1111111110    00     


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                           ....+..++..+.+||.+||..||.+|||+.+|++.|
T Consensus       223 -----~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 -----RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 0111223467899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.3e-42  Score=343.72  Aligned_cols=243  Identities=28%  Similarity=0.424  Sum_probs=194.5

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhc-CCCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGN-LLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~~~~  214 (491)
                      +.||+|+||+||+|++..         ++..||||++.....   .....+..|..++.. +.||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL   71 (316)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence            469999999999999875         577899999975421   223456678888876 4899999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      +|||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          72 FFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            99999999999999987653  5788899999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+......           
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~~-----------  210 (316)
T cd05619         147 MLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIRM-----------  210 (316)
T ss_pred             CCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh-----------
Confidence            22211  123467999999999999889999999999999999999999999754321   11111100           


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~-evl~~  415 (491)
                      ..+    .++...+..+.+|+.+||+.||.+||++. +++++
T Consensus       211 ~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         211 DNP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             CCC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence            001    11122367889999999999999999997 66543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.2e-42  Score=344.51  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=196.6

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  214 (491)
                      ++||+|+||.||+|.+..         ++..||+|++.+...   .....+..|+.++..+ +||||+++++++...+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK---------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence            469999999999999876         677899999976422   2334577899988877 799999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      +|||||+++|+|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          72 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            99999999999998886654  6889999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc--chhhHhhhcccCCccchh
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  372 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||........  .....+....        
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------  216 (329)
T cd05618         147 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------  216 (329)
T ss_pred             cCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------
Confidence            32221  12346799999999999999999999999999999999999999964222111  0111111000        


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR------MSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt------~~evl~~  415 (491)
                       +...  ...++...+..+.+||.+||+.||.+||+      +.+++++
T Consensus       217 -i~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         217 -ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             -HhcC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence             0000  01122334678899999999999999998      4566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.1e-42  Score=332.26  Aligned_cols=256  Identities=24%  Similarity=0.402  Sum_probs=207.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|++.+.||+|+||.||+|.+..          +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE   73 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            3579999999999999999998653          45799999865432 356789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++.......+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||++
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccc
Confidence            99999999999999999997655557888999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      ......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......   .........     
T Consensus       151 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~-----  221 (261)
T cd05072         151 RVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRGY-----  221 (261)
T ss_pred             eecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCC-----
Confidence            876442211 1223346778999999988899999999999999999998 999986533211   111111000     


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                           ..    ......+..+.+|+.+||..+|++||+++++++.|+.+
T Consensus       222 -----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         222 -----RM----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -----CC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                 00    01112367889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1e-41  Score=329.04  Aligned_cols=249  Identities=26%  Similarity=0.421  Sum_probs=198.1

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      +.||+|+||.||+|.+..         ++..||+|.+..... .....+.+|+++++.++||||+++++++......++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA---------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV   71 (252)
T ss_pred             CccCcccCccEEEEEEec---------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence            469999999999999876         567899998865432 2345688999999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      |||+++++|.+++...+ ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        72 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  147 (252)
T cd05084          72 MELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDG  147 (252)
T ss_pred             EeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccc
Confidence            99999999999986553 35889999999999999999999988   999999999999999999999999998765432


Q ss_pred             CCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhccC
Q 011180          298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  376 (491)
Q Consensus       298 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (491)
                      ..........++..|+|||.+.++.++.++|||||||++|||++ |..||.............                 
T Consensus       148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-----------------  210 (252)
T cd05084         148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-----------------  210 (252)
T ss_pred             cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-----------------
Confidence            11111111123457999999998899999999999999999998 888885432211100000                 


Q ss_pred             ccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       377 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      .......+...+..+.+|+.+||+.||.+|||+.+|++.|+
T Consensus       211 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         211 QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            00011122234678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-44  Score=331.63  Aligned_cols=249  Identities=27%  Similarity=0.394  Sum_probs=212.3

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCce
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      |.+..+||+|+||.||+|.+++         +|..||||.+..+  .+.+++.+|+.||.++..|+||++||.|.....+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~E---------sG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL  103 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRE---------SGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL  103 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhc---------cCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence            6677899999999999999987         7889999998766  4668899999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      |||||||.-|++.+.+..+. .++.+..+..++...++||+|||...   -||||||..||||+.+|.+||+|||.|..+
T Consensus       104 WIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQL  179 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQL  179 (502)
T ss_pred             EeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchh
Confidence            99999999999999987654 48999999999999999999999988   899999999999999999999999999877


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .+.-  ....++.||+.|||||++..-.|+.++||||||++..||..|++||....+.-....+..             .
T Consensus       180 TDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT-------------~  244 (502)
T KOG0574|consen  180 TDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT-------------K  244 (502)
T ss_pred             hhhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC-------------C
Confidence            5422  223457899999999999999999999999999999999999999977665433221110             0


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..|.+  ..+..-+.++.+++++||.++|++|-|+.++++|
T Consensus       245 PPPTF--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  245 PPPTF--KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCC--CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            11111  1223347889999999999999999999999986

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-42  Score=370.47  Aligned_cols=266  Identities=30%  Similarity=0.447  Sum_probs=215.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .....+.+.||+|+||.||.|.........    ....||||.+.+.. .+...+|++|..+|+.++|||||+++|++.+
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~----~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSV----SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCc----cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            345677889999999999999987643211    13469999997653 4556789999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKG-----SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      ....+|++|||.+|+|..+|.+..     ...+.....+.++.+||+|+.||++++   +|||||..+|+||++...+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEE
Confidence            999999999999999999997751     236888899999999999999999988   999999999999999999999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcc
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      +|||+|+.+.............-...|||||.+..+.++.|+|||||||+|||++| |..||......+....+      
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------  917 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------  917 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------
Confidence            99999997655544443333233568999999999999999999999999999999 66777654332221111      


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      +...           .-..+..|+..+.+||.+||+.+|++||++..|++.+..+.+
T Consensus       918 ~~gg-----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  918 LEGG-----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             HhCC-----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            1111           112345678999999999999999999999999997765533

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7e-42  Score=337.72  Aligned_cols=268  Identities=27%  Similarity=0.405  Sum_probs=211.2

Q ss_pred             HHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeee
Q 011180          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLV  205 (491)
Q Consensus       128 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~  205 (491)
                      +.+..++|++.+.||+|+||.||++.+.....    ......||+|.+..... ....++.+|+.++..+ +|+||++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~   82 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN----PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL   82 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCC----CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            34455679999999999999999998864221    12456899999875432 2335688999999999 799999999


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRK--------------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  271 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlK  271 (491)
                      +++...+..++||||+++|+|.+++...              ....+++..++.++.||+.||.|||+.+   |+|||||
T Consensus        83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlk  159 (293)
T cd05053          83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLA  159 (293)
T ss_pred             EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccc
Confidence            9999999999999999999999998642              2346889999999999999999999988   9999999


Q ss_pred             CCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 011180          272 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNR  350 (491)
Q Consensus       272 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~  350 (491)
                      |+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            9999999999999999999987654332222222345678999999988899999999999999999997 888886432


Q ss_pred             CCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          351 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ........                 ........+...+..+.+|+.+||..||.+|||+.++++.|+.+
T Consensus       240 ~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         240 VEELFKLL-----------------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHHHHHH-----------------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            21111100                 00001112233467899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-41  Score=349.70  Aligned_cols=267  Identities=23%  Similarity=0.257  Sum_probs=204.6

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ...+|.+.+.||+|+||.||+|.....       .++..||+|.+...     +...+|+++|+.|+|||||++++++..
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~-------~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~  157 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGD-------EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW  157 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCC-------ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee
Confidence            345799999999999999999976432       14678999988643     345689999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ....|+|||++ .++|.+++...  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||+
T Consensus       158 ~~~~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~  231 (392)
T PHA03207        158 KSTVCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA  231 (392)
T ss_pred             CCEEEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcc
Confidence            99999999999 57898888443  36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc--
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--  368 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--  368 (491)
                      +................||+.|+|||++.+..++.++|||||||++|||++|+.||..................+...  
T Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~  311 (392)
T PHA03207        232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL  311 (392)
T ss_pred             ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence            987654333333334679999999999999999999999999999999999999997654432211111100000000  


Q ss_pred             -------cch---hhccCccccCCCC-------hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 -------RRF---YRLLDPRLEGHFS-------IKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 -------~~~---~~~~~~~l~~~~~-------~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                             ..+   +..+.......+.       ...+.++.+||.+||..||.+|||+.+++.+
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                   000   0000000000000       1125678899999999999999999999977

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.1e-41  Score=334.67  Aligned_cols=247  Identities=28%  Similarity=0.391  Sum_probs=197.3

Q ss_pred             cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       141 lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      ||+|+||+||+|.+..         ++..||+|.+......   ..+.+..|+.+++.++|+||+++++++......++|
T Consensus         1 lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   71 (280)
T cd05608           1 LGKGGFGEVSACQMRA---------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV   71 (280)
T ss_pred             CCCCCceeEEEEEEcc---------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence            7999999999998875         6779999998754322   234567899999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCC
Q 011180          218 YEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  295 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~  295 (491)
                      |||+++|+|.+++...  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++....
T Consensus        72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  148 (280)
T cd05608          72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELK  148 (280)
T ss_pred             EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence            9999999999887542  2336889999999999999999999988   9999999999999999999999999997664


Q ss_pred             CCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhcc
Q 011180          296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  375 (491)
Q Consensus       296 ~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (491)
                      .....  .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........  ........         
T Consensus       149 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~---------  215 (280)
T cd05608         149 DGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRILN---------  215 (280)
T ss_pred             CCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhcc---------
Confidence            33221  233578999999999999999999999999999999999999997543221111  00000000         


Q ss_pred             CccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       376 ~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                       .  ...++...+..+.+|+.+||+.||.+||     ++++++++
T Consensus       216 -~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         216 -D--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             -c--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence             0  0012223477899999999999999999     66777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.8e-42  Score=343.26  Aligned_cols=238  Identities=32%  Similarity=0.414  Sum_probs=190.8

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHH-HHhcCCCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      ++||+|+||+||+|.+..         +|..||||++.....   ...+.+..|.. +++.++||||+++++++.+.+..
T Consensus         1 ~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~   71 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence            469999999999999876         677999999975422   22344555555 56789999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          72 YFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             EEEEcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            99999999999999987654  6888999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......      +.....+...      
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~~------  212 (323)
T cd05575         147 IEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILNKP------  212 (323)
T ss_pred             ccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCC------
Confidence            32211  223467999999999999999999999999999999999999999653211      1111111000      


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS  410 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~  410 (491)
                          +  ......+..+.+||.+||+.||.+||++.
T Consensus       213 ----~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 ----L--RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ----C--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                0  11122367899999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-41  Score=329.58  Aligned_cols=252  Identities=27%  Similarity=0.469  Sum_probs=202.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .+|++.+.||+|+||.||++.+..          +..+|+|.+.... .....+.+|+.+|+.++||||+++++++.+.+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK   72 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence            358888999999999999998753          3479999886543 23467889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        73 ~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          73 PLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             CEEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCcc
Confidence            99999999999999999875433 5889999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||......   ..........      
T Consensus       149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~~~~------  218 (256)
T cd05114         149 YVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMISRGF------  218 (256)
T ss_pred             ccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCCC------
Confidence            65432211 1122345678999999988899999999999999999999 89998654321   1111111100      


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                       ....       +...+..+.+|+.+||..||.+||++.++++.|.
T Consensus       219 -~~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         219 -RLYR-------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -CCCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             0001       1112567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.6e-42  Score=343.78  Aligned_cols=243  Identities=29%  Similarity=0.433  Sum_probs=197.2

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  214 (491)
                      +.||+|+||.||+|.+..         ++..||||++.+...   .....+..|+.++..+ .||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~   71 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG---------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL   71 (318)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            469999999999999875         567899999975422   2335567899999888 699999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      |+||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          72 FFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            99999999999999887654  6889999999999999999999988   999999999999999999999999998753


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......   .....   .....      
T Consensus       147 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~---i~~~~------  212 (318)
T cd05570         147 ILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQS---ILEDE------  212 (318)
T ss_pred             CcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHH---HHcCC------
Confidence            22211  123357999999999999999999999999999999999999999654311   11111   00000      


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~  415 (491)
                            ..++...+..+.+||.+||+.||.+||++     .+++++
T Consensus       213 ------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         213 ------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             ------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence                  01122336789999999999999999999     887765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-41  Score=333.93  Aligned_cols=262  Identities=27%  Similarity=0.423  Sum_probs=204.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .+|++.+.||+|+||+||+|.+..++..     ....|++|.+..... ....++..|+.++..+.||||+++++++. .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDS-----IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCc-----eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence            4688999999999999999998653221     123588888754322 22356778888999999999999999875 4


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ...++|+||+++|+|.+++..... .+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccc
Confidence            567899999999999999976543 6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +...............|+..|+|||.+.++.++.++|||||||++|||++ |..||...........+   ..    ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~---~~----~~~  229 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL---EK----GER  229 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HC----CCc
Confidence            87644333222334557789999999998999999999999999999998 99998654322111111   10    000


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                         ...       +..++..+.+++.+||..||.+|||+.++++.|..+.+
T Consensus       230 ---~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         230 ---LAQ-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ---CCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence               000       11135678899999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-42  Score=345.39  Aligned_cols=269  Identities=28%  Similarity=0.451  Sum_probs=221.6

Q ss_pred             hhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeee
Q 011180          126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       126 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l  204 (491)
                      .+..+..+...+.++||+|.||.||+|.+....     ++....||||..+.+. ....+.|+.|..+|+.++|||||++
T Consensus       382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~-----kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikL  456 (974)
T KOG4257|consen  382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPE-----KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKL  456 (974)
T ss_pred             CcceeehhhccHHHhhcCCcccceeeeEecccc-----cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhhe
Confidence            344555566777889999999999999987632     3356679999998853 4456779999999999999999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      +|+|.+. ..|||||+++.|.|..+|..+.. .++......++.||+.||.|||+..   +|||||...|||+.....+|
T Consensus       457 IGv~~e~-P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVK  531 (974)
T KOG4257|consen  457 IGVCVEQ-PMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVK  531 (974)
T ss_pred             eeeeecc-ceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceee
Confidence            9998864 78999999999999999987654 7888999999999999999999987   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhc
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      |+|||+++.+.++...... ...-...|||||.+.-..++.++|||.|||++||++. |..||.+-...+..-.++    
T Consensus       532 LaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE----  606 (974)
T KOG4257|consen  532 LADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE----  606 (974)
T ss_pred             ecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec----
Confidence            9999999998776555433 3334678999999999999999999999999999765 889997654333322111    


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  422 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~  422 (491)
                         ..          -.-..+.+|++.+..|+.+||+.||.+||.+.++...|..+...
T Consensus       607 ---nG----------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  607 ---NG----------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             ---CC----------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence               11          11234567899999999999999999999999999998766443

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-42  Score=346.54  Aligned_cols=242  Identities=30%  Similarity=0.370  Sum_probs=195.7

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL  216 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  216 (491)
                      +.||+|+||.||+++.....      .+|..||+|++.....  .....+..|+++|.+++||||+++++++.+.+..|+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   75 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGP------DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL   75 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccC------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence            57999999999999875322      2678999999975432  233456789999999999999999999999999999


Q ss_pred             EEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCC
Q 011180          217 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  296 (491)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~  296 (491)
                      ||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        76 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          76 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             EEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            999999999999986653  6889999999999999999999988   99999999999999999999999999886543


Q ss_pred             CCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccC
Q 011180          297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  376 (491)
Q Consensus       297 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (491)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....   ....        
T Consensus       151 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~i---~~~~--------  214 (318)
T cd05582         151 HEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TMTMI---LKAK--------  214 (318)
T ss_pred             CCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HHHHH---HcCC--------
Confidence            221  1234679999999999998889999999999999999999999996543211   11110   0000        


Q ss_pred             ccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHH
Q 011180          377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE  411 (491)
Q Consensus       377 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~e  411 (491)
                          ..++...+..+.+||.+||+.||.+||++.+
T Consensus       215 ----~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 ----LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                0112223678899999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.7e-41  Score=331.96  Aligned_cols=273  Identities=32%  Similarity=0.438  Sum_probs=206.9

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec--
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED--  211 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--  211 (491)
                      |.+.+.||+|+||+||++.....     ...++..||+|.+..... .....+.+|+++|+.++||||+++++++...  
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPA-----NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccc-----cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            48899999999999999875431     122677899999976532 2346788999999999999999999987654  


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ...++||||+++++|.+++...   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~  154 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA  154 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccc
Confidence            3578999999999999998654   5899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCce-eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +......... ......++..|+|||.+.+..++.++|||||||++|||++|..||........ ......... .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~  232 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVVR  232 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchhh
Confidence            8765432211 11223456779999999888999999999999999999999999864332111 111100000 00011


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      +...++.......+...+..+.+|+.+||+.||++|||+++|++.|+.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11111111111223345788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=4.1e-42  Score=358.76  Aligned_cols=261  Identities=24%  Similarity=0.374  Sum_probs=196.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||.+..+.    ....+|+.+|+.++|||||++++++...
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~  131 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICID---------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTE  131 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence            4579999999999999999999865         67789999886442    2345799999999999999999987542


Q ss_pred             --------CceEEEEEecCCCChHHHhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 011180          212 --------DQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       212 --------~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~  281 (491)
                              ..+++||||++ ++|.+++..  .....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++
T Consensus       132 ~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~  207 (440)
T PTZ00036        132 CFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNT  207 (440)
T ss_pred             ccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCC
Confidence                    13678999996 577776643  22346889999999999999999999988   99999999999998664


Q ss_pred             -CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011180          282 -NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       282 -~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  359 (491)
                       .+||+|||+++.......   ....+||+.|+|||++.+. .|+.++|||||||+||||++|.+||...........+.
T Consensus       208 ~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  284 (440)
T PTZ00036        208 HTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII  284 (440)
T ss_pred             CceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence             799999999987643221   1235789999999988754 68999999999999999999999997654322111110


Q ss_pred             hhhcccCCc--c------------chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          360 WARPHLGDK--R------------RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       360 ~~~~~~~~~--~------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .   .++..  .            .+.......+...++...+.++.+||.+||..||.+|||+.+++++
T Consensus       285 ~---~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        285 Q---VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             H---HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            0   00000  0            0000000111112233346789999999999999999999999976

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.4e-41  Score=330.91  Aligned_cols=255  Identities=24%  Similarity=0.370  Sum_probs=204.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .+|++.+.||+|+||.||+|.+..         ++..||+|++..........+.+|+.++..++||||+++++++...+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~   79 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLH---------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE   79 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECC---------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence            479999999999999999999865         56789999997654444566788999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+++...+  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++.
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~  154 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAA  154 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccce
Confidence            9999999999999999886554  6788999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      .......  ......|+..|+|||.+.   ...++.++|||||||++|||++|..||....+.......  ....     
T Consensus       155 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~~~-----  225 (267)
T cd06646         155 KITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKSN-----  225 (267)
T ss_pred             eeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ecCC-----
Confidence            6543211  112356889999999884   345788999999999999999999998644322111000  0000     


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                          ...+....  ....+..+.+||.+||..||.+|||+++++++|
T Consensus       226 ----~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         226 ----FQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ----CCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                00011100  112357889999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.2e-41  Score=342.13  Aligned_cols=250  Identities=27%  Similarity=0.390  Sum_probs=198.0

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  214 (491)
                      ++||+|+||.||+|.+..         ++..||+|++.....   ...+.+.+|+.++.++ .||||+.+++++.+.+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   71 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK---------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL   71 (327)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence            469999999999999876         567899999976532   2234577899999888 599999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      ||||||+++|+|..++...+  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          72 FLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            99999999999999887654  6899999999999999999999988   999999999999999999999999998753


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||+||||++|..||.............+.....         
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------  215 (327)
T cd05617         147 LGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI---------  215 (327)
T ss_pred             cCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH---------
Confidence            22211  1234679999999999999999999999999999999999999996543322221111111110         


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~------~evl~~  415 (491)
                      ...  ...++...+..+.+++.+||..||.+|+++      .+++++
T Consensus       216 ~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         216 LEK--PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             HhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            000  001222336788999999999999999985      566554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.8e-41  Score=332.97  Aligned_cols=261  Identities=27%  Similarity=0.436  Sum_probs=208.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||.||++.....    ....++..||+|.+..........+.+|+++++.++|+||+++++++.+.+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            4688899999999999999976431    122356789999987665555678999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGS-------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  279 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~  279 (491)
                      ..++||||+++++|.+++.....             ..+++..++.++.||+.||+|||+.+   |+||||||+|||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcC
Confidence            99999999999999999875431             24788999999999999999999988   999999999999999


Q ss_pred             CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 011180          280 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV  358 (491)
Q Consensus       280 ~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~  358 (491)
                      ++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |.+||........   .
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~  234 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I  234 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H
Confidence            99999999999876543222222223446788999999999999999999999999999998 8999854322111   1


Q ss_pred             HhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      .....    ..          ....+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       235 ~~~~~----~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 ECITQ----GR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHc----Cc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            11000    00          00111233678899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.1e-41  Score=333.47  Aligned_cols=272  Identities=28%  Similarity=0.415  Sum_probs=210.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcc-------cCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAP-------VKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~-------~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l  204 (491)
                      .+|++.+.||+|+||.||+|.+...+...       .....+..||+|.+..... ...+.+.+|++++..++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            47999999999999999999886543211       1223456799999876542 335678899999999999999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKG---------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  275 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NI  275 (491)
                      ++++..++..++||||+++++|.+++....         ...+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence            999999999999999999999999986643         125889999999999999999999988   99999999999


Q ss_pred             EECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCC
Q 011180          276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRRSMDKNRPNG  353 (491)
Q Consensus       276 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~pf~~~~~~~  353 (491)
                      |++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++  |..||.....  
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--  239 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--  239 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence            999999999999999986544333333334567889999999988899999999999999999998  6667754321  


Q ss_pred             cchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                       ..............       ........+...+.++.+|+.+||+.||.+|||+.+|++.|+
T Consensus       240 -~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 -QQVIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             -HHHHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence             11111111110000       000111112233678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2e-41  Score=332.34  Aligned_cols=248  Identities=28%  Similarity=0.409  Sum_probs=198.4

Q ss_pred             cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       141 lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      ||+|+||.||++....         +|..||+|.+......   ....+..|+++++.++||||+++++++.+....++|
T Consensus         1 lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv   71 (277)
T cd05607           1 LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV   71 (277)
T ss_pred             CCCCCceEEEEEEEcc---------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence            7999999999999876         6779999998653321   234456799999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      |||+++++|.+++.......+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||++......
T Consensus        72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            99999999999887666557889999999999999999999988   999999999999999999999999998866432


Q ss_pred             CCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCc
Q 011180          298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  377 (491)
Q Consensus       298 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (491)
                      .   ......|+..|+|||++.+..++.++|||||||++|||++|..||........  ............         
T Consensus       149 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~---------  214 (277)
T cd05607         149 K---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDE---------  214 (277)
T ss_pred             c---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccc---------
Confidence            2   12335689999999999988899999999999999999999999965432111  111111111100         


Q ss_pred             cccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       378 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                       ... .....+.++.+|+.+||+.||.+||++.|+++.+
T Consensus       215 -~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         215 -VKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             -ccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence             000 0012367889999999999999999998876544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-41  Score=337.29  Aligned_cols=266  Identities=26%  Similarity=0.385  Sum_probs=210.3

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||+|+||.||+|.+....    ...++..||||.++.... ...+.+.+|+.+++++ +|+||+++++++
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLS----KSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCC----CCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            3457999999999999999999864211    122566899999875432 2345688999999999 799999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      ...+..++||||+++|+|.+++.......+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.++|+||
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCC
Confidence            99999999999999999999997654445899999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      |++................++..|+|||.+.+..++.++|||||||++|||++ |..||........  ......     
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~-----  258 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK-----  258 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH-----
Confidence            99987654332222223456788999999998999999999999999999998 9999865432111  111110     


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                               .......+...+..+.+|+.+||..+|++|||+.++++.|+.+
T Consensus       259 ---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 ---------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ---------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                     0000011112357899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.6e-41  Score=333.43  Aligned_cols=263  Identities=28%  Similarity=0.415  Sum_probs=207.3

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +|++.+.||+|+||.||+|.......    ......||+|.+..... ....++.+|+.+++.+.||||+++++.+...+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKG----RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCC----CCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            47889999999999999998754221    11345799998875532 23457889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKG----------------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  270 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  270 (491)
                      ..++||||+.+++|.+++....                      ...+++..++.++.|++.||.|||+.+   |+||||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di  153 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL  153 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence            9999999999999999886421                      124788899999999999999999988   999999


Q ss_pred             CCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 011180          271 KTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKN  349 (491)
Q Consensus       271 Kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~  349 (491)
                      ||+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999986543322222223456778999999988899999999999999999998 99998654


Q ss_pred             CCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          350 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      .+..   +......              ......+...+..+.+|+.+||+.+|.+||++.++++.|+.+.
T Consensus       234 ~~~~---~~~~~~~--------------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         234 APER---LFNLLKT--------------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             CHHH---HHHHHhC--------------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            3221   1111110              0011112234678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=332.33  Aligned_cols=262  Identities=27%  Similarity=0.424  Sum_probs=208.6

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|.+.+.||+|+||.||+|.+.....    ..++..||+|.+..... .....+.+|+.+|..+.|+||+++++++..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVK----GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCC----CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            4579999999999999999998864221    12457899999865532 334568899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKG--------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      ....++||||+++++|.+++....        ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~  157 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLT  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCC
Confidence            999999999999999999986532        124678889999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  361 (491)
                      +||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .....
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~  234 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFV  234 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHH
Confidence            99999999986644332222233457889999999988899999999999999999998 898886533221   11111


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      .    ...          ...++...+..+.+|+.+||+.+|.+|||+.++++.|+
T Consensus       235 ~----~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 I----DGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             h----cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1    000          00112233678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.6e-41  Score=333.39  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=206.4

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +|++.+.||+|+||.||+|.+.....    ...+..||||++...... ....+.+|+.++..++||||+++++++.+.+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAP----GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCC----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            47788999999999999998754211    114578999999765432 2356888999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  278 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~  278 (491)
                      ..++++||+.+++|.+++....              ...+++..+..++.|++.||.|||+.+   |+||||||+|||++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence            9999999999999999985321              124788888999999999999999988   99999999999999


Q ss_pred             CCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011180          279 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL  357 (491)
Q Consensus       279 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~  357 (491)
                      .++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||......   ..
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~  235 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV  235 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence            999999999999887644333222333456789999999988899999999999999999998 77887653221   11


Q ss_pred             hHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                      .+.....             . ...++..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus       236 ~~~i~~~-------------~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIRNR-------------Q-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHcC-------------C-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1111100             0 011223347789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.6e-42  Score=349.69  Aligned_cols=254  Identities=26%  Similarity=0.350  Sum_probs=200.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++....   ......+.+|+.++..++|+||+++++++.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   71 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKD---------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ   71 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            368899999999999999999876         67799999997532   123356778999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..||||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          72 DKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             cCCEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeecc
Confidence            9999999999999999999987654  5888999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCc---------------------------------eeeeccccCCCCCCchhhhcCCCCccccchhHHHHH
Q 011180          290 LAKDAPEDGKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL  336 (491)
Q Consensus       290 la~~~~~~~~~---------------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil  336 (491)
                      ++.........                                 ......+||+.|+|||++.+..++.++|||||||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  226 (360)
T cd05627         147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (360)
T ss_pred             CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence            98754321100                                 001235799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC---HHHHH
Q 011180          337 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR---MSEVV  413 (491)
Q Consensus       337 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt---~~evl  413 (491)
                      |||++|..||....+......+.   . .....    .+.+      ....+..+.+||.+|+ .||.+|++   +.+++
T Consensus       227 yel~tG~~Pf~~~~~~~~~~~i~---~-~~~~~----~~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  291 (360)
T cd05627         227 YEMLIGYPPFCSETPQETYRKVM---N-WKETL----VFPP------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIK  291 (360)
T ss_pred             eecccCCCCCCCCCHHHHHHHHH---c-CCCce----ecCC------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence            99999999997654322111110   0 00000    0000      0113678899999987 49999985   66776


Q ss_pred             HH
Q 011180          414 ET  415 (491)
Q Consensus       414 ~~  415 (491)
                      +|
T Consensus       292 ~h  293 (360)
T cd05627         292 SH  293 (360)
T ss_pred             cC
Confidence            55

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.5e-41  Score=331.33  Aligned_cols=262  Identities=27%  Similarity=0.429  Sum_probs=205.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|.+.+.||+|+||.||+|.+.....    ..++..||+|.+...... ....+.+|+.+++.++|+||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDG----DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCC----CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            4579999999999999999998864211    114568999988754322 33568899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC---C
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGS-----LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---N  282 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~---~  282 (491)
                      .+..++||||+++++|.+++.....     ..+++..++.++.||+.||.|||+.+   ++||||||+|||++.++   .
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcc
Confidence            9999999999999999999876532     25889999999999999999999988   99999999999998654   5


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  361 (491)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   .....
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~  234 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFV  234 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence            99999999987643222111122334568999999999999999999999999999997 999986543221   11111


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      .   ..           ....++...+..+.+|+.+||+.+|++||++.+|+++|+
T Consensus       235 ~---~~-----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 T---GG-----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             H---cC-----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            0   00           011122334678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.1e-41  Score=327.39  Aligned_cols=260  Identities=25%  Similarity=0.353  Sum_probs=208.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|++..         ++..||||.+.....   .....+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL---------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI   72 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC---------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence            479999999999999999999876         567899998864322   23356788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +.+..++||||+++++|.+++...  ....+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.++|+|
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d  149 (267)
T cd08228          73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECc
Confidence            999999999999999999888532  2335788899999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ||++........  ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||....... ..........   
T Consensus       150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~---  223 (267)
T cd08228         150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIEQC---  223 (267)
T ss_pred             cccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHhcC---
Confidence            999887643221  1123568899999999988889999999999999999999999985432211 1111111000   


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                             ..+   .......+..+.+|+.+||..+|.+||++.+|++.|++++
T Consensus       224 -------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         224 -------DYP---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -------CCC---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                   000   0011223577999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-41  Score=326.78  Aligned_cols=254  Identities=27%  Similarity=0.406  Sum_probs=205.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-----cHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      ++|.+.+.||+|+||.||+|....         ++..||+|.+......     ....+.+|+.++++++||||++++++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   72 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVD---------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC   72 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcC---------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence            469999999999999999998765         5778999998654321     23467889999999999999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +.+.+..++||||+++++|.+++...+  .+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|
T Consensus        73 ~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~d  147 (263)
T cd06625          73 LRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGD  147 (263)
T ss_pred             EccCCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence            999999999999999999999987654  5788889999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCcee-eeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          288 FGLAKDAPEDGKTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       288 FGla~~~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      ||+++.......... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||........   ...      
T Consensus       148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~------  218 (263)
T cd06625         148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---IFK------  218 (263)
T ss_pred             cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---HHH------
Confidence            999876543211111 1235688899999999988899999999999999999999999864321110   000      


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                             .........++...+..+.+||.+||..+|.+|||+.+++++.
T Consensus       219 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         219 -------IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             -------HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence                   0000011122233467899999999999999999999999763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-41  Score=349.85  Aligned_cols=267  Identities=24%  Similarity=0.382  Sum_probs=208.1

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCC-CCceeeeeeE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLL-HPNLVKLVGY  207 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~~~  207 (491)
                      ...++|.+.+.||+|+||.||+|++....    ....+..||||+++..... ..+.+.+|+.+|..+. |||||+++++
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLS----HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCC----CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            33446888999999999999999975321    1124568999999765332 2346889999999997 9999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCC----------------------------------------------------
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGS----------------------------------------------------  235 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------  235 (491)
                      +...+..++|||||++|+|.++|...+.                                                    
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            9999999999999999999999865321                                                    


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 011180          236 --------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  271 (491)
Q Consensus       236 --------------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlK  271 (491)
                                                                  ..+++..+..++.||+.||.|||+.+   |+|||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlk  266 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLA  266 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCC
Confidence                                                        13567778889999999999999987   9999999


Q ss_pred             CCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 011180          272 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNR  350 (491)
Q Consensus       272 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~  350 (491)
                      |+|||++.++.+||+|||+++...............|++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999986543222112223467889999999998889999999999999999998 888886432


Q ss_pred             CCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          351 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ....  ......              .......+...+..+.+|+.+||..+|.+||++++|++.|+.+
T Consensus       347 ~~~~--~~~~~~--------------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         347 MNEQ--FYNAIK--------------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             chHH--HHHHHH--------------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2111  000000              0000111223467899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.3e-41  Score=330.57  Aligned_cols=274  Identities=27%  Similarity=0.390  Sum_probs=206.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec-
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-  211 (491)
                      .+|++.+.||+|+||.||+|....     ....++..||+|.+........+.+.+|++++..++||||+++++++... 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            478999999999999999998642     11226779999999776555567889999999999999999999987543 


Q ss_pred             -CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          212 -DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       212 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                       ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcc
Confidence             46789999999999999987553 25889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcee-eeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC--
Q 011180          291 AKDAPEDGKTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD--  367 (491)
Q Consensus       291 a~~~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--  367 (491)
                      ++.......... .....++..|+|||++.+..++.++|||||||++|||++|..++......    ...........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~  230 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQM  230 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhccccccccc
Confidence            987654322211 11123445699999999889999999999999999999988765332110    00000000000  


Q ss_pred             -ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          368 -KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       368 -~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                       ...+...+............+..+.+|+.+||..+|++|||+.+|++.|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence             0000011111111111223467899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.7e-41  Score=332.89  Aligned_cols=252  Identities=32%  Similarity=0.445  Sum_probs=204.0

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      |++.++||+|+||.||+|.+..         ++..||||.+......   ....+.+|+.+++.++|+||+.+++.+.+.
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK   72 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcC---------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC
Confidence            7778899999999999999876         6779999998654322   234577899999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++...+...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        73 ~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05630          73 DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLA  149 (285)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccce
Confidence            99999999999999999987655557899999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ........   .....|+..|+|||++.+..++.++|||||||++|+|++|..||...............   ...    
T Consensus       150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~---~~~----  219 (285)
T cd05630         150 VHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---VKE----  219 (285)
T ss_pred             eecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh---hhh----
Confidence            76543221   12347999999999999999999999999999999999999999754322111111000   000    


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  415 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~  415 (491)
                             ....++...+..+.+|+.+||+.||.+|||     +.+++++
T Consensus       220 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         220 -------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             -------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence                   001112233677899999999999999999     7888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.2e-41  Score=341.54  Aligned_cols=242  Identities=27%  Similarity=0.400  Sum_probs=196.2

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCC-CCceeeeeeEEe
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL-HPNLVKLVGYCI  209 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-HpnIv~l~~~~~  209 (491)
                      +|...+.||+|+||.||+|.+..         +|..||||++.....   ...+.+..|+.++..+. |++|+++++++.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence            47788999999999999999875         677999999975422   23355778999998886 577888999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..||||||+++|+|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          72 TVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccc
Confidence            9999999999999999999987654  6889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   ......   ...  
T Consensus       147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i---~~~--  216 (323)
T cd05615         147 MCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSI---MEH--  216 (323)
T ss_pred             cccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---HhC--
Confidence            9875432221  123457999999999999889999999999999999999999999754321   111110   000  


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM  409 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~  409 (491)
                                ...++...+..+.+|+.+||+.||.+|++.
T Consensus       217 ----------~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         217 ----------NVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ----------CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                      001222336788999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-41  Score=337.11  Aligned_cols=271  Identities=24%  Similarity=0.393  Sum_probs=211.2

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCceeeeeeE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~  207 (491)
                      +..++|.+.+.||+|+||.||+|++.....  .....+..||+|.+.... ......+.+|+.++..+ .||||++++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            345578999999999999999998643111  011245689999987543 23346788999999999 79999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTS  273 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~  273 (491)
                      +...+..++||||+++++|.+++.....              ..+++..++.++.||+.||.|||+.+   |+||||||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~  166 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR  166 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence            9999999999999999999999976421              24778888999999999999999988   999999999


Q ss_pred             cEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 011180          274 NILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPN  352 (491)
Q Consensus       274 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~  352 (491)
                      |||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            99999999999999999987654332222223446778999999988899999999999999999998 77887543211


Q ss_pred             CcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011180          353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  422 (491)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~  422 (491)
                      .   +.....    ...          ....+..++..+.+|+.+||..+|.+|||+.++++.|..+...
T Consensus       247 ~---~~~~~~----~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 E---LFKLLK----EGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             H---HHHHHH----cCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            1   111110    000          0011223467899999999999999999999999999876554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.9e-41  Score=337.35  Aligned_cols=268  Identities=25%  Similarity=0.381  Sum_probs=208.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+......  ...+...||+|.+.... .....++.+|+.++..+ .|+||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKE--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCc--ccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            35799999999999999999987532110  11134579999997653 23345688899999999 7999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  275 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NI  275 (491)
                      ..+..|+||||+++|+|.+++.....              ..+++..++.++.||+.||+|||+.+   |+||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence            99999999999999999999976421              24788999999999999999999988   99999999999


Q ss_pred             EECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCc
Q 011180          276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE  354 (491)
Q Consensus       276 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~  354 (491)
                      |++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......  
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--  249 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--  249 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--
Confidence            999999999999999876543221111122234578999999998899999999999999999998 88888543211  


Q ss_pred             chhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                       .+......              ......+...+..+.+|+.+||..+|.+|||+.+|++.|+.+..
T Consensus       250 -~~~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         250 -ELFKLLKE--------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             -HHHHHHHc--------------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence             11111000              00011222346789999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.6e-41  Score=347.09  Aligned_cols=262  Identities=24%  Similarity=0.304  Sum_probs=205.1

Q ss_pred             hhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCce
Q 011180          125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNL  201 (491)
Q Consensus       125 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnI  201 (491)
                      ..++....++|.+.+.||+|+||.||+|.+..         ++..||+|++.....   .....+.+|+.+++.++||||
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~i  105 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV  105 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECC---------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC
Confidence            34455666899999999999999999999876         677999999864321   223457789999999999999


Q ss_pred             eeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 011180          202 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       202 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~  281 (491)
                      +++++++.+.+..|+||||+++|+|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       106 v~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~  179 (371)
T cd05622         106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSG  179 (371)
T ss_pred             CeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCC
Confidence            99999999999999999999999999998654   4788888999999999999999988   99999999999999999


Q ss_pred             CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011180          282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  357 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~  357 (491)
                      .+||+|||+++....... ......+||+.|+|||++.+.    .++.++|||||||++|||++|..||.........  
T Consensus       180 ~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~--  256 (371)
T cd05622         180 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY--  256 (371)
T ss_pred             CEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH--
Confidence            999999999987643222 122346799999999998753    3789999999999999999999999754321111  


Q ss_pred             hHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 011180          358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETL  416 (491)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~L  416 (491)
                          ...+.....        +.-......+..+.+||.+||..++.+  |+++.+++++.
T Consensus       257 ----~~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         257 ----SKIMNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ----HHHHcCCCc--------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                100000000        000001123778999999999844443  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=333.01  Aligned_cols=273  Identities=26%  Similarity=0.426  Sum_probs=205.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCc-----ccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTA-----PVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVG  206 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-----~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~  206 (491)
                      ++|++.+.||+|+||.||+|++......     ....+....||+|.+..... .....+.+|+++|..++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            4799999999999999999987542110     01122345699999976532 23456889999999999999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKG----------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NIL  276 (491)
                      ++...+..++||||+++++|.+++....          ...+++..++.++.|++.||.|||+.+   ++||||||+|||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999986532          123678889999999999999999988   999999999999


Q ss_pred             ECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCCc
Q 011180          277 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRRSMDKNRPNGE  354 (491)
Q Consensus       277 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~pf~~~~~~~~  354 (491)
                      ++.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++  |..||....... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            99999999999999986543322222233455778999999998899999999999999999998  556665432211 


Q ss_pred             chhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                        .+..........       ........+...+..+.+|+.+||..||.+||++.+|++.|++
T Consensus       241 --~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 --VIENTGEFFRNQ-------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             --HHHHHHHhhhhc-------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence              111100000000       0000001111236789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.4e-41  Score=330.57  Aligned_cols=263  Identities=24%  Similarity=0.392  Sum_probs=205.7

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ..+|++.+.||+|+||+||+|.+..++..     ....||+|++..... ...+++.+|+.++..+.|+||+++++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN-----VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCc-----cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            35789999999999999999998653321     123589999875432 234678899999999999999999999875


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                       ...+++|||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~  155 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGL  155 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCc
Confidence             45789999999999999987643 36889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   +..+.....    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~----  228 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEKGE----  228 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCCC----
Confidence            987643322211222335678999999998899999999999999999998 888886432211   111111100    


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                ....+...+..+.+++.+||..||.+||++.++++.|+.+..
T Consensus       229 ----------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         229 ----------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ----------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                      001112236788999999999999999999999999876643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-43  Score=349.11  Aligned_cols=245  Identities=30%  Similarity=0.444  Sum_probs=203.0

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccH---HHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      |.-++.||.|+||.||-|++..         +...||||.+...+.+..   .+++.|+.+|..|.|||+|.+.|+|..+
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~---------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre   98 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE   98 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccC---------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence            5556789999999999999876         567899999987665543   5688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ...||||||| -|+-.|+|.-.. .++.+..+..|+.+.+.||+|||+++   .||||||..||||++.|.|||+|||.|
T Consensus        99 ~TaWLVMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSA  173 (948)
T KOG0577|consen   99 HTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSA  173 (948)
T ss_pred             chHHHHHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccch
Confidence            9999999999 678888886543 37888899999999999999999999   999999999999999999999999998


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      .....      ...++|||+|||||++.   .+.|+.++|||||||+..||...++|+...+.......+  +.      
T Consensus       174 si~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI--AQ------  239 (948)
T KOG0577|consen  174 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQ------  239 (948)
T ss_pred             hhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH--Hh------
Confidence            76643      24589999999999986   578999999999999999999999997543222111111  11      


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                           .-.|.+.   ....+..+..|+..||++-|.+|||.++++.+
T Consensus       240 -----NesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  240 -----NESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             -----cCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                 0111221   23348899999999999999999999998865

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.1e-41  Score=339.31  Aligned_cols=238  Identities=29%  Similarity=0.378  Sum_probs=189.8

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHH-HHhcCCCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      ++||+|+||.||+|++..         ++..||+|++.+...   .....+..|+. +++.++||||+++++++.+.+..
T Consensus         1 ~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~   71 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKS---------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL   71 (321)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence            469999999999999875         567899999975422   22334555554 67889999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      |+||||+++++|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          72 YFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            99999999999998886643  5788888899999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|..||......   ....   ......      
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~~~~------  212 (321)
T cd05603         147 VEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYD---NILHKP------  212 (321)
T ss_pred             CCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHH---HHhcCC------
Confidence            2221  1223467999999999999889999999999999999999999999654211   1111   111000      


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS  410 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~  410 (491)
                            ..++...+..+.+++.+||+.||.+||++.
T Consensus       213 ------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 ------LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ------CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                  012223367889999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.2e-41  Score=339.93  Aligned_cols=241  Identities=30%  Similarity=0.385  Sum_probs=191.9

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHH-HHhcCCCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      +.||+|+||+||+|.+..         +|..||||++.....   .....+..|.. +++.++||||+++++++...+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~   71 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL---------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL   71 (325)
T ss_pred             CceeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence            469999999999999875         577999999975421   22345556655 56779999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      |+||||+++|+|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          72 YFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            99999999999998887654  6889999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ..   ...+...      
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~---~~~~~~~------  212 (325)
T cd05604         147 IAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MY---DNILHKP------  212 (325)
T ss_pred             CCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HH---HHHHcCC------
Confidence            32211  1234679999999999999999999999999999999999999996543211   11   1111000      


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  413 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl  413 (491)
                          +  .+....+..+.+++.+||..||.+||++.+.+
T Consensus       213 ----~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         213 ----L--VLRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             ----c--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence                0  11122367889999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.6e-41  Score=332.61  Aligned_cols=266  Identities=24%  Similarity=0.348  Sum_probs=198.3

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcC---CCCceeeeeeEE
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNL---LHPNLVKLVGYC  208 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~HpnIv~l~~~~  208 (491)
                      +|++.+.||+|+||.||+|.+..         ++..||+|.+......  ....+.+|+.++..+   +||||+++++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~   71 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC   71 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECC---------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence            48889999999999999999876         6779999998754222  223456777777665   699999999988


Q ss_pred             eec-----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          209 IED-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       209 ~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ...     ...++||||+. ++|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~  147 (288)
T cd07863          72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQV  147 (288)
T ss_pred             ccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence            653     45789999996 58988887655556899999999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR  362 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~~  362 (491)
                      ||+|||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|.+||...........+ ....
T Consensus       148 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~  224 (288)
T cd07863         148 KLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG  224 (288)
T ss_pred             EECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence            999999998664321   123356899999999999889999999999999999999999999654322111110 0000


Q ss_pred             c----ccCCccch-hhccCc---cccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 P----HLGDKRRF-YRLLDP---RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~----~~~~~~~~-~~~~~~---~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .    .+...... ...+.+   ..........+..+.+|+.+||+.||.+|||+.+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0    00000000 000000   00001112336778999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-41  Score=325.70  Aligned_cols=251  Identities=26%  Similarity=0.421  Sum_probs=202.2

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCc
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  213 (491)
                      +|++.+.||+|+||.||+|.+..          +..+|+|++..... ....+.+|+.+++.++|+||+++++++...+.
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   73 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRG----------KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP   73 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecC----------CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            58889999999999999998752          34699999865432 34568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          214 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      .++||||+++++|.+++..... .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~  149 (256)
T cd05059          74 IFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY  149 (256)
T ss_pred             eEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCccccee
Confidence            9999999999999999876543 6889999999999999999999988   99999999999999999999999999986


Q ss_pred             CCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          294 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       294 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      ..+.... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ........        
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~--------  217 (256)
T cd05059         150 VLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESVSAG--------  217 (256)
T ss_pred             ccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHHHcC--------
Confidence            5432211 1111234567999999998999999999999999999999 788886543221   11111100        


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                            .....+...+..+.+|+.+||..+|++|||+.++++.|.
T Consensus       218 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         218 ------YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             ------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence                  001112234778999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-41  Score=342.04  Aligned_cols=242  Identities=28%  Similarity=0.363  Sum_probs=191.7

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHH-HHhcCCCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      +.||+|+||+||+|++..         ++..||+|++.....   .....+..|.. +++.+.||||+++++++...+..
T Consensus         1 ~~lg~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~   71 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA---------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL   71 (325)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence            469999999999999875         567899999975421   22234445544 56788999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      |+||||+++++|.+++....  .+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          72 YFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            99999999999999987654  5778888889999999999999988   999999999999999999999999999754


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......   .....   ....      
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i---~~~~------  212 (325)
T cd05602         147 IEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNI---LNKP------  212 (325)
T ss_pred             ccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHH---HhCC------
Confidence            32221  1234679999999999999999999999999999999999999996543211   11110   0000      


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  414 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~  414 (491)
                            ..+....+..+.+|+.+||+.||.+|+++.+.+.
T Consensus       213 ------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         213 ------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             ------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence                  0112233678999999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.9e-41  Score=326.23  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=202.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||.||+|.+..          +..||||.+..... ....+.+|+.++..++||||+++++++.+.+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR   72 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            368889999999999999997753          33699999875543 3467899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+.+++|.+++..... .+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||+++
T Consensus        73 ~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          73 PIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             CcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccce
Confidence            99999999999999999876543 6899999999999999999999988   9999999999999999999999999988


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   .......   ...  
T Consensus       149 ~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~---~~~--  219 (256)
T cd05113         149 YVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQ---GLR--  219 (256)
T ss_pred             ecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhc---CCC--
Confidence            6543221 11122345678999999988889999999999999999998 999986433211   1111100   000  


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                               ...+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus       220 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ---------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                     0011123678899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.4e-41  Score=325.62  Aligned_cols=254  Identities=28%  Similarity=0.418  Sum_probs=203.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|++.+.||+|+||.||+|.+..          +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++. .
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~   72 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E   72 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence            3478999999999999999997653          45699999876543 3467899999999999999999999875 4


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ...++||||+++++|.+++.......+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceee
Confidence            56899999999999999997655556899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      ......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .........      
T Consensus       150 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~------  219 (260)
T cd05070         150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVERG------  219 (260)
T ss_pred             eeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHcC------
Confidence            865432211 1122345678999999988899999999999999999999 88888653221   111111100      


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                              .....+...+..+.+|+.+||..||.+|||+.++++.|+.
T Consensus       220 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 --------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                    0011122336789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.1e-41  Score=323.76  Aligned_cols=251  Identities=28%  Similarity=0.415  Sum_probs=206.4

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|.+.+.||+|+||.||+|.+..         ++..|++|.+....  ......+.+|+++++.++||||+++++++.+.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK   71 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence            47888999999999999999876         56789999986542  23456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++.......+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccc
Confidence            99999999999999999997754457889999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ........  ......|++.|+|||++.+..++.++|+|||||++|+|++|..||......   ........   .    
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~---~----  216 (256)
T cd08529         149 KLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKIIR---G----  216 (256)
T ss_pred             eeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHc---C----
Confidence            86644322  123356899999999999999999999999999999999999999654311   11111000   0    


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        ..     ..++...+..+.+++.+||+.+|++||++.+++++
T Consensus       217 --~~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         217 --VF-----PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             --CC-----CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence              00     01111236789999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.1e-41  Score=346.42  Aligned_cols=263  Identities=26%  Similarity=0.388  Sum_probs=201.8

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|.+.+.||+|+||.||+|.+..         ++..||||.+...  .....+.+.+|+.+|+.++|+||+++++++...
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   71 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPR---------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP   71 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECC---------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence            48889999999999999998865         5778999998653  223446788999999999999999999999877


Q ss_pred             C-----ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          212 D-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       212 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      +     ..|+||||+. ++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~  145 (372)
T cd07853          72 HIDPFEEIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKIC  145 (372)
T ss_pred             CccccceEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEec
Confidence            6     7899999995 68888876543  6889999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      |||+++........ ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+......+..   .+
T Consensus       146 Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---~~  221 (372)
T cd07853         146 DFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD---LL  221 (372)
T ss_pred             cccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH---Hc
Confidence            99999865432211 22335689999999998764 578999999999999999999999976544322211110   00


Q ss_pred             CCc--cch-----------hh-ccC-ccccC--CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          366 GDK--RRF-----------YR-LLD-PRLEG--HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       366 ~~~--~~~-----------~~-~~~-~~l~~--~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      +..  ..+           .. ... +....  .+....+.++.+||.+||+.||.+|||+.+++++
T Consensus       222 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         222 GTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             CCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            000  000           00 000 00000  1112236788999999999999999999999976

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-41  Score=353.91  Aligned_cols=264  Identities=23%  Similarity=0.285  Sum_probs=200.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ...|.+.+.||+|+||.||+|.+..         ++..||||....      ..+.+|+++|++|+|+|||++++++...
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~  232 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD---------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG  232 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC---------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            4479999999999999999999876         567899996432      3457899999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..+||||++ .++|.+++..... .+++..++.|+.||+.||.|||+.+   ||||||||+||||+.++.+||+|||++
T Consensus       233 ~~~~lv~e~~-~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        233 GLTCLVLPKY-RSDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             CEEEEEEEcc-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCc
Confidence            9999999999 5789888865433 6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC-----cchh---hHhhhc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG-----EHNL---VEWARP  363 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~-----~~~~---~~~~~~  363 (491)
                      +..............+||+.|+|||++.+..++.++|||||||+||||++|..++.......     ...+   +.....
T Consensus       308 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~  387 (461)
T PHA03211        308 CFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV  387 (461)
T ss_pred             eecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc
Confidence            86643322222334679999999999999999999999999999999999887653322111     0111   111111


Q ss_pred             ccCCccc-----hhh--------ccCccccCC-CC--hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRR-----FYR--------LLDPRLEGH-FS--IKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~-----~~~--------~~~~~l~~~-~~--~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .......     +..        ...+..... +.  ...+..+.+||.+||+.||.+|||+.|||++
T Consensus       388 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        388 HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0000000     000        000000000 00  0224578999999999999999999999976

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=346.13  Aligned_cols=246  Identities=26%  Similarity=0.419  Sum_probs=204.6

Q ss_pred             ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEEEE
Q 011180          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE  219 (491)
Q Consensus       140 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  219 (491)
                      +||+|.||+||-|++..         +...+|||-+........+-+..||.+.++|+|.|||+++|.+.+++.+-|.||
T Consensus       582 VLGKGTYG~VYA~RD~~---------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME  652 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMD---------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME  652 (1226)
T ss_pred             EeecCceeEEEeecccc---------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence            59999999999999987         667899999987766666778899999999999999999999999999999999


Q ss_pred             ecCCCChHHHhhhCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC-CCCCeEEeccCCcccCCC
Q 011180          220 FMPRGSLENHLFRKGSLPL--PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDAPE  296 (491)
Q Consensus       220 ~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~-~~~~~kL~DFGla~~~~~  296 (491)
                      -++||+|.++|..+-+ ++  .+.....+..||++||.|||++.   |||||||-+||||+ -.|.+||+|||.++.+..
T Consensus       653 qVPGGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             cCCCCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            9999999999977643 55  67888899999999999999998   99999999999996 578999999999987643


Q ss_pred             CCCceeeeccccCCCCCCchhhhcC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          297 DGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       297 ~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                        ......++.||..|||||++..+  .|+.++|||||||++.||.||++||........    ..+...      ++. 
T Consensus       729 --inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----AMFkVG------myK-  795 (1226)
T KOG4279|consen  729 --INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----AMFKVG------MYK-  795 (1226)
T ss_pred             --CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----hhhhhc------cee-
Confidence              23345568899999999999865  689999999999999999999999964322110    000000      111 


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          .-...+...+.+++.+|.+|+..||.+||++.++|+.
T Consensus       796 ----vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  796 ----VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             ----cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence                1123445568999999999999999999999999864

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6e-41  Score=325.28  Aligned_cols=255  Identities=27%  Similarity=0.438  Sum_probs=205.9

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|++.++||+|+||.||+|...          .+..||+|.+..... ....+.+|+.+++.++|+||+++++++. .
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~   72 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-Q   72 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence            457999999999999999999864          356899999876543 3467899999999999999999999864 4


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+.+++|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcce
Confidence            67899999999999999987765567899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      ........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||......   .........      
T Consensus       150 ~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~------  219 (260)
T cd05067         150 RLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLERG------  219 (260)
T ss_pred             eecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHHcC------
Confidence            76643221 11223346788999999998899999999999999999999 99999654321   111111000      


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                              .....+...+..+.+|+.+||..+|++||+++++++.|+.+
T Consensus       220 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         220 --------YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence                    00011122357899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.1e-41  Score=331.78  Aligned_cols=266  Identities=26%  Similarity=0.414  Sum_probs=206.6

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      +..++|.+.+.||+|+||.||+|.++...    ....+..||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   78 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDII----KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV   78 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccC----CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            34568999999999999999999875321    111356899999865432 2334678899999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKG--------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  280 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~  280 (491)
                      .+.+..++||||+++|+|.+++....        ...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~  155 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHD  155 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCC
Confidence            99999999999999999999996532        123466778899999999999999988   9999999999999999


Q ss_pred             CCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhH
Q 011180          281 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       281 ~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~  359 (491)
                      +.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~  232 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK  232 (288)
T ss_pred             CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence            9999999999986543322222222345778999999998899999999999999999998 788885432211   111


Q ss_pred             hhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          360 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ..   .          +... ...+...+..+.+|+.+||+.||++|||+.++++.|+..
T Consensus       233 ~~---~----------~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         233 FV---M----------DGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HH---H----------cCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            10   0          0000 011122367899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.4e-41  Score=326.94  Aligned_cols=258  Identities=26%  Similarity=0.416  Sum_probs=199.5

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEeec-
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  211 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-  211 (491)
                      |.+.+.||+|+||.||+|.+...+       ....||+|.++...  ....+.+.+|+.+++.++|+||+++++++... 
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV   73 (272)
T ss_pred             CccccccCcccCceEEEeEEccCC-------CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence            457789999999999999986532       12369999887542  23346788899999999999999999987532 


Q ss_pred             -----CceEEEEEecCCCChHHHhhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          212 -----DQRLLVYEFMPRGSLENHLFRK----GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       212 -----~~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                           ...++||||+++|+|.+++...    ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.
T Consensus        74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  150 (272)
T cd05075          74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMN  150 (272)
T ss_pred             cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCC
Confidence                 2468999999999999887432    1234789999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  361 (491)
                      +||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......   ......
T Consensus       151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~  227 (272)
T cd05075         151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYL  227 (272)
T ss_pred             EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence            99999999987644322211222346778999999998899999999999999999999 78888643221   111111


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ..    ...          ...+...+..+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus       228 ~~----~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         228 RQ----GNR----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             Hc----CCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10    000          011123367789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.7e-41  Score=336.59  Aligned_cols=267  Identities=24%  Similarity=0.361  Sum_probs=203.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|.+.+.||+|+||.||+|++..         ++..||+|.+...... ....+.+|+.+++.++||||+++++++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD   76 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecC---------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence            469999999999999999998865         5678999998754322 234677899999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||++ ++|.+++...+. .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~  151 (309)
T cd07872          77 KSLTLVFEYLD-KDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLA  151 (309)
T ss_pred             CeEEEEEeCCC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccc
Confidence            99999999996 588888866543 5788889999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--------
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------  362 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--------  362 (491)
                      .........  .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||......+....+....        
T Consensus       152 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  229 (309)
T cd07872         152 RAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW  229 (309)
T ss_pred             eecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            765332211  223468999999998865 468899999999999999999999997654432222111100        


Q ss_pred             cccCCccchhhccCccccC----CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 PHLGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      +.+.....+...-.+....    ......+.++.+||.+||..||.+|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            0000000000000000000    0111236788999999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-41  Score=339.63  Aligned_cols=256  Identities=23%  Similarity=0.286  Sum_probs=199.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||.||++++..         ++..||||++.+..   ....+.+.+|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKN---------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ   71 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            479999999999999999999876         56789999996532   123355788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +++..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          72 DENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECC
Confidence            9999999999999999999997643 36888999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      ++......... .....+||+.|+|||++..     ..++.++|||||||++|+|++|+.||.........      ...
T Consensus       148 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i  220 (331)
T cd05597         148 SCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKI  220 (331)
T ss_pred             ceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHH
Confidence            98765433221 1223469999999999863     45788999999999999999999999654221110      001


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~  415 (491)
                      ...... ..+ .+     .....+..+.+||.+||..++.+  |+++.+++++
T Consensus       221 ~~~~~~-~~~-~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         221 MNHKEH-FQF-PP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HcCCCc-ccC-CC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            000000 000 00     01123678899999988654443  7899999987

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.6e-41  Score=323.88  Aligned_cols=251  Identities=23%  Similarity=0.332  Sum_probs=205.1

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +|.+.+.||+|+||.||++.+..         ++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.+++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   71 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVN---------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG   71 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcC---------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence            57889999999999999998865         57789999986543 234467888999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+++.......+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.++|+|||++.
T Consensus        72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~  148 (255)
T cd08219          72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSAR  148 (255)
T ss_pred             EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcce
Confidence            9999999999999999887654556889999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .......  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.......   .....   ....    
T Consensus       149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~---~~~~----  216 (255)
T cd08219         149 LLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---LILKV---CQGS----  216 (255)
T ss_pred             eeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---HHHHH---hcCC----
Confidence            6643222  1233568999999999988889999999999999999999999996532211   11100   0000    


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        .     ...+...+..+.+||.+||+.||.+||++.+++..
T Consensus       217 --~-----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 --Y-----KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --C-----CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              0     01112235678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.7e-41  Score=332.37  Aligned_cols=261  Identities=25%  Similarity=0.407  Sum_probs=204.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC-CcccHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  210 (491)
                      ++|++.++||+|+||.||+|.+..++       ....+++|.++.. .....+.+.+|+.++.++ +||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   74 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDG-------LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN   74 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCC-------CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence            47899999999999999999886532       2235788888743 223346788999999999 69999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NIL  276 (491)
                      .+..++||||+++++|.+++.....              ..+++..++.++.||+.||+|||+.+   |+||||||+|||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil  151 (297)
T cd05089          75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVL  151 (297)
T ss_pred             CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEE
Confidence            9999999999999999999865321              24788899999999999999999988   999999999999


Q ss_pred             ECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011180          277 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  355 (491)
Q Consensus       277 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~  355 (491)
                      ++.++.+||+|||++.......   .......+..|+|||++.+..++.++|||||||++|||++ |..||.......  
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--  226 (297)
T cd05089         152 VGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--  226 (297)
T ss_pred             ECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence            9999999999999986432110   1111223557999999988899999999999999999997 999996543211  


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcccc
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  423 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~~  423 (491)
                       .....              ........+...+..+.+|+.+||..+|.+||+++++++.|+.+.+..
T Consensus       227 -~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         227 -LYEKL--------------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             -HHHHH--------------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence             11110              000011112234678999999999999999999999999988765443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.2e-41  Score=327.50  Aligned_cols=254  Identities=24%  Similarity=0.383  Sum_probs=203.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||+|+++.........+.+|+.+++.++||||+++++++...+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~   79 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVN---------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD   79 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcC---------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence            468888999999999999998865         57789999997665444556788999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+++...+  .+++..++.++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++.
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd06645          80 KLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSA  154 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeee
Confidence            9999999999999999987654  6889999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ......  .......|+..|+|||++.   ...++.++|||||||++|+|++|..||....+.........  ..     
T Consensus       155 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--~~-----  225 (267)
T cd06645         155 QITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--SN-----  225 (267)
T ss_pred             EccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--cC-----
Confidence            654321  1123457899999999874   45688999999999999999999999865433221111000  00     


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          ...+....  ....+..+.+||.+||..||++||++.+|+++
T Consensus       226 ----~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         226 ----FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ----CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence                00000100  01225678999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-41  Score=322.90  Aligned_cols=251  Identities=29%  Similarity=0.499  Sum_probs=206.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|++.+.||.|+||.||+|..           .|..||||.+..... ..+++.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   72 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-----------RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG   72 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-----------cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence            35789999999999999999976           356899999976643 457889999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccc
Confidence            99999999999999999997765556899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +.......     ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   +......    .  
T Consensus       150 ~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~----~--  215 (256)
T cd05039         150 KEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEK----G--  215 (256)
T ss_pred             cccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhc----C--
Confidence            87632211     2334678999999988899999999999999999997 999986442211   1111100    0  


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                              .....+...+..+.+||.+||..+|.+|||+.++++.|+.+
T Consensus       216 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         216 --------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             --------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                    00011122367899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=9.6e-41  Score=323.10  Aligned_cols=249  Identities=29%  Similarity=0.447  Sum_probs=201.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEe-ec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI-ED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~  211 (491)
                      .+|.+.+.||+|+||.||++...           |..||+|.+..+.  ..+.+.+|+.+++.++|+||+++++++. ..
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   72 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence            46899999999999999999763           5579999986543  3467889999999999999999999765 45


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++.......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~  149 (256)
T cd05082          73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLT  149 (256)
T ss_pred             CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccc
Confidence            67899999999999999997765556889999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      .......     ....++..|+|||++.+..++.++|||||||++|+|++ |+.||......   .+.......      
T Consensus       150 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~~~------  215 (256)
T cd05082         150 KEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKG------  215 (256)
T ss_pred             eeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhcC------
Confidence            7653321     12345678999999988899999999999999999997 99988643211   111111000      


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                              .....+...+..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus       216 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         216 --------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                    00111223467899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.4e-40  Score=322.19  Aligned_cols=250  Identities=28%  Similarity=0.390  Sum_probs=199.0

Q ss_pred             ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       140 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      .||+|+||.||+|.+...       .++..||+|+++....  ...+++..|+.+++.+.||||+++++++. .+..++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv   73 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMK-------KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV   73 (257)
T ss_pred             cCCCcCCcceEEeEEecC-------CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence            589999999999987532       2567899999875432  23467889999999999999999999875 4567899


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      |||+++++|.+++....  .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          74 MELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            99999999999987553  6889999999999999999999988   999999999999999999999999999876443


Q ss_pred             CCcee-eeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhcc
Q 011180          298 GKTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  375 (491)
Q Consensus       298 ~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (491)
                      ..... .....++..|+|||.+....++.++|||||||++|||++ |..||.......   ........           
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i~~~-----------  214 (257)
T cd05116         149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMIESG-----------  214 (257)
T ss_pred             CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHCC-----------
Confidence            32211 122334678999999988889999999999999999998 999996543221   11111110           


Q ss_pred             CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       376 ~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                         .....+...+.++.+||.+||+.||.+||++.+|.+.|+..
T Consensus       215 ---~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         215 ---ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence               00112223478899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.4e-41  Score=330.12  Aligned_cols=252  Identities=31%  Similarity=0.430  Sum_probs=202.4

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      |+..++||+|+||+||+|.+..         +++.||+|.+......   ....+.+|+++|+.++|+||+.+++++..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRA---------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK   72 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECC---------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence            6777899999999999999876         5779999998654322   234577899999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++...+...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcc
Confidence            99999999999999999887655557999999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ........   .....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+.  ......    
T Consensus       150 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~~~~~----  220 (285)
T cd05632         150 VKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRVLET----  220 (285)
T ss_pred             eecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhhhcc----
Confidence            76533211   123578999999999998899999999999999999999999997543211111110  000000    


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  415 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~  415 (491)
                              ...+....+..+.+|+.+||+.||.+||+     +.+++.+
T Consensus       221 --------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 --------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             --------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                    01122233677899999999999999999     5666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.1e-41  Score=326.44  Aligned_cols=259  Identities=27%  Similarity=0.465  Sum_probs=205.5

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +|++.+.||+|+||.||+|.+...+.      .+..||||.+.... .....++..|+.+++.+.||||+++++++.++.
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   78 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR   78 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCC------CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence            58889999999999999999876432      24579999987642 233467899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccc
Confidence            99999999999999999876533 6889999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCceeeec-cc--cCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          293 DAPEDGKTHVSTR-VM--GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       293 ~~~~~~~~~~~~~-~~--Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ............. ..  ++..|+|||.+.+..++.++|||||||++|||++ |..||......   ....+.....   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~~---  228 (269)
T cd05065         155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQDY---  228 (269)
T ss_pred             ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCC---
Confidence            6543222111111 11  2457999999998999999999999999999886 99998654322   1111111000   


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                                 ....+..++..+.+++.+||..+|.+||++.+|+..|+.+
T Consensus       229 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 -----------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                       0011123367789999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.4e-41  Score=327.73  Aligned_cols=252  Identities=26%  Similarity=0.404  Sum_probs=200.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.++||+|+||.||+|.+..         ++..||+|.+..+. ......+.+|++++.+++||||+++++++...
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLL---------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE   71 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence            368889999999999999998865         67789999987553 22345688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|..+.      .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++
T Consensus        72 ~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~  142 (279)
T cd06619          72 NRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVS  142 (279)
T ss_pred             CEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence            9999999999999986542      4678888899999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~-~~~~~~~~~~~~~  370 (491)
                      .......    ....+||..|+|||++.+..++.++|||||||++|+|++|..||........... ........ ..  
T Consensus       143 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~--  215 (279)
T cd06619         143 TQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DE--  215 (279)
T ss_pred             eeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-cc--
Confidence            7654321    2335789999999999988999999999999999999999999965332211100 01000000 00  


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                          ..+.+   .....+..+.+||.+||+.||.+||++.+++++.
T Consensus       216 ----~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         216 ----DPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             ----CCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence                00000   0112356789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=9.7e-41  Score=325.11  Aligned_cols=261  Identities=26%  Similarity=0.445  Sum_probs=207.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|+..+.||+|+||.||+|.+..++.      ....||+|.+.... ....+.+..|+++++.++|+||+++++++.+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGR------KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK   77 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence            3468889999999999999999875322      24579999987553 2334678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcc
Confidence            999999999999999999987653 36889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceee-eccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          291 AKDAPEDGKTHVS-TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       291 a~~~~~~~~~~~~-~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      +............ .....+..|+|||++.+..++.++|||||||++|||++ |..||.......   ........    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i~~~----  226 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAINDG----  226 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhcC----
Confidence            9866433221111 11223457999999998899999999999999999997 999996543211   11111100    


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                                .........+..+.+|+.+||..+|.+||++.+|++.|+++
T Consensus       227 ----------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 ----------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                      00011123367889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=312.59  Aligned_cols=254  Identities=30%  Similarity=0.456  Sum_probs=203.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC-CcccHHHHHHHHHHHhcCC-CCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~  210 (491)
                      ++...+..||.|+-|.|++++++.         +|...|||.+... +....++++..+.++...+ .|+||+.+|||..
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs---------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRS---------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcc---------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            456667889999999999999987         7789999999765 3455677888888877665 8999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      +..+++.||.| ...++.+|.+. ..++++..+-++...++.||.||.+++  +|||||+||+|||||+.|++||||||+
T Consensus       163 n~dV~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGI  238 (391)
T KOG0983|consen  163 NTDVFICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGI  238 (391)
T ss_pred             CchHHHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccc
Confidence            99999999999 55666666554 347999999999999999999998865  499999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      +..+.+.   ...++..|.+.|||||.+.   ...|+.++||||||++|+||.||+.||....-.-+  ....   .+.+
T Consensus       239 sGrlvdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~ltk---vln~  310 (391)
T KOG0983|consen  239 SGRLVDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VLTK---VLNE  310 (391)
T ss_pred             cceeecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HHHH---HHhc
Confidence            9877553   2335578999999999986   34789999999999999999999999976432211  1111   1111


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                             ..|.+.+..  ..++.+.+|+..||.+|+.+||...+++++-
T Consensus       311 -------ePP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  311 -------EPPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             -------CCCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence                   112222211  1378899999999999999999999999873

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.2e-40  Score=332.00  Aligned_cols=266  Identities=27%  Similarity=0.398  Sum_probs=204.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||+|+||.||++.+..         ++..||+|.+..... ....++.+|++++.+++||||+++++++.++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRP---------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD   71 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcC---------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            368999999999999999998865         677899999875432 2335688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      +..++||||+++++|.+++...+  .+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.++|+|||+
T Consensus        72 ~~~~lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  146 (308)
T cd06615          72 GEISICMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV  146 (308)
T ss_pred             CEEEEEeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCC
Confidence            99999999999999999997653  67889999999999999999997 46   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc--
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--  368 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--  368 (491)
                      +.......    .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||......................  
T Consensus       147 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  222 (308)
T cd06615         147 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES  222 (308)
T ss_pred             cccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCC
Confidence            87653321    233578999999999988889999999999999999999999996543221111110000000000  


Q ss_pred             --------------cchhhccCccc---cCCCC-hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          369 --------------RRFYRLLDPRL---EGHFS-IKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       369 --------------~~~~~~~~~~l---~~~~~-~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                                    .......+...   ....+ ...+..+.+|+.+||..||++|||+.+|+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             cccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                          00000000000   00000 01356799999999999999999999999774

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.2e-40  Score=321.90  Aligned_cols=260  Identities=25%  Similarity=0.384  Sum_probs=208.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||.||+|.+..         +|..||+|.++...   ....+.+.+|+++++.++|+||+++++++.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~   72 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLL---------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI   72 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcC---------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence            579999999999999999999875         57789999886432   223467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +.+..++||||+++++|.+++...  ....+++..++.++.+++.||.|||+.+   |+||||+|+||+++.++.++|+|
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d  149 (267)
T cd08224          73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEec
Confidence            999999999999999999988642  2345889999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ||++.........  .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...... .....+.....   
T Consensus       150 ~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~---  223 (267)
T cd08224         150 LGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEKC---  223 (267)
T ss_pred             cceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhhcC---
Confidence            9998765432211  22356899999999999888999999999999999999999998543211 00111110000   


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                            ...+.    .....+..+.++|.+||..+|++|||+.+|++.|+.+.
T Consensus       224 ------~~~~~----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         224 ------DYPPL----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ------CCCCC----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                  00000    01133678899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.8e-41  Score=327.84  Aligned_cols=254  Identities=29%  Similarity=0.419  Sum_probs=202.4

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      +++.|.+.+.||+|+||.||+|.+..         ++..||+|++.... .....+..|+.++..+ +|+||+++++++.
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   73 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcC---------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence            34578899999999999999998875         56789999987553 3346788999999998 6999999999987


Q ss_pred             ec------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          210 ED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       210 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ..      ...|+||||+++++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~  150 (272)
T cd06637          74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  150 (272)
T ss_pred             ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCE
Confidence            53      35789999999999999997755557899999999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  358 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  358 (491)
                      +|+|||++........  ......|+..|+|||++.     ...++.++|||||||++|||++|..||............
T Consensus       151 ~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~  228 (272)
T cd06637         151 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  228 (272)
T ss_pred             EEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            9999999886533211  123467899999999986     346888999999999999999999999643321111100


Q ss_pred             HhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          .  ..       ...   .......+..+.+|+.+||..||.+|||+.+++++
T Consensus       229 ----~--~~-------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 ----P--RN-------PAP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ----h--cC-------CCC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                0  00       000   00111235789999999999999999999999865

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9e-41  Score=333.68  Aligned_cols=269  Identities=24%  Similarity=0.391  Sum_probs=208.0

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||+|+||.||+|.+.....  ........||+|.+..... .....+..|+.++..+ .||||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            34578999999999999999998643111  1112456799999875432 2345688999999999 599999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  274 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~N  274 (491)
                      .+.+..++||||+++|+|.+++....              ...+++..+..++.||+.||.|||+.+   |+||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence            99999999999999999999996532              134788899999999999999999988   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 011180          275 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  353 (491)
Q Consensus       275 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~  353 (491)
                      ||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999986643222111112234568999999998899999999999999999999 888885432211


Q ss_pred             cchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                         .......    .          .....+..++..+.+|+.+||..||.+|||+.++++.|..+..
T Consensus       245 ---~~~~~~~----~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 ---LFKLLRE----G----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             ---HHHHHHc----C----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence               1111110    0          0001122346788999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.5e-41  Score=328.20  Aligned_cols=265  Identities=26%  Similarity=0.400  Sum_probs=210.4

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ..++|.+.++||+|+||.||+|.+....     ..++..|++|.+.... ....+.+.+|+.+++.+.|+||+++++++.
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   78 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI   78 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            4568999999999999999999987532     1246789999987542 233466889999999999999999999877


Q ss_pred             e-cCceEEEEEecCCCChHHHhhhCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          210 E-DDQRLLVYEFMPRGSLENHLFRKGS------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       210 ~-~~~~~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      . ....++++||+++++|.+++.....      ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.
T Consensus        79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~  155 (280)
T cd05043          79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCc
Confidence            6 4678999999999999999865422      35889999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  361 (491)
                      +||+|||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||....+..   ...+.
T Consensus       156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~  232 (280)
T cd05043         156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL  232 (280)
T ss_pred             EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH
Confidence            99999999986644332222233456778999999988899999999999999999999 999996543221   11111


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      ....              .......++..+.+++.+||..||++|||+.++++.|+.+.
T Consensus       233 ~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         233 KDGY--------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             HcCC--------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1100              00111223678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-40  Score=339.42  Aligned_cols=263  Identities=22%  Similarity=0.300  Sum_probs=196.7

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ....+|.+.+.||+|+||.||+|.+..         ++..||+|+....      ....|+.+++.++|+||+++++++.
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~  127 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPG---------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV  127 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECC---------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE
Confidence            334579999999999999999999865         5668999985433      2356999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      .....++||||+ .++|.+++.... ..+++..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       128 ~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG  202 (357)
T PHA03209        128 SGAITCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLG  202 (357)
T ss_pred             eCCeeEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCc
Confidence            999999999999 568988886543 36899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch--------hhHhh
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN--------LVEWA  361 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~--------~~~~~  361 (491)
                      +++......   ......||+.|+|||++.+..++.++|||||||++|||+++..++....+.....        +....
T Consensus       203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~  279 (357)
T PHA03209        203 AAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII  279 (357)
T ss_pred             cccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH
Confidence            997543221   1233569999999999999999999999999999999998665553322221100        00000


Q ss_pred             hcccCCccch---------hhccCc--cccC---CC----ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 RPHLGDKRRF---------YRLLDP--RLEG---HF----SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 ~~~~~~~~~~---------~~~~~~--~l~~---~~----~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .........+         ...++.  ....   .+    ....+..+.+||.+||+.||.+|||+.||+++
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             HHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            0000000000         000000  0000   00    01225567789999999999999999999976

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2e-40  Score=328.20  Aligned_cols=273  Identities=26%  Similarity=0.417  Sum_probs=206.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCc-------ccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTA-------PVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-------~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l  204 (491)
                      ++|++.+.||+|+||.||++.+......       ....+++..||+|++..... ....++.+|+.+|+.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            4699999999999999999875431110       01223456799999975532 334678899999999999999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGS---------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  275 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NI  275 (491)
                      ++++...+..++||||+++++|.+++.....         ..+++..+..++.||+.||+|||+.+   |+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999876431         23667889999999999999999988   99999999999


Q ss_pred             EECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCC
Q 011180          276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRRSMDKNRPNG  353 (491)
Q Consensus       276 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~pf~~~~~~~  353 (491)
                      |++.++.++|+|||+++...............++..|++||.+.++.++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986644322222223345678999999888899999999999999999998  667875433211


Q ss_pred             cchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                      .   +..........       ........+..++..+.+|+.+||+.||.+||++.+|++.|++
T Consensus       242 ~---~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 V---IENTGEFFRDQ-------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H---HHHHHHHHhhc-------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1   11000000000       0000001112346789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.5e-41  Score=341.10  Aligned_cols=264  Identities=25%  Similarity=0.325  Sum_probs=198.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++....  ......+.+|+.+++.++||||+++++++.
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   90 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTV---------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFT   90 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcC---------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence            4679999999999999999998865         67799999996542  233456789999999999999999999987


Q ss_pred             ecC------ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          210 EDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ..+      ..|+||||+. ++|.+.+..    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~  162 (359)
T cd07876          91 PQKSLEEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  162 (359)
T ss_pred             cCCCccccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCE
Confidence            543      4699999995 467666532    4778888999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh-H---
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-E---  359 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~---  359 (491)
                      ||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ .   
T Consensus       163 kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  239 (359)
T cd07876         163 KILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG  239 (359)
T ss_pred             EEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999997643221   123457899999999999999999999999999999999999999754321110000 0   


Q ss_pred             ------------hhhcccCCc-----cchhhccCccc---cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          360 ------------WARPHLGDK-----RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       360 ------------~~~~~~~~~-----~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                  .........     ..+...+....   ........+..+.+||.+||..||.+|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                        000000000     00000000000   000111225678999999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-40  Score=324.38  Aligned_cols=260  Identities=27%  Similarity=0.388  Sum_probs=208.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||.|+||.||+|.+..         ++..||||.+.....   ....++.+|+.+++.+.|+||+++++++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   72 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI   72 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecC---------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence            368889999999999999999865         567899998865322   23357889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +.+..++||||+++++|.+++...  ....+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.++|+|
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~d  149 (267)
T cd08229          73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECc
Confidence            999999999999999999988642  2336889999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ||++.........  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ........     
T Consensus       150 fg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~-----  221 (267)
T cd08229         150 LGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIE-----  221 (267)
T ss_pred             chhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhhhh-----
Confidence            9998766433211  223568999999999988889999999999999999999999986432210 01111000     


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                           ....+.+   .....+..+.+|+.+||..||.+|||+.+|++.++++.
T Consensus       222 -----~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         222 -----QCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             -----cCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                 0000100   01123678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.8e-41  Score=324.58  Aligned_cols=254  Identities=27%  Similarity=0.400  Sum_probs=203.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|++.+.||+|+||.||+|.+..          ...||+|.+..... ..+.+.+|+++++.++|+||+++++++. .+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~----------~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~   73 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE   73 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecC----------CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CC
Confidence            469999999999999999998753          23599999976432 3467899999999999999999999875 45


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||+++
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~  150 (262)
T cd05071          74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR  150 (262)
T ss_pred             CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCcee
Confidence            6899999999999999997654446789999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||........   ....   ....   
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~~~---~~~~---  220 (262)
T cd05071         151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQV---ERGY---  220 (262)
T ss_pred             eccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HHHH---hcCC---
Confidence            66433221 1122346778999999988899999999999999999999 8888865432111   1100   0000   


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                              ....+...+..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus       221 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 --------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                    0011223467889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=355.87  Aligned_cols=261  Identities=27%  Similarity=0.476  Sum_probs=220.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ....++++||.|.||.||+|+++..++      ....||||.++..... ...+|+.|+.||.+++||||++|.|+....
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgk------re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks  702 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGK------REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS  702 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCC------cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence            456788999999999999999987554      4568999999876543 346799999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ..++||.|||++|+|+.+|..+.. .+.+.+..-+++.|+.|++||-+.+   +|||||...||||+.+..+|++||||+
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccce
Confidence            999999999999999999988765 5899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeecccc--CCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          292 KDAPEDGKTHVSTRVMG--TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~G--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      +.+.++.... .+...|  ..+|.|||.+....++.++|||||||+|||.++ |..|++.....+..+.++         
T Consensus       779 Rvledd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe---------  848 (996)
T KOG0196|consen  779 RVLEDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE---------  848 (996)
T ss_pred             eecccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH---------
Confidence            9876654322 222333  468999999999999999999999999999665 889997665443333222         


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                              ..+.-..+..|+..+.+|+..||++|-.+||++.+|+.+|.++-+
T Consensus       849 --------~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  849 --------QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             --------hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence                    112223356779999999999999999999999999999987643

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-42  Score=310.62  Aligned_cols=266  Identities=27%  Similarity=0.369  Sum_probs=210.5

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      +..++|++.+.||+|||+.||++....         ++..+|+|.+.....++.+..++|++..++++||||++++++..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s---------~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l   88 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLS---------TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL   88 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccC---------cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence            345689999999999999999998655         67789999998777677888999999999999999999998876


Q ss_pred             ecC-----ceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          210 EDD-----QRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       210 ~~~-----~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      .+.     ..||+++|...|+|.+.+...  ++..+++...+.|+.+|++||++||+.. .+++||||||.|||+.+.+.
T Consensus        89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCc
Confidence            543     489999999999999998653  2336899999999999999999999987 57999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCce-------eeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 011180          283 AKLSDFGLAKDAPEDGKTH-------VSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN  352 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~-------~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~  352 (491)
                      ++|.|||.++...-.-...       .-.....|..|.|||.+.   +...+.++|||||||+||+|+.|..||+.....
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~  247 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ  247 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence            9999999988653211100       001123589999999886   456789999999999999999999999754332


Q ss_pred             CcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      +.--..              .+..+.+.-.-....+..+.+||+.||+.||.+||++.+++..+..+
T Consensus       248 GgSlaL--------------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  248 GGSLAL--------------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             CCeEEE--------------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            211000              01111111111112378899999999999999999999999998765

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=322.81  Aligned_cols=256  Identities=30%  Similarity=0.438  Sum_probs=207.5

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ..++|.+.+.||+|+||.||+|.+..          +..||||.+..... ..+++.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSE   72 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence            44689999999999999999998753          35799999976543 45678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ....++||||+++++|.+++.......+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||+
T Consensus        73 ~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~  149 (261)
T cd05034          73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGL  149 (261)
T ss_pred             CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECcccc
Confidence            899999999999999999997765557899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +......... ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||......   .........     
T Consensus       150 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~-----  220 (261)
T cd05034         150 ARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVERG-----  220 (261)
T ss_pred             ceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC-----
Confidence            9876432111 1112234678999999998899999999999999999998 99998643221   111111000     


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                               .....+...+..+.+++.+||..+|.+||+++++++.|+.
T Consensus       221 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 ---------YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                     0001112236789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.4e-40  Score=321.80  Aligned_cols=253  Identities=29%  Similarity=0.449  Sum_probs=203.2

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      ++||+|+||.||+|.+....      +....||||.+..... ...+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSG------GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecCC------CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence            46899999999999986521      1345799999987766 456788999999999999999999999988 889999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      |||+++++|.+++.......+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence            99999999999997754346899999999999999999999988   999999999999999999999999999876543


Q ss_pred             CCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhcc
Q 011180          298 GKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  375 (491)
Q Consensus       298 ~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (491)
                      ... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......   .......   ...      
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~~------  218 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK---EGE------  218 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh---cCC------
Confidence            221 11123457889999999998899999999999999999998 999986432221   1111100   000      


Q ss_pred             CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       376 ~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                          ....+...+..+.+++.+||..+|.+||++.++++.|.
T Consensus       219 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 ----RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                00011123678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.1e-41  Score=339.80  Aligned_cols=266  Identities=29%  Similarity=0.401  Sum_probs=203.7

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      .++|++.+.||+|+||.||+|.+...+    ...+++.||||++..... .....+.+|+.+|.++ +||||+++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCC----ccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            457999999999999999999864211    112577899999976432 2345688999999999 6899999999886


Q ss_pred             ec-CceEEEEEecCCCChHHHhhhCCC-----------------------------------------------------
Q 011180          210 ED-DQRLLVYEFMPRGSLENHLFRKGS-----------------------------------------------------  235 (491)
Q Consensus       210 ~~-~~~~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------  235 (491)
                      .. ...++||||+++|+|.+++.....                                                     
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            54 467899999999999999864321                                                     


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceee
Q 011180          236 ------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS  303 (491)
Q Consensus       236 ------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  303 (491)
                                  ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  238 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  238 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence                        13677888899999999999999988   999999999999999999999999999865432222222


Q ss_pred             eccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCC
Q 011180          304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGH  382 (491)
Q Consensus       304 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  382 (491)
                      ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......  .......    ....          ..
T Consensus       239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~----~~~~----------~~  302 (343)
T cd05103         239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLK----EGTR----------MR  302 (343)
T ss_pred             CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHHHh----ccCC----------CC
Confidence            22345678999999988899999999999999999997 888886532211  1111000    0000          00


Q ss_pred             CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          383 FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       383 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      .+...+..+.+++.+||+.||.+|||+.+|+++|+.+.
T Consensus       303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            01112567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.3e-40  Score=324.34  Aligned_cols=260  Identities=26%  Similarity=0.459  Sum_probs=207.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .+|++.+.||+|+||.||+|.+...+.      .+..||+|.++.... ...+.+.+|+.++..++||||+++++++..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGK------REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS   77 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCC------CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            478899999999999999998864321      345799999875432 2345788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcc
Confidence            999999999999999999976543 6789999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcee-eeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          292 KDAPEDGKTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       292 ~~~~~~~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ........... .....++..|+|||.+.+..++.++|+|||||++||+++ |..||.......   ........    .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~~----~  226 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEEG----Y  226 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhCC----C
Confidence            87654322111 111233568999999998899999999999999999886 999986543221   11111100    0


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      .          ...+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       227 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 R----------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             c----------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            0          011122367889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.4e-40  Score=329.48  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=206.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .+|.+.+.||.|+||.||+|.+..         ++..||+|.+........+.+.+|+.+++.+.|+||+++++++....
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~   90 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECC---------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence            479999999999999999998765         56789999998766555677889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..|+||||+++++|.+++...   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++.
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~  164 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (296)
T ss_pred             EEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccch
Confidence            999999999999999988543   5788899999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .......  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+....  ......    ..   
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~~~----~~---  233 (296)
T cd06654         165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIATN----GT---  233 (296)
T ss_pred             hcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHhcC----CC---
Confidence            6533221  122356899999999998888999999999999999999999999654332111  100000    00   


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          +.  ...+...+..+.+|+.+||..||.+||++.+++++
T Consensus       234 ----~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         234 ----PE--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ----CC--CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence                00  01112235778999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.2e-40  Score=323.04  Aligned_cols=256  Identities=28%  Similarity=0.387  Sum_probs=194.7

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      +.||+|+||.||+|.+....       ++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   73 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGY-------TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV   73 (269)
T ss_pred             CcccccCCceEEEEEEcCCC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence            36999999999999875321       456799999876532 2335688899999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          218 YEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      |||+++|+|.+++....   ....++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccc
Confidence            99999999999986532   224567777889999999999999988   999999999999999999999999999765


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcC-------CCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccC
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTG-------HLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      .............|+..|+|||++.+.       .++.++|||||||++|||++ |..||........   ......  .
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~~~--~  225 (269)
T cd05087         151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYTVR--E  225 (269)
T ss_pred             cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHhh--c
Confidence            433222222345678899999988642       35789999999999999996 9999965432211   111000  0


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      ..   ....++.+    ....+..+.+|+.+|| .+|.+|||+++|+..|+
T Consensus       226 ~~---~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 QQ---LKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cc---CCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00   01111111    1123567889999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.8e-40  Score=320.56  Aligned_cols=251  Identities=25%  Similarity=0.401  Sum_probs=198.2

Q ss_pred             ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEEE
Q 011180          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY  218 (491)
Q Consensus       140 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  218 (491)
                      .||+|+||.||+|.+....       .+..||+|++..... ...+.+.+|+.+++.++|+||+++++++. .+..++||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~-------~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~   73 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRK-------KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM   73 (257)
T ss_pred             ccCCCCcccEEEEEEecCC-------CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence            3899999999999875321       456799999976532 23456889999999999999999999875 45789999


Q ss_pred             EecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCC
Q 011180          219 EFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  298 (491)
Q Consensus       219 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~  298 (491)
                      ||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++.......
T Consensus        74 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  149 (257)
T cd05115          74 EMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD  149 (257)
T ss_pred             EeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence            9999999999986543 36899999999999999999999988   9999999999999999999999999998654332


Q ss_pred             Ccee-eeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhccC
Q 011180          299 KTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  376 (491)
Q Consensus       299 ~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (491)
                      .... .....++..|+|||.+.+..++.++|||||||++|||++ |..||........   ......             
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~-------------  213 (257)
T cd05115         150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSFIEQ-------------  213 (257)
T ss_pred             cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHHHC-------------
Confidence            2211 111223578999999988889999999999999999996 9999865432211   111100             


Q ss_pred             ccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       377 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                       ......+..++.++.+||.+||..||++||++.+|++.|+.+
T Consensus       214 -~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         214 -GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence             001112233478899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-40  Score=320.00  Aligned_cols=253  Identities=34%  Similarity=0.526  Sum_probs=205.9

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      +.||+|+||.||+|.+....      ..+..||+|.+....... .+.+.+|+.++..+.|+||+++++++.+....++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence            46999999999999987531      136789999998664433 57788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          218 YEFMPRGSLENHLFRKG-------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      |||+++++|.+++....       ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||.
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~  151 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGL  151 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccc
Confidence            99999999999997651       246899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +................++..|+|||.+....++.++|||||||++|+|++ |..||......   ........    . 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~----~-  223 (262)
T cd00192         152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYLRK----G-  223 (262)
T ss_pred             ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc----C-
Confidence            987755432222334567899999999988899999999999999999999 58998665221   11111110    0 


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                               .....+...+..+.+++.+||..||.+|||+.+++++|+
T Consensus       224 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 ---------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                     001122233678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7e-41  Score=337.27  Aligned_cols=256  Identities=23%  Similarity=0.296  Sum_probs=199.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||++.+..         ++..||+|++.+...   .....+..|+.++..+.|+||+++++++.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ   71 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            378999999999999999999875         567899999864321   12344778999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..||||||+++|+|.+++..... .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          72 DENNLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             cCCEEEEEEeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999999976432 6888999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      ++........ ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||........      ....
T Consensus       148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i  220 (332)
T cd05623         148 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKI  220 (332)
T ss_pred             hheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHH
Confidence            9876543322 1223357999999999986     34688999999999999999999999965432111      1111


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~  415 (491)
                      ......+ . + +    ......+..+.+|+.+||..++.+  |+++.+++++
T Consensus       221 ~~~~~~~-~-~-p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         221 MNHKERF-Q-F-P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             hCCCccc-c-C-C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            1100000 0 0 0    001123678999999999665544  6899999877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.6e-41  Score=337.86  Aligned_cols=256  Identities=22%  Similarity=0.286  Sum_probs=199.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||++++..         ++..||+|++.....   .....+.+|+.++..+.|+||+++++++.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~   71 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKH---------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ   71 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            479999999999999999998875         567899999865321   22345778999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..||||||+++|+|.+++..... .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          72 DENYLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEecc
Confidence            99999999999999999999976432 6888999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      ++......... .....+||+.|+|||++.+     +.++.++|||||||+||||++|+.||........   ..   ..
T Consensus       148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~---~i  220 (331)
T cd05624         148 SCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YG---KI  220 (331)
T ss_pred             ceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH---HH---HH
Confidence            99766433221 1233579999999999875     5688899999999999999999999965432111   10   00


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~  415 (491)
                      ......+  .+.+.     ....+..+.+|+.+||..++.+  |+++++++++
T Consensus       221 ~~~~~~~--~~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         221 MNHEERF--QFPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HcCCCcc--cCCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0000000  00000     0123678999999999876654  4688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=9.7e-41  Score=336.40  Aligned_cols=270  Identities=26%  Similarity=0.375  Sum_probs=209.4

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCceeeeeeE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~  207 (491)
                      +...+|.+.+.||+|+||.||+|++.....  .....+..||+|.+.... ....+++.+|+++++++ .||||++++++
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDK--DKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCC--ccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            344579999999999999999998754221  011234579999887543 22346788999999999 79999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTS  273 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~  273 (491)
                      +...+..++||||+++|+|.+++....              ...+++..++.++.||+.||.|||+.+   |+||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence            999999999999999999999987532              124778888999999999999999988   999999999


Q ss_pred             cEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 011180          274 NILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPN  352 (491)
Q Consensus       274 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~  352 (491)
                      |||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999986643322211222334578999999999999999999999999999998 88888543211


Q ss_pred             CcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      .      .......           ......+...+..+.+|+.+||+.+|.+|||+.++++.|+.+..
T Consensus       244 ~------~~~~~~~-----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         244 E------LFKLLKE-----------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             H------HHHHHHc-----------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            1      1110000           00011122336789999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=8.8e-41  Score=332.13  Aligned_cols=260  Identities=25%  Similarity=0.429  Sum_probs=202.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+..++       ....+|+|.+.... ......+.+|+.++.++ +|+||+++++++.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~   78 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE   78 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCC-------ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence            347899999999999999999986532       12356888776432 22345788899999999 8999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  275 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NI  275 (491)
                      +++..++||||+++++|.+++...+              ...+++..++.++.||+.||+|||+.+   |+||||||+||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Ni  155 (303)
T cd05088          79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNI  155 (303)
T ss_pred             CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheE
Confidence            9999999999999999999986543              125788899999999999999999988   99999999999


Q ss_pred             EECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCc
Q 011180          276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE  354 (491)
Q Consensus       276 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~  354 (491)
                      |++.++.+||+|||++.......   ......++..|+|||++.+..++.++|||||||++|||++ |..||....... 
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-  231 (303)
T cd05088         156 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-  231 (303)
T ss_pred             EecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-
Confidence            99999999999999986432110   1111234668999999988889999999999999999998 999986433211 


Q ss_pred             chhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                        ......              .......+...+..+.+|+.+||+.+|.+||++.+++..|+.+..
T Consensus       232 --~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         232 --LYEKLP--------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             --HHHHHh--------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              111100              000001112236778999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.1e-40  Score=331.23  Aligned_cols=265  Identities=22%  Similarity=0.354  Sum_probs=191.2

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee--cCceE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--DDQRL  215 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~  215 (491)
                      ...||+|+||+||+|.+....       ++..||+|.+.....  ...+.+|+.+|+.++||||+++++++..  +...|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~-------~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   76 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGK-------DDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   76 (317)
T ss_pred             ccccccCCCeEEEEEEEccCC-------CCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence            467999999999999875321       466899999875532  3457889999999999999999998864  35678


Q ss_pred             EEEEecCCCChHHHhhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----CCCCCeE
Q 011180          216 LVYEFMPRGSLENHLFRK-------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNAK  284 (491)
Q Consensus       216 lV~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl----~~~~~~k  284 (491)
                      +||||+ +++|.+++...       ....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+|
T Consensus        77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~k  152 (317)
T cd07868          77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK  152 (317)
T ss_pred             EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEE
Confidence            999999 56888877532       1235888999999999999999999988   9999999999999    4567899


Q ss_pred             EeccCCcccCCCCCCc-eeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc------h
Q 011180          285 LSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH------N  356 (491)
Q Consensus       285 L~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~------~  356 (491)
                      |+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|++||.........      .
T Consensus       153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~  232 (317)
T cd07868         153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  232 (317)
T ss_pred             EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHH
Confidence            9999999876432211 11234678999999999876 46899999999999999999999999654322110      0


Q ss_pred             hhHhhhcccC--------------CccchhhccCcc------cc---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011180          357 LVEWARPHLG--------------DKRRFYRLLDPR------LE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  413 (491)
Q Consensus       357 ~~~~~~~~~~--------------~~~~~~~~~~~~------l~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl  413 (491)
                      ........++              ........+...      +.   .......+..+.+||.+||+.||.+|||++|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l  312 (317)
T cd07868         233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  312 (317)
T ss_pred             HHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHh
Confidence            0000000000              000000000000      00   000011245688999999999999999999999


Q ss_pred             HH
Q 011180          414 ET  415 (491)
Q Consensus       414 ~~  415 (491)
                      ++
T Consensus       313 ~h  314 (317)
T cd07868         313 QD  314 (317)
T ss_pred             cC
Confidence            75

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-42  Score=343.08  Aligned_cols=265  Identities=27%  Similarity=0.420  Sum_probs=223.0

Q ss_pred             hhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeee
Q 011180          126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLV  205 (491)
Q Consensus       126 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~  205 (491)
                      ++++....+..+..+||.|.||.||.|.|+.         ....||||.++.+. ...++|+.|+.+|+.+.|||+|+|+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk---------yslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLL  329 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLL  329 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeec---------cceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHh
Confidence            3445555567778899999999999999987         34579999998775 4568999999999999999999999


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      |+|..+..+|||.|||..|+|.+||.+.....++....++++.||..|+.||...+   +|||||...|+|+.++..|||
T Consensus       330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             hhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEe
Confidence            99999999999999999999999999988778888888999999999999999887   999999999999999999999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcc
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      +||||++.+..+.++.. ....-.+.|.|||-+.-..++.|+|||+|||+|||+.| |-.||.+...             
T Consensus       407 ADFGLsRlMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------------  472 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------------  472 (1157)
T ss_pred             eccchhhhhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-------------
Confidence            99999999876544321 11223578999999999999999999999999999988 5566654321             


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                          ...+.++...+.-.-+..|++.+.+||+.||+.+|.+||++.|+-+.++.+..
T Consensus       473 ----SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  473 ----SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             ----HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence                12334444444445566789999999999999999999999999998876533

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=340.80  Aligned_cols=242  Identities=29%  Similarity=0.362  Sum_probs=189.7

Q ss_pred             cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcC---CCCceeeeeeEEeecCce
Q 011180          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNL---LHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       141 lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~~~~  214 (491)
                      ||+|+||+||+|++..         ++..||||++.+....   ....+..|..++..+   .||||+++++++.+.+..
T Consensus         1 lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~   71 (330)
T cd05586           1 IGKGTFGQVYQVRKKD---------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL   71 (330)
T ss_pred             CCCCCceEEEEEEECC---------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence            7999999999999876         6779999999654222   223445677777655   699999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      |+||||+++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          72 YLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             EEEEcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            99999999999999987654  5889999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhh
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  373 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (491)
                      .....  .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+      .....    
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~----  214 (330)
T cd05586         147 LTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI------AFGKV----  214 (330)
T ss_pred             CCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH------HcCCC----
Confidence            32221  12346799999999998754 5899999999999999999999999654321110000      00000    


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC----CHHHHHHH
Q 011180          374 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP----RMSEVVET  415 (491)
Q Consensus       374 ~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP----t~~evl~~  415 (491)
                          .+.   ....+..+.+|+.+||..||.+||    ++.+++++
T Consensus       215 ----~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         215 ----RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             ----CCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence                000   011267889999999999999998    56777665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-40  Score=319.44  Aligned_cols=253  Identities=30%  Similarity=0.469  Sum_probs=201.0

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      +.||+|+||.||+|.+...+      +++..||+|.+...... ..+++.+|+.+++.+.|+||+++++++. .+..++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKS------GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeeccC------CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence            46999999999999875432      13468999999766542 3467889999999999999999999876 4568999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      |||+++++|.+++....  .+++..++.++.|++.||+|||..+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          74 MELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             EEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            99999999999997664  6889999999999999999999988   999999999999999999999999999876443


Q ss_pred             CCcee-eeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhcc
Q 011180          298 GKTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  375 (491)
Q Consensus       298 ~~~~~-~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (491)
                      ..... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......   ..........          
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~~~----------  215 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLESGE----------  215 (257)
T ss_pred             CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcCC----------
Confidence            32211 111223568999999998899999999999999999998 99998654321   1222111100          


Q ss_pred             CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       376 ~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                          ....+...+..+.+||.+||..+|.+||++.++++.|+.+.
T Consensus       216 ----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 ----RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                00112233678899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.7e-41  Score=341.55  Aligned_cols=265  Identities=23%  Similarity=0.309  Sum_probs=199.3

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||+|+||.||+|.+..         ++..||||.+....  ......+.+|+.+++.++||||+++++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   85 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF   85 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecC---------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence            34689999999999999999998765         57789999997542  22345678899999999999999999988


Q ss_pred             eecC------ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          209 IEDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       209 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      ....      ..++||||++ ++|.+.+..    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~  157 (355)
T cd07874          86 TPQKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT  157 (355)
T ss_pred             eccccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCC
Confidence            6543      4699999995 467776642    4788888999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hh-
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EW-  360 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~-  360 (491)
                      +||+|||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||............ .. 
T Consensus       158 ~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (355)
T cd07874         158 LKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL  234 (355)
T ss_pred             EEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999998654321   223457899999999999989999999999999999999999999754322111000 00 


Q ss_pred             --------------hhcccCCccc-----hhhccCccc---cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          361 --------------ARPHLGDKRR-----FYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       361 --------------~~~~~~~~~~-----~~~~~~~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                    ..........     +...+...+   ........+..+.+||.+||..||.+|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                          0000000000     000000000   001112235678999999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-40  Score=325.47  Aligned_cols=249  Identities=24%  Similarity=0.412  Sum_probs=192.6

Q ss_pred             ccccCCceEEEEEEEccCCCcc---------------cCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeee
Q 011180          140 LLGEGGFGCVFKGWVEENGTAP---------------VKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       140 ~lG~G~fg~Vy~~~~~~~~~~~---------------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l  204 (491)
                      +||+|+||.||+|.+...+...               ........||+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999999875322110               1122345799999876544445678889999999999999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC---
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---  281 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~---  281 (491)
                      ++++.+....+|||||+++|+|..++.... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence            999999999999999999999999886543 36888999999999999999999987   99999999999997643   


Q ss_pred             ----CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHH-hCCCCCCCCCCCCcc
Q 011180          282 ----NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEML-TGRRSMDKNRPNGEH  355 (491)
Q Consensus       282 ----~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~ell-tG~~pf~~~~~~~~~  355 (491)
                          .+||+|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+....
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                4899999988654221      12357888999998865 56899999999999999984 688888654332211


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      ...   ..    .        ..+    +......+.+||.+||+.+|.+|||+.+|++.|.
T Consensus       232 ~~~---~~----~--------~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         232 RFY---EK----K--------HRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHH---Hh----c--------cCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            110   00    0        000    1111357899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-40  Score=325.02  Aligned_cols=274  Identities=29%  Similarity=0.431  Sum_probs=205.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +.|.+.+.||+|+||.||+|.+....     ..++..||+|.+.... ......+.+|+.+++.+.||||+++++++.+.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   78 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCC-----CCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            35788999999999999999865321     1267789999987543 23346788999999999999999999998875


Q ss_pred             --CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          212 --DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       212 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                        ...++||||+++++|.+++..... .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||
T Consensus        79 ~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          79 GGNGIKLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             CCCceEEEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCc
Confidence              567899999999999999866532 5889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC-
Q 011180          290 LAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD-  367 (491)
Q Consensus       290 la~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-  367 (491)
                      +++........ .......|+..|+|||.+.+..++.++|||||||++|||++++.|+.......    .....+.... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~----~~~~~~~~~~~  230 (284)
T cd05079         155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF----LKMIGPTHGQM  230 (284)
T ss_pred             cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh----hhhcccccccc
Confidence            99876433221 11223557788999999988899999999999999999999877653211100    0000000000 


Q ss_pred             -ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          368 -KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       368 -~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                       .......+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence             0000000000000011223467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-41  Score=334.13  Aligned_cols=264  Identities=28%  Similarity=0.444  Sum_probs=216.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ....+.+.||+|.||.|.+|...          .+..||||.++.+... ..++|.+||++|.+|+|||||.++|+|..+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve----------g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D  607 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE----------GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD  607 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec----------CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence            35677899999999999999875          3578999999877544 347899999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +.+++|+|||++|+|.++|..+....+.......|+.||+.|++||.+.+   +|||||.+.|+|++.++++||+|||++
T Consensus       608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgms  684 (807)
T KOG1094|consen  608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMS  684 (807)
T ss_pred             CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccc
Confidence            99999999999999999998774323344555779999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +.+..........+.+-...|||+|.+.-+.++.++|||+||++|||+++  ...||......   ..++.....+.+..
T Consensus       685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~  761 (807)
T KOG1094|consen  685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQG  761 (807)
T ss_pred             cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCC
Confidence            98877777777777778899999999999999999999999999999765  56777543221   22222222222221


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      .       ......+.-|+..+.+||.+||..|-.+||+++++...|.+.
T Consensus       762 ~-------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 R-------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             c-------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1       111223445689999999999999999999999999888653

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1e-40  Score=340.21  Aligned_cols=264  Identities=22%  Similarity=0.282  Sum_probs=198.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~   93 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT   93 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECC---------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence            4579999999999999999998865         56789999997542  233456889999999999999999999876


Q ss_pred             ec------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          210 ED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       210 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ..      ...|+||||++ ++|.+.+..    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~  165 (364)
T cd07875          94 PQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  165 (364)
T ss_pred             ccccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcE
Confidence            43      35799999995 577777642    4778888999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-AR  362 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-~~  362 (491)
                      ||+|||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ..
T Consensus       166 kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  242 (364)
T cd07875         166 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG  242 (364)
T ss_pred             EEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999998654321   22345789999999999999999999999999999999999999976443211111000 00


Q ss_pred             ---------------cccCCccc-----hhhccCcc---ccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 ---------------PHLGDKRR-----FYRLLDPR---LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ---------------~~~~~~~~-----~~~~~~~~---l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                     ........     +.......   .........+..+.+||.+||+.||.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                           00000000     00000000   0001111224678999999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.1e-40  Score=325.45  Aligned_cols=252  Identities=27%  Similarity=0.429  Sum_probs=202.7

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCce
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      |++.+.||.|+||.||+|.+..         ++..+|+|.+........+.+.+|+++++.++||||+++++++...+..
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   77 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL   77 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECC---------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence            6778899999999999998875         5778999999766555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      ++||||+++++|..++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          78 WILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             EEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccc
Confidence            99999999999998876543 36899999999999999999999988   999999999999999999999999998765


Q ss_pred             CCCCCceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ....  .......|+..|+|||++.     +..++.++|||||||++|+|++|.+||........  ........     
T Consensus       154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~~~-----  224 (282)
T cd06643         154 TRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSE-----  224 (282)
T ss_pred             cccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHhhcC-----
Confidence            3321  1123356899999999884     34678899999999999999999999865332111  11110000     


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                            .+.+  ..+...+..+.+||.+||+.||.+||++.+++++-
T Consensus       225 ------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         225 ------PPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             ------CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence                  0000  01122367899999999999999999999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.6e-40  Score=319.99  Aligned_cols=253  Identities=28%  Similarity=0.407  Sum_probs=202.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||.||+|.+..          +..||+|.+.... ...+.+.+|+++++.+.|+||+++++++. .+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   73 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE   73 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence            468899999999999999998753          2369999886543 23467889999999999999999999875 45


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||++.
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccce
Confidence            6899999999999999997655456889999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .........      
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~------  220 (260)
T cd05069         151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVERGY------  220 (260)
T ss_pred             EccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC------
Confidence            65432211 1122346778999999988899999999999999999999 888986543211   111111000      


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                          .    ...+...+..+.+|+.+||..||.+||++++|++.|+.
T Consensus       221 ----~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 ----R----MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----C----CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                0    01112236789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3e-40  Score=324.44  Aligned_cols=267  Identities=23%  Similarity=0.320  Sum_probs=200.4

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|++.+.||+|+||.||+|.+..         ++..||||.+.....  ...+.+.+|+.+++.++||||+++++++.++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK---------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE   71 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC---------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence            58889999999999999999875         577899999865432  2235678899999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      +..++||||+. ++|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||+
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  147 (285)
T cd07861          72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGL  147 (285)
T ss_pred             CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccc
Confidence            99999999996 68988876533 246889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhh------
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWAR------  362 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~-~~~~~------  362 (491)
                      +.......  .......+++.|+|||++.+. .++.++|||||||++|+|++|++||........... .....      
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
T cd07861         148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV  225 (285)
T ss_pred             eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            87653321  112234678999999988654 578899999999999999999999975432111000 00000      


Q ss_pred             -cccCCccchhhccCccc---cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 -PHLGDKRRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 -~~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       ........+....+...   ........+.++.+||.+||..||.+|||+.+|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             00000000000000000   000111236788999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7e-41  Score=323.86  Aligned_cols=254  Identities=32%  Similarity=0.532  Sum_probs=202.6

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHH--HHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      |++.+.||+|+||+||++....         ++..||+|++.........  ...+|+.++++++||||+++++++.+..
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKK---------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN   71 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETT---------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred             CEEeEEEEeCCCEEEEEEEECC---------CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence            6678999999999999999876         6778999999877544332  3456999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+.+++|.+++....  .+++..+..++.||++||.|||+.+   |+|+||||+|||++.++.++|+|||++.
T Consensus        72 ~~~~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   72 YLYIVMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSV  146 (260)
T ss_dssp             EEEEEEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred             cccccccccccccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence            9999999999999999998433  6789999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhh-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      .....  ........++..|+|||++. +..++.++||||||+++|+|++|..||.............   .......  
T Consensus       147 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~~~--  219 (260)
T PF00069_consen  147 KLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKRPL--  219 (260)
T ss_dssp             ESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHTHH--
T ss_pred             ccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcccccc--
Confidence            64221  12234467899999999998 7889999999999999999999999997551111111111   1100000  


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ....      .........+.+||.+||+.||.+||++.+++++
T Consensus       220 ~~~~------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  220 PSSS------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHHT------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccc------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000      0000114789999999999999999999999865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.5e-40  Score=324.47  Aligned_cols=276  Identities=30%  Similarity=0.400  Sum_probs=210.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEee-
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~-  210 (491)
                      ++|.+.+.||+|+||.||+|.+...+.     +++..||||++...... ..+.+.+|+++++.+.|+||+++++++.. 
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~   78 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGD-----NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP   78 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCC-----CCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence            468888999999999999998764321     25789999999766543 45678999999999999999999999887 


Q ss_pred             -cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          211 -DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       211 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                       ....++||||+++++|.+++..... .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          79 GGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccc
Confidence             5578999999999999999976543 5889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCce-eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          290 LAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       290 la~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ++.......... ......++..|+|||.+.+..++.++|||||||++|||++|..||............. . ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~-~~~~~~  232 (284)
T cd05038         155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-A-QGQMIV  232 (284)
T ss_pred             cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-c-cccccH
Confidence            998775332221 1112345667999999988899999999999999999999999885432211000000 0 000000


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ..+...+........+..++..+.+|+.+||..+|.+|||+.+|++.|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            000111111111111223467899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.5e-40  Score=320.89  Aligned_cols=250  Identities=22%  Similarity=0.364  Sum_probs=192.9

Q ss_pred             cccccCCceEEEEEEEccCCCc---ccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTA---PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~---~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  215 (491)
                      +.||+|+||.||+|++......   .........||+|++..........+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            3689999999999986432110   0011234579999987654444567888999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC-------eEEecc
Q 011180          216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-------AKLSDF  288 (491)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~-------~kL~DF  288 (491)
                      +||||+++++|..++.... ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.       ++++||
T Consensus        81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999998886543 36889999999999999999999988   999999999999987664       899999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhh-cCCCCccccchhHHHHHHHHH-hCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |++......      ....|+..|+|||.+. +..++.++|||||||++|||+ .|..||...........   .    .
T Consensus       157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~---~----~  223 (262)
T cd05077         157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF---Y----E  223 (262)
T ss_pred             CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH---H----h
Confidence            998755321      2245788999999886 467899999999999999998 57777754322111000   0    0


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      ..   ..         .......++.+||.+||+.||.+||++.+|++.|.
T Consensus       224 ~~---~~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 GQ---CM---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             cC---cc---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            00   00         01112567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.9e-40  Score=320.54  Aligned_cols=251  Identities=26%  Similarity=0.433  Sum_probs=202.5

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc---------HHHHHHHHHHHhcCCCCceeee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---------HKEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~il~~l~HpnIv~l  204 (491)
                      +|.+...||.|+||.||+|.+..         ++..||+|.+.......         .+.+.+|+.+++.++||||+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   71 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNAS---------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY   71 (267)
T ss_pred             CccccceeecCCCeEEEEEEecC---------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            47888999999999999998765         56689999886543221         2457789999999999999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      ++++.+.+..++||||+++++|.+++...+  .+++..+..++.|++.||+|||+.+   ++||||+|+|||++.++.++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~  146 (267)
T cd06628          72 LGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIK  146 (267)
T ss_pred             EEEEEeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEE
Confidence            999999999999999999999999997654  6788889999999999999999988   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCc----eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011180          285 LSDFGLAKDAPEDGKT----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  360 (491)
Q Consensus       285 L~DFGla~~~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  360 (491)
                      |+|||+++........    .......|+..|+|||.+.+..++.++|||||||++|+|++|..||.......   .+..
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~  223 (267)
T cd06628         147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIFK  223 (267)
T ss_pred             ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHHH
Confidence            9999999876432111    11123468899999999998889999999999999999999999996532111   0000


Q ss_pred             hhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .          .....+    ..+...+..+.++|.+||+.||.+||++.+|+++
T Consensus       224 ~----------~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         224 I----------GENASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             H----------hccCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            0          000111    1222346789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.7e-40  Score=325.70  Aligned_cols=263  Identities=26%  Similarity=0.427  Sum_probs=205.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|++.+.||+|+||.||+|.+...    ....++..||+|++..... ....++.+|+.+++.+.||||+++++++.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            45799999999999999999987421    1112567899999875532 234668899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKG--------------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  270 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  270 (491)
                      ++..++||||+++++|.+++....                    ...+++..++.++.||+.||.|||+.+   ++||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl  156 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL  156 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence            999999999999999999986432                    124678888999999999999999988   999999


Q ss_pred             CCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 011180          271 KTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKN  349 (491)
Q Consensus       271 Kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~  349 (491)
                      ||+|||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999876533222111222345678999999998899999999999999999997 87888543


Q ss_pred             CCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          350 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                      ....   ......    ..         .. ...+...+..+.+|+.+||+.||.+|||+.|+++.|+.
T Consensus       237 ~~~~---~~~~~~----~~---------~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         237 AHEE---VIYYVR----DG---------NV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CHHH---HHHHHh----cC---------CC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            2211   111110    00         00 00112236789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.8e-40  Score=318.16  Aligned_cols=251  Identities=28%  Similarity=0.418  Sum_probs=206.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|++.+.||.|+||.||+|.+..         ++..||+|.+.....  .+++.+|+++++.++|+||+++++++.+..
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT   71 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence            579999999999999999999875         466899999875532  578899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..|++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          72 DLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             cEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccch
Confidence            9999999999999999986543 36899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .......  ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+.......   ..         
T Consensus       148 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---~~---------  213 (256)
T cd06612         148 QLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---PN---------  213 (256)
T ss_pred             hcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---cc---------
Confidence            7654321  122355889999999999889999999999999999999999999754332111000   00         


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       ...+.+  ..+...+..+.+++.+||+.||.+|||+.+|+++
T Consensus       214 -~~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         214 -KPPPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             -CCCCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence             000000  1112235688999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-40  Score=323.47  Aligned_cols=262  Identities=25%  Similarity=0.410  Sum_probs=208.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .+|++.+.||+|+||.||+|.+..++..     ....||+|.+..... ....++.+|+.++..+.||||+++++++.. 
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~-----~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEK-----VKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCC-----cceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            4688999999999999999998653321     234799998876643 234678899999999999999999999887 


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ...++||||+++|+|.+++..... .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccc
Confidence            788999999999999999976543 5899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +...............++..|+|||.+....++.++|+|||||++|||++ |..||.......   +......    .. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~----~~-  228 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLEK----GE-  228 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhC----CC-
Confidence            87653322222122234678999999988899999999999999999998 999996543221   1111110    00 


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                               ....+..++..+.+++.+||..||.+||++.++++.|+.+.+
T Consensus       229 ---------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         229 ---------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                     001112235678999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-42  Score=320.65  Aligned_cols=250  Identities=29%  Similarity=0.398  Sum_probs=209.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHH---HHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      -++|..+++||+|.||.|.+|+-+.         +++.+|+|+++++......+   -+.|-++|...+||.+..+.-.|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKa---------t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF  237 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKA---------TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF  237 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecc---------cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence            4578899999999999999998775         78899999999886655444   36799999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      +..+.+|+||||+.||.|.-+|.+..  .+++.....+-..|+.||.|||+.+   ||+||||.+|+|+|.+|++||+||
T Consensus       238 Qt~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDF  312 (516)
T KOG0690|consen  238 QTQDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDF  312 (516)
T ss_pred             ccCceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeec
Confidence            99999999999999999999887654  6788888889999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |+++.....+.  ....+||||.|.|||++....|+.++|+|.+||+||||++|+.||..........++-.      . 
T Consensus       313 GLCKE~I~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------e-  383 (516)
T KOG0690|consen  313 GLCKEEIKYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------E-  383 (516)
T ss_pred             ccchhcccccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------h-
Confidence            99986544332  34568999999999999999999999999999999999999999976543322222211      1 


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~  415 (491)
                                 .-.|+...+++++.|+..+|.+||.+|.-     +.||.++
T Consensus       384 -----------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  384 -----------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             -----------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence                       11234444889999999999999999953     4555443

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=325.31  Aligned_cols=253  Identities=27%  Similarity=0.426  Sum_probs=205.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||.|+||.||+|.+..         ++..||+|++........+.+.+|+.+++.++|+||+++++++....
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN   75 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence            468899999999999999998865         56789999997665555677889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..|+||||+++++|.+++..... .+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~  151 (280)
T cd06611          76 KLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSA  151 (280)
T ss_pred             eEEEEeeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccch
Confidence            99999999999999999876533 6899999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      .......  ......|++.|+|||.+.     ...++.++|||||||++|+|++|..||........  ......    .
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~----~  223 (280)
T cd06611         152 KNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKILK----S  223 (280)
T ss_pred             hhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHHhc----C
Confidence            6543221  122356899999999875     34577899999999999999999999965432111  111100    0


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                             ..+.+  ..+...+..+.+||.+||+.+|.+||++.+++++
T Consensus       224 -------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 -------EPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -------CCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                   00000  0112235788999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.6e-40  Score=325.65  Aligned_cols=253  Identities=27%  Similarity=0.417  Sum_probs=203.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +.|++.+.||.|+||.||+|.+..         ++..||+|.+........+.+.+|+.+++.+.|+||+++++++..++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG   82 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECC---------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence            469999999999999999998875         56789999998766555677889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|..++.... ..+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.++|+|||++.
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~  158 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSA  158 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccce
Confidence            9999999999999988876543 36889999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ......  .......|++.|+|||++.     ...++.++|||||||++|+|++|..||........  .......    
T Consensus       159 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~----  230 (292)
T cd06644         159 KNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKS----  230 (292)
T ss_pred             eccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHhcC----
Confidence            543221  1122356889999999885     34578899999999999999999999965432111  1111000    


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                             ..+..  ..+...+..+.+||.+||..||++||++.+++++
T Consensus       231 -------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         231 -------EPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -------CCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                   00000  0112235678999999999999999999999865

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.5e-40  Score=319.96  Aligned_cols=255  Identities=26%  Similarity=0.451  Sum_probs=195.3

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCceeeeeeEEe-ecCceEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI-EDDQRLL  216 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~l  216 (491)
                      +.||+|+||.||+|.+.....      .+..||||.+... .....+.+.+|+.+++.++||||+++++++. .++..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l   74 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDG------QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV   74 (262)
T ss_pred             CcccccCCceEEEEEEecCCC------ceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence            468999999999998754221      4567999998543 2234567889999999999999999999776 4556899


Q ss_pred             EEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCC
Q 011180          217 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  296 (491)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~  296 (491)
                      ||||+.+++|.+++..... .+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        75 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~  150 (262)
T cd05058          75 VLPYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYD  150 (262)
T ss_pred             EEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccC
Confidence            9999999999999876533 4677778889999999999999988   99999999999999999999999999986543


Q ss_pred             CCCce--eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhcccCCccchhh
Q 011180          297 DGKTH--VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  373 (491)
Q Consensus       297 ~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (491)
                      .....  ......++..|+|||.+.+..++.++|||||||++|||++| .+||......   .......   ...     
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~---~~~-----  219 (262)
T cd05058         151 KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLL---QGR-----  219 (262)
T ss_pred             CcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHh---cCC-----
Confidence            22111  11223467789999999888999999999999999999995 5555432211   1111110   000     


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          374 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       374 ~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                        .+    ..+...+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus       220 --~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 --RL----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             --CC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence              00    001122567899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.8e-40  Score=317.85  Aligned_cols=252  Identities=26%  Similarity=0.390  Sum_probs=206.8

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|++.+.||.|+||.||.+....         ++..|++|.+....  ....+++.+|+.++++++|+||+++++++.+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   71 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTE---------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD   71 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcC---------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence            58899999999999999998875         56789999886543  23346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++.......+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++
T Consensus        72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~  148 (256)
T cd08221          72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGIS  148 (256)
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcce
Confidence            99999999999999999997764456889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ........  ......|++.|+|||.+.+..++.++||||||+++|+|++|..||........   ..   ......   
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---~~---~~~~~~---  217 (256)
T cd08221         149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL---VV---KIVQGN---  217 (256)
T ss_pred             EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHHcCC---
Confidence            86644321  22345689999999999888899999999999999999999999965332111   10   000000   


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                         ..+     .....+..+.+++.+||..+|.+||++.++++++
T Consensus       218 ---~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         218 ---YTP-----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ---CCC-----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence               000     1122367899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-40  Score=319.50  Aligned_cols=255  Identities=27%  Similarity=0.398  Sum_probs=207.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||.|+||.||+|.+..         ++..+|+|++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   73 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD   73 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecC---------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence            478999999999999999998865         46689999998765556678899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..|++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++.
T Consensus        74 ~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~  149 (262)
T cd06613          74 KLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSA  149 (262)
T ss_pred             EEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccch
Confidence            9999999999999999886652 36889999999999999999999988   9999999999999999999999999988


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      .......  ......|+..|+|||.+.+.   .++.++|||||||++|+|++|..||...........  .....+    
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~--~~~~~~----  221 (262)
T cd06613         150 QLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL--ISKSNF----  221 (262)
T ss_pred             hhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhccC----
Confidence            6543221  12235688999999998776   889999999999999999999999975432211110  000000    


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                           ..+.+  ......+..+.+|+.+||..+|.+|||+.+|+.+
T Consensus       222 -----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         222 -----PPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             -----CCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 00000  1122346789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.7e-40  Score=326.75  Aligned_cols=251  Identities=25%  Similarity=0.378  Sum_probs=206.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .+|.+.+.||.|+||.||+|....         ++..||+|.+........+.+.+|+.+++.++|+||+++++++...+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECC---------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            579999999999999999998765         57789999997665555567889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++.
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~  163 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (297)
T ss_pred             EEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccce
Confidence            999999999999999998643   5788899999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .......  ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||....+.......  ..    ..    
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--~~----~~----  231 (297)
T cd06656         164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--AT----NG----  231 (297)
T ss_pred             EccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--cc----CC----
Confidence            6543221  122356899999999999888999999999999999999999999654332111100  00    00    


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         .+.  ...+...+..+.+|+.+||..||.+||++.+++++
T Consensus       232 ---~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         232 ---TPE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ---CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000  01112235778999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.1e-40  Score=330.90  Aligned_cols=265  Identities=22%  Similarity=0.267  Sum_probs=197.7

Q ss_pred             cCcccccC--CceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          137 PESLLGEG--GFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       137 ~~~~lG~G--~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +.++||+|  +|++||++....         +|..||+|.+.....  ...+.+.+|+.+++.++||||+++++++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~   72 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKP---------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   72 (327)
T ss_pred             hhhhccccccceEEEEEEeecc---------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence            46789999  789999998876         678999999976532  22345778999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++++||+.+.
T Consensus        73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhh
Confidence            9999999999999999997654446889999999999999999999988   9999999999999999999999998765


Q ss_pred             cCCCCCCce-----eeeccccCCCCCCchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011180          293 DAPEDGKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       293 ~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      .....+...     ......++..|+|||++.+  ..++.++|||||||++|||++|..||........  .........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~  227 (327)
T cd08227         150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV  227 (327)
T ss_pred             ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCc
Confidence            432211110     1112356788999999876  4689999999999999999999999964322110  000000000


Q ss_pred             C---Cc------------------cchhh--c---c----CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          366 G---DK------------------RRFYR--L---L----DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       366 ~---~~------------------~~~~~--~---~----~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .   +.                  ..+..  .   .    .......+....+..+.+|+.+||+.||.+|||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0   00                  00000  0   0    0000001122335789999999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.2e-40  Score=327.53  Aligned_cols=267  Identities=22%  Similarity=0.339  Sum_probs=202.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|.+.+.||.|+||.||+|.+..         ++..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~   76 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE   76 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcC---------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence            469999999999999999998865         567899999875432 2334677899999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||++ ++|.+++..... .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        77 ~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~  151 (301)
T cd07873          77 KSLTLVFEYLD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLA  151 (301)
T ss_pred             CeEEEEEeccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcch
Confidence            99999999996 689888866533 6888999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--------
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------  362 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--------  362 (491)
                      .........  .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||...........+....        
T Consensus       152 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  229 (301)
T cd07873         152 RAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW  229 (301)
T ss_pred             hccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc
Confidence            765332211  123457899999998865 457889999999999999999999997553321111000000        


Q ss_pred             cccCCccchhhccCccccC----CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 PHLGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      +.+.....+...-.+....    ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0000000000000000000    1112336788999999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.1e-40  Score=322.07  Aligned_cols=261  Identities=25%  Similarity=0.392  Sum_probs=206.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ..+|.+.+.||+|+||.||+|.+....      +....||||...... ....+.+.+|+.+++.+.||||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   78 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE   78 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence            346889999999999999999876421      134479999987654 3345678899999999999999999998875


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                       ...++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||+
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~  153 (270)
T cd05056          79 -NPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGL  153 (270)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCce
Confidence             567899999999999999976543 5899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++....... .......++..|+|||.+....++.++|||||||++|||++ |..||........   ......    ..
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~~----~~  225 (270)
T cd05056         154 SRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIEN----GE  225 (270)
T ss_pred             eeecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHc----CC
Confidence            986644321 11222334568999999988889999999999999999986 9999965432211   111100    00


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      .      .    ..+..++..+.+||.+||..+|.+|||+.++++.|+.+.+
T Consensus       226 ~------~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         226 R------L----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             c------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0      0    1122346789999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.3e-40  Score=321.42  Aligned_cols=256  Identities=30%  Similarity=0.484  Sum_probs=200.2

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      +.||+|+||.||+|.+.....   ....+..||||.+..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILG---PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeeccccc---CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            369999999999998865221   011346899998865432 3356788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-----CeEEec
Q 011180          218 YEFMPRGSLENHLFRKG-----SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-----NAKLSD  287 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-----~~kL~D  287 (491)
                      |||+++++|.+++....     ...+++..++.++.||+.||.|||+.+   ++|+||||+|||++.++     .++|+|
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECC
Confidence            99999999999996532     234788999999999999999999988   99999999999999877     899999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      ||++................++..|+|||++.++.++.++|||||||++|||++ |..||......   ........   
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~---  228 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHVTA---  228 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHHhc---
Confidence            999976543322222223346788999999999999999999999999999998 99998643211   11111100   


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                       ..          ....+...+..+.+||.+||..+|.+||++.+|++.|+
T Consensus       229 -~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 -GG----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -CC----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             00          00112234678999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-40  Score=363.85  Aligned_cols=260  Identities=23%  Similarity=0.350  Sum_probs=202.3

Q ss_pred             hHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeee
Q 011180          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       127 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l  204 (491)
                      +.....++|.+.+.||+|+||+||+|.+..         ++..||+|++.....  .....+..|+.+|..|.|||||++
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl   77 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKR---------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY   77 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECC---------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeE
Confidence            334455689999999999999999999875         577899999875432  234568899999999999999999


Q ss_pred             eeEEeec--CceEEEEEecCCCChHHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCcEE
Q 011180          205 VGYCIED--DQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAE----KPVIYRDFKTSNIL  276 (491)
Q Consensus       205 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~----~~iiHrDlKp~NIL  276 (491)
                      +++|.+.  ..+||||||+++++|.++|....  ...+++..++.|+.||+.||.|||..+.    ++||||||||+|||
T Consensus        78 ~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL  157 (1021)
T PTZ00266         78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF  157 (1021)
T ss_pred             EEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence            9988654  46899999999999999986531  2368999999999999999999998541    34999999999999


Q ss_pred             ECC-----------------CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc--CCCCccccchhHHHHHH
Q 011180          277 LDA-----------------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLL  337 (491)
Q Consensus       277 l~~-----------------~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~  337 (491)
                      |+.                 .+.+||+|||++.......   .....+||+.|+|||++.+  ..++.++||||||||||
T Consensus       158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY  234 (1021)
T PTZ00266        158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY  234 (1021)
T ss_pred             eecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence            954                 2358999999998664322   1234579999999999864  45889999999999999


Q ss_pred             HHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          338 EMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       338 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ||++|..||.......  .+.....    ..        +.+.   ....+..+.+||.+||..+|.+||++.++|.+
T Consensus       235 ELLTGk~PF~~~~~~~--qli~~lk----~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        235 ELCSGKTPFHKANNFS--QLISELK----RG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             HHHHCCCCCCcCCcHH--HHHHHHh----cC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            9999999996432111  1111000    00        0000   01126789999999999999999999999954

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-40  Score=335.91  Aligned_cols=263  Identities=23%  Similarity=0.356  Sum_probs=197.9

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||.|+||.||+|.+..         ++..||||.+.....  ...+.+.+|+.+|+.++||||+++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTR---------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECC---------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence            34689999999999999999998865         567899999875422  2335677899999999999999999987


Q ss_pred             eec------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          209 IED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       209 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      ...      ...|++||++ +++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~  156 (343)
T cd07878          84 TPATSIENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCE  156 (343)
T ss_pred             cccccccccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCC
Confidence            643      3468999998 88998877532   5889999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EW  360 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~  360 (491)
                      +||+|||+++.....     ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+ ..
T Consensus       157 ~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  231 (343)
T cd07878         157 LRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV  231 (343)
T ss_pred             EEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence            999999999865432     123578999999999876 57899999999999999999999999654321111000 00


Q ss_pred             hhc-------ccC-C-ccchhhccC----ccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          361 ARP-------HLG-D-KRRFYRLLD----PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       361 ~~~-------~~~-~-~~~~~~~~~----~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...       .+. . ...+...+.    ..+.. .....+..+.+||.+||..||.+|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hCCCCHHHHHhcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000       000 0 000000000    00000 001124567899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5e-40  Score=317.75  Aligned_cols=251  Identities=25%  Similarity=0.348  Sum_probs=202.7

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|++.+.||+|+||.||++.+..         ++..||+|.+.....  ...+.+.+|+++++.++|+||+++++.+...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRT---------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE   71 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcC---------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence            48899999999999999999875         566899999865432  2345678899999999999999999987644


Q ss_pred             -CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          212 -DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       212 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                       ...++||||+++++|.+++.......+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~  148 (257)
T cd08223          72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGI  148 (257)
T ss_pred             CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccc
Confidence             46789999999999999997654456899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +........  ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......   .   .........  
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~---~~~~~~~~~--  218 (257)
T cd08223         149 ARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---S---LVYRIIEGK--  218 (257)
T ss_pred             eEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---H---HHHHHHhcC--
Confidence            876543221  223456899999999999999999999999999999999999998643211   1   110000000  


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          +     ...+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       219 ----~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         219 ----L-----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----C-----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                0     01122346789999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.4e-40  Score=318.71  Aligned_cols=255  Identities=27%  Similarity=0.424  Sum_probs=204.6

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|.+.+.||+|+||.||+|.+..          +..||+|.+.... .....+.+|+.+++.++|+||+++++++.+ 
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-   72 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-   72 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence            4579999999999999999997643          3469999887543 234678899999999999999999999887 


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ...++||||+++++|.+++.......+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcce
Confidence            77899999999999999997755556888899999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      ......... ......++..|+|||++....++.++|+|||||++|+|++ |..||......   ..........     
T Consensus       150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~-----  220 (260)
T cd05073         150 RVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERGY-----  220 (260)
T ss_pred             eeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCC-----
Confidence            766432211 1222346678999999998899999999999999999998 89998653221   1111111000     


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                               ........+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       221 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         221 ---------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             ---------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence                     0011122367899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-40  Score=321.23  Aligned_cols=249  Identities=28%  Similarity=0.422  Sum_probs=205.2

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +|.+.+.||.|+||.||+|.+..         ++..||+|.+.... ......+.+|+.+++.++|+||+++++++.++.
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS   72 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECC---------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC
Confidence            68889999999999999999875         57799999987654 233456889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++|+||+++++|.+++...   .+++..++.++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||+++
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~  146 (274)
T cd06609          73 KLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSG  146 (274)
T ss_pred             eEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccce
Confidence            999999999999999998654   6889999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      ......  .......|+..|+|||++.+..++.++|||||||++|+|++|..||....+......+   ..         
T Consensus       147 ~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~---------  212 (274)
T cd06609         147 QLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI---PK---------  212 (274)
T ss_pred             eecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh---hh---------
Confidence            765432  1123456889999999999888999999999999999999999999654322111000   00         


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       ...+.+...   ..+..+.+++.+||..||++|||+++++++
T Consensus       213 -~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         213 -NNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -cCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             001111111   135678999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-41  Score=336.32  Aligned_cols=255  Identities=25%  Similarity=0.369  Sum_probs=207.8

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC--CcccHHHHHHHHHHHhcCC-CCceeeeee
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLL-HPNLVKLVG  206 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~~  206 (491)
                      +..+.|++++.||.||.+.||++...+          ...+|+|.+...  ..+...-+..|+.+|.+|. |.+||+||+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~D  427 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYD  427 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEee
Confidence            445679999999999999999997653          345777766433  2234567899999999997 999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      |-..++.+||||||= ..+|..+|..+......| .++.+..|++.++.++|+++   |||-||||.|+|+- .|.+||+
T Consensus       428 YEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLI  501 (677)
T KOG0596|consen  428 YEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLI  501 (677)
T ss_pred             eeccCceEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEee
Confidence            999999999999995 679999998876644445 67789999999999999999   99999999999994 5699999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCC-----------CCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-----------LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  355 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-----------~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~  355 (491)
                      |||+|..+..+.........+||+.||+||.+....           .+.++||||||||||+|+.|++||....     
T Consensus       502 DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----  576 (677)
T KOG0596|consen  502 DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----  576 (677)
T ss_pred             eechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----
Confidence            999999998887777777889999999999986432           4578999999999999999999995321     


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhh-HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG-SQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      +          ....+..+.+|...-+|+.-. ..++.++++.||++||.+||++.++|++
T Consensus       577 n----------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  577 N----------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             H----------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            0          112244556665544554322 3349999999999999999999999986

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.3e-40  Score=323.93  Aligned_cols=259  Identities=29%  Similarity=0.405  Sum_probs=204.0

Q ss_pred             hhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeee
Q 011180          126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKL  204 (491)
Q Consensus       126 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l  204 (491)
                      .++....+.|++.+.||.|+||.||+|.+..         ++..||+|++.... ....++..|+.++..+ +|+||+++
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~   78 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATY   78 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEE
Confidence            3444456789999999999999999999875         56789999986553 2345678899999998 69999999


Q ss_pred             eeEEee------cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC
Q 011180          205 VGYCIE------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  278 (491)
Q Consensus       205 ~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~  278 (491)
                      ++++..      ....|+||||+++|+|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+||+++
T Consensus        79 ~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~  155 (282)
T cd06636          79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLT  155 (282)
T ss_pred             eeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence            999863      457799999999999999997755556888889999999999999999988   99999999999999


Q ss_pred             CCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 011180          279 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG  353 (491)
Q Consensus       279 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~  353 (491)
                      .++.++|+|||++........  ......|+..|+|||.+.     ...++.++|||||||++|||++|..||....+..
T Consensus       156 ~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~  233 (282)
T cd06636         156 ENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR  233 (282)
T ss_pred             CCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence            999999999999876532211  122356899999999875     3468889999999999999999999996543221


Q ss_pred             cchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ......             ....+.+   .....+..+.+||.+||..||.+|||+.+|+++
T Consensus       234 ~~~~~~-------------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         234 ALFLIP-------------RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hhhhHh-------------hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            111000             0000000   011236789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.9e-40  Score=317.38  Aligned_cols=258  Identities=28%  Similarity=0.401  Sum_probs=207.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||.|+||+||+|....         ++..||+|++..... .....+.+|+.+++.++|+||+++++.+...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG   71 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence            478999999999999999998765         566899999975432 2456789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      +..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||+
T Consensus        72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~  148 (267)
T cd06610          72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGV  148 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccch
Confidence            999999999999999999976432 46889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCce--eeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          291 AKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       291 a~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      +..........  ......|+..|+|||++... .++.++|+|||||++|+|++|..||........  .......   .
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~---~  223 (267)
T cd06610         149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN---D  223 (267)
T ss_pred             HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC---C
Confidence            87665433221  22345789999999998876 789999999999999999999999965433211  1111110   0


Q ss_pred             ccchhhccCccccCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                              .+.+.... ....+..+.+|+.+||..||++||++.+|+++
T Consensus       224 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         224 --------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             --------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                    00111100 11336788999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.6e-40  Score=327.70  Aligned_cols=263  Identities=25%  Similarity=0.434  Sum_probs=205.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|+..+.||+|+||.||+|.+...+..     ....||+|.+...... ...++.+|+.+++.+.||||+++++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGET-----VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCc-----ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            34688999999999999999998653321     2246899988755332 23468899999999999999999999875


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      . ..++|+||+++|+|.+++..... .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccc
Confidence            4 56799999999999999876533 5788999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...+...    ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~~----~~  228 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLEK----GE  228 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHC----CC
Confidence            987643322222223445778999999998899999999999999999997 889986532111   1111110    00


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      .+          ..+..++..+.+++.+||..+|++||++.++++.|..+..
T Consensus       229 ~~----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         229 RL----------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             CC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            00          0111235678999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=314.44  Aligned_cols=248  Identities=29%  Similarity=0.458  Sum_probs=198.8

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      ++||.|+||.||+|.+..          +..||+|.+...... ..+.+.+|+++++.+.|+||+++++++.+....++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~----------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   70 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV   70 (251)
T ss_pred             CccccCCCceEEEEEEeC----------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence            469999999999998753          557999998765443 456788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      |||+++++|.+++..... .+++..+..++.+++.+|.|||+++   |+||||||+|||++.++.++|+|||++......
T Consensus        71 ~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          71 MELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             EEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            999999999999876533 6788899999999999999999988   999999999999999999999999999865432


Q ss_pred             CCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhccC
Q 011180          298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  376 (491)
Q Consensus       298 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (491)
                      ..........++..|+|||.+.++.++.++|||||||++|+|++ |..||...........+   ...            
T Consensus       147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~---~~~------------  211 (251)
T cd05041         147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI---ESG------------  211 (251)
T ss_pred             cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH---hcC------------
Confidence            21111112234567999999988899999999999999999999 78888554321111111   000            


Q ss_pred             ccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       377 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                        .....+...+..+.+|+.+||..+|.+|||+.++++.|.
T Consensus       212 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         212 --YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             --CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence              000112233678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.5e-40  Score=318.66  Aligned_cols=257  Identities=23%  Similarity=0.351  Sum_probs=203.5

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      +..++++.....||+|+||.||+|.+..         ++..||+|.+........+.+.+|+.+++.++|+||+++++++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   74 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLS---------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD   74 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee
Confidence            3445566667889999999999998765         5678999998776655667889999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCCeEE
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPL--PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKL  285 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kL  285 (491)
                      ..++..++||||+++++|.+++..... .+  ++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.++|
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l  150 (268)
T cd06624          75 SENGFFKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKI  150 (268)
T ss_pred             ccCCEEEEEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEE
Confidence            999999999999999999999876422 34  77888899999999999999988   999999999999976 679999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhcC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      +|||++........  ......|+..|+|||++.+.  .++.++||||||+++|+|++|..||........   ..+...
T Consensus       151 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~  225 (268)
T cd06624         151 SDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVG  225 (268)
T ss_pred             ecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhh
Confidence            99999876543221  12234589999999998654  378899999999999999999999864321111   011000


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...            ....++...+.++.+|+.+||..+|.+|||+.+++++
T Consensus       226 ~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         226 MFK------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hhc------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            000            0111222346789999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.8e-40  Score=323.45  Aligned_cols=260  Identities=27%  Similarity=0.431  Sum_probs=207.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||+|+||+||++.+..         ++..||+|++.... ....+.+.+|+++++.++||||+++++++...
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIP---------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE   75 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcC---------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence            568899999999999999999875         56789999886543 23356788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      +..+|||||+++++|.+++...+  .+++..+..++.+++.+|.|||+ .+   |+||||||+||+++.++.++|+|||+
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl  150 (284)
T cd06620          76 NNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGV  150 (284)
T ss_pred             CEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCc
Confidence            99999999999999999887654  68899999999999999999997 45   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc-----chhhHhhhccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-----HNLVEWARPHL  365 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~-----~~~~~~~~~~~  365 (491)
                      +.......    .....|+..|+|||++.+..++.++|||||||++|+|++|..||........     ..+.+......
T Consensus       151 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd06620         151 SGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV  226 (284)
T ss_pred             ccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence            87543221    1235789999999999888999999999999999999999999975443211     11111111111


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      ...       .+.+.   ....+..+.+|+.+||..||.+|||+.|++++..-++
T Consensus       227 ~~~-------~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         227 QEP-------PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             hcc-------CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            000       00010   0113567899999999999999999999998754443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-39  Score=314.17  Aligned_cols=247  Identities=31%  Similarity=0.452  Sum_probs=197.2

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      ++||.|+||.||+|...          .+..||+|.+...... ....+.+|+++++.++||||+++++++...+..++|
T Consensus         1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   70 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV   70 (250)
T ss_pred             CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence            36999999999999864          3558999998765432 234688999999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      |||+++++|.+++.... ..+.+..++.++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        71 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  146 (250)
T cd05085          71 MELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDG  146 (250)
T ss_pred             EECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccc
Confidence            99999999999886553 35789999999999999999999988   999999999999999999999999998754332


Q ss_pred             CCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhccC
Q 011180          298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  376 (491)
Q Consensus       298 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (491)
                      .. .......++..|+|||++.+..++.++||||||+++|+|++ |..||........   .......            
T Consensus       147 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~~~~~~------------  210 (250)
T cd05085         147 IY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---REQVEKG------------  210 (250)
T ss_pred             cc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHHcC------------
Confidence            11 11112234678999999998899999999999999999998 9999865422111   1111000            


Q ss_pred             ccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       377 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                        .....+...+..+.+|+.+||..+|.+||++.++++.|.
T Consensus       211 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         211 --YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence              001112234678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.8e-40  Score=325.81  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=206.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .+|.+.+.||.|+||.||+|.+..         ++..||+|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVA---------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD   89 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcC---------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence            369999999999999999998765         67799999997665555677889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~  163 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCA  163 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccch
Confidence            999999999999999988643   5789999999999999999999988   9999999999999999999999999988


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .......  ......|+..|+|||.+.+..++.++|||||||++|+|++|..||.............  ...        
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~--~~~--------  231 (296)
T cd06655         164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--TNG--------  231 (296)
T ss_pred             hcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcC--------
Confidence            6543321  1223568999999999988889999999999999999999999996644322111110  000        


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         .+.+  ..+...+..+.+||.+||..||.+||++.+++.+
T Consensus       232 ---~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         232 ---TPEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ---Cccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence               0000  1112236788999999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-40  Score=319.02  Aligned_cols=251  Identities=26%  Similarity=0.444  Sum_probs=195.8

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCceeeeeeEEeecCceEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQRLL  216 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l  216 (491)
                      ++||+|+||.||+|.+..++       ....+|+|.+.... ....+.+.+|++++.++ .||||+++++++...+..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   73 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   73 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCC-------CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence            36999999999999986532       12357889887533 23345788999999999 79999999999999999999


Q ss_pred             EEEecCCCChHHHhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          217 VYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       217 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      ||||+++++|.+++....              ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.
T Consensus        74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~  150 (270)
T cd05047          74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  150 (270)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCe
Confidence            999999999999986532              124788999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  361 (491)
                      +||+|||++.......   .......+..|+|||++....++.++|||||||++|||++ |..||.......   .....
T Consensus       151 ~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~  224 (270)
T cd05047         151 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL  224 (270)
T ss_pred             EEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHH
Confidence            9999999986332110   1111223567999999988899999999999999999997 999985432111   11110


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      .              .......+...+..+.+|+.+||..||.+|||+.+++..|+.+
T Consensus       225 ~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         225 P--------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             h--------------CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            0              0000011122356789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-40  Score=328.01  Aligned_cols=255  Identities=29%  Similarity=0.367  Sum_probs=204.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|....         ++..||+|.+......   ..+.+..|++++..+.|+||+++++++.
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG---------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ   71 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC---------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence            368899999999999999998875         5778999999766433   3456888999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +....|+||||+.+++|.+++.......+++..+..++.||+.||+|||..+   |+||||||+|||++.++.++|+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg  148 (316)
T cd05574          72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFD  148 (316)
T ss_pred             cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecc
Confidence            9999999999999999999987654557899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCc---------------------------eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhC
Q 011180          290 LAKDAPEDGKT---------------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG  342 (491)
Q Consensus       290 la~~~~~~~~~---------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG  342 (491)
                      ++.........                           .......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g  228 (316)
T cd05574         149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG  228 (316)
T ss_pred             hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence            98754322110                           011234689999999999988899999999999999999999


Q ss_pred             CCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC----HHHHHHH
Q 011180          343 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR----MSEVVET  415 (491)
Q Consensus       343 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt----~~evl~~  415 (491)
                      ..||........  ....              .............+..+.+||.+||..||.+||+    +.+++.+
T Consensus       229 ~~pf~~~~~~~~--~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         229 TTPFKGSNRDET--FSNI--------------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCCCCCCchHHH--HHHH--------------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            999965432111  1110              0000000001113688999999999999999999    7776654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-39  Score=325.26  Aligned_cols=263  Identities=23%  Similarity=0.361  Sum_probs=190.3

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee--cCceEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--DDQRLL  216 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~l  216 (491)
                      ..||+|+||.||+|......       ++..||+|.+.....  ...+.+|+.+|+.++||||+++++++..  +...++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~-------~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGK-------DEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL   77 (317)
T ss_pred             eEeccCCCeeEEEEEecCCC-------ccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence            57999999999999875421       456899999875532  3467889999999999999999998854  456789


Q ss_pred             EEEecCCCChHHHhhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----CCCCCeEE
Q 011180          217 VYEFMPRGSLENHLFRK-------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKL  285 (491)
Q Consensus       217 V~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl----~~~~~~kL  285 (491)
                      ||||+. ++|.+++...       ....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07867          78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEE
Confidence            999995 5787776432       1235788999999999999999999988   9999999999999    56679999


Q ss_pred             eccCCcccCCCCCCc-eeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc-------h
Q 011180          286 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-------N  356 (491)
Q Consensus       286 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~-------~  356 (491)
                      +|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.........       .
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~  233 (317)
T cd07867         154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ  233 (317)
T ss_pred             eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence            999999876433221 11234578999999999876 45899999999999999999999999654321110       0


Q ss_pred             hhHhhhcccC-----Ccc------chhhcc---------Cccc---cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011180          357 LVEWARPHLG-----DKR------RFYRLL---------DPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  413 (491)
Q Consensus       357 ~~~~~~~~~~-----~~~------~~~~~~---------~~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl  413 (491)
                      +.... ..++     +..      .+....         ...+   ...........+.+|+.+||..||.+|||+.|++
T Consensus       234 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l  312 (317)
T cd07867         234 LDRIF-SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQAL  312 (317)
T ss_pred             HHHHH-HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHh
Confidence            00000 0000     000      000000         0000   0001112245688999999999999999999998


Q ss_pred             HH
Q 011180          414 ET  415 (491)
Q Consensus       414 ~~  415 (491)
                      ++
T Consensus       313 ~h  314 (317)
T cd07867         313 QD  314 (317)
T ss_pred             cC
Confidence            65

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.8e-40  Score=358.52  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=202.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.++||+|+||.||+|++..         +|..||||++.....   ...+++.+|+++++.++||||+++++++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~---------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~   72 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPV---------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS   72 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECC---------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence            479999999999999999998865         677999999975422   22457889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKG---------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  280 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~  280 (491)
                      +.+..++||||++|++|.+++....         ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.+
T Consensus        73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~d  149 (932)
T PRK13184         73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLF  149 (932)
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCC
Confidence            9999999999999999999886421         123556777899999999999999988   9999999999999999


Q ss_pred             CCeEEeccCCcccCCCCCC----------------ceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCC
Q 011180          281 YNAKLSDFGLAKDAPEDGK----------------THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR  344 (491)
Q Consensus       281 ~~~kL~DFGla~~~~~~~~----------------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~  344 (491)
                      +.++|+|||+++.......                .......+||+.|||||++.+..++.++|||||||++|||++|..
T Consensus       150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~  229 (932)
T PRK13184        150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF  229 (932)
T ss_pred             CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence            9999999999986521110                001123579999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhcC
Q 011180          345 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-RMSEVVETLKPL  419 (491)
Q Consensus       345 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-t~~evl~~L~~l  419 (491)
                      ||.........    . .........    +.+      ....+..+.+++.+||..||++|+ +++++++.|+.+
T Consensus       230 PF~~~~~~ki~----~-~~~i~~P~~----~~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        230 PYRRKKGRKIS----Y-RDVILSPIE----VAP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             CCCCcchhhhh----h-hhhccChhh----ccc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            99653221110    0 000000000    000      012357789999999999999995 567777777654

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-39  Score=318.11  Aligned_cols=255  Identities=29%  Similarity=0.408  Sum_probs=191.0

Q ss_pred             ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEEE
Q 011180          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY  218 (491)
Q Consensus       140 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  218 (491)
                      .||+|+||.||+|.....       .....+|+|.+..... .....+.+|+.+++.++|+||+++++++.+....++||
T Consensus         2 ~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~   74 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL   74 (269)
T ss_pred             cCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence            599999999999976432       1345789998764432 23356789999999999999999999999999999999


Q ss_pred             EecCCCChHHHhhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCC
Q 011180          219 EFMPRGSLENHLFRKGS---LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  295 (491)
Q Consensus       219 E~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~  295 (491)
                      ||+++|+|.+++.....   ...++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccc
Confidence            99999999999876432   23467778899999999999999988   9999999999999999999999999987543


Q ss_pred             CCCCceeeeccccCCCCCCchhhhc-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          296 EDGKTHVSTRVMGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       296 ~~~~~~~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ............++..|+|||++..       ..++.++|||||||++|||++ |..||........  +......   .
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~~---~  226 (269)
T cd05042         152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQVVRE---Q  226 (269)
T ss_pred             cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHHHhhc---c
Confidence            3222222223456778999998753       356789999999999999999 7778754322111  1110000   0


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      .   .....+.    .+...+..+.+++..|| .||++|||+++|++.|.
T Consensus       227 ~---~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 D---IKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             C---ccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0   0111111    12233677788999998 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.7e-40  Score=322.81  Aligned_cols=262  Identities=27%  Similarity=0.360  Sum_probs=203.5

Q ss_pred             hhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceee
Q 011180          125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVK  203 (491)
Q Consensus       125 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~  203 (491)
                      +..+....++|.+.+.||+|+||.||+|.+..         ++..||+|++.... ....++..|+.++..+ +||||++
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~   79 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKK---------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVK   79 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECC---------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeee
Confidence            44555677899999999999999999999875         56789999886532 2235678899999999 6999999


Q ss_pred             eeeEEe-----ecCceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 011180          204 LVGYCI-----EDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       204 l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NIL  276 (491)
                      +++++.     .++..++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.+   |+||||||+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil  156 (286)
T cd06638          80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNIL  156 (286)
T ss_pred             eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEE
Confidence            999874     345689999999999999987532  2336788889999999999999999988   999999999999


Q ss_pred             ECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 011180          277 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  351 (491)
Q Consensus       277 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~  351 (491)
                      ++.++.++|+|||+++.......  ......|++.|+|||++..     ..++.++|||||||++|||++|..||.....
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         157 LTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             ECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            99999999999999886543221  1223468999999998753     4578899999999999999999999965432


Q ss_pred             CCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      ....  ....     ... .....+       +...+..+.+||.+||+.||++|||+.+|++++
T Consensus       235 ~~~~--~~~~-----~~~-~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         235 MRAL--FKIP-----RNP-PPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hHHH--hhcc-----ccC-CCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            1110  0000     000 000001       111256789999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-39  Score=318.55  Aligned_cols=259  Identities=25%  Similarity=0.442  Sum_probs=201.7

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      |.+.+.||+|+||.||+|.+..+.      +++..||||++.....  ...+++.+|+++++.++||||+++++++....
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   74 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR   74 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccC------CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            667889999999999999886532      2678999999875432  23456889999999999999999999886542


Q ss_pred             ------ceEEEEEecCCCChHHHhhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          213 ------QRLLVYEFMPRGSLENHLFRK----GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       213 ------~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                            ..++++||+.+|+|.+++...    ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.
T Consensus        75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~  151 (273)
T cd05074          75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMT  151 (273)
T ss_pred             CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCC
Confidence                  237889999999999887532    1235788889999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  361 (491)
                      +||+|||+++...............+++.|++||.+.+..++.++|||||||++|+|++ |.+||......   ....+.
T Consensus       152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~  228 (273)
T cd05074         152 VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL  228 (273)
T ss_pred             EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH
Confidence            99999999987643322222223445678999999998899999999999999999999 88888643221   111111


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ..    ...        +  ..+...+..+.+|+.+||..+|++||++.++++.|+.+
T Consensus       229 ~~----~~~--------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 IK----GNR--------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             Hc----CCc--------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00    000        0  01122357899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-39  Score=314.33  Aligned_cols=256  Identities=34%  Similarity=0.513  Sum_probs=204.7

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeecCc
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  213 (491)
                      |.+.+.||.|+||.||+|.+.....     ..+..||+|++...... ..+.+..|+.++..++|+||+++++++.+.+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG-----EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC-----CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence            4577899999999999999876321     13478999999766433 45688999999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          214 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      .++||||+++++|.+++.......+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++..
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~  152 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRD  152 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCcee
Confidence            999999999999999997654333899999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          294 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       294 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      ......... ....+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......   ........   ..    
T Consensus       153 ~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~~---~~----  221 (258)
T smart00219      153 LYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLKK---GY----  221 (258)
T ss_pred             ccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhc---CC----
Confidence            654422211 12337789999999988889999999999999999998 78887642211   11111100   00    


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                             ....+...+..+.+++.+||..||.+|||+.++++.|
T Consensus       222 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 -------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                   0011112467899999999999999999999999765

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.1e-40  Score=317.73  Aligned_cols=252  Identities=30%  Similarity=0.488  Sum_probs=200.9

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      +|++.+.||.|+||.||+|...          ++..+|||.+.....      .....+.+|+.+++.++|+||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   70 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT   70 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence            4888999999999999999763          466899998864421      122457889999999999999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +.+.+..++||||+++++|.+++.+..  .+++..+..++.|++.||+|||+.+   |+|+||+|+||+++.++.++|+|
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          71 CLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             eecCCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEecc
Confidence            999999999999999999999997654  5788999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCC----CceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          288 FGLAKDAPEDG----KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       288 FGla~~~~~~~----~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      ||++.......    .........|+..|+|||++.+..++.++|||||||++|+|++|..||.............    
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----  221 (265)
T cd06631         146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG----  221 (265)
T ss_pred             chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh----
Confidence            99987653211    1111223568999999999998889999999999999999999999996432211100000    


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         ...    ...+    ..+...+..+.++|.+||..+|.+||++.+++++
T Consensus       222 ---~~~----~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         222 ---AHR----GLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             ---hcc----CCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               000    0001    1122336788999999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-40  Score=320.49  Aligned_cols=248  Identities=23%  Similarity=0.398  Sum_probs=193.7

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY  218 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  218 (491)
                      +.||.|+||.||+|.+...+..  .......||+|.+........+.+..|+.+++.+.||||+++++++...+..++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDY--GELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccc--cccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            4699999999999988653210  01134468999886655444567889999999999999999999999999999999


Q ss_pred             EecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC--------eEEeccCC
Q 011180          219 EFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--------AKLSDFGL  290 (491)
Q Consensus       219 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~--------~kL~DFGl  290 (491)
                      ||+++|+|.+++...+. .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.        ++|+|||+
T Consensus        79 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          79 EYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             ecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999999876543 6889999999999999999999988   999999999999987664        69999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCC-CCCCCCCCCCcchhhHhhhcccCCc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~-~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      +......      ....++..|+|||.+.+ ..++.++|||||||++|||++|. .||........   ....    ...
T Consensus       155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~~~----~~~  221 (258)
T cd05078         155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQFY----EDR  221 (258)
T ss_pred             ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HHHH----Hcc
Confidence            8755321      23468889999999876 45899999999999999999995 55543221111   0000    000


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                                  ..++.....++.+|+.+||+.||++|||++++++.|+
T Consensus       222 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                        0111222467899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-39  Score=318.60  Aligned_cols=261  Identities=26%  Similarity=0.400  Sum_probs=206.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|.+...||+|+||.||+|+.+....    .+....||+|.+...... ....+.+|++++++++|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEE----EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCc----CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            468899999999999999999865321    234568999998655433 346789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGS-------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      +..++||||+++++|.+++.....       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence            999999999999999999976541       25899999999999999999999988   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhc
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      |+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .......
T Consensus       158 l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~~  233 (275)
T cd05046         158 VSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQA  233 (275)
T ss_pred             EcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHHc
Confidence            999999875432211 11223456778999999988889999999999999999999 778885432211   1111100


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                                   ..+....+...+..+.+++.+||..||.+|||+.+++..|.
T Consensus       234 -------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 -------------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -------------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                         00000111233678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6e-40  Score=323.82  Aligned_cols=246  Identities=30%  Similarity=0.434  Sum_probs=203.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||++.+..         +++.||+|++.....   ...+.+.+|+++|+++.||||+++++++.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ   71 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence            368999999999999999999876         567899999865432   23456888999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||+|+|||++.++.+||+|||
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          72 DDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCC
Confidence            9999999999999999999987664  6889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++......     .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.......   ....   ..... 
T Consensus       147 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~---~~~~~-  214 (290)
T cd05580         147 FAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---IYEK---ILEGK-  214 (290)
T ss_pred             CccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HhcCC-
Confidence            99876443     223568999999999988889999999999999999999999996543111   1110   00000 


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                                 ..++...+..+.+++.+||..||.+|+     ++++++++
T Consensus       215 -----------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         215 -----------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             -----------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                       011222367889999999999999998     77777755

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.6e-39  Score=316.50  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=198.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-----ccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      .+|.+.+.||+|+||.||+|.+..         ++..||+|.+.....     .....+.+|+.+++.++||||++++++
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   72 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVD---------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC   72 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcC---------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence            368999999999999999998765         677999998864421     123457889999999999999999998


Q ss_pred             Eeec--CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          208 CIED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       208 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      +.+.  ...+++|||+++++|.+++....  .+++...+.++.|++.||.|||+.+   |+||||||+||+++.++.++|
T Consensus        73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l  147 (266)
T cd06651          73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKL  147 (266)
T ss_pred             EEcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEE
Confidence            8753  56789999999999999987654  5788888999999999999999988   999999999999999999999


Q ss_pred             eccCCcccCCCCCCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          286 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       286 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      +|||+++........ .......|+..|+|||.+.+..++.++|||||||++|||++|+.||........   +....  
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---~~~~~--  222 (266)
T cd06651         148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---IFKIA--  222 (266)
T ss_pred             ccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---HHHHh--
Confidence            999998765321111 111234688999999999988899999999999999999999999964321111   00000  


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                 .......++...+..+.+|+ +||..+|++||++++|+++
T Consensus       223 -----------~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         223 -----------TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             -----------cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                       00001122233356778888 6888999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-39  Score=319.74  Aligned_cols=267  Identities=28%  Similarity=0.374  Sum_probs=202.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.+.||+|+||.||+|.+..         ++..||+|++.....  ...+.+.+|+.+++.+.|+||+++++++..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   71 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR   71 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECC---------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence            368899999999999999999875         577899998864422  233567899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ....++||||++++.|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  146 (286)
T cd07847          72 KRKLHLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGF  146 (286)
T ss_pred             CCEEEEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECcccc
Confidence            999999999999888877765433  5889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-hcccC--
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLG--  366 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~~~~~--  366 (491)
                      +.........  .....++..|+|||++.+ ..++.++|||||||++|+|++|..||......+....+... .....  
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  224 (286)
T cd07847         147 ARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH  224 (286)
T ss_pred             ceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence            9876543221  123457889999999876 56789999999999999999999999755432211111100 00000  


Q ss_pred             ----Cccchh-hccCccccCCC-----ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 ----DKRRFY-RLLDPRLEGHF-----SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ----~~~~~~-~~~~~~l~~~~-----~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          +...++ ....+......     ....+..+.+|+.+||+.||++||++.+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                000000 00001000000     01225778999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-39  Score=316.20  Aligned_cols=255  Identities=24%  Similarity=0.415  Sum_probs=204.0

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      +|+..+.||+|+||.||+|....         ++..||+|++.....      ...+.+.+|+.+++.++|+||++++++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   71 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVK---------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA   71 (268)
T ss_pred             CccccceecCcCceEEEEEEEcC---------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence            47888999999999999998765         677899999875431      123578899999999999999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-CeEEe
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLS  286 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kL~  286 (491)
                      +.+.+..++||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   |+|+||+|+||+++.++ .++|+
T Consensus        72 ~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~  146 (268)
T cd06630          72 TCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIA  146 (268)
T ss_pred             eccCCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEc
Confidence            999999999999999999999987654  6788999999999999999999988   99999999999998775 59999


Q ss_pred             ccCCcccCCCCCCc--eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          287 DFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       287 DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      |||++.........  .......|+..|+|||.+.+..++.++|||||||++|+|++|..||..............    
T Consensus       147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----  222 (268)
T cd06630         147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK----  222 (268)
T ss_pred             ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH----
Confidence            99998776432111  112235689999999999888899999999999999999999999964332211111100    


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                               .........++...+..+.+++.+||..+|.+||++.+++++
T Consensus       223 ---------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         223 ---------IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ---------HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                     000001112233346789999999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-40  Score=335.32  Aligned_cols=250  Identities=25%  Similarity=0.347  Sum_probs=210.3

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc--HHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ....|.+...||+|.|+.|.+|++..         ++..||||.+.+.....  ...+.+|+++|..|+|||||+++.+.
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~---------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~  124 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHIL---------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI  124 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecC---------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            34579999999999999999999987         78899999998876543  24478999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .....+|+||||+.+|.++++|.+.+.  ..+..+..++.|+..|++|||+++   |||||||++||||+.+.++||+||
T Consensus       125 ~t~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDf  199 (596)
T KOG0586|consen  125 ETEATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADF  199 (596)
T ss_pred             eecceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecc
Confidence            999999999999999999999998874  445778889999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      |++..+...   ....+.||++.|.|||++.+..|+ ..+|+||+|++||-|+.|..||++........-+      +-.
T Consensus       200 gfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv------l~g  270 (596)
T KOG0586|consen  200 GFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV------LRG  270 (596)
T ss_pred             ccceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh------eee
Confidence            999987533   334568999999999999987764 6899999999999999999999865433221111      100


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .          +  .++.-.+.++.+||+++|..+|.+|++++++.++
T Consensus       271 k----------~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  271 K----------Y--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             e----------e--cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            0          0  0112236788999999999999999999999865

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.1e-39  Score=317.63  Aligned_cols=249  Identities=26%  Similarity=0.387  Sum_probs=204.9

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .|+..+.||.|+||.||+|.+..         ++..||||++..... .....+.+|+.+++.+.|+||+++++++.+..
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNR---------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT   75 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEcc---------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            57788999999999999998875         567899999875432 33467889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~  149 (277)
T cd06640          76 KLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             EEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccce
Confidence            999999999999999988643   5788889999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .......  ......++..|+|||++.+..++.++|+|||||++|||++|..||....+.......              
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--------------  213 (277)
T cd06640         150 QLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI--------------  213 (277)
T ss_pred             eccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh--------------
Confidence            6643221  122346889999999998888999999999999999999999999654322111100              


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                         .......+....+..+.+|+.+||..+|.+||++.+++.+-
T Consensus       214 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         214 ---PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             ---hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence               00001122234578899999999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-39  Score=314.69  Aligned_cols=248  Identities=25%  Similarity=0.466  Sum_probs=193.7

Q ss_pred             cccccCCceEEEEEEEccCCCccc-CCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPV-KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      +.||+|+||.||+|.+........ .......|++|.+...... ...+.+|+.+|+.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            469999999999999976431100 0112346888887655433 5778899999999999999999999988 788999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-------CeEEeccCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-------NAKLSDFGL  290 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-------~~kL~DFGl  290 (491)
                      |||+++|+|.+++..... .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999876543 6888999999999999999999988   99999999999999887       799999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcC--CCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      +.....      .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||..........   +..    .
T Consensus       155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~----~  221 (259)
T cd05037         155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ----D  221 (259)
T ss_pred             cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh----c
Confidence            986543      1224577889999998876  78999999999999999999 567775543211111   000    0


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      ..            ..+......+.+|+.+||..+|.+|||+.++++.|+
T Consensus       222 ~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 QH------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CC------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00            001111368899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=7.2e-40  Score=321.72  Aligned_cols=264  Identities=23%  Similarity=0.305  Sum_probs=198.8

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|.+.+.||+|+||.||+|.+..         +|..||+|.+......  ....+.+|+.+++.++||||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~---------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD   71 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECC---------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence            47888999999999999999876         6778999998654221  234677899999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+. ++|.+++.... ..+++..++.++.||++||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        72 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~  146 (284)
T cd07839          72 KKLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLA  146 (284)
T ss_pred             CceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchh
Confidence            99999999995 58888876543 36899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc-------
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-------  363 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-------  363 (491)
                      +........  .....++..|+|||.+.+. .++.++|||||||++|+|++|..||........  .......       
T Consensus       147 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~  222 (284)
T cd07839         147 RAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTE  222 (284)
T ss_pred             hccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCCh
Confidence            865432211  1234678999999988764 478999999999999999999988643221110  0000000       


Q ss_pred             ----ccCCccch--hhccCcccc-CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 ----HLGDKRRF--YRLLDPRLE-GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ----~~~~~~~~--~~~~~~~l~-~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          .+.....+  ......... .......+..+.+||.+||+.||.+|||+++++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence                00000000  000000000 01112346788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.4e-39  Score=314.51  Aligned_cols=252  Identities=29%  Similarity=0.506  Sum_probs=202.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .+|++.+.||.|+||.||+|.+..          +..+|+|.+..... ...++.+|+++++.+.||||+++++++....
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS   72 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence            368888999999999999998752          44799999875433 3467889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+++..... .+++..++.++.|++.+|+|||+.+   ++||||||+||+++.++.++|+|||+++
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCccee
Confidence            99999999999999999876533 5788999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ....... .......++..|+|||.+.++.++.++|||||||++|||++ |..||......   ........    .   
T Consensus       149 ~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~----~---  217 (256)
T cd05112         149 FVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVETINA----G---  217 (256)
T ss_pred             ecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHhC----C---
Confidence            6543211 11122335678999999998899999999999999999998 89998643211   11111100    0   


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      .....+       ...+..+.+|+.+||+.+|.+|||+.++++.|.
T Consensus       218 ~~~~~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         218 FRLYKP-------RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCC-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            001111       112678999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7.1e-40  Score=320.89  Aligned_cols=248  Identities=25%  Similarity=0.399  Sum_probs=201.9

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .|...+.||+|+||.||+|.+..         ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNR---------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT   75 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcC---------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence            36677889999999999998865         567899999875432 23456889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+++...   .+++..+..++.||+.||.|||+.+   |+|+||+|+||++++++.++|+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06642          76 KLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             ceEEEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccc
Confidence            999999999999999988542   5788999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .......  ......|+..|+|||++.+..++.++|||||||++|||++|..||....+.....   .    ...     
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~----~~~-----  215 (277)
T cd06642         150 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---L----IPK-----  215 (277)
T ss_pred             cccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---h----hhc-----
Confidence            6643221  1123468899999999998899999999999999999999999986433221100   0    000     


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       ...+    ......+..+.+|+.+||..+|.+||++.+++++
T Consensus       216 -~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         216 -NSPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             -CCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence             0011    1122336788999999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-39  Score=318.20  Aligned_cols=256  Identities=26%  Similarity=0.436  Sum_probs=201.2

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc----------cHHHHHHHHHHHhcCCCCceee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ----------GHKEWLAEVNFLGNLLHPNLVK  203 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~il~~l~HpnIv~  203 (491)
                      +|.+.+.||.|+||.||+|....         +|..||+|.+......          ..+.+.+|+.+++.++|+||++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~   72 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVT---------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ   72 (272)
T ss_pred             ceeecceecccCceEEEEEeecC---------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence            57888999999999999998765         5678999988532110          1245778999999999999999


Q ss_pred             eeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          204 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      +++++...+..++||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~  147 (272)
T cd06629          73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGIC  147 (272)
T ss_pred             EEEEeccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeE
Confidence            9999999999999999999999999987663  6888999999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      +|+|||++................|+..|+|||.+....  ++.++|+||||+++|+|++|..||........  ..+..
T Consensus       148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~  225 (272)
T cd06629         148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKLG  225 (272)
T ss_pred             EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHhh
Confidence            999999997654322222223356899999999987654  88999999999999999999999853221100  00000


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .    .      ...+.+........+..+.+++.+||..+|.+||++.+|+++
T Consensus       226 ~----~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         226 N----K------RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             c----c------ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            0    0      000111111112336789999999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-39  Score=315.50  Aligned_cols=247  Identities=30%  Similarity=0.464  Sum_probs=199.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .+|.+.+.||+|+||.||++..           ++..||+|.+..+.  ....+.+|+.+++.++||||+++++++... 
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   71 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-   71 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence            3689999999999999999864           45679999986543  346788999999999999999999998764 


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+++.......+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccce
Confidence            5799999999999999997765556889999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ......     .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||........   ......    .   
T Consensus       149 ~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~----~---  213 (254)
T cd05083         149 VGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---KECVEK----G---  213 (254)
T ss_pred             eccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHHhC----C---
Confidence            543211     12234568999999988899999999999999999997 9999865432211   111100    0   


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                             .....+...+..+.+|+.+||+.+|.+||++.++++.|+.
T Consensus       214 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 -------YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -------CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                   0001112236788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.3e-39  Score=314.81  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=205.2

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|++.+.||+|+||.||++....         +|..||+|.+....  ....+++.+|+.+++.++||||+++++++...
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE---------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN   71 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC---------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence            48889999999999999998876         56789999986542  23345788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++.......+++..++.++.|++.||.|||+.+   ++|+||+|+|||++.++.++|+|||++
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~  148 (256)
T cd08218          72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIA  148 (256)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccce
Confidence            99999999999999999987655456889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      .........  .....|++.|+|||++.+..++.++|+|||||++|+|++|..||......   ...   ...+...   
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~---~~~~~~~---  217 (256)
T cd08218         149 RVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLV---LKIIRGS---  217 (256)
T ss_pred             eecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---HHH---HHHhcCC---
Confidence            765432211  12346889999999998889999999999999999999999998643211   111   0000000   


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                              ....+...+..+.++|.+||+.+|.+||++.+|+++
T Consensus       218 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 --------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             --------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                    001122336789999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-39  Score=320.57  Aligned_cols=253  Identities=27%  Similarity=0.432  Sum_probs=201.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||+|+||.||+|.+..         ++..||+|.+.... ......+.+|+.++++++|+||+++++++...
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE   71 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence            368899999999999999998875         56789999886542 22345788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +..++||||+++++|..++.... ...+++..+..++.||+.||.|||+. +   |+||||||+|||++.++.++|+|||
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg  148 (286)
T cd06622          72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFG  148 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecC
Confidence            99999999999999998886531 23688999999999999999999974 6   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      ++.......    .....|++.|+|||.+.+.      .++.++|||||||++|+|++|..||...............  
T Consensus       149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~--  222 (286)
T cd06622         149 VSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI--  222 (286)
T ss_pred             CcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH--
Confidence            987653321    1234688899999988543      3578999999999999999999999654322111111100  


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                 .+. ....++...+..+.+||.+||+.+|.+||++.+++++
T Consensus       223 -----------~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         223 -----------VDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -----------hhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                       000 0011222347788999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-41  Score=311.76  Aligned_cols=254  Identities=24%  Similarity=0.280  Sum_probs=204.1

Q ss_pred             hhcCCCcC-cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEE
Q 011180          131 ATRNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~  208 (491)
                      .+++|.+. .+||-|-.|.|..|.++.         +++.+|+|++..     .....+|+++.-... |||||.++++|
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~---------T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVy  124 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKR---------TQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVY  124 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEecc---------chhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhh
Confidence            45677765 479999999999999886         788999999843     345678888876665 99999999998


Q ss_pred             eec----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC---CCC
Q 011180          209 IED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---ADY  281 (491)
Q Consensus       209 ~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~---~~~  281 (491)
                      ...    ..+.+|||.|+||.|+..|..++...+.+..+..|+.||+.|+.|||+.+   |.||||||+|+|+.   .|.
T Consensus       125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na  201 (400)
T KOG0604|consen  125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNA  201 (400)
T ss_pred             hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCc
Confidence            753    45678999999999999999999999999999999999999999999998   99999999999995   456


Q ss_pred             CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      .+||+|||+|+.....   ....+.|-|++|.|||++....|+..+|+||+||++|.||+|.+||....-...       
T Consensus       202 ~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-------  271 (400)
T KOG0604|consen  202 PLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------  271 (400)
T ss_pred             ceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-------
Confidence            7999999999865432   223457889999999999989999999999999999999999999975432111       


Q ss_pred             hcccCCcc--chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          362 RPHLGDKR--RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       362 ~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      .+.+....  ..+.+.     ..-....++.++++|+.+|..+|.+|.|+.+++++-
T Consensus       272 spgMk~rI~~gqy~FP-----~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  272 SPGMKRRIRTGQYEFP-----EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             ChhHHhHhhccCccCC-----ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            00110000  001111     111234589999999999999999999999999873

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=338.07  Aligned_cols=254  Identities=28%  Similarity=0.438  Sum_probs=209.2

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeecCc
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  213 (491)
                      ..+.++||+|.||+|++|.|...+      ++-..||||.+..+... ...+|++|+.+|.+|+|+|+++|||+..+ ..
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~ps------gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPS------GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP  184 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCC------CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence            445688999999999999998633      24457999999887655 56789999999999999999999999887 67


Q ss_pred             eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          214 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      ..+|||+++.|+|.+.|.+.....|.......++.||+.||.||..++   +|||||...||||-..-.||||||||++.
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceec
Confidence            899999999999999998854557888888999999999999999988   99999999999999899999999999998


Q ss_pred             CCCCCCceeee-ccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          294 APEDGKTHVST-RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       294 ~~~~~~~~~~~-~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      +........+. ..--...|+|||.+....++.++|||+|||+||||++ |..||.+........               
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~---------------  326 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK---------------  326 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH---------------
Confidence            87654443322 2223568999999999999999999999999999998 567776544322221               


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        .+|..-.-.-+..|++.++++++.||..+|.+|||+..|.+.
T Consensus       327 --~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  327 --NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             --hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence              222222223345679999999999999999999999999744

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.3e-39  Score=315.06  Aligned_cols=252  Identities=27%  Similarity=0.382  Sum_probs=198.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-----ccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      .+|++.+.||+|+||.||+|.+..         ++..||||.+.....     ...+.+.+|+.+++.+.||||++++++
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   72 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC   72 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcC---------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence            478999999999999999998865         677999998864321     123567889999999999999999998


Q ss_pred             Eeec--CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          208 CIED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       208 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      +.+.  ...++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l  147 (265)
T cd06652          73 LRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKL  147 (265)
T ss_pred             eccCCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEE
Confidence            8764  46789999999999999987654  5778888999999999999999988   999999999999999999999


Q ss_pred             eccCCcccCCCCCCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          286 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       286 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      +|||+++........ .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........     ... .
T Consensus       148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~~-~  221 (265)
T cd06652         148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA-----IFK-I  221 (265)
T ss_pred             CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-----HHH-H
Confidence            999998865321111 112234689999999999888899999999999999999999999964321110     000 0


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..          .......+...+..+.+++.+|| .+|.+||++++|+++
T Consensus       222 ~~----------~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~  261 (265)
T cd06652         222 AT----------QPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH  261 (265)
T ss_pred             hc----------CCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence            00          00011123334677899999999 499999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-41  Score=326.41  Aligned_cols=257  Identities=32%  Similarity=0.455  Sum_probs=215.1

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeee
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVG  206 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~  206 (491)
                      +..+.|+.-++||+|+||.||-|+...         ||+.+|+|.+.+...   .+..-.+.|..||..++.+.||.+--
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvra---------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY  252 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRA---------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY  252 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEec---------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence            334678999999999999999998876         889999999865432   23345688999999999999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      +|+..+.+||||..|.||+|.-+|...+...+++..+..++.+|+.||++||+..   ||+|||||+|||||+.|+++|+
T Consensus       253 AfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRIS  329 (591)
T KOG0986|consen  253 AFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRIS  329 (591)
T ss_pred             eecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEee
Confidence            9999999999999999999999999888778999999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |+|||..+.+....   ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||..........-++  +..+.
T Consensus       330 DLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~~  404 (591)
T KOG0986|consen  330 DLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTLE  404 (591)
T ss_pred             ccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHhc
Confidence            99999988664322   23489999999999999999999999999999999999999997654433322111  11111


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~  415 (491)
                      +            ...|+.+.++++++|++.+|++||.+|.-.     .+|.+|
T Consensus       405 ~------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  405 D------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             c------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence            1            223445558999999999999999999754     455544

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8e-40  Score=321.70  Aligned_cols=267  Identities=27%  Similarity=0.357  Sum_probs=203.4

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|++.+.||+|+||.||+|.+..         ++..||||.+....  ....+.+.+|+++++.+.|+||+++++++...
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   72 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK   72 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCC---------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC
Confidence            68899999999999999998876         56789999986542  22346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||++++.|..++...  ..+++..+..++.||+.||.|||+.+   |+||||+|+||+++.++.+||+|||++
T Consensus        73 ~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~  147 (288)
T cd07833          73 GRLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFA  147 (288)
T ss_pred             CEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecc
Confidence            9999999999886666555433  25889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC----
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----  366 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~----  366 (491)
                      ........ .......|+..|+|||++.+. .++.++||||||+++|+|++|.+||......+...........+.    
T Consensus       148 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (288)
T cd07833         148 RALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ  226 (288)
T ss_pred             cccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence            87654432 122345788999999999887 889999999999999999999999975432211111000000000    


Q ss_pred             ----Ccc-----chhhccCcc-ccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 ----DKR-----RFYRLLDPR-LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ----~~~-----~~~~~~~~~-l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          ...     .+....++. ....++...+.++.+||++||..+|++||++++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                000     000000000 0011222337889999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.1e-39  Score=313.04  Aligned_cols=250  Identities=26%  Similarity=0.391  Sum_probs=204.2

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|.+.+.||+|+||.||+|....         ++..||||.+.....  ...+.+.+|+++|+.++||||+++++++...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA---------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED   71 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence            48889999999999999998875         567899999876532  2346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-CCeEEeccCC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGL  290 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kL~DFGl  290 (491)
                      +..++||||+++++|.+++.......+++..+..++.|++.+|.|||+++   |+|+||+|+||+++.+ +.++|+|||+
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~  148 (256)
T cd08220          72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGI  148 (256)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCC
Confidence            99999999999999999997765556899999999999999999999988   9999999999999755 4689999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +........   .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.......   .......  ..   
T Consensus       149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~--~~---  217 (256)
T cd08220         149 SKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIMS--GT---  217 (256)
T ss_pred             ceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHHHh--cC---
Confidence            987644321   123568999999999998889999999999999999999999996543211   1111000  00   


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                               ...++...+..+.+++.+||..||.+|||+.+++++
T Consensus       218 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         218 ---------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ---------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                     001112236789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.6e-40  Score=324.70  Aligned_cols=249  Identities=27%  Similarity=0.396  Sum_probs=201.3

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCce
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      |.....||+|+||.||++.+..         ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   94 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKH---------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL   94 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECC---------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence            4445679999999999998865         5678999998765545556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      ++||||+++++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        95 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (292)
T cd06658          95 WVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             EEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence            9999999999999987543   5788999999999999999999988   999999999999999999999999998765


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  ......|+..|+|||.+.+..++.++|||||||++|||++|..||........   .....          ..
T Consensus       169 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~----------~~  233 (292)
T cd06658         169 SKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRRIR----------DN  233 (292)
T ss_pred             ccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----------hc
Confidence            33221  12235689999999999888999999999999999999999999965332111   11000          01


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      +.+.+..  ....+..+.+++.+||..||.+|||+.+++++
T Consensus       234 ~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         234 LPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1111111  11235678999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.5e-39  Score=323.51  Aligned_cols=256  Identities=23%  Similarity=0.341  Sum_probs=201.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||++.+..         ++..||+|.+.....   .....+.+|+++++.++||||+++++++.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKE---------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE   71 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECC---------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence            368899999999999999999875         577899999876532   22356788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      ..+..++||||+++++|.+++...+  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          72 TKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCC
Confidence            9999999999999999999997654  5888999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCC-------------CceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011180          290 LAKDAPEDG-------------KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  356 (491)
Q Consensus       290 la~~~~~~~-------------~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~  356 (491)
                      +++......             .........|+..|+|||.+.+..++.++|+|||||++|||++|..||.......   
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---  223 (305)
T cd05609         147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---  223 (305)
T ss_pred             CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence            986421100             0001122467889999999988899999999999999999999999996543211   


Q ss_pred             hhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      +...   .....     ...+..    ....+..+.+||.+||+.||++||++.++++.|+
T Consensus       224 ~~~~---~~~~~-----~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         224 LFGQ---VISDD-----IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHHH---HHhcc-----cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            1110   00000     000000    0123677899999999999999999665555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-39  Score=312.94  Aligned_cols=249  Identities=30%  Similarity=0.473  Sum_probs=202.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-----ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      +|+..+.||+|+||.||+|....         ++..|++|.+.....     ...+.+.+|+.+++.++|+||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE   71 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC---------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence            47788999999999999998865         466899999865431     2346788999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+....++||||+++++|.+++....  .+++..+..++.||+.||+|||+.+   |+|+||+|+||+++.++.+||+||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          72 REEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccC
Confidence            99999999999999999999987653  5788999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      |++.......   ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||........  ......  ...
T Consensus       147 ~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~--~~~  219 (258)
T cd06632         147 GMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIGR--SKE  219 (258)
T ss_pred             ccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHHHh--ccc
Confidence            9988654332   123456899999999987766 89999999999999999999999965431111  000000  000


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                  ...++...+..+.+|+.+||..+|.+||++.+++.+
T Consensus       220 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         220 ------------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ------------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                        011122336788999999999999999999999865

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.5e-40  Score=322.23  Aligned_cols=267  Identities=28%  Similarity=0.367  Sum_probs=201.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||+|.+......  ..+.+.+|+++++.++||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR   71 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence            368899999999999999999865         5678999998654322  24567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ++..++||||+++++|..+.....  .+++..+..++.||+.||.|||+.+   |+|+||+|+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~  146 (286)
T cd07846          72 KKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGF  146 (286)
T ss_pred             CCeEEEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeee
Confidence            999999999999988887765433  4889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC-c
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD-K  368 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-~  368 (491)
                      +........  ......|+..|+|||++.+ ..++.++|||||||++|||++|.+||...........+......+.. .
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (286)
T cd07846         147 ARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH  224 (286)
T ss_pred             eeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhh
Confidence            886543321  1233568899999998875 45788999999999999999999998654321110000000000000 0


Q ss_pred             cch-------hhccCccccC-----CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRF-------YRLLDPRLEG-----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~-------~~~~~~~l~~-----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...       .....+....     ......+..+.+|+.+||..+|.+||++.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            000       0000000000     0011236789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.1e-39  Score=313.52  Aligned_cols=255  Identities=23%  Similarity=0.366  Sum_probs=190.9

Q ss_pred             ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEEE
Q 011180          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY  218 (491)
Q Consensus       140 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  218 (491)
                      .||+|+||.||+|......       ....+++|.+..... ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~   74 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDT-------GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF   74 (268)
T ss_pred             cCCCCcCceEEEEEEEcCC-------CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence            5999999999999765422       234577887765432 34567899999999999999999999999999999999


Q ss_pred             EecCCCChHHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCC
Q 011180          219 EFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  296 (491)
Q Consensus       219 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~  296 (491)
                      ||+++|+|.+++....  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||++.....
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCc
Confidence            9999999999987542  224566777899999999999999988   99999999999999999999999999864322


Q ss_pred             CCCceeeeccccCCCCCCchhhhc-------CCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          297 DGKTHVSTRVMGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       297 ~~~~~~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ..........+|+..|+|||++..       ..++.++|||||||++|||+++ ..||......   ......   +.. 
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~---~~~-  224 (268)
T cd05086         152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHV---IKD-  224 (268)
T ss_pred             chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---Hhh-
Confidence            222222234578899999998753       2457899999999999999974 6677543221   111110   000 


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                       ......++.+..    ..+..+.+++..|| .+|.+||++.+|++.|.
T Consensus       225 -~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         225 -QQVKLFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             -cccccCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence             011122222222    23577889999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-39  Score=323.08  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=201.4

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCce
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      |.....||+|+||.||+|.+..         ++..||+|.+........+.+.+|+.++..+.||||+++++++..++..
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   93 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL   93 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcC---------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence            4445579999999999998865         5678999999765545556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      ++||||+++++|.+++...   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        94 ~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~  167 (297)
T cd06659          94 WVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI  167 (297)
T ss_pred             EEEEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence            9999999999999877543   5789999999999999999999988   999999999999999999999999998765


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  ......|+..|+|||++.+..++.++|||||||++|||++|..||........   ........         
T Consensus       168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~---------  233 (297)
T cd06659         168 SKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLRDSP---------  233 (297)
T ss_pred             ccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhccC---------
Confidence            43221  12335689999999999988999999999999999999999999964332111   11110000         


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       .+..  ......+..+.++|.+||+.+|.+||++.+++++
T Consensus       234 -~~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         234 -PPKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             -CCCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             0000  0111235678999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.7e-39  Score=319.02  Aligned_cols=264  Identities=27%  Similarity=0.365  Sum_probs=203.5

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|.+.+.||.|+||.||+|.+..         +|..||||++.....  ...+.+.+|+.+++.++||||+++++++...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG   71 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC---------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence            48889999999999999999875         567899999976542  2346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.++|+|||++
T Consensus        72 ~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~  146 (286)
T cd07832          72 SGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLA  146 (286)
T ss_pred             CeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeec
Confidence            9999999999 999999987654 46899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC----
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----  366 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~----  366 (491)
                      ........ .......|+..|+|||.+.+. .++.++|||||||++|||++|.++|........   .......+.    
T Consensus       147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~  222 (286)
T cd07832         147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNE  222 (286)
T ss_pred             ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCCh
Confidence            87654332 112235689999999988654 468999999999999999999888864432111   111000000    


Q ss_pred             -------CccchhhccCccc----cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 -------DKRRFYRLLDPRL----EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 -------~~~~~~~~~~~~l----~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                             ..........+..    ........+..+.+||.+||..||.+|||+++++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         223 ETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                   0000000000000    000111235889999999999999999999999976

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.3e-39  Score=314.58  Aligned_cols=255  Identities=31%  Similarity=0.433  Sum_probs=205.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||.|+||.||+|.+..         ++..||+|.+..... ...+++.+|+++++.+.||||+++++++...
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRP---------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN   71 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcC---------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence            368888999999999999999875         567899999876532 3346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      +..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.++|+|||+
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~  147 (265)
T cd06605          72 GDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGV  147 (265)
T ss_pred             CEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999987653 478899999999999999999999 77   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +........    ....|+..|+|||.+.+..++.++|||||||++|+|++|..||........ .............  
T Consensus       148 ~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~--  220 (265)
T cd06605         148 SGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNEP--  220 (265)
T ss_pred             chhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcCC--
Confidence            876532211    115688999999999999999999999999999999999999965432111 1111111111000  


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                           .+.+..   ...+..+.+||.+||..||.+|||+.+++.+
T Consensus       221 -----~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         221 -----PPRLPS---GKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             -----CCCCCh---hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                 001100   1136779999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-39  Score=317.77  Aligned_cols=265  Identities=25%  Similarity=0.377  Sum_probs=198.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|.+.+.||+|+||.||+|....         ++..||||.+...... ....+.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKL---------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK   75 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcC---------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence            579999999999999999998865         5678999998654322 234567899999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+. ++|.+++..... .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~  150 (291)
T cd07844          76 KTLTLVFEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLA  150 (291)
T ss_pred             CeEEEEEecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccc
Confidence            99999999996 599998876543 6889999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC--c
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD--K  368 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--~  368 (491)
                      +........  .....++..|+|||++.+ ..++.++|||||||++|+|++|..||........  ........+..  .
T Consensus       151 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~  226 (291)
T cd07844         151 RAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTE  226 (291)
T ss_pred             cccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCCh
Confidence            754322111  122356889999998875 4688999999999999999999999965431110  00000000000  0


Q ss_pred             cch-------------hhccC-ccccCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRF-------------YRLLD-PRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~-------------~~~~~-~~l~~~~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..+             ..... ..+.... .......+.+++.+||+.||.+|||+.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            000             00000 0000000 01113678899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-38  Score=314.47  Aligned_cols=258  Identities=30%  Similarity=0.405  Sum_probs=203.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|...+.||.|+||.||+|.+..         ++..||+|.+..... .....+.+|+++++.++||||++++++|.+.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   71 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN---------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE   71 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC---------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence            368888999999999999999875         567899999875432 3346789999999999999999999998654


Q ss_pred             --CceEEEEEecCCCChHHHhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          212 --DQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       212 --~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                        +..++||||+++++|.+++..  .....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d  148 (287)
T cd06621          72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCD  148 (287)
T ss_pred             CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEee
Confidence              468999999999999988753  22345788899999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCC--CCcchhhHhhhccc
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP--NGEHNLVEWARPHL  365 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~--~~~~~~~~~~~~~~  365 (491)
                      ||++........    ....++..|+|||.+.+..++.++|||||||++|+|++|..||.....  ........+.... 
T Consensus       149 fg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  223 (287)
T cd06621         149 FGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-  223 (287)
T ss_pred             cccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-
Confidence            999876533211    234578899999999988999999999999999999999999976532  1111122211110 


Q ss_pred             CCccchhhccCccccCCCC--hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          366 GDKRRFYRLLDPRLEGHFS--IKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                       .        .+.+.....  ...+..+.+|+.+||..||.+|||+.|++++-
T Consensus       224 -~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         224 -P--------NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             -C--------chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence             0        000111000  12367899999999999999999999999864

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.8e-39  Score=310.65  Aligned_cols=253  Identities=28%  Similarity=0.430  Sum_probs=208.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||.+..... .....+.+|+.++..++|+||+++++++...
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKP---------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE   71 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcC---------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence            368899999999999999998875         577899999876643 3456789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      +..++||||+++++|.+++....  .+++..+..++.|+++||.|||+ .+   ++||||+|+||+++.++.++|+|||+
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~  146 (264)
T cd06623          72 GEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGI  146 (264)
T ss_pred             CeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCcc
Confidence            99999999999999999997653  68899999999999999999999 88   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +..........  ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..................      
T Consensus       147 ~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------  218 (264)
T cd06623         147 SKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG------  218 (264)
T ss_pred             ceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC------
Confidence            98764432221  2356889999999999889999999999999999999999999665431211222111100      


Q ss_pred             hhhccCccccCCCChh-hHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIK-GSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~-~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          ..+    ..+.. .+..+.++|.+||..+|++||++.+++++
T Consensus       219 ----~~~----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         219 ----PPP----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ----CCC----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                000    11112 36789999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-41  Score=355.84  Aligned_cols=260  Identities=26%  Similarity=0.312  Sum_probs=216.5

Q ss_pred             hhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCce
Q 011180          125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNL  201 (491)
Q Consensus       125 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnI  201 (491)
                      ..+++...++|.++++||+|+||.|.+++++.         +++.||+|++++..   .....-|..|-.+|..-+.+-|
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~---------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wi  137 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKS---------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWI  137 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeec---------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHH
Confidence            44566778899999999999999999999987         78899999998742   2233557889999999999999


Q ss_pred             eeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 011180          202 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       202 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~  281 (491)
                      |.++-+|.++.++|+|||||+||+|..++.+..  .+++..+..++..|+-||.-||+.|   +|||||||+|||||..|
T Consensus       138 v~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~G  212 (1317)
T KOG0612|consen  138 VQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSG  212 (1317)
T ss_pred             HHHHHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccC
Confidence            999999999999999999999999999998775  6899999999999999999999999   99999999999999999


Q ss_pred             CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhh----c-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011180          282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM----T-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  356 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~----~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~  356 (491)
                      ++||+|||.+..+..++.. .....+|||.|++||++.    + +.|+..+|+||+||++|||++|..||....      
T Consensus       213 HikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------  285 (1317)
T KOG0612|consen  213 HIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------  285 (1317)
T ss_pred             cEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------
Confidence            9999999999888765544 345578999999999996    2 679999999999999999999999997543      


Q ss_pred             hhHhhhcccCCccchhhccCccccCCCC--hhhHHHHHHHHHHhhhcCCCCCCC---HHHHHHHh
Q 011180          357 LVEWARPHLGDKRRFYRLLDPRLEGHFS--IKGSQKATQLAAQCLSRDPKARPR---MSEVVETL  416 (491)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cL~~dP~~RPt---~~evl~~L  416 (491)
                      +++.....+....          .-.||  ...+.++++||.+.+ -+|..|..   ++++-.|.
T Consensus       286 lveTY~KIm~hk~----------~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  286 LVETYGKIMNHKE----------SLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             HHHHHHHHhchhh----------hcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCc
Confidence            3332222222111          11222  335899999999988 67888887   88888774

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.8e-39  Score=318.94  Aligned_cols=266  Identities=26%  Similarity=0.351  Sum_probs=201.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-----cHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      +|.+.+.||+|+||.||+|.+..         ++..||||.+......     ....+..|+.+++.++|+||+++++++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF   71 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC---------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence            47888999999999999999875         5679999999765432     234567899999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..++||||+ +++|.+++.... ..+++..+..++.||++||.|||+.+   |+|+||||+|||++.++.++|+||
T Consensus        72 ~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          72 GHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             ecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccc
Confidence            9999999999999 999999987654 36899999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhhc---
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARP---  363 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~~~---  363 (491)
                      |++.........  .....+++.|+|||.+.+ ..++.++|||||||++|||++|.++|............ .....   
T Consensus       147 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~  224 (298)
T cd07841         147 GLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE  224 (298)
T ss_pred             eeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCch
Confidence            999876543221  122356888999998865 46789999999999999999998888654332111100 00000   


Q ss_pred             ----ccCCccchh--hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 ----HLGDKRRFY--RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ----~~~~~~~~~--~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          .........  ....+.-........+..+.+||.+||..||++|||+.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                000000000  0000000000112236789999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=313.92  Aligned_cols=255  Identities=30%  Similarity=0.419  Sum_probs=201.4

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      .+++|++.+.||.|+||.||+|.+..         ++..|++|++..... ...++.+|+.+++++ .|+||+++++++.
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKK---------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI   73 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECC---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence            35689999999999999999999865         567899999876543 346788999999999 6999999999997


Q ss_pred             ecC------ceEEEEEecCCCChHHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 011180          210 EDD------QRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~  281 (491)
                      ...      ..++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~  150 (275)
T cd06608          74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNA  150 (275)
T ss_pred             ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCC
Confidence            654      4899999999999999886533  346889999999999999999999988   99999999999999999


Q ss_pred             CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011180          282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  356 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~  356 (491)
                      .++|+|||++........  ......|+..|+|||++..     ..++.++|||||||+||+|++|..||........  
T Consensus       151 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--  226 (275)
T cd06608         151 EVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--  226 (275)
T ss_pred             eEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--
Confidence            999999999876543221  1223568999999998753     3467889999999999999999999964322111  


Q ss_pred             hhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .......           ..+.+  ..+...+..+.+||.+||..||.+|||+.+++++
T Consensus       227 ~~~~~~~-----------~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         227 LFKIPRN-----------PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             HHHhhcc-----------CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1110000           00000  1111236789999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.5e-39  Score=317.47  Aligned_cols=260  Identities=29%  Similarity=0.390  Sum_probs=202.5

Q ss_pred             hhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeee
Q 011180          126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKL  204 (491)
Q Consensus       126 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l  204 (491)
                      .++....++|.+.+.||+|+||.||+|....         ++..+|+|++.... .....+.+|+.++.++ +||||+++
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~   84 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKK---------DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKF   84 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEE
Confidence            4444567889999999999999999998865         57789999986542 2235677899999999 79999999


Q ss_pred             eeEEeec-----CceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 011180          205 VGYCIED-----DQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       205 ~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl  277 (491)
                      ++++...     +..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+   |+||||||+||++
T Consensus        85 ~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili  161 (291)
T cd06639          85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILL  161 (291)
T ss_pred             EEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEE
Confidence            9998754     3579999999999999988532  2336889999999999999999999988   9999999999999


Q ss_pred             CCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 011180          278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN  352 (491)
Q Consensus       278 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~pf~~~~~~  352 (491)
                      +.++.+||+|||++.........  .....|+..|+|||.+...     .++.++|||||||++|||++|+.||......
T Consensus       162 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~  239 (291)
T cd06639         162 TTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV  239 (291)
T ss_pred             cCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence            99999999999998865432211  1234688999999988643     3688999999999999999999999654321


Q ss_pred             CcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..  +..+.....           +.+  ..+......+.+||.+||+.||++||++.+++++
T Consensus       240 ~~--~~~~~~~~~-----------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         240 KT--LFKIPRNPP-----------PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HH--HHHHhcCCC-----------CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11  111110000           000  0111224678999999999999999999999976

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.3e-39  Score=317.07  Aligned_cols=266  Identities=26%  Similarity=0.371  Sum_probs=200.5

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|++.+.||.|+||.||+|.+..         ++..||||.+.....  .....+.+|++++++++||||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE   71 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECC---------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence            48889999999999999998865         577899999875432  2235688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+. ++|.+++.......+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccch
Confidence            99999999995 68998887655557899999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCcch-hhHhhhcc-----
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH-----  364 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~-----  364 (491)
                      .........  .....++..|+|||++.+.. ++.++|||||||++|+|+||+.||.......... ........     
T Consensus       148 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07860         148 RAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW  225 (284)
T ss_pred             hhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence            765432211  12345788999999887644 6889999999999999999999996543211100 00000000     


Q ss_pred             --cCCc----cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 --LGDK----RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 --~~~~----~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        ....    ..+.......+. ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         226 PGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence              0000    000000000000 0011235678899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.6e-39  Score=317.76  Aligned_cols=267  Identities=26%  Similarity=0.365  Sum_probs=202.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||.|+||.||+|.+..         ++..||+|.++.....  ....+.+|+.++..+.||||+++++++..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   75 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK---------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG   75 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC---------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence            368899999999999999998875         5678999999754322  22456789999999999999999999988


Q ss_pred             c--CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          211 D--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       211 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .  +..||||||+. ++|.+++..... .+++..++.++.||+.||+|||+.+   |+|+||||+|||++.++.++|+||
T Consensus        76 ~~~~~~~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~  150 (293)
T cd07843          76 SNLDKIYMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDF  150 (293)
T ss_pred             cCCCcEEEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeec
Confidence            7  88999999996 599998876543 6899999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH-hhh----
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WAR----  362 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~-~~~----  362 (491)
                      |++.........  .....+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||...........+. ...    
T Consensus       151 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (293)
T cd07843         151 GLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE  228 (293)
T ss_pred             CceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence            999876543211  1234578899999988754 46889999999999999999999997543221111000 000    


Q ss_pred             ---c---ccCCc--cchhhccCccccCCCChh-hHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 ---P---HLGDK--RRFYRLLDPRLEGHFSIK-GSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ---~---~~~~~--~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         +   .+...  ..+.......+...++.. .+..+.+||.+||+.||++|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence               0   00000  000000011111222222 36788999999999999999999999865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-39  Score=342.68  Aligned_cols=279  Identities=18%  Similarity=0.225  Sum_probs=191.2

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccC------CCCCeEE----EEEEecCCCcccHHHHHHHHHHHhcCCCCc
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVK------PGTGLTV----AVKTLNHDGLQGHKEWLAEVNFLGNLLHPN  200 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~------~~~~~~v----avK~~~~~~~~~~~~~~~E~~il~~l~Hpn  200 (491)
                      ..++|++++.||+|+||+||+|.++........      ...+...    +.|.+... ......+.+|+.+|..++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAG-SRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcc-hHHHHHHHHHHHHHHhCCCCC
Confidence            346899999999999999999987542111000      0000111    11111111 122356789999999999999


Q ss_pred             eeeeeeEEeecCceEEEEEecCCCChHHHhhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 011180          201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       201 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl  277 (491)
                      ||++++++.+.+..|+|||++ +++|.+++....   ........+..|+.||+.||.|||+.+   ||||||||+||||
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            999999999999999999999 567877775432   112335567789999999999999988   9999999999999


Q ss_pred             CCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCC-CCCCCcch
Q 011180          278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDK-NRPNGEHN  356 (491)
Q Consensus       278 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~-~~~~~~~~  356 (491)
                      +.++.+||+|||+++.+..... ......+||..|+|||++.+..++.++|||||||+||||++|..++.. ........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999987644322 122346799999999999999999999999999999999999865433 22221111


Q ss_pred             hhHhhhcc------cCCc-cchhhccCcccc----CCC-----ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          357 LVEWARPH------LGDK-RRFYRLLDPRLE----GHF-----SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       357 ~~~~~~~~------~~~~-~~~~~~~~~~l~----~~~-----~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      +.+.....      +.+. ..++..++....    ..+     ....+..+.++|.+||+.||.+|||+.|++.+
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            11111100      0000 001111100000    000     01124567889999999999999999999976

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.6e-39  Score=317.45  Aligned_cols=268  Identities=24%  Similarity=0.330  Sum_probs=199.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      +.+|.+.+.||+|+||.||+|....         ++..||+|.+...... ....+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   74 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRI---------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT   74 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcC---------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence            4679999999999999999998875         5678999998755322 23467889999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||+
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~  149 (291)
T cd07870          75 KETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGL  149 (291)
T ss_pred             CCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccc
Confidence            999999999995 77877765543 25778888899999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC---
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---  366 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---  366 (491)
                      ++........  .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.......+.....+......   
T Consensus       150 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  227 (291)
T cd07870         150 ARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED  227 (291)
T ss_pred             ccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence            8764332211  123457899999998875 3578899999999999999999999975432111100000000000   


Q ss_pred             ---------Ccc-chhhccCc-cccCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 ---------DKR-RFYRLLDP-RLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ---------~~~-~~~~~~~~-~l~~~~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                               ... .+.....+ .+.... ....+..+.+|+.+||..||.+|||+.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                     000 00000000 000000 00125678999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.8e-39  Score=310.36  Aligned_cols=251  Identities=25%  Similarity=0.364  Sum_probs=202.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee-
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-  210 (491)
                      +|.+.+.||.|+||.||+|.+..         ++..||+|.+.....  ...+.+..|+++++.++|+||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKS---------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR   71 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence            48889999999999999998876         567899999875433  234568889999999999999999998764 


Q ss_pred             -cCceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCcEEECCCCC
Q 011180          211 -DDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLH-----EEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       211 -~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH-----~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                       ....+++|||+++++|.+++...  ....+++..++.++.||+.||.|||     +.+   |+|+||||+||+++.++.
T Consensus        72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~  148 (265)
T cd08217          72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNN  148 (265)
T ss_pred             CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCC
Confidence             34578999999999999998653  1346889999999999999999999     655   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      +||+|||++.........  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....   ..+.....
T Consensus       149 ~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~  223 (265)
T cd08217         149 VKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKIK  223 (265)
T ss_pred             EEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHHh
Confidence            999999999876543321  2335689999999999988899999999999999999999999975431   11111111


Q ss_pred             cccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .              .....++...+..+.+|+.+||..+|.+||++.+|+++
T Consensus       224 ~--------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 E--------------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             c--------------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            0              00111222346789999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-39  Score=313.44  Aligned_cols=249  Identities=28%  Similarity=0.442  Sum_probs=201.1

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCC---CCceeeeeeEEe
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLL---HPNLVKLVGYCI  209 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~  209 (491)
                      .|++.+.||.|+||.||+|.+..         ++..||+|.+.... .....++.+|+.+++.+.   ||||+++++++.
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~   72 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL   72 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC---------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence            47788999999999999999865         56789999987543 233467888999999997   999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      .....++||||+++++|.+++...   .+++..++.++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          73 KGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             eCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCC
Confidence            999999999999999999988543   6889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ++.........  .....|+..|+|||.+.++ .++.++|+|||||++|+|++|..||............       .. 
T Consensus       147 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~-  216 (277)
T cd06917         147 VAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------PK-  216 (277)
T ss_pred             ceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------cc-
Confidence            99876543321  2335689999999988654 5788999999999999999999999654322111100       00 


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                           ...+.+...   ..+..+.+++.+||..||.+||++.+++.+
T Consensus       217 -----~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         217 -----SKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             -----CCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                 000111110   135788999999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.4e-39  Score=316.76  Aligned_cols=251  Identities=25%  Similarity=0.395  Sum_probs=204.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||.|+||.||++....         ++..||+|.+........+.+.+|+.+++.+.||||+++++++...+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~   89 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD   89 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcC---------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence            579999999999999999998765         56689999987554445567889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..|+||||+++++|.+++...   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~  163 (293)
T cd06647          90 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (293)
T ss_pred             cEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCccee
Confidence            999999999999999998654   4778889999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .......  ......|++.|+|||.+....++.++|||||||++|+|++|..||.............  .    ...   
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~--~----~~~---  232 (293)
T cd06647         164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--T----NGT---  232 (293)
T ss_pred             ccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh--c----CCC---
Confidence            6543322  1223468899999999988889999999999999999999999997543322111100  0    000   


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          +.+  ..+...+..+.+||.+||..+|.+||++.+++.+
T Consensus       233 ----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 ----PEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ----CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                000  0111235678999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-40  Score=334.98  Aligned_cols=248  Identities=24%  Similarity=0.399  Sum_probs=197.9

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC----CcccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .+...+||+|+|-+||+|.+..         +|..||--.++..    .....++|..|+.+|+.|+|||||++|.+|.+
T Consensus        42 ~k~~evLGrGafKtVYka~De~---------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d  112 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEE---------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD  112 (632)
T ss_pred             eehhhhcccccceeeeeccccc---------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence            3556789999999999998865         6777875443322    22334789999999999999999999999998


Q ss_pred             cCc--eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCCeEEec
Q 011180          211 DDQ--RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSD  287 (491)
Q Consensus       211 ~~~--~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kL~D  287 (491)
                      ...  ..+|+|++..|+|..|+.+.+  .+....+..|++||++||.|||++. +||||||||.+||+|+. .|.|||+|
T Consensus       113 ~~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGD  189 (632)
T KOG0584|consen  113 TDNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGD  189 (632)
T ss_pred             CCCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecc
Confidence            765  678999999999999998876  5677899999999999999999988 78999999999999975 58999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      +|||+.......    ...+|||.|||||++. ..|+..+||||||++|+||+|+..||.....     .....+.....
T Consensus       190 LGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYKKV~SG  259 (632)
T KOG0584|consen  190 LGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYKKVTSG  259 (632)
T ss_pred             hhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHHHHHcC
Confidence            999998754322    2378999999999776 8999999999999999999999999965431     11111111111


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..          ...+..-..+++++||.+||.. .++|+|+.|+|++
T Consensus       260 iK----------P~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  260 IK----------PAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             CC----------HHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            10          0111111257889999999999 9999999999975

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.2e-39  Score=314.75  Aligned_cols=252  Identities=29%  Similarity=0.403  Sum_probs=195.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHH-HhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNF-LGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||+|+||.||+|.+..         +|..||||.+..... .....+..|+.+ ++.++||||+++++++..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~   71 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVP---------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR   71 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcC---------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence            378999999999999999999875         678999999876532 233456667665 566789999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      ++..++||||++ |+|.+++...  ....+++..++.++.||+.||.|||++ +   ++||||||+|||++.++.+||+|
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~d  147 (283)
T cd06617          72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCD  147 (283)
T ss_pred             CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEee
Confidence            999999999995 6888877542  234689999999999999999999986 6   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhc----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      ||++.......   ..+...|+..|+|||.+.+    ..++.++|+|||||++|+|++|..||........ .+..... 
T Consensus       148 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~-  222 (283)
T cd06617         148 FGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QLKQVVE-  222 (283)
T ss_pred             ccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HHHHHHh-
Confidence            99998664321   1223568999999998864    4568899999999999999999999964221100 0000000 


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                ...+.+.   ....+..+.+||.+||..+|.+||++.+++++
T Consensus       223 ----------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         223 ----------EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ----------cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      0000000   01236789999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.9e-39  Score=312.95  Aligned_cols=249  Identities=26%  Similarity=0.351  Sum_probs=205.0

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      +|.+.+.||.|+||.||+|.+..         ++..||+|++.....   ...+.+.+|++++++++||||+++++++.+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRD---------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD   71 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEcc---------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence            48889999999999999998865         577899999976432   235678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ....++||||+.+++|.+++...  ..+++..+..++.||++||.|||+.+   |+|+||+|+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          72 EENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeeccc
Confidence            99999999999999999998765  36889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +.......   ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||................    .   
T Consensus       147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----~---  216 (258)
T cd05578         147 ATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE----T---  216 (258)
T ss_pred             ccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc----c---
Confidence            98765432   1233568899999999988889999999999999999999999997654321111111100    0   


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH--HHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM--SEVVE  414 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~--~evl~  414 (491)
                              ....++...+..+.++|.+||..||.+||++  .++++
T Consensus       217 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 --------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             --------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence                    0111222346889999999999999999999  66654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-38  Score=310.87  Aligned_cols=254  Identities=26%  Similarity=0.421  Sum_probs=201.0

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC----------cccHHHHHHHHHHHhc-CCCCcee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----------LQGHKEWLAEVNFLGN-LLHPNLV  202 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~il~~-l~HpnIv  202 (491)
                      +|++.+.||+|+||.||+|.+..+        .+..||+|.+....          .....++.+|+.++.. ++||||+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~   72 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV   72 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence            478889999999999999998652        35689999885322          1123457788888875 7899999


Q ss_pred             eeeeEEeecCceEEEEEecCCCChHHHhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEECC
Q 011180          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDA  279 (491)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlKp~NILl~~  279 (491)
                      ++++++.+.+..++||||+++++|.+++..  .....+++..++.++.|++.||.|||+ .+   |+|+||+|+|||++.
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~  149 (269)
T cd08528          73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGE  149 (269)
T ss_pred             eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECC
Confidence            999999999999999999999999998743  223468899999999999999999996 55   999999999999999


Q ss_pred             CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011180          280 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       280 ~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  359 (491)
                      ++.++|+|||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.......   ...
T Consensus       150 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~~  223 (269)
T cd08528         150 DDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LAT  223 (269)
T ss_pred             CCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HHH
Confidence            9999999999998654432   2234568999999999998889999999999999999999999986432211   111


Q ss_pred             hhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          360 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      ...   ..      ...+..    ....+..+.+||.+||+.||++||++.|+.++|+
T Consensus       224 ~~~---~~------~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         224 KIV---EA------VYEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHh---hc------cCCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            000   00      000100    0123578999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.5e-39  Score=317.63  Aligned_cols=254  Identities=29%  Similarity=0.396  Sum_probs=197.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~  211 (491)
                      +|...+.||+|+||.||++.+..         ++..||+|.+..... .....+.+|+.++.++. |+||+++++++..+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~   75 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE   75 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECC---------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence            56677889999999999998875         577999999875432 33456889999999996 99999999999999


Q ss_pred             CceEEEEEecCCCChHHHh---hhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          212 DQRLLVYEFMPRGSLENHL---FRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +..+++|||+. ++|.++.   .......+++..+..++.|++.||+|||+. +   |+||||||+|||++.++.++|+|
T Consensus        76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~d  151 (288)
T cd06616          76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCD  151 (288)
T ss_pred             CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEee
Confidence            99999999985 4665543   223334689999999999999999999974 6   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      ||+++.......   .....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||....     ...+.....
T Consensus       152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~  223 (288)
T cd06616         152 FGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQV  223 (288)
T ss_pred             cchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhh
Confidence            999976543221   1234689999999998766   68999999999999999999999996543     111111111


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...       ..+.+........+..+.+||.+||+.||.+|||+.+|+++
T Consensus       224 ~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         224 VKG-------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCC-------CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000       01111112222347789999999999999999999999976

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.3e-38  Score=308.83  Aligned_cols=254  Identities=31%  Similarity=0.463  Sum_probs=203.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|.+.+.||+|+||.||+|....         ++..||+|.+......  ..+.+..|+.+++.++|+||+++++++...
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~   71 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD---------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR   71 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC---------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence            48889999999999999998765         5678999999766443  456789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++|+||+++++|.+++....  .+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~  146 (264)
T cd06626          72 EKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCA  146 (264)
T ss_pred             CEEEEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccc
Confidence            99999999999999999987653  4788889999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcee--eeccccCCCCCCchhhhcCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          292 KDAPEDGKTHV--STRVMGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       292 ~~~~~~~~~~~--~~~~~Gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      ...........  .....++..|+|||++.+..   ++.++||||||+++|+|++|..||........  . .+... ..
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~-~~~~~-~~  222 (264)
T cd06626         147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--I-MFHVG-AG  222 (264)
T ss_pred             cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--H-HHHHh-cC
Confidence            87654332211  11356789999999998766   88999999999999999999999964321111  0 00000 00


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .        .+.+..  ....+..+.+||.+||+.+|.+|||+.+++.+
T Consensus       223 ~--------~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         223 H--------KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             C--------CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0        000100  11226778999999999999999999999854

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.9e-40  Score=306.96  Aligned_cols=274  Identities=23%  Similarity=0.313  Sum_probs=202.9

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee-
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-  210 (491)
                      .|++...||+|.||.||+|.-.+.+..     ....+|||.++....  .-.....+|+.+++.|+||||+.+..+|.. 
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~k-----r~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDK-----RTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcc-----cchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            588999999999999999965543210     234799999976522  223567899999999999999999999987 


Q ss_pred             cCceEEEEEecCCCChHHHhhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC----CCe
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD----YNA  283 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~----~~~  283 (491)
                      +..++|++||.+. +|...|....   ...++...+..|++||+.|+.|||++-   |+||||||.||||..+    |.|
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCee
Confidence            7889999999955 8888885432   246899999999999999999999998   9999999999999877    899


Q ss_pred             EEeccCCcccCCCCCCce-eeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch-----
Q 011180          284 KLSDFGLAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-----  356 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~-----  356 (491)
                      ||+|||+++.+.+.-... ....++-|..|+|||.+.+. .|+.+.|||++|||+.||++-.+.|..........     
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~  255 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH  255 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence            999999999886544433 22346779999999999874 79999999999999999999999986543322111     


Q ss_pred             -hhHhhhcccC-----CccchhhccCc-----cccC-CCCh-----------hhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011180          357 -LVEWARPHLG-----DKRRFYRLLDP-----RLEG-HFSI-----------KGSQKATQLAAQCLSRDPKARPRMSEVV  413 (491)
Q Consensus       357 -~~~~~~~~~~-----~~~~~~~~~~~-----~l~~-~~~~-----------~~~~~l~~li~~cL~~dP~~RPt~~evl  413 (491)
                       .....-..++     +...+....+-     .+.. .+..           .-++...+|+.+||..||.+|.|+++++
T Consensus       256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl  335 (438)
T KOG0666|consen  256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL  335 (438)
T ss_pred             HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence             1111101111     00000000000     0000 0000           0144589999999999999999999999


Q ss_pred             HHh
Q 011180          414 ETL  416 (491)
Q Consensus       414 ~~L  416 (491)
                      ++.
T Consensus       336 eh~  338 (438)
T KOG0666|consen  336 EHP  338 (438)
T ss_pred             ccc
Confidence            874

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.4e-38  Score=311.89  Aligned_cols=246  Identities=31%  Similarity=0.434  Sum_probs=196.7

Q ss_pred             cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       141 lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      ||+|+||.||+|.+..         +|..||+|.+.....   .....+..|+.+|+.++||||+++++++...+..|+|
T Consensus         1 lg~g~~g~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   71 (277)
T cd05577           1 LGKGGFGEVCACQVKA---------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV   71 (277)
T ss_pred             CCCCCceeEEEEEEcC---------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence            7999999999998765         577899999865322   2234567899999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.+   |+||||+|+|||++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~  148 (277)
T cd05577          72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG  148 (277)
T ss_pred             EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence            99999999999997766557899999999999999999999988   999999999999999999999999998765432


Q ss_pred             CCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCc
Q 011180          298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  377 (491)
Q Consensus       298 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (491)
                      ..   .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.  ......          
T Consensus       149 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~----------  213 (277)
T cd05577         149 KK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLEM----------  213 (277)
T ss_pred             Cc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hccccc----------
Confidence            11   123467889999999988889999999999999999999999996544321111111  000000          


Q ss_pred             cccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          378 RLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       378 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                        ...++...+..+.++|.+||+.||.+||     ++.+++++
T Consensus       214 --~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         214 --AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             --cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence              0112222367889999999999999999     66666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.1e-39  Score=309.47  Aligned_cols=251  Identities=22%  Similarity=0.373  Sum_probs=203.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|.+.+.||.|+||.||+|.+..         +|..||+|.+.....  ...+.+.+|+.+++.++|+||+++++++.+.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~   71 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS---------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN   71 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC---------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence            47888999999999999999876         566899999875432  2345678999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-CeEEeccCC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFGL  290 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kL~DFGl  290 (491)
                      +..++||||+++++|.+++.......+++..+..++.|++.||.|||+.+   |+|+||||+||++++++ .++|+|||.
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~  148 (257)
T cd08225          72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI  148 (257)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEeccccc
Confidence            99999999999999999997765556899999999999999999999988   99999999999998875 469999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +.........  .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.......      .........  
T Consensus       149 ~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~--  218 (257)
T cd08225         149 ARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQGY--  218 (257)
T ss_pred             chhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhccc--
Confidence            9876433211  123468999999999988889999999999999999999999986432211      111100000  


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          +     .......+..+.+++.+||..+|++|||+.+++++
T Consensus       219 ----~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         219 ----F-----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ----C-----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                0     01112235789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.4e-39  Score=324.47  Aligned_cols=265  Identities=23%  Similarity=0.311  Sum_probs=199.8

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ..++|++.+.||+|+||.||+|.+..         ++..||||.+...  .......+.+|+.+++.++|+||+++++++
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   84 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTV---------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF   84 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECC---------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence            34679999999999999999998876         6778999998653  223345678899999999999999999988


Q ss_pred             eec------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          209 IED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       209 ~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      ...      ...|+||||+. ++|.+.+...    ++...+..++.|++.||+|||..+   |+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~  156 (353)
T cd07850          85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT  156 (353)
T ss_pred             ccCCCccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCC
Confidence            644      34699999995 5888877532    788888999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh-H--
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-E--  359 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~--  359 (491)
                      +||+|||+++.......   .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+ .  
T Consensus       157 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  233 (353)
T cd07850         157 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL  233 (353)
T ss_pred             EEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence            99999999986643221   22346889999999999999999999999999999999999999654321110000 0  


Q ss_pred             ------h---hh----cccC-----CccchhhccCc----cccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          360 ------W---AR----PHLG-----DKRRFYRLLDP----RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       360 ------~---~~----~~~~-----~~~~~~~~~~~----~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                            +   ..    ....     ....+...+..    ..........+..+.+||.+||+.||.+|||+.++|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  0   00    0000     00000011100    00001112236678999999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.4e-38  Score=313.53  Aligned_cols=250  Identities=28%  Similarity=0.415  Sum_probs=202.3

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCc
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  213 (491)
                      +|...+.||+|+||.||++.+..         ++..||+|.+........+.+.+|+.+++.+.||||+++++++...+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~   90 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKS---------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE   90 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence            35556799999999999998765         567899999876554455678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          214 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      .++|+||+++++|.+++...   .+++..+..++.|++.||+|||+.+   |+||||+|+||+++.++.++|+|||++..
T Consensus        91 ~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648          91 LWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             EEEEEeccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchh
Confidence            99999999999999998762   5788999999999999999999988   99999999999999999999999998876


Q ss_pred             CCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhh
Q 011180          294 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  373 (491)
Q Consensus       294 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (491)
                      ......  ......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+...   .......         
T Consensus       165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~~~~~~---------  230 (285)
T cd06648         165 VSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MKRIRDN---------  230 (285)
T ss_pred             hccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHHhc---------
Confidence            543221  12235689999999999888899999999999999999999999865332111   1111100         


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          374 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       374 ~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       ..+.+.  .....+..+.+|+.+||..+|.+||++.+++++
T Consensus       231 -~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         231 -LPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             -CCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence             000110  011235789999999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.9e-38  Score=310.87  Aligned_cols=248  Identities=26%  Similarity=0.398  Sum_probs=201.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      -|++.+.||.|+||.||+|.+..         ++..||||++..... .....+.+|+.++..++||||+++++++..++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   75 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT   75 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECC---------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC
Confidence            37788999999999999998765         567899999865432 23456888999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+++...   .+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        76 ~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06641          76 KLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG  149 (277)
T ss_pred             eEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccce
Confidence            999999999999999988543   5789999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .......  ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||........   .....    ..    
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~----~~----  216 (277)
T cd06641         150 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LFLIP----KN----  216 (277)
T ss_pred             ecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HHHHh----cC----
Confidence            6543221  12235688999999999888899999999999999999999999864322111   11000    00    


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                            ....+....+..+.+++.+||..+|.+||++.+++++
T Consensus       217 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 ------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                  0011122236788999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.4e-38  Score=303.56  Aligned_cols=251  Identities=29%  Similarity=0.463  Sum_probs=206.4

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCc
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  213 (491)
                      +|.+.+.||.|+||.||++.+..         ++..|++|++..........+.+|+.+++.+.|+||+++++++.....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   71 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE   71 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            47888999999999999999875         567899999977655456788999999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          214 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      .++++||+++++|.+++.... ..+++..+..++.|++.||.|||..+   ++||||+|+||+++.++.++|+|||.+..
T Consensus        72 ~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~  147 (253)
T cd05122          72 LWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQ  147 (253)
T ss_pred             EEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccc
Confidence            999999999999999987653 36899999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhh
Q 011180          294 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  373 (491)
Q Consensus       294 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (491)
                      ......   .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...........   ...  ...     
T Consensus       148 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~--~~~-----  214 (253)
T cd05122         148 LSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---IAT--NGP-----  214 (253)
T ss_pred             cccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHh--cCC-----
Confidence            654322   2345689999999999888899999999999999999999999865432111110   000  000     


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          374 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       374 ~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         +.+  ......+..+.++|.+||..||.+|||+.+++++
T Consensus       215 ---~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         215 ---PGL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ---CCc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               000  0011125779999999999999999999999865

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.9e-38  Score=311.60  Aligned_cols=243  Identities=28%  Similarity=0.401  Sum_probs=190.1

Q ss_pred             ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHH---HHhcCCCCceeeeeeEEeecCc
Q 011180          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN---FLGNLLHPNLVKLVGYCIEDDQ  213 (491)
Q Consensus       140 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~---il~~l~HpnIv~l~~~~~~~~~  213 (491)
                      +||+|+||.||++.+..         ++..||+|.+......   ....+.+|..   ++....||||+.+++++...+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK   71 (279)
T ss_pred             CcccCCCeEEEEEEECC---------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence            48999999999998865         5779999998754322   1223344443   3344579999999999999999


Q ss_pred             eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          214 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      .++||||+++++|.+++...+  .+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||++..
T Consensus        72 ~~lv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          72 LCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            999999999999999887654  5899999999999999999999988   99999999999999999999999999875


Q ss_pred             CCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          294 APEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       294 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .....    .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||..............   ..       
T Consensus       147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~~-------  212 (279)
T cd05633         147 FSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL-------  212 (279)
T ss_pred             ccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---hh-------
Confidence            53321    123468999999998864 5689999999999999999999999975433221111110   00       


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                       .    ....++...+..+.++|.+||..||.+||     ++.+++++
T Consensus       213 -~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         213 -T----VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -c----CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence             0    01112223467899999999999999999     59988876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=9.8e-39  Score=315.55  Aligned_cols=268  Identities=22%  Similarity=0.324  Sum_probs=200.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||+|+||.||+|.+..         +|..||+|.+.....  .....+.+|+++++.++||||+++++++.+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRV---------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS   72 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecC---------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence            468999999999999999999865         577899999865432  223567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCCeEEeccC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFG  289 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kL~DFG  289 (491)
                      ....++||||++ ++|.+++.......+++..+..++.||+.||+|||+.+   |+||||+|+||+++. ++.+||+|||
T Consensus        73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccc
Confidence            999999999995 68888886655555788888899999999999999988   999999999999985 5679999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhhhcc---
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARPH---  364 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~~~~---  364 (491)
                      ++........  ......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||......+..... ......   
T Consensus       149 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (294)
T PLN00009        149 LARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE  226 (294)
T ss_pred             cccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9976533211  1123467899999998876 45789999999999999999999999754332111100 000000   


Q ss_pred             -------cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 -------LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 -------~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                             +.+.........+..........+..+.+++.+||+.+|.+||++.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   000000000000000001112236778999999999999999999999974

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.8e-38  Score=304.39  Aligned_cols=253  Identities=29%  Similarity=0.458  Sum_probs=207.3

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|.+.+.||+|+||.||+|.+..         ++..|++|++.....  ...+.+.+|+.++++++|+||+++++++.+.
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD---------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE   71 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence            47888999999999999998875         567899999876543  3456788999999999999999999999988


Q ss_pred             --CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          212 --DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       212 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                        ...++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~  146 (260)
T cd06606          72 EKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFG  146 (260)
T ss_pred             CCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccc
Confidence              88999999999999999997664  7899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      .+................++..|+|||.+.+..++.++||||||+++|+|++|..||....  ...... +  .      
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~-~--~------  215 (260)
T cd06606         147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAAL-Y--K------  215 (260)
T ss_pred             cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHH-H--h------
Confidence            9987755432111233568999999999988889999999999999999999999997544  110000 0  0      


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          .........++...+..+.+||.+||..||.+||++.+++.+
T Consensus       216 ----~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         216 ----IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ----ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                000001111222336889999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2e-38  Score=307.72  Aligned_cols=244  Identities=27%  Similarity=0.378  Sum_probs=198.5

Q ss_pred             cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       141 lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      ||.|+||.||+|.+..         ++..||+|++.....   ...+.+.+|+.+++.++||||+++++++.++...++|
T Consensus         1 lg~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (262)
T cd05572           1 LGVGGFGRVELVKVKS---------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML   71 (262)
T ss_pred             CCCCCceEEEEEEECC---------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence            7999999999999865         567899999975432   2345688999999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      |||+++++|.+++.+..  .+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          72 MEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             EecCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            99999999999997653  5788999999999999999999988   999999999999999999999999999876543


Q ss_pred             CCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCc
Q 011180          298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  377 (491)
Q Consensus       298 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (491)
                      .   ......|+..|++||.+.+..++.++|+||||+++|+|++|..||....... ....   ..          ....
T Consensus       147 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~----------~~~~  209 (262)
T cd05572         147 Q---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIY---ND----------ILKG  209 (262)
T ss_pred             c---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHH---HH----------Hhcc
Confidence            2   1223568999999999988889999999999999999999999997654211 1111   10          1100


Q ss_pred             cccCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011180          378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  415 (491)
Q Consensus       378 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~  415 (491)
                      .....++...+..+.++|.+||..||.+||+     +.|++++
T Consensus       210 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         210 NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            1111223333678999999999999999999     7777763

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=306.05  Aligned_cols=259  Identities=25%  Similarity=0.365  Sum_probs=202.2

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV  217 (491)
                      ++||+|+|+.|--|....         +|..+|||++.+...-...++.+|++++.+++ |+||+.|+++|+++...|||
T Consensus        84 e~LGeGAyasVqtcv~i~---------t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV  154 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQ---------TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV  154 (463)
T ss_pred             HHhcCccceeeeeeeeec---------cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence            679999999999998776         78899999998875556788999999999997 99999999999999999999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC---CeEEeccCCcccC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---NAKLSDFGLAKDA  294 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kL~DFGla~~~  294 (491)
                      ||-|.||+|..+|.++.  .+.+.++.++..+|+.||.|||..|   |.||||||+|||.....   -+|||||.|..-.
T Consensus       155 fEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  155 FEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             EecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence            99999999999998875  6888999999999999999999988   99999999999996543   4899999987543


Q ss_pred             CCCCC-----ceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          295 PEDGK-----THVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       295 ~~~~~-----~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      ...+.     +....+.+|+..|||||++.     ...|+.++|.||||||||.||+|.+||.+.--.+.    .|.+..
T Consensus       230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----GWdrGe  305 (463)
T KOG0607|consen  230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----GWDRGE  305 (463)
T ss_pred             ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----CccCCC
Confidence            22111     11123478999999999874     34789999999999999999999999976533211    111110


Q ss_pred             cCC--ccc-hhhccCccc--cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 LGD--KRR-FYRLLDPRL--EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ~~~--~~~-~~~~~~~~l--~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .-.  ... |..+-+-.+  .+.-....+.++++||..+|.+|+.+|.++.+++++
T Consensus       306 ~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  306 VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            000  001 111111111  111112348899999999999999999999999984

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-39  Score=313.84  Aligned_cols=266  Identities=23%  Similarity=0.323  Sum_probs=200.4

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      |++.+.||.|++|.||+|.+..         +|..||+|++.....  .....+.+|+.+++.++||||+++++++.+.+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~   71 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL---------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN   71 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC---------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence            6778899999999999999876         567899999875532  22356788999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+ +++|.+++.......+++..++.++.|++.||.|||+.+   ++||||+|+|||++.++.++|+|||++.
T Consensus        72 ~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          72 KLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             eEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            999999999 568999987665446899999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch-hhHhhhcc------
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH------  364 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~------  364 (491)
                      ........  .....++..|+|||++.+. .++.++|||||||++|+|++|..||.......... ........      
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (283)
T cd07835         148 AFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP  225 (283)
T ss_pred             ccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence            65332111  1223578899999987654 57889999999999999999999996543211100 00000000      


Q ss_pred             -cCCccchhhcc---CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 -LGDKRRFYRLL---DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 -~~~~~~~~~~~---~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       ......+...+   ............+..+.++|.+||+.||.+|||+.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             00000000000   0000001112235788999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2e-38  Score=315.15  Aligned_cols=269  Identities=25%  Similarity=0.336  Sum_probs=197.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||+|+||.||+|....         ++..||||.+......  ....+.+|+.+++.+.||||+++++++..
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   82 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKK---------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   82 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECC---------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence            469999999999999999998875         5779999988654322  23456789999999999999999999876


Q ss_pred             cCc--------eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          211 DDQ--------RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       211 ~~~--------~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      ...        .++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~  157 (310)
T cd07865          83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGI  157 (310)
T ss_pred             ccccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCc
Confidence            543        499999995 58888876543 36899999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCc--eeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011180          283 AKLSDFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  359 (491)
                      +||+|||++.........  .......++..|+|||.+.+. .++.++||||||+++|||++|..||...........+.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~  237 (310)
T cd07865         158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS  237 (310)
T ss_pred             EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999865432211  111234678899999988654 47889999999999999999999997654322222111


Q ss_pred             hhhcccCC-----cc--chhhcc-Ccc-----ccCC-CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          360 WARPHLGD-----KR--RFYRLL-DPR-----LEGH-FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       360 ~~~~~~~~-----~~--~~~~~~-~~~-----l~~~-~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ........     ..  .....+ .+.     .... .....+..+.+||.+||..||.+|||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            11100000     00  000000 000     0000 000124567899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3e-38  Score=310.10  Aligned_cols=267  Identities=24%  Similarity=0.353  Sum_probs=201.5

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +|++.+.||.|+||.||+|.+..         +|..||||.+...... ....+.+|+.+++.++|+||+++++++.+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   71 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN   71 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECC---------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence            58889999999999999999875         6779999999765432 3456778999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ..+|||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+||++++++.++|+|||++
T Consensus        72 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~  147 (284)
T cd07836          72 KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLA  147 (284)
T ss_pred             cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchh
Confidence            9999999997 58888886543 236899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh-hHhhhcc-----
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWARPH-----  364 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~-~~~~~~~-----  364 (491)
                      ........  ......++..|++||.+.+ ..++.++|||||||++|+|++|..||........... .......     
T Consensus       148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07836         148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW  225 (284)
T ss_pred             hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence            76543211  1123457899999998865 4578899999999999999999999975432211110 0000000     


Q ss_pred             --cCCccchhhccCc---cccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 --LGDKRRFYRLLDP---RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 --~~~~~~~~~~~~~---~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        +.....+......   .....+....+..+.+++.+||+.||.+||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              0000000000000   00001112236778999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.3e-38  Score=310.58  Aligned_cols=254  Identities=27%  Similarity=0.415  Sum_probs=206.6

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++.|.+...||.|+||.||+|.+..         ++..||+|++..... ..+.+.+|+++++.++|+||+++++++..
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   86 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV   86 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence            45678999999999999999999875         466899999976543 45678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          87 GDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccch
Confidence            999999999999999999997764 36889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +........  ......|+..|++||++.+..++.++|+|||||++|+|++|..||.........  ........     
T Consensus       163 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~~~~~~~-----  233 (286)
T cd06614         163 AAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FLITTKGI-----  233 (286)
T ss_pred             hhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcCC-----
Confidence            875543221  112345788999999998888999999999999999999999998643221111  10000000     


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                            +.+.  .....+..+.+||.+||+.+|.+||++.+++++
T Consensus       234 ------~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         234 ------PPLK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             ------CCCc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                  0000  011135789999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.4e-38  Score=313.32  Aligned_cols=265  Identities=17%  Similarity=0.217  Sum_probs=190.5

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccH-----------HHHHHHHHHHhcCCCC
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-----------KEWLAEVNFLGNLLHP  199 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~il~~l~Hp  199 (491)
                      ..++|.+.++||+|+||.||+|.+..+..      .+..+|+|+.........           .....++..+..+.|+
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~   83 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHC------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHL   83 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcc------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence            34679999999999999999999865321      144677776543321110           1123344556677899


Q ss_pred             ceeeeeeEEeecC----ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 011180          200 NLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  275 (491)
Q Consensus       200 nIv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NI  275 (491)
                      ||+++++++....    ..+++||++ ..++.+.+....  ..++..+..++.|++.||.|||+.+   |+||||||+||
T Consensus        84 ~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Ni  157 (294)
T PHA02882         84 GIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENI  157 (294)
T ss_pred             CCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence            9999999766543    346788887 456776665432  4577888999999999999999988   99999999999


Q ss_pred             EECCCCCeEEeccCCcccCCCCCCc-----eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 011180          276 LLDADYNAKLSDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  350 (491)
Q Consensus       276 Ll~~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~  350 (491)
                      |++.++.++|+|||+++........     .......||+.|+|||++.+..++.++|||||||+||||++|..||....
T Consensus       158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            9999999999999999866432211     11122469999999999999999999999999999999999999997653


Q ss_pred             CCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          351 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      .........  ...+     ...+....+   ....++..+.+++..||..+|.+||++.++++.|+
T Consensus       238 ~~~~~~~~~--~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        238 HNGNLIHAA--KCDF-----IKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             cchHHHHHh--HHHH-----HHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            222111000  0000     000000100   01123678999999999999999999999998763

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.8e-38  Score=309.78  Aligned_cols=260  Identities=25%  Similarity=0.344  Sum_probs=196.4

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCceeeeeeEEeec-
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYCIED-  211 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~-  211 (491)
                      |++.+.||+|+||.||+|....         ++..||+|.++.... .......+|+.++.++. |+||+++++++.+. 
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   71 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRK---------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK   71 (282)
T ss_pred             CceEeeccccccceEEEEEEcC---------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence            6778899999999999998875         567899999875422 22234567999999996 99999999999987 


Q ss_pred             -CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          212 -DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       212 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                       +..++||||+. ++|.+.+.... ..+++..++.++.||+.||.|||+.+   |+||||||+||+++. +.+||+|||+
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~  145 (282)
T cd07831          72 TGRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGS  145 (282)
T ss_pred             CCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccc
Confidence             88999999996 58888876543 36899999999999999999999988   999999999999999 9999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +........   .....++..|+|||.+.. ..++.++|||||||++|||++|..||......+.   +......++...
T Consensus       146 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~  219 (282)
T cd07831         146 CRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPD  219 (282)
T ss_pred             ccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCC
Confidence            987643221   123468899999997754 5678899999999999999999999976443221   111111110000


Q ss_pred             c-hhhc------c---CccccC----CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 R-FYRL------L---DPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~-~~~~------~---~~~l~~----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      . ....      .   .+....    ......+..+.+||.+||..||.+||++.+++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0 0000      0   000000    0011236889999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.5e-38  Score=314.91  Aligned_cols=248  Identities=29%  Similarity=0.436  Sum_probs=198.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ..|.+.+.||+|+||.||+|.+..         ++..||+|.+.....   ...+++.+|+.+++.++||||+++++++.
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~   85 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL   85 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcC---------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence            458899999999999999998865         567899999865432   22356889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..++||||+. |+|.+++..... .+++..+..++.||+.||.|||+.+   |+||||+|+||+++.++.++|+|||
T Consensus        86 ~~~~~~lv~e~~~-g~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          86 REHTAWLVMEYCL-GSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             eCCeEEEEHHhhC-CCHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecC
Confidence            9999999999995 678777755433 6899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      ++......      ....|+..|+|||++.   ...++.++||||||+++|||++|..||.............     ..
T Consensus       161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~-----~~  229 (307)
T cd06607         161 SASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----QN  229 (307)
T ss_pred             cceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh-----cC
Confidence            98765332      2346888999999874   4568899999999999999999999985432111100000     00


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      .        .+.+   .....+..+.+|+.+||..||.+||++.+|+.+.
T Consensus       230 ~--------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         230 D--------SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             C--------CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            0        0000   0112367899999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-38  Score=319.19  Aligned_cols=270  Identities=26%  Similarity=0.380  Sum_probs=202.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||+||+|.+..         ++..||||.+...  .......+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   74 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSE---------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP   74 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecC---------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence            3579999999999999999998865         6779999998653  2233456788999999999999999999876


Q ss_pred             ec-----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          210 ED-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       210 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      ..     ...||||||+. ++|.+++...+  .+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+|
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~k  148 (337)
T cd07858          75 PPHREAFNDVYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLK  148 (337)
T ss_pred             cccccccCcEEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEE
Confidence            54     34799999994 78988886553  6889999999999999999999988   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH-hhh
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WAR  362 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~-~~~  362 (491)
                      |+|||++.......  .......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||............. ...
T Consensus       149 L~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  226 (337)
T cd07858         149 ICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLG  226 (337)
T ss_pred             ECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence            99999998664332  11233568899999998865 468999999999999999999999996542211100000 000


Q ss_pred             c-------ccC--Cccchhhc----cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhcC
Q 011180          363 P-------HLG--DKRRFYRL----LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPL  419 (491)
Q Consensus       363 ~-------~~~--~~~~~~~~----~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--L~~l  419 (491)
                      .       ...  ....+...    .++.+. ......+..+.+||.+||+.||.+|||+.+++++  +..+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             CCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            0       000  00000000    000000 0112346788999999999999999999999988  4443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.7e-38  Score=303.69  Aligned_cols=251  Identities=25%  Similarity=0.395  Sum_probs=207.0

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|.+.+.||.|+||.||++.+..         ++..||+|++.....  ...+.+.+|+++++.++|+|++++++.+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   71 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS---------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK   71 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC---------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence            58889999999999999999865         567899999976543  3456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      ...++||||+++++|.+++....  ...+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~  148 (258)
T cd08215          72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFG  148 (258)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCcc
Confidence            99999999999999999987643  347899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++.......  .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......   .....   ...  
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~---~~~--  218 (258)
T cd08215         149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKI---LKG--  218 (258)
T ss_pred             ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHHH---hcC--
Confidence            998764432  12234578999999999988889999999999999999999999986543211   11110   000  


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          .     ....+...+..+.+++.+||..+|++|||+.+++++
T Consensus       219 ----~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         219 ----Q-----YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ----C-----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0     001112336789999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-38  Score=305.95  Aligned_cols=252  Identities=26%  Similarity=0.372  Sum_probs=200.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-----cccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      .+|.+.+.||+|+||.||+|.+..         ++..||+|.+....     ......+.+|+.+++.++|+||++++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   72 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC   72 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcC---------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence            479999999999999999998865         67799999875331     1233568889999999999999999999


Q ss_pred             Eeec--CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          208 CIED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       208 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      +.+.  ...++||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.++|
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l  147 (264)
T cd06653          73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKL  147 (264)
T ss_pred             EEcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence            8764  45789999999999999987654  4788889999999999999999988   999999999999999999999


Q ss_pred             eccCCcccCCCCCCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          286 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       286 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      +|||+++........ .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||........  ....    
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~----  221 (264)
T cd06653         148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IFKI----  221 (264)
T ss_pred             CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HHHH----
Confidence            999999865321111 111235689999999999888899999999999999999999999964321111  0000    


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                ........++...+..+.+++.+||. +|..||++.+++.+
T Consensus       222 ----------~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         222 ----------ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             ----------HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                      00001112233446889999999998 57999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2e-38  Score=315.84  Aligned_cols=267  Identities=28%  Similarity=0.345  Sum_probs=199.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||+|+||.||+|.+..         +|..||+|.+......  ....+.+|+.+++.++|+||+++++++..
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   77 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG   77 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec
Confidence            579999999999999999999875         6779999998754322  12346789999999999999999999876


Q ss_pred             c--CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          211 D--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       211 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .  +..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~df  152 (309)
T cd07845          78 KHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADF  152 (309)
T ss_pred             CCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcc
Confidence            5  46899999995 58888886543 36899999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-hcccC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLG  366 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~~~~~  366 (491)
                      |++.........  .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||...........+... .....
T Consensus       153 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  230 (309)
T cd07845         153 GLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE  230 (309)
T ss_pred             ceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            999876543211  122346788999998865 56889999999999999999999999754432221111100 00000


Q ss_pred             Ccc---------chhhccCccccC--CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKR---------RFYRLLDPRLEG--HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~---------~~~~~~~~~l~~--~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...         ..+.........  ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000         000000000000  0001126778999999999999999999999965

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=314.95  Aligned_cols=271  Identities=24%  Similarity=0.322  Sum_probs=199.8

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .|.+.+.||+|+||.||+|.+...       +++..||+|.+....   ....+.+.+|+.++..++||||+++++++.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE   73 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence            478889999999999999998652       146789999998633   2234667889999999999999999999998


Q ss_pred             c--CceEEEEEecCCCChHHHhhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC----CC
Q 011180          211 D--DQRLLVYEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA----DY  281 (491)
Q Consensus       211 ~--~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~----~~  281 (491)
                      .  ...++||||++ ++|.+++....   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.    ++
T Consensus        74 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~  149 (316)
T cd07842          74 HADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERG  149 (316)
T ss_pred             CCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccc
Confidence            8  78999999995 57777664322   236788999999999999999999988   999999999999999    89


Q ss_pred             CeEEeccCCcccCCCCCC-ceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch---
Q 011180          282 NAKLSDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN---  356 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~---  356 (491)
                      .+||+|||++........ ........++..|+|||.+.+. .++.++|||||||++|+|++|++||..........   
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~  229 (316)
T cd07842         150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF  229 (316)
T ss_pred             eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchh
Confidence            999999999987643322 1112335688999999988764 58899999999999999999999997654332000   


Q ss_pred             ---hhHhhhcccCC-----------ccchhhccCccccCCCC---------h--hhHHHHHHHHHHhhhcCCCCCCCHHH
Q 011180          357 ---LVEWARPHLGD-----------KRRFYRLLDPRLEGHFS---------I--KGSQKATQLAAQCLSRDPKARPRMSE  411 (491)
Q Consensus       357 ---~~~~~~~~~~~-----------~~~~~~~~~~~l~~~~~---------~--~~~~~l~~li~~cL~~dP~~RPt~~e  411 (491)
                         ........+..           ...+....+......++         .  ..+..+.+++.+||+.||.+|||+.+
T Consensus       230 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e  309 (316)
T cd07842         230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE  309 (316)
T ss_pred             HHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence               00000000000           00000000000000000         0  23567899999999999999999999


Q ss_pred             HHHH
Q 011180          412 VVET  415 (491)
Q Consensus       412 vl~~  415 (491)
                      ++++
T Consensus       310 il~~  313 (316)
T cd07842         310 ALEH  313 (316)
T ss_pred             HhcC
Confidence            9865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.1e-38  Score=317.39  Aligned_cols=263  Identities=23%  Similarity=0.288  Sum_probs=195.3

Q ss_pred             cccccC--CceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCce
Q 011180          139 SLLGEG--GFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G--~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      ..||+|  +||+||+|.+..         +|..||+|++.....  ...+.+.+|+.+++.++||||+++++++..++..
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~   74 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTP---------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL   74 (328)
T ss_pred             HHhCCcccCceeEEEEEEcC---------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence            456766  999999999876         677999999875432  2235678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      ++||||+.+++|.+++.......+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++++||+.+...
T Consensus        75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            99999999999999987765556889999999999999999999988   999999999999999999999999865433


Q ss_pred             CCCCCce-----eeeccccCCCCCCchhhhcC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc-cc-
Q 011180          295 PEDGKTH-----VSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-HL-  365 (491)
Q Consensus       295 ~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-~~-  365 (491)
                      .......     ......++..|+|||++.+.  .++.++|||||||++|+|++|..||........  ....... .. 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~  229 (328)
T cd08226         152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYS  229 (328)
T ss_pred             hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCC
Confidence            2211110     00112356679999998763  478999999999999999999999965432111  0000000 00 


Q ss_pred             -------CC-------cc-ch--------------hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          366 -------GD-------KR-RF--------------YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       366 -------~~-------~~-~~--------------~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                             ..       .. .+              .......+........+..+.+|+.+||..||.+|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                   00       00 00              00000111111223356789999999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-39  Score=322.46  Aligned_cols=265  Identities=24%  Similarity=0.335  Sum_probs=198.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||.+.... ......+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKP---------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP   74 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcC---------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence            4689999999999999999998875         67799999986432 2234567889999999999999999998765


Q ss_pred             cC-----ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          211 DD-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       211 ~~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      ..     ..++||||+. ++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl  147 (336)
T cd07849          75 PSFESFNDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKI  147 (336)
T ss_pred             ccccccceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEE
Confidence            43     4799999995 5888777543   6889999999999999999999988   999999999999999999999


Q ss_pred             eccCCcccCCCCCCc-eeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          286 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       286 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      +|||++......... .......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||........   ......
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~  224 (336)
T cd07849         148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILG  224 (336)
T ss_pred             CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHH
Confidence            999998765432211 11233578999999998754 5688999999999999999999999965432111   000000


Q ss_pred             ccCC--ccchhhccC-----------ccccCC---CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGD--KRRFYRLLD-----------PRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~--~~~~~~~~~-----------~~l~~~---~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+..  ...+..+.+           ......   .....+..+.+||.+||+.||.+|||+.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         225 VLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000  000000000           000000   001225678999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=8.4e-38  Score=306.80  Aligned_cols=243  Identities=28%  Similarity=0.409  Sum_probs=190.8

Q ss_pred             ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc---HHHHHHH---HHHHhcCCCCceeeeeeEEeecCc
Q 011180          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAE---VNFLGNLLHPNLVKLVGYCIEDDQ  213 (491)
Q Consensus       140 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E---~~il~~l~HpnIv~l~~~~~~~~~  213 (491)
                      +||+|+||.||+|.+..         +++.||+|.+.......   ...+..|   +.+++...||||+.+++++.+.+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   71 (278)
T ss_pred             CcccCCCeEEEEEEEec---------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence            48999999999998865         67799999987643221   1223334   344555679999999999999999


Q ss_pred             eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          214 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      .++||||+++++|.+++...+  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++..
T Consensus        72 ~~~v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          72 LSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            999999999999999886553  6899999999999999999999988   99999999999999999999999999876


Q ss_pred             CCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          294 APEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       294 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .....    .....|+..|+|||.+.++ .++.++|||||||++|+|++|..||...............   .       
T Consensus       147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~-------  212 (278)
T cd05606         147 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L-------  212 (278)
T ss_pred             cCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh---h-------
Confidence            53321    1235789999999998754 6899999999999999999999999765332211111000   0       


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                       ...    ..++...+..+.+++.+||..+|.+||     ++.+++++
T Consensus       213 -~~~----~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         213 -TMA----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             -ccC----CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence             001    112222367899999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=311.16  Aligned_cols=275  Identities=23%  Similarity=0.332  Sum_probs=212.5

Q ss_pred             hhhhhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-C-C
Q 011180          122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H-P  199 (491)
Q Consensus       122 ~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-H-p  199 (491)
                      .+.+......+.+|.+.+.||+|.||.|-+|++..         ++..||||+++.-. ...+..+-|+++|.++. + |
T Consensus        78 H~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP  147 (415)
T KOG0671|consen   78 HYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDP  147 (415)
T ss_pred             eEEEEeccccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCC
Confidence            35555566668899999999999999999999876         56799999996442 23455677999999994 2 2


Q ss_pred             ----ceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 011180          200 ----NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  275 (491)
Q Consensus       200 ----nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NI  275 (491)
                          -+|.+.+||...++.|||+|.+ |-++.++|..++-.+++...+..|+.|++++++|||+.+   ++|.||||+||
T Consensus       148 ~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENI  223 (415)
T KOG0671|consen  148 NGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENI  223 (415)
T ss_pred             CCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheE
Confidence                3888889999999999999999 779999999988889999999999999999999999998   99999999999


Q ss_pred             EECC--------------------CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHH
Q 011180          276 LLDA--------------------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVV  335 (491)
Q Consensus       276 Ll~~--------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvi  335 (491)
                      |+.+                    +..++|+|||.|+...+..     ..++.|..|.|||++.+-.++..+||||+|||
T Consensus       224 Lfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCI  298 (415)
T KOG0671|consen  224 LFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCI  298 (415)
T ss_pred             EEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeE
Confidence            9822                    2358999999999775543     34677899999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc-------cch--------------------hhccCcccc-CCCChhh
Q 011180          336 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK-------RRF--------------------YRLLDPRLE-GHFSIKG  387 (491)
Q Consensus       336 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~--------------------~~~~~~~l~-~~~~~~~  387 (491)
                      |+||++|...|......+...+.+.....++..       ..+                    .+...|--. -.-....
T Consensus       299 L~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e  378 (415)
T KOG0671|consen  299 LVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLE  378 (415)
T ss_pred             EEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHH
Confidence            999999999998766333222222211110000       000                    000000000 0011123


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          388 SQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       388 ~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...+.+|+++||..||.+|+|+.|+|.+
T Consensus       379 ~~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  379 HVQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HhHHHHHHHHHHccCccccccHHHHhcC
Confidence            5679999999999999999999999976

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=8.5e-38  Score=312.68  Aligned_cols=251  Identities=29%  Similarity=0.419  Sum_probs=199.9

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      |...+.||+|+||.||+|.+..         ++..||+|.+......   ....+.+|+++++.++|+||+++++++.++
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   97 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE   97 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            7788999999999999998865         5678999998754322   235688899999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+. |+|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||+|+||+++.++.++|+|||++
T Consensus        98 ~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~  172 (317)
T cd06635          98 HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA  172 (317)
T ss_pred             CeEEEEEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCc
Confidence            99999999996 58888776543 36899999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ......      ....|++.|+|||++.   .+.++.++|||||||++|||++|..||..........  .+...     
T Consensus       173 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~~~~-----  239 (317)
T cd06635         173 SIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQN-----  239 (317)
T ss_pred             cccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHHhc-----
Confidence            754321      2346889999999874   4578899999999999999999999986532111100  00000     


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                               ..........+..+.+|+.+||+.+|.+||++.++++++..+..
T Consensus       240 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         240 ---------ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             ---------cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence                     00000111235678999999999999999999999998765433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=355.92  Aligned_cols=254  Identities=29%  Similarity=0.394  Sum_probs=205.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      +-+|.....||.|.||.||-|.+.+         +|...|+|.++...  ....+.+.+|..+|..|+|||||++||+-.
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~---------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLD---------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCC---------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence            4478888999999999999998876         78899999886442  233467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..+|.||||++|+|.+++...+  .+++.....+..|++.||.|||++|   ||||||||+||||+.+|.+|++|||
T Consensus      1305 HRekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred             cHHHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccc
Confidence            9999999999999999999986543  4566666778899999999999999   9999999999999999999999999


Q ss_pred             CcccCCCCCCce--eeeccccCCCCCCchhhhcC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          290 LAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       290 la~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~---~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      .|..+.....+.  .-...+||+.|||||++.+.   ....+.||||||||+.||+||+.||.......    .......
T Consensus      1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~----aIMy~V~ 1455 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW----AIMYHVA 1455 (1509)
T ss_pred             ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh----HHHhHHh
Confidence            999876542111  11347899999999999754   45679999999999999999999996543211    1111111


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+.            ...+|...+.+..+||.+||..||.+|.++.|++++
T Consensus      1456 ~gh------------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 AGH------------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ccC------------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            111            112334458899999999999999999999999987

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.1e-38  Score=311.89  Aligned_cols=266  Identities=23%  Similarity=0.290  Sum_probs=197.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCC-CCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLL-HPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||.||+|.+..         ++..||||.+.....  .....+.+|+.+++.+. |+||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~   71 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN---------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH   71 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC---------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence            368999999999999999999875         577899999865432  22356888999999995 699999999988


Q ss_pred             ecCc-----eEEEEEecCCCChHHHhhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-C
Q 011180          210 EDDQ-----RLLVYEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-D  280 (491)
Q Consensus       210 ~~~~-----~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~-~  280 (491)
                      ..+.     .|+||||+++ +|.+++....   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++. +
T Consensus        72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~  147 (295)
T cd07837          72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQK  147 (295)
T ss_pred             ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCC
Confidence            7665     7999999975 8988876532   236899999999999999999999988   999999999999998 8


Q ss_pred             CCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011180          281 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       281 ~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  359 (491)
                      +.+||+|||++.........  .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.........  ..
T Consensus       148 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~  223 (295)
T cd07837         148 GLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LH  223 (295)
T ss_pred             CeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH
Confidence            89999999998765332111  122357889999998865 45789999999999999999999999654321111  00


Q ss_pred             hhhcc-cCCccchhh-----------ccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          360 WARPH-LGDKRRFYR-----------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       360 ~~~~~-~~~~~~~~~-----------~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..... ......+..           ...+..........+..+.+||.+||..||.+||++.+++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         224 IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             HHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000 000000000           000000000111236789999999999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.5e-38  Score=311.14  Aligned_cols=246  Identities=27%  Similarity=0.402  Sum_probs=198.8

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      ...||+|+||.||++....         ++..||||.+..........+.+|+.+++.++|+||+++++++...+..++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   95 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV   95 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcC---------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence            3679999999999998875         6779999998655444556788999999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      |||+++++|.+++...   .+++..+..++.|++.||+|||+.+   |+||||+|+||++++++.++|+|||++......
T Consensus        96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~  169 (292)
T cd06657          96 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  169 (292)
T ss_pred             EecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence            9999999999987533   5788999999999999999999988   999999999999999999999999998765432


Q ss_pred             CCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCc
Q 011180          298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  377 (491)
Q Consensus       298 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (491)
                      ..  ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||........   .......+          .+
T Consensus       170 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~~~----------~~  234 (292)
T cd06657         170 VP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNL----------PP  234 (292)
T ss_pred             cc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhhC----------Cc
Confidence            21  12235689999999999888899999999999999999999999864322111   11111111          01


Q ss_pred             cccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       378 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+..  ....+..+.+++.+||..||.+||++.+++++
T Consensus       235 ~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         235 KLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             ccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            1100  01235678999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.2e-38  Score=305.61  Aligned_cols=244  Identities=27%  Similarity=0.402  Sum_probs=196.5

Q ss_pred             cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       141 lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      ||.|+||.||+|.+..         +|..||+|++.....   ...+.+.+|+++++.+.||||+++++.+...+..|+|
T Consensus         1 lg~g~~~~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   71 (265)
T cd05579           1 ISKGAYGRVFLAKKKS---------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV   71 (265)
T ss_pred             CCCCCceEEEEEEECC---------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence            6899999999999865         577999999976543   3345688899999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      |||+++++|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||+|+|||++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          72 MEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            99999999999997654  6889999999999999999999988   999999999999999999999999998765432


Q ss_pred             CC------ceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          298 GK------THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       298 ~~------~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ..      ........++..|+|||.+....++.++||||||+++|+|++|..||........   ....   .....  
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~---~~~~~--  218 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQNI---LNGKI--  218 (265)
T ss_pred             cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH---hcCCc--
Confidence            11      1122335688999999999888899999999999999999999999965432111   1110   00000  


Q ss_pred             hhccCccccCCCChh--hHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          372 YRLLDPRLEGHFSIK--GSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~--~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                                .++..  .+..+.+|+.+||+.+|.+|||+..+.+.|
T Consensus       219 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         219 ----------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ----------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                      01111  267889999999999999999995544444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.6e-37  Score=303.13  Aligned_cols=245  Identities=22%  Similarity=0.266  Sum_probs=192.2

Q ss_pred             hcCCCcCccc--ccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          132 TRNFRPESLL--GEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~l--G~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      .++|.+.+.+  |.|+||.||++....         ++..+|+|.+........     |+.+...+ +|+||+++++++
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKP---------TQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcC---------CCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE
Confidence            3467777766  999999999998876         577899999875432211     22222222 699999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-CeEEec
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSD  287 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kL~D  287 (491)
                      ...+..|+||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++ .++|+|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence            99999999999999999999997654  7899999999999999999999988   99999999999999988 999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ||++......      ....|+..|+|||++.+..++.++|||||||++|+|++|..||....... .....+.... ..
T Consensus       154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~  225 (267)
T PHA03390        154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QK  225 (267)
T ss_pred             CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-cc
Confidence            9998765432      12458999999999998899999999999999999999999997432221 1111111110 00


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-~~evl~~  415 (491)
                      .            .......+..+.+||.+||+.||.+||+ +++++++
T Consensus       226 ~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        226 K------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             c------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            0            0111134788999999999999999996 6998864

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=300.11  Aligned_cols=249  Identities=32%  Similarity=0.525  Sum_probs=205.2

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|.+.+.||+|+||.||++.+..         ++..||+|.+.....  .....+.+|++++.++.|+||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS   71 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC---------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence            47889999999999999998865         567899999977654  3456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~  146 (254)
T cd06627          72 DSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVA  146 (254)
T ss_pred             CEEEEEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccc
Confidence            99999999999999999987653  6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      .........  .....|+..|+|||.+.+..++.++||||||+++|+|++|..||........  .  +.. ...     
T Consensus       147 ~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~--~~~-~~~-----  214 (254)
T cd06627         147 TKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--L--FRI-VQD-----  214 (254)
T ss_pred             eecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--H--HHH-hcc-----
Confidence            876543321  2335689999999999888889999999999999999999999864331100  0  000 000     


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                             ....++...+..+.+++.+||..+|++|||+.+++.+
T Consensus       215 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         215 -------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                   0011122336789999999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.3e-38  Score=319.17  Aligned_cols=265  Identities=25%  Similarity=0.381  Sum_probs=201.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||.|+||.||+|....         +|..||+|++....  ....+.+.+|+.+|+.++||||+++++++..
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   75 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTR---------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRP   75 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccc
Confidence            579999999999999999998876         67799999987542  2334667889999999999999999998763


Q ss_pred             ----cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          211 ----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       211 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                          ....++||||+ +++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        76 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~  149 (334)
T cd07855          76 PGADFKDVYVVMDLM-ESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIG  149 (334)
T ss_pred             cCCCCceEEEEEehh-hhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEec
Confidence                34679999999 468988886543  5899999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCc--eeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          287 DFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       287 DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      |||++.........  .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.   .
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~---~  226 (334)
T cd07855         150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLIL---S  226 (334)
T ss_pred             ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHH---H
Confidence            99998765432211  11234578999999998865 468899999999999999999999996543321111100   0


Q ss_pred             ccCCc-------------cchhhccCcccc---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDK-------------RRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~-------------~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..+..             ............   .......+..+.++|.+||+.||.+||++.+++.+
T Consensus       227 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00000             000000000000   00112236789999999999999999999999986

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=355.78  Aligned_cols=262  Identities=31%  Similarity=0.532  Sum_probs=207.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ..|...++||+|+||.||+|++..         ++..||||.+......    ...|++++++++|||||++++++.+.+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~  756 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIK---------NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK  756 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECC---------CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence            457788899999999999999865         5678999998644321    235688999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..|+||||+++|+|.+++.     .++|..+..++.||+.||+|||....++|+||||||+|||++.++..++. ||...
T Consensus       757 ~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        757 GAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             CCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence            9999999999999999984     37899999999999999999996644569999999999999999888876 66554


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .....      ....||+.|||||++.+..++.++|||||||++|||++|+.||+.... ......+|.+..... ....
T Consensus       831 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~  902 (968)
T PLN00113        831 LLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLD  902 (968)
T ss_pred             ccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchh
Confidence            33211      223689999999999999999999999999999999999999954322 223445555433222 1223


Q ss_pred             hccCccccCC--CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          373 RLLDPRLEGH--FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       373 ~~~~~~l~~~--~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ..+++.+...  .......++.+++.+||+.||.+||||.+|++.|+.+..
T Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            3445554332  334456678899999999999999999999999987644

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.4e-38  Score=302.41  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=203.7

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|++.+.||+|+||.||++.+..         ++..+|+|.+.....  .....+.+|+.+++.++|+||+++++++.+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLS---------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG   71 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECC---------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence            48889999999999999998765         567899999875432  2345678899999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      ...++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g  148 (256)
T cd08530          72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLG  148 (256)
T ss_pred             CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeecc
Confidence            9999999999999999988652  1236889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++......    ......|+..|++||.+.+..++.++|+||||+++|+|++|+.||......   .+......      
T Consensus       149 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~------  215 (256)
T cd08530         149 ISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKVQR------  215 (256)
T ss_pred             chhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhc------
Confidence            99876543    122346889999999999889999999999999999999999999654321   11110000      


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                              ......+...+.++.+++.+||..+|.+||++.+++++
T Consensus       216 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         216 --------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             --------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                    00011122346789999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=326.41  Aligned_cols=201  Identities=34%  Similarity=0.509  Sum_probs=174.3

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEeecC-
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD-  212 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-  212 (491)
                      |...+.||+|+||.||+|+++.         +|+.||||.++... ....+.+.+|+++|++|+|+|||+++++-.+.. 
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnke---------tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~   85 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKE---------TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL   85 (732)
T ss_pred             eeehhhhcCCccceeeeecccc---------cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence            5667889999999999999887         89999999998753 344577899999999999999999998755433 


Q ss_pred             -----ceEEEEEecCCCChHHHhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE--CCCC--C
Q 011180          213 -----QRLLVYEFMPRGSLENHLFRK-GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--DADY--N  282 (491)
Q Consensus       213 -----~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl--~~~~--~  282 (491)
                           ...+|||||.+|+|...|.+. +...+++.+.+.++..++.||.|||+++   ||||||||.||++  .++|  .
T Consensus        86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~I  162 (732)
T KOG4250|consen   86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSI  162 (732)
T ss_pred             CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceE
Confidence                 457999999999999999653 3457999999999999999999999998   9999999999998  3334  4


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhh-cCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  350 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltG~~pf~~~~  350 (491)
                      .||+|||.|+.+.++.   ..+.++||..|.+||.+. .+.|+..+|.|||||++|+.+||..||....
T Consensus       163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            7999999999886643   456789999999999998 4899999999999999999999999996543

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.9e-38  Score=317.78  Aligned_cols=267  Identities=29%  Similarity=0.365  Sum_probs=199.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC--CcccHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||.+...  .......+.+|+.++..+ +||||+++++++
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~   76 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRR---------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVI   76 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcC---------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeee
Confidence            4578999999999999999998865         5678999988543  223345677899999999 999999999998


Q ss_pred             eec--CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          209 IED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       209 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      ...  ...++||||++ ++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~  149 (337)
T cd07852          77 KAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLA  149 (337)
T ss_pred             ccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEe
Confidence            654  35799999996 5998888654   6788888999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCc---eeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          287 DFGLAKDAPEDGKT---HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       287 DFGla~~~~~~~~~---~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      |||++.........   .......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||................
T Consensus       150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~  229 (337)
T cd07852         150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI  229 (337)
T ss_pred             eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99999866443221   12234578999999998764 567889999999999999999999996543221111100000


Q ss_pred             cccC----------CccchhhccC----ccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 PHLG----------DKRRFYRLLD----PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~~~~----------~~~~~~~~~~----~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ....          ....+.....    ..+. ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCCCHHHHHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0000          0000000000    0000 0111246789999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.8e-38  Score=308.08  Aligned_cols=251  Identities=27%  Similarity=0.388  Sum_probs=205.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCC-CCceeeeeeEE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL-HPNLVKLVGYC  208 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-HpnIv~l~~~~  208 (491)
                      ++|.+.+.||.|+||.||+|....         ++..||+|++.....   ...+.+.+|+.++.++. |+||+++++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~   71 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF   71 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence            368999999999999999999875         577899999876422   22356788999999999 99999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      ...+..++||||+++++|.+++...+  .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df  146 (280)
T cd05581          72 QDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDF  146 (280)
T ss_pred             cCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCC
Confidence            99999999999999999999997664  6899999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCc------------------eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 011180          289 GLAKDAPEDGKT------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  350 (491)
Q Consensus       289 Gla~~~~~~~~~------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~  350 (491)
                      |++.........                  .......|+..|+|||.+....++.++||||||+++|+|++|..||....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            998866433211                  11223568899999999988889999999999999999999999997553


Q ss_pred             CCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH----HHHHHH
Q 011180          351 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM----SEVVET  415 (491)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~----~evl~~  415 (491)
                      ....   .....               .....++...+..+.+||.+||..||.+||++    .+++++
T Consensus       227 ~~~~---~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         227 EYLT---FQKIL---------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHH---HHHHH---------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            1111   00000               00111222336788999999999999999999    888765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-38  Score=307.15  Aligned_cols=266  Identities=25%  Similarity=0.342  Sum_probs=200.9

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEeec-
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  211 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-  211 (491)
                      |.+.+.||.|+||.||+|.+..         ++..||+|.+....  ......+.+|+.+++.+.|+||+++++++.+. 
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG   71 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence            6678899999999999998875         56789999998653  22345688999999999999999999999988 


Q ss_pred             -CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          212 -DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       212 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                       +..++||||++ ++|.+++.... ..+++..++.++.||+.||+|||+.+   ++|+||+|+|||+++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~  146 (287)
T cd07840          72 KGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGL  146 (287)
T ss_pred             CCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccc
Confidence             88999999996 58988886653 36889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hhcc-cCC
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-ARPH-LGD  367 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-~~~~-~~~  367 (491)
                      +......... ......++..|+|||.+.+ ..++.++||||||+++|||++|..||...........+.. .... ...
T Consensus       147 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd07840         147 ARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN  225 (287)
T ss_pred             eeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Confidence            9876543211 1223457889999997764 4678999999999999999999999976543211111100 0000 000


Q ss_pred             ccc-----hhhcc------CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRR-----FYRLL------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~-----~~~~~------~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...     .....      ...+...+...++..+.+++.+||..+|.+||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000     00000      0000111111136788999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=302.27  Aligned_cols=243  Identities=26%  Similarity=0.344  Sum_probs=189.2

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc---HHHHHHHHHHH-hcCCCCceeeeeeEEeecCce
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFL-GNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il-~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      +.||.|+||.||+|.+..         ++..||||++.......   ...+..|..++ ..+.|+||+++++++...+..
T Consensus         2 ~~l~~g~~~~v~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   72 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS---------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL   72 (260)
T ss_pred             ccCCcCCCeeEEEEEecC---------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence            569999999999998865         56789999997643222   22344555444 455899999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      ++||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||+|+|||++.++.++|+|||++...
T Consensus        73 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          73 YLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceec
Confidence            99999999999999987654  5788899999999999999999988   999999999999999999999999998764


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      ..      .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.......   .....   .....     
T Consensus       148 ~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~---~~~~~-----  210 (260)
T cd05611         148 LE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFDNI---LSRRI-----  210 (260)
T ss_pred             cc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---Hhccc-----
Confidence            33      123568899999999988889999999999999999999999996543211   11100   00000     


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         ..........+..+.++|.+||+.||++||++.++.+.
T Consensus       211 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         211 ---NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             ---CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence               00001111236789999999999999999977544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.3e-37  Score=308.34  Aligned_cols=270  Identities=26%  Similarity=0.338  Sum_probs=200.6

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      ...++|.+.+.||+|+||.||+|.+..         +|..||||.++....  .....+.+|+.+++.++||||++++++
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~   74 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI   74 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehe
Confidence            445689999999999999999999875         567899999975432  223567789999999999999999999


Q ss_pred             EeecC----------ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 011180          208 CIEDD----------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       208 ~~~~~----------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl  277 (491)
                      +.+..          ..++||||+++ +|.+.+... ...+++..+..++.||+.||+|||+.+   |+||||||+||++
T Consensus        75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili  149 (302)
T cd07864          75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILL  149 (302)
T ss_pred             ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            87655          78999999965 777777654 336899999999999999999999988   9999999999999


Q ss_pred             CCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011180          278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  356 (491)
Q Consensus       278 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~  356 (491)
                      ++++.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||..........
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~  228 (302)
T cd07864         150 NNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE  228 (302)
T ss_pred             CCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            99999999999999876443221 1122356788999998865 357889999999999999999999997543221111


Q ss_pred             hhHhh-hcccCCc-cc-----hhhccCc------cccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          357 LVEWA-RPHLGDK-RR-----FYRLLDP------RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       357 ~~~~~-~~~~~~~-~~-----~~~~~~~------~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+... ....... ..     .+...+.      .....+ ...+..+.+|+.+||..||.+||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHHHHhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11100 0000000 00     0000000      000001 1236789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.9e-37  Score=305.79  Aligned_cols=256  Identities=28%  Similarity=0.376  Sum_probs=199.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc----ccHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      +|++.+.||.|+||.||+|......      .+|..||+|++.....    ...+.+.+|++++..+ +|+||+++++++
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~------~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGH------DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   74 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCC------CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence            4788999999999999999875321      2577899999875422    2235678899999999 599999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      ..+...++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   ++||||+|+|||++.++.+||+||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          75 QTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             ecCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeC
Confidence            99999999999999999999997654  5788888999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |++......... ......|+..|+|||.+...  .++.++||||||+++|+|++|..||........  ..........
T Consensus       150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~  226 (290)
T cd05613         150 GLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILK  226 (290)
T ss_pred             ccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhc
Confidence            999865432211 12235689999999998753  467899999999999999999999964322111  1111111110


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                      .            ...++...+..+.+|+.+||..||.+||     ++.+++.+
T Consensus       227 ~------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         227 S------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             c------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            0            0112223467889999999999999997     67777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-38  Score=306.09  Aligned_cols=261  Identities=27%  Similarity=0.376  Sum_probs=202.3

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      |.+.+.||.|++|.||+|.+..         ++..+|+|.+......  ....+.+|+.+++.++|+||+++++++.+.+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG   71 (283)
T ss_pred             CccceeeecCCCceEEEEEcCC---------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence            5677899999999999998865         5778999998765432  3457888999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||++ ++|.+++.... ..+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.++|+|||.+.
T Consensus        72 ~~~~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~  146 (283)
T cd05118          72 DLYLVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLAR  146 (283)
T ss_pred             CEEEEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence            9999999996 48888886653 47899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc--c
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--R  369 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~  369 (491)
                      .......  ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+   ...+...  .
T Consensus       147 ~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~  221 (283)
T cd05118         147 SFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI---FRTLGTPDPE  221 (283)
T ss_pred             ecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCchH
Confidence            7654331  12234578899999998876 7899999999999999999999999654432111110   0000000  0


Q ss_pred             ---c-----------hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 ---R-----------FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ---~-----------~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         .           +........ .......+..+.+||.+||..||.+||++.+++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         222 VWPKFTSLARNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hcccchhhhhhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence               0           000000000 01112346789999999999999999999999865

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=302.95  Aligned_cols=263  Identities=25%  Similarity=0.336  Sum_probs=197.9

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcC---CCCceeeeeeEEe
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNL---LHPNLVKLVGYCI  209 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~HpnIv~l~~~~~  209 (491)
                      |++.+.||.|+||.||+|.+..         ++..||+|.+......  ....+.+|+.++..+   .|+||+++++++.
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   71 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH   71 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence            6778899999999999999875         5678999999754322  124566788777666   5999999999999


Q ss_pred             ecCc-----eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          210 EDDQ-----RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       210 ~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      ..+.     .+++|||+. ++|.+++.......+++..++.++.||+.||.|||+.+   |+|+||+|+|||++.++.++
T Consensus        72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~  147 (287)
T cd07838          72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVK  147 (287)
T ss_pred             eccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEE
Confidence            8776     899999996 58999887654446899999999999999999999988   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      |+|||++........   .....++..|+|||++.+..++.++|||||||++|+|++|.+||.........  ..+....
T Consensus       148 l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~  222 (287)
T cd07838         148 IADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVI  222 (287)
T ss_pred             EeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHc
Confidence            999999977643321   12345788999999999889999999999999999999999998754322111  1110000


Q ss_pred             c-CCc----------cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 L-GDK----------RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ~-~~~----------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      . ...          ...+...............+..+.+||.+||+.||.+||++.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            0 000          00000000000011112335778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.1e-37  Score=309.02  Aligned_cols=263  Identities=25%  Similarity=0.308  Sum_probs=193.0

Q ss_pred             cCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEeecCce
Q 011180          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       137 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      +.+.+|.|+++.||+  ...         ++..||||++....  ....+.+.+|+.+++.++|+||+++++++.+.+..
T Consensus         6 i~~~~~~~~~v~~~~--~~~---------~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (314)
T cd08216           6 IGKCFEDLMIVHLAK--HKP---------TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSEL   74 (314)
T ss_pred             hhHhhcCCceEEEEE--ecC---------CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeE
Confidence            444455555544444  443         57799999997652  23446788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      +++|||+++++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||.+...
T Consensus        75 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~  151 (314)
T cd08216          75 YVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSM  151 (314)
T ss_pred             EEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceee
Confidence            99999999999999997654456889999999999999999999988   999999999999999999999999988755


Q ss_pred             CCCCCc-----eeeeccccCCCCCCchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC-
Q 011180          295 PEDGKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-  366 (491)
Q Consensus       295 ~~~~~~-----~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~-  366 (491)
                      ......     .......++..|+|||++..  ..++.++|||||||++|||++|..||.......  ...+....... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~  229 (314)
T cd08216         152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPC  229 (314)
T ss_pred             ccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCcc
Confidence            332211     11123457889999999875  358899999999999999999999997543211  11111000000 


Q ss_pred             --Cccch-------h----hccCcc----ccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 --DKRRF-------Y----RLLDPR----LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 --~~~~~-------~----~~~~~~----l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        .....       .    ...++.    .........+..+.+|+.+||..||++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence              00000       0    000000    0111222336788999999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.7e-38  Score=310.67  Aligned_cols=269  Identities=28%  Similarity=0.359  Sum_probs=197.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||.|+||.||+|.+..         ++..||||.+......  ....+.+|+++++.++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIK---------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV   77 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence            4689999999999999999999875         5678999988654322  2345678999999999999999999876


Q ss_pred             ecC--------ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 011180          210 EDD--------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       210 ~~~--------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~  281 (491)
                      +..        ..++||||+. ++|...+... ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++
T Consensus        78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~  152 (311)
T cd07866          78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQG  152 (311)
T ss_pred             cccccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence            543        4699999995 5777777554 336899999999999999999999988   99999999999999999


Q ss_pred             CeEEeccCCcccCCCCCCc---------eeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 011180          282 NAKLSDFGLAKDAPEDGKT---------HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  351 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~---------~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~  351 (491)
                      .++|+|||+++........         ...+...|++.|+|||.+.+. .++.++|||||||++|||++|.+||.....
T Consensus       153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~  232 (311)
T cd07866         153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD  232 (311)
T ss_pred             CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999865432211         111234678899999988654 588999999999999999999999975443


Q ss_pred             CCcchhhHhhhcc-----cCCccch--------hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          352 NGEHNLVEWARPH-----LGDKRRF--------YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       352 ~~~~~~~~~~~~~-----~~~~~~~--------~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ......+......     +......        .....+.+...+ ......+.+||.+||..||.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         233 IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            2211111100000     0000000        000011111000 1123678899999999999999999999865

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.4e-37  Score=313.46  Aligned_cols=267  Identities=26%  Similarity=0.309  Sum_probs=197.8

Q ss_pred             cCCC-cCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc--------------HHHHHHHHHHHhcCC
Q 011180          133 RNFR-PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--------------HKEWLAEVNFLGNLL  197 (491)
Q Consensus       133 ~~y~-~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~il~~l~  197 (491)
                      ++|. +.+.||.|+||+||+|.+..         ++..||||++.......              ...+.+|+.+++.++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   78 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTL---------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK   78 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECC---------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC
Confidence            3454 45789999999999998765         57789999986543221              125778999999999


Q ss_pred             CCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 011180          198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       198 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl  277 (491)
                      |+||+++++++...+..++||||+. ++|.+++....  .+++.....++.|++.||.|||+.+   |+||||+|+|||+
T Consensus        79 h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill  152 (335)
T PTZ00024         79 HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFI  152 (335)
T ss_pred             CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEE
Confidence            9999999999999999999999995 68999886543  5888999999999999999999988   9999999999999


Q ss_pred             CCCCCeEEeccCCcccCCCCCC------------ceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCC
Q 011180          278 DADYNAKLSDFGLAKDAPEDGK------------THVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRR  344 (491)
Q Consensus       278 ~~~~~~kL~DFGla~~~~~~~~------------~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~  344 (491)
                      +.++.++|+|||++........            ........++..|+|||.+.+. .++.++|||||||++|+|++|.+
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~  232 (335)
T PTZ00024        153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP  232 (335)
T ss_pred             CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            9999999999999976541110            0111223568899999998764 47899999999999999999999


Q ss_pred             CCCCCCCCCcchhh-Hhhhcc----cCCc------cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011180          345 SMDKNRPNGEHNLV-EWARPH----LGDK------RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  413 (491)
Q Consensus       345 pf~~~~~~~~~~~~-~~~~~~----~~~~------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl  413 (491)
                      ||...........+ ......    +...      ..+.....+.+.. .....+..+.++|.+||..+|++||++++++
T Consensus       233 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l  311 (335)
T PTZ00024        233 LFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEAL  311 (335)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence            99755432111100 000000    0000      0000000000000 0112367789999999999999999999999


Q ss_pred             HH
Q 011180          414 ET  415 (491)
Q Consensus       414 ~~  415 (491)
                      .+
T Consensus       312 ~~  313 (335)
T PTZ00024        312 KH  313 (335)
T ss_pred             cC
Confidence            75

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.1e-37  Score=307.23  Aligned_cols=245  Identities=30%  Similarity=0.455  Sum_probs=195.5

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      |...+.||+|+||.||+|.+..         ++..||+|.+......   ....+.+|+.+++.++||||+++++++.+.
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   93 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSH---------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE   93 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            6667889999999999998765         5778999998754322   235678899999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ...|+||||+. ++|.+++.... ..+++..++.++.||+.+|.|||+.+   |+||||+|+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~  168 (313)
T cd06633          94 HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA  168 (313)
T ss_pred             CEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCC
Confidence            99999999995 67888776543 36889999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      .....      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||..............     .. 
T Consensus       169 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-----~~-  236 (313)
T cd06633         169 SKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-----ND-  236 (313)
T ss_pred             cccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----cC-
Confidence            64322      12356899999999884   45688899999999999999999999865432211111000     00 


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                             .+..   .....+..+.+|+.+||+.+|.+||++.+++.+
T Consensus       237 -------~~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         237 -------SPTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -------CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   0000   011124678999999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.7e-37  Score=307.76  Aligned_cols=250  Identities=28%  Similarity=0.407  Sum_probs=198.2

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .|...+.||+|+||.||+|.+..         ++..||+|.+.....   ....++.+|+++++.++|+||+++++++..
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   86 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcC---------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence            47778899999999999999875         567899999864322   223567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ....++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||+
T Consensus        87 ~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  161 (308)
T cd06634          87 EHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS  161 (308)
T ss_pred             CCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCccc
Confidence            999999999995 68888775543 35888999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      +......      ....|+..|+|||.+.   ...++.++|||||||++|+|++|..||..........  .+....   
T Consensus       162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~~---  230 (308)
T cd06634         162 ASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQNE---  230 (308)
T ss_pred             ceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHhhcC---
Confidence            8765322      2346889999999875   3567889999999999999999999985432211100  000000   


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                              .+..   .....+..+.+||.+||..+|.+||++.+++++...+
T Consensus       231 --------~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~  271 (308)
T cd06634         231 --------SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (308)
T ss_pred             --------CCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence                    0000   0112367789999999999999999999999885543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.5e-37  Score=304.58  Aligned_cols=259  Identities=28%  Similarity=0.371  Sum_probs=201.4

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc----ccHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      +|.+.+.||+|+||.||++.......      ++..||||++.....    ...+.+..|+.++.++ +||||+++++++
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~   74 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHD------AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF   74 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecccc------CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence            47888999999999999998653221      567899999875322    2235678899999999 599999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      ......++||||+++++|.+++....  .+++..+..++.|++.+|.|||+.+   ++||||||+|||++.++.++|+||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          75 QTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEEC
Confidence            99999999999999999999987543  5788899999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |+++........ ......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||........  ..+.......
T Consensus       150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~  226 (288)
T cd05583         150 GLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILK  226 (288)
T ss_pred             cccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHc
Confidence            998865433221 122356899999999987654  78899999999999999999999964322111  1111111100


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                      .        .+    ..+...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       227 ~--------~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         227 S--------KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             c--------CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            0        01    1112235778999999999999999998877766653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.4e-38  Score=339.98  Aligned_cols=257  Identities=29%  Similarity=0.419  Sum_probs=193.4

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ....+|+..++||+||||.||+++++-         +|..||||.|.... ......+.+|+.+|++|+|||||+++..|
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKl---------DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAW  546 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKL---------DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAW  546 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecc---------cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhh
Confidence            344578999999999999999999987         57799999997653 22335688999999999999999998766


Q ss_pred             ee-------------------------------------------------------c----------------------
Q 011180          209 IE-------------------------------------------------------D----------------------  211 (491)
Q Consensus       209 ~~-------------------------------------------------------~----------------------  211 (491)
                      .+                                                       .                      
T Consensus       547 VEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ded  626 (1351)
T KOG1035|consen  547 VESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDED  626 (1351)
T ss_pred             hccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccc
Confidence            53                                                       0                      


Q ss_pred             ------------------------------------------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHH
Q 011180          212 ------------------------------------------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG  249 (491)
Q Consensus       212 ------------------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~q  249 (491)
                                                                ..+||-||||+...|.+++..+.. .-.....++++++
T Consensus       627 g~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-~~~~d~~wrLFre  705 (1351)
T KOG1035|consen  627 GRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-NSQRDEAWRLFRE  705 (1351)
T ss_pred             ccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-chhhHHHHHHHHH
Confidence                                                      113789999988777777765532 1145677899999


Q ss_pred             HHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCC----------------CCCceeeeccccCCCCC
Q 011180          250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE----------------DGKTHVSTRVMGTYGYA  313 (491)
Q Consensus       250 i~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~----------------~~~~~~~~~~~Gt~~y~  313 (491)
                      |++||.|+|+.|   ||||||||.||+|++++.|||+|||+|.....                .......+..+||..|+
T Consensus       706 IlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYv  782 (1351)
T KOG1035|consen  706 ILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYV  782 (1351)
T ss_pred             HHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeee
Confidence            999999999999   99999999999999999999999999987210                11111345679999999


Q ss_pred             CchhhhcC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHH
Q 011180          314 APEYVMTG---HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQK  390 (491)
Q Consensus       314 aPE~~~~~---~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  390 (491)
                      |||++.+.   .|+.|+|+|||||||+||+.   ||....  +....+...+..     .+.   .+   ..|.......
T Consensus       783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~LR~g-----~iP---~~---~~f~~~~~~~  846 (1351)
T KOG1035|consen  783 APELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTNLRKG-----SIP---EP---ADFFDPEHPE  846 (1351)
T ss_pred             cHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHhcccC-----CCC---CC---cccccccchH
Confidence            99998764   49999999999999999996   464332  111111111100     000   00   1122223456


Q ss_pred             HHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          391 ATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       391 l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      -..+|.+||++||.+|||+.|+|+.
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhhc
Confidence            6789999999999999999999864

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=302.64  Aligned_cols=264  Identities=28%  Similarity=0.398  Sum_probs=199.7

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCceeeeeeEEeecC
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDD  212 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~  212 (491)
                      |.+.+.||.|+||.||+|....         ++..||||.+..... .......+|+..+.++. |+||+++++++.+++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   71 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND   71 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence            6778899999999999999865         567899999865432 12234567999999999 999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+ +++|.+++.......+++..+..++.|++.+|.|||+++   |+|+||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~  147 (283)
T cd07830          72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR  147 (283)
T ss_pred             cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccce
Confidence            999999999 889999887765457899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhh-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH-hhhccc----C
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARPHL----G  366 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~-~~~~~~----~  366 (491)
                      .......   .....|+..|+|||++. ...++.++|+||||+++|||++|++||............. ......    .
T Consensus       148 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (283)
T cd07830         148 EIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP  224 (283)
T ss_pred             eccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence            6643221   12356889999999875 4567899999999999999999999996553322111000 000000    0


Q ss_pred             Ccc--------chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKR--------RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~--------~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      +..        .+.......+. .+....+..+.+||.+||+.||.+|||+.|++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         225 EGYKLASKLGFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hHhhhhccccccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000        00000000000 0011125779999999999999999999999865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-37  Score=311.61  Aligned_cols=267  Identities=26%  Similarity=0.355  Sum_probs=203.0

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|.+.+.||.|+||.||+|.+..         ++..||||.+....  ....+.+.+|+.+++.++|+||+++++++...
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR---------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP   71 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC---------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence            58899999999999999999865         57789999987643  23446788999999999999999999998877


Q ss_pred             C-----ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          212 D-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       212 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      .     ..|+||||+. ++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~  145 (330)
T cd07834          72 SPEDFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKIC  145 (330)
T ss_pred             CcccccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEc
Confidence            5     7899999996 58988886554  7899999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCc-eeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc-
Q 011180          287 DFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-  363 (491)
Q Consensus       287 DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-  363 (491)
                      |||++......... .......++..|+|||++.+. .++.++|+||||+++|+|++|.+||...........+..... 
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  225 (330)
T cd07834         146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT  225 (330)
T ss_pred             ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCC
Confidence            99999876543210 112335688999999999877 889999999999999999999999976543211111000000 


Q ss_pred             ---------ccCCccchhhccCccc---cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 ---------HLGDKRRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ---------~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                               .......+........   ........+..+.+||.+||+.+|.+||++.+++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                     0000000000000000   000111236788999999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.4e-37  Score=314.55  Aligned_cols=267  Identities=23%  Similarity=0.307  Sum_probs=197.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec-
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-  211 (491)
                      .+|.+.+.||.|+||.||+|....         +|..||+|.+........+.+.+|+++++.++||||+++++++... 
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~---------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~   75 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSD---------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSG   75 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECC---------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence            579999999999999999998876         6779999999776655667788999999999999999999876654 


Q ss_pred             -------------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC
Q 011180          212 -------------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  278 (491)
Q Consensus       212 -------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~  278 (491)
                                   ...++||||+. ++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus        76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~  148 (342)
T cd07854          76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFIN  148 (342)
T ss_pred             cccccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEc
Confidence                         35789999996 6898877532   5888999999999999999999988   99999999999997


Q ss_pred             -CCCCeEEeccCCcccCCCCCCc-eeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011180          279 -ADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  355 (491)
Q Consensus       279 -~~~~~kL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~  355 (491)
                       .++.++|+|||++......... .......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||.........
T Consensus       149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~  228 (342)
T cd07854         149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM  228 (342)
T ss_pred             CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence             4567899999999765322111 11122467889999998754 56888999999999999999999999755432221


Q ss_pred             hhhHhhhcccCC--ccchhhccCc-----cccC-----CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          356 NLVEWARPHLGD--KRRFYRLLDP-----RLEG-----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       356 ~~~~~~~~~~~~--~~~~~~~~~~-----~l~~-----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .......+....  ...+......     ....     .+....+.++.+||.+||..||.+|||+.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            111100000000  0000000000     0000     0011235778999999999999999999999965

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.1e-37  Score=306.56  Aligned_cols=255  Identities=30%  Similarity=0.460  Sum_probs=197.8

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||.|+||.||+|.+..         ++..||||.+..... ....++..|+.++..+. |+||+++++++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~   83 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYF   83 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECC---------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheee
Confidence            34578999999999999999999875         577899999975432 23456777887777775 99999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      .+....++||||+ +++|.+++..... .+++..+..++.||+.||.|||+ .+   |+||||+|+|||+++++.+||+|
T Consensus        84 ~~~~~~~~v~e~~-~~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~d  158 (296)
T cd06618          84 ITDSDVFICMELM-STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCD  158 (296)
T ss_pred             ecCCeEEEEeecc-CcCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECc
Confidence            9999999999998 5578777765433 78999999999999999999997 46   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      ||++........   .....|+..|+|||.+.+..    ++.++||||||+++|+|++|+.||......  ......   
T Consensus       159 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~---  230 (296)
T cd06618         159 FGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTK---  230 (296)
T ss_pred             cccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHH---
Confidence            999876543221   12345788999999987553    788999999999999999999999643211  111110   


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      .+....       +..  ......+..+.+|+.+||..||.+||++.+++++.
T Consensus       231 ~~~~~~-------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         231 ILQEEP-------PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             HhcCCC-------CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            010000       000  00112367899999999999999999999999774

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-37  Score=312.41  Aligned_cols=272  Identities=24%  Similarity=0.350  Sum_probs=202.9

Q ss_pred             hhhhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCc
Q 011180          123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPN  200 (491)
Q Consensus       123 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~Hpn  200 (491)
                      ....++....++|.+.+.||+|+||.||+|.+..         ++..||+|++....  ....+.+.+|+.++.+++|||
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~   77 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN   77 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcC---------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCc
Confidence            3445566677899999999999999999998765         67799999987542  223456788999999999999


Q ss_pred             eeeeeeEEeec------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 011180          201 LVKLVGYCIED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  274 (491)
Q Consensus       201 Iv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~N  274 (491)
                      |+++++++...      ...+++++++ +++|.+++...   .+++..+..++.||+.||+|||+.+   |+||||||+|
T Consensus        78 iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N  150 (345)
T cd07877          78 VIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSN  150 (345)
T ss_pred             ccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHH
Confidence            99999988643      3467888887 88998877543   5889999999999999999999988   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 011180          275 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG  353 (491)
Q Consensus       275 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~  353 (491)
                      |+++.++.+||+|||+++.....     .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......
T Consensus       151 Ill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~  225 (345)
T cd07877         151 LAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID  225 (345)
T ss_pred             EEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999998865322     123468899999998866 568899999999999999999999996543221


Q ss_pred             cchhhHhhh--------cccCCc--cchhhccCccccC---CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          354 EHNLVEWAR--------PHLGDK--RRFYRLLDPRLEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       354 ~~~~~~~~~--------~~~~~~--~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ....+....        ..+...  ..+...+......   ......+..+.+||.+||+.||.+||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         226 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            111100000        000000  0000000000000   0011235678999999999999999999999976

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.7e-37  Score=310.08  Aligned_cols=268  Identities=26%  Similarity=0.327  Sum_probs=194.7

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  210 (491)
                      +|.+.+.||+|+||.||++.+....       .+..||||.+....  ....+.+.+|+.++.++ .||||+++++++..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   73 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS-------EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV   73 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC-------cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence            4788899999999999999986521       16689999986432  12345678899999999 49999999987543


Q ss_pred             c----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          211 D----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       211 ~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      .    ...+++|||+ +++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        74 ~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~  147 (332)
T cd07857          74 FPGNFNELYLYEELM-EADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKIC  147 (332)
T ss_pred             ccccCCcEEEEEecc-cCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeC
Confidence            2    4578899998 468998886543  6889999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCc--eeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          287 DFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       287 DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      |||+++........  .......||..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.....
T Consensus       148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  227 (332)
T cd07857         148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG  227 (332)
T ss_pred             cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence            99999865432211  11223578999999998765 4689999999999999999999999975432111000000000


Q ss_pred             --------ccCCc--cchhhccC----ccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 --------HLGDK--RRFYRLLD----PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 --------~~~~~--~~~~~~~~----~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                              .+...  ..+...+.    ..+. ......+..+.+|+.+||+.||.+|||+.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             CCCHHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                    00000  00000000    0000 0111235789999999999999999999999855

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=314.26  Aligned_cols=247  Identities=25%  Similarity=0.350  Sum_probs=204.0

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEeecCceE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  215 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  215 (491)
                      .++||.|.||+||-|.++.         +|+.||||++.+-...  ...++..|+.||.+++||.||.+...|+..+.++
T Consensus       569 devLGSGQFG~VYgg~hRk---------tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF  639 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRK---------TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF  639 (888)
T ss_pred             HhhccCCcceeeecceecc---------cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence            4789999999999999987         8899999999876543  3356888999999999999999999999999999


Q ss_pred             EEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC---CCeEEeccCCcc
Q 011180          216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLSDFGLAK  292 (491)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~---~~~kL~DFGla~  292 (491)
                      +|||-+ +|++.+.|.......+++.....++.||+.||.|||.++   |+|.||||+|||+...   -.+||||||+|+
T Consensus       640 VVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  640 VVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             EEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecccccee
Confidence            999999 667777776555557999999999999999999999988   9999999999999654   369999999999


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .+.+.   ......+||+.|.|||++....|+..-|+||.|||+|--++|..||.......  +.+..+.-         
T Consensus       716 iIgEk---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAaF---------  781 (888)
T KOG4236|consen  716 IIGEK---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAAF---------  781 (888)
T ss_pred             ecchh---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhcccc---------
Confidence            98653   34456899999999999999999999999999999999999999996542211  11111100         


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                       +..    .....+.+..+.+||..+|+..=.+|-+.+..+.+.
T Consensus       782 -MyP----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  782 -MYP----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             -ccC----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence             111    112234478899999999999999999999888763

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-37  Score=313.12  Aligned_cols=266  Identities=25%  Similarity=0.351  Sum_probs=196.9

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||.+.....  .....+.+|+.+++.+.||||+++++++.
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~   84 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKR---------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT   84 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCC---------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence            3689999999999999999998865         577999999875422  22356789999999999999999999987


Q ss_pred             ecC------ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          210 EDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ...      ..++||||+. .+|..++.    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~  156 (342)
T cd07879          85 SAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCEL  156 (342)
T ss_pred             ccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence            543      4589999995 47766542    25788999999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||+|||+++.....     .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus       157 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~  231 (342)
T cd07879         157 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  231 (342)
T ss_pred             EEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999998765322     123467889999999876 468899999999999999999999997643221111100000


Q ss_pred             c--------ccCC--ccchhhccCccccCCC---ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhcC
Q 011180          363 P--------HLGD--KRRFYRLLDPRLEGHF---SIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPL  419 (491)
Q Consensus       363 ~--------~~~~--~~~~~~~~~~~l~~~~---~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--L~~l  419 (491)
                      .        ....  ...+...+.......+   ....+..+.+||.+||+.||.+||++.+++.+  ++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            0        0000  0000000000000000   01235678999999999999999999999976  4444

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=296.00  Aligned_cols=255  Identities=28%  Similarity=0.384  Sum_probs=197.9

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhc-CCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGN-LLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~  211 (491)
                      +.+-+..||.|+||+|++-.++.         +|+..|||.++.... ...++++.|.....+ -+.||||++||++..+
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~---------sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E  135 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKP---------SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE  135 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCc---------cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence            34445679999999999998887         788999999986654 445678888876554 4699999999999999


Q ss_pred             CceEEEEEecCCCChHHHhh---hCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          212 DQRLLVYEFMPRGSLENHLF---RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~---~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      +..||.||+| ..+|+.+..   ......+++...-.|....+.||.||-....  |||||+||+||||+..|.+|||||
T Consensus       136 GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  136 GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecc
Confidence            9999999999 557765432   2333468899988999999999999988653  999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh-ccc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-PHL  365 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-~~~  365 (491)
                      |++..+.+.   ...+..+|...|||||.+..  ..|+.++||||||++|||+.||+.|+..+..     +.+... ...
T Consensus       213 GIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~  284 (361)
T KOG1006|consen  213 GICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI  284 (361)
T ss_pred             cchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc
Confidence            999876432   23345679999999999963  4599999999999999999999999976543     111111 112


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ++...   ++.    ..-....+..+..+|..||.+|-+.||.+.+++++
T Consensus       285 gdpp~---l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  285 GDPPI---LLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CCCCe---ecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            22111   111    11112347889999999999999999999998754

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4e-37  Score=309.39  Aligned_cols=265  Identities=25%  Similarity=0.345  Sum_probs=200.4

Q ss_pred             HHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeee
Q 011180          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLV  205 (491)
Q Consensus       128 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~  205 (491)
                      +...+++|.+.+.||.|+||.||+|....         ++..||||.+....  ....+.+.+|+.++..++||||++++
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~   75 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQL---------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS   75 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECC---------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEe
Confidence            34567789999999999999999998875         67789999886432  22346788999999999999999999


Q ss_pred             eEEee-cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          206 GYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       206 ~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      +++.. ....++||||+ +++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||+|+|||++.++.++
T Consensus        76 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~  148 (328)
T cd07856          76 DIFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLK  148 (328)
T ss_pred             eeEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEE
Confidence            99876 46789999999 67898887533   5778888899999999999999988   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh-
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-  361 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~-  361 (491)
                      |+|||++.......     ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+ +.. 
T Consensus       149 l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~  223 (328)
T cd07856         149 ICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLG  223 (328)
T ss_pred             eCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999987543221     23467889999998765 57899999999999999999999999654321111000 000 


Q ss_pred             -------hcccC-CccchhhccCccccCCCC-----hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 -------RPHLG-DKRRFYRLLDPRLEGHFS-----IKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 -------~~~~~-~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                             ..... ....+...+.  .....+     ...+..+.++|.+||+.+|.+|||+.+++.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         224 TPPDDVINTICSENTLRFVQSLP--KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCCHHHHHhccchhhHHHHhhcc--ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                   00000 0000000000  000011     1236789999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.5e-37  Score=334.93  Aligned_cols=146  Identities=27%  Similarity=0.360  Sum_probs=131.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|++..         ++..||||++......   ....+..|+.++..++||||+++++++.
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~   74 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKN---------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ   74 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence            479999999999999999999875         5778999999764322   2356788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      ..+..||||||+.+++|.+++...+  .+++..++.|+.||+.||.|||..+   ||||||||+||||+.++.+||+|||
T Consensus        75 ~~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFG  149 (669)
T cd05610          75 SANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFG  149 (669)
T ss_pred             ECCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCC
Confidence            9999999999999999999987654  5788889999999999999999988   9999999999999999999999999


Q ss_pred             Ccc
Q 011180          290 LAK  292 (491)
Q Consensus       290 la~  292 (491)
                      +++
T Consensus       150 ls~  152 (669)
T cd05610         150 LSK  152 (669)
T ss_pred             CCc
Confidence            986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-37  Score=300.19  Aligned_cols=265  Identities=27%  Similarity=0.387  Sum_probs=201.0

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      |++.+.||+|+||.||+|....         ++..||+|++....  ....+.+..|+.+++.++|+||+++++++.+.+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   71 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKK---------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER   71 (282)
T ss_pred             CeeehcccccCcceEEEeeecC---------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence            5677889999999999998876         57799999997653  223456788999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~  146 (282)
T cd07829          72 KLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR  146 (282)
T ss_pred             ceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccc
Confidence            9999999996 69999997653 36889999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh-------hc
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-------RP  363 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~-------~~  363 (491)
                      ........  .....++..|+|||.+.+. .++.++|||||||++|||++|.+||...........+ ...       ..
T Consensus       147 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
T cd07829         147 AFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP  224 (282)
T ss_pred             ccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHH
Confidence            76443221  1234567889999998766 8899999999999999999999999654322111000 000       00


Q ss_pred             ccCCccchhhccC---ccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~---~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .......+...+.   ...........+..+.++|.+||..||.+||++.+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0000000000000   000000001126789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=304.37  Aligned_cols=243  Identities=28%  Similarity=0.410  Sum_probs=201.7

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccH---HHHHHHHHHHhcCC-CCceeeeeeE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLL-HPNLVKLVGY  207 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~il~~l~-HpnIv~l~~~  207 (491)
                      ..+|..+.+||+|+||.|.+|..+.         +...+|||+++++.....   +--+.|-++|.... .|.+++++.+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkg---------tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc  418 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC  418 (683)
T ss_pred             ecccceEEEeccCccceeeeecccC---------cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH
Confidence            3479999999999999999997654         677899999998754322   33456888887664 7899999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      |+.-+.+|+||||+.||+|.-+|+.-+  .+.+..+..+|.+|+-||-|||+.+   ||+||||.+||||+.+|++||+|
T Consensus       419 FQTmDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~D  493 (683)
T KOG0696|consen  419 FQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIAD  493 (683)
T ss_pred             hhhhhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeee
Confidence            999999999999999999999998877  4667778889999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ||++....-++.+  ..++|||+.|+|||++.-.+|+..+|+|||||+||||+.|++||++....+..            
T Consensus       494 FGmcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF------------  559 (683)
T KOG0696|consen  494 FGMCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF------------  559 (683)
T ss_pred             cccccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH------------
Confidence            9999865433332  34689999999999999999999999999999999999999999875432211            


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR  408 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt  408 (491)
                          ..+++.  .-.|+...+.++.++++..|.+.|.+|.-
T Consensus       560 ----~aI~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  560 ----QAIMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ----HHHHHc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence                111111  12345555899999999999999999954

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-36  Score=307.43  Aligned_cols=262  Identities=25%  Similarity=0.359  Sum_probs=197.9

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||+|+||.||+|.+..         ++..||||.+.....  .....+.+|+.+|+.++||||+++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence            45689999999999999999998765         577899999864321  2235678999999999999999999998


Q ss_pred             eecC------ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          209 IEDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       209 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      ....      ..++||||+ +++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~  156 (343)
T cd07880          84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCE  156 (343)
T ss_pred             cCCccccccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence            7654      358999999 78998887542   6889999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      ++|+|||++......     .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||........  .....
T Consensus       157 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~  229 (343)
T cd07880         157 LKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIM  229 (343)
T ss_pred             EEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence            999999999865332     123467899999998876 4688999999999999999999999975432111  00000


Q ss_pred             hc----------ccC--CccchhhccCcccc---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 RP----------HLG--DKRRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 ~~----------~~~--~~~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..          .+.  ....+...+.....   .......+..+.++|.+||+.||.+|||+.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00          000  00000000000000   00112335678999999999999999999999965

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7e-37  Score=296.57  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=195.5

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC---C--cccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---G--LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      +|.+.+.||+|+||.||++.+..         .+..+++|+++..   .  .....++..|+.+++.++||||+++++++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK---------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF   71 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC---------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence            48889999999999999998765         2334555555432   1  12234567899999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      .+....++||||+++++|.+++..  .....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+
T Consensus        72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~  147 (260)
T cd08222          72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIG  147 (260)
T ss_pred             hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeec
Confidence            999999999999999999998864  22346899999999999999999999988   999999999999975 579999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||++........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......   ....   ....
T Consensus       148 d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~---~~~~  219 (260)
T cd08222         148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVVL---RIVE  219 (260)
T ss_pred             ccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHH---HHHc
Confidence            9999876543222  122356889999999998888999999999999999999999998543211   1111   0000


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .       ..+    ..+...+.++.++|.+||..||++||++.+++++
T Consensus       220 ~-------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         220 G-------PTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             C-------CCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            0       011    1122346789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=300.84  Aligned_cols=272  Identities=29%  Similarity=0.457  Sum_probs=201.1

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~~  211 (491)
                      ...+.++||+|.||+||+|.+.           ++.||||++...   ....|..|-+|.+.  +.|+||++|+++-...
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~  276 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRG  276 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-----------CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence            4566788999999999999985           468999999643   34567777777665  4699999999986655


Q ss_pred             C----ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCcEEECCCC
Q 011180          212 D----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA------EKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       212 ~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------~~~iiHrDlKp~NILl~~~~  281 (491)
                      .    .++||+||.+.|+|.++|..+   .++|....+|+..+++||+|||+..      +++|+|||||..||||.+|+
T Consensus       277 t~~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl  353 (534)
T KOG3653|consen  277 TADRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL  353 (534)
T ss_pred             CccccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence            5    789999999999999999766   6899999999999999999999853      46799999999999999999


Q ss_pred             CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCC-----ccccchhHHHHHHHHHhCCCCCCC-CCCCCc
Q 011180          282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLT-----SKSDVYSFGVVLLEMLTGRRSMDK-NRPNGE  354 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~-----~~~DvwSlGvil~elltG~~pf~~-~~~~~~  354 (491)
                      +..|+|||+|..+............+||.+|||||++.+. .+.     .+.||||+|.|||||++...-+.. ..+...
T Consensus       354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq  433 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ  433 (534)
T ss_pred             cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence            9999999999987654443334447899999999999764 222     368999999999999997765532 111111


Q ss_pred             chhh-Hh-hhcccCCccc--hhhccCccccCCCC-hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011180          355 HNLV-EW-ARPHLGDKRR--FYRLLDPRLEGHFS-IKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  422 (491)
Q Consensus       355 ~~~~-~~-~~~~~~~~~~--~~~~~~~~l~~~~~-~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~  422 (491)
                      .-+. +. ..+.+.+.+.  ..+...|.+...+- ......+.+.+..||..||+.|.|+.=+-+.+.++...
T Consensus       434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence            1000 00 0011100000  01111222221111 12367789999999999999999999998888776543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.2e-37  Score=310.49  Aligned_cols=264  Identities=24%  Similarity=0.365  Sum_probs=199.6

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||+|+||.||+|.+..         ++..||||++....  ....+.+.+|+.+++.+.|+||+++++++
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF   83 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence            35689999999999999999999876         56789999986532  22335678899999999999999999988


Q ss_pred             eecCc------eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          209 IEDDQ------RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       209 ~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      ...+.      .++|+||+ +++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~  156 (343)
T cd07851          84 TPASSLEDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCE  156 (343)
T ss_pred             hccccccccccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCC
Confidence            76654      89999999 77999988642   6889999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EW  360 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~  360 (491)
                      ++|+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+ ..
T Consensus       157 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~  231 (343)
T cd07851         157 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL  231 (343)
T ss_pred             EEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Confidence            999999999866432     223467889999998865 36788999999999999999999999654332111100 00


Q ss_pred             hhc-------ccC-C-ccchhhccCccccCCC---ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          361 ARP-------HLG-D-KRRFYRLLDPRLEGHF---SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       361 ~~~-------~~~-~-~~~~~~~~~~~l~~~~---~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...       .+. + ...+...+.......+   ....+..+.+||.+||..||.+|||+.+|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            000       000 0 0000000000000000   01236789999999999999999999999876

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=292.46  Aligned_cols=241  Identities=34%  Similarity=0.454  Sum_probs=196.3

Q ss_pred             cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEE
Q 011180          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       141 lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  217 (491)
                      ||.|+||.||++.+..         ++..||+|++......   ....+..|+.+++.+.|+||+++++.+..++..++|
T Consensus         1 lg~G~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   71 (250)
T cd05123           1 LGKGSFGKVLLVRKKD---------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV   71 (250)
T ss_pred             CCCCCceEEEEEEECC---------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence            7999999999998865         4678999998765432   345788899999999999999999999999999999


Q ss_pred             EEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          218 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       218 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          72 LEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            99999999999997654  5889999999999999999999988   999999999999999999999999999876443


Q ss_pred             CCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCc
Q 011180          298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  377 (491)
Q Consensus       298 ~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (491)
                      ..  ......|+..|++||.+.+..++.++|+||||+++|+|++|..||.....   ........   ..          
T Consensus       147 ~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~---~~----------  208 (250)
T cd05123         147 GS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL---KD----------  208 (250)
T ss_pred             CC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh---cC----------
Confidence            21  12345688999999999888889999999999999999999999965432   11111110   00          


Q ss_pred             cccCCCChhhHHHHHHHHHHhhhcCCCCCCCH---HHHHHH
Q 011180          378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRM---SEVVET  415 (491)
Q Consensus       378 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~---~evl~~  415 (491)
                        ...++...+..+.+++.+||..||++||++   .+++++
T Consensus       209 --~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         209 --PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence              011222236788999999999999999999   565543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=317.00  Aligned_cols=242  Identities=28%  Similarity=0.307  Sum_probs=198.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  210 (491)
                      ++.|.+...+|.|+|+.|-.|.+..         +++..++|++.+...    +..+|+.++... .||||+++.+++.+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~---------t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~  387 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSP---------TDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYED  387 (612)
T ss_pred             chhhccccccCCCCccceeeeeccc---------cccchhheecccccc----ccccccchhhhhcCCCcceeecceecC
Confidence            4578888889999999999998876         677899999976622    234567666555 59999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-CCCCCeEEeccC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNAKLSDFG  289 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl-~~~~~~kL~DFG  289 (491)
                      ..+.|+|||++.++.|.+.+.....   ....+..|+.+|+.|+.|||++|   ||||||||+|||+ +..++++|+|||
T Consensus       388 ~~~~~~v~e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG  461 (612)
T KOG0603|consen  388 GKEIYLVMELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFG  461 (612)
T ss_pred             CceeeeeehhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEec
Confidence            9999999999999999888876642   22667789999999999999988   9999999999999 689999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      .++.....     ....+-|..|.|||++....|+.++||||||++||+||+|+.||......  ..+.           
T Consensus       462 ~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~-----------  523 (612)
T KOG0603|consen  462 FWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH-----------  523 (612)
T ss_pred             hhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH-----------
Confidence            99877554     12346688999999999999999999999999999999999999654332  1111           


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                            .....+.++...+..+++|+.+||+.||.+|+++.+++.+-
T Consensus       524 ------~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  524 ------TRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             ------HhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence                  11112223345589999999999999999999999998763

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-37  Score=320.15  Aligned_cols=256  Identities=28%  Similarity=0.385  Sum_probs=211.5

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYC  208 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~  208 (491)
                      .-++-|.+.+.||.|.+|.||+++...         +++.+|+|++..+. ...+++..|.++|+.+. |||++.+||+|
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~---------~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVK---------TGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeee---------cCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            335579999999999999999999987         56688899887664 33467788999999885 99999999998


Q ss_pred             ee-----cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          209 IE-----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       209 ~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ..     ++++|||||||.+|+..|++.......+.|..+..|+..++.||.+||.+.   +||||||-.|||++.++.|
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcE
Confidence            74     468999999999999999998776778999999999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  358 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  358 (491)
                      ||+|||++..+...  .....+.+||+.|||||++..     ..|+..+|+||||++..||--|.+|+....+.-.... 
T Consensus       163 KLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-  239 (953)
T KOG0587|consen  163 KLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-  239 (953)
T ss_pred             EEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-
Confidence            99999999877532  222345789999999999863     3578899999999999999999999966544322111 


Q ss_pred             HhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                    ..-+|.....-+.+-++++.++|..||.+|..+||++.++|+|
T Consensus       240 --------------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  240 --------------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             --------------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                          1112222223345568999999999999999999999999986

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-37  Score=266.97  Aligned_cols=266  Identities=24%  Similarity=0.307  Sum_probs=202.1

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|...++||+|.||+||+|++.+         +++.||+|.++.+...  .....++||-+|+.|.|.|||+++++...+
T Consensus         3 ~ydkmekigegtygtvfkarn~~---------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd   73 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD   73 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCC---------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence            46667899999999999999887         7789999998765322  235678999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ..+-||+||| .-+|..+.....+ .++.+.+..++.|+++||.|+|+++   +.||||||.|+||+.+|.+||+|||++
T Consensus        74 kkltlvfe~c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfgla  148 (292)
T KOG0662|consen   74 KKLTLVFEFC-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLA  148 (292)
T ss_pred             ceeEEeHHHh-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchh
Confidence            9999999999 5688888766544 6888999999999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhccc--CC
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL--GD  367 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~--~~  367 (491)
                      +.+.-.-  ......+-|..|.+|.++.+. -|+...|+||.|||+.|+.. |++.|.+....+....+-+.....  ..
T Consensus       149 rafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~  226 (292)
T KOG0662|consen  149 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ  226 (292)
T ss_pred             hhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence            9875431  112334568999999999875 68899999999999999986 666676654433322222211100  00


Q ss_pred             ccchhhccCccccCCCC---------hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFS---------IKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~---------~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ......+.|-..-..|+         ++....-++|+.++|.-+|..|.++++++++
T Consensus       227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            01111111111111111         1223455899999999999999999998865

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=301.36  Aligned_cols=257  Identities=28%  Similarity=0.397  Sum_probs=201.7

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-------ccHHHHHHHHHHHhcCCCCceeee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~HpnIv~l  204 (491)
                      .++|-++.+||+|+|+.||+|.+..         ..+.||||+-.....       ...+...+|.+|.+.|+||.||++
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~---------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKl  532 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLT---------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKL  532 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccc---------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeee
Confidence            3578899999999999999998875         456899998643211       123456889999999999999999


Q ss_pred             eeEEe-ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC---CC
Q 011180          205 VGYCI-EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---AD  280 (491)
Q Consensus       205 ~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~---~~  280 (491)
                      |++|. +.+.+|-|+|||+|.+|+-+|....  .+++..+..|+.||+.||.||.+.. .+|||=||||.||||-   .-
T Consensus       533 YDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~Gtac  609 (775)
T KOG1151|consen  533 YDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTAC  609 (775)
T ss_pred             eeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCccc
Confidence            99986 5578899999999999999997765  6889999999999999999999876 7899999999999994   45


Q ss_pred             CCeEEeccCCcccCCCCCCce-----eeeccccCCCCCCchhhhcC----CCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 011180          281 YNAKLSDFGLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  351 (491)
Q Consensus       281 ~~~kL~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~----~~~~~~DvwSlGvil~elltG~~pf~~~~~  351 (491)
                      |.+||.||||+..+.++....     ......||++|++||.+.-+    .++.++||||+|||+|..+.|+.||..+..
T Consensus       610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs  689 (775)
T KOG1151|consen  610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS  689 (775)
T ss_pred             ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence            789999999999886554432     23457899999999987533    578899999999999999999999976532


Q ss_pred             CCcchhhHhhhcccCCccchhhccCccccCCCC--hhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011180          352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS--IKGSQKATQLAAQCLSRDPKARPRMSEVVE  414 (491)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cL~~dP~~RPt~~evl~  414 (491)
                      ..  .+.+.. ..+          ... +-.|+  +..+.++.+||++||+..-++|....++..
T Consensus       690 QQ--dILqeN-TIl----------kAt-EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  690 QQ--DILQEN-TIL----------KAT-EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             HH--HHHhhh-chh----------cce-eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            21  111110 011          100 11122  234788999999999999999998887653

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=311.31  Aligned_cols=244  Identities=25%  Similarity=0.327  Sum_probs=207.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ..++.++..||-|+||.|=++.....         ...+|+|++++....+   .+.+..|-+||..++.|.||++|-.|
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf  489 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF  489 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence            34677788899999999999887653         2258999998764332   34577899999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .++..+|++||-|-||.|...|..++  .++......++..+++|++|||.++   ||+|||||+|+||+.+|-+||.||
T Consensus       490 rd~kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDF  564 (732)
T KOG0614|consen  490 RDSKYVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDF  564 (732)
T ss_pred             ccchhhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeeh
Confidence            99999999999999999999998877  5777888889999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |+|+.+.....+   .++|||+.|.|||++.+...+.++|.||||+++|||++|.+||....+....+++-.....    
T Consensus       565 GFAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----  637 (732)
T KOG0614|consen  565 GFAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----  637 (732)
T ss_pred             hhHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----
Confidence            999998766544   4589999999999999999999999999999999999999999888776655554322111    


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR  408 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt  408 (491)
                                  -.+|......+.+||++++..+|.+|.-
T Consensus       638 ------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  638 ------------IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ------------hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                        1233444788999999999999999965

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-37  Score=308.10  Aligned_cols=244  Identities=26%  Similarity=0.341  Sum_probs=195.9

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccH---HHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      -|..++.||-|+||+|.+++-.+         +...+|+|.+.+......   ..+..|-.||...+.+-||+||-.|.+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvD---------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVD---------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD  700 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecc---------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence            47778889999999999997665         566899999977644332   235679999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+.+|+||+|++||++..+|.+.+  -|++..+..++.++..|+++.|..|   +|||||||+|||||.+|++||.||||
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGL  775 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL  775 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccc
Confidence            999999999999999999999886  6888888899999999999999999   99999999999999999999999999


Q ss_pred             cccCC---------CCCCc-------------------------------eeeeccccCCCCCCchhhhcCCCCccccch
Q 011180          291 AKDAP---------EDGKT-------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVY  330 (491)
Q Consensus       291 a~~~~---------~~~~~-------------------------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~Dvw  330 (491)
                      ++-+.         +.+..                               ......+||+.|+|||++....|+.-+|+|
T Consensus       776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww  855 (1034)
T KOG0608|consen  776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW  855 (1034)
T ss_pred             cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence            86321         10000                               001225799999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCCCcchhh-HhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC
Q 011180          331 SFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP  407 (491)
Q Consensus       331 SlGvil~elltG~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP  407 (491)
                      |.|||||||+.|++||....+.+....+ .|.           ..++-    .+..+.+.++.+||.+++ .+++.|.
T Consensus       856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~-----------~~l~~----~~~~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  856 SVGVILYEMLVGQPPFLADTPGETQYKVINWR-----------NFLHI----PYQGNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             HhhHHHHHHhhCCCCccCCCCCcceeeeeehh-----------hcccc----ccccccCHHHHHHHHHHh-cChhhhh
Confidence            9999999999999999988887654332 221           11221    122334677888887755 4566664

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.3e-36  Score=287.67  Aligned_cols=220  Identities=25%  Similarity=0.264  Sum_probs=178.3

Q ss_pred             CCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEEEEecCC
Q 011180          144 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR  223 (491)
Q Consensus       144 G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~  223 (491)
                      |.||.||++++..         ++..||+|.+....     .+..|...+....||||+++++++.+.+..++||||+++
T Consensus         4 g~~~~v~~~~~~~---------~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   69 (237)
T cd05576           4 GVIDKVLLVMDTR---------TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG   69 (237)
T ss_pred             cccceEEEEEEcc---------CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence            8999999999876         67799999997543     233455555566799999999999999999999999999


Q ss_pred             CChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceee
Q 011180          224 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS  303 (491)
Q Consensus       224 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  303 (491)
                      |+|.+++....  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++......     .
T Consensus        70 ~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~  139 (237)
T cd05576          70 GKLWSHISKFL--NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----C  139 (237)
T ss_pred             CCHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----c
Confidence            99999987654  5889999999999999999999988   999999999999999999999999988665432     1


Q ss_pred             eccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCC
Q 011180          304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF  383 (491)
Q Consensus       304 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  383 (491)
                      ....++..|+|||.+.+..++.++||||+||++|||++|..||........            ...          ...+
T Consensus       140 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~~----------~~~~  197 (237)
T cd05576         140 DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------THT----------TLNI  197 (237)
T ss_pred             ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------ccc----------ccCC
Confidence            224567789999999888899999999999999999999988753211000            000          0011


Q ss_pred             ChhhHHHHHHHHHHhhhcCCCCCCCH
Q 011180          384 SIKGSQKATQLAAQCLSRDPKARPRM  409 (491)
Q Consensus       384 ~~~~~~~l~~li~~cL~~dP~~RPt~  409 (491)
                      +...+..+.+||.+||+.||.+||++
T Consensus       198 ~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         198 PEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cccCCHHHHHHHHHHccCCHHHhcCC
Confidence            12236788999999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=282.75  Aligned_cols=253  Identities=26%  Similarity=0.399  Sum_probs=202.6

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcC-CCCceeee
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNL-LHPNLVKL  204 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l-~HpnIv~l  204 (491)
                      .+..++|.++++||+|+|+.|.+++++.         +.+.+|+|+++++-..   +...+..|..+..+. +||.+|-+
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~---------t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvgl  316 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKK---------TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGL  316 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcc---------cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEeh
Confidence            3556789999999999999999999876         7789999999876433   334456788888776 59999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      +.+|..+..+++|.||++||+|.-++++..  .++++.+..+...|+-||.|||+.|   ||+||||.+|+|++..|++|
T Consensus       317 hscfqtesrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghik  391 (593)
T KOG0695|consen  317 HSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIK  391 (593)
T ss_pred             hhhhcccceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCcee
Confidence            999999999999999999999988876654  6899999999999999999999988   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCC-CCcchhhHhhhc
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARP  363 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~-~~~~~~~~~~~~  363 (491)
                      |.|+|+++..-..+.  ...++||||.|.|||++.+..|+..+|+|+|||+|+||+.|+.||+.-.. +.+.+..++.-.
T Consensus       392 ltdygmcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq  469 (593)
T KOG0695|consen  392 LTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ  469 (593)
T ss_pred             ecccchhhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH
Confidence            999999986544332  24568999999999999999999999999999999999999999974321 122222222111


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR  408 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt  408 (491)
                      .         ++...+.  ++-..+..+..+++.-|.+||.+|..
T Consensus       470 v---------ilekqir--iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  470 V---------ILEKQIR--IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             H---------Hhhhccc--ccceeehhhHHHHHHhhcCCcHHhcC
Confidence            1         1111111  11122556778899999999999954

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=314.20  Aligned_cols=257  Identities=27%  Similarity=0.406  Sum_probs=212.5

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEeecCc
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  213 (491)
                      .+..++||.|+||+||+|.+...+..     -..+||||++.... .+...++++|+-+|.+|+||||++|+|++.... 
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~-----vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGEN-----VKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCce-----ecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            45567899999999999999764332     35689999986553 345688999999999999999999999998765 


Q ss_pred             eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          214 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      +.||++||+.|+|.|+++.++. .+-....+.|..||++||.|||.+.   ++||||-.+||||.+-..+||.|||+++.
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~l  847 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKL  847 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhc
Confidence            8899999999999999987644 6778888999999999999999988   99999999999999999999999999998


Q ss_pred             CCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          294 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       294 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      +..+..........-.+.|||-|.+....|+.++|||||||++||++| |..|++.....+..++.+...          
T Consensus       848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge----------  917 (1177)
T KOG1025|consen  848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE----------  917 (1177)
T ss_pred             cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc----------
Confidence            876655443333334678999999999999999999999999999888 778887665444433333211          


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                             .-.-++.++.++..++.+||..|+..||+++++...+..
T Consensus       918 -------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  918 -------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             -------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence                   122345678999999999999999999999999887754

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=318.47  Aligned_cols=268  Identities=31%  Similarity=0.464  Sum_probs=210.5

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCceeeeee
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVG  206 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~  206 (491)
                      ....++..+.+.||+|.||.|++|.........  ......||||.++.... ...+.+..|+++|+.+- |+||+.++|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            334445566779999999999999876422210  11256899999976543 34577899999999995 999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCC-------C-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKG-------S-------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  272 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-------~-------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp  272 (491)
                      ++...+..++|+||+..|+|.++|..++       .       ..+.....+.++.||+.|++||++..   +|||||-.
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999998765       0       13788889999999999999999977   99999999


Q ss_pred             CcEEECCCCCeEEeccCCcccCCCCCCceeeecccc--CCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 011180          273 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG--TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKN  349 (491)
Q Consensus       273 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~G--t~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~  349 (491)
                      +|||+.++..+||+|||+|+........... ...|  ...|||||.+....|+.++|||||||+||||++ |..|+...
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            9999999999999999999976554443322 1223  345999999999999999999999999999999 66676541


Q ss_pred             CCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          350 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                      ..  ...+.++.              .....-..+..++.++.+||+.||+.+|.+||++.++.+.|+.
T Consensus       526 ~~--~~~l~~~l--------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  526 PP--TEELLEFL--------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             Cc--HHHHHHHH--------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            11  11112211              1112223345568999999999999999999999999999886

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=287.56  Aligned_cols=266  Identities=29%  Similarity=0.431  Sum_probs=200.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~  209 (491)
                      .++..+.+.||+|.||.||+|.|+           |..||||++...   +...+.+|.+|...  |+|+||+.|++.-.
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~  275 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADN  275 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-----------CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence            356788899999999999999994           778999999654   34567787777765  58999999998754


Q ss_pred             ec----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCcEEECCC
Q 011180          210 ED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-----AEKPVIYRDFKTSNILLDAD  280 (491)
Q Consensus       210 ~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----~~~~iiHrDlKp~NILl~~~  280 (491)
                      .+    .++|||.+|.+.|+|+|+|.+.   .++....+++++.+|.||++||-.     |++.|.|||||..||||.++
T Consensus       276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn  352 (513)
T KOG2052|consen  276 KDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  352 (513)
T ss_pred             cCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence            33    3689999999999999999874   788899999999999999999973     66779999999999999999


Q ss_pred             CCeEEeccCCcccCCCCCCc--eeeeccccCCCCCCchhhhcCC------CCccccchhHHHHHHHHHhC----------
Q 011180          281 YNAKLSDFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTG----------  342 (491)
Q Consensus       281 ~~~kL~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG----------  342 (491)
                      +.+.|+|+|||.....+...  ......+||.+|||||++...-      .-..+||||||.|+||+...          
T Consensus       353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey  432 (513)
T KOG2052|consen  353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY  432 (513)
T ss_pred             CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence            99999999999876554222  1223468999999999986431      12368999999999999763          


Q ss_pred             CCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          343 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       343 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ++||....+.+.. ..+. +..+-     .+.+.|.+...+ +......+.+||+.||..||.-|.|+-.|-+.|.++.+
T Consensus       433 ~~Pyyd~Vp~DPs-~eeM-rkVVC-----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  433 QLPYYDVVPSDPS-FEEM-RKVVC-----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cCCcccCCCCCCC-HHHH-hccee-----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            3566544433321 1111 00000     011111111111 12345678899999999999999999999999988765

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-37  Score=279.80  Aligned_cols=269  Identities=25%  Similarity=0.381  Sum_probs=203.0

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .|.-..+||+|.||.||+|+.++         +|+.||+|++-.+.  ..--...++|+.+|..|.|+|++.++++|...
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n---------~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk   88 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKN---------TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   88 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcC---------ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence            46667789999999999999876         67789998764322  11224568999999999999999999887642


Q ss_pred             --------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          212 --------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       212 --------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                              ..+||||.+|+. +|.-+|... ...++...+.+++.++..||.|+|...   |+|||+|++|+||+.+|.+
T Consensus        89 ~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgil  163 (376)
T KOG0669|consen   89 ATPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGIL  163 (376)
T ss_pred             cCCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceE
Confidence                    347999999954 888887654 347889999999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCc--eeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011180          284 KLSDFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  360 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  360 (491)
                      ||+|||+++.+......  ...+..+-|..|.+||.+.+ ..|+...|||..||||.||+++.+.|.++.......++..
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~  243 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ  243 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence            99999999866432221  12234556999999999886 5799999999999999999999999988766544444332


Q ss_pred             h--------hcccCCccchhhcc--CccccCCC--------ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          361 A--------RPHLGDKRRFYRLL--DPRLEGHF--------SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       361 ~--------~~~~~~~~~~~~~~--~~~l~~~~--------~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      .        ++..... .++..+  .|-..+.+        +..-.+++.+|+.++|..||.+|+++++++++.-
T Consensus       244 LcGs~tkevWP~~d~l-pL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~  317 (376)
T KOG0669|consen  244 LCGSITKEVWPNVDNL-PLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF  317 (376)
T ss_pred             HhccCCcccCCCcccc-hHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence            1        1111111 111111  11111111        1111468899999999999999999999998853

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=6.2e-35  Score=311.72  Aligned_cols=268  Identities=21%  Similarity=0.245  Sum_probs=172.9

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeE---
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGY---  207 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~---  207 (491)
                      ..++|.+.+.||+|+||.||+|++..+..     ..+..||||.+.....  .+.+..|  .+....+.+++.++..   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            56789999999999999999999876311     1267899998864321  1111111  1222223333332222   


Q ss_pred             ---EeecCceEEEEEecCCCChHHHhhhCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 011180          208 ---CIEDDQRLLVYEFMPRGSLENHLFRKGSL------------------PLPWSIRMKIALGAAKGLAFLHEEAEKPVI  266 (491)
Q Consensus       208 ---~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  266 (491)
                         .......+|||||+.+++|.+++......                  ......+..++.||+.||.|||+.+   |+
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---Ii  277 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IV  277 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence               23556789999999999999988654210                  0112345679999999999999988   99


Q ss_pred             ecCCCCCcEEECC-CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC----------------------CC
Q 011180          267 YRDFKTSNILLDA-DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG----------------------HL  323 (491)
Q Consensus       267 HrDlKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~----------------------~~  323 (491)
                      ||||||+||||+. ++.+||+|||+++.+.... .......+||+.|||||.+...                      .+
T Consensus       278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~  356 (566)
T PLN03225        278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL  356 (566)
T ss_pred             eCcCCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence            9999999999985 5799999999998654322 2223456899999999976422                      24


Q ss_pred             CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccc----cCCCC--hhhHHHHHHHHHH
Q 011180          324 TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL----EGHFS--IKGSQKATQLAAQ  397 (491)
Q Consensus       324 ~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l----~~~~~--~~~~~~l~~li~~  397 (491)
                      +.++|||||||+||||+++..+++...    ..+.......-.+...+.....+..    ...+.  ........+||.+
T Consensus       357 ~~k~DVwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        357 PDRFDIYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             CCCcccHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence            456799999999999999776543210    0000000000000000001111110    00000  0013346689999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 011180          398 CLSRDPKARPRMSEVVET  415 (491)
Q Consensus       398 cL~~dP~~RPt~~evl~~  415 (491)
                      ||+.||.+|||+.++++|
T Consensus       433 mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        433 MMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HccCCcccCCCHHHHhCC
Confidence            999999999999999987

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5e-34  Score=298.03  Aligned_cols=272  Identities=19%  Similarity=0.272  Sum_probs=186.6

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcc-------cCCCCCeEEEEEEecCCCcccHHH--------------HHH
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAP-------VKPGTGLTVAVKTLNHDGLQGHKE--------------WLA  188 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~--------------~~~  188 (491)
                      ...++|.+.++||+|+||+||+|.+...+...       .....+..||||.+........++              ...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            34678999999999999999999864322110       112346789999987543222222              334


Q ss_pred             HHHHHhcCCCCce-----eeeeeEEee--------cCceEEEEEecCCCChHHHhhhCCC--------------------
Q 011180          189 EVNFLGNLLHPNL-----VKLVGYCIE--------DDQRLLVYEFMPRGSLENHLFRKGS--------------------  235 (491)
Q Consensus       189 E~~il~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------  235 (491)
                      |+.++.++.|.++     ++++++|..        .+..+|||||+++++|.+++.....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777766554     677777653        3567999999999999998864211                    


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCC
Q 011180          236 --LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA  313 (491)
Q Consensus       236 --~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~  313 (491)
                        ..+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++......... ......+|+.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence              12456778899999999999999988   999999999999999999999999999765432211 111233588999


Q ss_pred             CchhhhcCC--------------------CC--ccccchhHHHHHHHHHhCCC-CCCCCCCCCc------chhhHhhhcc
Q 011180          314 APEYVMTGH--------------------LT--SKSDVYSFGVVLLEMLTGRR-SMDKNRPNGE------HNLVEWARPH  364 (491)
Q Consensus       314 aPE~~~~~~--------------------~~--~~~DvwSlGvil~elltG~~-pf~~~~~~~~------~~~~~~~~~~  364 (491)
                      |||.+....                    |+  .+.||||+||++|+|++|.. ||........      .....|..  
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--  455 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--  455 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--
Confidence            999875422                    11  24799999999999999875 6643211110      00111110  


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCC---CCCCCHHHHHHHh
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP---KARPRMSEVVETL  416 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP---~~RPt~~evl~~L  416 (491)
                               .......-......+....+|+.+||..+|   .+|+|++|+|+|-
T Consensus       456 ---------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp  501 (507)
T PLN03224        456 ---------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR  501 (507)
T ss_pred             ---------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence                     000000001112346889999999999866   6899999999773

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.9e-34  Score=270.53  Aligned_cols=240  Identities=31%  Similarity=0.442  Sum_probs=194.8

Q ss_pred             CceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEEEEecCC
Q 011180          145 GFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR  223 (491)
Q Consensus       145 ~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~  223 (491)
                      +||.||+|.+..         ++..||+|++....... .+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus         1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   71 (244)
T smart00220        1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG   71 (244)
T ss_pred             CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence            589999999875         56789999998765444 67889999999999999999999999999999999999999


Q ss_pred             CChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceee
Q 011180          224 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS  303 (491)
Q Consensus       224 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  303 (491)
                      ++|.+++....  .+++..+..++.+++.+|.|||+.+   |+|+||+|+||+++.++.++|+|||.+.......   ..
T Consensus        72 ~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~  143 (244)
T smart00220       72 GDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LL  143 (244)
T ss_pred             CCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---cc
Confidence            99999987654  3788999999999999999999988   9999999999999999999999999998765432   22


Q ss_pred             eccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCC
Q 011180          304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF  383 (491)
Q Consensus       304 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  383 (491)
                      ....|+..|++||.+.+..++.++||||||+++|+|++|..||....  ......+.........            ...
T Consensus       144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~~------------~~~  209 (244)
T smart00220      144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIGKPKPPF------------PPP  209 (244)
T ss_pred             ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhccCCCC------------ccc
Confidence            34568899999999988889999999999999999999999986531  1111111111000000            000


Q ss_pred             ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          384 SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       384 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ....+..+.+++.+||..+|++||++.+++++
T Consensus       210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             cccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence            00035788999999999999999999999863

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-36  Score=275.50  Aligned_cols=268  Identities=22%  Similarity=0.355  Sum_probs=205.4

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +.+..+.||-|+||+||.+.+..         +|+.||+|.+..-  .+...+.+.+|+++|..++|.|++..+++....
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPR---------dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp  124 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPR---------SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA  124 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCC---------CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC
Confidence            56788999999999999987654         7889999988543  344567899999999999999999999887654


Q ss_pred             C-----ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          212 D-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       212 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      .     ++|+|+|+| ..+|..+|...  ..++...+.-++.||++||+|||+.+   |.||||||.|+|++.|..+|||
T Consensus       125 h~dfFqEiYV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKIC  198 (449)
T KOG0664|consen  125 NPSFFQELYVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKIC  198 (449)
T ss_pred             CchHHHHHHHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEec
Confidence            3     567889999 55888877654  36788888899999999999999999   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--c
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--P  363 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--~  363 (491)
                      |||+++....+...+ .+..+-|-+|.|||++++. .|+.++||||.|||+.||+..+..|....+.....++....  +
T Consensus       199 DFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP  277 (449)
T KOG0664|consen  199 DFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP  277 (449)
T ss_pred             ccccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence            999999876554443 3455678999999999974 79999999999999999999999998887765554442211  0


Q ss_pred             ccCC------ccc--h-hh-ccCccccCCCC----hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          364 HLGD------KRR--F-YR-LLDPRLEGHFS----IKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       364 ~~~~------~~~--~-~~-~~~~~l~~~~~----~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      .+..      ..+  + .. .-.|.+..-|.    .....+...++.++|..||++|.+..+.+.++-
T Consensus       278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            0000      000  0 00 00111111111    112456788899999999999999999998763

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-35  Score=259.49  Aligned_cols=206  Identities=28%  Similarity=0.375  Sum_probs=170.1

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCceeeeee
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVG  206 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~  206 (491)
                      .+..++...+..||+|+||.|-+-++..         +|...|+|.+...- .+..+++++|+.+..+. .+|.+|.+||
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~---------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyG  112 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQ---------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYG  112 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeecc---------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeeh
Confidence            3444455666789999999999988887         78899999987542 34456788899887665 5999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      .+..+...||.||.| ..+|+.+..+  .....+++...-+|+..+++||.|||++-.  |||||+||+||||+.+|.+|
T Consensus       113 a~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVK  189 (282)
T KOG0984|consen  113 ALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVK  189 (282)
T ss_pred             hhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEE
Confidence            999999999999999 5577765432  223478999999999999999999999654  99999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhc----CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTGRRSMDKN  349 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~----~~~~~~~DvwSlGvil~elltG~~pf~~~  349 (491)
                      +||||++-.+.+.-   ..+-..|...|||||.+..    ..|+.++||||||++++||.+++.|++.+
T Consensus       190 iCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  190 ICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             Ecccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            99999998775432   1222568999999998863    47899999999999999999999999754

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=270.73  Aligned_cols=271  Identities=25%  Similarity=0.341  Sum_probs=219.4

Q ss_pred             hhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceee
Q 011180          125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVK  203 (491)
Q Consensus       125 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~  203 (491)
                      ..++.+...+++...++-+|.||.||.|.|.+.++.    .+.+.|-+|.++.... .....++.|--.|..+.|||+..
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~----n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~  351 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTY----NDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLS  351 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCc----chHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccc
Confidence            456677778899999999999999999998865443    2345677887765432 23456889999999999999999


Q ss_pred             eeeEEeec-CceEEEEEecCCCChHHHhhh------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 011180          204 LVGYCIED-DQRLLVYEFMPRGSLENHLFR------KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       204 l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NIL  276 (491)
                      +.+++.++ ...++++.++.-|+|..+|..      .....+...+...++.|++.|++|||.++   |||.||..+|++
T Consensus       352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCv  428 (563)
T KOG1024|consen  352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCV  428 (563)
T ss_pred             eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcce
Confidence            99998765 567888999988999999973      22334666777889999999999999998   999999999999


Q ss_pred             ECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011180          277 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  355 (491)
Q Consensus       277 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~  355 (491)
                      |++...+||+|=.+++.+-..+..+.....-....||+||.+....|+.++|||||||+||||+| |+.|+....+.+..
T Consensus       429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~  508 (563)
T KOG1024|consen  429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME  508 (563)
T ss_pred             ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence            99999999999999998877766666555556789999999999999999999999999999998 77888665544332


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ..+       .+..          .-.-+.+|++++..++.-||..+|++||++++++..|.++
T Consensus       509 ~yl-------kdGy----------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  509 HYL-------KDGY----------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             HHH-------hccc----------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            221       1111          1123457899999999999999999999999999998765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.4e-34  Score=286.54  Aligned_cols=270  Identities=24%  Similarity=0.285  Sum_probs=207.9

Q ss_pred             HHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC------CCce
Q 011180          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL------HPNL  201 (491)
Q Consensus       128 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~------HpnI  201 (491)
                      ..+...+|.+....|+|-|++|.+|.+..         .|..||||+|..... -.+.=++|++||++|+      .-|+
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~---------r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQA---------RGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccC---------CCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHH
Confidence            34556789999999999999999998865         566999999986643 3456678999999996      3689


Q ss_pred             eeeeeEEeecCceEEEEEecCCCChHHHhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 011180          202 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  280 (491)
Q Consensus       202 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~  280 (491)
                      ++|+-.|...+++|||+|-+ ..+|.++|.+.+ ...|....+..++.|+.-||..|-.++   |+|.||||+|||+++.
T Consensus       497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~  572 (752)
T KOG0670|consen  497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNES  572 (752)
T ss_pred             HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccC
Confidence            99999999999999999998 679999998765 346788899999999999999999999   9999999999999865


Q ss_pred             -CCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011180          281 -YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       281 -~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  359 (491)
                       ..+||||||.|....+...+    ...-+..|.|||++.+..|+...|+||+||+||||+||+..|.+...+....+.-
T Consensus       573 k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m  648 (752)
T KOG0670|consen  573 KNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM  648 (752)
T ss_pred             cceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence             57899999999877554322    2334668999999999999999999999999999999999998766544322211


Q ss_pred             h---------------hhcccCCccch----------------hhccCc------cccC--CCC---hhhHHHHHHHHHH
Q 011180          360 W---------------ARPHLGDKRRF----------------YRLLDP------RLEG--HFS---IKGSQKATQLAAQ  397 (491)
Q Consensus       360 ~---------------~~~~~~~~~~~----------------~~~~~~------~l~~--~~~---~~~~~~l~~li~~  397 (491)
                      -               ...++.....|                ...+.|      .+..  .++   ...-..+.+|+.+
T Consensus       649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk  728 (752)
T KOG0670|consen  649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK  728 (752)
T ss_pred             HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence            0               00111100000                001111      0100  011   2335678999999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 011180          398 CLSRDPKARPRMSEVVET  415 (491)
Q Consensus       398 cL~~dP~~RPt~~evl~~  415 (491)
                      ||..||++|.|..++|.|
T Consensus       729 ml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  729 MLILDPEKRITVNQALKH  746 (752)
T ss_pred             HhccChhhcCCHHHHhcC
Confidence            999999999999999976

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=271.43  Aligned_cols=133  Identities=24%  Similarity=0.353  Sum_probs=116.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-----C---Cceee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-----H---PNLVK  203 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----H---pnIv~  203 (491)
                      ..+|.+.++||-|.|++||+|++..         ..+.||+|+.+... ...+..+.||++|++++     |   ..||+
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~  146 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ  146 (590)
T ss_pred             CceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence            3689999999999999999999987         56689999997553 23356789999999984     2   46999


Q ss_pred             eeeEEee----cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 011180          204 LVGYCIE----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       204 l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl  277 (491)
                      |++.|..    +.++|||+|++ |.+|..+|.......++...+.+|+.||+.||.|||....  |||-||||+|||+
T Consensus       147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl  221 (590)
T KOG1290|consen  147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL  221 (590)
T ss_pred             eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence            9999875    45889999999 8899999988877889999999999999999999999764  9999999999998

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.5e-33  Score=252.41  Aligned_cols=259  Identities=22%  Similarity=0.321  Sum_probs=196.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~  210 (491)
                      .++|++.+.+|+|.|+.||.|....         +...++||+++.-   ..+.+.+|+.||..|. ||||++++++..+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~---------~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~D  104 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINIT---------NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKD  104 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccC---------CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence            4589999999999999999998765         4568999999754   3467889999999998 9999999999876


Q ss_pred             c--CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCCeEEec
Q 011180          211 D--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSD  287 (491)
Q Consensus       211 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kL~D  287 (491)
                      .  ....||+||+.+.+...+..     .+....+..++.+++.||.|+|+.|   |+|||+||.|++||. .-.++|+|
T Consensus       105 p~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlID  176 (338)
T KOG0668|consen  105 PESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLID  176 (338)
T ss_pred             ccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeee
Confidence            5  45679999998877665542     3555667889999999999999999   999999999999985 45799999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      +|+|..........+   .+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||-....+.. .++..+. .++
T Consensus       177 WGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIak-VLG  251 (338)
T KOG0668|consen  177 WGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAK-VLG  251 (338)
T ss_pred             cchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHH-HhC
Confidence            999988765444332   356788999998864 5789999999999999999999999966554432 2222211 111


Q ss_pred             Cc------cchhhccCccccC-----------CC-----ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DK------RRFYRLLDPRLEG-----------HF-----SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~------~~~~~~~~~~l~~-----------~~-----~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..      ..+.-.+||.+.+           .|     ..-.++++.+|+.++|..|..+|+|+.|++.|
T Consensus       252 t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  252 TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            10      0111112222211           00     01125889999999999999999999999865

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-34  Score=288.22  Aligned_cols=252  Identities=24%  Similarity=0.385  Sum_probs=207.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+...+|.|+||.||+++++.         ++...|+|+++.....+..-+..|+-+++..+|||||.++|.|...+
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~---------s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d   85 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKR---------SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD   85 (829)
T ss_pred             cchhheeeecCCcccchhhhcccc---------cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc
Confidence            579999999999999999999987         78899999998776666677788999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      .+|++||||.+|+|.+.-+-.+  ++++.++..+++..++||+|||+.+   =+|||||-.|||+++.|.+||+|||.+.
T Consensus        86 klwicMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsa  160 (829)
T KOG0576|consen   86 KLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSA  160 (829)
T ss_pred             CcEEEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchh
Confidence            9999999999999999776554  7889999999999999999999988   8999999999999999999999999987


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      .+...  ......+.||++|||||+..   .+.|...+|||++|++..|+-.-++|.....+.....+....        
T Consensus       161 qitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS--------  230 (829)
T KOG0576|consen  161 QITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS--------  230 (829)
T ss_pred             hhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc--------
Confidence            66432  12234578999999999764   578999999999999999999888886554443222221110        


Q ss_pred             chhhccC-ccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011180          370 RFYRLLD-PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  414 (491)
Q Consensus       370 ~~~~~~~-~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~  414 (491)
                          .++ |.+.+  ..+-+..+.+|++.||.++|++||+++.+|.
T Consensus       231 ----~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  231 ----GFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ----CCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                011 11111  1123678899999999999999999987765

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=2.6e-33  Score=291.67  Aligned_cols=246  Identities=29%  Similarity=0.408  Sum_probs=187.3

Q ss_pred             CCcCcccccCCceE-EEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEEeecC
Q 011180          135 FRPESLLGEGGFGC-VFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDD  212 (491)
Q Consensus       135 y~~~~~lG~G~fg~-Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~  212 (491)
                      |...+++|.|+-|+ ||+|.+.           |+.||||.+-.+.   ..-..+||..|+.-+ |||||++|+.-.+.+
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q  576 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ  576 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence            45567899999875 7999884           6799999885432   234578999999885 999999999988889


Q ss_pred             ceEEEEEecCCCChHHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---C--CCeEE
Q 011180          213 QRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---D--YNAKL  285 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~---~--~~~kL  285 (491)
                      ..||+.|+| ..+|.+++...+  .........+.+..|++.||++||+.+   ||||||||.||||..   +  ..++|
T Consensus       577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~i  652 (903)
T KOG1027|consen  577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKI  652 (903)
T ss_pred             eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEe
Confidence            999999999 679999997641  111111334678899999999999988   999999999999965   2  57999


Q ss_pred             eccCCcccCCCCCCce-eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCcchhhHhhhc
Q 011180          286 SDFGLAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      +|||+++.+..+.... ......||-+|+|||++.....+.++||||||||+|+.++| ..||......+.        .
T Consensus       653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------N  724 (903)
T KOG1027|consen  653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------N  724 (903)
T ss_pred             cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------h
Confidence            9999999886543221 12346799999999999999889999999999999998887 889965432211        0


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+.....+.. +.+        ....++.+||.+|++.+|..||++.+||.|
T Consensus       725 Il~~~~~L~~-L~~--------~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  725 ILTGNYTLVH-LEP--------LPDCEAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             hhcCccceee-ecc--------CchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            1111111100 000        001288999999999999999999999976

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=8.9e-33  Score=260.24  Aligned_cols=261  Identities=23%  Similarity=0.308  Sum_probs=197.1

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +|.-...+|.|.- .|--|.+.-         .+..||+|.+...  .....++..+|+.++..+.|+||++++.+|.-.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v---------~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQV---------LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ   87 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhh---------ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence            5777788999988 565565543         6778999988644  223457788999999999999999999998754


Q ss_pred             ------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          212 ------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       212 ------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                            ...|+||||| ..+|...+..    .++-.....|+.|++.|++|||+.+   |+||||||+||++..++.+||
T Consensus        88 ~~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi  159 (369)
T KOG0665|consen   88 KTLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKI  159 (369)
T ss_pred             ccHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheee
Confidence                  3579999999 6789888862    4566778899999999999999999   999999999999999999999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH------
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE------  359 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~------  359 (491)
                      +|||+|+....+   -..+..+.|..|.|||++.+..|...+||||+||++.||++|.-.|.+....+....+.      
T Consensus       160 ~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp  236 (369)
T KOG0665|consen  160 LDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP  236 (369)
T ss_pred             ccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence            999999875433   34566789999999999998889999999999999999999999987543322211110      


Q ss_pred             ----------hhhcccCCc-----cchhhccCc-cc--cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          360 ----------WARPHLGDK-----RRFYRLLDP-RL--EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       360 ----------~~~~~~~~~-----~~~~~~~~~-~l--~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                .++......     ..+.+.+.. .+  ..+.+......+.+|+.+||..||++|.+++++|+|
T Consensus       237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                      000000000     111111111 00  011112235678999999999999999999999987

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.2e-30  Score=241.93  Aligned_cols=212  Identities=37%  Similarity=0.601  Sum_probs=184.1

Q ss_pred             cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEEEE
Q 011180          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE  219 (491)
Q Consensus       141 lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E  219 (491)
                      ||+|++|.||++....         ++..+++|++...... ....+.+|+++++.+.|++|+++++++......+++||
T Consensus         1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e   71 (215)
T cd00180           1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME   71 (215)
T ss_pred             CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence            6899999999998864         4678999999766432 34678899999999999999999999999899999999


Q ss_pred             ecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCCeEEeccCCcccCCCCC
Q 011180          220 FMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDAPEDG  298 (491)
Q Consensus       220 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kL~DFGla~~~~~~~  298 (491)
                      |+++++|.+++.... ..+++..+..++.+++.+|.|||+.+   ++|+||+|.||+++. ++.++|+|||.+.......
T Consensus        72 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          72 YCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             cCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            999899999987653 36888999999999999999999988   999999999999998 8999999999998764432


Q ss_pred             CceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCc
Q 011180          299 KTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  377 (491)
Q Consensus       299 ~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (491)
                      .  ......+...|++||.+... .++.+.|+|++|+++++|                                      
T Consensus       148 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------  187 (215)
T cd00180         148 S--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------  187 (215)
T ss_pred             c--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence            1  12235578899999998877 888999999999999999                                      


Q ss_pred             cccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       378 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                                 ..+.+++.+||..||.+||++.+++++|
T Consensus       188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                       2457899999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=274.39  Aligned_cols=196  Identities=24%  Similarity=0.342  Sum_probs=169.8

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccH--------HHHHHHHHHHhcCC---CCcee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--------KEWLAEVNFLGNLL---HPNLV  202 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~E~~il~~l~---HpnIv  202 (491)
                      +|..++.||+|+||.|++|.++.+         ...|+||.+.+...-..        -.+-.||+||..|+   |+||+
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n---------~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIl  632 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKEN---------NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENIL  632 (772)
T ss_pred             cceeeeeccccccceEEEeeeccc---------ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchh
Confidence            689999999999999999999874         45899999987643211        12346999999998   99999


Q ss_pred             eeeeEEeecCceEEEEEec-CCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 011180          203 KLVGYCIEDDQRLLVYEFM-PRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~  281 (491)
                      +++++|++++.+||+||-- ++.+|.++|..+.  .+.+..+..|+.||+.|+++||+.+   |||||||-+|+.++.+|
T Consensus       633 KlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g  707 (772)
T KOG1152|consen  633 KLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNG  707 (772)
T ss_pred             hhhheeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCC
Confidence            9999999999999999975 4569999998776  5788889999999999999999999   99999999999999999


Q ss_pred             CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCC
Q 011180          282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMD  347 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~  347 (491)
                      .+||+|||.+.......    ...++||..|.|||++.+..|- ..-|||++|++||.++....||.
T Consensus       708 ~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  708 FVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999999998764432    3447899999999999988774 56899999999999999988885

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3e-31  Score=244.52  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=190.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeE-Eee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGY-CIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~-~~~  210 (491)
                      +.|.+.+.||+|.||.+-+|.++.         +...+++|.+.... ...++|.+|...--.|. |.||+.-|++ |+.
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~---------s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQ---------SKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccC---------CceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            469999999999999999999987         66789999987664 44678999998776675 9999988865 667


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-C-CCCCeEEecc
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-D-ADYNAKLSDF  288 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl-~-~~~~~kL~DF  288 (491)
                      .+.++++|||++.|+|...+...   .+-+.....++.|++.||.|+|+.+   +||||||.+|||| + +..++|||||
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             CceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeec
Confidence            78888999999999999888654   4677788899999999999999988   9999999999999 3 3358999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      |+.+..+..-     ...--+..|.+||.+...     ...+.+|||.||+++|..+||++||......+. ...+|..-
T Consensus       168 G~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~~~~w  241 (378)
T KOG1345|consen  168 GLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWEWEQW  241 (378)
T ss_pred             ccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHHHHHH
Confidence            9988653211     112346679999987532     345679999999999999999999985443332 22333221


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .........+.+.+         .+..+..+.++-|..++.+|-...++-+.
T Consensus       242 ~~rk~~~~P~~F~~---------fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  242 LKRKNPALPKKFNP---------FSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             hcccCccCchhhcc---------cCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            11111111111111         16778899999999999999555554443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.4e-29  Score=238.69  Aligned_cols=200  Identities=35%  Similarity=0.468  Sum_probs=173.5

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeecCc
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  213 (491)
                      |.+.+.||.|+||.||+|.+..         ++..+|+|.+...... ..+.+.+|++.++.++|+||+++++++.....
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~   71 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP   71 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence            5677899999999999998875         4668999999876544 56788899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          214 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      .++++||+++++|.+++..... .+++..+..++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        72 ~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~  147 (225)
T smart00221       72 LYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARF  147 (225)
T ss_pred             eEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence            9999999999999999876542 2788999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCCceeeeccccCCCCCCchhh-hcCCCCccccchhHHHHHHHHHhCCCCCCC
Q 011180          294 APEDGKTHVSTRVMGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEMLTGRRSMDK  348 (491)
Q Consensus       294 ~~~~~~~~~~~~~~Gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltG~~pf~~  348 (491)
                      ....... ......++..|++||.+ ....++.++|+|+||+++|+|++|+.||..
T Consensus       148 ~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      148 IHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            6543211 12335688899999998 666788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=1.6e-30  Score=253.46  Aligned_cols=272  Identities=26%  Similarity=0.335  Sum_probs=200.4

Q ss_pred             hHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeee
Q 011180          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLV  205 (491)
Q Consensus       127 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~  205 (491)
                      .+....+.|.++++||+|+|++||++.+....      .....||+|.+.....  ...+..|+++|..+. +.||+++.
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~------~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~  101 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQD------TKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLN  101 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhc------cccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcch
Confidence            34455567999999999999999999987631      2567899999976643  356889999999996 99999999


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC-CCCCeE
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAK  284 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~-~~~~~k  284 (491)
                      +++..++++++||||++.....+++.     .++...+..+++.++.||.++|.+|   ||||||||+|+|++ ..+.-.
T Consensus       102 ~~~rnnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~  173 (418)
T KOG1167|consen  102 GCFRNNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGV  173 (418)
T ss_pred             hhhccCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCce
Confidence            99999999999999999988888874     3456788899999999999999999   99999999999997 457889


Q ss_pred             EeccCCcccCCC------------------CCC----------------c--------eeeeccccCCCCCCchhhhc-C
Q 011180          285 LSDFGLAKDAPE------------------DGK----------------T--------HVSTRVMGTYGYAAPEYVMT-G  321 (491)
Q Consensus       285 L~DFGla~~~~~------------------~~~----------------~--------~~~~~~~Gt~~y~aPE~~~~-~  321 (491)
                      |+|||+|.....                  .+.                .        ...-...||++|.|||++.. .
T Consensus       174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~  253 (418)
T KOG1167|consen  174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP  253 (418)
T ss_pred             EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence            999999872100                  000                0        00112469999999999875 4


Q ss_pred             CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh----------cc------cCC---------ccchhhccC
Q 011180          322 HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR----------PH------LGD---------KRRFYRLLD  376 (491)
Q Consensus       322 ~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~----------~~------~~~---------~~~~~~~~~  376 (491)
                      ..+.++||||.|||+.-+++++.||-...... ..+.+.+.          ..      +..         ...-++-++
T Consensus       254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~  332 (418)
T KOG1167|consen  254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLH  332 (418)
T ss_pred             CcCCccceeeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccC
Confidence            67889999999999999999999996433221 11111100          00      000         000011111


Q ss_pred             --cccc-------C-CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          377 --PRLE-------G-HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       377 --~~l~-------~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        ....       . ......+..+.+|+.+||..||.+|.|++++|.|
T Consensus       333 ~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  333 IESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             hhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence              0000       0 0111124588999999999999999999999976

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=2.8e-29  Score=280.34  Aligned_cols=197  Identities=20%  Similarity=0.278  Sum_probs=141.0

Q ss_pred             cCCC-CceeeeeeEE-------eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 011180          195 NLLH-PNLVKLVGYC-------IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVI  266 (491)
Q Consensus       195 ~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  266 (491)
                      .+.| .||+.++++|       .....++++|||+ +++|.++|... ...+++..++.++.||+.||.|||+++   ||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            4445 5788888877       2334567889988 67999999654 336899999999999999999999988   99


Q ss_pred             ecCCCCCcEEECC-------------------CCCeEEeccCCcccCCCCCC--------------ceeeeccccCCCCC
Q 011180          267 YRDFKTSNILLDA-------------------DYNAKLSDFGLAKDAPEDGK--------------THVSTRVMGTYGYA  313 (491)
Q Consensus       267 HrDlKp~NILl~~-------------------~~~~kL~DFGla~~~~~~~~--------------~~~~~~~~Gt~~y~  313 (491)
                      ||||||+||||+.                   ++.+||+|||+++.......              .......+||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   44566666666654211000              00011246899999


Q ss_pred             CchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHH
Q 011180          314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQ  393 (491)
Q Consensus       314 aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  393 (491)
                      |||++.+..|+.++|||||||+||||++|.+|+.....    .......          ..+.+..     ......+.+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~----------~~~~~~~-----~~~~~~~~~  243 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH----------RVLPPQI-----LLNWPKEAS  243 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH----------hhcChhh-----hhcCHHHHH
Confidence            99999999999999999999999999999887642110    0000000          0111110     011345678


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHH
Q 011180          394 LAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       394 li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ++.+||+.||.+||++.+|+++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhhc
Confidence            9999999999999999999875

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=3.4e-26  Score=229.26  Aligned_cols=263  Identities=22%  Similarity=0.245  Sum_probs=200.1

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCC----CceeeeeeEE-
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH----PNLVKLVGYC-  208 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H----pnIv~l~~~~-  208 (491)
                      +|.+.+.||+|+||.||+|......        ...+|+|+...........+..|+.+|..+..    .++..+++.. 
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~   90 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR   90 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence            7999999999999999999986531        35799998876533322367788998888873    6889999888 


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-----CCe
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-----YNA  283 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~-----~~~  283 (491)
                      ......++||+.+ |.+|.++........++...+..|+.|++.+|++||+.|   +|||||||+|+++...     ..+
T Consensus        91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceE
Confidence            4777889999998 999999886665568999999999999999999999998   9999999999999754     469


Q ss_pred             EEeccCCcc--cCCCCCCc---ee---eeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011180          284 KLSDFGLAK--DAPEDGKT---HV---STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  355 (491)
Q Consensus       284 kL~DFGla~--~~~~~~~~---~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~  355 (491)
                      .|.|||+++  ........   ..   .....||..|+++....+...+.+.|+||++.++.||+.|..||.........
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~  246 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK  246 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence            999999998  33222211   11   12356999999999999999999999999999999999999998654432221


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ..........        ....     +....+..+.++...+-..+...+|....+...|+.+..
T Consensus       247 ~~~~~~~~~~--------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  247 SKFEKDPRKL--------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             HHHHHHhhhh--------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            1111100000        0000     112225667777777777999999999999998776544

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.6e-26  Score=217.45  Aligned_cols=260  Identities=19%  Similarity=0.243  Sum_probs=202.1

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~  212 (491)
                      +|++.++||+|+||+.|+|.+.-         +++.||||.-....  ..-++..|.+..+.|. .++|...|-+..++-
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~---------nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~   97 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLY---------NNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK   97 (449)
T ss_pred             cceeccccccCcceeeecccccc---------cCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence            69999999999999999998876         57799999875442  3356777888888886 799999998888888


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-----CCeEEec
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-----YNAKLSD  287 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~-----~~~kL~D  287 (491)
                      +..||||++ |.+|+|++.-.++ .|+...+..+|.|++.-++|+|++.   +|+|||||+|+||...     ..+.|+|
T Consensus        98 ~NiLVidLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiD  172 (449)
T KOG1165|consen   98 YNILVIDLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIID  172 (449)
T ss_pred             hhhhhhhhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEe
Confidence            889999999 9999999987765 7999999999999999999999988   9999999999999643     4689999


Q ss_pred             cCCcccCCCCCCc-e----eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          288 FGLAKDAPEDGKT-H----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       288 FGla~~~~~~~~~-~----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||+|+...+.... +    ......||..||+--...+.+.+.+.|+-|||-+++.+|-|..||.+..........+.  
T Consensus       173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK--  250 (449)
T KOG1165|consen  173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK--  250 (449)
T ss_pred             ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH--
Confidence            9999977554322 1    12346799999999999999999999999999999999999999987654433222221  


Q ss_pred             cccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                        +++..+...      ...+....+.++...++-.-..+-.+-|+.+-+...+..+
T Consensus       251 --IGe~Kr~T~------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv  299 (449)
T KOG1165|consen  251 --IGETKRSTP------IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV  299 (449)
T ss_pred             --hccccccCC------HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence              111111000      0001112267777777777788888999988776665543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=9.5e-27  Score=212.24  Aligned_cols=167  Identities=26%  Similarity=0.289  Sum_probs=125.7

Q ss_pred             CChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceee
Q 011180          224 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS  303 (491)
Q Consensus       224 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  303 (491)
                      |+|.+++...+ ..+++..++.++.||+.||.|||+.+         ||+|||++.++.+|+  ||++......      
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence            68999997653 36999999999999999999999865         999999999999999  9998765432      


Q ss_pred             eccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCC
Q 011180          304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF  383 (491)
Q Consensus       304 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  383 (491)
                       ...||+.|||||++.+..++.++|||||||++|||++|+.||........  ............       ++. ....
T Consensus        63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~-------~~~-~~~~  131 (176)
T smart00750       63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMPAD-------DPR-DRSN  131 (176)
T ss_pred             -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhccC-------Ccc-cccc
Confidence             12589999999999999999999999999999999999999965432111  111110000000       000 0000


Q ss_pred             ChhhHH--HHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          384 SIKGSQ--KATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       384 ~~~~~~--~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ......  .+.++|.+||..||.+||++.++++++..+
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            111222  689999999999999999999999998644

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=3.2e-26  Score=229.95  Aligned_cols=177  Identities=19%  Similarity=0.161  Sum_probs=134.1

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-----cccHHHHHHHHHHHhcCCCCceee-
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGNLLHPNLVK-  203 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~-  203 (491)
                      ...++|.+.+.||+|+||+||+|++...        ++..||||++....     ......+.+|+++|..|.|+||+. 
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~   86 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ   86 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence            3446799999999999999999988642        45678999875331     112456889999999999999985 


Q ss_pred             eeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEECCCCC
Q 011180          204 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF-KTSNILLDADYN  282 (491)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl-Kp~NILl~~~~~  282 (491)
                      +++    .+..||||||++|++|.. +..     ..   ...++.|++++|.|||+.+   |+|||| ||+|||++.++.
T Consensus        87 l~~----~~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~  150 (365)
T PRK09188         87 LLA----TGKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGE  150 (365)
T ss_pred             EEE----cCCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCC
Confidence            443    246799999999999963 211     11   1457889999999999988   999999 999999999999


Q ss_pred             eEEeccCCcccCCCCCCcee------eeccccCCCCCCchhhhcC------CCCccccch
Q 011180          283 AKLSDFGLAKDAPEDGKTHV------STRVMGTYGYAAPEYVMTG------HLTSKSDVY  330 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~------~~~~~Gt~~y~aPE~~~~~------~~~~~~Dvw  330 (491)
                      +||+|||+|+.+........      -+..++++.|+|||.+...      ..+...|-|
T Consensus       151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99999999997654332111      1346789999999988643      223346666

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-26  Score=209.85  Aligned_cols=264  Identities=19%  Similarity=0.226  Sum_probs=206.6

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCC-CceeeeeeEEe
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH-PNLVKLVGYCI  209 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~  209 (491)
                      ..+.|++++.||.|+||.+|+|....         +|..||||+-+...  ...++..|.++.+.|++ ..|..+..+..
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~---------~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~   81 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISIT---------SGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGT   81 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeecc---------CCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcc
Confidence            34679999999999999999999876         68899999986553  33567889999999974 67888888888


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---CCCeEEe
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLS  286 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~---~~~~kL~  286 (491)
                      +.....|||+++ |.+|.+++.-... .++..+++.++-|++.-++|+|..+   +|||||||+|+|..-   ...+.|+
T Consensus        82 e~~ynvlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LI  156 (341)
T KOG1163|consen   82 EKDYNVLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLI  156 (341)
T ss_pred             ccccceeeeecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEE
Confidence            888999999999 9999999876643 6888999999999999999999988   999999999999853   3579999


Q ss_pred             ccCCcccCCCCCCc-----eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          287 DFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       287 DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      |||+|+...+....     .......||..|.+--.+.+...+.+.|+-|+|.+|..+.-|..||.+..........+..
T Consensus       157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI  236 (341)
T KOG1163|consen  157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI  236 (341)
T ss_pred             eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence            99999876543221     1223478999999988888888999999999999999999999999887666554433322


Q ss_pred             hcc-cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          362 RPH-LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       362 ~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ... +..   ..+.+        ....+.++.-.+.-|-..--.+-|+..-+.+.+..|.+
T Consensus       237 ~EkK~s~---~ie~L--------C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  237 SEKKMST---PIEVL--------CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             HHhhcCC---CHHHH--------hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence            110 000   00111        11226778888899988889999998887777665433

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=2e-24  Score=212.81  Aligned_cols=260  Identities=33%  Similarity=0.461  Sum_probs=197.9

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCC-ceeeeeeEEee
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHP-NLVKLVGYCIE  210 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~Hp-nIv~l~~~~~~  210 (491)
                      |.+...||.|+||.||++.+.            ..+++|.+......   ....+.+|+.++..+.|+ +|+++++++..
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   69 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD   69 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence            677889999999999999886            36999999765433   356789999999999988 79999999977


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-CeEEecc
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDF  288 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kL~DF  288 (491)
                      ....+++++|+.+++|.+++..... ..+.......++.|++.++.|+|..+   ++||||||+|||++..+ .++++||
T Consensus        70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~df  146 (384)
T COG0515          70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDF  146 (384)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEecc
Confidence            7778999999999999966654431 25788889999999999999999998   99999999999999988 7999999


Q ss_pred             CCcccCCCCCCce----eeeccccCCCCCCchhhhc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCC-CcchhhHh
Q 011180          289 GLAKDAPEDGKTH----VSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEW  360 (491)
Q Consensus       289 Gla~~~~~~~~~~----~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~-~~~~~~~~  360 (491)
                      |++..........    ......||..|+|||.+.+   ..+....|+||+|++++++++|..||...... ........
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~  226 (384)
T COG0515         147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI  226 (384)
T ss_pred             CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence            9998654433221    2345789999999999987   57889999999999999999999997654431 01111111


Q ss_pred             hhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .......      .................+.+++..|+..+|..|.+..+....
T Consensus       227 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         227 ILELPTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHhcCCc------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111100      000000000001223678899999999999999999887765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=2.2e-26  Score=245.64  Aligned_cols=256  Identities=20%  Similarity=0.248  Sum_probs=189.4

Q ss_pred             CcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEec----CCC-cc-cHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN----HDG-LQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       136 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~----~~~-~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ....++|.|++|.|+.+.......         .++.|...    ... .. ....+..|+-+-..|.|+|++..+..+.
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~---------~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~  391 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLK---------SFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ  391 (601)
T ss_pred             CccceeeecccCceEEEEecCCCc---------cchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence            456789999999887776654222         23333322    111 11 1122556888888899999998888877


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +....+-+||||++ +|..++...+  .+....+-.++.|++.||+|||..|   |.|||||++|+|+..+|.+||+|||
T Consensus       392 ~~~~~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  392 EIDGILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             hcccchhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecC
Confidence            77666666999999 9999987653  4667778899999999999999999   9999999999999999999999999


Q ss_pred             CcccCCCCCCc--eeeeccccCCCCCCchhhhcCCCCc-cccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          290 LAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       290 la~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~-~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      .+..+......  .....++|+..|+|||++.+..|+. ..||||.|++++.|++|+.||......+.............
T Consensus       466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~  545 (601)
T KOG0590|consen  466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN  545 (601)
T ss_pred             cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc
Confidence            99876554444  5566789999999999999999986 58999999999999999999976554443210000000000


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .......         .....+...+.+|.+||+.||.+|.|+++|++.
T Consensus       546 ~~~~~~~---------~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  546 IFEGPNR---------LLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             cccChHH---------HHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            0000000         011226778999999999999999999999863

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=7.3e-25  Score=202.37  Aligned_cols=247  Identities=24%  Similarity=0.367  Sum_probs=194.3

Q ss_pred             CcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEeecCc
Q 011180          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (491)
Q Consensus       136 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  213 (491)
                      .+..+|.+...|..|+|++..           ..+++|++......  ..++|..|.-.|+-+.||||+.++|.|.....
T Consensus       193 nl~tkl~e~hsgelwrgrwqg-----------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn  261 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQG-----------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN  261 (448)
T ss_pred             hhhhhhccCCCcccccccccC-----------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence            344568899999999999964           35778888655432  23678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec-CCCCCcEEECCCCCeEEe--ccCC
Q 011180          214 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYR-DFKTSNILLDADYNAKLS--DFGL  290 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHr-DlKp~NILl~~~~~~kL~--DFGl  290 (491)
                      +.+|..||+.|+|+..|........+..++.+++++|++|++|||+..+  +|-| -|....++||++.+.+|.  |--+
T Consensus       262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheeccccee
Confidence            9999999999999999998877778888999999999999999999773  4444 689999999999888775  3222


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCC---ccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~---~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      +..  +       ......+.||+||.+....-+   .++|+|||.++||||.|...||....+.+..-.+.        
T Consensus       340 sfq--e-------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--------  402 (448)
T KOG0195|consen  340 SFQ--E-------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--------  402 (448)
T ss_pred             eee--c-------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--------
Confidence            111  1       112347899999999865433   47999999999999999999998766554321111        


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                              -..+...+++..+..+..|+.-|+..||.+||.+..|+-.|+.++
T Consensus       403 --------leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  403 --------LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --------hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                    011233445556888999999999999999999999999888653

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=6.2e-24  Score=199.20  Aligned_cols=174  Identities=10%  Similarity=0.084  Sum_probs=135.1

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHH---------HHHHHHHHhcCCCC
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---------WLAEVNFLGNLLHP  199 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~il~~l~Hp  199 (491)
                      +...++|++.++||.|+||.||++..           ++..+|||++..........         +.+|++.+.+|.|+
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~   95 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE   95 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC
Confidence            35567999999999999999998644           23369999997543322221         57899999999999


Q ss_pred             ceeeeeeEEeec--------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 011180          200 NLVKLVGYCIED--------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  271 (491)
Q Consensus       200 nIv~l~~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlK  271 (491)
                      +|..+..++...        +..+|||||++|.+|.++.      .++.    ....+++.+|..||..+   |+|||||
T Consensus        96 GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dik  162 (232)
T PRK10359         96 GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHG---MVSGDPH  162 (232)
T ss_pred             CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcC---CccCCCC
Confidence            999999886643        3578999999999998873      2222    24558999999999998   9999999


Q ss_pred             CCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh
Q 011180          272 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT  341 (491)
Q Consensus       272 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt  341 (491)
                      |+||+++.++ ++|+|||...........              -.++....|+.++|+|+||+++..+..
T Consensus       163 p~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        163 KGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             hHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            9999999988 999999988765322111              013556667789999999999876653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=5.6e-23  Score=189.90  Aligned_cols=139  Identities=17%  Similarity=0.172  Sum_probs=107.7

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--c-------H-----------------HHHHHHHH
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--G-------H-----------------KEWLAEVN  191 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~  191 (491)
                      ...||+|+||.||+|.+.          +|..||||+++.....  .       .                 .....|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   71 (190)
T cd05147           2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR   71 (190)
T ss_pred             CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence            468999999999999874          4678999999754221  1       0                 12235999


Q ss_pred             HHhcCCCCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCC
Q 011180          192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL-HEEAEKPVIYRDF  270 (491)
Q Consensus       192 il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~~~iiHrDl  270 (491)
                      +|..|.+++|.....+..  ...+|||||+++++|...+...  ..++...+..++.|++.+|.|| |+.+   |+||||
T Consensus        72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDl  144 (190)
T cd05147          72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR---LVHADL  144 (190)
T ss_pred             HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence            999998877754433322  2348999999887776554333  2678889999999999999999 6878   999999


Q ss_pred             CCCcEEECCCCCeEEeccCCcccC
Q 011180          271 KTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       271 Kp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      ||+|||++ ++.++|+|||+|...
T Consensus       145 kP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         145 SEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CHHHEEEE-CCcEEEEEccccccC
Confidence            99999998 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=1.7e-23  Score=223.82  Aligned_cols=249  Identities=24%  Similarity=0.310  Sum_probs=181.9

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC----cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      +|...+.||.+.|=+|.+|++.+          |. |+||++-+..    +...++.+.|++ ...++|||++++.-+..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~   91 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV   91 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence            57788999999999999998874          44 8999986543    223445556666 66678999999998888


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      .+...|||-+|+ .-+|+|.|..+.  -+...+.+-|+.|++.||.-+|..+   |+|||||.+||||+.-.-+.|+||.
T Consensus        92 t~kAAylvRqyv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFA  165 (1431)
T KOG1240|consen   92 TDKAAYLVRQYV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFA  165 (1431)
T ss_pred             hhHHHHHHHHHH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhccc
Confidence            888889999999 459999997664  3566677789999999999999999   9999999999999999999999998


Q ss_pred             Cccc--CCCCCCce---eeeccccCCCCCCchhhhcC-----------CCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 011180          290 LAKD--APEDGKTH---VSTRVMGTYGYAAPEYVMTG-----------HLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPN  352 (491)
Q Consensus       290 la~~--~~~~~~~~---~~~~~~Gt~~y~aPE~~~~~-----------~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~  352 (491)
                      .-+.  +++++...   ...+...-..|.|||.+...           ..+++.||||+||+++||++ |+++|.-.   
T Consensus       166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---  242 (1431)
T KOG1240|consen  166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---  242 (1431)
T ss_pred             ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---
Confidence            6542  33332221   11122223479999988542           25778999999999999887 57777421   


Q ss_pred             CcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                         .+..+....-.+.....+.+           ....++.||..|++.||++|.++++.|+.-.
T Consensus       243 ---QL~aYr~~~~~~~e~~Le~I-----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  243 ---QLLAYRSGNADDPEQLLEKI-----------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             ---HHHhHhccCccCHHHHHHhC-----------cCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence               22222111111111111111           1346789999999999999999999997643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=6.4e-24  Score=217.25  Aligned_cols=229  Identities=30%  Similarity=0.372  Sum_probs=181.5

Q ss_pred             ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc--HHHHHHHHHHHhcCC-CCceeeeeeEEeecCceEE
Q 011180          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLL  216 (491)
Q Consensus       140 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l  216 (491)
                      .+|.|+||.|++++-....      ..|..+|+|++++.....  ......|..++..++ ||.+|++...+..+...++
T Consensus         1 vlg~g~~gkvfLvrk~~g~------da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l   74 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGA------DAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL   74 (612)
T ss_pred             CCCcCCCcchHHHHHhccc------cccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence            4799999999987643321      256789999887654321  113445888888887 9999999999999999999


Q ss_pred             EEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCC
Q 011180          217 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  296 (491)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~  296 (491)
                      ++++..+|.|...+....  .+.+.....+...++-+++++|+.+   |+|||+|++||+++.+|++++.|||+++...+
T Consensus        75 ~ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   75 ILDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             hhhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHh
Confidence            999999999988876554  4566666777788999999999999   99999999999999999999999999987654


Q ss_pred             CCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccC
Q 011180          297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  376 (491)
Q Consensus       297 ~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (491)
                      ...      .|||..|||||++.  ....++|.||||++++||++|..||..    +.      ....+          .
T Consensus       150 ~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~------~~~Il----------~  201 (612)
T KOG0603|consen  150 EKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DT------MKRIL----------K  201 (612)
T ss_pred             hhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HH------HHHHh----------h
Confidence            322      28999999999987  677899999999999999999999965    11      11111          0


Q ss_pred             ccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH
Q 011180          377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM  409 (491)
Q Consensus       377 ~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~  409 (491)
                        ..-.++...+..+.+++..++.++|..|.-.
T Consensus       202 --~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  202 --AELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             --hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence              1112334457889999999999999999654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=7e-22  Score=182.89  Aligned_cols=142  Identities=17%  Similarity=0.152  Sum_probs=110.8

Q ss_pred             cCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc--------------------------HHHHHHHH
Q 011180          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--------------------------HKEWLAEV  190 (491)
Q Consensus       137 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~  190 (491)
                      +.+.||+|+||.||+|.+.          +|..||||+++......                          ...+.+|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   70 (190)
T cd05145           1 INGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF   70 (190)
T ss_pred             CCceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH
Confidence            3578999999999999864          46799999997652110                          11235789


Q ss_pred             HHHhcCCCCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecC
Q 011180          191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRD  269 (491)
Q Consensus       191 ~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrD  269 (491)
                      ..+.++.|++|.....+...  ..+|||||++++++...+...  ..++......++.|++.+|.+||+ .+   |+|||
T Consensus        71 ~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrD  143 (190)
T cd05145          71 RNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGD  143 (190)
T ss_pred             HHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence            99999999988655544333  348999999887654432222  256778889999999999999999 88   99999


Q ss_pred             CCCCcEEECCCCCeEEeccCCcccCCC
Q 011180          270 FKTSNILLDADYNAKLSDFGLAKDAPE  296 (491)
Q Consensus       270 lKp~NILl~~~~~~kL~DFGla~~~~~  296 (491)
                      |||+|||++ ++.++|+|||++.....
T Consensus       144 lkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         144 LSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CChhhEEEE-CCCEEEEEcccceecCC
Confidence            999999998 88999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5.9e-22  Score=191.92  Aligned_cols=262  Identities=21%  Similarity=0.289  Sum_probs=173.4

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCccc--------------------------CCCCCeEEEEEEecCCCc-ccHH
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPV--------------------------KPGTGLTVAVKTLNHDGL-QGHK  184 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~--------------------------~~~~~~~vavK~~~~~~~-~~~~  184 (491)
                      .++|.+...||+|.-..||.|+...++...-                          ......+.|||.+-.-.. ....
T Consensus       156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~  235 (598)
T KOG4158|consen  156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA  235 (598)
T ss_pred             hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence            3579999999999999999998875332100                          011123567776532111 1111


Q ss_pred             H----HHHHHH--------------HHhc--------CCCCceeeeeeEEeec---------------------------
Q 011180          185 E----WLAEVN--------------FLGN--------LLHPNLVKLVGYCIED---------------------------  211 (491)
Q Consensus       185 ~----~~~E~~--------------il~~--------l~HpnIv~l~~~~~~~---------------------------  211 (491)
                      .    ..+|.-              ..+.        -.|||||++.++|.++                           
T Consensus       236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~  315 (598)
T KOG4158|consen  236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP  315 (598)
T ss_pred             HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence            1    111210              1111        2499999999988752                           


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE--CCCC--CeEEec
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--DADY--NAKLSD  287 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl--~~~~--~~kL~D  287 (491)
                      ..+|+||..+ ..+|..++-.+   ..+.....-++.|+++|+.|||.++   |.|||||.+||||  ++|+  .+.|+|
T Consensus       316 ~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaD  388 (598)
T KOG4158|consen  316 KTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVAD  388 (598)
T ss_pred             ceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcc
Confidence            2468999888 45899998655   3455666778899999999999999   9999999999999  4443  578999


Q ss_pred             cCCcccCCCCCCc----eeeeccccCCCCCCchhhhcCC------CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011180          288 FGLAKDAPEDGKT----HVSTRVMGTYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  357 (491)
Q Consensus       288 FGla~~~~~~~~~----~~~~~~~Gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~  357 (491)
                      ||++-.....+-.    .......|...-||||+....+      --.++|.|+.|.+.||++....||....... .+.
T Consensus       389 FGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~  467 (598)
T KOG4158|consen  389 FGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDT  467 (598)
T ss_pred             cceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-ech
Confidence            9987644332111    1122346888999999876421      1248999999999999999999997632211 111


Q ss_pred             hHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      ..+....+           |.    .+..++..+.+|+..+|+.||++|++..-..+.|
T Consensus       468 r~Yqe~qL-----------Pa----lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  468 RTYQESQL-----------PA----LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             hhhhhhhC-----------CC----CcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence            11111111           11    2234478899999999999999999976554443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=1.2e-21  Score=189.11  Aligned_cols=233  Identities=21%  Similarity=0.279  Sum_probs=149.7

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCC----------Cc
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLH----------PN  200 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~H----------pn  200 (491)
                      .+...+.||.|+|+.||.+++.+         +|+.+|+|+......   ...+++.+|.-....+.+          -.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~---------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r   83 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVE---------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR   83 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred             EEEEccccccCCceEEEEEEEcc---------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence            35567889999999999999976         889999999864432   234566666655544332          12


Q ss_pred             eeeeeeEEee---------cC--------ceEEEEEecCCCChHHHhh---hCCCC--CCCHHHHHHHHHHHHHHHHHHH
Q 011180          201 LVKLVGYCIE---------DD--------QRLLVYEFMPRGSLENHLF---RKGSL--PLPWSIRMKIALGAAKGLAFLH  258 (491)
Q Consensus       201 Iv~l~~~~~~---------~~--------~~~lV~E~~~~gsL~~~l~---~~~~~--~l~~~~~~~i~~qi~~aL~yLH  258 (491)
                      ++..++....         ..        ..+++|+-+ .++|.+++.   .....  .+....++.+..|+++.+++||
T Consensus        84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh  162 (288)
T PF14531_consen   84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH  162 (288)
T ss_dssp             B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence            2222222221         11        236788887 668887753   22211  2344555677789999999999


Q ss_pred             hcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC--------CCCccccch
Q 011180          259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--------HLTSKSDVY  330 (491)
Q Consensus       259 ~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--------~~~~~~Dvw  330 (491)
                      ..|   |+|+||+|+|+|++.+|.++|+||+.......   ..  .....+..|.+||.....        .++.+.|.|
T Consensus       163 ~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW  234 (288)
T PF14531_consen  163 SYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT---RY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAW  234 (288)
T ss_dssp             HTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTE---EE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHH
T ss_pred             hcc---eEecccceeeEEEcCCCCEEEcChHHHeecCc---ee--eccCCCcccCChhhhhhhcccCcccceeeeccCHH
Confidence            999   99999999999999999999999998775532   11  113346789999977542        578899999


Q ss_pred             hHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCC
Q 011180          331 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR  406 (491)
Q Consensus       331 SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~R  406 (491)
                      +||+++|.|++|..||....+......            .+.         ... ..++.++.||..+|+.||.+|
T Consensus       235 ~LG~~ly~lWC~~lPf~~~~~~~~~~~------------~f~---------~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  235 QLGITLYSLWCGRLPFGLSSPEADPEW------------DFS---------RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHSS-STCCCGGGSTSGG------------GGT---------TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHHccCCCCCCCccccccc------------cch---------hcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999999999999975432221110            110         011 348899999999999999987

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.6e-21  Score=179.36  Aligned_cols=189  Identities=17%  Similarity=0.090  Sum_probs=140.8

Q ss_pred             CcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc----HHHHHHHHHHHhcCC-CCceeeeeeEEee
Q 011180          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGNLL-HPNLVKLVGYCIE  210 (491)
Q Consensus       136 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~il~~l~-HpnIv~l~~~~~~  210 (491)
                      .+...|++|+||+||++..           .+..++.+.+.....-.    ...+.+|+++|++|. |++|++++++   
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---   70 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---   70 (218)
T ss_pred             ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence            4567899999999997654           34567777776543211    124778999999995 5889999886   


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCcEEECCCCCeEEeccC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF-KTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl-Kp~NILl~~~~~~kL~DFG  289 (491)
                       +..+++|||+.|.+|...+..        . ...++.|++.+|.++|..|   |+|||| ||+|||++.++.++|+|||
T Consensus        71 -~~~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         71 -DGRHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             -cCEEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECC
Confidence             446999999999998754321        1 1347789999999999999   999999 7999999999999999999


Q ss_pred             CcccCCCCCCc----ee-------eeccccCCCCCCchhhhcC-CCC-ccccchhHHHHHHHHHhCCCCCCCCCC
Q 011180          290 LAKDAPEDGKT----HV-------STRVMGTYGYAAPEYVMTG-HLT-SKSDVYSFGVVLLEMLTGRRSMDKNRP  351 (491)
Q Consensus       290 la~~~~~~~~~----~~-------~~~~~Gt~~y~aPE~~~~~-~~~-~~~DvwSlGvil~elltG~~pf~~~~~  351 (491)
                      ++.........    ..       .....+++.|++|+...-- ..+ .+.++++.|+-+|.++|++.++.....
T Consensus       138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            99865443310    00       0112368889999865422 223 567999999999999999998865544

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=2.5e-21  Score=211.07  Aligned_cols=250  Identities=19%  Similarity=0.201  Sum_probs=182.2

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCceeeee
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLV  205 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~  205 (491)
                      .+....|.|.+.||+|+||.||+|...          .|+.||+|+-+....-.   |.-=.+++.+|+   -+-|..+.
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~----------~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~  760 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHS----------NGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHIS  760 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecC----------CCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHH
Confidence            344567899999999999999999876          36789999987664321   111122333333   35566666


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC------
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA------  279 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~------  279 (491)
                      .++.-.+.-+||+||.+.|+|.+++..  ...+++..++.+..|++..|+.||..+   |||+||||+|+||..      
T Consensus       761 ~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~  835 (974)
T KOG1166|consen  761 SAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADS  835 (974)
T ss_pred             HHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCC
Confidence            667777788999999999999999973  347899999999999999999999999   999999999999932      


Q ss_pred             -CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011180          280 -DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  358 (491)
Q Consensus       280 -~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  358 (491)
                       .-.++|+|||.+..+.--.........++|-.+-.+|+..+..++..+|.|.|+.++|-||.|+..-.           
T Consensus       836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~-----------  904 (974)
T KOG1166|consen  836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV-----------  904 (974)
T ss_pred             cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh-----------
Confidence             34699999999987653333334556789999999999999999999999999999999999974310           


Q ss_pred             HhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                       +....+.....+.+..+           -....+|+..+|..|-..=|...++...|+..
T Consensus       905 -~~g~~~~~~~~~~Ry~~-----------~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~  953 (974)
T KOG1166|consen  905 -KNGSSWMVKTNFPRYWK-----------RDMWNKFFDLLLNPDCDTLPNLQELRTELEEV  953 (974)
T ss_pred             -cCCcceeccccchhhhh-----------HHHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence             00000000000111111           23445778888885555557777777777654

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=6.3e-21  Score=178.11  Aligned_cols=136  Identities=19%  Similarity=0.213  Sum_probs=106.1

Q ss_pred             CcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-----CCCceeeeeeEEee
Q 011180          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-----LHPNLVKLVGYCIE  210 (491)
Q Consensus       136 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~  210 (491)
                      .-..+||+|+||.||.  +..         ++.. +||++........+.+.+|+.+++.|     .||||++++|++.+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~---------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et   72 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPE---------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET   72 (210)
T ss_pred             CCcceecCCCceEEEE--CCC---------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence            3457899999999995  443         2333 69998765545567899999999999     57999999999988


Q ss_pred             cC---ceE-EEEEe--cCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCcEEECC----
Q 011180          211 DD---QRL-LVYEF--MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL-AFLHEEAEKPVIYRDFKTSNILLDA----  279 (491)
Q Consensus       211 ~~---~~~-lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL-~yLH~~~~~~iiHrDlKp~NILl~~----  279 (491)
                      +.   .++ +||||  +.+++|.+++.+.   .+++.  ..++.+++.++ +|||+++   ||||||||+|||++.    
T Consensus        73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~  144 (210)
T PRK10345         73 DCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISES  144 (210)
T ss_pred             CCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCC
Confidence            74   333 78999  5579999999653   35544  35577778777 9999999   999999999999974    


Q ss_pred             CCCeEEeccCCc
Q 011180          280 DYNAKLSDFGLA  291 (491)
Q Consensus       280 ~~~~kL~DFGla  291 (491)
                      ++.++|+||+.+
T Consensus       145 ~~~~~LiDg~G~  156 (210)
T PRK10345        145 EVIPVVCDNIGE  156 (210)
T ss_pred             CCcEEEEECCCC
Confidence            347999995544

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.85  E-value=8.6e-22  Score=210.81  Aligned_cols=209  Identities=27%  Similarity=0.400  Sum_probs=150.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .+|..+++|..|+||.||..+++.         +.+.+|+ .++++...     ++-  |+.....|.+|          
T Consensus        83 ~df~~IklisngAygavylvrh~~---------trqrfa~-kiNkq~li-----lRn--ilt~a~npfvv----------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKE---------TRQRFAM-KINKQNLI-----LRN--ILTFAGNPFVV----------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccc---------cccchhh-cccccchh-----hhc--cccccCCccee----------
Confidence            479999999999999999999986         6678999 44443321     111  33333344444          


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                                 |+-..++...+.  ++...        +.+++|||+.+   |+|||+||+|+||+.-|++|+.|||++.
T Consensus       136 -----------gDc~tllk~~g~--lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk  191 (1205)
T KOG0606|consen  136 -----------GDCATLLKNIGP--LPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK  191 (1205)
T ss_pred             -----------chhhhhcccCCC--Ccchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhh
Confidence                       555666655443  33222        67899999988   9999999999999999999999999986


Q ss_pred             cCCCCCCc-------------eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011180          293 DAPEDGKT-------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       293 ~~~~~~~~-------------~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  359 (491)
                      .......+             -.....|||+.|+|||++....|+..+|+|++|+|+||++.|+.||.+..+.+....+ 
T Consensus       192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v-  270 (1205)
T KOG0606|consen  192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV-  270 (1205)
T ss_pred             hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh-
Confidence            43221111             0113468999999999999999999999999999999999999999887654332221 


Q ss_pred             hhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC
Q 011180          360 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP  407 (491)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP  407 (491)
                           +.+...+.+-         ......+++++|.++|+.+|..|-
T Consensus       271 -----isd~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  271 -----ISDDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             -----hhhhcccccc---------CcCCCHHHHHHHHHHHHhChHhhc
Confidence                 1111111111         112268899999999999999994

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1.6e-20  Score=192.35  Aligned_cols=218  Identities=25%  Similarity=0.427  Sum_probs=165.5

Q ss_pred             HhcCCCCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecCCC
Q 011180          193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPV-IYRDFK  271 (491)
Q Consensus       193 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i-iHrDlK  271 (491)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+... ...+++.....+.++|+.||.|||.-.   | .|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeec
Confidence            46788999999999999999999999999999999999774 557889999999999999999999865   4 899999


Q ss_pred             CCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-------CCCccccchhHHHHHHHHHhCCC
Q 011180          272 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-------HLTSKSDVYSFGVVLLEMLTGRR  344 (491)
Q Consensus       272 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-------~~~~~~DvwSlGvil~elltG~~  344 (491)
                      ..|++++....+||.|||+.................-..-|.|||.+...       ..+.+.||||||+++||+++...
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998776431111111122235679999988753       14667999999999999999999


Q ss_pred             CCCCCCCCCcc-hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011180          345 SMDKNRPNGEH-NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  422 (491)
Q Consensus       345 pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~  422 (491)
                      ||......... .++.....   ...   ..+.|.+....  ...+.+..++.+||..+|.+||+++.|-..++.+...
T Consensus       157 ~~~~~~~~~~~~eii~~~~~---~~~---~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK---GGS---NPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccccccCChHHHHHHHHh---cCC---CCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            99765443332 22222111   010   11112211111  2245789999999999999999999999998876554

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=6.8e-21  Score=191.70  Aligned_cols=174  Identities=27%  Similarity=0.412  Sum_probs=129.3

Q ss_pred             ceEEEEEecCCCChHHHhhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          213 QRLLVYEFMPRGSLENHLFRK-GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      .+||.|++|...+|.++|..+ .....++.....++.|++.|++|   ++   .+|||+||.||++..+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999643 23356778889999999999999   55   999999999999999999999999999


Q ss_pred             ccCCCCC----CceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccC
Q 011180          292 KDAPEDG----KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       292 ~~~~~~~----~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      .......    .....+..+||..||+||.+.+..|+.++||||||+||+||+. -...|+...      .       +.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~------t-------~~  470 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA------T-------LT  470 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH------h-------hh
Confidence            8775544    1123355789999999999999999999999999999999998 222221100      0       00


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV  412 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~ev  412 (491)
                      +.+  ...++|.....     -+.-..|+.++|...|.+||++.+.
T Consensus       471 d~r--~g~ip~~~~~d-----~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  471 DIR--DGIIPPEFLQD-----YPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhh--cCCCChHHhhc-----CcHHHHHHHHhcCCCcccCchHHHH
Confidence            000  01112112112     2344689999999999999954443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.4e-19  Score=167.46  Aligned_cols=134  Identities=19%  Similarity=0.283  Sum_probs=112.4

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--------cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      +.||+|++|.||+|.+           .|..|++|+.......        ....+.+|+.++..+.|++|.....++.+
T Consensus         2 ~~l~~G~~~~vy~~~~-----------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~   70 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-----------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD   70 (211)
T ss_pred             cccccCceEEEEEEee-----------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence            5799999999999987           2457899986543221        12357789999999999999888888778


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..++||||++|++|.+++....     . .+..++.+++.+|.+||+.+   ++|||++|+|||++ ++.++|+|||+
T Consensus        71 ~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         71 PENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             CCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCc
Confidence            888999999999999999885432     1 67889999999999999988   99999999999999 78999999998


Q ss_pred             ccc
Q 011180          291 AKD  293 (491)
Q Consensus       291 a~~  293 (491)
                      +..
T Consensus       141 a~~  143 (211)
T PRK14879        141 AEF  143 (211)
T ss_pred             ccC
Confidence            864

>smart00090 RIO RIO-like kinase

Probab=99.81  E-value=1.9e-19  Score=171.98  Aligned_cols=145  Identities=17%  Similarity=0.154  Sum_probs=110.7

Q ss_pred             cCCCcCcccccCCceEEEEEE-EccCCCcccCCCCCeEEEEEEecCCCcc------------------------cHHHHH
Q 011180          133 RNFRPESLLGEGGFGCVFKGW-VEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------------GHKEWL  187 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~-~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~  187 (491)
                      ..|.+.+.||+|+||.||+|. +..         +|..||||++......                        ....+.
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   98 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDG---------SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAE   98 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCC---------CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHH
Confidence            358899999999999999998 433         5789999998754211                        012356


Q ss_pred             HHHHHHhcCCCCc--eeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011180          188 AEVNFLGNLLHPN--LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPV  265 (491)
Q Consensus       188 ~E~~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i  265 (491)
                      +|+.++.++.+.+  +.+++++    ...+|||||+++++|...+....  .+.......++.||+.+|.+||..+.  |
T Consensus        99 ~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~--i  170 (237)
T smart00090       99 KEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGE--L  170 (237)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCC--E
Confidence            7999999997533  3333432    24589999999888876553332  45556667899999999999998663  9


Q ss_pred             EecCCCCCcEEECCCCCeEEeccCCcccCC
Q 011180          266 IYRDFKTSNILLDADYNAKLSDFGLAKDAP  295 (491)
Q Consensus       266 iHrDlKp~NILl~~~~~~kL~DFGla~~~~  295 (491)
                      +||||||+|||++ ++.++|+|||++....
T Consensus       171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            9999999999999 8899999999987543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=3.4e-19  Score=165.95  Aligned_cols=131  Identities=21%  Similarity=0.331  Sum_probs=107.3

Q ss_pred             ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--------cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       140 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +||+|+||.||+|.+           .+..|++|+.......        ...++.+|++++..+.|+++.....++...
T Consensus         1 ~ig~G~~~~vy~~~~-----------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~   69 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-----------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP   69 (199)
T ss_pred             CCCCCceEEEEEeec-----------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence            489999999999985           3557999986543211        124567899999999988876666666677


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||++|++|.+++.....         .++.+++.+|.+||+.+   ++|||++|+|||++ ++.++|+|||++
T Consensus        70 ~~~~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        70 DNKTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             CCCEEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCC
Confidence            778999999999999988754321         78889999999999988   99999999999999 889999999998


Q ss_pred             ccC
Q 011180          292 KDA  294 (491)
Q Consensus       292 ~~~  294 (491)
                      ...
T Consensus       137 ~~~  139 (199)
T TIGR03724       137 KYS  139 (199)
T ss_pred             cCC
Confidence            764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.3e-18  Score=162.03  Aligned_cols=140  Identities=16%  Similarity=0.077  Sum_probs=109.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc----------------------cHHHHHHH
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAE  189 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E  189 (491)
                      ...|.+.+.||+|+||.||+|...          +|..||||++......                      ....+..|
T Consensus        14 ~~~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   83 (198)
T cd05144          14 GVVESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKE   83 (198)
T ss_pred             CchhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHH
Confidence            334888999999999999999764          4678999987643210                      01135678


Q ss_pred             HHHHhcCCCCc--eeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 011180          190 VNFLGNLLHPN--LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIY  267 (491)
Q Consensus       190 ~~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH  267 (491)
                      +.++..+.|++  ++..++    ....++||||+++++|..+...        .....++.+++.++.++|+.+   |+|
T Consensus        84 ~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H  148 (198)
T cd05144          84 FAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIH  148 (198)
T ss_pred             HHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCc
Confidence            99999998774  444443    2456899999999998765421        234578889999999999988   999


Q ss_pred             cCCCCCcEEECCCCCeEEeccCCcccCCC
Q 011180          268 RDFKTSNILLDADYNAKLSDFGLAKDAPE  296 (491)
Q Consensus       268 rDlKp~NILl~~~~~~kL~DFGla~~~~~  296 (491)
                      |||||+|||+++++.++|+|||++.....
T Consensus       149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         149 GDLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCCcccEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999999999976644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=1.7e-18  Score=185.24  Aligned_cols=137  Identities=23%  Similarity=0.289  Sum_probs=111.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--c------ccHHHHHHHHHHHhcCCCCceeee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--L------QGHKEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~il~~l~HpnIv~l  204 (491)
                      ..|...++||+|+||.||+|.+..           ..+++|+.....  .      ...+.+.+|++++..+.|++|+..
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~-----------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p  401 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLG-----------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP  401 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecC-----------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence            456778999999999999998743           234444322111  0      112457889999999999999988


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      +.++.+....++||||+++++|.+++.          ....++.+++.+|.|||+.+   |+||||||+|||+ .++.++
T Consensus       402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~  467 (535)
T PRK09605        402 VIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLY  467 (535)
T ss_pred             EEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEE
Confidence            888877778899999999999999874          34678999999999999988   9999999999999 678999


Q ss_pred             EeccCCcccC
Q 011180          285 LSDFGLAKDA  294 (491)
Q Consensus       285 L~DFGla~~~  294 (491)
                      |+|||+++..
T Consensus       468 liDFGla~~~  477 (535)
T PRK09605        468 LIDFGLGKYS  477 (535)
T ss_pred             EEeCcccccC
Confidence            9999998754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=1.7e-19  Score=192.93  Aligned_cols=257  Identities=25%  Similarity=0.303  Sum_probs=194.9

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCC-CCceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~  210 (491)
                      .|.+.+.||+|+|+.|-......+        ....+|+|.+....  ....+....|..+-..+. |.|++.+++...+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~--------~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~   92 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRD--------PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS   92 (601)
T ss_pred             cccccccccccccchhhhhhhcCC--------CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence            366778899999999988876543        33467788776553  122334455888888887 9999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEECCCC-CeEEecc
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH-EEAEKPVIYRDFKTSNILLDADY-NAKLSDF  288 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~~~~iiHrDlKp~NILl~~~~-~~kL~DF  288 (491)
                      .+..+++++|..++++.+.+........+....-.++.|+..++.|+| ..+   +.||||||+|.+++..+ .++++||
T Consensus        93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen   93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCc
Confidence            999999999999999998884322224455566778999999999999 777   99999999999999999 9999999


Q ss_pred             CCcccCCC-CCCceeeecccc-CCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011180          289 GLAKDAPE-DGKTHVSTRVMG-TYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       289 Gla~~~~~-~~~~~~~~~~~G-t~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      |+|..... .+........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+.......... ..|.... 
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~~-  247 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSNK-  247 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecccc-
Confidence            99998876 555555566789 9999999998874 55678999999999999999999987654433211 1111000 


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  414 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~  414 (491)
                         ..+        .............+++.+++..+|..|.+.+++-.
T Consensus       248 ---~~~--------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 ---GRF--------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ---ccc--------ccCccccCChhhhhcccccccCCchhccccccccc
Confidence               000        01111223567789999999999999999888753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=8.5e-17  Score=141.50  Aligned_cols=136  Identities=21%  Similarity=0.122  Sum_probs=113.4

Q ss_pred             cCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCC--CceeeeeeEEeecCce
Q 011180          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH--PNLVKLVGYCIEDDQR  214 (491)
Q Consensus       137 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~  214 (491)
                      +.+.||.|.++.||++....           ..+++|.......  ...+.+|+.++..+.|  .+++++++++...+..
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-----------~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~   68 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-----------EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS   68 (155)
T ss_pred             cceecccccccceEEEEecC-----------CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence            45779999999999998742           4799999866543  4578899999999976  5899999888888889


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      +++|||++++.+..+         +......++.+++++|++||.....+++|+||+|+|||++..+.++|+|||++...
T Consensus        69 ~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          69 YLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             EEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            999999988777654         44556778899999999999865455999999999999999899999999988643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=6.4e-17  Score=148.96  Aligned_cols=137  Identities=20%  Similarity=0.167  Sum_probs=96.9

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc--HHH----------------------HHHHHHHH
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKE----------------------WLAEVNFL  193 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~il  193 (491)
                      .+.||+|+||.||+|.+.          ++..||||++.......  ...                      ...|...+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l   71 (187)
T cd05119           2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL   71 (187)
T ss_pred             CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence            568999999999999764          36689999987542211  111                      13466666


Q ss_pred             hcCCCCc--eeeeeeEEeecCceEEEEEecCCCChHHH-hhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecC
Q 011180          194 GNLLHPN--LVKLVGYCIEDDQRLLVYEFMPRGSLENH-LFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRD  269 (491)
Q Consensus       194 ~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrD  269 (491)
                      ..+.+..  +.+++++    ...+|||||++++.+... +....   .. .....++.+++.++.++|. .+   |+|||
T Consensus        72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~D  140 (187)
T cd05119          72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGD  140 (187)
T ss_pred             HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCC
Confidence            6664432  4444433    346899999998544321 11111   11 4567899999999999999 77   99999


Q ss_pred             CCCCcEEECCCCCeEEeccCCcccCCC
Q 011180          270 FKTSNILLDADYNAKLSDFGLAKDAPE  296 (491)
Q Consensus       270 lKp~NILl~~~~~~kL~DFGla~~~~~  296 (491)
                      |||+|||++ ++.++|+|||.+.....
T Consensus       141 l~p~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         141 LSEYNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CChhhEEEE-CCcEEEEECcccccccC
Confidence            999999999 89999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=2.2e-16  Score=151.17  Aligned_cols=135  Identities=21%  Similarity=0.244  Sum_probs=102.7

Q ss_pred             cccc-cCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-------------ccHHHHHHHHHHHhcCCCCce--e
Q 011180          139 SLLG-EGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGNLLHPNL--V  202 (491)
Q Consensus       139 ~~lG-~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~il~~l~HpnI--v  202 (491)
                      ..|| .|+.|+||.+...           +..++||.+.....             .....+.+|+.++..|.|++|  +
T Consensus        37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP  105 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP  105 (239)
T ss_pred             ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence            4577 7888888888663           45788988754221             122457889999999998775  6


Q ss_pred             eeeeEEeecCc----eEEEEEecCC-CChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 011180          203 KLVGYCIEDDQ----RLLVYEFMPR-GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       203 ~l~~~~~~~~~----~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl  277 (491)
                      ..+++......    .+|||||++| .+|.+++...   .++..    .+.+|+.+|.+||+.|   |+||||||+|||+
T Consensus       106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv  175 (239)
T PRK01723        106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILL  175 (239)
T ss_pred             eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEE
Confidence            67776443322    2599999997 6898887542   34443    3568999999999999   9999999999999


Q ss_pred             CCCCCeEEeccCCcccC
Q 011180          278 DADYNAKLSDFGLAKDA  294 (491)
Q Consensus       278 ~~~~~~kL~DFGla~~~  294 (491)
                      +.++.++|+|||.+...
T Consensus       176 ~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        176 DPDGKFWLIDFDRGELR  192 (239)
T ss_pred             cCCCCEEEEECCCcccC
Confidence            99899999999988753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=1.4e-15  Score=156.29  Aligned_cols=250  Identities=26%  Similarity=0.312  Sum_probs=187.3

Q ss_pred             CCCcCccccc--CCceEEEEEEE--ccCCCcccCCCCCeEEEEEEecCC--CcccHHHHHHHHHHHhcCC-CCceeeeee
Q 011180          134 NFRPESLLGE--GGFGCVFKGWV--EENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLL-HPNLVKLVG  206 (491)
Q Consensus       134 ~y~~~~~lG~--G~fg~Vy~~~~--~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~~  206 (491)
                      .|.+...+|.  |.+|.||.+..  ..         ++..+|+|.-+..  .......-++|+.-.+.++ |+|.++.+.
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~---------s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~  185 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSE---------SPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP  185 (524)
T ss_pred             hcccccccccCCCCCceeecccCCccc---------CCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence            4777888999  99999999987  43         5668999874332  2233344466777777775 999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCcEEECCC-C
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK----GLAFLHEEAEKPVIYRDFKTSNILLDAD-Y  281 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~----aL~yLH~~~~~~iiHrDlKp~NILl~~~-~  281 (491)
                      .+...+..++-+|+| +.+|..+...... .++....+.+..+...    ||..+|..+   ++|-|+||+||+...+ .
T Consensus       186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~  260 (524)
T KOG0601|consen  186 AWEGSGILFIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWT  260 (524)
T ss_pred             ccccCCcceeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccc
Confidence            999999999999999 5788887765432 4777778888888888    999999988   9999999999999999 8


Q ss_pred             CeEEeccCCcccCCCCCCcee---eeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011180          282 NAKLSDFGLAKDAPEDGKTHV---STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  358 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  358 (491)
                      ..+++|||+...+.+......   ..+..|...|++||.. .+.++.+.|+|++|.++.+..++-..+.....      .
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~  333 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------S  333 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------C
Confidence            899999999998866542221   2334688899999955 67899999999999999999998766533210      0


Q ss_pred             HhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .|..     .+..+      +..+|....+..+...+..|+..+|..|++.+.+..+
T Consensus       334 ~W~~-----~r~~~------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  334 SWSQ-----LRQGY------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             Cccc-----ccccc------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            0110     11111      1222333335566669999999999999999887653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.55  E-value=2.3e-14  Score=148.79  Aligned_cols=145  Identities=21%  Similarity=0.204  Sum_probs=99.4

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccH------------------------------
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH------------------------------  183 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~------------------------------  183 (491)
                      .|. .+.||.|++|.||+|++.          +|+.||||+.+.......                              
T Consensus       119 ~fd-~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~  187 (437)
T TIGR01982       119 EFE-EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVV  187 (437)
T ss_pred             hCC-CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHH
Confidence            344 467999999999999986          477999999865421100                              


Q ss_pred             ----------HHHHHHHHHHhcCC-----CCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHH
Q 011180          184 ----------KEWLAEVNFLGNLL-----HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL  248 (491)
Q Consensus       184 ----------~~~~~E~~il~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~  248 (491)
                                -++.+|++.+.++.     +++|.-..-+.......+|||||++|++|.++...... ...   ...++.
T Consensus       188 ~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~  263 (437)
T TIGR01982       188 KEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAE  263 (437)
T ss_pred             HHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHH
Confidence                      01344555555542     34333222222234567999999999999887643211 122   234565


Q ss_pred             HHHH-HHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCC
Q 011180          249 GAAK-GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  296 (491)
Q Consensus       249 qi~~-aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~  296 (491)
                      .++. .+..+|..|   ++|+|+||.||+++.++.++|+|||++..+..
T Consensus       264 ~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       264 NLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            5555 478889888   99999999999999999999999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.55  E-value=4.9e-15  Score=141.15  Aligned_cols=205  Identities=23%  Similarity=0.327  Sum_probs=141.3

Q ss_pred             HHHhcCCCCceeeeeeEEeecC-----ceEEEEEecCCCChHHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 011180          191 NFLGNLLHPNLVKLVGYCIEDD-----QRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEK  263 (491)
Q Consensus       191 ~il~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~  263 (491)
                      .-|-.+.|-|||+++.|+.+..     ...++.|||..|+|..+|.+..  ...+......+|+-||+.||.|||+.. +
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence            3455567999999999987654     4689999999999999997532  335677777899999999999999987 7


Q ss_pred             CeEecCCCCCcEEECCCCCeEEeccCCcccCC--CCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh
Q 011180          264 PVIYRDFKTSNILLDADYNAKLSDFGLAKDAP--EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT  341 (491)
Q Consensus       264 ~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~--~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt  341 (491)
                      +|+|+++..+.|++..+|-+||.----.....  ............|-++|.+||.-.....+.++|||+||++..||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            89999999999999999888875211110000  0000001112346789999998777788889999999999999988


Q ss_pred             CCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          342 GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       342 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      +..--.......+.. .......++       .-+            ..-++++.+||+..|..||+|.+++-|.
T Consensus       278 lEiq~tnseS~~~~e-e~ia~~i~~-------len------------~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVE-ENIANVIIG-------LEN------------GLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             heeccCCCcceeehh-hhhhhheee-------ccC------------ccccCcCcccccCCCCCCcchhhhhcCc
Confidence            764321111110000 000000000       000            1114678999999999999999998764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.47  E-value=5.2e-14  Score=148.08  Aligned_cols=145  Identities=17%  Similarity=0.150  Sum_probs=94.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc-----------------------------
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------------------------  182 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------------------  182 (491)
                      ..+|.. +.||.|++|.||+|+++.         +|+.||||+.+......                             
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~  188 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPRE  188 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHH
Confidence            446776 789999999999999875         57899999997542100                             


Q ss_pred             -----HH------HHHHHHHHHhcCC----CCceeeeeeEEee-cCceEEEEEecCCCChHHHh--hhCCCC--CCCHHH
Q 011180          183 -----HK------EWLAEVNFLGNLL----HPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHL--FRKGSL--PLPWSI  242 (491)
Q Consensus       183 -----~~------~~~~E~~il~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~--~l~~~~  242 (491)
                           .+      ++.+|+..+.++.    +.+.+.+-.+|.+ ....+|||||++|+.|.++.  ...+..  .+....
T Consensus       189 ~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~  268 (537)
T PRK04750        189 VVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG  268 (537)
T ss_pred             HHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH
Confidence                 01      1334444444442    3333333333332 45668999999999998742  222210  122222


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC----CeEEeccCCcccCCC
Q 011180          243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NAKLSDFGLAKDAPE  296 (491)
Q Consensus       243 ~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~----~~kL~DFGla~~~~~  296 (491)
                      +..++.|+       +..|   ++|+|+||.||+++.++    .++++|||++..+..
T Consensus       269 v~~~~~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        269 VEVFFTQV-------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHHH-------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            22333333       3456   99999999999999888    999999999987754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=2e-13  Score=123.33  Aligned_cols=131  Identities=20%  Similarity=0.064  Sum_probs=96.0

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcee-eeeeEEeecCceEE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLV-KLVGYCIEDDQRLL  216 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~~~~~~~~~~~l  216 (491)
                      .+.|+.|.++.||++...           +..|++|+...... ....+.+|+.++..+.+.+++ +++.+  .....++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~l   68 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVL   68 (170)
T ss_pred             eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeE
Confidence            356899999999998763           55799999765432 123457899999988765554 44443  3344689


Q ss_pred             EEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          217 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA--EKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      ||||++|.++.+..      ..    ...++.+++++|+.||..+  ...++|+|++|.||+++ ++.++|+|||.+..
T Consensus        69 v~e~i~G~~l~~~~------~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          69 ITEFIEGSELLTED------FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EEEecCCCcccccc------cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99999998876430      01    1245678999999999976  22359999999999998 66899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.40  E-value=5.2e-12  Score=131.41  Aligned_cols=164  Identities=18%  Similarity=0.214  Sum_probs=125.5

Q ss_pred             CCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHH
Q 011180          166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK  245 (491)
Q Consensus       166 ~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~  245 (491)
                      ++.+|.|+..+...........+-++.|+.|+||||++++..+..++..|||+|-+  -.|..++.+.+     ...+..
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v~~  108 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEVCL  108 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHHHH
Confidence            56788888887665433345677889999999999999999999999999999997  46787886654     345566


Q ss_pred             HHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCc
Q 011180          246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS  325 (491)
Q Consensus       246 i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~  325 (491)
                      -+.||+.||.|||+.+.  ++|++|.-+.|+|++.|..||++|.++.........  .....---.|..|+.+....  -
T Consensus       109 Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  109 GLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--c
Confidence            78899999999986543  999999999999999999999999988655432210  01111122466666543222  4


Q ss_pred             cccchhHHHHHHHHHhC
Q 011180          326 KSDVYSFGVVLLEMLTG  342 (491)
Q Consensus       326 ~~DvwSlGvil~elltG  342 (491)
                      ..|.|-|||+++|++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            57999999999999999

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.38  E-value=1.1e-13  Score=149.17  Aligned_cols=248  Identities=23%  Similarity=0.243  Sum_probs=173.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .|.+.+.+-.|.|+.++.+.-..         +|...++|+......   ...+....+-.++-...+|-++...--+.-
T Consensus       805 ~~~i~~p~qS~sp~ss~p~~pa~---------sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~  875 (1205)
T KOG0606|consen  805 GFEITKPSQSGSPSSSFPASPAG---------SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC  875 (1205)
T ss_pred             cceecccccCCCCcccccCCccc---------cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC
Confidence            46666778888898888764332         454555555543321   122333444444444456777776655556


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ....+|||+|+.+++|...|...+  .............+..+++|||...   ++|||++|.|+|+..++..++.|||+
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence            677899999999999999987765  4555555667777889999999977   89999999999999999999999984


Q ss_pred             cccCCCC-----------------------------CCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh
Q 011180          291 AKDAPED-----------------------------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT  341 (491)
Q Consensus       291 a~~~~~~-----------------------------~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt  341 (491)
                      ......-                             +.........||+.|.+||.+.+......+|+|++|++++|.++
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence            3321100                             00011223679999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHH
Q 011180          342 GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS  410 (491)
Q Consensus       342 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~  410 (491)
                      |.+||....+.....-      .+...     +  +  ...-+...+.++.+++.+.|..+|.+|..+.
T Consensus      1031 g~pp~na~tpq~~f~n------i~~~~-----~--~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFEN------ILNRD-----I--P--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCCcchhhhhhc------cccCC-----C--C--CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9999977655432211      10000     0  0  0111233478899999999999999997766

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.37  E-value=7.5e-12  Score=115.15  Aligned_cols=145  Identities=14%  Similarity=0.091  Sum_probs=99.4

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc----------------------ccHHHH----HHHHH
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----------------------QGHKEW----LAEVN  191 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~----~~E~~  191 (491)
                      ...||.|--+.||.|.......   ....+..+|||+.+....                      ...+.+    .+|++
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~---~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r   78 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNET---EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH   78 (197)
T ss_pred             CCccccCcceEEEEEecCcccc---cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence            3579999999999997543110   011346899999752110                      001122    37999


Q ss_pred             HHhcCCC--CceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEec
Q 011180          192 FLGNLLH--PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL-HEEAEKPVIYR  268 (491)
Q Consensus       192 il~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~~~iiHr  268 (491)
                      .|.+|..  -++..++++    ...+|||||+.+..+.....+.  ..++......+..+++.+|..| |..+   |||+
T Consensus        79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG  149 (197)
T cd05146          79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA  149 (197)
T ss_pred             HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            9999863  456666654    4568999999664442221111  1344455667788999999999 8888   9999


Q ss_pred             CCCCCcEEECCCCCeEEeccCCcccCC
Q 011180          269 DFKTSNILLDADYNAKLSDFGLAKDAP  295 (491)
Q Consensus       269 DlKp~NILl~~~~~~kL~DFGla~~~~  295 (491)
                      ||++.|||++ ++.+.|+|||.+....
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9999999996 4689999999887653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.37  E-value=4.5e-13  Score=137.91  Aligned_cols=250  Identities=23%  Similarity=0.188  Sum_probs=178.2

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHH--HHHHHHHHhcCC-CCceeeeeeE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGNLL-HPNLVKLVGY  207 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~il~~l~-HpnIv~l~~~  207 (491)
                      ...+|..+..||.|.|+.||.+.....        ++..+++|.+...-.....+  -+.|+.+...+. |.+++.++..
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~--------~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~  334 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPE--------GDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS  334 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCC--------CCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence            345799999999999999999874422        45689999886654333222  256777777664 9999998888


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-CCeEEe
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLS  286 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kL~  286 (491)
                      |......|+-.|||.++++...+.-  ...+.....+.+..|++.++.++|+..   ++|+|+||+||++..+ +..++.
T Consensus       335 W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~  409 (524)
T KOG0601|consen  335 WSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLG  409 (524)
T ss_pred             ccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcc
Confidence            8888888899999999988766622  235667778899999999999999877   9999999999999876 788999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCC--CchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYA--APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~--aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      |||+...+.-..     ....+.-+++  +++......+..+.|++|||..+++.++|...-+...        .|....
T Consensus       410 ~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~i~  476 (524)
T KOG0601|consen  410 DFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLTIR  476 (524)
T ss_pred             ccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cceeee
Confidence            999987532211     1122333444  4555556678899999999999999999875432111        111000


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      -+.        -+.+    + .....+..+.+.++..++..||.+.++..+....
T Consensus       477 ~~~--------~p~~----~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  477 SGD--------TPNL----P-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ccc--------ccCC----C-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            000        0000    1 1136678889999999999999999887665543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=3.5e-11  Score=107.33  Aligned_cols=131  Identities=22%  Similarity=0.296  Sum_probs=100.4

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-----cc---cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-----LQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++++|+-+.+|.+.+.           |..+++|.-....     +.   ...+..+|+++|..+.--.|...+=+..+
T Consensus         2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD   70 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD   70 (204)
T ss_pred             chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence            46889999999999663           3456677532221     11   12345789999999876666665656777


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+...|+|||++|..|.+.+...         ...++..+-..+.-||..+   |||+||.++||++..+. +.++||||
T Consensus        71 ~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGL  137 (204)
T COG3642          71 PDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGL  137 (204)
T ss_pred             CCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCc
Confidence            78889999999999999888654         1456777778888999999   99999999999997664 99999999


Q ss_pred             ccc
Q 011180          291 AKD  293 (491)
Q Consensus       291 a~~  293 (491)
                      +..
T Consensus       138 g~~  140 (204)
T COG3642         138 GEF  140 (204)
T ss_pred             ccc
Confidence            874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.28  E-value=5.2e-11  Score=105.75  Aligned_cols=143  Identities=22%  Similarity=0.208  Sum_probs=107.9

Q ss_pred             cCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEec-----CCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-----HDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       137 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~-----~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .+.+|-+|+-+.|+++.+           .|+.+.||.-.     +..+   -..++..+|+++|.++.--.|.-..-++
T Consensus        11 ~l~likQGAEArv~~~~~-----------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~   79 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-----------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF   79 (229)
T ss_pred             cceeeeccceeeEeeecc-----------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence            567889999999999987           46677777532     2111   1235678899999998755666555567


Q ss_pred             eecCceEEEEEecCC-CChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC---CeE
Q 011180          209 IEDDQRLLVYEFMPR-GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---NAK  284 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~---~~k  284 (491)
                      .+...-.|+|||++| .++.+++...............++..|-+.|.-||.++   |||+||..+||+|..++   .+.
T Consensus        80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceE
Confidence            777778999999966 47888887654433333344678899999999999999   99999999999996554   458


Q ss_pred             EeccCCccc
Q 011180          285 LSDFGLAKD  293 (491)
Q Consensus       285 L~DFGla~~  293 (491)
                      |+|||++..
T Consensus       157 lIdfgls~~  165 (229)
T KOG3087|consen  157 LIDFGLSSV  165 (229)
T ss_pred             EEeecchhc
Confidence            999999764

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.27  E-value=4.5e-11  Score=112.66  Aligned_cols=142  Identities=20%  Similarity=0.217  Sum_probs=107.1

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCC--CceeeeeeEEeec---C
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLH--PNLVKLVGYCIED---D  212 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~---~  212 (491)
                      +.|+.|.++.||++...+          |..+++|+...... .....+..|+.++..+.+  .++.+++.+....   +
T Consensus         4 ~~l~~G~~n~~~~v~~~~----------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~   73 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG----------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG   73 (223)
T ss_pred             eecCCCccceEEEEEecC----------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence            568999999999997642          45799999865432 134567899999999975  4456677766553   2


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA-------------------------------  261 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------------  261 (491)
                      ..++||||++|.+|.+.+..   ..++......++.+++++|.+||+..                               
T Consensus        74 ~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (223)
T cd05154          74 TPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR  150 (223)
T ss_pred             CceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence            56899999999888776532   14666677778888888888888531                               


Q ss_pred             ----------------------CCCeEecCCCCCcEEECC--CCCeEEeccCCccc
Q 011180          262 ----------------------EKPVIYRDFKTSNILLDA--DYNAKLSDFGLAKD  293 (491)
Q Consensus       262 ----------------------~~~iiHrDlKp~NILl~~--~~~~kL~DFGla~~  293 (491)
                                            ...++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                  245899999999999988  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.19  E-value=5.7e-10  Score=113.03  Aligned_cols=216  Identities=17%  Similarity=0.228  Sum_probs=151.5

Q ss_pred             ceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEe----ecCceEEEEEec
Q 011180          146 FGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI----EDDQRLLVYEFM  221 (491)
Q Consensus       146 fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~----~~~~~~lV~E~~  221 (491)
                      -.+.|+|+...         +|..|++|.++.+..+.......-++.++++.|.|||++.++|.    .+..++|||+|+
T Consensus       289 ~~Ttyk~~s~~---------DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy  359 (655)
T KOG3741|consen  289 SITTYKATSNV---------DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY  359 (655)
T ss_pred             cceeEeeeecc---------CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence            35789998876         56789999996655444434456688999999999999999887    345789999999


Q ss_pred             CC-CChHHHhhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          222 PR-GSLENHLFRKG-------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       222 ~~-gsL~~~l~~~~-------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      ++ ++|.++.....             ....++...|.++.|+..||.++|+.|   +.-+-|.+.+||++.+.+++|..
T Consensus       360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~  436 (655)
T KOG3741|consen  360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISG  436 (655)
T ss_pred             CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEec
Confidence            86 67887654321             224678899999999999999999999   88899999999999999999988


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      .|....+..+...                -+.   --.+-|.=.||.+++.|.||..--........ ...+        
T Consensus       437 C~i~Dvl~~d~~~----------------~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~-s~~~--------  488 (655)
T KOG3741|consen  437 CGIMDVLQEDPTE----------------PLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQS-SHLT--------  488 (655)
T ss_pred             ccceeeecCCCCc----------------chh---HHhhhhHHHHHHHHHHHhhcccccccccchHH-HHHH--------
Confidence            8877655433200                011   12356888999999999999643111100000 0000        


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                            .        .....+.++.++|.-+...++++ -++.+++.++
T Consensus       489 ------~--------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  489 ------R--------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             ------H--------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                  0        01122667778888887777776 5666666543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.08  E-value=2.1e-09  Score=104.26  Aligned_cols=125  Identities=16%  Similarity=0.075  Sum_probs=90.3

Q ss_pred             CCeEEEEEEecCCCcc-cH----------HHHHHHHHHHhcCCCCc--eeeeeeEEee-----cCceEEEEEecCCC-Ch
Q 011180          166 TGLTVAVKTLNHDGLQ-GH----------KEWLAEVNFLGNLLHPN--LVKLVGYCIE-----DDQRLLVYEFMPRG-SL  226 (491)
Q Consensus       166 ~~~~vavK~~~~~~~~-~~----------~~~~~E~~il~~l~Hpn--Iv~l~~~~~~-----~~~~~lV~E~~~~g-sL  226 (491)
                      .|+.|.||........ ..          ..+.+|...+..|..-+  +..++++...     ....+||||++++. +|
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL  123 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL  123 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence            3568999977443311 01          13678999888885333  3344555443     23468999999875 79


Q ss_pred             HHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-------CCCeEEeccCCccc
Q 011180          227 ENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-------DYNAKLSDFGLAKD  293 (491)
Q Consensus       227 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~-------~~~~kL~DFGla~~  293 (491)
                      .+++...............++.+++..+.-||..|   |+|+||++.|||++.       +..+.|+||+.+..
T Consensus       124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            88875432234556677789999999999999999   999999999999975       46899999998753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.03  E-value=4.9e-08  Score=96.92  Aligned_cols=265  Identities=17%  Similarity=0.194  Sum_probs=159.8

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeeeeeE------
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGY------  207 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~------  207 (491)
                      ....+.||+|+-+.+|-.--..            ..+.|++.........+.   +..|... .||-+-.-+.|      
T Consensus        13 i~~gr~LgqGgea~ly~l~e~~------------d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~   77 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEVR------------DQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLH   77 (637)
T ss_pred             cCCCccccCCccceeeecchhh------------chhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhh
Confidence            3456789999999999542211            244577765543322222   2233333 35544331211      


Q ss_pred             EeecCc-eEEEEEecCCCC-hHHHhh---hCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 011180          208 CIEDDQ-RLLVYEFMPRGS-LENHLF---RKG-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       208 ~~~~~~-~~lV~E~~~~gs-L~~~l~---~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~  281 (491)
                      .-+.+. .-++|..+++.. +.+++.   ++. .-...|...++.++.++.+.+.||..|   .+-+|+.++|+|+.+++
T Consensus        78 G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~  154 (637)
T COG4248          78 GGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDS  154 (637)
T ss_pred             CCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCc
Confidence            112222 567888887642 222221   111 223678999999999999999999999   88999999999999999


Q ss_pred             CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCCcc
Q 011180          282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTG-RRSMDKNRPNGEH  355 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG-~~pf~~~~~~~~~  355 (491)
                      .+.|.|=..-... ..+  ....-.+|...|.+||...     +..-+...|.|.|||++++|+.| +.||.+.......
T Consensus       155 ~V~LVdsDsfqi~-~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a  231 (637)
T COG4248         155 KVVLVDSDSFQIN-ANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA  231 (637)
T ss_pred             eEEEEcccceeec-cCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence            9999985543322 111  2223367999999999654     23456679999999999999887 8999764322110


Q ss_pred             -hhh--HhhhcccCCccchhhccCccccCCCChh-hHHHHHHHHHHhhhc--CCCCCCCHHHHHHHhhcCcc
Q 011180          356 -NLV--EWARPHLGDKRRFYRLLDPRLEGHFSIK-GSQKATQLAAQCLSR--DPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       356 -~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cL~~--dP~~RPt~~evl~~L~~l~~  421 (491)
                       .-.  ......+.+...-..-+.+ -....+.. .+..+..|..+|+..  ++.-|||++..+..|..+..
T Consensus       232 p~p~E~~Ia~g~f~ya~~~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         232 PNPLETDIAHGRFAYASDQRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             CCcchhhhhcceeeechhccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence             000  0000000000000000000 01112211 267788999999965  36689999999988876543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=4.8e-09  Score=96.21  Aligned_cols=126  Identities=21%  Similarity=0.225  Sum_probs=78.6

Q ss_pred             EEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---------------------c-----cHHHHHHHHHHHhcCCCC--
Q 011180          148 CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---------------------Q-----GHKEWLAEVNFLGNLLHP--  199 (491)
Q Consensus       148 ~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------------------~-----~~~~~~~E~~il~~l~Hp--  199 (491)
                      .||.|...          .|..||||+.+....                     .     ......+|.+.|.++..-  
T Consensus         1 ~Vy~~~~~----------~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv   70 (188)
T PF01163_consen    1 DVYHAIDP----------DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGV   70 (188)
T ss_dssp             EEEEEEEC----------TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-
T ss_pred             CEEEEECC----------CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCc
Confidence            37888764          467899999753210                     0     012356799999999865  


Q ss_pred             ceeeeeeEEeecCceEEEEEecC--CCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCcEE
Q 011180          200 NLVKLVGYCIEDDQRLLVYEFMP--RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF-LHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       200 nIv~l~~~~~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~y-LH~~~~~~iiHrDlKp~NIL  276 (491)
                      ++.+++++    ...+|||||++  |..+..+. ...   +.......++.+++..+.. +|..|   |+|+||.+.|||
T Consensus        71 ~vP~p~~~----~~~~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIl  139 (188)
T PF01163_consen   71 PVPKPYDY----NRNVIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNIL  139 (188)
T ss_dssp             SS--EEEE----ETTEEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEE
T ss_pred             cCCcEEEE----eCCEEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEE
Confidence            45666544    24489999997  54454433 221   1122345567777775555 57877   999999999999


Q ss_pred             ECCCCCeEEeccCCcccCC
Q 011180          277 LDADYNAKLSDFGLAKDAP  295 (491)
Q Consensus       277 l~~~~~~kL~DFGla~~~~  295 (491)
                      ++++ .+.|+|||.+....
T Consensus       140 v~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  140 VDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             EETT-CEEE--GTTEEETT
T ss_pred             eecc-eEEEEecCcceecC
Confidence            9887 99999999887553

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.82  E-value=3.1e-08  Score=93.77  Aligned_cols=135  Identities=17%  Similarity=0.106  Sum_probs=94.4

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc----------------------cHHHHHHHHHH
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEVNF  192 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~i  192 (491)
                      +.+...||.|--+.||.|...          .|..+|||.-+.....                      ......+|.++
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~  162 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA  162 (304)
T ss_pred             HhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence            456788999999999999875          4778999975422110                      11235789999


Q ss_pred             HhcCCCC--ceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 011180          193 LGNLLHP--NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  270 (491)
Q Consensus       193 l~~l~Hp--nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  270 (491)
                      |..|...  .|.+.+++    +.-.+||||++|-.|...-.       .....-.++..|++-+.-+-..|   |||+|+
T Consensus       163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~G---iVHGDl  228 (304)
T COG0478         163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRG---IVHGDL  228 (304)
T ss_pred             HHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcC---ccccCC
Confidence            9999644  66666654    55689999998877665432       11122233334444444444556   999999


Q ss_pred             CCCcEEECCCCCeEEeccCCccc
Q 011180          271 KTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       271 Kp~NILl~~~~~~kL~DFGla~~  293 (491)
                      .+-|||++++|.+.++||--+..
T Consensus       229 SefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         229 SEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             chheEEEecCCCEEEEeCccccc
Confidence            99999999999999999976543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.79  E-value=8.5e-08  Score=89.78  Aligned_cols=106  Identities=25%  Similarity=0.203  Sum_probs=82.0

Q ss_pred             HHHHHHHHHHhcCC--CCceeeeeeEEeecC----ceEEEEEecCCC-ChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHH
Q 011180          184 KEWLAEVNFLGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRG-SLENHLFRKGSLPLPWSIRMKIALGAAKGLAF  256 (491)
Q Consensus       184 ~~~~~E~~il~~l~--HpnIv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~y  256 (491)
                      ....+|...+..|.  .-.+.+.+++.....    ..+||+|++++. +|.+++.....  .+......++.+++..+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            45778888888775  333445555555422    348999999874 79998876332  4556677899999999999


Q ss_pred             HHhcCCCCeEecCCCCCcEEECCCC---CeEEeccCCcccC
Q 011180          257 LHEEAEKPVIYRDFKTSNILLDADY---NAKLSDFGLAKDA  294 (491)
Q Consensus       257 LH~~~~~~iiHrDlKp~NILl~~~~---~~kL~DFGla~~~  294 (491)
                      ||..|   |+|+|+++.|||++.++   .+.|+||+.++..
T Consensus       134 lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999   99999999999998887   8999999977643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.73  E-value=5.7e-09  Score=109.49  Aligned_cols=151  Identities=23%  Similarity=0.316  Sum_probs=104.5

Q ss_pred             HHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCcee-------eeccccCCCCCCchhhhc
Q 011180          248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV-------STRVMGTYGYAAPEYVMT  320 (491)
Q Consensus       248 ~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-------~~~~~Gt~~y~aPE~~~~  320 (491)
                      .+++.||.|+|...+  +||++|.|++|.++.++..||+.|+.+...........       ..-..-...|.|||++..
T Consensus       106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345699999998654  99999999999999999999999998875543211100       001123567999999999


Q ss_pred             CCCCccccchhHHHHHHHHH-hCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhh
Q 011180          321 GHLTSKSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL  399 (491)
Q Consensus       321 ~~~~~~~DvwSlGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL  399 (491)
                      ...+.++|+||+||++|.+. .|+.-+............    ....+.          -...++.+.+.++.+=+.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~----~~~~~~----------~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS----RNLLNA----------GAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh----hccccc----------ccccccccCcHHHHHHHHHHh
Confidence            88899999999999999999 455444332211111110    001010          011233445789999999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 011180          400 SRDPKARPRMSEVVE  414 (491)
Q Consensus       400 ~~dP~~RPt~~evl~  414 (491)
                      ..+..-||++.+++.
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998777653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.71  E-value=7.6e-08  Score=101.12  Aligned_cols=143  Identities=17%  Similarity=0.173  Sum_probs=94.2

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc------------------------------HH----
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG------------------------------HK----  184 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------~~----  184 (491)
                      ..|+.++-|.||+|+++          +|+.||||+.+.+-...                              ..    
T Consensus       131 ~PiAsASIaQVH~A~L~----------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~  200 (517)
T COG0661         131 EPIASASIAQVHRAVLK----------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK  200 (517)
T ss_pred             CchhhhhHhhheeEEec----------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence            67999999999999997          48899999986431110                              00    


Q ss_pred             ------HHHHHHHHHhcCC-----CCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHH
Q 011180          185 ------EWLAEVNFLGNLL-----HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG  253 (491)
Q Consensus       185 ------~~~~E~~il~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~a  253 (491)
                            ++.+|..-+.++.     .++|.-..=|+.-.+...|+|||++|-.+.+...... ..++...+.....++.  
T Consensus       201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--  277 (517)
T COG0661         201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--  277 (517)
T ss_pred             HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--
Confidence                  1344555555552     3444333333444567799999999999988743222 2344333322222221  


Q ss_pred             HHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCC
Q 011180          254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  297 (491)
Q Consensus       254 L~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~  297 (491)
                      +..+=..|   ++|.|.+|.||+++.+|.+.+.|||+...+...
T Consensus       278 ~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         278 LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            22222345   999999999999999999999999999877543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.67  E-value=3.4e-07  Score=86.91  Aligned_cols=139  Identities=15%  Similarity=0.127  Sum_probs=84.0

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc--eeeeeeEEeecCceEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRLL  216 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~~~~~~~~~l  216 (491)
                      ..||+|..+.||+..             +..+++|......  ....+.+|.++++.+..-.  +.+.+++..+.+...+
T Consensus         7 ~~i~~G~t~~~y~~~-------------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl   71 (226)
T TIGR02172         7 TQTGEGGNGESYTHK-------------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL   71 (226)
T ss_pred             eeecCCCCcceeEec-------------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence            568999999999841             2257788876432  3355788999999886433  4666777777777889


Q ss_pred             EEEecCCCC-hHHHh---------------------hhCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhc-C
Q 011180          217 VYEFMPRGS-LENHL---------------------FRKGSLPLPWSIRM-KIAL----------GAAK-GLAFLHEE-A  261 (491)
Q Consensus       217 V~E~~~~gs-L~~~l---------------------~~~~~~~l~~~~~~-~i~~----------qi~~-aL~yLH~~-~  261 (491)
                      |||+++|.. +...+                     +............. .+..          .+.. ...+|... .
T Consensus        72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~  151 (226)
T TIGR02172        72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD  151 (226)
T ss_pred             eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence            999998863 21111                     00000011111000 0000          0001 12222211 1


Q ss_pred             CCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          262 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       262 ~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      ...++|+|+.|.||++++++ +.|+||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            23478999999999999888 99999997753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK09902 hypothetical protein; Provisional

Probab=98.65  E-value=3.8e-07  Score=84.37  Aligned_cols=138  Identities=18%  Similarity=0.146  Sum_probs=100.9

Q ss_pred             cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC---C---cccHHHHHHHHHHHhcCCC--CceeeeeeEEe-e-
Q 011180          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---G---LQGHKEWLAEVNFLGNLLH--PNLVKLVGYCI-E-  210 (491)
Q Consensus       141 lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~-~-  210 (491)
                      -|+||.+-|+...+.           |..+=+|.-...   .   ......|.+|+..|..|..  -.+.+++ ++. . 
T Consensus        26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k   93 (216)
T PRK09902         26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK   93 (216)
T ss_pred             cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec
Confidence            577999999987663           335777765411   1   2345779999999999863  2244444 322 1 


Q ss_pred             -c--CceEEEEEecCC-CChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC--eE
Q 011180          211 -D--DQRLLVYEFMPR-GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--AK  284 (491)
Q Consensus       211 -~--~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~--~k  284 (491)
                       .  -.-+||+|-+++ -+|.+++......+.+......+..+|+..|.-||+.+   +.|+|+.+.|||++.++.  ++
T Consensus        94 ~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~  170 (216)
T PRK09902         94 IEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAG  170 (216)
T ss_pred             cCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEE
Confidence             1  135799998753 58888886654345667777889999999999999999   999999999999986667  99


Q ss_pred             EeccCCccc
Q 011180          285 LSDFGLAKD  293 (491)
Q Consensus       285 L~DFGla~~  293 (491)
                      ++||.-++.
T Consensus       171 lIDlEk~r~  179 (216)
T PRK09902        171 FLDLEKSRR  179 (216)
T ss_pred             EEEhhccch
Confidence            999987654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.57  E-value=5.4e-07  Score=83.73  Aligned_cols=138  Identities=11%  Similarity=0.086  Sum_probs=90.9

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHH---------HHHHHHHHhcCCCC-
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---------WLAEVNFLGNLLHP-  199 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~il~~l~Hp-  199 (491)
                      ....+|.+.+++-......|.+...           .|..+++|..........+.         ..+++..+..+... 
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-----------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g   96 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-----------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG   96 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-----------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC
Confidence            4566788888888877777766554           35689999886543322221         23444444444322 


Q ss_pred             --ceeeeeeEEe-----ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 011180          200 --NLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  272 (491)
Q Consensus       200 --nIv~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp  272 (491)
                        .+..++.+..     -....+|||||++|..|.++..      ++.    .++..|.+++.-||..|   +.|+|.+|
T Consensus        97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hp  163 (229)
T PF06176_consen   97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHP  163 (229)
T ss_pred             ccccccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCc
Confidence              2222222222     2234568999999988877542      222    24456677899999999   99999999


Q ss_pred             CcEEECCCCCeEEeccCCcc
Q 011180          273 SNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       273 ~NILl~~~~~~kL~DFGla~  292 (491)
                      .|++++.+ .++++||+..+
T Consensus       164 gNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  164 GNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             CcEEEECC-cEEEEECcccc
Confidence            99999865 59999998665

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.53  E-value=9e-09  Score=106.83  Aligned_cols=188  Identities=18%  Similarity=0.124  Sum_probs=135.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc-eeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN-LVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~  211 (491)
                      ..+..-.-+++|+++.+|+.+...         +. ....+++...     ....-++++|.+++||| .+..++-+..+
T Consensus       242 kws~~fh~fvK~altknpKkRpta---------ek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E  306 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTA---------EK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGE  306 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCCh---------hh-heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcc
Confidence            344455568999999999886543         11 2225555332     34456899999999999 77778888888


Q ss_pred             CceEEEEEecCCC-ChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          212 DQRLLVYEFMPRG-SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       212 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      +..+++|+++.++ +....... ....+...+...+.+.-+++|+|||+..   =+|||    |||..+ +..++.||+.
T Consensus       307 ~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v  377 (829)
T KOG0576|consen  307 DYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAV  377 (829)
T ss_pred             cccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccC
Confidence            8999999999777 22221111 1112333344556667788999999854   48998    888755 6899999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCC
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD  347 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~  347 (491)
                      ...+....   ......+|+.++|||+.....+....|+|++|+-..+|--|-+|-.
T Consensus       378 ~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  378 PPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            88775432   2345679999999999999999999999999998888888777653

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.50  E-value=1.5e-06  Score=81.64  Aligned_cols=153  Identities=19%  Similarity=0.166  Sum_probs=99.2

Q ss_pred             hhhhhhHHHhhcCCCcCcccc---cCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-----------------
Q 011180          122 KFMFNDLKLATRNFRPESLLG---EGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-----------------  181 (491)
Q Consensus       122 ~~~~~~~~~~~~~y~~~~~lG---~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------------  181 (491)
                      ..+...+.....+..+..+.|   .|--+.||+|...          .+..||||+.+.....                 
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~----------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~  103 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG----------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNS  103 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC----------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcC
Confidence            344555555556666666555   5556679998653          4678999998643211                 


Q ss_pred             --cHH-----HHHHHHHHHhcCC--CCceeeeeeEEeecCceEEEEEecCCCCh-HHHhhhCCCCCCCHHHHHHHHHHHH
Q 011180          182 --GHK-----EWLAEVNFLGNLL--HPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGAA  251 (491)
Q Consensus       182 --~~~-----~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~qi~  251 (491)
                        ..+     ...+|+.-|.++.  +-.+.+.+++.    ...|||||+....+ .-.|.   ..++.......+..+++
T Consensus       104 ~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v  176 (268)
T COG1718         104 RSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVV  176 (268)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHH
Confidence              111     1356888888874  55555666553    34799999954311 11111   11233334556677777


Q ss_pred             HHHHHHHh-cCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCC
Q 011180          252 KGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  295 (491)
Q Consensus       252 ~aL~yLH~-~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~  295 (491)
                      +.+.-|-. .+   +||+||..-|||+. ++.+.|+|||-|....
T Consensus       177 ~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         177 EYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            87777776 56   99999999999999 8899999999887654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.43  E-value=2.5e-06  Score=81.88  Aligned_cols=138  Identities=19%  Similarity=0.117  Sum_probs=82.1

Q ss_pred             cccCCc-eEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEEeecCceEEEE
Q 011180          141 LGEGGF-GCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVY  218 (491)
Q Consensus       141 lG~G~f-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~  218 (491)
                      |-.|.. ..||+....           +..+.||+.....   ...+.+|++++..+. +--+.+++++....+..++||
T Consensus         6 ~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   71 (244)
T cd05150           6 VTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT   71 (244)
T ss_pred             cCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence            444555 789988542           2368888875443   235677888888874 434556777776666789999


Q ss_pred             EecCCCChHHHhh-------------------hCC--CCCCCHH--HHHHHHH--------------------HHHHHHH
Q 011180          219 EFMPRGSLENHLF-------------------RKG--SLPLPWS--IRMKIAL--------------------GAAKGLA  255 (491)
Q Consensus       219 E~~~~gsL~~~l~-------------------~~~--~~~l~~~--~~~~i~~--------------------qi~~aL~  255 (491)
                      |+++|.+|.....                   ...  ...+...  .......                    .+...+.
T Consensus        72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (244)
T cd05150          72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA  151 (244)
T ss_pred             EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence            9999887764321                   000  0011100  0000000                    0111122


Q ss_pred             HHHh----cCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          256 FLHE----EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       256 yLH~----~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      .|-.    .....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            2211    012348999999999999998778999998765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.41  E-value=1.8e-06  Score=81.70  Aligned_cols=141  Identities=18%  Similarity=0.150  Sum_probs=82.0

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--ceeeeeeEEee---cCc
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP--NLVKLVGYCIE---DDQ  213 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~~~~---~~~  213 (491)
                      +.|+.|..+.||+.....           ..+++|.....  .....+.+|+.+++.|...  -+.+++.+...   ...
T Consensus         3 ~~l~~G~~n~~~~v~~~~-----------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~   69 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-----------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF   69 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-----------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred             ccCCCCCeeeEEEEEECC-----------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence            568999999999998742           37999997654  3446778899998888533  34566654322   234


Q ss_pred             eEEEEEecCCCChHH----------------Hhh---hC--CCCCCCHHH---------HHHH------------HHHHH
Q 011180          214 RLLVYEFMPRGSLEN----------------HLF---RK--GSLPLPWSI---------RMKI------------ALGAA  251 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~----------------~l~---~~--~~~~l~~~~---------~~~i------------~~qi~  251 (491)
                      .+++|++++|..+..                .+.   ..  ....+....         ....            ...+.
T Consensus        70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (239)
T PF01636_consen   70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE  149 (239)
T ss_dssp             EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred             ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence            689999999987777                111   11  111111110         0000            11122


Q ss_pred             H-HHHHHHhc----CCCCeEecCCCCCcEEEC-CCCCeEEeccCCcc
Q 011180          252 K-GLAFLHEE----AEKPVIYRDFKTSNILLD-ADYNAKLSDFGLAK  292 (491)
Q Consensus       252 ~-aL~yLH~~----~~~~iiHrDlKp~NILl~-~~~~~kL~DFGla~  292 (491)
                      . .+..++..    ....++|+|+.+.|||++ +++.+.|+||+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2 33334331    234599999999999999 66667899998664

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.40  E-value=1.9e-06  Score=76.74  Aligned_cols=129  Identities=20%  Similarity=0.206  Sum_probs=90.1

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceee-eeeEEeecCc
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVK-LVGYCIEDDQ  213 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~-l~~~~~~~~~  213 (491)
                      ....+.||+|.+|.||+|.+.           |..+|+|+-..+..  ...+..|+++|..+.--++.+ +|.|.    .
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~   86 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----E   86 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----h
Confidence            345678999999999999984           55899999877743  467889999999998666553 34332    2


Q ss_pred             eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-C-CcEEECCCCCeEEeccCCc
Q 011180          214 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK-T-SNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlK-p-~NILl~~~~~~kL~DFGla  291 (491)
                      .++.|||+.|-.|.+.....     +.    +-...+++.---|...|   |-|..|. | .||++ .++.+.|+||..|
T Consensus        87 ~~i~me~i~G~~L~~~~~~~-----~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv-~~~~~~iIDFd~A  153 (201)
T COG2112          87 DFIRMEYIDGRPLGKLEIGG-----DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLV-NDRDVYIIDFDSA  153 (201)
T ss_pred             hhhhhhhhcCcchhhhhhcc-----cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEe-cCCcEEEEEccch
Confidence            35669999888888765321     11    22334455544455556   8898886 4 45555 4459999999988


Q ss_pred             cc
Q 011180          292 KD  293 (491)
Q Consensus       292 ~~  293 (491)
                      +.
T Consensus       154 t~  155 (201)
T COG2112         154 TF  155 (201)
T ss_pred             hh
Confidence            73

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.34  E-value=8.8e-06  Score=75.29  Aligned_cols=129  Identities=17%  Similarity=0.246  Sum_probs=91.7

Q ss_pred             cCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC----------------cccHHHHHHHHHHHhcCC---
Q 011180          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----------------LQGHKEWLAEVNFLGNLL---  197 (491)
Q Consensus       137 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~il~~l~---  197 (491)
                      -..+||.|+.-.||.-  ..+          ...+||++....                ....++..+|+.....+.   
T Consensus         5 ~~~~i~~G~~R~cy~H--P~d----------p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~   72 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--PDD----------PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRR   72 (199)
T ss_pred             CCcccccCCCceEEEC--CCC----------CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhcc
Confidence            3467999999999963  222          247899987665                123456677777666655   


Q ss_pred             ---CCceeeeeeEEeecCceEEEEEecCC------CChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 011180          198 ---HPNLVKLVGYCIEDDQRLLVYEFMPR------GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYR  268 (491)
Q Consensus       198 ---HpnIv~l~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHr  268 (491)
                         +.+|.+++|+...+...-+|+|.+.+      .+|.+++...   .++. .   +...+-+-..||-+++   |+.+
T Consensus        73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~---~~~~L~~f~~~l~~~~---Iv~~  142 (199)
T PF10707_consen   73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-E---LRQALDEFKRYLLDHH---IVIR  142 (199)
T ss_pred             CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-H---HHHHHHHHHHHHHHcC---Ceec
Confidence               88999999999999889999998743      3688888544   3444 2   3333344567777777   9999


Q ss_pred             CCCCCcEEECCC--C--CeEEec
Q 011180          269 DFKTSNILLDAD--Y--NAKLSD  287 (491)
Q Consensus       269 DlKp~NILl~~~--~--~~kL~D  287 (491)
                      ||+|.||++..+  +  .+.|+|
T Consensus       143 dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  143 DLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             CCCcccEEEEecCCCceEEEEEe
Confidence            999999999432  2  577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.23  E-value=1.3e-05  Score=73.77  Aligned_cols=125  Identities=28%  Similarity=0.429  Sum_probs=89.8

Q ss_pred             cCCCcCcccccCCc-eEEEEEEEccCCCcccCCCCCeEEEEEEecC---CC-------cc-----------cHHHHHHHH
Q 011180          133 RNFRPESLLGEGGF-GCVFKGWVEENGTAPVKPGTGLTVAVKTLNH---DG-------LQ-----------GHKEWLAEV  190 (491)
Q Consensus       133 ~~y~~~~~lG~G~f-g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~---~~-------~~-----------~~~~~~~E~  190 (491)
                      .+++.++.||.|.- |.||++..           .|..+|+|++..   ..       ..           ...-|..|.
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-----------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC  105 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-----------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC  105 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-----------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence            67889999999999 99999988           467999999321   10       00           012367788


Q ss_pred             HHHhcCC---CCce--eeeeeEEeecC------------------ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHH
Q 011180          191 NFLGNLL---HPNL--VKLVGYCIEDD------------------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA  247 (491)
Q Consensus       191 ~il~~l~---HpnI--v~l~~~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~  247 (491)
                      +...+|.   +.++  |+++||..-..                  ...||.||++...           .+    ...-+
T Consensus       106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~  170 (207)
T PF13095_consen  106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDI  170 (207)
T ss_pred             HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHH
Confidence            8777775   4566  99999874321                  1247888776543           11    12334


Q ss_pred             HHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       248 ~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      .+|.+-|..+|..+   |+-+|+++.|..     .-+|+|||.+
T Consensus       171 ~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  171 PQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            56777788999999   999999999987     5689999864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.19  E-value=5.6e-06  Score=86.92  Aligned_cols=138  Identities=17%  Similarity=0.118  Sum_probs=86.3

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc-------------------------------HH---
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-------------------------------HK---  184 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~---  184 (491)
                      +.||.-+.|.||+|+.+.          |..||||+-+..-...                               .+   
T Consensus       167 ~piaaASlaQVhrA~L~~----------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~  236 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN----------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP  236 (538)
T ss_pred             chhhhcchhheEEEEecC----------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence            579999999999999874          7789999965331100                               01   


Q ss_pred             ---HHHHHHHHHhcC----CCCc------eeeeeeEEeecCceEEEEEecCCCChHHHh--hhCCCCCCCHHHHHHHHHH
Q 011180          185 ---EWLAEVNFLGNL----LHPN------LVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIALG  249 (491)
Q Consensus       185 ---~~~~E~~il~~l----~Hpn------Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l--~~~~~~~l~~~~~~~i~~q  249 (491)
                         +|.+|++-..++    .|-+      |.++|-  .-.....|+||||+|..+.|.-  .+.   .++...+...+.+
T Consensus       237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~  311 (538)
T KOG1235|consen  237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVE  311 (538)
T ss_pred             hhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHH
Confidence               133444433332    3444      333322  2234678999999998777653  333   3444433333333


Q ss_pred             HHHHHHHHHhcCCCCeEecCCCCCcEEECC----CCCeEEeccCCcccCCC
Q 011180          250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDA----DYNAKLSDFGLAKDAPE  296 (491)
Q Consensus       250 i~~aL~yLH~~~~~~iiHrDlKp~NILl~~----~~~~kL~DFGla~~~~~  296 (491)
                      +..-+-+.  .|   ++|.|=+|.|||+..    ++.+.+.|||+...+..
T Consensus       312 ~~~~qIf~--~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  312 AYLEQIFK--TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHHHh--cC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            22112222  24   999999999999983    67899999999887654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.18  E-value=7.3e-06  Score=75.39  Aligned_cols=103  Identities=27%  Similarity=0.236  Sum_probs=81.4

Q ss_pred             HHHHHHhcCCC-CceeeeeeEEeecCceEEEEEecCCCChHHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011180          188 AEVNFLGNLLH-PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPV  265 (491)
Q Consensus       188 ~E~~il~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i  265 (491)
                      .|.-+|..+.+ +++.+++|+|-.    ++|.||...+++...... ..-...+|..+.+||.++++.+.+|+......+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            48888888875 699999999843    688999987766432100 011256899999999999999999998654458


Q ss_pred             EecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          266 IYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       266 iHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      .-.|++++|+-+++++++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            88999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.17  E-value=1.9e-05  Score=89.00  Aligned_cols=82  Identities=18%  Similarity=0.215  Sum_probs=56.8

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCC-CCce--eeeeeEEeec--
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLL-HPNL--VKLVGYCIED--  211 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-HpnI--v~l~~~~~~~--  211 (491)
                      .+.|+.|.+..+|+.......       ....+++|+..... ......+.+|+++|+.|. |.+|  .+++.++.+.  
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~-------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v  115 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGG-------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV  115 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCC-------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence            466899999999998764311       11357777764432 223456889999999996 6665  6777777654  


Q ss_pred             -CceEEEEEecCCCCh
Q 011180          212 -DQRLLVYEFMPRGSL  226 (491)
Q Consensus       212 -~~~~lV~E~~~~gsL  226 (491)
                       +..|+||||++|..+
T Consensus       116 ~G~~flVME~v~G~~~  131 (822)
T PLN02876        116 IGTAFYIMEYLEGRIF  131 (822)
T ss_pred             CCCceEEEEecCCccc
Confidence             467899999987643

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.10  E-value=2.1e-05  Score=75.12  Aligned_cols=73  Identities=15%  Similarity=0.132  Sum_probs=44.7

Q ss_pred             cccccCCce-EEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCC---ceeeeeeEEeec---
Q 011180          139 SLLGEGGFG-CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP---NLVKLVGYCIED---  211 (491)
Q Consensus       139 ~~lG~G~fg-~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~~~~~~~---  211 (491)
                      +.|+.|+.. .||+..              ..+++|......  ....+.+|+++|..|...   -+..+++.....   
T Consensus         3 ~~~~~gG~~n~vy~~~--------------~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~   66 (235)
T cd05155           3 EPVDSGGTDNATFRLG--------------DDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGY   66 (235)
T ss_pred             eeccCCCcccceEEcC--------------CceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCC
Confidence            457766665 588751              147778755422  235788899999887531   233344433322   


Q ss_pred             CceEEEEEecCCCChH
Q 011180          212 DQRLLVYEFMPRGSLE  227 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~  227 (491)
                      ...++||++++|.++.
T Consensus        67 ~~~~~l~~~i~G~~l~   82 (235)
T cd05155          67 PWPWSVYRWLEGETAT   82 (235)
T ss_pred             CcceEEEEeecCCCCC
Confidence            2348899999987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.97  E-value=8e-05  Score=70.94  Aligned_cols=75  Identities=21%  Similarity=0.157  Sum_probs=46.3

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCce-eeeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV  217 (491)
                      +.|..|-...+|++.....        .+..|++|+....... .-...+|+.++..+...++ .++++.+.    ..+|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l   70 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLI   70 (235)
T ss_pred             EEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEE
Confidence            4577788899999865310        1346889977543211 1223478888888854333 34443322    2489


Q ss_pred             EEecCCCCh
Q 011180          218 YEFMPRGSL  226 (491)
Q Consensus       218 ~E~~~~gsL  226 (491)
                      |||++|.++
T Consensus        71 ~e~i~G~~l   79 (235)
T cd05157          71 YEFIPGRTL   79 (235)
T ss_pred             EEeeCCCcC
Confidence            999988765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.96  E-value=0.00013  Score=72.34  Aligned_cols=77  Identities=12%  Similarity=0.059  Sum_probs=54.8

Q ss_pred             cCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCC---CceeeeeeEEeec--
Q 011180          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH---PNLVKLVGYCIED--  211 (491)
Q Consensus       137 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H---pnIv~l~~~~~~~--  211 (491)
                      -.+.||.|..+.||+.....          + .+.+|..+..  .....+..|...|+.|.-   -.+.++++++...  
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~----------~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~   84 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQ----------G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS   84 (297)
T ss_pred             eeeecCCccceeEEEEEcCC----------C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence            34679999999999985432          2 4667775331  123477889999988853   3577888877543  


Q ss_pred             -CceEEEEEecCCCCh
Q 011180          212 -DQRLLVYEFMPRGSL  226 (491)
Q Consensus       212 -~~~~lV~E~~~~gsL  226 (491)
                       +..+||||++++.++
T Consensus        85 ~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         85 PGPDVLLLERLRGVSV  100 (297)
T ss_pred             CCCeEEEEeccCCEec
Confidence             668999999988765

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.91  E-value=6e-05  Score=74.50  Aligned_cols=142  Identities=16%  Similarity=0.120  Sum_probs=83.7

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc--eeeeeeE------Ee
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGY------CI  209 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~------~~  209 (491)
                      .+.|..|....+|+....           +..+++|+...   .....+..|++++..|.+-+  +.+++..      ..
T Consensus        19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~   84 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE   84 (296)
T ss_pred             eecccCccccceEEEEeC-----------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence            456777888899987542           23588898764   23355677888888775322  4444331      22


Q ss_pred             ecCceEEEEEecCCCChHH----Hh----------hhC--C--C-----CCCCHHHHH----------HHHHHHHHHHHH
Q 011180          210 EDDQRLLVYEFMPRGSLEN----HL----------FRK--G--S-----LPLPWSIRM----------KIALGAAKGLAF  256 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~----~l----------~~~--~--~-----~~l~~~~~~----------~i~~qi~~aL~y  256 (491)
                      ..+..++||+|++|..+..    .+          +..  .  .     ....|....          .....+..++.+
T Consensus        85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  164 (296)
T cd05153          85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR  164 (296)
T ss_pred             eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence            3456689999998876532    00          000  0  0     011111110          011123344455


Q ss_pred             HHh----cCCCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          257 LHE----EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       257 LH~----~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      +..    .....+||+|+.|.|||+++++.+.|+||+.+..
T Consensus       165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            543    1224599999999999999887789999987653

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.89  E-value=8.5e-05  Score=71.89  Aligned_cols=137  Identities=15%  Similarity=0.100  Sum_probs=76.2

Q ss_pred             cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCce-eeeeeEEeecCceEEEEE
Q 011180          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLLVYE  219 (491)
Q Consensus       141 lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV~E  219 (491)
                      +..|-.+.+|+...           .+..+++|........-.-...+|..+++.+..-.+ .+++...  .  .++|||
T Consensus         4 ~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e   68 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVE   68 (256)
T ss_pred             CCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEE
Confidence            55688889998763           345788887654322111134678888888864333 2333332  2  379999


Q ss_pred             ecCCCChHHH--------------hh---hCC--CCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCCe
Q 011180          220 FMPRGSLENH--------------LF---RKG--SLPLPWSI-RMKIALGA---------AKGLAFLHEE-----AEKPV  265 (491)
Q Consensus       220 ~~~~gsL~~~--------------l~---~~~--~~~l~~~~-~~~i~~qi---------~~aL~yLH~~-----~~~~i  265 (491)
                      |++|..+...              +.   ...  ...+.... ...+..++         ...+..+-..     ....+
T Consensus        69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  148 (256)
T TIGR02721        69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP  148 (256)
T ss_pred             eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence            9988665321              11   110  11112111 11111111         1112222111     12348


Q ss_pred             EecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          266 IYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       266 iHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      +|+|+.|.|||+++++ +.|+||..+..
T Consensus       149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       149 LHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999999999876 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.89  E-value=3.3e-05  Score=85.94  Aligned_cols=196  Identities=21%  Similarity=0.260  Sum_probs=137.1

Q ss_pred             HHHHHHHHhcCCCCceeeeeeEEeecCce----EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011180          186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQR----LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA  261 (491)
Q Consensus       186 ~~~E~~il~~l~HpnIv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~  261 (491)
                      ...|+..+..+.|+|++.++.|.......    .+..++|..-++...+...+  .++....+.+..++.+||.|+|...
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            34577778888999999999987655332    24457888888888887765  5778888889999999999999975


Q ss_pred             CCCeEecCCCCC---cEEECCCCCeEEe--ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCcc--ccchhHHH
Q 011180          262 EKPVIYRDFKTS---NILLDADYNAKLS--DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK--SDVYSFGV  334 (491)
Q Consensus       262 ~~~iiHrDlKp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~--~DvwSlGv  334 (491)
                         ..|.-|..+   +...+..+.+.+.  ||+.+....+.....   ...-+..|.++|......+..+  .|+|.+|.
T Consensus       307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             ---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHH
Confidence               555555444   4444566777777  999888765533221   1233556788887766655554  79999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011180          335 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  414 (491)
Q Consensus       335 il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~  414 (491)
                      .+..+..|..+-....                   ....+++..        ......++..+|+..++++|+++.+++.
T Consensus       381 l~~~~~~~~~i~~~~~-------------------~~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSA-------------------VPVSLLDVL--------STSELLDALPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             HHhhhhhcCccccccc-------------------chhhhhccc--------cchhhhhhhhhhcchhhhhccchhhhhh
Confidence            9999998875432110                   000111110        0125678889999999999999999998


Q ss_pred             Hh
Q 011180          415 TL  416 (491)
Q Consensus       415 ~L  416 (491)
                      +.
T Consensus       434 ~~  435 (1351)
T KOG1035|consen  434 HP  435 (1351)
T ss_pred             ch
Confidence            74

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.82  E-value=0.00047  Score=70.67  Aligned_cols=76  Identities=20%  Similarity=0.172  Sum_probs=52.3

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecC------CC-cccHHHHHHHHHHHhcCC---CCceeeeeeEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH------DG-LQGHKEWLAEVNFLGNLL---HPNLVKLVGYC  208 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~------~~-~~~~~~~~~E~~il~~l~---HpnIv~l~~~~  208 (491)
                      +.||.|.+..||++....         .+..|+||.-..      +. .....+...|.+.|..+.   ..++.+++.+ 
T Consensus        32 ~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-  101 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-  101 (401)
T ss_pred             eEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence            579999999999998753         224799998531      11 123456677888888763   3456677765 


Q ss_pred             eecCceEEEEEecCCCC
Q 011180          209 IEDDQRLLVYEFMPRGS  225 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gs  225 (491)
                       +.+..++||||+++..
T Consensus       102 -D~~~~~lVME~L~~~~  117 (401)
T PRK09550        102 -DEELAVTVMEDLSDHK  117 (401)
T ss_pred             -CCCCCEEEEecCCCcc
Confidence             4456789999997643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.66  E-value=0.00035  Score=69.28  Aligned_cols=81  Identities=20%  Similarity=0.192  Sum_probs=48.8

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCce-eeeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV  217 (491)
                      +.|..|-...||+........   ....+..+++|+..... ....+..+|++++..+...++ .++++++.    -.+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~---~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDA---LSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCccc---ccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCch
Confidence            346667778999887542110   11235679999976543 222345678888888863333 34454443    2468


Q ss_pred             EEecCCCChH
Q 011180          218 YEFMPRGSLE  227 (491)
Q Consensus       218 ~E~~~~gsL~  227 (491)
                      |||++|..+.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.54  E-value=0.0021  Score=64.30  Aligned_cols=32  Identities=28%  Similarity=0.382  Sum_probs=26.7

Q ss_pred             CCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          262 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       262 ~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      +.++||+|+.+.|||++.+...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            35699999999999998765568999997753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.51  E-value=0.0012  Score=65.58  Aligned_cols=142  Identities=18%  Similarity=0.166  Sum_probs=81.0

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc--eeeeeeE------Ee
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGY------CI  209 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~------~~  209 (491)
                      .+.|+.|....+|+....          .| .+++|+.....  ....+..|++++..|....  +.+++..      ..
T Consensus        27 i~~~~~G~~n~~y~v~t~----------~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~   93 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD----------VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST   93 (307)
T ss_pred             ccccCCccccceEEEEeC----------CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence            566778877899987542          22 47788775432  2345566777777774222  3444331      12


Q ss_pred             ecCceEEEEEecCCCChHH-----------H---hhhC-CCC--------C-CCHHHHH------------HHHHHHHHH
Q 011180          210 EDDQRLLVYEFMPRGSLEN-----------H---LFRK-GSL--------P-LPWSIRM------------KIALGAAKG  253 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~-----------~---l~~~-~~~--------~-l~~~~~~------------~i~~qi~~a  253 (491)
                      ..+..++||||++|..+..           .   ++.. ...        . ..|....            .....+...
T Consensus        94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~  173 (307)
T TIGR00938        94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE  173 (307)
T ss_pred             cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence            2456789999998854321           1   1110 000        0 0111100            001123334


Q ss_pred             HHHHHh----cCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          254 LAFLHE----EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       254 L~yLH~----~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ++++..    .....+||+|+.+.||+++.++.+.|+||+.+.
T Consensus       174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       174 LDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            555543    223569999999999999988777899999765

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=97.30  E-value=0.0024  Score=64.71  Aligned_cols=145  Identities=17%  Similarity=0.109  Sum_probs=80.2

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcee-eeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLV-KLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~~~~~~~~~~~lV  217 (491)
                      ..|-.|-.-.+|++.......     ..+..|++|+........ -.-.+|+.++..+..-++. ++++.+..    ..|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~-----~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v  111 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEG-----NLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN----GRV  111 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCC-----CCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECC----ceE
Confidence            345558888999987543211     134679999886543221 1235688888888643333 44555432    268


Q ss_pred             EEecCCCChHHH--------------h---hhCC---CC-CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 011180          218 YEFMPRGSLENH--------------L---FRKG---SL-PLPWSIRMKIALGA-----------------AKGLAFL--  257 (491)
Q Consensus       218 ~E~~~~gsL~~~--------------l---~~~~---~~-~l~~~~~~~i~~qi-----------------~~aL~yL--  257 (491)
                      +||+++.+|...              +   +...   .. ...+..+..+..++                 ...+..|  
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            999987666421              0   1100   00 11122222222111                 1111122  


Q ss_pred             --Hh-cCCCCeEecCCCCCcEEECC-CCCeEEeccCCccc
Q 011180          258 --HE-EAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKD  293 (491)
Q Consensus       258 --H~-~~~~~iiHrDlKp~NILl~~-~~~~kL~DFGla~~  293 (491)
                        .. .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence              21 11235899999999999976 46899999987753

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.23  E-value=0.00032  Score=68.52  Aligned_cols=135  Identities=16%  Similarity=0.096  Sum_probs=90.7

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc----------------c------cHHHHHHHHHH
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----------------Q------GHKEWLAEVNF  192 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------------~------~~~~~~~E~~i  192 (491)
                      +.+.+.||-|.-+.||.+-+.          .|...++|.-.....                .      ..-...+|+..
T Consensus        94 ~svGnqIGVGKESDIY~v~d~----------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf  163 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE----------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF  163 (465)
T ss_pred             hhhccccccccccceEEEecC----------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence            677889999999999999775          366788886431110                0      01124578999


Q ss_pred             HhcCC-CCc-eeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 011180          193 LGNLL-HPN-LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  270 (491)
Q Consensus       193 l~~l~-Hpn-Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  270 (491)
                      |+.|. |-. |.+.++    .+.-++|||++.+-.|...-.-     .....   +...+..-+--|-.+|   +||+|+
T Consensus       164 mkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~---ly~~lm~~Iv~la~~G---lIHgDF  228 (465)
T KOG2268|consen  164 MKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHV-----EDPPT---LYDDLMGLIVRLANHG---LIHGDF  228 (465)
T ss_pred             HHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeec-----CChHH---HHHHHHHHHHHHHHcC---ceeccc
Confidence            98885 322 333333    3556899999988777654311     12222   3333334455566667   999999


Q ss_pred             CCCcEEECCCCCeEEeccCCcccC
Q 011180          271 KTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       271 Kp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      .-=||++++++.++++||--+...
T Consensus       229 NEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  229 NEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             chheeEEecCCCEEEeechHhhcc
Confidence            999999999999999999755433

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.13  E-value=0.0042  Score=60.85  Aligned_cols=31  Identities=29%  Similarity=0.394  Sum_probs=25.8

Q ss_pred             CeEecCCCCCcEEECCCCC-eEEeccCCcccC
Q 011180          264 PVIYRDFKTSNILLDADYN-AKLSDFGLAKDA  294 (491)
Q Consensus       264 ~iiHrDlKp~NILl~~~~~-~kL~DFGla~~~  294 (491)
                      .++|+|+++.|||++.++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999987555 569999987643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.12  E-value=9.9e-05  Score=84.09  Aligned_cols=175  Identities=13%  Similarity=0.003  Sum_probs=120.6

Q ss_pred             EEEEEecCCCcccH-----HHHHHHHHHHhcCCCCceeeeeeEEee--cCceEEEEEecCCCChHHHhhhCC--CCCCCH
Q 011180          170 VAVKTLNHDGLQGH-----KEWLAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRKG--SLPLPW  240 (491)
Q Consensus       170 vavK~~~~~~~~~~-----~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~  240 (491)
                      +.+|+.+.-..+..     +-.+.|..-++...|+++.....-...  ....|.+++|+.+|.+.+.|.+.-  ...+..
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence            45566544333322     223455566666789998876654443  346689999999999999986532  222333


Q ss_pred             HHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhh
Q 011180          241 SIRMKIALGAAKGLAFLHEEA--EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV  318 (491)
Q Consensus       241 ~~~~~i~~qi~~aL~yLH~~~--~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~  318 (491)
                      .-+.....+.+.+..-+|...  ..-.+|++||+-|.+|..+..+|+.++|+.+....  ........++++.|+++++.
T Consensus      1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred             chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHH
Confidence            333333333344455544432  24478999999999999999999999999983322  12223346678899999998


Q ss_pred             hcCCCCccccchhHHHHHHHHHhCCCCC
Q 011180          319 MTGHLTSKSDVYSFGVVLLEMLTGRRSM  346 (491)
Q Consensus       319 ~~~~~~~~~DvwSlGvil~elltG~~pf  346 (491)
                      ..-.++.++|+|..|+-+|++.-|..+|
T Consensus      1413 N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            8889999999999999999999888776

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.07  E-value=0.0042  Score=61.87  Aligned_cols=141  Identities=16%  Similarity=0.111  Sum_probs=91.8

Q ss_pred             cCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---------c-------------cHH----HHHHHH
Q 011180          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---------Q-------------GHK----EWLAEV  190 (491)
Q Consensus       137 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~-------------~~~----~~~~E~  190 (491)
                      +...|..|--+-||.|.-.          .|..+|||+++..-+         .             ..+    ....|+
T Consensus       148 inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~  217 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEM  217 (520)
T ss_pred             cccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHH
Confidence            4456778888899998654          477899999863211         0             011    234688


Q ss_pred             HHHhcCCCCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 011180          191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  270 (491)
Q Consensus       191 ~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  270 (491)
                      +-|.+|+.-.|...--+..  ....|||+|+. .+=.-.- ......++...+..+-.|++.-+.-|.+.+.  +||.||
T Consensus       218 RNLkRl~~aGIP~PePIlL--k~hVLVM~FlG-rdgw~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADL  291 (520)
T KOG2270|consen  218 RNLKRLNNAGIPCPEPILL--KNHVLVMEFLG-RDGWAAP-KLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADL  291 (520)
T ss_pred             HHHHHHHhcCCCCCCceee--ecceEeeeecc-CCCCcCc-ccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccch
Confidence            8888887555433222222  23379999994 3211110 1112356666777777788888877776553  999999


Q ss_pred             CCCcEEECCCCCeEEeccCCcccC
Q 011180          271 KTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       271 Kp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      .--|+|+. +|.+.|+|.+-+...
T Consensus       292 SEfN~Lyh-dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  292 SEFNLLYH-DGKLYIIDVSQSVEH  314 (520)
T ss_pred             hhhhheEE-CCEEEEEEccccccC
Confidence            99999994 569999999877644

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.00  E-value=0.011  Score=59.70  Aligned_cols=74  Identities=16%  Similarity=0.140  Sum_probs=46.9

Q ss_pred             ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecC------CC-cccHHHHHHHHHHHhcCC--CC-ceeeeeeEEe
Q 011180          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH------DG-LQGHKEWLAEVNFLGNLL--HP-NLVKLVGYCI  209 (491)
Q Consensus       140 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~------~~-~~~~~~~~~E~~il~~l~--Hp-nIv~l~~~~~  209 (491)
                      .||.|....||++....         .+..|+||.-..      .. .....+..-|...|....  -| .+.++|.  .
T Consensus         2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~   70 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F   70 (370)
T ss_pred             cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E
Confidence            47999999999998632         235799997431      11 223345566777777653  34 3444443  4


Q ss_pred             ecCceEEEEEecCCC
Q 011180          210 EDDQRLLVYEFMPRG  224 (491)
Q Consensus       210 ~~~~~~lV~E~~~~g  224 (491)
                      +.....+|||+++..
T Consensus        71 D~e~~~~vMEdL~~~   85 (370)
T TIGR01767        71 DTEMAVTVMEDLSHH   85 (370)
T ss_pred             ccccceehHhhCccc
Confidence            555667999998543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.89  E-value=0.011  Score=58.55  Aligned_cols=33  Identities=18%  Similarity=0.364  Sum_probs=29.2

Q ss_pred             CCeEecCCCCCcEEECCCCCeEEeccCCcccCC
Q 011180          263 KPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  295 (491)
Q Consensus       263 ~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~  295 (491)
                      ..++|+|+.+.||+|+.++-+-|+||+++....
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            459999999999999988889999999987643

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.68  E-value=0.03  Score=57.45  Aligned_cols=73  Identities=10%  Similarity=0.025  Sum_probs=47.8

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-------ccHHHHHHHHHHHhcCC---CCceeeeeeE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGNLL---HPNLVKLVGY  207 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~---HpnIv~l~~~  207 (491)
                      .+.||.|....||+....           +..|+||.-.....       -...+...|...|..+.   ..++.+++.+
T Consensus        37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~  105 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF  105 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence            457899999999997652           23588887641110       12334445666666553   3567778877


Q ss_pred             EeecCceEEEEEecCC
Q 011180          208 CIEDDQRLLVYEFMPR  223 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~  223 (491)
                      +.  +..+++|||+++
T Consensus       106 de--d~~vlvME~L~~  119 (418)
T PLN02756        106 DR--TMALIGMRYLEP  119 (418)
T ss_pred             CC--CCCEEEEeecCC
Confidence            66  456889999976

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.63  E-value=0.0047  Score=62.27  Aligned_cols=59  Identities=19%  Similarity=0.158  Sum_probs=40.1

Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  278 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~  278 (491)
                      .|+=+|..|.++..++...+   .++....+++.-.+.||--+---.  +++|.|+.|.||++.
T Consensus       321 vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR  379 (565)
T ss_pred             eeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence            56667888888888886553   445555666655555544333322  299999999999994

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.62  E-value=0.0014  Score=67.79  Aligned_cols=52  Identities=23%  Similarity=0.342  Sum_probs=41.6

Q ss_pred             cHHHHHHHHHHHhcCCCCceeeeeeEEeec-CceEEEEEecCCCChHHHhhhCC
Q 011180          182 GHKEWLAEVNFLGNLLHPNLVKLVGYCIED-DQRLLVYEFMPRGSLENHLFRKG  234 (491)
Q Consensus       182 ~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~  234 (491)
                      ...+++-..++++.+.|+|+..++.+.... ....+|||++ +.+|++++..+.
T Consensus        25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            345677889999999999999999876543 3467899999 789999886553

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.55  E-value=0.015  Score=58.51  Aligned_cols=76  Identities=18%  Similarity=0.224  Sum_probs=45.0

Q ss_pred             ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcee-eeeeEEeecCceEEEE
Q 011180          140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLV-KLVGYCIEDDQRLLVY  218 (491)
Q Consensus       140 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~~~~~~~~~~~lV~  218 (491)
                      .|..|=...+|+.......      +.+..|++|+....... .-.-.+|+.+++.+..-++- ++++++. .+   +|.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~------~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~   89 (330)
T PLN02421         21 RISGGITNLLLKVSVKEEN------GNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQ   89 (330)
T ss_pred             EeCCcccceEEEEEecCCC------CCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eee
Confidence            3444777889988654311      02337889987654321 12234688888888654443 4555542 22   589


Q ss_pred             EecCCCCh
Q 011180          219 EFMPRGSL  226 (491)
Q Consensus       219 E~~~~gsL  226 (491)
                      +|+++..|
T Consensus        90 ~fi~g~~l   97 (330)
T PLN02421         90 SFINARTL   97 (330)
T ss_pred             hhhcCCCC
Confidence            99977655

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.54  E-value=0.0042  Score=58.15  Aligned_cols=29  Identities=34%  Similarity=0.449  Sum_probs=20.7

Q ss_pred             CeEecCCCCCcEEE-CCCCCeEEeccCCcc
Q 011180          264 PVIYRDFKTSNILL-DADYNAKLSDFGLAK  292 (491)
Q Consensus       264 ~iiHrDlKp~NILl-~~~~~~kL~DFGla~  292 (491)
                      -++|.||.+.|||+ +.++.++|+||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            38999999999999 888999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.54  E-value=0.023  Score=55.87  Aligned_cols=73  Identities=21%  Similarity=0.252  Sum_probs=45.9

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCceeeeeeEEeecCce
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~  214 (491)
                      .+.|+.|....+|+...           .+..+.||+-...   ....|..|..-|+.|.   .-.+.+.+++....+..
T Consensus        22 ~~~v~GG~i~~a~~~~~-----------~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~   87 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLDT-----------DGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA   87 (288)
T ss_dssp             EEEE--SSSSEEEEEET-----------TS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred             eEecCCCChhheEEEEC-----------CCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence            45688899999998762           4568999987622   2245677887777773   45677888888877788


Q ss_pred             EEEEEecCCC
Q 011180          215 LLVYEFMPRG  224 (491)
Q Consensus       215 ~lV~E~~~~g  224 (491)
                      +|||||++.+
T Consensus        88 fLlle~l~~~   97 (288)
T PF03881_consen   88 FLLLEFLEMG   97 (288)
T ss_dssp             EEEEE-----
T ss_pred             eEEEEeecCC
Confidence            9999999766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.53  E-value=0.03  Score=55.60  Aligned_cols=29  Identities=24%  Similarity=0.376  Sum_probs=25.3

Q ss_pred             CCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          263 KPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       263 ~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      .++||+|+.+.|||++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            45999999999999987 678999998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.41  E-value=0.02  Score=58.48  Aligned_cols=75  Identities=21%  Similarity=0.257  Sum_probs=48.7

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecC-----CC-cccHHHHHHHHHHHhcCC--CC-ceeeeeeEE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-----DG-LQGHKEWLAEVNFLGNLL--HP-NLVKLVGYC  208 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~-----~~-~~~~~~~~~E~~il~~l~--Hp-nIv~l~~~~  208 (491)
                      .+.||.|.-..||++.+..         .+..|+||.-..     .. .-...+..-|.++|+.+.  -| ++.++|.  
T Consensus        34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--  102 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--  102 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--
Confidence            4578999999999998732         134688987431     11 223456667888887664  34 4444543  


Q ss_pred             eecCceEEEEEecCC
Q 011180          209 IEDDQRLLVYEFMPR  223 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~  223 (491)
                      .+.....+|||+++.
T Consensus       103 ~D~e~~~~vMEdL~~  117 (409)
T PRK12396        103 FDSVMNCCVMEDLSD  117 (409)
T ss_pred             ECcHHhhHHHHhCcc
Confidence            455566789999854

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.35  E-value=0.042  Score=54.70  Aligned_cols=32  Identities=19%  Similarity=0.192  Sum_probs=28.3

Q ss_pred             CCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          263 KPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       263 ~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      ..+||+|+.++|||++.++.+.|+||..+...
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASFA  227 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence            45999999999999999999999999887643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.03  E-value=0.017  Score=57.63  Aligned_cols=73  Identities=19%  Similarity=0.176  Sum_probs=55.2

Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      .+.|++|++- |++|.- +.     ...++++..++++.+..+.-+...  .+.=|||+...||||+ +|++.|+||-++
T Consensus       299 ~y~yl~~kdh-gt~is~-ik-----~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-IK-----ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             eEEEEEEecC-Cceeee-ee-----cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeee
Confidence            3456778775 555542 21     345678888999887777777653  4589999999999999 999999999999


Q ss_pred             ccC
Q 011180          292 KDA  294 (491)
Q Consensus       292 ~~~  294 (491)
                      +.-
T Consensus       369 Rl~  371 (488)
T COG5072         369 RLS  371 (488)
T ss_pred             ecc
Confidence            954

>PRK06148 hypothetical protein; Provisional

Probab=95.85  E-value=0.12  Score=59.95  Aligned_cols=32  Identities=44%  Similarity=0.475  Sum_probs=26.3

Q ss_pred             CCCeEecCCCCCcEEECCCC--CeE-EeccCCccc
Q 011180          262 EKPVIYRDFKTSNILLDADY--NAK-LSDFGLAKD  293 (491)
Q Consensus       262 ~~~iiHrDlKp~NILl~~~~--~~k-L~DFGla~~  293 (491)
                      +..+||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            35599999999999998775  454 999998754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.79  E-value=0.1  Score=52.24  Aligned_cols=138  Identities=23%  Similarity=0.300  Sum_probs=79.4

Q ss_pred             cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc------eeeeeeEEe--ecC
Q 011180          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN------LVKLVGYCI--EDD  212 (491)
Q Consensus       141 lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~~~~~--~~~  212 (491)
                      |.+ .-..||+....+          | .+++|+....  ....++.-|+..|..|.-..      |..+-|-..  -..
T Consensus        34 l~s-~eN~~f~~~~~~----------g-~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~   99 (331)
T COG2334          34 LNS-EENSNFRVQTED----------G-RYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSG   99 (331)
T ss_pred             ccc-ccCceEEEEecC----------C-CeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccC
Confidence            444 456788877643          3 3488988765  34466777888888774211      222222211  123


Q ss_pred             --ceEEEEEecCCCChHH-H----hh----------h--CCC--------CCCCHHH-------------HHHHHHHHHH
Q 011180          213 --QRLLVYEFMPRGSLEN-H----LF----------R--KGS--------LPLPWSI-------------RMKIALGAAK  252 (491)
Q Consensus       213 --~~~lV~E~~~~gsL~~-~----l~----------~--~~~--------~~l~~~~-------------~~~i~~qi~~  252 (491)
                        ..+-|++|++|..+.. .    +.          .  ++.        ....|..             ......++..
T Consensus       100 ~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~  179 (331)
T COG2334         100 GPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLA  179 (331)
T ss_pred             CceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHH
Confidence              6678899999887762 1    00          0  000        0122220             0112333444


Q ss_pred             HHHHHHhcC----CCC---eEecCCCCCcEEECCCCC-eEEeccCCcc
Q 011180          253 GLAFLHEEA----EKP---VIYRDFKTSNILLDADYN-AKLSDFGLAK  292 (491)
Q Consensus       253 aL~yLH~~~----~~~---iiHrDlKp~NILl~~~~~-~kL~DFGla~  292 (491)
                      .+..+.+.-    +..   +||+|+.|.|||++.+.. +.++|||-+.
T Consensus       180 ~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         180 ALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            455554431    122   999999999999998874 8999999765

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.56  E-value=0.28  Score=49.24  Aligned_cols=71  Identities=17%  Similarity=0.082  Sum_probs=42.5

Q ss_pred             CCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCC--Cceeeee---e--EEeecCceEE
Q 011180          144 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH--PNLVKLV---G--YCIEDDQRLL  216 (491)
Q Consensus       144 G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~---~--~~~~~~~~~l  216 (491)
                      +.-..||+....          .+..+++|+..... ....++..|++++..|..  -.++...   |  +...++..+.
T Consensus        36 s~eN~vy~v~~~----------~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~  104 (325)
T PRK11768         36 SYENRVYQFGDE----------DGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFA  104 (325)
T ss_pred             cccceEEEEecC----------CCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEE
Confidence            445678887653          34579999875433 244567778888777742  1122211   2  2233456778


Q ss_pred             EEEecCCCC
Q 011180          217 VYEFMPRGS  225 (491)
Q Consensus       217 V~E~~~~gs  225 (491)
                      |+++++|..
T Consensus       105 l~~~~~G~~  113 (325)
T PRK11768        105 LFPRRGGRA  113 (325)
T ss_pred             EEeeeCCCC
Confidence            999997764

>PTZ00384 choline kinase; Provisional

Probab=95.25  E-value=0.13  Score=52.69  Aligned_cols=81  Identities=12%  Similarity=0.077  Sum_probs=45.3

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcee-eeeeEEeecCceEEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLV-KLVGYCIEDDQRLLV  217 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~~~~~~~~~~~lV  217 (491)
                      +.|..|-...+|++..........   ..+.|.++...... ...-+-.+|+++++.|...++- ++++.+.    .++|
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~---~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l  127 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRY---PIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI  127 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCcc---ccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence            445558889999997643210000   01225555432211 1111235689999998755544 4455543    2699


Q ss_pred             EEecCCCChH
Q 011180          218 YEFMPRGSLE  227 (491)
Q Consensus       218 ~E~~~~gsL~  227 (491)
                      .||++|..|.
T Consensus       128 ~efIeGr~l~  137 (383)
T PTZ00384        128 QEWVEGNTMG  137 (383)
T ss_pred             EEEeccccCC
Confidence            9999887664

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.25  E-value=0.081  Score=49.66  Aligned_cols=70  Identities=24%  Similarity=0.359  Sum_probs=46.7

Q ss_pred             eEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCceeeeeeEEeecCceEEEEEecCC
Q 011180          147 GCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLVGYCIEDDQRLLVYEFMPR  223 (491)
Q Consensus       147 g~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~~  223 (491)
                      |.|..|....++        ...+-||+-...   ....|..|+.-|..|.   .-+|.+++.+..+.++.||||||++-
T Consensus        27 G~inea~~v~dg--------~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~   95 (286)
T COG3001          27 GDINEAWRLRDG--------TDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT   95 (286)
T ss_pred             ccccceeEeecC--------CcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence            455555554432        246778865332   2244666776666554   46678888888889999999999988


Q ss_pred             CChH
Q 011180          224 GSLE  227 (491)
Q Consensus       224 gsL~  227 (491)
                      +.+.
T Consensus        96 ~~~d   99 (286)
T COG3001          96 GPLD   99 (286)
T ss_pred             CCCC
Confidence            7665

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.23  E-value=0.099  Score=48.82  Aligned_cols=102  Identities=14%  Similarity=0.086  Sum_probs=65.5

Q ss_pred             EEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHH
Q 011180          170 VAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL  248 (491)
Q Consensus       170 vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~  248 (491)
                      ..+|.+..-... ...-+..+.+++++++  .|+++..-  +.-.+-+|+|+|-....           .    ...++.
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~----~~N~i~  148 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------N----FSNFIT  148 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------c----hhHHHH
Confidence            344554433222 3455677899988864  47777631  33345689999832110           0    011222


Q ss_pred             HHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       249 qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      .=+.+|.-.|+.. ...+|+|..|+||+-|..|.+||.|=+..
T Consensus       149 agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  149 AGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence            1246788889654 45999999999999999999999997653

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	491
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-53
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-52
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-48
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-44
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-44
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-43
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-41
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-24
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-24
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-24
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-24
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-24
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-24
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-24
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-22
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-21
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-20
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-20
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-20
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-19
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-19
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-19
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-19
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-18
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-18
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-18
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-18
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-18
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-18
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-17
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-17
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-17
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-17
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-17
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-17
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-17
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-17
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-17
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-17
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-16
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-16
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-16
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-16
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-16
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-16
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-16
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-16
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-16
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-16
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-15
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-15
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-15
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-15
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-15
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-15
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		9e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-06
3soa_A	444	Full-Length Human Camkii Length = 444		3e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		6e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		7e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  204 bits (520), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 116/304 (38%), Positives = 183/304 (60%), Gaps = 17/304 (5%)
Query: 119 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 178
           QL++F   +L++A+ NF  +++LG GGFG V+KG          +   G  VAVK L  +
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKG----------RLADGTLVAVKRLKEE 73
Query: 179 GLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GS 235
             QG + ++  EV  +   +H NL++L G+C+   +RLLVY +M  GS+ + L  +    
Sbjct: 74  RXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 133
Query: 236 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 295
            PL W  R +IALG+A+GLA+LH+  +  +I+RD K +NILLD ++ A + DFGLAK   
Sbjct: 134 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LM 192
Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
           +    HV   V GT G+ APEY+ TG  + K+DV+ +GV+LLE++TG+R+ D  R   + 
Sbjct: 193 DYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 252
Query: 356 N--LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
           +  L++W +  L +K +   L+D  L+G++  +  ++  Q+A  C    P  RP+MSEVV
Sbjct: 253 DVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 311
Query: 414 ETLK 417
             L+
Sbjct: 312 RMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  202 bits (515), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 115/304 (37%), Positives = 182/304 (59%), Gaps = 17/304 (5%)
Query: 119 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 178
           QL++F   +L++A+ NF  +++LG GGFG V+KG          +   G  VAVK L  +
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKG----------RLADGXLVAVKRLKEE 65
Query: 179 GLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GS 235
             QG + ++  EV  +   +H NL++L G+C+   +RLLVY +M  GS+ + L  +    
Sbjct: 66  RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 236 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 295
            PL W  R +IALG+A+GLA+LH+  +  +I+RD K +NILLD ++ A + DFGLAK   
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LM 184
Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
           +    HV   V G  G+ APEY+ TG  + K+DV+ +GV+LLE++TG+R+ D  R   + 
Sbjct: 185 DYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 356 N--LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
           +  L++W +  L +K +   L+D  L+G++  +  ++  Q+A  C    P  RP+MSEVV
Sbjct: 245 DVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 414 ETLK 417
             L+
Sbjct: 304 RMLE 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  190 bits (482), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 112/301 (37%), Positives = 175/301 (58%), Gaps = 18/301 (5%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           DL+ AT NF  + L+G G FG V+KG + +          G  VA+K    +  QG +E+
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESSQGIEEF 82
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRM 244
             E+  L    HP+LV L+G+C E ++ +L+Y++M  G+L+ HL+     ++ + W  R+
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
           +I +GAA+GL +LH  A   +I+RD K+ NILLD ++  K++DFG++K   E G+TH+  
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXX 199
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RP 363
            V GT GY  PEY + G LT KSDVYSFGVVL E+L  R ++ ++ P    NL EWA   
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK 423
           H  +  +  +++DP L      +  +K    A +CL+   + RP M +V+  L+    L+
Sbjct: 260 H--NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
Query: 424 D 424
           +
Sbjct: 318 E 318

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 111/301 (36%), Positives = 174/301 (57%), Gaps = 18/301 (5%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           DL+ AT NF  + L+G G FG V+KG + +          G  VA+K    +  QG +E+
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESSQGIEEF 82
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRM 244
             E+  L    HP+LV L+G+C E ++ +L+Y++M  G+L+ HL+     ++ + W  R+
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
           +I +GAA+GL +LH  A   +I+RD K+ NILLD ++  K++DFG++K   E  +TH+  
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXX 199
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RP 363
            V GT GY  PEY + G LT KSDVYSFGVVL E+L  R ++ ++ P    NL EWA   
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK 423
           H  +  +  +++DP L      +  +K    A +CL+   + RP M +V+  L+    L+
Sbjct: 260 H--NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
Query: 424 D 424
           +
Sbjct: 318 E 318

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 110/309 (35%), Positives = 172/309 (55%), Gaps = 21/309 (6%)
Query: 118 SQLRKFMFNDLKLATRNF--RPESL----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
           ++   F F +LK  T NF  RP S+    +GEGGFG V+KG+V     A  K    + + 
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 69
Query: 172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL- 230
            + L        +++  E+  +    H NLV+L+G+  + D   LVY +MP GSL + L 
Sbjct: 70  TEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 231 FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 290
              G+ PL W +R KIA GAA G+ FLHE      I+RD K++NILLD  + AK+SDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 179
Query: 291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 350
           A+ + +  +T + +R++GT  Y APE  + G +T KSD+YSFGVVLLE++TG  ++D++R
Sbjct: 180 ARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 351 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 410
                 L++       +++     +D ++    S    +    +A+QCL      RP + 
Sbjct: 239 E--PQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 411 EVVETLKPL 419
           +V + L+ +
Sbjct: 296 KVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  176 bits (445), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 110/309 (35%), Positives = 171/309 (55%), Gaps = 21/309 (6%)
Query: 118 SQLRKFMFNDLKLATRNF--RPESL----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
           ++   F F +LK  T NF  RP S+    +GEGGFG V+KG+V     A  K    + + 
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 69
Query: 172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL- 230
            + L        +++  E+  +    H NLV+L+G+  + D   LVY +MP GSL + L 
Sbjct: 70  TEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 231 FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 290
              G+ PL W +R KIA GAA G+ FLHE      I+RD K++NILLD  + AK+SDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 179
Query: 291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 350
           A+ + +  +T +  R++GT  Y APE  + G +T KSD+YSFGVVLLE++TG  ++D++R
Sbjct: 180 ARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 351 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 410
                 L++       +++     +D ++    S    +    +A+QCL      RP + 
Sbjct: 239 E--PQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 411 EVVETLKPL 419
           +V + L+ +
Sbjct: 296 KVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 170/309 (55%), Gaps = 21/309 (6%)
Query: 118 SQLRKFMFNDLKLATRNF--RPESL----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
           ++   F F +LK  T NF  RP S+    +GEGGFG V+KG+V     A  K    + + 
Sbjct: 4   TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 63
Query: 172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL- 230
            + L        +++  E+  +    H NLV+L+G+  + D   LVY +MP GSL + L 
Sbjct: 64  TEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 116
Query: 231 FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 290
              G+ PL W +R KIA GAA G+ FLHE      I+RD K++NILLD  + AK+SDFGL
Sbjct: 117 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 173
Query: 291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 350
           A+ + +  +  +  R++GT  Y APE  + G +T KSD+YSFGVVLLE++TG  ++D++R
Sbjct: 174 ARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 232
Query: 351 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 410
                 L++       +++     +D ++    S    +    +A+QCL      RP + 
Sbjct: 233 E--PQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIK 289
Query: 411 EVVETLKPL 419
           +V + L+ +
Sbjct: 290 KVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/307 (35%), Positives = 164/307 (53%), Gaps = 21/307 (6%)
Query: 118 SQLRKFMFNDLKLATRNF--RPESL----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
           ++   F F +LK  T NF  RP S+     GEGGFG V+KG+V     A  K    + + 
Sbjct: 1   TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 60
Query: 172 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL- 230
            + L        +++  E+       H NLV+L+G+  + D   LVY + P GSL + L 
Sbjct: 61  TEELK-------QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLS 113
Query: 231 FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 290
              G+ PL W  R KIA GAA G+ FLHE      I+RD K++NILLD  + AK+SDFGL
Sbjct: 114 CLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 170
Query: 291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 350
           A+ + +  +    +R++GT  Y APE  + G +T KSD+YSFGVVLLE++TG  ++D++R
Sbjct: 171 ARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 229
Query: 351 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 410
                 L++       +++     +D +     S    +    +A+QCL      RP + 
Sbjct: 230 E--PQLLLDIKEEIEDEEKTIEDYIDKKXNDADS-TSVEAXYSVASQCLHEKKNKRPDIK 286
Query: 411 EVVETLK 417
           +V + L+
Sbjct: 287 KVQQLLQ 293

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 142/298 (47%), Gaps = 34/298 (11%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           LA      E  +G+GGFG V KG  V++     +K    L +       + ++  +E+  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQR 72
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           EV  + NL HPN+VKL G  +  +   +V EF+P G L + L  K   P+ WS+++++ L
Sbjct: 73  EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLML 129
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDAPEDGKTHVS 303
             A G+ ++  +   P+++RD ++ NI L     +A   AK++DFGL++ +      H  
Sbjct: 130 DIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSV 183
Query: 304 TRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
           + ++G + + APE +       T K+D YSF ++L  +LTG    D+    G+   +   
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMI 242
Query: 362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           R   G +        PRL     +            C S DPK RP  S +V+ L  L
Sbjct: 243 REE-GLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 141/292 (48%), Gaps = 43/292 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
           +    E ++G G FG V K  W  ++            VA+K +  +  +  K ++ E+ 
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWRAKD------------VAIKQIESESER--KAFIVELR 54
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPW---SIRMKIAL 248
            L  + HPN+VKL G C+  +   LV E+   GSL N L   G+ PLP+   +  M   L
Sbjct: 55  QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCL 110
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVM 307
             ++G+A+LH    K +I+RD K  N+LL A     K+ DFG A D     +TH+ T   
Sbjct: 111 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHM-TNNK 165
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           G+  + APE     + + K DV+S+G++L E++T R+  D+    G    + WA  H G 
Sbjct: 166 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAV-HNGT 222
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           +    + L   +E             L  +C S+DP  RP M E+V+ +  L
Sbjct: 223 RPPLIKNLPKPIES------------LMTRCWSKDPSQRPSMEEIVKIMTHL 262

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 34/280 (12%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 15  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            LV+L G C+E     LV+EFM  G L ++L  +  L    ++ + + L   +G+A+L E
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 121
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
            +   VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE   
Sbjct: 122 AS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFS 177
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 379
               +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL 228
Query: 380 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                   S    Q+   C    P+ RP  S ++  L  +
Sbjct: 229 -------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 141/292 (48%), Gaps = 43/292 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
           +    E ++G G FG V K  W  ++            VA+K +  +  +  K ++ E+ 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKD------------VAIKQIESESER--KAFIVELR 53
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPW---SIRMKIAL 248
            L  + HPN+VKL G C+  +   LV E+   GSL N L   G+ PLP+   +  M   L
Sbjct: 54  QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCL 109
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVM 307
             ++G+A+LH    K +I+RD K  N+LL A     K+ DFG A D     +TH+ T   
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHM-TNNK 164
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           G+  + APE     + + K DV+S+G++L E++T R+  D+    G    + WA  H G 
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAV-HNGT 221
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           +    + L   +E             L  +C S+DP  RP M E+V+ +  L
Sbjct: 222 RPPLIKNLPKPIES------------LMTRCWSKDPSQRPSMEEIVKIMTHL 261

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 141/298 (47%), Gaps = 34/298 (11%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           LA      E  +G+GGFG V KG  V++     +K    L +       + ++  +E+  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQR 72
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           EV  + NL HPN+VKL G  +  +   +V EF+P G L + L  K   P+ WS+++++ L
Sbjct: 73  EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLML 129
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDAPEDGKTHVS 303
             A G+ ++  +   P+++RD ++ NI L     +A   AK++DFG ++ +      H  
Sbjct: 130 DIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-----VHSV 183
Query: 304 TRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
           + ++G + + APE +       T K+D YSF ++L  +LTG    D+    G+   +   
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMI 242
Query: 362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           R   G +        PRL     +            C S DPK RP  S +V+ L  L
Sbjct: 243 REE-GLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 133/280 (47%), Gaps = 34/280 (12%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 15  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            LV+L G C+E     LV+EFM  G L ++L  +  L    ++ + + L   +G+A+L E
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 121
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE   
Sbjct: 122 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFS 177
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 379
               +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL 228
Query: 380 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                   S    Q+   C    P+ RP  S ++  L  +
Sbjct: 229 -------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 141/298 (47%), Gaps = 34/298 (11%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           LA      E  +G+GGFG V KG  V++     +K    L +       + ++  +E+  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQR 72
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           EV  + NL HPN+VKL G  +  +   +V EF+P G L + L  K   P+ WS+++++ L
Sbjct: 73  EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLML 129
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDAPEDGKTHVS 303
             A G+ ++  +   P+++RD ++ NI L     +A   AK++DF L++ +      H  
Sbjct: 130 DIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-----VHSV 183
Query: 304 TRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
           + ++G + + APE +       T K+D YSF ++L  +LTG    D+    G+   +   
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMI 242
Query: 362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           R   G +        PRL     +            C S DPK RP  S +V+ L  L
Sbjct: 243 REE-GLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 133/280 (47%), Gaps = 34/280 (12%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 18  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            LV+L G C+E     LV+EFM  G L ++L  +  L    ++ + + L   +G+A+L E
Sbjct: 66  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 124
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE   
Sbjct: 125 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFS 180
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 379
               +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL
Sbjct: 181 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL 231
Query: 380 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                   S    Q+   C    P+ RP  S ++  L  +
Sbjct: 232 -------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 133/280 (47%), Gaps = 34/280 (12%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 13  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 60
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            LV+L G C+E     LV+EFM  G L ++L  +  L    ++ + + L   +G+A+L E
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 119
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE   
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFS 175
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 379
               +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL 226
Query: 380 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                   S    Q+   C    P+ RP  S ++  L  +
Sbjct: 227 -------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W+ ++            VA+KT+  +G     +++ E   +  L HP
Sbjct: 35  IGSGQFGLVHLGYWLNKD-----------KVAIKTIK-EGSMSEDDFIEEAEVMMKLSHP 82
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            LV+L G C+E     LV+EFM  G L ++L  +  L    ++ + + L   +G+A+L E
Sbjct: 83  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 141
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE   
Sbjct: 142 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFS 197
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 379
               +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL
Sbjct: 198 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL 248
Query: 380 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                   S    Q+   C    P+ RP  S ++  L  +
Sbjct: 249 -------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 16  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 63
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            LV+L G C+E     LV EFM  G L ++L  +  L    ++ + + L   +G+A+L E
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE   
Sbjct: 123 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFS 178
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 379
               +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL 229
Query: 380 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                   S    Q+   C    P+ RP  S ++  L  +
Sbjct: 230 -------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 111/218 (50%), Gaps = 32/218 (14%)
Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EVNF 192
           E ++G GGFG V++  W+            G  VAVK   HD  +   + +     E   
Sbjct: 12  EEIIGIGGFGKVYRAFWI------------GDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
              L HPN++ L G C+++    LV EF   G L   L  K    +P  I +  A+  A+
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIAR 116
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILL-----DADYN---AKLSDFGLAKDAPEDGKTHVST 304
           G+ +LH+EA  P+I+RD K+SNIL+     + D +    K++DFGLA++     K   + 
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA- 175
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
              G Y + APE +     +  SDV+S+GV+L E+LTG
Sbjct: 176 ---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 139/297 (46%), Gaps = 33/297 (11%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK- 184
           +D+ +   +   +  +G G FG V +   E +G+          VAVK L        + 
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRA--EWHGS---------DVAVKILMEQDFHAERV 78
Query: 185 -EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSI 242
            E+L EV  +  L HPN+V  +G   +     +V E++ RGSL   L + G+   L    
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           R+ +A   AKG+ +LH     P+++RD K+ N+L+D  Y  K+ DFGL++   +      
Sbjct: 139 RLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKASXFLX 195
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 362
           S    GT  + APE +       KSDVYSFGV+L E+ T +      +P G  N  +   
Sbjct: 196 SKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQ-VV 248
Query: 363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
             +G K +  RL  PR         + +   +   C + +P  RP  + +++ L+PL
Sbjct: 249 AAVGFKCK--RLEIPR-------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 142/298 (47%), Gaps = 35/298 (11%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK- 184
           +D+ +   +   +  +G G FG V +   E +G+          VAVK L        + 
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRA--EWHGS---------DVAVKILMEQDFHAERV 78
Query: 185 -EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSI 242
            E+L EV  +  L HPN+V  +G   +     +V E++ RGSL   L + G+   L    
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           R+ +A   AKG+ +LH     P+++R+ K+ N+L+D  Y  K+ DFGL++       T +
Sbjct: 139 RLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFL 194
Query: 303 STR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
           S++   GT  + APE +       KSDVYSFGV+L E+ T +      +P G  N  +  
Sbjct: 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQ-V 247
Query: 362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
              +G K +  RL  PR         + +   +   C + +P  RP  + +++ L+PL
Sbjct: 248 VAAVGFKCK--RLEIPR-------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E    +P K    + VAVK L    L   K++  E   L NL H +
Sbjct: 23  LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------------RKGSLPLPWSIRMKI 246
           +VK  G C + D  ++V+E+M  G L   L               R+    L  S  + I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           A   A G+ +L   A +  ++RD  T N L+ A+   K+ DFG+++D        V    
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           M    +  PE +M    T++SDV+SFGV+L E+ T
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E     P +    + VAVKTL        K++  E   L NL H +
Sbjct: 21  LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL---------FRKGSLP--LPWSIRMKIALG 249
           +VK  G C+E D  ++V+E+M  G L   L           +G+ P  L  S  + IA  
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
            A G+ +L   A +  ++RD  T N L+  +   K+ DFG+++D        V    M  
Sbjct: 137 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
             +  PE +M    T++SDV+S GVVL E+ T
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/325 (27%), Positives = 145/325 (44%), Gaps = 45/325 (13%)
Query: 123 FMFNDLKLATRNF---------RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 173
           F F D   A R F         + E ++G G FG V  G ++  G   +       VA+K
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREI------FVAIK 67
Query: 174 TLNHDGLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
           TL     +  + ++L+E + +G   HPN++ L G   +    +++ EFM  GSL++ L R
Sbjct: 68  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL-R 126
Query: 233 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
           +          + +  G A G+ +L   A+   ++RD    NIL++++   K+SDFGL++
Sbjct: 127 QNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 183
Query: 293 DAPEDGKTHVSTRVMG---TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDK 348
              +D      T  +G      + APE +     TS SDV+S+G+V+ E+++ G R    
Sbjct: 184 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 243
Query: 349 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 408
                  N +E          + YRL  P       +       QL   C  +D   RP+
Sbjct: 244 MTNQDVINAIE----------QDYRLPPP-------MDCPSALHQLMLDCWQKDRNHRPK 286
Query: 409 MSEVVETLKPL----QNLKDMASSS 429
             ++V TL  +     +LK MA  S
Sbjct: 287 FGQIVNTLDKMIRNPNSLKAMAPLS 311

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 42  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 95
Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 152
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 153 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 38  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 148
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 35  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 145
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 146 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 38  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 148
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 37  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 147
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 96  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 206
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 207 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 37  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 147
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 36  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 146
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWM 203
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG      V      P   GTG  VAVK L  D G Q    W  E++ L  L H 
Sbjct: 22  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 200 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           +++K  G C +  ++   LV E++P GSL ++L R     +  +  +  A    +G+A+L
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYL 133
Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAP 315
           H +     I+R+    N+LLD D   K+ DFGLAK  PE G  +   R  G     + AP
Sbjct: 134 HSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAP 189
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLT 341
           E +        SDV+SFGV L E+LT
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG      V      P   GTG  VAVK L  D G Q    W  E++ L  L H 
Sbjct: 22  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 200 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           +++K  G C +  ++   LV E++P GSL ++L R     +  +  +  A    +G+A+L
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYL 133
Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAP 315
           H +     I+R+    N+LLD D   K+ DFGLAK  PE G  +   R  G     + AP
Sbjct: 134 HAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAP 189
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLT 341
           E +        SDV+SFGV L E+LT
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 36  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 146
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 203
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 37  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 147
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 29  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 139
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 140 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 196
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 55  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 165
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 166 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 222
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 101/204 (49%), Gaps = 12/204 (5%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G FG V     E     P++  TG  VAVK L H   +  +++  E+  L +L H N
Sbjct: 21  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 201 LVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           +VK  G C    +R   L+ EF+P GSL  +L +K    +     ++      KG+ +L 
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERIDHIKLLQYTSQICKGMEYL- 133
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEY 317
               K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V         + APE 
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 318 VMTGHLTSKSDVYSFGVVLLEMLT 341
           +     +  SDV+SFGVVL E+ T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 37  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 147
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 56  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 166
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 167 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 223
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 35  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 145
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 146 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 202
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 34  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 144
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 145 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 201
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 32  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 199 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 255
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 142
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 313
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 143 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 132/281 (46%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 19  LGGGQFGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLA 183
Query: 320 TGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T G        P+  + L+E          + YR+  P 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE----------KDYRMERP- 232
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            EG       +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 233 -EG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 5   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 59
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 60  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 118
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 305
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 119 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 175
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 176 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 9   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 122
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 305
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 123 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 107/219 (48%), Gaps = 12/219 (5%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
           N  +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  ++
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 75
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIR 243
           +  E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     
Sbjct: 76  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 134
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THV 302
           ++      KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V
Sbjct: 135 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                    + APE +     +  SDV+SFGVVL E+ T
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 11  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 65
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 66  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 124
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 305
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 125 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 181
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 182 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 6   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 119
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 305
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 120 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 176
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 107/219 (48%), Gaps = 12/219 (5%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
           N  +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  ++
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 75
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIR 243
           +  E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     
Sbjct: 76  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 134
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THV 302
           ++      KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V
Sbjct: 135 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                    + APE +     +  SDV+SFGVVL E+ T
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 6   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 119
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 305
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 120 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 176
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 107/217 (49%), Gaps = 14/217 (6%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 6   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 119
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D K     + 
Sbjct: 120 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEFFKVKE 175
Query: 307 MGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            G     + APE +     +  SDV+SFGVVL E+ T
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 13  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 67
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 68  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 126
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 305
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 127 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 183
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 184 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 4   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 58
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 59  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 117
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 305
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 118 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 174
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 175 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 10  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 64
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 65  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 123
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 305
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 124 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 180
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 181 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 12  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 66
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 67  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 125
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 305
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 126 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 182
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 183 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 37  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 91
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 150
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 305
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 151 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 207
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 77/207 (37%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG      V      P   GTG  VAVK L  D G Q    W  E++ L  L H 
Sbjct: 39  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 200 NLVKLVGYCIEDD---QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
           +++K  G C ED       LV E++P GSL ++L R     +  +  +  A    +G+A+
Sbjct: 94  HIIKYKG-CCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAY 149
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAA 314
           LH +     I+RD    N+LLD D   K+ DFGLAK  PE G      R  G     + A
Sbjct: 150 LHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEXYRVREDGDSPVFWYA 205
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE +        SDV+SFGV L E+LT
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 34/288 (11%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           E ++G G FG V +G ++    AP K  +   VA+KTL     +  + E+L+E + +G  
Sbjct: 21  EEVIGAGEFGEVCRGRLK----APGKKES--CVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 255
            HPN+++L G        +++ EFM  G+L++ L    G   +   + M    G A G+ 
Sbjct: 75  EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGM--LRGIASGMR 132
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG---TYGY 312
           +L   AE   ++RD    NIL++++   K+SDFGL++   E+      T  +G      +
Sbjct: 133 YL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRW 189
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
            APE +     TS SD +S+G+V+ E+++ G R           N +E          + 
Sbjct: 190 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE----------QD 239
Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           YRL  P               QL   C  +D  ARPR  +VV  L  +
Sbjct: 240 YRLPPPP-------DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 19  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLA 183
Query: 320 TGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T G        P+  + L+E          + YR+  P 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE----------KDYRMERP- 232
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            EG       +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 233 -EG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 34/288 (11%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           E ++G G FG V +G ++    AP K  +   VA+KTL     +  + E+L+E + +G  
Sbjct: 19  EEVIGAGEFGEVCRGRLK----APGKKES--CVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 255
            HPN+++L G        +++ EFM  G+L++ L    G   +   + M    G A G+ 
Sbjct: 73  EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGM--LRGIASGMR 130
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG---TYGY 312
           +L   AE   ++RD    NIL++++   K+SDFGL++   E+      T  +G      +
Sbjct: 131 YL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRW 187
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
            APE +     TS SD +S+G+V+ E+++ G R           N +E          + 
Sbjct: 188 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE----------QD 237
Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           YRL  P               QL   C  +D  ARPR  +VV  L  +
Sbjct: 238 YRLPPPP-------DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 108/217 (49%), Gaps = 14/217 (6%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 7   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 61
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 120
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                KG+ +L     K  I+R+  T NIL++ +   K+ DFGL K  P+D K +   + 
Sbjct: 121 TSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD-KEYYKVKE 176
Query: 307 MGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            G     + APE +     +  SDV+SFGVVL E+ T
Sbjct: 177 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 22  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 71
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 129
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLA 186
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 187 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 229
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 230 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 133
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 190
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 190
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLA 190
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 199
           LGEG FG      VE     P    TG  VAVK+L  +    H   L  E+  L NL H 
Sbjct: 29  LGEGHFG-----KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 200 NLVKLVGYCIED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           N+VK  G C ED  +   L+ EF+P GSL+ +L  K    +    ++K A+   KG+ +L
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK--THVSTRVMGTYGYAAP 315
                +  ++RD    N+L+++++  K+ DFGL K    D +  T    R    + Y AP
Sbjct: 143 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-AP 198
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLT 341
           E +M       SDV+SFGV L E+LT
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 9   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +  +  +     ++ 
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QAHAERIDHIKLLQY 122
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 305
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 123 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 190
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 199
           LGEG FG      VE     P    TG  VAVK+L  +    H   L  E+  L NL H 
Sbjct: 17  LGEGHFG-----KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 71
Query: 200 NLVKLVGYCIED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           N+VK  G C ED  +   L+ EF+P GSL+ +L  K    +    ++K A+   KG+ +L
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL 130
Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK--THVSTRVMGTYGYAAP 315
                +  ++RD    N+L+++++  K+ DFGL K    D +  T    R    + Y AP
Sbjct: 131 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-AP 186
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLT 341
           E +M       SDV+SFGV L E+LT
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 116/231 (50%), Gaps = 30/231 (12%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLN 176
           +QLR     +LK          +LG G FG V+KG WV E  T  +       VA+K LN
Sbjct: 30  AQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKI------PVAIKILN 76
Query: 177 HD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-- 233
              G + + E++ E   + ++ HP+LV+L+G C+    +L V + MP G L  ++     
Sbjct: 77  ETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKD 135
Query: 234 ---GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 290
                L L W +++      AKG+ +L E   + +++RD    N+L+ +  + K++DFGL
Sbjct: 136 NIGSQLLLNWCVQI------AKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGL 186
Query: 291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           A+    D K + +        + A E +     T +SDV+S+GV + E++T
Sbjct: 187 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 23  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 187
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 230
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 231 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 25  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 74
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 132
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 189
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 232
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 190
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 136/303 (44%), Gaps = 42/303 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 267 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 316
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 374
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+R+    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 375 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 431
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 432 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 474
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL--------QNLKDMASSSY 430
                     +K  +L   C   +P  RP  +E+ +  + +        +  K++   + 
Sbjct: 475 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKENL 534
Query: 431 YFQ 433
           YFQ
Sbjct: 535 YFQ 537

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 19  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF--PIKWTAPESLA 183
Query: 320 TGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T G        P+  + L+E          + YR+  P 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE----------KDYRMERP- 232
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            EG       +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 233 -EG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 23  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 187
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 230
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 231 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 34  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 83
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 141
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 142 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 198
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 199 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 241
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 242 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 282

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 128
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 140 LLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL 197
           +LG G FG V+KG WV E  T  +       VA+K LN   G + + E++ E   + ++ 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKI------PVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSIRMKIALGAAK 252
           HP+LV+L+G C+    +L V + MP G L  ++          L L W +++      AK
Sbjct: 76  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AK 128
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+ +L E   + +++RD    N+L+ +  + K++DFGLA+    D K + +        +
Sbjct: 129 GMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 185
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            A E +     T +SDV+S+GV + E++T
Sbjct: 186 MALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 128
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 228 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 277
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 335
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+R+    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 336 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 392
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 435
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 27  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 76  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 133
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 134 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 190
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 239
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 240 -----NCPEELYQLMRLCWKERPEDRP 261

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 29  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 77
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 78  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 135
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 136 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 192
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 193 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 241
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 242 -----NCPEELYQLMRLCWKERPEDRP 263

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG      V      P   GTG  VAVK L    G Q    W  E+  L  L H 
Sbjct: 16  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 70
Query: 200 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           ++VK  G C +  ++   LV E++P GSL ++L R     +  +  +  A    +G+A+L
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMAYL 127
Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAP 315
           H +     I+R     N+LLD D   K+ DFGLAK  PE G  +   R  G     + AP
Sbjct: 128 HAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAP 183
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLT 341
           E +        SDV+SFGV L E+LT
Sbjct: 184 ECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 30  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 78
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 79  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 136
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 137 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 193
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 194 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 242
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 243 -----NCPEELYQLMRLCWKERPEDRP 264

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG      V      P   GTG  VAVK L    G Q    W  E+  L  L H 
Sbjct: 17  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 71
Query: 200 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           ++VK  G C +  ++   LV E++P GSL ++L R     +  +  +  A    +G+A+L
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMAYL 128
Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAP 315
           H +     I+R     N+LLD D   K+ DFGLAK  PE G  +   R  G     + AP
Sbjct: 129 HAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAP 184
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLT 341
           E +        SDV+SFGV L E+LT
Sbjct: 185 ECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 22  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 77
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 251
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 138 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 239
Query: 372 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 417
             ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 240 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 31  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 79
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 80  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 137
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 138 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 194
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 195 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 243
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 244 -----NCPEELYQLMRLCWKERPEDRP 265

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 32/280 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 22  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 71
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 129
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
            +K  I+RD    N L+  ++  K++DFGL++    D  T  +        + APE +  
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAY 187
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPRL 379
              + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+   
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 230
Query: 380 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                    +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 231 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 21  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 184
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 233
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 234 -----NCPEELYQLMRLCWKERPEDRP 255

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 251
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 242
Query: 372 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 417
             ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 243 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 136/298 (45%), Gaps = 36/298 (12%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           E ++G G FG V  G ++  G   +       VA+KTL     +  + ++L+E + +G  
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSEASIMGQF 65
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
            HPN++ L G   +    +++ EFM  GSL++ L R+          + +  G A G+ +
Sbjct: 66  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTVIQLVGMLRGIAAGMKY 124
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG---TYGYA 313
           L   A+   ++R     NIL++++   K+SDFGL++   +D      T  +G      + 
Sbjct: 125 L---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 372
           APE +     TS SDV+S+G+V+ E+++ G R           N +E          + Y
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE----------QDY 231
Query: 373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL----QNLKDMA 426
           RL  P       +       QL   C  +D   RP+  ++V TL  +     +LK MA
Sbjct: 232 RLPPP-------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMA 282

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 23  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 71
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 72  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 129
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 130 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 186
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 187 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 235
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 236 -----NCPEELYQLMRLCWKERPEDRP 257

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 26  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 74
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 75  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 132
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 133 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 189
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 190 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 238
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 239 -----NCPEELYQLMRLCWKERPEDRP 260

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 27  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 76  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 133
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 134 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 190
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 239
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 240 -----NCPEELYQLMRLCWKERPEDRP 261

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 32/280 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 23  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
            +K  I+RD    N L+  ++  K++DFGL++    D  T  +        + APE +  
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAY 188
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPRL 379
              + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+   
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 231
Query: 380 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                    +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 232 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 21  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 184
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 233
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 234 -----NCPEELYQLMRLCWKERPEDRP 255

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 22  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 70
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 71  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 128
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 129 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 185
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 186 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 234
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 235 -----NCPEELYQLMRLCWKERPEDRP 256

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 122/287 (42%), Gaps = 32/287 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 198
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 54  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL------PWSIR--MKIALGA 250
            N+V L+G C      L++ E+   G L N L RK    L      P  +R  +  +   
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
           A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V        
Sbjct: 170 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 226
Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 370
            + APE +     T +SDV+S+G++L E+     S+  N             P +    +
Sbjct: 227 KWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPGILVNSK 271
Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
           FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 272 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 318

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 122/287 (42%), Gaps = 32/287 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 198
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 46  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 101
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL------PWSIR--MKIALGA 250
            N+V L+G C      L++ E+   G L N L RK    L      P  +R  +  +   
Sbjct: 102 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
           A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V        
Sbjct: 162 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218
Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 370
            + APE +     T +SDV+S+G++L E+     S+  N             P +    +
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPGILVNSK 263
Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
           FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 264 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 310

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGLA+   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGG 210
Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 21  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 233
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 234 -----NCPEELYQLMRLCWKERPEDRP 255

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 16  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 64
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 65  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 122
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 123 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 179
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 228
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 229 -----NCPEELYQLMRLCWKERPEDRP 250

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 251
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR 197
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 242
Query: 372 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 417
             ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 243 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 24  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 251
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 140 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 241
Query: 372 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 417
             ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 242 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 251
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 242
Query: 372 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 417
             ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 243 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 66  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 124
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 125 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 232
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 233 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 82
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 83  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 141
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 142 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 198
Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 199 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 249
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 250 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 36/288 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 251
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 242
Query: 372 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 417
             ++D    G+     +  ++ T L   C   +P  RP   E+V  LK
Sbjct: 243 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 92
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 93  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 151
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 152 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 208
Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 209 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 259
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 260 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 137/293 (46%), Gaps = 35/293 (11%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           + ++G G FG V+KG ++ +      P     VA+KTL     +  + ++L E   +G  
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVP-----VAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL--GAAKGL 254
            H N+++L G   +    +++ E+M  G+L+  L  K      +S+   + +  G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGM 160
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYG 311
            +L   A    ++RD    NIL++++   K+SDFGL++   D PE   T    ++     
Sbjct: 161 KYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIR 215
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + APE +     TS SDV+SFG+V+ E++T        RP  E +  E  +  + D    
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTY-----GERPYWELSNHEVMKA-INDG--- 266
Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD 424
           +RL  P       +       QL  QC  ++   RP+ +++V  L  L    D
Sbjct: 267 FRLPTP-------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKF 177
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 136/293 (46%), Gaps = 28/293 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL +   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 127/287 (44%), Gaps = 34/287 (11%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           E ++G G  G V  G +   G   V       VA+K L     +  + ++L+E + +G  
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 255
            HPN+++L G        ++V E+M  GSL+  L    G   +   + M   +GA  G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA--GMR 165
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGY 312
           +L   ++   ++RD    N+L+D++   K+SDFGL++   D P+   T    ++     +
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRW 220
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 372
            APE +     +S SDV+SFGVV+ E+L        N  N         R  +      Y
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---------RDVISSVEEGY 271
Query: 373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           RL  P       +       QL   C  +D   RPR S++V  L  L
Sbjct: 272 RLPAP-------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 17  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 65
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 66  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 123
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+R+ + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 124 --RNYIHRNLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 180
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 181 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 229
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 230 -----NCPEELYQLMRLCWKERPEDRP 251

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 134/301 (44%), Gaps = 38/301 (12%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           E ++G G  G V  G +   G   V       VA+K L     +  + ++L+E + +G  
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 255
            HPN+++L G        ++V E+M  GSL+  L    G   +   + M   +GA  G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA--GMR 165
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGY 312
           +L   ++   ++RD    N+L+D++   K+SDFGL++   D P+   T    ++     +
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI--PIRW 220
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 372
            APE +     +S SDV+SFGVV+ E+L        N  N         R  +      Y
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---------RDVISSVEEGY 271
Query: 373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL----QNLKDMASS 428
           RL  P       +       QL   C  +D   RPR S++V  L  L    ++L+  A+ 
Sbjct: 272 RLPAP-------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATV 324
Query: 429 S 429
           S
Sbjct: 325 S 325

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVCEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 8   SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 55
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 56  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 110
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 111 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKF 166
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 167 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 217
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 218 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 249

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 10  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 57
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 58  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 112
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 113 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 168
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 169 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 219
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 220 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 251

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 136/293 (46%), Gaps = 28/293 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+++L G   +    ++V E M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 121/267 (45%), Gaps = 32/267 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G  G V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 21  LGAGQAGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDAEXTAREGAKFPIKWTAPEAINY 184
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 233
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARP 407
                   ++  QL   C    P+ RP
Sbjct: 234 -----NCPEELYQLMRLCWKERPEDRP 255

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 118/297 (39%), Gaps = 44/297 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 196
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 47  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 101
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK----------------GSLPLPW 240
            H N+V L+G C      L++ E+   G L N L RK                  L L  
Sbjct: 102 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D   
Sbjct: 161 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 218 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 262
Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 263 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 136/293 (46%), Gaps = 28/293 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+++L G   +    ++V E M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/234 (30%), Positives = 109/234 (46%), Gaps = 35/234 (14%)
Query: 133 RNFRPESL-----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
           R FRP  L     LG+G FG   K    E         TG  + +K L     +  + +L
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFL 55
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV  +  L HPN++K +G   +D +   + E++  G+L   + +      PWS R+  A
Sbjct: 56  KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFA 114
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA------KDAPE----- 296
              A G+A+LH      +I+RD  + N L+  + N  ++DFGLA      K  PE     
Sbjct: 115 KDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 297 ---DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 347
              D K   +  V+G   + APE +       K DV+SFG+VL E++ GR + D
Sbjct: 172 KKPDRKKRYT--VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 118/297 (39%), Gaps = 44/297 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 196
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 49  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 103
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK----------------GSLPLPW 240
            H N+V L+G C      L++ E+   G L N L RK                  L L  
Sbjct: 104 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D   
Sbjct: 163 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 220 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 264
Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 265 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 136/293 (46%), Gaps = 28/293 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+++L G   +    ++V E M  GSL++ L RK          + + 
Sbjct: 66  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGML 124
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 125 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 308 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 232
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 233 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 118/297 (39%), Gaps = 44/297 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 196
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 31  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK----------------GSLPLPW 240
            H N+V L+G C      L++ E+   G L N L RK                  L L  
Sbjct: 86  -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D   
Sbjct: 145 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 246
Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 125/281 (44%), Gaps = 34/281 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V+ G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 40  LGGGQYGEVYVG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 89
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    +V E+MP G+L ++L       +   + + +A   +  + +L   
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE-- 147
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 148 -KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 204
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 205 YNTFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYDLLEKG 247
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                      K  +L   C    P  RP  +E  +  + +
Sbjct: 248 YRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETM 288

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 125/284 (44%), Gaps = 38/284 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VAVK +  +G     E+  E   +  L HP 
Sbjct: 16  LGSGQFGVVKLG----------KWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPK 64
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LVK  G C ++    +V E++  G L N+L   G    P S  +++     +G+AFL   
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP-SQLLEMCYDVCEGMAFLESH 123
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAPEY 317
                I+RD    N L+D D   K+SDFG+ +   +D   +VS+  +GT     ++APE 
Sbjct: 124 Q---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--QYVSS--VGTKFPVKWSAPEV 176
Query: 318 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP 377
                 +SKSDV++FG+++ E+ +  +       N E  L       +    R YR   P
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------KVSQGHRLYR---P 227
Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 421
            L        S    Q+   C    P+ RP   +++ +++PL+ 
Sbjct: 228 HL-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 118/297 (39%), Gaps = 44/297 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 196
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 54  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 108
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK----------------GSLPLPW 240
            H N+V L+G C      L++ E+   G L N L RK                  L L  
Sbjct: 109 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D   
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 269
Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 270 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 41/293 (13%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEV 190
           NFR E  +G G F  V++     +G         + VA+K +    L   K   + + E+
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDG---------VPVALKKVQIFDLMDAKARADCIKEI 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIAL 248
           + L  L HPN++K     IED++  +V E    G L   +  F+K    +P     K  +
Sbjct: 84  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
                L  +H    + V++RD K +N+ + A    KL D GL +      KT  +  ++G
Sbjct: 144 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 198
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
           T  Y +PE +       KSD++S G +L EM                       P  GDK
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDK 240
Query: 369 RRFYRLLDPRLEGHF----SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
              Y L     +  +    S   S++  QL   C++ DP+ RP ++ V +  K
Sbjct: 241 MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  + H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 67  MKKIRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           + + E  LG G FG V+     ++            VAVKT+   G    + +LAE N +
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKH----------TKVAVKTMK-PGSMSVEAFLAEANVM 237
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             L H  LVKL    +  +   ++ EFM +GSL + L        P    +  +   A+G
Sbjct: 238 KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           +AF+ +   +  I+RD + +NIL+ A    K++DFGLA+   ED +            + 
Sbjct: 297 MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWT 352
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
           APE +  G  T KSDV+SFG++L+E++T  R
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 115/233 (49%), Gaps = 29/233 (12%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           VA+Q  +F  +   L  +  +    +G+G FG V  G              G  VAVK +
Sbjct: 177 VAAQ-DEFYRSGWALNMKELKLLQTIGKGEFGDVMLG-----------DYRGNKVAVKCI 224
Query: 176 NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKG 234
            +D     + +LAE + +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  +G
Sbjct: 225 KNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 282
Query: 235 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
              L     +K +L   + + +L        ++RD    N+L+  D  AK+SDFGL K+A
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339
Query: 295 P---EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
               + GK  V         + APE +     ++KSDV+SFG++L E+ +  R
Sbjct: 340 SSTQDTGKLPVK--------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 121/293 (41%), Gaps = 38/293 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 198
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 54  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 244
            N+V L+G C      L++ E+   G L N L RK    L +S                +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V  
Sbjct: 170 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+S+G++L E+     S+  N             P 
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPG 271
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
           +    +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 272 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 324

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD   +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLAAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 117/278 (42%), Gaps = 29/278 (10%)
Query: 131 ATRN-FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
            T+N FR   +LG+GGFG V    V   G              K          K+ L +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 190 VNFLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           VN          V  + Y  E  D   LV   M  G L+ H++  G    P +  +  A 
Sbjct: 241 VN-------SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
               GL  LH E    ++YRD K  NILLD   + ++SD GLA   PE G+T +  RV G
Sbjct: 294 EICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-G 347
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
           T GY APE V     T   D ++ G +L EM+ G+    + +   +   VE         
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------- 398
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
               RL+    E  +S + S +A  L +Q L +DP  R
Sbjct: 399 ----RLVKEVPE-EYSERFSPQARSLCSQLLCKDPAER 431

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           + + E  LG G FG V+     ++            VAVKT+   G    + +LAE N +
Sbjct: 16  SLKLEKKLGAGQFGEVWMATYNKHTK----------VAVKTMK-PGSMSVEAFLAEANVM 64
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             L H  LVKL    +  +   ++ EFM +GSL + L        P    +  +   A+G
Sbjct: 65  KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 123
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           +AF+ +   +  I+RD + +NIL+ A    K++DFGLA+   ED +            + 
Sbjct: 124 MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWT 179
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
           APE +  G  T KSDV+SFG++L+E++T  R
Sbjct: 180 APEAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 138/291 (47%), Gaps = 34/291 (11%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
           +LGEG FG V++G V  N       G  + VAVKT   D    +KE +++E   + NL H
Sbjct: 31  ILGEGFFGEVYEG-VYTN-----HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 84
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFL 257
           P++VKL+G  IE++   ++ E  P G L ++L R K SL +     +  +L   K +A+L
Sbjct: 85  PHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL 141
Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 317
                   ++RD    NIL+ +    KL DFGL++   ED   + ++       + +PE 
Sbjct: 142 E---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPES 197
Query: 318 VMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
           +     T+ SDV+ F V + E+L+ G++            ++E      GD+     L  
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-----KGDRLPKPDLCP 252
Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL-KDMA 426
           P L              L  +C   DP  RPR +E+V +L  +  + KD+A
Sbjct: 253 PVL------------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 291

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +G L +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVMEYMSKGCLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 114/230 (49%), Gaps = 29/230 (12%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           VA+Q  +F  +   L  +  +    +G+G FG V  G    N            VAVK +
Sbjct: 5   VAAQ-DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN-----------KVAVKCI 52
Query: 176 NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKG 234
            +D     + +LAE + +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  +G
Sbjct: 53  KNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 110
Query: 235 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
              L     +K +L   + + +L        ++RD    N+L+  D  AK+SDFGL K+A
Sbjct: 111 RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167
Query: 295 P---EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               + GK  V         + APE +     ++KSDV+SFG++L E+ +
Sbjct: 168 SSTQDTGKLPVK--------WTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 138/291 (47%), Gaps = 34/291 (11%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
           +LGEG FG V++G V  N       G  + VAVKT   D    +KE +++E   + NL H
Sbjct: 15  ILGEGFFGEVYEG-VYTN-----HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 68
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFL 257
           P++VKL+G  IE++   ++ E  P G L ++L R K SL +     +  +L   K +A+L
Sbjct: 69  PHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL 125
Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 317
                   ++RD    NIL+ +    KL DFGL++   ED   + ++       + +PE 
Sbjct: 126 E---SINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPES 181
Query: 318 VMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
           +     T+ SDV+ F V + E+L+ G++            ++E      GD+     L  
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-----KGDRLPKPDLCP 236
Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL-KDMA 426
           P L              L  +C   DP  RPR +E+V +L  +  + KD+A
Sbjct: 237 PVL------------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 275

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 9   SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 56
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 57  MKKLRHEKLVQLYA-VVSEEPIXIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDM--AA 111
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 112 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKF 167
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 168 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 218
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 219 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 250

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 117/278 (42%), Gaps = 29/278 (10%)
Query: 131 ATRN-FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
            T+N FR   +LG+GGFG V    V   G              K          K+ L +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 190 VNFLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           VN          V  + Y  E  D   LV   M  G L+ H++  G    P +  +  A 
Sbjct: 241 VN-------SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
               GL  LH E    ++YRD K  NILLD   + ++SD GLA   PE G+T +  RV G
Sbjct: 294 EICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-G 347
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
           T GY APE V     T   D ++ G +L EM+ G+    + +   +   VE         
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------- 398
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
               RL+    E  +S + S +A  L +Q L +DP  R
Sbjct: 399 ----RLVKEVPE-EYSERFSPQARSLCSQLLCKDPAER 431

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +G L +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGCLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 138/291 (47%), Gaps = 34/291 (11%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
           +LGEG FG V++G V  N       G  + VAVKT   D    +KE +++E   + NL H
Sbjct: 19  ILGEGFFGEVYEG-VYTN-----HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFL 257
           P++VKL+G  IE++   ++ E  P G L ++L R K SL +     +  +L   K +A+L
Sbjct: 73  PHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL 129
Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 317
                   ++RD    NIL+ +    KL DFGL++   ED   + ++       + +PE 
Sbjct: 130 E---SINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPES 185
Query: 318 VMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
           +     T+ SDV+ F V + E+L+ G++            ++E      GD+     L  
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-----KGDRLPKPDLCP 240
Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL-KDMA 426
           P L              L  +C   DP  RPR +E+V +L  +  + KD+A
Sbjct: 241 PVL------------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 279

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 12  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 59
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 60  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDM--AA 114
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 115 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKF 170
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 171 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 221
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 222 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 253

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 28/219 (12%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
           L  +  +    +G+G FG V  G    N            VAVK + +D     + +LAE
Sbjct: 9   LNMKELKLLQTIGKGEFGDVMLGDYRGN-----------KVAVKCIKNDATA--QAFLAE 55
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
            + +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  +G   L     +K +L
Sbjct: 56  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 115
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTR 305
              + + +L        ++RD    N+L+  D  AK+SDFGL K+A    + GK  V   
Sbjct: 116 DVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 170
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
                 + APE +     ++KSDV+SFG++L E+ +  R
Sbjct: 171 ------WTAPEALREAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E +   P +    + VAVK L        +++  E   L  L H +
Sbjct: 20  LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-------------PLPWSIRMKIA 247
           +V+  G C E    L+V+E+M  G L   L   G               PL     + +A
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
              A G+ +L   A    ++RD  T N L+      K+ DFG+++D        V  R M
Sbjct: 136 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 192
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               +  PE ++    T++SDV+SFGVVL E+ T
Sbjct: 193 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 232
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDM--AA 287
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 288 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 343
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 394
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 395 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 426

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 315
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 316 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDM--AA 370
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 371 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 426
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 477
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 478 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 509

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 232
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDM--AA 287
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 288 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 343
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 394
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 395 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 426

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E +   P +    + VAVK L        +++  E   L  L H +
Sbjct: 26  LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-------------PLPWSIRMKIA 247
           +V+  G C E    L+V+E+M  G L   L   G               PL     + +A
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
              A G+ +L   A    ++RD  T N L+      K+ DFG+++D        V  R M
Sbjct: 142 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 198
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               +  PE ++    T++SDV+SFGVVL E+ T
Sbjct: 199 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E +   P +    + VAVK L        +++  E   L  L H +
Sbjct: 49  LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-------------PLPWSIRMKIA 247
           +V+  G C E    L+V+E+M  G L   L   G               PL     + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
              A G+ +L   A    ++RD  T N L+      K+ DFG+++D        V  R M
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               +  PE ++    T++SDV+SFGVVL E+ T
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 28/219 (12%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
           L  +  +    +G+G FG V  G              G  VAVK + +D     + +LAE
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAE 49
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
            + +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  +G   L     +K +L
Sbjct: 50  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTR 305
              + + +L        ++RD    N+L+  D  AK+SDFGL K+A    + GK  V   
Sbjct: 110 DVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 164
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
                 + APE +     ++KSDV+SFG++L E+ +  R
Sbjct: 165 ------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 63
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M   +
Sbjct: 64  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLD--FLKGETGKYLRLPQLVDMSAQI 120
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 121 --ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 174
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 175 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 225
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 226 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 257

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 63
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M   +
Sbjct: 64  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLD--FLKGETGKYLRLPQLVDMSAQI 120
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 121 --ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEWTARQGAKF 174
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 175 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 225
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 226 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 257

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 131/285 (45%), Gaps = 30/285 (10%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           E ++G G FG V  G ++  G         L VA+KTL     +  + ++L E + +G  
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRE------LPVAIKTLKVGYTEKQRRDFLGEASIMGQF 80
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-GSLPLPWSIRMKIALGAAKGLA 255
            HPN++ L G   +    ++V E+M  GSL+  L +  G   +   + M    G + G+ 
Sbjct: 81  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGM--LRGISAGMK 138
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYAA 314
           +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR       + A
Sbjct: 139 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 195
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 374
           PE +     TS SDV+S+G+V+ E+++        RP  E       +  +      YRL
Sbjct: 196 PEAIAFRKFTSASDVWSYGIVMWEVVSY-----GERPYWEMT----NQDVIKAVEEGYRL 246
Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
             P       +       QL   C  ++  +RP+  E+V  L  L
Sbjct: 247 PSP-------MDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 113/230 (49%), Gaps = 21/230 (9%)
Query: 123 FMFNDLKLATRNF---------RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 173
           F F D   A R F         + E ++G G FG V  G ++  G   +       VA+K
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREI------CVAIK 63
Query: 174 TLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
           TL      +  +++L+E + +G   HPN++ L G   +    +++ E+M  GSL+  L R
Sbjct: 64  TLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-R 122
Query: 233 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
           K          + +  G   G+ +L   ++   ++RD    NIL++++   K+SDFG+++
Sbjct: 123 KNDGRFTVIQLVGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSR 179
Query: 293 DAPEDGKTHVSTRVMGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
              +D +   +TR       + APE +     TS SDV+S+G+V+ E+++
Sbjct: 180 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 128/288 (44%), Gaps = 36/288 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 26  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 81
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 251
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+    K  ++R+    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 142 DGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 243
Query: 372 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 417
             ++D    G+     +  ++ T L   C   +P  RP   E+V  LK
Sbjct: 244 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 128/288 (44%), Gaps = 36/288 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 251
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+    K  ++R+    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 141 DGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 242
Query: 372 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 417
             ++D    G+     +  ++ T L   C   +P  RP   E+V  LK
Sbjct: 243 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 232
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVGEYMSKGSLLD--FLKGETGKYLRLPQLVDM--AA 287
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 288 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 343
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 394
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 395 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 426

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   N T          VAVKTL   G    + +L E N +  L H  
Sbjct: 21  LGAGQFGEVWMGYYN-NST---------KVAVKTLKP-GTMSVQAFLEEANLMKTLQHDK 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLH 258
           LV+L      ++   ++ E+M +GSL + L     G + LP  I     +  A+G+A++ 
Sbjct: 70  LVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 127
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  I+RD + +N+L+      K++DFGLA+   ED +            + APE +
Sbjct: 128 R---KNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI 183
Query: 319 MTGHLTSKSDVYSFGVVLLEMLT 341
             G  T KSDV+SFG++L E++T
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVT 206

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 128/289 (44%), Gaps = 44/289 (15%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 32  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 75
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
              H N++  +GY  +  Q  +V ++    SL +HL             + IA   A+G+
Sbjct: 76  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGM 133
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + A
Sbjct: 134 DYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 315 PEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGDKRR 370
           PE +    +   + +SDVY+FG+VL E++TG+  +  +  N    ++E   R  L     
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLS 248
Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
             R   P+           +  +L A+CL +    RP    ++  ++ L
Sbjct: 249 KVRSNCPK-----------RMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 18  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 251
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 134 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 191 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 232
Query: 372 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 417
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 233 -QVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 280

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 120/291 (41%), Gaps = 36/291 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 198
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 54  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL------------PLPWSIRMKI 246
            N+V L+G C      L++ E+   G L N L RK  +             L     +  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHF 169
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V    
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + APE +     T +SDV+S+G++L E+     S+  N             P + 
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPGIL 271
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
              +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 186 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGNMSPEAFLQEAQV 233
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 248
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 234 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 288
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+A++        ++RD + +NIL+  +   K++DFGL +   ED +         
Sbjct: 289 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGR-LIEDNEYTARQGAKF 344
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 345 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 395
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 396 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 427

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V+ G+   N T          VAVKTL   G    + +L E N +  L H  
Sbjct: 20  LGAGQFGEVWMGYYN-NST---------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHDK 68
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLH 258
           LV+L     +++   ++ EFM +GSL + L     G + LP  I     +  A+G+A++ 
Sbjct: 69  LVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 126
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  I+RD + +N+L+      K++DFGLA+   ED +            + APE +
Sbjct: 127 R---KNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 319 MTGHLTSKSDVYSFGVVLLEMLT 341
             G  T KS+V+SFG++L E++T
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 122/300 (40%), Gaps = 45/300 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 198
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 39  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 94
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL-------------------P 239
            N+V L+G C      L++ E+   G L N L RK    L                   P
Sbjct: 95  ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 240 WSIR--MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 297
             +R  +  +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D
Sbjct: 155 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
               V         + APE +     T +SDV+S+G++L E+     S+  N        
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-------- 259
Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
                P +    +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 260 ---PYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 316

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 27  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 251
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 143 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 241
Query: 372 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 417
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 242 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 16/217 (7%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L     + E ++G G FG V  G ++  G   V       VA+KTL     +  + ++L
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDV------AVAIKTLKVGYTEKQRRDFL 92
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E + +G   HPN+V L G        ++V EFM  G+L+  L RK          + + 
Sbjct: 93  CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFL-RKHDGQFTVIQLVGML 151
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVST 304
            G A G+ +L   A+   ++RD    NIL++++   K+SDFGL++   D PE   T    
Sbjct: 152 RGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGG 208
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           ++     + APE +     TS SDV+S+G+V+ E+++
Sbjct: 209 KI--PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 127/289 (43%), Gaps = 44/289 (15%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 32  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 75
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
              H N++  +GY     Q  +V ++    SL +HL             + IA   A+G+
Sbjct: 76  KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGM 133
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + A
Sbjct: 134 DYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 315 PEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGDKRR 370
           PE +    +   + +SDVY+FG+VL E++TG+  +  +  N    ++E   R  L     
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLS 248
Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
             R   P+           +  +L A+CL +    RP    ++  ++ L
Sbjct: 249 KVRSNCPK-----------RMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R+ +  S LG+G FG V     E     P+   TG  VAVK L H G    +++  E+  
Sbjct: 10  RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 64
Query: 193 LGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
           L  L    +VK   V Y        LV E++P G L + L R  +  L  S  +  +   
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQI 123
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT- 309
            KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D K +   R  G  
Sbjct: 124 CKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQS 179
Query: 310 -YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
              + APE +     + +SDV+SFGVVL E+ T
Sbjct: 180 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R+ +  S LG+G FG V     E     P+   TG  VAVK L H G    +++  E+  
Sbjct: 11  RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 65
Query: 193 LGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
           L  L    +VK   V Y        LV E++P G L + L R  +  L  S  +  +   
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQI 124
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT- 309
            KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D K +   R  G  
Sbjct: 125 CKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQS 180
Query: 310 -YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
              + APE +     + +SDV+SFGVVL E+ T
Sbjct: 181 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 22/214 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGNLL 197
           +LGEG FG V +G +++      + GT L VAVKT+  D     +  E+L+E   + +  
Sbjct: 41  ILGEGEFGSVMEGNLKQ------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 198 HPNLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIAL 248
           HPN+++L+G CIE   +     +++  FM  G L  +L       G   +P    +K  +
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A G+ +L   + +  ++RD    N +L  D    ++DFGL+K     G  +   R+  
Sbjct: 155 DIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI-YSGDYYRQGRIAK 210
Query: 309 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               + A E +     TSKSDV++FGV + E+ T
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 117/297 (39%), Gaps = 44/297 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 196
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 54  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 108
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK----------------GSLPLPW 240
            H N+V L+G C      L++ E+   G L N L RK                  L L  
Sbjct: 109 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+    D   
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 269
Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 270 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R+ +  S LG+G FG V     E     P+   TG  VAVK L H G    +++  E+  
Sbjct: 23  RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 193 LGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
           L  L    +VK   V Y        LV E++P G L + L R  +  L  S  +  +   
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQI 136
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT- 309
            KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D K +   R  G  
Sbjct: 137 CKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQS 192
Query: 310 -YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
              + APE +     + +SDV+SFGVVL E+ T
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 121/291 (41%), Gaps = 36/291 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 198
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 54  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG-------SLPLPWSIR-----MKI 246
            N+V L+G C      L++ E+   G L N L RK        +  +  S       +  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V    
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + APE +     T +SDV+S+G++L E+     S+  N             P + 
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPGIL 271
Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
              +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 138/307 (44%), Gaps = 38/307 (12%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQ 181
           F+ ++ ++A         LG+G FG V++G  +  G    +P T   VA+KT+N    ++
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMR 61
Query: 182 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGS 235
              E+L E + +      ++V+L+G   +    L++ E M RG L+++L           
Sbjct: 62  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 121
Query: 236 LPLPWSIRMKIALGA--AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 293
           +  P S+   I +    A G+A+L+       ++RD    N ++  D+  K+ DFG+ +D
Sbjct: 122 VLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 178
Query: 294 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 353
             E        + +    + +PE +  G  T+ SDV+SFGVVL E+ T            
Sbjct: 179 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------ 226
Query: 354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMS 410
              L E  +P+ G      ++L   +EG    K         +L   C   +PK RP   
Sbjct: 227 ---LAE--QPYQGLSNE--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL 279
Query: 411 EVVETLK 417
           E++ ++K
Sbjct: 280 EIISSIK 286

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 138/311 (44%), Gaps = 38/311 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 26  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 251
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 142 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 240
Query: 372 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASS 428
            ++L   +EG    K         +L   C   +PK RP   E++ ++K          S
Sbjct: 241 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 299
Query: 429 SYYFQTMQADN 439
            YY +  + +N
Sbjct: 300 FYYSEENKMEN 310

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 244
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 260
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 416
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 261 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R+ +  S LG+G FG V     E     P+   TG  VAVK L H G    +++  E+  
Sbjct: 7   RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 61
Query: 193 LGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
           L  L    +VK   V Y     +  LV E++P G L + L R  +  L  S  +  +   
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQI 120
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT- 309
            KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D    V  R  G  
Sbjct: 121 CKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXV-VREPGQS 176
Query: 310 -YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
              + APE +     + +SDV+SFGVVL E+ T
Sbjct: 177 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 127/289 (43%), Gaps = 44/289 (15%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 20  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 63
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
              H N++  +GY  +  Q  +V ++    SL +HL             + IA   A+G+
Sbjct: 64  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGM 121
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + A
Sbjct: 122 DYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 178
Query: 315 PEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGDKRR 370
           PE +    +   + +SDVY+FG+VL E++TG+  +  +  N    ++E   R  L     
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLS 236
Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
             R   P+           +  +L A+CL +    RP    ++  ++ L
Sbjct: 237 KVRSNCPK-----------RMKRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 20  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 251
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 136 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 234
Query: 372 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 417
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 235 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 133/289 (46%), Gaps = 38/289 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 33  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 251
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+  A K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 149 DGMAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 247
Query: 372 YRLLDPRLEGHFSIKGS---QKATQLAAQCLSRDPKARPRMSEVVETLK 417
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 248 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 42/288 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 44  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 87
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 88  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 145
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + A
Sbjct: 146 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 202
Query: 315 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 261
Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 262 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 42/288 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 36  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 79
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 80  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 137
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + A
Sbjct: 138 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 194
Query: 315 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 195 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 253
Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 254 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 290

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 27  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 251
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 143 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 241
Query: 372 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 417
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 242 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 55  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 110
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 251
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 111 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 170
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 171 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 227
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 228 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 269
Query: 372 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 417
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 270 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 317

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 42/288 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 59
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 117
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + A
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 174
Query: 315 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 233
Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 234 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 26  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 251
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 142 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 240
Query: 372 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 417
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 241 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 244
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 260
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 416
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 261 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 25  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 244
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 249
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 416
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 250 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 295

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 30/213 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           + + E  LG G FG V+     ++            VAVKT+   G    + +LAE N +
Sbjct: 183 SLKLEKKLGAGQFGEVWMATYNKHTK----------VAVKTMK-PGSMSVEAFLAEANVM 231
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             L H  LVKL    +  +   ++ EFM +GSL + L        P    +  +   A+G
Sbjct: 232 KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 290
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--G 311
           +AF+ +   +  I+RD + +NIL+ A    K++DFGLA             RV   +   
Sbjct: 291 MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLA-------------RVGAKFPIK 334
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
           + APE +  G  T KSDV+SFG++L+E++T  R
Sbjct: 335 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 29  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 244
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 253
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 416
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 254 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 299

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 28  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 244
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 252
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 416
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 253 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 298

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 244
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 260
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 416
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 261 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 23  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 251
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 139 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 196 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 237
Query: 372 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 417
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 238 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 285

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 133/289 (46%), Gaps = 38/289 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 33  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 251
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+  A K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 149 DGMAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 247
Query: 372 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 417
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 248 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 44/231 (19%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           +GEG FG VF+      G  P +P T   VAVK L  +       ++  E   +    +P
Sbjct: 55  IGEGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----------------------GSL 236
           N+VKL+G C       L++E+M  G L N   R                        G  
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDL-NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 237 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-- 294
           PL  + ++ IA   A G+A+L   +E+  ++RD  T N L+  +   K++DFGL+++   
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 295 ----PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                 DG   +  R M       PE +     T++SDV+++GVVL E+ +
Sbjct: 227 ADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 77  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 244
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 301
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 416
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 302 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 140/295 (47%), Gaps = 40/295 (13%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 186
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K+
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKV 109
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           ++   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF 163
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
           +GT  Y +PE +   H + +SD++S G+ L+EM  GR  +    P+ +    E +RP + 
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAK----EDSRPPMA 217
Query: 367 DKRRFYRLLD-------PRL-EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
                + LLD       P+L  G FS+    +      +CL ++P  R  + +++
Sbjct: 218 ----IFELLDYIVNEPPPKLPSGVFSL----EFQDFVNKCLIKNPAERADLKQLM 264

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 120
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V    
Sbjct: 121 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 177
Query: 307 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               + + APE + T   +  SD + FGV L EM T
Sbjct: 178 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 243
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 241
Query: 364 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 243
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 241
Query: 364 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 43  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 86
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 87  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 144
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + A
Sbjct: 145 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 201
Query: 315 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 260
Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 261 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 297

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 38/289 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 20  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 251
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+L+       ++RD    N  +  D+  K+ DFG+ +D  E        + +    
Sbjct: 136 DGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 234
Query: 372 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 417
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 235 -QVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 115/226 (50%), Gaps = 28/226 (12%)
Query: 128 LKLATRNFRPESL-----LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTL-NHDGL 180
           +K+  R F+   L     LG G FG V KG W+ E  +  +       V +K + +  G 
Sbjct: 3   MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKI------PVCIKVIEDKSGR 56
Query: 181 QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLP-- 237
           Q  +     +  +G+L H ++V+L+G C     +L V +++P GSL +H+ + +G+L   
Sbjct: 57  QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQ 115
Query: 238 --LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 295
             L W +++      AKG+ +L E     +++R+    N+LL +    +++DFG+A   P
Sbjct: 116 LLLNWGVQI------AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166
Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            D K  + +       + A E +  G  T +SDV+S+GV + E++T
Sbjct: 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 12/209 (5%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFL 193
            + E ++G G FG V  G ++  G   +       VA+KTL      +  +++L+E + +
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREI------CVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
           G   HPN++ L G   +    +++ E+M  GSL+  L RK          + +  G   G
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGMLRGIGSG 128
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGY 312
           + +L   ++   ++RD    NIL++++   K+SDFG+++   +D +   +TR       +
Sbjct: 129 MKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 185
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            APE +     TS SDV+S+G+V+ E+++
Sbjct: 186 TAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 44  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 87
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 88  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 145
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + A
Sbjct: 146 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 202
Query: 315 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 261
Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 262 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 18  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 61
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 62  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 119
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + A
Sbjct: 120 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 176
Query: 315 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 235
Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 236 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 272

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 120
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V    
Sbjct: 121 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 177
Query: 307 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               + + APE + T   +  SD + FGV L EM T
Sbjct: 178 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 116
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V    
Sbjct: 117 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 307 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               + + APE + T   +  SD + FGV L EM T
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 40/271 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V+ G W   NG           VA+KTL   G    + +L E   +  L H 
Sbjct: 17  LGNGQFGEVWMGTW---NGNT--------KVAIKTLK-PGTMSPESFLEEAQIMKKLKHD 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAF 256
            LV+L    + ++   +V E+M +GSL + L + G   +L LP  + M  A   A G+A+
Sbjct: 65  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFL-KDGEGRALKLPNLVDM--AAQVAAGMAY 120
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           +        I+RD +++NIL+      K++DFGLA+   ED +            + APE
Sbjct: 121 IER---MNYIHRDLRSANILVGNGLICKIADFGLAR-LIEDNEXTARQGAKFPIKWTAPE 176
Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
             + G  T KSDV+SFG++L E++T  R       N         R  L    R YR+  
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---------REVLEQVERGYRMPC 227
Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
           P+ +   S+       +L   C  +DP+ RP
Sbjct: 228 PQ-DCPISLH------ELMIHCWKKDPEERP 251

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 23/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVN 191
             R   +LG G FG V KG W+ E  +  +       V +K + +  G Q  +     + 
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGESIKI------PVCIKVIEDKSGRQSFQAVTDHML 85
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLP----LPWSIRMKI 246
            +G+L H ++V+L+G C     +L V +++P GSL +H+ + +G+L     L W +++  
Sbjct: 86  AIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI-- 142
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
               AKG+ +L E     +++R+    N+LL +    +++DFG+A   P D K  + +  
Sbjct: 143 ----AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 195
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                + A E +  G  T +SDV+S+GV + E++T
Sbjct: 196 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 12/209 (5%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFL 193
            + E ++G G FG V  G ++  G   +       VA+KTL      +  +++L+E + +
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREI------CVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
           G   HPN++ L G   +    +++ E+M  GSL+  L RK          + +  G   G
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGMLRGIGSG 122
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGY 312
           + +L   ++   ++RD    NIL++++   K+SDFG+++   +D +   +TR       +
Sbjct: 123 MKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 179
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            APE +     TS SDV+S+G+V+ E+++
Sbjct: 180 TAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 21  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 244
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +                 +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 245
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 416
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 246 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 243
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 250
Query: 364 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 126
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V    
Sbjct: 127 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 307 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               + + APE + T   +  SD + FGV L EM T
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 128/294 (43%), Gaps = 54/294 (18%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 21  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 64
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIAL 248
              H N++  +GY  +  Q  +V ++    SL +HL      F    L       + IA 
Sbjct: 65  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-------IDIAR 116
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A+G+ +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G
Sbjct: 117 QTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 173
Query: 309 TYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
           +  + APE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L
Sbjct: 174 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYL 232
Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                  R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 233 SPDLSKVRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 116
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V    
Sbjct: 117 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 307 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               + + APE + T   +  SD + FGV L EM T
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 128/294 (43%), Gaps = 54/294 (18%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 59
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIAL 248
              H N++  +GY  +  Q  +V ++    SL +HL      F    L       + IA 
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-------IDIAR 111
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A+G+ +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G
Sbjct: 112 QTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 309 TYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
           +  + APE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYL 227
Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                  R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 228 SPDLSKVRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 21  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 64
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 65  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 122
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + A
Sbjct: 123 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 315 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 238
Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 239 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 244
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +                 +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 260
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 416
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 261 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 243
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRK 207
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 250
Query: 364 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 243
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 241
Query: 364 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 243
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 241
Query: 364 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 117/240 (48%), Gaps = 25/240 (10%)
Query: 112 EELKVASQLRK----FMFNDLK---LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 164
           EEL++  Q RK    F+    K   L   +F   S LG G  G VFK           KP
Sbjct: 5   EELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFK--------VSHKP 56
Query: 165 GTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
            +GL +A K ++ +     + + + E+  L     P +V   G    D +  +  E M  
Sbjct: 57  -SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 224 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 283
           GSL+  L + G +P    I  K+++   KGL +L E+ +  +++RD K SNIL+++    
Sbjct: 116 GSLDQVLKKAGRIP--EQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEI 171
Query: 284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           KL DFG++    +     ++   +GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 172 KLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 118/283 (41%), Gaps = 36/283 (12%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           D ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E 
Sbjct: 4   DPRVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEV 54
Query: 187 ---LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR 243
              L E   L N  HP L  L       D+   V E+   G L  HL R+       +  
Sbjct: 55  AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF 114
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
               + +A  L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T   
Sbjct: 115 YGAEIVSA--LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--M 168
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
               GT  Y APE +         D +  GVV+ EM+ GR             L+     
Sbjct: 169 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----- 223
Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
            L ++ RF R L P            +A  L +  L +DPK R
Sbjct: 224 -LMEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 253

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 243
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 250
Query: 364 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 127/294 (43%), Gaps = 54/294 (18%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 194
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 59
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIAL 248
              H N++  +GY     Q  +V ++    SL +HL      F    L       + IA 
Sbjct: 60  KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-------IDIAR 111
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A+G+ +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G
Sbjct: 112 QTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 309 TYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
           +  + APE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYL 227
Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                  R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 228 SPDLSKVRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 118/281 (41%), Gaps = 36/281 (12%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E   
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 197
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
            L E   L N  HP L  L       D+   V E+   G L  HL R+       +    
Sbjct: 198 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 257
Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
             + +A  L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T  +  
Sbjct: 258 AEIVSA--LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-- 311
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
             GT  Y APE +         D +  GVV+ EM+ GR             L+      L
Sbjct: 312 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L 365
Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
            ++ RF R L P            +A  L +  L +DPK R
Sbjct: 366 MEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 394

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 131 ATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
            TR+  PE        LG+G FG V+K   +E         T +  A K ++    +  +
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELE 79
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
           +++ E++ L +  HPN+VKL+     ++   ++ EF   G+++  +      PL  S   
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQ 138
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            +       L +LH   +  +I+RD K  NIL   D + KL+DFG++  A          
Sbjct: 139 VVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRD 193
Query: 305 RVMGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEM 339
             +GT  + APE VM           K+DV+S G+ L+EM
Sbjct: 194 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 131 ATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
            TR+  PE        LG+G FG V+K   +E         T +  A K ++    +  +
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELE 79
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
           +++ E++ L +  HPN+VKL+     ++   ++ EF   G+++  +      PL  S   
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQ 138
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            +       L +LH   +  +I+RD K  NIL   D + KL+DFG++  A          
Sbjct: 139 VVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRD 193
Query: 305 RVMGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEM 339
             +GT  + APE VM           K+DV+S G+ L+EM
Sbjct: 194 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 118/281 (41%), Gaps = 36/281 (12%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E   
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 194
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
            L E   L N  HP L  L       D+   V E+   G L  HL R+       +    
Sbjct: 195 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 254
Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
             + +A  L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T  +  
Sbjct: 255 AEIVSA--LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-- 308
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
             GT  Y APE +         D +  GVV+ EM+ GR             L+      L
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L 362
Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
            ++ RF R L P            +A  L +  L +DPK R
Sbjct: 363 MEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 391

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 131 ATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
            TR+  PE        LG+G FG V+K   +E         T +  A K ++    +  +
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELE 79
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
           +++ E++ L +  HPN+VKL+     ++   ++ EF   G+++  +      PL  S   
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQ 138
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            +       L +LH   +  +I+RD K  NIL   D + KL+DFG++  A          
Sbjct: 139 VVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRD 193
Query: 305 RVMGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEM 339
             +GT  + APE VM           K+DV+S G+ L+EM
Sbjct: 194 XFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 121/291 (41%), Gaps = 39/291 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIRMK----------IA 247
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+    K           +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
              AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D          
Sbjct: 151 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 207
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
               + APE +     T +SDV+SFGV+L E+ +                   A P+ G 
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPGV 250
Query: 368 K--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 121/291 (41%), Gaps = 39/291 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIRMK----------IA 247
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+    K           +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
              AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D          
Sbjct: 151 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
               + APE +     T +SDV+SFGV+L E+ +                   A P+ G 
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPGV 250
Query: 368 K--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 KIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 121/293 (41%), Gaps = 41/293 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 37  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR------------MK 245
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+               + 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
            +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D        
Sbjct: 153 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
                 + APE +     T +SDV+SFGV+L E+ +                   A P+ 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYP 252
Query: 366 GDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 126
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++    V    
Sbjct: 127 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEH 183
Query: 307 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               + + APE + T   +  SD + FGV L EM T
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 116
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++    V    
Sbjct: 117 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEH 173
Query: 307 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
               + + APE + T   +  SD + FGV L EM T
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 72  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 243
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 188 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 244
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 287
Query: 364 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 288 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 121/294 (41%), Gaps = 42/294 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 36  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSI-------------RM 244
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+                +
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
             +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D       
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV+L E+ +                   A P+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPY 251
Query: 365 LGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
            G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 252 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + +
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQII 114
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K++
Sbjct: 115 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 172
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           +   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 173 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 226
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 421
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 422 L 422
           L
Sbjct: 319 L 319

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 421
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 422 L 422
           L
Sbjct: 319 L 319

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 86/282 (30%), Positives = 119/282 (42%), Gaps = 38/282 (13%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E   
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 55
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
            L E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       +   
Sbjct: 56  TLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY 114
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
              + +A  L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T    
Sbjct: 115 GAEIVSA--LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MK 168
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
              GT  Y APE +         D +  GVV+ EM+ GR             L+      
Sbjct: 169 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------ 222
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           L ++ RF R L P            +A  L +  L +DPK R
Sbjct: 223 LMEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 252

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 117/281 (41%), Gaps = 36/281 (12%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E   
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 54
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
            L E   L N  HP L  L       D+   V E+   G L  HL R+       +    
Sbjct: 55  TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 114
Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
             + +A  L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T     
Sbjct: 115 AEIVSA--LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKX 168
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
             GT  Y APE +         D +  GVV+ EM+ GR             L+      L
Sbjct: 169 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L 222
Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
            ++ RF R L P            +A  L +  L +DPK R
Sbjct: 223 MEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 251

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 136/307 (44%), Gaps = 38/307 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG VFKG   +N T  V       VA+K ++  +     ++   E+  L     P
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            + K  G  ++D +  ++ E++  GS  + L   G  PL  +    I     KGL +LH 
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHS 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
           E +   I+RD K +N+LL      KL+DFG+A     D +   +T V GT  + APE + 
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVIK 177
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 379
                SK+D++S G+  +E+  G     +  P     L+    P             P L
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTL 224
Query: 380 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADN 439
           EG++    S+   +    CL+++P  RP   E+++    L+N K    +SY  + +    
Sbjct: 225 EGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK---KTSYLTELIDRYK 277
Query: 440 TWSIRNS 446
            W    S
Sbjct: 278 RWKAEQS 284

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 111
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 112 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 171
Query: 258 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D    G        M    +  
Sbjct: 172 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 231
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 232 PEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 258 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D    G        M    +  
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 18/216 (8%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + +
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQII 55
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K++
Sbjct: 56  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 113
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           +   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    ++    ++   +
Sbjct: 114 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFV 167
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 168 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 18/217 (8%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 186
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K+
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKV 109
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           ++   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF 163
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           +GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 18/217 (8%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 186
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K+
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKV 109
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           ++   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF 163
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           +GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVN 191
           +F    +LG+G FG VF            +P +G   A+K L    L+         E +
Sbjct: 29  HFELLKVLGQGSFGKVFLV------RKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD 82
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
            L ++ HP +VKL  Y  + + +L L+ +F+  G L   L  K  +     ++  +A   
Sbjct: 83  ILADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-EL 139
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
           A GL  LH      +IYRD K  NILLD + + KL+DFGL+K+A +  K   S    GT 
Sbjct: 140 ALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTV 194
Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            Y APE V     +  +D +S+GV++ EMLTG
Sbjct: 195 EYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 421
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 422 L 422
           L
Sbjct: 319 L 319

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 136/310 (43%), Gaps = 40/310 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG VFKG   +N T  V       VA+K ++  +     ++   E+  L     P
Sbjct: 30  IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            + K  G  ++D +  ++ E++  GS  + L   G  PL  +    I     KGL +LH 
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHS 137
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRVMGTYGYAAPEYV 318
           E +   I+RD K +N+LL      KL+DFG+A    +   T +     +GT  + APE +
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVI 191
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 378
                 SK+D++S G+  +E+  G     +  P     L+    P             P 
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PT 238
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQAD 438
           LEG++    S+   +    CL+++P  RP   E+++    L+N K    +SY  + +   
Sbjct: 239 LEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK---KTSYLTELIDRY 291
Query: 439 NTWSIRNSKN 448
             W    S +
Sbjct: 292 KRWKAEQSHD 301

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 3   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 46
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ PRG +   L +
Sbjct: 47  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK 106
Query: 233 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
                   +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG + 
Sbjct: 107 LSKFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 161
Query: 293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 352
            AP   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 162 HAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217
Query: 353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 218 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 259
Query: 413 VE 414
           +E
Sbjct: 260 LE 261

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 421
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 422 L 422
           L
Sbjct: 319 L 319

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 421
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 422 L 422
           L
Sbjct: 319 L 319

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 24/225 (10%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW- 186
           +KL   NF    +LG+G FG V             + GT    A+K L  D +    +  
Sbjct: 16  VKLTDFNFL--MVLGKGSFGKVMLA---------DRKGTEELYAIKILKKDVVIQDDDVE 64
Query: 187 --LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
             + E   L  L  P  +  +  C +   RL  V E++  G L  H+ + G    P ++ 
Sbjct: 65  CTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF 124
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
              A   + GL FLH+     +IYRD K  N++LD++ + K++DFG+ K+   DG   V+
Sbjct: 125 Y--AAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG---VT 176
Query: 304 TR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 347
           TR   GT  Y APE +         D +++GV+L EML G+   D
Sbjct: 177 TREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 421
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 422 L 422
           L
Sbjct: 319 L 319

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 18/217 (8%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 186
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K+
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKV 109
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           ++   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF 163
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           +GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 18/217 (8%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 186
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K+
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKV 109
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           ++   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF 163
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           +GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 135/308 (43%), Gaps = 40/308 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG VFKG   +N T  V       VA+K ++  +     ++   E+  L     P
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            + K  G  ++D +  ++ E++  GS  + L   G  PL  +    I     KGL +LH 
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHS 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRVMGTYGYAAPEYV 318
           E +   I+RD K +N+LL      KL+DFG+A    +   T +     +GT  + APE +
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVI 176
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 378
                 SK+D++S G+  +E+  G     +  P     L+    P             P 
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PT 223
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQAD 438
           LEG++    S+   +    CL+++P  RP   E+++    L+N K    +SY  + +   
Sbjct: 224 LEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK---KTSYLTELIDRY 276
Query: 439 NTWSIRNS 446
             W    S
Sbjct: 277 KRWKAEQS 284

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 89  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 313
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 421
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 314 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364
Query: 422 L 422
           L
Sbjct: 365 L 365

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +  L H 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQ 94
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 258 HEEAEKPVIYRDFKTSNILLDAD---YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 155 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 130/305 (42%), Gaps = 52/305 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTG--LTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           LGEG FG V K       TA    G     TVAVK L  +      ++ L+E N L  + 
Sbjct: 31  LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------------- 236
           HP+++KL G C +D   LL+ E+   GSL   L     +                     
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 237 -PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 295
             L     +  A   ++G+ +L   AE  +++RD    NIL+      K+SDFGL++D  
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
           E+      ++      + A E +     T++SDV+SFGV+L E++T    +  N      
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGN------ 251
Query: 356 NLVEWARPHLG-DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                  P+ G    R + LL            S++  +L  QC  ++P  RP  +++ +
Sbjct: 252 -------PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 415 TLKPL 419
            L+ +
Sbjct: 305 DLEKM 309

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENG--TAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           K + ++F+    LG G FG V       NG   A       + V +K + H         
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN------- 54
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
             E   L  + HP ++++ G   +  Q  ++ +++  G L + L +    P P  +    
Sbjct: 55  -DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP--VAKFY 111
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           A      L +LH    K +IYRD K  NILLD + + K++DFG AK  P+     V+  +
Sbjct: 112 AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXL 163
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            GT  Y APE V T       D +SFG+++ EML G
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           +L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + +
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQII 71
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K++
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 129
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           +   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 130 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 183
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 184 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 30  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 148 SCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 254
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 421
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 255 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 305
Query: 422 L 422
           L
Sbjct: 306 L 306

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +  L H 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQ 108
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 258 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 169 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 32  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 150 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 256
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 421
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 257 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 307
Query: 422 L 422
           L
Sbjct: 308 L 308

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 35  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 153 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 259
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 421
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 260 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 310
Query: 422 L 422
           L
Sbjct: 311 L 311

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 130/305 (42%), Gaps = 52/305 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTG--LTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           LGEG FG V K       TA    G     TVAVK L  +      ++ L+E N L  + 
Sbjct: 31  LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------------- 236
           HP+++KL G C +D   LL+ E+   GSL   L     +                     
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 237 -PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 295
             L     +  A   ++G+ +L   AE  +++RD    NIL+      K+SDFGL++D  
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
           E+      ++      + A E +     T++SDV+SFGV+L E++T    +  N      
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGN------ 251
Query: 356 NLVEWARPHLG-DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                  P+ G    R + LL            S++  +L  QC  ++P  RP  +++ +
Sbjct: 252 -------PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 415 TLKPL 419
            L+ +
Sbjct: 305 DLEKM 309

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 16/214 (7%)
Query: 135 FRPES-----LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
            RPE      +LG+GG+G VF+  V +   A       + V  K +     +      AE
Sbjct: 14  IRPECFELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
            N L  + HP +V L+ Y  +   +L L+ E++  G L   L R+G      +      +
Sbjct: 72  RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A  L  LH+   K +IYRD K  NI+L+   + KL+DFGL K++  DG   V+    G
Sbjct: 131 SMA--LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCG 183
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           T  Y APE +M        D +S G ++ +MLTG
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 16/214 (7%)
Query: 135 FRPES-----LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
            RPE      +LG+GG+G VF+  V +   A       + V  K +     +      AE
Sbjct: 14  IRPECFELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
            N L  + HP +V L+ Y  +   +L L+ E++  G L   L R+G      +      +
Sbjct: 72  RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A  L  LH+   K +IYRD K  NI+L+   + KL+DFGL K++  DG   V+    G
Sbjct: 131 SMA--LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCG 183
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           T  Y APE +M        D +S G ++ +MLTG
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 108/239 (45%), Gaps = 26/239 (10%)
Query: 113 ELKVASQLRKFMFND----LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGL 168
           E K A+ + KF  N     +KL   NF    +LG+G FG V             + GT  
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTDFNFL--MVLGKGSFGKVM---------LSERKGTDE 367
Query: 169 TVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRG 224
             AVK L  D +    +    + E   L     P  +  +  C +   RL  V E++  G
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427
Query: 225 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 284
            L  H+ + G    P ++    A   A GL FL     K +IYRD K  N++LD++ + K
Sbjct: 428 DLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIK 482
Query: 285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           ++DFG+ K+   DG T  +    GT  Y APE +         D ++FGV+L EML G+
Sbjct: 483 IADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   +++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 421
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 422 L 422
           L
Sbjct: 319 L 319

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 121/295 (41%), Gaps = 43/295 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 198
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 37  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 199 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 243
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+                 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 153 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 209
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 210 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 252
Query: 364 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 253 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWL 187
           L     R   +LG G FG V+KG W+      P      + VA+K L  +   + +KE L
Sbjct: 14  LKETELRKVKVLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEIL 67
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF----RKGSLPLPWSIR 243
            E   +  +  P + +L+G C+    +L V + MP G L +H+     R GS  L     
Sbjct: 68  DEAYVMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDL----- 121
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           +   +  AKG+++L +     +++RD    N+L+ +  + K++DFGLA+    D   + +
Sbjct: 122 LNWCMQIAKGMSYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 178
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                   + A E ++    T +SDV+S+GV + E++T
Sbjct: 179 DGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 130/305 (42%), Gaps = 52/305 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTG--LTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           LGEG FG V K       TA    G     TVAVK L  +      ++ L+E N L  + 
Sbjct: 31  LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------------- 236
           HP+++KL G C +D   LL+ E+   GSL   L     +                     
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 237 -PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 295
             L     +  A   ++G+ +L   AE  +++RD    NIL+      K+SDFGL++D  
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
           E+      ++      + A E +     T++SDV+SFGV+L E++T    +  N      
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGN------ 251
Query: 356 NLVEWARPHLG-DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                  P+ G    R + LL            S++  +L  QC  ++P  RP  +++ +
Sbjct: 252 -------PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 415 TLKPL 419
            L+ +
Sbjct: 305 DLEKM 309

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 120
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 121 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 180
Query: 258 HEEAEKPVIYRDFKTSNILLDAD---YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 181 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 240
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 241 PEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 54
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       +   
Sbjct: 55  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 113
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
              + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  + 
Sbjct: 114 GAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 167
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARP 363
              GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E    
Sbjct: 168 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI-- 220
Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
            L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 221 -LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 250

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 118/293 (40%), Gaps = 49/293 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTA--PVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL 196
           +LG G FG V       N TA    K G  + VAVK L        +E L +E+  +  L
Sbjct: 52  VLGSGAFGKVM------NATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 197 -LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLP------------ 237
             H N+V L+G C       L++E+   G L N+L      F +  +             
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 238 ---LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
              L +   +  A   AKG+ FL     K  ++RD    N+L+      K+ DFGLA+D 
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 354
             D    V         + APE +  G  T KSDV+S+G++L E+     S+  N     
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF----SLGVN----- 273
Query: 355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
                   P +     FY+L+    +       +++   +   C + D + RP
Sbjct: 274 ------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 320

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 69
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 128
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 129 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 179
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 180 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       +   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
              + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  + 
Sbjct: 111 GAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 164
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARP 363
              GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E    
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI-- 217
Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
            L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 -LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 8   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 56
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 57  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 116 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 170
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 125 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 94
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 258 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 155 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 100
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 101 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 160
Query: 258 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 161 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 220
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 221 PEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L++ +       +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSY 108
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 66
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 125
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 126 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 176
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 177 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 110
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 111 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 170
Query: 258 HEEAEKPVIYRDFKTSNILLDAD---YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 171 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 230
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 231 PEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 22  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 75
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 76  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 134
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 135 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 185
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 186 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 128 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 127 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 177
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 136/301 (45%), Gaps = 41/301 (13%)
Query: 130 LATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           L  ++  PE L      +G+G FG VFKG   +N T  V       VA+K ++ +  +  
Sbjct: 18  LYFQSMDPEELFTKLEKIGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDE 68
Query: 184 KEWLA-EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSI 242
            E +  E+  L     P + K  G  ++D +  ++ E++  GS  + L   G  PL  + 
Sbjct: 69  IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQ 125
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
              I     KGL +LH E +   I+RD K +N+LL      KL+DFG+A     D +   
Sbjct: 126 IATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKR 181
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 362
           +T V GT  + APE +      SK+D++S G+  +E+  G     +  P     L+    
Sbjct: 182 NTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN 240
Query: 363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL 422
           P             P LEG++    S+   +    CL+++P  RP   E+++    L+N 
Sbjct: 241 P-------------PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 283
Query: 423 K 423
           K
Sbjct: 284 K 284

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 57
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +S    
Sbjct: 118 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS---- 168
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 220
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 221 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 30/222 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSI 242
           + E++ L  L HPN+VKL+     +++  LV+EF+   S++   F   S    +PLP  +
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLP--L 107
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
                    +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+ 
Sbjct: 108 IKSYLFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX 164
Query: 303 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
              V  T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 165 HEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 131/310 (42%), Gaps = 39/310 (12%)
Query: 108 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 167
           P+ + E ++AS+ +       + A  +F     LG+G FG V+    ++         + 
Sbjct: 9   PENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQ---------SK 59
Query: 168 LTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
             +A+K L    L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G
Sbjct: 60  FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 119
Query: 225 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 284
           ++   L +        +      L  A  L++ H    K VI+RD K  N+LL +    K
Sbjct: 120 TVYRELQKLSKFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELK 174
Query: 285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
           ++DFG +  AP   +    T + GT  Y  PE +       K D++S GV+  E L G+ 
Sbjct: 175 IADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230
Query: 345 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 404
             + N     +  +                   R+E  F    ++ A  L ++ L  +P 
Sbjct: 231 PFEANTYQETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPS 272
Query: 405 ARPRMSEVVE 414
            RP + EV+E
Sbjct: 273 QRPMLREVLE 282

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 117/284 (41%), Gaps = 39/284 (13%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           D K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E 
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEV 54
Query: 187 ---LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSI 242
              + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       + 
Sbjct: 55  AHTVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 113
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
                + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  
Sbjct: 114 FYGAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 166
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 362
                GT  Y APE +         D +  GVV+ EM+ GR             L+    
Sbjct: 167 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---- 222
Query: 363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
             L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 223 --LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 252

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 119/283 (42%), Gaps = 41/283 (14%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       +   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
              + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T    
Sbjct: 111 GAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MK 163
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARP 363
              GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E    
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI-- 217
Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
            L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 -LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       +   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
              + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  + 
Sbjct: 111 GAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 164
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARP 363
              GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E    
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI-- 217
Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
            L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 -LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 119/283 (42%), Gaps = 41/283 (14%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       +   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
              + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T    
Sbjct: 111 GAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MK 163
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARP 363
              GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E    
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI-- 217
Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
            L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 -LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 18  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 71
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 72  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 130
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 131 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 181
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 182 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 258 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THE 164
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
           + T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 109/222 (49%), Gaps = 30/222 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSI 242
           + E++ L  L HPN+VKL+     +++  LV+EF+   S++   F   S    +PLP   
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIK 107
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
                L   +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+ 
Sbjct: 108 SYLFQL--LQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX 162
Query: 303 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
              V  T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 163 HEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 94
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 258 HEEAEKPVIYRDFKTSNILLDAD---YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 155 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMP 214
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 128 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 258 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 85
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 86  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 145
Query: 258 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 146 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 205
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 206 PEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 66
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCV 125
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 126 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 176
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 177 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 127/302 (42%), Gaps = 46/302 (15%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 3   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 46
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ PRG +   L +
Sbjct: 47  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK 106
Query: 233 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
                   +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG + 
Sbjct: 107 LSKFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 161
Query: 293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 352
            AP   +      + GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 162 HAPSSRR----XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217
Query: 353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 218 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 259
Query: 413 VE 414
           +E
Sbjct: 260 LE 261

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L++ +       +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSY 111
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 128 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 132 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 46/300 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 5   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 48
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 49  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 108
Query: 235 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
                 +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  A
Sbjct: 109 KFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 163
Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 354
           P   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 164 PSSRR----TTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLE 261

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 108
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 258 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 169 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 37  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 90
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 91  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 149
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 150 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 200
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 201 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 125 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 128 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 127 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 177
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 11  NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 59
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 60  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 173
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 125 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 111
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L++ +       +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSY 110
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 109/242 (45%), Gaps = 24/242 (9%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN---HDGLQGHKE 185
           K+    ++    LG GG   V   ++ E+    +K      VA+K +     +  +  K 
Sbjct: 7   KIINERYKIVDKLGGGGMSTV---YLAEDTILNIK------VAIKAIFIPPREKEETLKR 57
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
           +  EV+    L H N+V ++    EDD   LV E++   +L  ++   G L +  +I   
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFT 117
Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
             +    G+   H+     +++RD K  NIL+D++   K+ DFG+AK   E   T  +  
Sbjct: 118 NQI--LDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNH 171
Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
           V+GT  Y +PE          +D+YS G+VL EML G         NGE   V  A  H+
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF-----NGE-TAVSIAIKHI 225
Query: 366 GD 367
            D
Sbjct: 226 QD 227

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 11  NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 59
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 60  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 173
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 174 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSY 111
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 123/304 (40%), Gaps = 67/304 (22%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +F+   L+G GGFG VFK     +G          T  +K + ++  +  +E    V  L
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGK---------TYVIKRVKYNNEKAERE----VKAL 58
Query: 194 GNLLHPNLVKLVG------YCIEDDQR----------LLVYEFMPRGSLENHLFRKGSLP 237
             L H N+V   G      Y  E   +           +  EF  +G+LE  + ++    
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 238 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 297
           L   + +++     KG+ ++H    K +I RD K SNI L      K+ DFGL      D
Sbjct: 119 LDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
           GK     R  GT  Y +PE + +     + D+Y+ G++L E+L                 
Sbjct: 176 GK---RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL----------------- 215
Query: 358 VEWARPHLGD-----KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                 H+ D      + F  L D  +   F     +K   L  + LS+ P+ RP  SE+
Sbjct: 216 ------HVCDTAFETSKFFTDLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEI 265
Query: 413 VETL 416
           + TL
Sbjct: 266 LRTL 269

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 111
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 126/301 (41%), Gaps = 43/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++  +  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 421
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 422 L 422
           L
Sbjct: 319 L 319

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQ 108
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 257
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 258 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 169 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCV 124
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 125 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V  T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 53
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 112
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 113 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 170 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 116/282 (41%), Gaps = 39/282 (13%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       +   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
              + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T    
Sbjct: 111 GAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MK 163
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
              GT  Y APE +         D +  GVV+ EM+ GR             L+      
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------ 217
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V  T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 59
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 118
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 119 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 5   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 53
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 54  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V  T
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 167
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 46/300 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 17  SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 60
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 61  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 120
Query: 235 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
                 +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  A
Sbjct: 121 KFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 175
Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 354
           P   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 176 PSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 231
Query: 355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 232 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 273

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 46/300 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 5   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 48
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 49  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 108
Query: 235 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
                 +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  A
Sbjct: 109 KFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 163
Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 354
           P   +T +     GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 164 PSSRRTDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 46/300 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 1   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 44
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 45  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104
Query: 235 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
                 +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  A
Sbjct: 105 KFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159
Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 354
           P   +T +     GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 160 PSSRRTDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215
Query: 355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 216 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 3   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 46
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 47  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 106
Query: 233 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
                   +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG + 
Sbjct: 107 LSKFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV 161
Query: 293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 352
            AP   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 162 HAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217
Query: 353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 218 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 259
Query: 413 VE 414
           +E
Sbjct: 260 LE 261

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     
Sbjct: 117 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC---- 167
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 1   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 44
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 45  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 233 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
                   +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG + 
Sbjct: 105 LSKFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV 159
Query: 293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 352
            AP   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 160 HAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215
Query: 353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 216 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 413 VE 414
           +E
Sbjct: 258 LE 259

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           +G G FG VF G +  + T          VAVK+         K ++L E   L    HP
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL----GAAKGLA 255
           N+V+L+G C +     +V E +  G     L  +G+      +R+K  L     AA G+ 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGME 227
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYAA 314
           +L     K  I+RD    N L+      K+SDFG++++   DG    S  +      + A
Sbjct: 228 YLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVXAASGGLRQVPVKWTA 283
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY-- 372
           PE +  G  +S+SDV+SFG++L E  +   S   N  N +              R F   
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------------TREFVEK 330
Query: 373 --RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 421
             RL  P L             +L  QC + +P  RP  S + + L+ ++ 
Sbjct: 331 GGRLPCPEL-------CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 21/219 (9%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAE 189
           ++  F+    LG G +  V+KG         +   TG+ VA+K +  D  +G     + E
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKG---------LNKTTGVYVALKEVKLDSEEGTPSTAIRE 53
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GSLP--LPWSIRMK 245
           ++ +  L H N+V+L      +++  LV+EFM    L+ ++  +  G+ P  L  ++   
Sbjct: 54  ISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
                 +GLAF HE     +++RD K  N+L++     KL DFGLA+       T  S  
Sbjct: 113 FQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 306 VMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
           V  T  Y AP+ +M     S S D++S G +L EM+TG+
Sbjct: 170 V--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G FG V+K   +E         TG   A K +     +  ++++ E+  L    HP 
Sbjct: 27  LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +VKL+G    D +  ++ EF P G+++  +           I++ +     + L FLH  
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLH-- 134
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             K +I+RD K  N+L+  + + +L+DFG++  A            +GT  + APE VM 
Sbjct: 135 -SKRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 321 GHLTS-----KSDVYSFGVVLLEM 339
             +       K+D++S G+ L+EM
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           +G G FG VF G +  + T          VAVK+         K ++L E   L    HP
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL----GAAKGLA 255
           N+V+L+G C +     +V E +  G     L  +G+      +R+K  L     AA G+ 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGME 227
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYAA 314
           +L     K  I+RD    N L+      K+SDFG++++   DG    S  +      + A
Sbjct: 228 YLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTA 283
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY-- 372
           PE +  G  +S+SDV+SFG++L E  +   S   N  N +              R F   
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------------TREFVEK 330
Query: 373 --RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 421
             RL  P L             +L  QC + +P  RP  S + + L+ ++ 
Sbjct: 331 GGRLPCPEL-------CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GL+F H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 112 LLQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     
Sbjct: 117 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---- 167
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +    T + 
Sbjct: 117 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 167
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 126/301 (41%), Gaps = 43/301 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 198
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 244
            N++ L+G C +D    ++  +  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 421
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 422 L 422
           L
Sbjct: 319 L 319

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 1   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 44
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 45  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 233 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
                   +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG + 
Sbjct: 105 LSKFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV 159
Query: 293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 352
            AP   +T +     GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 160 HAPSSRRTTLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215
Query: 353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 216 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 413 VE 414
           +E
Sbjct: 258 LE 259

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     
Sbjct: 117 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---- 167
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G FG V+K   +E         TG   A K +     +  ++++ E+  L    HP 
Sbjct: 19  LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +VKL+G    D +  ++ EF P G+++  +           I++ +     + L FLH  
Sbjct: 70  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLH-- 126
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             K +I+RD K  N+L+  + + +L+DFG++  A            +GT  + APE VM 
Sbjct: 127 -SKRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMC 183
Query: 321 GHLTS-----KSDVYSFGVVLLEM 339
             +       K+D++S G+ L+EM
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     
Sbjct: 117 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC---- 167
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTV----AVKTLNHDGLQGHKEWLAE 189
            F    +LG+G FG VF   V++   +  +    + V     +K  +    +  ++ L E
Sbjct: 25  QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           VN      HP +VKL  Y  + + +L L+ +F+  G L   L  K  +     ++  +A 
Sbjct: 83  VN------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA- 133
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A  L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K   S    G
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCG 188
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           T  Y APE V     T  +D +SFGV++ EMLTG
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 131/291 (45%), Gaps = 44/291 (15%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V+KG W   +G   VK      + V     +  Q  +    EV  L    H 
Sbjct: 44  IGSGSFGTVYKGKW---HGDVAVK-----ILKVVDPTPEQFQAFRN---EVAVLRKTRHV 92
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N++  +GY  +D+   +V ++    SL  HL  + +    + + + IA   A+G+ +LH 
Sbjct: 93  NILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMFQL-IDIARQTAQGMDYLHA 150
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
              K +I+RD K++NI L      K+ DFGLA        +    +  G+  + APE + 
Sbjct: 151 ---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIR 207
Query: 320 TGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL- 375
                  + +SDVYS+G+VL E++TG                E    H+ ++ +   ++ 
Sbjct: 208 MQDNNPFSFQSDVYSYGIVLYELMTG----------------ELPYSHINNRDQIIFMVG 251
Query: 376 ----DPRLEGHFSIKGSQKATQ-LAAQCLSRDPKARPRMSEVVETLKPLQN 421
                P L   +  K   KA + L A C+ +  + RP   +++ +++ LQ+
Sbjct: 252 RGYASPDLSKLY--KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    E+N        +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLA-REKN--------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     
Sbjct: 117 L--ANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC---- 167
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRIS-------- 219
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 130/310 (41%), Gaps = 39/310 (12%)
Query: 108 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 167
           P+ + E ++AS+ +       + A  +F     LG+G FG V+    ++         + 
Sbjct: 9   PENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQ---------SK 59
Query: 168 LTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
             +A+K L    L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G
Sbjct: 60  FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 119
Query: 225 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 284
           ++   L +        +      L  A  L++ H    K VI+RD K  N+LL +    K
Sbjct: 120 TVYRELQKLSKFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELK 174
Query: 285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
           ++DFG +  AP   +  +     GT  Y  PE +       K D++S GV+  E L G+ 
Sbjct: 175 IADFGWSVHAPSSRRDDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230
Query: 345 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 404
             + N     +  +                   R+E  F    ++ A  L ++ L  +P 
Sbjct: 231 PFEANTYQETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPS 272
Query: 405 ARPRMSEVVE 414
            RP + EV+E
Sbjct: 273 QRPMLREVLE 282

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 60
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 120
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     
Sbjct: 121 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---- 171
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 223
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 224 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 260

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           NF+    +GEG +G V+K   +  G         L    + +    ++       E++ L
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-------EISLL 56
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             L HPN+VKL+     +++  LV+EF+    L+  +       +P  +         +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           LAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T  Y 
Sbjct: 116 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYR 170
Query: 314 APEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
           APE ++   + ++  D++S G +  EM+T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           NF+    +GEG +G V+K   +  G         L    + +    ++       E++ L
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-------EISLL 55
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             L HPN+VKL+     +++  LV+EF+    L+  +       +P  +         +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           LAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T  Y 
Sbjct: 115 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYR 169
Query: 314 APEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
           APE ++   + ++  D++S G +  EM+T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTV----AVKTLNHDGLQGHKEWLAE 189
            F    +LG+G FG VF   V++   +  +    + V     +K  +    +  ++ L E
Sbjct: 25  QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           VN      HP +VKL  Y  + + +L L+ +F+  G L   L  K  +     ++  +A 
Sbjct: 83  VN------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA- 133
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A  L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K   S    G
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCG 188
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           T  Y APE V     T  +D +SFGV++ EMLTG
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 55
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 115
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     
Sbjct: 116 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---- 166
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 167 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 218
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 219 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 255

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTV----AVKTLNHDGLQGHKEWLAE 189
            F    +LG+G FG VF   V++   +  +    + V     +K  +    +  ++ L E
Sbjct: 26  QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 83
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           VN      HP +VKL  Y  + + +L L+ +F+  G L   L  K  +     ++  +A 
Sbjct: 84  VN------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA- 134
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             A  L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K   S    G
Sbjct: 135 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCG 189
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           T  Y APE V     T  +D +SFGV++ EMLTG
Sbjct: 190 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + 
Sbjct: 127 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW- 186
           +KL   NF    +LG+G FG V             + GT    AVK L  D +    +  
Sbjct: 17  MKLTDFNFL--MVLGKGSFGKV---------MLSERKGTDELYAVKILKKDVVIQDDDVE 65
Query: 187 --LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
             + E   L     P  +  +  C +   RL  V E++  G L  H+ + G    P ++ 
Sbjct: 66  CTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 125
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
              A   A GL FL     K +IYRD K  N++LD++ + K++DFG+ K+   DG T  +
Sbjct: 126 Y--AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--T 178
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
               GT  Y APE +         D ++FGV+L EML G+
Sbjct: 179 KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +L  G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 132 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/326 (24%), Positives = 141/326 (43%), Gaps = 57/326 (17%)
Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGH 183
           +ND+K        + ++GEG FG V K  ++       K G  +  A+K +  +     H
Sbjct: 24  WNDIKF-------QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDH 69
Query: 184 KEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL------ 236
           +++  E+  L  L  HPN++ L+G C       L  E+ P G+L + L +   L      
Sbjct: 70  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 129
Query: 237 --------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF 288
                    L     +  A   A+G+ +L   ++K  I+RD    NIL+  +Y AK++DF
Sbjct: 130 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 186
Query: 289 GLAKDAPEDGKTHVSTRVMGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 346
           GL++     G+     + MG     + A E +     T+ SDV+S+GV+L E++    S+
Sbjct: 187 GLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SL 237
Query: 347 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
                 G      + +   G     YRL  P       +    +   L  QC    P  R
Sbjct: 238 GGTPYCGMTCAELYEKLPQG-----YRLEKP-------LNCDDEVYDLMRQCWREKPYER 285
Query: 407 PRMSEVVETL-KPLQNLKDMASSSYY 431
           P  ++++ +L + L+  K   +++ Y
Sbjct: 286 PSFAQILVSLNRMLEERKTYVNTTLY 311

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 9   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 62
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 63  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 121
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      A+G+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 122 QI------AEGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 172
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 173 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 126/293 (43%), Gaps = 56/293 (19%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNL 196
           + ++G+G FG V+ G   +     ++       A+K+L+    +Q  + +L E   +  L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQ------CAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 197 LHPNLVKLVGYCIEDD---QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
            HPN++ L+G  +  +     LL Y  M  G L   +      P    + +   L  A+G
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPY--MCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARG 136
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE----DGKTHVSTRVMGT 309
           + +L   AE+  ++RD    N +LD  +  K++DFGLA+D  +      + H   R+   
Sbjct: 137 MEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--P 191
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 369
             + A E + T   T+KSDV+SFGV+L E+LT      +  P                  
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLT------RGAPP----------------- 228
Query: 370 RFYRLLDPRLEGHFSIKGSQ---------KATQLAAQCLSRDPKARPRMSEVV 413
             YR +DP    HF  +G +            Q+  QC   DP  RP    +V
Sbjct: 229 --YRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLV 279

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+  L      + +KE L
Sbjct: 46  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIMELREATSPKANKEIL 99
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 100 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 158
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 159 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 209
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 210 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/317 (25%), Positives = 128/317 (40%), Gaps = 80/317 (25%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +F+   L+G GGFG VFK     +G          T  ++ + ++  +  +E    V  L
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGK---------TYVIRRVKYNNEKAERE----VKAL 59
Query: 194 GNLLHPNLVKLVGYCIE---------DDQR---------------------LLVYEFMPR 223
             L H N+V   G C +         DD                        +  EF  +
Sbjct: 60  AKLDHVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 224 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 283
           G+LE  + ++    L   + +++     KG+ ++H    K +I+RD K SNI L      
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQV 175
Query: 284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           K+ DFGL      DGK    TR  GT  Y +PE + +     + D+Y+ G++L E+L   
Sbjct: 176 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL--- 229
Query: 344 RSMDKNRPNGEHNLVEWARPHLGD----KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 399
                               H+ D      +F+   D R +G  S    +K   L  + L
Sbjct: 230 --------------------HVCDTAFETSKFF--TDLR-DGIISDIFDKKEKTLLQKLL 266
Query: 400 SRDPKARPRMSEVVETL 416
           S+ P+ RP  SE++ TL
Sbjct: 267 SKKPEDRPNTSEILRTL 283

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + 
Sbjct: 127 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + 
Sbjct: 127 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 69
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 128
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + 
Sbjct: 129 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 179
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 180 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +L  G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 132 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 21  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 74
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 75  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 131
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 132 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 187
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 377
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 188 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 242
Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 243 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 272

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/326 (24%), Positives = 141/326 (43%), Gaps = 57/326 (17%)
Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGH 183
           +ND+K        + ++GEG FG V K  ++       K G  +  A+K +  +     H
Sbjct: 14  WNDIKF-------QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDH 59
Query: 184 KEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL------ 236
           +++  E+  L  L  HPN++ L+G C       L  E+ P G+L + L +   L      
Sbjct: 60  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 119
Query: 237 --------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF 288
                    L     +  A   A+G+ +L   ++K  I+RD    NIL+  +Y AK++DF
Sbjct: 120 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 176
Query: 289 GLAKDAPEDGKTHVSTRVMGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 346
           GL++     G+     + MG     + A E +     T+ SDV+S+GV+L E++    S+
Sbjct: 177 GLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SL 227
Query: 347 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
                 G      + +   G     YRL  P       +    +   L  QC    P  R
Sbjct: 228 GGTPYCGMTCAELYEKLPQG-----YRLEKP-------LNCDDEVYDLMRQCWREKPYER 275
Query: 407 PRMSEVVETL-KPLQNLKDMASSSYY 431
           P  ++++ +L + L+  K   +++ Y
Sbjct: 276 PSFAQILVSLNRMLEERKTYVNTTLY 301

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +L  G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 125 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 23  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 77  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 133
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 134 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 189
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 377
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 190 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 244
Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 245 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 115/257 (44%), Gaps = 30/257 (11%)
Query: 166 TGLTVAVKTLNHDG-LQGHKEWLAEVNF-LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  +AVK +   G  + +K  L +++  L +   P +V+  G  I +    +  E M  
Sbjct: 49  TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-- 106
Query: 224 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 283
           G+    L ++   P+P  I  K+ +   K L +L E+    VI+RD K SNILLD     
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQI 164
Query: 284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-----KSDVYSFGVVLLE 338
           KL DFG++    +D       R  G   Y APE +     T      ++DV+S G+ L+E
Sbjct: 165 KLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 339 MLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQ 397
           + TG+      + + E    V    P             P L GH    G  ++      
Sbjct: 222 LATGQFPYKNCKTDFEVLTKVLQEEP-------------PLLPGHMGFSGDFQS--FVKD 266
Query: 398 CLSRDPKARPRMSEVVE 414
           CL++D + RP+ ++++E
Sbjct: 267 CLTKDHRKRPKYNKLLE 283

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 126/300 (42%), Gaps = 46/300 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 2   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 45
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 46  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 105
Query: 235 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
                 +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  A
Sbjct: 106 KFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 160
Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 354
           P   +  +     GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 161 PSSRRXXLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216
Query: 355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 217 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 20  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 73
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 74  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 130
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 131 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 186
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 377
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 187 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 241
Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 242 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 271

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 30/216 (13%)
Query: 198 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAK 252
           HP LV L   C + + RL  V E++  G L  H+ R+  LP      +S  + +AL    
Sbjct: 112 HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN--- 167
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
              +LHE   + +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y
Sbjct: 168 ---YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 219
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRR 370
            APE +         D ++ GV++ EM+ GR   D   +  N + N  ++          
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--------- 270
Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           F  +L+ ++    S+  S KA  +    L++DPK R
Sbjct: 271 FQVILEKQIRIPRSL--SVKAASVLKSFLNKDPKER 304

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 127/300 (42%), Gaps = 46/300 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 2   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 45
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 46  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 105
Query: 235 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
                 +      L  A  L++ H    K VI+RD K  N+LL +    K+++FG +  A
Sbjct: 106 KFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHA 160
Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 354
           P   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 161 PSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216
Query: 355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 217 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + 
Sbjct: 132 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 182
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 46  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 99
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 100 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 156
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 157 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 212
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 377
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 213 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 267
Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 268 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 297

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 130 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 187
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 242
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + 
Sbjct: 125 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 175
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 113/247 (45%), Gaps = 30/247 (12%)
Query: 113 ELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAV 172
           E+ + +Q ++    ++ L+   F  E  LGE  FG V+KG +   G AP +      VA+
Sbjct: 8   EMPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHL--FGPAPGEQTQA--VAI 61
Query: 173 KTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 230
           KTL  D  +G   +E+  E      L HPN+V L+G   +D    +++ +   G L   L
Sbjct: 62  KTLK-DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL 120
Query: 231 FR----------------KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN 274
                             K +L  P  + +   + A  G+ +L   +   V+++D  T N
Sbjct: 121 VMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA--GMEYL---SSHHVVHKDLATRN 175
Query: 275 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGV 334
           +L+    N K+SD GL ++        +    +    + APE +M G  +  SD++S+GV
Sbjct: 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 235
Query: 335 VLLEMLT 341
           VL E+ +
Sbjct: 236 VLWEVFS 242

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++             +A+K L    L+      +  
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRK---------FILALKVLFKAQLEKAGVEHQLR 53
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 54  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 113
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     
Sbjct: 114 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---- 164
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 165 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 216
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 217 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 253

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 1   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 44
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 45  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 233 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
                   +      L  A  L++ H    K VI+RD K  N+LL +    K+++FG + 
Sbjct: 105 LSKFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSV 159
Query: 293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 352
            AP   +T +     GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 160 HAPSSRRTTLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215
Query: 353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 216 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 413 VE 414
           +E
Sbjct: 258 LE 259

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 119/286 (41%), Gaps = 40/286 (13%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----- 188
           +F+  +LLG+G F  V++              TGL VA+K ++   +  +K  +      
Sbjct: 12  DFKVGNLLGKGSFAGVYRAE---------SIHTGLEVAIKMIDKKAM--YKAGMVQRVQN 60
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           EV     L HP++++L  Y  + +   LV E    G +  +L  +   P   +       
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMH 119
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
               G+ +LH      +++RD   SN+LL  + N K++DFGLA       + H +  + G
Sbjct: 120 QIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCG 174
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
           T  Y +PE         +SDV+S G +   +L GR   D +      N V  A       
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------- 227
Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                  D  +    SI    +A  L  Q L R+P  R  +S V++
Sbjct: 228 -------DYEMPSFLSI----EAKDLIHQLLRRNPADRLSLSSVLD 262

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
           +KL   +F    +LG+G FG VF         A  K  T    A+K L  D +    +  
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVF--------LAEFK-KTNQFFAIKALKKDVVLMDDD-- 61
Query: 188 AEVNFLGNLL------HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 241
            E   +   +      HP L  +       +    V E++  G L  H+  +       S
Sbjct: 62  VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLS 119
Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKT 300
                A     GL FLH    K ++YRD K  NILLD D + K++DFG+ K+    D KT
Sbjct: 120 RATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 176
Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           +      GT  Y APE ++        D +SFGV+L EML G+
Sbjct: 177 N---EFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 15  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 69  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 125
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 126 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 181
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 377
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 182 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236
Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 237 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 198 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
           HP LV L   C + + RL  V E++  G L  H+ R+  LP   +      +  A  L +
Sbjct: 80  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNY 136
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           LHE   + +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y APE
Sbjct: 137 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPE 191
Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRL 374
            +         D ++ GV++ EM+ GR   D   +  N + N  ++          F  +
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVI 242
Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           L+ ++    S+  S KA  +    L++DPK R
Sbjct: 243 LEKQIRIPRSM--SVKAASVLKSFLNKDPKER 272

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 72  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 128
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 129 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 184
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 377
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 239
Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 240 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 198 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
           HP LV L   C + + RL  V E++  G L  H+ R+  LP   +      +  A  L +
Sbjct: 69  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNY 125
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           LHE     +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y APE
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPE 180
Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRL 374
            +         D ++ GV++ EM+ GR   D   +  N + N  ++          F  +
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVI 231
Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           L+ ++    S+  S KA  +    L++DPK R
Sbjct: 232 LEKQIRIPRSL--SVKAASVLKSFLNKDPKER 261

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 123/291 (42%), Gaps = 34/291 (11%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLL 197
           L+GEG +G V K   ++         TG  VA+K    + D     K  + E+  L  L 
Sbjct: 32  LVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIRMKIALGAAKGLAF 256
           H NLV L+  C +  +  LV+EF+    L++  LF  G   L + +  K       G+ F
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGF 139
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
            H      +I+RD K  NIL+      KL DFG A+     G+ +     + T  Y APE
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRAPE 194
Query: 317 YVMTGHLTSKS-DVYSFGVVLLEMLTGRRSM--DKNRPNGEH------NLVEWARPHLGD 367
            ++      K+ DV++ G ++ EM  G      D +     H      NL+   +     
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 368 KRRFYRLLDPRLEGHFSI-----KGSQKATQLAAQCLSRDPKARPRMSEVV 413
              F  +  P ++    +     K S+    LA +CL  DP  RP  +E++
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 21/236 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 32  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 137
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             K  ++RD    N L++     K+SDFGL++   +D +T  S        ++ PE +M 
Sbjct: 138 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS-SVGSKFPVRWSPPEVLMY 195
Query: 321 GHLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 371
              +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 251

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 197
           +G G FG V+      N            VA+K +++ G Q +++W   + EV FL  L 
Sbjct: 62  IGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           HPN ++  G  + +    LV E+   GS  + L      PL       +  GA +GLA+L
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKTHVSTRVMGTYGYAAPE 316
           H      +I+RD K  NILL      KL DFG A   AP       +   +GT  + APE
Sbjct: 171 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPE 220
Query: 317 YVMT---GHLTSKSDVYSFGVVLLEM 339
            ++    G    K DV+S G+  +E+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 198 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
           HP LV L   C + + RL  V E++  G L  H+ R+  LP   +      +  A  L +
Sbjct: 65  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNY 121
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           LHE   + +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y APE
Sbjct: 122 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPE 176
Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRL 374
            +         D ++ GV++ EM+ GR   D   +  N + N  ++          F  +
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVI 227
Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           L+ ++    S+  S KA  +    L++DPK R
Sbjct: 228 LEKQIRIPRSL--SVKAASVLKSFLNKDPKER 257

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 101/229 (44%), Gaps = 26/229 (11%)
Query: 121 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT-LNHDG 179
           RKF  +D  +     RP   LG+G FG V+    ++N     K    L V  K+ L  +G
Sbjct: 9   RKFTIDDFDIV----RP---LGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEG 56
Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
           ++   +   E+    +L HPN++++  Y  +  +  L+ EF PRG L   L + G     
Sbjct: 57  VE--HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ 114
Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
            S      L  A     LH   E+ VI+RD K  N+L+      K++DFG +  AP    
Sbjct: 115 RSATFMEELADA-----LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--- 166
Query: 300 THVSTRVM-GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 347
             +  R M GT  Y  PE +       K D++  GV+  E L G    D
Sbjct: 167 --LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 126/300 (42%), Gaps = 46/300 (15%)
Query: 118 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 1   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 44
Query: 178 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 234
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 45  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104
Query: 235 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
                 +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  A
Sbjct: 105 KFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159
Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 354
           P   +      + GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 160 PSSRR----DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215
Query: 355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 216 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 123/282 (43%), Gaps = 33/282 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 398 IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 452 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLE 508
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  ++RD    N+L+ A    KL DFGL++   ED   + +++      + APE +
Sbjct: 509 S---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 564
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 377
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619
Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 620 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 123/282 (43%), Gaps = 33/282 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 72  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLE 128
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  ++RD    N+L+ A    KL DFGL++   ED   + +++      + APE +
Sbjct: 129 S---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 184
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 377
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 239
Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 240 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 59
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     
Sbjct: 120 L--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC---- 170
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 222
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 223 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 189
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           ++ L  L HPN+VKL+     +++  LV+E +    L+  +       +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQ 110
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 101/229 (44%), Gaps = 26/229 (11%)
Query: 121 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT-LNHDG 179
           RKF  +D  +     RP   LG+G FG V+    ++N     K    L V  K+ L  +G
Sbjct: 10  RKFTIDDFDIG----RP---LGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEG 57
Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
           ++   +   E+    +L HPN++++  Y  +  +  L+ EF PRG L   L + G     
Sbjct: 58  VE--HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ 115
Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
            S      L  A     LH   E+ VI+RD K  N+L+      K++DFG +  AP    
Sbjct: 116 RSATFMEELADA-----LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--- 167
Query: 300 THVSTRVM-GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 347
             +  R M GT  Y  PE +       K D++  GV+  E L G    D
Sbjct: 168 --LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 398 IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 452 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLE 508
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 509 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 564
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 377
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619
Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 620 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     
Sbjct: 117 L--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---- 167
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 197
           +G G FG V+      N            VA+K +++ G Q +++W   + EV FL  L 
Sbjct: 23  IGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           HPN ++  G  + +    LV E+   GS  + L      PL       +  GA +GLA+L
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKTHVSTRVMGTYGYAAPE 316
           H      +I+RD K  NILL      KL DFG A   AP       +   +GT  + APE
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPE 181
Query: 317 YVMT---GHLTSKSDVYSFGVVLLEM 339
            ++    G    K DV+S G+  +E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 59
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     
Sbjct: 120 L--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC---- 170
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 222
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 223 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 187
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     
Sbjct: 117 L--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC---- 167
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 186
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E++ L  L HPN+VKL+     +++  LV+E + +  L+  +       +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSY 111
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 21/236 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 16  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 64
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 65  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 121
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M 
Sbjct: 122 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMY 179
Query: 321 GHLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 371
              +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 235

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 72  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 128
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 129 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 184
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 377
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 239
Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 240 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 127/302 (42%), Gaps = 46/302 (15%)
Query: 116 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 175
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 1   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 44
Query: 176 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 45  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 233 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
                   +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG + 
Sbjct: 105 LSKFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 159
Query: 293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 352
            AP   +  +     GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 160 HAPSSRRXXLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215
Query: 353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 216 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 413 VE 414
           +E
Sbjct: 258 LE 259

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 114/245 (46%), Gaps = 36/245 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 188
           N++    LGEG FG V   +            TG  VA+K +N   L     QG  E   
Sbjct: 15  NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 63
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           E+++L  L HP+++KL       D+ ++V E+     L +++ ++  +    + R    +
Sbjct: 64  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQI 122
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
            +A      H+     +++RD K  N+LLD   N K++DFGL+    +      S    G
Sbjct: 123 ISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---G 174
Query: 309 TYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLV 358
           +  YAAPE V++G L +  + DV+S GV+L  ML  R   D        KN  NG + L 
Sbjct: 175 SPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP 233
Query: 359 EWARP 363
           ++  P
Sbjct: 234 KFLSP 238

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 21/236 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 12  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 60
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M 
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMY 175
Query: 321 GHLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 371
              +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 231

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 38/293 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 17  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 65
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 122
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M 
Sbjct: 123 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMY 180
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
              +SKSD+++FGV++ E+ +  +   +   N E         H+    R YR   P L 
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL- 230
Query: 381 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQ 433
                  S+K   +   C       RP    +      L N+ D+   + Y Q
Sbjct: 231 ------ASEKVYTIMYSCWHEKADERPTFKIL------LSNILDVMDENLYGQ 271

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 114/245 (46%), Gaps = 36/245 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 188
           N++    LGEG FG V   +            TG  VA+K +N   L     QG  E   
Sbjct: 5   NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 53
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           E+++L  L HP+++KL       D+ ++V E+     L +++ ++  +    + R    +
Sbjct: 54  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQI 112
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
            +A      H+     +++RD K  N+LLD   N K++DFGL+    +      S    G
Sbjct: 113 ISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---G 164
Query: 309 TYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLV 358
           +  YAAPE V++G L +  + DV+S GV+L  ML  R   D        KN  NG + L 
Sbjct: 165 SPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP 223
Query: 359 EWARP 363
           ++  P
Sbjct: 224 KFLSP 228

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 114/245 (46%), Gaps = 36/245 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 188
           N++    LGEG FG V   +            TG  VA+K +N   L     QG  E   
Sbjct: 14  NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 62
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           E+++L  L HP+++KL       D+ ++V E+     L +++ ++  +    + R    +
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQI 121
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
            +A      H+     +++RD K  N+LLD   N K++DFGL+    +      S    G
Sbjct: 122 ISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---G 173
Query: 309 TYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLV 358
           +  YAAPE V++G L +  + DV+S GV+L  ML  R   D        KN  NG + L 
Sbjct: 174 SPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP 232
Query: 359 EWARP 363
           ++  P
Sbjct: 233 KFLSP 237

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 96/219 (43%), Gaps = 22/219 (10%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           +L   NF    +LG+G FG V    V+E         TG   AVK L  D +    +   
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVEC 69
Query: 187 -LAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
            + E   L     HP L +L       D+   V EF+  G L  H+ +          R 
Sbjct: 70  TMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARA 126
Query: 245 KI-ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           +  A      L FLH+   K +IYRD K  N+LLD + + KL+DFG+ K+   +G T  +
Sbjct: 127 RFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--T 181
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
               GT  Y APE +         D ++ GV+L EML G
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG +G V+K   +E         TG  VA+K +  +     +E + E++ +     P+
Sbjct: 37  LGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPH 85
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +VK  G   ++    +V E+   GS+ + + R  +  L       I     KGL +LH  
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
            +   I+RD K  NILL+ + +AKL+DFG+A    +         V+GT  + APE +  
Sbjct: 145 RK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKR--NXVIGTPFWMAPEVIQE 199
Query: 321 GHLTSKSDVYSFGVVLLEMLTGR 343
                 +D++S G+  +EM  G+
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 188
           +L   +F   S LG G  G V K     +G    +    L +     N        + + 
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRN--------QIIR 63
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           E+  L     P +V   G    D +  +  E M  GSL+  L  K +  +P  I  K+++
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSI 121
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
              +GLA+L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +G
Sbjct: 122 AVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVG 175
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           T  Y APE +   H + +SD++S G+ L+E+  GR
Sbjct: 176 TRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/326 (24%), Positives = 141/326 (43%), Gaps = 57/326 (17%)
Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGH 183
           +ND+K        + ++GEG FG V K  ++       K G  +  A+K +  +     H
Sbjct: 21  WNDIKF-------QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDH 66
Query: 184 KEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL------ 236
           +++  E+  L  L  HPN++ L+G C       L  E+ P G+L + L +   L      
Sbjct: 67  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 126
Query: 237 --------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF 288
                    L     +  A   A+G+ +L   ++K  I+R+    NIL+  +Y AK++DF
Sbjct: 127 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADF 183
Query: 289 GLAKDAPEDGKTHVSTRVMGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 346
           GL++     G+     + MG     + A E +     T+ SDV+S+GV+L E++    S+
Sbjct: 184 GLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SL 234
Query: 347 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
                 G      + +   G     YRL  P       +    +   L  QC    P  R
Sbjct: 235 GGTPYCGMTCAELYEKLPQG-----YRLEKP-------LNCDDEVYDLMRQCWREKPYER 282
Query: 407 PRMSEVVETL-KPLQNLKDMASSSYY 431
           P  ++++ +L + L+  K   +++ Y
Sbjct: 283 PSFAQILVSLNRMLEERKTYVNTTLY 308

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 21/236 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 32  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 137
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M 
Sbjct: 138 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMY 195
Query: 321 GHLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 371
              +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 251

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 123/282 (43%), Gaps = 33/282 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 72  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLE 128
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               K  ++RD    N+L+ ++   KL DFGL++   ED     +++      + APE +
Sbjct: 129 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLPIKWMAPESI 184
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 377
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 239
Query: 378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 240 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 114/245 (46%), Gaps = 36/245 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 188
           N++    LGEG FG V   +            TG  VA+K +N   L     QG  E   
Sbjct: 9   NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 57
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           E+++L  L HP+++KL       D+ ++V E+     L +++ ++  +    + R    +
Sbjct: 58  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQI 116
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
            +A      H+     +++RD K  N+LLD   N K++DFGL+    +      S    G
Sbjct: 117 ISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---G 168
Query: 309 TYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLV 358
           +  YAAPE V++G L +  + DV+S GV+L  ML  R   D        KN  NG + L 
Sbjct: 169 SPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP 227
Query: 359 EWARP 363
           ++  P
Sbjct: 228 KFLSP 232

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
           +KL   +F    +LG+G FG VF    ++         T    A+K L  D +    +  
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDD-- 60
Query: 188 AEVNFLGNLL------HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 241
            E   +   +      HP L  +       +    V E++  G L  H+  +       S
Sbjct: 61  VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLS 118
Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKT 300
                A     GL FLH    K ++YRD K  NILLD D + K++DFG+ K+    D KT
Sbjct: 119 RATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175
Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           +      GT  Y APE ++        D +SFGV+L EML G+
Sbjct: 176 N---XFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 21/236 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 23  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 71
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 72  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 128
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
             K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M 
Sbjct: 129 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMY 186
Query: 321 GHLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 371
              +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 242

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 112/239 (46%), Gaps = 27/239 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 17  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 65
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 122
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAPEY 317
             K  ++RD    N L++     K+SDFGL++   +D  T  S+R  G+     ++ PE 
Sbjct: 123 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSR--GSKFPVRWSPPEV 177
Query: 318 VMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 371
           +M    +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 236

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 128/297 (43%), Gaps = 43/297 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNF 192
           ++  + ++G G    V   +      AP K      VA+K +N +  Q    E L E+  
Sbjct: 16  DYELQEVIGSGATAVVQAAY-----CAPKKE----KVAIKRINLEKCQTSMDELLKEIQA 66
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN---HLFRKG---SLPLPWSIRMKI 246
           +    HPN+V      +  D+  LV + +  GS+ +   H+  KG   S  L  S    I
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG---KTHVS 303
                +GL +LH+  +   I+RD K  NILL  D + +++DFG++      G   +  V 
Sbjct: 127 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 304 TRVMGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
              +GT  + APE +  + G+   K+D++SFG+  +E+ TG     K  P     L    
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT-----QLAAQCLSRDPKARPRMSEVV 413
            P             P LE     K   K       ++ + CL +DP+ RP  +E++
Sbjct: 243 DP-------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 128/297 (43%), Gaps = 43/297 (14%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNF 192
           ++  + ++G G    V   +      AP K      VA+K +N +  Q    E L E+  
Sbjct: 11  DYELQEVIGSGATAVVQAAY-----CAPKKE----KVAIKRINLEKCQTSMDELLKEIQA 61
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN---HLFRKG---SLPLPWSIRMKI 246
           +    HPN+V      +  D+  LV + +  GS+ +   H+  KG   S  L  S    I
Sbjct: 62  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 121
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG---KTHVS 303
                +GL +LH+  +   I+RD K  NILL  D + +++DFG++      G   +  V 
Sbjct: 122 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 178
Query: 304 TRVMGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
              +GT  + APE +  + G+   K+D++SFG+  +E+ TG     K  P     L    
Sbjct: 179 KTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 237
Query: 362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT-----QLAAQCLSRDPKARPRMSEVV 413
            P             P LE     K   K       ++ + CL +DP+ RP  +E++
Sbjct: 238 DP-------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 23/214 (10%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLL 197
           LG G FG V  G  E          TG  VAVK LN   ++      +   E+  L    
Sbjct: 24  LGVGTFGKVKVGKHE---------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           HP+++KL           +V E++  G L +++ + G L    S R+   + +  G+ + 
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GVDYC 132
Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 317
           H      V++RD K  N+LLDA  NAK++DFGL+ +   DG+    +   G+  YAAPE 
Sbjct: 133 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRXS--CGSPNYAAPE- 185
Query: 318 VMTGHLTS--KSDVYSFGVVLLEMLTGRRSMDKN 349
           V++G L +  + D++S GV+L  +L G    D +
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 113/228 (49%), Gaps = 46/228 (20%)
Query: 144 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNL 201
           G FGCV+K  +  +            VAVK      LQ  + W +E        + H NL
Sbjct: 26  GRFGCVWKAQLMND-----------FVAVKIFP---LQDKQSWQSEREIFSTPGMKHENL 71
Query: 202 VKLV-----GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
           ++ +     G  +E  +  L+  F  +GSL ++L  KG++ + W+    +A   ++GL++
Sbjct: 72  LQFIAAEKRGSNLEV-ELWLITAFHDKGSLTDYL--KGNI-ITWNELCHVAETMSRGLSY 127
Query: 257 LHE-------EAEKPVI-YRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTR 305
           LHE       E  KP I +RDFK+ N+LL +D  A L+DFGLA   +     G TH    
Sbjct: 128 LHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ-- 185
Query: 306 VMGTYGYAAPEYVMTGHLTSKS------DVYSFGVVLLEMLTGRRSMD 347
            +GT  Y APE V+ G +  +       D+Y+ G+VL E+++  ++ D
Sbjct: 186 -VGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 37/276 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG V+KG   +N T  V       VA+K ++  +     ++   E+  L     P
Sbjct: 27  IGKGSFGEVYKGI--DNHTKEV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 77
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            + +  G  ++  +  ++ E++  GS  + L + G  PL  +    I     KGL +LH 
Sbjct: 78  YITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPG--PLEETYIATILREILKGLDYLHS 134
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRVMGTYGYAAPEYV 318
           E +   I+RD K +N+LL    + KL+DFG+A    +   T +     +GT  + APE +
Sbjct: 135 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVI 188
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 378
                  K+D++S G+  +E+  G        P     L+    P             P 
Sbjct: 189 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PT 235
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           LEG    + S+   +    CL++DP+ RP   E+++
Sbjct: 236 LEG----QHSKPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 17/222 (7%)
Query: 122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 181
           K ++ D KL T     +  LG G FG V KG+ +      V     + +     N   L+
Sbjct: 361 KEVYLDRKLLTLE---DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK 414
Query: 182 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 241
              E LAE N +  L +P +V+++G C E +  +LV E    G L  +L +   +     
Sbjct: 415 --DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI 471
Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 301
           I  ++    + G+ +L E      ++RD    N+LL   + AK+SDFGL+K    D + +
Sbjct: 472 I--ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENY 525
Query: 302 VSTRVMGTY--GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
              +  G +   + APE +     +SKSDV+SFGV++ E  +
Sbjct: 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 17/222 (7%)
Query: 122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 181
           K ++ D KL T     +  LG G FG V KG+ +      V     + +     N   L+
Sbjct: 362 KEVYLDRKLLTLE---DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK 415
Query: 182 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 241
              E LAE N +  L +P +V+++G C E +  +LV E    G L  +L +   +     
Sbjct: 416 --DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI 472
Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 301
           I  ++    + G+ +L E      ++RD    N+LL   + AK+SDFGL+K    D + +
Sbjct: 473 I--ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENY 526
Query: 302 VSTRVMGTY--GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
              +  G +   + APE +     +SKSDV+SFGV++ E  +
Sbjct: 527 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 30/235 (12%)
Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-- 182
             ++ L+   F  E  LGE  FG V+KG +   G AP +      VA+KTL  D  +G  
Sbjct: 3   LKEISLSAVRFMEE--LGEDRFGKVYKGHL--FGPAPGEQTQA--VAIKTLK-DKAEGPL 55
Query: 183 HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---------- 232
            +E+  E      L HPN+V L+G   +D    +++ +   G L   L            
Sbjct: 56  REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 233 ------KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 286
                 K +L  P  + +   + A  G+ +L   +   V+++D  T N+L+    N K+S
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAA--GMEYL---SSHHVVHKDLATRNVLVYDKLNVKIS 170
Query: 287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           D GL ++        +    +    + APE +M G  +  SD++S+GVVL E+ +
Sbjct: 171 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAEVNFLGNL 196
           +GEG +G V+K           K   G  VA+K +  D    G+      + E++ L  L
Sbjct: 29  VGEGTYGVVYKA----------KDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKEL 76
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL-GAAKGLA 255
            HPN+V L+     +    LV+EFM +   +     K  L      ++KI L    +G+A
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ---DSQIKIYLYQLLRGVA 133
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 313
             H+     +++RD K  N+L+++D   KL+DFGLA+    P    TH       T  Y 
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYR 186
Query: 314 APEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
           AP+ +M     S S D++S G +  EM+TG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAEVNFLGNL 196
           +GEG +G V+K           K   G  VA+K +  D    G+      + E++ L  L
Sbjct: 29  VGEGTYGVVYKA----------KDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKEL 76
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL-GAAKGLA 255
            HPN+V L+     +    LV+EFM +   +     K  L      ++KI L    +G+A
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ---DSQIKIYLYQLLRGVA 133
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 313
             H+     +++RD K  N+L+++D   KL+DFGLA+    P    TH       T  Y 
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYR 186
Query: 314 APEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
           AP+ +M     S S D++S G +  EM+TG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 119/284 (41%), Gaps = 52/284 (18%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 159 IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 209
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 254
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 210 VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLQAL 260
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG----LAKDAPEDGKTHVSTRVMGTY 310
           + LH +    VI+RD K+ +ILL  D   KLSDFG    ++K+ P          ++GT 
Sbjct: 261 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTP 311
Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 370
            + APE +       + D++S G++++EM+ G                 +  P L   + 
Sbjct: 312 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKM 358
Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
               L PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 359 IRDNLPPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 400

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 33  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 87
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 88  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEES 144
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 318
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 145 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 200
Query: 319 MTGHLTSKSDVYSFGVVLLEMLT 341
                +SKSDV+SFGV++ E  +
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 35  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 89
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 90  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEES 146
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 318
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 202
Query: 319 MTGHLTSKSDVYSFGVVLLEMLT 341
                +SKSDV+SFGV++ E  +
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 35  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 89
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 90  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEES 146
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 318
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 202
Query: 319 MTGHLTSKSDVYSFGVVLLEMLT 341
                +SKSDV+SFGV++ E  +
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 256
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF 131
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 315
           LH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPYWMAP 185
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           E V       K D++S G++ +EM+ G 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 25  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 79
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 80  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEE- 135
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 318
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 136 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 192
Query: 319 MTGHLTSKSDVYSFGVVLLEMLT 341
                +SKSDV+SFGV++ E  +
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHP 199
           LG G FG V +G               + VA+K L     +   +E + E   +  L +P
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            +V+L+G C + +  +LV E    G L   L  K    +P S   ++    + G+ +L E
Sbjct: 71  YIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEE 128
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEY 317
              K  ++RD    N+LL   + AK+SDFGL+K    D  ++ + R  G +   + APE 
Sbjct: 129 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPEC 184
Query: 318 VMTGHLTSKSDVYSFGVVLLEMLT 341
           +     +S+SDV+S+GV + E L+
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 19  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 73
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEE- 129
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 318
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 130 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 186
Query: 319 MTGHLTSKSDVYSFGVVLLEMLT 341
                +SKSDV+SFGV++ E  +
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 13  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 67
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 68  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEE- 123
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 318
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 124 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 180
Query: 319 MTGHLTSKSDVYSFGVVLLEMLT 341
                +SKSDV+SFGV++ E  +
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 25/238 (10%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGH 183
           ++ L   +F    ++G GGFG V+            K  TG   A+K L+   +   QG 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGE 233
Query: 184 KEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 240
              L E   L  +   +   +  + Y      +L  + + M  G L  HL + G      
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--- 290
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
                +   AA+ +  L     + V+YRD K +NILLD   + ++SD GLA D  +  K 
Sbjct: 291 --EADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KP 347
Query: 301 HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
           H S   +GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 348 HAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 25/238 (10%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGH 183
           ++ L   +F    ++G GGFG V+            K  TG   A+K L+   +   QG 
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGE 232
Query: 184 KEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 240
              L E   L  +   +   +  + Y      +L  + + M  G L  HL + G      
Sbjct: 233 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--- 289
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
                +   AA+ +  L     + V+YRD K +NILLD   + ++SD GLA D  +  K 
Sbjct: 290 --EADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KP 346
Query: 301 HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
           H S   +GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 347 HAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 12/218 (5%)
Query: 124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           M  D+K   + +     LGEG F  V+K    +  T  +     + +  ++   DG+  +
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGI--N 56
Query: 184 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR 243
           +  L E+  L  L HPN++ L+          LV++FM    LE  + +  SL L  S  
Sbjct: 57  RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEV-IIKDNSLVLTPSHI 114
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
               L   +GL +LH+     +++RD K +N+LLD +   KL+DFGLAK      + +  
Sbjct: 115 KAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXH 171
Query: 304 TRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEML 340
             V  T  Y APE +    +     D+++ G +L E+L
Sbjct: 172 QVV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 29  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 256
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF 132
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 315
           LH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 133 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAP 186
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           E V       K D++S G++ +EM+ G 
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           LG GGFG V + W+ ++        TG  VA+K    +    ++E W  E+  +  L HP
Sbjct: 23  LGTGGFGYVLR-WIHQD--------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 73
Query: 200 NLVKL------VGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIALGAA 251
           N+V        +     +D  LL  E+   G L  +L  F          IR  ++   +
Sbjct: 74  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DIS 132
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             L +LHE     +I+RD K  NI+L         K+ D G AK   E  +  + T  +G
Sbjct: 133 SALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVG 186
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
           T  Y APE +     T   D +SFG +  E +TG R
Sbjct: 187 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 256
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF 131
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 315
           LH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAP 185
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           E V       K D++S G++ +EM+ G 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 256
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF 131
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 315
           LH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAP 185
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           E V       K D++S G++ +EM+ G 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 25/238 (10%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGH 183
           ++ L   +F    ++G GGFG V+            K  TG   A+K L+   +   QG 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGE 233
Query: 184 KEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 240
              L E   L  +   +   +  + Y      +L  + + M  G L  HL + G      
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--- 290
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
                +   AA+ +  L     + V+YRD K +NILLD   + ++SD GLA D  +  K 
Sbjct: 291 --EADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KP 347
Query: 301 HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
           H S   +GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 348 HAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 25/238 (10%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGH 183
           ++ L   +F    ++G GGFG V+            K  TG   A+K L+   +   QG 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGE 233
Query: 184 KEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 240
              L E   L  +   +   +  + Y      +L  + + M  G L  HL + G      
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--- 290
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
                +   AA+ +  L     + V+YRD K +NILLD   + ++SD GLA D  +  K 
Sbjct: 291 --EADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KP 347
Query: 301 HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
           H S   +GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 348 HAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 199
           LG GGFG V + W+ ++        TG  VA+K    +    ++E W  E+  +  L HP
Sbjct: 22  LGTGGFGYVLR-WIHQD--------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 200 NLVKL------VGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIALGAA 251
           N+V        +     +D  LL  E+   G L  +L  F          IR  ++   +
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DIS 131
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             L +LHE     +I+RD K  NI+L         K+ D G AK   E  +  + T  +G
Sbjct: 132 SALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVG 185
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
           T  Y APE +     T   D +SFG +  E +TG R
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 15  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 69
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 70  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEE- 125
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 318
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 126 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 182
Query: 319 MTGHLTSKSDVYSFGVVLLEMLT 341
                +SKSDV+SFGV++ E  +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 131/303 (43%), Gaps = 40/303 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG VFKG   +N T  V       VA+K ++  +     ++   E+  L      
Sbjct: 31  IGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSS 81
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKGLAFLH 258
            + K  G  ++  +  ++ E++  GS  + L R G       +  +K  L   KGL +LH
Sbjct: 82  YVTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEIL---KGLDYLH 137
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
            E +   I+RD K +N+LL    + KL+DFG+A     D +   +T V GT  + APE +
Sbjct: 138 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVI 192
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 378
                 SK+D++S G+  +E+  G        P     L+    P             P 
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------------PT 239
Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQAD 438
           L G F    ++   +    CL++DP  RP   E+   LK    +K+   +SY  + +   
Sbjct: 240 LVGDF----TKSFKEFIDACLNKDPSFRPTAKEL---LKHKFIVKNSKKTSYLTELIDRF 292
Query: 439 NTW 441
             W
Sbjct: 293 KRW 295

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT-LNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V+     ++     K    L V  KT L   G++   +   EV    +L HP
Sbjct: 20  LGKGKFGNVYLARERQS-----KFILALKVLFKTQLEKAGVE--HQLRREVEIQSHLRHP 72
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+++L GY  +  +  L+ E+ P G++   L +        +      L  A  L++ H 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL--ANALSYCHS 130
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
              K VI+RD K  N+LL ++   K++DFG +  AP   +    T + GT  Y  PE + 
Sbjct: 131 ---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIE 183
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
                 K D++S GV+  E L G
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 44/280 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 82  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 132
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 254
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLQAL 183
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           + LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + A
Sbjct: 184 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMA 238
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 374
           PE +       + D++S G++++EM+ G                 +  P L   +     
Sbjct: 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDN 285
Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           L PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 286 LPPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 323

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 37/212 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V             +  TG  VAVK ++    Q  +    EV  + +  H N
Sbjct: 53  IGEGSTGIV---------CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDN 103
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 254
           +V +    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIATVCLSVLRAL 154
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG----LAKDAPEDGKTHVSTRVMGTY 310
           ++LH +    VI+RD K+ +ILL +D   KLSDFG    ++K+ P+         ++GT 
Sbjct: 155 SYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------RKXLVGTP 205
Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            + APE +      ++ D++S G++++EM+ G
Sbjct: 206 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG GGFG VF   ++  G              K   + G    K+ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIALGAAKGL 254
             +  + Y  E    L LV   M  G +  H++           P +I     +    GL
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGL 302
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
             LH+   + +IYRD K  N+LLD D N ++SD GLA +  + G+T       GT G+ A
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYA-GTPGFMA 357
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           PE ++        D ++ GV L EM+  R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/312 (24%), Positives = 134/312 (42%), Gaps = 40/312 (12%)
Query: 112 EELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 171
           + L ++ +L++    D+ +  + F    +LG+G FG V +  +++      + G+ + VA
Sbjct: 3   DSLGISDELKE-KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQ------EDGSFVKVA 55
Query: 172 VKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR------LLVYEFMPR 223
           VK L  D +     +E+L E   +    HP++ KLVG  +    +      +++  FM  
Sbjct: 56  VKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKH 115
Query: 224 GSLENHLF--RKGSLP--LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 279
           G L   L   R G  P  LP    ++  +  A G+ +L   + +  I+RD    N +L  
Sbjct: 116 GDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAE 172
Query: 280 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 339
           D    ++DFGL++                   + A E +     T  SDV++FGV + E+
Sbjct: 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232
Query: 340 LTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQC 398
           +T  ++      N E +N +      +G      RL  P        +  ++   L  QC
Sbjct: 233 MTRGQTPYAGIENAEIYNYL------IGGN----RLKQPP-------ECMEEVYDLMYQC 275
Query: 399 LSRDPKARPRMS 410
            S DPK RP  +
Sbjct: 276 WSADPKQRPSFT 287

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG GGFG VF   ++  G              K   + G    K+ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIALGAAKGL 254
             +  + Y  E    L LV   M  G +  H++           P +I     +    GL
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGL 302
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
             LH+   + +IYRD K  N+LLD D N ++SD GLA +  + G+T       GT G+ A
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYA-GTPGFMA 357
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           PE ++        D ++ GV L EM+  R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 19  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 73
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEE- 129
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH-VSTRVMGTYGYAAPEYVM 319
                ++RD    N+LL   + AK+SDFGL+K    D   +   T       + APE + 
Sbjct: 130 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECIN 187
Query: 320 TGHLTSKSDVYSFGVVLLEMLT 341
               +SKSDV+SFGV++ E  +
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG GGFG VF   ++  G              K   + G    K+ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIALGAAKGL 254
             +  + Y  E    L LV   M  G +  H++           P +I     +    GL
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGL 302
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
             LH+   + +IYRD K  N+LLD D N ++SD GLA +  + G+T       GT G+ A
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYA-GTPGFMA 357
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           PE ++        D ++ GV L EM+  R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG GGFG VF   ++  G              K   + G    K+ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIALGAAKGL 254
             +  + Y  E    L LV   M  G +  H++           P +I     +    GL
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGL 302
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
             LH+   + +IYRD K  N+LLD D N ++SD GLA +  + G+T       GT G+ A
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYA-GTPGFMA 357
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           PE ++        D ++ GV L EM+  R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 13  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 121
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 88/191 (46%), Gaps = 23/191 (12%)
Query: 166 TGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VA+K ++   L     ++   EV  +  L HPN+VKL      +    L+ E+   
Sbjct: 36  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 95
Query: 224 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 277
           G + ++L   G        RMK     +K       + + H+   K +++RD K  N+LL
Sbjct: 96  GEVFDYLVAHG--------RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLL 144
Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 336
           DAD N K++DFG + +    GK        G+  YAAPE          + DV+S GV+L
Sbjct: 145 DADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 201
Query: 337 LEMLTGRRSMD 347
             +++G    D
Sbjct: 202 YTLVSGSLPFD 212

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 98/227 (43%), Gaps = 40/227 (17%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPG----TGLTVAVKTLNHDGLQ--GHKEWL 187
           N+R +  +G+G F             A VK      TG  VAVK ++   L     ++  
Sbjct: 16  NYRLQKTIGKGNF-------------AKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV  +  L HPN+VKL      +    LV E+   G + ++L   G        RMK  
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--------RMKEK 114
Query: 248 LGAAK------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 301
              AK       + + H+   K +++RD K  N+LLD D N K++DFG + +     K  
Sbjct: 115 EARAKFRQIVSAVQYCHQ---KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLD 171
Query: 302 VSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMD 347
                 G+  YAAPE          + DV+S GV+L  +++G    D
Sbjct: 172 T---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 44/280 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 37  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 87
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 254
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 88  VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLQAL 138
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           + LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + A
Sbjct: 139 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMA 193
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 374
           PE +       + D++S G++++EM+ G                 +  P L   +     
Sbjct: 194 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDN 240
Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           L PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 241 LPPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 278

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 44/280 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 39  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 89
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 254
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 90  VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLQAL 140
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           + LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + A
Sbjct: 141 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMA 195
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 374
           PE +       + D++S G++++EM+ G                 +  P L   +     
Sbjct: 196 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDN 242
Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           L PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 243 LPPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 280

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHP 199
           LG G FG V +G               + VA+K L     +   +E + E   +  L +P
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 396
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            +V+L+G C + +  +LV E    G L   L  K    +P S   ++    + G+ +L E
Sbjct: 397 YIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEE 454
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEY 317
              K  ++R+    N+LL   + AK+SDFGL+K    D  ++ + R  G +   + APE 
Sbjct: 455 ---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPEC 510
Query: 318 VMTGHLTSKSDVYSFGVVLLEMLT 341
           +     +S+SDV+S+GV + E L+
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG +G V            V   T   VAVK ++    +   +    E+     L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 38/232 (16%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 192
           +F P   LG GGFG VF+   + +             A+K +     +  +E  + EV  
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDC---------NYAIKRIRLPNRELAREKVMREVKA 56
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL--ENHLFRKGSLPLPW---------- 240
           L  L HP +V+     +E +    +    P+  L  +  L RK +L   W          
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLK-DWMNGRCTIEER 115
Query: 241 --SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL--AKDAPE 296
             S+ + I L  A+ + FLH    K +++RD K SNI    D   K+ DFGL  A D  E
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 297 DGKTHVS--------TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
           + +T ++        T  +GT  Y +PE +     + K D++S G++L E+L
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 166 TGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VA+K ++   L     ++   EV  +  L HPN+VKL      +    L+ E+   
Sbjct: 39  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98
Query: 224 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 277
           G + ++L   G        RMK     +K       + + H+   K +++RD K  N+LL
Sbjct: 99  GEVFDYLVAHG--------RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLL 147
Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 336
           DAD N K++DFG + +    GK        G   YAAPE          + DV+S GV+L
Sbjct: 148 DADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
Query: 337 LEMLTGRRSMD 347
             +++G    D
Sbjct: 205 YTLVSGSLPFD 215

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 166 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VAVK ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 224 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 277
           G + ++L   G        RMK     AK       + + H+   K +++RD K  N+LL
Sbjct: 98  GEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLL 146
Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 336
           DAD N K++DFG + +     K        G+  YAAPE          + DV+S GV+L
Sbjct: 147 DADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 337 LEMLTGRRSMD 347
             +++G    D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 73/138 (52%), Gaps = 6/138 (4%)
Query: 216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 275
           +V E++   +L + +  +G  P+     +++   A + L F H+     +I+RD K +NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGV 334
           ++ A    K+ DFG+A+   + G +   T  V+GT  Y +PE      + ++SDVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 335 VLLEMLTGRRSMDKNRPN 352
           VL E+LTG      + P+
Sbjct: 208 VLYEVLTGEPPFTGDSPD 225

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 118/279 (42%), Gaps = 37/279 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNLLHP 199
           LG G FG V    VEE  +       GL   +KT+N D  Q   E + AE+  L +L HP
Sbjct: 30  LGSGAFGDV--HLVEERSS-------GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--PLPWSIRMKIALGAAKGLAFL 257
           N++K+     +     +V E    G L   +    +    L      ++       LA+ 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 258 HEEAEKPVIYRDFKTSNILL-DADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           H +    V+++D K  NIL  D   ++  K+ DFGLA+    D     ST   GT  Y A
Sbjct: 141 HSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMA 194
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 374
           PE V    +T K D++S GVV+  +LTG                 +  P+   +    R 
Sbjct: 195 PE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE---CRP 250
Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
           L P            +A  L  Q L++DP+ RP  ++V+
Sbjct: 251 LTP------------QAVDLLKQMLTKDPERRPSAAQVL 277

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 166 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VAVK ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 224 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 277
           G + ++L   G        RMK     AK       + + H+   K +++RD K  N+LL
Sbjct: 98  GEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLL 146
Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 336
           DAD N K++DFG + +     K        G+  YAAPE          + DV+S GV+L
Sbjct: 147 DADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 337 LEMLTGRRSMD 347
             +++G    D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 17/192 (8%)
Query: 170 VAVKTLNHDGLQGHKEWLA---EVNFLGNLLHPNLVKLVGYCIEDDQR------LLVYEF 220
           VAVK L  D  +    +L    E      L HP +V +  Y   + +        +V E+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV--YATGEAETPAGPLPYIVMEY 97
Query: 221 MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD 280
           +   +L + +  +G  P+     +++   A + L F H+     +I+RD K +NI++ A 
Sbjct: 98  VDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISAT 152
Query: 281 YNAKLSDFGLAKDAPEDGKTHVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 339
              K+ DFG+A+   + G +   T  V+GT  Y +PE      + ++SDVYS G VL E+
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 340 LTGRRSMDKNRP 351
           LTG      + P
Sbjct: 213 LTGEPPFTGDSP 224

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 72/137 (52%), Gaps = 6/137 (4%)
Query: 216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 275
           +V E++   +L + +  +G  P+     +++   A + L F H+     +I+RD K +NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGV 334
           L+ A    K+ DFG+A+   + G +   T  V+GT  Y +PE      + ++SDVYS G 
Sbjct: 148 LISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 335 VLLEMLTGRRSMDKNRP 351
           VL E+LTG      + P
Sbjct: 208 VLYEVLTGEPPFTGDSP 224

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 120/286 (41%), Gaps = 53/286 (18%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           +GEG FG        E+G   V         +K +N   +     +E   EV  L N+ H
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYV---------IKEINISRMSSKEREESRREVAVLANMKH 82
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-------ENHLFRKGSLPLPWSIRMKIALGAA 251
           PN+V+      E+    +V ++   G L       +  LF++  + L W +++ +AL   
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-LDWFVQICLALKHV 141
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
                     ++ +++RD K+ NI L  D   +L DFG+A+    +    ++   +GT  
Sbjct: 142 H---------DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPY 190
Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           Y +PE        +KSD+++ G VL E+ T + + +        NLV             
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLVLKI---------- 237
Query: 372 YRLLDPRLEGHF---SIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                  + G F   S+  S     L +Q   R+P+ RP ++ ++E
Sbjct: 238 -------ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 44/280 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 28  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 254
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLQAL 129
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           + LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + A
Sbjct: 130 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMA 184
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 374
           PE +       + D++S G++++EM+ G                 +  P L   +     
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDN 231
Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           L PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 232 LPPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 269

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 38  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 88
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +C +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 89  DVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 147
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 148 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 86/191 (45%), Gaps = 23/191 (12%)
Query: 166 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VAVK ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 224 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 277
           G + ++L   G        RMK     AK       + + H+   K +++RD K  N+LL
Sbjct: 98  GEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLL 146
Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 336
           DAD N K++DFG + +     K        G   YAAPE          + DV+S GV+L
Sbjct: 147 DADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 337 LEMLTGRRSMD 347
             +++G    D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 29  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 256
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF 132
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 315
           LH      VI+R+ K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 133 LHS---NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAP 186
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           E V       K D++S G++ +EM+ G 
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 44/280 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 32  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 82
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 254
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 83  VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLQAL 133
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           + LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + A
Sbjct: 134 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMA 188
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 374
           PE +       + D++S G++++EM+ G                 +  P L   +     
Sbjct: 189 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDN 235
Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           L PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 236 LPPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 273

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 72/137 (52%), Gaps = 6/137 (4%)
Query: 216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 275
           +V E++   +L + +  +G  P+     +++   A + L F H+     +I+RD K +NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGV 334
           ++ A    K+ DFG+A+   + G +   T  V+GT  Y +PE      + ++SDVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 335 VLLEMLTGRRSMDKNRP 351
           VL E+LTG      + P
Sbjct: 208 VLYEVLTGEPPFTGDSP 224

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 72/137 (52%), Gaps = 6/137 (4%)
Query: 216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 275
           +V E++   +L + +  +G  P+     +++   A + L F H+     +I+RD K +NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGV 334
           ++ A    K+ DFG+A+   + G +   T  V+GT  Y +PE      + ++SDVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 335 VLLEMLTGRRSMDKNRP 351
           VL E+LTG      + P
Sbjct: 208 VLYEVLTGEPPFTGDSP 224

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 166 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VAV+ ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 224 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 277
           G + ++L   G        RMK     AK       + + H+   K +++RD K  N+LL
Sbjct: 98  GEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLL 146
Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 336
           DAD N K++DFG + +     K        G+  YAAPE          + DV+S GV+L
Sbjct: 147 DADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 337 LEMLTGRRSMD 347
             +++G    D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 166 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VAV+ ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 224 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 277
           G + ++L   G        RMK     AK       + + H+   K +++RD K  N+LL
Sbjct: 98  GEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLL 146
Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 336
           DAD N K++DFG + +     K        G+  YAAPE          + DV+S GV+L
Sbjct: 147 DADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 337 LEMLTGRRSMD 347
             +++G    D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT-LNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V+     ++     K    L V  KT L   G++   +   EV    +L HP
Sbjct: 20  LGKGKFGNVYLARERQS-----KFILALKVLFKTQLEKAGVE--HQLRREVEIQSHLRHP 72
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+++L GY  +  +  L+ E+ P G++   L +        +      L  A  L++ H 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL--ANALSYCHS 130
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
              K VI+RD K  N+LL ++   K++DFG +  AP   +      + GT  Y  PE + 
Sbjct: 131 ---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMIE 183
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
                 K D++S GV+  E L G
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 72/137 (52%), Gaps = 6/137 (4%)
Query: 216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 275
           +V E++   +L + +  +G  P+     +++   A + L F H+     +I+RD K +NI
Sbjct: 110 IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 164
Query: 276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGV 334
           ++ A    K+ DFG+A+   + G +   T  V+GT  Y +PE      + ++SDVYS G 
Sbjct: 165 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 224
Query: 335 VLLEMLTGRRSMDKNRP 351
           VL E+LTG      + P
Sbjct: 225 VLYEVLTGEPPFTGDSP 241

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LGEG  G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAAGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 320 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 348
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 31/227 (13%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDGLQGHK 184
           DL++   ++    ++G G FG V    V    T  V     L+    +K  +       +
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW--- 240
           + +A  N       P +V+L  Y  +DD+ L +V E+MP G L N L     +P  W   
Sbjct: 121 DIMAFAN------SPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF 172
Query: 241 -SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
            +  + +AL A   + F+H         RD K  N+LLD   + KL+DFG      ++G 
Sbjct: 173 YTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 300 THVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 342
               T V GT  Y +PE + +    G+   + D +S GV L EML G
Sbjct: 224 VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 37/277 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 28  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 81
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLAF 256
           ++V   G+  ++D   +V E   R SL     R+ +L  P   + +R +I LG      +
Sbjct: 82  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 136
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+   +  + GT  Y APE
Sbjct: 137 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPE 191
Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 192 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 240
Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 241 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 270

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 95/187 (50%), Gaps = 14/187 (7%)
Query: 166 TGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP 222
           TG  VAVK LN   ++      +   E+  L    HP+++KL           +V E++ 
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 223 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN 282
            G L +++ + G +    + R+   + +A      H      V++RD K  N+LLDA  N
Sbjct: 95  GGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM-----VVHRDLKPENVLLDAHMN 149
Query: 283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEML 340
           AK++DFGL+ +   DG+   ++   G+  YAAPE V++G L +  + D++S GV+L  +L
Sbjct: 150 AKIADFGLS-NMMSDGEFLRTS--CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALL 205
Query: 341 TGRRSMD 347
            G    D
Sbjct: 206 CGTLPFD 212

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLL 197
           +LG+G FG V K              T    AVK +N    +       L EV  L  L 
Sbjct: 29  MLGKGSFGEVLKCK---------DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           HPN++KL     +     +V E    G L + + ++       + R  I      G+ ++
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYM 137
Query: 258 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           H+     +++RD K  NILL++   D + K+ DFGL+    ++  T +  R+ GT  Y A
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIA 191
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           PE V+ G    K DV+S GV+L  +L+G
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 136/309 (44%), Gaps = 48/309 (15%)
Query: 144 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLGNLLHPNL 201
           G FGCV+K  +               VAVK      +Q  + W    EV  L  + H N+
Sbjct: 35  GRFGCVWKAQLLNE-----------YVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENI 80
Query: 202 VKLVGY----CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           ++ +G        D    L+  F  +GSL +  F K ++ + W+    IA   A+GLA+L
Sbjct: 81  LQFIGAEKRGTSVDVDLWLITAFHEKGSLSD--FLKANV-VSWNELCHIAETMARGLAYL 137
Query: 258 HEE------AEKPVI-YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VMGT 309
           HE+        KP I +RD K+ N+LL  +  A ++DFGLA    E GK+   T   +GT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF-EAGKSAGDTHGQVGT 196
Query: 310 YGYAAPEYVMTGHLTS------KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL----VE 359
             Y APE V+ G +        + D+Y+ G+VL E+ +  R    + P  E+ L      
Sbjct: 197 RRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS--RCTAADGPVDEYMLPFEEEI 253
Query: 360 WARPHLGDKRR--FYRLLDPRLEGHFSI-KGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
              P L D +    ++   P L  ++    G     +   +C   D +AR     V E +
Sbjct: 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313
Query: 417 KPLQNLKDM 425
             +Q L ++
Sbjct: 314 TQMQRLTNI 322

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 37/277 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 77
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLAF 256
           ++V   G+  ++D   +V E   R SL     R+ +L  P   + +R +I LG      +
Sbjct: 78  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 132
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+   +  + GT  Y APE
Sbjct: 133 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPE 187
Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 236
Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 237 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 266

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 37/277 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 77
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLAF 256
           ++V   G+  ++D   +V E   R SL     R+ +L  P   + +R +I LG      +
Sbjct: 78  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 132
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+   +  + GT  Y APE
Sbjct: 133 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPE 187
Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 236
Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 237 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 266

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 91/181 (50%), Gaps = 16/181 (8%)
Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           +G  VAVK ++    Q  +    EV  + +  H N+V++    +  ++  ++ EF+  G+
Sbjct: 69  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 226 LENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 285
           L + +     + L       +     + LA+LH +    VI+RD K+ +ILL  D   KL
Sbjct: 129 LTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKL 182
Query: 286 SDFG----LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           SDFG    ++KD P+         ++GT  + APE +      ++ D++S G++++EM+ 
Sbjct: 183 SDFGFCAQISKDVPK------RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD 236
Query: 342 G 342
           G
Sbjct: 237 G 237

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 31/227 (13%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDGLQGHK 184
           DL++   ++    ++G G FG V    V    T  V     L+    +K  +       +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW--- 240
           + +A  N       P +V+L  Y  +DD+ L +V E+MP G L N L     +P  W   
Sbjct: 126 DIMAFAN------SPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF 177
Query: 241 -SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
            +  + +AL A   + F+H         RD K  N+LLD   + KL+DFG      ++G 
Sbjct: 178 YTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 300 THVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 342
               T V GT  Y +PE + +    G+   + D +S GV L EML G
Sbjct: 229 VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 31/227 (13%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDGLQGHK 184
           DL++   ++    ++G G FG V    V    T  V     L+    +K  +       +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW--- 240
           + +A  N       P +V+L  Y  +DD+ L +V E+MP G L N L     +P  W   
Sbjct: 126 DIMAFAN------SPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF 177
Query: 241 -SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
            +  + +AL A   + F+H         RD K  N+LLD   + KL+DFG      ++G 
Sbjct: 178 YTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 300 THVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 342
               T V GT  Y +PE + +    G+   + D +S GV L EML G
Sbjct: 229 VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 37/277 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 46  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 99
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLAF 256
           ++V   G+  ++D   +V E   R SL     R+ +L  P   + +R +I LG      +
Sbjct: 100 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 154
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+      + GT  Y APE
Sbjct: 155 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE 209
Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 210 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 258
Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 259 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 288

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 134 NFRPESLLGEGGFGCVF--KGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLA 188
           +F    ++G+G FG V   +   EE           +  AVK L    +   KE    ++
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEE-----------VFYAVKVLQKKAILKKKEEKHIMS 87
Query: 189 EVN-FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI- 246
           E N  L N+ HP LV L       D+   V +++  G L  HL R+     P   R +  
Sbjct: 88  ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFY 144
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           A   A  L +LH      ++YRD K  NILLD+  +  L+DFGL K+  E   T  ++  
Sbjct: 145 AAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTF 199
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            GT  Y APE +         D +  G VL EML G
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 37/277 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 48  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 101
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLAF 256
           ++V   G+  ++D   +V E   R SL     R+ +L  P   + +R +I LG      +
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 156
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+      + GT  Y APE
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE 211
Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 260
Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 261 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 290

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 94/187 (50%), Gaps = 14/187 (7%)
Query: 166 TGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP 222
           TG  VAVK LN   ++      +   E+  L    HP+++KL           +V E++ 
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 223 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN 282
            G L +++ + G +    + R+   + +A      H      V++RD K  N+LLDA  N
Sbjct: 95  GGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM-----VVHRDLKPENVLLDAHMN 149
Query: 283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEML 340
           AK++DFGL+ +   DG+    +   G+  YAAPE V++G L +  + D++S GV+L  +L
Sbjct: 150 AKIADFGLS-NMMSDGEFLRDS--CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALL 205
Query: 341 TGRRSMD 347
            G    D
Sbjct: 206 CGTLPFD 212

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNL 196
            +LG+G FG V K              T    AVK +N    +       L EV  L  L
Sbjct: 28  CMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
            HPN++KL     +     +V E    G L + + ++       + R  I      G+ +
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITY 136
Query: 257 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           +H+     +++RD K  NILL++   D + K+ DFGL+    ++  T +  R+ GT  Y 
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYI 190
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           APE V+ G    K DV+S GV+L  +L+G
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNL 196
            +LG+G FG V K              T    AVK +N    +       L EV  L  L
Sbjct: 28  CMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
            HPN++KL     +     +V E    G L + + ++       + R  I      G+ +
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITY 136
Query: 257 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           +H+     +++RD K  NILL++   D + K+ DFGL+    ++  T +  R+ GT  Y 
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYI 190
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           APE V+ G    K DV+S GV+L  +L+G
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPG----TGLTVAVKTLNHDGLQGH--KEWL 187
           N+R    +G+G F             A VK      TG  VAVK ++   L     ++  
Sbjct: 8   NYRLLKTIGKGNF-------------AKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF 54
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            EV  +  L HPN+VKL      +    LV E+   G + ++L   G     W    +  
Sbjct: 55  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-----WMKEKEAR 109
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
               + ++ +    +K +++RD K  N+LLDAD N K++DFG + +     K        
Sbjct: 110 AKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FC 166
Query: 308 GTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMD 347
           G+  YAAPE          + DV+S GV+L  +++G    D
Sbjct: 167 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F    L+G G +G V+KG         VK  TG   A+K ++  G +  +E   E+N L 
Sbjct: 26  FELVELVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTGDE-EEEIKQEINMLK 75
Query: 195 NLLHP-NLVKLVGYCIE------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
              H  N+    G  I+      DDQ  LV EF   GS+ + +       L       I 
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
               +GL+ LH+     VI+RD K  N+LL  +   KL DFG++  A  D         +
Sbjct: 136 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI 190
Query: 308 GTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEMLTG 342
           GT  + APE +            KSD++S G+  +EM  G
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 37/277 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 22  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 75
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLAF 256
           ++V   G+  ++D   +V E   R SL     R+ +L  P   + +R +I LG      +
Sbjct: 76  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 130
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+      + GT  Y APE
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE 185
Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 234
Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 235 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 264

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLL 197
           LGEG FG V                T   VA+K ++   L+    H     E+++L  L 
Sbjct: 17  LGEGSFGKV---------KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           HP+++KL          ++V E+   G L +++  K  +      R    +  A      
Sbjct: 68  HPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR 126
Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 317
           H+     +++RD K  N+LLD + N K++DFGL+    +      S    G+  YAAPE 
Sbjct: 127 HK-----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE- 177
Query: 318 VMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD 347
           V+ G L +  + DV+S G+VL  ML GR   D
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 181
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 22  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 72
Query: 182 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
               +  L EV  L  L HPN++KL  +  +     LV E    G L + +  +      
Sbjct: 73  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 132
Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPE 296
            + R  I      G+ ++H+     +++RD K  N+LL++   D N ++ DFGL+     
Sbjct: 133 DAAR--IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 187
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             K       +GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 188 SKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 29/224 (12%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA- 188
           +AT  + P + +G G +G V+K            P +G  VA+K++      G    L  
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGGGGGGGLPI 56
Query: 189 ----EVNFLGNLL---HPNLVKLVGYCIED--DQRL---LVYEFMPRGSLENHLFRKGSL 236
               EV  L  L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +    
Sbjct: 57  STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP 115
Query: 237 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 296
            LP      +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+    
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY-- 170
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
                  T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 171 -SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F+ E + G+G FG V  G          +  TG++VA+K +  D    ++E L  +  L 
Sbjct: 25  FQVERMAGQGTFGTVQLGK---------EKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLA 74
Query: 195 NLLHPNLVKLVGYCI---EDDQRLL----VYEFMP---RGSLENHLFRKGSLPLPWSIRM 244
            L HPN+V+L  Y     E D+R +    V E++P        N+ +R+   P P  I++
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY-YRRQVAPPPILIKV 133
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNAKLSDFGLAK--DAPEDGKTH 301
                  + +  LH  +   V +RD K  N+L+ +AD   KL DFG AK     E    +
Sbjct: 134 -FLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 302 VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTG 342
           + +R      Y APE +    H T+  D++S G +  EM+ G
Sbjct: 192 ICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK----E 185
           A + +   + +GEG +G VFK    +NG        G  VA+K +    G +G       
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 60
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPW 240
            +A +  L    HPN+V+L   C       + +  LV+E + +  L  +L +     +P 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
                +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQ 173
Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
              T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 181
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 39  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 89
Query: 182 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
               +  L EV  L  L HPN++KL  +  +     LV E    G L + +  +      
Sbjct: 90  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 149
Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPE 296
            + R  I      G+ ++H+     +++RD K  N+LL++   D N ++ DFGL+     
Sbjct: 150 DAAR--IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 204
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             K       +GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 205 SKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 181
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 40  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 90
Query: 182 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
               +  L EV  L  L HPN++KL  +  +     LV E    G L + +  +      
Sbjct: 91  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 150
Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPE 296
            + R  I      G+ ++H+     +++RD K  N+LL++   D N ++ DFGL+     
Sbjct: 151 DAAR--IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 205
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             K       +GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 206 SKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 75/154 (48%), Gaps = 23/154 (14%)
Query: 199 PNLVKLVGYC-IEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW----SIRMKIALGAAK 252
           P +V+L  +C  +DD+ L +V E+MP G L N L     +P  W    +  + +AL A  
Sbjct: 135 PWVVQL--FCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIH 191
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
            +  +H         RD K  N+LLD   + KL+DFG      E G  H  T V GT  Y
Sbjct: 192 SMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDY 241
Query: 313 AAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 342
            +PE + +    G+   + D +S GV L EML G
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 28/228 (12%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 181
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 66
Query: 182 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
               +  L EV  L  L HPN++KL  +  +     LV E    G L + +  +      
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 126
Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAK--DA 294
            + R  I      G+ ++H+     +++RD K  N+LL++   D N ++ DFGL+   +A
Sbjct: 127 DAAR--IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181
Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            +  K  +     GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 182 SKKMKDKI-----GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 198
            LG+GGF   ++  + +  T  V  G  +  ++    H      KE ++ E+    +L +
Sbjct: 49  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 101
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLA 255
           P++V   G+  +DD   +V E   R SL     R+ ++  P   + +R  I     +G+ 
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 156
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 315
           +LH      VI+RD K  N+ L+ D + K+ DFGLA     DG+      + GT  Y AP
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAP 211
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           E +     + + D++S G +L  +L G+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 10/160 (6%)
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRKGS-----LPLP 239
           ++EVN L  L HPN+V+     I+  +    +V E+   G L + +  KG+     L   
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEE 111
Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
           + +R+   L  A        +    V++RD K +N+ LD   N KL DFGLA+    D  
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-- 169
Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 339
           T  +   +GT  Y +PE +       KSD++S G +L E+
Sbjct: 170 TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 198
            LG+GGF   ++  + +  T  V  G  +  ++    H      KE ++ E+    +L +
Sbjct: 49  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 101
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLA 255
           P++V   G+  +DD   +V E   R SL     R+ ++  P   + +R  I     +G+ 
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 156
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 315
           +LH      VI+RD K  N+ L+ D + K+ DFGLA     DG+   +  + GT  Y AP
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAP 211
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           E +     + + D++S G +L  +L G+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK-EWL 187
           +AT  + P + +G G +G V+K            P +G  VA+K++   +G +G     +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 188 AEVNFLGNLL---HPNLVKLVGYCIED--DQRL---LVYEFMPRGSLENHLFRKGSLPLP 239
            EV  L  L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +     LP
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
                 +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+       
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SY 164
Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
                 V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 165 QMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 198
            LG+GGF   ++  + +  T  V  G  +  ++    H      KE ++ E+    +L +
Sbjct: 49  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 101
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLA 255
           P++V   G+  +DD   +V E   R SL     R+ ++  P   + +R  I     +G+ 
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 156
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 315
           +LH      VI+RD K  N+ L+ D + K+ DFGLA     DG+      + GT  Y AP
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAP 211
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           E +     + + D++S G +L  +L G+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 10/160 (6%)
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRKGS-----LPLP 239
           ++EVN L  L HPN+V+     I+  +    +V E+   G L + +  KG+     L   
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEE 111
Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
           + +R+   L  A        +    V++RD K +N+ LD   N KL DFGLA+    D  
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-- 169
Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 339
           T  +   +GT  Y +PE +       KSD++S G +L E+
Sbjct: 170 TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 198
            LG+GGF   ++  + +  T  V  G  +  ++    H      KE ++ E+    +L +
Sbjct: 33  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 85
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLA 255
           P++V   G+  +DD   +V E   R SL     R+ ++  P   + +R  I     +G+ 
Sbjct: 86  PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 140
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 315
           +LH      VI+RD K  N+ L+ D + K+ DFGLA     DG+      + GT  Y AP
Sbjct: 141 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAP 195
Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           E +     + + D++S G +L  +L G+
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK----E 185
           A + +   + +GEG +G VFK    +NG        G  VA+K +    G +G       
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 60
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPW 240
            +A +  L    HPN+V+L   C       + +  LV+E + +  L  +L +     +P 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
                +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQ 173
Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
              T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK-EWL 187
           +AT  + P + +G G +G V+K            P +G  VA+K++   +G +G     +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 188 AEVNFLGNLL---HPNLVKLVGYCIED--DQRL---LVYEFMPRGSLENHLFRKGSLPLP 239
            EV  L  L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +     LP
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
                 +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+       
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SY 164
Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
                 V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 165 QMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK----E 185
           A + +   + +GEG +G VFK    +NG        G  VA+K +    G +G       
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 60
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPW 240
            +A +  L    HPN+V+L   C       + +  LV+E + +  L  +L +     +P 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
                +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQ 173
Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
              T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 10  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 60
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 61  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 119
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 120 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIV 142
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 143 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +     +  SD+++ G ++ +++ G
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 9   DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 60  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 118
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 119 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK-EWL 187
           +AT  + P + +G G +G V+K            P +G  VA+K++   +G +G     +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 188 AEVNFLGNLL---HPNLVKLVGYCIED--DQRL---LVYEFMPRGSLENHLFRKGSLPLP 239
            EV  L  L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +     LP
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
                 +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+       
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SY 164
Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
                 V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 165 QMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 8   DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 58
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 59  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 117
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 118 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 84/191 (43%), Gaps = 23/191 (12%)
Query: 166 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 223
           TG  VAVK ++   L     ++   EV     L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASG 97
Query: 224 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 277
           G + ++L   G        R K     AK       + + H+   K +++RD K  N+LL
Sbjct: 98  GEVFDYLVAHG--------RXKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLL 146
Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 336
           DAD N K++DFG + +     K        G   YAAPE          + DV+S GV+L
Sbjct: 147 DADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 337 LEMLTGRRSMD 347
             +++G    D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 11  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 61
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 62  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 120
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 121 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 143 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 31  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 82  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 141 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 34  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 85  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 143
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 144 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 143 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 34  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 85  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 143
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 144 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 31  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 82  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 141 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 181
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 66
Query: 182 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
               +  L EV  L  L HPN+ KL  +  +     LV E    G L + +  +      
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 126
Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAK--DA 294
            + R  I      G+ + H+     +++RD K  N+LL++   D N ++ DFGL+   +A
Sbjct: 127 DAAR--IIRQVLSGITYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181
Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            +  K  +     GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 182 SKKXKDKI-----GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 30/189 (15%)
Query: 237 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 296
           P+     +  +   A+G+ FL   + +  I+RD    NILL  +   K+ DFGLA+D  +
Sbjct: 195 PITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 297 D------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 350
           +      G T +  + M      APE +     ++KSDV+S+GV+L E+ +   S     
Sbjct: 252 NPDYVRKGDTRLPLKWM------APESIFDKIYSTKSDVWSYGVLLWEIFSLGGS---PY 302
Query: 351 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 410
           P  + +    +R   G + R      P +             Q+   C  RDPK RPR +
Sbjct: 303 PGVQMDEDFCSRLREGMRMRAPEYSTPEI------------YQIMLDCWHRDPKERPRFA 350
Query: 411 EVVETLKPL 419
           E+VE L  L
Sbjct: 351 ELVEKLGDL 359

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 143 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 143 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 31  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 82  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 141 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 36  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 86
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 87  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 145
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 146 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 30  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     + R   A  
Sbjct: 81  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTA-E 137
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
               L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 138 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 143 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 15  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 65
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     + R   A  
Sbjct: 66  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTA-E 122
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
               L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 123 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 190
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 30  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     + R   A  
Sbjct: 81  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTA-E 137
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
               L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 138 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 49  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAA 251
           H N++      I D  R    E M    L  HL       L  +  +             
Sbjct: 100 HENIIG-----INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 154
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVSTRVMGTY 310
           +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T  + T 
Sbjct: 155 RGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 311 GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            Y APE ++     +KS D++S G +L EML+ R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRKGS-----LPLP 239
           ++EVN L  L HPN+V+     I+  +    +V E+   G L + +  KG+     L   
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEE 111
Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
           + +R+   L  A        +    V++RD K +N+ LD   N KL DFGLA+    D  
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-- 169
Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 339
              +   +GT  Y +PE +       KSD++S G +L E+
Sbjct: 170 EDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 183 HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-PLPWS 241
           H+E   E++ L +L HPN++KL     +     LV EF   G L   +  +        +
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149
Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLSDFGLAKDAPEDG 298
             MK  L    G+ +LH+     +++RD K  NILL+      N K+ DFGL+    +D 
Sbjct: 150 NIMKQILS---GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           K       +GT  Y APE V+      K DV+S GV++  +L G
Sbjct: 204 KLRDR---LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 7/155 (4%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
           E + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      
Sbjct: 80  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           + +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +
Sbjct: 139 IVSA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           GT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  Y  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  Y  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E+MP G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  Y  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 28/225 (12%)
Query: 121 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL 180
           R F  +D ++     RP   LG+G FG V+            +  +   VA+K L    +
Sbjct: 18  RHFTIDDFEIG----RP---LGKGKFGNVYLAR---------EKKSHFIVALKVLFKSQI 61
Query: 181 QGH---KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP 237
           +      +   E+    +L HPN+++L  Y  +  +  L+ E+ PRG L   L  + S  
Sbjct: 62  EKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL--QKSCT 119
Query: 238 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 297
                   I    A  L + H    K VI+RD K  N+LL      K++DFG +  AP  
Sbjct: 120 FDEQRTATIMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSL 176
Query: 298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            +      + GT  Y  PE +       K D++  GV+  E+L G
Sbjct: 177 RR----KTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E+MP G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 117/261 (44%), Gaps = 25/261 (9%)
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMK 245
           L EV  L  L HPN++KL  +  +     LV E    G L + +  +     +  ++ +K
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK 143
Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHV 302
             L    G+ +LH+     +++RD K  N+LL++   D   K+ DFGL+  A  + +  +
Sbjct: 144 QVLS---GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS--AVFENQKKM 195
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG--------RRSMDKNRPNGE 354
             R +GT  Y APE V+      K DV+S GV+L  +L G         + + +    G+
Sbjct: 196 KER-LGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK 253
Query: 355 HNLV--EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR-PRMSE 411
           +     EW     G K    ++L    +   S + + +   +   C  ++     P ++ 
Sbjct: 254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLAN 313
Query: 412 VVETLKPLQNLKDMASSSYYF 432
            +E ++  QN + +A ++  +
Sbjct: 314 AIENMRKFQNSQKLAQAALLY 334

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDD-HVQFLI-YQILR 136
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 134 NFRPESLLGEGGFG----CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
           N+ P+ +LG G       C+ K   +E     +    G + + + +     +  +  L E
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ----ELREATLKE 73
Query: 190 VNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           V+ L  +  HPN+++L      +    LV++ M +G L ++L  K +L    + ++  AL
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
              + +  LH+     +++RD K  NILLD D N KL+DFG +       K      V G
Sbjct: 134 --LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCG 185
Query: 309 TYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTG 342
           T  Y APE +             + D++S GV++  +L G
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 32  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 136
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 137 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 24/227 (10%)
Query: 122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 181
           +FM N     + N+  +  LG+G F  V +          V   TGL  A K +N   L 
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLS 68
Query: 182 GH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPL 238
               ++   E      L HPN+V+L     E+    LV++ +  G L E+ + R+     
Sbjct: 69  ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA 128
Query: 239 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAP 295
             S  ++  L   + +A+ H      +++R+ K  N+LL +       KL+DFGLA +  
Sbjct: 129 DASHCIQQIL---ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           +    H      GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 183 DSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 35  IGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 141
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDD-HVQFLI-YQILR 136
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 23/220 (10%)
Query: 134 NFRPESLLGEGGFG----CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
           N+ P+ +LG G       C+ K   +E     +    G + + + +     +  +  L E
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ----ELREATLKE 60
Query: 190 VNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           V+ L  +  HPN+++L      +    LV++ M +G L ++L  K +L    +   KI  
Sbjct: 61  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--RKIMR 118
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
              + +  LH+     +++RD K  NILLD D N KL+DFG +       K      V G
Sbjct: 119 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCG 172
Query: 309 TYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTG 342
           T  Y APE +             + D++S GV++  +L G
Sbjct: 173 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 95
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 96  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 152
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 153 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 204
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 134 NFRPESLLGEGGFG----CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 189
           N+ P+ +LG G       C+ K   +E     +    G + + + +     +  +  L E
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ----ELREATLKE 73
Query: 190 VNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           V+ L  +  HPN+++L      +    LV++ M +G L ++L  K +L    + ++  AL
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
              + +  LH+     +++RD K  NILLD D N KL+DFG +       K      V G
Sbjct: 134 --LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SVCG 185
Query: 309 TYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTG 342
           T  Y APE +             + D++S GV++  +L G
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 139/322 (43%), Gaps = 76/322 (23%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-- 197
           +G+G +G V++G W             G +VAVK  +    +  + W  E      +L  
Sbjct: 16  VGKGRYGEVWRGLW------------HGESVAVKIFSS---RDEQSWFRETEIYNTVLLR 60
Query: 198 HPNLVKLVGYCI----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
           H N++  +   +       Q  L+  +   GSL + L R+   P    + +++A+ AA G
Sbjct: 61  HDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP---HLALRLAVSAACG 117
Query: 254 LAFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST---- 304
           LA LH E      KP I +RDFK+ N+L+ ++    ++D GLA      G  ++      
Sbjct: 118 LAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAV-MHSQGSDYLDIGNNP 176
Query: 305 RVMGTYGYAAPEY----VMTGHLTSK--SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358
           RV GT  Y APE     + T    S   +D+++FG+VL E+   RR++     NG   +V
Sbjct: 177 RV-GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI----VNG---IV 226
Query: 359 EWARPHLGDKRRFYRLL--DPRLEGHFSIKGSQKAT-----------------QLAAQCL 399
           E  RP       FY ++  DP  E    +    + T                 Q+  +C 
Sbjct: 227 EDYRP------PFYDVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECW 280
Query: 400 SRDPKARPRMSEVVETLKPLQN 421
             +P AR     + +TL+ + N
Sbjct: 281 YPNPSARLTALRIKKTLQKISN 302

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 122/299 (40%), Gaps = 46/299 (15%)
Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK----TLNHDGLQGH 183
           +++   +  P   LG G +G V     E+    P    +G  +AVK    T+N    Q  
Sbjct: 2   MEVKADDLEPIMELGRGAYGVV-----EKMRHVP----SGQIMAVKRIRATVNS---QEQ 49
Query: 184 KEWLAEVNF-LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG--SLENHLFRKGSLPLPW 240
           K  L +++  +  +  P  V   G    +    +  E M          +  KG   +P 
Sbjct: 50  KRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQ-TIPE 108
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
            I  KIA+   K L  LH +    VI+RD K SN+L++A    K+ DFG++    +D   
Sbjct: 109 DILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166
Query: 301 HVSTRVMGTYGYAAPEYV-----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
            +     G   Y APE +       G+ + KSD++S G+ ++E+   R   D        
Sbjct: 167 DIDA---GCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD-------- 214
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
               W  P     ++      P+L      K S +     +QCL ++ K RP   E+++
Sbjct: 215 ---SWGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 32  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 136
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 137 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 123
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 180
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 181 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRT---WXLCGTPEYLAPEIIL 232
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 32  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 136
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 137 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 126
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 183
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 37  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 84
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 141
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 142 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 197
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 198 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 36  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 83
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 140
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 141 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVAT 196
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 197 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 37  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 84
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 141
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 142 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 197
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 198 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 27  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 131
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 132 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 187
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 188 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 35  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 141
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 77/181 (42%), Gaps = 21/181 (11%)
Query: 238 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 297
           +P  I  KI L   K L  L E  +  +I+RD K SNILLD   N KL DFG++    + 
Sbjct: 122 IPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD- 178
Query: 298 GKTHVSTRVMGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 353
             +   TR  G   Y APE +           +SDV+S G+ L E+ TGR       P  
Sbjct: 179 --SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY----PKW 232
Query: 354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
                +  +   GD         P+L      + S         CL++D   RP+  E++
Sbjct: 233 NSVFDQLTQVVKGDP--------PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
Query: 414 E 414
           +
Sbjct: 285 K 285

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R    +  +G+G FG V++G              G  VAVK  +    +  + W  E   
Sbjct: 4   RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 49
Query: 193 LGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
              ++  H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K+
Sbjct: 50  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKL 106
Query: 247 ALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGK 299
           AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D  
Sbjct: 107 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 166
Query: 300 THVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 339
                  +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 167 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 95
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 96  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 152
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 153 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 204
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 37  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYREL 84
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 141
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 142 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 197
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 198 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 36/227 (15%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
            R    +  +G+G FG V++G              G  VAVK  +    +  + W  E  
Sbjct: 5   ARTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAE 50
Query: 192 FLGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
               ++  H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K
Sbjct: 51  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIK 107
Query: 246 IALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDG 298
           +AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D 
Sbjct: 108 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 167
Query: 299 KTHVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 339
                   +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 168 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 31  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 135
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 136 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 191
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 126
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 183
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+++D     K++DFGLAK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 31  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 135
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 136 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 191
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 36  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 83
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 84  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 140
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 141 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 196
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 197 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 27  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 131
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 132 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVAT 187
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 188 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 126
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 183
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 31  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 81
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 128
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 129 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 185
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 36/227 (15%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
            R    +  +G+G FG V++G              G  VAVK  +    +  + W  E  
Sbjct: 2   ARTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAE 47
Query: 192 FLGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
               ++  H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K
Sbjct: 48  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIK 104
Query: 246 IALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDG 298
           +AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D 
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 299 KTHVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 339
                   +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYXQRTLREIKILLRFR 83
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 130
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 31  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 135
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 136 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVAT 191
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LGEG +  V+KG             T   VA+K +  +  +G     + EV+ L +L H 
Sbjct: 10  LGEGTYATVYKG---------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+V L      +    LV+E++ +  L+ +L   G++    ++++       +GLA+ H 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKL-FLFQLLRGLAYCHR 118
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
           +    V++RD K  N+L++     KL+DFGLA+      KT+ +  V  T  Y  P+ ++
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILL 173
Query: 320 -TGHLTSKSDVYSFGVVLLEMLTGR 343
            +   +++ D++  G +  EM TGR
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 32  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 136
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 137 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 192
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R    +  +G+G FG V++G              G  VAVK  +    +  + W  E   
Sbjct: 42  RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 87
Query: 193 LGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
              ++  H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K+
Sbjct: 88  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKL 144
Query: 247 ALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGK 299
           AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D  
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 300 THVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 339
                  +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 27  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 131
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 132 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 187
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 188 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 35  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 141
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 29  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 79
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 135
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 136 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 187
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 126
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGF 183
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 48  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 95
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 152
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 153 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVAT 208
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 209 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 130
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 49  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 146
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 147 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 203
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 204 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 48  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 95
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 152
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 153 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 208
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 209 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R    +  +G+G FG V++G              G  VAVK  +    +  + W  E   
Sbjct: 29  RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 74
Query: 193 LGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
              ++  H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K+
Sbjct: 75  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKL 131
Query: 247 ALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGK 299
           AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D  
Sbjct: 132 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 191
Query: 300 THVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 339
                  +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 192 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 36/227 (15%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
            R    +  +G+G FG V++G              G  VAVK  +    +  + W  E  
Sbjct: 8   ARTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAE 53
Query: 192 FLGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
               ++  H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K
Sbjct: 54  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIK 110
Query: 246 IALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDG 298
           +AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D 
Sbjct: 111 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 170
Query: 299 KTHVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 339
                   +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 171 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 50  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 156
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 157 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 49  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 99
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 155
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 156 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 26  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 132
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 32  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 138
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 139 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 28  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 78
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 134
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 135 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 186
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 27  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 77
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 133
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 134 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 185
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 35  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 141
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 34  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 84
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 131
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 132 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 189 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 35  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 85
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 86  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 132
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 133 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 189
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 190 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 26  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 76
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 77  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 123
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 124 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 180
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 181 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 130
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 190
           + +F+ +SLLGEG +G V         +A  KP TG  VA+K +   D        L E+
Sbjct: 10  SSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL-G 249
             L +  H N++ +      D        ++ +  ++  L R  S  +     ++  +  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED--------GKTH 301
             + +  LH      VI+RD K SN+L++++ + K+ DFGLA+   E         G+  
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 302 VSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
             T  + T  Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 27  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 77
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 124
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 125 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 190
           + +F+ +SLLGEG +G V         +A  KP TG  VA+K +   D        L E+
Sbjct: 10  SSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL-G 249
             L +  H N++ +      D        ++ +  ++  L R  S  +     ++  +  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED--------GKTH 301
             + +  LH      VI+RD K SN+L++++ + K+ DFGLA+   E         G+  
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 302 VSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
             T  + T  Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 178 GMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 37  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 87
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 88  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 134
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 135 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 191
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 192 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 126
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 183
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 27  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 77
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 124
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 125 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 27  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 77
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 133
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 134 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 185
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 38/232 (16%)
Query: 134 NFRPESLLGEGGFGCVFKG---------WVEENGTAPVKPGTGLT--VAVKTLNHD-GLQ 181
           +F   ++LG+G FG V K           +++      K  T L+  + + +LNH   ++
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 182 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 241
            +  WL   NF         VK +    +     +  E+   G+L + L    +L     
Sbjct: 67  YYAAWLERRNF---------VKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRD 116
Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED---- 297
              ++     + L+++H +    +I+RD K  NI +D   N K+ DFGLAK+        
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 298 --------GKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEML 340
                   G +   T  +GT  Y A E +  TGH   K D+YS G++  EM+
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT---LCGTPEYLAPEIIL 212
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 31  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 128
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 129 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 185
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 192
           +FR   +LG G F  V     E+  T  +       VA+K +  + L+G +  +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVILA--EDKRTQKL-------VAIKCIAKEALEGKEGSMENEIAV 69
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
           L  + HPN+V L           L+ + +  G L + +  KG      + R+        
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLD 127
Query: 253 GLAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
            + +LH+     +++RD K  N+L   LD D    +SDFGL+K   ED  + +ST   GT
Sbjct: 128 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGT 181
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            GY APE +     +   D +S GV+   +L G
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 69/154 (44%), Gaps = 6/154 (3%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           E    G L  P++V +  +   D Q  +    +    L   L R+G L  P ++ +   +
Sbjct: 84  EARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQI 143
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
           G+A               +RD K  NIL+ AD  A L DFG+A    ++  T +   V G
Sbjct: 144 GSAL-----DAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-G 197
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           T  Y APE     H T ++D+Y+   VL E LTG
Sbjct: 198 TLYYXAPERFSESHATYRADIYALTCVLYECLTG 231

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVSTRVMGTY 310
           +GL ++H      V++RD K SN+L++   + K+ DFGLA+ A PE   T   T  + T 
Sbjct: 155 RGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 311 GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            Y APE ++     +KS D++S G +L EML+ R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 88
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 89  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 145
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 146 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT---LCGTPEYLAPEIIL 197
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHI------------- 130
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 31  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 128
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 129 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGF 185
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 39/267 (14%)
Query: 165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD--QRLLVYEFMP 222
           G  + V V  +     +  +++  E   L    HPN++ ++G C         L+  +MP
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92
Query: 223 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD-FKTSNILLDADY 281
            GSL N L    +  +  S  +K AL  A+G+AFLH    +P+I R    + ++++D D 
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDM 150
Query: 282 NAKLS--DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK---SDVYSFGVVL 336
            A++S  D   +  +P  G+       M    + APE +      +    +D++SF V+L
Sbjct: 151 TARISMADVKFSFQSP--GR-------MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201
Query: 337 LEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQL 394
            E++T         N   G    +E  RP           + P +  H S        +L
Sbjct: 202 WELVTREVPFADLSNMEIGMKVALEGLRP----------TIPPGISPHVS--------KL 243
Query: 395 AAQCLSRDPKARPRMSEVVETLKPLQN 421
              C++ DP  RP+   +V  L+ +Q+
Sbjct: 244 MKICMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDD-HVQF 129
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGL +   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVAT 185
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 192
           +FR   +LG G F  V     E+  T  +       VA+K +  + L+G +  +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVILA--EDKRTQKL-------VAIKCIAKEALEGKEGSMENEIAV 69
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
           L  + HPN+V L           L+ + +  G L + +  KG      + R+        
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLD 127
Query: 253 GLAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
            + +LH+     +++RD K  N+L   LD D    +SDFGL+K   ED  + +ST   GT
Sbjct: 128 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGT 181
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            GY APE +     +   D +S GV+   +L G
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 192
           +FR   +LG G F  V     E+  T  +       VA+K +    L+G +  +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVI--LAEDKRTQKL-------VAIKCIAKKALEGKEGSMENEIAV 69
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
           L  + HPN+V L           L+ + +  G L + +  KG      + R+   +  A 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA- 128
Query: 253 GLAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
            + +LH+     +++RD K  N+L   LD D    +SDFGL+K   ED  + +ST   GT
Sbjct: 129 -VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGT 181
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            GY APE +     +   D +S GV+   +L G
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 160
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 121/301 (40%), Gaps = 46/301 (15%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK----TLNHDGLQ 181
            + ++   +  P   LG G +G V     E+    P    +G  +AVK    T+N    Q
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVV-----EKMRHVP----SGQIMAVKRIRATVNS---Q 91
Query: 182 GHKEWLAEVNF-LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG--SLENHLFRKGSLPL 238
             K  L +++  +  +  P  V   G    +    +  E M          +  KG   +
Sbjct: 92  EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQT-I 150
Query: 239 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 298
           P  I  KIA+   K L  LH +    VI+RD K SN+L++A    K+ DFG++    +  
Sbjct: 151 PEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV 208
Query: 299 KTHVSTRVMGTYGYAAPEYV-----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 353
              +     G   Y APE +       G+ + KSD++S G+ ++E+   R   D      
Sbjct: 209 AKTIDA---GCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD------ 258
Query: 354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
                 W  P     ++      P+L      K S +     +QCL ++ K RP   E++
Sbjct: 259 -----SWGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELM 309
Query: 414 E 414
           +
Sbjct: 310 Q 310

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+++D     +++DFGLAK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 104/236 (44%), Gaps = 49/236 (20%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           N +   L+G G +G V+KG ++E      +P     VAVK  +    Q    ++ E N  
Sbjct: 14  NLKLLELIGRGRYGAVYKGSLDE------RP-----VAVKVFSFANRQN---FINEKNIY 59
Query: 194 GNLL--HPNLVKLV--GYCIEDDQR---LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
              L  H N+ + +     +  D R   LLV E+ P GSL  +L    S    W    ++
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRL 116
Query: 247 ALGAAKGLAFLHEEA-----EKPVI-YRDFKTSNILLDADYNAKLSDFGLAKDAP----- 295
           A    +GLA+LH E       KP I +RD  + N+L+  D    +SDFGL+         
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 296 ---EDGKTHVSTRVMGTYGYAAPEYVMTGHLT--------SKSDVYSFGVVLLEML 340
              E+    +S   +GT  Y APE V+ G +          + D+Y+ G++  E+ 
Sbjct: 177 RPGEEDNAAISE--VGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 192
           +FR   +LG G F  V     E+  T  +       VA+K +  + L+G +  +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVILA--EDKRTQKL-------VAIKCIAKEALEGKEGSMENEIAV 69
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
           L  + HPN+V L           L+ + +  G L + +  KG      + R+        
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLD 127
Query: 253 GLAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
            + +LH+     +++RD K  N+L   LD D    +SDFGL+K   ED  + +ST   GT
Sbjct: 128 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGT 181
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            GY APE +     +   D +S GV+   +L G
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA++ ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIRKISPFEHQTYCQRTLREIKILLRFR 83
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 130
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 29/222 (13%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
            ++  AT   R    LG G FG V +  +E+  T       G   AVK +  +  +    
Sbjct: 90  EEVHWATHQLR----LGRGSFGEVHR--MEDKQT-------GFQCAVKKVRLEVFRAE-- 134
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
              E+     L  P +V L G   E     +  E +  GSL   +  +G LP     R  
Sbjct: 135 ---ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRAL 188
Query: 246 IALGAA-KGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDG---KT 300
             LG A +GL +LH    + +++ D K  N+LL +D  +A L DFG A     DG     
Sbjct: 189 YYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSL 245
Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
                + GT  + APE V+     +K DV+S   ++L ML G
Sbjct: 246 LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMK 245
           L EV  L  L HPN++KL  +  +     LV E    G L +  + R+    +  ++ MK
Sbjct: 52  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 111
Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHV 302
             L    G  +LH+     +++RD K  N+LL++   D   K+ DFGL+      GK   
Sbjct: 112 QVLS---GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM-- 163
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
               +GT  Y APE V+      K DV+S GV+L  +L G
Sbjct: 164 -KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ D+GLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVAT 185
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 29/222 (13%)
Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
            ++  AT   R    LG G FG V +  +E+  T       G   AVK +  +  +    
Sbjct: 71  EEVHWATHQLR----LGRGSFGEVHR--MEDKQT-------GFQCAVKKVRLEVFRAE-- 115
Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
              E+     L  P +V L G   E     +  E +  GSL   +  +G LP     R  
Sbjct: 116 ---ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRAL 169
Query: 246 IALGAA-KGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDG---KT 300
             LG A +GL +LH    + +++ D K  N+LL +D  +A L DFG A     DG     
Sbjct: 170 YYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDL 226
Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
                + GT  + APE V+     +K DV+S   ++L ML G
Sbjct: 227 LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGNLLH 198
           +GEG +G VFK    E         T   VA+K   L+ D        L E+  L  L H
Sbjct: 10  IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            N+V+L      D +  LV+EF  +  L+ + F   +  L   I         KGL F H
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               + V++RD K  N+L++ +   KL+DFGLA+      + + +  V  T  Y  P+ +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVL 173
Query: 319 MTGHLTSKS-DVYSFGVVLLEMLTGRRSM 346
               L S S D++S G +  E+    R +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMK 245
           L EV  L  L HPN++KL  +  +     LV E    G L +  + R+    +  ++ MK
Sbjct: 69  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 128
Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHV 302
             L    G  +LH+     +++RD K  N+LL++   D   K+ DFGL+      GK   
Sbjct: 129 QVLS---GTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM-- 180
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
               +GT  Y APE V+      K DV+S GV+L  +L G
Sbjct: 181 -KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR-----WY 188
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 58/242 (23%)
Query: 134 NFRPESLLGEGGFGCVFKG---------WVEENGTAPVKPGTGLT--VAVKTLNHD-GLQ 181
           +F   ++LG+G FG V K           +++      K  T L+  + + +LNH   ++
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 182 GHKEWLAEVNFLGNLL----HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENH------LF 231
            +  WL   NF+  +        L   + YC   + R L Y+ +   +L         LF
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYC---ENRTL-YDLIHSENLNQQRDEYWRLF 122
Query: 232 RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 291
           R+                  + L+++H +    +I+RD K  NI +D   N K+ DFGLA
Sbjct: 123 RQ----------------ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLA 163
Query: 292 KDAPED------------GKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLE 338
           K+                G +   T  +GT  Y A E +  TGH   K D+YS G++  E
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
Query: 339 ML 340
           M+
Sbjct: 224 MI 225

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 23/223 (10%)
Query: 129 KLATRNFRPESLLGEGGFGCVF---KGWVEENGTA-PVKPGTGLTVAVKTLNHDGLQGHK 184
           K+   NF    +LG G +G VF   K    + G    +K     T+  K    +  +  +
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
           + L  +        P LV L  Y  + + +L L+ +++  G L  HL ++          
Sbjct: 110 QVLEHIR-----QSPFLVTL-HYAFQTETKLHLILDYINGGELFTHLSQRERFT---EHE 160
Query: 244 MKIALG-AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++I +G     L  LH+     +IYRD K  NILLD++ +  L+DFGL+K+   D +T  
Sbjct: 161 VQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETER 216
Query: 303 STRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTG 342
           +    GT  Y AP+ V    +GH     D +S GV++ E+LTG
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTG 258

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 117/283 (41%), Gaps = 51/283 (18%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           F  ES LG G    V++   ++ GT   KP   L V  KT++   ++       E+  L 
Sbjct: 55  FEVESELGRGATSIVYR--CKQKGTQ--KP-YALKVLKKTVDKKIVR------TEIGVLL 103
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK-- 252
            L HPN++KL        +  LV E +  G L + +  KG          + A  A K  
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY------SERDAADAVKQI 157
Query: 253 --GLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
              +A+LHE     +++RD K  N+L      D   K++DFGL+K         +   V 
Sbjct: 158 LEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVC 211
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           GT GY APE +       + D++S G++   +L G       R               GD
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER---------------GD 256
Query: 368 KRRFYRLLDPRLEGHFSI----KGSQKATQLAAQCLSRDPKAR 406
           +  F R+L+   E +F      + S  A  L  + +  DPK R
Sbjct: 257 QFMFRRILN--CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKR 297

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 55/295 (18%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQG      E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAP--EDGKTHVSTRV 306
             + LA++H      + +RD K  N+LLD D    KL DFG AK     E   +++ +R 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
                Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +  L
Sbjct: 188 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIK-VL 239
Query: 366 GDKRR---------FYRLLDPRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
           G   R         +     P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 240 GTPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E G             VK    +     K     VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 86/205 (41%), Gaps = 19/205 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLLH 198
           +GEG +G VFK    +         TG  VA+K    + D     K  L E+  L  L H
Sbjct: 11  IGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           PNLV L+       +  LV+E+     L  H   +    +P  +   I     + + F H
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
           +      I+RD K  NIL+      KL DFG A+     G +      + T  Y +PE +
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLL--TGPSDYYDDEVATRWYRSPELL 174
Query: 319 M-TGHLTSKSDVYSFGVVLLEMLTG 342
           +         DV++ G V  E+L+G
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 23/223 (10%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 190
           + +F+ +SLLGEG +G V         +A  KP TG  VA+K +   D        L E+
Sbjct: 10  SSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL-G 249
             L +  H N++ +      D        ++ +  ++  L R  S  +     ++  +  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED--------GKTH 301
             + +  LH      VI+RD K SN+L++++ + K+ DFGLA+   E         G+  
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 302 VSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
                + T  Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 131/294 (44%), Gaps = 53/294 (18%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQG      E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAP--EDGKTHVSTRV 306
             + LA++H      + +RD K  N+LLD D    KL DFG AK     E   +++ +R 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 307 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
                Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +   
Sbjct: 188 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLG 240
Query: 366 GDKRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
              R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 132/293 (45%), Gaps = 51/293 (17%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQG      E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 184
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +  LG 
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIK-VLGT 241
Query: 368 KRR---------FYRLLDPRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
             R         +     P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 192
           ++  S +G G +G V   +        VK  +GL +AVK L+     +   K    E+  
Sbjct: 53  YQTLSPVGSGAYGSVCSSY-------DVK--SGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 193 LGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++  I
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI 160
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR 
Sbjct: 161 -YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 215
Query: 307 MGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 216 ----WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 61  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 107
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +     ++       LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 164
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 165 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 218
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 276
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+++D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 26  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDD-HVQFLI-YQILR 132
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 130
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
               + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 42/222 (18%)
Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 197
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 34  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 84
Query: 198 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 243
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 131
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 302
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 132 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 303 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
               + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 189 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 43/229 (18%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLL 197
           LG+G +G V+K          +   TG  VAVK +  D  Q   +      E+  L  L 
Sbjct: 17  LGKGAYGIVWKS---------IDRRTGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELS 66
Query: 198 -HPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
            H N+V L+     D+ R   LV+++M     + H   + ++  P   +  +     K +
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPVH-KQYVVYQLIKVI 122
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE------------------ 296
            +LH      +++RD K SNILL+A+ + K++DFGL++                      
Sbjct: 123 KYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 297 -DGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
            D    + T  + T  Y APE ++ +   T   D++S G +L E+L G+
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHA-RF-YAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 65  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 111
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +     ++       LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 168
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 169 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 222
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 223 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 280
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 281 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 332

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLAGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 63  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 109
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +     ++       LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 166
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 167 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 220
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 221 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 278
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 279 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 330

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 61  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 107
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +     ++       LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 164
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 165 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 218
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 276
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG G FG V K   EE  T       GL +A K +   G++  +E   E++ +  L H 
Sbjct: 96  ILGGGRFGQVHK--CEETAT-------GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           NL++L       +  +LV E++  G L + +  + S  L     +       +G+  +H 
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMH- 204
Query: 260 EAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
             +  +++ D K  NIL    DA    K+ DFGLA+      K  V+    GT  + APE
Sbjct: 205 --QMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVN---FGTPEFLAPE 258
Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTG 342
            V    ++  +D++S GV+   +L+G
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLXGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 36  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 142
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 143 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 89
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 90  LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 146
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 147 ---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 198
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 106 VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 152
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +     ++       LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 209
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 210 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 263
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 264 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 321
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 322 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 373

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 46  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 92
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 149
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 150 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 203
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 204 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 261
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 262 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 313

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 97
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 98  LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 154
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 155 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 206
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAG 229

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 55  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 101
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 158
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 159 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 212
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 213 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 270
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 271 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 322

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA-RF-YAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 51/222 (22%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLL 197
           +G G +G V          + +   +G  VA+K L+    Q     K    E+  L ++ 
Sbjct: 32  VGSGAYGSV---------CSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQ 81
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           H N++ L+              F P  SL N  F    L +P+   M+  L    GL F 
Sbjct: 82  HENVIGLLDV------------FTPASSLRN--FYDFYLVMPF---MQTDLQKIMGLKFS 124
Query: 258 HEEAE---------------KPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
            E+ +                 V++RD K  N+ ++ D   K+ DFGLA+ A  +   +V
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV 184
Query: 303 STRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            TR      Y APE +++  H     D++S G ++ EMLTG+
Sbjct: 185 VTR-----WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 85/203 (41%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           L KL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 40  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 90
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 146
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 147 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 198
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 35  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 81
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 138
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 139 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 192
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 193 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 250
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 251 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 302

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA-RF-YAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 85/203 (41%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           L KL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 89/183 (48%), Gaps = 21/183 (11%)
Query: 170 VAVKTLNH--DGLQGHKEWLAEVNFLGNLLHPNLVKLV-----GYCIED-DQRLLVYEFM 221
           VAVK L+     L   +    E+  L +L H N++ L+        IED  +  LV   M
Sbjct: 56  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM 115
Query: 222 PRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 281
             G+  N++ +  +L       +   L   +GL ++H      +I+RD K SN+ ++ D 
Sbjct: 116 --GADLNNIVKSQALSDEHVQFLVYQL--LRGLKYIHSAG---IIHRDLKPSNVAVNEDS 168
Query: 282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEML 340
             ++ DFGLA+ A E+   +V+TR      Y APE ++   H     D++S G ++ E+L
Sbjct: 169 ELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 341 TGR 343
            G+
Sbjct: 224 QGK 226

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           KGL ++H      V++RD K  N+ ++ D   K+ DFGLA+ A  +   +V TR      
Sbjct: 155 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 206
Query: 312 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           Y APE +++  H     D++S G ++ EMLTG+
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 39  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 85
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 142
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 143 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 196
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 254
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 255 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 306

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV-- 190
           + + P+ ++G G    V +          V   TG   AVK +     +   E L EV  
Sbjct: 94  QKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 191 ------NFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR 243
                 + L  +  HP+++ L+          LV++ M +G L ++L  K +L    +  
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET-- 202
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
             I     + ++FLH      +++RD K  NILLD +   +LSDFG +       K    
Sbjct: 203 RSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR-- 257
Query: 304 TRVMGTYGYAAPEYVMTGHLTS------KSDVYSFGVVLLEMLTG 342
             + GT GY APE +      +      + D+++ GV+L  +L G
Sbjct: 258 -ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 50  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 156
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 157 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 49  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 99
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 155
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 156 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 40  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 86
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 143
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 144 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 197
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 198 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 255
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 256 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 307

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 123
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 180
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 181 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 232
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 26  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 132
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 39  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 85
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 142
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 143 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 196
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 254
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 255 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 306

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 85/203 (41%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           L KL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 160
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 184
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 242
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+  FGLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVAT 185
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFL 193
           F  +  LG G F  V             +  TG   AVK +    L+G +  +  E+  L
Sbjct: 24  FEFKETLGTGAFSEV---------VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVL 74
Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAK 252
             + H N+V L       +   LV + +  G L + +  KG       S  ++  L A  
Sbjct: 75  RKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA-- 132
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
            + +LH      +++RD K  N+L    D +    +SDFGL+K    +GK  V +   GT
Sbjct: 133 -VYYLHRMG---IVHRDLKPENLLYYSQDEESKIMISDFGLSK---MEGKGDVMSTACGT 185
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            GY APE +     +   D +S GV+   +L G
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 33/226 (14%)
Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--- 183
           +++   R+ +P   +G G +G V          + V   TG  VA+K L +   Q     
Sbjct: 22  EVRAVYRDLQP---VGSGAYGAV---------CSAVDGRTGAKVAIKKL-YRPFQSELFA 68
Query: 184 KEWLAEVNFLGNLLHPNLVKLVGYCIED---DQRLLVYEFMP-RGSLENHLFRKGSLPLP 239
           K    E+  L ++ H N++ L+     D   D     Y  MP  G+    L +   L   
Sbjct: 69  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG-- 126
Query: 240 WSIRMK-IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 298
              R++ +     KGL ++H      +I+RD K  N+ ++ D   K+ DFGLA+ A  + 
Sbjct: 127 -EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
Query: 299 KTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
              V TR      Y APE ++     T   D++S G ++ EM+TG+
Sbjct: 183 XGXVVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           +GL ++H      +I+RD K SN+ ++ D   ++ DFGLA+ A E+   +V+TR      
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----W 185
Query: 312 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           Y APE ++   H     D++S G ++ E+L G+
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 32  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 78
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 135
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 136 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 189
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 190 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 247
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 248 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 299

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 184
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 242
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ D GLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVAT 185
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 28  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 74
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 131
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 132 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 185
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 186 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 243
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 244 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 295

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+++D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIII 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +     ++       LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 184
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 242
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           +GL ++H      +I+RD K SN+ ++ D   ++ DFGLA+ A E+   +V+TR      
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----W 193
Query: 312 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           Y APE ++   H     D++S G ++ E+L G+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 184
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 242
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 123
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 180
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G T     + GT  Y APE ++
Sbjct: 181 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GATWT---LCGTPEYLAPEIIL 232
Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           +       D ++ GV++ EM  G      ++P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 31  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 77
Query: 200 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 250
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 134
Query: 251 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 308
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 135 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 188
Query: 309 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 189 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 246
Query: 368 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 406
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 247 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 298

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ D GLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WY 188
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGNLLH 198
           +GEG +G VFK    E         T   VA+K   L+ D        L E+  L  L H
Sbjct: 10  IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            N+V+L      D +  LV+EF  +  L+ + F   +  L   I         KGL F H
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
               + V++RD K  N+L++ +   KL++FGLA+      + + +  V  T  Y  P+ +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVL 173
Query: 319 MTGHLTSKS-DVYSFGVVLLEMLTGRRSM 346
               L S S D++S G +  E+    R +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ +M  G
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 98/239 (41%), Gaps = 41/239 (17%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 191
           N+  + L+G G +G V+  +            T   VA+K +N   + L   K  L E+ 
Sbjct: 27  NYIIKHLIGRGSYGYVYLAY---------DKNTEKNVAIKKVNRMFEDLIDCKRILREIT 77
Query: 192 FLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            L  L    +++L    I DD      L +   +    L+  LF+         I+  I 
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKK-LFKTPIFLTEEHIKT-IL 135
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS---- 303
                G  F+HE     +I+RD K +N LL+ D + K+ DFGLA+    +  T++     
Sbjct: 136 YNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 304 ----------------TRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRS 345
                           T  + T  Y APE ++     +KS D++S G +  E+L   +S
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVN 191
           N+  +  LG+G F  V +          V   TGL  A K +N   L     ++   E  
Sbjct: 6   NYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREAR 56
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGA 250
               L HPN+V+L     E+    LV++ +  G L E+ + R+       S  ++  L  
Sbjct: 57  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-- 114
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVM 307
            + +A+ H      +++R+ K  N+LL +       KL+DFGLA +  +    H      
Sbjct: 115 -ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 167
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 168 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 102/250 (40%), Gaps = 46/250 (18%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 191
           N+  + L+G G +G V+  + ++N            VA+K +N   + L   K  L E+ 
Sbjct: 29  NYEIKHLIGRGSYGYVYLAY-DKNANK--------NVAIKKVNRMFEDLIDCKRILREIT 79
Query: 192 FLGNLLHPNLVKLVGYCI-ED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
            L  L    +++L    I ED    D+  +V E     S    LF+         ++  I
Sbjct: 80  ILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEQHVKT-I 136
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS--- 303
                 G  F+HE     +I+RD K +N LL+ D + K+ DFGLA+    D   H+    
Sbjct: 137 LYNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDL 193
Query: 304 --------------------TRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTG 342
                               T  + T  Y APE ++   + T+  D++S G +  E+L  
Sbjct: 194 EEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNM 253
Query: 343 RRSMDKNRPN 352
            +S   N  N
Sbjct: 254 MKSHINNPTN 263

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 70/172 (40%), Gaps = 22/172 (12%)
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D         
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + APE +     T +SDV+SFGV+L E+ +                   A P+ G
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPG 298
Query: 367 DK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
            K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 299 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVN 191
           N+  +  LG+G F  V +          V   TGL  A K +N   L     ++   E  
Sbjct: 7   NYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREAR 57
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGA 250
               L HPN+V+L     E+    LV++ +  G L E+ + R+       S  ++  L  
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-- 115
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVM 307
            + +A+ H      +++R+ K  N+LL +       KL+DFGLA +  +    H      
Sbjct: 116 -ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 168
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V         ++  +  TG  VA+K + +  D +   K  L E+  L +  H
Sbjct: 63  IGNGAYGVV---------SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH 113
Query: 199 PNLVKLVGY---CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
            N++ +       +   +   VY  +     + H     S PL             +GL 
Sbjct: 114 DNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 173
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYA 313
           ++H      VI+RD K SN+L++ +   K+ DFG+A+        H    T  + T  Y 
Sbjct: 174 YMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 230
Query: 314 APEYVMTGH-LTSKSDVYSFGVVLLEMLTGRR 344
           APE +++ H  T   D++S G +  EML  R+
Sbjct: 231 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 70/172 (40%), Gaps = 22/172 (12%)
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D         
Sbjct: 204 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + APE +     T +SDV+SFGV+L E+ +                   A P+ G
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPG 303
Query: 367 DK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
            K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 304 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 70/172 (40%), Gaps = 22/172 (12%)
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D         
Sbjct: 206 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + APE +     T +SDV+SFGV+L E+ +                   A P+ G
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPG 305
Query: 367 DK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
            K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 306 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 190
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            I     +GL ++H      +I+RD K SN+ ++ D   K+ D GLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVAT 185
Query: 305 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 50  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 156
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y
Sbjct: 157 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----WY 208
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVN 191
           N+  +  LG+G F  V +          V   TGL  A K +N   L     ++   E  
Sbjct: 7   NYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREAR 57
Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGA 250
               L HPN+V+L     E+    LV++ +  G L E+ + R+       S  ++  L  
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-- 115
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVM 307
            + +A+ H      +++R+ K  N+LL +       KL+DFGLA +  +    H      
Sbjct: 116 -ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 168
Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 26/182 (14%)
Query: 238 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 297
           +P  I  KIA+   K L  LH +    VI+RD K SN+L++A    K  DFG++    +D
Sbjct: 133 IPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDD 190
Query: 298 GKTHVSTRVMGTYGYAAPEYV-----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 352
               +     G   Y APE +       G+ + KSD++S G+  +E+   R   D     
Sbjct: 191 VAKDIDA---GCKPYXAPERINPELNQKGY-SVKSDIWSLGITXIELAILRFPYDS---- 242
Query: 353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                  W  P     ++      P+L      K S +     +QCL ++ K RP   E+
Sbjct: 243 -------WGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPEL 291
Query: 413 VE 414
            +
Sbjct: 292 XQ 293

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 70/172 (40%), Gaps = 22/172 (12%)
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D         
Sbjct: 197 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + APE +     T +SDV+SFGV+L E+ +                   A P+ G
Sbjct: 254 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPG 296
Query: 367 DK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
            K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 297 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 16/182 (8%)
Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           TG   AVK +  +  +     + E+     L  P +V L G   E     +  E +  GS
Sbjct: 82  TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 226 LENHLFRKGSLPLPWSIRMKIALGAA-KGLAFLHEEAEKPVIYRDFKTSNILLDADYN-A 283
           L   + + G LP     R    LG A +GL +LH    + +++ D K  N+LL +D + A
Sbjct: 137 LGQLIKQMGCLP---EDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRA 190
Query: 284 KLSDFGLAKDAPEDG---KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
            L DFG A     DG          + GT  + APE VM     +K D++S   ++L ML
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250
Query: 341 TG 342
            G
Sbjct: 251 NG 252

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/302 (22%), Positives = 120/302 (39%), Gaps = 43/302 (14%)
Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
           F  + +  R +     +G GG   VF+   E+     +K      V ++  ++  L  ++
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYR 74
Query: 185 EWLAEVNFLGNLLHPN-LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSI 242
             +A +N L    H + +++L  Y I D     +Y  M  G+++ N   +K     PW  
Sbjct: 75  NEIAYLNKLQQ--HSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE- 128
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           R        + +  +H+     +++ D K +N L+  D   KL DFG+A     D  + V
Sbjct: 129 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 184
Query: 303 STRVMGTYGYAAPEYV-----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
               +GT  Y  PE +               ++ KSDV+S G +L  M  G+    +   
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-- 242
Query: 352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
                        +    + + ++DP  E  F     +    +   CL RDPK R  + E
Sbjct: 243 -------------INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 412 VV 413
           ++
Sbjct: 290 LL 291

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 36/240 (15%)
Query: 198 HPNLVKLVGYCIED----DQRLLVYEFMPRGSLENHLFR---KGSLPLPWSIRMKIALGA 250
           HPN+++LV YC+ +     +  L+  F  RG+L N + R   KG+      I + + LG 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-LWLLLGI 143
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTRVM 307
            +GL  +H    K   +RD K +NILL  +    L D G    A    E  +  ++ +  
Sbjct: 144 CRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 308 G----TYGYAAPE-YVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
                T  Y APE + +  H  +  ++DV+S G VL  M+ G    D     G+   +  
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA- 259
Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 420
                         +  +L    S + S    QL    ++ DP  RP +  ++  L+ LQ
Sbjct: 260 --------------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 26  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 132
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 184
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 30/217 (13%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V         ++  +  TG  VA+K + +  D +   K  L E+  L +  H
Sbjct: 62  IGNGAYGVV---------SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH 112
Query: 199 PNLVKLVGYCIEDDQRLLV--------YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
            N++      I+D  R  V        Y  +     + H     S PL            
Sbjct: 113 DNII-----AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQL 167
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH--VSTRVMG 308
            +GL ++H      VI+RD K SN+L++ +   K+ DFG+A+        H    T  + 
Sbjct: 168 LRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 309 TYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRR 344
           T  Y APE +++ H  T   D++S G +  EML  R+
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 117/290 (40%), Gaps = 49/290 (16%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
            +R   LLG+GGFG VF G      T  ++    +    + L    L        EV  L
Sbjct: 32  EYRLGPLLGKGGFGTVFAG---HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 194 GNLL----HPNLVKLVGYCIEDDQRLLVYEF-MPRGSLENHLFRKGSLPLPWSIRMKIAL 248
             +     HP +++L+ +    +  +LV E  +P   L +++  KG L    S   +   
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS---RCFF 145
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKLSDFG---LAKDAPEDGKTHVST 304
           G    +A +     + V++RD K  NIL+D     AKL DFG   L  D P        T
Sbjct: 146 GQV--VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-------YT 196
Query: 305 RVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
              GT  Y+ PE++      +  + V+S G++L +M+ G    ++++   E  L      
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL------ 250
Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
                             HF    S     L  +CL+  P +RP + E++
Sbjct: 251 ------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 16/182 (8%)
Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           TG   AVK +  +  +     + E+     L  P +V L G   E     +  E +  GS
Sbjct: 96  TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 150
Query: 226 LENHLFRKGSLPLPWSIRMKIALGAA-KGLAFLHEEAEKPVIYRDFKTSNILLDADYN-A 283
           L   + + G LP     R    LG A +GL +LH    + +++ D K  N+LL +D + A
Sbjct: 151 LGQLIKQMGCLP---EDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRA 204
Query: 284 KLSDFGLAKDAPEDG---KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
            L DFG A     DG          + GT  + APE VM     +K D++S   ++L ML
Sbjct: 205 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 264
Query: 341 TG 342
            G
Sbjct: 265 NG 266

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 16/182 (8%)
Query: 166 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 225
           TG   AVK +  +  +     + E+     L  P +V L G   E     +  E +  GS
Sbjct: 98  TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 152
Query: 226 LENHLFRKGSLPLPWSIRMKIALGAA-KGLAFLHEEAEKPVIYRDFKTSNILLDADYN-A 283
           L   + + G LP     R    LG A +GL +LH    + +++ D K  N+LL +D + A
Sbjct: 153 LGQLIKQMGCLP---EDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRA 206
Query: 284 KLSDFGLAKDAPEDG---KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
            L DFG A     DG          + GT  + APE VM     +K D++S   ++L ML
Sbjct: 207 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 266
Query: 341 TG 342
            G
Sbjct: 267 NG 268

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGNL 196
           +GEG +G V+K           +   G T A+K +      +G+      + E++ L  L
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK-IALGAAKGLA 255
            H N+VKL        + +LV+E + +   +     +G L    S+  K   L    G+A
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE---SVTAKSFLLQLLNGIA 114
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 313
           + H+   + V++RD K  N+L++ +   K++DFGLA+    P    TH       T  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYR 167
Query: 314 APEYVM-TGHLTSKSDVYSFGVVLLEMLTG 342
           AP+ +M +   ++  D++S G +  EM+ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGNL 196
           +GEG +G V+K           +   G T A+K +      +G+      + E++ L  L
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK-IALGAAKGLA 255
            H N+VKL        + +LV+E + +   +     +G L    S+  K   L    G+A
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE---SVTAKSFLLQLLNGIA 114
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 313
           + H+   + V++RD K  N+L++ +   K++DFGLA+    P    TH       T  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYR 167
Query: 314 APEYVM-TGHLTSKSDVYSFGVVLLEMLTG 342
           AP+ +M +   ++  D++S G +  EM+ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 118/302 (39%), Gaps = 43/302 (14%)
Query: 124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           M +D  L    +    ++G+G F  V +    E G    +    +    K  +  GL   
Sbjct: 15  MADDDVLFEDVYELCEVIGKGAFSVVRRCINRETGQ---QFAVKIVDVAKFTSSPGLST- 70
Query: 184 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS-- 241
           ++   E +    L HP++V+L+     D    +V+EFM    L   + ++      +S  
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA---KLSDFGLAKDAPEDG 298
           +         + L + H+     +I+RD K  N+LL +  N+   KL DFG+A    E G
Sbjct: 131 VASHYMRQILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG 187
Query: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358
              V+   +GT  + APE V         DV+  GV+L  +L+G                
Sbjct: 188 L--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG---------------- 229
Query: 359 EWARPHLGDKRRFYR-------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
               P  G K R +         ++PR   H     S+ A  L  + L  DP  R  + E
Sbjct: 230 --CLPFYGTKERLFEGIIKGKYKMNPRQWSHI----SESAKDLVRRMLMLDPAERITVYE 283
Query: 412 VV 413
            +
Sbjct: 284 AL 285

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGNL 196
           +GEG +G V+K           +   G T A+K +      +G+      + E++ L  L
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK-IALGAAKGLA 255
            H N+VKL        + +LV+E + +   +     +G L    S+  K   L    G+A
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE---SVTAKSFLLQLLNGIA 114
Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 313
           + H+   + V++RD K  N+L++ +   K++DFGLA+    P    TH     + T  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EIVTLWYR 167
Query: 314 APEYVM-TGHLTSKSDVYSFGVVLLEMLTG 342
           AP+ +M +   ++  D++S G +  EM+ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y AP  ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPAIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 50/235 (21%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSIR 243
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  +
Sbjct: 71  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 128
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 300
           M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T
Sbjct: 129 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GET 176
Query: 301 HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
            +   + GT  Y APE ++   T       D +S GV+L   L+G               
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 221
Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKAR 406
                P   + R    L D    G ++       + S+KA  L  + L  DPKAR
Sbjct: 222 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 272

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/302 (22%), Positives = 119/302 (39%), Gaps = 43/302 (14%)
Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
           F  + +  R +     +G GG   VF+   E+     +K      V ++  ++  L  ++
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYR 74
Query: 185 EWLAEVNFLGNLLHPN-LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSI 242
             +A +N L    H + +++L  Y I D     +Y  M  G+++ N   +K     PW  
Sbjct: 75  NEIAYLNKLQQ--HSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE- 128
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           R        + +  +H+     +++ D K +N L+  D   KL DFG+A     D    V
Sbjct: 129 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVV 184
Query: 303 STRVMGTYGYAAPEYV-----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
               +GT  Y  PE +               ++ KSDV+S G +L  M  G+    +   
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-- 242
Query: 352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
                        +    + + ++DP  E  F     +    +   CL RDPK R  + E
Sbjct: 243 -------------INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 412 VV 413
           ++
Sbjct: 290 LL 291

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 141 LGEGGFG--CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGN 195
           +G+G FG  C+    V++N T  +        A+K +N        E      E+  +  
Sbjct: 23  IGKGSFGKVCI----VQKNDTKKM-------YAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL-----FRKGSLPLPWSIRMKIALG 249
           L HP LV L  Y  +D++ + +V + +  G L  HL     F++ ++ L +   + +AL 
Sbjct: 72  LEHPFLVNL-WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-FICELVMALD 129
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
             +          + +I+RD K  NILLD   +  ++DF +A   P + +    T + GT
Sbjct: 130 YLQN---------QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGT 177
Query: 310 YGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRR 344
             Y APE   +      +   D +S GV   E+L GRR
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 50/235 (21%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSIR 243
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  +
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 122
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 300
           M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T
Sbjct: 123 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GET 170
Query: 301 HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
            +   + GT  Y APE ++   T       D +S GV+L   L+G               
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 215
Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKAR 406
                P   + R    L D    G ++       + S+KA  L  + L  DPKAR
Sbjct: 216 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 101/243 (41%), Gaps = 50/243 (20%)
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSI 242
            E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 246
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGK 299
           +M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+
Sbjct: 247 QMLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GE 294
Query: 300 THVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 356
           T +   + GT  Y APE ++   T       D +S GV+L   L+G              
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG-------------- 340
Query: 357 LVEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKARPRMS 410
                 P   + R    L D    G ++       + S+KA  L  + L  DPKAR    
Sbjct: 341 -----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 395
Query: 411 EVV 413
           E +
Sbjct: 396 EAL 398

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 101/242 (41%), Gaps = 50/242 (20%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSIR 243
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  +
Sbjct: 64  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 121
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 300
           M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T
Sbjct: 122 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GET 169
Query: 301 HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
            +   + GT  Y APE ++   T       D +S GV+L   L+G               
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 214
Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKARPRMSE 411
                P   + R    L D    G ++       + S+KA  L  + L  DPKAR    E
Sbjct: 215 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 270
Query: 412 VV 413
            +
Sbjct: 271 AL 272

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 50/235 (21%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSIR 243
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  +
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 122
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 300
           M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T
Sbjct: 123 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GET 170
Query: 301 HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
            +   + GT  Y APE ++   T       D +S GV+L   L+G               
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 215
Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKAR 406
                P   + R    L D    G ++       + S+KA  L  + L  DPKAR
Sbjct: 216 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 50/235 (21%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSIR 243
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  +
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 122
Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 300
           M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T
Sbjct: 123 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GET 170
Query: 301 HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
            +   + GT  Y APE ++   T       D +S GV+L   L+G               
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 215
Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKAR 406
                P   + R    L D    G ++       + S+KA  L  + L  DPKAR
Sbjct: 216 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 116
Query: 201 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            +++L  Y I D     +Y  M  G+++ N   +K     PW  R        + +  +H
Sbjct: 117 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 172
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 173 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 319 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 72
Query: 201 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            +++L  Y I D     +Y  M  G+++ N   +K     PW  R        + +  +H
Sbjct: 73  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 128
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 129 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184
Query: 319 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQ 229
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 230 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 101/243 (41%), Gaps = 50/243 (20%)
Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSI 242
            E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 260
Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGK 299
           +M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+
Sbjct: 261 QMLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GE 308
Query: 300 THVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 356
           T +   + GT  Y APE ++   T       D +S GV+L   L+G              
Sbjct: 309 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG-------------- 354
Query: 357 LVEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKARPRMS 410
                 P   + R    L D    G ++       + S+KA  L  + L  DPKAR    
Sbjct: 355 -----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 409
Query: 411 EVV 413
           E +
Sbjct: 410 EAL 412

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK------EWLAEVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +      E   EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
            +LHPN++ L          +L+ E +  G L + L +K SL    +           G+
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA--TSFIKQILDGV 128
Query: 255 AFLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
            +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTP 182
Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            + APE V    L  ++D++S GV+   +L+G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG+G +G V+ G    N          + +A+K +     +  +    E+    +L H 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQ---------VRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK---GLAF 256
           N+V+ +G   E+    +  E +P GSL + L R    PL  +    I     +   GL +
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDN-EQTIGFYTKQILEGLKY 137
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           LH+     +++RD K  N+L++  Y+   K+SDFG +K     G    +    GT  Y A
Sbjct: 138 LHDNQ---IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMA 191
Query: 315 PEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 343
           PE +  G       +D++S G  ++EM TG+
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 89/215 (41%), Gaps = 38/215 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G F  V+KG ++   T  V       +  + L     Q  KE   E   L  L HPN
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEV---AWCELQDRKLTKSERQRFKE---EAEXLKGLQHPN 86
Query: 201 LVKLVGY---------CIEDDQRLLVYEFMPRGSLENHLFR----KGSLPLPWSIRMKIA 247
           +V+             CI     +LV E    G+L+ +L R    K  +   W  ++   
Sbjct: 87  IVRFYDSWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI--- 138
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFGLAKDAPEDGKTHVSTRV 306
               KGL FLH     P+I+RD K  NI +     + K+ D GLA       +   +  V
Sbjct: 139 ---LKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAV 190
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           +GT  + APE     +  S  DVY+FG   LE  T
Sbjct: 191 IGTPEFXAPEXYEEKYDES-VDVYAFGXCXLEXAT 224

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 116
Query: 201 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            +++L  Y I D     +Y  M  G+++ N   +K     PW  R        + +  +H
Sbjct: 117 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 172
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 173 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 319 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 69
Query: 201 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            +++L  Y I D     +Y  M  G+++ N   +K     PW  R        + +  +H
Sbjct: 70  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 125
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 126 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 319 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 226
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 227 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 198
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 199 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           GL ++H      +I+RD K SN+ ++ D   K+ DF LA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WY 188
Query: 313 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 343
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT    APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEALAPEIIL 211
Query: 320 TGHLTSKSDVYSFGVVLLEMLTG 342
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 68
Query: 201 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            +++L  Y I D     +Y  M  G+++ N   +K     PW  R        + +  +H
Sbjct: 69  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 124
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 125 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180
Query: 319 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 181 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 225
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 226 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 119/296 (40%), Gaps = 55/296 (18%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G F  +FKG   E G       T   V +K L+       + +    + +  L H +
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHET--EVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LV   G C+  D+ +LV EF+  GSL+ +L + K  + + W + +   L AA     +H 
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA-----MHF 128
Query: 260 EAEKPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDA-PEDGKTHVSTRVMGTY 310
             E  +I+ +    NILL  + +         KLSD G++    P+D    +  R+    
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI---LQERI---- 181
Query: 311 GYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPHL 365
            +  PE +    +L   +D +SFG  L E+ +G      ++D  R               
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--------------- 226
Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKA--TQLAAQCLSRDPKARPRMSEVVETLKPL 419
             K +FY       E    +   + A    L   C+  +P  RP    ++  L  L
Sbjct: 227 --KLQFY-------EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 103/262 (39%), Gaps = 29/262 (11%)
Query: 165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD--QRLLVYEFMP 222
           G  + V V  +     +  +++  E   L    HPN++ ++G C         L+  + P
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXP 92
Query: 223 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD-FKTSNILLDADY 281
            GSL N L    +  +  S  +K AL  A+G AFLH    +P+I R    + ++ +D D 
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHALNSRSVXIDEDX 150
Query: 282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            A++S   +       G+ +    V        PE          +D +SF V+L E++T
Sbjct: 151 TARISXADVKFSFQSPGRXYAPAWVAPEALQKKPEDTN----RRSADXWSFAVLLWELVT 206
Query: 342 GRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 399
                    N   G    +E  RP           + P +  H S        +L   C 
Sbjct: 207 REVPFADLSNXEIGXKVALEGLRP----------TIPPGISPHVS--------KLXKICX 248
Query: 400 SRDPKARPRMSEVVETLKPLQN 421
           + DP  RP+   +V  L+  Q+
Sbjct: 249 NEDPAKRPKFDXIVPILEKXQD 270

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++        D++S GV++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++        D++S GV++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V +          V+  TG     K +N            E++ +  L HP 
Sbjct: 59  LGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           L+ L     +  + +L+ EF+  G L + +  +    +  +  +     A +GL  +HE 
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 261 AEKPVIYRDFKTSNILLDAD--YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
           +   +++ D K  NI+ +     + K+ DFGLA     D    V+T    T  +AAPE V
Sbjct: 169 S---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIV 222
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTG 342
               +   +D+++ GV+   +L+G
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG+G +G V+ G    N          + +A+K +     +  +    E+    +L H 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQ---------VRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 65
Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK---GLAF 256
           N+V+ +G   E+    +  E +P GSL + L R    PL  +    I     +   GL +
Sbjct: 66  NIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDN-EQTIGFYTKQILEGLKY 123
Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           LH+     +++RD K  N+L++  Y+   K+SDFG +K     G    +    GT  Y A
Sbjct: 124 LHDNQ---IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMA 177
Query: 315 PEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 343
           PE +  G       +D++S G  ++EM TG+
Sbjct: 178 PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           HPN+VKL     +     LV E +  G L   + +K       +  +   L +A  ++ +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSA--VSHM 122
Query: 258 HEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           H+     V++RD K  N+L    + +   K+ DFG A+  P D +  + T    T  YAA
Sbjct: 123 HDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPCF-TLHYAA 177
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 374
           PE +         D++S GV+L  ML+G+     +    + +L   +   +  K +    
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH----DRSLTCTSAVEIMKKIK---- 229
Query: 375 LDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMS 410
                +G FS +G      SQ+A  L    L+ DP  R +MS
Sbjct: 230 -----KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V +  V E  T       G   A K +        +    E+  +  L HP 
Sbjct: 59  LGTGAFGVVHR--VTERAT-------GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 109
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV L     +D++ +++YEFM  G L   +  + +  +     ++      KGL  +HE 
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 261 AEKPVIYRDFKTSNILLDADYN--AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
                ++ D K  NI+     +   KL DFGL           V+T   GT  +AAPE  
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 222
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTG 342
               +   +D++S GV+   +L+G
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 128 LKLATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 181
           + L T N   +S+      LG+G F  V +          VK   G   A K +N   L 
Sbjct: 11  VDLGTENLYFQSMYQLFEELGKGAFSVVRRC---------VKVLAGQEYAAKIINTKKLS 61
Query: 182 G--HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPL 238
              H++   E      L HPN+V+L     E+    L+++ +  G L E+ + R+     
Sbjct: 62  ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA 121
Query: 239 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAP 295
             S  ++  L A      LH   +  V++RD K  N+LL +       KL+DFGLA +  
Sbjct: 122 DASHCIQQILEAV-----LHCH-QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEV- 174
Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            +G+        GT GY +PE +         D+++ GV+L  +L G
Sbjct: 175 -EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 57/109 (52%), Gaps = 13/109 (11%)
Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL--AKDAPEDGK 299
           + + I +  A+ + FLH    K +++RD K SNI    D   K+ DFGL  A D  E+ +
Sbjct: 165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 300 THVSTR--------VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 340
           T ++           +GT  Y +PE +   + + K D++S G++L E+L
Sbjct: 222 TVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 132/313 (42%), Gaps = 50/313 (15%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-- 197
           +G+G +G V+ G W             G  VAVK            W  E      +L  
Sbjct: 45  IGKGRYGEVWMGKW------------RGEKVAVKVF---FTTEEASWFRETEIYQTVLMR 89
Query: 198 HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
           H N++  +   I+      Q  L+ ++   GSL ++L    S  L     +K+A  +  G
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSG 146
Query: 254 LAFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDAPEDGKTHV--STR 305
           L  LH E      KP I +RD K+ NIL+  +    ++D GLA K   +  +  +  +TR
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 306 VMGTYGYAAPEYVMTG----HLTS--KSDVYSFGVVLLEMLTGRRSMD----KNRPNGEH 355
           V GT  Y  PE +       H  S   +D+YSFG++L E+   RR +     +      H
Sbjct: 207 V-GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLPYH 263
Query: 356 NLVEWARPHLGDKRRFYRL--LDPRLEGHFSIKGS-QKATQLAAQCLSRDPKARPRMSEV 412
           +LV  + P   D R    +  L P     +S     ++  +L  +C + +P +R     V
Sbjct: 264 DLVP-SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 413 VETLKPLQNLKDM 425
            +TL  +   +D+
Sbjct: 323 KKTLAKMSESQDI 335

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 40/233 (17%)
Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +F   ++LG+G FG V K     N             A+K + H   +     L+EV  L
Sbjct: 7   DFEEIAVLGQGAFGQVVKA---RNAL------DSRYYAIKKIRHTE-EKLSTILSEVXLL 56
Query: 194 GNLLHPNLVKLVGYCIE-------------DDQRLLVYEFMPRGSLENHLFRKGSLPLPW 240
            +L H  +V+     +E                  +  E+    +L + L    +L    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYD-LIHSENLNQQR 115
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED--- 297
               ++     + L+++H +    +I+R+ K  NI +D   N K+ DFGLAK+       
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 298 ---------GKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEML 340
                    G +   T  +GT  Y A E +  TGH   K D YS G++  E +
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 76/182 (41%), Gaps = 29/182 (15%)
Query: 202 VKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP------WSIRMKIALGAAKGL 254
           +  + Y  +DD  L LV ++   G L   L  K    LP      +   M IA+ +   L
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLT-LLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            ++H         RD K  NIL+D + + +L+DFG      EDG    S  V GT  Y +
Sbjct: 195 HYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYIS 244
Query: 315 PEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 369
           PE +       G    + D +S GV + EML G        P    +LVE     +  K 
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMNHKE 298
Query: 370 RF 371
           RF
Sbjct: 299 RF 300

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V +  V E  T       G   A K +        +    E+  +  L HP 
Sbjct: 165 LGTGAFGVVHR--VTERAT-------GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV L     +D++ +++YEFM  G L   +  + +  +     ++      KGL  +HE 
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 261 AEKPVIYRDFKTSNILLDADYN--AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
                ++ D K  NI+     +   KL DFGL           V+T   GT  +AAPE  
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 328
Query: 319 MTGHLTSKSDVYSFGVVLLEMLTG 342
               +   +D++S GV+   +L+G
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 114/286 (39%), Gaps = 43/286 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 116
Query: 201 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            +++L  Y I D     +Y  M  G+++ N   +K     PW  R        + +  +H
Sbjct: 117 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 172
Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 318
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +G   Y  PE +
Sbjct: 173 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 319 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++        D++S G ++ EM+ G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 19/178 (10%)
Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG 182
           F+   ++L     R   +L EGGF  V++             G+G   A+K L  +  + 
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEAQ---------DVGSGREYALKRLLSNEEEK 68
Query: 183 HKEWLAEVNFLGNLL-HPNLVKLVGYCI----EDDQ---RLLVYEFMPRGSLENHLFRKG 234
           ++  + EV F+  L  HPN+V+          E D      L+   + +G L   L +  
Sbjct: 69  NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME 128
Query: 235 SL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 291
           S  PL     +KI     + +  +H + + P+I+RD K  N+LL      KL DFG A
Sbjct: 129 SRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 116/289 (40%), Gaps = 51/289 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           + GTG   A K +    L   +  ++      EVN L 
Sbjct: 13  LGSGQFAIVRKCR---------QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
            + HPN++ L          +L+ E +  G L + L  K SL    + +    +    G+
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGV 121
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDAPEDGKTHVSTRVMGT 309
            +LH    K + + D K  NI+L  D N      KL DFG+A    E G       + GT
Sbjct: 122 HYLH---SKRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGT 174
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 369
             + APE V    L  ++D++S GV+   +L+G                  A P LG+ +
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGETK 216
Query: 370 RF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           +        ++   +  +    S+ A     + L +DPK R  +++ +E
Sbjct: 217 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 116/289 (40%), Gaps = 51/289 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           + GTG   A K +    L   +  ++      EVN L 
Sbjct: 20  LGSGQFAIVRKCR---------QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 70
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
            + HPN++ L          +L+ E +  G L + L  K SL    + +    +    G+
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGV 128
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDAPEDGKTHVSTRVMGT 309
            +LH    K + + D K  NI+L  D N      KL DFG+A    E G       + GT
Sbjct: 129 HYLH---SKRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGT 181
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 369
             + APE V    L  ++D++S GV+   +L+G                  A P LG+ +
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGETK 223
Query: 370 RF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           +        ++   +  +    S+ A     + L +DPK R  +++ +E
Sbjct: 224 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 272

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPEVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 116/289 (40%), Gaps = 51/289 (17%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           + GTG   A K +    L   +  ++      EVN L 
Sbjct: 34  LGSGQFAIVRKCR---------QKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILR 84
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
            + HPN++ L          +L+ E +  G L + L  K SL    + +    +    G+
Sbjct: 85  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGV 142
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDAPEDGKTHVSTRVMGT 309
            +LH    K + + D K  NI+L  D N      KL DFG+A    E G       + GT
Sbjct: 143 HYLH---SKRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGT 195
Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 369
             + APE V    L  ++D++S GV+   +L+G                  A P LG+ +
Sbjct: 196 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGETK 237
Query: 370 RF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           +        ++   +  +    S+ A     + L +DPK R  +++ +E
Sbjct: 238 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 286

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 120/296 (40%), Gaps = 55/296 (18%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG+G F  +FKG   E G       T   V +K L+       + +    + +  L H +
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHET--EVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFLHE 259
           LV   G C   D+ +LV EF+  GSL+ +L + K  + + W  ++++A   A  + FL E
Sbjct: 74  LVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEE 131
Query: 260 EAEKPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDA-PEDGKTHVSTRVMGTY 310
                +I+ +    NILL  + +         KLSD G++    P+D    +  R+    
Sbjct: 132 NT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI---LQERI---- 181
Query: 311 GYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPHL 365
            +  PE +    +L   +D +SFG  L E+ +G      ++D  R               
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--------------- 226
Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKA--TQLAAQCLSRDPKARPRMSEVVETLKPL 419
             K +FY       E    +   + A    L   C+  +P  RP    ++  L  L
Sbjct: 227 --KLQFY-------EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 229
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 348
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 349 SVDDALQ 355

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + +    + T  Y
Sbjct: 140 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMVPFVVTRYY 193
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++        D++S G ++ EM+ G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 229
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 348
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 349 SVDDALQ 355

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 137 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 190
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 250
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 251 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 309
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 310 SVDDALQ 316

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 311
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 312 SVDDALQ 318

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 303
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 304 SVDDALQ 310

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 311
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 312 SVDDALQ 318

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 13/160 (8%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           E+  L  L HPN+VKLV    +  +D   +V+E + +G +      K   PL        
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFY 142
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                KG+ +LH +    +I+RD K SN+L+  D + K++DFG++ +    G   + +  
Sbjct: 143 FQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF--KGSDALLSNT 197
Query: 307 MGTYGYAAPEYVMTGH--LTSKS-DVYSFGVVLLEMLTGR 343
           +GT  + APE +       + K+ DV++ GV L   + G+
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 303
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 304 SVDDALQ 310

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 304
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 305 SVDDALQ 311

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 304
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 305 SVDDALQ 311

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 66/137 (48%), Gaps = 14/137 (10%)
Query: 212 DQRLLVYEFMPRGSL---ENHLF---RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPV 265
           D+  ++YE+M   S+   + + F   +  +  +P  +   I        +++H E  K +
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNI 173
Query: 266 IYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHL 323
            +RD K SNIL+D +   KLSDFG   +   D K   S    GTY +  PE+    + + 
Sbjct: 174 CHRDVKPSNILMDKNGRVKLSDFG-ESEYMVDKKIKGSR---GTYEFMPPEFFSNESSYN 229
Query: 324 TSKSDVYSFGVVLLEML 340
            +K D++S G+ L  M 
Sbjct: 230 GAKVDIWSLGICLYVMF 246

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 356
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 357 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 407
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 408 RMSEVVE 414
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 33/215 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           ++G G FG VF+  + E+            VA+K +    LQ  +    E+  +  + HP
Sbjct: 47  VIGNGSFGVVFQAKLVESD----------EVAIKKV----LQDKRFKNRELQIMRIVKHP 92
Query: 200 NLVKLVGYCIEDDQRL------LVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAK 252
           N+V L  +   +  +       LV E++P      +  + K    +P  +         +
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAK--DAPEDGKTHVSTRVMGT 309
            LA++H      + +RD K  N+LLD      KL DFG AK   A E   + + +R    
Sbjct: 153 SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY--- 206
Query: 310 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
             Y APE +    + T+  D++S G V+ E++ G+
Sbjct: 207 --YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
            +LH N++ L          +L+ E +  G L + L +K SL    +      +    G+
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGV 128
Query: 255 AFLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
            +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTP 182
Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            + APE V    L  ++D++S GV+   +L+G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
           +   R+      +G+G +G V++G W  EN            VAVK  +    +  K W 
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWF 48
Query: 188 AEVNFLGNLL--HPNLVKLVGYCI----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 241
            E      ++  H N++  +   +       Q  L+  +   GSL ++L +  +L     
Sbjct: 49  RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSC 107
Query: 242 IRMKIALGAAKGLAFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDAP 295
           +R  I L  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   + 
Sbjct: 108 LR--IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165
Query: 296 EDGKTHVSTR-VMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 339
              +  V     +GT  Y APE     +      S  + D+++FG+VL E+
Sbjct: 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           +G+G F  V +          VK  TG   A K +N   L    H++   E      L H
Sbjct: 12  IGKGAFSVVRRC---------VKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
            N+V+L     E+    LV++ +  G L E+ + R+       S  ++  L A      L
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----L 117
Query: 258 HEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           H   +  V++RD K  N+LL +       KL+DFGLA +   D +        GT GY +
Sbjct: 118 HCH-QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           PE +         D+++ GV+L  +L G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 143 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 196
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
            APE ++        D++S G ++ EM+  +
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK------EWLAEVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +      E   EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
            +LH N++ L          +L+ E +  G L + L +K SL    +      +    G+
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGV 128
Query: 255 AFLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
            +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTP 182
Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            + APE V    L  ++D++S GV+   +L+G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           + F    +LG G F  VF            +  TG   A+K +             E+  
Sbjct: 9   KTFIFMEVLGSGAFSEVF---------LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAV 59
Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP-WSIRMKIALGAA 251
           L  + H N+V L           LV + +  G L + +  +G       S+ ++  L A 
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNIL-LDADYNAKL--SDFGLAKDAPEDGKTHVSTRVMG 308
           K   +LHE     +++RD K  N+L L  + N+K+  +DFGL+K   ++G   + +   G
Sbjct: 120 K---YLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNG---IMSTACG 169
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           T GY APE +     +   D +S GV+   +L G
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
            +LH N++ L          +L+ E +  G L + L +K SL    +      +    G+
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGV 128
Query: 255 AFLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
            +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTP 182
Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            + APE V    L  ++D++S GV+   +L+G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
            +LH N++ L          +L+ E +  G L + L +K SL    +      +    G+
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGV 128
Query: 255 AFLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
            +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTP 182
Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            + APE V    L  ++D++S GV+   +L+G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 38/231 (16%)
Query: 129 KLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
           +   R       +G+G +G V++G W  EN            VAVK  +    +  K W 
Sbjct: 33  RTVARQITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWF 77
Query: 188 AEVNFLGNLL--HPNLVKLVGYCI----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 241
            E      ++  H N++  +   +       Q  L+  +   GSL ++L +  +L     
Sbjct: 78  RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSC 136
Query: 242 IRMKIALGAAKGLAFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDAP 295
           +R  I L  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   + 
Sbjct: 137 LR--IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 194
Query: 296 EDGKTHVSTR-VMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 339
              +  V     +GT  Y APE     +      S  + D+++FG+VL E+
Sbjct: 195 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
            APE ++        D++S G ++ EM+  +
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 23/208 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG+G F  V +          +K  TG   A K +N   L    H++   E      L H
Sbjct: 12  LGKGAFSVVRRC---------MKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           PN+V+L     E+    LV++ +  G L E+ + R+       S  ++  L +       
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL- 121
Query: 258 HEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
                  +++RD K  N+LL +       KL+DFGLA +   D +        GT GY +
Sbjct: 122 -----NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           PE +         D+++ GV+L  +L G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           EV+ L  +LH N++ L          +L+ E +  G L + L +K SL    +      +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVST 304
               G+ +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG      
Sbjct: 125 --LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--K 176
Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            + GT  + APE V    L  ++D++S GV+   +L+G
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 87/215 (40%), Gaps = 19/215 (8%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNF 192
           +  +  +  G +G V  G   E     +K         +T+N   D     K  L E+  
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC-KRVLREIRL 82
Query: 193 LGNLLHPNLVKLVGYCIEDDQ-----RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
           L +  HPN++ L    +  ++       LV E M R  L   +  +  +  P  I+    
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY-FM 140
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRV 306
                GL  LHE     V++RD    NILL  + +  + DF LA+ D  +  KTH  T  
Sbjct: 141 YHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH- 196
Query: 307 MGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEML 340
                Y APE VM     T   D++S G V+ EM 
Sbjct: 197 ---RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 87/215 (40%), Gaps = 19/215 (8%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNF 192
           +  +  +  G +G V  G   E     +K         +T+N   D     K  L E+  
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC-KRVLREIRL 82
Query: 193 LGNLLHPNLVKLVGYCIEDDQ-----RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
           L +  HPN++ L    +  ++       LV E M R  L   +  +  +  P  I+    
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY-FM 140
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRV 306
                GL  LHE     V++RD    NILL  + +  + DF LA+ D  +  KTH  T  
Sbjct: 141 YHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH- 196
Query: 307 MGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEML 340
                Y APE VM     T   D++S G V+ EM 
Sbjct: 197 ---RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-- 197
           +G+G +G V++G W  EN            VAVK  +    +  K W  E      ++  
Sbjct: 16  VGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWFRETELYNTVMLR 60
Query: 198 HPNLVKLVGYCI----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
           H N++  +   +       Q  L+  +   GSL ++L +  +L     +R  I L  A G
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLR--IVLSIASG 117
Query: 254 LAFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDAPEDGKTHVSTR-V 306
           LA LH E      KP I +RD K+ NIL+  +    ++D GLA   +    +  V     
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 307 MGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 339
           +GT  Y APE     +      S  + D+++FG+VL E+
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 104/251 (41%), Gaps = 42/251 (16%)
Query: 109 KFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVK-PGTG 167
           +F E  K  +QL K    +++L   +F    ++G G FG V          A VK   T 
Sbjct: 54  EFLEWAKPFTQLVK----EMQLHREDFEIIKVIGRGAFGEV----------AVVKMKNTE 99
Query: 168 LTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPR 223
              A+K LN   +    E   +  E + L N      +  + Y  +D+  L LV ++   
Sbjct: 100 RIYAMKILNKWEMLKRAETACFREERDVLVNG-DCQWITALHYAFQDENHLYLVMDYYVG 158
Query: 224 GSLENHLFRKGSLPLPWSI------RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL 277
           G L   L  K    LP  +       M +A+ +   L ++H         RD K  N+LL
Sbjct: 159 GDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLL 208
Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSF 332
           D + + +L+DFG      +DG    S  V GT  Y +PE +       G    + D +S 
Sbjct: 209 DVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSL 267
Query: 333 GVVLLEMLTGR 343
           GV + EML G 
Sbjct: 268 GVCMYEMLYGE 278

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 104/251 (41%), Gaps = 42/251 (16%)
Query: 109 KFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVK-PGTG 167
           +F E  K  +QL K    +++L   +F    ++G G FG V          A VK   T 
Sbjct: 70  EFLEWAKPFTQLVK----EMQLHREDFEIIKVIGRGAFGEV----------AVVKMKNTE 115
Query: 168 LTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPR 223
              A+K LN   +    E   +  E + L N      +  + Y  +D+  L LV ++   
Sbjct: 116 RIYAMKILNKWEMLKRAETACFREERDVLVNG-DCQWITALHYAFQDENHLYLVMDYYVG 174
Query: 224 GSLENHLFRKGSLPLPWSI------RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL 277
           G L   L  K    LP  +       M +A+ +   L ++H         RD K  N+LL
Sbjct: 175 GDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLL 224
Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSF 332
           D + + +L+DFG      +DG    S  V GT  Y +PE +       G    + D +S 
Sbjct: 225 DVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSL 283
Query: 333 GVVLLEMLTGR 343
           GV + EML G 
Sbjct: 284 GVCMYEMLYGE 294

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG GG G VF           V       VA+K +     Q  K  L E+  +  L H N
Sbjct: 19  LGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 201 LVKL--------------VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           +VK+              VG   E +   +V E+M    L N +  +G L L    R+  
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLAN-VLEQGPL-LEEHARL-F 125
Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAK--DAPEDGKTHVS 303
                +GL ++H      V++RD K +N+ ++  D   K+ DFGLA+  D     K H+S
Sbjct: 126 MYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 304 TRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 343
             ++ T  Y +P  +++  + T   D+++ G +  EMLTG+
Sbjct: 183 EGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 253
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 306
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 367 DKRR----FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H 198
           LLGEG +  V            V    G   AVK +             EV  L     +
Sbjct: 20  LLGEGAYAKV---------QGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGN 70
Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
            N+++L+ +  EDD R  LV+E +  GS+  H+ ++       + R+   + AA  L FL
Sbjct: 71  KNILELIEF-FEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAA--LDFL 127
Query: 258 HEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAP-EDGKTHVSTRVM----GT 309
           H    K + +RD K  NIL ++       K+ DF L       +  T ++T  +    G+
Sbjct: 128 H---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGS 184
Query: 310 YGYAAPEY--VMTGHLT---SKSDVYSFGVVLLEMLTG 342
             Y APE   V T   T    + D++S GVVL  ML+G
Sbjct: 185 AEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 23/208 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG+G F  V +          +K  TG   A K +N   L    H++   E      L H
Sbjct: 12  LGKGAFSVVRRC---------MKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           PN+V+L     E+    LV++ +  G L E+ + R+       S  ++  L +       
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL- 121
Query: 258 HEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
                  +++RD K  N+LL +       KL+DFGLA +   D +        GT GY +
Sbjct: 122 -----NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           PE +         D+++ GV+L  +L G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 43/305 (14%)
Query: 121 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL 180
           R  M +D  L    +    ++G+G F  V +    E G    +    +    K  +  GL
Sbjct: 14  RGSMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQ---QFAVKIVDVAKFTSSPGL 70
Query: 181 QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPW 240
              ++   E +    L HP++V+L+     D    +V+EFM    L   + ++      +
Sbjct: 71  ST-EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 129
Query: 241 S--IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA---KLSDFGLAKDAP 295
           S  +         + L + H+     +I+RD K   +LL +  N+   KL  FG+A    
Sbjct: 130 SEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 186
Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
           E G   V+   +GT  + APE V         DV+  GV+L  +L+G             
Sbjct: 187 ESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG------------- 231
Query: 356 NLVEWARPHLGDKRRFYR-------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 408
                  P  G K R +         ++PR   H     S+ A  L  + L  DP  R  
Sbjct: 232 -----CLPFYGTKERLFEGIIKGKYKMNPRQWSHI----SESAKDLVRRMLMLDPAERIT 282
Query: 409 MSEVV 413
           + E +
Sbjct: 283 VYEAL 287

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 87/220 (39%), Gaps = 36/220 (16%)
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           HPN++ L     +     +V E M  G L + + R+       +    +     K + +L
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA--SAVLFTITKTVEYL 132
Query: 258 HEEAEKPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDA-PEDGKTHVSTRVMGTYGY 312
           H +    V++RD K SNIL +D   N    ++ DFG AK    E+G          T  +
Sbjct: 133 HAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY---TANF 186
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 372
            APE +      +  D++S GV+L  MLTG         NG  +  E     +G      
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF----ANGPDDTPEEILARIG------ 236
Query: 373 RLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKAR 406
                   G FS+ G      S  A  L ++ L  DP  R
Sbjct: 237 -------SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQR 269

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 35/221 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLH 198
           +LG+G    VF+G  ++         TG   A+K  N+   L+     + E   L  L H
Sbjct: 16  ILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 199 PNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKG 253
            N+VKL  + IE++     ++L+ EF P GSL   L     +  LP S  + +      G
Sbjct: 67  KNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 254 LAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +  L E     +++R+ K  NI+     D     KL+DFG A++  ED +  VS  + GT
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVS--LYGT 178
Query: 310 YGYAAPEYVMTGHLT--------SKSDVYSFGVVLLEMLTG 342
             Y  P+      L         +  D++S GV      TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG+G F  V +          VK   G   A   +N   L    H++   E      L H
Sbjct: 19  LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           PN+V+L     E+    L+++ +  G L E+ + R+       S  ++  L A      L
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----L 124
Query: 258 HEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
           H   +  V++R+ K  N+LL +       KL+DFGLA +   +G+        GT GY +
Sbjct: 125 HCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV--EGEQQAWFGFAGTPGYLS 181
Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           PE +         D+++ GV+L  +L G
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 36/228 (15%)
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           HPN++ L     +     LV E M  G L + + R+       +  +   +G  K + +L
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG--KTVEYL 137
Query: 258 HEEAEKPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDA-PEDGKTHVSTRVMGTYGY 312
           H +    V++RD K SNIL +D   N    ++ DFG AK    E+G          T  +
Sbjct: 138 HSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY---TANF 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 372
            APE +         D++S G++L  ML G         NG  +  E     +G      
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF----ANGPSDTPEEILTRIGS----- 242
Query: 373 RLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 414
                   G F++ G      S+ A  L ++ L  DP  R    +V++
Sbjct: 243 --------GKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQ 282

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 21/216 (9%)
Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAE 189
           T +++    LG+G F  V +          VK       A K +N   L    H++   E
Sbjct: 30  TDDYQLFEELGKGAFSVVRRC---------VKKTPTQEYAAKIINTKKLSARDHQKLERE 80
Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
                 L HPN+V+L     E+    LV++ +  G L   +  +      +      +  
Sbjct: 81  ARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHC 135
Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRV 306
             + L  ++   +  +++RD K  N+LL +       KL+DFGLA +    G+       
Sbjct: 136 IHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEV--QGEQQAWFGF 193
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            GT GY +PE +         D+++ GV+L  +L G
Sbjct: 194 AGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A       + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++     +  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 36/228 (15%)
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           HPN++ L     +     LV E M  G L + + R+       +  +   +G  K + +L
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG--KTVEYL 137
Query: 258 HEEAEKPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDA-PEDGKTHVSTRVMGTYGY 312
           H +    V++RD K SNIL +D   N    ++ DFG AK    E+G          T  +
Sbjct: 138 HSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY---TANF 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 372
            APE +         D++S G++L  ML G         NG  +  E     +G      
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF----ANGPSDTPEEILTRIG------ 241
Query: 373 RLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 414
                   G F++ G      S+ A  L ++ L  DP  R    +V++
Sbjct: 242 -------SGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQ 282

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 116/302 (38%), Gaps = 43/302 (14%)
Query: 124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           M +D  L    +    ++G+G F  V +    E G    +    +    K  +  GL   
Sbjct: 15  MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQ---QFAVKIVDVAKFTSSPGLST- 70
Query: 184 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS-- 241
           ++   E +    L HP++V+L+     D    +V+EFM    L   + ++      +S  
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA---KLSDFGLAKDAPEDG 298
           +         + L + H+     +I+RD K   +LL +  N+   KL  FG+A    E G
Sbjct: 131 VASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187
Query: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358
              V+   +GT  + APE V         DV+  GV+L  +L+G                
Sbjct: 188 L--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG---------------- 229
Query: 359 EWARPHLGDKRRFYR-------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
               P  G K R +         ++PR   H     S+ A  L  + L  DP  R  + E
Sbjct: 230 --CLPFYGTKERLFEGIIKGKYKMNPRQWSHI----SESAKDLVRRMLMLDPAERITVYE 283
Query: 412 VV 413
            +
Sbjct: 284 AL 285

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 48/234 (20%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLL 197
           L+G G +G V + + +              VA+K +    + L   K  L E+  L  L 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKR---------VVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 198 HPNLVKLVGYCIEDD-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
           H ++VK++   I  D     +  +V E     S    LFR         I+  +      
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKT-LLYNLLV 167
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVS------- 303
           G+ ++H      +++RD K +N L++ D + K+ DFGLA+  D PE+G + +        
Sbjct: 168 GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 304 ----------------TRVMGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEML 340
                           T  + T  Y APE + +  + T   DV+S G +  E+L
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 253
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 306
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 367 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + +    + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPEVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
            APE ++        D++S G ++ EM+  +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 59/308 (19%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 18  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 253
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 125
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 306
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 126 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 176
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 218
Query: 367 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ 420
           D ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP  
Sbjct: 219 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278
Query: 421 NLKDMASS 428
             + ++S+
Sbjct: 279 TQQALSSA 286

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 59/308 (19%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 18  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 253
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 125
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 306
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 126 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 176
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 218
Query: 367 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ 420
           D ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP  
Sbjct: 219 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278
Query: 421 NLKDMASS 428
             + ++S+
Sbjct: 279 TQQALSSA 286

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 59/308 (19%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 253
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 306
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 367 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ 420
           D ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP  
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279
Query: 421 NLKDMASS 428
             + ++S+
Sbjct: 280 TQQALSSA 287

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 59/308 (19%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGKFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 253
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 306
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 367 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ 420
           D ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP  
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279
Query: 421 NLKDMASS 428
             + ++S+
Sbjct: 280 TQQALSSA 287

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 253
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 306
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 367 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           EV+ L  + HPN++ L          +L+ E +  G L + L  K SL    +      +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTH 301
               G+ +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K  
Sbjct: 124 --LNGVYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN- 176
Query: 302 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
               + GT  + APE V    L  ++D++S GV+   +L+G                  A
Sbjct: 177 ----IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------A 214
Query: 362 RPHLGDKRR----FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
            P LGD ++        ++   E  +    S  A     + L +DPK R  + + ++
Sbjct: 215 SPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A       + T  + T  Y
Sbjct: 136 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPYVVTRYY 189
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE ++        D++S G ++ E++ G
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 35/221 (15%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLH 198
           +LG+G    VF+G  ++         TG   A+K  N+   L+     + E   L  L H
Sbjct: 16  ILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 199 PNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKG 253
            N+VKL  + IE++     ++L+ EF P GSL   L     +  LP S  + +      G
Sbjct: 67  KNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 254 LAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +  L E     +++R+ K  NI+     D     KL+DFG A++  +D +      + GT
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VXLYGT 178
Query: 310 YGYAAPEYVMTGHLT--------SKSDVYSFGVVLLEMLTG 342
             Y  P+      L         +  D++S GV      TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 253
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 306
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 367 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 44/254 (17%)
Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIA 247
           EV+ L  + HPN++ L          +L+ E +  G L + L  K SL    +   +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKT 300
           L    G+ +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K 
Sbjct: 124 LN---GVYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
                + GT  + APE V    L  ++D++S GV+   +L+G                  
Sbjct: 177 -----IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ 213
Query: 361 ARPHLGDKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET- 415
           A P LGD ++        ++   E  +    S  A     + L +DPK R  + + ++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 416 -LKPLQNLKDMASS 428
            +KP    + ++S+
Sbjct: 274 WIKPKDTQQALSSA 287

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 190
           +R  + LGEG +G V+K          +   T  TVA+K +      +G+ G    + EV
Sbjct: 36  YRRITKLGEGTYGEVYKA---------IDTVTNETVAIKRIRLEHEEEGVPGTA--IREV 84
Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
           + L  L H N+++L      + +  L++E+     L+ ++ +   + +   +        
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSM--RVIKSFLYQL 141
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKD--APEDGKTHVS 303
             G+ F H    +  ++RD K  N+LL     +     K+ DFGLA+    P    TH  
Sbjct: 142 INGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH-- 196
Query: 304 TRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEML 340
              + T  Y  PE ++ + H ++  D++S   +  EML
Sbjct: 197 --EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 253
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 306
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 367 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 125/306 (40%), Gaps = 50/306 (16%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 26  IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 196 LLHPNLVKLVGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRKGSLPLPWSIRM 244
           L H N+V L+  C               LV++F      G L N L +     +   ++M
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTH 301
            +      GL ++H      +++RD K +N+L+  D   KL+DFGLA+    A       
Sbjct: 134 LL-----NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 302 VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
              RV+ T  Y  PE ++         D++  G ++ EM T    M  N    +  L+  
Sbjct: 186 YXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 244
Query: 361 ----ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
                 P +      Y L + +LE    +KG ++  +   +   RDP A   + +++  L
Sbjct: 245 LCGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL-VL 299
Query: 417 KPLQNL 422
            P Q +
Sbjct: 300 DPAQRI 305

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + +    + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPEVVTRYY 191
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
            APE ++        D++S G ++ EM+  +
Sbjct: 192 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 253
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 306
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 367 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 253
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 306
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 367 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 59/308 (19%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 253
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 306
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 367 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ 420
           D ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP  
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279
Query: 421 NLKDMASS 428
             + ++S+
Sbjct: 280 TQQALSSA 287

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 119/280 (42%), Gaps = 34/280 (12%)
Query: 147 GCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLV 205
           GC+  G +     A  +   G  V +K L H G  +     +AE  FL  ++HP++V++ 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 206 GYCIEDDQR-----LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
            +    D+       +V E++   SL+    R     LP +  +   L     L++LH  
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLK----RSKGQKLPVAEAIAYLLEILPALSYLHSI 201
Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 320
               ++Y D K  NI+L  +   KL D G        G  +      GT G+ APE V T
Sbjct: 202 G---LVYNDLKPENIML-TEEQLKLIDLGAVSRINSFGYLY------GTPGFQAPEIVRT 251
Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPHLGDKRRFYRLL---- 375
           G  T  +D+Y+ G  L  +     ++D    NG + + +    P L     + RLL    
Sbjct: 252 GP-TVATDIYTVGRTLAAL-----TLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAI 305
Query: 376 --DPRLEGHFSIKGSQKATQLAAQCLSRDPKA-RPRMSEV 412
             DPR     + + S + T +  + +++D    RP +S +
Sbjct: 306 DPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTI 345

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 125/306 (40%), Gaps = 50/306 (16%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 26  IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 196 LLHPNLVKLVGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRKGSLPLPWSIRM 244
           L H N+V L+  C               LV++F      G L N L +     +   ++M
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTH 301
            +      GL ++H      +++RD K +N+L+  D   KL+DFGLA+    A       
Sbjct: 134 LL-----NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 302 VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
              RV+ T  Y  PE ++         D++  G ++ EM T    M  N    +  L+  
Sbjct: 186 YXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 244
Query: 361 ----ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
                 P +      Y L + +LE    +KG ++  +   +   RDP A   + +++  L
Sbjct: 245 LCGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL-VL 299
Query: 417 KPLQNL 422
            P Q +
Sbjct: 300 DPAQRI 305

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 125/306 (40%), Gaps = 50/306 (16%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 25  IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 72
Query: 196 LLHPNLVKLVGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRKGSLPLPWSIRM 244
           L H N+V L+  C               LV++F      G L N L +     +   ++M
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTH 301
            +      GL ++H      +++RD K +N+L+  D   KL+DFGLA+    A       
Sbjct: 133 LL-----NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 302 VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
              RV+ T  Y  PE ++         D++  G ++ EM T    M  N    +  L+  
Sbjct: 185 YXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 361 ----ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
                 P +      Y L + +LE    +KG ++  +   +   RDP A   + +++  L
Sbjct: 244 LCGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL-VL 298
Query: 417 KPLQNL 422
            P Q +
Sbjct: 299 DPAQRI 304

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 125/306 (40%), Gaps = 50/306 (16%)
Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 26  IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 196 LLHPNLVKLVGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRKGSLPLPWSIRM 244
           L H N+V L+  C               LV++F      G L N L +     +   ++M
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTH 301
            +      GL ++H      +++RD K +N+L+  D   KL+DFGLA+    A       
Sbjct: 134 LL-----NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 302 VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
              RV+ T  Y  PE ++         D++  G ++ EM T    M  N    +  L+  
Sbjct: 186 YXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 244
Query: 361 ----ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
                 P +      Y L + +LE    +KG ++  +   +   RDP A   + +++  L
Sbjct: 245 LCGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL-VL 299
Query: 417 KPLQNL 422
            P Q +
Sbjct: 300 DPAQRI 305

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 111/287 (38%), Gaps = 59/287 (20%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 15  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYEFM-PRGSLENHLFRKGSLPLPWSIRMKIALGA 250
             +      +++L+ +    D  +L+ E M P   L + +  +G+L     +        
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQE--ELARSFFWQV 123
Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPEDGKTHVSTRV 306
            + +   H      V++RD K  NIL+D +    KL DFG   L KD        V T  
Sbjct: 124 LEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-------VYTDF 173
Query: 307 MGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
            GT  Y+ PE++       +S  V+S G++L +M+ G    + +         E  R  +
Sbjct: 174 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRGQV 225
Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
             ++R                 S +   L   CL+  P  RP   E+
Sbjct: 226 FFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 197
           E+ +G G +G V            V+ GT +  A K +    ++    +  E+  + +L 
Sbjct: 31  ENTIGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 81
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKGLAF 256
           HPN+++L     ++    LV E    G L   +  K       + R MK  L A   +A+
Sbjct: 82  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAY 138
Query: 257 LHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
            H+     V +RD K  N L      D   KL DFGLA    + GK  + T+V GT  Y 
Sbjct: 139 CHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKM-MRTKV-GTPYYV 192
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           +P+ V+ G    + D +S GV++  +L G
Sbjct: 193 SPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 197
           E+ +G G +G V            V+ GT +  A K +    ++    +  E+  + +L 
Sbjct: 14  ENTIGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKGLAF 256
           HPN+++L     ++    LV E    G L   +  K       + R MK  L A   +A+
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAY 121
Query: 257 LHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
            H+     V +RD K  N L      D   KL DFGLA    + GK  + T+V GT  Y 
Sbjct: 122 CHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKM-MRTKV-GTPYYV 175
Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           +P+ V+ G    + D +S GV++  +L G
Sbjct: 176 SPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 31/163 (19%)
Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMG 308
           +G+ +LH+     +++ D K  NILL + Y   + K+ DFG+++     G       +MG
Sbjct: 142 EGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELREIMG 195
Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
           T  Y APE +    +T+ +D+++ G++   +LT                     P +G+ 
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH------------------TSPFVGED 237
Query: 369 RRFYRLLDPRLEGHFSIKG----SQKATQLAAQCLSRDPKARP 407
            +   L   ++   +S +     SQ AT      L ++P+ RP
Sbjct: 238 NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP 280

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 57/131 (43%), Gaps = 10/131 (7%)
Query: 215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN 274
           L++ E M  G L + +  +G          +I       + FLH      + +RD K  N
Sbjct: 83  LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPEN 139
Query: 275 ILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYS 331
           +L    + D   KL+DFG AK+  ++    + T     Y Y APE +         D++S
Sbjct: 140 LLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPY-YVAPEVLGPEKYDKSCDMWS 195
Query: 332 FGVVLLEMLTG 342
            GV++  +L G
Sbjct: 196 LGVIMYILLCG 206

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 16  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R       W
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW 122
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
            +   +      G           V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 123 QVLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 169
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 170 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 219
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 220 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 30  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 81  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 140
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 141 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 183
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 184 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 233
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 234 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 271

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 31  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 142 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 184
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 185 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 234
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 235 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 272

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 57/131 (43%), Gaps = 10/131 (7%)
Query: 215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN 274
           L++ E M  G L + +  +G          +I       + FLH      + +RD K  N
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPEN 158
Query: 275 ILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYS 331
           +L    + D   KL+DFG AK+  ++    + T     Y Y APE +         D++S
Sbjct: 159 LLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPY-YVAPEVLGPEKYDKSCDMWS 214
Query: 332 FGVVLLEMLTG 342
            GV++  +L G
Sbjct: 215 LGVIMYILLCG 225

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 16  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 126
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 127 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 169
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 170 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 219
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 220 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 30  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 81  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 140
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 141 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 183
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 184 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 233
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 234 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 271

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 15  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 126 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 168
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 169 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 218
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 219 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 76/169 (44%), Gaps = 19/169 (11%)
Query: 189 EVNFLGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGS------LPLPW 240
           E+  L  L HPN++ L  V     D +  L++++          F + S      + LP 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NAKLSDFGLAK--DA 294
            +   +      G+ +LH      V++RD K +NIL+  +       K++D G A+  ++
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 295 PEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTG 342
           P      +   V+ T+ Y APE ++   H T   D+++ G +  E+LT 
Sbjct: 185 PLKPLADLDP-VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 50  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 100
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R       W
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW 156
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
            +   +      G           V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 157 QVLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 203
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 204 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 253
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 254 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 291

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 16  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R       W
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW 122
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
            +   +      G           V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 123 QVLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 169
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 170 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 219
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 220 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 66/145 (45%), Gaps = 20/145 (13%)
Query: 212 DQRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF 270
           D+  LV+E M  GS+ +H+ ++     L  S+   +    A  L FLH    K + +RD 
Sbjct: 84  DRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLH---NKGIAHRDL 137
Query: 271 KTSNILLDADYN---AKLSDFGLAKDAPEDGKTH-VSTRVM----GTYGYAAPEYV---- 318
           K  NIL +        K+ DFGL      +G    +ST  +    G+  Y APE V    
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 319 -MTGHLTSKSDVYSFGVVLLEMLTG 342
                   + D++S GV+L  +L+G
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSG 222

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 11  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R       W
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW 117
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
            +   +      G           V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 118 QVLEAVRHCHNXG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 164
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 165 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 214
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 215 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 252

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 43  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 154 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 196
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 197 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 246
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 247 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 14  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 64
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 65  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 124
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 125 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 167
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 168 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 217
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 218 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 255

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 58  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 168
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 169 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 211
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 212 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 261
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 262 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 299

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 31  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 142 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 184
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 185 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 234
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 235 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 272

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 31  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 142 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 184
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 185 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 234
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 235 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPXDRPTFEEI 272

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 63  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 113
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 114 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 173
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 174 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 216
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 217 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 266
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 267 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 304

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 38  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 88
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R       W
Sbjct: 89  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW 144
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
            +   +      G           V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 145 QVLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 191
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 192 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 241
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 242 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 279

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 43  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 154 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 196
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 197 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 246
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 247 --------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 43  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 154 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 196
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 197 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 246
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 247 --------EIIGGQVFFRQ-----------RVSXECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 44  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 155 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 197
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 198 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 247
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 248 --------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 58  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 168
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 169 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 211
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 212 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 261
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 262 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 299

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 43  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 154 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 196
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 197 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 246
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 247 --------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 44  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 155 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 197
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 198 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 247
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 248 --------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 44  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 155 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 197
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 198 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 247
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 248 --------EIIGGQVFFRQ-----------RVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 91/227 (40%), Gaps = 55/227 (24%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 44  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 155 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 197
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTG 342
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G
Sbjct: 198 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 11  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 122 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 164
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 165 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 214
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 215 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 85/220 (38%), Gaps = 36/220 (16%)
Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           HPN++ L     +     +V E    G L + + R+       +    +     K + +L
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREA--SAVLFTITKTVEYL 132
Query: 258 HEEAEKPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDA-PEDGKTHVSTRVMGTYGY 312
           H +    V++RD K SNIL +D   N    ++ DFG AK    E+G          T  +
Sbjct: 133 HAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY---TANF 186
Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 372
            APE +      +  D++S GV+L   LTG         NG  +  E     +G      
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF----ANGPDDTPEEILARIG------ 236
Query: 373 RLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKAR 406
                   G FS+ G      S  A  L ++ L  DP  R
Sbjct: 237 -------SGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQR 269

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 85/222 (38%), Gaps = 25/222 (11%)
Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
           +L HPN+V+     +      ++ E+   G L   +   G      +      L    G+
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL--LSGV 129
Query: 255 AFLHEEAEKPVIYRDFKTSNILLDAD--YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           ++ H      + +RD K  N LLD       K+ DFG +K +    +   +   +GT  Y
Sbjct: 130 SYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAY 183
Query: 313 AAPEYVMTGHLTSK-SDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNLVEWARPHLGDKRR 370
            APE ++      K +DV+S GV L  ML G     D   P      ++           
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ----------- 232
Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
             R+L  +      I+ S +   L ++    DP  R  + E+
Sbjct: 233 --RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 193
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 11  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 194 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 240
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 296
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 122 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 164
Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 165 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 214
Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 215 --------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 252
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	491
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	0.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-160
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-88
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-67
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-66
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-65
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-64
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-63
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-63
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-60
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-60
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-58
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-58
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-57
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-46
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-45
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-45
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-45
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-44
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-43
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-42
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-41
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	8e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-41
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-39
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-39
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-39
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-39
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-39
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-38
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-38
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-37
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-37
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-37
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-36
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-35
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-34
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-34
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-34
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-33
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-33
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-31
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-31
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-30
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-30
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-30
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-29
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-29
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-29
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-29
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-28
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-27
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-26
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-26
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-26
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-26
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-26
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-26
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-25
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-25
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-25
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-25
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-24
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-23
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-21
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-06

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  536 bits (1383), Expect = 0.0
 Identities = 111/321 (34%), Positives = 175/321 (54%), Gaps = 30/321 (9%)

Query: 112 EELKVAS-QLRKFMFNDLKLATRNFRPE------SLLGEGGFGCVFKGWVEENGTAPVKP 164
           + L+V+  +   F F +LK  T NF         + +GEGGFG V+KG+V          
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT------- 55

Query: 165 GTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEF 220
               TVAVK L    +    +  +++  E+  +    H NLV+L+G+  + D   LVY +
Sbjct: 56  ----TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111

Query: 221 MPRGSLENHLF-RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 279
           MP GSL + L    G+ PL W +R KIA GAA G+ FLHE      I+RD K++NILLD 
Sbjct: 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168

Query: 280 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 339
            + AK+SDFGLA+ + +  +T +++R++GT  Y APE  + G +T KSD+YSFGVVLLE+
Sbjct: 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEI 227

Query: 340 LTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 399
           +TG  ++D++R      L++       +++     +D ++         +    +A+QCL
Sbjct: 228 ITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCL 284

Query: 400 SRDPKARPRMSEVVETLKPLQ 420
                 RP + +V + L+ + 
Sbjct: 285 HEKKNKRPDIKKVQQLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  518 bits (1336), Expect = 0.0
 Identities = 114/332 (34%), Positives = 182/332 (54%), Gaps = 16/332 (4%)

Query: 97  TTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEE 156
           +  +  + S     S    V  +  +    DL+ AT NF  + L+G G FG V+KG + +
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 157 NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL 216
                     G  VA+K    +  QG +E+  E+  L    HP+LV L+G+C E ++ +L
Sbjct: 63  ----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112

Query: 217 VYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN 274
           +Y++M  G+L+ HL+     ++ + W  R++I +GAA+GL +LH      +I+RD K+ N
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSIN 169

Query: 275 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGV 334
           ILLD ++  K++DFG++K   E  +TH+ST V GT GY  PEY + G LT KSDVYSFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229

Query: 335 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQL 394
           VL E+L  R ++ ++ P    NL EWA     +  +  +++DP L      +  +K    
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDT 288

Query: 395 AAQCLSRDPKARPRMSEVVETLKPLQNLKDMA 426
           A +CL+   + RP M +V+  L+    L++  
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  457 bits (1178), Expect = e-160
 Identities = 119/304 (39%), Positives = 186/304 (61%), Gaps = 17/304 (5%)

Query: 119 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 178
           QL++F   +L++A+ NF  +++LG GGFG V+KG +  +GT          VAVK L  +
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGT---------LVAVKRLKEE 65

Query: 179 GLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--RKGS 235
             QG + ++  EV  +   +H NL++L G+C+   +RLLVY +M  GS+ + L    +  
Sbjct: 66  RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125

Query: 236 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 295
            PL W  R +IALG+A+GLA+LH+  +  +I+RD K +NILLD ++ A + DFGLAK   
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185

Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
               THV+T V GT G+ APEY+ TG  + K+DV+ +GV+LLE++TG+R+ D  R   + 
Sbjct: 186 -YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244

Query: 356 --NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
              L++W +  L +K +   L+D  L+G++  +  ++  Q+A  C    P  RP+MSEVV
Sbjct: 245 DVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303

Query: 414 ETLK 417
             L+
Sbjct: 304 RMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  272 bits (698), Expect = 2e-88
 Identities = 77/322 (23%), Positives = 127/322 (39%), Gaps = 40/322 (12%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           +L   +   +   +   G FGCV+K  +               VAVK      +Q  + W
Sbjct: 18  NLYFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFP---IQDKQSW 63

Query: 187 LAE--VNFLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPW 240
             E  V  L  + H N+++ +G             L+  F  +GSL + L       + W
Sbjct: 64  QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSW 120

Query: 241 SIRMKIALGAAKGLAFLHEE------AEKP-VIYRDFKTSNILLDADYNAKLSDFGLAKD 293
           +    IA   A+GLA+LHE+        KP + +RD K+ N+LL  +  A ++DFGLA  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 294 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-----KSDVYSFGVVLLEMLTGRRSMDK 348
                    +   +GT  Y APE +            + D+Y+ G+VL E+ +   + D 
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

Query: 349 NRPNGEHNLVE--WARPHLGDKRRF--YRLLDPRLEGHF-SIKGSQKATQLAAQCLSRDP 403
                     E     P L D +    ++   P L  ++    G     +   +C   D 
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300

Query: 404 KARPRMSEVVETLKPLQNLKDM 425
           +AR     V E +  +Q L ++
Sbjct: 301 EARLSAGCVGERITQMQRLTNI 322

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  218 bits (557), Expect = 1e-67
 Identities = 85/344 (24%), Positives = 132/344 (38%), Gaps = 69/344 (20%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           + ++++          +G G FG V K  W                VA+K +  +  +  
Sbjct: 7   YKEIEVEEV-------VGRGAFGVVCKAKW------------RAKDVAIKQIESESER-- 45

Query: 184 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSI 242
           K ++ E+  L  + HPN+VKL G C+      LV E+   GSL N L     LP    + 
Sbjct: 46  KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAH 103

Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKLSDFGLAKDAPEDGKTH 301
            M   L  ++G+A+LH    K +I+RD K  N+LL A     K+ DFG A D        
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQT 158

Query: 302 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
             T   G+  + APE     + + K DV+S+G++L E++T R      +P  E     + 
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFR 212

Query: 362 ---------RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                    RP L         L   +E             L  +C S+DP  RP M E+
Sbjct: 213 IMWAVHNGTRPPLIKN------LPKPIE------------SLMTRCWSKDPSQRPSMEEI 254

Query: 413 VETLKPLQN-----LKDMASSSYYFQTMQADNTWSIRNSKNGIR 451
           V+ +  L        + +     +      D             
Sbjct: 255 VKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFY 298

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  216 bits (552), Expect = 2e-66
 Identities = 65/337 (19%), Positives = 119/337 (35%), Gaps = 53/337 (15%)

Query: 123 FMFNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQ 181
              ++  L   N +   L+G G +G V+KG   E              VAVK  +     
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER------------PVAVKVFS---FA 47

Query: 182 GHKEWLAEVN--FLGNLLHPNLVKLVGYCIEDD-----QRLLVYEFMPRGSLENHLFRKG 234
             + ++ E N   +  + H N+ + +            + LLV E+ P GSL  +L    
Sbjct: 48  NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH- 106

Query: 235 SLPLPWSIRMKIALGAAKGLAFLHEEAEK------PVIYRDFKTSNILLDADYNAKLSDF 288
                W    ++A    +GLA+LH E  +       + +RD  + N+L+  D    +SDF
Sbjct: 107 --TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164

Query: 289 GLAK------DAPEDGKTHVSTRVMGTYGYAAPEYVM-------TGHLTSKSDVYSFGVV 335
           GL+             + + +   +GT  Y APE +              + D+Y+ G++
Sbjct: 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224

Query: 336 LLEMLTGRRSMDKNRPNGEHNL----VEWARPHLGDKRRF--YRLLDPRLEGHFSI--KG 387
             E+      +       E+ +         P   D +         P+    +      
Sbjct: 225 YWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLA 284

Query: 388 SQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD 424
            +   +    C  +D +AR       E +  L  + +
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  212 bits (541), Expect = 3e-65
 Identities = 83/309 (26%), Positives = 134/309 (43%), Gaps = 58/309 (18%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           + DL +  +       +G G FG V +  W   +G+          VAVK L        
Sbjct: 36  WCDLNIKEK-------IGAGSFGTVHRAEW---HGS---------DVAVKILMEQDFHAE 76

Query: 184 --KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS-LPLPW 240
              E+L EV  +  L HPN+V  +G   +     +V E++ RGSL   L + G+   L  
Sbjct: 77  RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDE 136

Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
             R+ +A   AKG+ +LH     P+++R+ K+ N+L+D  Y  K+ DFGL++       +
Sbjct: 137 RRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195

Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
             S    GT  + APE +       KSDVYSFGV+L E+ T +      +P G  N  + 
Sbjct: 196 --SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQV 247

Query: 361 A--------RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                    R  +         L+P++              +   C + +P  RP  + +
Sbjct: 248 VAAVGFKCKRLEIPRN------LNPQVA------------AIIEGCWTNEPWKRPSFATI 289

Query: 413 VETLKPLQN 421
           ++ L+PL  
Sbjct: 290 MDLLRPLIK 298

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  210 bits (536), Expect = 2e-64
 Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 47/307 (15%)

Query: 133 RNFRPESL-----LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           R FRP  L     LG+G FG   K               TG  + +K L     +  + +
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTH----------RETGEVMVMKELIRFDEETQRTF 54

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           L EV  +  L HPN++K +G   +D +   + E++  G+L   + +      PWS R+  
Sbjct: 55  LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSF 113

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT------ 300
           A   A G+A+LH      +I+RD  + N L+  + N  ++DFGLA+   ++         
Sbjct: 114 AKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170

Query: 301 ------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 354
                      V+G   + APE +       K DV+SFG+VL E++    +     P+  
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYL 226

Query: 355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
              +++      + R F     P                +  +C   DP+ RP   ++  
Sbjct: 227 PRTMDFGL----NVRGFLDRYCPP-------NCPPSFFPITVRCCDLDPEKRPSFVKLEH 275

Query: 415 TLKPLQN 421
            L+ L+ 
Sbjct: 276 WLETLRM 282

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  206 bits (526), Expect = 2e-63
 Identities = 68/314 (21%), Positives = 119/314 (37%), Gaps = 69/314 (21%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           F  L   T+       L E   G ++KG W    G           + VK L        
Sbjct: 9   FKQLNFLTK-------LNENHSGELWKGRW---QGN---------DIVVKVLKVRDWSTR 49

Query: 184 --KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHLFRKGSLPLP 239
             +++  E   L    HPN++ ++G C          +  +MP GSL N L    +  + 
Sbjct: 50  KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVD 109

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
            S  +K AL  A+G+AFLH   E  +      + ++++D D  A++S   +         
Sbjct: 110 QSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK-------F 161

Query: 300 THVSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
           +  S   M    + APE  +           +D++SF V+L E++T         P  + 
Sbjct: 162 SFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADL 214

Query: 356 NLVEWA--------RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
           + +E          RP +         + P +            ++L   C++ DP  RP
Sbjct: 215 SNMEIGMKVALEGLRPTIPPG------ISPHV------------SKLMKICMNEDPAKRP 256

Query: 408 RMSEVVETLKPLQN 421
           +   +V  L+ +Q+
Sbjct: 257 KFDMIVPILEKMQD 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  206 bits (527), Expect = 2e-63
 Identities = 86/318 (27%), Positives = 141/318 (44%), Gaps = 71/318 (22%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH- 183
            N+++        E  +G+GGFG V KG + ++ +          VA+K+L     +G  
Sbjct: 18  DNEIEY-------EKQIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGET 61

Query: 184 ------KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP 237
                 +E+  EV  + NL HPN+VKL G         +V EF+P G L + L    + P
Sbjct: 62  EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRL-LDKAHP 118

Query: 238 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-----ADYNAKLSDFGLAK 292
           + WS+++++ L  A G+ ++  +   P+++RD ++ NI L      A   AK++DFGL++
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

Query: 293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEMLTGRR----- 344
                   H  + ++G + + APE  +       T K+D YSF ++L  +LTG       
Sbjct: 178 Q-----SVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

Query: 345 ---SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSR 401
               +       E  L    RP + +         PRL              +   C S 
Sbjct: 232 SYGKIKFINMIREEGL----RPTIPED------CPPRLR------------NVIELCWSG 269

Query: 402 DPKARPRMSEVVETLKPL 419
           DPK RP  S +V+ L  L
Sbjct: 270 DPKKRPHFSYIVKELSEL 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  204 bits (522), Expect = 8e-63
 Identities = 83/316 (26%), Positives = 129/316 (40%), Gaps = 71/316 (22%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           F +L L          +G GGFG V++  W    G           VAVK   HD  +  
Sbjct: 6   FAELTLEEI-------IGIGGFGKVYRAFW---IGD---------EVAVKAARHDPDEDI 46

Query: 184 ----KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 239
               +    E      L HPN++ L G C+++    LV EF   G L   L  K    +P
Sbjct: 47  SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIP 103

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--------ADYNAKLSDFGLA 291
             I +  A+  A+G+ +LH+EA  P+I+RD K+SNIL+         ++   K++DFGLA
Sbjct: 104 PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163

Query: 292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351
           ++     K        G Y + APE +     +  SDV+S+GV+L E+LTG        P
Sbjct: 164 REWHRTTKMS----AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VP 213

Query: 352 NGEHNLVEWA--------RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP 403
               + +  A           +                           +L   C + DP
Sbjct: 214 FRGIDGLAVAYGVAMNKLALPIPST------CPEPFA------------KLMEDCWNPDP 255

Query: 404 KARPRMSEVVETLKPL 419
            +RP  + +++ L  +
Sbjct: 256 HSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  198 bits (506), Expect = 6e-60
 Identities = 61/345 (17%), Positives = 123/345 (35%), Gaps = 64/345 (18%)

Query: 103 SASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAP 161
           SA S P+ + +  +  Q     F  L++          +G+G FG V+ G W   +G   
Sbjct: 10  SARSFPRKASQTSIFLQEWDIPFEQLEIGEL-------IGKGRFGQVYHGRW---HGE-- 57

Query: 162 VKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE 219
                   VA++ ++ +       K +  EV       H N+V  +G C+      ++  
Sbjct: 58  --------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109

Query: 220 FMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 279
                +L + + R   + L  +   +IA    KG+ +LH    K ++++D K+ N+  D 
Sbjct: 110 LCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD- 164

Query: 280 DYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGYAAPEYVMTG---------HLTSKS 327
           +    ++DFGL           +        G   + APE +              +  S
Sbjct: 165 NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHS 224

Query: 328 DVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS 384
           DV++ G +  E+       ++            + W            +    ++     
Sbjct: 225 DVFALGTIWYELHAREWPFKTQPAEA-------IIWQ------MGTGMKPNLSQIGMGKE 271

Query: 385 IKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSS 429
           I        +   C + + + RP  +++++ L+ L   K     S
Sbjct: 272 IS------DILLFCWAFEQEERPTFTKLMDMLEKLP--KRNRRLS 308

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  197 bits (503), Expect = 8e-60
 Identities = 79/302 (26%), Positives = 126/302 (41%), Gaps = 43/302 (14%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
              + +  R       +G G FG V+KG W   +G           VAVK LN       
Sbjct: 23  DGQITVGQR-------IGSGSFGTVYKGKW---HGD----------VAVKMLNVTAPTPQ 62

Query: 184 --KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 241
             + +  EV  L    H N++  +GY     Q  +V ++    SL +HL           
Sbjct: 63  QLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHL-HASETKFEMK 120

Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 301
             + IA   A+G+ +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H
Sbjct: 121 KLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177

Query: 302 VSTRVMGTYGYAAPE---YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358
              ++ G+  + APE      +   + +SDVY+FG+VL E++TG+       P    N  
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNR 231

Query: 359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP 418
           +     +G       L   R      +K      +L A+CL +    RP    ++  ++ 
Sbjct: 232 DQIIEMVGRGSLSPDLSKVRSNCPKRMK------RLMAECLKKKRDERPSFPRILAEIEE 285

Query: 419 LQ 420
           L 
Sbjct: 286 LA 287

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  194 bits (495), Expect = 2e-58
 Identities = 70/311 (22%), Positives = 116/311 (37%), Gaps = 52/311 (16%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 194
              +G+G +G V++G W  E             VAVK  +    +  K W  E  +    
Sbjct: 13  LECVGKGRYGEVWRGSWQGE------------NVAVKIFSS---RDEKSWFRETELYNTV 57

Query: 195 NLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
            L H N++  +   +       Q  L+  +   GSL ++L       L     ++I L  
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSI 114

Query: 251 AKGLAFLHEEAEK-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVS 303
           A GLA LH E         + +RD K+ NIL+  +    ++D GLA       +     +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 304 TRVMGTYGYAAPEYVMTGHL-------TSKSDVYSFGVVLLEMLTGRRSMDKNRP----- 351
              +GT  Y APE V+   +         + D+++FG+VL E+     S           
Sbjct: 175 NPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233

Query: 352 ---NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 408
                     E  R  +   ++  R   P     FS        +L  +C  ++P AR  
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQ--RPNIP--NRWFSDPTLTSLAKLMKECWYQNPSARLT 289

Query: 409 MSEVVETLKPL 419
              + +TL  +
Sbjct: 290 ALRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  194 bits (496), Expect = 3e-58
 Identities = 69/314 (21%), Positives = 120/314 (38%), Gaps = 46/314 (14%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLG 194
              +G+G +G V+ G W  E             VAVK            W    E+    
Sbjct: 42  VKQIGKGRYGEVWMGKWRGE------------KVAVKVFFT---TEEASWFRETEIYQTV 86

Query: 195 NLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
            + H N++  +   I+      Q  L+ ++   GSL ++L       L     +K+A  +
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSS 143

Query: 251 AKGLAFLHEEAEK-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVS 303
             GL  LH E         + +RD K+ NIL+  +    ++D GLA    +  +      
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203

Query: 304 TRVMGTYGYAAPEYVMTGHL-------TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-- 354
              +GT  Y  PE V+   L          +D+YSFG++L E+   R          +  
Sbjct: 204 NTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLP 261

Query: 355 HNLVEWARPHLGDKRRF--YRLLDPRLEGHFSIKGSQKA-TQLAAQCLSRDPKARPRMSE 411
           ++ +  + P   D R     + L P     +S     +   +L  +C + +P +R     
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321

Query: 412 VVETLKPLQNLKDM 425
           V +TL  +   +D+
Sbjct: 322 VKKTLAKMSESQDI 335

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  193 bits (492), Expect = 1e-57
 Identities = 75/317 (23%), Positives = 127/317 (40%), Gaps = 52/317 (16%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 194
           +  +G+G FG V++G W  E             VAVK  +    +  + W  E  +    
Sbjct: 47  QESIGKGRFGEVWRGKWRGE------------EVAVKIFS---SREERSWFREAEIYQTV 91

Query: 195 NLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
            L H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K+AL  
Sbjct: 92  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALST 148

Query: 251 AKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVS 303
           A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D      
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208

Query: 304 TRVMGTYGYAAPEYVMTGHL-------TSKSDVYSFGVVLLEMLTGRRSMDKNRP----- 351
              +GT  Y APE V+   +         ++D+Y+ G+V  E+         +       
Sbjct: 209 NHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267

Query: 352 ---NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 408
                    VE  R  + +++   R   P      S +  +   ++  +C   +  AR  
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKL--RPNIP--NRWQSCEALRVMAKIMRECWYANGAARLT 323

Query: 409 MSEVVETLKPLQNLKDM 425
              + +TL  L   + +
Sbjct: 324 ALRIKKTLSQLSQQEGI 340

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  163 bits (416), Expect = 4e-46
 Identities = 73/282 (25%), Positives = 116/282 (41%), Gaps = 32/282 (11%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           +G G FG VF G +  + T          VAVK+           ++L E   L    HP
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+V+L+G C +     +V E +  G     L R     L     +++   AA G+ +L  
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE- 230

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
              K  I+RD    N L+      K+SDFG++++  +               + APE + 
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPR 378
            G  +S+SDV+SFG++L E  +   S   N  N +    VE          +  RL  P 
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE----------KGGRL--PC 336

Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 420
            E            +L  QC + +P  RP  S + + L+ ++
Sbjct: 337 PELC-----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  160 bits (406), Expect = 2e-45
 Identities = 77/308 (25%), Positives = 127/308 (41%), Gaps = 45/308 (14%)

Query: 133 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
           R+ +    LG+G FG V    +       P++  TG  VAVK L H   +  +++  E+ 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIAL 248
            L +L H N+VK  G C    +R   L+ E++P GSL ++L + K  +     ++     
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY--TS 121

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST---- 304
              KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +         
Sbjct: 122 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178

Query: 305 ---RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
                       APE +     +  SDV+SFGVVL E+ T         P  E   +   
Sbjct: 179 SPIFWY------APESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGN 230

Query: 362 RPHLGDK--------RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
                          +   RL  PR +G        +   +  +C + +   RP   ++ 
Sbjct: 231 DKQGQMIVFHLIELLKNNGRL--PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLA 283

Query: 414 ETLKPLQN 421
             +  +++
Sbjct: 284 LRVDQIRD 291

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  160 bits (406), Expect = 3e-45
 Identities = 76/311 (24%), Positives = 126/311 (40%), Gaps = 51/311 (16%)

Query: 133 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
           R+ +    LG+G FG V    +       P++  TG  VAVK L H   +  +++  E+ 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIAL 248
            L +L H N+VK  G C    +R   L+ E++P GSL ++L + K  +     ++     
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY--TS 152

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST---- 304
              KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D + +       
Sbjct: 153 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209

Query: 305 ---RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
                       APE +     +  SDV+SFGVVL E+ T         P  E   +   
Sbjct: 210 SPIFWY------APESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGN 261

Query: 362 RPHLGDK--------RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMS 410
                          +   RL  P     E +           +  +C + +   RP   
Sbjct: 262 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY----------MIMTECWNNNVNQRPSFR 311

Query: 411 EVVETLKPLQN 421
           ++   +  +++
Sbjct: 312 DLALRVDQIRD 322

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  159 bits (403), Expect = 7e-45
 Identities = 86/303 (28%), Positives = 121/303 (39%), Gaps = 39/303 (12%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 191
           R  +    LGEG FG V     +     P   GTG  VAVK L  D G Q    W  E++
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
            L  L H +++K  G C +       LV E++P GSL ++L  + S+ L   +    A  
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLF--AQQ 142

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST----- 304
             +G+A+LH    +  I+RD    N+LLD D   K+ DFGLAK  PE  + +        
Sbjct: 143 ICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199

Query: 305 --RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 361
                      APE +        SDV+SFGV L E+LT    S        E   +   
Sbjct: 200 PVFWY------APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253

Query: 362 RPHLGDKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
           +  +           RL  P        K   +   L   C   +   RP    ++  LK
Sbjct: 254 QMTVLRLTELLERGERLPRPD-------KCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

Query: 418 PLQ 420
            + 
Sbjct: 307 TVH 309

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  158 bits (401), Expect = 2e-44
 Identities = 80/303 (26%), Positives = 123/303 (40%), Gaps = 40/303 (13%)

Query: 133 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
           R+ +  S LG+G FG V    +       P+   TG  VAVK L H G    +++  E+ 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYD------PLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIAL 248
            L  L    +VK  G      ++   LV E++P G L + L R +  L     +    + 
Sbjct: 77  ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY--SS 134

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST---- 304
              KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D   +V      
Sbjct: 135 QICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191

Query: 305 ---RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 360
                       APE +     + +SDV+SFGVVL E+ T   +S   +         E 
Sbjct: 192 SPIFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245

Query: 361 ARPHLGDKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
             P L           RL  P            +  +L   C +  P+ RP  S +   L
Sbjct: 246 DVPALSRLLELLEEGQRL--PAPPA-----CPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

Query: 417 KPL 419
             L
Sbjct: 299 DML 301

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  156 bits (396), Expect = 5e-44
 Identities = 81/306 (26%), Positives = 123/306 (40%), Gaps = 45/306 (14%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 191
           R  +    LGEG FG V     +     P    TG  VAVK+L  + G     +   E+ 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIAL 248
            L NL H N+VK  G C ED      L+ EF+P GSL+ +L + K  + L   ++   A+
Sbjct: 76  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY--AV 133

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST---- 304
              KG+ +L     +  ++RD    N+L+++++  K+ DFGL K    D + +       
Sbjct: 134 QICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190

Query: 305 ---RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV-- 358
                       APE +M       SDV+SFGV L E+LT             +      
Sbjct: 191 SPVFWY------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244

Query: 359 -EWARPHLGDK-RRFYRLLDPR---LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
            +     L +  +   RL  P     E +          QL  +C    P  R     ++
Sbjct: 245 GQMTVTRLVNTLKEGKRLPCPPNCPDEVY----------QLMRKCWEFQPSNRTSFQNLI 294

Query: 414 ETLKPL 419
           E  + L
Sbjct: 295 EGFEAL 300

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  155 bits (393), Expect = 2e-43
 Identities = 69/302 (22%), Positives = 131/302 (43%), Gaps = 54/302 (17%)

Query: 132 TRNFRPESL-----LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHK 184
            R  +         LG G FG V+KG W+ E     +       VA+K L      + +K
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANK 62

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIR 243
           E L E   + ++ +P++ +L+G C+      L+ + MP G L +++   K ++   + + 
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
               +  AKG+ +L    ++ +++RD    N+L+    + K++DFGLAK    + K + +
Sbjct: 122 W--CVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176

Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLV 358
                   + A E ++    T +SDV+S+GV + E++T G +    +    P  E  +++
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSIL 232

Query: 359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT----QLAAQCLSRDPKARPRMSEVVE 414
           E          +  RL  P              T     +  +C   D  +RP+  E++ 
Sbjct: 233 E----------KGERLPQP-----------PICTIDVYMIMRKCWMIDADSRPKFRELII 271

Query: 415 TL 416
             
Sbjct: 272 EF 273

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  150 bits (381), Expect = 7e-42
 Identities = 80/348 (22%), Positives = 110/348 (31%), Gaps = 60/348 (17%)

Query: 70  GTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLK 129
           GT   Y       + RR       S T  S     S    F ++                
Sbjct: 14  GTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ---------------- 57

Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWL 187
               +F+  S LG G +G VFK               G   AVK       G +     L
Sbjct: 58  ----SFQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKL 104

Query: 188 AEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           AEV     +  HP  V+L     E     L  E     SL+ H    G+  LP +     
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA-SLPEAQVWGY 162

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                  LA LH    + +++ D K +NI L      KL DFGL  +    G   V    
Sbjct: 163 LRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---Q 216

Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
            G   Y APE +   +  + +DV+S G+ +LE+               H    W    L 
Sbjct: 217 EGDPRYMAPELLQGSY-GTAADVFSLGLTILEVACNMELP--------HGGEGW--QQLR 265

Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                   L P          S +   +    L  DPK R     ++ 
Sbjct: 266 QGY-----LPPEFTAGL----SSELRSVLVMMLEPDPKLRATAEALLA 304

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  150 bits (380), Expect = 7e-42
 Identities = 64/294 (21%), Positives = 107/294 (36%), Gaps = 47/294 (15%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG+G F  +FKG   E      +       V +K L+       + +    + +  L H 
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHE---TEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           +LV   G C+  D+ +LV EF+  GSL+ +L   K  + + W + +  A   A  + FL 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAAAMHFL- 129

Query: 259 EEAEKPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
              E  +I+ +    NILL  + +         KLSD G++               +   
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV--- 184

Query: 311 GYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDK 368
               PE +    +L   +D +SFG  L E+ +G         +       E         
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE--------- 232

Query: 369 RRFYRLLDPRL-EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 421
              ++L  P+  E             L   C+  +P  RP    ++  L  L  
Sbjct: 233 -DRHQLPAPKAAELA----------NLINNCMDYEPDHRPSFRAIIRDLNSLFT 275

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  149 bits (377), Expect = 3e-41
 Identities = 73/315 (23%), Positives = 116/315 (36%), Gaps = 51/315 (16%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
            + +  +++     LGEGGF  V    VE           G   A+K +     Q  +E 
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDL--VEGLHD-------GHFYALKRILCHEQQDREEA 73

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQR----LLVYEFMPRGSLENHL--FRKGSLPLPW 240
             E +      HPN+++LV YC+ +        L+  F  RG+L N +   +     L  
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133

Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
              + + LG  +GL  +H    K   +RD K +NILL  +    L D G    A    + 
Sbjct: 134 DQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190

Query: 301 HVSTRVM-------GTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 350
                 +        T  Y APE         +  ++DV+S G VL  M+ G    D   
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

Query: 351 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSI----KGSQKATQLAAQCLSRDPKAR 406
             G+                    +   ++   SI    + S    QL    ++ DP  R
Sbjct: 251 QKGD-------------------SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291

Query: 407 PRMSEVVETLKPLQN 421
           P +  ++  L+ LQ 
Sbjct: 292 PHIPLLLSQLEALQP 306

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  149 bits (378), Expect = 3e-41
 Identities = 71/313 (22%), Positives = 137/313 (43%), Gaps = 47/313 (15%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLH 198
           LG G FG V+KG W+ E     +       VA+K L      + +KE L E   + ++ +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYVMASVDN 76

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFL 257
           P++ +L+G C+      L+ + MP G L +++   K ++   + +     +  AKG+ +L
Sbjct: 77  PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNYL 133

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 317
               ++ +++RD    N+L+    + K++DFGLAK    + K + +        + A E 
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 318 VMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDKRRFY 372
           ++    T +SDV+S+GV + E++T G +    +    P  E  +++E          +  
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILE----------KGE 236

Query: 373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYF 432
           RL  P          +     +  +C   D  +RP+  E++           MA     +
Sbjct: 237 RLPQPP-------ICTIDVYMIMVKCWMIDADSRPKFRELIIE------FSKMARDPQRY 283

Query: 433 QTMQADNTWSIRN 445
             +Q D    + +
Sbjct: 284 LVIQGDERMHLPS 296

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  148 bits (376), Expect = 5e-41
 Identities = 78/311 (25%), Positives = 128/311 (41%), Gaps = 54/311 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V++G     G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 33  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------FRKGSLPLPWSIRMKIALGAA 251
           ++V+L+G   +    L++ E M RG L+++L              P   S  +++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTHVSTR 305
            G+A+L        ++RD    N ++  D+  K+ DFG+ +D  E       GK  +  R
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVE----W 360
            M      +PE +  G  T+ SDV+SFGVVL E+ T      +   N +    V      
Sbjct: 206 WM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259

Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 420
            +P        + L+                      C   +PK RP   E++ ++K   
Sbjct: 260 DKPD-NCPDMLFELM--------------------RMCWQYNPKMRPSFLEIISSIKEEM 298

Query: 421 NLKDMASSSYY 431
                  S YY
Sbjct: 299 EPGFREVSFYY 309

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  146 bits (372), Expect = 5e-41
 Identities = 82/285 (28%), Positives = 125/285 (43%), Gaps = 44/285 (15%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G G FG V  G W        V        A+KT+  +G    ++++ E   +  L HP
Sbjct: 16  IGSGQFGLVHLGYW---LNKDKV--------AIKTI-REGAMSEEDFIEEAEVMMKLSHP 63

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            LV+L G C+E     LV EFM  G L ++L  ++G       + M   L   +G+A+L 
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM--CLDVCEGMAYL- 120

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAP 315
              E  VI+RD    N L+  +   K+SDFG+ +   +D      T   GT     +A+P
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWASP 174

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 374
           E       +SKSDV+SFGV++ E+ +  +   +NR N E    +             +RL
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------TGFRL 224

Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
             PRL        S    Q+   C    P+ RP  S ++  L  +
Sbjct: 225 YKPRL-------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  147 bits (372), Expect = 7e-41
 Identities = 76/309 (24%), Positives = 121/309 (39%), Gaps = 57/309 (18%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
            +F+   L+G GGFG VFK   +           G T  +K + ++  +  +E    V  
Sbjct: 11  MDFKEIELIGSGGFGQVFK--AKHRID-------GKTYVIKRVKYNNEKAERE----VKA 57

Query: 193 LGNLLHPNLVKLVGYCIEDDQRL----------------LVYEFMPRGSLENHLFRKGSL 236
           L  L H N+V   G     D                   +  EF  +G+LE  + ++   
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117

Query: 237 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 296
            L   + +++     KG+ ++H    K +I RD K SNI L      K+ DFGL      
Sbjct: 118 KLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174

Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 356
           DGK    TR  GT  Y +PE + +     + D+Y+ G++L E+L                
Sbjct: 175 DGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-------------- 217

Query: 357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
                       + F  L D  +   F     +K   L  + LS+ P+ RP  SE++ TL
Sbjct: 218 ----CDTAFETSKFFTDLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

Query: 417 KPLQNLKDM 425
              +   + 
Sbjct: 270 TVWKKSPEK 278

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  148 bits (375), Expect = 7e-41
 Identities = 73/298 (24%), Positives = 128/298 (42%), Gaps = 46/298 (15%)

Query: 132 TRNFRPESL-----LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHK 184
            R F+   L     LG G FG V KG W+ E  +  +       V +K +    G Q  +
Sbjct: 7   ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIP------VCIKVIEDKSGRQSFQ 60

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIR 243
                +  +G+L H ++V+L+G C       LV +++P GSL +H+   +G+L     + 
Sbjct: 61  AVTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
               +  AKG+ +L    E  +++R+    N+LL +    +++DFG+A   P D K  + 
Sbjct: 120 W--GVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174

Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLV 358
           +       + A E +  G  T +SDV+S+GV + E++T G      +       E  +L+
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL----RLAEVPDLL 230

Query: 359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           E          +  RL  P++        +     +  +C   D   RP   E+    
Sbjct: 231 E----------KGERLAQPQI-------CTIDVYMVMVKCWMIDENIRPTFKELANEF 271

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  152 bits (385), Expect = 8e-41
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 34/281 (12%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G +G V++G W              LTVAVKTL  D ++  +E+L E   +  + HP
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 276

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           NLV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L  
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-- 334

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
             +K  I+R+    N L+  ++  K++DFGL++                   + APE + 
Sbjct: 335 -EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 392

Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPR 378
               + KSDV++FGV+L E+ T   S        + + L+E          + YR+  P 
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERPE 442

Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 443 G-------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  146 bits (370), Expect = 9e-41
 Identities = 77/285 (27%), Positives = 118/285 (41%), Gaps = 44/285 (15%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V  G W    G   V        AVK +  +G     E+  E   +  L HP
Sbjct: 16  LGSGQFGVVKLGKW---KGQYDV--------AVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            LVK  G C ++    +V E++  G L N+L      L     + M       +G+AFL 
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM--CYDVCEGMAFL- 120

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAP 315
                  I+RD    N L+D D   K+SDFG+ +   +D         +GT     ++AP
Sbjct: 121 --ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD----QYVSSVGTKFPVKWSAP 174

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 374
           E       +SKSDV++FG+++ E+ +  +       N E    V           + +RL
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS----------QGHRL 224

Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
             P L        S    Q+   C    P+ RP   +++ +++PL
Sbjct: 225 YRPHL-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  145 bits (367), Expect = 4e-40
 Identities = 67/285 (23%), Positives = 115/285 (40%), Gaps = 44/285 (15%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V  G W    G   V        A+K +  +G     E++ E   + NL H 
Sbjct: 32  LGTGQFGVVKYGKW---RGQYDV--------AIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
            LV+L G C +     ++ E+M  G L N+L   +        + M       + + +L 
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYL- 136

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAP 315
               K  ++RD    N L++     K+SDFGL++   +D      T  +G+     ++ P
Sbjct: 137 --ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRWSPP 190

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 374
           E +M    +SKSD+++FGV++ E+ +  +   +   N E    +           +  RL
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA----------QGLRL 240

Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
             P L        S+K   +   C       RP    ++  +  +
Sbjct: 241 YRPHL-------ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  146 bits (370), Expect = 4e-40
 Identities = 85/312 (27%), Positives = 136/312 (43%), Gaps = 60/312 (19%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 196
           E ++G G  G V  G +   G   V       VA+K L     +  + ++L+E + +G  
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 255
            HPN+++L G        ++V E+M  GSL+  L    G   +   + M    G   G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM--LRGVGAGMR 165

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG---- 311
           +L   ++   ++RD    N+L+D++   K+SDFGL++   +D     +T      G    
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIP 217

Query: 312 --YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPH 364
             + APE +     +S SDV+SFGVV+ E+L  G R   +M     N +  + VE     
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT----NRDVISSVE----- 268

Query: 365 LGDKRRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL-- 419
                  YRL  P       H          QL   C  +D   RPR S++V  L  L  
Sbjct: 269 -----EGYRLPAPMGCPHALH----------QLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

Query: 420 --QNLKDMASSS 429
             ++L+  A+ S
Sbjct: 314 SPESLRATATVS 325

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  145 bits (368), Expect = 4e-40
 Identities = 76/303 (25%), Positives = 124/303 (40%), Gaps = 50/303 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           +G G FGCV+ G      T     G  +  AVK+LN    +    ++L E   + +  HP
Sbjct: 33  IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86

Query: 200 NLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           N++ L+G C+  +   L+V  +M  G L N + R  +        +   L  AKG+ +L 
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL- 144

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG------TYGY 312
             A K  ++RD    N +LD  +  K++DFGLA+D  +     V  +             
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM--- 199

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGD 367
            A E + T   T+KSDV+SFGV+L E++T G      ++      +    +         
Sbjct: 200 -ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDITVYLL-------- 246

Query: 368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMAS 427
             +  RLL P               ++  +C     + RP  SE+V  +  +        
Sbjct: 247 --QGRRLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI--FSTFIG 295

Query: 428 SSY 430
             Y
Sbjct: 296 EHY 298

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  149 bits (377), Expect = 4e-40
 Identities = 82/284 (28%), Positives = 124/284 (43%), Gaps = 36/284 (12%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL 196
           E  LG+G FG V+ G W   NGT  V        A+KTL   G    + +L E   +  L
Sbjct: 189 EVKLGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKL 236

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
            H  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A G+A+
Sbjct: 237 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 316
           +        ++RD + +NIL+  +   K++DFGLA+   ED +            + APE
Sbjct: 296 V---ERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE 351

Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLL 375
             + G  T KSDV+SFG++L E+ T  R       N E  + VE          R YR+ 
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRMP 401

Query: 376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            P           +    L  QC  ++P+ RP    +   L+  
Sbjct: 402 CPPE-------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  145 bits (367), Expect = 8e-40
 Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 43/261 (16%)

Query: 100 NAESASSTPKFSEELKVASQLRKFMF--NDLKLATRNFRPESLLGEGGFGCVFKGWVEEN 157
           +  S+   P+ SEEL+  ++L   +   N L L         +LGEG FG V +G     
Sbjct: 8   HHHSSGLVPRGSEELQ--NKLEDVVIDRNLLIL-------GKILGEGEFGSVMEG----- 53

Query: 158 GTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR- 214
                + GT L VAVKT+  D    +  +E+L+E   + +  HPN+++L+G CIE   + 
Sbjct: 54  -NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112

Query: 215 ----LLVYEFMPRGSLENHLFRKGSLPLPWSIRMK----IALGAAKGLAFLHEEAEKPVI 266
               +++  FM  G L  +L        P  I ++      +  A G+ +L   + +  +
Sbjct: 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFL 169

Query: 267 YRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTHVSTRVMGTYGYAAPEYVMT 320
           +RD    N +L  D    ++DFGL+K               +  + +      A E +  
Sbjct: 170 HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI------AIESLAD 223

Query: 321 GHLTSKSDVYSFGVVLLEMLT 341
              TSKSDV++FGV + E+ T
Sbjct: 224 RVYTSKSDVWAFGVTMWEIAT 244

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  143 bits (364), Expect = 1e-39
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 40/285 (14%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNL 196
           LG+G FG V +G W   +G         ++VAVK L  D L   +   +++ EVN + +L
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKT-------VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 255
            H NL++L G  +      +V E  P GSL + L   +G   L    R   A+  A+G+ 
Sbjct: 79  DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMG 135

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGY 312
           +L     K  I+RD    N+LL      K+ DFGL +  P++   +V          + +
Sbjct: 136 YL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAW 190

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRF 371
            APE + T   +  SD + FGV L EM T  +         +  + ++         +  
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID---------KEG 241

Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
            RL  P           Q    +  QC +  P+ RP    + + L
Sbjct: 242 ERLPRPED-------CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  143 bits (363), Expect = 2e-39
 Identities = 77/322 (23%), Positives = 128/322 (39%), Gaps = 62/322 (19%)

Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGL--QG 182
             L L  +       LG G FG V KG +  +     V        AVK L ++      
Sbjct: 16  KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTV--------AVKILKNEANDPAL 61

Query: 183 HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSI 242
             E LAE N +  L +P +V+++G C E +  +LV E    G L  +L +   +     I
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120

Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
            +      + G+ +L    E   ++RD    N+LL   + AK+SDFGL+K    D   + 
Sbjct: 121 EL--VHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175

Query: 303 STRVMGTYG------YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPN 352
           +              + APE +     +SKSDV+SFGV++ E  + G++    M      
Sbjct: 176 AQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KG 226

Query: 353 GE-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
            E   ++E          +  R+      G       ++   L   C + D + RP  + 
Sbjct: 227 SEVTAMLE----------KGERM--GCPAG-----CPREMYDLMNLCWTYDVENRPGFAA 269

Query: 412 VVETLKPLQNLKDMASSSYYFQ 433
           V   L+      D+ +  ++  
Sbjct: 270 VELRLRNY--YYDVVNEGHHHH 289

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  144 bits (365), Expect = 2e-39
 Identities = 77/296 (26%), Positives = 129/296 (43%), Gaps = 57/296 (19%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLH 198
           +G G FG V+KG     +G   V       VA+KTL      +   ++L E   +G   H
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVP------VAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFL 257
            N+++L G   +    +++ E+M  G+L+  L  + G   +   + M    G A G+ +L
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM--LRGIAAGMKYL 163

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG------ 311
              A    ++RD    NIL++++   K+SDFGL++   +D +   +T      G      
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIR 215

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLG 366
           + APE +     TS SDV+SFG+V+ E++T G R    +     N E    +        
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVMKAIN------- 264

Query: 367 DKRRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                +RL  P       +          QL  QC  ++   RP+ +++V  L  L
Sbjct: 265 ---DGFRLPTPMDCPSAIY----------QLMMQCWQQERARRPKFADIVSILDKL 307

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  143 bits (362), Expect = 2e-39
 Identities = 69/310 (22%), Positives = 120/310 (38%), Gaps = 53/310 (17%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGN 195
           +  LG G FG V +G +        V        A+K L         +E + E   +  
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 66

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
           L +P +V+L+G C + +  +LV E    G L   L       +P S   ++    + G+ 
Sbjct: 67  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMK 124

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG---- 311
           +L    EK  ++RD    N+LL   + AK+SDFGL+K    D   + +            
Sbjct: 125 YL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWP 176

Query: 312 --YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPH 364
             + APE +     +S+SDV+S+GV + E L+ G++    M       E    +E     
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFIE----- 227

Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL-QNLK 423
                +  R+  P        +   +   L + C     + RP    V + ++    +L 
Sbjct: 228 -----QGKRMECPP-------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275

Query: 424 DMASSSYYFQ 433
                 ++  
Sbjct: 276 SKVEGHHHHH 285

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  143 bits (362), Expect = 2e-39
 Identities = 75/285 (26%), Positives = 127/285 (44%), Gaps = 42/285 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G +G V++G         V     LTVAVKTL  +     +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPN 70

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 260
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--- 127

Query: 261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTHVSTRV----MGTYGYAAP 315
            +K  I+RD    N L+  ++  K++DFGL++    D    H   +            AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------AP 181

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 374
           E +     + KSDV++FGV+L E+ T   S        + + L+E          + YR+
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRM 231

Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
              R EG       +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 232 --ERPEG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  145 bits (368), Expect = 2e-39
 Identities = 82/378 (21%), Positives = 144/378 (38%), Gaps = 59/378 (15%)

Query: 66  SSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMF 125
           S       +  +  +S  K+     +      T + + ++  P+  + ++          
Sbjct: 31  SPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSS-- 88

Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHK 184
             +           ++G G FGCV+ G      T     G  +  AVK+LN    +    
Sbjct: 89  LIVHF-------NEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVS 135

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIR 243
           ++L E   + +  HPN++ L+G C+  +   L+V  +M  G L N + R  +        
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDL 194

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
           +   L  AKG+ FL   A K  ++RD    N +LD  +  K++DFGLA+D  +     V 
Sbjct: 195 IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 251

Query: 304 TRVMG------TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNG 353
            +              A E + T   T+KSDV+SFGV+L E++T G      ++      
Sbjct: 252 NKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TF 303

Query: 354 E-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
           +    +           +  RLL P               ++  +C     + RP  SE+
Sbjct: 304 DITVYLL----------QGRRLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSEL 346

Query: 413 VETLKPLQNLKDMASSSY 430
           V  +  +          Y
Sbjct: 347 VSRISAI--FSTFIGEHY 362

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  143 bits (364), Expect = 3e-39
 Identities = 78/307 (25%), Positives = 122/307 (39%), Gaps = 56/307 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E +   P +      VAVK L        +++  E   L  L H +
Sbjct: 49  LGEGAFGKVFLA--ECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL---------FRKGSLPLPWSIRMK----IA 247
           +V+  G C E    L+V+E+M  G L   L            G    P  + +     +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTH 301
              A G+ +L   A    ++RD  T N L+      K+ DFG+++D          G+T 
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221

Query: 302 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGEHNL 357
           +  R M       PE ++    T++SDV+SFGVVL E+ T G++    +     N E   
Sbjct: 222 LPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL----SNTE--A 269

Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
           ++          +   L  PR           +   +   C  R+P+ R  + +V   L+
Sbjct: 270 IDCI-------TQGRELERPR-------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315

Query: 418 PLQNLKD 424
            L     
Sbjct: 316 ALAQAPP 322

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  146 bits (370), Expect = 4e-39
 Identities = 76/285 (26%), Positives = 125/285 (43%), Gaps = 48/285 (16%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG V  G +             G  VAVK + +D     + +LAE + +  L H 
Sbjct: 201 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 246

Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           NLV+L+G  +E+   L +V E+M +GSL ++L  +G   L     +K +L   + + +L 
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 305

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTHVSTRVMGTYGYAAP 315
                  ++RD    N+L+  D  AK+SDFGL K+     + GK  V  +        AP
Sbjct: 306 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV--KWT------AP 355

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 374
           E +     ++KSDV+SFG++L E+ +  R      P  +    VE          + Y++
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----------KGYKM 405

Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
             P                +   C   D   RP   ++ E L+ +
Sbjct: 406 DAPDG-------CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  141 bits (359), Expect = 5e-39
 Identities = 79/305 (25%), Positives = 133/305 (43%), Gaps = 60/305 (19%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           LGEG FG V++G            G  + VAVKT   D    +K ++++E   + NL HP
Sbjct: 20  LGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           ++VKL+G   E+    ++ E  P G L ++L   K SL +   +    +L   K +A+L 
Sbjct: 74  HIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYL- 129

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-----GKTHVSTRVMGTYGYA 313
                  ++RD    NIL+ +    KL DFGL++   ++       T +  + M      
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------ 181

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDK 368
           +PE +     T+ SDV+ F V + E+L+ G++    ++    N +   ++E         
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE----NKDVIGVLE--------- 228

Query: 369 RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDM 425
            +  RL  P L     +           L  +C   DP  RPR +E+V +   L ++  M
Sbjct: 229 -KGDRLPKPDLCPPVLY----------TLMTRCWDYDPSDRPRFTELVCS---LSDVYQM 274

Query: 426 ASSSY 430
                
Sbjct: 275 EKDIA 279

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  142 bits (360), Expect = 6e-39
 Identities = 72/304 (23%), Positives = 125/304 (41%), Gaps = 52/304 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG V+ G          +    +  A+K+L+    +Q  + +L E   +  L HP
Sbjct: 29  IGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82

Query: 200 NLVKLVGYCIEDD-QRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFL 257
           N++ L+G  +  +    ++  +M  G L   +   + +  +   I     L  A+G+ +L
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGMEYL 140

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG------TYG 311
              AE+  ++RD    N +LD  +  K++DFGLA+D  +     V            T  
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-- 195

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLG 366
             A E + T   T+KSDV+SFGV+L E+LT G      +D      +  + +        
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----PFDLTHFLA------- 242

Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMA 426
              +  RL  P               Q+  QC   DP  RP    +V  ++ +  +  + 
Sbjct: 243 ---QGRRLPQPE-------YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI--VSALL 290

Query: 427 SSSY 430
              Y
Sbjct: 291 GDHY 294

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  141 bits (359), Expect = 9e-39
 Identities = 86/305 (28%), Positives = 130/305 (42%), Gaps = 57/305 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LGEG FG VF    E    +P K      VAVK L    L   K++  E   L NL H +
Sbjct: 23  LGEGAFGKVFLA--ECYNLSPTKDKM--LVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------------FRKGSLPLPWSIRMKI 246
           +VK  G C + D  ++V+E+M  G L   L               R+    L  S  + I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKT 300
           A   A G+ +L   A +  ++RD  T N L+ A+   K+ DFG+++D          G T
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGEHN 356
            +  R M       PE +M    T++SDV+SFGV+L E+ T G++    +     N E  
Sbjct: 196 MLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL----SNTE-- 243

Query: 357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           ++E          +   L  PR          ++   +   C  R+P+ R  + E+ + L
Sbjct: 244 VIECI-------TQGRVLERPR-------VCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289

Query: 417 KPLQN 421
             L  
Sbjct: 290 HALGK 294

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  142 bits (359), Expect = 1e-38
 Identities = 77/292 (26%), Positives = 118/292 (40%), Gaps = 49/292 (16%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 190
           NFR E  +G G F  V++               G+ VA+K +    L   K     + E+
Sbjct: 33  NFRIEKKIGRGQFSEVYRA---------ACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIAL 248
           + L  L HPN++K     IED++  +V E    G L   +  F+K    +P     K  +
Sbjct: 84  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
                L  +H    + V++RD K +N+ + A    KL D GL +       T   + V G
Sbjct: 144 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLV-G 198

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
           T  Y +PE +       KSD++S G +L EM   +                   P  GDK
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDK 240

Query: 369 RRFYRLL--------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
              Y L          P    H+    S++  QL   C++ DP+ RP ++ V
Sbjct: 241 MNLYSLCKKIEQCDYPPLPSDHY----SEELRQLVNMCINPDPEKRPDVTYV 288

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  140 bits (356), Expect = 1e-38
 Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 56/291 (19%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +G+G FG V  G +             G  VAVK + +D     + +LAE + +  L H 
Sbjct: 29  IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 74

Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           NLV+L+G  +E+   L +V E+M +GSL ++L  +G   L     +K +L   + + +L 
Sbjct: 75  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 133

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTHVSTRVMGTYGYAAP 315
                  ++RD    N+L+  D  AK+SDFGL K+     + GK  V  +        AP
Sbjct: 134 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV--KWT------AP 183

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDKRR 370
           E +     ++KSDV+SFG++L E+ + GR     +    P  +    VE          +
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVE----------K 229

Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 421
            Y++  P               ++   C   D   RP   ++ E L+ ++ 
Sbjct: 230 GYKMDAPDG-------CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  142 bits (359), Expect = 2e-38
 Identities = 70/329 (21%), Positives = 128/329 (38%), Gaps = 74/329 (22%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLH 198
           LG+G FG V +           + G+ + VAVK L  D +     +E+L E   +    H
Sbjct: 31  LGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84

Query: 199 PNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHLFRKGSLPLPWSIRMK----IAL 248
           P++ KLVG  +    +      +++  FM  G L   L        P+++ ++      +
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTHV 302
             A G+ +L   + +  I+RD    N +L  D    ++DFGL++             + +
Sbjct: 145 DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201

Query: 303 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNL 357
             + +      A E +     T  SDV++FGV + E++T G+     ++    N E +N 
Sbjct: 202 PVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE----NAEIYNY 251

Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
           +              RL  P        +  ++   L  QC S DPK RP  + +   L+
Sbjct: 252 LI----------GGNRLKQPP-------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294

Query: 418 PL---------------QNLKDMASSSYY 431
            +                N++      ++
Sbjct: 295 NILGHLSVLSTSQDPLYINIERAHHHHHH 323

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  140 bits (356), Expect = 2e-38
 Identities = 65/283 (22%), Positives = 107/283 (37%), Gaps = 41/283 (14%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 190
           R  + +  +G G F  V+KG   E         T + VA   L    L     + +  E 
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEA 76

Query: 191 NFLGNLLHPNLVKLVGYCI---EDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIRMKI 246
             L  L HPN+V+         +  + +++  E M  G+L+ +L R     +   +    
Sbjct: 77  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSW 134

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFGLAKDAPEDGKTHVSTR 305
                KGL FLH     P+I+RD K  NI +     + K+ D GLA       +   +  
Sbjct: 135 CRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKA 189

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPH 364
           V+GT  + APE     +     DVY+FG+ +LEM T         P +   N  +     
Sbjct: 190 VIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSE------YPYSECQNAAQI---- 238

Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
                 + R+        F      +  ++   C+ ++   R 
Sbjct: 239 ------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY 275

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  140 bits (355), Expect = 2e-38
 Identities = 76/291 (26%), Positives = 117/291 (40%), Gaps = 51/291 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 199
           +GEG FG V +G               L VA+KT  +      + ++L E   +    HP
Sbjct: 23  IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 258
           ++VKL+G   E+    ++ E    G L + L  RK SL L   I    A   +  LA+L 
Sbjct: 77  HIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY--AYQLSTALAYL- 132

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-----GKTHVSTRVMGTYGYA 313
               K  ++RD    N+L+ ++   KL DFGL++   +       K  +  + M      
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------ 184

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDK 368
           APE +     TS SDV+ FGV + E+L  G +    +     N +    +E         
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIE--------- 231

Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
               RL  P                L  +C + DP  RPR +E+   L  +
Sbjct: 232 -NGERL--PMPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  140 bits (355), Expect = 3e-38
 Identities = 71/307 (23%), Positives = 116/307 (37%), Gaps = 60/307 (19%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGE  FG V+KG     G AP +      VA+KTL         +E+  E      L HP
Sbjct: 17  LGEDRFGKVYKG--HLFGPAPGEQTQ--AVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL----------FRKGSLPLPWSIRMK---- 245
           N+V L+G   +D    +++ +   G L   L                 +  ++       
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GK 299
           +    A G+ +L   +   V+++D  T N+L+    N K+SD GL ++          G 
Sbjct: 133 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189

Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE- 354
           + +  R M      APE +M G  +  SD++S+GVVL E+ + G +          N + 
Sbjct: 190 SLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----SNQDV 239

Query: 355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
             ++               L  P                L  +C +  P  RPR  ++  
Sbjct: 240 VEMIR----------NRQVLPCPD-------DCPAWVYALMIECWNEFPSRRPRFKDIHS 282

Query: 415 TLKPLQN 421
            L+   N
Sbjct: 283 RLRAWGN 289

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  145 bits (367), Expect = 3e-38
 Identities = 82/292 (28%), Positives = 125/292 (42%), Gaps = 39/292 (13%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG+G FG V+ G W   NGT  V        A+KTL   G    + +L E   +  L H 
Sbjct: 275 LGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKLRHE 322

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            LV+L     E+    +V E+M +GSL + L  +    L     + +A   A G+A++  
Sbjct: 323 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-- 379

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 319
                 ++RD + +NIL+  +   K++DFGLA+   ED +            + APE  +
Sbjct: 380 -ERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAAL 437

Query: 320 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPR 378
            G  T KSDV+SFG++L E+ T  R       N E  + VE          R YR+  P 
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRMPCPP 487

Query: 379 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSY 430
                     +    L  QC  ++P+ RP    +      L++        Y
Sbjct: 488 E-------CPESLHDLMCQCWRKEPEERPTFEYLQAF---LEDYFTSTEPQY 529

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  140 bits (354), Expect = 4e-38
 Identities = 66/305 (21%), Positives = 112/305 (36%), Gaps = 55/305 (18%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 192
           +F P   LG GGFG VF+                   A+K +     +  +E  + EV  
Sbjct: 6   DFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56

Query: 193 LGNLLHPNLVKLVGYCIEDD---------QRLLVY---EFMPRGSLENHL-FRKGSLPLP 239
           L  L HP +V+     +E +          ++ +Y   +   + +L++ +  R       
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK------- 292
            S+ + I L  A+ + FLH    K +++RD K SNI    D   K+ DFGL         
Sbjct: 117 RSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173

Query: 293 ---DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 349
                         T  +GT  Y +PE +     + K D++S G++L E+L         
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------- 225

Query: 350 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 409
             + +   V               + + +    F+ K       +    LS  P  RP  
Sbjct: 226 PFSTQMERVR----------TLTDVRNLKFPPLFTQK-YPCEYVMVQDMLSPSPMERPEA 274

Query: 410 SEVVE 414
             ++E
Sbjct: 275 INIIE 279

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  141 bits (358), Expect = 5e-38
 Identities = 76/293 (25%), Positives = 131/293 (44%), Gaps = 52/293 (17%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL 196
           + ++G G FG V  G ++      +       VA+KTL      +  +++L E + +G  
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEIS------VAIKTLKVGYTEKQRRDFLGEASIMGQF 103

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
            HPN+++L G   +    ++V E+M  GSL++ L RK          + +  G A G+ +
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYA 313
           L   ++   ++RD    NIL++++   K+SDFGL +   +D +   +TR  G      + 
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWT 217

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDK 368
           +PE +     TS SDV+S+G+VL E+++ G R    M     N +    V+         
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS----NQDVIKAVD--------- 264

Query: 369 RRFYRLLDPRLEG-----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
              YRL  P         +          QL   C  +D   RP+  ++V  L
Sbjct: 265 -EGYRL--PPPMDCPAALY----------QLMLDCWQKDRNNRPKFEQIVSIL 304

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  139 bits (352), Expect = 6e-38
 Identities = 81/284 (28%), Positives = 126/284 (44%), Gaps = 42/284 (14%)

Query: 141 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V+ G +   NG   V        AVK+L   G      +LAE N +  L H 
Sbjct: 21  LGAGQFGEVWMGYY---NGHTKV--------AVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
            LV+L     ++    ++ E+M  GSL + L     + L  +  + +A   A+G+AF+  
Sbjct: 69  RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-- 125

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAPE 316
             E+  I+RD + +NIL+    + K++DFGLA+   ++      T   G      + APE
Sbjct: 126 -EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWTAPE 180

Query: 317 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLL 375
            +  G  T KSDV+SFG++L E++T  R       N E    +E          R YR+ 
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE----------RGYRM- 229

Query: 376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
             R +        ++  QL   C    P+ RP    +   L+  
Sbjct: 230 -VRPDN-----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  139 bits (352), Expect = 8e-38
 Identities = 62/312 (19%), Positives = 109/312 (34%), Gaps = 66/312 (21%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
             +F   ++LG+G FG V K                   A+K + H   +     L+EV 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEK-LSTILSEVM 54

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRL-------------LVYEFMPRGSLENHLFRKGSLPL 238
            L +L H  +V+     +E    +             +  E+   G+L + +  +     
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114

Query: 239 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK------ 292
                 ++     + L+++H    + +I+RD K  NI +D   N K+ DFGLAK      
Sbjct: 115 RDEYW-RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170

Query: 293 -------DAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEMLTGR 343
                          ++++ + GT  Y A E V+  TGH   K D+YS G++  EM+   
Sbjct: 171 DILKLDSQNLPGSSDNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYP- 227

Query: 344 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL---DPRLEGHFSIKGSQKATQLAAQCLS 400
                   +     V              + L          F     +   ++    + 
Sbjct: 228 -------FSTGMERVN-----------ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLID 269

Query: 401 RDPKARPRMSEV 412
            DP  RP    +
Sbjct: 270 HDPNKRPGARTL 281

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  142 bits (360), Expect = 1e-37
 Identities = 79/296 (26%), Positives = 125/296 (42%), Gaps = 41/296 (13%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL 196
           E  LG G FG V+   +   N    V        AVKT+   G    + +LAE N +  L
Sbjct: 193 EKKLGAGQFGEVWMATY---NKHTKV--------AVKTM-KPGSMSVEAFLAEANVMKTL 240

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 256
            H  LVKL     ++    ++ EFM +GSL + L        P    +  +   A+G+AF
Sbjct: 241 QHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299

Query: 257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTHVSTRVMGTYGYAAP 315
           +    ++  I+RD + +NIL+ A    K++DFGLA+   ++        +      + AP
Sbjct: 300 I---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP--IKWTAP 354

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 374
           E +  G  T KSDV+SFG++L+E++T  R       N E    +E          R YR+
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE----------RGYRM 404

Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSY 430
             P           ++   +  +C    P+ RP    +      L +      S Y
Sbjct: 405 PRPEN-------CPEELYNIMMRCWKNRPEERPTFEYIQSV---LDDFYTATESQY 450

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  140 bits (354), Expect = 1e-37
 Identities = 65/358 (18%), Positives = 128/358 (35%), Gaps = 38/358 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 190
            +     +GEG FG                   G    +K +N   +   KE      EV
Sbjct: 25  KYVRLQKIGEGSFGKAILV---------KSTEDGRQYVIKEINISRMS-SKEREESRREV 74

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
             L N+ HPN+V+      E+    +V ++   G L   +  +  +       +   +  
Sbjct: 75  AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
              L  +H+   + +++RD K+ NI L  D   +L DFG+A+    +    ++   +GT 
Sbjct: 135 CLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTP 189

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 370
            Y +PE        +KSD+++ G VL E+ T + + +          +            
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF------- 242

Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNLKDMASS 428
                 P +  H+    S     L +Q   R+P+ RP ++ ++E   +            
Sbjct: 243 ------PPVSLHY----SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292

Query: 429 SYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPK 486
                 ++  + +         R   G  + +  P + ++ P   +  P  + +   K
Sbjct: 293 IAEEFCLKTFSKFG-SQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYGDK 349

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  144 bits (366), Expect = 2e-37
 Identities = 75/294 (25%), Positives = 117/294 (39%), Gaps = 51/294 (17%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 196
              +GEG FG V +G               + VA+KT  +       +++L E   +   
Sbjct: 395 GRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 448

Query: 197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 255
            HP++VKL+G   E+    ++ E    G L + L  RK SL L   I    A   +  LA
Sbjct: 449 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILY--AYQLSTALA 505

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-----GKTHVSTRVMGTY 310
           +L     K  ++RD    N+L+ ++   KL DFGL++   +       K  +  + M   
Sbjct: 506 YL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM--- 559

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHL 365
              APE +     TS SDV+ FGV + E+L  G +    +     N +    +E      
Sbjct: 560 ---APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIE------ 606

Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                  RL  P                L  +C + DP  RPR +E+   L  +
Sbjct: 607 ----NGERL--PMPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  139 bits (352), Expect = 2e-37
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 33/223 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 198
           LGEG FG V     E  G    KP   +TVAVK L  D   +   + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------------FRKGSLPLPWSIRM 244
            N++ L+G C +D    ++ E+  +G+L  +L               R     + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTHV 302
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D       K   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217

Query: 303 STRV----MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
           + R+    M      APE +     T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  139 bits (353), Expect = 3e-37
 Identities = 90/400 (22%), Positives = 157/400 (39%), Gaps = 63/400 (15%)

Query: 45  IGCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESA 104
           +G            P+  K+   +          +SS+    + P+V +++  +S A++ 
Sbjct: 1   MGSSHHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTP 60

Query: 105 SSTPKFSEELKVASQLRKFMF--NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPV 162
                   EL    +  K+ F  + L L          LGEG FG V     E  G    
Sbjct: 61  MLAGVSEYEL---PEDPKWEFPRDKLTL-------GKPLGEGCFGQVVMA--EAVGIDKD 108

Query: 163 KPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEF 220
           KP   +TVAVK L  D   +   + ++E+  +  +  H N++ L+G C +D    ++ E+
Sbjct: 109 KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 168

Query: 221 MPRGSLENHL--------------FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVI 266
             +G+L  +L               R     + +   +      A+G+ +L   A +  I
Sbjct: 169 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCI 225

Query: 267 YRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTHVSTRV----MGTYGYAAPEYVMT 320
           +RD    N+L+  +   K++DFGLA+D       K   + R+    M      APE +  
Sbjct: 226 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------APEALFD 279

Query: 321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPRL 379
              T +SDV+SFGV++ E+ T   S     P  E   L+          +  +R+  P  
Sbjct: 280 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL----------KEGHRMDKPA- 328

Query: 380 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                   + +   +   C    P  RP   ++VE L  +
Sbjct: 329 ------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  139 bits (353), Expect = 3e-37
 Identities = 81/314 (25%), Positives = 126/314 (40%), Gaps = 51/314 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 198
           LGEG FG V     E  G    KP     VAVK L  D   +   + ++E+  +  +  H
Sbjct: 77  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL----------FRKGSLPLPWSIRMK--- 245
            N++ L+G C +D    ++ E+  +G+L  +L              S      +  K   
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 246 -IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTHV 302
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D       K   
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251

Query: 303 STRV----MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNL 357
           + R+    M      APE +     T +SDV+SFGV+L E+ T   S     P  E   L
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305

Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
           ++            +R+   +         + +   +   C    P  RP   ++VE L 
Sbjct: 306 LK----------EGHRM--DKPSNC-----TNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348

Query: 418 PLQNLKDMASSSYY 431
            +  L       YY
Sbjct: 349 RIVALTSNQEMGYY 362

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  136 bits (344), Expect = 2e-36
 Identities = 79/313 (25%), Positives = 124/313 (39%), Gaps = 54/313 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V  +G           VAVKTL      Q   ++L E   +    H 
Sbjct: 38  LGHGAFGEVYEGQV--SGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMK----IALGAAKGL 254
           N+V+ +G  ++   R ++ E M  G L++ L   +     P S+ M     +A   A G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPED------GKTHVSTR 305
            +L    E   I+RD    N LL        AK+ DFG+A+D          G   +  +
Sbjct: 154 QYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEW 360
            M       PE  M G  TSK+D +SFGV+L E+ + G     S      N E    V  
Sbjct: 211 WM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SNQEVLEFV-- 258

Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 420
                       R+  P+              ++  QC    P+ RP  + ++E ++   
Sbjct: 259 --------TSGGRMDPPK-------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303

Query: 421 NLKDMASSSYYFQ 433
              D+ +++   +
Sbjct: 304 QDPDVINTALPIE 316

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  135 bits (343), Expect = 3e-36
 Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 63/304 (20%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 196
           + ++GEG FG V K  ++       K G  +  A+K +        H+++  E+  L  L
Sbjct: 30  QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82

Query: 197 L-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------------FRKGSLPLPWS 241
             HPN++ L+G C       L  E+ P G+L + L                  +  L   
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 301
             +  A   A+G+ +L   ++K  I+RD    NIL+  +Y AK++DFGL++      K  
Sbjct: 143 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 199

Query: 302 VSTRV----MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNG 353
              R+    M      A E +     T+ SDV+S+GV+L E+++ G      M       
Sbjct: 200 -MGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TCA 248

Query: 354 E-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
           E +  +           + YRL  P            +   L  QC    P  RP  +++
Sbjct: 249 ELYEKLP----------QGYRLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQI 291

Query: 413 VETL 416
           + +L
Sbjct: 292 LVSL 295

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  140 bits (354), Expect = 4e-36
 Identities = 67/289 (23%), Positives = 114/289 (39%), Gaps = 44/289 (15%)

Query: 138 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGN 195
           +  LG G FG V +G +        V        A+K L         +E + E   +  
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 392

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
           L +P +V+L+G C + +  +LV E    G L   L       +P S   ++    + G+ 
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMK 450

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGY 312
           +L    EK  ++R+    N+LL   + AK+SDFGL+K    D   + +           +
Sbjct: 451 YL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKW 505

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRF 371
            APE +     +S+SDV+S+GV + E L+  +   K     E    +E          + 
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE----------QG 555

Query: 372 YRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
            R+  P     E +           L + C     + RP    V + ++
Sbjct: 556 KRMECPPECPPELY----------ALMSDCWIYKWEDRPDFLTVEQRMR 594

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  135 bits (342), Expect = 7e-36
 Identities = 77/299 (25%), Positives = 119/299 (39%), Gaps = 54/299 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LG G FG V++G V  +G           VAVKTL      Q   ++L E   +    H 
Sbjct: 79  LGHGAFGEVYEGQV--SGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---KGSLPLPWSIR--MKIALGAAKGL 254
           N+V+ +G  ++   R ++ E M  G L++ L     + S P   ++   + +A   A G 
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPED------GKTHVSTR 305
            +L    E   I+RD    N LL        AK+ DFG+A+D          G   +  +
Sbjct: 195 QYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEW 360
            M       PE  M G  TSK+D +SFGV+L E+ + G     S      N E    V  
Sbjct: 252 WM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SNQEVLEFV-- 299

Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                       R+  P+              ++  QC    P+ RP  + ++E ++  
Sbjct: 300 --------TSGGRMDPPK-------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  133 bits (337), Expect = 9e-36
 Identities = 68/321 (21%), Positives = 117/321 (36%), Gaps = 57/321 (17%)

Query: 94  SSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGW 153
           S  +T   +  S   ++  E                          +LG+G +G V+ G 
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYD------------------ENGDRVVLGKGTYGIVYAG- 41

Query: 154 VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ 213
                         + +A+K +     +  +    E+    +L H N+V+ +G   E+  
Sbjct: 42  --------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93

Query: 214 RLLVYEFMPRGSLENHLFRK-GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT 272
             +  E +P GSL   L  K G L               +GL +LH+     +++RD K 
Sbjct: 94  IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKG 150

Query: 273 SNILLDA-DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV---MTGHLTSKSD 328
            N+L++      K+SDFG +K          +    GT  Y APE +     G+    +D
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGY-GKAAD 207

Query: 329 VYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--HLGDKRRFYRLLDPRLEGHFSIK 386
           ++S G  ++EM TG+       P   + L E       +G  +     + P +       
Sbjct: 208 IWSLGCTIIEMATGK------PPF--YELGEPQAAMFKVGMFK-----VHPEIPESM--- 251

Query: 387 GSQKATQLAAQCLSRDPKARP 407
            S +A     +C   DP  R 
Sbjct: 252 -SAEAKAFILKCFEPDPDKRA 271

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  133 bits (337), Expect = 1e-35
 Identities = 78/307 (25%), Positives = 116/307 (37%), Gaps = 60/307 (19%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 198
           LG G FG V +      G          TVAVK L     L   +  ++E+  L  L  H
Sbjct: 31  LGAGAFGKVVEA--TAYGLIKSDAAM--TVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL----------------FRKGSLPLPWSI 242
            N+V L+G C      L++ E+   G L N L                     L L    
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED----- 297
            +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D     
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 298 -GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPN 352
            G   +  + M      APE +     T +SDV+S+G+ L E+ + G      M  +   
Sbjct: 204 KGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255

Query: 353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                 +     +   +  +R+L P            +   +   C   DP  RP   ++
Sbjct: 256 ---KFYK----MI---KEGFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQI 298

Query: 413 VETLKPL 419
           V+ ++  
Sbjct: 299 VQLIEKQ 305

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  133 bits (337), Expect = 2e-35
 Identities = 69/342 (20%), Positives = 116/342 (33%), Gaps = 54/342 (15%)

Query: 78  GKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRP 137
           G  S+ +      +  + ++ S             E  + ++  K +  + +        
Sbjct: 3   GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH 62

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 197
           +  +G G FG V +              TG   AVK +    L+  +    E+     L 
Sbjct: 63  QPRVGRGSFGEVHRM---------KDKQTGFQCAVKKVR---LEVFRV--EELVACAGLS 108

Query: 198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
            P +V L G   E     +  E +  GSL   + + G   LP    +     A +GL +L
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYL 166

Query: 258 HEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTR---VMGTYGYA 313
           H      +++ D K  N+LL +D   A L DFG A     DG          + GT  + 
Sbjct: 167 HTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223

Query: 314 APEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-------LVEWARPHL 365
           APE VM      +K D++S   ++L ML G        P  ++        +     P  
Sbjct: 224 APEVVMGKPC-DAKVDIWSSCCMMLHMLNGC------HPWTQYFRGPLCLKIASEPPPI- 275

Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
                        +        +    Q   + L ++P  R 
Sbjct: 276 -----------REIPPSC----APLTAQAIQEGLRKEPVHRA 302

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  132 bits (333), Expect = 2e-35
 Identities = 65/290 (22%), Positives = 111/290 (38%), Gaps = 36/290 (12%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 190
            ++     +G G +G   K  +            G  +  K L++  +     +  ++EV
Sbjct: 6   EDYEVLYTIGTGSYGRCQK--IRRKSD-------GKILVWKELDYGSMTEAEKQMLVSEV 56

Query: 191 NFLGNLLHPNLVKLVG-YCIEDDQRL-LVYEFMPRGSLENHL--FRKGSLPLPWSIRMKI 246
           N L  L HPN+V+         +  L +V E+   G L + +    K    L     +++
Sbjct: 57  NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116

Query: 247 ALGAAKGLAFLHE--EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
                  L   H   +    V++RD K +N+ LD   N KL DFGLA+       +   T
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT 175

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
            V GT  Y +PE +       KSD++S G +L E+           P    +  E A   
Sbjct: 176 FV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKI 228

Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
              K         R+   +    S +  ++  + L+     RP + E++E
Sbjct: 229 REGKF-------RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 267

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  134 bits (339), Expect = 3e-35
 Identities = 74/361 (20%), Positives = 128/361 (35%), Gaps = 67/361 (18%)

Query: 69  SGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDL 128
           SG     +  K +   + +R  +      T + + ASS+                    +
Sbjct: 8   SGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSAN----------------ECI 51

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEW 186
            +  R +     +G GG   VF+          V        A+K +N +    Q    +
Sbjct: 52  SVKGRIYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQTLDSY 101

Query: 187 LAEVNFLGNLLHPNL--VKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
             E+ +L  L   +   ++L  Y    DQ + +V E      L + L +K S+      R
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--R 157

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
                   + +  +H+     +++ D K +N L+  D   KL DFG+A     D  + V 
Sbjct: 158 KSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 213

Query: 304 TRVMGTYGYAAPEYVM-----------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP- 351
              +G   Y  PE +               ++ KSDV+S G +L  M  G+       P 
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPF 267

Query: 352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
               N +           + + ++DP  E  F     +    +   CL RDPK R  + E
Sbjct: 268 QQIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 317

Query: 412 V 412
           +
Sbjct: 318 L 318

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  132 bits (335), Expect = 3e-35
 Identities = 66/305 (21%), Positives = 113/305 (37%), Gaps = 51/305 (16%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH- 183
           F  + +  R +     +G GG   VF+  + E              A+K +N +      
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQ---------IYAIKYVNLEEADNQT 69

Query: 184 -KEWLAEVNFLGNLLHPNL--VKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP 239
              +  E+ +L  L   +   ++L  Y    DQ + +V E      L + L +K S+   
Sbjct: 70  LDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWLKKKKSIDPW 127

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
                       + +  +H+     +++ D K +N L+  D   KL DFG+A     D  
Sbjct: 128 ER--KSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181

Query: 300 THVSTRVMGTYGYAAPEYVM-----------TGHLTSKSDVYSFGVVLLEMLTGRRSMDK 348
           + V    +GT  Y  PE +               ++ KSDV+S G +L  M  G+     
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK----- 236

Query: 349 NRP-NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
             P     N +           + + ++DP  E  F     +    +   CL RDPK R 
Sbjct: 237 -TPFQQIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 285

Query: 408 RMSEV 412
            + E+
Sbjct: 286 SIPEL 290

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  132 bits (334), Expect = 3e-35
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 20/214 (9%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EV 190
           +R   L+G GG G V++                  VA+K +  + L     +      E 
Sbjct: 36  YRLRRLVGRGGMGDVYEA---------EDTVRERIVALKLM-SETLSSDPVFRTRMQREA 85

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
              G L  P++V +  +   D Q  +    +    L   L R+G L  P ++   I    
Sbjct: 86  RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA--IVRQI 143

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
              L   H        +RD K  NIL+ AD  A L DFG+A    ++  T +    +GT 
Sbjct: 144 GSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTL 199

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 344
            Y APE     H T ++D+Y+   VL E LTG  
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSP 233

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  132 bits (334), Expect = 4e-35
 Identities = 79/306 (25%), Positives = 118/306 (38%), Gaps = 59/306 (19%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 198
           LG G FG V +   +  G          TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQVIEA--DAFGIDKTATCR--TVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 199 PNLVKLVGYCIEDDQ-RLLVYEFMPRGSLENHL--------------FRKGSLPLPWSIR 243
            N+V L+G C +     +++ EF   G+L  +L                     L     
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTH 301
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207

Query: 302 VSTRV----MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNG 353
              R+    M      APE +     T +SDV+SFGV+L E+ + G      +  +    
Sbjct: 208 GDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---- 257

Query: 354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
                      L   +   R+  P          + +  Q    C   +P  RP  SE+V
Sbjct: 258 -EEFCR----RL---KEGTRMRAPD-------YTTPEMYQTMLDCWHGEPSQRPTFSELV 302

Query: 414 ETLKPL 419
           E L  L
Sbjct: 303 EHLGNL 308

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  133 bits (336), Expect = 4e-35
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 42/230 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           +GEG FG VF+      G  P +P T   VAVK L  +       ++  E   +    +P
Sbjct: 55  IGEGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------------------FRKGSLPLPWS 241
           N+VKL+G C       L++E+M  G L   L                    + S P P  
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 242 IRMK----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 297
           +       IA   A G+A+L   +E+  ++RD  T N L+  +   K++DFGL+++    
Sbjct: 171 LSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 298 ------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                 G   +  R M       PE +     T++SDV+++GVVL E+ +
Sbjct: 228 DYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  132 bits (335), Expect = 4e-35
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 33/221 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 198
           LG G FG V +           K    L VAVK L         +  ++E+  + +L  H
Sbjct: 54  LGAGAFGKVVEATAFG----LGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------------FRKGSLPLPWSIRMKI 246
            N+V L+G C      L++ E+   G L N L            F   +        +  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKT 300
           +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D      G  
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226

Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
            +  + M      APE +     T +SDV+S+G++L E+ +
Sbjct: 227 RLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  131 bits (331), Expect = 7e-35
 Identities = 74/292 (25%), Positives = 119/292 (40%), Gaps = 42/292 (14%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGL--TVAVKTLNHDGLQGHKEWLA---- 188
           ++    LG GG   V+               T L   VA+K +     +  +E L     
Sbjct: 13  YKIVDKLGGGGMSTVYLAE-----------DTILNIKVAIKAI-FIPPREKEETLKRFER 60

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           EV+    L H N+V ++    EDD   LV E++   +L  ++   G L +  +I      
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN--FTN 118

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
               G+   H+     +++RD K  NIL+D++   K+ DFG+AK   E   T  +  V+G
Sbjct: 119 QILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLG 174

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGD 367
           T  Y +PE          +D+YS G+VL EML G        P NGE   V  A  H+ D
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE------PPFNGE-TAVSIAIKHIQD 227

Query: 368 KR-RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETLK 417
                   +   +         Q  + +  +   +D   R + + E+ + L 
Sbjct: 228 SVPNVTTDVRKDI--------PQSLSNVILRATEKDKANRYKTIQEMKDDLS 271

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  131 bits (331), Expect = 1e-34
 Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 42/230 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 199
           LGEG FG V K              T  TVAVK L  +      ++ L+E N L  + HP
Sbjct: 31  LGEGEFGKVVKA--TAFHLKGRAGYT--TVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL----------------------FRKGSLP 237
           +++KL G C +D   LL+ E+   GSL   L                             
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 238 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 297
           L     +  A   ++G+ +L   AE  +++RD    NIL+      K+SDFGL++D  E+
Sbjct: 147 LTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 298 ------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
                  +  +  + M      A E +     T++SDV+SFGV+L E++T
Sbjct: 204 DSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  132 bits (332), Expect = 2e-34
 Identities = 50/390 (12%), Positives = 83/390 (21%), Gaps = 63/390 (16%)

Query: 78  GKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRP 137
           G S       R    +        +  ++  +              + + L    R  + 
Sbjct: 7   GDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKL 66

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLG 194
              L  G    VF                    A+K           E            
Sbjct: 67  VEPLRVGDRSVVFLV---------RDVERLEDFALKVFTMGAENSRSELERLHEATFAAA 117

Query: 195 NLLHPNLVKLVGYC-----------------------IEDDQRLLVYEFMPR--GSLEN- 228
            LL  +  +                             +D         MP     LE  
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL 177

Query: 229 ----HLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 284
                                +     +  A L     K +++  F   N+ +  D    
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLM 234

Query: 285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTG 342
           L D          G             YA  E++       T   + +  G+ +  +   
Sbjct: 235 LGDVSALWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289

Query: 343 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRD 402
                   P  +     W RP L             L              L  + L+ D
Sbjct: 290 FLPFGLVTPGIKG---SWKRPSLRVPGT------DSLAFGSCTPLPDFVKTLIGRFLNFD 340

Query: 403 PKARPRMSEVVET--LKPLQNLKDMASSSY 430
            + R    E +ET     LQN    + S+ 
Sbjct: 341 RRRRLLPLEAMETPEFLQLQNEISSSLSTG 370

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  130 bits (329), Expect = 3e-34
 Identities = 64/290 (22%), Positives = 107/290 (36%), Gaps = 51/290 (17%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLL 197
            +G GG   VF+                   A+K +N +         +  E+ +L  L 
Sbjct: 16  QIGSGGSSKVFQV----------LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65

Query: 198 HPNL--VKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
             +   ++L  Y    DQ + +V E      L + L +K S+      R        + +
Sbjct: 66  QHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--RKSYWKNMLEAV 121

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
             +H+     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  
Sbjct: 122 HTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 315 PEYVM-----------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWAR 362
           PE +               ++ KSDV+S G +L  M  G+       P     N +    
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQIS--- 228

Query: 363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 412
                  + + ++DP  E  F     +    +   CL RDPK R  + E+
Sbjct: 229 -------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  131 bits (331), Expect = 4e-34
 Identities = 68/340 (20%), Positives = 115/340 (33%), Gaps = 55/340 (16%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
           +LG+G    VF+G             TG   A+K  N+       +  + E   L  L H
Sbjct: 16  ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 199 PNLVKLVGYCIEDDQR----LLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKG 253
            N+VKL  + IE++      +L+ EF P GSL   L    +   LP S  + +      G
Sbjct: 67  KNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 254 LAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +  L E     +++R+ K  NI+     D     KL+DFG A++  +D +    +   GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GT 178

Query: 310 YGYAAPEYVMTGHL--------TSKSDVYSFGVVLLEMLTGRR-------------SMDK 348
             Y  P+      L         +  D++S GV      TG                M K
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238

Query: 349 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 408
                    +   +        +   +        S       T + A  L  D +    
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPV--SCSLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 409 MSEVVETLKPLQNLK-----DMASSSYYFQTMQADNTWSI 443
             +       + +        +   + +   + + NT +I
Sbjct: 297 FDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATI 336

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (329), Expect = 4e-34
 Identities = 73/323 (22%), Positives = 118/323 (36%), Gaps = 67/323 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 198
           LG G FG V        G +         VAVK L         +  ++E+  +  L  H
Sbjct: 53  LGSGAFGKVMNA--TAYGISKTGVSI--QVAVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------- 243
            N+V L+G C       L++E+   G L N+L  K        I                
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 244 ------MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 297
                 +  A   AKG+ FL     K  ++RD    N+L+      K+ DFGLA+D   D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 298 ------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMD 347
                 G   +  + M      APE +  G  T KSDV+S+G++L E+ + G      + 
Sbjct: 226 SNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279

Query: 348 KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            +      N  +     +   +  +++  P          +++   +   C + D + RP
Sbjct: 280 VD-----ANFYK----LI---QNGFKMDQPF-------YATEEIYIIMQSCWAFDSRKRP 320

Query: 408 RMSEVVETLKPLQNLKDMASSSY 430
               +   L     L D   + Y
Sbjct: 321 SFPNLTSFLGCQ--LADAEEAMY 341

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  130 bits (328), Expect = 5e-34
 Identities = 80/330 (24%), Positives = 130/330 (39%), Gaps = 47/330 (14%)

Query: 92  PVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFK 151
           P  +          + P        A ++ + + +      R +     LG+GGF   F+
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR--RRYVRGRFLGKGGFAKCFE 59

Query: 152 GWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYC 208
                         T    A K +    L       +   E++   +L H ++V   G+ 
Sbjct: 60  I---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF- 109

Query: 209 IEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIY 267
            ED+  + +V E   R SL     R+ +L  P + R         G  +LH      VI+
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-R-YYLRQIVLGCQYLHR---NRVIH 164

Query: 268 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAAPEYVMTGHLTS- 325
           RD K  N+ L+ D   K+ DFGLA     DG+     +V+ GT  Y APE V++    S 
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPE-VLSKKGHSF 220

Query: 326 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARPHLGDKRRFYRLLDPRLEGHFS 384
           + DV+S G ++  +L G+       P     L E + R    +    Y +  P+   H  
Sbjct: 221 EVDVWSIGCIMYTLLVGK------PPFETSCLKETYLRIKKNE----YSI--PK---HI- 264

Query: 385 IKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
              +  A  L  + L  DP ARP ++E++ 
Sbjct: 265 ---NPVAASLIQKMLQTDPTARPTINELLN 291

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  130 bits (329), Expect = 6e-34
 Identities = 55/395 (13%), Positives = 110/395 (27%), Gaps = 98/395 (24%)

Query: 83  EKRRDRPVVPVSSTTTSNAESASSTPKFSEE--LKVASQLRKFMFNDLKLATRNFRPESL 140
            +     V   S    S A+S  ST  ++     +V S+L +          R     ++
Sbjct: 29  NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGER--------PRTLVRGTV 80

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------------------- 180
           LG+       +              TG +  V                            
Sbjct: 81  LGQEDPYAYLEA---------TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 181 --------QGHKEWLAEVNFLGNLLHPNLVKLVGYC--IEDDQRLLVYEFM--PRGSLEN 228
                   + H  ++   + + +     ++++      +    R  +Y  M     +   
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 229 HLFRKGSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 286
            L    S    L    R+++ L   + LA LH      +++   +  +I+LD      L+
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLT 248

Query: 287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVV 335
            F        DG   VS     + G+  PE                 +T   D ++ G+V
Sbjct: 249 GFEHLV---RDGARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302

Query: 336 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLA 395
           +  +           P  +   +  +       +                   Q    L 
Sbjct: 303 IYWIWCAD------LPITKDAALGGSEWIFRSCKNI----------------PQPVRALL 340

Query: 396 AQCLSRDPKARPRMSEVVETLKP-LQNLKDMASSS 429
              L    + R    + +ET  P  + L+   S++
Sbjct: 341 EGFLRYPKEDRLLPLQAMET--PEYEQLRTELSAA 373

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  128 bits (323), Expect = 1e-33
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 45/289 (15%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAE 189
           R +     LG+GGF   F+              T    A K +    L       +   E
Sbjct: 15  RRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSME 65

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           ++   +L H ++V   G+  ED+  + +V E   R SL     R+ +L  P +      +
Sbjct: 66  ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM- 307
               G  +LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+     +V+ 
Sbjct: 125 --VLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLC 176

Query: 308 GTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARPHL 365
           GT  Y APE V++    S + DV+S G ++  +L G+       P     L E + R   
Sbjct: 177 GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETYLRIKK 229

Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
            +    Y +  P+   H     +  A  L  + L  DP ARP ++E++ 
Sbjct: 230 NE----YSI--PK---HI----NPVAASLIQKMLQTDPTARPTINELLN 265

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  128 bits (324), Expect = 1e-33
 Identities = 65/314 (20%), Positives = 108/314 (34%), Gaps = 48/314 (15%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 198
           +LG+G    VF+G             TG   A+K  N+       +  + E   L  L H
Sbjct: 16  ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 199 PNLVKLVGYCIEDDQR----LLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKG 253
            N+VKL  + IE++      +L+ EF P GSL   L    +   LP S  + +      G
Sbjct: 67  KNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 254 LAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
           +  L E     +++R+ K  NI+     D     KL+DFG A++  +D +    +   GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GT 178

Query: 310 YGYAAPEYVMTGHL--------TSKSDVYSFGVVLLEMLTGR------------RSMDKN 349
             Y  P+      L         +  D++S GV      TG             + +   
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238

Query: 350 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 409
              G+ +          +    +    P      S       T + A  L  D +     
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPV-SCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 410 SEVVETLKPLQNLK 423
            +       + +  
Sbjct: 298 DQFFAETSDILHRG 311

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  133 bits (336), Expect = 1e-33
 Identities = 78/388 (20%), Positives = 126/388 (32%), Gaps = 53/388 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 192
            +  +  LG GGFG V +          +   TG  VA+K    +    ++E W  E+  
Sbjct: 15  PWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQI 65

Query: 193 LGNLLHPNLVKLVGYCIEDDQR--------LLVYEFMPRGSLENHLFRKG-SLPLPWSIR 243
           +  L HPN+V      + D  +        LL  E+   G L  +L +      L     
Sbjct: 66  MKKLNHPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA---KLSDFGLAKDAPEDGKT 300
             +    +  L +LHE     +I+RD K  NI+L         K+ D G AK+  +    
Sbjct: 124 RTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180

Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR---------SMDKNRP 351
                V GT  Y APE +     T   D +SFG +  E +TG R                
Sbjct: 181 T--EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
              +  +       G  +    L  P    H S   + K  +     L    + R    +
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPN---HLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294

Query: 412 V--------VETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRN--- 460
                    ++++  L+ L  M   S    T       +++N K+ ++   G        
Sbjct: 295 NPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQEL 354

Query: 461 GQPLRTLSHPNGPHASPYRHPQQSPKPN 488
            Q      +   P               
Sbjct: 355 LQASGLALNSAQPLTQYVIDCTVIDGRQ 382

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  128 bits (324), Expect = 2e-33
 Identities = 54/311 (17%), Positives = 108/311 (34%), Gaps = 64/311 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------------ 188
           L +G F  +     E++             A+K      L+  +++              
Sbjct: 39  LNQGKFNKIIL--CEKDNK---------FYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 189 -----EVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSI 242
                E+  + ++ +   +   G  I +   + ++YE+M   S+         L   ++ 
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146

Query: 243 RMKIALGA------AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 296
            + I +            +++H   EK + +RD K SNIL+D +   KLSDFG ++    
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV- 203

Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEMLTGRRSMDKNRP-N 352
           D K   S    GTY +  PE   +   +   +K D++S G+ L  M           P +
Sbjct: 204 DKKIKGS---RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV------VPFS 253

Query: 353 GEHNL---------VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP 403
            + +L              P   +   +          +  +  S +        L ++P
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFL--SNEDIDFLKLFLRKNP 311

Query: 404 KARPRMSEVVE 414
             R    + ++
Sbjct: 312 AERITSEDALK 322

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  127 bits (320), Expect = 9e-33
 Identities = 44/253 (17%), Positives = 80/253 (31%), Gaps = 23/253 (9%)

Query: 105 SSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 164
           SS P   E       ++     + +L ++      LLGEG F  V++    +      K 
Sbjct: 39  SSYPNTFEWQCKLPAIKPKT--EFQLGSKLVYVHHLLGEGAFAQVYE--ATQGDLNDAK- 93

Query: 165 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 224
                  +K                +  L   +    +K     +  +  +LV E    G
Sbjct: 94  -NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYG 152

Query: 225 SLENHLFRKGSL---PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---- 277
           +L N +    +     +P  + +  A+     +  +H+     +I+ D K  N +L    
Sbjct: 153 TLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGF 209

Query: 278 -------DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVY 330
                  D      L D G + D     K  + T    T G+   E +       + D +
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269

Query: 331 SFGVVLLEMLTGR 343
                +  ML G 
Sbjct: 270 GVAATVYCMLFGT 282

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  123 bits (310), Expect = 5e-32
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 23/208 (11%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLA-EVNFLGNL 196
            LG+G FG V+            +      +A+K L    L+       L  E+    +L
Sbjct: 21  PLGKGKFGNVYLA---------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
            HPN++++  Y   D +R+ L+ EF PRG L   L + G      S    +    A  L 
Sbjct: 72  RHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS-ATFMEE-LADALH 128

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 315
           + HE   + VI+RD K  N+L+      K++DFG +  AP   +        GT  Y  P
Sbjct: 129 YCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPP 181

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           E +       K D++  GV+  E L G 
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  122 bits (309), Expect = 7e-32
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 23/208 (11%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNL 196
            LG+G FG V+            +  +   +A+K L    L+      +   EV    +L
Sbjct: 16  PLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66

Query: 197 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
            HPN+++L GY   D  R+ L+ E+ P G++   L +        +         A  L+
Sbjct: 67  RHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--ATYITELANALS 123

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 315
           + H    K VI+RD K  N+LL +    K++DFG +  AP   +        GT  Y  P
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC---GTLDYLPP 176

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           E +       K D++S GV+  E L G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (310), Expect = 7e-32
 Identities = 69/291 (23%), Positives = 115/291 (39%), Gaps = 45/291 (15%)

Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGL--TVAVKTLNHDGLQGHKEWL 187
           L+ R +    +LG GG   V                      VAVK L    L     + 
Sbjct: 10  LSDR-YELGEILGFGGMSEVHLAR-----------DLRDHRDVAVKVL-RADLARDPSFY 56

Query: 188 A----EVNFLGNLLHPNLVKLVGYCIEDDQRL----LVYEFMPRGSLENHLFRKGSLPLP 239
                E      L HP +V +      +        +V E++   +L + +  +G +   
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
            +I   +   A + L F H+     +I+RD K +NI++ A    K+ DFG+A+   + G 
Sbjct: 117 RAIE--VIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171

Query: 300 THVST-RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNL 357
           +   T  V+GT  Y +PE      + ++SDVYS G VL E+LTG        P  G+ + 
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGD-SP 224

Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 408
           V  A  H+ +           L        S     +  + L+++P+ R +
Sbjct: 225 VSVAYQHVREDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQ 267

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  122 bits (308), Expect = 1e-31
 Identities = 62/302 (20%), Positives = 99/302 (32%), Gaps = 65/302 (21%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAE 189
           T  F     +G G FG VFK          VK   G   A+K       G    +  L E
Sbjct: 10  TTEFHELEKIGSGEFGSVFKC---------VKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60

Query: 190 VNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKI 246
           V     L  H ++V+      EDD  L+  E+   GSL + +    +       +    +
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-------------------YNAKLSD 287
            L   +GL ++H  +   +++ D K SNI +                         K+ D
Sbjct: 121 LLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEMLTGRRS 345
            G            V     G   + A E +     HL  K+D+++  + ++        
Sbjct: 178 LGHVT---RISSPQVEE---GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPL 230

Query: 346 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 405
                P       +W     G          PR+        SQ+ T+L    +  DP+ 
Sbjct: 231 -----PRNGD---QWHEIRQGRL--------PRIPQVL----SQEFTELLKVMIHPDPER 270

Query: 406 RP 407
           RP
Sbjct: 271 RP 272

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  125 bits (314), Expect = 1e-31
 Identities = 56/393 (14%), Positives = 113/393 (28%), Gaps = 95/393 (24%)

Query: 83  EKRRDRPVVPVSSTTTSNAESASSTPKFSE--ELKVASQLRKFMFNDLKLATRNFRPESL 140
            +     V   S    S A+S  ST  ++     +V S+L +          R     ++
Sbjct: 34  NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGER--------PRTLVRGTV 85

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---------------------- 178
           LG+       +   +E         TG +  V                            
Sbjct: 86  LGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136

Query: 179 GLQGHKEWLAEVNFLGN---LLHPNLVKLVGYCIEDDQRLLVYEF--MPR-----GSLEN 228
           G++  K+    + F+     +  P   K++   +++    ++  F   PR      +   
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196

Query: 229 HLFRKGSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 286
            L    S    L    R+++ L   + LA LH      +++   +  +I+LD      L+
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLT 253

Query: 287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM----------TGHLTSKSDVYSFGVVL 336
            F           +          G+A PE                +T   D ++ G+ +
Sbjct: 254 GFEHLVRDGASAVS------PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307

Query: 337 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA 396
             +           PN +   +  +       +                   Q    L  
Sbjct: 308 YWIWCAD------LPNTDDAALGGSEWIFRSCKNI----------------PQPVRALLE 345

Query: 397 QCLSRDPKARPRMSEVVETLKPLQNLKDMASSS 429
             L    + R    + +ET    + L+   S++
Sbjct: 346 GFLRYPKEDRLLPLQAMET-PEYEQLRTELSAA 377

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  124 bits (314), Expect = 2e-31
 Identities = 74/340 (21%), Positives = 119/340 (35%), Gaps = 55/340 (16%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +F P+ +LG G  G +        G           VAVK +  +          EV  L
Sbjct: 25  SFCPKDVLGHGAEGTIVYR-----GMF-----DNRDVAVKRILPECFSFADR---EVQLL 71

Query: 194 GNLL-HPNLVKLVGYCIEDDQRL--LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
                HPN+++   +C E D++   +  E     +L+ ++ +K    L       +    
Sbjct: 72  RESDEHPNVIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQT 127

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKD-APEDGKTHVST 304
             GLA LH      +++RD K  NIL+          A +SDFGL K  A         +
Sbjct: 128 TSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184

Query: 305 RVMGTYGYAAPEYV---MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
            V GT G+ APE +      + T   D++S G V   +++         P G+    +  
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQRQ-- 237

Query: 362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV------VET 415
                       L     E H        A +L  + ++ DP+ RP    V         
Sbjct: 238 ---ANILLGACSLDCLHPEKHE----DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

Query: 416 LKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGG 455
            K LQ  +D+   S   +    D     +  + G      
Sbjct: 291 EKQLQFFQDV---SDRIEKESLDGPIVKQLERGGRAVVKM 327

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  126 bits (319), Expect = 2e-31
 Identities = 85/340 (25%), Positives = 127/340 (37%), Gaps = 50/340 (14%)

Query: 79  KSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPE 138
               E+   + +    +  T    S +    + + +     L+        +    FR  
Sbjct: 130 TQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQY 189

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGN 195
            +LG+GGFG V     +          TG   A K L    ++  K     L E   L  
Sbjct: 190 RVLGKGGFGEVCA--CQ-------VRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK-----IALG 249
           +    +V L  Y  E    L LV   M  G L+ H++  G    P + R       I  G
Sbjct: 241 VNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-RAVFYAAEICCG 298

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
               L  LH E    ++YRD K  NILLD   + ++SD GLA   PE        RV GT
Sbjct: 299 ----LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GT 348

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLG 366
            GY APE V     T   D ++ G +L EM+ G+   +   + +      +         
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ--QRKKKIKREEV--------- 397

Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
                  + +   E  +S + S +A  L +Q L +DP  R
Sbjct: 398 ----ERLVKEVPEE--YSERFSPQARSLCSQLLCKDPAER 431

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  125 bits (316), Expect = 6e-31
 Identities = 79/317 (24%), Positives = 117/317 (36%), Gaps = 37/317 (11%)

Query: 40  EEEEEIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTS 99
           E EEE     R  F    M          S ++  +  G    ++       P       
Sbjct: 96  ETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQ 155

Query: 100 NAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 159
           N            +        K +  ++ L   +F    ++G GGFG V+         
Sbjct: 156 NLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYG--CR---- 209

Query: 160 APVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFL---GNLLHPNLVKLVGYCIEDDQ 213
              K  TG   A+K L+   ++  +     L E   L        P +V +  Y      
Sbjct: 210 ---KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPD 265

Query: 214 RL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK-----IALGAAKGLAFLHEEAEKPVIY 267
           +L  + + M  G L  HL + G         M+     I LG    L  +H      V+Y
Sbjct: 266 KLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----LEHMHNRF---VVY 315

Query: 268 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS 327
           RD K +NILLD   + ++SD GLA D  +  K H    V GT+GY APE +  G     S
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKK-KPH--ASV-GTHGYMAPEVLQKGVAYDSS 371

Query: 328 -DVYSFGVVLLEMLTGR 343
            D +S G +L ++L G 
Sbjct: 372 ADWFSLGCMLFKLLRGH 388

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (312), Expect = 2e-30
 Identities = 62/293 (21%), Positives = 105/293 (35%), Gaps = 60/293 (20%)

Query: 135 FRPESLLGEGGFGCVFKGW---VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEV 190
           +  +  +  GG G ++      V            G  V +K L H G    +   +AE 
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVN-----------GRPVVLKGLVHSGDAEAQAMAMAER 130

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRL-----LVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
            FL  ++HP++V++  +    D+       +V E++   SL+        LP+  +I   
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIA-- 186

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
             L     L++LH      ++Y D K  NI+L  +   KL D G        G       
Sbjct: 187 YLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG------Y 236

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
           + GT G+ APE ++    T  +D+Y+ G  L  +                          
Sbjct: 237 LYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDL------------------PTRN 277

Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETLK 417
           G         DP L+ + S        +L  + +  DP+ R     E+   L 
Sbjct: 278 GRYVDGLPEDDPVLKTYDSYG------RLLRRAIDPDPRQRFTTAEEMSAQLT 324

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  119 bits (299), Expect = 5e-30
 Identities = 66/331 (19%), Positives = 123/331 (37%), Gaps = 66/331 (19%)

Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW 186
           ++L     R   +L EGGF  V++           +  G+G   A+K L  +  + ++  
Sbjct: 23  VELGELRLRVRRVLAEGGFAFVYE----------AQDVGSGREYALKRLLSNEEEKNRAI 72

Query: 187 LAEVNFLGNLL-HPNLVKLVGYCIEDDQR-------LLVYEFMPRGSLENHLFR---KGS 235
           + EV F+  L  HPN+V+         +         L+   + +G L   L +   +G 
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132

Query: 236 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---K 292
           L    ++  KI     + +  +H   + P+I+RD K  N+LL      KL DFG A    
Sbjct: 133 LSCD-TVL-KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189

Query: 293 DAPEDGKTHVSTRVM-------GTYGYAAPEYV-MTGHL--TSKSDVYSFGVVLLEMLTG 342
             P+   +     ++        T  Y  PE + +  +     K D+++ G +L  +   
Sbjct: 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249

Query: 343 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSI----KGSQKATQLAAQC 398
           +       P  +   +                    + G +SI            L    
Sbjct: 250 Q------HPFEDGAKLRI------------------VNGKYSIPPHDTQYTVFHSLIRAM 285

Query: 399 LSRDPKARPRMSEVVETLKPLQNLKDMASSS 429
           L  +P+ R  ++EVV  L+ +   +++   S
Sbjct: 286 LQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  119 bits (301), Expect = 5e-30
 Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 39/225 (17%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 190
           +F     +G+G FG V    V++N T           A+K +N        E      E+
Sbjct: 16  HFEILRAIGKGSFGKVCI--VQKNDT-------KKMYAMKYMNKQKCVERNEVRNVFKEL 66

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK---- 245
             +  L HP LV L  Y  +D++ + +V + +  G L  HL +           +K    
Sbjct: 67  QIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFIC 122

Query: 246 -IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            + +     L +L     + +I+RD K  NILLD   +  ++DF +A   P + +    T
Sbjct: 123 ELVMA----LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---T 172

Query: 305 RVMGTYGYAAPEYVM----TGHLTSKS-DVYSFGVVLLEMLTGRR 344
            + GT  Y APE        G+  S + D +S GV   E+L GRR
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGY--SFAVDWWSLGVTAYELLRGRR 215

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  121 bits (306), Expect = 6e-30
 Identities = 84/345 (24%), Positives = 122/345 (35%), Gaps = 54/345 (15%)

Query: 79  KSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDL---KLATRNF 135
             +  + R      +         +      F E L     LR   +  L    +    F
Sbjct: 128 AETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWF 187

Query: 136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNF 192
               +LG GGFG VF    +          TG   A K LN   L+  K +   + E   
Sbjct: 188 LDFRVLGRGGFGEVFA--CQ-------MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238

Query: 193 LGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSI-RMK----- 245
           L  +    +V L  Y  E    L LV   M  G +  H++        +   R       
Sbjct: 239 LAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
           I  G    L  LH+     +IYRD K  N+LLD D N ++SD GLA +            
Sbjct: 298 IVSG----LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGY 349

Query: 306 VMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWA 361
             GT G+ APE ++ G     S D ++ GV L EM+  R   R+  +   N E       
Sbjct: 350 A-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE------- 400

Query: 362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
                      R+L+  +   +  K S  +       L +DP+ R
Sbjct: 401 --------LKQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKR 435

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  116 bits (294), Expect = 8e-30
 Identities = 75/297 (25%), Positives = 121/297 (40%), Gaps = 42/297 (14%)

Query: 124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           +   +     +F+  +LLG+G F  V++              TGL VA+K ++   +   
Sbjct: 2   LATCIGEKIEDFKVGNLLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKA 52

Query: 184 K---EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP 239
                   EV     L HP++++L  Y  ED   + LV E    G +  +L  +      
Sbjct: 53  GMVQRVQNEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE 111

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
              R  +      G+ +LH      +++RD   SN+LL  + N K++DFGLA       +
Sbjct: 112 NEARHFMH-QIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167

Query: 300 THVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358
            H  T + GT  Y +PE    + H   +SDV+S G +   +L GR       P     + 
Sbjct: 168 KH-YT-LCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR------PPFDTDTVK 218

Query: 359 E-WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
               +  L D    Y +  P          S +A  L  Q L R+P  R  +S V++
Sbjct: 219 NTLNKVVLAD----YEM--PS---FL----SIEAKDLIHQLLRRNPADRLSLSSVLD 262

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  117 bits (295), Expect = 2e-29
 Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 31/225 (13%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K     F    +LG+G FG VF   V++              A+K L    L+       
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFL--VKKISG----SDARQLYAMKVLKKATLKVRDRVRT 73

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
             E + L  + HP +VKL  Y  + + +L L+ +F+  G L   L ++          +K
Sbjct: 74  KMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVK 129

Query: 246 -----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
                +AL     L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K 
Sbjct: 130 FYLAELALA----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182

Query: 301 HVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
                   GT  Y APE V+     ++S D +SFGV++ EMLTG 
Sbjct: 183 ---AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (296), Expect = 2e-29
 Identities = 80/338 (23%), Positives = 134/338 (39%), Gaps = 55/338 (16%)

Query: 104 ASSTPKFSEELKVASQLRKFMFNDLK---LATRNFRPESLLGEGGFGCVFKGWVEENGTA 160
                +   + +   +L  F+    K   L   +F   S LG G  G VFK   +     
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP---- 56

Query: 161 PVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE 219
                +GL +A K ++ +       + + E+  L     P +V   G    D +  +  E
Sbjct: 57  -----SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111

Query: 220 FMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 279
            M  GSL+  L + G +P    I  K+++   KGL +L E+    +++RD K SNIL+++
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNS 167

Query: 280 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 339
               KL DFG++    +   +  ++ V GT  Y +PE +   H + +SD++S G+ L+EM
Sbjct: 168 RGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223

Query: 340 LTGR----------------------RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD- 376
             GR                       +    RP      +             + LLD 
Sbjct: 224 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283

Query: 377 ------PRL-EGHFSIKGSQKATQLAAQCLSRDPKARP 407
                 P+L  G F    S +      +CL ++P  R 
Sbjct: 284 IVNEPPPKLPSGVF----SLEFQDFVNKCLIKNPAERA 317

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  115 bits (290), Expect = 4e-29
 Identities = 75/313 (23%), Positives = 121/313 (38%), Gaps = 71/313 (22%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFL 193
           F     +G+G FG VFKG         +   T   VA+K ++ +  +   E +  E+  L
Sbjct: 24  FTKLEKIGKGSFGEVFKG---------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL---GA 250
                P + K  G  ++D +  ++ E++  GS    L   G L         IA      
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQ-----IATILREI 128

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
            KGL +LH E     I+RD K +N+LL      KL+DFG+A               +GT 
Sbjct: 129 LKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTP 183

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR---------RSM---DKNRPNGEHNLV 358
            + APE +      SK+D++S G+  +E+  G          + +    KN P       
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------- 236

Query: 359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE------V 412
                             P LEG++    S+   +    CL+++P  RP   E      +
Sbjct: 237 ------------------PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

Query: 413 VETLKPLQNLKDM 425
           +   K    L ++
Sbjct: 275 LRNAKKTSYLTEL 287

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  116 bits (292), Expect = 5e-29
 Identities = 72/226 (31%), Positives = 100/226 (44%), Gaps = 35/226 (15%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL--VREKAT-------GRYYAMKILRKEVIIAKDEVAH 51

Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+         R 
Sbjct: 52  TVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RA 107

Query: 245 K-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
           +     I       L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG 
Sbjct: 108 RFYGAEIVSA----LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160

Query: 300 THVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
           T    +   GT  Y APE V+  +   ++ D +  GVV+ EM+ GR
Sbjct: 161 T---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  115 bits (290), Expect = 5e-29
 Identities = 62/255 (24%), Positives = 102/255 (40%), Gaps = 38/255 (14%)

Query: 99  SNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENG 158
             A          +  +   Q RK    D       F+   +LGEG F  V      E  
Sbjct: 3   GTAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVL--ARELA 53

Query: 159 TAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIEDDQRL 215
           T           A+K L    +    +      E + +  L HP  VKL  +  +DD++L
Sbjct: 54  T-------SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKL 105

Query: 216 -LVYEFMPRGSLENHLFRKGSLPLPWSIRMK-----IALGAAKGLAFLHEEAEKPVIYRD 269
                +   G L  ++ + GS         +     I       L +LH    K +I+RD
Sbjct: 106 YFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSA----LEYLHG---KGIIHRD 155

Query: 270 FKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-D 328
            K  NILL+ D + +++DFG AK    + K   +   +GT  Y +PE ++T     KS D
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKSACKSSD 214

Query: 329 VYSFGVVLLEMLTGR 343
           +++ G ++ +++ G 
Sbjct: 215 LWALGCIIYQLVAGL 229

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  117 bits (296), Expect = 5e-29
 Identities = 86/346 (24%), Positives = 137/346 (39%), Gaps = 48/346 (13%)

Query: 5   PESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPSRSKV 64
           P+ V  +   +NN         +  + + +    +  +     W         + +  + 
Sbjct: 42  PQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQ-----WTTVIERTFHVETPEER 96

Query: 65  DSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFM 124
           +   +   T      +   K++    +   S + S+   A        E+ +A    +  
Sbjct: 97  EEWTTAIQT-----VADGLKKQAAAEMDFRSGSPSDNSGAEEM-----EVSLAKPKHRVT 146

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
            N+       F    LLG+G FG V    V+E  T       G   A+K L  + +    
Sbjct: 147 MNE-------FEYLKLLGKGTFGKVIL--VKEKAT-------GRYYAMKILKKEVIVAKD 190

Query: 185 EW---LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 240
           E    L E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       
Sbjct: 191 EVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED- 248

Query: 241 SIRMKI-ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
             R +         L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG 
Sbjct: 249 --RARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304

Query: 300 THVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
           T    +   GT  Y APE V+  +   ++ D +  GVV+ EM+ GR
Sbjct: 305 T---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  114 bits (289), Expect = 8e-29
 Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 33/227 (14%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---E 185
           K+    F    +LG+GG+G VF+  V +         TG   A+K L    +  +     
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQ--VRKVTG----ANTGKIFAMKVLKKAMIVRNAKDTA 66

Query: 186 W-LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
              AE N L  + HP +V L+ Y  +   +L L+ E++  G L   L R+G         
Sbjct: 67  HTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---T 122

Query: 244 MK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 298
                  I++     L  LH+   K +IYRD K  NI+L+   + KL+DFGL K++  DG
Sbjct: 123 ACFYLAEISMA----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175

Query: 299 KTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
                T    GT  Y APE ++     +++ D +S G ++ +MLTG 
Sbjct: 176 TV---THTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (286), Expect = 2e-28
 Identities = 74/314 (23%), Positives = 123/314 (39%), Gaps = 48/314 (15%)

Query: 103 SASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPV 162
           S+ S+ K +  L +  Q  +   NDL+           +G G  G V+K    +      
Sbjct: 2   SSGSSGKQTGYLTIGGQRYQAEINDLEN-------LGEMGSGTCGQVWKMRFRK------ 48

Query: 163 KPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEF 220
              TG  +AVK +   G  + +K  L +++ +      P +V+  G  I +    +  E 
Sbjct: 49  ---TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105

Query: 221 MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD 280
           M   + +     +G +P    +  K+ +   K L +L E+    VI+RD K SNILLD  
Sbjct: 106 MGTCAEKLKKRMQGPIPERI-LG-KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDER 161

Query: 281 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-----TSKSDVYSFGVV 335
              KL DFG++             R  G   Y APE +            ++DV+S G+ 
Sbjct: 162 GQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218

Query: 336 LLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQ 393
           L+E+ TG+      + + E    +++   P L     F                S     
Sbjct: 219 LVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF----------------SGDFQS 262

Query: 394 LAAQCLSRDPKARP 407
               CL++D + RP
Sbjct: 263 FVKDCLTKDHRKRP 276

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  113 bits (285), Expect = 3e-28
 Identities = 69/351 (19%), Positives = 120/351 (34%), Gaps = 100/351 (28%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVN 191
            +F P   +G GGFG VF+                   A+K +     +  +E  + EV 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAK---------NKVDDCNYAIKRIRLPNRELAREKVMREVK 56

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYE-------------------------------- 219
            L  L HP +V+     +E        E                                
Sbjct: 57  ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116

Query: 220 ---------FMPRGSLENHLF------RKGSL-----------PLPWSIRMKIALGAAKG 253
                     +   S + +L+      RK +L                + + I +  A+ 
Sbjct: 117 PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVS-------- 303
           + FLH    K +++RD K SNI    D   K+ DFGL    D  E+ +T ++        
Sbjct: 177 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233

Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
           T  +GT  Y +PE +   + + K D++S G++L E+L           + +   V     
Sbjct: 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS--------FSTQMERVR---- 281

Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                     + + +    F+ K   +   +    LS  P  RP  ++++E
Sbjct: 282 ------IITDVRNLKFPLLFTQK-YPQEHMMVQDMLSPSPTERPEATDIIE 325

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  113 bits (286), Expect = 4e-28
 Identities = 69/278 (24%), Positives = 111/278 (39%), Gaps = 35/278 (12%)

Query: 81  SNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESL 140
           ++           S      +       +    +K   +      +  K+   NF    +
Sbjct: 2   AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKV 61

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----LAEVNFLGNL 196
           LG G +G VF   V +         TG   A+K L    +    +       E   L ++
Sbjct: 62  LGTGAYGKVFL--VRKISG----HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 197 LH-PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK-----IALG 249
              P LV L  Y  + + +L L+ +++  G L  HL ++          ++     I L 
Sbjct: 116 RQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLA 171

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
               L  LH+     +IYRD K  NILLD++ +  L+DFGL+K+   D          GT
Sbjct: 172 ----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GT 223

Query: 310 YGYAAPEYVM---TGHLTSKS-DVYSFGVVLLEMLTGR 343
             Y AP+ V    +GH   K+ D +S GV++ E+LTG 
Sbjct: 224 IEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGA 259

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  112 bits (282), Expect = 4e-28
 Identities = 66/296 (22%), Positives = 106/296 (35%), Gaps = 54/296 (18%)

Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEW 186
           +++   +  P   LG G +G V K              +G  +AVK +      Q  K  
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRL 52

Query: 187 LAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIR 243
           L +++     +  P  V   G    +    +  E M   SL+            +P  I 
Sbjct: 53  LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDIL 111

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
            KIA+   K L  LH +    VI+RD K SN+L++A    K+ DFG++            
Sbjct: 112 GKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAK 166

Query: 304 TRVMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 359
               G   Y APE +         + KSD++S G+ ++E+   R                
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR---------------- 210

Query: 360 WARPHLGDKRRFYRLLD-------PRL-EGHFSIKGSQKATQLAAQCLSRDPKARP 407
                       ++ L        P+L    FS     +     +QCL ++ K RP
Sbjct: 211 ---FPYDSWGTPFQQLKQVVEEPSPQLPADKFS----AEFVDFTSQCLKKNSKERP 259

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (284), Expect = 4e-28
 Identities = 68/297 (22%), Positives = 107/297 (36%), Gaps = 50/297 (16%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKE 185
                  + +    +G G +G V K   +          +G  +AVK +      +  K+
Sbjct: 16  HWDFTAEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQ 66

Query: 186 WLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN---HLFRKGSLPLPWS 241
            L +++ +      P +V+  G    +    +  E M   S +    +++      +P  
Sbjct: 67  LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEE 125

Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 301
           I  KI L   K L  L E     +I+RD K SNILLD   N KL DFG++    +   + 
Sbjct: 126 ILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSI 180

Query: 302 VSTRVMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
             TR  G   Y APE +           +SDV+S G+ L E+ TGR              
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR-------------- 226

Query: 358 VEWARPHLGDKRRFYRLLD-------PRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
                         +  L        P+L      + S         CL++D   RP
Sbjct: 227 -----FPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  113 bits (285), Expect = 1e-27
 Identities = 71/316 (22%), Positives = 109/316 (34%), Gaps = 77/316 (24%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
              E +LG G  G V                 G  VAVK +    +      L E+  L 
Sbjct: 17  VVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRML---IDFCDIALMEIKLLT 63

Query: 195 NLL-HPNLVKLVGYCIEDDQRL--LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKI 246
               HPN+++   YC E   R   +  E     +L++ +  K        ++     + +
Sbjct: 64  ESDDHPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-------------ADYNAKLSDFGLAKD 293
               A G+A LH      +I+RD K  NIL+               +    +SDFGL K 
Sbjct: 121 LRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 294 APED---GKTHVSTRVMGTYGYAAPE-------YVMTGHLTSKSDVYSFGVVLLEMLTG- 342
                   +T+++    GT G+ APE             LT   D++S G V   +L+  
Sbjct: 178 LDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236

Query: 343 ------RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA 396
                 + S + N   G  +L E    H                         +AT L +
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSL-------------------IAEATDLIS 277

Query: 397 QCLSRDPKARPRMSEV 412
           Q +  DP  RP   +V
Sbjct: 278 QMIDHDPLKRPTAMKV 293

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  112 bits (283), Expect = 2e-27
 Identities = 60/256 (23%), Positives = 100/256 (39%), Gaps = 35/256 (13%)

Query: 106 STPKFSEELKVASQLRKF-----MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTA 160
              + +++  VA  L+          +++L   +F    ++G G F  V    V+   T 
Sbjct: 29  GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAV--VKMKQTG 86

Query: 161 PVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-L 216
            V        A+K +N   +    E   +  E + L N     + +L  +  +D+  L L
Sbjct: 87  QV-------YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYL 138

Query: 217 VYEFMPRGSLENHLFRKGS-LPLPWSIRMKIA-LGAAKGLAFLHEEAEKPVIYRDFKTSN 274
           V E+   G L   L + G  +P   + R  +A +  A  +  +H       ++RD K  N
Sbjct: 139 VMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVHR---LGYVHRDIKPDN 192

Query: 275 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVY---- 330
           ILLD   + +L+DFG       DG       V GT  Y +PE +        +  Y    
Sbjct: 193 ILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPEC 251

Query: 331 ---SFGVVLLEMLTGR 343
              + GV   EM  G+
Sbjct: 252 DWWALGVFAYEMFYGQ 267

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (272), Expect = 1e-26
 Identities = 76/305 (24%), Positives = 126/305 (41%), Gaps = 49/305 (16%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
            + +     +G+G  G V+           +   TG  VA++ +N       +  + E+ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
            +    +PN+V  +   +  D+  +V E++  GSL + +  +  +     I   +     
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQ-I-AAVCRECL 126

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTY 310
           + L FLH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    T V GT 
Sbjct: 127 QALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTP 180

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK-- 368
            + APE V       K D++S G++ +EM+ G        P           P+L +   
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-------EP-----------PYLNENPL 222

Query: 369 RRFYRLLD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV-----VETLKPLQ 420
           R  Y +     P L+     K S        +CL  D + R    E+     ++  KPL 
Sbjct: 223 RALYLIATNGTPELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280

Query: 421 NLKDM 425
           +L  +
Sbjct: 281 SLTPL 285

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  109 bits (274), Expect = 2e-26
 Identities = 69/254 (27%), Positives = 103/254 (40%), Gaps = 42/254 (16%)

Query: 102 ESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAP 161
            + +  P  S+++ +                 +F    ++G+G FG V            
Sbjct: 13  ANPAPPPAPSQQINLGPSSNP------HAKPSDFHFLKVIGKGSFGKVLL--AR------ 58

Query: 162 VKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL-HPNLVKLVGYCIEDDQRL-L 216
                 +  AVK L    +   KE    ++E N L   + HP LV L  +  +   +L  
Sbjct: 59  -HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYF 116

Query: 217 VYEFMPRGSLENHLFRKGSLPLPWSIRMK-----IALGAAKGLAFLHEEAEKPVIYRDFK 271
           V +++  G L  HL R+     P   R +     IA      L +LH      ++YRD K
Sbjct: 117 VLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA----LGYLHS---LNIVYRDLK 166

Query: 272 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DV 329
             NILLD+  +  L+DFGL K+  E   T   T    GT  Y APE V+      ++ D 
Sbjct: 167 PENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPE-VLHKQPYDRTVDW 222

Query: 330 YSFGVVLLEMLTGR 343
           +  G VL EML G 
Sbjct: 223 WCLGAVLYEMLYGL 236

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (277), Expect = 2e-26
 Identities = 70/290 (24%), Positives = 110/290 (37%), Gaps = 62/290 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 197
           LG+G FG V                TG   AVK ++   ++   +    L EV  L  L 
Sbjct: 34  LGKGSFGEVILC---------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 198 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAA 251
           HPN++KL  +  ED     LV E    G L + +  +       S       ++  L   
Sbjct: 85  HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRF----SEVDAARIIRQVLSG- 138

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             + ++H   +  +++RD K  N+LL     D N ++ DFGL+               +G
Sbjct: 139 --ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKDKIG 190

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
           T  Y APE V+ G    K DV+S GV+L  +L+G                    P  G  
Sbjct: 191 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC------------------PPFNGAN 231

Query: 369 RRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 412
                +L    +G ++ +       S+ A  L  + L+  P  R    + 
Sbjct: 232 EY--DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  108 bits (271), Expect = 4e-26
 Identities = 70/227 (30%), Positives = 96/227 (42%), Gaps = 36/227 (15%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           KL   +F    +LG+G FG VF    E   T           A+K L  D +    +   
Sbjct: 13  KLKIEDFILHKMLGKGSFGKVFL--AEFKKT-------NQFFAIKALKKDVVLMDDDVEC 63

Query: 187 -LAEVN-FLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
            + E         HP L  +     +  + L  V E++  G L  H+       L    R
Sbjct: 64  TMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---R 119

Query: 244 MK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 298
                  I LG    L FLH    K ++YRD K  NILLD D + K++DFG+ K+     
Sbjct: 120 ATFYAAEIILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172

Query: 299 KTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
                T    GT  Y APE ++ G   + S D +SFGV+L EML G+
Sbjct: 173 AK---TNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  109 bits (274), Expect = 4e-26
 Identities = 62/229 (27%), Positives = 95/229 (41%), Gaps = 28/229 (12%)

Query: 126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
             ++L   +F    ++G G FG V    V+      V        A+K LN   +    E
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAV--VKLKNADKV-------FAMKILNKWEMLKRAE 117

Query: 186 ---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-KGSLPLPW 240
              +  E + L N     +  L  Y  +DD  L LV ++   G L   L + +  LP   
Sbjct: 118 TACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM 176

Query: 241 SIRMKIA-LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
           + R  +A +  A  +  +H+      ++RD K  NIL+D + + +L+DFG      EDG 
Sbjct: 177 A-RFYLAEMVIA--IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230

Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKS-----DVYSFGVVLLEMLTGR 343
              S  V GT  Y +PE +              D +S GV + EML G 
Sbjct: 231 VQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  107 bits (268), Expect = 5e-26
 Identities = 77/315 (24%), Positives = 130/315 (41%), Gaps = 55/315 (17%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
                    +GEG  G V             +  +G  VAVK ++    Q  +    EV 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLA---------REKHSGRQVAVKMMDLRKQQRRELLFNEVV 94

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
            + +  H N+V++    +  ++  ++ EF+  G+L + +  +  L     I   +     
Sbjct: 95  IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQ-IAT-VCEAVL 151

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTY 310
           + LA+LH +    VI+RD K+ +ILL  D   KLSDFG  A+ + +  K    + V GT 
Sbjct: 152 QALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTP 205

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK-- 368
            + APE +      ++ D++S G++++EM+ G        P           P+  D   
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDG-------EP-----------PYFSDSPV 247

Query: 369 RRFYRLLD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----------RMSEVVE 414
           +   RL D   P+L+   S K S        + L RDP+ R              + + E
Sbjct: 248 QAMKRLRDSPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE 305

Query: 415 TLKPLQNLKDMASSS 429
            L PL  L    +S+
Sbjct: 306 CLVPLIQLYRKQTST 320

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  109 bits (275), Expect = 5e-26
 Identities = 68/289 (23%), Positives = 107/289 (37%), Gaps = 61/289 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG G +G V                T +  A+K +    +    + + L EV  L  L H
Sbjct: 45  LGSGAYGEVLLC---------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAK 252
           PN++KL  +  ED +   LV E    G L + +  +       +       +K  L    
Sbjct: 96  PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRMKF----NEVDAAVIIKQVLSG-- 148

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
            + +LH   +  +++RD K  N+LL   + D   K+ DFGL+               +GT
Sbjct: 149 -VTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGT 201

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 369
             Y APE V+      K DV+S GV+L  +L G                    P  G   
Sbjct: 202 AYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY------------------PPFGGQTD 242

Query: 370 RFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 412
           +   +L    +G ++         S+ A  L  Q L  D + R    + 
Sbjct: 243 Q--EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  107 bits (270), Expect = 5e-26
 Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 53/294 (18%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
            L  ++F    ++G G +  V    V           T    A+K +  + +   ++   
Sbjct: 5   PLGLQDFDLLRVIGRGSYAKVLL--VR-------LKKTDRIYAMKVVKKELVNDDEDIDW 55

Query: 187 -LAEVNFLGNLL-HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
              E +       HP LV L   C + + RL  V E++  G L  H+ R+  LP   + R
Sbjct: 56  VQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-R 113

Query: 244 M---KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 300
               +I+L     L +LHE   + +IYRD K  N+LLD++ + KL+D+G+ K+    G T
Sbjct: 114 FYSAEISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166

Query: 301 HVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR----RSMDKNRPNGE 354
              T    GT  Y APE ++ G     S D ++ GV++ EM+ GR         + P+  
Sbjct: 167 ---TSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222

Query: 355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKAR 406
                        +   ++++   LE    I    S KA  +    L++DPK R
Sbjct: 223 ------------TEDYLFQVI---LEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  107 bits (270), Expect = 6e-26
 Identities = 71/227 (31%), Positives = 104/227 (45%), Gaps = 36/227 (15%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           ++   +F    +LG+G FG V     E       + GT    AVK L  D +    +   
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVML--SE-------RKGTDELYAVKILKKDVVIQDDDVEC 66

Query: 187 -LAEVNFLGNLL-HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
            + E   L      P L +L   C +   RL  V E++  G L  H+ + G    P    
Sbjct: 67  TMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---H 122

Query: 244 MK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 298
                  IA+G    L FL     K +IYRD K  N++LD++ + K++DFG+ K+   DG
Sbjct: 123 AVFYAAEIAIG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175

Query: 299 KTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T   T+   GT  Y APE ++      KS D ++FGV+L EML G+
Sbjct: 176 VT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  106 bits (266), Expect = 7e-26
 Identities = 65/316 (20%), Positives = 125/316 (39%), Gaps = 70/316 (22%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           +     LG+G FG V+K              TG   A K +     +  ++++ E+  L 
Sbjct: 21  WEIVGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIEILA 71

Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
              HP +VKL+G    D +  ++ EF P G+++  +  +    L       +     + L
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEAL 130

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTRVMGTYG 311
            FLH +    +I+RD K  N+L+  + + +L+DFG++       +   + +     GT  
Sbjct: 131 NFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPY 182

Query: 312 YAAPEYVMTGHLT-----SKSDVYSFGVVLLEMLTGR---------RSM---DKNRPNGE 354
           + APE VM   +       K+D++S G+ L+EM             R +    K+ P   
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP--- 239

Query: 355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV-- 412
                   P L    ++                S +        L ++P+ RP  +++  
Sbjct: 240 --------PTLLTPSKW----------------SVEFRDFLKIALDKNPETRPSAAQLLE 275

Query: 413 ---VETLKPLQNLKDM 425
              V ++   + L+++
Sbjct: 276 HPFVSSITSNKALREL 291

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  107 bits (270), Expect = 9e-26
 Identities = 83/330 (25%), Positives = 133/330 (40%), Gaps = 51/330 (15%)

Query: 92  PVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFK 151
                TT N     +     EE K A   R+       L  ++F    ++G G +  V  
Sbjct: 11  DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLL 70

Query: 152 GWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL-HPNLVKLVGY 207
             V           T    A++ +  + +   ++      E +       HP LV L   
Sbjct: 71  --VR-------LKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-S 120

Query: 208 CIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK-----IALGAAKGLAFLHEEA 261
           C + + RL  V E++  G L  H+ R+  LP       +     I+L     L +LHE  
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLA----LNYLHE-- 171

Query: 262 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAAPEYVMT 320
            + +IYRD K  N+LLD++ + KL+D+G+ K+    G T   T    GT  Y APE ++ 
Sbjct: 172 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-ILR 226

Query: 321 GHLTSKS-DVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 376
           G     S D ++ GV++ EM+ GR     +  +    ++      +  L  + R  R L 
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL- 285

Query: 377 PRLEGHFSIKGSQKATQLAAQCLSRDPKAR 406
                      S KA  +    L++DPK R
Sbjct: 286 -----------SVKAASVLKSFLNKDPKER 304

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  106 bits (268), Expect = 1e-25
 Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 34/259 (13%)

Query: 94  SSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGW 153
           ++          S  +F  + K     +    +        F     LG G FG V    
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML-- 59

Query: 154 VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIE 210
           V+   +       G   A+K L+   +   K+    L E   L  +  P LVKL  +  +
Sbjct: 60  VKHKES-------GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFK 111

Query: 211 DDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM---KIALGAAKGLAFLHEEAEKPVI 266
           D+  L +V E++  G + +HL R G    P + R    +I L       +LH      +I
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAAQIVLT----FEYLHS---LDLI 163

Query: 267 YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTS 325
           YRD K  N+L+D     +++DFG AK       T     + GT    APE +++ G+  +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGY--N 216

Query: 326 KS-DVYSFGVVLLEMLTGR 343
           K+ D ++ GV++ EM  G 
Sbjct: 217 KAVDWWALGVLIYEMAAGY 235

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  108 bits (272), Expect = 1e-25
 Identities = 71/289 (24%), Positives = 108/289 (37%), Gaps = 61/289 (21%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG+G FG V K              T    AVK +N    +       L EV  L  L H
Sbjct: 30  LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAK 252
           PN++KL     ED     +V E    G L + + ++       S       +K       
Sbjct: 81  PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRF----SEHDAARIIKQVFSG-- 133

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
            + ++H   +  +++RD K  NILL   + D + K+ DFGL+    ++         +GT
Sbjct: 134 -ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGT 186

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 369
             Y APE V+ G    K DV+S GV+L  +L+G                    P  G   
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------------------PPFYGKNE 227

Query: 370 RFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 412
               +L     G ++         S  A  L  + L+  P  R   ++ 
Sbjct: 228 Y--DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  108 bits (272), Expect = 1e-25
 Identities = 71/341 (20%), Positives = 120/341 (35%), Gaps = 72/341 (21%)

Query: 100 NAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 159
           +    SS  +      +A     ++         ++     LG G +G V          
Sbjct: 3   HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLC------- 55

Query: 160 APVKPGTGLTVAVKTLN------------HDGLQGHKEWLA-EVNFLGNLLHPNLVKLVG 206
              +       A+K +             +  ++   E +  E++ L +L HPN++KL  
Sbjct: 56  --KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113

Query: 207 YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKGLAFLHEE 260
              ED +   LV EF   G L   +  +               MK  L     + +LH  
Sbjct: 114 VF-EDKKYFYLVTEFYEGGELFEQIINRHKF----DECDAANIMKQILSG---ICYLH-- 163

Query: 261 AEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 317
            +  +++RD K  NILL   ++  N K+ DFGL+    +D   +     +GT  Y APE 
Sbjct: 164 -KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPE- 218

Query: 318 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP 377
           V+      K DV+S GV++  +L G                    P  G   +   ++  
Sbjct: 219 VLKKKYNEKCDVWSCGVIMYILLCGY------------------PPFGGQNDQ--DIIKK 258

Query: 378 RLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 412
             +G +          S +A +L    L+ D   R    E 
Sbjct: 259 VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  105 bits (264), Expect = 2e-25
 Identities = 70/304 (23%), Positives = 111/304 (36%), Gaps = 53/304 (17%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 197
           E +LGEG    V            +   T    AVK +             EV  L    
Sbjct: 18  EDVLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68

Query: 198 -HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGA 250
            H N+++L+ +  E++ R  LV+E M  GS+ +H+ ++       +       ++    A
Sbjct: 69  GHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRRHF----NELEASVVVQDVASA 123

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKD-APEDGKTHVSTRV 306
              L FLH    K + +RD K  NIL    +     K+ DF L          + +ST  
Sbjct: 124 ---LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177

Query: 307 M----GTYGYAAPEYVMTGHLTSKS-----DVYSFGVVLLEMLTGRRSMDKNRP-NGEHN 356
           +    G+  Y APE V      +       D++S GV+L  +L+G        P  G   
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY------PPFVGRCG 231

Query: 357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMS 410
                            L +   EG +          S  A  L ++ L RD K R   +
Sbjct: 232 SDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA 291

Query: 411 EVVE 414
           +V++
Sbjct: 292 QVLQ 295

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  105 bits (265), Expect = 2e-25
 Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 52/291 (17%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----E 189
           N+R    +G+G F  V                TG  VA+K ++   L      L     E
Sbjct: 16  NYRLLKTIGKGNFAKVKLA---------RHILTGREVAIKIIDKTQLN--PTSLQKLFRE 64

Query: 190 VNFLGNLLHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
           V  +  L HPN+VKL  +  IE ++ L L+ E+   G + ++L   G +    +      
Sbjct: 65  VRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 122

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
           + +A  + + H+   K +++RD K  N+LLDAD N K++DFG + +    GK        
Sbjct: 123 IVSA--VQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC--- 174

Query: 308 GTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
           G   YAAPE +  G      + DV+S GV+L  +++G    D        NL E      
Sbjct: 175 GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKE------ 221

Query: 366 GDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 414
                   L +  L G + I    S     L  + L  +P  R  + ++++
Sbjct: 222 --------LRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  105 bits (265), Expect = 2e-25
 Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 38/226 (16%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K + ++F+    LG G FG V    +            G   A+K L  + +   K+   
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHL--IRSRHN-------GRYYAMKVLKKEIVVRLKQVEH 52

Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
              E   L  + HP ++++     +D Q++ ++ +++  G L + L +    P P     
Sbjct: 53  TNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VA 108

Query: 245 K-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 299
           K     + L     L +LH    K +IYRD K  NILLD + + K++DFG AK  P+   
Sbjct: 109 KFYAAEVCLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161

Query: 300 THVSTRVMGTYGYAAPEYVMT-GHLTSKS-DVYSFGVVLLEMLTGR 343
           T     + GT  Y APE V T  +  +KS D +SFG+++ EML G 
Sbjct: 162 T-----LCGTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGY 200

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  105 bits (265), Expect = 3e-25
 Identities = 71/227 (31%), Positives = 98/227 (43%), Gaps = 36/227 (15%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           +L   NF    +LG+G FG V                TG   AVK L  D +    +   
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVML--AR-------VKETGDLYAVKVLKKDVILQDDDVEC 69

Query: 187 -LAEVNFLGNLL-HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
            + E   L     HP L +L   C +   RL  V EF+  G L  H+ +          R
Sbjct: 70  TMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---R 125

Query: 244 MK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 298
            +     I       L FLH+   K +IYRD K  N+LLD + + KL+DFG+ K+   +G
Sbjct: 126 ARFYAAEIISA----LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178

Query: 299 KTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            T   T    GT  Y APE ++   L   + D ++ GV+L EML G 
Sbjct: 179 VT---TATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  104 bits (262), Expect = 3e-25
 Identities = 63/297 (21%), Positives = 115/297 (38%), Gaps = 55/297 (18%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 192
           ++  + ++G G    V                    VA+K +N +  Q   + L  E+  
Sbjct: 16  DYELQEVIGSGATAVVQAA---------YCAPKKEKVAIKRINLEKCQTSMDELLKEIQA 66

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK---IAL- 248
           +    HPN+V      +  D+  LV + +  GS+ + +    +     S  +    IA  
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 249 --GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVS 303
                +GL +LH+      I+RD K  NILL  D + +++DFG++       +  +  V 
Sbjct: 127 LREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183

Query: 304 TRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGR---------RSM---DKNR 350
              +GT  + APE +        K+D++SFG+  +E+ TG          + +    +N 
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243

Query: 351 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
           P           P          L     +     K  +   ++ + CL +DP+ RP
Sbjct: 244 P-----------P---------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  108 bits (271), Expect = 3e-25
 Identities = 75/253 (29%), Positives = 109/253 (43%), Gaps = 28/253 (11%)

Query: 99  SNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENG 158
             A+    T    E+            N  ++   +F    +LG+G FG V     E   
Sbjct: 307 ERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVML--SE--- 361

Query: 159 TAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL-HPNLVKLVGYCIEDDQR 214
               + GT    AVK L  D +    +    + E   L      P L +L   C +   R
Sbjct: 362 ----RKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDR 416

Query: 215 L-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKI-ALGAAKGLAFLHEEAEKPVIYRDFKT 272
           L  V E++  G L  H+ + G    P        A   A GL FL     K +IYRD K 
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIGLFFLQS---KGIIYRDLKL 470

Query: 273 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVY 330
            N++LD++ + K++DFG+ K+   DG T   T+   GT  Y APE ++      KS D +
Sbjct: 471 DNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWW 526

Query: 331 SFGVVLLEMLTGR 343
           +FGV+L EML G+
Sbjct: 527 AFGVLLYEMLAGQ 539

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  106 bits (266), Expect = 3e-25
 Identities = 68/252 (26%), Positives = 109/252 (43%), Gaps = 32/252 (12%)

Query: 106 STPKFSEELKVASQLRKF-----MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTA 160
             P   +   + + L ++        DL++   ++    ++G G FG V    V    T 
Sbjct: 37  DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL--VRHKSTR 94

Query: 161 PVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-L 216
            V        A+K L+   +    +   +  E + +     P +V+L  Y  +DD+ L +
Sbjct: 95  KV-------YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYM 146

Query: 217 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIA-LGAAKGLAFLHEEAEKPVIYRDFKTSNI 275
           V E+MP G L N +     +P  W+ R   A +  A  L  +H       I+RD K  N+
Sbjct: 147 VMEYMPGGDLVNLM-SNYDVPEKWA-RFYTAEVVLA--LDAIHS---MGFIHRDVKPDNM 199

Query: 276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYS 331
           LLD   + KL+DFG      ++G     T V GT  Y +PE + +    G+   + D +S
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 258

Query: 332 FGVVLLEMLTGR 343
            GV L EML G 
Sbjct: 259 VGVFLYEMLVGD 270

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (265), Expect = 4e-25
 Identities = 54/304 (17%), Positives = 90/304 (29%), Gaps = 51/304 (16%)

Query: 142 GEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHP 199
           G      V                TG  V V+ +N +            E++      HP
Sbjct: 36  GFEDLMTVNLA---------RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 259
           N+V      I D++  +V  FM  GS ++ +       +       I  G  K L ++H 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146

Query: 260 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-----THVSTRVMGTYGYAA 314
                 ++R  K S+IL+  D    LS           G+            +    + +
Sbjct: 147 MG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 315 PEYVMTGHL---TSKSDVYSFGVVLLEMLTGR---------------------------- 343
           PE V+  +L    +KSD+YS G+   E+  G                             
Sbjct: 204 PE-VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262

Query: 344 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP 403
              ++   +   ++                         +    S        QCL R+P
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322

Query: 404 KARP 407
            ARP
Sbjct: 323 DARP 326

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (260), Expect = 5e-25
 Identities = 74/312 (23%), Positives = 125/312 (40%), Gaps = 63/312 (20%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
              F     LGEG +G V+K   +E         TG  VA+K +  +     +E + E++
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVE--SDLQEIIKEIS 76

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
            +     P++VK  G   ++    +V E+   GS+ + + R  +  L       I     
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTL 135

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTY 310
           KGL +LH       I+RD K  NILL+ + +AKL+DFG+  +      K +    V+GT 
Sbjct: 136 KGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTP 189

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR---------RSM---DKNRPNGEHNLV 358
            + APE +        +D++S G+  +EM  G+         R++     N P       
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP------- 242

Query: 359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV-----V 413
               P       +                S   T    QCL + P+ R   +++     V
Sbjct: 243 ----PTFRKPELW----------------SDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282

Query: 414 ETLKPLQNLKDM 425
            + K +  L+D+
Sbjct: 283 RSAKGVSILRDL 294

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  104 bits (262), Expect = 7e-25
 Identities = 70/295 (23%), Positives = 111/295 (37%), Gaps = 61/295 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           +G+G F  V +          +   TG   AVK ++                 E +    
Sbjct: 32  IGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALG 249
           L HP++V+L+      D  L +V+EFM    L   + ++      +S       M+  L 
Sbjct: 83  LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           A   L + H   +  +I+RD K   +LL   +     KL  FG+A    E G      RV
Sbjct: 142 A---LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRV 194

Query: 307 MGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
            GT  + APE V+      K  DV+  GV+L  +L+G                    P  
Sbjct: 195 -GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGC------------------LPFY 234

Query: 366 GDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 414
           G K R +  +   ++G + +        S+ A  L  + L  DP  R  + E + 
Sbjct: 235 GTKERLFEGI---IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  105 bits (264), Expect = 8e-25
 Identities = 76/327 (23%), Positives = 119/327 (36%), Gaps = 68/327 (20%)

Query: 118 SQLRKFMFNDLKLATRNFRPESL---------LGEGGFGCVFKGWVEENGTAPVKPGTGL 168
           S+ + F+F DL +  ++  P++L         LG G  G V             +  T  
Sbjct: 111 SRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA---------FERKTCK 161

Query: 169 TVAVKTLNHDGLQGHKEWLA--------EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEF 220
            VA++ ++           A        E+  L  L HP ++K+  +  + +   +V E 
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLEL 220

Query: 221 MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--- 277
           M  G L + +     L           +     + +LH   E  +I+RD K  N+LL   
Sbjct: 221 MEGGELFDKVVGNKRLKEATCKLYFYQM--LLAVQYLH---ENGIIHRDLKPENVLLSSQ 275

Query: 278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL----TSKSDVYSFG 333
           + D   K++DFG +K   E       T   GT  Y APE V+            D +S G
Sbjct: 276 EEDCLIKITDFGHSKILGETSLM--RTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLG 331

Query: 334 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------ 387
           V+L   L+G                    P   + R    L D    G ++         
Sbjct: 332 VILFICLSG-------------------YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372

Query: 388 SQKATQLAAQCLSRDPKARPRMSEVVE 414
           S+KA  L  + L  DPKAR    E + 
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALR 399

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  101 bits (255), Expect = 4e-24
 Identities = 73/291 (25%), Positives = 116/291 (39%), Gaps = 56/291 (19%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHP 199
           LGEG F    K          V   +    AVK ++       ++   E+  L     HP
Sbjct: 19  LGEGSFSICRKC---------VHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHP 66

Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKG 253
           N+VKL      D     LV E +  G L   + +K       S       M+  + A   
Sbjct: 67  NIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKKHF----SETEASYIMRKLVSA--- 118

Query: 254 LAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
           ++ +H   +  V++RD K  N+L    + +   K+ DFG A+  P D +  + T    T 
Sbjct: 119 VSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTL 173

Query: 311 GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 369
            YAAPE ++  +   +S D++S GV+L  ML+G+       P         +        
Sbjct: 174 HYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQ------VPF-------QSHDRSLTCT 219

Query: 370 RFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 414
               ++    +G FS +G      SQ+A  L    L+ DP  R +MS +  
Sbjct: 220 SAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  100 bits (251), Expect = 6e-24
 Identities = 66/287 (22%), Positives = 105/287 (36%), Gaps = 59/287 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G +G V            V+ GT +  A K +    ++    +  E+  + +L HPN
Sbjct: 17  IGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKGL 254
           +++L     ED+  + LV E    G L   +  K               MK  L A   +
Sbjct: 68  IIRLYET-FEDNTDIYLVMELCTGGELFERVVHKRVF----RESDAARIMKDVLSA---V 119

Query: 255 AFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           A+ H   +  V +RD K  N L      D   KL DFGLA          +    +GT  
Sbjct: 120 AYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPY 173

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           Y +P+ V+ G    + D +S GV++  +L G                    P        
Sbjct: 174 YVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGY------------------PPFSAPTDS- 213

Query: 372 YRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 412
             ++    EG F+         S +A  L  + L++ PK R    + 
Sbjct: 214 -EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  101 bits (253), Expect = 9e-24
 Identities = 73/322 (22%), Positives = 118/322 (36%), Gaps = 81/322 (25%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LA 188
            + F     +G G FG V+                   VA+K +++ G Q +++W   + 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 103

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           EV FL  L HPN ++  G  + +    LV E+    + +     K  L         IA 
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAA 158

Query: 249 ---GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
              GA +GLA+LH      +I+RD K  NILL      KL DFG A        + ++  
Sbjct: 159 VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPA 207

Query: 306 --VMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGR---------RSM---DK 348
              +GT  + APE ++    G    K DV+S G+  +E+   +          ++    +
Sbjct: 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 267

Query: 349 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 408
           N                           P L+       S+        CL + P+ RP 
Sbjct: 268 NES-------------------------PALQSG---HWSEYFRNFVDSCLQKIPQDRPT 299

Query: 409 MSEV-----VETLKPLQNLKDM 425
              +     V   +P   + D+
Sbjct: 300 SEVLLKHRFVLRERPPTVIMDL 321

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  100 bits (251), Expect = 1e-23
 Identities = 67/336 (19%), Positives = 113/336 (33%), Gaps = 69/336 (20%)

Query: 94  SSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGW 153
           S      +  A      + +L    +               ++   LLG GGFG V+ G 
Sbjct: 12  SGLVPRGSHMAPCNDLHATKLAPGKEKEPLE--------SQYQVGPLLGSGGFGSVYSG- 62

Query: 154 VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLGNLLH--PNLVKLV 205
                   ++    L VA+K +  D +    E         EV  L  +      +++L+
Sbjct: 63  --------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114

Query: 206 GYCIEDDQRL-LVYEF-MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEK 263
            +  E      L+ E   P   L + +  +G+L    +          + +   H     
Sbjct: 115 DW-FERPDSFVLILERPEPVQDLFDFITERGALQEELARS--FFWQVLEAVRHCHN---C 168

Query: 264 PVIYRDFKTSNILLDADY-NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH 322
            V++RD K  NIL+D +    KL DFG      +D          GT  Y+ PE++   H
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWIR-YH 223

Query: 323 L--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
                 + V+S G++L +M+ G                    P   D+          + 
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGD------------------IPFEHDEE--------IIR 257

Query: 381 GHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 414
           G    +   S +   L   CL+  P  RP   E+  
Sbjct: 258 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 78/325 (24%), Positives = 122/325 (37%), Gaps = 79/325 (24%)

Query: 117 ASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN 176
           A  L +   + L+     F    L+G G +G V+KG   +         TG   A+K ++
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMD 58

Query: 177 HDGLQGHKEWLAEVNFLGNLL-HPNLVK-----LVGYCIEDDQRL-LVYEFMPRGSLEN- 228
             G    +E   E+N L     H N+       +       D +L LV EF   GS+ + 
Sbjct: 59  VTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117

Query: 229 -HLFRKGSLPLPWSIRMKIAL---GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 284
               +  +L   W     IA       +GL+ LH+     VI+RD K  N+LL  +   K
Sbjct: 118 IKNTKGNTLKEEW-----IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169

Query: 285 LSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-----SKSDVYSFGVVLLE 338
           L DFG+ A+     G+ +     +GT  + APE +            KSD++S G+  +E
Sbjct: 170 LVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

Query: 339 MLTGR---------RSM---DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIK 386
           M  G          R++    +N                           PRL+     K
Sbjct: 227 MAEGAPPLCDMHPMRALFLIPRNPA-------------------------PRLKSK---K 258

Query: 387 GSQKATQLAAQCLSRDPKARPRMSE 411
            S+K       CL ++   RP   +
Sbjct: 259 WSKKFQSFIESCLVKNHSQRPATEQ 283

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 77/287 (26%), Positives = 113/287 (39%), Gaps = 55/287 (19%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 199
           LG G FG V             +  +GL   +KT+N D  Q   E +  E+  L +L HP
Sbjct: 30  LGSGAFGDVHLV---------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKG 253
           N++K+     ED   + +V E    G L   +    +     S       MK  + A   
Sbjct: 81  NIIKIFEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA--- 136

Query: 254 LAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
           LA+ H    + V+++D K  NIL          K+ DFGLA+    D     ST   GT 
Sbjct: 137 LAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGTA 190

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 370
            Y APE V    +T K D++S GVV+  +LTG                    P  G    
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGC------------------LPFTGTSLE 231

Query: 371 FYRLLDPRLEGHFSIKG-----SQKATQLAAQCLSRDPKARPRMSEV 412
              +         +        + +A  L  Q L++DP+ RP  ++V
Sbjct: 232 --EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  100 bits (250), Expect = 3e-23
 Identities = 79/377 (20%), Positives = 139/377 (36%), Gaps = 75/377 (19%)

Query: 61  RSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQL 120
           R +    +        + + +  +         ++      +   + PK +E L   S  
Sbjct: 19  RRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMG 78

Query: 121 RKFMFNDLKLA---TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 177
            +    D   A    + + P+ ++G G    V +          V   TG   AVK +  
Sbjct: 79  PEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIMEV 129

Query: 178 DGLQGHKEWLA--------EVNFLGNLL-HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLE 227
              +   E L         E + L  +  HP+++ L+    E    + LV++ M +G L 
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELF 188

Query: 228 NHLFRKGSLPLPWSIR-----MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN 282
           ++L  K +L    S +     M+  L A   ++FLH      +++RD K  NILLD +  
Sbjct: 189 DYLTEKVAL----SEKETRSIMRSLLEA---VSFLHA---NNIVHRDLKPENILLDDNMQ 238

Query: 283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-------KSDVYSFGVV 335
            +LSDFG +       K        GT GY APE ++   +         + D+++ GV+
Sbjct: 239 IRLSDFGFSCHLEPGEKL--RELC-GTPGYLAPE-ILKCSMDETHPGYGKEVDLWACGVI 294

Query: 336 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQ 389
           L  +L G                    P    ++    +L   +EG +          S 
Sbjct: 295 LFTLLAGS------------------PPFWHRRQ--ILMLRMIMEGQYQFSSPEWDDRSS 334

Query: 390 KATQLAAQCLSRDPKAR 406
               L ++ L  DP+AR
Sbjct: 335 TVKDLISRLLQVDPEAR 351

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 74/291 (25%), Positives = 112/291 (38%), Gaps = 61/291 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG+G FG V K              T    AVK +N    +       L EV  L  L H
Sbjct: 30  LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAK 252
           PN++KL     ED     +V E    G L + + ++       S       +K       
Sbjct: 81  PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRF----SEHDAARIIKQVFSG-- 133

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
            + ++H   +  +++RD K  NILL   + D + K+ DFGL+    ++ K     R+ GT
Sbjct: 134 -ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRI-GT 186

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 369
             Y APE V+ G    K DV+S GV+L  +L+G                    P  G   
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------------------PPFYGKNE 227

Query: 370 RFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 414
               +L     G ++         S  A  L  + L+  P  R   ++ +E
Sbjct: 228 Y--DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 97.7 bits (244), Expect = 5e-23
 Identities = 61/211 (28%), Positives = 89/211 (42%), Gaps = 26/211 (12%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 198
            LGEG +G V            V   T   VAVK ++        E +  E+     L H
Sbjct: 14  TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM---KIALGAAKGL 254
            N+VK  G    +     L  E+   G L + +     +P P + R     +A     G+
Sbjct: 65  ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH      + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 315 PEYVMTGHL--TSKSDVYSFGVVLLEMLTGR 343
           PE ++          DV+S G+VL  ML G 
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 96.9 bits (242), Expect = 9e-23
 Identities = 74/290 (25%), Positives = 114/290 (39%), Gaps = 61/290 (21%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGNL 196
            LG G FG V  G             TG  VAVK LN   ++          E+  L   
Sbjct: 18  TLGVGTFGKVKIG---------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68

Query: 197 LHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK-- 252
            HP+++KL  Y  I       +V E++  G L +++ + G        R++         
Sbjct: 69  RHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG--------RVEEMEARRLFQ 118

Query: 253 ----GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
                + + H      V++RD K  N+LLDA  NAK++DFGL+    +      S    G
Sbjct: 119 QILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---G 172

Query: 309 TYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
           +  YAAPE V++G L    + D++S GV+L  +L G    D      + ++         
Sbjct: 173 SPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD------DEHVPT------- 218

Query: 367 DKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 414
                  L      G F I    ++    L    L  DP  R  + ++ E
Sbjct: 219 -------LFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 65/330 (19%), Positives = 105/330 (31%), Gaps = 93/330 (28%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGN 195
           +G+G +G V            ++  T    A+K +N + ++            EV  +  
Sbjct: 34  IGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 196 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG----- 249
           L HPN+ +L     ED+Q + LV E    G L + L               +        
Sbjct: 85  LHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 250 --------------------------AAK-------GLAFLHEEAEKPVIYRDFKTSNIL 276
                                      +         L +LH    + + +RD K  N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200

Query: 277 LDADYNA--KLSDFGLAK--DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS---KSDV 329
              + +   KL DFGL+K      +G+ +  T   GT  + APE V+     S   K D 
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDA 259

Query: 330 YSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG- 387
           +S GV+L  +L G        P  G ++                  +   L      +  
Sbjct: 260 WSAGVLLHLLLMGA------VPFPGVND---------------ADTISQVLNKKLCFENP 298

Query: 388 -----SQKATQLAAQCLSRDPKARPRMSEV 412
                S  A  L +  L+R+   R      
Sbjct: 299 NYNVLSPLARDLLSNLLNRNVDERFDAMRA 328

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 75/336 (22%), Positives = 113/336 (33%), Gaps = 69/336 (20%)

Query: 95  STTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWV 154
           S  T   +   + P              F           +R   LLG+GGFG VF G  
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDREAFE--------AEYRLGPLLGKGGFGTVFAG-- 50

Query: 155 EENGTAPVKPGTGLTVAVKTLN------HDGLQGHKEWLAEVNFL----GNLLHPNLVKL 204
                   +    L VA+K +          L        EV  L        HP +++L
Sbjct: 51  -------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103

Query: 205 VGYCIEDDQRL-LVYEF-MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAE 262
           + +  E  +   LV E  +P   L +++  KG L    S R          +   H    
Sbjct: 104 LDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-R-CFFGQVVAAIQHCHS--- 157

Query: 263 KPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 321
           + V++RD K  NIL+D      KL DFG       D          GT  Y+ PE++   
Sbjct: 158 RGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD---GTRVYSPPEWISRH 213

Query: 322 HLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 380
                 + V+S G++L +M+ G                    P   D+          LE
Sbjct: 214 QYHALPATVWSLGILLYDMVCGD------------------IPFERDQE--------ILE 247

Query: 381 GHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 414
                    S     L  +CL+  P +RP + E++ 
Sbjct: 248 AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 72/300 (24%), Positives = 105/300 (35%), Gaps = 69/300 (23%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--------EVNF 192
           LG G  G V             +  T   VA+K ++           A        E+  
Sbjct: 18  LGSGACGEVKLA---------FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIA 247
           L  L HP ++K+  +  + +   +V E M  G L + +     L                
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRL----KEATCKLYFYQM 123

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVST 304
           L A   + +LH   E  +I+RD K  N+LL   + D   K++DFG +K   E       T
Sbjct: 124 LLA---VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RT 175

Query: 305 RVMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
              GT  Y APE V+            D +S GV+L   L+G                  
Sbjct: 176 LC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG------------------ 215

Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 414
             P   + R    L D    G ++         S+KA  L  + L  DPKAR    E + 
Sbjct: 216 -YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 58/212 (27%), Positives = 86/212 (40%), Gaps = 31/212 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 195
           +GEG +G VFK    +         TG  VA+K                  L E+  L  
Sbjct: 11  IGEGSYGVVFKCRNRD---------TGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQ 58

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
           L HPNLV L+       +  LV+E+    ++ + L R         ++  I     + + 
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTLQAVN 116

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTH-VSTRVMGTYGY 312
           F H+      I+RD K  NIL+      KL DFG A+    P D     V+TR      Y
Sbjct: 117 FCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WY 168

Query: 313 AAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
            +PE ++         DV++ G V  E+L+G 
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 33/212 (15%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 199
           +LG G F  VF            +  TG   A+K +             E+  L  + H 
Sbjct: 16  VLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66

Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKG 253
           N+V L     E      LV + +  G L + +  +G      + +     ++  L A   
Sbjct: 67  NIVTLEDI-YESTTHYYLVMQLVSGGELFDRILERGVY----TEKDASLVIQQVLSA--- 118

Query: 254 LAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
           + +LH   E  +++RD K  N+L    + +    ++DFGL+K   ++G    ST   GT 
Sbjct: 119 VKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIM--STAC-GTP 171

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           GY APE +     +   D +S GV+   +L G
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 58/219 (26%), Positives = 87/219 (39%), Gaps = 35/219 (15%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EVNFLGN 195
           LLGEG +G V +    E         T    AVK L    L+      A    E+  L  
Sbjct: 12  LLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 196 LLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLF---RKGSLPLPWSIRMKIALGA 250
           L H N+++L  V Y  E  +  +V E+   G  E  +     +   P+  +      L  
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQL-- 118

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTRVM 307
             GL +LH    + ++++D K  N+LL      K+S  G+A        D     S    
Sbjct: 119 IDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--- 172

Query: 308 GTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEMLTGR 343
           G+  +  PE +  G  T    K D++S GV L  + TG 
Sbjct: 173 GSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 61/211 (28%), Positives = 89/211 (42%), Gaps = 26/211 (12%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 198
            LGEG +G V            V   T   VAVK ++        E +  E+     L H
Sbjct: 14  TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM---KIALGAAKGL 254
            N+VK  G    +     L  E+   G L + +     +P P + R     +A     G+
Sbjct: 65  ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH      + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 315 PEYVMTGHL--TSKSDVYSFGVVLLEMLTGR 343
           PE ++          DV+S G+VL  ML G 
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 60/297 (20%), Positives = 103/297 (34%), Gaps = 63/297 (21%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----- 188
            +   S LG G FG V+           V       V VK +  + +             
Sbjct: 25  KYSTMSPLGSGAFGFVWTA---------VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75

Query: 189 ---EVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGS-LENHLFRKGSLPLPWSIR 243
              E+  L  + H N++K++    E+     LV E    G  L   + R   L  P +  
Sbjct: 76  VTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134

Query: 244 M--KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 301
           +  ++       + +L     K +I+RD K  NI++  D+  KL DFG A         +
Sbjct: 135 IFRQLVSA----VGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY 187

Query: 302 VSTRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 359
                 GT  Y APE V+ G+     + +++S GV L  ++       +           
Sbjct: 188 TFC---GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE----------- 232

Query: 360 WARPHLGDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 414
                          L+  +E         S++   L +  L   P+ R  + ++V 
Sbjct: 233 ---------------LEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 95.0 bits (237), Expect = 5e-22
 Identities = 71/311 (22%), Positives = 117/311 (37%), Gaps = 71/311 (22%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--------HDGLQGH 183
             N+ P+ +LG G    V +          +   T    AVK ++         + +Q  
Sbjct: 16  YENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66

Query: 184 KEWLA-EVNFLGNL-LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 240
           +E    EV+ L  +  HPN+++L     E +    LV++ M +G L ++L  K +L    
Sbjct: 67  REATLKEVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTL---- 121

Query: 241 SIR-----MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 295
           S +     M+  L     +  LH+     +++RD K  NILLD D N KL+DFG +    
Sbjct: 122 SEKETRKIMRALLEV---ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175

Query: 296 EDGKTHVSTRVMGTYGYAAPE------YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 349
              K        GT  Y APE               + D++S GV++  +L G       
Sbjct: 176 PGEKL--REVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------ 226

Query: 350 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDP 403
                        P    K+    +L   + G++          S     L ++ L   P
Sbjct: 227 ------------PPFWHRKQ--MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272

Query: 404 KARPRMSEVVE 414
           + R    E + 
Sbjct: 273 QKRYTAEEALA 283

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 69/295 (23%), Positives = 115/295 (38%), Gaps = 41/295 (13%)

Query: 59  PSRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVAS 118
             +S  +S    + + + + K           +PV S  TS        P    + ++ +
Sbjct: 20  YFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVT 79

Query: 119 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 178
             ++   N             +LG G FG V K   EE  T       GL +A K +   
Sbjct: 80  -AKQGAVNSFY----TVSKTEILGGGRFGQVHK--CEETAT-------GLKLAAKIIKTR 125

Query: 179 GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSL------ENHLF 231
           G++  +E   E++ +  L H NL++L     E    + LV E++  G L      E++  
Sbjct: 126 GMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNL 184

Query: 232 --RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--DADYNAKLSD 287
                 L       MK       G+  +H   +  +++ D K  NIL         K+ D
Sbjct: 185 TELDTIL------FMKQICE---GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIID 232

Query: 288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           FGLA+      K  V     GT  + APE V    ++  +D++S GV+   +L+G
Sbjct: 233 FGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 77/406 (18%), Positives = 135/406 (33%), Gaps = 84/406 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G +G V+K   ++              A+K +   G+        E+  L  L HPN
Sbjct: 29  VGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79

Query: 201 LVKLVGYCIED-DQRL-LVYEFMP---RGSLENH---LFRKGSLPLPWSIRMKIALGAAK 252
           ++ L    +   D+++ L++++        ++ H      K  + LP  +   +      
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DAPEDGKTHVSTRV 306
           G+ +LH      V++RD K +NIL+  +       K++D G A+  ++P      +   V
Sbjct: 140 GIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 307 MGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR-----RSMDKNRPNGEH---- 355
           + T+ Y APE ++ G  H T   D+++ G +  E+LT       R  D    N  H    
Sbjct: 197 V-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254

Query: 356 ----------NLVEW-----------ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQL 394
                        +W                         L   +E H   K   KA  L
Sbjct: 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV-KPDSKAFHL 313

Query: 395 AAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQT---------MQADNTWSIRN 445
             + L+ DP  R    +              A    YF                 +  R 
Sbjct: 314 LQKLLTMDPIKRITSEQ--------------AMQDPYFLEDPLPTSDVFAGCQIPYPKRE 359

Query: 446 SKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPKPNGKQ 491
                        +N Q  +  +H NG      +    +  P  K+
Sbjct: 360 FLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLKK 405

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 33/215 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           LG G +  V+KG  +          TG+ VA+K +  D     +E      + E++ +  
Sbjct: 13  LGNGTYATVYKGLNKT---------TGVYVALKEVKLD----SEEGTPSTAIREISLMKE 59

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMP---RGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
           L H N+V+L      +++  LV+EFM    +  +++         L  ++         +
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVSTRVMGTY 310
           GLAF HE     +++RD K  N+L++     KL DFGLA     P +  +     V+ T 
Sbjct: 120 GLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TL 172

Query: 311 GYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 343
            Y AP+ V+ G    ++  D++S G +L EM+TG+
Sbjct: 173 WYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 38/277 (13%)

Query: 81  SNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESL 140
           S   R              +A  +    +  +  KV + +        +    ++    +
Sbjct: 2   SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV 61

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           +G G FG V++  + +         +G  VA+K +    LQ  +    E+  +  L H N
Sbjct: 62  IGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHCN 108

Query: 201 LVKLVGYCI------EDDQRL-LVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIALGAA 251
           +V+L  Y        +D+  L LV +++P  ++      + +    LP            
Sbjct: 109 IVRLR-YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKD-APEDGKTH-VSTRVMG 308
           + LA++H      + +RD K  N+LLD D    KL DFG AK     +     + +R   
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 220

Query: 309 TYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 343
            Y Y APE ++ G    TS  DV+S G VL E+L G+
Sbjct: 221 -Y-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 68/317 (21%), Positives = 121/317 (38%), Gaps = 60/317 (18%)

Query: 115 KVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT 174
           +   +  +FM N     + N+  +  LG+G F  V +          V   TGL  A K 
Sbjct: 11  QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKI 61

Query: 175 LNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLF 231
           +N   L     ++   E      L HPN+V+L    I+++    LV++ +  G L   + 
Sbjct: 62  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIV 120

Query: 232 RKGSLPLPWSIR-----MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNA 283
            +       S       ++  L +   +A+ H      +++R+ K  N+LL         
Sbjct: 121 AREFY----SEADASHCIQQILES---IAYCH---SNGIVHRNLKPENLLLASKAKGAAV 170

Query: 284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           KL+DFGLA +  +    H      GT GY +PE +     +   D+++ GV+L  +L G 
Sbjct: 171 KLADFGLAIEVNDSEAWH--GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 227

Query: 344 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQ 397
                              P   + +  +RL      G +          + +A  L   
Sbjct: 228 ------------------PPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267

Query: 398 CLSRDPKARPRMSEVVE 414
            L+ +PK R    + ++
Sbjct: 268 MLTVNPKKRITADQALK 284

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 95.7 bits (238), Expect = 4e-21
 Identities = 69/363 (19%), Positives = 116/363 (31%), Gaps = 49/363 (13%)

Query: 60  SRSKVDSSMSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQ 119
                 S     +          ++RR   V             +S+   +  ++     
Sbjct: 85  ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144

Query: 120 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 179
            +        +   ++     LG G FG V +  V E  T       G   A K +    
Sbjct: 145 PQPVEIKHDHV-LDHYDIHEELGTGAFGVVHR--VTERAT-------GNNFAAKFVMTPH 194

Query: 180 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPL 238
               +    E+  +  L HP LV L     +D++ +++YEFM  G L E        +  
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 254

Query: 239 PWSIR-MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--DADYNAKLSDFGLAKDAP 295
             ++  M+      KGL  +H   E   ++ D K  NI+         KL DFGL     
Sbjct: 255 DEAVEYMRQVC---KGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308

Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
                 V     GT  +AAPE      +   +D++S GV+   +L+G             
Sbjct: 309 PKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG------------- 352

Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRM 409
                  P  G+       L       +++        S+       + L  DP  R  +
Sbjct: 353 -----LSPFGGENDD--ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTI 405

Query: 410 SEV 412
            + 
Sbjct: 406 HQA 408

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 31/219 (14%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LA 188
            +    L+GEG +G V K   ++         TG  VA+K           +      + 
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFL---ESDDDKMVKKIAMR 73

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           E+  L  L H NLV L+  C +  +  LV+EF+   ++ + L       L + +  K   
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLF 131

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTH-VSTR 305
               G+ F H      +I+RD K  NIL+      KL DFG A+   AP +     V+TR
Sbjct: 132 QIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR 188

Query: 306 VMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
                 Y APE ++      K+ DV++ G ++ EM  G 
Sbjct: 189 -----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 92.2 bits (230), Expect = 4e-21
 Identities = 66/293 (22%), Positives = 113/293 (38%), Gaps = 62/293 (21%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAE 189
           + N+  +  LG+G F  V +          V   TGL  A K +N   L     ++   E
Sbjct: 5   SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 55

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR----- 243
                 L HPN+V+L    I+++    LV++ +  G L   +  +       S       
Sbjct: 56  ARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIVAREFY----SEADASHC 110

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 300
           ++  L +   +A+ H      +++R+ K  N+LL         KL+DFGLA +  +    
Sbjct: 111 IQQILES---IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164

Query: 301 HVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 359
           H      GT GY +PE V+     +   D+++ GV+L  +L G                 
Sbjct: 165 H--GFA-GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVG----------------- 203

Query: 360 WARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKAR 406
              P   + +  +RL      G +          + +A  L    L+ +PK R
Sbjct: 204 -YPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKR 253

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.1 bits (232), Expect = 7e-21
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 32/226 (14%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
              F+ E + G+G FG V  G  +          TG++VA+K +  D    ++E L  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPRFRNRE-LQIMQ 71

Query: 192 FLGNLLHPNLVKL------VGYCIEDDQRL-LVYEFMPRGSLENHL--FRKGSLPLPWSI 242
            L  L HPN+V+L      +G     D  L +V E++P  +L      + +  +  P  +
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130

Query: 243 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDA-PEDGKT 300
                    + +  LH  +   V +RD K  N+L++ AD   KL DFG AK   P +   
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189

Query: 301 H-VSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 343
             + +R    Y Y APE ++ G  H T+  D++S G +  EM+ G 
Sbjct: 190 AYICSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 93.7 bits (233), Expect = 1e-20
 Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 39/223 (17%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 190
           ++     LG G FG V  G             TG  VAVK LN   ++          E+
Sbjct: 17  HYILGDTLGVGTFGKVKVG---------KHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67

Query: 191 NFLGNLLHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
             L    HP+++KL  Y  I     + +V E++  G L +++ + G        R+    
Sbjct: 68  QNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG--------RLDEKE 117

Query: 249 GAAK------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
                     G+ + H      V++RD K  N+LLDA  NAK++DFGL+    +      
Sbjct: 118 SRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174

Query: 303 STRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGR 343
           S    G+  YAAPE V++G L    + D++S GV+L  +L G 
Sbjct: 175 SC---GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 68/296 (22%), Positives = 107/296 (36%), Gaps = 70/296 (23%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           +G G +    +          +   T +  AVK ++        E   E+  L     HP
Sbjct: 30  IGVGSYSVCKRC---------IHKATNMEFAVKIIDKSKRDP-TE---EIEILLRYGQHP 76

Query: 200 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKG 253
           N++ L     +D + + +V E M  G L + + R+       S R     +         
Sbjct: 77  NIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQKFF----SEREASAVLFTITKT--- 128

Query: 254 LAFLHEEAEKPVIYRDFKTSNILL-DADYNA---KLSDFGLAKDAPEDGKTHVSTRVMGT 309
           + +LH    + V++RD K SNIL  D   N    ++ DFG AK    +    + T    T
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-YT 183

Query: 310 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPH 364
             + APE V+       + D++S GV+L  MLTG        D                 
Sbjct: 184 ANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE------------- 229

Query: 365 LGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 414
                    +L     G FS+ G      S  A  L ++ L  DP  R   + V+ 
Sbjct: 230 --------EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 72/296 (24%), Positives = 114/296 (38%), Gaps = 62/296 (20%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 190
            +     LGEG FG V                T   VA+K ++   L+     +    E+
Sbjct: 10  PYIIRETLGEGSFGKVKLA---------THYKTQQKVALKFISRQLLKKSDMHMRVEREI 60

Query: 191 NFLGNLLHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           ++L  L HP+++KL  Y  I     + +V E+   G L +++  K         RM    
Sbjct: 61  SYLKLLRHPHIIKL--YDVITTPTDIVMVIEYAG-GELFDYIVEKK--------RMTEDE 109

Query: 249 GAAK------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           G          + + H      +++RD K  N+LLD + N K++DFGL+    +      
Sbjct: 110 GRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166

Query: 303 STRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
           S    G+  YAAPE V+ G L    + DV+S G+VL  ML GR   D      +  +   
Sbjct: 167 SC---GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD------DEFIPN- 215

Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 414
                        L        + +    S  A  L  + +  DP  R  + E+  
Sbjct: 216 -------------LFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 89.9 bits (224), Expect = 3e-20
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 31/214 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           + GTG   A K +    L   +  ++      EVN L 
Sbjct: 13  LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 195 NLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAK 252
            + HPN++ L     E+   + L+ E +  G L + L  K SL    + + +K  L    
Sbjct: 64  EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD--- 119

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
           G+ +LH    K + + D K  NI+L      +   KL DFG+A       +      + G
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFG 173

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           T  + APE V    L  ++D++S GV+   +L+G
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 61/292 (20%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG+G F  V +          VK   G   A   +N   L    H++   E      L H
Sbjct: 19  LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 199 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAK 252
           PN+V+L    I ++    L+++ +  G L   +  +       S       ++  L A  
Sbjct: 70  PNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDIVAREYY----SEADASHCIQQILEA-- 122

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
            +   H   +  V++R+ K  N+LL         KL+DFGLA +   + +        GT
Sbjct: 123 -VLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA-WFGFA-GT 176

Query: 310 YGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
            GY +PE V+         D+++ GV+L  +L G                    P   + 
Sbjct: 177 PGYLSPE-VLRKDPYGKPVDLWACGVILYILLVGY------------------PPFWDED 217

Query: 369 RRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 414
           +  +RL      G +          + +A  L  + L+ +P  R   +E ++
Sbjct: 218 Q--HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 39/223 (17%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           +    ++G G FG VF+  + E+            VA+K +    LQ  +    E+  + 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE----------VAIKKV----LQDKRFKNRELQIMR 87

Query: 195 NLLHPNLVKLVGYCI------EDDQRL-LVYEFMPRGSLENHL--FRKGSLPLPWSIRMK 245
            + HPN+V L           +D+  L LV E++P  ++      + K    +P  +   
Sbjct: 88  IVKHPNVVDLK-AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKL 145

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKD-APEDGKTH-V 302
                 + LA++H      + +RD K  N+LLD      KL DFG AK     +     +
Sbjct: 146 YMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202

Query: 303 STRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 343
            +R    Y Y APE ++ G  + T+  D++S G V+ E++ G+
Sbjct: 203 CSR----Y-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 90.9 bits (226), Expect = 4e-20
 Identities = 54/213 (25%), Positives = 84/213 (39%), Gaps = 36/213 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V +          V+  TG     K +N            E++ +  L HP 
Sbjct: 59  LGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSL------ENHLF--RKGSLPLPWSIRMKIALGAA 251
           L+ L     ED   + L+ EF+  G L      E++     +          M+ A    
Sbjct: 110 LINLHDA-FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN------YMRQACE-- 160

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILL--DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
            GL  +H   E  +++ D K  NI+       + K+ DFGLA     D    V      T
Sbjct: 161 -GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTAT 213

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
             +AAPE V    +   +D+++ GV+   +L+G
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 31/214 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 20  LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 195 NLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAK 252
            +LH N++ L     E+   + L+ E +  G L + L +K SL    +   +K  L    
Sbjct: 71  QVLHHNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD--- 126

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
           G+ +LH    K + + D K  NI+L        + KL DFGLA +  +  +      + G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           T  + APE V    L  ++D++S GV+   +L+G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 61/294 (20%), Positives = 102/294 (34%), Gaps = 61/294 (20%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H 198
           +LG G  G V +              TG   A+K L         +   EV+        
Sbjct: 36  VLGLGVNGKVLEC---------FHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGG 81

Query: 199 PNLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGA 250
           P++V ++    E+        L++ E M  G L + +  +G         +  M+    A
Sbjct: 82  PHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
              + FLH      + +RD K  N+L    + D   KL+DFG AK+  ++    + T   
Sbjct: 141 ---IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPC- 190

Query: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLG 366
            T  Y APE +         D++S GV++  +L G        P                
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF------PPFYSNT----------- 233

Query: 367 DKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 414
            +     +      G +          S+ A QL    L  DP  R  +++ + 
Sbjct: 234 GQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 90.1 bits (224), Expect = 7e-20
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 31/214 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  +       EV+ L 
Sbjct: 20  LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 195 NLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAK 252
            +LHPN++ L     E+   + L+ E +  G L + L +K SL    +   +K  L    
Sbjct: 71  QVLHPNIITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD--- 126

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
           G+ +LH    K + + D K  NI+L        + KL DFGLA +  +  +      + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           T  + APE V    L  ++D++S GV+   +L+G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 88.3 bits (220), Expect = 1e-19
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 36/214 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +GEG +G V+K           +   G T A+K +    L+   E      + E++ L  
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE 56

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--MKIALGAAKG 253
           L H N+VKL        + +LV+E + +  L+  L          + +  +   L    G
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NG 112

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYG 311
           +A+ H+   + V++RD K  N+L++ +   K++DFGLA+    P    TH    ++ T  
Sbjct: 113 IAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLW 165

Query: 312 YAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 343
           Y AP+ V+ G    ++  D++S G +  EM+ G 
Sbjct: 166 YRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 88.3 bits (220), Expect = 1e-19
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 31/213 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +GEG +G VFK    E         T   VA+K +    L    E      L E+  L  
Sbjct: 10  IGEGTYGTVFKAKNRE---------THEIVALKRVR---LDDDDEGVPSSALREICLLKE 57

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
           L H N+V+L      D +  LV+EF  +  L+   F   +  L   I         KGL 
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLK-KYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 313
           F H    + V++RD K  N+L++ +   KL++FGLA+    P    +     V+ T  Y 
Sbjct: 116 FCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYR 168

Query: 314 APEYVMTG--HLTSKSDVYSFGVVLLEMLTGRR 344
            P+ V+ G    ++  D++S G +  E+    R
Sbjct: 169 PPD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 32/212 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +GEG +G V+K           K   G  VA+K +    L    E      + E++ L  
Sbjct: 29  VGEGTYGVVYKA----------KDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKE 75

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
           L HPN+V L+     +    LV+EFM +  L+  L  +    L  S          +G+A
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLLRGVA 133

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 313
             H+     +++RD K  N+L+++D   KL+DFGLA+    P    TH    V+ T  Y 
Sbjct: 134 HCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYR 186

Query: 314 APEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 343
           AP+ V+ G    ++  D++S G +  EM+TG+
Sbjct: 187 APD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 65/296 (21%), Positives = 104/296 (35%), Gaps = 57/296 (19%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 192
            +     +G G FG                  T   VAVK +         E +  E+  
Sbjct: 21  RYDFVKDIGSGNFGVARLM---------RDKLTKELVAVKYIERGAAI--DENVQREIIN 69

Query: 193 LGNLLHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK----I 246
             +L HPN+V+      I     L ++ E+   G L   +   G      + R      +
Sbjct: 70  HRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEA-RFFFQQLL 126

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY--NAKLSDFGLAKDAPEDGKTHVST 304
           +     G+++ H      + +RD K  N LLD       K+ DFG +K +    +    +
Sbjct: 127 S-----GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--S 176

Query: 305 RVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 362
            V GT  Y APE V+         +DV+S GV L  ML G    +   P           
Sbjct: 177 TV-GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE--DPE---------- 222

Query: 363 PHLGDKRRFYRLLDPRLEGHFSIKG----SQKATQLAAQCLSRDPKARPRMSEVVE 414
               + R + + +   L   +SI      S +   L ++    DP  R  + E+  
Sbjct: 223 ----EPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 32/219 (14%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLA 188
            +     LGEG +  V+KG  +          T   VA+K +  +    H+E      + 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLE----HEEGAPCTAIR 49

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           EV+ L +L H N+V L      +    LV+E++ +  L+ +L       +          
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHNVKLFLF 107

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVSTRV 306
              +GLA+ H    + V++RD K  N+L++     KL+DFGLA  K  P     +    V
Sbjct: 108 QLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EV 161

Query: 307 MGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 343
           + T  Y  P+ ++ G    +++ D++  G +  EM TGR
Sbjct: 162 V-TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 31/214 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 194
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 195 NLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAK 252
            + HPN++ L     E+   + L+ E +  G L + L  K SL    +   +K  L    
Sbjct: 70  EIQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG-- 126

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
            + +LH      + + D K  NI+L          K+ DFGLA       +      + G
Sbjct: 127 -VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFG 179

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
           T  + APE V    L  ++D++S GV+   +L+G
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 82/362 (22%), Positives = 126/362 (34%), Gaps = 72/362 (19%)

Query: 68  MSGTSTNYADGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFND 127
           M     + +      E    +     S T ++   +AS  P +  +      L  F    
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQS--MSSVTASAAPGTASLVPDYWIDGSNRDALSDF---- 54

Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 187
                  F  ES LG G    V++           + GT    A+K L        K   
Sbjct: 55  -------FEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKT--VDKKIVR 96

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR--- 243
            E+  L  L HPN++KL     E    + LV E +  G L + +  KG      S R   
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYY----SERDAA 151

Query: 244 --MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDG 298
             +K  L A   +A+LHE     +++RD K  N+L      D   K++DFGL+K      
Sbjct: 152 DAVKQILEA---VAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205

Query: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358
                  V GT GY APE +       + D++S G++   +L G                
Sbjct: 206 LM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG---------------- 246

Query: 359 EWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 412
                   D+R    +    L   +          S  A  L  + +  DPK R    + 
Sbjct: 247 ---FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303

Query: 413 VE 414
           ++
Sbjct: 304 LQ 305

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 69/230 (30%), Positives = 103/230 (44%), Gaps = 30/230 (13%)

Query: 124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 183
           M  D+K   + +     LGEG F  V+K   +          T   VA+K +        
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEA 51

Query: 184 KE-----WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL 238
           K+      L E+  L  L HPN++ L+          LV++FM    LE  + +  SL L
Sbjct: 52  KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLE-VIIKDNSLVL 109

Query: 239 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPE 296
             S      L   +GL +LH+     +++RD K +N+LLD +   KL+DFGLAK   +P 
Sbjct: 110 TPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166

Query: 297 DGKTH-VSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 343
              TH V TR      Y APE ++ G        D+++ G +L E+L   
Sbjct: 167 RAYTHQVVTR-----WYRAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 51/237 (21%), Positives = 89/237 (37%), Gaps = 52/237 (21%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----------- 188
            +G+G +G V                     A+K L+   L     +             
Sbjct: 20  EIGKGSYGVVKLA---------YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70

Query: 189 ---------------EVNFLGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLF 231
                          E+  L  L HPN+VKL  V     +D   +V+E + +G +   + 
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VP 129

Query: 232 RKGSLPLPWSIRM--KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG 289
               L    +      +  G    + +LH    + +I+RD K SN+L+  D + K++DFG
Sbjct: 130 TLKPLSEDQARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEMLTGR 343
           ++ +  +     +S  V GT  + APE +            DV++ GV L   + G+
Sbjct: 183 VSNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 38/281 (13%), Positives = 74/281 (26%), Gaps = 60/281 (21%)

Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 186
              R +R     G       ++                  VA+  ++  G+      +E 
Sbjct: 29  ANGR-YRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQET 78

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           L+    L  +  P + +++         L+V E++  GSL+       S     +IR   
Sbjct: 79  LSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIR--A 134

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
               A      H      V       S + +  D +  L+                    
Sbjct: 135 MQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------------- 174

Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                              + D+   G  L  +L  R  + +    G  + +  A     
Sbjct: 175 -----TMPDA-------NPQDDIRGIGASLYALLVNRWPLPE---AGVRSGLAPAERDTA 219

Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            +      +D  +    S         +AA+ +  D   R 
Sbjct: 220 GQPIEPADIDRDIPFQIS--------AVAARSVQGDGGIRS 252

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 68/356 (19%), Positives = 114/356 (32%), Gaps = 61/356 (17%)

Query: 79  KSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFR-P 137
             S       P  P    T +     +  P    +      ++  +         +++  
Sbjct: 7   GQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVT 66

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 197
             +LG G  G V +              T    A+K L         +   EV       
Sbjct: 67  SQVLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRAS 112

Query: 198 -HPNLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIAL 248
             P++V++V    E+        L+V E +  G L + +  +G         S  MK   
Sbjct: 113 QCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNA--KLSDFGLAKDAPEDGKTHVSTR 305
            A   + +LH      + +RD K  N+L      NA  KL+DFG AK+        ++T 
Sbjct: 172 EA---IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTP 223

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPH 364
              T  Y APE +         D++S GV++  +L G        P    H         
Sbjct: 224 C-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNH-------GL 269

Query: 365 LGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 414
                   R+      G +          S++   L    L  +P  R  ++E + 
Sbjct: 270 AISPGMKTRI----RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.2 bits (209), Expect = 5e-18
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 41/219 (18%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           LGEG +G V+K              T  TVA+K +    L+  +E      + EV+ L  
Sbjct: 42  LGEGTYGEVYKAIDTV---------TNETVAIKRIR---LEHEEEGVPGTAIREVSLLKE 89

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--MKIALGAAKG 253
           L H N+++L      + +  L++E+     L+ ++ +   +     I+  +   +    G
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVS-MRVIKSFLYQLI---NG 144

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKD--APEDGKTHVSTRV 306
           + F H    +  ++RD K  N+LL     +     K+ DFGLA+    P    TH    +
Sbjct: 145 VNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EI 198

Query: 307 MGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 343
           + T  Y  PE ++ G  H ++  D++S   +  EML   
Sbjct: 199 I-TLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 84.6 bits (209), Expect = 5e-18
 Identities = 77/350 (22%), Positives = 109/350 (31%), Gaps = 97/350 (27%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFL------ 193
           LG G FG V +           K  T  TVAVK L        H+  ++E+  L      
Sbjct: 30  LGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 194 --------------------------GNLLH-------------------PNLVKLVGYC 208
                                     GNL                           VG  
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145

Query: 209 IEDDQRLLVYEFMPRGSLENHLFRKGSL---------------PLPWSIRMKIALGAAKG 253
             D +R L      + S  +    + SL                L     +  +   AKG
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           + FL   A +  I+RD    NILL      K+ DFGLA+D  +D              + 
Sbjct: 206 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGEHNLVEWARPHLGDKR 369
           APE +     T +SDV+SFGV+L E+ + G      +  +                   +
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCRRL-------K 310

Query: 370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
              R+  P          + +  Q    C   +P  RP  SE+VE L  L
Sbjct: 311 EGTRMRAPDY-------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 40/210 (19%), Positives = 79/210 (37%), Gaps = 31/210 (14%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 200
           LG G FG V +          V+  +  T   K +   G         E++ L    H N
Sbjct: 13  LGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRN 62

Query: 201 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKGL 254
           ++ L     E  + L +++EF+    +   +          + R     +       + L
Sbjct: 63  ILHLHESF-ESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVC---EAL 115

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
            FLH      + + D +  NI+     ++  K+ +FG A+         +   +     Y
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEY 169

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            APE      +++ +D++S G ++  +L+G
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 82.6 bits (205), Expect = 1e-17
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 33/217 (15%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +GEG +G VFK    +N         G  VA+K +    +Q  +E      + EV  L +
Sbjct: 19  IGEGAYGKVFKARDLKN--------GGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67

Query: 196 L---LHPNLVKL----VGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
           L    HPN+V+L         + + +L LV+E + +  L  +L +     +P      + 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRV 306
               +GL FLH      V++RD K  NIL+ +    KL+DFGLA+        T     V
Sbjct: 127 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VV 180

Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           + T  Y APE ++     +  D++S G +  EM   +
Sbjct: 181 V-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 37/220 (16%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--------EVNF 192
           +G G +G V+K              +G  VA+K++    +                EV  
Sbjct: 17  IGVGAYGTVYKARDPH---------SGHFVALKSVR---VPNGGGGGGGLPISTVREVAL 64

Query: 193 LGNL---LHPNLVKL----VGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
           L  L    HPN+V+L         + + ++ LV+E + +  L  +L +     LP     
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVS 303
            +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+        T   
Sbjct: 124 DLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP-- 178

Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
             V+ T  Y APE ++     +  D++S G +  EM   +
Sbjct: 179 -VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 29/212 (13%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 198
           LG G F  V +          +   TG   A K L           E L E+  L     
Sbjct: 37  LGRGKFAVVRQC---------ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87

Query: 199 -PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKG 253
            P ++ L     E+   + L+ E+   G + +    + +  +        +K  L    G
Sbjct: 88  CPRVINLHEV-YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE---G 143

Query: 254 LAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
           + +LH   +  +++ D K  NILL       + K+ DFG+++      +      +MGT 
Sbjct: 144 VYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTP 197

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 342
            Y APE +    +T+ +D+++ G++   +LT 
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 55/232 (23%), Positives = 87/232 (37%), Gaps = 41/232 (17%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----- 186
              +  +  +  G +G V                 G+ VA+K + +    G         
Sbjct: 21  QSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70

Query: 187 ------LAEVNFLGNLLHPNLVKL----VGYCIEDDQRL-LVYEFMPRGSLENHLFRKGS 235
                 L E+  L +  HPN++ L    V +      +L LV E M    L   +     
Sbjct: 71  FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DL-AQVIHDQR 128

Query: 236 LPLPWSIRMK-IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
           + +     ++        GL  LHE A   V++RD    NILL  + +  + DF LA++ 
Sbjct: 129 IVIS-PQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLARED 184

Query: 295 PEDGKT--HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 343
             D     +V+ R      Y APE VM     T   D++S G V+ EM   +
Sbjct: 185 TADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 82.2 bits (203), Expect = 5e-17
 Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 32/222 (14%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
            + ++    +G G  G V                    VA+K L+         K    E
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 111

Query: 190 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
           +  +  + H N++ L+        +E+ Q + LV E M   +    + +        S  
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYL 169

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT--H 301
           +   L    G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A        +
Sbjct: 170 LYQML---CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223

Query: 302 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           V TR      Y APE ++        D++S G ++ EM+  +
Sbjct: 224 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 34/219 (15%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +++    LG G +  VF+     N            V VK L        K+   E+  L
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNE---------KVVVKILK---PVKKKKIKREIKIL 84

Query: 194 GNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP-WSIR--MKIALG 249
            NL   PN++ L     +   R     F     + N  F++    L  + IR  M   L 
Sbjct: 85  ENLRGGPNIITLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTDYDIRFYMYEIL- 140

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAK-DAPEDGKTH-VSTRV 306
             K L + H      +++RD K  N+++D ++   +L D+GLA+   P       V++R 
Sbjct: 141 --KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195

Query: 307 MGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRR 344
                +  PE ++   +   S D++S G +L  M+  + 
Sbjct: 196 -----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 53/232 (22%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
            + +   + +G G +G V            +   +G  VA+K L+         K    E
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRE 73

Query: 190 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
           +  L ++ H N++ L+        + +     LV  FM     +  L +         + 
Sbjct: 74  LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQK--------IMG 120

Query: 244 MKIA-----------LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
           +K +           L   KGL ++H  A   V++RD K  N+ ++ D   K+ DFGLA+
Sbjct: 121 LKFSEEKIQYLVYQML---KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLAR 174

Query: 293 DAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 343
            A  +   +V TR    + Y APE +++  H     D++S G ++ EMLTG+
Sbjct: 175 HADAEMTGYVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 34/223 (15%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
            + ++    +G G  G V                    VA+K L+         K    E
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAA---------YDAILERNVAIKKLSRPFQNQTHAKRAYRE 74

Query: 190 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
           +  +  + H N++ L+        +E+ Q + +V E M     + +L +   + L    R
Sbjct: 75  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMEL-DHER 128

Query: 244 MKIAL-GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-- 300
           M   L     G+  LH  A   +I+RD K SNI++ +D   K+ DFGLA+ A        
Sbjct: 129 MSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185

Query: 301 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
           +V TR      Y APE ++        D++S G ++ EM+ G 
Sbjct: 186 YVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 78.0 bits (193), Expect = 6e-16
 Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 39/222 (17%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 195
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 25  IGQGTFGEVFKARHRK---------TGQKVALKKVL---MENEKEGFPITALREIKILQL 72

Query: 196 LLHPNLVKLVGYCIEDDQRL--------LVYEFMP---RGSLENHLFRKGSLPLPWSIRM 244
           L H N+V L+  C               LV++F      G L N       +    S   
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIK 127

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHV 302
           ++      GL ++H      +++RD K +N+L+  D   KL+DFGLA+     ++ + + 
Sbjct: 128 RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 303 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 343
            T  + T  Y  PE ++         D++  G ++ EM T  
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 56/259 (21%), Positives = 99/259 (38%), Gaps = 72/259 (27%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK-TLNHDGLQGHKEWLAEV 190
           ++ +     LG G FG V + +  E         +G   A+K  L        +    E+
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDP-----RYKNREL 51

Query: 191 NFLGNLLHPNLVKL-------------------------------------VGYCIEDDQ 213
           + +  L H N++KL                                     V      ++
Sbjct: 52  DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111

Query: 214 RL-LVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIAL-GAAKGLAFLHEEAEKPVIYRD 269
            L ++ E++P  +L   L  F +    +P    + I +    + + F+H      + +RD
Sbjct: 112 YLNVIMEYVP-DTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSLG---ICHRD 166

Query: 270 FKTSNILLDA-DYNAKLSDFGLAKDA-PEDGKTH-VSTRVMGTYGYAAPEYVMTG--HLT 324
            K  N+L+++ D   KL DFG AK   P +     + +R    + Y APE +M G    T
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE-LMLGATEYT 220

Query: 325 SKSDVYSFGVVLLEMLTGR 343
              D++S G V  E++ G+
Sbjct: 221 PSIDLWSIGCVFGELILGK 239

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 32/222 (14%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
              ++  S +G G +G V   +  +         TGL VAVK L+     +   K    E
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRE 78

Query: 190 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
           +  L ++ H N++ L+        +E+   + LV   M  G+  N++ +   L       
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLT---DDH 133

Query: 244 MK-IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++ +     +GL ++H  A+  +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V
Sbjct: 134 VQFLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV 190

Query: 303 STRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 343
           +TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 191 ATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 52/235 (22%), Positives = 94/235 (40%), Gaps = 45/235 (19%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
              +     LG GG G VF           V       VA+K +     Q  K  L E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTDPQSVKHALREIK 60

Query: 192 FLGNLLHPNLVKL-------------VGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLP 237
            +  L H N+VK+                 + +   + +V E+M   +   ++  +G L 
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLL 118

Query: 238 LPWSIRMK-IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDAP 295
                  +       +GL ++H  A   V++RD K +N+ ++  D   K+ DFGLA+   
Sbjct: 119 ---EEHARLFMYQLLRGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 296 EDGKT------HVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
                       + T+      Y +P  +++ +  +K+ D+++ G +  EMLTG+
Sbjct: 173 PHYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 42/229 (18%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 190
              +   S +GEG +G V   +   N            VA+K ++  +     +  L E+
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKV---------RVAIKKISPFEHQTYCQRTLREI 76

Query: 191 NFLGNLLHPNLVKLVG----YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
             L    H N++ +        IE  + + +V + M   +    L +   L    +  + 
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLS---NDHIC 131

Query: 246 I----ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT- 300
                 L   +GL ++H  A   V++RD K SN+LL+   + K+ DFGLA+ A  D    
Sbjct: 132 YFLYQIL---RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

Query: 301 -----HVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
                +V+TR      Y APE ++     +KS D++S G +L EML+ R
Sbjct: 186 GFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 57/237 (24%), Positives = 100/237 (42%), Gaps = 51/237 (21%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 190
           + +F+ +SLLGEG +G V     +  G           VA+K +   D        L E+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGE---------IVAIKKIEPFDKPLFALRTLREI 60

Query: 191 NFLGNLLHPNLVKLV----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
             L +  H N++ +         E+   + ++ E M     +  L R         I  +
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHR--------VISTQ 107

Query: 246 IALGAA----------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---- 291
           + L             + +  LH  +   VI+RD K SN+L++++ + K+ DFGLA    
Sbjct: 108 M-LSDDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

Query: 292 KDAPEDGKTHVSTRVMGTY----GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 343
           + A ++ +       M  +     Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 32/222 (14%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
              +R    +G G +G V            V   TG  VA+K L          K    E
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRE 74

Query: 190 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 243
           +  L ++ H N++ L+        ++D     LV  FM  G+    L +   L      R
Sbjct: 75  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLG---EDR 129

Query: 244 MK-IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 302
           ++ +     KGL ++H  A   +I+RD K  N+ ++ D   K+ DFGLA+ A  +   +V
Sbjct: 130 IQFLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 186

Query: 303 STRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 343
            TR      Y APE ++     T   D++S G ++ EM+TG+
Sbjct: 187 VTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 49/319 (15%), Positives = 97/319 (30%), Gaps = 75/319 (23%)

Query: 81  SNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESL 140
           S+ +          +  T +        +        +       +D ++  R +    L
Sbjct: 2   SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDR-YEIRHL 60

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGN 195
           +G G +G V +                  VA+K +                  E+  L  
Sbjct: 61  IGTGSYGHVCEA---------YDKLEKRVVAIKKILRVF---EDLIDCKRILREIAILNR 108

Query: 196 LLHPNLVKLV----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
           L H ++VK++       +E    L +V E       ++   +          R  + L  
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKK--------LFRTPVYLTE 155

Query: 251 A----------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA--------- 291
                       G+ ++H  A   +++RD K +N L++ D + K+ DFGLA         
Sbjct: 156 LHIKTLLYNLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212

Query: 292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH------------LTSKS-----DVYSFGV 334
                         ++        +  +TGH            L  ++     DV+S G 
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272

Query: 335 VLLEMLTGRRSMDKNRPNG 353
           +  E+L   +       + 
Sbjct: 273 IFAELLNMIKENVAYHADR 291

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 54/259 (20%), Positives = 95/259 (36%), Gaps = 63/259 (24%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
             N+  + L+G G +G V+  + +              VA+K +N   + L   K  L E
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEK---------NVAIKKVNRMFEDLIDCKRILRE 75

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRL-----LVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
           +  L  L    +++L    I DD        +V E       ++ L +          + 
Sbjct: 76  ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKK--------LFKT 122

Query: 245 KIALGAA----------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 294
            I L              G  F+HE +   +I+RD K +N LL+ D + K+ DFGLA+  
Sbjct: 123 PIFLTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

Query: 295 PEDGKTHVSTRVMGTYGYAAP---------EYVMT------------GHLTSKSDVYSFG 333
             +  T++   +                   +V+T             + T   D++S G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239

Query: 334 VVLLEMLTGRRSMDKNRPN 352
            +  E+L   +S   +  N
Sbjct: 240 CIFAELLNMLQSHINDPTN 258

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 54/294 (18%), Positives = 89/294 (30%), Gaps = 83/294 (28%)

Query: 141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 199
           LG G  G V +              T    A+K L         +   EV         P
Sbjct: 26  LGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQCP 71

Query: 200 NLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAA 251
           ++V++V    E+        L+V E +  G L + +  +G         S  MK    A 
Sbjct: 72  HIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA- 129

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
             + +LH      + +RD K  N+L      +   KL+DFG    A E           G
Sbjct: 130 --IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKE---------TTG 172

Query: 309 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS-MDKNRPNGEHNLVEWARPHLG 366
             Y  +              D++S GV++  +L G       +                 
Sbjct: 173 EKYDKSC-------------DMWSLGVIMYILLCGYPPFYSNHGLAISP----------- 208

Query: 367 DKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 414
                  +      G +          S++   L    L  +P  R  ++E + 
Sbjct: 209 ------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 46/249 (18%), Positives = 87/249 (34%), Gaps = 56/249 (22%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH 198
             LG G F  V+      N T          VA+K +  D     +    E+  L  +  
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDK-VYTEAAEDEIKLLQRVND 74

Query: 199 PNLVKLVG----YCIEDDQRLLVYEFMPRGSLENHL-----------------FRKGSLP 237
            +  K       + +    +LL + F  +G    H+                 +    +P
Sbjct: 75  ADNTKEDSMGANHIL----KLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129

Query: 238 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD------ADYNAKLSDFGLA 291
           L   ++ +I+     GL ++H      +I+ D K  N+L++           K++D G A
Sbjct: 130 LI-YVK-QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

Query: 292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-----RSM 346
               E     + TR      Y +PE ++       +D++S   ++ E++TG         
Sbjct: 186 CWYDEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240

Query: 347 DKNRPNGEH 355
                + +H
Sbjct: 241 HSYTKDDDH 249

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 58/247 (23%), Positives = 95/247 (38%), Gaps = 61/247 (24%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 189
            R +     LG+G +G V+K              TG  VAVK +          +    E
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRR---------TGEVVAVKKIFDAFQNSTDAQRTFRE 58

Query: 190 VNFLGNL-LHPNLVKLVGYCI-EDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           +  L  L  H N+V L+     ++D+ + LV+++M     E  L           IR  I
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHA--------VIRANI 105

Query: 247 ALGAA----------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 296
            L             K + +LH      +++RD K SNILL+A+ + K++DFGL++    
Sbjct: 106 -LEPVHKQYVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161

Query: 297 DGKTHVSTRVMGTYGYAAP--------EYVMT------------GHLTSKSDVYSFGVVL 336
             +   +  +                 +YV T               T   D++S G +L
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221

Query: 337 LEMLTGR 343
            E+L G+
Sbjct: 222 GEILCGK 228

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 53/226 (23%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGNLL 197
            ++G+G FG V K +  +             VA+K + N      H++   E+  L +L 
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQ---------HVALKMVRNEKRF--HRQAAEEIRILEHLR 151

Query: 198 H------PNLVKLVGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRKGSLPLP 239
                   N++ ++         C+  E    LL   +YE      ++ + F+  SLPL 
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFE----LLSMNLYEL-----IKKNKFQGFSLPL- 201

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNA-KLSDFGLAKDAPED 297
             +R K A    + L  LH+     +I+ D K  NILL     +  K+ DFG +    + 
Sbjct: 202 --VR-KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255

Query: 298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
             T++ +R      Y APE ++        D++S G +L E+LTG 
Sbjct: 256 VYTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 61/236 (25%), Positives = 91/236 (38%), Gaps = 54/236 (22%)

Query: 130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLA 188
              R +  +SL+G+G FG V K +                VA+K + N        +   
Sbjct: 52  WMDR-YEIDSLIGKGSFGQVVKAYDRVEQE---------WVAIKIIKNKKAF--LNQAQI 99

Query: 189 EVNFLGNLLHP------NLVKLVGY-------CI--EDDQRLL---VYEFMPRGSLENHL 230
           EV  L  +          +V L  +       C+  E    +L   +Y+      L N  
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----MLSYNLYDL-----LRNTN 150

Query: 231 FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA--KLSDF 288
           FR  SL L    R K A      L FL    E  +I+ D K  NILL     +  K+ DF
Sbjct: 151 FRGVSLNL---TR-KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205

Query: 289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGR 343
           G +    +    ++ +R      Y +PE V+ G       D++S G +L+EM TG 
Sbjct: 206 GSSCQLGQRIYQYIQSRF-----YRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 41/236 (17%), Positives = 80/236 (33%), Gaps = 37/236 (15%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----------LQG 182
           R ++ +S       G +++     +             ++K    DG             
Sbjct: 42  RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100

Query: 183 HKEWLAEVNFLGNLLHPNLVKLVGY-CIEDDQRLLVYEFMPR--GSLENHLFRKGSLPLP 239
               + +   L +     +   +G+   +D  R LV   +P    SL++ L       L 
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQSALDVSPKHVLS 157

Query: 240 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK--LSDFGLAKDAPED 297
               +++A      L FLH   E   ++ +    NI +D +  ++  L+ +G A      
Sbjct: 158 ERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC-P 213

Query: 298 GKTHVSTR------VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 343
              HV+          G   + +    M  H     + +SD+ S G  +L+ L G 
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 45/236 (19%), Positives = 86/236 (36%), Gaps = 37/236 (15%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----L 187
             ++    +G+GGFGC++   +  +       G+     VK    D      E       
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSE----SVGSDAPCVVKVEPSDNGPLFTELKFYQRA 90

Query: 188 AEVNFLGNLLHPNLVKLVG-----YCIEDDQRLLVYEF--MPR--GSLENHLFRKGSLPL 238
           A+   +   +    +K +G          D+    Y F  M R    L+  ++   +   
Sbjct: 91  AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEANAKRF 149

Query: 239 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK--LSDFGLAKD-AP 295
                ++++L     L ++H   E   ++ D K SN+LL+     +  L D+GLA    P
Sbjct: 150 SRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206

Query: 296 EDGKTHVSTR----VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 343
           E      +        GT  + +    +  H     + + D+   G  +++ LTG 
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 51/223 (22%), Positives = 79/223 (35%), Gaps = 33/223 (14%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
            +R    +G G FG ++ G     G           VA+K         H +   E    
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVK--TKHPQLHIESKIY 58

Query: 194 GNLLH-PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
             +     +  +     E D  ++V E +   SLE  LF   S        + +A     
Sbjct: 59  KMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLKTVLLLADQMIS 116

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-APEDGKTHVSTR--- 305
            + ++H    K  I+RD K  N L+          + DFGLAK         H+  R   
Sbjct: 117 RIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173

Query: 306 -VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 343
            + GT  YA+    +  HL    + + D+ S G VL+    G 
Sbjct: 174 NLTGTARYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 49/228 (21%), Positives = 80/228 (35%), Gaps = 41/228 (17%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 191
           +++    +GEG FG +F+G                 VA+K      D  Q   E+     
Sbjct: 11  HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL 61

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
             G      +  +  +  E    +LV + +   SLE  L                A    
Sbjct: 62  LAGC---TGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVKTVAMAAKQML 116

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DAPEDGKTHVS 303
             +  +H   EK ++YRD K  N L+    +       + DFG+ K   D     K H+ 
Sbjct: 117 ARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP--VTKQHIP 171

Query: 304 TR----VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 343
            R    + GT  Y +    +  HL    + + D+ + G V +  L G 
Sbjct: 172 YREKKNLSGTARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 42/278 (15%), Positives = 77/278 (27%), Gaps = 87/278 (31%)

Query: 216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 275
           +V+E +    L   + +     LP     KI     +GL +LH +    +I+ D K  NI
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178

Query: 276 LLDAD-------------------------------------------------YNAKLS 286
           LL  +                                                    K++
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238

Query: 287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 346
           D G A    +     + TR      Y + E ++     + +D++S   +  E+ TG    
Sbjct: 239 DLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293

Query: 347 DKNRPNGEHN-------------------LVEWARPHL-----GDKRRFYRLLDPRLEG- 381
           + +                          +V            GD +   +L    L   
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353

Query: 382 -----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                 +S + +   T      L   P+ R   +E + 
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 52/228 (22%), Positives = 82/228 (35%), Gaps = 41/228 (17%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVN 191
           NFR    +G G FG +  G             T   VA+K   +     Q H E+     
Sbjct: 10  NFRVGKKIGCGNFGELRLG---------KNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ 60

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
                    + ++  +        +V E +   SLE  LF            + IA+   
Sbjct: 61  LGSG---DGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLKTVLMIAIQLI 115

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DAPEDGKTHVS 303
             + ++H    K +IYRD K  N L+    N       + DF LAK   D   + K H+ 
Sbjct: 116 SRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP--ETKKHIP 170

Query: 304 TR----VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 343
            R    + GT  Y +    +  HL    + + D+ + G + +  L G 
Sbjct: 171 YREHKSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 61/260 (23%), Positives = 89/260 (34%), Gaps = 73/260 (28%)

Query: 122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGL 180
                D  L  R +     LGEG FG V +                  VA+K + N    
Sbjct: 10  VCRIGDW-LQER-YEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVGKY 59

Query: 181 QGHKEWLAEVNFLGNLLHP------NLVKLVGY-------CI--EDDQRLL---VYEFMP 222
              +    E+N L  +           V +  +       CI  E    LL    +EF  
Sbjct: 60  --REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE----LLGKNTFEF-- 111

Query: 223 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADY 281
              L+ + F+   LP    +R  +A      L FLHE     + + D K  NIL  ++++
Sbjct: 112 ---LKENNFQPYPLPH---VR-HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEF 161

Query: 282 NA------------------KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL 323
                               +++DFG A    E   T V+TR      Y  PE V+    
Sbjct: 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH-----YRPPE-VILELG 215

Query: 324 -TSKSDVYSFGVVLLEMLTG 342
                DV+S G +L E   G
Sbjct: 216 WAQPCDVWSIGCILFEYYRG 235

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.5 bits (130), Expect = 3e-08
 Identities = 40/226 (17%), Positives = 57/226 (25%), Gaps = 64/226 (28%)

Query: 114 LKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 173
           +   SQ     F+   L T   +    +GEG FG VF+                  VA+K
Sbjct: 2   MGECSQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIK 49

Query: 174 TLNHDGLQGH--------KEWLAEVNFLGNLL---------HPNLVKLVGYCI------- 209
            +  +G            +E L E+     L              + L            
Sbjct: 50  IIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPP 109

Query: 210 -----------------------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
                                  +DDQ  +V EF   G     +  K       +    I
Sbjct: 110 LLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSI 166

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
                  LA           +RD    N+LL      KL      K
Sbjct: 167 LHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 69/260 (26%), Positives = 98/260 (37%), Gaps = 73/260 (28%)

Query: 122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGL 180
                D+ L+ R +     LGEG FG V +    + G        G  VAVK + N D  
Sbjct: 5   ICQSGDV-LSAR-YEIVDTLGEGAFGKVVECIDHKAG--------GRHVAVKIVKNVDRY 54

Query: 181 QGHKEWLAEVNFLGNLLHP------NLVKLVGY-------CI--EDDQRLL---VYEFMP 222
              +   +E+  L +L           V+++ +       CI  E    LL    Y+F  
Sbjct: 55  --CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE----LLGLSTYDF-- 106

Query: 223 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADY 281
              ++ + F    L     IR K+A    K + FLH      + + D K  NIL   +DY
Sbjct: 107 ---IKENGFLPFRLDH---IR-KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDY 156

Query: 282 NA------------------KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL 323
                               K+ DFG A    E   T VSTR      Y APE V+    
Sbjct: 157 TEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPE-VILALG 210

Query: 324 -TSKSDVYSFGVVLLEMLTG 342
            +   DV+S G +L+E   G
Sbjct: 211 WSQPCDVWSIGCILIEYYLG 230

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 57/223 (25%), Positives = 86/223 (38%), Gaps = 33/223 (14%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
            FR    +G G FG ++ G   +             VA+K  N      H + L E    
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNE---------EVAIKLENVK--TKHPQLLYESKIY 56

Query: 194 GNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
             L     +  +  + +E D  +LV + +   SLE  LF   S  L     + +A     
Sbjct: 57  RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQMIN 114

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-APEDGKTHVSTR--- 305
            + F+H    K  ++RD K  N L+     A    + DFGLAK         H+  R   
Sbjct: 115 RVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171

Query: 306 -VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 343
            + GT  YA+    +  HL    + + D+ S G VL+  L G 
Sbjct: 172 NLTGTARYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 39/240 (16%), Positives = 77/240 (32%), Gaps = 48/240 (20%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----L 187
             +     +G GGFG ++  +                  VK    +      E      +
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKP------EKDARHVVKVEYQENGPLFSELKFYQRV 90

Query: 188 AEVNFLGNLLHPNLVKLVG-----YC-----IEDDQRLLVYEFMPR--GSLENHLFRKGS 235
           A+ + +   +    +  +G                 R +V   M R    L+    + G+
Sbjct: 91  AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV---MERLGIDLQKISGQNGT 147

Query: 236 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK--LSDFGLAKD 293
                ++   + +     L ++H   E   ++ D K +N+LL      +  L+D+GL+  
Sbjct: 148 FKKS-TVLQ-LGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202

Query: 294 APEDGKTHV------STRVMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 343
                  H            GT  + +    +  H     + +SDV   G  +L  L G+
Sbjct: 203 Y-CPNGNHKQYQENPRKGHNGTIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 54/248 (21%), Positives = 83/248 (33%), Gaps = 77/248 (31%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGNL- 196
             +G+G FG V      +N             AVK + N       +    E + L  + 
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKK---------YYAVKVVRNIKKY--TRSAKIEADILKKIQ 89

Query: 197 ----LHPNLVKLVGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRKGSLPLPW 240
                + N+VK  G        C+  E     L   +YE      +  + +         
Sbjct: 90  NDDINNNNIVKYHGKFMYYDHMCLIFE----PLGPSLYEI-----ITRNNYN----GFHI 136

Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNA---------------- 283
                  +   K L +L + +   + + D K  NILL D  +                  
Sbjct: 137 EDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193

Query: 284 --------KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGV 334
                   KL DFG A    +   + ++TR      Y APE V+        SD++SFG 
Sbjct: 194 YRTKSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFGC 247

Query: 335 VLLEMLTG 342
           VL E+ TG
Sbjct: 248 VLAELYTG 255

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.5 bits (112), Expect = 8e-06
 Identities = 64/419 (15%), Positives = 112/419 (26%), Gaps = 142/419 (33%)

Query: 49  VRFRFIESCMPSRSKVDSSMSGT-STNYADGKSSNEKRRDRPVVPVSSTTTSNAESASST 107
               F          V   +      NY    S  +  + +P +             +  
Sbjct: 64  TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123

Query: 108 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLL---GEGGFGCVFKGWVEENGTAPVKP 164
             F++   V+   R   +  L+ A    RP   +   G  G G   K W           
Sbjct: 124 QVFAK-YNVS---RLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTW----------- 165

Query: 165 GTGLTVAVKTLNHDGLQGHKE----WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL----- 215
                VA+       +Q   +    WL                 +  C   +  L     
Sbjct: 166 -----VALDVCLSYKVQCKMDFKIFWLN----------------LKNCNSPETVLEMLQK 204

Query: 216 LVYEFMPRG-SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN 274
           L+Y+  P   S  +H            I+++I    A+    L          + ++   
Sbjct: 205 LLYQIDPNWTSRSDHSSN---------IKLRIHSIQAELRRLLKS--------KPYENCL 247

Query: 275 ILLDADYNAK-LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFG 333
           ++L    NAK  + F L        K  ++TR                       V  F 
Sbjct: 248 LVLLNVQNAKAWNAFNL------SCKILLTTR--------------------FKQVTDF- 280

Query: 334 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQ 393
             L    T   S+D +                         L P            +   
Sbjct: 281 --LSAATTTHISLDHHSMT----------------------LTPD-----------EVKS 305

Query: 394 LAAQCLSRDPKARPRMSEVVETLKPL------QNLKDMASSSYYFQTMQADNTWSIRNS 446
           L  + L   P+  PR  EV+ T  P       ++++D  ++   ++ +  D   +I  S
Sbjct: 306 LLLKYLDCRPQDLPR--EVLTTN-PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	491
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.45
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.1
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.76
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.6
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.58
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.52
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.44
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.38
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.26
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.04
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.0
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.75
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.53
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.52
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.49
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.43
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.39
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.38
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.36
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.18
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.09
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.02
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.81
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.96
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.24
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.53
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.55
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.3

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-59  Score=471.37  Aligned_cols=252  Identities=24%  Similarity=0.386  Sum_probs=207.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++++.||+|+||+||+|++..         +|+.||||++......  ..+.+.+|+++|++|+|||||++++++.+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~   94 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTE---------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE   94 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETT---------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence            579999999999999999999876         6789999999766432  34678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ++.+|||||||+||+|.++|...+...+++..++.|+.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+
T Consensus        95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl  171 (350)
T 4b9d_A           95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGI  171 (350)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccccc
Confidence            999999999999999999998776667899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      |+.....  .......+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   +...   .....  
T Consensus       172 a~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~---i~~~~--  241 (350)
T 4b9d_A          172 ARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVLK---IISGS--  241 (350)
T ss_dssp             ESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH---HHHTC--
T ss_pred             ceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHH---HHcCC--
Confidence            9876432  112345789999999999999999999999999999999999999997643211   1111   11000  


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          . +    ..+...+.++.+||.+||+.||.+|||+.|++++
T Consensus       242 ----~-~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          242 ----F-P----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ----C-C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----C-C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                0 0    1123347889999999999999999999999976

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.6e-59  Score=461.55  Aligned_cols=265  Identities=29%  Similarity=0.448  Sum_probs=217.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||+||+|++....    ...++..||||+++.......++|.+|+++|++|+|||||+++|+|.+.+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC--------CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcc----cCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            57889999999999999999986421    12267899999998776666788999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKG-----------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~  281 (491)
                      ..|||||||++|+|.++|...+           ...+++..++.|+.||+.||.|||+++   ||||||||+||||+.++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCC
Confidence            9999999999999999997642           346999999999999999999999988   99999999999999999


Q ss_pred             CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 011180          282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW  360 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~  360 (491)
                      .+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||......   .+...
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~  242 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIEC  242 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence            999999999987654443333444679999999999999999999999999999999998 89999764322   11111


Q ss_pred             hhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ....              .....+..++.++.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       243 i~~~--------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          243 ITQG--------------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcC--------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1100              0012233457899999999999999999999999999987643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.7e-59  Score=463.92  Aligned_cols=265  Identities=27%  Similarity=0.436  Sum_probs=210.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||+||+|++...    ....++..||||+++.......++|.+|+++|++|+|||||+++|+|.+.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            4678889999999999999998641    112367899999998776666788999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKG-------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  279 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~  279 (491)
                      ..|||||||++|+|.++|....             ..++++..++.|+.||+.||.|||+.+   ||||||||+||||+.
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECC
Confidence            9999999999999999997643             235899999999999999999999988   999999999999999


Q ss_pred             CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhh
Q 011180          280 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV  358 (491)
Q Consensus       280 ~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~  358 (491)
                      ++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||......   .+.
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~  270 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAI  270 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHH
Confidence            99999999999997755444444456789999999999999999999999999999999999 89999754321   111


Q ss_pred             HhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ......              .....+..++.++.+||.+||+.||++|||+.||+++|+.+.+
T Consensus       271 ~~i~~g--------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          271 DCITQG--------------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHT--------------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHcC--------------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            111100              0112233457889999999999999999999999999987644

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-58  Score=455.94  Aligned_cols=263  Identities=26%  Similarity=0.429  Sum_probs=206.9

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      +..++|.+.+.||+|+||+||+|++..            .||||+++....  ...++|.+|+.+|++|+|||||+++|+
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~  100 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY  100 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            344678899999999999999998643            599999975432  345679999999999999999999998


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +.+ +.+|||||||++|+|.++|.... ..+++..++.|+.||+.||+|||+.+   ||||||||+||||++++.+||+|
T Consensus       101 ~~~-~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~D  175 (307)
T 3omv_A          101 MTK-DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGD  175 (307)
T ss_dssp             ECS-SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECC
T ss_pred             EEC-CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEee
Confidence            764 57899999999999999997653 36999999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      ||+|+..............+||+.|||||++.+   +.|+.++|||||||+||||+||+.||........  +.......
T Consensus       176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~~~~~~~  253 (307)
T 3omv_A          176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--IIFMVGRG  253 (307)
T ss_dssp             CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHHTT
T ss_pred             ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HHHHHhcC
Confidence            999987654433334456789999999999974   4689999999999999999999999975432211  11111100


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                               ...|.+ ...+..++..+.+||.+||+.||.+|||+.+|+++|+.|+.
T Consensus       254 ---------~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          254 ---------YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             ---------CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             ---------CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                     011111 12234457889999999999999999999999999987643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.1e-59  Score=460.93  Aligned_cols=251  Identities=23%  Similarity=0.319  Sum_probs=213.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++.+...   ...+.+.+|+++|+.|+|||||+++++|.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  102 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ  102 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            469999999999999999999876         688999999975422   33567899999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +++.+|||||||+||+|.++|.+.+  .+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||
T Consensus       103 ~~~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          103 DDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcC
Confidence            9999999999999999999998765  6899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +|+.+............+||+.|||||++.+..|+.++|||||||+||||++|++||......   .+...   ..... 
T Consensus       178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~---i~~~~-  250 (311)
T 4aw0_A          178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFAK---IIKLE-  250 (311)
T ss_dssp             TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHTC-
T ss_pred             CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HHcCC-
Confidence            999876544444455689999999999999999999999999999999999999999754321   11111   11000 


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                 ..++...+.++.+||.+||+.||.+|||++|++.+
T Consensus       251 -----------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          251 -----------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             -----------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence                       11223346789999999999999999999987543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-58  Score=463.22  Aligned_cols=251  Identities=27%  Similarity=0.386  Sum_probs=212.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ..|++.+.||+|+||+||+|+++.         +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+++
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  144 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD  144 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhcEEeEEeecCcCeEEEEEEECC---------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            469999999999999999999876         68899999997665555667899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      .+|||||||+||+|.+++...   .+++..+..|+.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+
T Consensus       145 ~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          145 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             EEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCce
Confidence            999999999999999998754   5899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .+.....  .....+||+.|||||++.+..|+.++|||||||+||||++|++||.......   ........        
T Consensus       219 ~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~--------  285 (346)
T 4fih_A          219 QVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRDN--------  285 (346)
T ss_dssp             ECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHS--------
T ss_pred             ecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcC--------
Confidence            7754322  2345799999999999999999999999999999999999999997543221   11111111        


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        ..+.+  ......+.++.+||.+||+.||.+|||+.|+++|
T Consensus       286 --~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          286 --LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             --SCCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              01111  1122347889999999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.4e-58  Score=458.67  Aligned_cols=253  Identities=25%  Similarity=0.289  Sum_probs=210.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||+||+|+++.         +|+.||||+++.+...     .+|+.+|+.|+|||||++++++.+++
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~---------~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~  123 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQ---------TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP  123 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred             hheEeCcEeccCCCeEEEEEEECC---------CCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            468888999999999999999876         6889999999865432     46999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-CeEEeccCCc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFGLA  291 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kL~DFGla  291 (491)
                      .+|||||||+||+|.++|...+  .+++..+..|+.||+.||+|||+++   ||||||||+||||+.+| .+||+|||+|
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla  198 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHA  198 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred             EEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence            9999999999999999998765  6899999999999999999999988   99999999999999987 6999999999


Q ss_pred             ccCCCCCCc---eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          292 KDAPEDGKT---HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       292 ~~~~~~~~~---~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      +.+......   ......+||+.|||||++.+..|+.++|||||||+||||++|++||...........+...      .
T Consensus       199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~  272 (336)
T 4g3f_A          199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE------P  272 (336)
T ss_dssp             EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS------C
T ss_pred             eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC------C
Confidence            877543221   1223468999999999999999999999999999999999999999765544332222110      0


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ..+         ..++..++..+.+||.+||++||.+|||+.|++++|...
T Consensus       273 ~~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          273 PPI---------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             CGG---------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCc---------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            000         122334578899999999999999999999999998653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3e-58  Score=455.86  Aligned_cols=264  Identities=25%  Similarity=0.379  Sum_probs=215.0

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++++.+.||+|+||+||+|.+....    ...+++.||||+++.... ...++|.+|+.+|++|+|||||+++|+|.+++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~----~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPA----PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCc----cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            4677889999999999999975311    112578999999975432 34578999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  278 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~  278 (491)
                      ..+||||||++|+|.++|....              ...+++..++.|+.||+.||+|||+.+   ||||||||+||||+
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEEC
Confidence            9999999999999999996542              135899999999999999999999988   99999999999999


Q ss_pred             CCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011180          279 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL  357 (491)
Q Consensus       279 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~  357 (491)
                      +++.+||+|||+|+..............+||+.|||||++.++.|+.++|||||||+||||+| |..||......   .+
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~  256 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV  256 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence            999999999999987654433334455789999999999999999999999999999999998 89999764321   22


Q ss_pred             hHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      .......              .....+..++..+.+||.+||+.||.+|||+.+|+++|+.+.+
T Consensus       257 ~~~i~~~--------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          257 VEMIRNR--------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             HHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             HHHHHcC--------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence            2211110              0112234557889999999999999999999999999987654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.6e-58  Score=469.00  Aligned_cols=251  Identities=27%  Similarity=0.386  Sum_probs=213.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +.|++.+.||+|+||+||+|+++.         +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+++
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  221 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD  221 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhcEeeeEeccCcCcEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence            569999999999999999999876         78899999998776666677899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      .+|||||||+||+|.+++...   .+++..+..|+.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+
T Consensus       222 ~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~  295 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA  295 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccce
Confidence            999999999999999998654   5899999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .+.....  .....+||+.|||||++.+..|+.++|||||||+||||++|++||.......   ........        
T Consensus       296 ~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~--------  362 (423)
T 4fie_A          296 QVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRDN--------  362 (423)
T ss_dssp             ECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHS--------
T ss_pred             ECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcC--------
Confidence            7654322  2345799999999999999999999999999999999999999997543221   11111111        


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        ..+.+  ......+.++.+||.+||..||.+|||+.|+|+|
T Consensus       363 --~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          363 --LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             --CCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              11111  1112347889999999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.5e-57  Score=438.70  Aligned_cols=247  Identities=26%  Similarity=0.367  Sum_probs=194.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++.+...   ...+.+.+|+.+|+.|+|||||++++++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   83 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTT---------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK   83 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTT---------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            579999999999999999999876         678999999976533   23467899999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +++.+||||||| +|+|.+++...+  .+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||
T Consensus        84 ~~~~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFG  157 (275)
T 3hyh_A           84 SKDEIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFG  157 (275)
T ss_dssp             CSSEEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSS
T ss_pred             ECCEEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecC
Confidence            999999999999 789999998765  6899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      +|+......   .....+||+.|||||++.+..| +.++|||||||+||||++|+.||......   .+....   ....
T Consensus       158 la~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~~i---~~~~  228 (275)
T 3hyh_A          158 LSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFKNI---SNGV  228 (275)
T ss_dssp             CC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHTC
T ss_pred             CCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HcCC
Confidence            998764432   2345789999999999988776 57999999999999999999999753211   111111   0000


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                  ..++...+.++.+||.+||+.||.+|||++|++++
T Consensus       229 ------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          229 ------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                        01222347889999999999999999999999976

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1e-56  Score=440.45  Aligned_cols=249  Identities=25%  Similarity=0.402  Sum_probs=201.1

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee--
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--  210 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--  210 (491)
                      |++.+.||+|+||+||+|.+..         ++..||||++.....  ...+.+.+|+.+|++|+|||||+++++|.+  
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   98 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence            3677889999999999999876         678999999975432  234678999999999999999999999875  


Q ss_pred             --cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC-CCCCeEEec
Q 011180          211 --DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSD  287 (491)
Q Consensus       211 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~-~~~~~kL~D  287 (491)
                        ++.+|||||||++|+|.++|.+.+  .+++..+..|+.||+.||+|||+++ .+||||||||+||||+ .++.+||+|
T Consensus        99 ~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~D  175 (290)
T 3fpq_A           99 KGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             TTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred             CCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEe
Confidence              345799999999999999998764  6899999999999999999999976 4599999999999997 479999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ||+|+.....    .....+||+.|||||++. +.|+.++|||||||+||||+||+.||......  ..+......   .
T Consensus       176 FGla~~~~~~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i~~---~  245 (290)
T 3fpq_A          176 LGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTS---G  245 (290)
T ss_dssp             TTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTT---T
T ss_pred             CcCCEeCCCC----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHHHc---C
Confidence            9999864332    234578999999999886 46999999999999999999999999643221  111111110   0


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .          ....++...++++.+||.+||+.||.+|||+.|+++|
T Consensus       246 ~----------~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          246 V----------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             C----------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             C----------CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0          0001112235789999999999999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.4e-57  Score=447.20  Aligned_cols=252  Identities=29%  Similarity=0.349  Sum_probs=202.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.+.||+|+||+||+|++..+..      +++.||||++++...  .....+.+|+++|++|+|||||++++++.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSD------ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTT------TTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCC------CCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            479999999999999999998854322      678999999976532  223468889999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ++.+|||||||+||+|.++|.+.+  .+++..+..++.||+.||+|||+++   ||||||||+|||++.+|.+||+|||+
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl  172 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL  172 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccc
Confidence            999999999999999999998765  6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      |+.......  .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   +...   .....  
T Consensus       173 a~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~---i~~~~--  242 (304)
T 3ubd_A          173 SKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMTM---ILKAK--  242 (304)
T ss_dssp             EEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHCC--
T ss_pred             ceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHHH---HHcCC--
Confidence            986543322  2345789999999999999999999999999999999999999997543221   1111   11000  


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~  415 (491)
                                ..++...+.++.+||.+||+.||.+|||+     +|+++|
T Consensus       243 ----------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          243 ----------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             ----------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                      01223347889999999999999999984     676654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.4e-56  Score=451.72  Aligned_cols=271  Identities=28%  Similarity=0.376  Sum_probs=220.4

Q ss_pred             hHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCC-Cceeee
Q 011180          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLH-PNLVKL  204 (491)
Q Consensus       127 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~H-pnIv~l  204 (491)
                      ++++..++|++.+.||+|+||+||+|.+...+.    ..+++.||||.+...... ..+++.+|+++|.++.| ||||++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~----~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSS----TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            344556789999999999999999999875321    125678999999765433 34679999999999975 999999


Q ss_pred             eeEEeec-CceEEEEEecCCCChHHHhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 011180          205 VGYCIED-DQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD  269 (491)
Q Consensus       205 ~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrD  269 (491)
                      +|+|.+. +.+|||||||++|+|.++|....              ...+++..++.++.||+.||+|||+++   |||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9999765 56899999999999999997532              235889999999999999999999988   99999


Q ss_pred             CCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 011180          270 FKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDK  348 (491)
Q Consensus       270 lKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~  348 (491)
                      |||+||||++++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999998765554444556789999999999999999999999999999999998 9999976


Q ss_pred             CCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          349 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      ......  +......              ......+..++.++.+||.+||+.||.+|||+.+|+++|+.+.
T Consensus       291 ~~~~~~--~~~~i~~--------------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          291 VKIDEE--FCRRLKE--------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             CCCSHH--HHHHHHH--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHH--HHHHHHc--------------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            433211  1111110              0011223345788999999999999999999999999998753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.1e-55  Score=433.43  Aligned_cols=269  Identities=25%  Similarity=0.312  Sum_probs=201.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||+||+|++           +|..||||+++..... ...+..|+..+..|+|||||++++++.+++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-----------~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~   70 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-----------TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence            4688899999999999999987           4678999999754321 122345666777899999999999998765


Q ss_pred             ----ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEECCCCCe
Q 011180          213 ----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA-----EKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       213 ----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----~~~iiHrDlKp~NILl~~~~~~  283 (491)
                          .+|||||||++|+|.++|...   .+++..+..++.|++.||+|||++.     .++||||||||+||||+.++.+
T Consensus        71 ~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~  147 (303)
T 3hmm_A           71 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence                579999999999999999765   5899999999999999999999861     2349999999999999999999


Q ss_pred             EEeccCCcccCCCCCCce--eeeccccCCCCCCchhhhcC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011180          284 KLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  355 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~  355 (491)
                      ||+|||+|+.........  .....+||+.|||||++.+.      .|+.++|||||||+||||+||.+||.........
T Consensus       148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p  227 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence            999999998764433221  22346899999999999754      4678999999999999999999887543221110


Q ss_pred             ---------hhhHhhhcccCCccchhhccCccccCC-CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011180          356 ---------NLVEWARPHLGDKRRFYRLLDPRLEGH-FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  422 (491)
Q Consensus       356 ---------~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~  422 (491)
                               ..........      ...++|.+... .+..++..+.+||.+||+.||.+|||+.||++.|+.+.+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~------~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          228 YYDLVPSDPSVEEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHT------TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chhcccccchHHHHHHHHh------cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                     0000000000      01112222211 1234567899999999999999999999999999887553

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.2e-54  Score=426.79  Aligned_cols=248  Identities=25%  Similarity=0.418  Sum_probs=189.6

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +|++.+.||+|+||+||+|+++.         +|..||||++...... ..+.+.+|+.+|++|+|||||+++++|.+.+
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   76 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKN   76 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETT---------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC
T ss_pred             hCEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecC
Confidence            59999999999999999999876         6789999999765432 3467899999999999999999999998655


Q ss_pred             c------------eEEEEEecCCCChHHHhhhCCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC
Q 011180          213 Q------------RLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  279 (491)
Q Consensus       213 ~------------~~lV~E~~~~gsL~~~l~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~  279 (491)
                      .            +|||||||++|+|.+++...... ..++..++.|+.||+.||+|||+++   ||||||||+||||+.
T Consensus        77 ~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~  153 (299)
T 4g31_A           77 TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTM  153 (299)
T ss_dssp             ----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred             ccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECC
Confidence            3            68999999999999999765432 3456778899999999999999988   999999999999999


Q ss_pred             CCCeEEeccCCcccCCCCCCce----------eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 011180          280 DYNAKLSDFGLAKDAPEDGKTH----------VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN  349 (491)
Q Consensus       280 ~~~~kL~DFGla~~~~~~~~~~----------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~  349 (491)
                      ++.+||+|||+|+.........          ..+..+||+.|||||++.+..|+.++|||||||+||||++   ||...
T Consensus       154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            9999999999998765432211          1234689999999999999999999999999999999996   66421


Q ss_pred             CCCCcchhhHhhhcccCCccchhhccCccccCCCC---hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          350 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS---IKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                           ..........          .    ...++   ...++.+.+||.+||+.||.+|||+.|++++
T Consensus       231 -----~~~~~~~~~~----------~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          231 -----MERVRTLTDV----------R----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             -----HHHHHHHHHH----------H----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----cHHHHHHHHH----------h----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                 1111100000          0    00111   1224567899999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-53  Score=432.26  Aligned_cols=268  Identities=23%  Similarity=0.316  Sum_probs=206.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++++.||+|+||+||+|++..         +|+.||||++.....  ...+.+++|+++|+.|+|||||++++++..
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  124 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRL---------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP  124 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeec
Confidence            579999999999999999999876         788999999976532  334678899999999999999999998764


Q ss_pred             ------cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          211 ------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       211 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                            .+.+|||||||. |+|.++|...+  .+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+|
T Consensus       125 ~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~K  198 (398)
T 4b99_A          125 TVPYGEFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELK  198 (398)
T ss_dssp             SSCTTTCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEE
T ss_pred             ccccccCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEE
Confidence                  357899999995 78999997654  7999999999999999999999998   99999999999999999999


Q ss_pred             EeccCCcccCCCCCC--ceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          285 LSDFGLAKDAPEDGK--THVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       285 L~DFGla~~~~~~~~--~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      |+|||+|+.+.....  .......+||+.|||||++.+. .|+.++||||+|||+|||++|++||...........+...
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~  278 (398)
T 4b99_A          199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV  278 (398)
T ss_dssp             ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHH
T ss_pred             EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence            999999987643221  2223457999999999998875 5699999999999999999999999765433222221111


Q ss_pred             hcccCC----------ccchhhccCccccC---CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 RPHLGD----------KRRFYRLLDPRLEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 ~~~~~~----------~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ......          ...+...+.+....   ......+.++.+||.+||..||.+|||+.|+|+|
T Consensus       279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000          00000001110000   0011236789999999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.5e-52  Score=419.82  Aligned_cols=270  Identities=23%  Similarity=0.288  Sum_probs=204.1

Q ss_pred             HHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeeeee
Q 011180          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVG  206 (491)
Q Consensus       128 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~  206 (491)
                      +....++|++.+.||+|+||+||+|+++.+      .++++.||||.+....  ...++.+|+++|..+ .|||||++++
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~------~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~   87 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQ------VGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKY   87 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBT------TSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSE
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEccc------CCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEE
Confidence            334567899999999999999999987632      2267899999986653  345788999999998 5999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-CCeEE
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKL  285 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~-~~~kL  285 (491)
                      +|.+.+.+|||||||++|+|.+++.     .+++..+..++.||+.||+|||+++   ||||||||+||||+.+ +.+||
T Consensus        88 ~~~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl  159 (361)
T 4f9c_A           88 CFRKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYAL  159 (361)
T ss_dssp             EEEETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEE
T ss_pred             EEEECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEE
Confidence            9999999999999999999999983     4889999999999999999999998   9999999999999876 79999


Q ss_pred             eccCCcccCCCCCCc--------------------------eeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHH
Q 011180          286 SDFGLAKDAPEDGKT--------------------------HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLE  338 (491)
Q Consensus       286 ~DFGla~~~~~~~~~--------------------------~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~e  338 (491)
                      +|||+|+........                          ......+||+.|||||++.+. .|+.++||||+|||+||
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e  239 (361)
T 4f9c_A          160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS  239 (361)
T ss_dssp             CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred             CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence            999999765432110                          112345899999999999875 58999999999999999


Q ss_pred             HHhCCCCCCCCCCCCcchhhHhhhcccC------------------------Cccchhhc---c---Ccc---------c
Q 011180          339 MLTGRRSMDKNRPNGEHNLVEWARPHLG------------------------DKRRFYRL---L---DPR---------L  379 (491)
Q Consensus       339 lltG~~pf~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~---~---~~~---------l  379 (491)
                      |++|+.||......  ..........++                        +.......   .   .+.         .
T Consensus       240 ll~G~~Pf~~~~~~--~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  317 (361)
T 4f9c_A          240 LLSGRYPFYKASDD--LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHAT  317 (361)
T ss_dssp             HHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------------
T ss_pred             HHHCCCCCCCCCCH--HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccc
Confidence            99999999643321  111000000000                        00000000   0   000         0


Q ss_pred             cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          380 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       380 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ........+.++.+||.+||+.||.+|||++|+|+|
T Consensus       318 ~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          318 NLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            001112346789999999999999999999999976

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.9e-52  Score=442.98  Aligned_cols=253  Identities=23%  Similarity=0.308  Sum_probs=212.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||+||+|+++.         +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+.+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~---------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~  227 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN  227 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred             cccEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            579999999999999999999876         78899999998776666678899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC--CCeEEeccCC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD--YNAKLSDFGL  290 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~--~~~kL~DFGl  290 (491)
                      .+|||||||+||+|.++|.... ..+++..+..++.||+.||.|||+++   |+||||||+||||+.+  +.+||+|||+
T Consensus       228 ~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~  303 (573)
T 3uto_A          228 EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL  303 (573)
T ss_dssp             EEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred             EEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccc
Confidence            9999999999999999986543 36899999999999999999999998   9999999999999754  8999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      |+.+....   .....+||+.|||||++.+..|+.++|||||||+||||++|.+||...........+..      ..  
T Consensus       304 a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~------~~--  372 (573)
T 3uto_A          304 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS------CD--  372 (573)
T ss_dssp             CEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT------TC--
T ss_pred             eeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh------CC--
Confidence            99875432   23446899999999999999999999999999999999999999975432211111110      00  


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                            ..+........+.++.+||.+||+.||.+|||+.|+|+|
T Consensus       373 ------~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          373 ------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             ------CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  001111112337889999999999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.2e-51  Score=439.25  Aligned_cols=251  Identities=27%  Similarity=0.385  Sum_probs=206.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHH---HHHHHHHhcCCCCceeeee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW---LAEVNFLGNLLHPNLVKLV  205 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~---~~E~~il~~l~HpnIv~l~  205 (491)
                      -++|.+.++||+|+||+||+|+++.         +|..||||++.+...   .....+   ..++.+++.++|||||+++
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~---------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~  258 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS  258 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence            3689999999999999999999876         788999999975422   112223   3456778888999999999


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      ++|.+.+.+|||||||+||+|.++|.+.+  .+++..+..++.||+.||.|||+++   ||||||||+||||+.+|.+||
T Consensus       259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL  333 (689)
T 3v5w_A          259 YAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI  333 (689)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEe
Confidence            99999999999999999999999998765  6899999999999999999999988   999999999999999999999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      +|||+|+......    ....+||+.|||||++.+ ..|+.++|||||||+||||++|.+||..........+....   
T Consensus       334 ~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---  406 (689)
T 3v5w_A          334 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---  406 (689)
T ss_dssp             CCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---
T ss_pred             cccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---
Confidence            9999998765432    234789999999999974 57999999999999999999999999754433222211111   


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  415 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~  415 (491)
                      ...            ...++...+.++.+||.+||++||.+|++     ++||++|
T Consensus       407 ~~~------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          407 LTM------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HHC------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             cCC------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            100            01223334788999999999999999998     6888875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.7e-50  Score=398.90  Aligned_cols=286  Identities=39%  Similarity=0.692  Sum_probs=239.9

Q ss_pred             hhhhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcee
Q 011180          123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLV  202 (491)
Q Consensus       123 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv  202 (491)
                      +.+.++...+++|.+.+.||+|+||.||+|.+.          ++..||||++........+.+.+|+.+|+.++||||+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   98 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLV   98 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBC
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEe
Confidence            344455667789999999999999999999864          4678999999877666677899999999999999999


Q ss_pred             eeeeEEeecCceEEEEEecCCCChHHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 011180          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  280 (491)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~  280 (491)
                      ++++++.+.+..++||||+++|+|.+++....  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~  175 (321)
T 2qkw_B           99 SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN  175 (321)
T ss_dssp             CEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTT
T ss_pred             eEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCC
Confidence            99999999999999999999999999986543  235899999999999999999999988   9999999999999999


Q ss_pred             CCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011180          281 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  360 (491)
Q Consensus       281 ~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  360 (491)
                      +.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|
T Consensus       176 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~  255 (321)
T 2qkw_B          176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW  255 (321)
T ss_dssp             CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred             CCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence            99999999999865443333333446799999999999999999999999999999999999999987776666555555


Q ss_pred             hhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011180          361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  422 (491)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~  422 (491)
                      ..... ....+...+++.+........+..+.+|+.+||+.||.+|||+.+++++|+.+...
T Consensus       256 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          256 AVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             THHHH-TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hhhcc-ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            43221 11223345566666667778899999999999999999999999999999876543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.5e-48  Score=388.08  Aligned_cols=289  Identities=40%  Similarity=0.733  Sum_probs=235.3

Q ss_pred             hhchhhhhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCC
Q 011180          119 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLL  197 (491)
Q Consensus       119 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~  197 (491)
                      .+..+.+.++....++|.+.+.||+|+||.||+|.+.          ++..||||++...... ....+.+|+.++..+.
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~   85 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAV   85 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTCC
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhcc
Confidence            4566788899999999999999999999999999753          4668999999765322 2236889999999999


Q ss_pred             CCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 011180          198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  275 (491)
Q Consensus       198 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NI  275 (491)
                      ||||+++++++.+.+..++||||+++|+|.+++....  ...+++..+..++.||+.||.|||+....+|+||||||+||
T Consensus        86 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni  165 (326)
T 3uim_A           86 HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI  165 (326)
T ss_dssp             CTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred             CCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence            9999999999999999999999999999999997653  23489999999999999999999998212299999999999


Q ss_pred             EECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCC--CCC
Q 011180          276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR--PNG  353 (491)
Q Consensus       276 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~--~~~  353 (491)
                      |++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||....  ...
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  244 (326)
T 3uim_A          166 LLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD  244 (326)
T ss_dssp             EECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS
T ss_pred             EECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc
Confidence            999999999999999987654332 23344669999999999999999999999999999999999999996321  112


Q ss_pred             cchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ......|...... ........+..+...+....+..+.+|+.+||+.||.+|||+.+|+++|+..
T Consensus       245 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          245 DVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             CSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             chhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            2223333333222 2233455566666777788899999999999999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.8e-48  Score=379.82  Aligned_cols=252  Identities=25%  Similarity=0.381  Sum_probs=211.4

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++........+.+.+|+.+++.++||||+++++++...
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG   89 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhceeeeeeeccCCCeEEEEEEECC---------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence            4579999999999999999998765         6779999999766555667889999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++|+|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC  163 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            9999999999999999999765   5889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ........  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+  ....       
T Consensus       164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~-------  232 (297)
T 3fxz_A          164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--ATNG-------  232 (297)
T ss_dssp             EECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHHC-------
T ss_pred             eecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCC-------
Confidence            87654332  223467999999999999999999999999999999999999999654321111110  0000       


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          .+  ....+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       233 ----~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          233 ----TP--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             ----SC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----CC--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                00  011122346789999999999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.7e-48  Score=393.77  Aligned_cols=268  Identities=24%  Similarity=0.384  Sum_probs=217.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+.....  ....++..||||++..... ...+.+.+|+.+|+.+ +||||+++++++.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            4679999999999999999999753211  1123577899999976543 2346789999999999 8999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  275 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NI  275 (491)
                      +.+..||||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhE
Confidence            99999999999999999999976532              24789999999999999999999988   99999999999


Q ss_pred             EECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCc
Q 011180          276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE  354 (491)
Q Consensus       276 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~  354 (491)
                      ||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||....... 
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-  313 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-  313 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-
Confidence            999999999999999987654433333334567889999999999999999999999999999999 999997543221 


Q ss_pred             chhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                        +......              ......+..++..+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       314 --~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          314 --LFKLLKE--------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             --HHHHHHT--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHhc--------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              1111100              00112233457889999999999999999999999999987643

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.6e-48  Score=382.42  Aligned_cols=261  Identities=26%  Similarity=0.413  Sum_probs=214.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||+||+|.+..         ++..||+|++........+.+.+|+.+|+.++||||+++++++.+++
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   80 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK   80 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             hHeeccceecCCCCEEEEEEEECC---------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence            579999999999999999999876         57799999987666566678999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  156 (310)
T 3s95_A           81 RLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLAR  156 (310)
T ss_dssp             EEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred             eeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccce
Confidence            9999999999999999997753 36899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCce------------eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011180          293 DAPEDGKTH------------VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  360 (491)
Q Consensus       293 ~~~~~~~~~------------~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  360 (491)
                      .........            .....+||+.|+|||++.+..++.++|||||||++|||++|..||............. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-  235 (310)
T 3s95_A          157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-  235 (310)
T ss_dssp             ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-
T ss_pred             ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-
Confidence            764432211            0114679999999999999999999999999999999999999986544322211000 


Q ss_pred             hhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                .....+.    ..+..++..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       236 ----------~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          236 ----------VRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             ----------HHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------hhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                      0000000    1122335678999999999999999999999999987754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.8e-48  Score=386.71  Aligned_cols=249  Identities=27%  Similarity=0.397  Sum_probs=208.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++.....  ...+.+.+|+++|+.++||||+++++++.
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   84 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHIL---------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE   84 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            3579999999999999999999876         678999999976532  33467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..|+||||+++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG  159 (328)
T 3fe3_A           85 TEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFG  159 (328)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             ECCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeecc
Confidence            9999999999999999999997764  5889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ++........   ....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.......   +....   ....
T Consensus       160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i---~~~~  230 (328)
T 3fe3_A          160 FSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERV---LRGK  230 (328)
T ss_dssp             CCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHCC
T ss_pred             CceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH---HhCC
Confidence            9987644322   2446899999999999988775 79999999999999999999997543211   11110   0000


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                  ..++...+..+.+|+.+||..||.+|||+.+++++
T Consensus       231 ------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 ------------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ------------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                        01122346789999999999999999999999976

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=5.9e-48  Score=385.39  Aligned_cols=273  Identities=26%  Similarity=0.351  Sum_probs=211.2

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ..++|++.++||+|+||+||+|++.           +..||||++.... .......+|+.+|..++||||+++++++.+
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   89 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKR   89 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence            3457999999999999999999873           5689999996543 223456679999999999999999999988


Q ss_pred             cCc----eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEecCCCCCcEE
Q 011180          211 DDQ----RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE----------AEKPVIYRDFKTSNIL  276 (491)
Q Consensus       211 ~~~----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------~~~~iiHrDlKp~NIL  276 (491)
                      ...    .+|||||+++|+|.+++...   .+++..++.++.||+.||.|||+.          +   |+||||||+|||
T Consensus        90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nil  163 (322)
T 3soc_A           90 GTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVL  163 (322)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEE
T ss_pred             CCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEE
Confidence            654    69999999999999999764   589999999999999999999998          7   999999999999


Q ss_pred             ECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-----CCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 011180          277 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  351 (491)
Q Consensus       277 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-----~~~~~~DvwSlGvil~elltG~~pf~~~~~  351 (491)
                      ++.++.+||+|||+++..............+||+.|+|||++.+.     .++.++|||||||++|||++|+.||.....
T Consensus       164 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  243 (322)
T 3soc_A          164 LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD  243 (322)
T ss_dssp             ECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred             ECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence            999999999999999876544333333446799999999999863     556689999999999999999999976544


Q ss_pred             CCcchhhHhhhcccCCccchh-----hccCccccCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011180          352 NGEHNLVEWARPHLGDKRRFY-----RLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  422 (491)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~~~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~  422 (491)
                      ............. .......     ....+.+...+ ....+..+.+||.+||+.||.+|||+.+|++.|+.+++.
T Consensus       244 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          244 EYMLPFEEEIGQH-PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CCCCTTHHHHCSS-CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhccchhhhhccC-CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            3322221111000 0000000     01111111111 123467799999999999999999999999999987654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.7e-47  Score=383.26  Aligned_cols=249  Identities=31%  Similarity=0.398  Sum_probs=208.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||.||+|++..         +|..||||++.+..   ......+.+|+.+|..++||||+++++++.
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~   75 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ   75 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE
Confidence            579999999999999999999875         67899999997542   233467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..||||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        76 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG  150 (337)
T 1o6l_A           76 THDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeecc
Confidence            9999999999999999999997654  6889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+...   ..... 
T Consensus       151 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~---i~~~~-  221 (337)
T 1o6l_A          151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFEL---ILMEE-  221 (337)
T ss_dssp             TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHHCC-
T ss_pred             chhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHHH---HHcCC-
Confidence            9986433222  234578999999999999999999999999999999999999999653211   11111   00000 


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                                 ..++...+..+.+||.+||+.||.+||     ++.+|++|
T Consensus       222 -----------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 -----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                       012233478899999999999999999     89999876

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.7e-47  Score=380.30  Aligned_cols=263  Identities=26%  Similarity=0.433  Sum_probs=212.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|.+.+.||+|+||.||+|.+...+.      .+..||||++..... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQ------RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTS------CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCC------CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            3579999999999999999999875332      456799999976532 334678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..+|||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCc
Confidence            999999999999999999996553 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          291 AKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       291 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ++........ .......||+.|+|||++.+..++.++|||||||++|||++ |..||.......   .......     
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~~-----  269 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VISSVEE-----  269 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHT-----
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHc-----
Confidence            9876543222 12233456788999999999999999999999999999999 999996543211   1111110     


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                               ......+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       270 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          270 ---------GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                     01111223447889999999999999999999999999987644

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-46  Score=382.14  Aligned_cols=253  Identities=25%  Similarity=0.339  Sum_probs=208.9

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc------cHHHHHHHHHHHhcCCCCceeeee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLLHPNLVKLV  205 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~  205 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++......      ..+.+.+|+.+|..+.||||++++
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~---------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~   81 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH   81 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECC---------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence            3579999999999999999999876         6789999999765432      346789999999999999999999


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC----
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----  281 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~----  281 (491)
                      +++.+.+..+|||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    
T Consensus        82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~  156 (361)
T 2yab_A           82 DVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIP  156 (361)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSC
T ss_pred             EEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCcc
Confidence            99999999999999999999999997654  6899999999999999999999988   99999999999998776    


Q ss_pred             CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      .+||+|||++........   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......   .....
T Consensus       157 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~~~i  230 (361)
T 2yab_A          157 HIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANI  230 (361)
T ss_dssp             CEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH
T ss_pred             CEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence            799999999987654322   234679999999999999899999999999999999999999997543211   11110


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         ......    +++    .+....+..+.+||.+||..||.+|||+.+++++
T Consensus       231 ---~~~~~~----~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          231 ---TAVSYD----FDE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             ---HTTCCC----CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---HhcCCC----CCc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               000000    000    0111236789999999999999999999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.6e-47  Score=378.68  Aligned_cols=254  Identities=26%  Similarity=0.351  Sum_probs=206.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||+|+||+||+|.+..         ++..||||++...... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   77 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   77 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhceeeeEEecCCCEEEEEEEECC---------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            579999999999999999999876         6779999999755332 235688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..||||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  152 (323)
T 3tki_A           78 NIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA  152 (323)
T ss_dssp             SEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CeEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeecc
Confidence            99999999999999999986553  5899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      ...............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ....+.....     
T Consensus       153 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~-----  226 (323)
T 3tki_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKT-----  226 (323)
T ss_dssp             EECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTCT-----
T ss_pred             ceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcccc-----
Confidence            86643333333345789999999999987765 7789999999999999999999976443221 1111111000     


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         ..      ......+..+.+||.+||..||.+|||+.|++++
T Consensus       227 ---~~------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          227 ---YL------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ---TS------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---cC------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence               00      0012236788999999999999999999999865

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.5e-47  Score=377.81  Aligned_cols=262  Identities=29%  Similarity=0.473  Sum_probs=204.9

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      +..++|++.+.||+|+||+||+|.+           +|..||||++......  ..+.+.+|+.+|++++||||++++++
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  102 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-----------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA  102 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-----------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            4456899999999999999999976           4668999999765432  34578899999999999999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      +.+.+..++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+
T Consensus       103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEEC
Confidence            9999999999999999999999976531 23889999999999999999999876 459999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...     
T Consensus       182 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~-----  254 (309)
T 3p86_A          182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK-----  254 (309)
T ss_dssp             CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS-----
T ss_pred             CCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-----
Confidence            999998654322  1223467999999999999999999999999999999999999999654321111111000     


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                 .....++...+..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus       255 -----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          255 -----------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             -----------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             -----------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                       00112223346789999999999999999999999999987644

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.7e-47  Score=386.99  Aligned_cols=273  Identities=28%  Similarity=0.380  Sum_probs=218.5

Q ss_pred             hhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceee
Q 011180          126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVK  203 (491)
Q Consensus       126 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~  203 (491)
                      ..+....++|.+.+.||+|+||.||+|.+....    ...++..||||++..... ...+.+.+|+++|..+ +||||++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccccccceeeceeecCCCCceEEEEEecccc----ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            344556678999999999999999999875421    123678999999976533 3346789999999999 7999999


Q ss_pred             eeeEEeecCc-eEEEEEecCCCChHHHhhhCCC-----------------------------------------------
Q 011180          204 LVGYCIEDDQ-RLLVYEFMPRGSLENHLFRKGS-----------------------------------------------  235 (491)
Q Consensus       204 l~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------  235 (491)
                      +++++.+.+. .++|||||++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999987654 8999999999999999976532                                               


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCC
Q 011180          236 -----------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  298 (491)
Q Consensus       236 -----------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~  298 (491)
                                       ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                             12889999999999999999999988   9999999999999999999999999998775544


Q ss_pred             CceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhccCc
Q 011180          299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  377 (491)
Q Consensus       299 ~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (491)
                      .........||+.|+|||++.+..++.++|||||||++|||++ |..||........  ........             
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~~-------------  312 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEG-------------  312 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHHHT-------------
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHHcC-------------
Confidence            4444455778999999999999999999999999999999998 9999976443221  11111000             


Q ss_pred             cccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          378 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       378 ~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                       .....+...+..+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus       313 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          313 -TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence             0111122336789999999999999999999999999987643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.1e-47  Score=386.36  Aligned_cols=251  Identities=29%  Similarity=0.409  Sum_probs=203.8

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCceeeeee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKLVG  206 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~  206 (491)
                      ..++|++.+.||+|+||.||+|++..         +|..||||++.+..   ....+.+.+|+.+|..+ .||||+++++
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~   91 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC   91 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcC---------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEE
Confidence            34689999999999999999999876         67799999997542   12345678899999988 6999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      ++.+.+..|||||||++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+
T Consensus        92 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~  166 (353)
T 3txo_A           92 CFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLA  166 (353)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEc
Confidence            9999999999999999999999997764  6899999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.......   +...   ...
T Consensus       167 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~---i~~  238 (353)
T 3txo_A          167 DFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEA---ILN  238 (353)
T ss_dssp             CCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHH
T ss_pred             cccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HHHH---HHc
Confidence            9999986433222  2345789999999999999999999999999999999999999997543221   1111   110


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~------~evl~~  415 (491)
                      ..            ..++...+..+.+||.+||..||.+||++      .++++|
T Consensus       239 ~~------------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          239 DE------------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             CC------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             CC------------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            00            11222346789999999999999999998      777765

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.5e-46  Score=366.76  Aligned_cols=283  Identities=37%  Similarity=0.616  Sum_probs=226.6

Q ss_pred             hchhhhhhHHHhhcCCCcC------cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC----cccHHHHHHH
Q 011180          120 LRKFMFNDLKLATRNFRPE------SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAE  189 (491)
Q Consensus       120 ~~~~~~~~~~~~~~~y~~~------~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E  189 (491)
                      ...|.+.++..++++|...      +.||+|+||.||+|.+           ++..||||++....    ....+.+.+|
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~E   80 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQE   80 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHHH
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHHH
Confidence            3457778888888888777      8999999999999976           35689999986532    2234678899


Q ss_pred             HHHHhcCCCCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 011180          190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYR  268 (491)
Q Consensus       190 ~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHr  268 (491)
                      +.+++.++||||+++++++.+.+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+   |+||
T Consensus        81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~  157 (307)
T 2nru_A           81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHR  157 (307)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred             HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecC
Confidence            999999999999999999999999999999999999999986432 346899999999999999999999988   9999


Q ss_pred             CCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCC
Q 011180          269 DFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDK  348 (491)
Q Consensus       269 DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~  348 (491)
                      ||||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus       158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence            9999999999999999999999987654433333445679999999998764 688999999999999999999999976


Q ss_pred             CCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          349 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      .........  +..........+...++..+ ...+...+..+.+|+.+||+.||.+|||+.+|+++|+.+.
T Consensus       237 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          237 HREPQLLLD--IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             TBSSSBTTH--HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             CcchHHHHH--HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            543322111  11111111122223333333 2345566889999999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.8e-46  Score=366.79  Aligned_cols=263  Identities=24%  Similarity=0.362  Sum_probs=209.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|++.+.||+|+||.||+|.+..         ++..||+|++.....   ...+.+.+|+.++..++||||+++++++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~   80 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTI---------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD   80 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETT---------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECC---------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence            4579999999999999999999875         677999999865432   2346788999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..++||||+++++|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Df  155 (294)
T 4eqm_A           81 EEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDF  155 (294)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred             eeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999999997764  6899999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |++........ ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ........   .
T Consensus       156 g~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~---~  229 (294)
T 4eqm_A          156 GIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDS---V  229 (294)
T ss_dssp             SSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHHHSSC---C
T ss_pred             CCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhhcc---C
Confidence            99987644322 222346799999999999999999999999999999999999999965432110  00100000   0


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhcCccc
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-RMSEVVETLKPLQNL  422 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-t~~evl~~L~~l~~~  422 (491)
                              +.....+....+..+.++|.+||+.||.+|| ++.++++.|..+...
T Consensus       230 --------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          230 --------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             --------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             --------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                    0011111223368899999999999999998 899999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.9e-46  Score=373.12  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=208.6

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCce
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  214 (491)
                      |...+.||+|+||.||+|++..         +|..||||++........+.+.+|+.+|+.++||||+++++++...+..
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL  117 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhccEEeccCCCeEEEEEEECC---------CCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            6777899999999999999875         5779999999877666677899999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          215 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       215 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      ++||||+++++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       118 ~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  191 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI  191 (321)
T ss_dssp             EEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence            9999999999999988643   6899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......   ........          .
T Consensus       192 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~~~~~----------~  256 (321)
T 2c30_A          192 SKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRD----------S  256 (321)
T ss_dssp             CSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH----------S
T ss_pred             ccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhc----------C
Confidence            54322  123467999999999999999999999999999999999999999654221   11111110          0


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      ..+.+  ......+..+.+||.+||+.||.+|||+.+++++-
T Consensus       257 ~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          257 PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            01111  11123367899999999999999999999999863

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-46  Score=374.74  Aligned_cols=254  Identities=19%  Similarity=0.248  Sum_probs=209.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||+|++.... .....+.+|+.+|+.++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   73 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             hhceEeeeEEecCCCeEEEEEEECC---------CCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence            4579999999999999999999875         67899999997553 3345688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC--CCCeEEeccC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA--DYNAKLSDFG  289 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~--~~~~kL~DFG  289 (491)
                      +..++|||||++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           74 EELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            99999999999999999996553 36899999999999999999999988   999999999999987  7899999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++.......   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......   ........   ...
T Consensus       150 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~---~~~  220 (321)
T 1tki_A          150 QARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMN---AEY  220 (321)
T ss_dssp             TCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHH---TCC
T ss_pred             CCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHc---CCC
Confidence            998775432   223467999999999999888999999999999999999999999754321   11111100   000


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      .+    +..    .....+..+.+||.+||..||.+|||+.+++++-
T Consensus       221 ~~----~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          221 TF----DEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             CC----CHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             CC----Chh----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            00    000    0012367899999999999999999999999873

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-46  Score=374.59  Aligned_cols=246  Identities=27%  Similarity=0.396  Sum_probs=207.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|++..         +|..||+|++.+...   ...+.+.+|+.+|+.+.||||+++++++.
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~   76 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ   76 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE
Confidence            579999999999999999999876         677999999975421   23466788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..|+||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        77 ~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg  151 (318)
T 1fot_A           77 DAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG  151 (318)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecC
Confidence            9999999999999999999997754  6889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ...   ..+... 
T Consensus       152 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~---~i~~~~-  219 (318)
T 1fot_A          152 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYE---KILNAE-  219 (318)
T ss_dssp             SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHHCC-
T ss_pred             cceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCC-
Confidence            99876432     234689999999999999999999999999999999999999996542211   111   111000 


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                                 ..++...+..+.+||.+||..||.+||     +++++++|
T Consensus       220 -----------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          220 -----------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                       012223367899999999999999999     88898865

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.5e-47  Score=389.40  Aligned_cols=262  Identities=25%  Similarity=0.404  Sum_probs=212.1

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ...++|.+.+.||+|+||.||+|.+..         ++..||||++...... ....+.+|+++|+.++||||+++++++
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  181 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC  181 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345679999999999999999999875         5678999999755322 234688999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..+|||||+++|+|.+++...+ ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+||
T Consensus       182 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~Df  257 (377)
T 3cbl_A          182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDF  257 (377)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCG
T ss_pred             ecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcC
Confidence            99999999999999999999997653 25889999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      |+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......   ........    
T Consensus       258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~~~~----  330 (377)
T 3cbl_A          258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREFVEK----  330 (377)
T ss_dssp             GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHHHHT----
T ss_pred             CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc----
Confidence            99986543221111112235778999999999999999999999999999998 99999654321   11111110    


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                ......+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       331 ----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          331 ----------GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                      00111223346789999999999999999999999999987643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=375.94  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=207.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc------cHHHHHHHHHHHhcCCCCceeeeee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLLHPNLVKLVG  206 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~  206 (491)
                      ++|.+.+.||+|+||.||+|.+..         +|..||||++......      ..+.+.+|+.+|+.++||||+++++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~   81 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE   81 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECC---------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            469999999999999999999876         6779999999765322      3567899999999999999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC----C
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----N  282 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~----~  282 (491)
                      ++.+.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .
T Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~  156 (326)
T 2y0a_A           82 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR  156 (326)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCC
T ss_pred             EEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCC
Confidence            9999999999999999999999997653  6899999999999999999999988   99999999999998887    8


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      +||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.  .
T Consensus       157 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~  231 (326)
T 2y0a_A          157 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--A  231 (326)
T ss_dssp             EEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--H
T ss_pred             EEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH--h
Confidence            99999999987643322   234679999999999998999999999999999999999999996543211111000  0


Q ss_pred             cccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      ...            .+...+....+..+.+||.+||..||.+|||+.+++++-
T Consensus       232 ~~~------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  273 (326)
T 2y0a_A          232 VNY------------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP  273 (326)
T ss_dssp             TCC------------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             cCC------------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence            000            000000112367889999999999999999999999873

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-46  Score=364.42  Aligned_cols=259  Identities=27%  Similarity=0.403  Sum_probs=212.8

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ..++|++.+.||+|+||.||+|.+.          ++..||||++..... ..+++.+|+.++..++||||+++++++.+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK----------GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK   74 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheeeeeeeccCCCceEEEEEec----------CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            3467999999999999999999775          356799999976543 35678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..++||||+++++|.+++...+. .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~  150 (268)
T 3sxs_A           75 EYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGM  150 (268)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTC
T ss_pred             CCceEEEEEccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCcc
Confidence            9999999999999999999976532 5899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +......... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||........   ......   .  
T Consensus       151 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~---~--  221 (268)
T 3sxs_A          151 TRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV---VLKVSQ---G--  221 (268)
T ss_dssp             EEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHHT---T--
T ss_pred             ceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH---HHHHHc---C--
Confidence            9876543322 2233456778999999999999999999999999999999 9999965432111   110000   0  


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  422 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~  422 (491)
                               .....+...+..+.+|+.+||+.||.+|||+.+++++|+.+...
T Consensus       222 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          222 ---------HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ---------CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                     00011122367899999999999999999999999999988654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=382.68  Aligned_cols=272  Identities=25%  Similarity=0.374  Sum_probs=219.5

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||+|+||.||+|.+...+.  .....+..||||++..... ...+.+.+|+++++.+ +||||+++++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSST--TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccc--cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            34579999999999999999999754221  1123567899999976533 2346788999999999 899999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  274 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~N  274 (491)
                      .+.+..+|||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence            999999999999999999999976542              35899999999999999999999988   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 011180          275 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  353 (491)
Q Consensus       275 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~  353 (491)
                      |||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...... 
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-  300 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  300 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999987654433333344567889999999999999999999999999999999 99999654321 


Q ss_pred             cchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccccc
Q 011180          354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD  424 (491)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~~~  424 (491)
                        .+.......              .....+..++..+.+||.+||+.||.+|||+.+|+++|+.+.....
T Consensus       301 --~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          301 --ELFKLLKEG--------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             --HHHHHHHTT--------------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             --HHHHHHHcC--------------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence              111111100              0111223347889999999999999999999999999988755443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-46  Score=373.56  Aligned_cols=268  Identities=28%  Similarity=0.410  Sum_probs=217.7

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      ....++|.+.+.||+|+||.||+|.+....    ...++..||||++..... ...+.+.+|+.+|+.++||||++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLK----GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGG----GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccC----cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            344568999999999999999999885321    112567899999976532 334678899999999999999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGS----------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPV  265 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i  265 (491)
                      +.+.+..++||||+++++|.+++.....                      ..+++..++.++.||+.||.|||+.+   |
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i  171 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---L  171 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence            9999999999999999999999976542                      23789999999999999999999988   9


Q ss_pred             EecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCC
Q 011180          266 IYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR  344 (491)
Q Consensus       266 iHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~  344 (491)
                      +||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987655443333344567889999999999999999999999999999999 999


Q ss_pred             CCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          345 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       345 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      ||...........+.   .              ......+...+..+.+||.+||+.||.+|||+.+++++|+.+.
T Consensus       252 p~~~~~~~~~~~~~~---~--------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          252 PYPGIPPERLFNLLK---T--------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             SSTTCCGGGHHHHHH---T--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHhh---c--------------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            997544322111111   0              0011122334788999999999999999999999999998753

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.4e-46  Score=376.20  Aligned_cols=262  Identities=24%  Similarity=0.399  Sum_probs=206.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||+|+||.||+|++...+..     ....||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCce-----EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            4799999999999999999998653221     23457888886443 23457899999999999999999999999875


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                       ..++||||+.+|+|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus        90 -~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           90 -TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             -CeEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcce
Confidence             47899999999999999977543 6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+..          
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~----------  234 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----------  234 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT----------
T ss_pred             eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc----------
Confidence            87654443333344567889999999999999999999999999999999 9999976433221111110          


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                             ......+..++..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus       235 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          235 -------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -------TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -------CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                   00111223346789999999999999999999999999987644

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.7e-46  Score=383.44  Aligned_cols=256  Identities=24%  Similarity=0.387  Sum_probs=206.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      ++|.+.++||+|+||.||+|++..         ++..||||++++....   ....+.+|+.+|..+ +|||||++++++
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~  122 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF  122 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence            479999999999999999999876         6789999999765322   234578899999887 799999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..|||||||++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus       123 ~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF  197 (396)
T 4dc2_A          123 QTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY  197 (396)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeec
Confidence            99999999999999999999997754  6899999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch--hhHhhhcccC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN--LVEWARPHLG  366 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~~~~  366 (491)
                      |+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..........  .......   
T Consensus       198 Gla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~---  272 (396)
T 4dc2_A          198 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ---  272 (396)
T ss_dssp             TTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH---
T ss_pred             ceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH---
Confidence            99986433222  2345789999999999999999999999999999999999999996543221110  0000000   


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~------~evl~~  415 (491)
                            .+...  ...++...+..+.+||.+||+.||.+||++      .+|+++
T Consensus       273 ------~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          273 ------VILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             ------HHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             ------HHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence                  00000  012233347889999999999999999995      677665

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.8e-47  Score=381.94  Aligned_cols=253  Identities=28%  Similarity=0.428  Sum_probs=207.0

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCceeee
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKL  204 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l  204 (491)
                      ....++|.+.+.||+|+||.||+|+++.         +|+.||||++++..   ......+..|..+|..+ .||||+++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l   83 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM   83 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcE
Confidence            3455789999999999999999999876         68899999997542   12345678899999877 89999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      ++++.+.+..||||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        84 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vk  158 (345)
T 1xjd_A           84 FCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIK  158 (345)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEE
Confidence            999999999999999999999999997754  6889999999999999999999988   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      |+|||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+...... 
T Consensus       159 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~-  232 (345)
T 1xjd_A          159 IADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRM-  232 (345)
T ss_dssp             ECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH-
T ss_pred             EeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHh-
Confidence            999999986533221  234578999999999999999999999999999999999999999754321   11111100 


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  415 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~-evl~~  415 (491)
                        .        .+    .++...+..+.+||.+||..||.+||++. +|+++
T Consensus       233 --~--------~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          233 --D--------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             --C--------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             --C--------CC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence              0        01    12223468899999999999999999997 66543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4e-47  Score=386.50  Aligned_cols=266  Identities=27%  Similarity=0.397  Sum_probs=211.7

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|.+.+.||+|+||.||+|.+....    ...++..||||++.... ......+.+|+.+|..++||||+++++++.+
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCC----CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            357999999999999999999975321    11267899999997543 2344578899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC---C
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGS-----LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---N  282 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~---~  282 (491)
                      ....+||||||++|+|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++   .
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCce
Confidence            9999999999999999999976432     35889999999999999999999988   99999999999998554   5


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  361 (491)
                      +||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......   .+....
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~i  299 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV  299 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence            99999999975432222222334578999999999999999999999999999999998 99999654321   111111


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ...              .....+..++..+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus       300 ~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          300 TSG--------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HcC--------------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            100              0011123346789999999999999999999999999987644

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.5e-46  Score=397.00  Aligned_cols=262  Identities=25%  Similarity=0.402  Sum_probs=219.0

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .....+|.+.+.||+|+||.||+|.+..         ++..||||++.... ...+++.+|+.+|++++|||||++++++
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~  285 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC  285 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3445678999999999999999999875         57799999997654 3467899999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..+||||||++|+|.+++.......+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+||
T Consensus       286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred             ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeec
Confidence            99999999999999999999998766667999999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      |+++...... ........+++.|+|||++.+..++.++|||||||+||||++ |..||.......   +.....     
T Consensus       363 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~~-----  433 (495)
T 1opk_A          363 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE-----  433 (495)
T ss_dssp             TCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHH-----
T ss_pred             ccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH-----
Confidence            9998765432 222233456789999999999999999999999999999999 999997543221   111111     


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                               .......+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       434 ---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          434 ---------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ---------cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                     111112233457889999999999999999999999999998754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-46  Score=363.97  Aligned_cols=257  Identities=28%  Similarity=0.445  Sum_probs=211.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|++.+.||+|+||.||+|.+.          ++..||||++..... ..+++.+|+.++++++||||+++++++.+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   77 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hhhceeeheecCCCccEEEEEEec----------CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            457999999999999999999885          356799999986543 456799999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~  153 (269)
T 4hcu_A           78 APICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMT  153 (269)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred             CceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccc
Confidence            99999999999999999996653 36899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      ........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......   .........      
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~~~~~~------  223 (269)
T 4hcu_A          154 RFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDISTG------  223 (269)
T ss_dssp             GGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT------
T ss_pred             cccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHhcC------
Confidence            86643221 11223457788999999999999999999999999999999 99999654321   111111100      


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                              .....+...+..+.+|+.+||+.||.+|||+.+++++|+.+.+
T Consensus       224 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          224 --------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                    0011122236789999999999999999999999999987644

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-46  Score=377.69  Aligned_cols=269  Identities=25%  Similarity=0.383  Sum_probs=216.1

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      ....++|.+.+.||+|+||.||+|.+....    ...++..||||++..... ...+.+.+|+.+|+.++||||++++++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSS----TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcC----CCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            345678999999999999999999986421    012567999999976543 234678999999999999999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKG----------------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPV  265 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i  265 (491)
                      +.+.+..+|||||+++|+|.+++....                      ...+++..++.++.||+.||.|||+.+   |
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i  195 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F  195 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            999999999999999999999997642                      146899999999999999999999988   9


Q ss_pred             EecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCC
Q 011180          266 IYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR  344 (491)
Q Consensus       266 iHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~  344 (491)
                      +||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999976543322222334568999999999999999999999999999999999 999


Q ss_pred             CCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          345 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       345 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ||......   ........   ..           ....+..++..+.+||.+||+.||.+|||+.+++++|+.+..
T Consensus       276 p~~~~~~~---~~~~~~~~---~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          276 PYYGMAHE---EVIYYVRD---GN-----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTTTSCHH---HHHHHHHT---TC-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCCCCChH---HHHHHHhC---CC-----------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            99653221   11111100   00           011223346789999999999999999999999999998754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.1e-46  Score=381.95  Aligned_cols=263  Identities=25%  Similarity=0.444  Sum_probs=201.6

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ..+|.+.+.||+|+||.||+|++....      .++..||||++..... ...+.+.+|+.+|.+++||||+++++++.+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  117 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPS------KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK  117 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTT------SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCC------CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            357999999999999999999876322      2567899999976532 334678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..+|||||+++|+|.+++...+ ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  193 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGL  193 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcc
Confidence            999999999999999999997653 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCce-eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          291 AKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       291 a~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......   ........     
T Consensus       194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~i~~-----  265 (373)
T 2qol_A          194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKAVDE-----  265 (373)
T ss_dssp             --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHHHHT-----
T ss_pred             ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc-----
Confidence            98765432211 1122345788999999999999999999999999999998 99999654321   11111110     


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                               ......+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus       266 ---------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          266 ---------GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             ---------TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                     01111223346889999999999999999999999999987643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.9e-46  Score=369.16  Aligned_cols=267  Identities=24%  Similarity=0.328  Sum_probs=203.9

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|++.+.||+|+||+||+|.+.          +|..||||++......  ....+.+|+.+|+.++||||+++++++.
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   89 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH   89 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence            357999999999999999999874          4678999999755322  2467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..+|||||++ ++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg  164 (311)
T 3niz_A           90 SERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFG  164 (311)
T ss_dssp             CSSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cCCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCc
Confidence            9999999999996 58888886653 36899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc-cC-
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH-LG-  366 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~-~~-  366 (491)
                      +++.......  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...... .. 
T Consensus       165 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  242 (311)
T 3niz_A          165 LARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR  242 (311)
T ss_dssp             TCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred             CceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence            9987643222  2234578999999999876 56899999999999999999999999765544332221110000 00 


Q ss_pred             Cc---cch-------hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DK---RRF-------YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~---~~~-------~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..   ...       +..+............+.++.+||.+||+.||.+|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            00   000       00000000000112235788999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.9e-46  Score=367.47  Aligned_cols=264  Identities=25%  Similarity=0.402  Sum_probs=220.7

Q ss_pred             hHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeee
Q 011180          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVG  206 (491)
Q Consensus       127 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~  206 (491)
                      ++....++|++.+.||+|+||.||+|.+..         ++..||||++..+. ...+.+.+|+.+++.++||||+++++
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~   76 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLG   76 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            344556789999999999999999999976         57799999997654 34577899999999999999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      ++.+.+..++||||+++++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~  153 (288)
T 3kfa_A           77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVA  153 (288)
T ss_dssp             EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEc
Confidence            9999999999999999999999998866667999999999999999999999998   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhccc
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      |||++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |..||...........+   ..  
T Consensus       154 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~---~~--  227 (288)
T 3kfa_A          154 DFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EK--  227 (288)
T ss_dssp             CCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---HT--
T ss_pred             cCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---hc--
Confidence            9999987654332 22334567889999999999999999999999999999999 99999654322211111   10  


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                  ......+...+..+.+|+.+||..||.+|||+.++++.|+.+..
T Consensus       228 ------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          228 ------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             ------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                        01111223346889999999999999999999999999987644

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.2e-46  Score=380.35  Aligned_cols=253  Identities=23%  Similarity=0.344  Sum_probs=207.6

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++......  ..+.+.+|+.+|+.|+||||+++++++.
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   98 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   98 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4579999999999999999999875         6779999999765432  3456889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC---CCeEEe
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLS  286 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~---~~~kL~  286 (491)
                      +.+..|+||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~  173 (362)
T 2bdw_A           99 EESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA  173 (362)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEe
Confidence            9999999999999999999987654  6899999999999999999999988   9999999999999764   459999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||++........   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......   .+.......  
T Consensus       174 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~~~--  245 (362)
T 2bdw_A          174 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAG--  245 (362)
T ss_dssp             CCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHT--
T ss_pred             ecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhC--
Confidence            9999987654322   23467999999999999989999999999999999999999999654221   111111100  


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       ...        +........+..+.+||.+||..||.+|||+.+++++
T Consensus       246 -~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          246 -AYD--------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -CCC--------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -CCC--------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             000        0000112236789999999999999999999999976

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-46  Score=377.92  Aligned_cols=247  Identities=26%  Similarity=0.324  Sum_probs=205.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||++.....   .....+.+|+.+|+.++||||+++++++.
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   79 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYK---------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT   79 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            579999999999999999999875         677999999865321   22357889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..+|||||+ +|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        80 ~~~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG  153 (336)
T 3h4j_B           80 TPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFG  153 (336)
T ss_dssp             CSSEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSS
T ss_pred             eCCEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEec
Confidence            999999999999 789999987764  6899999999999999999999998   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ++........   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+..        
T Consensus       154 ~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~--------  222 (336)
T 3h4j_B          154 LSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS--------  222 (336)
T ss_dssp             CTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS--------
T ss_pred             cceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--------
Confidence            9987654322   234679999999999988776 6899999999999999999999975432221111000        


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                ....++...+..+.+||.+||..||.+|||+.|++++
T Consensus       223 ----------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          223 ----------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             ----------SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             ----------CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                      0011222346789999999999999999999999876

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2e-46  Score=368.99  Aligned_cols=277  Identities=25%  Similarity=0.379  Sum_probs=210.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|++.+.||+|+||.||+|++...     ...++..||||++........+.+.+|+.+|+.++||||+++++++...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPL-----QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTT-----CSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecc-----cCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            45799999999999999999986431     1237889999999877655667899999999999999999999998654


Q ss_pred             --CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          212 --DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       212 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                        ...++||||+++++|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCc
Confidence              568999999999999999977543 5899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          290 LAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       290 la~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ++......... .......|+..|+|||++.+..++.++|||||||++|||++|..||......    ............
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~  235 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQ  235 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccc
Confidence            99876543221 1223345778899999999999999999999999999999999988532110    000000000000


Q ss_pred             ---cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          369 ---RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       369 ---~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                         ......+........+..++..+.+||.+||+.||.+|||+.++++.|+.+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence               00001111111122234457889999999999999999999999999987643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.5e-46  Score=387.65  Aligned_cols=254  Identities=22%  Similarity=0.302  Sum_probs=207.9

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||+|++......  ..+.+.+|+.+|+.|+||||+++++++.
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~---------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~   80 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVL---------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS   80 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETT---------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence            4579999999999999999999876         6889999999766432  3456889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC---CCCCeEEe
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLS  286 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~---~~~~~kL~  286 (491)
                      +.+..|||||||.+|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+
T Consensus        81 ~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~  155 (444)
T 3soa_A           81 EEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA  155 (444)
T ss_dssp             CSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred             ECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence            9999999999999999999998765  6899999999999999999999988   99999999999998   46789999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||++.........  ....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||......   .........  
T Consensus       156 DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~--  228 (444)
T 3soa_A          156 DFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQQIKAG--  228 (444)
T ss_dssp             CCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHT--
T ss_pred             cCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHhC--
Confidence            99999876543222  23468999999999999989999999999999999999999999654321   111111100  


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       ..        .+........+..+.+||.+||+.||.+|||+.+++++
T Consensus       229 -~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          229 -AY--------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -CC--------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -CC--------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence             00        00011112336889999999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=367.29  Aligned_cols=272  Identities=23%  Similarity=0.282  Sum_probs=212.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|.+.++||+|+||.||+|.+..         ++..||||++..... ...+.+.+|+++|+.++||||+++++++..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence            3579999999999999999999876         577999999975432 345678899999999999999999999987


Q ss_pred             cC--ceEEEEEecCCCChHHHhhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----CCCCCe
Q 011180          211 DD--QRLLVYEFMPRGSLENHLFRKGS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNA  283 (491)
Q Consensus       211 ~~--~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl----~~~~~~  283 (491)
                      ..  ..+|||||+++++|.+++..... ..+++..++.++.||+.||.|||+.+   |+||||||+||||    +.++.+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  155 (319)
T 4euu_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY  155 (319)
T ss_dssp             TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEE
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceE
Confidence            65  77999999999999999976432 24899999999999999999999988   9999999999999    788889


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhh--------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  355 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~--------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~  355 (491)
                      ||+|||+++.......   ....+||+.|+|||++.        +..++.++|||||||++|||++|..||.........
T Consensus       156 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  232 (319)
T 4euu_A          156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (319)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred             EEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence            9999999987654332   23457999999999986        578899999999999999999999999654332211


Q ss_pred             -hhhHhhhcccCCc--cchhh------cc--CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          356 -NLVEWARPHLGDK--RRFYR------LL--DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       356 -~~~~~~~~~~~~~--~~~~~------~~--~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                       .............  .....      ..  +......++...+..+.+|+.+||+.||.+|||++|++++...
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence             1111110000000  00000      00  0011223455678899999999999999999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=368.74  Aligned_cols=251  Identities=24%  Similarity=0.349  Sum_probs=198.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--------------------------cHHH
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------------------GHKE  185 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~  185 (491)
                      .++|.+.+.||+|+||.||+|++..         ++..||||++......                          ..+.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNEN---------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ   82 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETT---------TTEEEEEEEEECC-------------------------------CH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence            3579999999999999999999875         6789999999765321                          1246


Q ss_pred             HHHHHHHHhcCCCCceeeeeeEEee--cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 011180          186 WLAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEK  263 (491)
Q Consensus       186 ~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~  263 (491)
                      +.+|+.+|+.++||||+++++++.+  .+..+|||||+++++|.+++..   ..+++..+..++.||+.||.|||+.+  
T Consensus        83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--  157 (298)
T 2zv2_A           83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK--  157 (298)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence            8899999999999999999999987  5678999999999999886533   26899999999999999999999988  


Q ss_pred             CeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCC---CCccccchhHHHHHHHHH
Q 011180          264 PVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEML  340 (491)
Q Consensus       264 ~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~ell  340 (491)
                       |+||||||+|||++.++.+||+|||+++.......  ......||+.|+|||++.+..   ++.++|||||||++|+|+
T Consensus       158 -ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~  234 (298)
T 2zv2_A          158 -IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV  234 (298)
T ss_dssp             -EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred             -eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence             99999999999999999999999999987654322  223467999999999987654   477899999999999999


Q ss_pred             hCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          341 TGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       341 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      +|..||......   ........   ..          +........+..+.+||.+||+.||.+|||+.+++++
T Consensus       235 ~g~~pf~~~~~~---~~~~~~~~---~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          235 FGQCPFMDERIM---CLHSKIKS---QA----------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HSSCSSCCSSHH---HHHHHHHH---CC----------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HCCCCCCCccHH---HHHHHHhc---cc----------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            999999653211   11111000   00          0000011236789999999999999999999999865

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.3e-46  Score=380.50  Aligned_cols=252  Identities=25%  Similarity=0.334  Sum_probs=208.6

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++....   ....+.+.+|+.+|..++|||||++++++
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   84 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKND---------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF   84 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3579999999999999999999876         67799999996542   22346788999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..|+||||+.+|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DF  159 (384)
T 4fr4_A           85 QDEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDF  159 (384)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEecc
Confidence            99999999999999999999997654  6899999999999999999999998   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      |++.......   .....+||+.|+|||++..   ..|+.++|||||||++|||++|..||.................. 
T Consensus       160 G~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-  235 (384)
T 4fr4_A          160 NIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-  235 (384)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-
T ss_pred             ceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-
Confidence            9998765432   2245789999999999864   45899999999999999999999999765443332222211110 


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVET  415 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-~~evl~~  415 (491)
                                    ...++...+..+.+||.+||..||.+||+ +.+|+++
T Consensus       236 --------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          236 --------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             --------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             --------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                          01122334788999999999999999998 7777653

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.6e-46  Score=377.99  Aligned_cols=247  Identities=26%  Similarity=0.335  Sum_probs=208.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|.+.+.||+|+||.||+|++..         +|..||||++.....   ...+.+.+|+.+|..++||||+++++++
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  110 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF  110 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3579999999999999999999876         677999999965422   3346788999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..||||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus       111 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DF  185 (350)
T 1rdq_E          111 KDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEccc
Confidence            99999999999999999999998764  5889999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |+++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ....   .....
T Consensus       186 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~---i~~~~  254 (350)
T 1rdq_E          186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEK---IVSGK  254 (350)
T ss_dssp             TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHCC
T ss_pred             ccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HHHH---HHcCC
Confidence            999876432     234689999999999999999999999999999999999999997543211   1111   00000


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~  415 (491)
                                  ..++...+..+.+||.+||+.||.+||+     +++|+++
T Consensus       255 ------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          255 ------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                        0122234688999999999999999998     8888765

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.8e-46  Score=363.99  Aligned_cols=265  Identities=24%  Similarity=0.300  Sum_probs=204.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.+.||+|+||+||+|.+..         ++..||||++......  ....+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   72 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECC---------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence            479999999999999999999876         6779999999765432  34678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..+|||||+++ +|.+.+.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~  147 (292)
T 3o0g_A           73 DKKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence            9999999999964 6766665543 36899999999999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC---
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---  366 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---  366 (491)
                      +........  .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......  ...........   
T Consensus       148 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~  223 (292)
T 3o0g_A          148 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPT  223 (292)
T ss_dssp             CEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred             ceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCC
Confidence            987643222  223457899999999998765 8999999999999999999988864332111  11111000000   


Q ss_pred             --Cccchhhcc---------CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 --DKRRFYRLL---------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 --~~~~~~~~~---------~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        .........         ............+..+.+||.+||+.||.+|||++|++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence              000000000         0000111223357889999999999999999999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-46  Score=381.40  Aligned_cols=253  Identities=22%  Similarity=0.315  Sum_probs=209.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||.||+|.+..         +|..||+|++..........+.+|+.+|..|+||||+++++++.+..
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  121 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY  121 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             cceEEEEEEecCCCEEEEEEEECC---------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC
Confidence            579999999999999999999875         67799999998765555667899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC--CCCeEEeccCC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA--DYNAKLSDFGL  290 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~--~~~~kL~DFGl  290 (491)
                      ..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~  197 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL  197 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             EEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccc
Confidence            9999999999999999987553 36899999999999999999999988   999999999999974  57899999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      ++.......   ....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .........      
T Consensus       198 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~~~------  265 (387)
T 1kob_A          198 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRC------  265 (387)
T ss_dssp             CEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHC------
T ss_pred             ceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHHHhC------
Confidence            987654322   23357999999999999999999999999999999999999999754221   111111000      


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                           ...+........+..+.+||.+||..||.+|||+.+++++
T Consensus       266 -----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          266 -----DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -----CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -----CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                 0001111112346789999999999999999999999987

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.8e-46  Score=376.18  Aligned_cols=254  Identities=26%  Similarity=0.353  Sum_probs=205.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-----cccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      ++|++.+.||+|+||+||+|.+..         +|..||||++....     ....+.+.+|+.+|+.++||||++++++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~   94 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRE---------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET   94 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            469999999999999999999876         67799999986432     1235678999999999999999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC---
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---  282 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~---  282 (491)
                      +.+.+..|||||||++++|.+++...  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   
T Consensus        95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~  171 (351)
T 3c0i_A           95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAP  171 (351)
T ss_dssp             EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCC
T ss_pred             EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCc
Confidence            99999999999999999999887643  2335899999999999999999999988   999999999999976654   


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      +||+|||++........  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....    ..+.....
T Consensus       172 vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~  245 (351)
T 3c0i_A          172 VKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGII  245 (351)
T ss_dssp             EEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHH
T ss_pred             EEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHH
Confidence            99999999987654322  2234679999999999999999999999999999999999999996531    11111100


Q ss_pred             cccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .   ....    +.+...    ...+..+.+||.+||..||.+|||+.+++++
T Consensus       246 ~---~~~~----~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          246 K---GKYK----MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             H---TCCC----CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             c---CCCC----CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0   0000    000000    1236789999999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.2e-46  Score=374.33  Aligned_cols=262  Identities=25%  Similarity=0.403  Sum_probs=208.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||+|+||.||+|.+..++..     ....||+|.+.... ......+.+|+.++..++||||+++++++. +
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGES-----IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCS-----CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCce-----EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            5799999999999999999998764321     23458888885443 223356778999999999999999999886 5


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             CccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcc
Confidence            67899999999999999997653 36888899999999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+....        
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------  234 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE--------  234 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC--------
T ss_pred             cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC--------
Confidence            98765544444455678899999999999999999999999999999999 999997654332222211110        


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                               ....+..++..+.+||.+||..||.+|||+.+++++|+.+..
T Consensus       235 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          235 ---------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ---------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ---------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                     001112235567899999999999999999999999987643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-46  Score=376.79  Aligned_cols=269  Identities=25%  Similarity=0.391  Sum_probs=215.6

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCceeeeeeE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~  207 (491)
                      ...++|.+.+.||+|+||.||+|.+....    ..+++..||||++.... ....+.+.+|+.+|..+ .||||++++++
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCS----SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccc----cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            34568999999999999999999974321    12367789999997543 23346789999999999 89999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGS---------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVI  266 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  266 (491)
                      +...+..+|||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||+.+   |+
T Consensus       118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv  194 (344)
T 1rjb_A          118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV  194 (344)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence            9999999999999999999999976532                     23789999999999999999999988   99


Q ss_pred             ecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCC
Q 011180          267 YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRS  345 (491)
Q Consensus       267 HrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~p  345 (491)
                      ||||||+||||+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999987654444334445678999999999999999999999999999999998 9999


Q ss_pred             CCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          346 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       346 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      |........  .......              ......+...+..+.+||.+||..||.+|||+.+|+++|+.+..
T Consensus       275 ~~~~~~~~~--~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          275 YPGIPVDAN--FYKLIQN--------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             STTCCCSHH--HHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cccCCcHHH--HHHHHhc--------------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            976532211  1111111              01111223347889999999999999999999999999986543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1e-46  Score=391.40  Aligned_cols=265  Identities=22%  Similarity=0.280  Sum_probs=213.1

Q ss_pred             hhhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCc
Q 011180          124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPN  200 (491)
Q Consensus       124 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~Hpn  200 (491)
                      .+.++....++|.+.++||+|+||+||+|++..         +++.||||++.+...   .....+.+|+.+|..++|||
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~  135 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW  135 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTT
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcC---------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCC
Confidence            345566777899999999999999999999876         678999999975321   11234788999999999999


Q ss_pred             eeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 011180          201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  280 (491)
Q Consensus       201 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~  280 (491)
                      |++++++|.+.+.+|||||||++|+|.+++.... ..+++..+..++.||+.||.|||+.+   ||||||||+||||+.+
T Consensus       136 Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~  211 (437)
T 4aw2_A          136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMN  211 (437)
T ss_dssp             BCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred             EEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCC
Confidence            9999999999999999999999999999997643 36899999999999999999999988   9999999999999999


Q ss_pred             CCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011180          281 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  355 (491)
Q Consensus       281 ~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~  355 (491)
                      +.+||+|||+++....... ......+||+.|+|||++.     ...|+.++|||||||++|||++|+.||.........
T Consensus       212 g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~  290 (437)
T 4aw2_A          212 GHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  290 (437)
T ss_dssp             SCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             CCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH
Confidence            9999999999987654332 2234468999999999997     467899999999999999999999999754322111


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVET  415 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~  415 (491)
                      ..+      +....   ...-|.    .....+..+.+||++||..+|.+  ||+++++++|
T Consensus       291 ~~i------~~~~~---~~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          291 GKI------MNHKE---RFQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHH------HTHHH---HCCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             Hhh------hhccc---cccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            111      00000   000000    01123788999999999988888  9999999976

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.4e-46  Score=377.48  Aligned_cols=251  Identities=27%  Similarity=0.382  Sum_probs=207.4

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcC-CCCceeeeee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVG  206 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~  206 (491)
                      ..++|.+.+.||+|+||.||+|++..         ++..||||++.+...   ...+.+..|..+|..+ .||||+++++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~   88 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS   88 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETT---------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence            34689999999999999999999875         678999999975421   2346688999999988 7999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      ++.+.+..||||||+++|+|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+
T Consensus        89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           89 CFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEE
Confidence            9999999999999999999999997754  5889999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+...   ...
T Consensus       164 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~---i~~  235 (353)
T 2i0e_A          164 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQS---IME  235 (353)
T ss_dssp             CCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HHH
T ss_pred             eCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHHH---HHh
Confidence            9999986433222  234578999999999999999999999999999999999999999754221   11111   110


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~  415 (491)
                      ..            ..++...+..+.+||.+||..||.+||+     +.+|+++
T Consensus       236 ~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          236 HN------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             CC------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             CC------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            00            1122334788999999999999999995     5777765

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.5e-46  Score=369.72  Aligned_cols=267  Identities=27%  Similarity=0.408  Sum_probs=217.7

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeeeeE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~  207 (491)
                      ...++|.+.+.||+|+||.||+|.+...    ....++..||||++..... ...+.+.+|+.+|..+ +||||++++++
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            3446799999999999999999987431    1223678999999976543 3346788999999999 89999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGS----------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  271 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlK  271 (491)
                      +.+.+..++||||+++|+|.+++.....                ..+++..++.++.||+.||.|||+.+   |+|||||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk  172 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA  172 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence            9999999999999999999999976542                24899999999999999999999988   9999999


Q ss_pred             CCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 011180          272 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNR  350 (491)
Q Consensus       272 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~  350 (491)
                      |+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            9999999999999999999987765544444445668899999999999999999999999999999999 999996543


Q ss_pred             CCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          351 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ....  ........              .....+...+..+.+||.+||..||.+|||+.+++++|+.+
T Consensus       253 ~~~~--~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          253 VDSK--FYKMIKEG--------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             SSHH--HHHHHHHT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhH--HHHHhccC--------------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            2211  11111100              01111223467899999999999999999999999999865

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.4e-46  Score=370.47  Aligned_cols=262  Identities=18%  Similarity=0.192  Sum_probs=211.6

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  210 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++.....  ...+.+|+.+++.| .||||+++++++..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   76 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLY---------TNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC   76 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETT---------TTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECC---------CCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence            3579999999999999999999865         678999999976532  24588999999999 89999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC-----eEE
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-----AKL  285 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~-----~kL  285 (491)
                      .+..+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl  151 (330)
T 2izr_A           77 GKYNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHI  151 (330)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred             CCccEEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEE
Confidence            99999999999 999999997653 37999999999999999999999988   999999999999998887     999


Q ss_pred             eccCCcccCCCCCCce-----eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011180          286 SDFGLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  360 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  360 (491)
                      +|||+++.........     .....+||+.|+|||++.+..++.++|||||||++|||++|..||..............
T Consensus       152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~  231 (330)
T 2izr_A          152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK  231 (330)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred             EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence            9999998764332211     12356899999999999999999999999999999999999999987644333222211


Q ss_pred             hhcc-cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          361 ARPH-LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       361 ~~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      .... ....   ...+        ....+ .+.+|+.+||..||.+||++.+|++.|+.+..
T Consensus       232 i~~~~~~~~---~~~~--------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          232 IGDTKRATP---IEVL--------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HHHHHHHSC---HHHH--------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHhhhccCC---HHHH--------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            1000 0000   0000        01124 89999999999999999999999999986543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.8e-46  Score=374.77  Aligned_cols=256  Identities=25%  Similarity=0.390  Sum_probs=205.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      ++|.+.+.||+|+||.||+|++..         ++..||||++.+....   ..+.+.+|+.+|..+ +||||+++++++
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~   79 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF   79 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence            479999999999999999999876         6789999999765332   335578899999988 799999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..||||||+++|+|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus        80 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DF  154 (345)
T 3a8x_A           80 QTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY  154 (345)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCG
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEec
Confidence            99999999999999999999997654  6899999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc--hhhHhhhcccC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWARPHLG  366 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~~  366 (491)
                      |+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.........  ........   
T Consensus       155 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---  229 (345)
T 3a8x_A          155 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ---  229 (345)
T ss_dssp             GGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH---
T ss_pred             cccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH---
Confidence            99986433222  234568999999999999999999999999999999999999999653221110  00000000   


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~------~evl~~  415 (491)
                            .+...  ...++...+..+.+||.+||..||.+||++      .++++|
T Consensus       230 ------~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          230 ------VILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             ------HHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             ------HHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                  00000  011233347889999999999999999995      566654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.5e-46  Score=375.51  Aligned_cols=253  Identities=23%  Similarity=0.297  Sum_probs=197.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||+||+|++..         ++..||||++..... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   89 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKL---------TKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPT   89 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETT---------TCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence            479999999999999999999876         677999999976543 3367889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC--eEEeccCC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--AKLSDFGL  290 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~--~kL~DFGl  290 (491)
                      ..+|||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.  +||+|||+
T Consensus        90 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~  164 (361)
T 3uc3_A           90 HLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGY  164 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCC
T ss_pred             EEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCc
Confidence            9999999999999999997654  6899999999999999999999988   999999999999987765  99999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCcc-ccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~-~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++......   .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............  .....    
T Consensus       165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~----  235 (361)
T 3uc3_A          165 SKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRIL----  235 (361)
T ss_dssp             C------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHH----
T ss_pred             cccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHh----
Confidence            97543221   1234579999999999988887665 89999999999999999999764433221111  11000    


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                            ............+..+.+||.+||..||.+|||+.+++++
T Consensus       236 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          236 ------SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ------TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ------cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                  0000001111236789999999999999999999999987

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.5e-46  Score=373.03  Aligned_cols=268  Identities=24%  Similarity=0.376  Sum_probs=197.8

Q ss_pred             HHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeee
Q 011180          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLV  205 (491)
Q Consensus       128 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~  205 (491)
                      +.+..++|.+.+.||+|+||.||+|.+...+.      ....||||++....  ....+.+.+|+.+++.++||||++++
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   91 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDG------SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV   91 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCC------cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhh
Confidence            33456689999999999999999998865321      22379999997653  23456789999999999999999999


Q ss_pred             eEEeecCce------EEEEEecCCCChHHHhhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 011180          206 GYCIEDDQR------LLVYEFMPRGSLENHLFRKG----SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  275 (491)
Q Consensus       206 ~~~~~~~~~------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NI  275 (491)
                      +++......      ++||||+++|+|.+++....    ...+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus        92 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NI  168 (323)
T 3qup_A           92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNC  168 (323)
T ss_dssp             EEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             ceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceE
Confidence            999887655      99999999999999986432    225899999999999999999999988   99999999999


Q ss_pred             EECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCc
Q 011180          276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE  354 (491)
Q Consensus       276 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~  354 (491)
                      ||+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|+|++ |..||........
T Consensus       169 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~  248 (323)
T 3qup_A          169 MLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI  248 (323)
T ss_dssp             EECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred             EEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH
Confidence            999999999999999987654433333334567889999999999999999999999999999999 8999975432221


Q ss_pred             chhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ...+.   .   .           .....+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       249 ~~~~~---~---~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          249 YNYLI---G---G-----------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HHHHH---T---T-----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHh---c---C-----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11110   0   0           0011123346789999999999999999999999999987644

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1e-45  Score=386.22  Aligned_cols=255  Identities=28%  Similarity=0.438  Sum_probs=211.8

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .+..++|.+.+.||+|+||.||+|.+.           |..||||+++...  ..+.+.+|+.+|+.++||||+++++++
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~  255 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI  255 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEE
Confidence            345568999999999999999999873           5689999998654  457899999999999999999999998


Q ss_pred             eecC-ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          209 IEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       209 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      .+.. ..+||||||++|+|.+++...+...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|
T Consensus       256 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~D  332 (450)
T 1k9a_A          256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSD  332 (450)
T ss_dssp             ECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECC
T ss_pred             EcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEee
Confidence            7765 7899999999999999998776556899999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      ||+++.....     .....+++.|+|||++.+..++.++|||||||+||||++ |..||...........+.   ..  
T Consensus       333 fG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~~--  402 (450)
T 1k9a_A          333 FGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---KG--  402 (450)
T ss_dssp             CTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH---TT--
T ss_pred             CCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cC--
Confidence            9999855322     122357899999999999999999999999999999998 999997654332211111   00  


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                  .....+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       403 ------------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          403 ------------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                        0112233457889999999999999999999999999987654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2e-46  Score=386.29  Aligned_cols=261  Identities=25%  Similarity=0.311  Sum_probs=210.7

Q ss_pred             hhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCcee
Q 011180          126 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLV  202 (491)
Q Consensus       126 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv  202 (491)
                      .++....++|.+.+.||+|+||.||+|++..         ++..||+|++.+...   .....+.+|+.+|..++|||||
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv  132 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV  132 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBC
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECC---------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCC
Confidence            3445567899999999999999999999876         677999999965321   1223578899999999999999


Q ss_pred             eeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      ++++++.+.+.+|||||||++|+|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.
T Consensus       133 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~  206 (410)
T 3v8s_A          133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH  206 (410)
T ss_dssp             CEEEEEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred             eEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCC
Confidence            9999999999999999999999999998654   5889999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  358 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~----~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  358 (491)
                      +||+|||+++....... ......+||+.|+|||++.+..    |+.++|||||||+||||++|..||...........+
T Consensus       207 ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i  285 (410)
T 3v8s_A          207 LKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI  285 (410)
T ss_dssp             EEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH
Confidence            99999999987654332 2234578999999999998655    889999999999999999999999754322111111


Q ss_pred             HhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 011180          359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETL  416 (491)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~L  416 (491)
                            +.....        +........+..+.+||.+||..+|.+  ||++++|++|-
T Consensus       286 ------~~~~~~--------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          286 ------MNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             ------HTHHHH--------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             ------Hhcccc--------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence                  000000        000001123688999999999999988  99999999873

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.9e-45  Score=360.29  Aligned_cols=256  Identities=31%  Similarity=0.551  Sum_probs=206.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc-------HHHHHHHHHHHhcCCCCceeee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~il~~l~HpnIv~l  204 (491)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++.......       .+.+.+|+.+++.++||||+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   88 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVK---------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL   88 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETT---------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hccceehhccccCCceeEEEEEEcC---------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence            3579999999999999999999876         57789999986543321       1678899999999999999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC--
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--  282 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~--  282 (491)
                      ++++.+..  ++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.  
T Consensus        89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~  164 (287)
T 4f0f_A           89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENA  164 (287)
T ss_dssp             EEEETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTC
T ss_pred             heeecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCC
Confidence            99986554  79999999999999887654 37899999999999999999999876 45999999999999988776  


Q ss_pred             ---eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhh--cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011180          283 ---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  357 (491)
Q Consensus       283 ---~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~--~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~  357 (491)
                         +||+|||+++....     ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||...........
T Consensus       165 ~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  239 (287)
T 4f0f_A          165 PVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI  239 (287)
T ss_dssp             SCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH
T ss_pred             ceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH
Confidence               99999999985433     123467999999999983  45678899999999999999999999975443221111


Q ss_pred             hHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      .....              ......++...+..+.+||.+||+.||.+|||+.++++.|+.+
T Consensus       240 ~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 NMIRE--------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHH--------------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHhc--------------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11100              0111122334478899999999999999999999999999864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7.9e-46  Score=370.91  Aligned_cols=252  Identities=29%  Similarity=0.412  Sum_probs=198.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc----ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ++|.+.+.||+|+||.||+|++....      .++..||||++.....    .....+.+|+.+|+.++||||+++++++
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGA------NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSST------TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccC------CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            47999999999999999999885321      2688999999976532    2334578899999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..||||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Df  165 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF  165 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCC
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeC
Confidence            99999999999999999999997654  5888999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |+++.......  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......   ......   ....
T Consensus       166 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i---~~~~  237 (327)
T 3a62_A          166 GLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDKI---LKCK  237 (327)
T ss_dssp             SCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH---HHTC
T ss_pred             CcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HhCC
Confidence            99976433221  223467999999999999999999999999999999999999999754221   111110   0000


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                                  ..++...+..+.+||.+||..||.+||     ++.++++|
T Consensus       238 ------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 ------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                        012223467899999999999999999     78888876

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.9e-46  Score=364.48  Aligned_cols=262  Identities=24%  Similarity=0.367  Sum_probs=201.0

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ..++|++.+.||+|+||.||+|.+.....      .+..||||++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            34579999999999999999999865322      466899999876432 33467889999999999999999999974


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                       ++..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        87 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  161 (281)
T 1mp8_A           87 -ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG  161 (281)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred             -cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccc
Confidence             567899999999999999997653 36899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      +++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||........   .......    
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~~~----  233 (281)
T 1mp8_A          162 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENG----  233 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTT----
T ss_pred             cccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHHcC----
Confidence            99876543221 2233457889999999999999999999999999999997 9999975433221   1111000    


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                ....++...+..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus       234 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          234 ----------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                      0011223447889999999999999999999999999987643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.4e-45  Score=367.36  Aligned_cols=264  Identities=25%  Similarity=0.369  Sum_probs=192.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++..... .....+.+|+.+|+.++||||+++++++.++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   75 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKT---------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE   75 (317)
T ss_dssp             --------------CEEEEEECSS---------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT
T ss_pred             cceeEeeEECCCCCEEEEEEEECC---------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC
Confidence            579999999999999999998865         677999999976532 2346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKG----SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +..+|||||++ ++|.+++....    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        76 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D  151 (317)
T 2pmi_A           76 NKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGD  151 (317)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             CeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECc
Confidence            99999999996 69999886532    235889999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc--
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH--  364 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~--  364 (491)
                      ||+++.......  .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+......  
T Consensus       152 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  229 (317)
T 2pmi_A          152 FGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN  229 (317)
T ss_dssp             CSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             CccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999987643221  1234578999999999876 46899999999999999999999999764322111111000000  


Q ss_pred             ------cCCc------------cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 ------LGDK------------RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ------~~~~------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                            ....            ..+...+.+    ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQP----HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGG----GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhHhhhhhhhhhcccccccccchhHHHhhcc----cccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                  0000            000000011    1111236789999999999999999999999865

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.1e-45  Score=358.87  Aligned_cols=254  Identities=31%  Similarity=0.519  Sum_probs=197.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc----ccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      .++|.+.+.||+|+||.||+|.+           ++..||||++.....    ...+.+.+|+.+++.++||||++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-----------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV   74 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-----------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            35799999999999999999987           356899999875432    224678899999999999999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC--------
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA--------  279 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~--------  279 (491)
                      +.+.+..++||||+++++|.+++...   .+++..++.++.||+.||.|||+.+..+|+||||||+|||++.        
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~  151 (271)
T 3dtc_A           75 CLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS  151 (271)
T ss_dssp             ECCC--CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred             EecCCceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence            99999999999999999999988533   6899999999999999999999987445899999999999986        


Q ss_pred             CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011180          280 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       280 ~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  359 (491)
                      ++.+||+|||++........    ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......   ...
T Consensus       152 ~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~  224 (271)
T 3dtc_A          152 NKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---VAY  224 (271)
T ss_dssp             SCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHH
T ss_pred             CcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence            77899999999986643221    23579999999999999999999999999999999999999996532111   100


Q ss_pred             hhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          360 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      .             ..........+...+..+.+|+.+||+.||.+|||+.+++++|+.+
T Consensus       225 ~-------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          225 G-------------VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             H-------------HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             h-------------hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            0             0001111122334478899999999999999999999999999764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.1e-46  Score=364.29  Aligned_cols=257  Identities=23%  Similarity=0.370  Sum_probs=208.1

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ..++|++.+.||+|+||.||+|.+.          ++..||||++..... ..+++.+|+.++..++||||+++++++.+
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   90 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK   90 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence            3457999999999999999999875          356799999986643 35678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~  166 (283)
T 3gen_A           91 QRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGL  166 (283)
T ss_dssp             SSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred             CCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccc
Confidence            999999999999999999997643 26899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +........ .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.......   ........     
T Consensus       167 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~-----  237 (283)
T 3gen_A          167 SRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQG-----  237 (283)
T ss_dssp             GGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHHHHTT-----
T ss_pred             ccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HHHHHhcc-----
Confidence            986643221 11223456788999999999999999999999999999998 999996543211   11111000     


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                               .....+...+..+.+||.+||+.||.+|||+.+++++|..+.
T Consensus       238 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          238 ---------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence                     011112223678999999999999999999999999998764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.1e-46  Score=365.23  Aligned_cols=260  Identities=23%  Similarity=0.367  Sum_probs=208.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|.+.+.||+|+||.||+|.+...+..  ....+..||+|++........+.+.+|+.+|+.++||||+++++++.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDY--GQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGG--GCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEeccccc--ccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            35799999999999999999998763210  0001357999999776656667899999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC--------e
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--------A  283 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~--------~  283 (491)
                      +..++||||+++++|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.        +
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence            999999999999999999977542 4899999999999999999999988   999999999999988887        9


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||+|||++......      ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+.......  .......
T Consensus       161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~~~~~  232 (289)
T 4fvq_A          161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQFYE  232 (289)
T ss_dssp             EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHH
T ss_pred             eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHHHHhh
Confidence            99999998765321      23568999999999987 779999999999999999999665543321111  1111000


Q ss_pred             cccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                          ..        .    .++...+..+.+||.+||+.||.+|||+.+++++|+.+..
T Consensus       233 ----~~--------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          233 ----DR--------H----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             ----TT--------C----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             ----cc--------C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence                00        0    0111124567899999999999999999999999998855

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-45  Score=383.65  Aligned_cols=267  Identities=23%  Similarity=0.313  Sum_probs=189.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||+|+||+||+|++..         ++..||||++....  ....+.+.+|+.+|+.|+|||||++++++..
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  123 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKL---------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIP  123 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC-----------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             CCeEEeeEeeecCCeEEEEEEECC---------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence            579999999999999999999876         67799999996542  2345678999999999999999999999854


Q ss_pred             c-----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          211 D-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       211 ~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      .     ..+||||||+ +++|.+++....  .+++..+..++.||+.||+|||+.+   ||||||||+||||+.++.+||
T Consensus       124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl  197 (458)
T 3rp9_A          124 KDVEKFDELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKV  197 (458)
T ss_dssp             SCTTTCCCEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEE
T ss_pred             CCcccCceEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEee
Confidence            3     5689999998 679999986653  6899999999999999999999988   999999999999999999999


Q ss_pred             eccCCcccCCCCCCc-------------------------eeeeccccCCCCCCchhh-hcCCCCccccchhHHHHHHHH
Q 011180          286 SDFGLAKDAPEDGKT-------------------------HVSTRVMGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEM  339 (491)
Q Consensus       286 ~DFGla~~~~~~~~~-------------------------~~~~~~~Gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~el  339 (491)
                      +|||+++........                         ...+..+||+.|+|||++ .+..|+.++||||||||||||
T Consensus       198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el  277 (458)
T 3rp9_A          198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL  277 (458)
T ss_dssp             CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence            999999876432111                         122446899999999976 466799999999999999999


Q ss_pred             Hh-----------CCCCCCCCCCCCc-----------------chhhHhhhcccCCc-------------cchhhccCc-
Q 011180          340 LT-----------GRRSMDKNRPNGE-----------------HNLVEWARPHLGDK-------------RRFYRLLDP-  377 (491)
Q Consensus       340 lt-----------G~~pf~~~~~~~~-----------------~~~~~~~~~~~~~~-------------~~~~~~~~~-  377 (491)
                      ++           |+++|.+......                 ..........++..             ..+...+.. 
T Consensus       278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~  357 (458)
T 3rp9_A          278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR  357 (458)
T ss_dssp             HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred             HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence            99           6666654331100                 00000000000000             000000000 


Q ss_pred             ---cccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          378 ---RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       378 ---~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         .+.. .....+..+.+||.+||..||.+|||++|+|+|
T Consensus       358 ~~~~~~~-~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          358 EGTDLAE-RFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             CCCCGGG-GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCHHH-HCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence               0000 112236789999999999999999999999987

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-46  Score=374.77  Aligned_cols=254  Identities=25%  Similarity=0.376  Sum_probs=200.5

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCC--Cceeeeee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLH--PNLVKLVG  206 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~H--pnIv~l~~  206 (491)
                      ..++|++.+.||+|+||.||+|.+.          ++..||||++.....  ...+.+.+|+.+|..+.|  +||+++++
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   76 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   76 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEee
Confidence            4567999999999999999999864          467899999976543  234678899999999986  99999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      ++.+.+..+||||+ .+++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+ ++.+||+
T Consensus        77 ~~~~~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~  149 (343)
T 3dbq_A           77 YEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLI  149 (343)
T ss_dssp             EEECSSEEEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEEC
T ss_pred             eEeeCCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEe
Confidence            99999999999995 5889999998764  6889999999999999999999988   99999999999997 6789999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  355 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~  355 (491)
                      |||+++..............+||+.|+|||++.+           ..++.++|||||||++|||++|+.||......   
T Consensus       150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---  226 (343)
T 3dbq_A          150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---  226 (343)
T ss_dssp             CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred             ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---
Confidence            9999987755443333445689999999999875           67899999999999999999999999643211   


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                        ..          .+...+++.....++...+..+.+||.+||+.||.+|||+.+++++.
T Consensus       227 --~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          227 --IS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             --HH----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --HH----------HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence              00          01112222222233334467899999999999999999999999874

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=366.00  Aligned_cols=269  Identities=25%  Similarity=0.334  Sum_probs=204.1

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-----ccHHHHHHHHHHHhcCC---CCce
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGNLL---HPNL  201 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~---HpnI  201 (491)
                      ...++|++.+.||+|+||+||+|++..         ++..||||++.....     .....+.+|+.+++.+.   ||||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni   76 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV   76 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTT---------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTB
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCe
Confidence            446789999999999999999998765         677999999864321     12346677888777765   9999


Q ss_pred             eeeeeEEeecC-----ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 011180          202 VKLVGYCIEDD-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       202 v~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NIL  276 (491)
                      +++++++....     ..++||||+. ++|.+++.......+++..+..++.||+.||+|||+.+   |+||||||+|||
T Consensus        77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil  152 (308)
T 3g33_A           77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENIL  152 (308)
T ss_dssp             CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEE
T ss_pred             EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence            99999998765     4789999995 69999998776556999999999999999999999998   999999999999


Q ss_pred             ECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011180          277 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  356 (491)
Q Consensus       277 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~  356 (491)
                      ++.++.+||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|+|++|++||..........
T Consensus       153 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  229 (308)
T 3g33_A          153 VTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG  229 (308)
T ss_dssp             ECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH
T ss_pred             EcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999987643322   244689999999999999999999999999999999999999997643322111


Q ss_pred             hhHhhhcccCCccchh-------hccCc---cccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          357 LVEWARPHLGDKRRFY-------RLLDP---RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       357 ~~~~~~~~~~~~~~~~-------~~~~~---~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+...... .....+.       ..+.+   ..........+..+.+||.+||+.||.+|||+.+++++
T Consensus       230 ~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          230 KIFDLIGL-PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHHHHCC-CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhCC-CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            11000000 0000000       00000   00000112236789999999999999999999999976

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.1e-45  Score=361.50  Aligned_cols=265  Identities=17%  Similarity=0.188  Sum_probs=213.8

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      ..++|.+.+.||+|+||.||+|.+..         ++..||||++....  ..+.+.+|+.++..+ .|+||+++++++.
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~   76 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ   76 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence            35679999999999999999999865         67899999986543  234578899999999 7999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC-----eE
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-----AK  284 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~-----~k  284 (491)
                      +....++||||+ +++|.+++...+. .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.     +|
T Consensus        77 ~~~~~~lv~e~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~k  151 (298)
T 1csn_A           77 EGLHNVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIY  151 (298)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEE
T ss_pred             CCceeEEEEEec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEE
Confidence            999999999999 9999999976543 6899999999999999999999988   999999999999987766     99


Q ss_pred             EeccCCcccCCCCCCc-----eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011180          285 LSDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       285 L~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  359 (491)
                      |+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus       152 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  231 (298)
T 1csn_A          152 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE  231 (298)
T ss_dssp             ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred             EEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHH
Confidence            9999999876543221     11234679999999999999999999999999999999999999997754433322222


Q ss_pred             hhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          360 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ........ ...     +.+    ....+..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       232 ~~~~~~~~-~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          232 RIGEKKQS-TPL-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHHHHHHH-SCH-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHhhccC-ccH-----HHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            11100000 000     000    11236789999999999999999999999999987654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.1e-46  Score=378.07  Aligned_cols=249  Identities=24%  Similarity=0.329  Sum_probs=200.3

Q ss_pred             cCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEE
Q 011180          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL  216 (491)
Q Consensus       137 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  216 (491)
                      ..++||+|+||.||+|.+..         +|..||||++........+.+.+|+.+|..|+||||+++++++.+.+..+|
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETA---------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             EEEECC-----CEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEecCcCEEEEEEEEcC---------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            35789999999999999876         677999999987766666789999999999999999999999999999999


Q ss_pred             EEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE--CCCCCeEEeccCCcccC
Q 011180          217 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--DADYNAKLSDFGLAKDA  294 (491)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl--~~~~~~kL~DFGla~~~  294 (491)
                      ||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++..
T Consensus       164 v~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             EEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence            999999999999887653 36889999999999999999999988   9999999999999  56789999999999876


Q ss_pred             CCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          295 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       295 ~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .....   ....+||+.|+|||++.+..++.++|||||||++|||++|..||........  +.........        
T Consensus       240 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i~~~~~~--------  306 (373)
T 2x4f_A          240 KPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNILACRWD--------  306 (373)
T ss_dssp             CTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHTCCC--------
T ss_pred             CCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCC--------
Confidence            54322   2335799999999999999999999999999999999999999975432111  1111100000        


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          +........+..+.+||.+||+.||.+|||+.+++++
T Consensus       307 ----~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          307 ----LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             ----SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                0000011236789999999999999999999999985

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.8e-46  Score=376.18  Aligned_cols=277  Identities=23%  Similarity=0.265  Sum_probs=215.1

Q ss_pred             hchhhhhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC--
Q 011180          120 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL--  197 (491)
Q Consensus       120 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--  197 (491)
                      ...+.+.+.....++|.+.+.||+|+||.||+|++..         ++..||||++.... .....+..|+.+++.+.  
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~   91 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---------NKKYYAVKVVRNIK-KYTRSAKIEADILKKIQND   91 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---------CCeEEEEEEeccch-hhhhhhHHHHHHHHHhccc
Confidence            3456666777778899999999999999999999875         57799999997432 33456778999999986  


Q ss_pred             ---CCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 011180          198 ---HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  274 (491)
Q Consensus       198 ---HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~N  274 (491)
                         ||||+++++++...+..+|||||+ +++|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|
T Consensus        92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N  167 (360)
T 3llt_A           92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPEN  167 (360)
T ss_dssp             STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCccc
Confidence               999999999999999999999999 999999998776557999999999999999999999988   9999999999


Q ss_pred             EEECC-------------------------CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccc
Q 011180          275 ILLDA-------------------------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDV  329 (491)
Q Consensus       275 ILl~~-------------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~Dv  329 (491)
                      |||+.                         ++.+||+|||+++.....     ....+||+.|+|||++.+..++.++||
T Consensus       168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di  242 (360)
T 3llt_A          168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDM  242 (360)
T ss_dssp             EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred             EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccch
Confidence            99975                         789999999999865432     234679999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc-------hhhcc-CccccCC-------------------
Q 011180          330 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR-------FYRLL-DPRLEGH-------------------  382 (491)
Q Consensus       330 wSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~-~~~l~~~-------------------  382 (491)
                      |||||++|+|++|+.||...........+............       ....+ ...+...                   
T Consensus       243 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  322 (360)
T 3llt_A          243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP  322 (360)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc
Confidence            99999999999999999764332211111111100000000       00000 0000000                   


Q ss_pred             -CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          383 -FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       383 -~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       +....+..+.+||.+||+.||.+|||+.|+|++
T Consensus       323 ~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             001113678899999999999999999999865

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.6e-46  Score=389.19  Aligned_cols=250  Identities=30%  Similarity=0.393  Sum_probs=199.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++....   ......+.+|+.+|+.++||||+++++++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~  217 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF  217 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcC---------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence            4579999999999999999999876         67899999997542   22345678899999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      .+.+..+|||||+++|+|.+++....  .+++..+..++.||+.||+|||+ .+   ||||||||+||||+.++.+||+|
T Consensus       218 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~D  292 (446)
T 4ejn_A          218 QTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITD  292 (446)
T ss_dssp             EETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECC
T ss_pred             eeCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEcc
Confidence            99999999999999999999997654  68999999999999999999998 77   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ||+++.......  .....+||+.|+|||++.+..++.++|||||||+||||++|+.||......   .+....   ...
T Consensus       293 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i---~~~  364 (446)
T 4ejn_A          293 FGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELI---LME  364 (446)
T ss_dssp             CCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHC
T ss_pred             CCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHH---HhC
Confidence            999986543322  234478999999999999999999999999999999999999999654221   111110   000


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                      .            ..++...+..+.+||.+||+.||.+||     ++.++++|
T Consensus       365 ~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          365 E------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             C------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            0            012223467899999999999999999     99999876

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.5e-45  Score=377.45  Aligned_cols=269  Identities=21%  Similarity=0.255  Sum_probs=207.5

Q ss_pred             cCCCcCcccccC--CceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          133 RNFRPESLLGEG--GFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       133 ~~y~~~~~lG~G--~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ++|++.+.||+|  +||.||+|++..         +|..||||++.....  ...+.+.+|+.+|+.++|||||++++++
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   95 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKP---------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF   95 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence            479999999999  999999999876         677999999976532  2345678899999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..|||||||++|+|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~df  172 (389)
T 3gni_B           96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGL  172 (389)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCG
T ss_pred             EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence            99999999999999999999998765557999999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCc-----eeeeccccCCCCCCchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          289 GLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       289 Gla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      |++.........     ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........  ..
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--~~  250 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--KL  250 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH--C-
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--Hh
Confidence            998654322111     11122478999999999987  5799999999999999999999999976443322111  00


Q ss_pred             hcccC---Ccc-----c-------------hhhcc---------CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHH
Q 011180          362 RPHLG---DKR-----R-------------FYRLL---------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE  411 (491)
Q Consensus       362 ~~~~~---~~~-----~-------------~~~~~---------~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~e  411 (491)
                      .....   +..     .             +...+         .......+....+..+.+||.+||+.||.+|||+.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e  330 (389)
T 3gni_B          251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST  330 (389)
T ss_dssp             -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence            00000   000     0             00000         000000122334678999999999999999999999


Q ss_pred             HHHH
Q 011180          412 VVET  415 (491)
Q Consensus       412 vl~~  415 (491)
                      ++++
T Consensus       331 ll~h  334 (389)
T 3gni_B          331 LLNH  334 (389)
T ss_dssp             HTTS
T ss_pred             HhcC
Confidence            9976

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.2e-46  Score=390.44  Aligned_cols=261  Identities=26%  Similarity=0.412  Sum_probs=213.3

Q ss_pred             HHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       128 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      +.+..++|.+.+.||+|+||.||+|.+.          .+..||||+++... ...+.+.+|+.+|+.|+|||||+++++
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~  251 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYN----------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV  251 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEEC----------CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            3445568999999999999999999885          35689999998654 456789999999999999999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +. .+..+||||||++|+|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus       252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~D  327 (454)
T 1qcf_A          252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD  327 (454)
T ss_dssp             EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECS
T ss_pred             Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEee
Confidence            86 567899999999999999997654346888999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      ||+++....... .......+|+.|+|||++....++.++|||||||+||||++ |+.||......   .........  
T Consensus       328 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~~~--  401 (454)
T 1qcf_A          328 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERG--  401 (454)
T ss_dssp             TTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHHHT--
T ss_pred             CCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC--
Confidence            999987643211 11123446788999999999999999999999999999999 99999654321   111111100  


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                  .....+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       402 ------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          402 ------------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ------------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                        0011123447889999999999999999999999999998754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=368.41  Aligned_cols=263  Identities=24%  Similarity=0.397  Sum_probs=205.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|++.+.||+|+||.||+|.+...+..     ....||+|.+.... ....+.+.+|+.+|+.++||||+++++++..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCS-----CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCce-----EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence            45799999999999999999998764321     23357888875442 3456789999999999999999999999987


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .. .++||||+.+|+|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        89 ~~-~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           89 ST-VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             SS-EEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             CC-ceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcc
Confidence            54 7899999999999999977543 6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+..         
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~---------  234 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---------  234 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---------
T ss_pred             eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---------
Confidence            987654433333344567889999999999999999999999999999999 9999976533222111110         


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                              ......+...+..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus       235 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          235 --------GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             --------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                    00111223346789999999999999999999999999987654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=9.7e-46  Score=380.58  Aligned_cols=253  Identities=22%  Similarity=0.280  Sum_probs=195.8

Q ss_pred             cCCCcC-cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhc-CCCCceeeeeeEEee
Q 011180          133 RNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN-LLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~  210 (491)
                      ++|.+. ++||+|+||+||+|.+..         ++..||||++...     ..+.+|+.++.+ ++||||++++++|..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~---------~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~  126 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN  126 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECC---------CCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence            457666 789999999999999876         6779999999632     457788888744 579999999999876


Q ss_pred             ----cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---CCCe
Q 011180          211 ----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNA  283 (491)
Q Consensus       211 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~---~~~~  283 (491)
                          .+.+|||||||++|+|.+++...+...+++..+..|+.||+.||.|||+.+   |+||||||+||||+.   ++.+
T Consensus       127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~  203 (400)
T 1nxk_A          127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL  203 (400)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCE
T ss_pred             cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccE
Confidence                567899999999999999998766557999999999999999999999988   999999999999987   7899


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch-hhHhhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWAR  362 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~  362 (491)
                      ||+|||+++......   .....+||+.|+|||++.+..|+.++|||||||+||||++|..||.......... ......
T Consensus       204 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~  280 (400)
T 1nxk_A          204 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  280 (400)
T ss_dssp             EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred             EEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence            999999998664322   2235689999999999999999999999999999999999999997654332111 111100


Q ss_pred             cccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      .  ..         ..+........+..+.+||.+||..||.+|||+.+++++-
T Consensus       281 ~--~~---------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          281 M--GQ---------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             H--TC---------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             c--Cc---------ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0  00         0000001123467899999999999999999999999874

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.5e-45  Score=361.76  Aligned_cols=266  Identities=23%  Similarity=0.307  Sum_probs=201.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.+.||+|+||.||+|.+.          +|..||||++......  ....+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence            47999999999999999999873          5678999999755322  23678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..++||||++ ++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           72 KKRLVLVFEHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             CCeEEEEEEecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECcc
Confidence            999999999996 49999887653 36889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hhcc-cCC
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-ARPH-LGD  367 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-~~~~-~~~  367 (491)
                      +........  ......||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+.. .... ...
T Consensus       147 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (288)
T 1ob3_A          147 ARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN  224 (288)
T ss_dssp             HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhh
Confidence            986543211  1234578999999999876 4689999999999999999999999975432111111000 0000 000


Q ss_pred             ccch--hhccCccc-------cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRF--YRLLDPRL-------EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~--~~~~~~~l-------~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ....  ....++.+       ...+....+..+.+||.+||+.||.+|||+.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000  00001110       111122346789999999999999999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=385.40  Aligned_cols=264  Identities=22%  Similarity=0.281  Sum_probs=210.9

Q ss_pred             hhhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCc
Q 011180          124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPN  200 (491)
Q Consensus       124 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~Hpn  200 (491)
                      .+.+.....++|.+.+.||+|+||.||+|+++.         +|+.||||++.+...   ...+.+.+|+.+|..++|||
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~---------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~  122 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW  122 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTT
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCC
Confidence            345556677899999999999999999999875         678999999975321   12234788999999999999


Q ss_pred             eeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 011180          201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  280 (491)
Q Consensus       201 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~  280 (491)
                      |+++++++.+.+..||||||+++|+|.+++.+.+. .+++..+..++.||+.||.|||+.+   ||||||||+||||+.+
T Consensus       123 Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~  198 (412)
T 2vd5_A          123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC  198 (412)
T ss_dssp             BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred             eeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCC
Confidence            99999999999999999999999999999976532 6899999999999999999999988   9999999999999999


Q ss_pred             CCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhh-------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 011180          281 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG  353 (491)
Q Consensus       281 ~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~  353 (491)
                      +.+||+|||+++....... ......+||+.|+|||++.       ...|+.++|||||||++|||++|+.||.......
T Consensus       199 g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~  277 (412)
T 2vd5_A          199 GHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE  277 (412)
T ss_dssp             SCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             CCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999987654332 2223468999999999997       3578999999999999999999999997543221


Q ss_pred             cchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 011180          354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR---PRMSEVVET  415 (491)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~R---Pt~~evl~~  415 (491)
                      ....+......         ..-+.    +....+.++.+||.+||. +|.+|   |++++|++|
T Consensus       278 ~~~~i~~~~~~---------~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          278 TYGKIVHYKEH---------LSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHHHHTHHHH---------CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHHHHhcccC---------cCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            11111000000         00010    112237889999999998 99998   589999876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.4e-45  Score=361.65  Aligned_cols=261  Identities=26%  Similarity=0.379  Sum_probs=201.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+           ++..||||++...   ....+.+|.+++..  ++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~   72 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDM   72 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence            45799999999999999999987           4678999999654   34556667777666  78999999999876


Q ss_pred             ec----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEEE
Q 011180          210 ED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH--------EEAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       210 ~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~~~iiHrDlKp~NILl  277 (491)
                      ..    ...++||||+++|+|.+++...   .+++..++.++.||+.||.|||        +.+   |+||||||+|||+
T Consensus        73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill  146 (301)
T 3q4u_A           73 TSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILV  146 (301)
T ss_dssp             EEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEE
T ss_pred             cccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEE
Confidence            53    4579999999999999999543   6899999999999999999999        766   9999999999999


Q ss_pred             CCCCCeEEeccCCcccCCCCCCce--eeeccccCCCCCCchhhhcC------CCCccccchhHHHHHHHHHhC-------
Q 011180          278 DADYNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTG-------  342 (491)
Q Consensus       278 ~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG-------  342 (491)
                      +.++.+||+|||+++.........  .....+||+.|+|||++.+.      .++.++|||||||++|||++|       
T Consensus       147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence            999999999999997654332221  12234799999999999876      455799999999999999999       


Q ss_pred             ---CCCCCCCCCCCcchhhHhhhcccCCccchhhccCccc-cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          343 ---RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL-EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       343 ---~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                         ..||.............. ......      ...+.+ ...++...+..+.+||.+||+.||.+|||+.+|++.|+.
T Consensus       227 ~~~~~pf~~~~~~~~~~~~~~-~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDPSFEDMR-KVVCVD------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHH-HHHTTS------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccccccccCCCCcchhhhh-HHHhcc------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence               788865443332211110 000000      000111 111223457889999999999999999999999999986


Q ss_pred             C
Q 011180          419 L  419 (491)
Q Consensus       419 l  419 (491)
                      +
T Consensus       300 i  300 (301)
T 3q4u_A          300 I  300 (301)
T ss_dssp             H
T ss_pred             c
Confidence            4

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.1e-45  Score=360.94  Aligned_cols=262  Identities=28%  Similarity=0.472  Sum_probs=197.9

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      +..++|++.+.||+|+||.||+|.+..            .||||++.....  ...+.+.+|+.+|+.++||||++++++
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS------------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC------------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence            345689999999999999999997643            599999976543  334678899999999999999999996


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      + .....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~D  163 (289)
T 3og7_A           89 S-TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGD  163 (289)
T ss_dssp             E-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECC
T ss_pred             c-cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEcc
Confidence            5 5567899999999999999986553 36899999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      ||++................||+.|+|||++.   +..++.++|||||||++|+|++|+.||.......  .........
T Consensus       164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~  241 (289)
T 3og7_A          164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRG  241 (289)
T ss_dssp             CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHHT
T ss_pred             ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhccc
Confidence            99998664433333334567999999999986   5678889999999999999999999996543221  111111110


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                               ...+. .......++..+.+||.+||..||.+|||+.++++.|+.+.
T Consensus       242 ---------~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          242 ---------SLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ---------SCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ---------ccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                     00010 01122334688999999999999999999999999998774

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.4e-45  Score=362.06  Aligned_cols=265  Identities=25%  Similarity=0.310  Sum_probs=201.0

Q ss_pred             cCCCcC-cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 011180          133 RNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  210 (491)
                      +.|.+. ++||+|+||.||+|.+..         ++..||||++..........+.+|+.+|.++ .||||+++++++.+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~   82 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLI---------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE   82 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSS---------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcC---------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            468884 789999999999998765         6779999999876555667899999999985 69999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC---eEEec
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSD  287 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~---~kL~D  287 (491)
                      .+..+|||||+++++|.+++....  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.   +||+|
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~D  157 (316)
T 2ac3_A           83 EDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICD  157 (316)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEE
Confidence            999999999999999999997754  6889999999999999999999988   999999999999988765   99999


Q ss_pred             cCCcccCCCCCCc-----eeeeccccCCCCCCchhhhc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011180          288 FGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  357 (491)
Q Consensus       288 FGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~-----~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~  357 (491)
                      ||++.........     ......+||+.|+|||++.+     ..++.++|||||||++|||++|..||...........
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  237 (316)
T 2ac3_A          158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD  237 (316)
T ss_dssp             TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred             ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence            9999865422111     11223569999999999875     5688999999999999999999999976543321100


Q ss_pred             hHhhhcccCCccchh-hccCccccCCCC----hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          358 VEWARPHLGDKRRFY-RLLDPRLEGHFS----IKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       358 ~~~~~~~~~~~~~~~-~~~~~~l~~~~~----~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .......  ....+. .+....  ..++    ...+..+.+||.+||..||.+|||+.+++++
T Consensus       238 ~~~~~~~--~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          238 RGEACPA--CQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             ---CCHH--HHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccccchh--HHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0000000  000000 000000  0011    1236789999999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.3e-45  Score=366.30  Aligned_cols=256  Identities=24%  Similarity=0.367  Sum_probs=197.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++.......   ...+.+|+.++..++||||+++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   81 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLR---------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   81 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECC---------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence            3579999999999999999999865         67899999997654322   35688999999999999999999998


Q ss_pred             eecCce----EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          209 IEDDQR----LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       209 ~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      ......    ||||||+++++|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+|
T Consensus        82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k  156 (311)
T 3ork_A           82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK  156 (311)
T ss_dssp             EEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEE
T ss_pred             eccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEE
Confidence            876544    99999999999999997664  6899999999999999999999988   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          285 LSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       285 L~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      |+|||+++........ ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.........  ..... 
T Consensus       157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~-  233 (311)
T 3ork_A          157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--YQHVR-  233 (311)
T ss_dssp             ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHH-
T ss_pred             EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhc-
Confidence            9999999876543222 1223467999999999999999999999999999999999999999654321110  00000 


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         ........        .....+..+.+||.+||+.||.+||+..+++.+
T Consensus       234 ---~~~~~~~~--------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          234 ---EDPIPPSA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             ---CCCCCHHH--------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ---CCCCCccc--------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence               00000000        011236789999999999999999987776654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.9e-46  Score=370.03  Aligned_cols=271  Identities=25%  Similarity=0.404  Sum_probs=215.7

Q ss_pred             hHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeee
Q 011180          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLV  205 (491)
Q Consensus       127 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~  205 (491)
                      ++.+..++|.+.+.||+|+||.||+|.+...    ....++..||||++..... .....+.+|+.+|+.+.||||++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            3445567899999999999999999987631    0111467899999976532 3345688999999999999999999


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRKG--------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl  277 (491)
                      +++.+.+..++||||+++|+|.+++....        ...+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence            99999999999999999999999986532        135789999999999999999999988   9999999999999


Q ss_pred             CCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcch
Q 011180          278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN  356 (491)
Q Consensus       278 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~  356 (491)
                      +.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......   .
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~  248 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---Q  248 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---H
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---H
Confidence            9999999999999986644332222334567899999999999999999999999999999999 88888653211   1


Q ss_pred             hhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      .......   ..           ....+...+..+.+||.+||..||.+|||+.+++++|+.+..
T Consensus       249 ~~~~~~~---~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 VLRFVME---GG-----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHHT---TC-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHc---CC-----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1111100   00           001122346789999999999999999999999999987644

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.7e-45  Score=367.41  Aligned_cols=252  Identities=24%  Similarity=0.414  Sum_probs=198.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||+|+||.||+|++..         +|..||||++..... ...+.+.+|+.+|+.|+||||++++++|.+.
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   76 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLET   76 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETT---------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEEC
T ss_pred             hcCceeeEecCCCCeEEEEEEEcC---------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEe
Confidence            469999999999999999999875         677999999975443 3456789999999999999999999998765


Q ss_pred             Cc---------------------------------------------------------eEEEEEecCCCChHHHhhhCC
Q 011180          212 DQ---------------------------------------------------------RLLVYEFMPRGSLENHLFRKG  234 (491)
Q Consensus       212 ~~---------------------------------------------------------~~lV~E~~~~gsL~~~l~~~~  234 (491)
                      ..                                                         .++|||||++++|.+++....
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  156 (332)
T 3qd2_B           77 PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC  156 (332)
T ss_dssp             CSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC
T ss_pred             ccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc
Confidence            42                                                         799999999999999997654


Q ss_pred             C-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCc----------eee
Q 011180          235 S-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT----------HVS  303 (491)
Q Consensus       235 ~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~~  303 (491)
                      . ....+..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++........          ...
T Consensus       157 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T 3qd2_B          157 SLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH  233 (332)
T ss_dssp             SGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred             CccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence            3 23566678899999999999999988   999999999999999999999999999876543211          112


Q ss_pred             eccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCC
Q 011180          304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF  383 (491)
Q Consensus       304 ~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  383 (491)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|..|+...     .........             ..+ ...
T Consensus       234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~~-------------~~~-~~~  294 (332)
T 3qd2_B          234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVRN-------------LKF-PLL  294 (332)
T ss_dssp             CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHHT-------------TCC-CHH
T ss_pred             cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhhc-------------cCC-Ccc
Confidence            3457999999999999999999999999999999999987654210     000000000             000 000


Q ss_pred             ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          384 SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       384 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ....+..+.+||.+||+.||.+|||+.+++++
T Consensus       295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            11234677999999999999999999999976

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.3e-45  Score=355.83  Aligned_cols=254  Identities=24%  Similarity=0.336  Sum_probs=207.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||+|+||.||+|.+.           +..||||++.....  ...+.+.+|+.+++.++||||+++++++.+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS   78 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence            47999999999999999999873           56899999976542  334678999999999999999999999988


Q ss_pred             c--CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          211 D--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       211 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .  +..++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.++|+||
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~  157 (271)
T 3kmu_A           79 PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMA  157 (271)
T ss_dssp             TTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred             CCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEec
Confidence            7  78899999999999999998776556899999999999999999999865 45999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCc---cccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS---KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~---~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      |++.....       ....||+.|+|||++.+..++.   ++|||||||++|||++|+.||........   ...   . 
T Consensus       158 ~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~---~-  223 (271)
T 3kmu_A          158 DVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---GMK---V-  223 (271)
T ss_dssp             GSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH---HHH---H-
T ss_pred             cceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH---HHH---H-
Confidence            88765322       2246899999999998765554   79999999999999999999965322111   000   0 


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                               ........++...+..+.+|+.+||+.||.+|||+.++++.|+.+.+
T Consensus       224 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          224 ---------ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ---------HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ---------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                     00001112223347889999999999999999999999999987653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.5e-45  Score=367.96  Aligned_cols=269  Identities=24%  Similarity=0.387  Sum_probs=215.0

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||+|+||.||+|.+.....  ....++..||||++..... ...+.+.+|+.+|..+ .||||+++++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            34679999999999999999999863221  1123577899999976532 3346788999999999 899999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  274 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~N  274 (491)
                      .+.+..++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence            999999999999999999999976532              24889999999999999999999988   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 011180          275 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  353 (491)
Q Consensus       275 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~  353 (491)
                      ||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...... 
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-  266 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-  266 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH-
Confidence            9999999999999999987655433333344567889999999999999999999999999999999 99999654221 


Q ss_pred             cchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                        .+.......              .....+..++..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus       267 --~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          267 --ELFKLLKEG--------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             --HHHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --HHHHHHhcC--------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              111111000              0011223346789999999999999999999999999987744

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.1e-46  Score=370.34  Aligned_cols=276  Identities=28%  Similarity=0.374  Sum_probs=216.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEe--e
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI--E  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~  210 (491)
                      ++|++.+.||+|+||.||+|++...     ...++..||||++........+.+.+|+++|+.++||||+++++++.  +
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPL-----GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTT-----SSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccC-----CCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            5799999999999999999986432     12378899999998776666677999999999999999999999887  4


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ....+|||||+++++|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             CceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccc
Confidence            4568999999999999999976432 5899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCce-eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--cccCC
Q 011180          291 AKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PHLGD  367 (491)
Q Consensus       291 a~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--~~~~~  367 (491)
                      +.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......    ......  .....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~  249 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE----FLRMMGCERDVPA  249 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHCC----CCH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch----hhhhccccccccc
Confidence            98765433222 223356888999999999999999999999999999999999998542110    000000  00000


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      .......+........+...+..+.+||.+||+.||.+|||+.+++++|+.+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             HHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            011111111222223344557889999999999999999999999999987744

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.9e-45  Score=370.51  Aligned_cols=253  Identities=23%  Similarity=0.340  Sum_probs=204.4

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  210 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++......    ..+|+++|.++ .||||+++++++.+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~   87 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKA---------TNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDD   87 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence            3469999999999999999999876         6889999999765432    34688888888 69999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC----CCeEEe
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD----YNAKLS  286 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~----~~~kL~  286 (491)
                      .+..|||||||++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||+..+    +.+||+
T Consensus        88 ~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~  162 (342)
T 2qr7_A           88 GKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRIC  162 (342)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEE
Confidence            999999999999999999997654  6899999999999999999999988   9999999999998433    359999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||++........  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||..........+.......  
T Consensus       163 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--  238 (342)
T 2qr7_A          163 DFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--  238 (342)
T ss_dssp             CCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC--
T ss_pred             ECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC--
Confidence            9999987644322  223468999999999998888999999999999999999999999754322222222111100  


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                               ...+...+....+..+.+||.+||..||.+|||+.+++++
T Consensus       239 ---------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          239 ---------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             ---------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ---------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                     0011112223447889999999999999999999999876

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.1e-45  Score=391.41  Aligned_cols=257  Identities=32%  Similarity=0.443  Sum_probs=213.9

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeee
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVG  206 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~  206 (491)
                      ...++|.+.++||+|+||.||+|++..         +|..||||++.+...   .....+.+|+.+|..++|||||++++
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~  251 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY  251 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEE
Confidence            345679999999999999999999876         678999999965421   23456889999999999999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      ++.+.+..||||||+++|+|.+++...+...+++..++.++.||+.||.|||+.+   ||||||||+||||+.++.+||+
T Consensus       252 ~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~  328 (576)
T 2acx_A          252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRIS  328 (576)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred             EEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEE
Confidence            9999999999999999999999998766556999999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||++........   ....+||+.|+|||++.+..|+.++|||||||++|||++|..||...........+......  
T Consensus       329 DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--  403 (576)
T 2acx_A          329 DLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--  403 (576)
T ss_dssp             CCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--
T ss_pred             ecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--
Confidence            9999987654322   23468999999999999989999999999999999999999999765432221111110000  


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                                  ....++...+..+.+||.+||..||.+||     ++.+|++|
T Consensus       404 ------------~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          404 ------------VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             ------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ------------ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                        01122333478899999999999999999     78999876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.4e-46  Score=371.71  Aligned_cols=267  Identities=26%  Similarity=0.388  Sum_probs=215.0

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||+|+||.||+|.+...+..    ..+..||+|++..... ...+.+.+|+.+|..+ .||||+++++++
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKE----DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSS----CCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcc----cchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            346899999999999999999998653221    1345899999976543 3346788999999999 899999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKG------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NIL  276 (491)
                      .+.+..++||||+++|+|.+++....            ...+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            99999999999999999999986532            235789999999999999999999988   999999999999


Q ss_pred             ECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 011180          277 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  355 (491)
Q Consensus       277 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~  355 (491)
                      ++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||........ 
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-  275 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-  275 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence            99999999999999987654433333344668899999999999999999999999999999998 9999975432211 


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                       ........              .....+...+..+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus       276 -~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          276 -FYKLVKDG--------------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             -HHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHhcC--------------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence             11111100              011112233678999999999999999999999999998653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.8e-46  Score=378.84  Aligned_cols=268  Identities=23%  Similarity=0.333  Sum_probs=195.2

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC--CcccHHHHHHHHHHHhcCC-CCceeeeeeE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLL-HPNLVKLVGY  207 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-HpnIv~l~~~  207 (491)
                      ..++|.+.+.||+|+||.||+|.+..         +|..||||++...  .....+.+.+|+.+|..+. ||||++++++
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~   77 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRR---------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNV   77 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETT---------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeE
Confidence            34689999999999999999999876         6779999998654  2234467889999999997 9999999999


Q ss_pred             EeecC--ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          208 CIEDD--QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       208 ~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      +...+  ..|||||||+ ++|.+++...   .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||
T Consensus        78 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl  150 (388)
T 3oz6_A           78 LRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKV  150 (388)
T ss_dssp             EECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred             EecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEe
Confidence            97654  6899999996 6899988763   6889999999999999999999998   999999999999999999999


Q ss_pred             eccCCcccCCCCC-------------------CceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCC
Q 011180          286 SDFGLAKDAPEDG-------------------KTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRS  345 (491)
Q Consensus       286 ~DFGla~~~~~~~-------------------~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p  345 (491)
                      +|||+++......                   .....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++|
T Consensus       151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  230 (388)
T 3oz6_A          151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI  230 (388)
T ss_dssp             CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence            9999998653211                   1112234689999999999986 6799999999999999999999999


Q ss_pred             CCCCCCCCcchhhHhhhcccCCccchhhcc------------------CccccCC------------CChhhHHHHHHHH
Q 011180          346 MDKNRPNGEHNLVEWARPHLGDKRRFYRLL------------------DPRLEGH------------FSIKGSQKATQLA  395 (491)
Q Consensus       346 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~l~~~------------~~~~~~~~l~~li  395 (491)
                      |...........+... ........+....                  .......            .....+..+.+||
T Consensus       231 f~~~~~~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll  309 (388)
T 3oz6_A          231 FPGSSTMNQLERIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL  309 (388)
T ss_dssp             CCCSSHHHHHHHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHH
Confidence            9765322211111000 0000000000000                  0000000            0112367899999


Q ss_pred             HHhhhcCCCCCCCHHHHHHH
Q 011180          396 AQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       396 ~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+||..||.+|||+.|+++|
T Consensus       310 ~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          310 DKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHCCSSGGGSCCHHHHTTS
T ss_pred             HHhhccCcccCCCHHHHhCC
Confidence            99999999999999999987

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-45  Score=384.48  Aligned_cols=249  Identities=27%  Similarity=0.368  Sum_probs=207.6

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++.....   .....+.+|+.+|+.++||||+++++++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~   85 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHEL---------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI   85 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETT---------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4579999999999999999999875         678999999975422   2345788999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..||||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DF  160 (476)
T 2y94_A           86 STPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADF  160 (476)
T ss_dssp             ECSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEec
Confidence            99999999999999999999997654  6899999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      |++........   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......   .+.....   ..
T Consensus       161 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~---~~  231 (476)
T 2y94_A          161 GLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKIC---DG  231 (476)
T ss_dssp             SSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHHH---TT
T ss_pred             cchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHHh---cC
Confidence            99987654322   234689999999999988765 68999999999999999999999754321   1111110   00


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                ..  ..+...+..+.+||.+||..||.+|||+.+++++
T Consensus       232 ----------~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          232 ----------IF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             ----------CC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ----------Cc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                      00  1112236789999999999999999999999985

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.5e-46  Score=376.89  Aligned_cols=247  Identities=28%  Similarity=0.361  Sum_probs=195.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHH-HhcCCCCceeeeeeEE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNF-LGNLLHPNLVKLVGYC  208 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~i-l~~l~HpnIv~l~~~~  208 (491)
                      ++|.+.+.||+|+||.||+|+++.         ++..||||++.+....   ....+.+|..+ ++.++||||+++++++
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~  108 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKA---------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF  108 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETT---------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence            479999999999999999999876         6779999999765432   23456677776 5778999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..||||||+++|+|.+++...+  .+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+||
T Consensus       109 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DF  183 (373)
T 2r5t_A          109 QTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF  183 (373)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeC
Confidence            99999999999999999999997754  6888999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ..   ...+...
T Consensus       184 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~---~~i~~~~  255 (373)
T 2r5t_A          184 GLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MY---DNILNKP  255 (373)
T ss_dssp             CBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HH---HHHHHSC
T ss_pred             ccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HH---HHHHhcc
Confidence            99986432221  2345789999999999999999999999999999999999999996532211   11   1111000


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  413 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl  413 (491)
                                  ..++...+..+.+||.+||+.||.+||++.+.+
T Consensus       256 ------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          256 ------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             ------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             ------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                        012223467899999999999999999985433

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.1e-45  Score=364.80  Aligned_cols=268  Identities=26%  Similarity=0.412  Sum_probs=203.0

Q ss_pred             hHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeee
Q 011180          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       127 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l  204 (491)
                      ++....++|.+.+.||+|+||.||+|.+..+..      ++..||||++.....  ...+.+.+|+.+++.++||||+++
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~  101 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG------TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL  101 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTS------CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCC------ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeee
Confidence            334456789999999999999999998865332      567899999976532  234678899999999999999999


Q ss_pred             eeEEeecCc-----eEEEEEecCCCChHHHhhhC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 011180          205 VGYCIEDDQ-----RLLVYEFMPRGSLENHLFRK----GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  275 (491)
Q Consensus       205 ~~~~~~~~~-----~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NI  275 (491)
                      ++++.+.+.     .++||||+++++|.+++...    ....+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NI  178 (313)
T 3brb_A          102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNC  178 (313)
T ss_dssp             CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGE
T ss_pred             eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceE
Confidence            999987653     49999999999999998532    2346899999999999999999999988   99999999999


Q ss_pred             EECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCc
Q 011180          276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE  354 (491)
Q Consensus       276 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~  354 (491)
                      |++.++.+||+|||++................|++.|+|||.+.+..++.++|||||||++|+|++ |..||........
T Consensus       179 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  258 (313)
T 3brb_A          179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM  258 (313)
T ss_dssp             EECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence            999999999999999987654333233334567889999999999999999999999999999999 8888865432211


Q ss_pred             chhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                         .......              .....+...+..+.+||.+||..||.+|||+.+++++|+.+.
T Consensus       259 ---~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          259 ---YDYLLHG--------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             ---HHHHHTT--------------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHcC--------------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               1111000              001112234678999999999999999999999999998764

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=371.46  Aligned_cols=253  Identities=26%  Similarity=0.327  Sum_probs=192.7

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ..++|.+.+.||+|+||.||+|.+..         ++..||||++....  ..+.+.+|+.+|..+.||||+++++++.+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~  119 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKG---------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET  119 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECC---------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence            34679999999999999999999875         57789999997653  34567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---CCCeEEec
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSD  287 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~---~~~~kL~D  287 (491)
                      .+..+|||||+++++|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|
T Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          120 PTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEcc
Confidence            999999999999999999997654  5899999999999999999999988   999999999999975   88999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ||+++......   .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......  ......   ...
T Consensus       195 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i---~~~  266 (349)
T 2w4o_A          195 FGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRI---LNC  266 (349)
T ss_dssp             CC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHH---HTT
T ss_pred             CccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHH---HhC
Confidence            99998664321   2234679999999999999999999999999999999999999996543211  011100   000


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..        .....+....+..+.+||.+||..||.+|||+.+++++
T Consensus       267 ~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          267 EY--------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             CC--------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CC--------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00        00111122346789999999999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.1e-45  Score=358.77  Aligned_cols=248  Identities=27%  Similarity=0.435  Sum_probs=204.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++.....   .....+.+|+.+++.++||||+++++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   78 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF   78 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEcc---------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE
Confidence            4579999999999999999999876         577899999865422   2345688999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Df  153 (279)
T 3fdn_A           79 HDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADF  153 (279)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSC
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEec
Confidence            99999999999999999999997654  5889999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..        
T Consensus       154 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------  221 (279)
T 3fdn_A          154 GWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--------  221 (279)
T ss_dssp             CEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------
T ss_pred             cccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh--------
Confidence            9986554322    2345799999999999999999999999999999999999999965422111111100        


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                ....++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       222 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 ----------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ----------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ----------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                      0011222336788999999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.6e-45  Score=376.21  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=199.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCC--CCceeeeeeEE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLL--HPNLVKLVGYC  208 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~--HpnIv~l~~~~  208 (491)
                      ++|.+.+.||+|+||.||+|.+.          .+..||||++.....  ...+.+.+|+.+|..|.  ||||+++++++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~  125 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE  125 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence            46999999999999999999864          366899999976543  33467899999999996  59999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      ...+..||||| +.+++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+ ++.+||+||
T Consensus       126 ~~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DF  198 (390)
T 2zmd_A          126 ITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDF  198 (390)
T ss_dssp             ECSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCC
T ss_pred             ecCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEec
Confidence            99999999999 45889999998764  6888899999999999999999988   99999999999995 579999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  357 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~  357 (491)
                      |+++..............+||+.|+|||++.+           ..++.++|||||||+||||++|..||......     
T Consensus       199 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----  273 (390)
T 2zmd_A          199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----  273 (390)
T ss_dssp             SSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----
T ss_pred             CccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----
Confidence            99987754433333345689999999999875           46889999999999999999999999643211     


Q ss_pred             hHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      ...          +..++++.....++...+..+.+||.+||..||.+|||+.+++++-
T Consensus       274 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          274 ISK----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             HHH----------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHH----------HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence            011          1111222222223333367899999999999999999999999863

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2e-45  Score=364.85  Aligned_cols=271  Identities=28%  Similarity=0.382  Sum_probs=216.9

Q ss_pred             hHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeee
Q 011180          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKL  204 (491)
Q Consensus       127 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l  204 (491)
                      .+....++|++.+.||+|+||.||+|.+....    ...++..||||++..... ...+.+.+|+.++..+ +||||+++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCC----ccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            33445678999999999999999999875311    123678999999976543 2345788999999999 69999999


Q ss_pred             eeEEeecC-ceEEEEEecCCCChHHHhhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 011180          205 VGYCIEDD-QRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD  269 (491)
Q Consensus       205 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrD  269 (491)
                      ++++...+ ..++||||+++++|.+++.....              ..+++..++.++.||+.||.|||+.+   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99988765 48999999999999999976542              12789999999999999999999988   99999


Q ss_pred             CCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 011180          270 FKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDK  348 (491)
Q Consensus       270 lKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~  348 (491)
                      |||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987755444334445678999999999999999999999999999999998 9999965


Q ss_pred             CCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          349 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      ......  .........              ....+...+..+.+||.+||+.||.+|||+.+|+++|+.+.
T Consensus       254 ~~~~~~--~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          254 VKIDEE--FCRRLKEGT--------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CCCSHH--HHHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhHH--HHHHhccCc--------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            432211  111110000              00112223678999999999999999999999999998764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.9e-45  Score=362.80  Aligned_cols=274  Identities=29%  Similarity=0.423  Sum_probs=210.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||+|+||.||+|++....     ..++..||||++.... ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTS-----SSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhccCCCCceEEEEEEEcccc-----CccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            35889999999999999999864322     2278899999997543 23457789999999999999999999999877


Q ss_pred             --CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          212 --DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       212 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                        ...++||||+++++|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccc
Confidence              668999999999999999965533 6899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC--
Q 011180          290 LAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--  366 (491)
Q Consensus       290 la~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~--  366 (491)
                      ++......... .......||..|+|||++.+..++.++|||||||++|+|++|..|+.....    .......+...  
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~  247 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQM  247 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCccccc
Confidence            99877544322 223345688899999999999999999999999999999999988632110    00000000000  


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ....+...+........+...+..+.+||.+||+.||.+|||+.++++.|+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            00001111111111223344578899999999999999999999999999865

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-45  Score=368.18  Aligned_cols=251  Identities=26%  Similarity=0.334  Sum_probs=182.1

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEEeecCceEE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLL  216 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l  216 (491)
                      .+.||+|+||.||+|.+..         ++..||||++...   ....+.+|+.++..+. ||||+++++++.+....||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKK---------SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             SCCSEEETTEEEEEEEETT---------TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCccccCCCeEEEEEEECC---------CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            4789999999999999876         6779999999653   3456788999999997 9999999999999999999


Q ss_pred             EEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC---CeEEeccCCccc
Q 011180          217 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---NAKLSDFGLAKD  293 (491)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~---~~kL~DFGla~~  293 (491)
                      ||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||+++.
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           84 VMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             EECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            999999999999998764  6899999999999999999999988   99999999999997665   899999999986


Q ss_pred             CCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc-hhhHhhhcccCCccchh
Q 011180          294 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPHLGDKRRFY  372 (491)
Q Consensus       294 ~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~  372 (491)
                      ......  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...+.........    
T Consensus       159 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~----  232 (325)
T 3kn6_A          159 KPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD----  232 (325)
T ss_dssp             CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC----
T ss_pred             cCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC----
Confidence            644322  223467899999999999999999999999999999999999999764432111 1111111000000    


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          ..+........+..+.+||.+||..||.+|||+.+++++
T Consensus       233 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          233 ----FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             ----CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             ----CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence                000000111236789999999999999999999998865

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.2e-45  Score=358.45  Aligned_cols=261  Identities=27%  Similarity=0.424  Sum_probs=211.6

Q ss_pred             hHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeee
Q 011180          127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVG  206 (491)
Q Consensus       127 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~  206 (491)
                      ++.+..++|++.+.||+|+||.||+|.+.          .+..||||++.... ...+.+.+|+++|+.++||||+++++
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~   75 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA   75 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEE
Confidence            34455578999999999999999999875          35689999997654 34578899999999999999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      ++. .+..++||||+++++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        76 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~  151 (279)
T 1qpc_A           76 VVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA  151 (279)
T ss_dssp             EEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred             EEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEEC
Confidence            876 456899999999999999996543336889999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhccc
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      |||++........ .......|+..|+|||++.+..++.++|||||||++|||++ |..||......   ......... 
T Consensus       152 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~~-  226 (279)
T 1qpc_A          152 DFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLERG-  226 (279)
T ss_dssp             CCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTT-
T ss_pred             CCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHHhcc-
Confidence            9999987654321 22233457889999999998999999999999999999999 89998654221   111111100 


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                                   .....+...+..+.+|+.+||..||.+|||+.++++.|+.+.
T Consensus       227 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          227 -------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             -------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence                         001112234678999999999999999999999999998763

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.3e-45  Score=355.31  Aligned_cols=251  Identities=23%  Similarity=0.296  Sum_probs=206.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||+|++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKG---------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT   79 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCC---------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            469999999999999999999875         56789999998765566788999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---CCCCCeEEeccC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFG  289 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl---~~~~~~kL~DFG  289 (491)
                      ..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg  154 (277)
T 3f3z_A           80 DIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFG  154 (277)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             eEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence            9999999999999999987654  5889999999999999999999988   9999999999999   788999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++........   .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.......   ........   ..
T Consensus       155 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~---~~  224 (277)
T 3f3z_A          155 LAARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VMLKIREG---TF  224 (277)
T ss_dssp             TCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHC---CC
T ss_pred             cceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhC---CC
Confidence            9987654322   234579999999998765 49999999999999999999999996543211   11111000   00


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+..        ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       225 ~~~~--------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          225 TFPE--------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             CCCH--------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCCc--------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000        0001236789999999999999999999999864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=360.48  Aligned_cols=267  Identities=25%  Similarity=0.334  Sum_probs=201.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++......  ..+.+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   73 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR   73 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence            579999999999999999999876         6779999998665432  24567899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        74 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  148 (311)
T 4agu_A           74 KRRLHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGF  148 (311)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCeEEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCC
Confidence            999999999999999988876553  6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc----
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL----  365 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~----  365 (491)
                      +........  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......    
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (311)
T 4agu_A          149 ARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH  226 (311)
T ss_dssp             CEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             chhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccc
Confidence            987653322  2234579999999999976 678999999999999999999999997654322211111100000    


Q ss_pred             ----CCccchh--hccCccccCC---CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          366 ----GDKRRFY--RLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       366 ----~~~~~~~--~~~~~~l~~~---~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          .....+.  ...++.....   .....+..+.+||.+||+.||.+|||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                0000000  0000000000   001236779999999999999999999999976

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.7e-45  Score=371.30  Aligned_cols=274  Identities=17%  Similarity=0.235  Sum_probs=208.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc-----------HHHHHHHHHHHhcCCCCc
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------HKEWLAEVNFLGNLLHPN  200 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~il~~l~Hpn  200 (491)
                      .++|.+.+.||+|+||.||+|.+.....    ...+..||||++.......           ...+..|+..+..+.|||
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~  109 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSES----VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG  109 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSC----CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccc----cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence            4579999999999999999998865321    1246789999987654211           123456777788889999


Q ss_pred             eeeeeeEEeec----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 011180          201 LVKLVGYCIED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       201 Iv~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NIL  276 (491)
                      |+++++++...    ...+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nil  184 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLL  184 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEE
Confidence            99999998875    4579999999 999999997753 36999999999999999999999988   999999999999


Q ss_pred             EC--CCCCeEEeccCCcccCCCCCCce-----eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 011180          277 LD--ADYNAKLSDFGLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN  349 (491)
Q Consensus       277 l~--~~~~~kL~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~  349 (491)
                      |+  .++.+||+|||+++.........     .....+||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            98  88999999999997664322111     113356999999999999999999999999999999999999999753


Q ss_pred             CCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          350 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      .....  .........  ...+..++++.+.   ....+..+.+|+..||..||.+||++.+|++.|+.+..
T Consensus       265 ~~~~~--~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          265 LKDPK--YVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             TTCHH--HHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccCHH--HHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            32211  111111100  0011112221111   01236789999999999999999999999999987544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.2e-44  Score=376.30  Aligned_cols=200  Identities=29%  Similarity=0.407  Sum_probs=168.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|++..         ++..||||++....  ....+.+.+|+.+|+.++||||+++++++.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~   95 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKN---------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII   95 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence            3579999999999999999999876         67899999997542  234567899999999999999999999998


Q ss_pred             ec-----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          210 ED-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       210 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      ..     ...||||||+. ++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+|
T Consensus        96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~k  169 (432)
T 3n9x_A           96 PDDLLKFDELYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVK  169 (432)
T ss_dssp             CSCTTTCCCEEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred             cCCCCcCCeEEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEE
Confidence            76     56899999995 69999987643  6899999999999999999999998   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCc--------------------eeeeccccCCCCCCchhh-hcCCCCccccchhHHHHHHHHHhCC
Q 011180          285 LSDFGLAKDAPEDGKT--------------------HVSTRVMGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEMLTGR  343 (491)
Q Consensus       285 L~DFGla~~~~~~~~~--------------------~~~~~~~Gt~~y~aPE~~-~~~~~~~~~DvwSlGvil~elltG~  343 (491)
                      |+|||+++........                    ...+..+||+.|+|||++ ....|+.++|||||||+||||++|.
T Consensus       170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~  249 (432)
T 3n9x_A          170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML  249 (432)
T ss_dssp             ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred             EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence            9999999876443211                    122457899999999986 4567999999999999999999865


Q ss_pred             CCC
Q 011180          344 RSM  346 (491)
Q Consensus       344 ~pf  346 (491)
                      .||
T Consensus       250 ~p~  252 (432)
T 3n9x_A          250 QSH  252 (432)
T ss_dssp             TTT
T ss_pred             ccc
Confidence            544

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=362.93  Aligned_cols=246  Identities=27%  Similarity=0.317  Sum_probs=196.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      ++|++.++||+|+||+||+|.+..         +|..||||++.....  .....+..|+..+..+ .||||+++++++.
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~  127 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKE---------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE  127 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT---------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECC---------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence            469999999999999999999876         577999999865432  2234455666666655 8999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..+|||||+ +++|.+++...+ ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          128 EGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCT
T ss_pred             eCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccce
Confidence            999999999999 779999887664 36999999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++.......   ......||+.|+|||++.+ .++.++|||||||++|||++|..+|....     ........      
T Consensus       203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~~~------  267 (311)
T 3p1a_A          203 LLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQLRQG------  267 (311)
T ss_dssp             TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHHHTTT------
T ss_pred             eeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHhcc------
Confidence            998764332   2234569999999998875 79999999999999999999977764321     11110000      


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          ...+    .++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       268 ----~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          268 ----YLPP----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ----CCCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ----CCCc----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence                0000    1112236789999999999999999999999975

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.1e-45  Score=381.55  Aligned_cols=261  Identities=23%  Similarity=0.301  Sum_probs=197.7

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|++.+.||+|+||+||+|++..         ++..||||++...  .....+.+.+|+.+|+.++|||||++++++.
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  131 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT  131 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence            4689999999999999999999876         6789999999764  2233567889999999999999999999997


Q ss_pred             ecC------ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          210 EDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ...      ..||||||+++ +|.+.+..    .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+
T Consensus       132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~  203 (464)
T 3ttj_A          132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  203 (464)
T ss_dssp             SCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred             cCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCE
Confidence            653      46999999965 57666632    4889999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      ||+|||+++......   ..+..+||+.|+|||++.+..|+.++|||||||+||||++|+.||...........+.   .
T Consensus       204 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~---~  277 (464)
T 3ttj_A          204 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI---E  277 (464)
T ss_dssp             EECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H
T ss_pred             EEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---H
Confidence            999999998764322   2344689999999999999999999999999999999999999997653221111110   0


Q ss_pred             ccCC------------------------ccchhhccCccccC---CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGD------------------------KRRFYRLLDPRLEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~------------------------~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .++.                        ...+...+...+..   ......+..+.+||.+||..||.+|||++|+++|
T Consensus       278 ~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000                        00000111000000   0001126789999999999999999999999987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.3e-45  Score=356.24  Aligned_cols=262  Identities=27%  Similarity=0.406  Sum_probs=209.0

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ..++|.+.+.||+|+||.||+|.+....      +++..||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTT------CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCC------CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            3457999999999999999999986532      246679999997653 234567899999999999999999999976


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      + +..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        84 ~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           84 E-EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             C-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccC
Confidence            5 46789999999999999997653 36899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ++......... ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+.   ..  . 
T Consensus       159 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---~~--~-  231 (281)
T 3cc6_A          159 LSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---KG--D-  231 (281)
T ss_dssp             GGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---HT--C-
T ss_pred             CCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---cC--C-
Confidence            99876543221 1233457889999999999999999999999999999998 999996543222111111   00  0 


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                 ....+...+..+.+||.+||..||.+|||+.+++++|+.+..
T Consensus       232 -----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          232 -----------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                       001112236789999999999999999999999999987654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=356.28  Aligned_cols=250  Identities=28%  Similarity=0.422  Sum_probs=186.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|.+..         +|..||||++.....   ...+.+.+|+.+++.++||||+++++++.
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   81 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIH---------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE   81 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEcc---------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence            479999999999999999999865         577999999964421   22467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg  157 (278)
T 3cok_A           82 DSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFG  157 (278)
T ss_dssp             CSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeec
Confidence            9999999999999999999987653 36899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............      ...  
T Consensus       158 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~--  227 (278)
T 3cok_A          158 LATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------VLA--  227 (278)
T ss_dssp             TCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C------CSS--
T ss_pred             ceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH------hhc--
Confidence            99876432221  22357999999999999889999999999999999999999999754332211100      000  


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                            +    ...+...+..+.+||.+||+.||.+|||+.+++++
T Consensus       228 ------~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          228 ------D----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             ------C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ------c----cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                  0    01122336789999999999999999999999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.2e-44  Score=360.95  Aligned_cols=252  Identities=24%  Similarity=0.330  Sum_probs=207.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc------cHHHHHHHHHHHhcCCCCceeeeee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLLHPNLVKLVG  206 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~  206 (491)
                      ++|.+.+.||+|+||.||+|.+..         +|..||||++......      ..+.+.+|+.+|..+.||||+++++
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   82 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD   82 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECC---------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEE
Confidence            469999999999999999999875         6779999999765322      3567899999999999999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC----C
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----N  282 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~----~  282 (491)
                      ++.+.+..++||||+++++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~  157 (321)
T 2a2a_A           83 VYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPH  157 (321)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCC
T ss_pred             EEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCC
Confidence            9999999999999999999999997653  6889999999999999999999988   99999999999999887    7


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      +||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ......
T Consensus       158 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~  231 (321)
T 2a2a_A          158 IKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANIT  231 (321)
T ss_dssp             EEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH
T ss_pred             EEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH
Confidence            99999999987654322   234579999999999999999999999999999999999999996542211   111110


Q ss_pred             cccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...   ..    +++.    +....+..+.+||.+||..||.+|||+.+++++
T Consensus       232 ~~~---~~----~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          232 SVS---YD----FDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             TTC---CC----CCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             hcc---cc----cChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000   00    0000    011236789999999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-44  Score=363.69  Aligned_cols=264  Identities=25%  Similarity=0.424  Sum_probs=205.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ..+|.+.+.||+|+||.||+|.+...+.     ..+..||||++..... .....+.+|+.++..++||||+++++++.+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCC-----CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            3578889999999999999999865321     1345799999976532 234568899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..+|||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~  193 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL  193 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCc
Confidence            999999999999999999997653 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCce-eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          291 AKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       291 a~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ++......... ......||+.|+|||++.+..++.++|||||||++|||++ |..||......   .+.......    
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~~~----  266 (333)
T 1mqb_A          194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAINDG----  266 (333)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT----
T ss_pred             chhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHCC----
Confidence            98765432211 1222456889999999999999999999999999999999 99999654221   111111100    


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                .....+...+..+.+||.+||+.||.+||++.++++.|+.+..
T Consensus       267 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          267 ----------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             ----------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                      0011122346789999999999999999999999999987643

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.7e-45  Score=352.74  Aligned_cols=257  Identities=28%  Similarity=0.436  Sum_probs=211.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|.+.+.||+|+||.||+|.+.          ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   75 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   75 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hhheeeeeEecCCCceeEEEEEec----------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            457999999999999999999885          356899999986643 346789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~  151 (267)
T 3t9t_A           76 APICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMT  151 (267)
T ss_dssp             SSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred             CCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccc
Confidence            99999999999999999997653 36899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      ....... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||......   .........      
T Consensus       152 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~i~~~------  221 (267)
T 3t9t_A          152 RFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVEDISTG------  221 (267)
T ss_dssp             GGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT------
T ss_pred             ccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHHHHhcC------
Confidence            8664321 111223457889999999999999999999999999999999 89998654221   111111100      


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                              .....+...+..+.+|+.+||..||.+|||+.+++++|+.+..
T Consensus       222 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          222 --------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                    0001122236789999999999999999999999999987643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-45  Score=367.12  Aligned_cols=260  Identities=23%  Similarity=0.264  Sum_probs=200.9

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC-----CcccHHHHHHHHHHHhcCCCCceeee
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-----GLQGHKEWLAEVNFLGNLLHPNLVKL  204 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l  204 (491)
                      ...++|.+.+.||+|+||.||+|.+..         ++..||||++...     .....+.+.+|+.+|+.++||||+++
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   93 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQ---------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL   93 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECC---------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence            445679999999999999999998875         6779999998653     22345678999999999999999999


Q ss_pred             eeEEeecCceEEEEEecCCCChHHHhhhCC--------------------------------------CCCCCHHHHHHH
Q 011180          205 VGYCIEDDQRLLVYEFMPRGSLENHLFRKG--------------------------------------SLPLPWSIRMKI  246 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i  246 (491)
                      ++++.+.+..+||||||++|+|.+++....                                      ...+++..++.+
T Consensus        94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  173 (345)
T 3hko_A           94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI  173 (345)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred             ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence            999999999999999999999999885210                                      112356778889


Q ss_pred             HHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC--CeEEeccCCcccCCCCC--CceeeeccccCCCCCCchhhhc--
Q 011180          247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY--NAKLSDFGLAKDAPEDG--KTHVSTRVMGTYGYAAPEYVMT--  320 (491)
Q Consensus       247 ~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~--~~kL~DFGla~~~~~~~--~~~~~~~~~Gt~~y~aPE~~~~--  320 (491)
                      +.||+.||.|||+.+   |+||||||+||||+.++  .+||+|||++.......  .........||+.|+|||++.+  
T Consensus       174 ~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  250 (345)
T 3hko_A          174 MRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN  250 (345)
T ss_dssp             HHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred             HHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence            999999999999988   99999999999998776  89999999998653221  1112344679999999999875  


Q ss_pred             CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhh
Q 011180          321 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLS  400 (491)
Q Consensus       321 ~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~  400 (491)
                      ..++.++|||||||++|||++|+.||..........  ....    ....        +........+..+.+||.+||+
T Consensus       251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~----~~~~--------~~~~~~~~~~~~~~~li~~~l~  316 (345)
T 3hko_A          251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS--QVLN----KKLC--------FENPNYNVLSPLARDLLSNLLN  316 (345)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH----CCCC--------TTSGGGGGSCHHHHHHHHHHSC
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHH--HHHh----cccc--------cCCcccccCCHHHHHHHHHHcC
Confidence            678999999999999999999999996543211111  1000    0000        0000011236789999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 011180          401 RDPKARPRMSEVVET  415 (491)
Q Consensus       401 ~dP~~RPt~~evl~~  415 (491)
                      .||.+|||+.+++++
T Consensus       317 ~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          317 RNVDERFDAMRALQH  331 (345)
T ss_dssp             SCTTTSCCHHHHHHS
T ss_pred             CChhHCCCHHHHhcC
Confidence            999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.6e-45  Score=381.45  Aligned_cols=260  Identities=27%  Similarity=0.401  Sum_probs=207.3

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .+..++|++.+.||+|+||.||+|.+..          +..||||+++... ...+++.+|+.+|+.|+||||+++++++
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~  248 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV  248 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3445679999999999999999998863          4579999998654 3457899999999999999999999998


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+ +..+|||||+++|+|.+++.......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCC
Confidence            76 67899999999999999997543346899999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      |+++....... .......+++.|+|||++.+..++.++|||||||+||||++ |..||......   .........   
T Consensus       325 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~~~---  397 (452)
T 1fmk_A          325 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVERG---  397 (452)
T ss_dssp             CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTT---
T ss_pred             ccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC---
Confidence            99987643321 12223457889999999999999999999999999999999 99999654321   111111100   


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                 .....+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       398 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          398 -----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             -----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence                       0111223457889999999999999999999999999998754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-44  Score=356.97  Aligned_cols=263  Identities=26%  Similarity=0.409  Sum_probs=205.4

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEe-
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCI-  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~-  209 (491)
                      ..+|.+.+.||+|+||.||+|.+.....      ....||+|.+..... ...+.+.+|+.++++++||||+++++++. 
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR   97 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCC------ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence            3468999999999999999999765322      455799999976432 33467889999999999999999999865 


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      .++..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        98 ~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  173 (298)
T 3f66_A           98 SEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG  173 (298)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCG
T ss_pred             CCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccc
Confidence            4567899999999999999997643 36889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCc--eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccC
Q 011180          290 LAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       290 la~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      +++........  .......||+.|+|||.+.+..++.++|||||||++|+|++ |.+||..............   .  
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~---~--  248 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---G--  248 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT---T--
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc---C--
Confidence            99876443211  12234567889999999999999999999999999999999 5556544332221111110   0  


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                       .           ....+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       249 -~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          249 -R-----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             -C-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -C-----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             0           001112236789999999999999999999999999987644

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1e-44  Score=352.60  Aligned_cols=254  Identities=26%  Similarity=0.355  Sum_probs=207.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   77 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cceEEEEEeecCCCcEEEEEEECC---------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC
Confidence            469999999999999999999875         577999999975432 3346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  152 (276)
T 2yex_A           78 NIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA  152 (276)
T ss_dssp             TEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence            99999999999999999986543  6889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      ................||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+....     .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-----~  226 (276)
T 2yex_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKK-----T  226 (276)
T ss_dssp             EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTC-----T
T ss_pred             cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhcc-----c
Confidence            86543332222345679999999999987665 7799999999999999999999976443221 111111100     0


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         ..      ......+..+.+||.+||..||.+|||+.+++++
T Consensus       227 ---~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          227 ---YL------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             ---TS------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---cc------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence               00      0012236788999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-44  Score=359.46  Aligned_cols=269  Identities=23%  Similarity=0.363  Sum_probs=201.9

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC--CCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL--LHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~~~~  208 (491)
                      ..++|++.+.||+|+||.||+|.+           ++..||||++...   ....+.+|.+++..+  .||||+++++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~  100 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKW-----------RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAAD  100 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEE-----------CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence            345799999999999999999987           3668999998643   234455666666655  899999999999


Q ss_pred             eec----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEECC
Q 011180          209 IED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA-----EKPVIYRDFKTSNILLDA  279 (491)
Q Consensus       209 ~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----~~~iiHrDlKp~NILl~~  279 (491)
                      ...    ...++||||+++|+|.+++...   .+++..++.++.|++.||.|||+..     ..+|+||||||+||||+.
T Consensus       101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~  177 (337)
T 3mdy_A          101 IKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK  177 (337)
T ss_dssp             EESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred             ccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence            887    6789999999999999999654   5899999999999999999999870     112999999999999999


Q ss_pred             CCCeEEeccCCcccCCCCCCce--eeeccccCCCCCCchhhhcCCCCcc------ccchhHHHHHHHHHhC---------
Q 011180          280 DYNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTGHLTSK------SDVYSFGVVLLEMLTG---------  342 (491)
Q Consensus       280 ~~~~kL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~~~~~------~DvwSlGvil~elltG---------  342 (491)
                      ++.+||+|||+++.........  .....+||+.|+|||++.+..++..      +|||||||++|||++|         
T Consensus       178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~  257 (337)
T 3mdy_A          178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE  257 (337)
T ss_dssp             TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence            9999999999997664432221  1124579999999999987766665      9999999999999999         


Q ss_pred             -CCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          343 -RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       343 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                       ..||...................       ....+.+...+ ...++..+.+||.+||+.||.+|||+.+|+++|+.+.
T Consensus       258 ~~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          258 YQLPYHDLVPSDPSYEDMREIVCI-------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTT-------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccHhhhcCCCCchhhhHHHHhh-------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence             55554433222111000000000       00111111111 1256788999999999999999999999999999875


Q ss_pred             ccc
Q 011180          421 NLK  423 (491)
Q Consensus       421 ~~~  423 (491)
                      +..
T Consensus       331 ~~~  333 (337)
T 3mdy_A          331 ESQ  333 (337)
T ss_dssp             HTT
T ss_pred             hhc
Confidence            543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=367.21  Aligned_cols=269  Identities=17%  Similarity=0.221  Sum_probs=202.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-----------cHHHHHHHHHHHhcCCCCc
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-----------GHKEWLAEVNFLGNLLHPN  200 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~il~~l~Hpn  200 (491)
                      .++|.+.+.||+|+||.||+|.+...+.      ++..||||++......           ....+.+|+.++..+.|||
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n  109 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPE------KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG  109 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCG------GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCC------ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence            3579999999999999999999875322      4668999999765421           1134678899999999999


Q ss_pred             eeeeeeEEee----cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 011180          201 LVKLVGYCIE----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       201 Iv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NIL  276 (491)
                      |+++++++..    ....||||||+ +++|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  183 (345)
T 2v62_A          110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLL  183 (345)
T ss_dssp             CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEE
Confidence            9999999988    67889999999 999999997665  7899999999999999999999988   999999999999


Q ss_pred             ECCCC--CeEEeccCCcccCCCCCCc-----eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 011180          277 LDADY--NAKLSDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN  349 (491)
Q Consensus       277 l~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~  349 (491)
                      |+.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            98877  9999999999866432111     1113457999999999999999999999999999999999999999643


Q ss_pred             CCCCcchhhHhhhcccCCccc-hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          350 RPNGEHNLVEWARPHLGDKRR-FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      ...... .............. +.....       ....+..+.+||.+||..||.+|||+.+|++.|+.+.
T Consensus       264 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          264 LKDPVA-VQTAKTNLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             TTCHHH-HHHHHHHHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             ccccHH-HHHHHHhhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            221111 11100000000000 000000       0123678999999999999999999999999998753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.2e-45  Score=366.31  Aligned_cols=244  Identities=23%  Similarity=0.303  Sum_probs=204.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--------cHHHHHHHHHHHhcCCCCceee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGNLLHPNLVK  203 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~  203 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++......        ....+.+|+.+|+.++||||++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~   93 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKE---------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK   93 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETT---------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCC
T ss_pred             ccceEEEeEEEecCCEEEEEEEECC---------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEee
Confidence            3579999999999999999999876         6789999999765321        2235678999999999999999


Q ss_pred             eeeEEeecCceEEEEEecCCC-ChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          204 LVGYCIEDDQRLLVYEFMPRG-SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      +++++.+.+..++||||+.+| +|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~  168 (335)
T 3dls_A           94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT  168 (335)
T ss_dssp             EEEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred             EEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence            999999999999999999776 9999987654  6899999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      +||+|||++........   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....        ..
T Consensus       169 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~  237 (335)
T 3dls_A          169 IKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TV  237 (335)
T ss_dssp             EEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GT
T ss_pred             EEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HH
Confidence            99999999987654322   234679999999999988776 7899999999999999999999954210        00


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      ..          ..      ..+...+..+.+||.+||+.||.+|||+.+++++-
T Consensus       238 ~~----------~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          238 EA----------AI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             TT----------CC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred             hh----------cc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            00          00      01112367899999999999999999999999873

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.1e-45  Score=365.18  Aligned_cols=265  Identities=22%  Similarity=0.294  Sum_probs=195.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++......  ..+.+.+|+.+|+.++||||+++++++.+
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDTV---------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             hhEEEEEEEEecCCeEEEEEEECC---------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            469999999999999999998876         6789999999765432  23567899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE-----CCCCCeEE
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKL  285 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl-----~~~~~~kL  285 (491)
                      .+..+|||||++ |+|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+||||     +.++.+||
T Consensus       105 ~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl  178 (329)
T 3gbz_A          105 NHRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKI  178 (329)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEE
T ss_pred             CCEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEE
Confidence            999999999996 59999997765  5889999999999999999999988   9999999999999     45556999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      +|||+++.......  .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...........+.... .
T Consensus       179 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~  255 (329)
T 3gbz_A          179 GDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL-G  255 (329)
T ss_dssp             CCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-C
T ss_pred             CcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh-C
Confidence            99999986543221  22345789999999999874 58999999999999999999999997643221111110000 0


Q ss_pred             cCCccch-------------hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 LGDKRRF-------------YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~~~-------------~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ......+             .......+...+....+..+.+||.+||+.||.+|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            0000000             00000000000111136788999999999999999999999975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-44  Score=353.33  Aligned_cols=253  Identities=23%  Similarity=0.344  Sum_probs=206.6

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|++.+.||+|+||.||+|.+..         ++..||+|++.....  ...+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   75 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcC---------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            4689999999999999999999876         577999999975532  23466889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC---eEEe
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLS  286 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~---~kL~  286 (491)
                      +.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+
T Consensus        76 ~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           76 EESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             cCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEe
Confidence            9999999999999999999887664  6889999999999999999999988   999999999999976655   9999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ......... 
T Consensus       151 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~-  223 (284)
T 3kk8_A          151 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIKAGA-  223 (284)
T ss_dssp             CCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTC-
T ss_pred             eceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HHHHHHhcc-
Confidence            9999987654322   234679999999999999999999999999999999999999996542211   111110000 


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        ..        .........+..+.+||.+||+.||.+|||+.+++++
T Consensus       224 --~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          224 --YD--------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             --CC--------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             --cc--------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              00        0000111236789999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9e-45  Score=356.62  Aligned_cols=261  Identities=27%  Similarity=0.385  Sum_probs=207.8

Q ss_pred             hhcCCCcCc-ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          131 ATRNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       131 ~~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      ..++|.+.+ .||+|+||.||+|.+...       .++..||||++......  ..+++.+|+.+++.++||||++++++
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   86 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI   86 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCC-------CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            345788888 999999999999976432       15778999999765322  24678999999999999999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      + ..+..++||||+++++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        87 ~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~D  160 (291)
T 1xbb_A           87 C-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD  160 (291)
T ss_dssp             E-ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred             E-CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEcc
Confidence            8 5678899999999999999997754  5889999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCce-eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhccc
Q 011180          288 FGLAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       288 FGla~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      ||++.......... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.......   ........ 
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~-  236 (291)
T 1xbb_A          161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEKG-  236 (291)
T ss_dssp             CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTT-
T ss_pred             CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcC-
Confidence            99998765433221 1223456789999999999899999999999999999999 999996543211   11111100 


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                   ....++...+..+.+||.+||+.||.+||++.++++.|+.+..
T Consensus       237 -------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          237 -------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             -------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                         0111223447889999999999999999999999999987643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=354.95  Aligned_cols=261  Identities=25%  Similarity=0.377  Sum_probs=209.8

Q ss_pred             hcCCCcCc-ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+ .||+|+||.||+|.+...       .++..||||++..... ...+.+.+|+.++..++||||+++++++ 
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-   79 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-   79 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             HHHhhhhhccccccCceeEEEeEeccC-------CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence            34566766 999999999999987532       1577899999986532 3456789999999999999999999998 


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      ..+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg  155 (287)
T 1u59_A           80 QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFG  155 (287)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCT
T ss_pred             cCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccc
Confidence            5567899999999999999986543 36899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCce-eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          290 LAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       290 la~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ++.......... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.......   ........   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~~~---  229 (287)
T 1u59_A          156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQG---  229 (287)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHTT---
T ss_pred             ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHhcC---
Confidence            998765432221 1223457899999999998999999999999999999998 999996543221   11111100   


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                 ....++...+..+.+||.+||..||.+||++.+++++|+.+..
T Consensus       230 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          230 -----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                       0112233447889999999999999999999999999987643

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-44  Score=383.97  Aligned_cols=256  Identities=26%  Similarity=0.377  Sum_probs=209.9

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|.+.++||+|+||.||+|++..         +|+.||||++.+...   .....+.+|+.+|..++||||+++++++
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  254 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKA---------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF  254 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            4689999999999999999999875         678999999975432   2346788999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      .+.+.+||||||++||+|.+++....  ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.+|.+||+
T Consensus       255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~  331 (543)
T 3c4z_A          255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRIS  331 (543)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEe
Confidence            99999999999999999999987643  346899999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||+++........  ....+||+.|+|||++.+..|+.++|||||||++|||++|..||...........  .....+.
T Consensus       332 DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~--~~~~i~~  407 (543)
T 3c4z_A          332 DLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE--LKQRVLE  407 (543)
T ss_dssp             CCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH--HHHHHHH
T ss_pred             ecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH--HHHHHhh
Confidence            99999876543221  2346899999999999999999999999999999999999999976543221111  1111110


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~  415 (491)
                      .            ...++...+..+.+||.+||..||.+||++     .+|+++
T Consensus       408 ~------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          408 Q------------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             C------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             c------------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            0            011233447889999999999999999975     666654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-45  Score=370.74  Aligned_cols=261  Identities=26%  Similarity=0.427  Sum_probs=198.7

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEee-c
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-D  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~  211 (491)
                      .|.+.+.||+|+||.||+|.+.....      .+..||||.+.... ....+++.+|+.+|+.++||||+++++++.. +
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  163 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE  163 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTT------EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCC------cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            47788999999999999999864321      34579999987543 2345678999999999999999999998754 4


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a  239 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA  239 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccc
Confidence            67899999999999999997653 36889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCc--eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          292 KDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       292 ~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      +........  .......||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+...      .
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~------~  313 (373)
T 3c1x_A          240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG------R  313 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT------C
T ss_pred             ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC------C
Confidence            866433211  11233567889999999999999999999999999999999 67777654332221111100      0


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                 ....+..++..+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       314 -----------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          314 -----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                       001122346789999999999999999999999999987643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1e-44  Score=355.40  Aligned_cols=252  Identities=28%  Similarity=0.361  Sum_probs=199.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||+|++..... ...+.+.+|+++|+.++||||+++++++.+.
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   92 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERS---------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY   92 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hheeecceeccCCCeEEEEEEEcc---------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence            368999999999999999999875         577899999876532 3457889999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---CCCCCeEEe
Q 011180          212 DQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLS  286 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl---~~~~~~kL~  286 (491)
                      +..++||||+++++|.+++...  ....+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~  169 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKII  169 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEE
Confidence            9999999999999999988543  1246899999999999999999999988   9999999999999   456789999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||++.......   ......||+.|+|||++. ..++.++|||||||++|+|++|..||................    
T Consensus       170 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----  241 (285)
T 3is5_A          170 DFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE----  241 (285)
T ss_dssp             CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----
T ss_pred             eeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC----
Confidence            999998664432   123467999999999875 678999999999999999999999997543211111111000    


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                +.... .....+..+.+||.+||+.||.+|||+.+++++
T Consensus       242 ----------~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          242 ----------PNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ----------CCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ----------ccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      00000 001125788999999999999999999999965

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-44  Score=354.29  Aligned_cols=262  Identities=24%  Similarity=0.367  Sum_probs=207.4

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .|.+.++||+|+||.||+|.+.....      .+..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   95 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQ------NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE   95 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSS------CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             EEccCceeccCCCceEEEEEEecCCC------ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence            46677999999999999999865332      455799999976433 33467889999999999999999999998776


Q ss_pred             ce-EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          213 QR-LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       213 ~~-~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      .. ++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~  171 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLA  171 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred             CCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCc
Confidence            65 99999999999999997643 36899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCc--eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          292 KDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       292 ~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +........  .......||+.|+|||.+.+..++.++|||||||++|+|++|..|+......  ...........    
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~----  245 (298)
T 3pls_A          172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLAQGR----  245 (298)
T ss_dssp             CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHHHHTTC----
T ss_pred             ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHHhhcCC----
Confidence            866432211  1223356789999999999999999999999999999999966555332211  11111111000    


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                ....+...+..+.+|+.+||..||.+|||+.++++.|+.+..
T Consensus       246 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          246 ----------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                      011122336789999999999999999999999999987643

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-44  Score=360.70  Aligned_cols=258  Identities=26%  Similarity=0.438  Sum_probs=206.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeE--EEEEEecCCC-cccHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~--vavK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..  ||||.+.... ....+.+.+|+.+|..+ .||||+++++++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~   95 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC   95 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence            479999999999999999999876         4444  5999987532 23345688999999999 899999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  274 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~N  274 (491)
                      .+.+..+|||||+++++|.+++....              ...+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N  172 (327)
T 1fvr_A           96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN  172 (327)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccce
Confidence            99999999999999999999997643              236899999999999999999999988   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 011180          275 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  353 (491)
Q Consensus       275 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~  353 (491)
                      ||++.++.+||+|||+++.....   .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...... 
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-  248 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-  248 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-
T ss_pred             EEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-
Confidence            99999999999999999754321   11223457889999999999999999999999999999998 99999654321 


Q ss_pred             cchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011180          354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  422 (491)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~  422 (491)
                        ........              ......+...+..+.+||.+||..||.+|||+.+++++|..+...
T Consensus       249 --~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          249 --ELYEKLPQ--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             --HHHHHGGG--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             --HHHHHhhc--------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence              11111100              011112234468899999999999999999999999999876443

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=354.82  Aligned_cols=253  Identities=23%  Similarity=0.284  Sum_probs=202.7

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC----cccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++....    ......+.+|+.+++.++||||++++++
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   74 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV   74 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTT---------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECC---------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence            3689999999999999999998765         67799999997542    2334678999999999999999999999


Q ss_pred             Ee--ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          208 CI--EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       208 ~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      +.  +.+..++||||++++ |.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl  150 (305)
T 2wtk_C           75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKI  150 (305)
T ss_dssp             EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEe
Confidence            84  446789999999765 888887665567999999999999999999999988   999999999999999999999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhcCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      +|||++................||+.|+|||++.+..  ++.++|||||||++|+|++|..||......   ........
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~  227 (305)
T 2wtk_C          151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFENIGK  227 (305)
T ss_dssp             CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred             eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHHhc
Confidence            9999998765433333334567999999999987644  377999999999999999999999753211   11111000


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         ..            ..++...+..+.+||.+||..||.+|||+.+++++
T Consensus       228 ---~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          228 ---GS------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ---CC------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---CC------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               00            01122346788999999999999999999999976

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.4e-45  Score=363.80  Aligned_cols=274  Identities=31%  Similarity=0.428  Sum_probs=211.5

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec--
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED--  211 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--  211 (491)
                      |++.+.||+|+||.||+|.+...     ...++..||||++..... ...+.+.+|+.+|+.++||||+++++++.+.  
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPT-----NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSC-----C--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HhhhheecCCCCeEEEEEEEccC-----CCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            48999999999999999977532     223788999999986543 3346789999999999999999999999884  


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      ...++||||+++++|.+++...   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             ceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccc
Confidence            5679999999999999999765   4889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      ......... .......||..|+|||++.+..++.++|||||||++|+|++|..||....... .....+..... ....
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~-~~~~  259 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQM-TVLR  259 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHH-HHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccch-hHHH
Confidence            877544322 22334568889999999999999999999999999999999999985421100 00000000000 0000


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      +...+........+..++..+.+||.+||+.||.+|||+.++++.|+.+.+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            111111222223334457899999999999999999999999999987644

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.5e-45  Score=376.03  Aligned_cols=243  Identities=18%  Similarity=0.199  Sum_probs=191.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC---CcccHHHHHHHH---HHHhcCCCCceeeee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---GLQGHKEWLAEV---NFLGNLLHPNLVKLV  205 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~il~~l~HpnIv~l~  205 (491)
                      .++|.+.+.||+|+||.||+|++..         +|..||||++...   .....+.+.+|+   ++|+.++|||||+++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~  142 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH  142 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-C---------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred             CceEEEcceeecCCCEEEEEEEECC---------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence            4679999999999999999999865         6779999999743   223456788999   555566899999998


Q ss_pred             -------eEEeecCc-----------------eEEEEEecCCCChHHHhhhCCCC-----CCCHHHHHHHHHHHHHHHHH
Q 011180          206 -------GYCIEDDQ-----------------RLLVYEFMPRGSLENHLFRKGSL-----PLPWSIRMKIALGAAKGLAF  256 (491)
Q Consensus       206 -------~~~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~~~-----~l~~~~~~~i~~qi~~aL~y  256 (491)
                             +++.+.+.                 .||||||+ +|+|.+++...+..     .+++..++.|+.||+.||+|
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  221 (377)
T 3byv_A          143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS  221 (377)
T ss_dssp             HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence                   66655532                 78999999 68999999764321     23357788899999999999


Q ss_pred             HHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-----------CCCc
Q 011180          257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-----------HLTS  325 (491)
Q Consensus       257 LH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-----------~~~~  325 (491)
                      ||+.+   |+||||||+||||+.++.+||+|||+++....     .....+| +.|+|||++.+.           .++.
T Consensus       222 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~  292 (377)
T 3byv_A          222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF  292 (377)
T ss_dssp             HHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred             HHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence            99988   99999999999999999999999999986432     2344678 999999999887           8999


Q ss_pred             cccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCC
Q 011180          326 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA  405 (491)
Q Consensus       326 ~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~  405 (491)
                      ++|||||||+||||++|+.||...........+                ..      .....+..+.+||.+||..||.+
T Consensus       293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~----------------~~------~~~~~~~~~~~li~~~L~~dp~~  350 (377)
T 3byv_A          293 SFDAWALGLVIYWIWCADLPITKDAALGGSEWI----------------FR------SCKNIPQPVRALLEGFLRYPKED  350 (377)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCC------CCSGGG----------------GS------SCCCCCHHHHHHHHHHTCSSGGG
T ss_pred             hhhHHHHHHHHHHHHHCCCCCcccccccchhhh----------------hh------hccCCCHHHHHHHHHHcCCCchh
Confidence            999999999999999999999654332211110                00      00122678999999999999999


Q ss_pred             CCCHHHHHHH
Q 011180          406 RPRMSEVVET  415 (491)
Q Consensus       406 RPt~~evl~~  415 (491)
                      |||+.+++++
T Consensus       351 Rpt~~e~l~h  360 (377)
T 3byv_A          351 RLLPLQAMET  360 (377)
T ss_dssp             CCCHHHHHTS
T ss_pred             CCCHHHHhhC
Confidence            9999999975

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.1e-44  Score=357.03  Aligned_cols=264  Identities=27%  Similarity=0.391  Sum_probs=201.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++.....   .....+.+|+.+++.++||||+++++++.
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  102 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI  102 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETT---------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcC---------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            469999999999999999999875         577999999975432   33467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +.+..++||||+++++|.+++..  .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~D  179 (310)
T 2wqm_A          103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD  179 (310)
T ss_dssp             ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred             cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEe
Confidence            99999999999999999999864  22346899999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..........  .
T Consensus       180 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~  254 (310)
T 2wqm_A          180 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQC--D  254 (310)
T ss_dssp             C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHHHTT--C
T ss_pred             ccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHhhcc--c
Confidence            999986643221  1234579999999999999999999999999999999999999996543211 1111111000  0


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccccc
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD  424 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~~~  424 (491)
                             ..+    ......+..+.+||.+||..||.+|||+.+|++.|+.+.....
T Consensus       255 -------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          255 -------YPP----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             -------SCC----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             -------CCC----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence                   000    0112236789999999999999999999999999998866544

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3e-45  Score=366.36  Aligned_cols=263  Identities=24%  Similarity=0.337  Sum_probs=192.7

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYC  208 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~  208 (491)
                      ....+|++.+.||+|+||.||+|.+..         ++..||||++........+.+.+|+.++..+. ||||+++++++
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~   95 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVG---------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA   95 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECC---------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence            334579999999999999999999875         67799999997666556677899999999996 99999999998


Q ss_pred             ee--------cCceEEEEEecCCCChHHHhhh-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC
Q 011180          209 IE--------DDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  279 (491)
Q Consensus       209 ~~--------~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~  279 (491)
                      ..        ....++||||+ +|+|.+++.. .....+++..++.++.||+.||.|||+.+ .+|+||||||+||||+.
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~  173 (337)
T 3ll6_A           96 SIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSN  173 (337)
T ss_dssp             EECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECT
T ss_pred             cccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECC
Confidence            43        33478999999 5799998865 22336899999999999999999999865 45999999999999999


Q ss_pred             CCCeEEeccCCcccCCCCCCce----------eeeccccCCCCCCchhh---hcCCCCccccchhHHHHHHHHHhCCCCC
Q 011180          280 DYNAKLSDFGLAKDAPEDGKTH----------VSTRVMGTYGYAAPEYV---MTGHLTSKSDVYSFGVVLLEMLTGRRSM  346 (491)
Q Consensus       280 ~~~~kL~DFGla~~~~~~~~~~----------~~~~~~Gt~~y~aPE~~---~~~~~~~~~DvwSlGvil~elltG~~pf  346 (491)
                      ++.+||+|||++..........          ......||+.|+|||++   .+..++.++|||||||++|+|++|..||
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~  253 (337)
T 3ll6_A          174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF  253 (337)
T ss_dssp             TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            9999999999998765432211          11135699999999998   5667899999999999999999999999


Q ss_pred             CCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcccc
Q 011180          347 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  423 (491)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~~  423 (491)
                      ........   ..   .              ..........+..+.+||.+||+.||.+|||+.+++++|+.+....
T Consensus       254 ~~~~~~~~---~~---~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          254 EDGAKLRI---VN---G--------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             --------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             cchhHHHh---hc---C--------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            64322110   00   0              0000011112455789999999999999999999999998775543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-44  Score=363.79  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=207.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||+|++.....   ...+.+.+|+.+++.+.||||+++++++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  110 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF  110 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3579999999999999999999876         577899999875432   2346688999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..++||||+++++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Df  185 (335)
T 2owb_A          111 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF  185 (335)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCC
T ss_pred             ecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeec
Confidence            99999999999999999999987654  6889999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ......   .. 
T Consensus       186 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~---~~-  256 (335)
T 2owb_A          186 GLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIK---KN-  256 (335)
T ss_dssp             TTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH---HT-
T ss_pred             cCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHh---cC-
Confidence            999876433221  234679999999999999899999999999999999999999996532111   110000   00 


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                             .    ..++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       257 -------~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 -------E----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             -------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -------C----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   0    01122336788999999999999999999999865

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.3e-45  Score=363.87  Aligned_cols=266  Identities=27%  Similarity=0.392  Sum_probs=206.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|.+.+.||+|+||.||+|.+....    ...++..||||++.... .....++.+|+.+++.+.||||+++++++.+
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCC----CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            357999999999999999999864311    11267789999997543 2344678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---CCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGS-----LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYN  282 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~---~~~  282 (491)
                      .+..+|||||+++++|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.   +..
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcce
Confidence            9999999999999999999976542     34889999999999999999999988   999999999999984   456


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  361 (491)
                      +||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......   ......
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~  258 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV  258 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHH
Confidence            99999999975533322222334678999999999999999999999999999999998 99998654221   111111


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ...              .....+...+..+.+||.+||..||.+|||+.+|+++|+.+..
T Consensus       259 ~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          259 TSG--------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcC--------------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            100              0011122346789999999999999999999999999987644

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=357.03  Aligned_cols=254  Identities=32%  Similarity=0.514  Sum_probs=198.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||.||+|.+.           +..||||++...  ...+.+.+|+++|++++||||+++++++.  +
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~   72 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--N   72 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--T
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence            46899999999999999999873           568999999654  34567899999999999999999999877  4


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC-eEEeccCC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKLSDFGL  290 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~-~kL~DFGl  290 (491)
                      ..+|||||+++++|.+++...... .+++..++.++.||+.||.|||+.+.++|+||||||+|||++.++. +||+|||+
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~  152 (307)
T 2eva_A           73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT  152 (307)
T ss_dssp             TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred             CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence            589999999999999999765432 4788899999999999999999943334999999999999988886 79999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+... ..    
T Consensus       153 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~-~~~~~~-~~----  220 (307)
T 2eva_A          153 ACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-R-IMWAVH-NG----  220 (307)
T ss_dssp             -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-H-HHHHHH-TT----
T ss_pred             ccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-H-HHHHHh-cC----
Confidence            9765332     1234699999999999999999999999999999999999999965432111 1 111000 00    


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                          ..+    ......+..+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       221 ----~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          221 ----TRP----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             ----CCC----CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             ----CCC----CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                001    1112336789999999999999999999999999987643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.6e-44  Score=357.05  Aligned_cols=251  Identities=23%  Similarity=0.351  Sum_probs=204.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|.+.+.||+|+||.||+|.+..         +|..||||++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRL---------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT   79 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccceeeeeccCCCCceEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence            469999999999999999999875         57799999998665445567889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---CCCCCeEEeccC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFG  289 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl---~~~~~~kL~DFG  289 (491)
                      ..++||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg  154 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFG  154 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred             EEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCC
Confidence            9999999999999999987654  6889999999999999999999988   9999999999999   788999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   ..........   .
T Consensus       155 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~---~  224 (304)
T 2jam_A          155 LSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIKEGY---Y  224 (304)
T ss_dssp             TTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHCC---C
T ss_pred             cceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCC---C
Confidence            99765332    123357999999999999999999999999999999999999999654321   1111111000   0


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                              .....+....+..+.+||.+||..||.+|||+.+++++
T Consensus       225 --------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          225 --------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             --------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             --------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                    00111122346789999999999999999999999976

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8e-45  Score=354.40  Aligned_cols=252  Identities=28%  Similarity=0.441  Sum_probs=201.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|++.+.||+|+||.||+|.+           +|..||||++....  ..+.+.+|+.+++.++||||+++++++.+.
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   86 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   86 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-----------TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-----------cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            45799999999999999999976           36689999997653  456789999999999999999999997654


Q ss_pred             -CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          212 -DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       212 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                       +..++||||+++++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~  163 (278)
T 1byg_A           87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL  163 (278)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccc
Confidence             47899999999999999997654334788999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +.......     ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.......   .......      
T Consensus       164 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~------  229 (278)
T 1byg_A          164 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK------  229 (278)
T ss_dssp             -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTT------
T ss_pred             cccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhc------
Confidence            88654321     22457899999999999999999999999999999998 999996543211   1111100      


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                              ......+...+..+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       230 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          230 --------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence                    01111223347889999999999999999999999999987654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=371.66  Aligned_cols=276  Identities=22%  Similarity=0.281  Sum_probs=214.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|.+.++||+|+||.||+|++..         +|..||||++..... ...+.+.+|+++|+.++||||+++++++.+
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   78 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence            3579999999999999999999876         677999999975432 335678899999999999999999999987


Q ss_pred             cC--ceEEEEEecCCCChHHHhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----CCCCCe
Q 011180          211 DD--QRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNA  283 (491)
Q Consensus       211 ~~--~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl----~~~~~~  283 (491)
                      .+  ..+||||||++|+|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEE
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeE
Confidence            65  6799999999999999997643 223899999999999999999999988   9999999999999    777889


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc--------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc-
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-  354 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~-  354 (491)
                      ||+|||+++.......   ....+||+.|+|||++.+        ..++.++|||||||++|||++|+.||........ 
T Consensus       156 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~  232 (396)
T 4eut_A          156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (396)
T ss_dssp             EECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred             EEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence            9999999987644321   234679999999999875        5678899999999999999999999965432221 


Q ss_pred             chhhHhhhcccCCc--cchhhc------c--CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011180          355 HNLVEWARPHLGDK--RRFYRL------L--DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  422 (491)
Q Consensus       355 ~~~~~~~~~~~~~~--~~~~~~------~--~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~  422 (491)
                      ..............  ......      .  +......++...+..+.+|+.+||..||.+||++.++++.|..+...
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            11111111000000  000000      0  00112234456788999999999999999999999999998876543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.7e-44  Score=376.57  Aligned_cols=264  Identities=21%  Similarity=0.259  Sum_probs=210.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCC-CceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH-PNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~  210 (491)
                      .++|.+.++||+|+||.||+|.+..         ++..||||++.....  ..++.+|++++..|.| ++|..+..++..
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~   74 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQ---------TNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVE   74 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETT---------TCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECC---------CCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            4689999999999999999999875         577999999876543  2457899999999986 556666667777


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---CCCCCeEEec
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSD  287 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl---~~~~~~kL~D  287 (491)
                      .+..+|||||+ +++|.+++..... .+++..++.|+.||+.||.|||+.+   ||||||||+||||   +.++.+||+|
T Consensus        75 ~~~~~lvme~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~D  149 (483)
T 3sv0_A           75 GDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIID  149 (483)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECC
T ss_pred             CCEEEEEEECC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEe
Confidence            88889999999 9999999976433 6999999999999999999999988   9999999999999   6889999999


Q ss_pred             cCCcccCCCCCCc-----eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          288 FGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       288 FGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||+++........     ......+||+.|+|||++.+..++.++||||||||||||++|+.||................
T Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (483)
T 3sv0_A          150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (483)
T ss_dssp             CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred             CCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence            9999876543321     11225689999999999999999999999999999999999999998765443332222111


Q ss_pred             cc-cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011180          363 PH-LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  422 (491)
Q Consensus       363 ~~-~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~  422 (491)
                      .. +...  .. .    +    ...++.++.+||.+||..||.+||++.+|++.|+.+...
T Consensus       230 ~~~~~~~--~~-~----l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          230 EKKVATS--IE-A----L----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HHHHHSC--HH-H----H----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hcccccc--HH-H----H----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            10 0000  00 0    0    012267899999999999999999999999999876543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9.4e-45  Score=360.50  Aligned_cols=263  Identities=27%  Similarity=0.347  Sum_probs=206.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee-
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-  210 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++........+.+.+|+.+++.++||||+++++++.. 
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLH---------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE   98 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecC---------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence            4579999999999999999999865         677999999976655566788999999999999999999999873 


Q ss_pred             ---cCceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          211 ---DDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       211 ---~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                         ....++||||+++|+|.+++...  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl  175 (317)
T 2buj_A           99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVL  175 (317)
T ss_dssp             ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEE
T ss_pred             cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEE
Confidence               34778999999999999998752  2346899999999999999999999988   999999999999999999999


Q ss_pred             eccCCcccCCCCCCce-------eeeccccCCCCCCchhhhcCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011180          286 SDFGLAKDAPEDGKTH-------VSTRVMGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  355 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~-------~~~~~~Gt~~y~aPE~~~~~~---~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~  355 (491)
                      +|||++..........       ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||.........
T Consensus       176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  255 (317)
T 2buj_A          176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS  255 (317)
T ss_dssp             CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred             EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence            9999987653211000       012245799999999987543   688999999999999999999998531111100


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                       .......              ..........+..+.+||.+||+.||.+|||+.+++++|+.++.
T Consensus       256 -~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          256 -VALAVQN--------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             -HHHHHHC--------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             -hhHHhhc--------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence             0000000              00011112336789999999999999999999999999998754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.4e-44  Score=372.48  Aligned_cols=255  Identities=25%  Similarity=0.349  Sum_probs=195.6

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--------ccHHHHHHHHHHHhcCCCCce
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGNLLHPNL  201 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~HpnI  201 (491)
                      ...++|.+.+.||+|+||.||+|.+..         ++..||||++.....        .....+.+|+.+|++++||||
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  202 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI  202 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECC---------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence            345789999999999999999999876         677999999975421        112247899999999999999


Q ss_pred             eeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-
Q 011180          202 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-  280 (491)
Q Consensus       202 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~-  280 (491)
                      +++++++. .+..+|||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+ 
T Consensus       203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~  276 (419)
T 3i6u_A          203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQE  276 (419)
T ss_dssp             CCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSS
T ss_pred             eeEEEEEe-cCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCC
Confidence            99999975 456899999999999999887654  6899999999999999999999988   9999999999999654 


Q ss_pred             --CCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011180          281 --YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  355 (491)
Q Consensus       281 --~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~  355 (491)
                        +.+||+|||+++.....   ......+||+.|+|||++.+   ..++.++|||||||++|+|++|..||........ 
T Consensus       277 ~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-  352 (419)
T 3i6u_A          277 EDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-  352 (419)
T ss_dssp             SSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-
T ss_pred             CcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-
Confidence              45999999999876532   22345689999999999853   6788899999999999999999999975432221 


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       +.........   .+    .+..    ....+..+.+||.+||+.||.+|||+.+++++
T Consensus       353 -~~~~i~~~~~---~~----~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          353 -LKDQITSGKY---NF----IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             -HHHHHHTTCC---CC----CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -HHHHHhcCCC---CC----Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             1111110000   00    0000    01236789999999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.6e-44  Score=355.12  Aligned_cols=250  Identities=26%  Similarity=0.366  Sum_probs=207.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||+|++.....   ...+.+.+|+.+++.+.||||+++++++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF   84 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECC---------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence            3579999999999999999999876         577899999875532   2345688999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  159 (294)
T 2rku_A           85 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF  159 (294)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred             ccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEec
Confidence            99999999999999999999887654  6889999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||........   ...   .....
T Consensus       160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~---~~~~~  231 (294)
T 2rku_A          160 GLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET---YLR---IKKNE  231 (294)
T ss_dssp             TTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHH---HHTTC
T ss_pred             cCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH---Hhhcc
Confidence            999876433221  2346799999999999988899999999999999999999999965422111   000   00000


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                  ..++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       232 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 ------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                        01122336788999999999999999999999865

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-44  Score=365.78  Aligned_cols=249  Identities=29%  Similarity=0.415  Sum_probs=203.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      +.|.+.+.||+|+||.||+|++..         ++..||||++......   ..+.+.+|+.+|+.++||||+++++++.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  124 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL  124 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEcc---------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            358899999999999999999865         6789999999765332   2356889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..+|||||+. |+|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       125 ~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG  199 (348)
T 1u5q_A          125 REHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFG  199 (348)
T ss_dssp             ETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             ECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeecc
Confidence            9999999999996 68888886543 36899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      ++......      ...+||+.|+|||++.   ...++.++|||||||++|||++|+.||........  +......   
T Consensus       200 ~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~~~~~---  268 (348)
T 1u5q_A          200 SASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQN---  268 (348)
T ss_dssp             TCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHS---
T ss_pred             CceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhc---
Confidence            99876432      2357999999999985   56789999999999999999999999965421111  0000000   


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                              ..+.+   .....+..+.+||.+||+.||.+|||+.+++++.-
T Consensus       269 --------~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          269 --------ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             --------CCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             --------CCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence                    00000   11223678999999999999999999999997643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.1e-45  Score=354.28  Aligned_cols=249  Identities=29%  Similarity=0.444  Sum_probs=206.7

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee-
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-  210 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++....    ..+.+|+++++.++||||+++++++.. 
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGF   76 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETT---------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred             ccccceeeeeccCCceEEEEEEEcC---------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence            3469999999999999999999875         57799999997653    356789999999999999999998865 


Q ss_pred             ---------------cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcE
Q 011180          211 ---------------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  275 (491)
Q Consensus       211 ---------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NI  275 (491)
                                     ....++||||+++++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Ni  153 (284)
T 2a19_B           77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNI  153 (284)
T ss_dssp             EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred             ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHE
Confidence                           445799999999999999997665457899999999999999999999988   99999999999


Q ss_pred             EECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011180          276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  355 (491)
Q Consensus       276 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~  355 (491)
                      |++.++.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...     .
T Consensus       154 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~  225 (284)
T 2a19_B          154 FLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----S  225 (284)
T ss_dssp             EEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----H
T ss_pred             EEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----H
Confidence            999999999999999987654322   23356999999999999999999999999999999999999886321     0


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ....             ......    ++...+..+.+||.+||..||.+|||+.+++++|..+..
T Consensus       226 ~~~~-------------~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          226 KFFT-------------DLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             HHHH-------------HHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             HHHH-------------Hhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            0000             000111    112235778999999999999999999999999987654

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.1e-44  Score=350.78  Aligned_cols=265  Identities=19%  Similarity=0.233  Sum_probs=210.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEE-ee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC-IE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~  210 (491)
                      .++|++.+.||+|+||.||+|++..         ++..||||++.....  ...+.+|+.++..+.|++++..+.++ ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcC---------CCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCC
Confidence            4689999999999999999999865         678999999876543  24688999999999988877666655 55


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---CCCCCeEEec
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSD  287 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl---~~~~~~kL~D  287 (491)
                      .+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  151 (296)
T 3uzp_A           77 GDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             CCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEee
Confidence            67789999999 999999997543 36899999999999999999999988   9999999999999   4888999999


Q ss_pred             cCCcccCCCCCCce-----eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          288 FGLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       288 FGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||++..........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 3uzp_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence            99998765432211     1234679999999999999999999999999999999999999998654433322221111


Q ss_pred             c-ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcccc
Q 011180          363 P-HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  423 (491)
Q Consensus       363 ~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~~  423 (491)
                      . .....       .+.+    ....+..+.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus       232 ~~~~~~~-------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          232 EKKMSTP-------IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHSC-------HHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccccCCc-------hHHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            0 00000       0000    1123678999999999999999999999999998765433

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.1e-45  Score=368.36  Aligned_cols=267  Identities=26%  Similarity=0.381  Sum_probs=206.6

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ..++|.+.+.||+|+||.||+|.+..         ++..||+|++..... ...+.+.+|+.+|+.++||||+++++++.
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  101 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY  101 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECC---------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence            34689999999999999999999875         677999999976532 33467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      +.+..+|||||+++++|.+++...+  .+++..+..++.||+.||.|||+. +   |+||||||+||||+.++.+||+||
T Consensus       102 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Df  176 (360)
T 3eqc_A          102 SDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDF  176 (360)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCC
T ss_pred             ECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEEC
Confidence            9999999999999999999997764  588999999999999999999985 7   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh------
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR------  362 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~------  362 (491)
                      |++......    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................      
T Consensus       177 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3eqc_A          177 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  252 (360)
T ss_dssp             CCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred             CCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence            998754221    1234579999999999999999999999999999999999999997543211100000000      


Q ss_pred             ----------------cccCCccchhhcc----CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 ----------------PHLGDKRRFYRLL----DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ----------------~~~~~~~~~~~~~----~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                      ............+    ............+..+.+||.+||+.||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                            0000000000000    0000001112236789999999999999999999999976

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=367.36  Aligned_cols=259  Identities=17%  Similarity=0.189  Sum_probs=206.9

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCceeeee
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLV  205 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~  205 (491)
                      ....++|.+.+.||+|+||+||+|.+....    ...++..||||++....   ..++.+|++++..+.   |+||+.++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLN----DAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCc----ccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            345678999999999999999999643211    11267899999997653   456778888888886   99999999


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRK---GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---  279 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~---  279 (491)
                      +++...+..|||||||++|+|.+++...   ....+++..++.|+.||+.||+|||+.+   ||||||||+||||+.   
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGT
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccccc
Confidence            9999999999999999999999999742   2346999999999999999999999988   999999999999998   


Q ss_pred             --------CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 011180          280 --------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  351 (491)
Q Consensus       280 --------~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~  351 (491)
                              ++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                    899999999999765433333444567899999999999999999999999999999999999999854321


Q ss_pred             CCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCC-CCHHHHHHHhhcC
Q 011180          352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR-PRMSEVVETLKPL  419 (491)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~R-Pt~~evl~~L~~l  419 (491)
                      ...               .    +...+.. +  ..+..+.+++..||+.+|.+| |++.++.+.|+.+
T Consensus       291 ~~~---------------~----~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          291 GEC---------------K----PEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             TEE---------------E----ECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             Cce---------------e----echhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            100               0    0000000 0  126778899999999999999 6788888887754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.6e-44  Score=353.47  Aligned_cols=247  Identities=27%  Similarity=0.396  Sum_probs=206.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||++.....   .....+.+|+.+++.++||||+++++++.
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   84 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQ---------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH   84 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcC---------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence            579999999999999999999875         677999999865321   23467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..++||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg  159 (284)
T 2vgo_A           85 DRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFG  159 (284)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEeccc
Confidence            9999999999999999999997764  5889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......   ..   ......  
T Consensus       160 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~~~~~--  227 (284)
T 2vgo_A          160 WSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---TH---RRIVNV--  227 (284)
T ss_dssp             TCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHTT--
T ss_pred             ccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HH---HHHhcc--
Confidence            987654321    233579999999999999999999999999999999999999996532111   11   000000  


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                            +    ..++...+..+.+||.+||..||.+|||+.+++++
T Consensus       228 ------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          228 ------D----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ------C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ------c----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                  0    11222346789999999999999999999999875

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.7e-45  Score=362.88  Aligned_cols=263  Identities=20%  Similarity=0.280  Sum_probs=209.1

Q ss_pred             hhhhHHHhhcCCCcC-cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCC-CC
Q 011180          124 MFNDLKLATRNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLL-HP  199 (491)
Q Consensus       124 ~~~~~~~~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-Hp  199 (491)
                      .+.......++|.+. +.||+|+||.||+|.+..         ++..||||++....  ......+.+|+.++..+. ||
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   89 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP   89 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCT
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCC
Confidence            344445555678887 899999999999999876         67799999997543  234578899999999995 69


Q ss_pred             ceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC
Q 011180          200 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  279 (491)
Q Consensus       200 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~  279 (491)
                      ||+++++++.+.+..++||||+++|+|.+++.......+++..++.++.||+.||+|||+.+   |+||||||+||||+.
T Consensus        90 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~  166 (327)
T 3lm5_A           90 RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSS  166 (327)
T ss_dssp             TBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESC
T ss_pred             CEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEec
Confidence            99999999999999999999999999999987655557999999999999999999999988   999999999999987


Q ss_pred             ---CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011180          280 ---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  356 (491)
Q Consensus       280 ---~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~  356 (491)
                         ++.+||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus       167 ~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  243 (327)
T 3lm5_A          167 IYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL  243 (327)
T ss_dssp             BTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence               78999999999987643321   234679999999999999999999999999999999999999996543211111


Q ss_pred             hhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+.  ..            ............+..+.+||.+||+.||.+|||+++++++
T Consensus       244 ~i~--~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          244 NIS--QV------------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHH--HT------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHH--hc------------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            110  00            0001111112346789999999999999999999999876

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.4e-44  Score=394.91  Aligned_cols=252  Identities=27%  Similarity=0.383  Sum_probs=208.7

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCceeeee
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKLV  205 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~  205 (491)
                      ...++|.+.++||+|+||.||+|++..         ++..||||++.+..   ....+.+..|..+|..+ +||||+.++
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~  408 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH  408 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESS---------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence            445689999999999999999999876         67799999997542   12345678899999988 699999999


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      +++.+.+.+||||||+++|+|.+++...+  .+++..++.++.||+.||+|||+.+   ||||||||+||||+.++.+||
T Consensus       409 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL  483 (674)
T 3pfq_A          409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKI  483 (674)
T ss_dssp             EECBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEE
T ss_pred             EEEEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEE
Confidence            99999999999999999999999998765  6899999999999999999999988   999999999999999999999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      +|||+++.......  .....+||+.|+|||++.+..|+.++|||||||+||||++|..||......   .+..   ..+
T Consensus       484 ~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~~---~i~  555 (674)
T 3pfq_A          484 ADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SIM  555 (674)
T ss_dssp             CCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHH
T ss_pred             eecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHHH---HHH
Confidence            99999986433322  234578999999999999999999999999999999999999999754321   1111   111


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  415 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~~  415 (491)
                      ...            ..++...+.++.+||.+||+.||.+||++     ++|+++
T Consensus       556 ~~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          556 EHN------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             SSC------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             hCC------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            111            12233447889999999999999999997     777654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-44  Score=356.36  Aligned_cols=259  Identities=23%  Similarity=0.290  Sum_probs=201.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||++......   ..+.+.+|+.++..++||||+++++++.
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  104 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTV---------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE  104 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcC---------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence            579999999999999999999875         6789999999765332   2367889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..++||||+++++|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg  179 (309)
T 2h34_A          105 IDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFG  179 (309)
T ss_dssp             ETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCC
T ss_pred             eCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCc
Confidence            9999999999999999999997654  6899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......   ............  
T Consensus       180 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~--  253 (309)
T 2h34_A          180 IASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAIPR--  253 (309)
T ss_dssp             C-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCCCC--
T ss_pred             cCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCCCC--
Confidence            99866443221 223457999999999999999999999999999999999999999653211   111110000000  


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhcCcc
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-RMSEVVETLKPLQN  421 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-t~~evl~~L~~l~~  421 (491)
                                ...+....+..+.+||.+||..||.+|| +++++++.|+.+..
T Consensus       254 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          254 ----------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             ----------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             ----------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence                      0111223367899999999999999999 99999999986544

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.9e-44  Score=351.89  Aligned_cols=263  Identities=19%  Similarity=0.241  Sum_probs=206.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEE-ee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC-IE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~  210 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++......  ..+.+|+.++..+.|++++..+.++ ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcC---------CCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence            4689999999999999999999865         6789999987654322  3578899999999988877766655 56


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---CCCCCeEEec
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSD  287 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl---~~~~~~kL~D  287 (491)
                      .+..++||||+ +++|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~D  151 (296)
T 4hgt_A           77 GDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECC
T ss_pred             CCceEEEEEcc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEec
Confidence            67789999999 9999999875433 6899999999999999999999988   9999999999999   7889999999


Q ss_pred             cCCcccCCCCCCc-----eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          288 FGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       288 FGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus       152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 4hgt_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence            9999876543221     11234679999999999999999999999999999999999999997655443322222111


Q ss_pred             -cccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          363 -PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       363 -~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                       ......   ...    +    ....+..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       232 ~~~~~~~---~~~----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          232 EKKMSTP---IEV----L----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHHHHSC---HHH----H----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             cccccch---hhh----h----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence             000000   000    0    01125789999999999999999999999999987654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.9e-45  Score=389.77  Aligned_cols=260  Identities=27%  Similarity=0.401  Sum_probs=212.0

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .+..++|++.+.||+|+||.||+|.+..          +..||||+++... ...+++.+|+++|+.|+||||+++++++
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~  331 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV  331 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3445678999999999999999998863          4579999998654 3457899999999999999999999998


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+ +..+||||||++|+|.++|.......+++..++.++.||+.||.|||+++   ||||||||+||||+.++.+||+||
T Consensus       332 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          332 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             CS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCT
T ss_pred             ee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccc
Confidence            76 67899999999999999997543346889999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      |+++...... ........++..|+|||++.+..++.++|||||||+||||++ |..||......   .+.......   
T Consensus       408 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~~i~~~---  480 (535)
T 2h8h_A          408 GLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLDQVERG---  480 (535)
T ss_dssp             TSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHHHHHTT---
T ss_pred             ccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC---
Confidence            9998764321 111223456789999999999999999999999999999999 89999654221   111111100   


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                                 .....+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       481 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          481 -----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                       0111223447889999999999999999999999999998754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.7e-45  Score=364.67  Aligned_cols=267  Identities=22%  Similarity=0.327  Sum_probs=197.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||||++....... ...+.+|+.+|+.++||||+++++++.+.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   72 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE   72 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred             CceEEEEEEcCCCCEEEEEEEECC---------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence            479999999999999999999875         57799999997543221 12356799999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..+|||||++ |+|.+++...+. .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a  147 (324)
T 3mtl_A           73 KSLTLVFEYLD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLA  147 (324)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred             CEEEEEecccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccc
Confidence            99999999996 699998877643 6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc-----
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL-----  365 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~-----  365 (491)
                      +.......  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......     
T Consensus       148 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  225 (324)
T 3mtl_A          148 RAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW  225 (324)
T ss_dssp             ECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhc
Confidence            86543221  2234578999999999876 578999999999999999999999997653322111111000000     


Q ss_pred             C---CccchhhccCccccC----CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          366 G---DKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       366 ~---~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .   ....+.....+....    ......+..+.+||.+||+.||.+|||+.|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0   000000000000000    0011236788999999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4e-44  Score=371.88  Aligned_cols=200  Identities=22%  Similarity=0.325  Sum_probs=175.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC------CCCceeeee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL------LHPNLVKLV  205 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~  205 (491)
                      ..+|++.+.||+|+||.||+|.+..         ++..||||++.... .....+.+|+.++..+      .|+||++++
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~---------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~  165 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHK---------VHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHML  165 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECC---------CCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence            3579999999999999999999876         67899999997542 3345677888888877      578999999


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC--e
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--A  283 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~--~  283 (491)
                      +++...+..+|||||+. ++|.+++.......+++..+..++.||+.||.|||+.+   ||||||||+||||+.++.  +
T Consensus       166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCE
T ss_pred             eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcce
Confidence            99999999999999994 79999998776667999999999999999999999998   999999999999999887  9


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  350 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~  350 (491)
                      ||+|||++......     ....+||+.|+|||++.+..++.++|||||||+||||++|.+||....
T Consensus       242 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          242 KVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999999765432     223579999999999999999999999999999999999999997653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-44  Score=365.82  Aligned_cols=263  Identities=24%  Similarity=0.321  Sum_probs=198.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++.....  ...+.+.+|+.+|+.++||||+++++++.
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   94 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT   94 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence            3579999999999999999999875         678999999965432  23467889999999999999999999998


Q ss_pred             ecC------ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          210 EDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ...      ..|+||||+ +++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~  167 (367)
T 1cm8_A           95 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCEL  167 (367)
T ss_dssp             SCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred             cCCccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCE
Confidence            763      459999999 88999998763   6889999999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||+|||+++.....     ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus       168 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~  242 (367)
T 1cm8_A          168 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT  242 (367)
T ss_dssp             EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999999876432     234678999999999887 689999999999999999999999997643221111110000


Q ss_pred             cc--------cCC--ccchhhccCcc---ccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 PH--------LGD--KRRFYRLLDPR---LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~~--------~~~--~~~~~~~~~~~---l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..        +..  ...+...+...   .........+..+.+||.+||..||.+|||+.+++++
T Consensus       243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            00        000  00000000000   0001122346889999999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3e-44  Score=379.52  Aligned_cols=251  Identities=26%  Similarity=0.347  Sum_probs=200.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||+|+||+||+|++..         ++..||||++.....  .....+.+|+.+|+.++|||||++++++.+
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  107 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKV---------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED  107 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETT---------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             cCeEEeeEEecCCCEEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            469999999999999999999876         677999999976532  335678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---CCCeEEec
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSD  287 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~---~~~~kL~D  287 (491)
                      .+..|||||||++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.   ++.+||+|
T Consensus       108 ~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D  182 (494)
T 3lij_A          108 KRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD  182 (494)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEE
Confidence            999999999999999999887664  6889999999999999999999988   999999999999975   45599999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ||++.......   .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||...........+......   
T Consensus       183 fG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---  255 (494)
T 3lij_A          183 FGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT---  255 (494)
T ss_dssp             CTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---
T ss_pred             CCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---
Confidence            99998764432   223467999999999876 57999999999999999999999999764322111111100000   


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                             ++    .......+..+.+||.+||+.||.+|||+.+++++
T Consensus       256 -------~~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          256 -------FD----SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             -------CC----SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -------CC----chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                   00    00011236789999999999999999999999976

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.8e-44  Score=352.53  Aligned_cols=252  Identities=25%  Similarity=0.354  Sum_probs=203.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc------cHHHHHHHHHHHhcCCCCceeeeee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLLHPNLVKLVG  206 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~  206 (491)
                      ++|.+.+.||+|+||.||+|.+..         ++..||+|++......      ..+.+.+|+.+|+.+.||||+++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   75 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKG---------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD   75 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcC---------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhh
Confidence            469999999999999999999875         5779999998754321      3577899999999999999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC----C
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----N  282 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~----~  282 (491)
                      ++.+.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~  150 (283)
T 3bhy_A           76 IFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPR  150 (283)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCC
T ss_pred             eecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCc
Confidence            9999999999999999999999997654  6899999999999999999999988   99999999999998877    8


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      +||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......   ......
T Consensus       151 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~  224 (283)
T 3bhy_A          151 IKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLTNIS  224 (283)
T ss_dssp             EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH
T ss_pred             eEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHHHhH
Confidence            99999999987644321   234579999999999998999999999999999999999999996543211   111000


Q ss_pred             cccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..   ...    ...    ......+..+.+|+.+||..||.+|||+.+++++
T Consensus       225 ~~---~~~----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          225 AV---NYD----FDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             TT---CCC----CCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             hc---ccC----Ccc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            00   000    000    0011236788999999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=366.60  Aligned_cols=258  Identities=28%  Similarity=0.371  Sum_probs=206.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc----ccHHHHHHHHHHHhcC-CCCceeeeeeE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l-~HpnIv~l~~~  207 (491)
                      ++|.+.+.||+|+||.||+|++....      .++..||||++.....    ...+.+.+|+.+|..+ .||||++++++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  127 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGH------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA  127 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSST------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccC------CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence            47999999999999999999985321      2678999999975422    2335577899999999 69999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +...+..+|||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~D  202 (355)
T 1vzo_A          128 FQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD  202 (355)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESC
T ss_pred             EeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEee
Confidence            999999999999999999999997754  6889999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      ||+++....... ......+||+.|+|||++.+  ..++.++|||||||+||||++|..||...........+  .....
T Consensus       203 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~  279 (355)
T 1vzo_A          203 FGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRIL  279 (355)
T ss_dssp             SSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHH
T ss_pred             CCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHh
Confidence            999986543222 22334689999999999985  35789999999999999999999999754433221111  11110


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  416 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~L  416 (491)
                      ..            ...++...+..+.+||.+||..||.+||     ++.+++++.
T Consensus       280 ~~------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          280 KS------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HC------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             cc------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            00            0112233467899999999999999999     999999774

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.6e-44  Score=361.59  Aligned_cols=267  Identities=27%  Similarity=0.412  Sum_probs=201.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++......  ..+.+.+|+.+++.++||||+++++++.+
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   95 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK   95 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETT---------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECC---------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence            469999999999999999999876         6779999998655332  23567899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  170 (331)
T 4aaa_A           96 KKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGF  170 (331)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCC
Confidence            999999999999988888765543  6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc----
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL----  365 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~----  365 (491)
                      +........  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.......    
T Consensus       171 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (331)
T 4aaa_A          171 ARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH  248 (331)
T ss_dssp             C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence            986643322  22345799999999999875 78999999999999999999999997653221111110000000    


Q ss_pred             ----CCccchhhccCccccCC-----CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          366 ----GDKRRFYRLLDPRLEGH-----FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       366 ----~~~~~~~~~~~~~l~~~-----~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          .....+.....+.+...     .....+..+.+||.+||+.||.+|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                00000000000111100     111336789999999999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.4e-44  Score=380.95  Aligned_cols=251  Identities=26%  Similarity=0.376  Sum_probs=206.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++.....   .....+.+|+.+|+.++||||+++++++.
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   96 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKI---------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE   96 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECC---------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            469999999999999999999876         677999999976532   34577899999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE---CCCCCeEEe
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLS  286 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl---~~~~~~kL~  286 (491)
                      +.+..++|||||.+|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||   +.++.+||+
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~  171 (484)
T 3nyv_A           97 DKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRII  171 (484)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEE
Confidence            9999999999999999999987654  6899999999999999999999988   9999999999999   567899999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||+++.......   ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.......   ......... 
T Consensus       172 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~-  243 (484)
T 3nyv_A          172 DFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKKVEKGK-  243 (484)
T ss_dssp             CTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCC-
T ss_pred             eeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHcCC-
Confidence            9999987654322   234679999999998865 79999999999999999999999997643221   111111000 


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        ..        +........+..+.+||.+||+.||.+|||+.+++++
T Consensus       244 --~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          244 --YT--------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             --CC--------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --CC--------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence              00        0000112336889999999999999999999999976

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.9e-44  Score=360.94  Aligned_cols=269  Identities=24%  Similarity=0.318  Sum_probs=203.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.+.||+|+||.||+|++..         +|..||||++......  ....+.+|+.+|+.++||||+++++++..
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   87 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   87 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETT---------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cceeEEEEEecCCCcEEEEEEECC---------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence            479999999999999999999875         6779999998655322  24578899999999999999999999987


Q ss_pred             c--------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          211 D--------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       211 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      .        +..+|||||+. ++|.+.+.... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~  162 (351)
T 3mi9_A           88 KASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGV  162 (351)
T ss_dssp             C--------CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred             cccccccCCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCC
Confidence            3        46899999996 57887776543 36899999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCC--ceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011180          283 AKLSDFGLAKDAPEDGK--THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~--~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  359 (491)
                      +||+|||+++.......  .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.
T Consensus       163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  242 (351)
T 3mi9_A          163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS  242 (351)
T ss_dssp             EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            99999999986643221  122234678999999999876 568999999999999999999999997654322211111


Q ss_pred             hhhcccCC-----c--cchhhccCccccCCCCh-------hhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          360 WARPHLGD-----K--RRFYRLLDPRLEGHFSI-------KGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       360 ~~~~~~~~-----~--~~~~~~~~~~l~~~~~~-------~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ........     .  ...+..+..........       ..+..+.+||.+||+.||.+|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            11000000     0  00000000000000000       014568999999999999999999999976

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5e-44  Score=386.88  Aligned_cols=258  Identities=25%  Similarity=0.381  Sum_probs=204.7

Q ss_pred             cCCCcCc-ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+ .||+|+||.||+|.+....       ++..||||+++.... ...+++.+|+++|+.++|||||++++++..
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSS-------CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCC-------CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            3444455 7999999999999886421       466899999976532 346789999999999999999999999876


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                       +..+||||||++|+|.+++.... ..+++..++.++.||+.||+|||+.+   ||||||||+||||+.++.+||+|||+
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGl  482 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGL  482 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCST
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccC
Confidence             56899999999999999997653 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          291 AKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       291 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ++........ .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.......   +.......    
T Consensus       483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~~----  555 (613)
T 2ozo_A          483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQG----  555 (613)
T ss_dssp             TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHHHTT----
T ss_pred             cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcC----
Confidence            9876543221 11122346789999999999999999999999999999998 999997643322   11111100    


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                                ....++..++..+.+||.+||..||.+||++.+|++.|+.+
T Consensus       556 ----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          556 ----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                      01122334578999999999999999999999999999865

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-44  Score=362.40  Aligned_cols=270  Identities=25%  Similarity=0.323  Sum_probs=199.8

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc-----HHHHHHHHHHHhcCCCCceeeee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGNLLHPNLVKLV  205 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~il~~l~HpnIv~l~  205 (491)
                      ..++|.+.+.||+|+||.||+|.+..         +|..||||++.......     .+.+.+|+.+++.++||||++++
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   78 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL   78 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence            34689999999999999999998865         67799999997543221     24678999999999999999999


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      +++.+.+..++||||+++ +|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  153 (346)
T 1ua2_A           79 DAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKL  153 (346)
T ss_dssp             EEECCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred             EEEeeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEE
Confidence            999999999999999965 8988886543 36888889999999999999999998   999999999999999999999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh-Hhh-h
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-R  362 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~-~  362 (491)
                      +|||+++.......  .....+||+.|+|||++.+. .++.++|||||||++|||++|.+||...........+ ... .
T Consensus       154 ~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~  231 (346)
T 1ua2_A          154 ADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT  231 (346)
T ss_dssp             CCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             EecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCC
Confidence            99999987644322  22346799999999998764 5899999999999999999999999764322111110 000 0


Q ss_pred             cccCCccchhhccCccccC--------CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          363 PHLGDKRRFYRLLDPRLEG--------HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~--------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      +............+.....        ......+..+.+||.+||..||.+|||+.|++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            0000000000000000000        00123367899999999999999999999999763

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.1e-44  Score=378.65  Aligned_cols=252  Identities=26%  Similarity=0.344  Sum_probs=203.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-------------ccHHHHHHHHHHHhcCCC
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGNLLH  198 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~il~~l~H  198 (491)
                      .++|.+.+.||+|+||+||+|.+..         ++..||||++.....             ...+.+.+|+.+|+.|+|
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  105 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKN---------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH  105 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC
T ss_pred             ccceEEEeEecccCCeEEEEEEECC---------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999999999999876         677999999976432             224678899999999999


Q ss_pred             CceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC
Q 011180          199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  278 (491)
Q Consensus       199 pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~  278 (491)
                      |||+++++++.+....|||||||++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus       106 pniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~  180 (504)
T 3q5i_A          106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLE  180 (504)
T ss_dssp             TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred             CCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEe
Confidence            999999999999999999999999999999987764  6899999999999999999999988   99999999999998


Q ss_pred             CCC---CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011180          279 ADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  355 (491)
Q Consensus       279 ~~~---~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~  355 (491)
                      .++   .+||+|||++........   ....+||+.|+|||++. +.++.++|||||||++|+|++|..||.........
T Consensus       181 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  256 (504)
T 3q5i_A          181 NKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII  256 (504)
T ss_dssp             STTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             cCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            775   699999999987654322   23467999999999876 56999999999999999999999999764322111


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..+....  .    .    ++..    .....+..+.+||.+||..||.+|||+.+++++
T Consensus       257 ~~i~~~~--~----~----~~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          257 KKVEKGK--Y----Y----FDFN----DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHHHCC--C----C----CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHcCC--C----C----CCcc----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1111000  0    0    0000    001236789999999999999999999999976

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.5e-44  Score=351.24  Aligned_cols=246  Identities=22%  Similarity=0.264  Sum_probs=200.4

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++.....  ....++.+|+.++..+ .||||+++++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~   80 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRL---------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW   80 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcC---------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence            3579999999999999999999875         577999999976432  3456788999999999 899999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC------
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD------  280 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~------  280 (491)
                      .+.+..++||||+++++|.+++....  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+      
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~  157 (289)
T 1x8b_A           81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA  157 (289)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccc
Confidence            99999999999999999999997642  136899999999999999999999988   9999999999999844      


Q ss_pred             -------------CCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCC
Q 011180          281 -------------YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSM  346 (491)
Q Consensus       281 -------------~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf  346 (491)
                                   ..+||+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++
T Consensus       158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             ------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             ccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence                         479999999998765422      23589999999999765 6678999999999999999998876


Q ss_pred             CCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          347 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ....     .........               ...++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       232 ~~~~-----~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          232 RNGD-----QWHEIRQGR---------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             SSSH-----HHHHHHTTC---------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             cchh-----HHHHHHcCC---------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            4321     111111000               011122336789999999999999999999999976

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3e-44  Score=378.76  Aligned_cols=251  Identities=26%  Similarity=0.357  Sum_probs=203.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||+|+||+||+|.+..         ++..||||++....  ......+.+|+.+|+.++||||+++++++.+
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   92 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED   92 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETT---------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence            369999999999999999999875         67799999986432  2345678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC---CCCCeEEec
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSD  287 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~---~~~~~kL~D  287 (491)
                      .+..|+|||||.+|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+   .++.+||+|
T Consensus        93 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D  167 (486)
T 3mwu_A           93 SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIID  167 (486)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEE
Confidence            999999999999999999987764  6899999999999999999999988   99999999999995   456899999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ||+++......   .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||...........+...  ... 
T Consensus       168 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~-  240 (486)
T 3mwu_A          168 FGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG--KYA-  240 (486)
T ss_dssp             CSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCC-
T ss_pred             CCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC-
Confidence            99998764432   2234679999999998865 6999999999999999999999999754322111111100  000 


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                 .........+..+.+||.+||+.||.+|||+.+++++
T Consensus       241 -----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          241 -----------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -----------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -----------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                       0000112336789999999999999999999999987

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=358.03  Aligned_cols=276  Identities=25%  Similarity=0.374  Sum_probs=212.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|++.+.||+|+||.||+|.+...     ...++..||||++........+.+.+|+.+|+.++||||+++++++...+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPL-----QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTT-----SSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             HHceeeeeeccCCCeEEEEEEeccc-----cCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            4689999999999999999986421     12368899999998766556678999999999999999999999987654


Q ss_pred             --ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          213 --QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       213 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                        ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcc
Confidence              7899999999999999997764 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCce-eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc-
Q 011180          291 AKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK-  368 (491)
Q Consensus       291 a~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-  368 (491)
                      +.......... ......|+..|+|||++.+..++.++|||||||++|||++|..||.....    ............. 
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~  267 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQM  267 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhh
Confidence            98775443221 12234578889999999999999999999999999999999988753210    0000000000000 


Q ss_pred             --cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          369 --RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       369 --~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                        ..+...+........+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              00001111111112233457889999999999999999999999999987643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=360.41  Aligned_cols=261  Identities=29%  Similarity=0.403  Sum_probs=202.9

Q ss_pred             hhhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCcee
Q 011180          124 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLV  202 (491)
Q Consensus       124 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv  202 (491)
                      .+.++....++|++.+.||+|+||.||+|.+..         ++..||||++.... .....+.+|+.++..+ .||||+
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~   84 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA   84 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECC---------CCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCee
Confidence            334444556789999999999999999999875         57799999997553 3346788999999999 799999


Q ss_pred             eeeeEEee------cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 011180          203 KLVGYCIE------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       203 ~l~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NIL  276 (491)
                      ++++++..      .+..+|||||+++++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus        85 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl  161 (326)
T 2x7f_A           85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVL  161 (326)
T ss_dssp             CEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEE
T ss_pred             eeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEE
Confidence            99999987      467899999999999999998765457899999999999999999999988   999999999999


Q ss_pred             ECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 011180          277 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  351 (491)
Q Consensus       277 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~  351 (491)
                      ++.++.+||+|||++........  ......||+.|+|||++.     +..++.++|||||||++|+|++|..||.....
T Consensus       162 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  239 (326)
T 2x7f_A          162 LTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP  239 (326)
T ss_dssp             ECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             EcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence            99999999999999986643211  123457999999999987     56789999999999999999999999965332


Q ss_pred             CCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ....  .....           ...+.   ......+..+.+||.+||..||.+|||+.+++++
T Consensus       240 ~~~~--~~~~~-----------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          240 MRAL--FLIPR-----------NPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HHHH--HHHHH-----------SCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHH--HHhhc-----------Ccccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1110  00000           00000   0112236789999999999999999999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=348.90  Aligned_cols=253  Identities=23%  Similarity=0.347  Sum_probs=202.1

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecCc
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  213 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  213 (491)
                      +|....+||+|+||.||+|.+..         ++..||||.+........+.+.+|+.+++.+.||||+++++++.+.+.
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   93 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF   93 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETT---------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             CCCCcEEEeecCcEEEEEEEECC---------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence            45666699999999999999875         577999999987665556789999999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHHhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCCeEEeccCCc
Q 011180          214 RLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLA  291 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~~kL~DFGla  291 (491)
                      .++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++. ++.+||+|||++
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~  170 (295)
T 2clq_A           94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTS  170 (295)
T ss_dssp             EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTC
T ss_pred             EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccc
Confidence            999999999999999997653 345678889999999999999999988   999999999999987 899999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~--~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ........  ......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||........   .......     
T Consensus       171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~-----  240 (295)
T 2clq_A          171 KRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGM-----  240 (295)
T ss_dssp             EESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHH-----
T ss_pred             cccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhcc-----
Confidence            87643221  123457999999999997653  88999999999999999999999954221110   0000000     


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         ....+    .++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       241 ---~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          241 ---FKVHP----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ---HCCCC----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ---ccccc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               00111    1223346789999999999999999999999865

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-44  Score=356.52  Aligned_cols=265  Identities=25%  Similarity=0.384  Sum_probs=189.1

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ...++|.+.+.||+|+||.||+|.+..         ++..||||++..... ...+++.+|+.++..++||||+++++++
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAP---------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECC---------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            445689999999999999999998765         567899999875432 3346788999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRK------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      ...+..++||||+++++|.+++...      ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~  159 (303)
T 2vwi_A           83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGS  159 (303)
T ss_dssp             ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred             eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCC
Confidence            9999999999999999999998641      2336899999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCC---ceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh
Q 011180          283 AKLSDFGLAKDAPEDGK---THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  358 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~---~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~  358 (491)
                      +||+|||++........   ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........... 
T Consensus       160 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-  238 (303)
T 2vwi_A          160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-  238 (303)
T ss_dssp             EEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-
T ss_pred             EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-
Confidence            99999999876543221   111234579999999999876 5789999999999999999999999976533221110 


Q ss_pred             HhhhcccCCccchh-hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          359 EWARPHLGDKRRFY-RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       359 ~~~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       ....   ...... ...++    ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       239 -~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          239 -TLQN---DPPSLETGVQDK----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             -HHTS---SCCCTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -Hhcc---CCCccccccccc----hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence             0000   000000 00011    1112236789999999999999999999999976

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.6e-44  Score=367.98  Aligned_cols=265  Identities=20%  Similarity=0.259  Sum_probs=206.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC--------CCceee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL--------HPNLVK  203 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--------HpnIv~  203 (491)
                      .++|.+.+.||+|+||+||+|++..         ++..||||++.... ...+.+.+|+.+|+.+.        |+||++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQ---------GKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecC---------CCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            4679999999999999999998875         67899999997542 33467889999999985        788999


Q ss_pred             eeeEEe----ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEEC
Q 011180          204 LVGYCI----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLD  278 (491)
Q Consensus       204 l~~~~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlKp~NILl~  278 (491)
                      +++++.    .....+|||||+ +++|.+.+.......+++..++.++.||+.||.|||++ +   |+||||||+||||+
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~  181 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLS  181 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEEC
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEe
Confidence            999988    456789999999 77788777766555799999999999999999999997 7   99999999999998


Q ss_pred             CCC-------------------------------------------------CeEEeccCCcccCCCCCCceeeeccccC
Q 011180          279 ADY-------------------------------------------------NAKLSDFGLAKDAPEDGKTHVSTRVMGT  309 (491)
Q Consensus       279 ~~~-------------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~Gt  309 (491)
                      .++                                                 .+||+|||++......     ....+||
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt  256 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQT  256 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSC
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCC
Confidence            775                                                 7999999999876432     2335799


Q ss_pred             CCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH---hhhcccCCc------------------
Q 011180          310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE---WARPHLGDK------------------  368 (491)
Q Consensus       310 ~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~---~~~~~~~~~------------------  368 (491)
                      +.|+|||++.+..++.++|||||||+||||++|+.||.............   .....++..                  
T Consensus       257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  336 (397)
T 1wak_A          257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK  336 (397)
T ss_dssp             GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred             CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence            99999999999999999999999999999999999997655433211110   000000000                  


Q ss_pred             cchhhccCcc---------ccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          369 RRFYRLLDPR---------LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~---------l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..+..+.+..         -...++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            0000000000         0012345667889999999999999999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=361.04  Aligned_cols=269  Identities=23%  Similarity=0.377  Sum_probs=196.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHH--HhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF--LGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~i--l~~l~HpnIv~l~~~~~  209 (491)
                      .++|++.+.||+|+||.||+|.+           ++..||||++....   ...+..|.++  +..+.||||+++++++.
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~   77 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDE   77 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccc
Confidence            35799999999999999999976           46789999997543   3344444444  55689999999998654


Q ss_pred             e-----cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEecCCCCCcE
Q 011180          210 E-----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE---------AEKPVIYRDFKTSNI  275 (491)
Q Consensus       210 ~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------~~~~iiHrDlKp~NI  275 (491)
                      .     ...++|||||+++|+|.+++...   ..++..+..++.||+.||.|||+.         +   |+||||||+||
T Consensus        78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Ni  151 (336)
T 3g2f_A           78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNV  151 (336)
T ss_dssp             EECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGE
T ss_pred             ccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceE
Confidence            3     22568999999999999999765   358889999999999999999998         6   99999999999


Q ss_pred             EECCCCCeEEeccCCcccCCCCCC------ceeeeccccCCCCCCchhhhc-------CCCCccccchhHHHHHHHHHhC
Q 011180          276 LLDADYNAKLSDFGLAKDAPEDGK------THVSTRVMGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEMLTG  342 (491)
Q Consensus       276 Ll~~~~~~kL~DFGla~~~~~~~~------~~~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~elltG  342 (491)
                      ||+.++.+||+|||+++.......      .......+||+.|+|||++.+       ..++.++|||||||++|||++|
T Consensus       152 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g  231 (336)
T 3g2f_A          152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR  231 (336)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence            999999999999999987643221      112234579999999999976       4566789999999999999999


Q ss_pred             CCCCCCCCCCCcchhh-HhhhcccCCccchh-----hccCccccCCC--ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011180          343 RRSMDKNRPNGEHNLV-EWARPHLGDKRRFY-----RLLDPRLEGHF--SIKGSQKATQLAAQCLSRDPKARPRMSEVVE  414 (491)
Q Consensus       343 ~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~l~~~~--~~~~~~~l~~li~~cL~~dP~~RPt~~evl~  414 (491)
                      ..||............ ..............     ....+.+...+  ....+..+.+||.+||..||.+|||+.++++
T Consensus       232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence            7776443322211110 00000000000000     00111111111  1235778999999999999999999999999


Q ss_pred             HhhcCc
Q 011180          415 TLKPLQ  420 (491)
Q Consensus       415 ~L~~l~  420 (491)
                      .|+.+.
T Consensus       312 ~L~~ll  317 (336)
T 3g2f_A          312 RMAELM  317 (336)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            998764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.7e-44  Score=353.94  Aligned_cols=262  Identities=27%  Similarity=0.410  Sum_probs=200.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||.||+|.+....      +.+..||||++.....   ...+.+.+|+++++.++||||+++++++.
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   91 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCC------CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            47999999999999999999875421      1345799999876532   33567889999999999999999999988


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.. .++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg  166 (291)
T 1u46_A           92 TPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFG  166 (291)
T ss_dssp             SSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             cCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccc
Confidence            764 899999999999999997653 25889999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCce-eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          290 LAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       290 la~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ++.......... ......||..|+|||++.+..++.++|||||||++|+|++ |..||......   .......   ..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~---~~  240 (291)
T 1u46_A          167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKID---KE  240 (291)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH---TS
T ss_pred             ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHHHH---cc
Confidence            998775433222 2233567889999999999999999999999999999999 99999654321   1111110   00


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      .          .....+...+..+.+||.+||..||.+|||+.++++.|+.++.
T Consensus       241 ~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          241 G----------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             C----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             C----------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            0          0011122346889999999999999999999999999987654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=8.9e-44  Score=355.50  Aligned_cols=258  Identities=22%  Similarity=0.285  Sum_probs=201.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEEee-
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIE-  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~-  210 (491)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++...   ..+.+.+|+.+|+.+. ||||+++++++.+ 
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~  103 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDP  103 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CceEEEEEecccCCeEEEEEEECC---------CCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence            579999999999999999999876         5779999999754   3467899999999997 9999999999988 


Q ss_pred             -cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-CeEEecc
Q 011180          211 -DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDF  288 (491)
Q Consensus       211 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kL~DF  288 (491)
                       ....++||||+.+++|.+++.     .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+||
T Consensus       104 ~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Df  175 (330)
T 3nsz_A          104 VSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDW  175 (330)
T ss_dssp             TTCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CCCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeC
Confidence             567899999999999999874     3788899999999999999999988   99999999999999776 8999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC-
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-  366 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~-  366 (491)
                      |+++.......   .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......... +.... ..++ 
T Consensus       176 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~-~~~~~  250 (330)
T 3nsz_A          176 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIA-KVLGT  250 (330)
T ss_dssp             TTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHH-HHHCH
T ss_pred             CCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHH-HhcCC
Confidence            99987654322   233578999999999887 67999999999999999999999999543321110 00000 0000 


Q ss_pred             -------------Cccchhhcc--------CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 -------------DKRRFYRLL--------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 -------------~~~~~~~~~--------~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                   ....+...+        ............+..+.+||.+||+.||.+|||+++++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                         000000000        0001111122247889999999999999999999999976

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-44  Score=366.50  Aligned_cols=264  Identities=23%  Similarity=0.332  Sum_probs=199.0

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ....++|.+.+.||+|+||+||+|.+..         +|..||||++..+..    ...+|+.+|+.++||||+++++++
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~   69 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYF   69 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhhee
Confidence            3456789999999999999999999876         678999999875532    234799999999999999999998


Q ss_pred             eec--------------------------------------CceEEEEEecCCCChHHHhhh--CCCCCCCHHHHHHHHH
Q 011180          209 IED--------------------------------------DQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIAL  248 (491)
Q Consensus       209 ~~~--------------------------------------~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~  248 (491)
                      ...                                      ...+|||||++ ++|.+.+..  .....+++..+..++.
T Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~  148 (383)
T 3eb0_A           70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY  148 (383)
T ss_dssp             EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred             eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence            543                                      33789999996 588877753  2234789999999999


Q ss_pred             HHHHHHHHHHhcCCCCeEecCCCCCcEEEC-CCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCcc
Q 011180          249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSK  326 (491)
Q Consensus       249 qi~~aL~yLH~~~~~~iiHrDlKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~  326 (491)
                      ||+.||.|||+.+   |+||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||++.+. .++.+
T Consensus       149 qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~  222 (383)
T 3eb0_A          149 QLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPS  222 (383)
T ss_dssp             HHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred             HHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcc
Confidence            9999999999988   99999999999997 688999999999987644322   2345789999999998765 58999


Q ss_pred             ccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc--c------------chhhccCccccCCCChhhHHHHH
Q 011180          327 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--R------------RFYRLLDPRLEGHFSIKGSQKAT  392 (491)
Q Consensus       327 ~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--~------------~~~~~~~~~l~~~~~~~~~~~l~  392 (491)
                      +|||||||++|||++|+.||......+....  ... .++..  .            .+...........++...+..+.
T Consensus       223 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~--i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (383)
T 3eb0_A          223 IDLWSIGCVFGELILGKPLFSGETSIDQLVR--IIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI  299 (383)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHH
T ss_pred             hhhhhHHHHHHHHHhCCCCCCCCChHHHHHH--HHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHH
Confidence            9999999999999999999976432221111  100 00000  0            00000000111112333477899


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 011180          393 QLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       393 ~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      +||.+||..||.+|||+.|++++
T Consensus       300 ~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          300 DLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHccCChhhCCCHHHHhcC
Confidence            99999999999999999999975

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.4e-44  Score=351.97  Aligned_cols=251  Identities=26%  Similarity=0.397  Sum_probs=208.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      +.|.+.+.||+|+||.||+|.+..         ++..||||++..... ...+.+.+|+.+++.+.||||+++++++.+.
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   92 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD   92 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             HHHHHhhhhcccCCeEEEEEEECC---------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            468999999999999999998865         677999999976543 3457789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~  166 (303)
T 3a7i_A           93 TKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA  166 (303)
T ss_dssp             TEEEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccc
Confidence            9999999999999999998643   6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   .......        
T Consensus       167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~--------  233 (303)
T 3a7i_A          167 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLIPK--------  233 (303)
T ss_dssp             EECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHH--------
T ss_pred             eecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHHhhc--------
Confidence            87643321  1234579999999999999999999999999999999999999996542211   1111000        


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                        ...+.    +....+..+.+||.+||..||.+|||+.+++++.-
T Consensus       234 --~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          234 --NNPPT----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             --SCCCC----CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             --CCCCC----CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence              00111    12233678999999999999999999999998743

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.2e-44  Score=347.93  Aligned_cols=250  Identities=26%  Similarity=0.357  Sum_probs=198.7

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      ..++|.+.+.||+|+||.||+|.+..         +|..||||++....   ....+.+.+|+.+++.++||||++++++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   79 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQL---------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV   79 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECC---------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            34689999999999999999999875         57799999986542   1234678899999999999999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +.+.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d  154 (276)
T 2h6d_A           80 ISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIAD  154 (276)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECC
T ss_pred             EecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEee
Confidence            999999999999999999999997664  5889999999999999999999998   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      ||++........   .....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||......   .......... 
T Consensus       155 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~-  227 (276)
T 2h6d_A          155 FGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKIRGGV-  227 (276)
T ss_dssp             CCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCC-
T ss_pred             cccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhhcCc-
Confidence            999987654321   234578999999999987765 68999999999999999999999653211   1111111000 


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                    ..++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       228 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 --------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                          01122236788999999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=352.51  Aligned_cols=253  Identities=26%  Similarity=0.401  Sum_probs=202.6

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ..++|.+.+.||+|+||.||+|.+..         +|..||||++....  ..+.+.+|+.++..+.||||+++++++..
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   95 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK   95 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETT---------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECC---------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence            34579999999999999999999875         57799999997653  34678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  171 (314)
T 3com_A           96 NTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGV  171 (314)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeeccc
Confidence            999999999999999999986443 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........   .......      
T Consensus       172 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~------  240 (314)
T 3com_A          172 AGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA---IFMIPTN------  240 (314)
T ss_dssp             CEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHS------
T ss_pred             chhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHhcC------
Confidence            976643221  12345799999999999988999999999999999999999999965322111   0000000      


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          ..+.+  ..+...+..+.+||.+||..||.+|||+.+++++
T Consensus       241 ----~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          241 ----PPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             ----CCCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ----CCccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                00000  1112236789999999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-43  Score=348.41  Aligned_cols=251  Identities=25%  Similarity=0.398  Sum_probs=201.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      +.|.+.+.||+|+||.||+|.+..         ++..||+|++.....  ...+.+.+|+.+|+.++||||+++++++..
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES   96 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecC---------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence            358888999999999999998876         677899999875432  334678899999999999999999999876


Q ss_pred             ----cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC-CCCCeEE
Q 011180          211 ----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKL  285 (491)
Q Consensus       211 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~-~~~~~kL  285 (491)
                          ....++||||+++++|.+++....  .+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl  173 (290)
T 1t4h_A           97 TVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKI  173 (290)
T ss_dssp             ESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEE
T ss_pred             ccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEE
Confidence                345799999999999999997654  6889999999999999999999876 4599999999999997 7899999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      +|||++.......    .....||+.|+|||++. +.++.++|||||||++|+|++|+.||.......  ..........
T Consensus       174 ~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~  246 (290)
T 1t4h_A          174 GDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGV  246 (290)
T ss_dssp             CCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTTTC
T ss_pred             eeCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHHHHhccC
Confidence            9999997654322    23457999999999876 569999999999999999999999996532211  1111110000


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                   ....++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       247 -------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          247 -------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                         0001112225679999999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.5e-43  Score=359.53  Aligned_cols=268  Identities=23%  Similarity=0.304  Sum_probs=204.4

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++..... ...+.+.+|+++|..++||||+++++++..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   96 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNL---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA   96 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECC---------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence            3579999999999999999999875         678999999975432 234678899999999999999999999876


Q ss_pred             c-----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          211 D-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       211 ~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      .     ...++||||+. ++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||
T Consensus        97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl  169 (364)
T 3qyz_A           97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKI  169 (364)
T ss_dssp             SSTTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred             CCccccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEE
Confidence            5     36899999995 6999988654   5899999999999999999999988   999999999999999999999


Q ss_pred             eccCCcccCCCCCCc-eeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          286 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       286 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      +|||+++........ ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus       170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  249 (364)
T 3qyz_A          170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG  249 (364)
T ss_dssp             CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred             EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence            999999876432211 11234689999999998764 5589999999999999999999999976543332221110000


Q ss_pred             ccC--------Cc--cchhhccCccc---cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLG--------DK--RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~--------~~--~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...        ..  ..+...+....   ...+....+..+.+||.+||..||.+|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000        00  00000000000   000112236789999999999999999999999976

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.6e-43  Score=359.69  Aligned_cols=255  Identities=25%  Similarity=0.371  Sum_probs=205.3

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--------cHHHHHHHHHHHhcC-CCCc
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGNL-LHPN  200 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l-~Hpn  200 (491)
                      ...++|.+.+.||+|+||.||+|.+..         +|..||||++......        ..+.+.+|+.++..+ .|||
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~  161 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRA---------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH  161 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECC---------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            344679999999999999999999875         5779999999754311        134578899999999 7999


Q ss_pred             eeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 011180          201 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  280 (491)
Q Consensus       201 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~  280 (491)
                      |+++++++...+..+|||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus       162 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~  236 (365)
T 2y7j_A          162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN  236 (365)
T ss_dssp             BCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred             EeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence            9999999999999999999999999999997654  6899999999999999999999988   9999999999999999


Q ss_pred             CCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC------CCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 011180          281 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  354 (491)
Q Consensus       281 ~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~  354 (491)
                      +.+||+|||++........   ....+||+.|+|||++.+.      .++.++|||||||++|+|++|..||......  
T Consensus       237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--  311 (365)
T 2y7j_A          237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--  311 (365)
T ss_dssp             CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred             CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--
Confidence            9999999999987654322   2346799999999998643      5888999999999999999999999653211  


Q ss_pred             chhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          355 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       .........   ...+   ..+.     ....+..+.+||.+||..||.+|||+.+++++
T Consensus       312 -~~~~~i~~~---~~~~---~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          312 -LMLRMIMEG---QYQF---SSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             -HHHHHHHHT---CCCC---CHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -HHHHHHHhC---CCCC---CCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             111111000   0000   0000     01125679999999999999999999999976

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1e-43  Score=367.80  Aligned_cols=260  Identities=27%  Similarity=0.378  Sum_probs=196.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .+|.+.+.||+|+||+||+|++..         +|..||||++..+..    .+.+|+++|+.|+|||||+++++|....
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~  120 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG  120 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECC---------CCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence            368999999999999999999876         677999999865432    2347999999999999999999986432


Q ss_pred             ------ceEEEEEecCCCChHHHhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC-CCe
Q 011180          213 ------QRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNA  283 (491)
Q Consensus       213 ------~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~-~~~  283 (491)
                            .++|||||+++ +|.+.+..  .....+++..++.++.||+.||.|||+.+   |+||||||+||||+.+ +.+
T Consensus       121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~  196 (420)
T 1j1b_A          121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL  196 (420)
T ss_dssp             TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEE
T ss_pred             CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeE
Confidence                  36799999965 67666542  22347899999999999999999999988   9999999999999965 578


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||+|||+++.......   ....+||+.|+|||++.+. .|+.++|||||||+||||++|+.||.......  .+.....
T Consensus       197 kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~  271 (420)
T 1j1b_A          197 KLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIK  271 (420)
T ss_dssp             EECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred             EeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence            9999999987643322   2346799999999998765 79999999999999999999999997643221  1111111


Q ss_pred             cccCCc-cchhhccCc--------cc-----cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 PHLGDK-RRFYRLLDP--------RL-----EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~~~~~~-~~~~~~~~~--------~l-----~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       .++.. ......+++        .+     ...+....+..+.+||.+||..||.+|||+.|+++|
T Consensus       272 -~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          272 -VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             -HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence             00000 000000000        00     001223346889999999999999999999999976

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.9e-44  Score=365.68  Aligned_cols=254  Identities=15%  Similarity=0.062  Sum_probs=184.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHH---HHHhcCCCCceeeee-
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV---NFLGNLLHPNLVKLV-  205 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~il~~l~HpnIv~l~-  205 (491)
                      .+|.+.+.||+|+||.||+|.+..         +|..||||++.....   ...+.+.+|+   .+|+. +||||++++ 
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~  131 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVE---------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR  131 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred             eeeeeeeeccCCCCEEEEEEEECC---------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence            458899999999999999999876         678999999987643   2234567775   45555 699988755 


Q ss_pred             ------eEEeecC-----------------ceEEEEEecCCCChHHHhhhCCCCCCCHHHH------HHHHHHHHHHHHH
Q 011180          206 ------GYCIEDD-----------------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIR------MKIALGAAKGLAF  256 (491)
Q Consensus       206 ------~~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~qi~~aL~y  256 (491)
                            +++...+                 ..|||||||+ |+|.+++...+. .+++..+      ..++.||+.||+|
T Consensus       132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~  209 (371)
T 3q60_A          132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAAN  209 (371)
T ss_dssp             CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHH
Confidence                  4444332                 3799999997 899999976432 3455555      6788999999999


Q ss_pred             HHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc--CCCCccccchhHHH
Q 011180          257 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGV  334 (491)
Q Consensus       257 LH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwSlGv  334 (491)
                      ||+++   |+||||||+||||+.++.+||+|||+++.....     .....||+.|+|||++.+  ..++.++|||||||
T Consensus       210 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~  281 (371)
T 3q60_A          210 LQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGL  281 (371)
T ss_dssp             HHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred             HHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence            99988   999999999999999999999999999876421     124567899999999987  68999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011180          335 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  414 (491)
Q Consensus       335 il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~  414 (491)
                      +||||++|+.||............   ....      .......+........+..+.+||.+||+.||.+|||+.++++
T Consensus       282 il~elltg~~Pf~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          282 SIYRVWCLFLPFGLVTPGIKGSWK---RPSL------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHHHSSCSTTBCCTTCTTCCC---BCCT------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHHHHhCCCCCCCcCcccccchh---hhhh------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999999999999766433211110   0000      0000001111111234788999999999999999999999986


Q ss_pred             H
Q 011180          415 T  415 (491)
Q Consensus       415 ~  415 (491)
                      +
T Consensus       353 h  353 (371)
T 3q60_A          353 T  353 (371)
T ss_dssp             S
T ss_pred             C
Confidence            4

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.4e-43  Score=353.27  Aligned_cols=253  Identities=26%  Similarity=0.354  Sum_probs=199.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--------ccHHHHHHHHHHHhcCCCCceee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGNLLHPNLVK  203 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~HpnIv~  203 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++.....        .....+.+|+.+|+.+.||||++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   79 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK   79 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCC
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcC---------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCce
Confidence            3579999999999999999999875         678999999975432        12235789999999999999999


Q ss_pred             eeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC-
Q 011180          204 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-  282 (491)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~-  282 (491)
                      +++++...+ .++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++. 
T Consensus        80 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  153 (322)
T 2ycf_A           80 IKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED  153 (322)
T ss_dssp             EEEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSS
T ss_pred             EeeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCC
Confidence            999987654 899999999999999886543  6899999999999999999999988   999999999999987654 


Q ss_pred             --eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011180          283 --AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  357 (491)
Q Consensus       283 --~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~  357 (491)
                        +||+|||++.......   ......||+.|+|||++.   ...++.++|||||||++|+|++|..||.........  
T Consensus       154 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--  228 (322)
T 2ycf_A          154 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--  228 (322)
T ss_dssp             CCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--
T ss_pred             CeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--
Confidence              9999999998764321   123467999999999874   467899999999999999999999999765433221  


Q ss_pred             hHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ........   ..    ..+..    ....+..+.+||.+||..||.+|||+.+++++
T Consensus       229 ~~~~~~~~---~~----~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          229 KDQITSGK---YN----FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHHHHHTC---CC----CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhCc---cc----cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            11111000   00    00000    01226789999999999999999999999975

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.9e-44  Score=350.29  Aligned_cols=259  Identities=24%  Similarity=0.339  Sum_probs=205.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.+.||+|+||.||+|.+..         ++..||+|++.....  ...+.+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   76 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID   76 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec
Confidence            579999999999999999999875         577999999976543  234568899999999999999999998864


Q ss_pred             --cCceEEEEEecCCCChHHHhhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEECCCCCeE
Q 011180          211 --DDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEA--EKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       211 --~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                        ....++||||+++++|.+++....  ...+++..++.++.||+.||.|||+.+  ..+|+||||||+|||++.++.+|
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~k  156 (279)
T 2w5a_A           77 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  156 (279)
T ss_dssp             GGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEE
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEE
Confidence              567899999999999999986532  335899999999999999999999976  23499999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      |+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   .........
T Consensus       157 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~~  231 (279)
T 2w5a_A          157 LGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIREG  231 (279)
T ss_dssp             ECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHT
T ss_pred             EecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHHHhhc
Confidence            999999987643221  123357999999999999999999999999999999999999999754321   111111100


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                        .            ...++...+..+.+||.+||+.||.+|||+.+|++++..-
T Consensus       232 --~------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          232 --K------------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             --C------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             --c------------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence              0            0011223467899999999999999999999999887543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.6e-44  Score=387.08  Aligned_cols=251  Identities=27%  Similarity=0.396  Sum_probs=200.6

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL  216 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  216 (491)
                      +.||+|+||.||+|.+...       .++..||||+++....  ...+++.+|+++|..|+|||||++++++.. +..+|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l  446 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML  446 (635)
T ss_dssp             EEEEECSSEEEEEEEEECS-------SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CEeccCCCEEEEEEEEcCC-------CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence            4799999999999977532       1567899999976432  235789999999999999999999999864 56899


Q ss_pred             EEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCC
Q 011180          217 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  296 (491)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~  296 (491)
                      |||||++|+|.+++....  .+++..++.|+.||+.||+|||+.+   ||||||||+||||+.++.+||+|||+++....
T Consensus       447 v~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  521 (635)
T ss_dssp             EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred             EEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence            999999999999997654  6889999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          297 DGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       297 ~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      .... .......||+.|+|||++.+..++.++|||||||+||||++ |+.||.......   +......           
T Consensus       522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~-----------  587 (635)
T 4fl3_A          522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEK-----------  587 (635)
T ss_dssp             -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT-----------
T ss_pred             CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc-----------
Confidence            3221 22233457889999999999999999999999999999998 999996543221   1111110           


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                         ......+..++..+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus       588 ---~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          588 ---GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               011122334578899999999999999999999999999865

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=364.75  Aligned_cols=272  Identities=19%  Similarity=0.250  Sum_probs=206.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceee---------
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVK---------  203 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~---------  203 (491)
                      ++|.+.+.||+|+||.||+|.+...... .....+..||||++...     +.+.+|+.+++.++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~-~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTC-DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccc-cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            5799999999999999999998752110 00112678999999754     36789999999999999988         


Q ss_pred             ------eeeEEee-cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 011180          204 ------LVGYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       204 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NIL  276 (491)
                            +++++.. .+..+|||||+ +++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence                  6777766 67889999999 999999998763447999999999999999999999988   999999999999


Q ss_pred             ECCCC--CeEEeccCCcccCCCCCCce-----eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 011180          277 LDADY--NAKLSDFGLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN  349 (491)
Q Consensus       277 l~~~~--~~kL~DFGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~  349 (491)
                      ++.++  .+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  99999999998764322111     113357999999999999999999999999999999999999999754


Q ss_pred             CCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          350 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      ..... ...............   ..+..   ......+..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       272 ~~~~~-~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  336 (352)
T 2jii_A          272 LPNTE-DIMKQKQKFVDKPGP---FVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ  336 (352)
T ss_dssp             TTCHH-HHHHHHHHHHHSCCC---EECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CcCHH-HHHHHHHhccCChhh---hhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence            32211 111111100000000   00000   0001236889999999999999999999999999987644

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.2e-44  Score=354.00  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=201.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|++.+.||+|+||.||+|.+..         ++..||+|++........+.+.+|+.++..+.||||+++++++.+.
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD   88 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETT---------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred             ccceeecceeccCCCeEEEEEEEcC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence            3579999999999999999999875         5779999999876666678899999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~  164 (302)
T 2j7t_A           89 GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS  164 (302)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCC
Confidence            99999999999999999887643 36899999999999999999999988   999999999999999999999999987


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      ......  ........||+.|+|||++.     +..++.++|||||||++|+|++|..||........  .......   
T Consensus       165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~---  237 (302)
T 2j7t_A          165 AKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKS---  237 (302)
T ss_dssp             HHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHS---
T ss_pred             cccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHhcc---
Confidence            532111  01122357899999999984     56789999999999999999999999965432111  0000000   


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..        +  ....+...+..+.+||.+||..||.+|||+.+++++
T Consensus       238 ~~--------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          238 DP--------P--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             CC--------C--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             CC--------c--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            00        0  001122336789999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.1e-43  Score=354.40  Aligned_cols=265  Identities=26%  Similarity=0.383  Sum_probs=206.5

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||+|+||.||+|.+           +|..||||++...   ....+.+|++++..  ++||||+++++++
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~  105 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD  105 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE-----------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence            345799999999999999999987           3678999999643   34567889998887  7899999999999


Q ss_pred             eecC----ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCcEE
Q 011180          209 IEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH--------EEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       209 ~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~~~iiHrDlKp~NIL  276 (491)
                      ....    ..++||||+++|+|.+++...   .+++..++.++.||+.||.|||        +.+   |+||||||+|||
T Consensus       106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIl  179 (342)
T 1b6c_B          106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNIL  179 (342)
T ss_dssp             ECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEE
T ss_pred             cccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEE
Confidence            8876    789999999999999999764   5889999999999999999999        666   999999999999


Q ss_pred             ECCCCCeEEeccCCcccCCCCCCce--eeeccccCCCCCCchhhhcC------CCCccccchhHHHHHHHHHhC------
Q 011180          277 LDADYNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTG------  342 (491)
Q Consensus       277 l~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~------~~~~~~DvwSlGvil~elltG------  342 (491)
                      |+.++.+||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||++|      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            9999999999999997664433221  12345799999999998765      234689999999999999999      


Q ss_pred             ----CCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCC-CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          343 ----RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGH-FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       343 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                          ..||.......... ..+......      ..+.+.+... ....++..+.+||.+||+.||.+|||+.+|+++|+
T Consensus       260 ~~~~~~p~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSDPSV-EEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             CCCCCCTTTTTSCSSCCH-HHHHHHHTT------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             ccccccCccccCcCcccH-HHHHHHHHH------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence                67776543322111 111110000      0111111111 12355788999999999999999999999999999


Q ss_pred             cCccc
Q 011180          418 PLQNL  422 (491)
Q Consensus       418 ~l~~~  422 (491)
                      .+...
T Consensus       333 ~i~~~  337 (342)
T 1b6c_B          333 QLSQQ  337 (342)
T ss_dssp             HHHHT
T ss_pred             HHHHH
Confidence            87543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.2e-43  Score=360.91  Aligned_cols=263  Identities=25%  Similarity=0.367  Sum_probs=186.7

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++....  ....+.+.+|+.+|+.++||||+++++++.
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   98 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   98 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETT---------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            3689999999999999999998865         68899999997542  234467889999999999999999999987


Q ss_pred             ec------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          210 ED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       210 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ..      ...|+||||+ +++|.+++..   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~  171 (367)
T 2fst_X           99 PARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL  171 (367)
T ss_dssp             SCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred             cCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCE
Confidence            54      5679999999 7899988864   26899999999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||+|||+++.....     ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus       172 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~  246 (367)
T 2fst_X          172 KILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  246 (367)
T ss_dssp             EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99999999865432     234679999999999887 689999999999999999999999997654322111110000


Q ss_pred             c--------ccCCc--cchhhccCccccCC---CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 P--------HLGDK--RRFYRLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~--------~~~~~--~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .        .+...  ..+...+.......   .....+..+.+||.+||..||.+|||+.+++++
T Consensus       247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            0        00000  00000000000000   011236789999999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.5e-43  Score=358.93  Aligned_cols=261  Identities=23%  Similarity=0.291  Sum_probs=194.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++.....  ...+.+.+|+.+++.++||||+++++++.
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   94 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT   94 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECC---------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence            3579999999999999999998875         678999999976432  23466889999999999999999999998


Q ss_pred             ecC------ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          210 EDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ..+      ..||||||++ ++|.+++..    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~  166 (371)
T 2xrw_A           95 PQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  166 (371)
T ss_dssp             SCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCE
T ss_pred             cccccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCE
Confidence            765      6799999996 578888742    4889999999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      ||+|||+++......   .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........   ...
T Consensus       167 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~  240 (371)
T 2xrw_A          167 KILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK---VIE  240 (371)
T ss_dssp             EECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHC
T ss_pred             EEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHH
Confidence            999999998664321   22346799999999999999999999999999999999999999976432111100   000


Q ss_pred             ccCCc------------------------cchhhccCcccc---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDK------------------------RRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~------------------------~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .++..                        ..+...+.....   .......+..+.+||.+||..||.+|||+++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          241 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             -CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            00000                        000000000000   00011236789999999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.2e-44  Score=349.20  Aligned_cols=254  Identities=25%  Similarity=0.319  Sum_probs=188.5

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cH-HHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GH-KEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ..++|++.+.||+|+||.||+|.+..         +|..||||++...... .. +.+.++...++.+.||||+++++++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   75 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL   75 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecC---------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee
Confidence            34679999999999999999999875         6789999999765322 22 2344555568888999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEECCCCCeEE
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      .+.+..++||||++ |+|.+++..  .....+++..++.++.||+.||.|||+. +   |+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl  151 (290)
T 3fme_A           76 FREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKM  151 (290)
T ss_dssp             ECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEB
T ss_pred             eccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEE
Confidence            99999999999996 588877754  1234789999999999999999999997 8   999999999999999999999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhh----hcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      +|||++........   .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||........ .+....
T Consensus       152 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~  227 (290)
T 3fme_A          152 CDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQVV  227 (290)
T ss_dssp             CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHHH
T ss_pred             eecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHHh
Confidence            99999987644322   2234799999999996    466789999999999999999999999964321110 111110


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..              ..........+..+.+||.+||+.||.+|||+.+++++
T Consensus       228 ~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          228 EE--------------PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HS--------------CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cc--------------CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            00              00001112236789999999999999999999999874

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.6e-43  Score=352.36  Aligned_cols=268  Identities=23%  Similarity=0.315  Sum_probs=207.8

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCC------ceee
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP------NLVK  203 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hp------nIv~  203 (491)
                      ...++|++.+.||+|+||.||+|.+...        ++..||||++.... ...+.+.+|+.++..+.|+      +|++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~   81 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKA--------GGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQ   81 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCC--------CCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence            3456899999999999999999987432        57899999997542 3346688899999988765      4999


Q ss_pred             eeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC----
Q 011180          204 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA----  279 (491)
Q Consensus       204 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~----  279 (491)
                      +++++.+.+..+|||||+ +++|.+++...+...+++..+..++.||+.||+|||+.+   |+||||||+|||++.    
T Consensus        82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~  157 (339)
T 1z57_A           82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYT  157 (339)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEE
T ss_pred             eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccc
Confidence            999999999999999999 899999998876667899999999999999999999988   999999999999987    


Q ss_pred             ---------------CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCC
Q 011180          280 ---------------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR  344 (491)
Q Consensus       280 ---------------~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~  344 (491)
                                     ++.+||+|||+++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  232 (339)
T 1z57_A          158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT  232 (339)
T ss_dssp             EEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence                           678999999999865432     234579999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcchhhHhhhcccCCc-------cch------------------hhccCcc-ccCCCChhhHHHHHHHHHHh
Q 011180          345 SMDKNRPNGEHNLVEWARPHLGDK-------RRF------------------YRLLDPR-LEGHFSIKGSQKATQLAAQC  398 (491)
Q Consensus       345 pf~~~~~~~~~~~~~~~~~~~~~~-------~~~------------------~~~~~~~-l~~~~~~~~~~~l~~li~~c  398 (491)
                      ||...........+..........       ..+                  .....+. .........+..+.+||.+|
T Consensus       233 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  312 (339)
T 1z57_A          233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM  312 (339)
T ss_dssp             SCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence            997643322111111110000000       000                  0000000 00011234578899999999


Q ss_pred             hhcCCCCCCCHHHHHHH
Q 011180          399 LSRDPKARPRMSEVVET  415 (491)
Q Consensus       399 L~~dP~~RPt~~evl~~  415 (491)
                      |+.||.+|||+.|++++
T Consensus       313 L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          313 LEYDPAKRITLREALKH  329 (339)
T ss_dssp             TCSSTTTSCCHHHHTTS
T ss_pred             hCcCcccccCHHHHhcC
Confidence            99999999999999865

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.6e-43  Score=346.82  Aligned_cols=253  Identities=26%  Similarity=0.343  Sum_probs=205.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---------ccHHHHHHHHHHHhcCC-CCce
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHKEWLAEVNFLGNLL-HPNL  201 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~il~~l~-HpnI  201 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++.....         ...+.+.+|+.+|+++. ||||
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i   86 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI   86 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred             hhccceeeeecCCCceEEEEEEEcC---------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence            3579999999999999999999875         678999999975531         12346789999999996 9999


Q ss_pred             eeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 011180          202 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       202 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~  281 (491)
                      +++++++.+.+..++||||+++++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus        87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~  161 (298)
T 1phk_A           87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDM  161 (298)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred             eeeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCC
Confidence            999999999999999999999999999997654  6889999999999999999999988   99999999999999999


Q ss_pred             CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhh------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 011180          282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  355 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~  355 (491)
                      .+||+|||++........   .....||+.|+|||++.      ...++.++|||||||++|+|++|..||......   
T Consensus       162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---  235 (298)
T 1phk_A          162 NIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---  235 (298)
T ss_dssp             CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred             cEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---
Confidence            999999999987654322   23457999999999885      456888999999999999999999999653211   


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ........   ...        ..........+..+.+||.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~---~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          236 LMLRMIMS---GNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHHHHHHH---TCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHhc---CCc--------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            11111000   000        00001112336789999999999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.9e-44  Score=358.14  Aligned_cols=264  Identities=19%  Similarity=0.276  Sum_probs=206.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc-----------------HHHHHHHHHHHh
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------------HKEWLAEVNFLG  194 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~il~  194 (491)
                      .++|.+.+.||+|+||.||+|.+           ++..||||++.......                 .+.+.+|+.++.
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   98 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT   98 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence            46899999999999999999987           36789999986432211                 178899999999


Q ss_pred             cCCCCceeeeeeEEeecCceEEEEEecCCCChHHH------hhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEe
Q 011180          195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENH------LFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIY  267 (491)
Q Consensus       195 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH  267 (491)
                      .++||||+++++++.+.+..++||||+++++|.++      +.......+++..++.++.||+.||.|||+ .+   |+|
T Consensus        99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H  175 (348)
T 2pml_X           99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICH  175 (348)
T ss_dssp             TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---Eee
Confidence            99999999999999999999999999999999998      655435579999999999999999999999 88   999


Q ss_pred             cCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCc-cccchhHHHHHHHHHhCCCC
Q 011180          268 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTS-KSDVYSFGVVLLEMLTGRRS  345 (491)
Q Consensus       268 rDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~-~~DvwSlGvil~elltG~~p  345 (491)
                      |||||+|||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++|||||||++|+|++|..|
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  251 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP  251 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999876432    23446799999999999877 6666 99999999999999999999


Q ss_pred             CCCCCCCCcchhhHhhhcc---cCCc-cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          346 MDKNRPNGEHNLVEWARPH---LGDK-RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       346 f~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      |......  ..........   .... ..+................+..+.+||.+||+.||.+|||+.+++++
T Consensus       252 f~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          252 FSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             SCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            9765431  1111111110   0000 00000000000001112347889999999999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.5e-44  Score=360.22  Aligned_cols=275  Identities=23%  Similarity=0.292  Sum_probs=200.7

Q ss_pred             hhhhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-----------cHHHHHHHHH
Q 011180          123 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-----------GHKEWLAEVN  191 (491)
Q Consensus       123 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~  191 (491)
                      ....++....++|.+.+.||+|+||.||+|.+.          .|..||||++......           ..+.+.+|+.
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   81 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR   81 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHH
Confidence            345677788899999999999999999999874          4678999998643221           1267899999


Q ss_pred             HHhcCCCCceeeeeeEEeec-----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 011180          192 FLGNLLHPNLVKLVGYCIED-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVI  266 (491)
Q Consensus       192 il~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  266 (491)
                      +|+.++||||+++++++...     ...|+||||+. |+|.+++.... ..+++..+..++.||+.||.|||+.+   |+
T Consensus        82 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iv  156 (362)
T 3pg1_A           82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAG---VV  156 (362)
T ss_dssp             HHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             HHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CE
Confidence            99999999999999998653     35799999996 68888887543 36899999999999999999999988   99


Q ss_pred             ecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCC
Q 011180          267 YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRS  345 (491)
Q Consensus       267 HrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~p  345 (491)
                      ||||||+||||+.++.+||+|||++.......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus       157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  233 (362)
T 3pg1_A          157 HRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL  233 (362)
T ss_dssp             CCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence            99999999999999999999999997553322   2234678999999999877 6799999999999999999999999


Q ss_pred             CCCCCCCCcchhhHhhhcccC-------Cccchhhcc-------CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHH
Q 011180          346 MDKNRPNGEHNLVEWARPHLG-------DKRRFYRLL-------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE  411 (491)
Q Consensus       346 f~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-------~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~e  411 (491)
                      |...........+........       ........+       ............+..+.+||.+||+.||.+|||+.+
T Consensus       234 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  313 (362)
T 3pg1_A          234 FRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ  313 (362)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence            976432211111100000000       000000000       000000111223677999999999999999999999


Q ss_pred             HHHH
Q 011180          412 VVET  415 (491)
Q Consensus       412 vl~~  415 (491)
                      ++++
T Consensus       314 ll~h  317 (362)
T 3pg1_A          314 ALRH  317 (362)
T ss_dssp             HHTS
T ss_pred             HHcC
Confidence            9976

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.1e-43  Score=352.54  Aligned_cols=262  Identities=25%  Similarity=0.368  Sum_probs=201.5

Q ss_pred             hhhhhhHHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCC--
Q 011180          122 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLL--  197 (491)
Q Consensus       122 ~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~--  197 (491)
                      .+.+..+....++|.+.+.||+|+||.||+|.+.          ++..||||++.....  ...+.+.+|+.++..+.  
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~   86 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH   86 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGG
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhcccc
Confidence            3445555666778999999999999999999874          366899999976532  33467889999999997  


Q ss_pred             CCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 011180          198 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       198 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl  277 (491)
                      |+||+++++++.+.+..++|||+ .+++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus        87 ~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~  160 (313)
T 3cek_A           87 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI  160 (313)
T ss_dssp             CTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             CCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEE
Confidence            59999999999999999999994 5889999998754  6889999999999999999999988   9999999999999


Q ss_pred             CCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-----------CCCCccccchhHHHHHHHHHhCCCCC
Q 011180          278 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVVLLEMLTGRRSM  346 (491)
Q Consensus       278 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-----------~~~~~~~DvwSlGvil~elltG~~pf  346 (491)
                      + ++.+||+|||++................||+.|+|||++.+           ..++.++|||||||++|+|++|..||
T Consensus       161 ~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (313)
T 3cek_A          161 V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF  239 (313)
T ss_dssp             E-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             E-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCch
Confidence            6 48999999999987654433333344679999999999875           47888999999999999999999999


Q ss_pred             CCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          347 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .......     ..          +....++.....++...+..+.+||.+||..||.+|||+.+++++
T Consensus       240 ~~~~~~~-----~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          240 QQIINQI-----SK----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             TTCCSHH-----HH----------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhHHHHH-----HH----------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            6432110     00          011112222222233336789999999999999999999999976

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=349.50  Aligned_cols=268  Identities=24%  Similarity=0.326  Sum_probs=197.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEe--
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI--  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--  209 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++........+.+.+|+.+++.++||||+++++++.  
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   80 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDND---------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS   80 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETT---------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred             CCceeEEEEeccCCCeEEEEEEECC---------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence            3579999999999999999999875         67899999998766566678899999999999999999999874  


Q ss_pred             ------------ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE
Q 011180          210 ------------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       210 ------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl  277 (491)
                                  +....++||||+. |+|.+++...   .+++..++.++.||+.||+|||+.+   |+||||||+|||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  153 (320)
T 2i6l_A           81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFI  153 (320)
T ss_dssp             SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEE
T ss_pred             ccccccccccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEE
Confidence                        3467899999996 6999988542   6889999999999999999999988   9999999999999


Q ss_pred             C-CCCCeEEeccCCcccCCCCCC-ceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc
Q 011180          278 D-ADYNAKLSDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  354 (491)
Q Consensus       278 ~-~~~~~kL~DFGla~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~  354 (491)
                      + .++.+||+|||+++....... ........||..|+|||.+.+ ..++.++|||||||++|||++|+.||........
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  233 (320)
T 2i6l_A          154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ  233 (320)
T ss_dssp             ETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             cCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            7 567999999999987643211 112234568999999998875 6789999999999999999999999976532211


Q ss_pred             chhhHhhhcccCC--ccchhhcc---------Ccc-ccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          355 HNLVEWARPHLGD--KRRFYRLL---------DPR-LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       355 ~~~~~~~~~~~~~--~~~~~~~~---------~~~-l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...+....+....  ...+...+         .+. ....+....+..+.+||.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            1111000000000  00000000         000 0000111236789999999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=361.54  Aligned_cols=270  Identities=22%  Similarity=0.333  Sum_probs=185.8

Q ss_pred             CCCc-CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee--
Q 011180          134 NFRP-ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--  210 (491)
Q Consensus       134 ~y~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--  210 (491)
                      .|.+ .++||+|+||.||+|.+...       .++..||||++.....  ...+.+|+.+|+.|+|||||++++++..  
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDG-------KDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSS-------SCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccC-------CCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            4666 45899999999999997642       1567899999976543  3578899999999999999999999965  


Q ss_pred             cCceEEEEEecCCCChHHHhhhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE----CC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRK-------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DA  279 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl----~~  279 (491)
                      ....+|||||+. ++|.+++...       ....+++..++.++.||+.||.|||+.+   |+||||||+||||    +.
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTT
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCC
Confidence            568899999995 6888877532       1224899999999999999999999988   9999999999999    67


Q ss_pred             CCCeEEeccCCcccCCCCCCc-eeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCc---
Q 011180          280 DYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE---  354 (491)
Q Consensus       280 ~~~~kL~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~---  354 (491)
                      ++.+||+|||+++........ ......+||+.|+|||++.+ ..++.++|||||||+||||++|.+||........   
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            789999999999876432211 22234689999999999987 4599999999999999999999999975443210   


Q ss_pred             ---chhhHhhhcccCC-----cc---------chhhccCccccC---------CCChhhHHHHHHHHHHhhhcCCCCCCC
Q 011180          355 ---HNLVEWARPHLGD-----KR---------RFYRLLDPRLEG---------HFSIKGSQKATQLAAQCLSRDPKARPR  408 (491)
Q Consensus       355 ---~~~~~~~~~~~~~-----~~---------~~~~~~~~~l~~---------~~~~~~~~~l~~li~~cL~~dP~~RPt  408 (491)
                         ..........++.     ..         .+...+......         ......+..+.+||.+||..||.+|||
T Consensus       248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence               0000000000000     00         000000000000         001112567899999999999999999


Q ss_pred             HHHHHHHh
Q 011180          409 MSEVVETL  416 (491)
Q Consensus       409 ~~evl~~L  416 (491)
                      +.|+|++-
T Consensus       328 a~e~L~hp  335 (405)
T 3rgf_A          328 SEQAMQDP  335 (405)
T ss_dssp             HHHHHTSG
T ss_pred             HHHHhcCh
Confidence            99999873

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.1e-43  Score=352.22  Aligned_cols=268  Identities=24%  Similarity=0.310  Sum_probs=201.4

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++..... .....+.+|+.+|+.++||||+++++++..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   80 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKP---------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP   80 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECC---------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence            4589999999999999999999875         678999999965432 234567899999999999999999998876


Q ss_pred             c-----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          211 D-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       211 ~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      .     ...++||||+. ++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl  153 (353)
T 2b9h_A           81 DSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKV  153 (353)
T ss_dssp             SCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEE
T ss_pred             cccCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEE
Confidence            4     67899999995 6999988763   6899999999999999999999988   999999999999999999999


Q ss_pred             eccCCcccCCCCCCce--------eeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011180          286 SDFGLAKDAPEDGKTH--------VSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  356 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~--------~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~  356 (491)
                      +|||++..........        .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus       154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  233 (353)
T 2b9h_A          154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL  233 (353)
T ss_dssp             CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            9999998764322111        1223578999999998765 678999999999999999999999997643211111


Q ss_pred             hhHhhhcccC--C------c---cchhhccCccc---cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          357 LVEWARPHLG--D------K---RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       357 ~~~~~~~~~~--~------~---~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+........  .      .   ..+...+....   ........+..+.+||.+||..||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000000000  0      0   00000000000   000012336789999999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-42  Score=354.42  Aligned_cols=262  Identities=24%  Similarity=0.353  Sum_probs=198.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++......  ..+.+.+|+.+++.++||||+++++++.
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  111 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT  111 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECC---------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence            3579999999999999999999876         6889999999765322  2467889999999999999999999998


Q ss_pred             ecCce------EEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          210 EDDQR------LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       210 ~~~~~------~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ..+..      ++||||+. ++|.+++.    ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+
T Consensus       112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~  183 (371)
T 4exu_A          112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCEL  183 (371)
T ss_dssp             SCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred             ccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCE
Confidence            87665      99999995 68888773    24899999999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||+|||+++.....     ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus       184 kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~  258 (371)
T 4exu_A          184 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  258 (371)
T ss_dssp             EECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99999999865432     234678999999999887 689999999999999999999999997643221111100000


Q ss_pred             c--------ccCCc--cchhhccCccccC---CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 P--------HLGDK--RRFYRLLDPRLEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~--------~~~~~--~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .        .+...  ..+...+......   ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            0        00000  0000000000000   0112236789999999999999999999999976

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.6e-43  Score=349.53  Aligned_cols=269  Identities=25%  Similarity=0.344  Sum_probs=204.4

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcC---CCCceeeee
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNL---LHPNLVKLV  205 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~  205 (491)
                      ..++|++.+.||+|+||.||+|.+...        +|..||||++.....  .....+.+|+.+++.+   .||||++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~   80 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF   80 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCC--------CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence            346899999999999999999998531        577899999864321  1123466777777766   899999999


Q ss_pred             eEEe-----ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC
Q 011180          206 GYCI-----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  280 (491)
Q Consensus       206 ~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~  280 (491)
                      +++.     .....++||||+. |+|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~  156 (326)
T 1blx_A           81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS  156 (326)
T ss_dssp             EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred             eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCC
Confidence            9987     4567899999996 69999998766556899999999999999999999988   9999999999999999


Q ss_pred             CCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011180          281 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  360 (491)
Q Consensus       281 ~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  360 (491)
                      +.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..
T Consensus       157 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (326)
T 1blx_A          157 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD  233 (326)
T ss_dssp             CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            999999999998664321   22346789999999999999999999999999999999999999976432211111100


Q ss_pred             hhcccCCccch----------hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          361 ARPHLGDKRRF----------YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       361 ~~~~~~~~~~~----------~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .. .......+          +..........+....+..+.+||.+||..||.+|||+.+++++
T Consensus       234 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          234 VI-GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             HH-CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             Hc-CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00 00000000          00000000111223347889999999999999999999999965

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=8.2e-43  Score=352.72  Aligned_cols=267  Identities=26%  Similarity=0.364  Sum_probs=190.8

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ...++|.+.+.||+|+||.||+|.+..         +|..||||++..+.. ....+.+|++.+..++||||+++++++.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~   89 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFY   89 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETT---------TCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence            445689999999999999999999875         677999999865532 2345678888899999999999999997


Q ss_pred             ecCc-------eEEEEEecCCCChHHHhhh--CCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCcEEEC
Q 011180          210 EDDQ-------RLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLH--EEAEKPVIYRDFKTSNILLD  278 (491)
Q Consensus       210 ~~~~-------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH--~~~~~~iiHrDlKp~NILl~  278 (491)
                      ..+.       .++||||+++ +|.+.+..  .....+++..+..++.||+.||.|||  +.+   |+||||||+||||+
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~  165 (360)
T 3e3p_A           90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVN  165 (360)
T ss_dssp             EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEE
T ss_pred             ccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEe
Confidence            6544       7899999965 55554432  23346889999999999999999999  777   99999999999998


Q ss_pred             C-CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011180          279 A-DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  356 (491)
Q Consensus       279 ~-~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~  356 (491)
                      . ++.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||..........
T Consensus       166 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  242 (360)
T 3e3p_A          166 EADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH  242 (360)
T ss_dssp             TTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence            6 89999999999987654322   2345789999999998765 48999999999999999999999997643221111


Q ss_pred             hhHhhhcccCCccchhhccCc----------------cccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          357 LVEWARPHLGDKRRFYRLLDP----------------RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~----------------~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .  ...............+++                ..........+..+.+||.+||+.||.+|||+.+++++
T Consensus       243 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          243 E--IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             H--HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             H--HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1  111000000000000000                00111222357899999999999999999999999975

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.7e-43  Score=344.91  Aligned_cols=253  Identities=24%  Similarity=0.386  Sum_probs=194.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee--
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--  210 (491)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++.... ...+.+.+|+.+++.++||||+++++++.+  
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNAL---------DSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERR   75 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECC
T ss_pred             ccchhhheeccCCcEEEEEEEEcC---------CCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhc
Confidence            469999999999999999999875         57799999996432 334678899999999999999999998865  


Q ss_pred             -----------cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC
Q 011180          211 -----------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  279 (491)
Q Consensus       211 -----------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~  279 (491)
                                 .+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.
T Consensus        76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~  151 (303)
T 1zy4_A           76 NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDE  151 (303)
T ss_dssp             CCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred             chhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcC
Confidence                       356799999999999999997653 36788899999999999999999988   999999999999999


Q ss_pred             CCCeEEeccCCcccCCCCCC------------ceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCC
Q 011180          280 DYNAKLSDFGLAKDAPEDGK------------THVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSM  346 (491)
Q Consensus       280 ~~~~kL~DFGla~~~~~~~~------------~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf  346 (491)
                      ++.+||+|||++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   ||
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~  228 (303)
T 1zy4_A          152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF  228 (303)
T ss_dssp             TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred             CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence            99999999999987643210            1112345799999999999764 78999999999999999998   44


Q ss_pred             CCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          347 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...     ...........        .....+...++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       229 ~~~-----~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          229 STG-----MERVNILKKLR--------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             SSH-----HHHHHHHHHHH--------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCc-----hhHHHHHHhcc--------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            311     01111110000        011112223344456789999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7e-44  Score=354.33  Aligned_cols=263  Identities=19%  Similarity=0.318  Sum_probs=201.7

Q ss_pred             HHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeee
Q 011180          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLV  205 (491)
Q Consensus       128 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~  205 (491)
                      +.+..++|.+.+.||+|+||.||+|.+..            .||+|++.....  ...+.+.+|+.+++.++||||++++
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   95 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM   95 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCC
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEE
Confidence            34445789999999999999999998753            499999875432  2235577899999999999999999


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      +++.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||
T Consensus        96 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l  170 (319)
T 2y4i_B           96 GACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVI  170 (319)
T ss_dssp             EEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEE
T ss_pred             EEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEE
Confidence            99999999999999999999999997653 36889999999999999999999988   99999999999998 679999


Q ss_pred             eccCCcccCCCCCC---ceeeeccccCCCCCCchhhhc---------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 011180          286 SDFGLAKDAPEDGK---THVSTRVMGTYGYAAPEYVMT---------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG  353 (491)
Q Consensus       286 ~DFGla~~~~~~~~---~~~~~~~~Gt~~y~aPE~~~~---------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~  353 (491)
                      +|||++........   ........||+.|+|||++.+         ..++.++|||||||++|||++|..||.......
T Consensus       171 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  250 (319)
T 2y4i_B          171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA  250 (319)
T ss_dssp             CCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH
T ss_pred             eecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999876532111   111223568999999999874         457889999999999999999999996543211


Q ss_pred             cchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcccc
Q 011180          354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  423 (491)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~~  423 (491)
                         ........          ..+.+   .....+..+.+|+.+||..||.+|||+.++++.|+.+....
T Consensus       251 ---~~~~~~~~----------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          251 ---IIWQMGTG----------MKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             ---HHHHHHTT----------CCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             ---HHHHhccC----------CCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence               11110000          00100   01123567899999999999999999999999999886654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.6e-43  Score=361.83  Aligned_cols=259  Identities=25%  Similarity=0.354  Sum_probs=193.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      .+|.+.++||+|+||+||+|++..         ++ .||+|.+..+...    ..+|+.+|+.++||||+++++++...+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~---------~~-~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~  105 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVE---------SD-EVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNG  105 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT---------TE-EEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECC---------CC-eEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence            469999999999999999999864         33 4888887654321    236999999999999999999997654


Q ss_pred             c------eEEEEEecCCCChHHHhhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC-CCCCe
Q 011180          213 Q------RLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNA  283 (491)
Q Consensus       213 ~------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~-~~~~~  283 (491)
                      .      .+|||||++++ |.+.+..  .....+++..+..++.||+.||+|||+.+   |+||||||+||||+ .++.+
T Consensus       106 ~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~  181 (394)
T 4e7w_A          106 DKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVL  181 (394)
T ss_dssp             SSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred             CCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcE
Confidence            3      78999999764 4443321  12347899999999999999999999988   99999999999998 79999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||+|||+++.......   ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.........  .....
T Consensus       182 kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l--~~i~~  256 (394)
T 4e7w_A          182 KLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL--VEIIK  256 (394)
T ss_dssp             EECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH
T ss_pred             EEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHH
Confidence            9999999987643322   2345789999999998765 5999999999999999999999999765322111  11110


Q ss_pred             cccCC--cc------------chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 PHLGD--KR------------RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~~~~~--~~------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       .++.  ..            .+.......+...+....+..+.+||.+||+.||.+|||+.++++|
T Consensus       257 -~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          257 -VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             -HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence             0000  00            0000000001111222346889999999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3e-43  Score=357.50  Aligned_cols=263  Identities=19%  Similarity=0.268  Sum_probs=203.1

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-----------CCc
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-----------HPN  200 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------Hpn  200 (491)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++..+. .....+.+|+.++..+.           |||
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecC---------CCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence            3579999999999999999999865         67899999997543 33466788999999886           899


Q ss_pred             eeeeeeEEeecC----ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcE
Q 011180          201 LVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNI  275 (491)
Q Consensus       201 Iv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlKp~NI  275 (491)
                      |+++++++...+    ..++||||+ +++|.+++.......+++..+..++.||+.||.|||+. +   |+||||||+||
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NI  163 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENV  163 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGE
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHe
Confidence            999999998754    789999999 89999999876555799999999999999999999997 8   99999999999


Q ss_pred             EEC------CCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 011180          276 LLD------ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN  349 (491)
Q Consensus       276 Ll~------~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~  349 (491)
                      ||+      ..+.+||+|||++......     ....+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          164 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            994      4458999999999876432     23357999999999999999999999999999999999999999754


Q ss_pred             CCCCcc---hhhHhhhcccCCccc-----------------------------hhhccCccccCCCChhhHHHHHHHHHH
Q 011180          350 RPNGEH---NLVEWARPHLGDKRR-----------------------------FYRLLDPRLEGHFSIKGSQKATQLAAQ  397 (491)
Q Consensus       350 ~~~~~~---~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~~~~~~~~~~l~~li~~  397 (491)
                      ......   .........++....                             ....+.  ....++...+..+.+||.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~  316 (373)
T 1q8y_A          239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSP  316 (373)
T ss_dssp             ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGG
T ss_pred             cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHH
Confidence            422111   000000000000000                             000000  0113445668899999999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 011180          398 CLSRDPKARPRMSEVVET  415 (491)
Q Consensus       398 cL~~dP~~RPt~~evl~~  415 (491)
                      ||+.||.+|||+.+++++
T Consensus       317 ~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          317 MLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             GGCSSTTTCBCHHHHHTC
T ss_pred             HhccCccccCCHHHHhhC
Confidence            999999999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.5e-43  Score=381.18  Aligned_cols=263  Identities=24%  Similarity=0.375  Sum_probs=209.3

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      ....++|.+.+.||+|+||.||+|.+...+.      .+..||||.+..... ...+.+.+|+.+|+.++||||++++++
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~  459 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPEN------PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV  459 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSS------CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCC------ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3445679999999999999999999865322      467899999876432 234678999999999999999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +. ++..+|||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~D  534 (656)
T 2j0j_A          460 IT-ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGD  534 (656)
T ss_dssp             EC-SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred             Ee-cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEe
Confidence            85 467899999999999999997653 36899999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      ||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.......   ........  
T Consensus       535 FG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~~--  608 (656)
T 2j0j_A          535 FGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENG--  608 (656)
T ss_dssp             CCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHHT--
T ss_pred             cCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHcC--
Confidence            999987654322 22233567889999999999999999999999999999997 999996543211   11111100  


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                                  ....++..++..+.+||.+||..||.+|||+.+|++.|+.+.
T Consensus       609 ------------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          609 ------------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                        001122344788999999999999999999999999998763

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-42  Score=354.18  Aligned_cols=205  Identities=24%  Similarity=0.293  Sum_probs=174.5

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CC-----cee
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP-----NLV  202 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-Hp-----nIv  202 (491)
                      ....++|.+.+.||+|+||+||+|.+..         ++..||||++.... ....++..|+.++..+. |+     +|+
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv  119 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRV---------EQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIV  119 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcC---------CCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEE
Confidence            3445689999999999999999999875         67899999997542 23456778888888875 44     499


Q ss_pred             eeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC--CC
Q 011180          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--AD  280 (491)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~--~~  280 (491)
                      ++++++...+..+|||||+. ++|.+++.......+++..+..++.||+.||.|||.+. .+|+||||||+||||+  .+
T Consensus       120 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~  197 (382)
T 2vx3_A          120 HLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKR  197 (382)
T ss_dssp             CEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTS
T ss_pred             EeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCC
Confidence            99999999999999999995 69999998775557899999999999999999999532 3399999999999994  47


Q ss_pred             CCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 011180          281 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  350 (491)
Q Consensus       281 ~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~  350 (491)
                      +.+||+|||+++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       198 ~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          198 SAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            88999999999876432     234679999999999999999999999999999999999999997653

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.5e-42  Score=349.32  Aligned_cols=266  Identities=21%  Similarity=0.263  Sum_probs=204.4

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc------eeeee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN------LVKLV  205 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~  205 (491)
                      .++|.+.+.||+|+||.||+|.+...        .+..||||++.... ...+.+.+|+.+++.+.|++      |+.++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMS   88 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence            46899999999999999999998652        23689999997542 33466788999999997665      99999


Q ss_pred             eEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEE--------
Q 011180          206 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--------  277 (491)
Q Consensus       206 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl--------  277 (491)
                      +++...+..+|||||+ +++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+||||        
T Consensus        89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~  164 (355)
T 2eu9_A           89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETL  164 (355)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEE
T ss_pred             eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccc
Confidence            9999999999999999 778888887765557999999999999999999999988   9999999999999        


Q ss_pred             -----------CCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCC
Q 011180          278 -----------DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM  346 (491)
Q Consensus       278 -----------~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf  346 (491)
                                 +.++.+||+|||+++......     ...+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus       165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (355)
T 2eu9_A          165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF  239 (355)
T ss_dssp             ECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence                       567899999999998654321     3357999999999999999999999999999999999999999


Q ss_pred             CCCCCCCcchhhHhhhcccCC-------ccc------------------hhhccCcc-ccCCCChhhHHHHHHHHHHhhh
Q 011180          347 DKNRPNGEHNLVEWARPHLGD-------KRR------------------FYRLLDPR-LEGHFSIKGSQKATQLAAQCLS  400 (491)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~-------~~~------------------~~~~~~~~-l~~~~~~~~~~~l~~li~~cL~  400 (491)
                      ...........+.........       ...                  ......+. .........+..+.+||.+||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  319 (355)
T 2eu9_A          240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE  319 (355)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence            754322111111110000000       000                  00000000 0001122346789999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 011180          401 RDPKARPRMSEVVET  415 (491)
Q Consensus       401 ~dP~~RPt~~evl~~  415 (491)
                      .||.+|||+.+++++
T Consensus       320 ~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          320 FDPAQRITLAEALLH  334 (355)
T ss_dssp             SSTTTSCCHHHHTTS
T ss_pred             CChhhCcCHHHHhcC
Confidence            999999999999865

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-42  Score=346.63  Aligned_cols=257  Identities=27%  Similarity=0.360  Sum_probs=182.6

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHH-HHhcCCCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVN-FLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-il~~l~HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||+|+||.||+|.+..         +|..||||++..... ....++..|+. +++.+.||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~   90 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL   90 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETT---------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcC---------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence            34689999999999999999999875         678999999976532 23345666666 77788999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhh---CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEECCCCCeE
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFR---KGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      .+.+..+|||||++ ++|.+++..   .....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+|
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~k  166 (327)
T 3aln_A           91 FREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIK  166 (327)
T ss_dssp             ECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEE
T ss_pred             EeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEE
Confidence            99999999999996 588877753   2234789999999999999999999998 8   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhh----hcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  360 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~----~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  360 (491)
                      |+|||+++.......   .....||+.|+|||++    .+..++.++|||||||++|+|++|..||........     .
T Consensus       167 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~  238 (327)
T 3aln_A          167 LCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----Q  238 (327)
T ss_dssp             ECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred             EccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----H
Confidence            999999987643321   2334799999999998    456789999999999999999999999975322110     0


Q ss_pred             hhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ......       ...+.+........+..+.+||.+||..||.+|||+.+|+++
T Consensus       239 ~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          239 LTQVVK-------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             -CCCCC-------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHhc-------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            000000       001111111122346789999999999999999999999865

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.5e-43  Score=349.89  Aligned_cols=255  Identities=23%  Similarity=0.281  Sum_probs=176.9

Q ss_pred             hcCCCcC-cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|.+. ++||+|+||.||+|.+..         ++..||||++....    .........+..+.||||+++++++..
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~   93 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRR---------TGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYEN   93 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECC---------CCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence            3478885 469999999999999876         67799999996531    222223334566789999999999876


Q ss_pred             ----cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---CCCe
Q 011180          211 ----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNA  283 (491)
Q Consensus       211 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~---~~~~  283 (491)
                          ....+|||||+++|+|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+||||+.   ++.+
T Consensus        94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~  170 (336)
T 3fhr_A           94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVL  170 (336)
T ss_dssp             EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCE
T ss_pred             ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceE
Confidence                445899999999999999998776667999999999999999999999988   999999999999975   4569


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      ||+|||++.......    ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.............  ..
T Consensus       171 kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~  244 (336)
T 3fhr_A          171 KLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--RR  244 (336)
T ss_dssp             EECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred             EEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--Hh
Confidence            999999998654321    234578999999999988899999999999999999999999996543322110000  00


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  416 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L  416 (491)
                      ..        .....+........+..+.+||.+||..||.+|||+.+++++-
T Consensus       245 ~~--------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          245 IR--------LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             --------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hh--------ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            00        0000001111123477899999999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=347.54  Aligned_cols=262  Identities=24%  Similarity=0.346  Sum_probs=199.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++......  ..+.+.+|+.+++.++||||+++++++.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   93 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT   93 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECC---------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence            3579999999999999999999875         6889999999764322  2467889999999999999999999998


Q ss_pred             ecCc------eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          210 EDDQ------RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       210 ~~~~------~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ..+.      .++||||+. ++|.+++..    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~  165 (353)
T 3coi_A           94 PASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCEL  165 (353)
T ss_dssp             SCSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCE
T ss_pred             cccccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcE
Confidence            7654      499999996 688887632    4889999999999999999999988   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus       166 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~  240 (353)
T 3coi_A          166 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  240 (353)
T ss_dssp             EECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHH
T ss_pred             EEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99999999865432     234578999999999886 678999999999999999999999997643221111100000


Q ss_pred             c--------ccCCc--cchhhccCcccc---CCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 P--------HLGDK--RRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~--------~~~~~--~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .        .+.+.  ..+...+.....   .......+..+.+||.+||..||.+|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0        00000  000000000000   11122447889999999999999999999999976

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.5e-42  Score=340.08  Aligned_cols=252  Identities=26%  Similarity=0.374  Sum_probs=203.4

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++....  ......+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            3579999999999999999999875         57799999986543  234577899999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC---CCeEEe
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLS  286 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~---~~~kL~  286 (491)
                      +.+..++||||+++++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~  166 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII  166 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEe
Confidence            9999999999999999999887654  6889999999999999999999988   9999999999999654   479999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  366 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  366 (491)
                      |||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......   .........  
T Consensus       167 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~--  237 (287)
T 2wei_A          167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILKRVETG--  237 (287)
T ss_dssp             STTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHC--
T ss_pred             ccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcC--
Confidence            9999987644322   123568999999998865 5899999999999999999999999754321   111111000  


Q ss_pred             CccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       ...    .+.    ......+..+.+||.+||..||.+|||+.+++++
T Consensus       238 -~~~----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          238 -KYA----FDL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             -CCC----CCS----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -CCC----CCc----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence             000    000    0001236789999999999999999999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=342.77  Aligned_cols=244  Identities=28%  Similarity=0.453  Sum_probs=194.5

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc------cHHHHHHHHHHHhcC----CCC
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNL----LHP  199 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l----~Hp  199 (491)
                      ...++|++.+.||+|+||.||+|.+..         ++..||||++......      ....+.+|+.++..+    .||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~   98 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLT---------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP   98 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTT---------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEcc---------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence            345689999999999999999998765         5779999999765432      123356799999988    899


Q ss_pred             ceeeeeeEEeecCceEEEEEe-cCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC
Q 011180          200 NLVKLVGYCIEDDQRLLVYEF-MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  278 (491)
Q Consensus       200 nIv~l~~~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~  278 (491)
                      ||+++++++.+.+..++|||| +.+++|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus        99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~  173 (312)
T 2iwi_A           99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILID  173 (312)
T ss_dssp             SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEE
T ss_pred             CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEe
Confidence            999999999999999999999 78999999997754  6899999999999999999999998   99999999999998


Q ss_pred             -CCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011180          279 -ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  356 (491)
Q Consensus       279 -~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~-~~~DvwSlGvil~elltG~~pf~~~~~~~~~~  356 (491)
                       .++.+||+|||++.......    .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||....     .
T Consensus       174 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~  244 (312)
T 2iwi_A          174 LRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----E  244 (312)
T ss_dssp             TTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H
T ss_pred             CCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----H
Confidence             88999999999998765432    2345699999999999877664 58999999999999999999995321     0


Q ss_pred             hhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..   ..                ...++...+..+.+||.+||..||.+|||+.+++++
T Consensus       245 ~~---~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          245 IL---EA----------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HH---HT----------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             Hh---hh----------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00   00                001122336789999999999999999999999976

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-42  Score=345.26  Aligned_cols=245  Identities=25%  Similarity=0.405  Sum_probs=202.0

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc------cHHHHHHHHHHHhcCC--CCc
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLL--HPN  200 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~--Hpn  200 (491)
                      ....++|.+.+.||+|+||.||+|.+..         ++..||||++......      ....+.+|+.+++.+.  |+|
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~  109 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG  109 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETT---------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence            3445689999999999999999998875         6789999999754322      1245678999999996  599


Q ss_pred             eeeeeeEEeecCceEEEEEecCC-CChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC-
Q 011180          201 LVKLVGYCIEDDQRLLVYEFMPR-GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-  278 (491)
Q Consensus       201 Iv~l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~-  278 (491)
                      |+++++++.+.+..++||||+.+ ++|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+||||+ 
T Consensus       110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~  184 (320)
T 3a99_A          110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL  184 (320)
T ss_dssp             BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred             ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeC
Confidence            99999999999999999999976 89999997754  6889999999999999999999988   99999999999998 


Q ss_pred             CCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchh
Q 011180          279 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  357 (491)
Q Consensus       279 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~  357 (491)
                      .++.+||+|||++.......    .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....       
T Consensus       185 ~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------  253 (320)
T 3a99_A          185 NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------  253 (320)
T ss_dssp             TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred             CCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------
Confidence            78999999999998765422    233579999999999987665 688999999999999999999995421       


Q ss_pred             hHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       .......                .++...+..+.+||.+||..||.+|||+.+|+++
T Consensus       254 -~~~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          254 -EIIRGQV----------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             -HHHHCCC----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -hhhcccc----------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0000000                0112236789999999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=337.12  Aligned_cols=253  Identities=28%  Similarity=0.430  Sum_probs=182.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cH-HHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GH-KEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++...... .. +.+..+..+++.+.||||+++++++.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~   94 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRK---------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI   94 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETT---------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEec---------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence            3579999999999999999999875         5779999999765432 22 23444556788889999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      +.+..+|||||+ ++.+..++... ...+++..+..++.||+.||.|||+. +   |+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~df  169 (318)
T 2dyl_A           95 TNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDF  169 (318)
T ss_dssp             CSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred             cCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEEC
Confidence            999999999999 55565555433 33689999999999999999999995 8   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      |++.......   ......||+.|+|||++.     ...++.++|||||||++|+|++|+.||......  .......  
T Consensus       170 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~--  242 (318)
T 2dyl_A          170 GISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKV--  242 (318)
T ss_dssp             TTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHH--
T ss_pred             CCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHH--
Confidence            9997664322   123457999999999984     567889999999999999999999999653211  1111110  


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                       ....       .+.+..  ....+..+.+||.+||..||.+|||+.+++++
T Consensus       243 -~~~~-------~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          243 -LQEE-------PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -HHSC-------CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -hccC-------CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             0000       000100  11236789999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.7e-41  Score=352.58  Aligned_cols=253  Identities=26%  Similarity=0.317  Sum_probs=186.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~  211 (491)
                      +.|.+.++||+|+||+||.+...          +|..||||++..+   ..+.+.+|+.+|..+ +|||||++++++.+.
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~----------~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   81 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTD   81 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEES----------SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             heeeccCeEeeCCCeEEEEEEEE----------CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            34666789999999999865332          5779999998654   235678999999876 799999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCC-----CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC------
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPL-----PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD------  280 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l-----~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~------  280 (491)
                      +..|||||||. |+|.+++........     .+..++.++.||+.||.|||+.+   |+||||||+||||+.+      
T Consensus        82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~  157 (434)
T 2rio_A           82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTAD  157 (434)
T ss_dssp             SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSC
T ss_pred             CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccc
Confidence            99999999995 699999976542211     22235679999999999999988   9999999999999654      


Q ss_pred             -------CCeEEeccCCcccCCCCCCce--eeeccccCCCCCCchhhhc-------CCCCccccchhHHHHHHHHHh-CC
Q 011180          281 -------YNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEMLT-GR  343 (491)
Q Consensus       281 -------~~~kL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~-------~~~~~~~DvwSlGvil~ellt-G~  343 (491)
                             +.+||+|||++..........  .....+||+.|+|||++.+       ..++.++|||||||++|||++ |.
T Consensus       158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence                   489999999998765432211  1234679999999999975       678999999999999999999 99


Q ss_pred             CCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          344 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       344 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .||....... ....   ..... .        +.+........+..+.+||.+||+.||.+|||+.+|+++
T Consensus       238 ~Pf~~~~~~~-~~i~---~~~~~-~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          238 HPFGDKYSRE-SNII---RGIFS-L--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             CTTCSTTTHH-HHHH---HTCCC-C--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCchhhH-HHHh---cCCCC-c--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            9996532211 1111   10000 0        001111223457899999999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=351.97  Aligned_cols=251  Identities=25%  Similarity=0.341  Sum_probs=186.5

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  210 (491)
                      ..+|.+.++||+|+||+||.....          ++..||||++......   .+.+|+.+|+.+ .|||||++++++.+
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~----------~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~   89 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKD   89 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEES----------SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEe----------CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEec
Confidence            346899999999999996543222          5678999999765433   356899999999 79999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-----CCCeEE
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-----DYNAKL  285 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~-----~~~~kL  285 (491)
                      .+..|||||||. |+|.+++..... .+.+..++.++.||+.||.|||+.+   |+||||||+||||+.     ...+||
T Consensus        90 ~~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL  164 (432)
T 3p23_A           90 RQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMI  164 (432)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred             CCEEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEE
Confidence            999999999995 699999976543 3444556789999999999999988   999999999999953     235889


Q ss_pred             eccCCcccCCCCCCc-eeeeccccCCCCCCchhhh---cCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHh
Q 011180          286 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW  360 (491)
Q Consensus       286 ~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~---~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~  360 (491)
                      +|||+++........ ......+||+.|+|||++.   ...++.++|||||||++|||++ |..||.......    ...
T Consensus       165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~  240 (432)
T 3p23_A          165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANI  240 (432)
T ss_dssp             CCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHH
T ss_pred             ecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHH
Confidence            999999876533211 2234467999999999997   4577889999999999999999 888985432111    000


Q ss_pred             hhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .   .... .. ...      ......+..+.+||.+||+.||.+|||+.+|+++
T Consensus       241 ~---~~~~-~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          241 L---LGAC-SL-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             H---TTCC-CC-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             H---hccC-Cc-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            0   0000 00 000      1112346778999999999999999999999965

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2e-40  Score=325.63  Aligned_cols=233  Identities=13%  Similarity=0.093  Sum_probs=186.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|++.+.||+|+||.||+|++..         +++.||||++......   ..+.+.+|+.++..+.||||+++++++
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~  100 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV  100 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETT---------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecC---------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence            3579999999999999999999865         6789999999866432   236789999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..||||||+++++|.+++...    .....+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+++
T Consensus       101 ~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~  173 (286)
T 3uqc_A          101 HTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP  173 (286)
T ss_dssp             EETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC
T ss_pred             EECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec
Confidence            9999999999999999999998432    344567889999999999999998   999999999999999999999855


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |                      |++       .++.++|||||||++|||++|+.||............   .......
T Consensus       174 ~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~~  221 (286)
T 3uqc_A          174 A----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTAGQ  221 (286)
T ss_dssp             C----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTTSC
T ss_pred             c----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhccC
Confidence            3                      333       3688999999999999999999999765433211000   0000000


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      .....        .+....+..+.+||.+||+.||.+| |+.++++.|+.+..
T Consensus       222 ~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          222 PIEPA--------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             BCCHH--------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             CCChh--------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            00000        1112236789999999999999999 99999999987543

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4e-41  Score=362.26  Aligned_cols=259  Identities=27%  Similarity=0.362  Sum_probs=199.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCceeeeeeEEee-
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-  210 (491)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++.... ....+.+.+|+.+|+.++||||+++++++.. 
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~---------tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~   84 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQD---------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL   84 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTT---------TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence            579999999999999999998765         67789999987653 2335678999999999999999999998765 


Q ss_pred             -----cCceEEEEEecCCCChHHHhhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC--
Q 011180          211 -----DDQRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--  282 (491)
Q Consensus       211 -----~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~--  282 (491)
                           .+..+||||||++|+|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.  
T Consensus        85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~  161 (676)
T 3qa8_A           85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRL  161 (676)
T ss_dssp             CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSC
T ss_pred             ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCce
Confidence                 667899999999999999997643 235888899999999999999999988   999999999999987664  


Q ss_pred             -eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          283 -AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 -~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                       +||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....     ...|.
T Consensus       162 ~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~  233 (676)
T 3qa8_A          162 IHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWH  233 (676)
T ss_dssp             EEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSS
T ss_pred             eEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhh
Confidence             99999999987654322   2346799999999999999999999999999999999999999965311     11111


Q ss_pred             hc-------------ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011180          362 RP-------------HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  413 (491)
Q Consensus       362 ~~-------------~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl  413 (491)
                      ..             .......+...  ......+....+..+.+||.+||..||.+|||+.+++
T Consensus       234 ~~i~~~~~~~~~~~~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          234 GKVREKSNEHIVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             TTCC------CCSCCCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhcccchhhhhhhhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            00             00000000000  0111234445689999999999999999999998744

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.9e-40  Score=324.34  Aligned_cols=232  Identities=21%  Similarity=0.289  Sum_probs=181.8

Q ss_pred             cCCCcC-cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHH-hcCCCCceeeeeeEEee
Q 011180          133 RNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL-GNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+. ++||+|+||.||+|.+..         ++..||||++..     ...+.+|+.++ +.+.||||+++++++..
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~   82 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYEN   82 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcC---------CCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence            357776 789999999999999875         677999999964     24677899888 55689999999999887


Q ss_pred             ----cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---CCCe
Q 011180          211 ----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNA  283 (491)
Q Consensus       211 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~---~~~~  283 (491)
                          ....+|||||+++|+|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~  159 (299)
T 3m2w_A           83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL  159 (299)
T ss_dssp             EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCE
T ss_pred             hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcE
Confidence                677899999999999999998876667999999999999999999999988   999999999999987   7899


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      ||+|||++....                        +..++.++|||||||++|||++|..||............   ..
T Consensus       160 kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---~~  212 (299)
T 3m2w_A          160 KLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KT  212 (299)
T ss_dssp             EECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS---CC
T ss_pred             EEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH---HH
Confidence            999999986432                        245678999999999999999999999654322110000   00


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .....       ...+........+..+.+||.+||+.||.+|||+.+++++
T Consensus       213 ~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          213 RIRMG-------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             SSCTT-------CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhhc-------cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            00000       0000000001236789999999999999999999999976

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-41  Score=346.61  Aligned_cols=244  Identities=18%  Similarity=0.185  Sum_probs=184.3

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCC-Ccee----
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLH-PNLV----  202 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~H-pnIv----  202 (491)
                      ..+.|.+.++||+|+||+||+|.+..         +|..||||++......   ..+.+.+|+.++..+.| .|+.    
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~  146 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV  146 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHH
T ss_pred             CceeEEEecccccCCCEEEEEEEecC---------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHH
Confidence            34468888999999999999999876         6779999999744322   25678999999999987 2211    


Q ss_pred             -----------e------eeeEEee-----cCceEEEEEecCCCChHHHhh-----hCCCCCCCHHHHHHHHHHHHHHHH
Q 011180          203 -----------K------LVGYCIE-----DDQRLLVYEFMPRGSLENHLF-----RKGSLPLPWSIRMKIALGAAKGLA  255 (491)
Q Consensus       203 -----------~------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~qi~~aL~  255 (491)
                                 .      ++.++..     ...++++|+++ +++|.+++.     ......+++..++.++.||+.||+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  225 (413)
T 3dzo_A          147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA  225 (413)
T ss_dssp             HTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHH
T ss_pred             hcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHH
Confidence                       1      1111111     12457778776 789999884     222335778889999999999999


Q ss_pred             HHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhh----------hcCCCCc
Q 011180          256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV----------MTGHLTS  325 (491)
Q Consensus       256 yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~----------~~~~~~~  325 (491)
                      |||+.+   ||||||||+||||+.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.
T Consensus       226 ~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~  296 (413)
T 3dzo_A          226 SLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF  296 (413)
T ss_dssp             HHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH
T ss_pred             HHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCc
Confidence            999988   999999999999999999999999998865432     344678 999999999          4456888


Q ss_pred             cccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCC
Q 011180          326 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA  405 (491)
Q Consensus       326 ~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~  405 (491)
                      ++|||||||++|||++|+.||..........      .          .+..      ....+..+.+||.+||+.||.+
T Consensus       297 ~~DvwSlGvil~elltg~~Pf~~~~~~~~~~------~----------~~~~------~~~~~~~~~~li~~~l~~dP~~  354 (413)
T 3dzo_A          297 AFDTWTLGLAIYWIWCADLPNTDDAALGGSE------W----------IFRS------CKNIPQPVRALLEGFLRYPKED  354 (413)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG------G----------GGSS------CCCCCHHHHHHHHHHTCSSGGG
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCcchhhhHH------H----------HHhh------cccCCHHHHHHHHHHccCChhh
Confidence            9999999999999999999996543221110      0          0100      0122578999999999999999


Q ss_pred             CCCHHHHHHH
Q 011180          406 RPRMSEVVET  415 (491)
Q Consensus       406 RPt~~evl~~  415 (491)
                      |||+.+++++
T Consensus       355 Rpt~~~~l~~  364 (413)
T 3dzo_A          355 RLLPLQAMET  364 (413)
T ss_dssp             SCCHHHHTTS
T ss_pred             CcCHHHHHhC
Confidence            9999999865

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-40  Score=362.50  Aligned_cols=240  Identities=25%  Similarity=0.408  Sum_probs=193.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|++.+.||+|+||.||+|.+...        +|..||||++..... .....+.+|+.+|..++||||+++++++..
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  150 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH  150 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence            46899999999999999999998642        467899999875432 334568899999999999999999999988


Q ss_pred             cCc-----eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEE
Q 011180          211 DDQ-----RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  285 (491)
Q Consensus       211 ~~~-----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL  285 (491)
                      .+.     .||||||+++++|.+++..    .+++..++.++.||+.||.|||+.+   ||||||||+||||+.+ .+||
T Consensus       151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl  222 (681)
T 2pzi_A          151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKL  222 (681)
T ss_dssp             ECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEE
T ss_pred             cCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEE
Confidence            766     7999999999999987643    6899999999999999999999988   9999999999999886 9999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      +|||+++.....      ...+||+.|+|||++.+. ++.++|||||||+||+|++|.+||........           
T Consensus       223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------  284 (681)
T 2pzi_A          223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------  284 (681)
T ss_dssp             CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------
T ss_pred             EecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-----------
Confidence            999999876442      335799999999998765 48899999999999999999988754211100           


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-HHHHHHHhhc
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETLKP  418 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-~~evl~~L~~  418 (491)
                      ..             .......+..+.+||.+||+.||.+||+ ++++.+.|..
T Consensus       285 ~~-------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          285 PE-------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             CT-------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             cc-------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            00             0001123467899999999999999996 5555555544

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.5e-40  Score=333.51  Aligned_cols=243  Identities=16%  Similarity=0.144  Sum_probs=183.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--------ccHHHHHHHHHHHhcCC-------
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGNLL-------  197 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~-------  197 (491)
                      ++|.+.+.||+|+||+||+|++           +|..||||++.....        ...+.+.+|+.+|+.|+       
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~   88 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVC   88 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSS
T ss_pred             ccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccc
Confidence            4688999999999999999987           367999999976532        23367889999998886       


Q ss_pred             --CCceeeeeeEE-----------------ee-------------cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHH
Q 011180          198 --HPNLVKLVGYC-----------------IE-------------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK  245 (491)
Q Consensus       198 --HpnIv~l~~~~-----------------~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~  245 (491)
                        |||||++++++                 .+             .+..|||||||++|++.+.+.+   ..+++..++.
T Consensus        89 ~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~  165 (336)
T 2vuw_A           89 NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKS  165 (336)
T ss_dssp             SBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHH
T ss_pred             ccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHH
Confidence              66666666654                 32             6789999999999987777644   2689999999


Q ss_pred             HHHHHHHHHHHHH-hcCCCCeEecCCCCCcEEECCCC--------------------CeEEeccCCcccCCCCCCceeee
Q 011180          246 IALGAAKGLAFLH-EEAEKPVIYRDFKTSNILLDADY--------------------NAKLSDFGLAKDAPEDGKTHVST  304 (491)
Q Consensus       246 i~~qi~~aL~yLH-~~~~~~iiHrDlKp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~  304 (491)
                      ++.||+.||.||| +.+   |+||||||+||||+.++                    .+||+|||+|+.....       
T Consensus       166 i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------  235 (336)
T 2vuw_A          166 ILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------
T ss_pred             HHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------
Confidence            9999999999999 888   99999999999999887                    8999999999866431       


Q ss_pred             ccccCCCCCCchhhhcCCCCccccchhHHHH-HHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCC
Q 011180          305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVV-LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF  383 (491)
Q Consensus       305 ~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvi-l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  383 (491)
                      ..+||+.|+|||++.+.. +.++|||||+++ .+++++|..||....  .............        ..........
T Consensus       236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--~~~~~~~~~~~~~--------~~~~~~~~~~  304 (336)
T 2vuw_A          236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--WLHYLTDKMLKQM--------TFKTKCNTPA  304 (336)
T ss_dssp             EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--HHHHHHHHHHHTC--------CCSSCCCSHH
T ss_pred             cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--hhhHHHHhhhhhh--------ccCcccchhh
Confidence            347999999999988665 889999998777 788999998883210  0000000000000        0000011112


Q ss_pred             ChhhHHHHHHHHHHhhhcCCCCCCCHHHHH-HH
Q 011180          384 SIKGSQKATQLAAQCLSRDPKARPRMSEVV-ET  415 (491)
Q Consensus       384 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl-~~  415 (491)
                      ....+.++.+||.+||+.|     |+.|++ +|
T Consensus       305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             hhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            2345889999999999977     999998 65

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=8e-34  Score=303.85  Aligned_cols=185  Identities=18%  Similarity=0.111  Sum_probs=130.9

Q ss_pred             cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc----------ccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          141 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----------QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       141 lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      ++.|++|.+..++...         .|..||||++.++..          ...++|.+|+++|+++ .|+||+++++++.
T Consensus       242 ~~~~~~~~h~~~rr~~---------fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e  312 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYF---------FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE  312 (569)
T ss_dssp             -C--------CCEEEE---------ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE
T ss_pred             cccCCccccccccccc---------ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Confidence            4555555555544433         567899999976532          1235689999999999 6999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +++..|||||||+|++|.++|...+  +++..   .|+.||+.||+|||++|   ||||||||+||||+.+|.+||+|||
T Consensus       313 d~~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFG  384 (569)
T 4azs_A          313 NAQSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFG  384 (569)
T ss_dssp             CSSEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCT
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecc
Confidence            9999999999999999999998765  45543   58899999999999999   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCC
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS  345 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~p  345 (491)
                      +|+.......  .....+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus       385 lAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          385 SIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             TEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             cCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            9987654332  2345789999999998864 577889999999999988766443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.1e-29  Score=270.13  Aligned_cols=185  Identities=19%  Similarity=0.224  Sum_probs=146.2

Q ss_pred             CcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--------cHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       136 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      ...++||+|+||.||+|..           .+..+|+|........        ..+.+.+|+++|++++||||+++..+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-----------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~  407 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-----------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF  407 (540)
T ss_dssp             ---------CCEEEEEEEC-----------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-----------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence            4467899999999999944           3568999987543221        12457899999999999999977777


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +...+..||||||+++++|.+++..          +..++.||+.||.|||+++   |+||||||+|||++.  .+||+|
T Consensus       408 ~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~D  472 (540)
T 3en9_A          408 DVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIID  472 (540)
T ss_dssp             EEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECC
T ss_pred             EEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEE
Confidence            7788888999999999999999865          4579999999999999988   999999999999998  999999


Q ss_pred             cCCcccCCCCCCce-----eeeccccCCCCCCchhhhc--CCCCccccchhHHHHHHHHHhCCCCC
Q 011180          288 FGLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSM  346 (491)
Q Consensus       288 FGla~~~~~~~~~~-----~~~~~~Gt~~y~aPE~~~~--~~~~~~~DvwSlGvil~elltG~~pf  346 (491)
                      ||+++.........     .....+||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            99999875432111     1235789999999999986  67888999999999999888877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=8e-26  Score=221.04  Aligned_cols=162  Identities=15%  Similarity=0.084  Sum_probs=127.1

Q ss_pred             HHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc------------------ccHHHHHHH
Q 011180          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------------------QGHKEWLAE  189 (491)
Q Consensus       128 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E  189 (491)
                      +......|.+.+.||+|+||.||+|.+ .         +|..||||++.....                  .....+.+|
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~---------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E  154 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYS-E---------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE  154 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEE-T---------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHH
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEe-C---------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHH
Confidence            334455677889999999999999998 4         678999999964321                  123568899


Q ss_pred             HHHHhcCCCCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 011180          190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD  269 (491)
Q Consensus       190 ~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrD  269 (491)
                      +.+|+.+.  | +++++++.. +..|+||||+++++|.+ +..        .....++.||+.||.|||+.+   |+|||
T Consensus       155 ~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrD  218 (282)
T 1zar_A          155 FRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGD  218 (282)
T ss_dssp             HHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred             HHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCC
Confidence            99999998  5 777776544 56799999999999998 421        123469999999999999988   99999


Q ss_pred             CCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc----------CCCCccccchh
Q 011180          270 FKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT----------GHLTSKSDVYS  331 (491)
Q Consensus       270 lKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~----------~~~~~~~DvwS  331 (491)
                      |||+|||++ ++.+||+|||+++.               +..|+|||++..          ..|+..+|+|.
T Consensus       219 lkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          219 LSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             CSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             CCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            999999999 99999999999863               345889998853          34555666664

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1e-21  Score=189.27  Aligned_cols=137  Identities=18%  Similarity=0.067  Sum_probs=105.8

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeE--EEEEEecCCCcc------------------------cHHHHHH
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDGLQ------------------------GHKEWLA  188 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~  188 (491)
                      |.+.+.||+|+||.||+|.+..         +|..  ||||+++.....                        ....+.+
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~---------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  119 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVF---------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK  119 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEE---------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcC---------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence            6788999999999999999854         5778  999997543211                        0135788


Q ss_pred             HHHHHhcCCCCce--eeeeeEEeecCceEEEEEecCC-C----ChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHH-hc
Q 011180          189 EVNFLGNLLHPNL--VKLVGYCIEDDQRLLVYEFMPR-G----SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH-EE  260 (491)
Q Consensus       189 E~~il~~l~HpnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~  260 (491)
                      |+.+|..|.|++|  ..++++    +..+|||||+.+ |    +|.+++..     .++..+..++.||+.+|.||| +.
T Consensus       120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~  190 (258)
T 1zth_A          120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA  190 (258)
T ss_dssp             HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC
Confidence            9999999988764  333332    367899999942 3    67666532     123456789999999999999 88


Q ss_pred             CCCCeEecCCCCCcEEECCCCCeEEeccCCcccC
Q 011180          261 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  294 (491)
Q Consensus       261 ~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~  294 (491)
                      +   |+||||||+|||++.  .++|+|||+|...
T Consensus       191 g---ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          191 E---LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             C---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             C---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            8   999999999999988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=8.1e-19  Score=176.84  Aligned_cols=138  Identities=14%  Similarity=0.112  Sum_probs=98.8

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--------------cHHH--------HHHHHH
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------GHKE--------WLAEVN  191 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~E~~  191 (491)
                      -|.+...||.|+||.||+|.+.          +|..||||+++.....              ....        ..+|..
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~  165 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA  165 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence            3899999999999999999864          5779999997532110              0111        234666


Q ss_pred             HHhcCCCCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 011180          192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  271 (491)
Q Consensus       192 il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlK  271 (491)
                      .|.+|.+.++....-+..  ...+|||||++|++|..+..      .+  ....++.||+.+|.|||+.+   |||||||
T Consensus       166 nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~------~~--~~~~l~~qll~~l~~lH~~g---IVHrDLK  232 (397)
T 4gyi_A          166 FMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS------VP--DPASLYADLIALILRLAKHG---LIHGDFN  232 (397)
T ss_dssp             HHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC------CS--CHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred             HHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc------cH--HHHHHHHHHHHHHHHHHHCC---CcCCCCC
Confidence            666665444322221111  23479999999988866532      11  23467899999999999988   9999999


Q ss_pred             CCcEEECCCC----------CeEEeccCCcccC
Q 011180          272 TSNILLDADY----------NAKLSDFGLAKDA  294 (491)
Q Consensus       272 p~NILl~~~~----------~~kL~DFGla~~~  294 (491)
                      |.||||++++          .+.|+||+-+...
T Consensus       233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            9999998776          3899999977643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.45  E-value=2.5e-13  Score=130.36  Aligned_cols=142  Identities=14%  Similarity=0.001  Sum_probs=110.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~  211 (491)
                      ..|.+...++.|+++.||++..           .+..+++|+...........+.+|+.+|+.|. +..+.++++++.+.
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~-----------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~   82 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             ccceeEeeccCCCCCeEEEEEC-----------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC
Confidence            4688889999999999999864           24579999986532122345888999999885 67788899999888


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------  261 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------  261 (491)
                      +..|+||||++|.+|.+.+...       .....++.+++++|..||+..                              
T Consensus        83 ~~~~lv~e~i~G~~l~~~~~~~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T 3tm0_A           83 GWSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHCCTT-------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred             CceEEEEEecCCeehhhccCCc-------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence            8999999999999998764211       123467889999999999811                              


Q ss_pred             --------------------------CCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          262 --------------------------EKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       262 --------------------------~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                                                ...++|+|+++.|||++.+..+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                      1339999999999999876566799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=3.8e-12  Score=121.34  Aligned_cols=136  Identities=17%  Similarity=0.058  Sum_probs=98.8

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc--eeeeeeEEeec
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGYCIED  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~~~~~  211 (491)
                      +|.+..+.+.|.++.||++...          +|..+++|+.....   ...+.+|+.+|+.|.+.+  +.+++++....
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~   87 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA   87 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred             CCceEecccCCCCceEEEEecC----------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence            4555455556777999998642          35579999976542   245678999998886444  45688888877


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------  261 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------  261 (491)
                      +..++||||++|.+|.  +..     ..   ...++.+++..|..||...                              
T Consensus        88 ~~~~~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD  157 (264)
T ss_dssp             SCEEEEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred             CCCEEEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence            7889999999998884  211     11   1256777888888888743                              


Q ss_pred             -------------------------CCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          262 -------------------------EKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       262 -------------------------~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                                               ...++|+|++|.|||++.++.+.|+|||.+.
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                     1129999999999999877667799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=3.2e-11  Score=121.19  Aligned_cols=142  Identities=15%  Similarity=0.185  Sum_probs=105.0

Q ss_pred             cCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEec--CCC-cccHHHHHHHHHHHhcCC--CCceeeeeeEEeec
Q 011180          137 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDG-LQGHKEWLAEVNFLGNLL--HPNLVKLVGYCIED  211 (491)
Q Consensus       137 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~  211 (491)
                      ..+.|+.|.++.||++...           +..+++|+..  ... ......+.+|+.+|+.|.  +..+.+++.++.+.
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            4567899999999998653           3468888775  332 122346788999999997  45678888888766


Q ss_pred             ---CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------
Q 011180          212 ---DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA---------------------------  261 (491)
Q Consensus       212 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------  261 (491)
                         +..|+||||++|..|.+..    ...++......++.+++..|..||...                           
T Consensus       111 ~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (359)
T 3dxp_A          111 SVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY  186 (359)
T ss_dssp             TTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred             CccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence               4579999999988775422    114667788889999999999999831                           


Q ss_pred             ----------------------------CCCeEecCCCCCcEEECCCCC--eEEeccCCccc
Q 011180          262 ----------------------------EKPVIYRDFKTSNILLDADYN--AKLSDFGLAKD  293 (491)
Q Consensus       262 ----------------------------~~~iiHrDlKp~NILl~~~~~--~kL~DFGla~~  293 (491)
                                                  ...+||+|+++.|||++.++.  +.|+||+.+..
T Consensus       187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                        245999999999999987753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.10  E-value=1.3e-10  Score=114.06  Aligned_cols=183  Identities=21%  Similarity=0.218  Sum_probs=120.8

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCc--eeeeeeEEeecC--
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPN--LVKLVGYCIEDD--  212 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-Hpn--Iv~l~~~~~~~~--  212 (491)
                      .+.++.|.+..||++.              ..+++|+....  .....+.+|+.+|+.|. +..  +.+++.+....+  
T Consensus        25 i~~~~~G~~n~v~~v~--------------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~   88 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN--------------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY   88 (304)
T ss_dssp             CCEEEECSSEEEEEST--------------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred             eEecCCCCcceEEEEC--------------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence            4568999999999852              25889986533  33467889999998874 332  334444433332  


Q ss_pred             -ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 011180          213 -QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------  261 (491)
Q Consensus       213 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------  261 (491)
                       ..|+|||+++|.+|.+....    .++...+..++.+++..|..||...                              
T Consensus        89 ~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (304)
T 3sg8_A           89 QMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRE  164 (304)
T ss_dssp             SCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhccc
Confidence             34899999999888754322    4566777788888888888888611                              


Q ss_pred             -------------------------CCCeEecCCCCCcEEECC--CCCeEEeccCCcccCCCCCCceeeeccccCCCC--
Q 011180          262 -------------------------EKPVIYRDFKTSNILLDA--DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY--  312 (491)
Q Consensus       262 -------------------------~~~iiHrDlKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y--  312 (491)
                                               ...++|+|+++.|||++.  ...+.|+||+.+.......      .......+  
T Consensus       165 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~  238 (304)
T 3sg8_A          165 LKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDE  238 (304)
T ss_dssp             SCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTT
T ss_pred             CCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhcc
Confidence                                     134899999999999987  5568899999886532210      01111111  


Q ss_pred             -CCchhhhc-----CC---------CCccccchhHHHHHHHHHhCCCCC
Q 011180          313 -AAPEYVMT-----GH---------LTSKSDVYSFGVVLLEMLTGRRSM  346 (491)
Q Consensus       313 -~aPE~~~~-----~~---------~~~~~DvwSlGvil~elltG~~pf  346 (491)
                       ..|+....     +.         .....+.|+++.++|.+.+|..+|
T Consensus       239 ~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          239 EYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             ccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             23332211     01         112358999999999999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.60  E-value=1.5e-07  Score=90.20  Aligned_cols=134  Identities=17%  Similarity=0.098  Sum_probs=94.5

Q ss_pred             cccCCce-EEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEEeecCceEEEE
Q 011180          141 LGEGGFG-CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVY  218 (491)
Q Consensus       141 lG~G~fg-~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~  218 (491)
                      +..|..| .||+.....         .+..+++|+-...   ....+.+|..+|+.|. +--|.++++++.+.+..++||
T Consensus        32 ~~~G~S~~~v~rl~~~~---------~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm   99 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKP---------NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT   99 (272)
T ss_dssp             EECSSSSCEEEEEECCT---------TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             ccCCCcCCeEEEEEecC---------CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence            4445555 689876543         3456889986533   3456788999998885 333667888888889999999


Q ss_pred             EecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 011180          219 EFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA-------------------------------------  261 (491)
Q Consensus       219 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------------------  261 (491)
                      |+++|.++.+......      .....++.+++..|.-||...                                     
T Consensus       100 e~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (272)
T 4gkh_A          100 TAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG  173 (272)
T ss_dssp             ECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred             EeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence            9999988877653321      122345556666666666421                                     


Q ss_pred             ------------------CCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          262 ------------------EKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       262 ------------------~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                                        ...++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                              1128999999999999987777899999765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=3.5e-07  Score=89.59  Aligned_cols=136  Identities=21%  Similarity=0.142  Sum_probs=91.5

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCC---ceeeeeeEEe-ecCc
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP---NLVKLVGYCI-EDDQ  213 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~~~~~-~~~~  213 (491)
                      .+.++.|....||+.              |..+++|+...  ......+.+|+.+|..|.+.   .|.+++.+.. ..+.
T Consensus        24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~   87 (306)
T 3tdw_A           24 VESLGEGFRNYAILV--------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN   87 (306)
T ss_dssp             EEEEEECSSEEEEEE--------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred             eeecCCCcceeEEEE--------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence            456888999999987              12488888532  22345788999999999742   2556666654 3456


Q ss_pred             eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------
Q 011180          214 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE---------------------------------  260 (491)
Q Consensus       214 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------------------------------  260 (491)
                      .++||||++|..|.+....    .++......++.+++..|..||..                                 
T Consensus        88 ~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~  163 (306)
T 3tdw_A           88 PFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL  163 (306)
T ss_dssp             EEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred             eEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence            7899999999888763211    223444444555555555555542                                 


Q ss_pred             ------------------------CCCCeEecCCCCCcEEECC---CCC-eEEeccCCccc
Q 011180          261 ------------------------AEKPVIYRDFKTSNILLDA---DYN-AKLSDFGLAKD  293 (491)
Q Consensus       261 ------------------------~~~~iiHrDlKp~NILl~~---~~~-~kL~DFGla~~  293 (491)
                                              ....++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                    2234799999999999987   455 48999997754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.44  E-value=3.5e-07  Score=91.32  Aligned_cols=85  Identities=5%  Similarity=-0.078  Sum_probs=54.8

Q ss_pred             Cccc-ccCCceEEEEEEEcc--CCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCC-C--CceeeeeeEE
Q 011180          138 ESLL-GEGGFGCVFKGWVEE--NGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLL-H--PNLVKLVGYC  208 (491)
Q Consensus       138 ~~~l-G~G~fg~Vy~~~~~~--~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-H--pnIv~l~~~~  208 (491)
                      .+.| +.|....+|+.....  ++.     ..+..+++|+.....   ......+.+|+.+|+.|. +  ..+.+++.++
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~-----~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~   99 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGR-----SIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIE   99 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTE-----EEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred             EEECCCCCccceEEEEEEecccCCC-----CCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence            3567 889999999886530  000     014578899865432   111245678888888874 2  3466777776


Q ss_pred             eec---CceEEEEEecCCCChH
Q 011180          209 IED---DQRLLVYEFMPRGSLE  227 (491)
Q Consensus       209 ~~~---~~~~lV~E~~~~gsL~  227 (491)
                      .+.   +..++||||++|..|.
T Consensus       100 ~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          100 TTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             CSSTTTSSCEEEEECCCCBCCC
T ss_pred             cCCCccCCceEEEEecCCCChh
Confidence            654   3568999999887654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.38  E-value=1.1e-06  Score=89.14  Aligned_cols=76  Identities=14%  Similarity=0.104  Sum_probs=49.1

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-------ccHHHHHHHHHHHhcCCC--Cc-eeeeeeE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGNLLH--PN-LVKLVGY  207 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~H--pn-Iv~l~~~  207 (491)
                      .+.||.|.++.||++....         .+..|+||.......       .....+..|+++|..+..  +. +.+++.+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~  105 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS  105 (397)
T ss_dssp             EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred             EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence            4679999999999997543         345799998643211       123456778888887742  33 3455543


Q ss_pred             EeecCceEEEEEecCCC
Q 011180          208 CIEDDQRLLVYEFMPRG  224 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~g  224 (491)
                        +.+..++||||+++.
T Consensus       106 --d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          106 --DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             --ETTTTEEEECCCTTS
T ss_pred             --cCCccEEEEEeCCCc
Confidence              455678999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.26  E-value=5.7e-06  Score=81.60  Aligned_cols=139  Identities=14%  Similarity=0.172  Sum_probs=78.2

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC--CCceeeeee------EEee
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL--HPNLVKLVG------YCIE  210 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~~------~~~~  210 (491)
                      +.|+.|..+.||++...           +..+++|+....    ...+..|+.++..|.  .-.+.+++.      +...
T Consensus        38 ~~l~gG~~n~~~~v~~~-----------~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~  102 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD-----------SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH  102 (346)
T ss_dssp             EECC----CEEEEEEET-----------TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE
T ss_pred             eeccccccCcEEEEEeC-----------CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE
Confidence            44666788999998653           225889998752    233445566555553  112333332      1234


Q ss_pred             cCceEEEEEecCCCChH-----------H---HhhhC-CCC-----------CCCHHHH---------------------
Q 011180          211 DDQRLLVYEFMPRGSLE-----------N---HLFRK-GSL-----------PLPWSIR---------------------  243 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~-----------~---~l~~~-~~~-----------~l~~~~~---------------------  243 (491)
                      .+..++||+|++|..+.           .   .++.. ...           ...|...                     
T Consensus       103 ~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  182 (346)
T 2q83_A          103 GSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKED  182 (346)
T ss_dssp             TTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSC
T ss_pred             CCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCC
Confidence            56789999999986542           0   11110 000           0122111                     


Q ss_pred             ----------HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          244 ----------MKIALGAAKGLAFLHE----------EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       244 ----------~~i~~qi~~aL~yLH~----------~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                                ..+..++..++.+|+.          .....+||+|+++.|||++.++.+.|+||+.+.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          183 PFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                      0111123445666763          123559999999999999888899999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.04  E-value=2.1e-05  Score=77.01  Aligned_cols=75  Identities=19%  Similarity=0.099  Sum_probs=58.3

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCceeeeeeEEeecCce
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLVGYCIEDDQR  214 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~  214 (491)
                      .+.|+.|.+..+|+...           .+..+++|+....   ....+..|+..|+.|.   ...+.+++.+....+..
T Consensus        41 ~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~  106 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS  106 (312)
T ss_dssp             EEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred             eEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence            45689999999999864           2447889987543   2456788999888884   35678888888877889


Q ss_pred             EEEEEecCCCCh
Q 011180          215 LLVYEFMPRGSL  226 (491)
Q Consensus       215 ~lV~E~~~~gsL  226 (491)
                      ++||||+++..+
T Consensus       107 ~lvme~l~G~~~  118 (312)
T 3jr1_A          107 FLLLEALNKSKN  118 (312)
T ss_dssp             EEEEECCCCCCC
T ss_pred             EEEEEeccCCCC
Confidence            999999998765

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.00  E-value=2.6e-05  Score=79.73  Aligned_cols=76  Identities=13%  Similarity=0.137  Sum_probs=45.0

Q ss_pred             CCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeecccc--CCCCCCchhhhcC---CCCccccchhHHHHHH
Q 011180          263 KPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG--TYGYAAPEYVMTG---HLTSKSDVYSFGVVLL  337 (491)
Q Consensus       263 ~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~G--t~~y~aPE~~~~~---~~~~~~DvwSlGvil~  337 (491)
                      ..++|+|+++.|||++.++ ++|+||+.+......-.  .. ...+  ...|++|+.....   .-....++..+...+|
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            4499999999999998776 99999998865321100  00 0000  1235555544211   1112244557777788


Q ss_pred             HHHhC
Q 011180          338 EMLTG  342 (491)
Q Consensus       338 elltG  342 (491)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.75  E-value=0.00011  Score=70.76  Aligned_cols=79  Identities=19%  Similarity=0.165  Sum_probs=55.5

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCC---CceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH---PNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H---pnIv~l~~~~~~  210 (491)
                      ...-.+.+|.|..+.||+....          +|..|.+|+...........+.+|+..|+.|.-   --+.+++++   
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---   82 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---   82 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---
T ss_pred             CeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---
Confidence            4555677999999999999875          477899998765544444567789999888842   123444443   


Q ss_pred             cCceEEEEEecCCCCh
Q 011180          211 DDQRLLVYEFMPRGSL  226 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL  226 (491)
                       +..++||||++++..
T Consensus        83 -~~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           83 -DDRTLAMEWVDERPP   97 (288)
T ss_dssp             -ETTEEEEECCCCCCC
T ss_pred             -cCceEEEEeecccCC
Confidence             234899999987643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.53  E-value=0.00058  Score=66.63  Aligned_cols=141  Identities=13%  Similarity=0.099  Sum_probs=77.0

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc--eeeeeeE------Eee
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGY------CIE  210 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~------~~~  210 (491)
                      +.|+.|....+|+.....          | .+++|+.....  ....+..|+.++..|...+  +.+++..      ...
T Consensus        28 ~~i~~G~~n~~~~v~~~~----------g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~   94 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTK----------D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   94 (322)
T ss_dssp             EEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             eccCCCcccceEEEEeCC----------c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence            457778889999986532          2 58899886531  1234556777777664212  2333321      123


Q ss_pred             cCceEEEEEecCCCChHH-----------H---hhhC-CCC--C----C---CHHHHHH------------HHHHHHHHH
Q 011180          211 DDQRLLVYEFMPRGSLEN-----------H---LFRK-GSL--P----L---PWSIRMK------------IALGAAKGL  254 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~-----------~---l~~~-~~~--~----l---~~~~~~~------------i~~qi~~aL  254 (491)
                      .+..++||+|++|..+..           .   ++.. ...  .    .   .|...+.            +...+...+
T Consensus        95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~  174 (322)
T 2ppq_A           95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  174 (322)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence            456789999998865321           0   1110 000  0    1   1211100            001134455


Q ss_pred             HHHHhc----CCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          255 AFLHEE----AEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       255 ~yLH~~----~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      .+|+..    ....+||+|+++.|||++.+..+.|+||+.+.
T Consensus       175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            555532    12459999999999999887666899998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.52  E-value=0.00013  Score=70.78  Aligned_cols=71  Identities=7%  Similarity=0.050  Sum_probs=43.9

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCce-eeeeeEEeecCceEE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLL  216 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~l  216 (491)
                      .+.|+.|....+|++  .             .+++|+....... .....+|+.+++.+..-++ .+++++  +.+.-++
T Consensus        23 i~~l~gG~tN~~~~~--~-------------~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~   84 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA--G-------------DLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVM   84 (301)
T ss_dssp             CEEEESCSSEEEEEE--T-------------TEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCE
T ss_pred             eeEcCCcccccccee--e-------------eEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEE
Confidence            678999999999998  2             3888987643211 1122457777776642222 344443  3444589


Q ss_pred             EEEec-CCCCh
Q 011180          217 VYEFM-PRGSL  226 (491)
Q Consensus       217 V~E~~-~~gsL  226 (491)
                      |+||+ ++.+|
T Consensus        85 v~e~i~~g~~l   95 (301)
T 3dxq_A           85 VTRYIAGAQTM   95 (301)
T ss_dssp             EEECCTTCEEC
T ss_pred             EEeecCCCccC
Confidence            99999 66544

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.49  E-value=0.00017  Score=73.96  Aligned_cols=81  Identities=19%  Similarity=0.115  Sum_probs=50.6

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCce-eeeeeEEeecCceEE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLL  216 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~l  216 (491)
                      .+.|+.|....||++........  ....+..|++|+.....  ....+.+|+.++..|...+| .++++.+.+    .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~--~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPP--IRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCC--SSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEeCCCcccceEEEEeCCCccc--cCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence            45688898999999976421100  00124579999884321  12456689999888853333 566665432    38


Q ss_pred             EEEecCCCCh
Q 011180          217 VYEFMPRGSL  226 (491)
Q Consensus       217 V~E~~~~gsL  226 (491)
                      ||||++|.+|
T Consensus       150 v~e~l~G~~l  159 (429)
T 1nw1_A          150 LEEYIPSRPL  159 (429)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeCCccc
Confidence            9999986443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.43  E-value=0.00036  Score=70.10  Aligned_cols=151  Identities=15%  Similarity=0.129  Sum_probs=82.7

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEEeecC
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDD  212 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~  212 (491)
                      .+. .+.|..|-...+|++.......  ...+.+..|++|+... .......+.+|.++++.|. +.-..++++++.+  
T Consensus        52 ~l~-v~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--  125 (379)
T 3feg_A           52 ELR-VYPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE--  125 (379)
T ss_dssp             GCC-CEEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--
T ss_pred             ceE-EEEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--
Confidence            344 3457778889999987642100  0011345799998633 2234456678999998885 3223556665543  


Q ss_pred             ceEEEEEecCCCChHHH--------------h---hhCC---CCCCC--HHHHHHHHHHHHH------------------
Q 011180          213 QRLLVYEFMPRGSLENH--------------L---FRKG---SLPLP--WSIRMKIALGAAK------------------  252 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~--------------l---~~~~---~~~l~--~~~~~~i~~qi~~------------------  252 (491)
                        .+||||++|..|...              |   +...   .....  +..+.++..++..                  
T Consensus       126 --g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  203 (379)
T 3feg_A          126 --GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLK  203 (379)
T ss_dssp             --EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHH
T ss_pred             --ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHH
Confidence              399999987654311              1   1110   01111  3344444433321                  


Q ss_pred             -HHHHHH----hc-CCCCeEecCCCCCcEEECCC----CCeEEeccCCcc
Q 011180          253 -GLAFLH----EE-AEKPVIYRDFKTSNILLDAD----YNAKLSDFGLAK  292 (491)
Q Consensus       253 -aL~yLH----~~-~~~~iiHrDlKp~NILl~~~----~~~kL~DFGla~  292 (491)
                       .+..|.    .. ....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       204 ~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          204 DEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence             223332    21 12359999999999999876    789999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.39  E-value=0.00065  Score=70.06  Aligned_cols=75  Identities=13%  Similarity=0.037  Sum_probs=46.5

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCce-eeeeeEEeecCceEE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLL  216 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~l  216 (491)
                      .+.|+.|-...+|++....         .+..+++|+..... ...-...+|..+|..|...++ .++++++.  +  .+
T Consensus       113 i~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~  178 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS---------KQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GR  178 (458)
T ss_dssp             EEEECC--CEEEEEEEETT---------TTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred             EEEcCCCeEeEEEEEEECC---------CCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence            3468888889999987642         23578899875432 111112478888888874444 46666652  2  36


Q ss_pred             EEEecCCCCh
Q 011180          217 VYEFMPRGSL  226 (491)
Q Consensus       217 V~E~~~~gsL  226 (491)
                      ||||++|.+|
T Consensus       179 v~e~I~G~~l  188 (458)
T 2qg7_A          179 IEEFMDGYAL  188 (458)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEeeCCccC
Confidence            9999987544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.38  E-value=0.001  Score=65.31  Aligned_cols=32  Identities=28%  Similarity=0.318  Sum_probs=27.3

Q ss_pred             CCeEecCCCCCcEEECCC----CCeEEeccCCcccC
Q 011180          263 KPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDA  294 (491)
Q Consensus       263 ~~iiHrDlKp~NILl~~~----~~~kL~DFGla~~~  294 (491)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            459999999999999874    68999999987643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.36  E-value=0.00095  Score=65.25  Aligned_cols=141  Identities=15%  Similarity=0.096  Sum_probs=78.7

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--ceeeeeeE-----Eeec
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP--NLVKLVGY-----CIED  211 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~-----~~~~  211 (491)
                      ..|+ |....||++...          .|..+++|+..... .....+..|+.++..|...  .+++++..     ....
T Consensus        32 ~~l~-g~~n~~y~v~~~----------~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~   99 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ   99 (328)
T ss_dssp             EEEC-CSSSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred             Eeec-CcccceEEEEcC----------CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence            4566 888899987542          34569999986432 2345677788888877421  23444432     2234


Q ss_pred             CceEEEEEecCCCChH-----H------H---hhh----CC---CCCCCHHHH----HHH---------------HHHHH
Q 011180          212 DQRLLVYEFMPRGSLE-----N------H---LFR----KG---SLPLPWSIR----MKI---------------ALGAA  251 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~-----~------~---l~~----~~---~~~l~~~~~----~~i---------------~~qi~  251 (491)
                      +..++||+|++|..+.     .      .   ++.    ..   .....+...    ..+               ...+.
T Consensus       100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  179 (328)
T 1zyl_A          100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD  179 (328)
T ss_dssp             TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred             CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence            5567899999875432     1      0   110    00   001121111    000               00111


Q ss_pred             HHHHHHHhc----CCCCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          252 KGLAFLHEE----AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       252 ~aL~yLH~~----~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      ..+..+...    ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            122333221    234489999999999998 4 899999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.18  E-value=0.00058  Score=68.21  Aligned_cols=83  Identities=10%  Similarity=0.023  Sum_probs=44.2

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc-eeeeeeEEeecCceEE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN-LVKLVGYCIEDDQRLL  216 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~l  216 (491)
                      ...|+.|....+|++........ ..+..+..+++|+..... ........|..++..|...+ +.++++..  .  -++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~-~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETAN-NYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHT-TCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcc-cccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence            34678888899999876421000 000112578899875432 11112356888887775333 34566543  2  378


Q ss_pred             EEEecCCCCh
Q 011180          217 VYEFMPRGSL  226 (491)
Q Consensus       217 V~E~~~~gsL  226 (491)
                      ||||++|..|
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999987543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.09  E-value=0.0022  Score=58.65  Aligned_cols=139  Identities=14%  Similarity=0.057  Sum_probs=89.3

Q ss_pred             ChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeee
Q 011180          225 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST  304 (491)
Q Consensus       225 sL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  304 (491)
                      +|.++|...+. ++.++++|.++.|.+.+|.-+-... . -..+=+-|..|+|..+|.|-+.+ +.+.            
T Consensus        34 SL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc------------
Confidence            78999877754 8999999999999998877662111 0 11233456899999999988864 2110            


Q ss_pred             ccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCC
Q 011180          305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS  384 (491)
Q Consensus       305 ~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  384 (491)
                        .....+.+||... ...+.+.=|||||+++|.-+--..|-..                                   .
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e-----------------------------------E  139 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE-----------------------------------E  139 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE-----------------------------------E
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc-----------------------------------c
Confidence              1123466888653 3445677899999999998854332110                                   0


Q ss_pred             hhhHHHHHHHHHHhhhc-------------------------CCCCCCCHHHHHHHhh
Q 011180          385 IKGSQKATQLAAQCLSR-------------------------DPKARPRMSEVVETLK  417 (491)
Q Consensus       385 ~~~~~~l~~li~~cL~~-------------------------dP~~RPt~~evl~~L~  417 (491)
                      ...++.+.+||..|...                         .+..|+++++|++.-.
T Consensus       140 ~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~  197 (229)
T 2yle_A          140 RELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA  197 (229)
T ss_dssp             ECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred             hhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence            11167788888888755                         3468899999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.02  E-value=0.0016  Score=64.30  Aligned_cols=31  Identities=13%  Similarity=0.149  Sum_probs=27.3

Q ss_pred             CCeEecCCCCCcEEECCCCCeEEeccCCccc
Q 011180          263 KPVIYRDFKTSNILLDADYNAKLSDFGLAKD  293 (491)
Q Consensus       263 ~~iiHrDlKp~NILl~~~~~~kL~DFGla~~  293 (491)
                      ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999987654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.96  E-value=0.022  Score=57.88  Aligned_cols=82  Identities=9%  Similarity=-0.019  Sum_probs=47.5

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEEeecCceEE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLL  216 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~l  216 (491)
                      .+.|..|-...+|++........  ....+..|++++..... ...-+..+|..+++.|. +.-..++++.+  .  -++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMS--LSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEEcCCCcccceEEEEeCCCccc--ccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence            34577788899999987531110  00114679999865432 11112356888887775 22234555432  2  378


Q ss_pred             EEEecCCCCh
Q 011180          217 VYEFMPRGSL  226 (491)
Q Consensus       217 V~E~~~~gsL  226 (491)
                      ||||++|..|
T Consensus       148 I~efI~G~~l  157 (424)
T 3mes_A          148 IEEFIDGEPL  157 (424)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEeCCccC
Confidence            9999988654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.24  E-value=0.092  Score=52.82  Aligned_cols=28  Identities=29%  Similarity=0.363  Sum_probs=24.2

Q ss_pred             eEecCCCCCcEEE------CCCCCeEEeccCCcc
Q 011180          265 VIYRDFKTSNILL------DADYNAKLSDFGLAK  292 (491)
Q Consensus       265 iiHrDlKp~NILl------~~~~~~kL~DFGla~  292 (491)
                      ++|+|+.+.|||+      +++..++|+||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            6799999999999      456789999998775

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.53  E-value=1.1  Score=40.90  Aligned_cols=114  Identities=10%  Similarity=0.092  Sum_probs=75.0

Q ss_pred             CCCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCCcE
Q 011180          197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA-FLHEEAEKPVIYRDFKTSNI  275 (491)
Q Consensus       197 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~-yLH~~~~~~iiHrDlKp~NI  275 (491)
                      .||++  -..+-.+++.+.|.++.-+++.=...+.     .++...+++++.+|+.... +++.     -+|--|+|+||
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence            47877  3334466677777776653332223332     4677888999998887666 5544     67888999999


Q ss_pred             EECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCC
Q 011180          276 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM  346 (491)
Q Consensus       276 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf  346 (491)
                      +++.++.++|.-.|+-..+..              .=+.+|.+          +-.+=|++..++.++..|
T Consensus       116 ~f~~~~~p~i~hRGi~~~lpP--------------~e~~ee~f----------l~qyKali~all~~K~~F  162 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKESLPP--------------DEWDDERL----------LREVKATVLALTEGEYRF  162 (219)
T ss_dssp             EECTTCCEEESCCEETTTBSS--------------CSCCHHHH----------HHHHHHHHHHHTTCSSCH
T ss_pred             EEeCCCcEEEEEcCCcccCCC--------------CCCCHHHH----------HHHHHHHHHHHHcCCCCH
Confidence            999999999998886433211              11223322          235667888888887766

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.55  E-value=0.083  Score=54.30  Aligned_cols=63  Identities=11%  Similarity=0.156  Sum_probs=18.8

Q ss_pred             CcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEE------EEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          136 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAV------KTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       136 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vav------K~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      .+.+.||   ||+||+|.+..         ....|||      |.......  .....+.+|..++..+.|||+++.+++
T Consensus       145 ~l~~~lG---fG~v~~g~~~~---------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f  212 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYK---------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF  212 (463)
T ss_dssp             CSTTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCE
T ss_pred             cccccCC---chhhhcccccc---------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence            4566777   99999998864         2236777      66654322  223468889999999999999999987


Q ss_pred             Eee
Q 011180          208 CIE  210 (491)
Q Consensus       208 ~~~  210 (491)
                      ...
T Consensus       213 ~~~  215 (463)
T 3cxl_A          213 KVH  215 (463)
T ss_dssp             EEE
T ss_pred             EEe
Confidence            653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.30  E-value=0.84  Score=41.39  Aligned_cols=123  Identities=9%  Similarity=0.038  Sum_probs=80.2

Q ss_pred             HHHHHhcCCCCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 011180          189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYR  268 (491)
Q Consensus       189 E~~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHr  268 (491)
                      |+.+|.. .||+++.. .+-.+++.+.|.++.-+  ....+-.-+   .++...+++++.+|+....+++.     =+|-
T Consensus        36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~~~-----r~tf  103 (215)
T 4ann_A           36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIK---SFTKNEKLRYLLNIKNLEEVNRT-----RYTF  103 (215)
T ss_dssp             GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGG---GSCHHHHHHHHHHGGGGGGGGGS-----SEEC
T ss_pred             HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHH---hcCHHHHHHHHHHHHHHHHHhcC-----ceEE
Confidence            4444432 58888876 45566666666665543  222222111   46678889999999887766654     5788


Q ss_pred             CCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCC
Q 011180          269 DFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD  347 (491)
Q Consensus       269 DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~  347 (491)
                      -|.|+||+++.++.+++.-.|+-..+...              =+..|.+          +-.+=|++..+++++..|+
T Consensus       104 ~L~P~NL~f~~~~~p~i~~RGik~~l~P~--------------~~~ee~f----------L~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          104 VLAPDELFFTRDGLPIAKTRGLQNVVDPL--------------PVSEAEF----------LTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CCSGGGEEECTTSCEEESCCEETTTBSCC--------------CCCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred             EEecceEEEcCCCCEEEEEccCccCCCCC--------------CCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence            89999999999999999888764433211              0122222          3356788888999888774

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	491
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-76
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-69
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-69
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-69
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-68
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-68
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-68
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-68
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-68
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-68
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-67
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-66
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-65
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-65
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-64
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-64
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-64
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-63
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-63
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-63
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-62
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-62
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-62
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-61
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-59
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-58
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-58
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-58
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-56
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-55
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-53
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-53
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-52
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-51
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-50
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-49
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-48
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-47
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-47
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-46
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-46
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-45
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-45
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-45
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-44
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-43
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-42
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-41
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-39
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-37
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-33
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (611), Expect = 2e-76
 Identities = 76/292 (26%), Positives = 122/292 (41%), Gaps = 34/292 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 191
                  +G G FG V+KG                 VAVK LN      Q  + +  EV 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVG 56

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
            L    H N++  +GY     Q  +V ++    SL +HL    +        + IA   A
Sbjct: 57  VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTA 114

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           +G+ +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  
Sbjct: 115 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171

Query: 312 YAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
           + APE +        + +SDVY+FG+VL E++TG+       P    N  +     +G  
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRG 225

Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 420
                L   R          +   +L A+CL +    RP   +++ +++ L 
Sbjct: 226 YLSPDLSKVRSN------CPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 2e-69
 Identities = 70/314 (22%), Positives = 127/314 (40%), Gaps = 44/314 (14%)

Query: 128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEW 186
           ++L   +F   S LG G  G VFK              +GL +A K ++ +       + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQI 51

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           + E+  L     P +V   G    D +  +  E M  GSL+  L + G   +P  I  K+
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKV 109

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
           ++   KGL +L E+    +++RD K SNIL+++    KL DFG++    +     ++   
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF 163

Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR---------------------- 344
           +GT  Y +PE +   H + +SD++S G+ L+EM  GR                       
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223

Query: 345 ----SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLS 400
                  +       +    +RP +        +++       S   S +      +CL 
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283

Query: 401 RDPKARPRMSEVVE 414
           ++P  R  + +++ 
Sbjct: 284 KNPAERADLKQLMV 297

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (561), Expect = 4e-69
 Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 32/286 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
             +    LG G FG V+ G+                VAVK+L          +LAE N +
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLM 62

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             L H  LV+L       +   ++ E+M  GSL + L     + L  +  + +A   A+G
Sbjct: 63  KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           +AF+ E   +  I+RD + +NIL+    + K++DFGLA+   ++ +            + 
Sbjct: 122 MAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWT 177

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 373
           APE +  G  T KSDV+SFG++L E++T  R       N E          + +  R YR
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYR 228

Query: 374 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           ++ P           ++  QL   C    P+ RP    +   L+  
Sbjct: 229 MVRPD-------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  219 bits (560), Expect = 7e-69
 Identities = 71/302 (23%), Positives = 129/302 (42%), Gaps = 30/302 (9%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 184
           ++  ++   +   +  LG G +G V++G         V     LTVAVKTL  D ++  +
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-E 58

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
           E+L E   +  + HPNLV+L+G C  +    ++ EFM  G+L ++L       +   + +
Sbjct: 59  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 118

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            +A   +  + +L    +K  I+RD    N L+  ++  K++DFGL++    D       
Sbjct: 119 YMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHA 174

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
                  + APE +     + KSDV++FGV+L E+ T   S        +          
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------- 224

Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD 424
                  Y LL+            +K  +L   C   +P  RP  +E+ +  + +     
Sbjct: 225 ------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278

Query: 425 MA 426
           ++
Sbjct: 279 IS 280

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 1e-68
 Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 42/292 (14%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           +  +    +G+G FG V  G              G  VAVK + +D     + +LAE + 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATA--QAFLAEASV 53

Query: 193 LGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
           +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  +G   L     +K +L   
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           + + +L        ++RD    N+L+  D  AK+SDFGL K+A     T           
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVK 165

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGDKR 369
           + APE +     ++KSDV+SFG++L E+ +  R      P  +    + +  +    D  
Sbjct: 166 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 225

Query: 370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 421
                                  ++   C   D   RP   ++ E L+ ++ 
Sbjct: 226 ------------------PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 1e-68
 Identities = 79/287 (27%), Positives = 124/287 (43%), Gaps = 32/287 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
                  +G G FG V  G+                VA+KT+        ++++ E   +
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVM 54

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             L HP LV+L G C+E     LV+EFM  G L ++L  +  L       + + L   +G
Sbjct: 55  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEG 113

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           +A+L E     VI+RD    N L+  +   K+SDFG+ +   +D +   ST       +A
Sbjct: 114 MAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWA 169

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 373
           +PE       +SKSDV+SFGV++ E+ +  +   +NR N E          + D    +R
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFR 220

Query: 374 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 420
           L  PRL        S    Q+   C    P+ RP  S ++  L  + 
Sbjct: 221 LYKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 3e-68
 Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 32/285 (11%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           ++      LG G FG V  G                 VA+K +         E++ E   
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKV 52

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
           + NL H  LV+L G C +     ++ E+M  G L N+L             +++     +
Sbjct: 53  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCE 111

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
            + +L     K  ++RD    N L++     K+SDFGL++   +D +   S        +
Sbjct: 112 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRW 167

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 372
           + PE +M    +SKSD+++FGV++ E+ +  +      P       E A        +  
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAE----HIAQGL 218

Query: 373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
           RL  P L        S+K   +   C       RP    ++  + 
Sbjct: 219 RLYRPHLA-------SEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 5e-68
 Identities = 73/307 (23%), Positives = 115/307 (37%), Gaps = 45/307 (14%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 192
           N     +LG G FG V             K G  + VAVK L        +E  ++E+  
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKM 93

Query: 193 LGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------- 236
           +  L  H N+V L+G C       L++E+   G L N+L  K                  
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 237 ------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 290
                  L +   +  A   AKG+ FL     K  ++RD    N+L+      K+ DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 350
           A+D   D    V         + APE +  G  T KSDV+S+G++L E+ +   +     
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 351 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 410
           P   +               FY+L+    +       +++   +   C + D + RP   
Sbjct: 271 PVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315

Query: 411 EVVETLK 417
            +   L 
Sbjct: 316 NLTSFLG 322

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 5e-68
 Identities = 80/295 (27%), Positives = 127/295 (43%), Gaps = 32/295 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 198
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 34  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 199 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 257
           PN++ L+G C+  +   L+V  +M  G L N +  +   P      +   L  AKG+ FL
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL 146

Query: 258 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTHVSTRVMGTYGYAAP 315
                K  ++RD    N +LD  +  K++DFGLA+D  +      H  T       + A 
Sbjct: 147 AS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 316 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 375
           E + T   T+KSDV+SFGV+L E++T         P  + N  +     L    +  RLL
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLL----QGRRLL 254

Query: 376 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSY 430
            P               ++  +C     + RP  SE+V  +  +          Y
Sbjct: 255 QPEYC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI--FSTFIGEHY 300

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  217 bits (554), Expect = 7e-68
 Identities = 76/310 (24%), Positives = 130/310 (41%), Gaps = 39/310 (12%)

Query: 123 FMFNDLKLATRNFRPE---------SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 173
           F F D   A R F  E          ++G G FG V  G ++  G         + VA+K
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60

Query: 174 TLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 232
           TL      +  +++L+E + +G   HPN++ L G   +    +++ EFM  GSL++ L +
Sbjct: 61  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120

Query: 233 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 292
                      + +  G A G+ +L +      ++RD    NIL++++   K+SDFGL++
Sbjct: 121 NDG-QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176

Query: 293 DAPEDGKTHVSTRV---MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 349
              +D      T          + APE +     TS SDV+S+G+V+ E+++        
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE----- 231

Query: 350 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 409
           RP  +    +       D R               +       QL   C  +D   RP+ 
Sbjct: 232 RPYWDMTNQDVINAIEQDYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKF 280

Query: 410 SEVVETLKPL 419
            ++V TL  +
Sbjct: 281 GQIVNTLDKM 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 9e-67
 Identities = 79/314 (25%), Positives = 118/314 (37%), Gaps = 45/314 (14%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 192
                  LG G FG V +          +K    +TVAVK L        +E  ++E+  
Sbjct: 24  RLSFGKTLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79

Query: 193 LGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG----------------S 235
           L  L  H N+V L+G C      L++ E+   G L N L RK                  
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 236 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 295
           L L     +  +   AKG+AFL     K  I+RD    NILL      K+ DFGLA+D  
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 296 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 355
            D    V         + APE +     T +SDV+S+G+ L E+ +   S     P    
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 415
                          FY+++              +   +   C   DP  RP   ++V+ 
Sbjct: 257 ---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 416 LKPLQNLKDMASSS 429
           ++     K ++ S+
Sbjct: 302 IE-----KQISEST 310

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 3e-66
 Identities = 69/314 (21%), Positives = 121/314 (38%), Gaps = 36/314 (11%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 192
           R    +  +G+G FG V++G              G  VAVK  +    +      AE+  
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQ 50

Query: 193 LGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
              L H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K+AL
Sbjct: 51  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLAL 107

Query: 249 GAAKGLAFLHEEA-----EKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTH 301
             A GLA LH E      +  + +RD K+ NIL+  +    ++D GLA   D+  D    
Sbjct: 108 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 167

Query: 302 VSTRVMGTYGYAAPEYVMT------GHLTSKSDVYSFGVVLLEMLTGRR----SMDKNRP 351
                +GT  Y APE +             ++D+Y+ G+V  E+           D   P
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227

Query: 352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
             +    + +   +       +L         S +  +   ++  +C   +  AR     
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

Query: 412 VVETLKPLQNLKDM 425
           + +TL  L   + +
Sbjct: 288 IKKTLSQLSQQEGI 301

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 1e-65
 Identities = 69/311 (22%), Positives = 120/311 (38%), Gaps = 32/311 (10%)

Query: 127 DLKLATRNFRPESL-LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-K 184
            L L   N     + LG G FG V +G               + VA+K L     +   +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGTEKADTE 54

Query: 185 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
           E + E   +  L +P +V+L+G C + +  +LV E    G L   L  K    +P S   
Sbjct: 55  EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVA 112

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVS 303
           ++    + G+ +L E   K  ++RD    N+LL   + AK+SDFGL+K    D       
Sbjct: 113 ELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169

Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
           +       + APE +     +S+SDV+S+GV + E L+  +     +P  +    E    
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPE---- 220

Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK-PLQNL 422
                      ++         +   +   L + C     + RP    V + ++    +L
Sbjct: 221 -------VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273

Query: 423 KDMASSSYYFQ 433
                  ++  
Sbjct: 274 ASKVEGHHHHH 284

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  210 bits (534), Expect = 7e-65
 Identities = 68/318 (21%), Positives = 114/318 (35%), Gaps = 46/318 (14%)

Query: 125 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-H 183
              L+    N      +GEG FG VF+          +       VAVK L  +      
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARA----PGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 184 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG--------- 234
            ++  E   +    +PN+VKL+G C       L++E+M  G L   L             
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 235 -------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 281
                          PL  + ++ IA   A G+A+L E   +  ++RD  T N L+  + 
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177

Query: 282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 341
             K++DFGL+++                  +  PE +     T++SDV+++GVVL E+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 342 GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSR 401
                     + E                 Y + D  +          +   L   C S+
Sbjct: 238 YGLQPYYGMAHEE---------------VIYYVRDGNIL-ACPENCPLELYNLMRLCWSK 281

Query: 402 DPKARPRMSEVVETLKPL 419
            P  RP    +   L+ +
Sbjct: 282 LPADRPSFCSIHRILQRM 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 1e-64
 Identities = 66/298 (22%), Positives = 127/298 (42%), Gaps = 27/298 (9%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 187
           ++       + ++G G FG V+KG ++ +          + VA+KTL     +  + ++L
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK-----KEVPVAIKTLKAGYTEKQRVDFL 57

Query: 188 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
            E   +G   H N+++L G   +    +++ E+M  G+  +   R+          + + 
Sbjct: 58  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGML 116

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTHVSTRV 306
            G A G+ +L        ++RD    NIL++++   K+SDFGL++   +D   T+ ++  
Sbjct: 117 RGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173

Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
                + APE +     TS SDV+SFG+V+ E++T          N E            
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------ 221

Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD 424
                 + ++        +       QL  QC  ++   RP+ +++V  L  L    D
Sbjct: 222 ----VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 2e-64
 Identities = 77/292 (26%), Positives = 122/292 (41%), Gaps = 30/292 (10%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAE 189
           ++ R    LG+G FG V +G  +         G  ++VAVK L  D L   +   +++ E
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
           VN + +L H NL++L G  +    ++ V E  P GSL + L +            + A+ 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQ 119

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV-STRVMG 308
            A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V       
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176

Query: 309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 368
            + + APE + T   +  SD + FGV L EM T  +      P    N  +       + 
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEG 231

Query: 369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 420
            R      PR E        Q    +  QC +  P+ RP    + + L   Q
Sbjct: 232 ERL-----PRPEDC-----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 3e-64
 Identities = 73/297 (24%), Positives = 123/297 (41%), Gaps = 34/297 (11%)

Query: 138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGN 195
           +  LG G FG V KG+ +             TVAVK L ++        E LAE N +  
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEANDPALKDELLAEANVMQQ 64

Query: 196 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 255
           L +P +V+++G C E +  +LV E    G L  +L +     +     +++    + G+ 
Sbjct: 65  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMK 121

Query: 256 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH-VSTRVMGTYGYAA 314
           +L E      ++RD    N+LL   + AK+SDFGL+K    D   +   T       + A
Sbjct: 122 YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 315 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 374
           PE +     +SKSDV+SFGV++ E  +  +     +P       E              +
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSE-----------VTAM 222

Query: 375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYY 431
           L+            ++   L   C + D + RP  + V   L+      D+ +  ++
Sbjct: 223 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY--YYDVVNEGHH 277

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 1e-63
 Identities = 75/309 (24%), Positives = 127/309 (41%), Gaps = 48/309 (15%)

Query: 132 TRNFRPE------SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 185
           TR+  PE        LG+G FG V+K              T +  A K ++    +  ++
Sbjct: 5   TRDLNPEDFWEIIGELGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELED 55

Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
           ++ E++ L +  HPN+VKL+     ++   ++ EF   G+++  +      PL  S    
Sbjct: 56  YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQV 114

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
           +       L +LH   +  +I+RD K  NIL   D + KL+DFG++       +      
Sbjct: 115 VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DS 169

Query: 306 VMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 360
            +GT  + APE VM           K+DV+S G+ L+EM           P+ E N +  
Sbjct: 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRV 223

Query: 361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV-------V 413
                  K     L  P        + S        +CL ++  AR   S++       V
Sbjct: 224 LLKIA--KSEPPTLAQPS-------RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274

Query: 414 ETLKPLQNL 422
           ++ KP++ L
Sbjct: 275 DSNKPIREL 283

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 2e-63
 Identities = 65/283 (22%), Positives = 109/283 (38%), Gaps = 31/283 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNF 192
           ++     LGEG +G V            V   T   VAVK ++    +   +    E+  
Sbjct: 6   DWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
              L H N+VK  G+  E + + L  E+   G L + +       +P     +       
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA 114

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
           G+ +LH      + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y
Sbjct: 115 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171

Query: 313 AAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
            APE +          DV+S G+VL  ML G    D+   + +                +
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------Y 216

Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
               + +   +   K       L  + L  +P AR  + ++ +
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 6e-63
 Identities = 73/325 (22%), Positives = 131/325 (40%), Gaps = 49/325 (15%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNF 192
           + + + ++GEG FG V K  ++++G         +  A+K +        H+++  E+  
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYASKDDHRDFAGELEV 63

Query: 193 LGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------P 237
           L  L  HPN++ L+G C       L  E+ P G+L + L +   L               
Sbjct: 64  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123

Query: 238 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 297
           L     +  A   A+G+ +L +   K  I+RD    NIL+  +Y AK++DFGL++     
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
            K    T       + A E +     T+ SDV+S+GV+L E+++   +     P      
Sbjct: 181 VKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTC 232

Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
            E            Y  L         +    +   L  QC    P  RP  ++++ +L 
Sbjct: 233 AEL-----------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

Query: 418 PLQNLKDMASSSYYFQTMQADNTWS 442
            +   +     +Y   T+    T++
Sbjct: 282 RMLEER----KTYVNTTLYEKFTYA 302

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 6e-63
 Identities = 66/289 (22%), Positives = 113/289 (39%), Gaps = 36/289 (12%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 191
           ++     +G G +G   K           +   G  +  K L++  +     +  ++EVN
Sbjct: 5   DYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHLFR--KGSLPLPWSIRMKIA 247
            L  L HPN+V+     I+     L  V E+   G L + + +  K    L     +++ 
Sbjct: 56  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115

Query: 248 LGAAKGLAFLHE--EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
                 L   H   +    V++RD K +N+ LD   N KL DFGLA+    D  T  +  
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKA 173

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
            +GT  Y +PE +       KSD++S G +L E+           P    +  E A    
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIR 227

Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
             K         R+   +    S +  ++  + L+     RP + E++E
Sbjct: 228 EGKF-------RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 1e-62
 Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 32/286 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           + R E  LG+G FG V+ G                 VA+KTL        + +L E   +
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPG-TMSPEAFLQEAQVM 66

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             L H  LV+L      ++   +V E+M +GSL + L  +    L     + +A   A G
Sbjct: 67  KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           +A++        ++RD + +NIL+  +   K++DFGLA+   ED +            + 
Sbjct: 126 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT 181

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 373
           APE  + G  T KSDV+SFG++L E+ T  R       N E                   
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLD 225

Query: 374 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
            ++         +  +    L  QC  ++P+ RP    +   L+  
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 3e-62
 Identities = 62/286 (21%), Positives = 121/286 (42%), Gaps = 27/286 (9%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFL 193
           F+   +LG G FG V+KG     G         + VA+K L      + +KE L E   +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
            ++ +P++ +L+G C+    +L + + MP G L +++       +     +   +  AKG
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKG 123

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           + +L +   + +++RD    N+L+    + K++DFGLAK    + K + +        + 
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 373
           A E ++    T +SDV+S+GV + E++T         P  E                   
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISS 224

Query: 374 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
           +L+           +     +  +C   D  +RP+  E++     +
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 5e-62
 Identities = 68/284 (23%), Positives = 112/284 (39%), Gaps = 39/284 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 190
           +F     LG+G FG V+            +  +   +A+K L    L       +   EV
Sbjct: 7   DFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREV 57

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
               +L HPN+++L GY  +  +  L+ E+ P G++   L +                  
Sbjct: 58  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITEL 115

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 310
           A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     GT 
Sbjct: 116 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTL 168

Query: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 370
            Y  PE +       K D++S GV+  E L G+   + N     +  +        D   
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV- 227

Query: 371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                            ++ A  L ++ L  +P  RP + EV+E
Sbjct: 228 -----------------TEGARDLISRLLKHNPSQRPMLREVLE 254

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 2e-61
 Identities = 64/289 (22%), Positives = 108/289 (37%), Gaps = 39/289 (13%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 190
           R  + +  +G G F  V+KG         +   T + VA   L    L     + +  E 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEA 59

Query: 191 NFLGNLLHPNLVKLVGYCIE----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
             L  L HPN+V+               +LV E M  G+L+ +L R     +   +    
Sbjct: 60  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSW 117

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDAPEDGKTHVSTR 305
                KGL FLH     P+I+RD K  NI +     + K+ D GLA       +   +  
Sbjct: 118 CRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKA 172

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
           V+GT  + APE +         DVY+FG+ +LEM T      + +   +           
Sbjct: 173 VIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------- 221

Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                + R+        F      +  ++   C+ ++   R  + +++ 
Sbjct: 222 -----YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (509), Expect = 4e-61
 Identities = 71/309 (22%), Positives = 117/309 (37%), Gaps = 47/309 (15%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LA 188
            + F     +G G FG V+                   VA+K +++ G Q +++W   + 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           EV FL  L HPN ++  G  + +    LV E+    + +     K   PL       +  
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTH 122

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 308
           GA +GLA+LH      +I+RD K  NILL      KL DFG A           +   +G
Sbjct: 123 GALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVG 173

Query: 309 TYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
           T  + APE ++    G    K DV+S G+  +E+   +       P    N +       
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIA 227

Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE-----TLKPLQ 420
            ++     L             S+        CL + P+ RP    +++       +P  
Sbjct: 228 QNESPA--LQSGHW--------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277

Query: 421 NLKDMASSS 429
            + D+   +
Sbjct: 278 VIMDLIQRT 286

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 2e-59
 Identities = 66/303 (21%), Positives = 118/303 (38%), Gaps = 37/303 (12%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 191
            + +     +G+G  G V+           +   TG  VA++ +N       +  + E+ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
            +    +PN+V  +   +  D+  +V E++  GSL + +               +     
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECL 126

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           + L FLH      VI+RD K+ NILL  D + KL+DFG       +      + ++GT  
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPY 181

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           + APE V       K D++S G++ +EM+ G        P    N +             
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYLIA--TNGT 233

Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE-----TLKPLQNLKDMA 426
             L +P        K S        +CL  D + R    E+++       KPL +L  + 
Sbjct: 234 PELQNPE-------KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

Query: 427 SSS 429
           +++
Sbjct: 287 AAA 289

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 2e-58
 Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 29/287 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 192
                  +GEG FG V +G               L VA+KT  +      +E +L E   
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 252
           +    HP++VKL+G    ++   ++ E    G L + L  +    L  +  +  A   + 
Sbjct: 62  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLST 119

Query: 253 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 312
            LA+L     K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      +
Sbjct: 120 ALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 175

Query: 313 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 372
            APE +     TS SDV+ FGV + E+L         +P       +        +R   
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGER--- 227

Query: 373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                 +  +           L  +C + DP  RPR +E+   L  +
Sbjct: 228 ----LPMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 2e-58
 Identities = 80/303 (26%), Positives = 117/303 (38%), Gaps = 39/303 (12%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNF 192
             +    LG G FG V +           K  T  TVAVK L        H+  ++E+  
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 193 LGNLLH-PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSL-------------- 236
           L ++ H  N+V L+G C +    L ++ EF   G+L  +L  K +               
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 237 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 296
            L     +  +   AKG+ FL     +  I+RD    NILL      K+ DFGLA+D  +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 297 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 356
           D              + APE +     T +SDV+SFGV+L E+ +   S     P     
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVK 241

Query: 357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 416
           + E     L +  R                 + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 IDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 417 KPL 419
             L
Sbjct: 292 GNL 294

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 4e-58
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 36/295 (12%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 192
                  LG+G FG V++G         VK      VA+KT+N    ++   E+L E + 
Sbjct: 21  KITMSRELGQGSFGMVYEGVA----KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76

Query: 193 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------PLPWSIRM 244
           +      ++V+L+G   +    L++ E M RG L+++L              P   S  +
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
           ++A   A G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        
Sbjct: 137 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWAR 362
           + +    + +PE +  G  T+ SDV+SFGVVL E+ T      +   N +    ++E   
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253

Query: 363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
               D                         +L   C   +PK RP   E++ ++K
Sbjct: 254 LDKPDNC------------------PDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 9e-58
 Identities = 75/305 (24%), Positives = 118/305 (38%), Gaps = 37/305 (12%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNF 192
                  LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  
Sbjct: 14  RLVLGKPLGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71

Query: 193 LGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-------------- 237
           +  +  H N++ L+G C +D    ++ E+  +G+L  +L  +                  
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 238 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 297
           L     +  A   A+G+ +L     K  I+RD    N+L+  D   K++DFGLA+D    
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 298 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
                +T       + APE +     T +SDV+SFGV+L E+ T   S     P  E   
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245

Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
                         ++LL            + +   +   C    P  RP   ++VE L 
Sbjct: 246 -------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

Query: 418 PLQNL 422
            +  L
Sbjct: 293 RIVAL 297

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 1e-56
 Identities = 61/297 (20%), Positives = 104/297 (35%), Gaps = 39/297 (13%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKE 185
           K    +F+   +LGEG F  V             +  T    A+K L    +        
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPY 54

Query: 186 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
              E + +  L HP  VKL     +D++      +   G L  ++ + G      +    
Sbjct: 55  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRF 112

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
                   L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +  
Sbjct: 113 YTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
            +GT  Y +PE +        SD+++ G ++ +++ G                    P  
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------------------PPFR 211

Query: 366 GDKRRFYRLLDPRLEGHFSI--KGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 420
                 Y +    ++  +    K   KA  L  + L  D   R    E+        
Sbjct: 212 AGNE--YLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  186 bits (472), Expect = 4e-55
 Identities = 63/283 (22%), Positives = 102/283 (36%), Gaps = 32/283 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           ++     LG G FG V +           +  TG   A K +        +    E+  +
Sbjct: 27  HYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTM 77

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             L HP LV L     +D++ +++YEFM  G L   +  + +  +     ++      KG
Sbjct: 78  SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKG 136

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYN--AKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           L  +H   E   ++ D K  NI+     +   KL DFGL           V     GT  
Sbjct: 137 LCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAE 190

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           +AAPE      +   +D++S GV+   +L+G        P G  N  E  R         
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWNM 244

Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                  +        S+       + L  DP  R  + + +E
Sbjct: 245 DDSAFSGI--------SEDGKDFIRKLLLADPNTRMTIHQALE 279

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  179 bits (456), Expect = 1e-53
 Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 37/296 (12%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVN 191
           +    +LG GG   V                    VAVK L  D  +    +  +  E  
Sbjct: 9   YELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRL----LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
               L HP +V +      +        +V E++   +L + +  +G  P+     +++ 
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVI 117

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST-RV 306
             A + L F H+     +I+RD K +NI++ A    K+ DFG+A+   + G +   T  V
Sbjct: 118 ADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
           +GT  Y +PE      + ++SDVYS G VL E+LTG        P    + V  A  H+ 
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVR 228

Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETLKPLQN 421
           +           L        S     +  + L+++P+ R +  +E+   L  + N
Sbjct: 229 EDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  181 bits (461), Expect = 2e-53
 Identities = 58/283 (20%), Positives = 106/283 (37%), Gaps = 32/283 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
            +     LG G FG V +          V+  TG     K +N            E++ +
Sbjct: 30  YYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             L HP L+ L     +  + +L+ EF+  G L + +  +    +  +  +     A +G
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEG 139

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           L  +H   E  +++ D K  NI+ +    +  K+ DFGLA     D           T  
Sbjct: 140 LKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAE 193

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           +AAPE V    +   +D+++ GV+   +L+G        P    + +E  +        F
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWEF 247

Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                  +        S +A       L ++P+ R  + + +E
Sbjct: 248 DEDAFSSV--------SPEAKDFIKNLLQKEPRKRLTVHDALE 282

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 69/297 (23%), Positives = 111/297 (37%), Gaps = 47/297 (15%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHK 184
           N+ P+ +LG G    V +          +   T    AVK ++  G          +  +
Sbjct: 4   NYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54

Query: 185 EWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR 243
             L EV+ L  +  HPN+++L      +    LV++ M +G L ++L  K    L     
Sbjct: 55  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKET 112

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
            KI     + +  LH   +  +++RD K  NILLD D N KL+DFG +       K    
Sbjct: 113 RKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--- 166

Query: 304 TRVMGTYGYAAPEYVMTGHL------TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 357
             V GT  Y APE +             + D++S GV++  +L G        P      
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQ 220

Query: 358 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
           +   R  +    +F                S     L ++ L   P+ R    E + 
Sbjct: 221 MLMLRMIMSGNYQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (441), Expect = 4e-51
 Identities = 56/281 (19%), Positives = 94/281 (33%), Gaps = 29/281 (10%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 193
           +    +LG G F  V                T   VA+K +    L+G +     E+  L
Sbjct: 11  YDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             + HPN+V L           L+ + +  G L + +  KG          ++       
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDA 119

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 313
           + +LH+        +        LD D    +SDFGL+K           +   GT GY 
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYV 176

Query: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 373
           APE +     +   D +S GV+   +L G        P  + N  +     L  +  F  
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEYEFDS 230

Query: 374 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                +        S  A       + +DP+ R    + ++
Sbjct: 231 PYWDDI--------SDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 3e-50
 Identities = 54/337 (16%), Positives = 117/337 (34%), Gaps = 45/337 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
            +     LG G FG V +          V+  +  T   K +   G         E++ L
Sbjct: 6   KYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
               H N++ L       ++ ++++EF+    +   +       L     +       + 
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEA 114

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           L FLH      + + D +  NI+     ++  K+ +FG A+         +   +     
Sbjct: 115 LQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPE 168

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           Y APE      +++ +D++S G ++  +L+G        P       +     +  +  F
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYTF 222

Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV------ETLKPLQN--LK 423
                  +        S +A     + L ++ K+R   SE +      + ++ +    ++
Sbjct: 223 DEEAFKEI--------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274

Query: 424 DMASSSYYFQTMQADNTWSI----RNSKNGIRTQGGF 456
            +    YY   ++ D    +     +    IR+Q G 
Sbjct: 275 TLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGV 311

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  173 bits (440), Expect = 3e-50
 Identities = 70/285 (24%), Positives = 107/285 (37%), Gaps = 40/285 (14%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 190
           +F    ++G GGFG V+            K  TG   A+K L+   +   QG    L E 
Sbjct: 5   DFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNER 55

Query: 191 N---FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 247
                +     P +V +       D+   + + M  G L  HL + G      +     A
Sbjct: 56  IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYA 113

Query: 248 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 307
                GL  +H    + V+YRD K +NILLD   + ++SD GLA D  +          +
Sbjct: 114 AEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SV 166

Query: 308 GTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 366
           GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +         
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-- 224

Query: 367 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
                       L   F    S +   L    L RD   R     
Sbjct: 225 ---------AVELPDSF----SPELRSLLEGLLQRDVNRRLGCLG 256

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-49
 Identities = 72/278 (25%), Positives = 103/278 (37%), Gaps = 38/278 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 190
           +F    +LG+G FG VF               T    A+K L  D +    +    + E 
Sbjct: 3   DFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53

Query: 191 NFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
             L     HP L  +       +    V E++  G L  H+          S     A  
Sbjct: 54  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAE 111

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
              GL FLH    K ++YRD K  NILLD D + K++DFG+ K+              GT
Sbjct: 112 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGT 166

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 369
             Y APE ++        D +SFGV+L EML G+       P    +  E       D  
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNP 220

Query: 370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
            + R L             ++A  L  +   R+P+ R 
Sbjct: 221 FYPRWL------------EKEAKDLLVKLFVREPEKRL 246

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (420), Expect = 4e-48
 Identities = 49/299 (16%), Positives = 92/299 (30%), Gaps = 34/299 (11%)

Query: 127 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 186
           +L++  R +R    +G G FG ++ G              G  VA+K         H + 
Sbjct: 2   ELRVGNR-YRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVK--TKHPQL 49

Query: 187 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
             E      +     +  + +C  +    ++   +   SLE+               + +
Sbjct: 50  HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-KFSLKTVLLL 108

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDG----- 298
           A      + ++H    K  I+RD K  N L           + DFGLAK   +       
Sbjct: 109 ADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165

Query: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358
               +  + GT  YA+    +    + + D+ S G VL+    G       +   +    
Sbjct: 166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225

Query: 359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 417
           E          +        L   +      +       C S     +P  S + +  +
Sbjct: 226 ER------ISEKKMSTPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-47
 Identities = 66/291 (22%), Positives = 108/291 (37%), Gaps = 32/291 (10%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLG 194
            LGEG F  V+K              T   VA+K +        K+      L E+  L 
Sbjct: 5   FLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55

Query: 195 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
            L HPN++ L+          LV++FM        + +  SL L  S      L   +GL
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGL 113

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 314
            +LH   +  +++RD K +N+LLD +   KL+DFGLAK      + +  T  + T  Y A
Sbjct: 114 EYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRA 168

Query: 315 PEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRP----------NGEHNLVEWARP 363
           PE +    +     D+++ G +L E+L     +  +             G     +W   
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228

Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                   ++        H           L       +P AR   ++ ++
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 5e-47
 Identities = 70/309 (22%), Positives = 126/309 (40%), Gaps = 33/309 (10%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 191
           NF+    +GEG +G V+K              TG  VA+K +  D          + E++
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
            L  L HPN+VKL+     +++  LV+EF+ +  L+  +       +P  +         
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLL 112

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+ +  V+  + 
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWY 168

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNLVEWA 361
            A    +   + ++  D++S G +  EM+T R     +             G  + V W 
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228

Query: 362 RP-HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV------E 414
               + D +  +     +          +    L +Q L  DP  R      +      +
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

Query: 415 TLKPLQNLK 423
             KP+ +L+
Sbjct: 289 VTKPVPHLR 297

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  163 bits (413), Expect = 5e-47
 Identities = 68/278 (24%), Positives = 110/278 (39%), Gaps = 40/278 (14%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAE 189
           ++F+    LG G FG V                 G   A+K L  + +   K+      E
Sbjct: 4   QDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54

Query: 190 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 249
              L  + HP ++++ G   +  Q  ++ +++  G L + L +    P P +      + 
Sbjct: 55  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV- 113

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
                  L     K +IYRD K  NILLD + + K++DFG AK  P+   T       GT
Sbjct: 114 ----CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GT 164

Query: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 369
             Y APE V T       D +SFG+++ EML G        P  + N ++     L  + 
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNAEL 218

Query: 370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 407
           RF                ++    L ++ ++RD   R 
Sbjct: 219 RFPPFF------------NEDVKDLLSRLITRDLSQRL 244

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 7e-47
 Identities = 66/308 (21%), Positives = 110/308 (35%), Gaps = 44/308 (14%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------ 188
           +     LG G F  V K           +  TGL  A K +     +  +  ++      
Sbjct: 12  YDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 189 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 248
           EV+ L  + HPN++ L          +L+ E +  G L + L  K    L      +   
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLK 120

Query: 249 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDAPEDGKTHVST 304
               G+ +LH      + + D K  NI+L          K+ DFGLA       +     
Sbjct: 121 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---K 174

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
            + GT  + APE V    L  ++D++S GV+   +L+G        P       E     
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGDTKQETLANV 228

Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNL 422
                 F                S  A     + L +DPK R  + + ++   +KP ++ 
Sbjct: 229 SAVNYEFEDEYFSNT--------SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP-KDT 279

Query: 423 KDMASSSY 430
           +   SS++
Sbjct: 280 QQALSSAW 287

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 3e-46
 Identities = 67/315 (21%), Positives = 117/315 (37%), Gaps = 36/315 (11%)

Query: 131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---- 186
           A + +   + +GEG +G VFK    +NG        G  VA+K +     +         
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 56

Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP----RGSLENHLFRKGSLPLPWS 241
            +A +  L    HPN+V+L   C            +        L  +L +     +P  
Sbjct: 57  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116

Query: 242 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 301
               +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+         
Sbjct: 117 TIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---M 170

Query: 302 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--- 358
             T V+ T  Y APE ++     +  D++S G +  EM   +     +    +   +   
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230

Query: 359 -------EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
                  +W R     ++ F+      +E   +    +    L  +CL+ +P  R     
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPAKRISAYS 289

Query: 412 VVET--LKPLQNLKD 424
            +     + L+  K+
Sbjct: 290 ALSHPYFQDLERCKE 304

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 5e-46
 Identities = 60/300 (20%), Positives = 110/300 (36%), Gaps = 29/300 (9%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEV 190
              +   S +GEG +G V   +              + VA+K ++    Q + +  L E+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57

Query: 191 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-GSLPLPWSIRMKIALG 249
             L    H N++ +           +   ++    +   L++   +  L           
Sbjct: 58  KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ 117

Query: 250 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH-VSTRVMG 308
             +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A  D       T  + 
Sbjct: 118 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174

Query: 309 TYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 367
           T  Y APE ++     +KS D++S G +L EML+ R          + N +         
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 368 KRRFYRLLDPRLEGHFSIKG-------------SQKATQLAAQCLSRDPKARPRMSEVVE 414
           +     +         S+                 KA  L  + L+ +P  R  + + + 
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  158 bits (400), Expect = 2e-45
 Identities = 58/294 (19%), Positives = 111/294 (37%), Gaps = 29/294 (9%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 191
            +     +GEG +G V+K           +   G T A+K +  +          + E++
Sbjct: 3   KYHGLEKIGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTTIREIS 52

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
            L  L H N+VKL        + +LV+E + +   +     +G   L         L   
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLL 110

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            G+A+ H+   + V++RD K  N+L++ +   K++DFGLA+      + +    ++  + 
Sbjct: 111 NGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWY 166

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNLVEWA 361
            A    + +   ++  D++S G +  EM+ G                    G  N   W 
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 362 R-PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
               L      + + +P     F     +    L ++ L  DP  R    + +E
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  157 bits (397), Expect = 7e-45
 Identities = 46/296 (15%), Positives = 86/296 (29%), Gaps = 35/296 (11%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +++    +GEG FG +F+G                 VA+K           +   E    
Sbjct: 6   HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRR--SDAPQLRDEYRTY 54

Query: 194 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 253
             L     +  V Y  ++    ++   +   SLE+ L   G            A      
Sbjct: 55  KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-KFSVKTVAMAAKQMLAR 113

Query: 254 LAFLHEEAEKPVIYRDFKTSNILLDADYN-----AKLSDFGLAKDAPEDG-----KTHVS 303
           +  +HE   K ++YRD K  N L+    +       + DFG+ K   +            
Sbjct: 114 VQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170

Query: 304 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 363
             + GT  Y +    +    + + D+ + G V +  L G       +        E    
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI-- 228

Query: 364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 419
                 +        L   F     ++  +      +    A P    +      +
Sbjct: 229 ----GEKKQSTPLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 8e-45
 Identities = 55/283 (19%), Positives = 93/283 (32%), Gaps = 38/283 (13%)

Query: 140 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H 198
           +LG G  G V +              T    A+K L         +   EV         
Sbjct: 19  VLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 64

Query: 199 PNLVKLVGYC----IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 254
           P++V++V             L+V E +  G L + +  +G          +I     + +
Sbjct: 65  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124

Query: 255 AFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
            +LH      + +RD K  N+L  +       KL+DFG AK+               T  
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPY 178

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 371
           Y APE +         D++S GV++  +L G      N  +G              +  F
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN--HGLAISPGMKTRIRMGQYEF 236

Query: 372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                  +        S++   L    L  +P  R  ++E + 
Sbjct: 237 PNPEWSEV--------SEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-44
 Identities = 80/284 (28%), Positives = 109/284 (38%), Gaps = 37/284 (13%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 186
           K+   +F    LLG+G FG V             +  TG   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51

Query: 187 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
            + E   L N  HP L  L       D+   V E+   G L  HL R+            
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARF 109

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
                   L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T     
Sbjct: 110 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT 164

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 365
             GT  Y APE +         D +  GVV+ EM+ GR       P    +        L
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELIL 218

Query: 366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 409
            ++ RF R L P            +A  L A  L +DPK R   
Sbjct: 219 MEEIRFPRTLSP------------EAKSLLAGLLKKDPKQRLGG 250

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 8e-44
 Identities = 60/290 (20%), Positives = 102/290 (35%), Gaps = 51/290 (17%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE------WLA 188
           ++   LLG GGFG V+ G         ++    L VA+K +  D +    E         
Sbjct: 6   YQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56

Query: 189 EVNFLGNL--LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           EV  L  +      +++L+ +    D  +L+ E             +    L   +    
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSF 115

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTR 305
                + +   H      V++RD K  NIL+D +    KL DFG      +   T     
Sbjct: 116 FWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD---- 168

Query: 306 VMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 364
             GT  Y+ PE++       +S  V+S G++L +M+ G    +      +  ++      
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEII------ 217

Query: 365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                R       R+        S +   L   CL+  P  RP   E+  
Sbjct: 218 -----RGQVFFRQRV--------SSECQHLIRWCLALRPSDRPTFEEIQN 254

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 5e-43
 Identities = 62/300 (20%), Positives = 106/300 (35%), Gaps = 37/300 (12%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           ++    ++G G FG V++              +G  VA+K +  D     +    E+  +
Sbjct: 21  SYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQD----KRFKNRELQIM 67

Query: 194 GNLLHPNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKI 246
             L H N+V+L  +     ++       LV +++P         + +    LP       
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTR 305
                + LA++H      + +RD K  N+LLD D    KL DFG AK           + 
Sbjct: 128 MYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SY 182

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA---- 361
           +   Y  A          TS  DV+S G VL E+L G+     +    +   +       
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242

Query: 362 --RPHLGDKRRFYRLLDPRLEGH-----FSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                      +     P+++ H     F  +   +A  L ++ L   P AR    E   
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 4e-42
 Identities = 62/308 (20%), Positives = 109/308 (35%), Gaps = 41/308 (13%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVN 191
            +   + +G+G FG VFK              TG  VA+K +  +  +       L E+ 
Sbjct: 11  KYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIK 61

Query: 192 FLGNLLHPNLVKLVGYCIEDDQR--------LLVYEFMPRGSLENHLFRKGSLPLPWSIR 243
            L  L H N+V L+  C               LV++F                 L    R
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTH 301
           +   L     L  L+      +++RD K +N+L+  D   KL+DFGLA+     ++ + +
Sbjct: 122 VMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176

Query: 302 VSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRP--------N 352
             T  + T  Y  PE ++         D++  G ++ EM T    M  N           
Sbjct: 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236

Query: 353 GEHNLVEWARPHLGDKRRFYRLLDPR------LEGHFSIKGSQKATQLAAQCLSRDPKAR 406
              ++     P++ +   + +L   +       +   +      A  L  + L  DP  R
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 296

Query: 407 PRMSEVVE 414
               + + 
Sbjct: 297 IDSDDALN 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-41
 Identities = 62/295 (21%), Positives = 103/295 (34%), Gaps = 29/295 (9%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 191
            +     +GEG +G VFK              T   VA+K +  D          L E+ 
Sbjct: 3   KYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREIC 53

Query: 192 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 251
            L  L H N+V+L      D +  LV+EF  +   +      G   L   I         
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLL 111

Query: 252 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 311
           KGL F H    + V++RD K  N+L++ +   KL++FGLA+      + + S  V+  + 
Sbjct: 112 KGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWY 167

Query: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-----------GEHNLVEW 360
                       ++  D++S G +  E+    R +                 G     +W
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227

Query: 361 AR-PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 414
                L D + +          +   K +     L    L  +P  R    E ++
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 6e-40
 Identities = 69/324 (21%), Positives = 117/324 (36%), Gaps = 43/324 (13%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 192
           +R    +G G +G V            V   TG  VA+K L          K    E+  
Sbjct: 20  YRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70

Query: 193 LGNLLHPNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 246
           L ++ H N++ L+     D+         LV  FM  G+    L +     L       +
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE--KLGEDRIQFL 126

Query: 247 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 306
                KGL ++H      +I+RD K  N+ ++ D   K+ DFGLA+ A       ++  V
Sbjct: 127 VYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYV 179

Query: 307 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-------- 358
           +  +  A    +     T   D++S G ++ EM+TG+     +    +   +        
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239

Query: 359 -EWARPHLGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 413
            E+ +    D+ + Y    P LE           S  A  L  + L  D + R    E +
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

Query: 414 ET--LKPLQNLKDMASSSYYFQTM 435
                + L + +D      Y  + 
Sbjct: 300 AHPYFESLHDTEDEPQVQKYDDSF 323

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  142 bits (358), Expect = 9e-39
 Identities = 71/317 (22%), Positives = 111/317 (35%), Gaps = 49/317 (15%)

Query: 103 SASSTPKFSEELKVASQL---RKFMFNDLKLATRN------FRPESLLGEGGFGCVFKGW 153
           +A++  K SE+  V   L   ++      +  ++N      F     LG G FG V    
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV- 60

Query: 154 VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIE 210
                       +G   A+K L+   +   K+    L E   L  +  P LVKL     +
Sbjct: 61  --------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112

Query: 211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF 270
           +    +V E++  G + +HL R G            A        +LH      +IYRD 
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167

Query: 271 KTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVY 330
           K  N+L+D     +++DFG AK       T     + GT    APE +++       D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWW 222

Query: 331 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQK 390
           + GV++ EM  G        P      ++     +  K RF                S  
Sbjct: 223 ALGVLIYEMAAGY------PPFFADQPIQIYEKIVSGKVRFPSHF------------SSD 264

Query: 391 ATQLAAQCLSRDPKARP 407
              L    L  D   R 
Sbjct: 265 LKDLLRNLLQVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 3e-37
 Identities = 70/290 (24%), Positives = 114/290 (39%), Gaps = 33/290 (11%)

Query: 129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHK 184
           K+   NF    +LG G +G VF               TG   A+K L    +    +  +
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVRKISG------HDTGKLYAMKVLKKATIVQKAKTTE 73

Query: 185 EWLAEVNFLGNLLH-PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR 243
               E   L ++   P LV L      + +  L+ +++  G L  HL ++          
Sbjct: 74  HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI 133

Query: 244 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 303
                   + +  L    +  +IYRD K  NILLD++ +  L+DFGL+K+   D +T  +
Sbjct: 134 Y-----VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERA 187

Query: 304 TRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
               GT  Y AP+ V  G        D +S GV++ E+LTG           +++  E +
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT--VDGEKNSQAEIS 245

Query: 362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 411
           R  L  +  + + +            S  A  L  + L +DPK R     
Sbjct: 246 RRILKSEPPYPQEM------------SALAKDLIQRLLMKDPKKRLGCGP 283

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  129 bits (325), Expect = 2e-34
 Identities = 53/306 (17%), Positives = 101/306 (33%), Gaps = 48/306 (15%)

Query: 134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 193
           +++    LG G +  VF+          +       V VK L        K+   E+  L
Sbjct: 36  DYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKIL 83

Query: 194 GNL-LHPNLVKLVGYCIEDDQRL--LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 250
            NL   PN++ L     +   R   LV+E +     +          L            
Sbjct: 84  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEI 138

Query: 251 AKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTRVMGT 309
            K L + H      +++RD K  N+++D +    +L D+GLA+      +       + +
Sbjct: 139 LKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVAS 192

Query: 310 YGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-------------- 354
             +  PE ++         D++S G +L  M+  +        N +              
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252

Query: 355 ------HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 408
                 +N+    R +    R   +  +  +        S +A     + L  D ++R  
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312

Query: 409 MSEVVE 414
             E +E
Sbjct: 313 AREAME 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 9e-33
 Identities = 59/314 (18%), Positives = 111/314 (35%), Gaps = 52/314 (16%)

Query: 133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 190
           + ++    +G G  G V   +                VA+K L+         K    E+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67

Query: 191 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 244
             +  + H N++ L+          E     LV E M     +                 
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMS 122

Query: 245 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 304
            +      G+  LH      +I+RD K SNI++ +D   K+ DFGLA+     G + + T
Sbjct: 123 YLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMT 176

Query: 305 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR----------------RSMDK 348
             + T  Y APE ++        D++S G ++ EM+  +                  +  
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 349 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRL--------EGHFSIKGSQKATQLAAQCLS 400
             P     L    R ++ ++ ++  L  P+L        +   +   + +A  L ++ L 
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 401 RDPKARPRMSEVVE 414
            DP  R  + + ++
Sbjct: 297 IDPAKRISVDDALQ 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-32
 Identities = 62/300 (20%), Positives = 112/300 (37%), Gaps = 37/300 (12%)

Query: 132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAE 189
              ++  S +G G +G V   +            TGL VAVK L+         K    E
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67

Query: 190 VNFLGNLLHPNLVKLVGYCIED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 245
           +  L ++ H N++ L+          +   +       G+  N++ +     L       
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQF 125

Query: 246 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 305
           +     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182

Query: 306 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN----------RPNGEH 355
               +  A    +   H     D++S G ++ E+LTGR                R  G  
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238

Query: 356 NLVEWARPHLGDKRRFYRLLDPRLEGHFS---IKGSQKATQLAAQCLSRDPKARPRMSEV 412
                 +      R + + L    + +F+   I  +  A  L  + L  D   R   ++ 
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  109 bits (272), Expect = 7e-27
 Identities = 52/325 (16%), Positives = 100/325 (30%), Gaps = 57/325 (17%)

Query: 135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 194
           +     LG G F  V+      N T          VA+K +  D +   +    E+  L 
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDKVY-TEAAEDEIKLLQ 64

Query: 195 NLLHPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLF-------------RKGSLPLPW 240
            +   +  K          +LL  +       +   +              +     +P 
Sbjct: 65  RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124

Query: 241 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDAPEDGK 299
               +I+     GL ++H      +I+ D K  N+L++  D    L    +A        
Sbjct: 125 IYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182

Query: 300 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR--------------- 344
               T  + T  Y +PE ++       +D++S   ++ E++TG                 
Sbjct: 183 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242

Query: 345 --------------SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGH-FSIKGSQ 389
                          + +N                  K +F+ L D   E + FS   ++
Sbjct: 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 302

Query: 390 KATQLAAQCLSRDPKARPRMSEVVE 414
           + +   +  L  DP+ R     +V 
Sbjct: 303 EISDFLSPMLQLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 75.2 bits (184), Expect = 2e-16
 Identities = 25/155 (16%), Positives = 50/155 (32%), Gaps = 9/155 (5%)

Query: 139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH 198
            L+GEG    VF  + E+ G   VK       + K +      G   +            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 199 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 258
             L KL G  +        Y +     L   +  K    +      ++     + +A  +
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 259 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 293
               + +++ D    N+L+  +    + DF  + +
Sbjct: 121 ---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	491
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.7
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.04
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.04
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.28
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.11
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.74

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-57  Score=438.77  Aligned_cols=254  Identities=26%  Similarity=0.335  Sum_probs=208.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ++|++.+.||+|+||+||+|+++.         +|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~   75 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   75 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cceEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence            479999999999999999999876         6789999999765432 345688999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..|||||||++|+|.++|...+  .+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|
T Consensus        76 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a  150 (271)
T d1nvra_          76 NIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA  150 (271)
T ss_dssp             TEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceeEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhh
Confidence            99999999999999999996554  6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +..............+||+.|||||++.+..+ +.++|||||||+||||++|+.||........... .....       
T Consensus       151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-~~~~~-------  222 (271)
T d1nvra_         151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DWKEK-------  222 (271)
T ss_dssp             EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-HHHTT-------
T ss_pred             eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-HHhcC-------
Confidence            87754443444456789999999999988776 5789999999999999999999975443222111 11000       


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                             ..........+.++.+||.+||+.||.+|||++|++++
T Consensus       223 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         223 -------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             -------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                   00001112336788999999999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=436.85  Aligned_cols=251  Identities=25%  Similarity=0.376  Sum_probs=211.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|++.+.||+|+||+||+|.+..         +|..||||++........+.+.+|+.+|+.++|||||++++++.+.+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   90 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence            479999999999999999999876         67899999998765556678999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..|||||||++|+|.+++...   .+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhhe
Confidence            999999999999999988654   5899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      .......  .....+||+.|||||++.+..|+.++|||||||++|+|++|+.||...........  .....        
T Consensus       165 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--~~~~~--------  232 (293)
T d1yhwa1         165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL--IATNG--------  232 (293)
T ss_dssp             ECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHHC--------
T ss_pred             eeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHH--HHhCC--------
Confidence            7654332  23456899999999999999999999999999999999999999965432211110  00000        


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         .+  ....+...+..+.+||.+||+.||.+|||+.|+++|
T Consensus       233 ---~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         233 ---TP--ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             ---SC--CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             ---CC--CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               00  011223347889999999999999999999999865

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=436.55  Aligned_cols=263  Identities=28%  Similarity=0.440  Sum_probs=206.6

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      +..++|.+.+.||+|+||+||+|++..            .||||+++...  ....+.|.+|+.+|++++|||||+++++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~   72 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY   72 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESSS------------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEECC------------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence            345689999999999999999997642            59999997543  3345788999999999999999999998


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +. ++..+||||||++|+|.++|..... .+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|
T Consensus        73 ~~-~~~~~lv~Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~D  147 (276)
T d1uwha_          73 ST-APQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD  147 (276)
T ss_dssp             EC-SSSCEEEEECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECC
T ss_pred             Ee-ccEEEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcc
Confidence            75 4578999999999999999976543 6899999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      ||+|+...............||+.|||||++.+   ..|+.++|||||||+||||+||+.||..........  ......
T Consensus       148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~~~~  225 (276)
T d1uwha_         148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGRG  225 (276)
T ss_dssp             CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHHT
T ss_pred             ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--HHHhcC
Confidence            999987754444344456789999999999864   358999999999999999999999997643322111  111100


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                               ...+.+ ...+..++..+.+||.+||..||.+|||+.+|+++|+.+.+
T Consensus       226 ---------~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         226 ---------YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             ---------SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                     001111 12233457889999999999999999999999999987654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-56  Score=438.48  Aligned_cols=263  Identities=25%  Similarity=0.389  Sum_probs=220.1

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      ++..++|++.+.||+|+||+||+|++..         ++..||||+++.+. ...+++.+|+++|++|+|||||+++++|
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGG---------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECC---------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccE
Confidence            3445679999999999999999999976         67899999997654 3467899999999999999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+.+..+||||||++|+|.+++.......+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+||
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccc
Confidence            99999999999999999999998776678999999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |+|+....... .......||+.|||||++.+..|+.++|||||||++|||++|..||......  ..+....       
T Consensus       160 G~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~i-------  229 (287)
T d1opja_         160 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELL-------  229 (287)
T ss_dssp             CCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHH-------
T ss_pred             cceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHHH-------
Confidence            99987654332 2334456899999999999999999999999999999999987776432211  1111111       


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                             .......++..++..+.+||.+||+.||.+|||+++|++.|+.+..
T Consensus       230 -------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         230 -------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             -------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             -------hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                   1111122334457889999999999999999999999999987644

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=431.96  Aligned_cols=247  Identities=27%  Similarity=0.419  Sum_probs=209.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||+||+|+++.         ++..||||++.+..   ....+.+.+|+.+|+.++|||||++++++.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   76 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH   76 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECC---------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence            469999999999999999999876         67799999986432   223467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +++..|||||||++|+|.+++...+  .+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||
T Consensus        77 ~~~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG  151 (263)
T d2j4za1          77 DATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG  151 (263)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             ECCEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccc
Confidence            9999999999999999999998765  6899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +|.......    ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   .....   ...  
T Consensus       152 ~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i---~~~--  219 (263)
T d2j4za1         152 WSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRI---SRV--  219 (263)
T ss_dssp             SCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---HTT--
T ss_pred             eeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHHHH---HcC--
Confidence            998765432    234689999999999999999999999999999999999999996543211   11110   000  


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                ...++...+.++.+||.+||+.||.+|||++|+++|
T Consensus       220 ----------~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         220 ----------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ----------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                      011223347889999999999999999999999865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-56  Score=432.87  Aligned_cols=253  Identities=26%  Similarity=0.404  Sum_probs=210.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +.|++.+.||+|+||+||+|++..         +|..||||++........+.+.+|+++|++|+|||||++++++.+++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   82 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN   82 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECC---------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            368999999999999999999876         67799999998776666678999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..|||||||++|+|.+++.... ..+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+
T Consensus        83 ~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~  158 (288)
T d2jfla1          83 NLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSA  158 (288)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhh
Confidence            9999999999999999886653 36999999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhh-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      .....  .......+||+.|||||++.     +..|+.++|||||||+||||++|+.||...........+  ...   .
T Consensus       159 ~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i--~~~---~  231 (288)
T d2jfla1         159 KNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--AKS---E  231 (288)
T ss_dssp             ECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HHS---C
T ss_pred             ccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH--HcC---C
Confidence            65321  11123468999999999984     456899999999999999999999999765432221111  100   0


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .        +  ....+...+.++.+||.+||+.||.+|||+.|+++|
T Consensus       232 ~--------~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         232 P--------P--TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             C--------C--CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             C--------C--CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0        0  011123447889999999999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=425.91  Aligned_cols=256  Identities=29%  Similarity=0.436  Sum_probs=201.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|++.+.||+|+||+||+|.+.          ++..||||+++.+. ...+++.+|+++|++++|||||+++|++.+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   73 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   73 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET----------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC----------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence            57899999999999999999885          35679999997654 34578999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..+||||||++|+|.+++.... ..+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        74 ~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          74 PICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             ceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchhe
Confidence            9999999999999999987653 36899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchh
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  372 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (491)
                      ........ ......||+.|||||++.+..|+.++|||||||+||||+|+..|+.....  ...+.......        
T Consensus       150 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~~--------  218 (263)
T d1sm2a_         150 FVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTG--------  218 (263)
T ss_dssp             ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHHHT--------
T ss_pred             eccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHHhc--------
Confidence            76543322 22346799999999999999999999999999999999996444432211  11111111110        


Q ss_pred             hccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          373 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       373 ~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                            .....+..++.++.+||.+||+.||.+|||+++|+++|+.+.
T Consensus       219 ------~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         219 ------FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                  011122334678999999999999999999999999998764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-56  Score=441.32  Aligned_cols=267  Identities=26%  Similarity=0.394  Sum_probs=208.8

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ..++|++.+.||+|+||+||+|++..         +|..||+|+++.... .....+.+|+.+|+.++|||||+++++|.
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~   74 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY   74 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETT---------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            35689999999999999999999875         788999999976533 33467899999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      +.+.+|||||||++|+|.+++.+.+  .+++..+..++.||+.||.|||+ ++   ||||||||+||||+.++.+||+||
T Consensus        75 ~~~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DF  149 (322)
T d1s9ja_          75 SDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDF  149 (322)
T ss_dssp             CSSEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeC
Confidence            9999999999999999999998765  58999999999999999999997 47   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHh-hhcccC-
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-ARPHLG-  366 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-~~~~~~-  366 (491)
                      |+|+.....    .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.............. ...... 
T Consensus       150 Gla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~  225 (322)
T d1s9ja_         150 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  225 (322)
T ss_dssp             CCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred             CCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence            999865322    22346899999999999999999999999999999999999999976433211000000 000000 


Q ss_pred             -----------------C---ccchhhcc----CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 -----------------D---KRRFYRLL----DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 -----------------~---~~~~~~~~----~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                       +   ........    ............+.++.+||.+||+.||.+|||++|+++|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             --------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                             0   00000000    0000000011236789999999999999999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-56  Score=435.22  Aligned_cols=251  Identities=23%  Similarity=0.313  Sum_probs=207.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++.+..   ....+.+.+|+++|++++|||||++++++.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~   78 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ   78 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence            479999999999999999999876         67799999997542   123467899999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +++..|||||||++|+|.+++...+  .+++..++.++.||+.||+|||+.+   ||||||||+||||++++.+||+|||
T Consensus        79 ~~~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          79 DDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             ECCEEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccc
Confidence            9999999999999999999987765  6899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +|+.+............+||+.|||||++.+..|+.++|||||||+||||++|..||.......   +..   ...... 
T Consensus       154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~---~i~~~~-  226 (288)
T d1uu3a_         154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQ---KIIKLE-  226 (288)
T ss_dssp             TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHTTC-
T ss_pred             cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HHH---HHHcCC-
Confidence            9987755444444455789999999999999999999999999999999999999997543211   111   111000 


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                                 ..++...+.++.+||.+||+.||.+|||++|++++
T Consensus       227 -----------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         227 -----------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             -----------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             -----------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                       11223347889999999999999999999997654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-55  Score=431.07  Aligned_cols=260  Identities=26%  Similarity=0.451  Sum_probs=202.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .+|++.++||+|+||+||+|++..++.      ....||||.+..... ...++|.+|+++|++|+|||||+++|++.+.
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   99 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS   99 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            468888999999999999999875322      344799999876533 3456799999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..+||||||++|+|.+++..... .+++..++.++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||++
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla  175 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLS  175 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccc
Confidence            999999999999999998876533 6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcee---eeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          292 KDAPEDGKTHV---STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       292 ~~~~~~~~~~~---~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      +..........   .....||+.|||||++.++.|+.++|||||||+||||+| |+.||......   .+......    
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~~----  248 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIEQ----  248 (299)
T ss_dssp             --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHT----
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHHc----
Confidence            87654332211   122467999999999999999999999999999999998 89999654322   11111111    


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                                ......+..++..+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus       249 ----------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         249 ----------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             ----------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                      011122334578899999999999999999999999999865

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=427.79  Aligned_cols=255  Identities=24%  Similarity=0.356  Sum_probs=197.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.+.||+|+||+||+|+++.         +|+.||||++......  ..+.+.+|+++|++++|||||++++++.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   74 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID   74 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred             hhCEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence            579999999999999999999876         6789999999766432  34568899999999999999999999875


Q ss_pred             --cCceEEEEEecCCCChHHHhhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCcEEECCCCCeE
Q 011180          211 --DDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEA--EKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       211 --~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                        .+.+|||||||++|+|.+++.+.  ....+++..++.++.||+.||.|||+.+  ..+||||||||+||||+.++.+|
T Consensus        75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence              45689999999999999998642  2347999999999999999999999865  23499999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcc
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  364 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  364 (491)
                      |+|||+++.......  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......   .+.......
T Consensus       155 l~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~~~  229 (269)
T d2java1         155 LGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIREG  229 (269)
T ss_dssp             ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHT
T ss_pred             EeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHHcC
Confidence            999999987654322  234578999999999999999999999999999999999999999754321   111111000


Q ss_pred             cCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        .           . ..++...+.++.+||.+||+.||.+|||+.|++++
T Consensus       230 --~-----------~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         230 --K-----------F-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             --C-----------C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --C-----------C-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence              0           0 01223347789999999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-55  Score=426.31  Aligned_cols=258  Identities=27%  Similarity=0.416  Sum_probs=210.2

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      +..++|++.+.||+|+||.||+|.++          ++..||||+++... ...+.+.+|+.+|++++|||||++++++.
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~   78 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT   78 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            44567999999999999999999975          45689999997654 34578999999999999999999999875


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      + +..+||||||++|+|.+++.......+++..++.|+.||+.||.|||+.+   |+||||||+||||++++.+||+|||
T Consensus        79 ~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG  154 (272)
T d1qpca_          79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFG  154 (272)
T ss_dssp             S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             c-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeecccc
Confidence            4 56799999999999999886655456899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +|+...... ........||+.|||||++.++.++.++|||||||+||||+||..|+.....  ...+.......     
T Consensus       155 la~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~~~-----  226 (272)
T d1qpca_         155 LARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLERG-----  226 (272)
T ss_dssp             TCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTT-----
T ss_pred             ceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhc-----
Confidence            998775432 2233456799999999999999999999999999999999997665533221  11111111100     


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                               .....+..++..+.+||.+||+.||.+|||+++|++.|+.+
T Consensus       227 ---------~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         227 ---------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                     01112233467899999999999999999999999998864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=431.92  Aligned_cols=263  Identities=25%  Similarity=0.401  Sum_probs=213.7

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      .++|++.++||+|+||+||+|++.....    ......||||.+.... ......+.+|+.+|.++ +|||||++++++.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISK----TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSS----SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCc----ccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            4579999999999999999999875321    1234579999986543 23346789999999998 8999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGS---------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYR  268 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHr  268 (491)
                      +.+..+||||||++|+|.++|.....                     ..+++..++.++.||+.||+|||+++   ||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence            99999999999999999999976432                     24889999999999999999999988   9999


Q ss_pred             CCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCC
Q 011180          269 DFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMD  347 (491)
Q Consensus       269 DlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~  347 (491)
                      ||||+|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |..||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987765544444456779999999999999999999999999999999997 899997


Q ss_pred             CCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011180          348 KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  417 (491)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~  417 (491)
                      .......  +.....              .......+..++.++.+||.+||+.||++|||++||+++|.
T Consensus       269 ~~~~~~~--~~~~~~--------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVDAN--FYKLIQ--------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCSHH--HHHHHH--------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHHH--HHHHHh--------------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            5433221  111111              11111233445789999999999999999999999999985

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.1e-55  Score=430.93  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=194.3

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .+.|++.+.||+|+||+||+|+++.         +|+.||||++...... ..+.+.+|+.+|+.|+|||||++++++.+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   78 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKR---------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES   78 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETT---------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            3569999999999999999999876         6789999999765433 23567899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC---CCCCeEEec
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSD  287 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~---~~~~~kL~D  287 (491)
                      ++.+|||||||+||+|.++|...+  .+++..+..++.||+.||+|||+.+   ||||||||+|||+.   +++.+||+|
T Consensus        79 ~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~D  153 (307)
T d1a06a_          79 GGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISD  153 (307)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEec
Confidence            999999999999999999997654  6899999999999999999999988   99999999999994   578999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ||+++......   .....+||+.|||||++.+..|+.++|||||||+||||++|..||.......   +....   ...
T Consensus       154 FG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i---~~~  224 (307)
T d1a06a_         154 FGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQI---LKA  224 (307)
T ss_dssp             C---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH---HTT
T ss_pred             cceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH---hcc
Confidence            99998664332   2234689999999999999999999999999999999999999997543211   11111   100


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .        ..+........+.++.+||.+||+.||.+|||+.|++++
T Consensus       225 ~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         225 E--------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             C--------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             C--------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            0        011111223347889999999999999999999999987

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-54  Score=434.55  Aligned_cols=253  Identities=23%  Similarity=0.318  Sum_probs=211.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|++.+.||+|+||+||+|++..         +|..||||++........+.+.+|+.+|++|+|||||++++++.+++
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~---------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   96 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN   96 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            479999999999999999999876         68899999998776666678899999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC--CCCCeEEeccCC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--ADYNAKLSDFGL  290 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~--~~~~~kL~DFGl  290 (491)
                      .+|||||||++|+|.+++..... .+++..+..|+.||+.||.|||+++   ||||||||+||||+  .++.+||+|||+
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~  172 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL  172 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEEEcCCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecch
Confidence            99999999999999999865433 6999999999999999999999998   99999999999995  467899999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      ++.......   ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+.  ...      
T Consensus       173 a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~------  241 (350)
T d1koaa2         173 TAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK--SCD------  241 (350)
T ss_dssp             CEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTC------
T ss_pred             heecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH--hCC------
Confidence            987754322   234689999999999999999999999999999999999999997543211111110  000      


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                            ..+........+..+.+||.+||+.||.+|||++|+++|
T Consensus       242 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         242 ------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ------CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  000111112346789999999999999999999999987

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-54  Score=413.69  Aligned_cols=254  Identities=23%  Similarity=0.381  Sum_probs=213.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|++.+.||+|+||+||+|+++          ++..||||+++.... ..+++.+|+.++++++|||||+++|++.+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~   72 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   72 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence            58999999999999999999985          466899999987654 4578999999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..++||||+++|+|.+++..... .+++..++.++.||++||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        73 ~~~iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          73 PIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             SEEEEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             ceEEEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhe
Confidence            99999999999999998765533 6889999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      ........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.......   +.......       
T Consensus       149 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~~~-------  217 (258)
T d1k2pa_         149 YVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQG-------  217 (258)
T ss_dssp             BCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHTT-------
T ss_pred             eccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHHhC-------
Confidence            76543322 2334679999999999999999999999999999999998 899997553221   11111100       


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                             .....+..++..+.+||.+||+.||.+|||+++|+++|..+
T Consensus       218 -------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         218 -------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -------CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                   01112233467899999999999999999999999998653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=418.22  Aligned_cols=249  Identities=25%  Similarity=0.403  Sum_probs=200.2

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee--
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--  210 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--  210 (491)
                      |++.+.||+|+||+||+|.+..         ++..||+|++.....  ...+.+.+|+++|++|+|||||++++++.+  
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~---------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   81 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   81 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence            4677889999999999999876         677999999875432  234578899999999999999999999875  


Q ss_pred             --cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC-CCCCeEEec
Q 011180          211 --DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSD  287 (491)
Q Consensus       211 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~-~~~~~kL~D  287 (491)
                        ...+|||||||++|+|.+++.+..  .+++..+..++.||+.||+|||+++ .+||||||||+||||+ +++.+||+|
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~D  158 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD  158 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEee
Confidence              345799999999999999997764  6899999999999999999999876 5599999999999996 578999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      ||+|+.....    .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||.......  .+.......   
T Consensus       159 FGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i~~~---  228 (270)
T d1t4ha_         159 LGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSG---  228 (270)
T ss_dssp             TTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTTT---
T ss_pred             cCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHHHcC---
Confidence            9999865332    2234689999999998865 69999999999999999999999996432211  111111100   


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .          ....++...++++.+||.+||+.||++|||++|+++|
T Consensus       229 ~----------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         229 V----------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             C----------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             C----------CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            0          0011122235779999999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.6e-54  Score=433.59  Aligned_cols=253  Identities=22%  Similarity=0.313  Sum_probs=212.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      ++|++.+.||+|+||+||+|++..         +|..||||++........+.+.+|+.+|++|+|||||+++++|.+++
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   99 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY   99 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             cceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            469999999999999999999876         67899999998776566677889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC--CCCCeEEeccCC
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--ADYNAKLSDFGL  290 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~--~~~~~kL~DFGl  290 (491)
                      .+|||||||++|+|.+++...+ ..+++..++.|+.||+.||.|||+++   ||||||||+||||+  .++.+||+|||+
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             EEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccc
Confidence            9999999999999999876553 36899999999999999999999988   99999999999997  678999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      |+.......   ....+||+.|||||++.+..|+.++|||||||+||||++|+.||........   ......       
T Consensus       176 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~~-------  242 (352)
T d1koba_         176 ATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKR-------  242 (352)
T ss_dssp             CEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHH-------
T ss_pred             ceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh-------
Confidence            988754332   2346799999999999999999999999999999999999999965432211   111100       


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          .+..+........+.++.+||.+||+.||.+|||+.|+++|
T Consensus       243 ----~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         243 ----CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ----CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                00111112223347889999999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-54  Score=419.37  Aligned_cols=258  Identities=25%  Similarity=0.394  Sum_probs=209.3

Q ss_pred             cCCCcCcc-cccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESL-LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~-lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+. ||+|+||+||+|.++..+       ++..||||+++.... ...+++.+|+++|++++|||||+++|++.+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~   80 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA   80 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCC-------CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            46777775 999999999999886422       456899999976543 345679999999999999999999999865


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                       +..|||||||++|+|.+++.... ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+
T Consensus        81 -~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl  155 (285)
T d1u59a_          81 -EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL  155 (285)
T ss_dssp             -SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             -CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchh
Confidence             56899999999999999886543 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          291 AKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       291 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      ++........ .......||+.|||||++.++.++.++|||||||++|||+| |+.||......   .+......    .
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~~----~  228 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQ----G  228 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHT----T
T ss_pred             hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHHc----C
Confidence            9877543322 22234578999999999999999999999999999999998 89999764322   11111110    0


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                                .....+..++.++.+||.+||+.||.+|||+.+|++.|+.+
T Consensus       229 ----------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         229 ----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                      01122334578899999999999999999999999998753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-54  Score=425.03  Aligned_cols=246  Identities=28%  Similarity=0.410  Sum_probs=204.0

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .|++.+.||+|+||+||+|++..         +|..||||++.......   .+.+.+|+.+|++|+|||||++++++.+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   86 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECC---------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence            48999999999999999999876         68899999997664332   3568899999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..|||||||.+|+|..++...+  .+++..++.++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+
T Consensus        87 ~~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~  161 (309)
T d1u5ra_          87 EHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS  161 (309)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             CCEEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccc
Confidence            999999999999999987765553  6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      |+.....      ...+||+.|||||++.+   +.|+.++|||||||++|||++|..||.........  .....   ..
T Consensus       162 a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~--~~i~~---~~  230 (309)
T d1u5ra_         162 ASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQ---NE  230 (309)
T ss_dssp             CBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHH---SC
T ss_pred             ccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHh---CC
Confidence            9865432      34679999999999864   46899999999999999999999999654321110  00000   00


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                              .+.   ..+...+..+.+||.+||+.||.+|||++|+++|
T Consensus       231 --------~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         231 --------SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             --------CCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --------CCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence                    000   1112336789999999999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=414.35  Aligned_cols=250  Identities=28%  Similarity=0.396  Sum_probs=201.4

Q ss_pred             cccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEeecCceEE
Q 011180          139 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL  216 (491)
Q Consensus       139 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  216 (491)
                      +.||+|+||+||+|.+....       +++.||||+++....  ...+++.+|+.+|++|+|||||++++++.+ +..+|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l   84 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKK-------VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML   84 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSS-------SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred             CCcccCCCeEEEEEEEccCC-------cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence            46999999999999876422       567899999975432  234679999999999999999999999865 56789


Q ss_pred             EEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCCC
Q 011180          217 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  296 (491)
Q Consensus       217 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~  296 (491)
                      |||||++|+|.+++....  .+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++....
T Consensus        85 vmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~  159 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  159 (277)
T ss_dssp             EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccc
Confidence            999999999999997654  6899999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCCce-eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccchhhc
Q 011180          297 DGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  374 (491)
Q Consensus       297 ~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (491)
                      ..... ......||+.|||||++.+..++.++|||||||++|||++ |+.||......   .+.......          
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~i~~~----------  226 (277)
T d1xbba_         160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLEKG----------  226 (277)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTT----------
T ss_pred             cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHHHHcC----------
Confidence            43322 2234679999999999999999999999999999999998 89999754321   111111110          


Q ss_pred             cCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011180          375 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  418 (491)
Q Consensus       375 ~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~  418 (491)
                          ....++..++.++.+||.+||+.||.+|||+++|++.|+.
T Consensus       227 ----~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         227 ----ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence                0112233457889999999999999999999999988864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=416.64  Aligned_cols=264  Identities=25%  Similarity=0.411  Sum_probs=204.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      ..|++.++||+|+||.||+|.++..+..     ....||||++...... ...+|.+|+.+|++|+|||||+++|++.+.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGK-----KEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---C-----CEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCE-----EEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            4688899999999999999998753211     2357999999765333 345789999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++|||||.+++|.+++.... ..+++..+..++.||+.||+|||+.+   ||||||||+||||+.++.+||+|||++
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             CceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchh
Confidence            99999999999999999886653 37999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCc-eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +........ .......||+.|||||++.++.++.++|||||||+||||++|..||......  ..+.....        
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i~--------  227 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAIN--------  227 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHH--------
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHHh--------
Confidence            876543222 2233456899999999999999999999999999999999976665433211  11111111        


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                            .......+..++..+.+||.+||+.||.+|||+.+|++.|+.+.+
T Consensus       228 ------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         228 ------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ------TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                  111122334457889999999999999999999999999986543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=426.29  Aligned_cols=249  Identities=31%  Similarity=0.404  Sum_probs=210.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|.+.+.||+|+||.||+|+++.         +|+.||||++++...   ...+.+.+|+.+|+.++|||||++++++.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~   75 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ   75 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec
Confidence            579999999999999999999876         678999999975422   23567889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+.+|||||||++|+|.+++...+  .+++..++.++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||
T Consensus        76 ~~~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG  150 (337)
T d1o6la_          76 THDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cccccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecc
Confidence            9999999999999999999998765  6889999999999999999999998   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +|+.......  .....+||+.|||||++.+..|+.++|||||||++|||++|++||.......   +....   .... 
T Consensus       151 ~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~i---~~~~-  221 (337)
T d1o6la_         151 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELI---LMEE-  221 (337)
T ss_dssp             TCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHCC-
T ss_pred             cccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHHH---hcCC-
Confidence            9987654332  2345789999999999999999999999999999999999999997643221   11111   0000 


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~  415 (491)
                                 ..++...+.++.+||.+||++||.+|++     +.++++|
T Consensus       222 -----------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 -----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                       1123334788999999999999999995     8888875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=416.95  Aligned_cols=252  Identities=24%  Similarity=0.333  Sum_probs=208.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCceeeeee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGNLLHPNLVKLVG  206 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~~  206 (491)
                      ++|++.+.||+|+||+||+|+++.         +|..||||++.+...      ...+.+.+|+.+|++|+|||||++++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~   80 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE   80 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            579999999999999999999876         678999999975432      23577899999999999999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC----C
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----N  282 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~----~  282 (491)
                      ++.+.+..|||||||++|+|.++|...+  .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++    .
T Consensus        81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~  155 (293)
T d1jksa_          81 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR  155 (293)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCC
T ss_pred             EEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccc
Confidence            9999999999999999999999997765  6899999999999999999999988   99999999999998776    5


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      +||+|||++........   .....||+.|+|||++.+..++.++|||||||+||||++|+.||.......   ......
T Consensus       156 vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~  229 (293)
T d1jksa_         156 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS  229 (293)
T ss_dssp             EEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             eEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HHHHHH
Confidence            99999999987654322   234679999999999999999999999999999999999999997543221   111110


Q ss_pred             cccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         .....        ....+....+..+.+||.+||+.||.+|||++|++++
T Consensus       230 ---~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         230 ---AVNYE--------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ---TTCCC--------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---hcCCC--------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               00000        0001112236789999999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.4e-53  Score=419.51  Aligned_cols=246  Identities=27%  Similarity=0.396  Sum_probs=208.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||+||+|+++.         +|+.||||++++..   ....+.+.+|+.+|+.++|||||++++++.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   74 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ   74 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence            469999999999999999999876         67899999997542   233567889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +.+..|+|||||+||+|..++....  .+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||
T Consensus        75 ~~~~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG  149 (316)
T d1fota_          75 DAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG  149 (316)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eCCeeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCc
Confidence            9999999999999999999887765  5788888999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +|+.....     ....+||+.|||||++.+..|+.++|||||||+||||++|+.||...........      ....  
T Consensus       150 ~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~~~--  216 (316)
T d1fota_         150 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK------ILNA--  216 (316)
T ss_dssp             SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHC--
T ss_pred             cceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH------HHcC--
Confidence            99876542     2346899999999999999999999999999999999999999975432111111      1000  


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                                ...++...+.++.+++.+||..||.+|+     |++++++|
T Consensus       217 ----------~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         217 ----------ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                      0112233467899999999999999996     89999876

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-53  Score=412.20  Aligned_cols=260  Identities=24%  Similarity=0.369  Sum_probs=201.7

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      .++|++.+.||+|+||.||+|++...+.      .+..||||.++..... ..+.+.+|+.+|++++|||||++++++. 
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-   78 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   78 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCc------eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            4579999999999999999999865332      4568999998754433 3467899999999999999999999986 


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ++..|||||||++|+|.+++.... ..+++..++.++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          79 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchh
Confidence            467899999999999999876653 37899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++....... .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||........   .......     
T Consensus       155 a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~~i~~~-----  225 (273)
T d1mp8a_         155 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENG-----  225 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTT-----
T ss_pred             heeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HHHHHcC-----
Confidence            987643322 22344678999999999999999999999999999999998 8899876543221   1111110     


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                               ....++..++..+.+||.+||..||.+|||+.+|+++|+.+.
T Consensus       226 ---------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         226 ---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                     001223345788999999999999999999999999998653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-53  Score=417.69  Aligned_cols=261  Identities=24%  Similarity=0.400  Sum_probs=207.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .+|+++++||+|+||+||+|.+..++..     ....||||.++.. .....+++.+|+.+|++++|||||+++|++.++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCE-----EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4699999999999999999998763321     2346999998654 234567899999999999999999999999864


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                       ..+++|||+.+|+|.+++.... ..+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|||++
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla  158 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA  158 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred             -CeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccc
Confidence             5688899999999999887664 47999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCccc
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  370 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  370 (491)
                      +...............||+.|||||++.++.|+.++|||||||+||||+| |.+||...........+.   .       
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~---~-------  228 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---K-------  228 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH---H-------
T ss_pred             eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---c-------
Confidence            98765444444445679999999999999999999999999999999998 788886543222111111   0       


Q ss_pred             hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          371 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       371 ~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                             ......+..++..+.+||.+||+.||.+|||+.+|+++|+.+.
T Consensus       229 -------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         229 -------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             -------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence                   0011223345788999999999999999999999999987653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-53  Score=413.23  Aligned_cols=257  Identities=26%  Similarity=0.391  Sum_probs=204.6

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|++++.||+|+||+||+|++..          +..||||+++... ...+.|.+|+.+|++++|||||++++++. +
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~   83 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E   83 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence            4579999999999999999998863          4579999997654 44578999999999999999999999985 4


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  291 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla  291 (491)
                      +..++|||||++|+|..++.......+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||++
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchh
Confidence            56899999999999999887654446999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccch
Q 011180          292 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  371 (491)
Q Consensus       292 ~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  371 (491)
                      +....... .......||+.|+|||++..+.++.++|||||||+||||++|..||......  ..+......        
T Consensus       161 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~--------  229 (285)
T d1fmka3         161 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVER--------  229 (285)
T ss_dssp             C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT--------
T ss_pred             hhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHh--------
Confidence            87644322 2234467999999999999999999999999999999999977666443211  111111110        


Q ss_pred             hhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          372 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       372 ~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                            ......+..++.++.+||.+||+.||++|||+++|++.|+...
T Consensus       230 ------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         230 ------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             ------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ------cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                  0111223345788999999999999999999999999988754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2e-52  Score=406.93  Aligned_cols=261  Identities=25%  Similarity=0.365  Sum_probs=205.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCCceeeeeeEE
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYC  208 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~  208 (491)
                      .++|++.+.||+|+||+||+|++..         +|+.||||+++.....   ..+.+.+|+++|+.++|||||++++++
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~   76 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLR---------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   76 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence            3579999999999999999999876         6889999999765433   235688999999999999999999999


Q ss_pred             eecCc----eEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          209 IEDDQ----RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       209 ~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      ...+.    .|||||||+|++|.+++...+  .+++..++.++.||+.||+|||+++   ||||||||+||||+.++.++
T Consensus        77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~  151 (277)
T d1o6ya_          77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK  151 (277)
T ss_dssp             EEECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEE
T ss_pred             eeccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccce
Confidence            87653    789999999999999987765  6899999999999999999999988   99999999999999999999


Q ss_pred             EeccCCcccCCCCCC-ceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          285 LSDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       285 L~DFGla~~~~~~~~-~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      |+|||++........ .......+||+.|||||++.+..|+.++|||||||++|||+||++||........      ...
T Consensus       152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~  225 (277)
T d1o6ya_         152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQ  225 (277)
T ss_dssp             ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHH
T ss_pred             eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHH
Confidence            999999876543222 2233456899999999999999999999999999999999999999975432111      111


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhcCc
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-RMSEVVETLKPLQ  420 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-t~~evl~~L~~l~  420 (491)
                      .+......        ........+..+.+||.+||+.||.+|| |++++++.|..+.
T Consensus       226 ~~~~~~~~--------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         226 HVREDPIP--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHCCCCC--------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHhcCCCC--------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            11111000        0111123378899999999999999999 8999998887654

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=407.17  Aligned_cols=252  Identities=28%  Similarity=0.440  Sum_probs=201.8

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEee-
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-  210 (491)
                      .++|++.+.||+|+||.||+|.++           |..||||+++.+.  ..+++.+|+++|++++|||||+++|++.+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   72 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence            356889999999999999999873           5689999997653  44779999999999999999999999865 


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+.++|||||+++|+|.++|.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~  149 (262)
T d1byga_          73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL  149 (262)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeeccccc
Confidence            466899999999999999997665446899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      ++.....     .....+|..|+|||++.+..++.++|||||||++|||+| |++||.......   +......      
T Consensus       150 s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~------  215 (262)
T d1byga_         150 TKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK------  215 (262)
T ss_dssp             -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTT------
T ss_pred             ceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc------
Confidence            9865432     223568999999999999999999999999999999998 677776543221   2221111      


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                              .....++...+..+.+||.+||+.||.+|||+.+|+++|+.++.
T Consensus       216 --------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         216 --------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                    01112333446889999999999999999999999999987654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-52  Score=413.78  Aligned_cols=269  Identities=25%  Similarity=0.373  Sum_probs=215.9

Q ss_pred             HHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCceeeeee
Q 011180          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVG  206 (491)
Q Consensus       128 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~  206 (491)
                      ++.-.++|++.+.||+|+||+||+|+++...    ...++..||||+++..... ..+++.+|+.+|++++||||+++++
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSS----TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCc----cCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee
Confidence            3344568999999999999999999986421    1225678999999765433 3467999999999999999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKG----------------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKP  264 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~  264 (491)
                      ++.+.+..++||||+++|+|.++|....                      ...+++..++.|+.||+.||+|||+.+   
T Consensus        84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---  160 (301)
T d1lufa_          84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---  160 (301)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---
Confidence            9999999999999999999999986532                      224789999999999999999999988   


Q ss_pred             eEecCCCCCcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCC-
Q 011180          265 VIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-  343 (491)
Q Consensus       265 iiHrDlKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-  343 (491)
                      ||||||||+||||+.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||+||||++|. 
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence            9999999999999999999999999998765444444445578999999999999999999999999999999999996 


Q ss_pred             CCCCCCCCCCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          344 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       344 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                      +||......   .+......   ..           ....+..++.++.+||.+||+.||.+||||.||++.|+++.
T Consensus       241 ~p~~~~~~~---e~~~~v~~---~~-----------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         241 QPYYGMAHE---EVIYYVRD---GN-----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CTTTTSCHH---HHHHHHHT---TC-----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCHH---HHHHHHHc---CC-----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            566543221   11111110   00           01122344678999999999999999999999999998764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-52  Score=420.99  Aligned_cols=246  Identities=26%  Similarity=0.343  Sum_probs=208.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++++.||+|+||.||+|+++.         +|..||||++.+..   ....+.+.+|+++|+.++|||||++++++.
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~---------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~  111 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence            579999999999999999999876         67899999996542   233467899999999999999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      +....++||||+.+|+|.+++...+  .+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||
T Consensus       112 ~~~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         112 DNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cccccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeece
Confidence            9999999999999999999998765  6899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +|+.....     ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   +....   .... 
T Consensus       187 ~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i---~~~~-  254 (350)
T d1rdqe_         187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKI---VSGK-  254 (350)
T ss_dssp             TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHCC-
T ss_pred             eeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHHH---hcCC-
Confidence            99876432     234689999999999999999999999999999999999999997543211   11111   0000 


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                                 ..++...+.++.+||.+||..||.+|+     |+++|++|
T Consensus       255 -----------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         255 -----------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                       011223478899999999999999994     89999865

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=413.04  Aligned_cols=253  Identities=18%  Similarity=0.234  Sum_probs=208.7

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .++|.+.+.||+|+||+||+|.+..         +|..||||+++.... ....+.+|+++|+.++|||||++++++.++
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~---------~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   73 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             ccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            4579999999999999999999876         688999999987643 345678999999999999999999999999


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCC--CCeEEeccC
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD--YNAKLSDFG  289 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~--~~~kL~DFG  289 (491)
                      +.+|||||||+||+|.++|...+ ..+++..++.|+.||+.||+|||+.+   |+||||||+||||+.+  +.+||+|||
T Consensus        74 ~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          74 EELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             CEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccc
Confidence            99999999999999999997653 36899999999999999999999988   9999999999999754  589999999


Q ss_pred             CcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCcc
Q 011180          290 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  369 (491)
Q Consensus       290 la~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  369 (491)
                      +++......   .....+||+.|+|||.+.+..|+.++|||||||++|+|++|..||...........+      .....
T Consensus       150 ~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i------~~~~~  220 (321)
T d1tkia_         150 QARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEY  220 (321)
T ss_dssp             TCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCC
T ss_pred             hhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC
Confidence            998764432   233467999999999999999999999999999999999999999764322111111      00000


Q ss_pred             chhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          370 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       370 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+..        ......+.++.+||.+||..||.+|||+.|+++|
T Consensus       221 ~~~~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         221 TFDE--------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CCCH--------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCh--------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000        0001236789999999999999999999999985

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=413.50  Aligned_cols=267  Identities=28%  Similarity=0.369  Sum_probs=204.0

Q ss_pred             HhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeeeeE
Q 011180          130 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGY  207 (491)
Q Consensus       130 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~  207 (491)
                      +..++|++.+.||+|+||.||+|.+.....    ..+++.||||+++.... ...+.+.+|+.++.++ +|+|||.++++
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~----~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTS----SSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            334679999999999999999999865321    22678999999976533 3346678888888877 58999999998


Q ss_pred             Eeec-CceEEEEEecCCCChHHHhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 011180          208 CIED-DQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  272 (491)
Q Consensus       208 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp  272 (491)
                      +.+. ..+++|||||++|+|.++|....              ...+++..+..++.||+.||.|||+++   ||||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence            8765 46899999999999999996542              224889999999999999999999988   99999999


Q ss_pred             CcEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCC-CCCCCCCC
Q 011180          273 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-RSMDKNRP  351 (491)
Q Consensus       273 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~pf~~~~~  351 (491)
                      +||||+.++.+||+|||+|+..............+||+.|||||++.+..++.++|||||||++|||++|. +||.....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998765544444445578999999999999999999999999999999999975 56754332


Q ss_pred             CCcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          352 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ...  +.......              .....+...+.++.+||.+||+.||.+|||+.||+++|+.+
T Consensus       243 ~~~--~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         243 DEE--FCRRLKEG--------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             SHH--HHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH--HHHHHhcC--------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            211  11111100              01112233467899999999999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.6e-52  Score=418.00  Aligned_cols=250  Identities=28%  Similarity=0.394  Sum_probs=204.8

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHH---HHHHHHhcCCCCceeeeee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWL---AEVNFLGNLLHPNLVKLVG  206 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~---~E~~il~~l~HpnIv~l~~  206 (491)
                      ++|++.++||+|+||.||+|++..         +|..||||++.+...   .....+.   .|+.+++.++|||||++++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~   74 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY   74 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECC---------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence            579999999999999999999876         678999999864322   1222333   4577888889999999999


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEe
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  286 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~  286 (491)
                      ++.+.+.+|||||||++|+|.++|....  .+++..++.++.||+.||.|||+++   ||||||||+||||+.++.+||+
T Consensus        75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~  149 (364)
T d1omwa3          75 AFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS  149 (364)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEEC
T ss_pred             EEEECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEe
Confidence            9999999999999999999999997764  6789999999999999999999988   9999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011180          287 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       287 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      |||+|+......    ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||..........+...   ..
T Consensus       150 DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~  222 (364)
T d1omwa3         150 DLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL  222 (364)
T ss_dssp             CCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---SS
T ss_pred             eeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cc
Confidence            999998765432    234679999999999975 5689999999999999999999999976544332222111   11


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  415 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~  415 (491)
                      ..            ...++...+.++.+||.+||+.||.+|||     ++++++|
T Consensus       223 ~~------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         223 TM------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             SC------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             cC------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            10            01122234788999999999999999999     6888876

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.1e-52  Score=403.46  Aligned_cols=252  Identities=26%  Similarity=0.339  Sum_probs=208.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc---------cHHHHHHHHHHHhcCC-CCcee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---------GHKEWLAEVNFLGNLL-HPNLV  202 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~il~~l~-HpnIv  202 (491)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++......         ..+.+.+|+.+|++|. |||||
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv   73 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII   73 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             ccCEEceEEecCcCeEEEEEEECC---------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeE
Confidence            579999999999999999999876         6789999999765321         1235789999999997 99999


Q ss_pred             eeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          203 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       203 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                      ++++++.+++..|||||||++|+|.++|...+  .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.
T Consensus        74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~  148 (277)
T d1phka_          74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN  148 (277)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEEeecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCC
Confidence            99999999999999999999999999997765  6899999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhc------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcch
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  356 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~------~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~  356 (491)
                      +||+|||+++.......   ....+||+.|+|||++.+      ..++.++||||+||+||||++|+.||..........
T Consensus       149 ~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~  225 (277)
T d1phka_         149 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR  225 (277)
T ss_dssp             EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             eEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH
Confidence            99999999987754322   244689999999999864      356889999999999999999999997653221111


Q ss_pred             hhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          357 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .+.      ....        .+........++++.+||.+||+.||.+|||++||+++
T Consensus       226 ~i~------~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         226 MIM------SGNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHH------HTCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHH------hCCC--------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            110      0000        01111122347899999999999999999999999876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=407.05  Aligned_cols=260  Identities=27%  Similarity=0.416  Sum_probs=201.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      ++|++.+.||+|+||.||+|++....      +....||||++..+..   ...+++.+|+.+|++++|||||+++|++.
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~------~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~   81 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   81 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCC------CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            57999999999999999999886432      1445799999876532   33467899999999999999999999997


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  289 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFG  289 (491)
                      + ...++|||||++|+|.+++..... .+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||
T Consensus        82 ~-~~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          82 T-PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             e-cchheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccch
Confidence            6 567899999999999998876533 6899999999999999999999988   9999999999999999999999999


Q ss_pred             CcccCCCCCCce-eeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCCcchhhHhhhcccCC
Q 011180          290 LAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  367 (491)
Q Consensus       290 la~~~~~~~~~~-~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  367 (491)
                      +++......... ......||..|+|||++.+..++.++|||||||++|||+| |..||.......   ......   ..
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i~---~~  230 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKID---KE  230 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH---TS
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHHH---hC
Confidence            999875543332 2234568889999999999999999999999999999998 899996542221   111111   01


Q ss_pred             ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          368 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       368 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                                ......+...+..+.+||.+||+.||.+|||+.+|++.|++.
T Consensus       231 ----------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         231 ----------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                      011112233467899999999999999999999999998764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-52  Score=413.89  Aligned_cols=253  Identities=22%  Similarity=0.264  Sum_probs=202.5

Q ss_pred             cCCCcCc-ccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 011180          133 RNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  210 (491)
                      ++|.+.. +||+|+||+||+|++..         +++.||||+++.     ...+.+|+.++.++ +|||||+++++|.+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~   76 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYEN   76 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECC---------CCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            5788764 69999999999999876         678999999964     35677899987655 79999999999876


Q ss_pred             ----cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC---CCCe
Q 011180          211 ----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNA  283 (491)
Q Consensus       211 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~---~~~~  283 (491)
                          ...+|||||||+||+|.++|..++...+++..++.|+.||+.||+|||+.+   |+||||||+|||++.   ++.+
T Consensus        77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~  153 (335)
T d2ozaa1          77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL  153 (335)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCE
T ss_pred             cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccc
Confidence                456899999999999999998776667999999999999999999999988   999999999999975   5679


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      ||+|||+|+.......   ....+||+.|||||++.+..|+.++|||||||+||+|+||+.||..............  .
T Consensus       154 Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~--~  228 (335)
T d2ozaa1         154 KLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--R  228 (335)
T ss_dssp             EECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------C
T ss_pred             cccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH--H
Confidence            9999999987654332   2346899999999999999999999999999999999999999975543222111100  0


Q ss_pred             ccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .....        ..+........+.++.+||.+||+.||.+|||+.|++++
T Consensus       229 i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         229 IRMGQ--------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CCSCS--------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCC--------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00000        000011112347889999999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=413.70  Aligned_cols=249  Identities=28%  Similarity=0.428  Sum_probs=206.2

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC---cccHHHHHHHHHHHh-cCCCCceeeeeeEE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLG-NLLHPNLVKLVGYC  208 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~-~l~HpnIv~l~~~~  208 (491)
                      ++|.+.+.||+|+||+||+|++..         +|+.||||++++..   ....+.+..|+.++. .++|||||++++++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~---------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~   72 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   72 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECC---------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence            479999999999999999999876         78899999997542   123456677777765 68999999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEecc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  288 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DF  288 (491)
                      .+++..|||||||++|+|.+++....  .+++..+..++.||+.||+|||+++   ||||||||+|||+++++.+||+||
T Consensus        73 ~~~~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          73 QTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ccCCceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceecccc
Confidence            99999999999999999999997765  5889999999999999999999988   999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCc
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  368 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  368 (491)
                      |+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......   +......   . 
T Consensus       148 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~---~-  218 (320)
T d1xjda_         148 GMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRM---D-  218 (320)
T ss_dssp             TTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH---C-
T ss_pred             chhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHc---C-
Confidence            99987643322  2344689999999999999999999999999999999999999997543221   1111100   0 


Q ss_pred             cchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011180          369 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  415 (491)
Q Consensus       369 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~-evl~~  415 (491)
                             .+    .++...+..+.+||.+||..||.+|||+. ++++|
T Consensus       219 -------~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         219 -------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             -------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -------CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                   01    12223478899999999999999999985 67654

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-52  Score=406.63  Aligned_cols=268  Identities=25%  Similarity=0.378  Sum_probs=212.4

Q ss_pred             hhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc-cHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 011180          131 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNL-LHPNLVKLVGYC  208 (491)
Q Consensus       131 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l-~HpnIv~l~~~~  208 (491)
                      ..++|.+.+.||+|+||.||+|++...+..  ...++..||||+++.+... ...++.+|+..+.++ +|||||+++++|
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcc--cccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            345799999999999999999987653221  1224568999999876542 346788999999888 799999999999


Q ss_pred             eecCceEEEEEecCCCChHHHhhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 011180          209 IEDDQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  274 (491)
Q Consensus       209 ~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~N  274 (491)
                      .+++..++|||||++|+|.++|....              ...+++..++.++.||+.||+|||+.+   ||||||||+|
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N  165 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  165 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence            99999999999999999999997553              235899999999999999999999988   9999999999


Q ss_pred             EEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCC
Q 011180          275 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  353 (491)
Q Consensus       275 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-G~~pf~~~~~~~  353 (491)
                      ||++.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |.+||...... 
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-  244 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  244 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-
Confidence            9999999999999999997765544444455789999999999999999999999999999999998 68888644321 


Q ss_pred             cchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 011180          354 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  420 (491)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~  420 (491)
                        .+.....              ......++...+..+.+||.+||+.||.+|||+.||++.|+.+.
T Consensus       245 --~~~~~i~--------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         245 --ELFKLLK--------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             --HHHHHHH--------------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHH--------------cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence              1111111              01111223334678999999999999999999999999998763

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=403.07  Aligned_cols=268  Identities=25%  Similarity=0.355  Sum_probs=203.3

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.+.||+|+||+||+|++..         +|+.||||+++....  ...+++.+|+++|++++|||||++++++.+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~   72 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT   72 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence            479999999999999999999876         677999999975532  234678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+.+||||||+. +++.+++.......+++..++.++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          73 ENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             ccceeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCc
Confidence            999999999995 55666665555557999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC--C
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG--D  367 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~--~  367 (491)
                      |+.......  .....+||+.|+|||.+.... ++.++|||||||++|+|++|+.||...........+........  .
T Consensus       149 a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  226 (298)
T d1gz8a_         149 ARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV  226 (298)
T ss_dssp             HHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence            987644322  223457999999999887665 57899999999999999999999975432211111000000000  0


Q ss_pred             ccchhhccC--cc----ccC---CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          368 KRRFYRLLD--PR----LEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       368 ~~~~~~~~~--~~----l~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ........+  ..    ...   ......+.++.+||.+||..||.+|||+.|+++|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000000000  00    000   0011236789999999999999999999999976

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-52  Score=407.09  Aligned_cols=262  Identities=24%  Similarity=0.286  Sum_probs=196.2

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCccc-----HHHHHHHHHHHhcCCCCceeeeeeEEeecC
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  212 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  212 (491)
                      +++||+|+||+||+|++..         +|+.||||+++......     .+.+.+|+.+|+.++|||||++++++.+++
T Consensus         3 l~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~   73 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   73 (299)
T ss_dssp             EEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             ceEeccCcCeEEEEEEECC---------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence            5789999999999999875         67899999997553321     246889999999999999999999999999


Q ss_pred             ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          213 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       213 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      ..|||||||.++++..++...  ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        74 ~~~ivmE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~  148 (299)
T d1ua2a_          74 NISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  148 (299)
T ss_dssp             CCEEEEECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             ceeehhhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCcccc
Confidence            999999999887766555433  36888889999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--c---ccC
Q 011180          293 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--P---HLG  366 (491)
Q Consensus       293 ~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--~---~~~  366 (491)
                      ........  ....+||+.|+|||++... .|+.++|||||||++|||++|.+||......+....+....  +   ...
T Consensus       149 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~  226 (299)
T d1ua2a_         149 SFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  226 (299)
T ss_dssp             TTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            76543322  2346899999999998754 68999999999999999999999997653322111110000  0   000


Q ss_pred             Cccchhh-----ccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 DKRRFYR-----LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 ~~~~~~~-----~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .......     ..............+.++.+||.+||+.||.+|||++|+|+|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            0000000     000000000011236789999999999999999999999865

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=404.21  Aligned_cols=265  Identities=27%  Similarity=0.393  Sum_probs=215.4

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  209 (491)
                      .++|++.+.||+|+||.||+|++...    ....++..||||+++.... .....+.+|+.++..+ +|||||++++++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            45789999999999999999998532    1123678999999976543 3345788999999999 6999999999999


Q ss_pred             ecCceEEEEEecCCCChHHHhhhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 011180          210 EDDQRLLVYEFMPRGSLENHLFRKG----------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTS  273 (491)
Q Consensus       210 ~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~  273 (491)
                      +.+..+||||||++|+|.++|....                ...+++..+..++.||+.||+|||+++   ||||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence            9999999999999999999997643                235889999999999999999999988   999999999


Q ss_pred             cEEECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCC-CCCCCCCCC
Q 011180          274 NILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-RSMDKNRPN  352 (491)
Q Consensus       274 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~pf~~~~~~  352 (491)
                      |||++.++.+||+|||+++..............+||+.|+|||++.++.++.++|||||||++|||+|++ +||......
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999999876655555556678999999999999999999999999999999999954 445433222


Q ss_pred             CcchhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          353 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ..  +......              ......+...+..+.+||.+||+.||.+|||+.+|++.|++.
T Consensus       255 ~~--~~~~i~~--------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         255 SK--FYKMIKE--------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HH--HHHHHHH--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH--HHHHHhc--------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            11  1111110              111112223468899999999999999999999999999753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-51  Score=402.80  Aligned_cols=259  Identities=25%  Similarity=0.428  Sum_probs=206.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  210 (491)
                      ++|++.++||+|+||+||+|+++.++       ....||||.+.... ....+.+.+|+++|.++ +|||||++++++.+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   82 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   82 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETT-------EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCC-------eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence            57899999999999999999997622       12357888876442 23456789999999999 69999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRK--------------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NIL  276 (491)
                      ++..+|||||+++|+|.++|...              ....+++..+..++.||+.||.|||+.+   ||||||||+|||
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL  159 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL  159 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEE
Confidence            99999999999999999998654              2346899999999999999999999988   999999999999


Q ss_pred             ECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCC-CCCCCCCCCcc
Q 011180          277 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR-SMDKNRPNGEH  355 (491)
Q Consensus       277 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~-pf~~~~~~~~~  355 (491)
                      ++.++.+||+|||+++.......   .....||..|+|||.+.++.|+.++|||||||++|||++|.. ||.....   .
T Consensus       160 ~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~  233 (309)
T d1fvra_         160 VGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---A  233 (309)
T ss_dssp             ECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H
T ss_pred             EcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---H
Confidence            99999999999999986543221   223568999999999999999999999999999999999765 5643321   1


Q ss_pred             hhhHhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          356 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                      .+......              ......+..++.++.+||.+||+.||++|||+.+|+++|+.+.+
T Consensus       234 ~~~~~i~~--------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         234 ELYEKLPQ--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHHHHGGG--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHh--------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11111110              01112233457899999999999999999999999999987643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=398.90  Aligned_cols=258  Identities=27%  Similarity=0.442  Sum_probs=204.9

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCceeeeeeEEeec-CceE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-DQRL  215 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~  215 (491)
                      .++||+|+||+||+|++...+.      +...||||.++.. .....+++.+|+++|++|+|||||+++|++.+. +..+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            5789999999999999875321      3457999999754 333457799999999999999999999998764 5789


Q ss_pred             EEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCCcccCC
Q 011180          216 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  295 (491)
Q Consensus       216 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGla~~~~  295 (491)
                      +|||||++|+|.+++.... ..+++..++.++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++...
T Consensus       106 lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             EEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            9999999999999887553 36788889999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCc--eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccCCccchhh
Q 011180          296 EDGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  373 (491)
Q Consensus       296 ~~~~~--~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (491)
                      .....  .......||+.|+|||.+.+..++.++|||||||+||||++|+.||.......  ........   ..+    
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~~---g~~----  252 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQ---GRR----  252 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT---TCC----
T ss_pred             ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc---CCC----
Confidence            43222  12233578999999999999999999999999999999999888876433211  11111110   000    


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 011180          374 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  421 (491)
Q Consensus       374 ~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~  421 (491)
                             ...+..++..+.+||.+||+.||.+|||+.||+++|+.+.+
T Consensus       253 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         253 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                   01122346789999999999999999999999999987743

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-51  Score=401.46  Aligned_cols=267  Identities=25%  Similarity=0.396  Sum_probs=214.1

Q ss_pred             HHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeE
Q 011180          129 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGY  207 (491)
Q Consensus       129 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~  207 (491)
                      .+..++|.+.+.||+|+||.||+|.+....    ...++..||||+++.... .....+.+|+.++++++|||||+++++
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEE----TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcc----cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            334467899999999999999999885311    111456899999976532 334568999999999999999999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRK--------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  279 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~  279 (491)
                      +..++..++|||||++|+|.+++...        ....+++..+..++.|++.||.|||+++   |+||||||+||||+.
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE  168 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecC
Confidence            99999999999999999999988642        1235788999999999999999999988   999999999999999


Q ss_pred             CCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCC-CCCCCCCCCCcchhh
Q 011180          280 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLV  358 (491)
Q Consensus       280 ~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~-~pf~~~~~~~~~~~~  358 (491)
                      ++++||+|||+++..............+||+.|+|||.+.++.++.++|||||||+||||+||. +||......   ...
T Consensus       169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~~  245 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVL  245 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHH
T ss_pred             CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HHH
Confidence            9999999999998775544444445567999999999999999999999999999999999985 666433211   111


Q ss_pred             HhhhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          359 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ...   .          +.. ....+..++..+.+||.+||+.||.+|||+.+|+++|+..
T Consensus       246 ~~i---~----------~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         246 RFV---M----------EGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHH---H----------TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHH---H----------hCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            111   0          000 0112233467899999999999999999999999999865

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=397.46  Aligned_cols=269  Identities=24%  Similarity=0.320  Sum_probs=201.2

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcC---CCCceeeeee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNL---LHPNLVKLVG  206 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~~  206 (491)
                      .++|++++.||+|+||+||+|++...        +++.||||++.....  .....+.+|+.+|+.|   +||||+++++
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~   77 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD   77 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECC--------CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence            46899999999999999999998642        366899999865422  1223466788777666   7999999999


Q ss_pred             EEee-----cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC
Q 011180          207 YCIE-----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       207 ~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~  281 (491)
                      +|..     ....+++|||+.++.+.... ......+++..++.++.||+.||+|||+++   ||||||||+|||++.++
T Consensus        78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~  153 (305)
T d1blxa_          78 VCTVSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSG  153 (305)
T ss_dssp             EEEEEECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTC
T ss_pred             eecccccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCC
Confidence            9864     34678999999776665443 334457899999999999999999999988   99999999999999999


Q ss_pred             CeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          282 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      .+||+|||+++.....   ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+...
T Consensus       154 ~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  230 (305)
T d1blxa_         154 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV  230 (305)
T ss_dssp             CEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             Ceeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence            9999999998865432   2234578999999999999999999999999999999999999999765432211111100


Q ss_pred             hc-----ccCC----ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 RP-----HLGD----KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 ~~-----~~~~----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ..     .+..    ....+..........+....+..+.+||.+||+.||.+|||+.|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00     0000    000000000111112223346789999999999999999999999976

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-51  Score=394.95  Aligned_cols=241  Identities=25%  Similarity=0.424  Sum_probs=199.5

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc------cHHHHHHHHHHHhcCC--CCceeee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLL--HPNLVKL  204 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~--HpnIv~l  204 (491)
                      ++|++.++||+|+||+||+|++..         +|..||||++......      ...++.+|+.+|++++  |||||++
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~   74 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL   74 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEE
Confidence            579999999999999999999876         6789999999754321      1234678999999997  8999999


Q ss_pred             eeEEeecCceEEEEEecCC-CChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-CCC
Q 011180          205 VGYCIEDDQRLLVYEFMPR-GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYN  282 (491)
Q Consensus       205 ~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~-~~~  282 (491)
                      ++++.+.+..++||||+.+ +++.+++....  .+++..++.++.||+.||+|||+.+   ||||||||+|||++. ++.
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~  149 (273)
T d1xwsa_          75 LDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE  149 (273)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTE
T ss_pred             EEEEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCe
Confidence            9999999999999999976 57778876654  6899999999999999999999988   999999999999985 479


Q ss_pred             eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh
Q 011180          283 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  361 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  361 (491)
                      +||+|||+|+.....    ..+..+||+.|||||++.+..+ +.++|||||||++|||++|+.||....     ...   
T Consensus       150 vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~---  217 (273)
T d1xwsa_         150 LKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII---  217 (273)
T ss_dssp             EEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH---
T ss_pred             EEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh---
Confidence            999999999865432    2234689999999999987765 677999999999999999999996421     110   


Q ss_pred             hcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...                ..++...+.++.+||.+||..||.+|||++|++++
T Consensus       218 ~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         218 RGQ----------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             HCC----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hcc----------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            000                01122336889999999999999999999999976

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=397.24  Aligned_cols=273  Identities=25%  Similarity=0.343  Sum_probs=201.6

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHH--HHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|.+.+.||+|+||.||+|++           +|..||||+++.+.   .+.+.+  |+..+..++|||||++++++.+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-----------~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~   68 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK   68 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEe
Confidence            5688899999999999999986           46799999996542   233444  5556667899999999999987


Q ss_pred             cC----ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCcEEECCCC
Q 011180          211 DD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA-----EKPVIYRDFKTSNILLDADY  281 (491)
Q Consensus       211 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----~~~iiHrDlKp~NILl~~~~  281 (491)
                      .+    .+|||||||++|+|.++|.+.   .+++..++.++.|++.||.|||+..     .++||||||||+||||+.++
T Consensus        69 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~  145 (303)
T d1vjya_          69 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  145 (303)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred             CCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence            65    578999999999999999765   5889999999999999999999741     24599999999999999999


Q ss_pred             CeEEeccCCcccCCCCCCce--eeeccccCCCCCCchhhhcCC------CCccccchhHHHHHHHHHhCCCCCCCCCCCC
Q 011180          282 NAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG  353 (491)
Q Consensus       282 ~~kL~DFGla~~~~~~~~~~--~~~~~~Gt~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltG~~pf~~~~~~~  353 (491)
                      .+||+|||+++.........  .....+||+.|||||++.+..      ++.++|||||||+||||+||..||.......
T Consensus       146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~  225 (303)
T d1vjya_         146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  225 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred             CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence            99999999998764433221  223468999999999987543      5678999999999999999998875433221


Q ss_pred             cchhhHh-hhcccCCc--cchhhccCccccCCC-ChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCccc
Q 011180          354 EHNLVEW-ARPHLGDK--RRFYRLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  422 (491)
Q Consensus       354 ~~~~~~~-~~~~~~~~--~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l~~~  422 (491)
                      ....... ........  ......++|.+...+ +......+.+|+.+||+.||.+|||+.||++.|+++.+.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         226 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            1100000 00000000  000111222222211 223456799999999999999999999999999877543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.5e-50  Score=390.38  Aligned_cols=266  Identities=22%  Similarity=0.311  Sum_probs=201.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.+.||+|+||+||+|++.          +|+.||||++......  ..+.+.+|+.+|++++|||||++++++.+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   71 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence            57999999999999999999875          4678999999765432  24688999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      .+..+++|||+.++.+..+....  ..+++..+..++.||+.||+|||+.+   ||||||||+||||+.++.+||+|||+
T Consensus        72 ~~~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          72 KKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             SSCEEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             CCceeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccc
Confidence            99999999999776665555433  37999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh--cc---
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PH---  364 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--~~---  364 (491)
                      +.........  .....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....  +.   
T Consensus       147 a~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~  224 (286)
T d1ob3a_         147 ARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN  224 (286)
T ss_dssp             HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ceecccCccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhh
Confidence            9876443221  233568999999999875 457899999999999999999999997543221111110000  00   


Q ss_pred             cCCccc------hhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          365 LGDKRR------FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       365 ~~~~~~------~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ......      ......+.....+....+..+.+||++||+.||++|||++|+++|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000000      000001111111222346789999999999999999999999865

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-48  Score=387.74  Aligned_cols=268  Identities=24%  Similarity=0.332  Sum_probs=199.6

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|++.+.||+|+||+||+|.+..         +|+.||||+++....  ...+.+.+|+++|+.++|||||+++++|.
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~   87 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT   87 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence            4689999999999999999999876         678999999976432  23457889999999999999999999998


Q ss_pred             ecC------ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCe
Q 011180          210 EDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  283 (491)
Q Consensus       210 ~~~------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~  283 (491)
                      ..+      .+||||||| +.+|..++...   .+++..++.++.||+.||.|||+++   ||||||||+|||++.++.+
T Consensus        88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~  160 (346)
T d1cm8a_          88 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCEL  160 (346)
T ss_dssp             SCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred             cCccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccc
Confidence            765      469999999 66777776543   6899999999999999999999998   9999999999999999999


Q ss_pred             EEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhh
Q 011180          284 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  362 (491)
Q Consensus       284 kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  362 (491)
                      ||+|||+|+.....     .+..+||+.|+|||++.+. .++.++|||||||++|+|++|++||................
T Consensus       161 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~  235 (346)
T d1cm8a_         161 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT  235 (346)
T ss_dssp             EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             ccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhcc
Confidence            99999999876443     2346799999999998764 57899999999999999999999997653221111110000


Q ss_pred             cc--------cCC--ccchhhccCc---cccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhcCc
Q 011180          363 PH--------LGD--KRRFYRLLDP---RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ  420 (491)
Q Consensus       363 ~~--------~~~--~~~~~~~~~~---~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--L~~l~  420 (491)
                      ..        ...  .......+..   ..........+..+.+||.+||..||.+|||+.|+|+|  |+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            00        000  0000000000   00001112346788999999999999999999999987  55443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-48  Score=386.73  Aligned_cols=268  Identities=22%  Similarity=0.303  Sum_probs=199.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~  211 (491)
                      .+|++++.||+|+||+||+|++..         +|+.||||++..... ...+.+++|+.+|+.|+||||+++++++...
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~   78 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNV---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAP   78 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETT---------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred             CCeEEEEEEeeccCeEEEEEEECC---------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence            469999999999999999999876         678999999976542 3346788999999999999999999998765


Q ss_pred             C----ceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          212 D----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       212 ~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      .    ..+++|+|+.+|+|.+++...   .+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|
T Consensus        79 ~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~D  152 (345)
T d1pmea_          79 TIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICD  152 (345)
T ss_dssp             STTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             cccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcc
Confidence            3    234555667799999999754   5899999999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCc-eeeeccccCCCCCCchhhh-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011180          288 FGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       288 FGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      ||++......... ......+||+.|+|||++. +..++.++||||+||++|||++|+.||...................
T Consensus       153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~  232 (345)
T d1pmea_         153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP  232 (345)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence            9999865432221 1223467999999999985 4577899999999999999999999997654322111111000000


Q ss_pred             CCc----------cchhhccCccccC---CCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          366 GDK----------RRFYRLLDPRLEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       366 ~~~----------~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ...          .............   ......+.++.+|+.+||+.||.+|||+.|+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000          0000000000000   0011225678999999999999999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-48  Score=384.52  Aligned_cols=269  Identities=23%  Similarity=0.298  Sum_probs=196.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++.....  ...+++.+|+.+|+.++||||+++++++..
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~   80 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   80 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCEEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence            579999999999999999999876         678999999865532  234678999999999999999999998865


Q ss_pred             --------cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCC
Q 011180          211 --------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  282 (491)
Q Consensus       211 --------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~  282 (491)
                              .+..|+|||||.++.+......  ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.
T Consensus        81 ~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~  155 (318)
T d3blha1          81 KASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGV  155 (318)
T ss_dssp             ----------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSC
T ss_pred             ccccccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCc
Confidence                    3467999999977665544333  336889999999999999999999988   999999999999999999


Q ss_pred             eEEeccCCcccCCCCCCc--eeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH
Q 011180          283 AKLSDFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  359 (491)
Q Consensus       283 ~kL~DFGla~~~~~~~~~--~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~  359 (491)
                      +||+|||+++........  ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...........+.
T Consensus       156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~  235 (318)
T d3blha1         156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS  235 (318)
T ss_dssp             EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence            999999999866533221  122335799999999998765 68999999999999999999999997543222211111


Q ss_pred             hhhcccCCc-------cchhhccCccccCCCC-------hhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          360 WARPHLGDK-------RRFYRLLDPRLEGHFS-------IKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       360 ~~~~~~~~~-------~~~~~~~~~~l~~~~~-------~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      .........       ................       ...+..+.+||.+||+.||++|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            111000000       0000000000000000       1124577899999999999999999999976

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-48  Score=390.26  Aligned_cols=263  Identities=24%  Similarity=0.312  Sum_probs=196.0

Q ss_pred             CCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCceeeeeeEEeec--
Q 011180          134 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED--  211 (491)
Q Consensus       134 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--  211 (491)
                      +|+..++||+|+||+||+|++..         +|+.||||++..+..    ...+|+++|++|+|||||+++++|...  
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~   87 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGE   87 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             CcEeeeEEeeCcCeEEEEEEECC---------CCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence            58888999999999999999876         678999999976542    234799999999999999999998653  


Q ss_pred             ----CceEEEEEecCCCChHHHhh-hCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-CeEE
Q 011180          212 ----DQRLLVYEFMPRGSLENHLF-RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKL  285 (491)
Q Consensus       212 ----~~~~lV~E~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kL  285 (491)
                          ..+|||||||+++.+..+.. ......+++..+..++.||+.||+|||+++   ||||||||+||||+.++ .+||
T Consensus        88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl  164 (350)
T d1q5ka_          88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKL  164 (350)
T ss_dssp             CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEE
T ss_pred             cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeE
Confidence                24689999997654333322 123447999999999999999999999988   99999999999999775 8999


Q ss_pred             eccCCcccCCCCCCceeeeccccCCCCCCchhhhc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh---
Q 011180          286 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA---  361 (491)
Q Consensus       286 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~---  361 (491)
                      +|||+++.......   ....+||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||...........+...   
T Consensus       165 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~  241 (350)
T d1q5ka_         165 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT  241 (350)
T ss_dssp             CCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999987644322   234679999999998875 57899999999999999999999999765322211111000   


Q ss_pred             ------hcccCC--ccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          362 ------RPHLGD--KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       362 ------~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                            ......  ...+................+.++.+||.+||..||.+|||+.|+|+|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  000000  000000000001111222347789999999999999999999999976

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-47  Score=377.30  Aligned_cols=260  Identities=19%  Similarity=0.214  Sum_probs=200.7

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcee-eeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLV-KLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~~~~~~~  211 (491)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++.....  ..++..|+++++.+.|+|++ .+.+++.+.
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~   75 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG   75 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECC---------CCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence            469999999999999999999875         678999999876532  24578899999999876655 555566777


Q ss_pred             CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEEC---CCCCeEEecc
Q 011180          212 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDF  288 (491)
Q Consensus       212 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~---~~~~~kL~DF  288 (491)
                      +..++||||+ +++|.+.+.... ..+++..+..++.|++.||+|||+++   ||||||||+|||++   .+..+||+||
T Consensus        76 ~~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DF  150 (299)
T d1ckia_          76 DYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF  150 (299)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             CEEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeecc
Confidence            8889999999 667777765543 36899999999999999999999988   99999999999985   4567999999


Q ss_pred             CCcccCCCCCCc-----eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhh-h
Q 011180          289 GLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-R  362 (491)
Q Consensus       289 Gla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~  362 (491)
                      |+|+........     ......+||+.|||||++.+..++.++|||||||++|||++|..||............... .
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~  230 (299)
T d1ckia_         151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  230 (299)
T ss_dssp             SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred             CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence            999876543321     1223468999999999999999999999999999999999999999765544332222111 1


Q ss_pred             cccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          363 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       363 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ..+...       .+.+    ...++.++.+||.+||..||.+||++.++.+.|+.+
T Consensus       231 ~~~~~~-------~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         231 KKMSTP-------IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHHSC-------HHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             ccCCCC-------hhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            000000       0001    112367899999999999999999999998888754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=374.02  Aligned_cols=265  Identities=24%  Similarity=0.296  Sum_probs=206.4

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++++.||+|+||+||+|++..         ++..||||+++....  ...+++.+|+.+|+.++|||||++++++.+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   72 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCCEeeeEEecCcCeEEEEEEECC---------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence            479999999999999999999876         677999999976543  235678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEeccCC
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  290 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~DFGl  290 (491)
                      ....++|||++.+++|..++...+  .+++..+..++.|++.||+|||+++   ||||||||+|||++.++.+||+|||.
T Consensus        73 ~~~~~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          73 DKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             SSEEEEEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ccceeEEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecch
Confidence            999999999999988888776544  6789999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCceeeeccccCCCCCCchhhhcCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhcccC---
Q 011180          291 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---  366 (491)
Q Consensus       291 a~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---  366 (491)
                      ++........  .....+++.|+|||++.... ++.++|||||||++|||++|+.||.......  ...........   
T Consensus       148 a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~  223 (292)
T d1unla_         148 ARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPT  223 (292)
T ss_dssp             CEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred             hhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCC
Confidence            9876543322  23346788999999987664 6899999999999999999999975432211  11111000000   


Q ss_pred             --Cccchhhcc---------CccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          367 --DKRRFYRLL---------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       367 --~~~~~~~~~---------~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                        .........         ............+..+.+||.+||+.||.+|||++|||+|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              000000000         0001111223346789999999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=384.41  Aligned_cols=257  Identities=28%  Similarity=0.367  Sum_probs=207.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc----ccHHHHHHHHHHHhcCCC-CceeeeeeE
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLLH-PNLVKLVGY  207 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~H-pnIv~l~~~  207 (491)
                      ++|++.+.||+|+||+||+|++..+.      .+|..||||+++....    ...+.+.+|+++|++++| |||++++++
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~   97 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGH------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA   97 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSST------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccC------CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence            46999999999999999999885432      2788999999875432    234567889999999976 899999999


Q ss_pred             EeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeEEec
Q 011180          208 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  287 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~kL~D  287 (491)
                      +.+....++||||+.+|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|
T Consensus        98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_          98 FQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESC
T ss_pred             eccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEee
Confidence            999999999999999999999998765  5678888999999999999999988   99999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeeccccCCCCCCchhhhcC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhccc
Q 011180          288 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  365 (491)
Q Consensus       288 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  365 (491)
                      ||+++....... .......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||...........+....  .
T Consensus       173 FG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~  249 (322)
T d1vzoa_         173 FGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--L  249 (322)
T ss_dssp             SSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--H
T ss_pred             ccchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--c
Confidence            999987644322 223446799999999999754  46789999999999999999999997765444322221110  0


Q ss_pred             CCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011180          366 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  415 (491)
Q Consensus       366 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~  415 (491)
                      ..            ...++...+.++.+||.+||..||.+||     |++|+++|
T Consensus       250 ~~------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         250 KS------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             HC------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             cC------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            00            0112234478999999999999999999     47888864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3e-47  Score=373.06  Aligned_cols=262  Identities=18%  Similarity=0.197  Sum_probs=209.4

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCC-CceeeeeeEEee
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH-PNLVKLVGYCIE  210 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~  210 (491)
                      .++|++.+.||+|+||+||+|++..         +|+.||||++....  ....+.+|++++..|.| +||+.+++++.+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~   72 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE   72 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence            4689999999999999999999876         67899999986543  22457788999999975 899999999999


Q ss_pred             cCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECC-----CCCeEE
Q 011180          211 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-----DYNAKL  285 (491)
Q Consensus       211 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~-----~~~~kL  285 (491)
                      ....++||||+ +++|.+++...+. .+++..+..++.|++.||+|||+.+   ||||||||+||||+.     ++.+||
T Consensus        73 ~~~~~~vme~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          73 GLHNVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             CCccEEEEEec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEE
Confidence            99999999999 7899998876543 6899999999999999999999988   999999999999964     578999


Q ss_pred             eccCCcccCCCCCCc-----eeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHh
Q 011180          286 SDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  360 (491)
Q Consensus       286 ~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  360 (491)
                      +|||+|+........     ......+||+.|||||++.+..++.++|||||||++|||++|..||..............
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~  227 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  227 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence            999999876433211     122346899999999999999999999999999999999999999976554433322211


Q ss_pred             hhcccCCccchhhccCccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 011180          361 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  419 (491)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L~~l  419 (491)
                      ..... ..... ..    +    ....+.++.+|+..|+..+|.+||+++.+.+.|+.+
T Consensus       228 i~~~~-~~~~~-~~----l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         228 IGEKK-QSTPL-RE----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHHHH-HHSCH-HH----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HHhcc-CCCCh-HH----h----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            11000 00000 00    1    112357899999999999999999999998888765

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.5e-47  Score=381.40  Aligned_cols=260  Identities=20%  Similarity=0.256  Sum_probs=199.9

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeeeEEeec
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIED  211 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~  211 (491)
                      ++|+++++||+|+||+||+|++..         +|+.||||+++...   .+++.+|+.+|+.+. ||||++++++|...
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~  102 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP  102 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence            579999999999999999999876         68899999997543   467889999999996 99999999998754


Q ss_pred             --CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCC-CeEEecc
Q 011180          212 --DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDF  288 (491)
Q Consensus       212 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~-~~kL~DF  288 (491)
                        ...++|||||.+++|..+.     ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++ .+||+||
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DF  174 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDW  174 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCG
T ss_pred             CCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeeccc
Confidence              5689999999999987653     25889999999999999999999998   99999999999998655 6999999


Q ss_pred             CCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhh--H------
Q 011180          289 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--E------  359 (491)
Q Consensus       289 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~--~------  359 (491)
                      |+|+.......   ....+||+.|+|||.+.+. .++.++|||||||++|||++|+.||............  .      
T Consensus       175 G~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~  251 (328)
T d3bqca1         175 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED  251 (328)
T ss_dssp             GGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred             ccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCch
Confidence            99987654322   2346799999999998765 5799999999999999999999999754332111000  0      


Q ss_pred             ---hhh-cccCCccchhhccC--------ccccCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          360 ---WAR-PHLGDKRRFYRLLD--------PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       360 ---~~~-~~~~~~~~~~~~~~--------~~l~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                         +.. ........+.....        ...........+.++.+||++||..||.+|||++|+|+|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               000 00000000000000        001111112346789999999999999999999999865

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=379.38  Aligned_cols=263  Identities=22%  Similarity=0.291  Sum_probs=192.0

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  210 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~  210 (491)
                      ++|++.++||+|+||+||+|++..         +|..||||++.....  ...+++.+|+.+|++++|||||+++++|..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~---------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~   87 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETT---------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             CCeEEEEEeecCcCeEEEEEEECC---------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence            579999999999999999999876         788999999976543  234568899999999999999999999964


Q ss_pred             c------CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          211 D------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       211 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      .      ...|+|||||.+ +|.+.+.    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        88 ~~~~~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~k  159 (355)
T d2b1pa1          88 QKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  159 (355)
T ss_dssp             CCSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred             ccccccCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCcccccccccccee
Confidence            3      578999999965 4555442    25889999999999999999999998   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhH-----
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-----  359 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~-----  359 (491)
                      |+|||+++......   ..+..+||+.|+|||++.+..++.++||||+||++|+|++|+.||...........+.     
T Consensus       160 l~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~  236 (355)
T d2b1pa1         160 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  236 (355)
T ss_dssp             ECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             eechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence            99999988664432   2344679999999999999999999999999999999999999997543211110000     


Q ss_pred             ----hh-----------hccc-CCccchhhccCccc---cCCCChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          360 ----WA-----------RPHL-GDKRRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       360 ----~~-----------~~~~-~~~~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                          +.           .... ..............   ........+..+.+||++||..||++|||++|||+|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                00           0000 00000001110000   001122347789999999999999999999999977

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=377.30  Aligned_cols=264  Identities=24%  Similarity=0.341  Sum_probs=198.0

Q ss_pred             hcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 011180          132 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  209 (491)
Q Consensus       132 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~  209 (491)
                      .++|++.+.||+|+||+||+|++..         +|+.||||++.....  ...+.+.+|+++|+.|+|||||++++++.
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~   87 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   87 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETT---------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4679999999999999999999876         688999999976543  33457889999999999999999999986


Q ss_pred             ec-----CceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEEECCCCCeE
Q 011180          210 ED-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  284 (491)
Q Consensus       210 ~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NILl~~~~~~k  284 (491)
                      ..     ...++||+|+.+|+|.+++...   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|
T Consensus        88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~k  161 (348)
T d2gfsa1          88 PARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  161 (348)
T ss_dssp             SCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             eccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccccc
Confidence            43     3446777788899999998543   5899999999999999999999988   99999999999999999999


Q ss_pred             EeccCCcccCCCCCCceeeeccccCCCCCCchhhhcC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCCcchhhHhhhc
Q 011180          285 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  363 (491)
Q Consensus       285 L~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  363 (491)
                      |+|||++......     .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.....
T Consensus       162 l~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~  236 (348)
T d2gfsa1         162 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  236 (348)
T ss_dssp             ECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999765322     2346789999999987765 468899999999999999999999976432221111110000


Q ss_pred             ccCC----------ccchhhccCccccCC---CChhhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011180          364 HLGD----------KRRFYRLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  415 (491)
Q Consensus       364 ~~~~----------~~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~  415 (491)
                      ....          ...+...+.......   .....+..+.+||.+||..||.+|||+.|+|+|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            0000          000000000000000   011236788999999999999999999999976

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.3e-42  Score=343.54  Aligned_cols=265  Identities=20%  Similarity=0.263  Sum_probs=193.1

Q ss_pred             cCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-----------CCce
Q 011180          133 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-----------HPNL  201 (491)
Q Consensus       133 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------HpnI  201 (491)
                      ++|+++++||+|+||+||+|++..         +|+.||||+++.+.. ..+.+.+|+.+|+.++           |+||
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~---------~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            359999999999999999999876         688999999986542 2456788999888875           5789


Q ss_pred             eeeeeEEeec--CceEEEEEecCCCC-hHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCcEEE
Q 011180          202 VKLVGYCIED--DQRLLVYEFMPRGS-LENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILL  277 (491)
Q Consensus       202 v~l~~~~~~~--~~~~lV~E~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlKp~NILl  277 (491)
                      +++++++...  ...+++|+++..+. ............+++..+..++.||+.||.|||+ .+   |+||||||+||||
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll  159 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLM  159 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeee
Confidence            9999988654  45667777765543 3333444445578899999999999999999998 66   9999999999999


Q ss_pred             CCCCC------eEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 011180          278 DADYN------AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  351 (491)
Q Consensus       278 ~~~~~------~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil~elltG~~pf~~~~~  351 (491)
                      +.++.      ++|+|||.+......     ....+||+.|+|||++....|+.++||||+||++++|++|+.||.....
T Consensus       160 ~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         160 EIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             EEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             eccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence            76653      999999999865432     2346799999999999999999999999999999999999999975433


Q ss_pred             CCcchhhHhhh---cccCCc-----------cch------hhccCc----------cccCCCChhhHHHHHHHHHHhhhc
Q 011180          352 NGEHNLVEWAR---PHLGDK-----------RRF------YRLLDP----------RLEGHFSIKGSQKATQLAAQCLSR  401 (491)
Q Consensus       352 ~~~~~~~~~~~---~~~~~~-----------~~~------~~~~~~----------~l~~~~~~~~~~~l~~li~~cL~~  401 (491)
                      ...........   ..++..           ..+      ...+..          .....+....+..+.+||.+||..
T Consensus       235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  314 (362)
T d1q8ya_         235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  314 (362)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence            22111100000   000000           000      000000          001123445678999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 011180          402 DPKARPRMSEVVET  415 (491)
Q Consensus       402 dP~~RPt~~evl~~  415 (491)
                      ||.+|||++|+|+|
T Consensus       315 dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         315 DPRKRADAGGLVNH  328 (362)
T ss_dssp             STTTCBCHHHHHTC
T ss_pred             ChhHCcCHHHHhcC
Confidence            99999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=5.8e-26  Score=206.83  Aligned_cols=170  Identities=15%  Similarity=0.114  Sum_probs=119.4

Q ss_pred             CCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcc------------------cHHHHHHHHHHHhcC
Q 011180          135 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------GHKEWLAEVNFLGNL  196 (491)
Q Consensus       135 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~il~~l  196 (491)
                      +.+.+.||+|+||+||+|.+.          +|..||||+++.....                  .......|+..|.++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   71 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL   71 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             chhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc
Confidence            346789999999999999874          5779999987532110                  012345688999999


Q ss_pred             CCCceeeeeeEEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcEE
Q 011180          197 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  276 (491)
Q Consensus       197 ~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlKp~NIL  276 (491)
                      .|.+++..+++.    ..+|||||+++..+.++         +......++.|++.+|.|||+++   |+||||||+|||
T Consensus        72 ~~~~v~~~~~~~----~~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NIL  135 (191)
T d1zara2          72 QGLAVPKVYAWE----GNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL  135 (191)
T ss_dssp             TTSSSCCEEEEE----TTEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             cCCCcceEEEec----CCEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhhee
Confidence            999999887653    24899999987655432         22335678999999999999988   999999999999


Q ss_pred             ECCCCCeEEeccCCcccCCCCCCceeeeccccCCCCCCchhhhcCCCCccccchhHHHHH
Q 011180          277 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL  336 (491)
Q Consensus       277 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~~~~~~~~~~~DvwSlGvil  336 (491)
                      ++++ .++|+|||+|+............+.+..    -.+ +....|+.++|+||+.--+
T Consensus       136 v~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         136 VSEE-GIWIIDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EETT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             eeCC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHH
Confidence            9865 5899999999766432211100000000    011 1246788999999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.70  E-value=6.5e-08  Score=89.87  Aligned_cols=147  Identities=15%  Similarity=0.010  Sum_probs=98.9

Q ss_pred             HHHhhcCCCcCcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCceeeeee
Q 011180          128 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVG  206 (491)
Q Consensus       128 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~  206 (491)
                      +...-..|++.+..+.++.+.||+...           .+..++||............+.+|...+..|. +--+.+++.
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~   77 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLH   77 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEE
Confidence            334445677777766666689998753           34467888876543333345678888887774 433567777


Q ss_pred             EEeecCceEEEEEecCCCChHHHhhhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------
Q 011180          207 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA-------------------------  261 (491)
Q Consensus       207 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------  261 (491)
                      +..+++..++||++++|.++.+.....    ..   ...++.++++.|..||+..                         
T Consensus        78 ~~~~~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (263)
T d1j7la_          78 FERHDGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL  150 (263)
T ss_dssp             EEEETTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred             EEecCCceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHh
Confidence            888888899999999988876554221    11   2234445555555565421                         


Q ss_pred             -------------------------------CCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          262 -------------------------------EKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       262 -------------------------------~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                                                     ...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                           1127999999999999987667799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.04  E-value=1.1e-05  Score=73.87  Aligned_cols=74  Identities=20%  Similarity=0.098  Sum_probs=50.4

Q ss_pred             cccCC-ceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCC--CceeeeeeEEeecCceEEE
Q 011180          141 LGEGG-FGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH--PNLVKLVGYCIEDDQRLLV  217 (491)
Q Consensus       141 lG~G~-fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~~lV  217 (491)
                      +..|. -+.||+....          .+..+++|.......   ..+..|+..|+.|..  --+.+++.+..+.+..++|
T Consensus        18 ~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v   84 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   84 (255)
T ss_dssp             CSCTTSSCEEEEEECT----------TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             cCCcccCCeEEEEEeC----------CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence            44444 3678988653          355688898765432   245677777776642  3356678887888889999


Q ss_pred             EEecCCCChH
Q 011180          218 YEFMPRGSLE  227 (491)
Q Consensus       218 ~E~~~~gsL~  227 (491)
                      |++++|.++.
T Consensus        85 ~~~i~G~~~~   94 (255)
T d1nd4a_          85 LGEVPGQDLL   94 (255)
T ss_dssp             EECCSSEETT
T ss_pred             EEeeeccccc
Confidence            9999876653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.04  E-value=9.2e-06  Score=79.91  Aligned_cols=78  Identities=14%  Similarity=0.106  Sum_probs=48.6

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecC------CC-cccHHHHHHHHHHHhcCC-C--CceeeeeeE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH------DG-LQGHKEWLAEVNFLGNLL-H--PNLVKLVGY  207 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~------~~-~~~~~~~~~E~~il~~l~-H--pnIv~l~~~  207 (491)
                      .+.||.|....||++....         +++.|+||.-..      +. .....+...|...|+.+. +  ..+.+++. 
T Consensus        31 ~~eig~G~~N~vfrV~~~~---------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~-  100 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-  100 (392)
T ss_dssp             EEECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-
T ss_pred             EEEeCCCceEeEEEEEeCC---------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE-
Confidence            3468999999999997654         456799997532      11 112334566888877663 2  34555554 


Q ss_pred             EeecCceEEEEEecCCCCh
Q 011180          208 CIEDDQRLLVYEFMPRGSL  226 (491)
Q Consensus       208 ~~~~~~~~lV~E~~~~gsL  226 (491)
                       .+.+..++|||++.+..+
T Consensus       101 -~d~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         101 -SDTEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             -EETTTTEEEECCCTTSEE
T ss_pred             -EcCCCCEEEEeccCCccc
Confidence             355667899999976543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.28  E-value=0.00032  Score=68.46  Aligned_cols=81  Identities=19%  Similarity=0.117  Sum_probs=52.4

Q ss_pred             CcccccCCceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCce-eeeeeEEeecCceEE
Q 011180          138 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLL  216 (491)
Q Consensus       138 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~l  216 (491)
                      .+.|+.|-.-.+|++.......  +.......|.+++....  .......+|..+++.+.-.+| .++++++.+    .+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            3568889999999998765322  11223456778877532  223455689999988863344 466766542    68


Q ss_pred             EEEecCCCCh
Q 011180          217 VYEFMPRGSL  226 (491)
Q Consensus       217 V~E~~~~gsL  226 (491)
                      ||||++|..|
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            9999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.11  E-value=0.00081  Score=63.64  Aligned_cols=68  Identities=15%  Similarity=0.055  Sum_probs=44.0

Q ss_pred             ceEEEEEEEccCCCcccCCCCCeEEEEEEecCCCcccHHHHHHHHHHHhcCCCCce-----eeee--eEEeecCceEEEE
Q 011180          146 FGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-----VKLV--GYCIEDDQRLLVY  218 (491)
Q Consensus       146 fg~Vy~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~--~~~~~~~~~~lV~  218 (491)
                      --.||++...          +|..|++|+..... ...+++..|...|..|....|     +..-  ..+...+..+.|+
T Consensus        35 EN~vy~v~~~----------dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~  103 (325)
T d1zyla1          35 ENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF  103 (325)
T ss_dssp             SSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred             cceeEEEEcC----------CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence            3589998764          46689999986543 345678889988888752222     1111  1234456678899


Q ss_pred             EecCCC
Q 011180          219 EFMPRG  224 (491)
Q Consensus       219 E~~~~g  224 (491)
                      ++++|.
T Consensus       104 ~~~~G~  109 (325)
T d1zyla1         104 PSVGGR  109 (325)
T ss_dssp             ECCCCE
T ss_pred             eecCCc
Confidence            998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.74  E-value=0.0018  Score=60.63  Aligned_cols=31  Identities=29%  Similarity=0.259  Sum_probs=27.2

Q ss_pred             CCCeEecCCCCCcEEECCCCCeEEeccCCcc
Q 011180          262 EKPVIYRDFKTSNILLDADYNAKLSDFGLAK  292 (491)
Q Consensus       262 ~~~iiHrDlKp~NILl~~~~~~kL~DFGla~  292 (491)
                      +.++||+|+.++|||++.+...-|+||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            3569999999999999988777899999764